_unit_id,_created_at,_canary,_id,_started_at,_channel,_trust,_worker_id,_country,_region,_city,_ip,direction,b1,b2,direction_gold,e1,e2,relation,relex_relcos,sent_id,sentence,term1,term2,twrex
502808358,7/13/2014 13:56:13,,1321896442,7/13/2014 13:56:06,neodev,0.875,25224036,CAN,ON,Sudbury,67.204.218.187,LIVER location HEPATOCELLULAR CARCINOMA,168,60,,173,84,location,0.353553390593274,902330-FS1-9,"Therefore, although serum P III P can be a useful marker in HEPATOCELLULAR CARCINOMA it may possibly be difficult to discriminate it from benign diseases involving the LIVER and biliary tract.",LIVER,HEPATOCELLULAR CARCINOMA,RO-disease_has_primary_anatomic_site
502808358,7/13/2014 14:01:56,,1321899070,7/13/2014 14:01:23,tremorgames,0.8611,24449707,CAN,QC,Laval,96.21.249.72,LIVER location HEPATOCELLULAR CARCINOMA,168,60,,173,84,location,0.353553390593274,902330-FS1-9,"Therefore, although serum P III P can be a useful marker in HEPATOCELLULAR CARCINOMA it may possibly be difficult to discriminate it from benign diseases involving the LIVER and biliary tract.",LIVER,HEPATOCELLULAR CARCINOMA,RO-disease_has_primary_anatomic_site
502808358,7/13/2014 14:19:32,,1321907640,7/13/2014 14:18:48,clixsense,0.625,25402344,CAN,ON,Wawa,24.109.124.45,HEPATOCELLULAR CARCINOMA location LIVER,168,60,,173,84,location,0.353553390593274,902330-FS1-9,"Therefore, although serum P III P can be a useful marker in HEPATOCELLULAR CARCINOMA it may possibly be difficult to discriminate it from benign diseases involving the LIVER and biliary tract.",LIVER,HEPATOCELLULAR CARCINOMA,RO-disease_has_primary_anatomic_site
502808358,7/13/2014 15:01:44,,1321929083,7/13/2014 15:01:29,clixsense,0.6917,15189335,GBR,K3,Peterborough,81.156.166.189,HEPATOCELLULAR CARCINOMA location LIVER,168,60,,173,84,location,0.353553390593274,902330-FS1-9,"Therefore, although serum P III P can be a useful marker in HEPATOCELLULAR CARCINOMA it may possibly be difficult to discriminate it from benign diseases involving the LIVER and biliary tract.",LIVER,HEPATOCELLULAR CARCINOMA,RO-disease_has_primary_anatomic_site
502808358,7/13/2014 15:03:03,,1321929788,7/13/2014 15:02:34,prodege,0.6014,27979711,CAN,ON,Stouffville,99.247.121.227,no_relation,168,60,,173,84,location,0.353553390593274,902330-FS1-9,"Therefore, although serum P III P can be a useful marker in HEPATOCELLULAR CARCINOMA it may possibly be difficult to discriminate it from benign diseases involving the LIVER and biliary tract.",LIVER,HEPATOCELLULAR CARCINOMA,RO-disease_has_primary_anatomic_site
502808358,7/13/2014 15:19:38,,1321936558,7/13/2014 15:18:57,quickrewards,0.6764,20452113,USA,NY,Port Henry,108.176.206.207,no_relation,168,60,,173,84,location,0.353553390593274,902330-FS1-9,"Therefore, although serum P III P can be a useful marker in HEPATOCELLULAR CARCINOMA it may possibly be difficult to discriminate it from benign diseases involving the LIVER and biliary tract.",LIVER,HEPATOCELLULAR CARCINOMA,RO-disease_has_primary_anatomic_site
502808358,7/13/2014 15:58:38,,1321951960,7/13/2014 15:57:36,prodege,0.596,27934334,GBR,E4,Loughton,86.162.38.12,HEPATOCELLULAR CARCINOMA location LIVER,168,60,,173,84,location,0.353553390593274,902330-FS1-9,"Therefore, although serum P III P can be a useful marker in HEPATOCELLULAR CARCINOMA it may possibly be difficult to discriminate it from benign diseases involving the LIVER and biliary tract.",LIVER,HEPATOCELLULAR CARCINOMA,RO-disease_has_primary_anatomic_site
502808359,7/13/2014 13:45:50,,1321891503,7/13/2014 13:45:17,clixsense,0.9167,27871219,NLD,07,Amsterdam,87.210.207.223,ENDOTOXEMIA diagnosed by ESCHERICHIA COLI ENDOTOXIN,45,0,,71,11,diagnosed by,0.31622776601683805,903581-FS1-13,ENDOTOXEMIA was evoked by bolus injection of ESCHERICHIA COLI ENDOTOXIN (2 ng/kg body weight) in six healthy subjects to investigate the early kinetics of cytokine release in relation to the development of clinical and hematologic abnormalities frequently seen in gram negative septicemia.,ESCHERICHIA COLI ENDOTOXIN,ENDOTOXEMIA,RO-has_causative_agent
502808359,7/13/2014 14:02:54,,1321899573,7/13/2014 14:02:31,neodev,0.875,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,45,0,,71,11,diagnosed by,0.31622776601683805,903581-FS1-13,ENDOTOXEMIA was evoked by bolus injection of ESCHERICHIA COLI ENDOTOXIN (2 ng/kg body weight) in six healthy subjects to investigate the early kinetics of cytokine release in relation to the development of clinical and hematologic abnormalities frequently seen in gram negative septicemia.,ESCHERICHIA COLI ENDOTOXIN,ENDOTOXEMIA,RO-has_causative_agent
502808359,7/13/2014 14:23:36,,1321909507,7/13/2014 14:22:59,clixsense,0.765,17648398,GBR,K4,Plymouth,89.241.102.134,no_relation,45,0,,71,11,diagnosed by,0.31622776601683805,903581-FS1-13,ENDOTOXEMIA was evoked by bolus injection of ESCHERICHIA COLI ENDOTOXIN (2 ng/kg body weight) in six healthy subjects to investigate the early kinetics of cytokine release in relation to the development of clinical and hematologic abnormalities frequently seen in gram negative septicemia.,ESCHERICHIA COLI ENDOTOXIN,ENDOTOXEMIA,RO-has_causative_agent
502808359,7/13/2014 15:59:52,,1321952416,7/13/2014 15:59:20,prodege,0.669,27096445,GBR,H9,London,86.186.168.254,no_relation,45,0,,71,11,diagnosed by,0.31622776601683805,903581-FS1-13,ENDOTOXEMIA was evoked by bolus injection of ESCHERICHIA COLI ENDOTOXIN (2 ng/kg body weight) in six healthy subjects to investigate the early kinetics of cytokine release in relation to the development of clinical and hematologic abnormalities frequently seen in gram negative septicemia.,ESCHERICHIA COLI ENDOTOXIN,ENDOTOXEMIA,RO-has_causative_agent
502808359,7/13/2014 16:13:50,,1321957821,7/13/2014 16:13:41,bitcoinget,0.5274,27786287,USA,FL,Jacksonville,76.106.186.209,no_relation,45,0,,71,11,diagnosed by,0.31622776601683805,903581-FS1-13,ENDOTOXEMIA was evoked by bolus injection of ESCHERICHIA COLI ENDOTOXIN (2 ng/kg body weight) in six healthy subjects to investigate the early kinetics of cytokine release in relation to the development of clinical and hematologic abnormalities frequently seen in gram negative septicemia.,ESCHERICHIA COLI ENDOTOXIN,ENDOTOXEMIA,RO-has_causative_agent
502808359,7/13/2014 16:28:10,,1321963290,7/13/2014 16:27:32,rewardsspot,0.5546,24482174,GBR,H9,London,46.23.68.180,ENDOTOXEMIA diagnosed by ESCHERICHIA COLI ENDOTOXIN,45,0,,71,11,diagnosed by,0.31622776601683805,903581-FS1-13,ENDOTOXEMIA was evoked by bolus injection of ESCHERICHIA COLI ENDOTOXIN (2 ng/kg body weight) in six healthy subjects to investigate the early kinetics of cytokine release in relation to the development of clinical and hematologic abnormalities frequently seen in gram negative septicemia.,ESCHERICHIA COLI ENDOTOXIN,ENDOTOXEMIA,RO-has_causative_agent
502808359,7/13/2014 16:33:36,,1321965691,7/13/2014 16:32:57,instagc,0.6948,20183814,USA,,,166.182.83.213,no_relation,45,0,,71,11,diagnosed by,0.31622776601683805,903581-FS1-13,ENDOTOXEMIA was evoked by bolus injection of ESCHERICHIA COLI ENDOTOXIN (2 ng/kg body weight) in six healthy subjects to investigate the early kinetics of cytokine release in relation to the development of clinical and hematologic abnormalities frequently seen in gram negative septicemia.,ESCHERICHIA COLI ENDOTOXIN,ENDOTOXEMIA,RO-has_causative_agent
502808367,7/13/2014 14:17:56,,1321906926,7/13/2014 14:17:15,clixsense,0.625,25402344,CAN,ON,Wawa,24.109.124.45,TUBERCULOSIS diagnosed by TUBERCULIN SENSITIVITY,111,187,,123,209,diagnosed by,0.31622776601683805,906613-FS1-13,The trends in tuberculin reactions of Mantoux test (2 TU) performed annually before and after the diagnosis of TUBERCULOSIS shows that the risk groups consist of subjects with increasing TUBERCULIN SENSITIVITY and those susceptible to acute respiratory virus infections.,TUBERCULOSIS,TUBERCULIN SENSITIVITY,RO-may_diagnose
502808367,7/13/2014 14:21:25,,1321908451,7/13/2014 14:20:48,instagc,0.7389,19686223,CAN,BC,Surrey,154.20.155.106,TUBERCULIN SENSITIVITY diagnosed by TUBERCULOSIS,111,187,,123,209,diagnosed by,0.31622776601683805,906613-FS1-13,The trends in tuberculin reactions of Mantoux test (2 TU) performed annually before and after the diagnosis of TUBERCULOSIS shows that the risk groups consist of subjects with increasing TUBERCULIN SENSITIVITY and those susceptible to acute respiratory virus infections.,TUBERCULOSIS,TUBERCULIN SENSITIVITY,RO-may_diagnose
502808367,7/13/2014 14:24:19,,1321909834,7/13/2014 14:23:58,clixsense,0.765,17648398,GBR,K4,Plymouth,89.241.102.134,no_relation,111,187,,123,209,diagnosed by,0.31622776601683805,906613-FS1-13,The trends in tuberculin reactions of Mantoux test (2 TU) performed annually before and after the diagnosis of TUBERCULOSIS shows that the risk groups consist of subjects with increasing TUBERCULIN SENSITIVITY and those susceptible to acute respiratory virus infections.,TUBERCULOSIS,TUBERCULIN SENSITIVITY,RO-may_diagnose
502808367,7/13/2014 16:04:26,,1321954138,7/13/2014 16:03:47,pedtoclick,0.5837,20864559,GBR,B8,Bromley,213.106.94.78,no_relation,111,187,,123,209,diagnosed by,0.31622776601683805,906613-FS1-13,The trends in tuberculin reactions of Mantoux test (2 TU) performed annually before and after the diagnosis of TUBERCULOSIS shows that the risk groups consist of subjects with increasing TUBERCULIN SENSITIVITY and those susceptible to acute respiratory virus infections.,TUBERCULOSIS,TUBERCULIN SENSITIVITY,RO-may_diagnose
502808367,7/13/2014 16:55:35,,1321973603,7/13/2014 16:54:50,clixsense,0.6639,28037714,GBR,I4,Mitcham,94.4.232.118,TUBERCULOSIS diagnosed by TUBERCULIN SENSITIVITY,111,187,,123,209,diagnosed by,0.31622776601683805,906613-FS1-13,The trends in tuberculin reactions of Mantoux test (2 TU) performed annually before and after the diagnosis of TUBERCULOSIS shows that the risk groups consist of subjects with increasing TUBERCULIN SENSITIVITY and those susceptible to acute respiratory virus infections.,TUBERCULOSIS,TUBERCULIN SENSITIVITY,RO-may_diagnose
502808367,7/13/2014 16:58:38,,1321974790,7/13/2014 16:57:28,prodege,0.6048,28255346,GBR,L9,Sheffield,2.125.183.137,TUBERCULIN SENSITIVITY diagnosed by TUBERCULOSIS,111,187,,123,209,diagnosed by,0.31622776601683805,906613-FS1-13,The trends in tuberculin reactions of Mantoux test (2 TU) performed annually before and after the diagnosis of TUBERCULOSIS shows that the risk groups consist of subjects with increasing TUBERCULIN SENSITIVITY and those susceptible to acute respiratory virus infections.,TUBERCULOSIS,TUBERCULIN SENSITIVITY,RO-may_diagnose
502808367,7/13/2014 17:14:02,,1321979647,7/13/2014 17:13:26,prodege,0.6151,2422962,USA,IA,Honey Creek,12.73.110.97,no_relation,111,187,,123,209,diagnosed by,0.31622776601683805,906613-FS1-13,The trends in tuberculin reactions of Mantoux test (2 TU) performed annually before and after the diagnosis of TUBERCULOSIS shows that the risk groups consist of subjects with increasing TUBERCULIN SENSITIVITY and those susceptible to acute respiratory virus infections.,TUBERCULOSIS,TUBERCULIN SENSITIVITY,RO-may_diagnose
502808372,7/13/2014 13:42:25,,1321890122,7/13/2014 13:42:14,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,THYROID causes GOITER,278,42,,285,48,causes,0.625543242171224,902026-FS1-4,"Ninety eight hypothyroid children without GOITER were divided into 6 groups: (i) athyreosis: RAIU low, no thyroid tissue identifiable (n = 39); (ii) hypoplasia: RAIU low, gland small, in normal position (n = 7); (iii) ectopia: RAIU low, gland in ectopic position (n = 24); (iv) THYROIDitis: TMA positive (n = 2); (v) iodine deficiency: low urinary iodine (n = 1); and (vi) cause unknown: RAIU.",THYROID,GOITER,RO-disease_has_primary_anatomic_site
502808372,7/13/2014 13:56:20,,1321896475,7/13/2014 13:56:15,neodev,0.875,25224036,CAN,ON,Sudbury,67.204.218.187,THYROID causes GOITER,278,42,,285,48,causes,0.625543242171224,902026-FS1-4,"Ninety eight hypothyroid children without GOITER were divided into 6 groups: (i) athyreosis: RAIU low, no thyroid tissue identifiable (n = 39); (ii) hypoplasia: RAIU low, gland small, in normal position (n = 7); (iii) ectopia: RAIU low, gland in ectopic position (n = 24); (iv) THYROIDitis: TMA positive (n = 2); (v) iodine deficiency: low urinary iodine (n = 1); and (vi) cause unknown: RAIU.",THYROID,GOITER,RO-disease_has_primary_anatomic_site
502808372,7/13/2014 14:17:56,,1321906925,7/13/2014 14:17:15,clixsense,0.625,25402344,CAN,ON,Wawa,24.109.124.45,GOITER causes THYROID,278,42,,285,48,causes,0.625543242171224,902026-FS1-4,"Ninety eight hypothyroid children without GOITER were divided into 6 groups: (i) athyreosis: RAIU low, no thyroid tissue identifiable (n = 39); (ii) hypoplasia: RAIU low, gland small, in normal position (n = 7); (iii) ectopia: RAIU low, gland in ectopic position (n = 24); (iv) THYROIDitis: TMA positive (n = 2); (v) iodine deficiency: low urinary iodine (n = 1); and (vi) cause unknown: RAIU.",THYROID,GOITER,RO-disease_has_primary_anatomic_site
502808372,7/13/2014 14:44:31,,1321919699,7/13/2014 14:44:09,neodev,0.7569,14861092,GBR,I2,Manchester,90.194.137.76,no_relation,278,42,,285,48,causes,0.625543242171224,902026-FS1-4,"Ninety eight hypothyroid children without GOITER were divided into 6 groups: (i) athyreosis: RAIU low, no thyroid tissue identifiable (n = 39); (ii) hypoplasia: RAIU low, gland small, in normal position (n = 7); (iii) ectopia: RAIU low, gland in ectopic position (n = 24); (iv) THYROIDitis: TMA positive (n = 2); (v) iodine deficiency: low urinary iodine (n = 1); and (vi) cause unknown: RAIU.",THYROID,GOITER,RO-disease_has_primary_anatomic_site
502808372,7/13/2014 15:04:09,,1321930307,7/13/2014 15:03:39,prodege,0.6014,27979711,CAN,ON,Stouffville,99.247.121.227,no_relation,278,42,,285,48,causes,0.625543242171224,902026-FS1-4,"Ninety eight hypothyroid children without GOITER were divided into 6 groups: (i) athyreosis: RAIU low, no thyroid tissue identifiable (n = 39); (ii) hypoplasia: RAIU low, gland small, in normal position (n = 7); (iii) ectopia: RAIU low, gland in ectopic position (n = 24); (iv) THYROIDitis: TMA positive (n = 2); (v) iodine deficiency: low urinary iodine (n = 1); and (vi) cause unknown: RAIU.",THYROID,GOITER,RO-disease_has_primary_anatomic_site
502808372,7/13/2014 16:05:08,,1321954401,7/13/2014 16:04:40,prodege,0.5529999999999999,28039757,GBR,L8,Southport,109.155.158.54,no_relation,278,42,,285,48,causes,0.625543242171224,902026-FS1-4,"Ninety eight hypothyroid children without GOITER were divided into 6 groups: (i) athyreosis: RAIU low, no thyroid tissue identifiable (n = 39); (ii) hypoplasia: RAIU low, gland small, in normal position (n = 7); (iii) ectopia: RAIU low, gland in ectopic position (n = 24); (iv) THYROIDitis: TMA positive (n = 2); (v) iodine deficiency: low urinary iodine (n = 1); and (vi) cause unknown: RAIU.",THYROID,GOITER,RO-disease_has_primary_anatomic_site
502808372,7/13/2014 16:15:49,,1321958691,7/13/2014 16:15:33,fusioncash,0.7619,22139728,USA,,,66.67.91.242,no_relation,278,42,,285,48,causes,0.625543242171224,902026-FS1-4,"Ninety eight hypothyroid children without GOITER were divided into 6 groups: (i) athyreosis: RAIU low, no thyroid tissue identifiable (n = 39); (ii) hypoplasia: RAIU low, gland small, in normal position (n = 7); (iii) ectopia: RAIU low, gland in ectopic position (n = 24); (iv) THYROIDitis: TMA positive (n = 2); (v) iodine deficiency: low urinary iodine (n = 1); and (vi) cause unknown: RAIU.",THYROID,GOITER,RO-disease_has_primary_anatomic_site
502808373,7/13/2014 13:43:16,,1321890467,7/13/2014 13:43:05,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,FLUMAZENIL treats OPIOID OVERDOSE,136,162,,151,172,treats,0.589767824619588,907481-FS1-2,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected OPIOID OVERDOSE; consider FLUMAZENIL for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG.",OPIOID OVERDOSE,FLUMAZENIL,RO-may_treat
502808373,7/13/2014 13:56:28,,1321896574,7/13/2014 13:56:11,instagc,0.6667,19378092,USA,PA,Reading,174.55.181.238,no_relation,136,162,,151,172,treats,0.589767824619588,907481-FS1-2,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected OPIOID OVERDOSE; consider FLUMAZENIL for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG.",OPIOID OVERDOSE,FLUMAZENIL,RO-may_treat
502808373,7/13/2014 14:02:13,,1321899271,7/13/2014 14:01:58,tremorgames,0.8611,24449707,CAN,QC,Laval,96.21.249.72,no_relation,136,162,,151,172,treats,0.589767824619588,907481-FS1-2,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected OPIOID OVERDOSE; consider FLUMAZENIL for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG.",OPIOID OVERDOSE,FLUMAZENIL,RO-may_treat
502808373,7/13/2014 15:18:57,,1321936333,7/13/2014 15:18:23,quickrewards,0.6764,20452113,USA,NY,Port Henry,108.176.206.207,no_relation,136,162,,151,172,treats,0.589767824619588,907481-FS1-2,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected OPIOID OVERDOSE; consider FLUMAZENIL for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG.",OPIOID OVERDOSE,FLUMAZENIL,RO-may_treat
502808373,7/13/2014 16:15:18,,1321958501,7/13/2014 16:15:05,fusioncash,0.7619,22139728,USA,,,66.67.91.242,FLUMAZENIL treats OPIOID OVERDOSE,136,162,,151,172,treats,0.589767824619588,907481-FS1-2,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected OPIOID OVERDOSE; consider FLUMAZENIL for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG.",OPIOID OVERDOSE,FLUMAZENIL,RO-may_treat
502808373,7/13/2014 16:31:51,,1321965045,7/13/2014 16:31:12,instagc,0.6948,20183814,USA,,,166.182.83.213,FLUMAZENIL treats OPIOID OVERDOSE,136,162,,151,172,treats,0.589767824619588,907481-FS1-2,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected OPIOID OVERDOSE; consider FLUMAZENIL for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG.",OPIOID OVERDOSE,FLUMAZENIL,RO-may_treat
502808373,7/13/2014 16:32:23,,1321965240,7/13/2014 16:32:03,elite,0.3923,28276268,USA,CA,San Diego,76.88.95.100,OPIOID OVERDOSE treats FLUMAZENIL,136,162,,151,172,treats,0.589767824619588,907481-FS1-2,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected OPIOID OVERDOSE; consider FLUMAZENIL for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG.",OPIOID OVERDOSE,FLUMAZENIL,RO-may_treat
502808376,7/13/2014 13:42:39,,1321890216,7/13/2014 13:42:26,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,ATENOLOL treats HYPERTENSION,145,115,,157,123,treats,0.9855274566525741,907512-FS1-2,"Stumpe KO, Haworth D, Hoglund C et al et al. Comparison of the angiotensin II receptor antagonist, irbesartan, and ATENOLOL for the treatment of HYPERTENSION",HYPERTENSION,ATENOLOL,RO-may_treat
502808376,7/13/2014 13:50:59,,1321893949,7/13/2014 13:50:46,neodev,0.8333,17610000,GBR,I2,Manchester,90.200.140.201,HYPERTENSION treats ATENOLOL,145,115,,157,123,treats,0.9855274566525741,907512-FS1-2,"Stumpe KO, Haworth D, Hoglund C et al et al. Comparison of the angiotensin II receptor antagonist, irbesartan, and ATENOLOL for the treatment of HYPERTENSION",HYPERTENSION,ATENOLOL,RO-may_treat
502808376,7/13/2014 13:56:11,,1321896426,7/13/2014 13:55:57,instagc,0.6667,19378092,USA,PA,Reading,174.55.181.238,ATENOLOL treats HYPERTENSION,145,115,,157,123,treats,0.9855274566525741,907512-FS1-2,"Stumpe KO, Haworth D, Hoglund C et al et al. Comparison of the angiotensin II receptor antagonist, irbesartan, and ATENOLOL for the treatment of HYPERTENSION",HYPERTENSION,ATENOLOL,RO-may_treat
502808376,7/13/2014 14:23:57,,1321909702,7/13/2014 14:23:37,clixsense,0.765,17648398,GBR,K4,Plymouth,89.241.102.134,ATENOLOL treats HYPERTENSION,145,115,,157,123,treats,0.9855274566525741,907512-FS1-2,"Stumpe KO, Haworth D, Hoglund C et al et al. Comparison of the angiotensin II receptor antagonist, irbesartan, and ATENOLOL for the treatment of HYPERTENSION",HYPERTENSION,ATENOLOL,RO-may_treat
502808376,7/13/2014 16:32:23,,1321965241,7/13/2014 16:32:03,elite,0.3923,28276268,USA,CA,San Diego,76.88.95.100,ATENOLOL treats HYPERTENSION,145,115,,157,123,treats,0.9855274566525741,907512-FS1-2,"Stumpe KO, Haworth D, Hoglund C et al et al. Comparison of the angiotensin II receptor antagonist, irbesartan, and ATENOLOL for the treatment of HYPERTENSION",HYPERTENSION,ATENOLOL,RO-may_treat
502808376,7/13/2014 16:42:52,,1321969205,7/13/2014 16:42:27,instagc,0.7262,24252915,GBR,B7,Bristol,77.98.139.82,ATENOLOL treats HYPERTENSION,145,115,,157,123,treats,0.9855274566525741,907512-FS1-2,"Stumpe KO, Haworth D, Hoglund C et al et al. Comparison of the angiotensin II receptor antagonist, irbesartan, and ATENOLOL for the treatment of HYPERTENSION",HYPERTENSION,ATENOLOL,RO-may_treat
502808376,7/13/2014 16:57:44,,1321974450,7/13/2014 16:57:11,clixsense,0.6639,28037714,GBR,I4,Mitcham,94.4.232.118,ATENOLOL treats HYPERTENSION,145,115,,157,123,treats,0.9855274566525741,907512-FS1-2,"Stumpe KO, Haworth D, Hoglund C et al et al. Comparison of the angiotensin II receptor antagonist, irbesartan, and ATENOLOL for the treatment of HYPERTENSION",HYPERTENSION,ATENOLOL,RO-may_treat
502808379,7/13/2014 13:42:13,,1321890076,7/13/2014 13:41:57,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,no_relation,169,59,,179,69,causes,0.44172610429938597,908350-FS1-4,"With successful treatment of the patient's depression with IMIPRAMINE the tremors disappeared, but slowly began again after drug noncompliance resulted in recurrence of DEPRESSION.",DEPRESSION,IMIPRAMINE,RO-may_treat
502808379,7/13/2014 13:47:09,,1321892091,7/13/2014 13:45:51,clixsense,0.9167,27871219,NLD,07,Amsterdam,87.210.207.223,IMIPRAMINE causes DEPRESSION,169,59,,179,69,causes,0.44172610429938597,908350-FS1-4,"With successful treatment of the patient's depression with IMIPRAMINE the tremors disappeared, but slowly began again after drug noncompliance resulted in recurrence of DEPRESSION.",DEPRESSION,IMIPRAMINE,RO-may_treat
502808379,7/13/2014 14:45:04,,1321920003,7/13/2014 14:44:32,neodev,0.7569,14861092,GBR,I2,Manchester,90.194.137.76,no_relation,169,59,,179,69,causes,0.44172610429938597,908350-FS1-4,"With successful treatment of the patient's depression with IMIPRAMINE the tremors disappeared, but slowly began again after drug noncompliance resulted in recurrence of DEPRESSION.",DEPRESSION,IMIPRAMINE,RO-may_treat
502808379,7/13/2014 16:03:45,,1321953862,7/13/2014 16:02:58,pedtoclick,0.5837,20864559,GBR,B8,Bromley,213.106.94.78,no_relation,169,59,,179,69,causes,0.44172610429938597,908350-FS1-4,"With successful treatment of the patient's depression with IMIPRAMINE the tremors disappeared, but slowly began again after drug noncompliance resulted in recurrence of DEPRESSION.",DEPRESSION,IMIPRAMINE,RO-may_treat
502808379,7/13/2014 16:05:08,,1321954400,7/13/2014 16:04:40,prodege,0.5529999999999999,28039757,GBR,L8,Southport,109.155.158.54,IMIPRAMINE causes DEPRESSION,169,59,,179,69,causes,0.44172610429938597,908350-FS1-4,"With successful treatment of the patient's depression with IMIPRAMINE the tremors disappeared, but slowly began again after drug noncompliance resulted in recurrence of DEPRESSION.",DEPRESSION,IMIPRAMINE,RO-may_treat
502808379,7/13/2014 16:14:39,,1321958227,7/13/2014 16:13:26,instagc,0.7496,22391553,CAN,NB,Bathurst,156.34.43.239,IMIPRAMINE causes DEPRESSION,169,59,,179,69,causes,0.44172610429938597,908350-FS1-4,"With successful treatment of the patient's depression with IMIPRAMINE the tremors disappeared, but slowly began again after drug noncompliance resulted in recurrence of DEPRESSION.",DEPRESSION,IMIPRAMINE,RO-may_treat
502808379,7/13/2014 16:20:42,,1321960309,7/13/2014 16:20:19,prodege,0.7709999999999999,19192508,USA,OK,Broken Arrow,70.177.111.89,no_relation,169,59,,179,69,causes,0.44172610429938597,908350-FS1-4,"With successful treatment of the patient's depression with IMIPRAMINE the tremors disappeared, but slowly began again after drug noncompliance resulted in recurrence of DEPRESSION.",DEPRESSION,IMIPRAMINE,RO-may_treat
502808383,7/13/2014 15:00:51,,1321928604,7/13/2014 15:00:07,clixsense,0.6917,15189335,GBR,K3,Peterborough,81.156.166.189,ELEVATED BLOOD PRESSURE causes RELATED BLOOD PRESSURE/HYPERTENSION,101,3,,124,38,causes,0.5303300858899109,904916-FS1-4,OC RELATED BLOOD PRESSURE/HYPERTENSION is defined as: women with neither history of hypertension nor ELEVATED BLOOD PRESSURE before OC use develop increased blood pressure or hypertension that is reversible once OC use ceases.,ELEVATED BLOOD PRESSURE,RELATED BLOOD PRESSURE/HYPERTENSION,RO-has_definitional_manifestation
502808383,7/13/2014 16:15:32,,1321958580,7/13/2014 16:15:19,fusioncash,0.7619,22139728,USA,,,66.67.91.242,no_relation,101,3,,124,38,causes,0.5303300858899109,904916-FS1-4,OC RELATED BLOOD PRESSURE/HYPERTENSION is defined as: women with neither history of hypertension nor ELEVATED BLOOD PRESSURE before OC use develop increased blood pressure or hypertension that is reversible once OC use ceases.,ELEVATED BLOOD PRESSURE,RELATED BLOOD PRESSURE/HYPERTENSION,RO-has_definitional_manifestation
502808383,7/13/2014 16:16:58,,1321959105,7/13/2014 16:15:57,instagc,0.7496,22391553,CAN,NB,Bathurst,156.34.43.239,no_relation,101,3,,124,38,causes,0.5303300858899109,904916-FS1-4,OC RELATED BLOOD PRESSURE/HYPERTENSION is defined as: women with neither history of hypertension nor ELEVATED BLOOD PRESSURE before OC use develop increased blood pressure or hypertension that is reversible once OC use ceases.,ELEVATED BLOOD PRESSURE,RELATED BLOOD PRESSURE/HYPERTENSION,RO-has_definitional_manifestation
502808383,7/13/2014 16:33:01,,1321965473,7/13/2014 16:32:25,elite,0.3923,28276268,USA,CA,San Diego,76.88.95.100,RELATED BLOOD PRESSURE/HYPERTENSION causes ELEVATED BLOOD PRESSURE,101,3,,124,38,causes,0.5303300858899109,904916-FS1-4,OC RELATED BLOOD PRESSURE/HYPERTENSION is defined as: women with neither history of hypertension nor ELEVATED BLOOD PRESSURE before OC use develop increased blood pressure or hypertension that is reversible once OC use ceases.,ELEVATED BLOOD PRESSURE,RELATED BLOOD PRESSURE/HYPERTENSION,RO-has_definitional_manifestation
502808383,7/13/2014 16:46:47,,1321970576,7/13/2014 16:46:20,neodev,0.6552,27597779,CAN,AB,Calgary,68.146.86.137,no_relation,101,3,,124,38,causes,0.5303300858899109,904916-FS1-4,OC RELATED BLOOD PRESSURE/HYPERTENSION is defined as: women with neither history of hypertension nor ELEVATED BLOOD PRESSURE before OC use develop increased blood pressure or hypertension that is reversible once OC use ceases.,ELEVATED BLOOD PRESSURE,RELATED BLOOD PRESSURE/HYPERTENSION,RO-has_definitional_manifestation
502808383,7/13/2014 16:58:49,,1321974834,7/13/2014 16:57:46,clixsense,0.6639,28037714,GBR,I4,Mitcham,94.4.232.118,RELATED BLOOD PRESSURE/HYPERTENSION causes ELEVATED BLOOD PRESSURE,101,3,,124,38,causes,0.5303300858899109,904916-FS1-4,OC RELATED BLOOD PRESSURE/HYPERTENSION is defined as: women with neither history of hypertension nor ELEVATED BLOOD PRESSURE before OC use develop increased blood pressure or hypertension that is reversible once OC use ceases.,ELEVATED BLOOD PRESSURE,RELATED BLOOD PRESSURE/HYPERTENSION,RO-has_definitional_manifestation
502808383,7/13/2014 17:05:21,,1321976874,7/13/2014 17:04:53,prodege,0.6048,28255346,GBR,L9,Sheffield,2.125.183.137,no_relation,101,3,,124,38,causes,0.5303300858899109,904916-FS1-4,OC RELATED BLOOD PRESSURE/HYPERTENSION is defined as: women with neither history of hypertension nor ELEVATED BLOOD PRESSURE before OC use develop increased blood pressure or hypertension that is reversible once OC use ceases.,ELEVATED BLOOD PRESSURE,RELATED BLOOD PRESSURE/HYPERTENSION,RO-has_definitional_manifestation
502808385,7/13/2014 13:47:09,,1321892092,7/13/2014 13:45:51,clixsense,0.9167,27871219,NLD,07,Amsterdam,87.210.207.223,no_relation,392,440,,404,464,causes,0.404519917477945,902839-FS1-4,"The therapeutic results of Lp TAE (transcatheter arterial embolization in the presence or absence of Gelfoam particles preceded by the infusion of a mixture of lipiodol and an anticancer drug via the proper hepatic artery) or DSM TAE (transcatheter arterial embolization with degradable starch microspheres and the arterial injection of anticancer drugs via the hepatic artery) combined with HYPERTHERMIA were evaluated in 30 patients with HEPATOCELLULAR CARCINOMA (HCC), 5 subjects with hepatic cholangiocarcinoma, and 22 patients with metastatic liver carcinoma.",HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
502808385,7/13/2014 14:02:19,,1321899294,7/13/2014 14:02:06,instagc,0.9097,18960682,GBR,,,86.29.147.112,no_relation,392,440,,404,464,causes,0.404519917477945,902839-FS1-4,"The therapeutic results of Lp TAE (transcatheter arterial embolization in the presence or absence of Gelfoam particles preceded by the infusion of a mixture of lipiodol and an anticancer drug via the proper hepatic artery) or DSM TAE (transcatheter arterial embolization with degradable starch microspheres and the arterial injection of anticancer drugs via the hepatic artery) combined with HYPERTHERMIA were evaluated in 30 patients with HEPATOCELLULAR CARCINOMA (HCC), 5 subjects with hepatic cholangiocarcinoma, and 22 patients with metastatic liver carcinoma.",HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
502808385,7/13/2014 14:36:42,,1321915626,7/13/2014 14:36:16,instagc,0.7431,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,392,440,,404,464,causes,0.404519917477945,902839-FS1-4,"The therapeutic results of Lp TAE (transcatheter arterial embolization in the presence or absence of Gelfoam particles preceded by the infusion of a mixture of lipiodol and an anticancer drug via the proper hepatic artery) or DSM TAE (transcatheter arterial embolization with degradable starch microspheres and the arterial injection of anticancer drugs via the hepatic artery) combined with HYPERTHERMIA were evaluated in 30 patients with HEPATOCELLULAR CARCINOMA (HCC), 5 subjects with hepatic cholangiocarcinoma, and 22 patients with metastatic liver carcinoma.",HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
502808385,7/13/2014 14:44:08,,1321919428,7/13/2014 14:43:36,neodev,0.7569,14861092,GBR,I2,Manchester,90.194.137.76,no_relation,392,440,,404,464,causes,0.404519917477945,902839-FS1-4,"The therapeutic results of Lp TAE (transcatheter arterial embolization in the presence or absence of Gelfoam particles preceded by the infusion of a mixture of lipiodol and an anticancer drug via the proper hepatic artery) or DSM TAE (transcatheter arterial embolization with degradable starch microspheres and the arterial injection of anticancer drugs via the hepatic artery) combined with HYPERTHERMIA were evaluated in 30 patients with HEPATOCELLULAR CARCINOMA (HCC), 5 subjects with hepatic cholangiocarcinoma, and 22 patients with metastatic liver carcinoma.",HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
502808385,7/13/2014 15:14:39,,1321934724,7/13/2014 15:14:04,uniquerewards,0.8194,20281752,GBR,M1,Slough,86.136.105.36,no_relation,392,440,,404,464,causes,0.404519917477945,902839-FS1-4,"The therapeutic results of Lp TAE (transcatheter arterial embolization in the presence or absence of Gelfoam particles preceded by the infusion of a mixture of lipiodol and an anticancer drug via the proper hepatic artery) or DSM TAE (transcatheter arterial embolization with degradable starch microspheres and the arterial injection of anticancer drugs via the hepatic artery) combined with HYPERTHERMIA were evaluated in 30 patients with HEPATOCELLULAR CARCINOMA (HCC), 5 subjects with hepatic cholangiocarcinoma, and 22 patients with metastatic liver carcinoma.",HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
502808385,7/13/2014 16:32:37,,1321965333,7/13/2014 16:32:06,instagc,0.6948,20183814,USA,,,166.182.83.213,HEPATOCELLULAR CARCINOMA causes HYPERTHERMIA,392,440,,404,464,causes,0.404519917477945,902839-FS1-4,"The therapeutic results of Lp TAE (transcatheter arterial embolization in the presence or absence of Gelfoam particles preceded by the infusion of a mixture of lipiodol and an anticancer drug via the proper hepatic artery) or DSM TAE (transcatheter arterial embolization with degradable starch microspheres and the arterial injection of anticancer drugs via the hepatic artery) combined with HYPERTHERMIA were evaluated in 30 patients with HEPATOCELLULAR CARCINOMA (HCC), 5 subjects with hepatic cholangiocarcinoma, and 22 patients with metastatic liver carcinoma.",HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
502808385,7/13/2014 16:33:01,,1321965463,7/13/2014 16:32:25,elite,0.3923,28276268,USA,CA,San Diego,76.88.95.100,HEPATOCELLULAR CARCINOMA causes HYPERTHERMIA,392,440,,404,464,causes,0.404519917477945,902839-FS1-4,"The therapeutic results of Lp TAE (transcatheter arterial embolization in the presence or absence of Gelfoam particles preceded by the infusion of a mixture of lipiodol and an anticancer drug via the proper hepatic artery) or DSM TAE (transcatheter arterial embolization with degradable starch microspheres and the arterial injection of anticancer drugs via the hepatic artery) combined with HYPERTHERMIA were evaluated in 30 patients with HEPATOCELLULAR CARCINOMA (HCC), 5 subjects with hepatic cholangiocarcinoma, and 22 patients with metastatic liver carcinoma.",HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
502808392,7/13/2014 13:42:51,,1321890290,7/13/2014 13:42:40,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,INTERFERON BETA 1A treats MULTIPLE SCLEROSIS,50,17,,68,35,treats,0.985329278164293,907946-FS1-2,Natalizumab plus INTERFERON BETA 1A for relapsing MULTIPLE SCLEROSIS,MULTIPLE SCLEROSIS,INTERFERON BETA 1A,RO-may_treat
502808392,7/13/2014 13:50:32,,1321893706,7/13/2014 13:50:20,neodev,0.8333,17610000,GBR,I2,Manchester,90.200.140.201,INTERFERON BETA 1A treats MULTIPLE SCLEROSIS,50,17,,68,35,treats,0.985329278164293,907946-FS1-2,Natalizumab plus INTERFERON BETA 1A for relapsing MULTIPLE SCLEROSIS,MULTIPLE SCLEROSIS,INTERFERON BETA 1A,RO-may_treat
502808392,7/13/2014 14:36:42,,1321915624,7/13/2014 14:36:16,instagc,0.7431,15445601,USA,FL,Jacksonville,24.129.68.254,INTERFERON BETA 1A treats MULTIPLE SCLEROSIS,50,17,,68,35,treats,0.985329278164293,907946-FS1-2,Natalizumab plus INTERFERON BETA 1A for relapsing MULTIPLE SCLEROSIS,MULTIPLE SCLEROSIS,INTERFERON BETA 1A,RO-may_treat
502808392,7/13/2014 15:00:36,,1321928472,7/13/2014 14:59:44,prodege,0.6014,27979711,CAN,ON,Stouffville,99.247.121.227,INTERFERON BETA 1A treats MULTIPLE SCLEROSIS,50,17,,68,35,treats,0.985329278164293,907946-FS1-2,Natalizumab plus INTERFERON BETA 1A for relapsing MULTIPLE SCLEROSIS,MULTIPLE SCLEROSIS,INTERFERON BETA 1A,RO-may_treat
502808392,7/13/2014 15:13:00,,1321934126,7/13/2014 15:12:06,uniquerewards,0.8194,20281752,GBR,M1,Slough,86.136.105.36,INTERFERON BETA 1A treats MULTIPLE SCLEROSIS,50,17,,68,35,treats,0.985329278164293,907946-FS1-2,Natalizumab plus INTERFERON BETA 1A for relapsing MULTIPLE SCLEROSIS,MULTIPLE SCLEROSIS,INTERFERON BETA 1A,RO-may_treat
502808392,7/13/2014 16:14:47,,1321958252,7/13/2014 16:14:17,fusioncash,0.7619,22139728,USA,,,66.67.91.242,INTERFERON BETA 1A treats MULTIPLE SCLEROSIS,50,17,,68,35,treats,0.985329278164293,907946-FS1-2,Natalizumab plus INTERFERON BETA 1A for relapsing MULTIPLE SCLEROSIS,MULTIPLE SCLEROSIS,INTERFERON BETA 1A,RO-may_treat
502808392,7/13/2014 16:32:56,,1321965405,7/13/2014 16:32:38,instagc,0.6948,20183814,USA,,,166.182.83.213,INTERFERON BETA 1A treats MULTIPLE SCLEROSIS,50,17,,68,35,treats,0.985329278164293,907946-FS1-2,Natalizumab plus INTERFERON BETA 1A for relapsing MULTIPLE SCLEROSIS,MULTIPLE SCLEROSIS,INTERFERON BETA 1A,RO-may_treat
502808395,7/13/2014 13:43:16,,1321890466,7/13/2014 13:43:05,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,no_relation,86,52,,116,82,causes,0.5,902798-FS1-4,"These skin lesions included an intradermal nevus, a PIGMENTED SEBORRHEIC KERATOSIS an ISOLATED PAPULE ON THE FOREARM a perianal lesion, and an acantholytic acanthoma.",ISOLATED PAPULE ON THE FOREARM,PIGMENTED SEBORRHEIC KERATOSIS,RO-disease_may_have_finding
502808395,7/13/2014 14:23:36,,1321909504,7/13/2014 14:22:59,clixsense,0.765,17648398,GBR,K4,Plymouth,89.241.102.134,no_relation,86,52,,116,82,causes,0.5,902798-FS1-4,"These skin lesions included an intradermal nevus, a PIGMENTED SEBORRHEIC KERATOSIS an ISOLATED PAPULE ON THE FOREARM a perianal lesion, and an acantholytic acanthoma.",ISOLATED PAPULE ON THE FOREARM,PIGMENTED SEBORRHEIC KERATOSIS,RO-disease_may_have_finding
502808395,7/13/2014 15:10:16,,1321933081,7/13/2014 15:09:32,uniquerewards,0.8194,20281752,GBR,M1,Slough,86.136.105.36,no_relation,86,52,,116,82,causes,0.5,902798-FS1-4,"These skin lesions included an intradermal nevus, a PIGMENTED SEBORRHEIC KERATOSIS an ISOLATED PAPULE ON THE FOREARM a perianal lesion, and an acantholytic acanthoma.",ISOLATED PAPULE ON THE FOREARM,PIGMENTED SEBORRHEIC KERATOSIS,RO-disease_may_have_finding
502808395,7/13/2014 15:17:45,,1321935926,7/13/2014 15:17:08,quickrewards,0.6764,20452113,USA,NY,Port Henry,108.176.206.207,no_relation,86,52,,116,82,causes,0.5,902798-FS1-4,"These skin lesions included an intradermal nevus, a PIGMENTED SEBORRHEIC KERATOSIS an ISOLATED PAPULE ON THE FOREARM a perianal lesion, and an acantholytic acanthoma.",ISOLATED PAPULE ON THE FOREARM,PIGMENTED SEBORRHEIC KERATOSIS,RO-disease_may_have_finding
502808395,7/13/2014 16:13:56,,1321957881,7/13/2014 16:13:51,bitcoinget,0.5274,27786287,USA,FL,Jacksonville,76.106.186.209,no_relation,86,52,,116,82,causes,0.5,902798-FS1-4,"These skin lesions included an intradermal nevus, a PIGMENTED SEBORRHEIC KERATOSIS an ISOLATED PAPULE ON THE FOREARM a perianal lesion, and an acantholytic acanthoma.",ISOLATED PAPULE ON THE FOREARM,PIGMENTED SEBORRHEIC KERATOSIS,RO-disease_may_have_finding
502808395,7/13/2014 16:15:57,,1321958732,7/13/2014 16:15:32,instagc,0.7496,22391553,CAN,NB,Bathurst,156.34.43.239,no_relation,86,52,,116,82,causes,0.5,902798-FS1-4,"These skin lesions included an intradermal nevus, a PIGMENTED SEBORRHEIC KERATOSIS an ISOLATED PAPULE ON THE FOREARM a perianal lesion, and an acantholytic acanthoma.",ISOLATED PAPULE ON THE FOREARM,PIGMENTED SEBORRHEIC KERATOSIS,RO-disease_may_have_finding
502808395,7/13/2014 16:56:13,,1321973846,7/13/2014 16:55:37,clixsense,0.6639,28037714,GBR,I4,Mitcham,94.4.232.118,PIGMENTED SEBORRHEIC KERATOSIS causes ISOLATED PAPULE ON THE FOREARM,86,52,,116,82,causes,0.5,902798-FS1-4,"These skin lesions included an intradermal nevus, a PIGMENTED SEBORRHEIC KERATOSIS an ISOLATED PAPULE ON THE FOREARM a perianal lesion, and an acantholytic acanthoma.",ISOLATED PAPULE ON THE FOREARM,PIGMENTED SEBORRHEIC KERATOSIS,RO-disease_may_have_finding
502808397,7/13/2014 14:20:46,,1321908143,7/13/2014 14:20:19,instagc,0.7389,19686223,CAN,BC,Surrey,154.20.155.106,no_relation,147,49,,171,81,diagnosed by,0.6859943405700349,903802-FS1-13,A selected review is presented of the history of GROUP B STREPTOCOCCAL INFECTIONS and the laboratory tests used to identify Group B streptococcus (STREPTOCOCCUS AGALACTIAE an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups.,STREPTOCOCCUS AGALACTIAE,GROUP B STREPTOCOCCAL INFECTIONS,RO-has_causative_agent
502808397,7/13/2014 14:45:04,,1321920004,7/13/2014 14:44:32,neodev,0.7569,14861092,GBR,I2,Manchester,90.194.137.76,no_relation,147,49,,171,81,diagnosed by,0.6859943405700349,903802-FS1-13,A selected review is presented of the history of GROUP B STREPTOCOCCAL INFECTIONS and the laboratory tests used to identify Group B streptococcus (STREPTOCOCCUS AGALACTIAE an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups.,STREPTOCOCCUS AGALACTIAE,GROUP B STREPTOCOCCAL INFECTIONS,RO-has_causative_agent
502808397,7/13/2014 15:00:51,,1321928598,7/13/2014 15:00:07,clixsense,0.6917,15189335,GBR,K3,Peterborough,81.156.166.189,GROUP B STREPTOCOCCAL INFECTIONS diagnosed by STREPTOCOCCUS AGALACTIAE,147,49,,171,81,diagnosed by,0.6859943405700349,903802-FS1-13,A selected review is presented of the history of GROUP B STREPTOCOCCAL INFECTIONS and the laboratory tests used to identify Group B streptococcus (STREPTOCOCCUS AGALACTIAE an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups.,STREPTOCOCCUS AGALACTIAE,GROUP B STREPTOCOCCAL INFECTIONS,RO-has_causative_agent
502808397,7/13/2014 15:03:37,,1321930064,7/13/2014 15:03:03,prodege,0.6014,27979711,CAN,ON,Stouffville,99.247.121.227,STREPTOCOCCUS AGALACTIAE diagnosed by GROUP B STREPTOCOCCAL INFECTIONS,147,49,,171,81,diagnosed by,0.6859943405700349,903802-FS1-13,A selected review is presented of the history of GROUP B STREPTOCOCCAL INFECTIONS and the laboratory tests used to identify Group B streptococcus (STREPTOCOCCUS AGALACTIAE an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups.,STREPTOCOCCUS AGALACTIAE,GROUP B STREPTOCOCCAL INFECTIONS,RO-has_causative_agent
502808397,7/13/2014 16:01:02,,1321952899,7/13/2014 16:00:21,prodege,0.596,27934334,GBR,E4,Loughton,86.162.38.12,no_relation,147,49,,171,81,diagnosed by,0.6859943405700349,903802-FS1-13,A selected review is presented of the history of GROUP B STREPTOCOCCAL INFECTIONS and the laboratory tests used to identify Group B streptococcus (STREPTOCOCCUS AGALACTIAE an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups.,STREPTOCOCCUS AGALACTIAE,GROUP B STREPTOCOCCAL INFECTIONS,RO-has_causative_agent
502808397,7/13/2014 16:07:51,,1321955511,7/13/2014 16:07:13,prodege,0.5529999999999999,28039757,GBR,L8,Southport,109.155.158.54,GROUP B STREPTOCOCCAL INFECTIONS diagnosed by STREPTOCOCCUS AGALACTIAE,147,49,,171,81,diagnosed by,0.6859943405700349,903802-FS1-13,A selected review is presented of the history of GROUP B STREPTOCOCCAL INFECTIONS and the laboratory tests used to identify Group B streptococcus (STREPTOCOCCUS AGALACTIAE an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups.,STREPTOCOCCUS AGALACTIAE,GROUP B STREPTOCOCCAL INFECTIONS,RO-has_causative_agent
502808397,7/13/2014 16:28:53,,1321963634,7/13/2014 16:28:17,rewardsspot,0.5546,24482174,GBR,H9,London,46.23.68.180,no_relation,147,49,,171,81,diagnosed by,0.6859943405700349,903802-FS1-13,A selected review is presented of the history of GROUP B STREPTOCOCCAL INFECTIONS and the laboratory tests used to identify Group B streptococcus (STREPTOCOCCUS AGALACTIAE an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups.,STREPTOCOCCUS AGALACTIAE,GROUP B STREPTOCOCCAL INFECTIONS,RO-has_causative_agent
502808404,7/13/2014 13:50:59,,1321893946,7/13/2014 13:50:46,neodev,0.8333,17610000,GBR,I2,Manchester,90.200.140.201,DIARRHEA causes IMMUNOHISTOCHEMICAL DIAGNOSIS OF SOMATOSTATINOMA,66,92,,74,140,causes,0.529812942826018,902928-FS1-4,"A 61 yr old woman with gallbladder stones, diabetes, weight loss, DIARRHEA and steatorrhea, IMMUNOHISTOCHEMICAL DIAGNOSIS OF SOMATOSTATINOMA (liver biopsy) and high plasma values of somatostatin was studied by somatostatin receptor scintigraphy.",DIARRHEA,IMMUNOHISTOCHEMICAL DIAGNOSIS OF SOMATOSTATINOMA,RO-disease_may_have_finding
502808404,7/13/2014 13:56:28,,1321896573,7/13/2014 13:56:11,instagc,0.6667,19378092,USA,PA,Reading,174.55.181.238,no_relation,66,92,,74,140,causes,0.529812942826018,902928-FS1-4,"A 61 yr old woman with gallbladder stones, diabetes, weight loss, DIARRHEA and steatorrhea, IMMUNOHISTOCHEMICAL DIAGNOSIS OF SOMATOSTATINOMA (liver biopsy) and high plasma values of somatostatin was studied by somatostatin receptor scintigraphy.",DIARRHEA,IMMUNOHISTOCHEMICAL DIAGNOSIS OF SOMATOSTATINOMA,RO-disease_may_have_finding
502808404,7/13/2014 14:00:26,,1321898468,7/13/2014 13:59:48,tremorgames,0.8611,24449707,CAN,QC,Laval,96.21.249.72,no_relation,66,92,,74,140,causes,0.529812942826018,902928-FS1-4,"A 61 yr old woman with gallbladder stones, diabetes, weight loss, DIARRHEA and steatorrhea, IMMUNOHISTOCHEMICAL DIAGNOSIS OF SOMATOSTATINOMA (liver biopsy) and high plasma values of somatostatin was studied by somatostatin receptor scintigraphy.",DIARRHEA,IMMUNOHISTOCHEMICAL DIAGNOSIS OF SOMATOSTATINOMA,RO-disease_may_have_finding
502808404,7/13/2014 14:02:55,,1321899579,7/13/2014 14:02:39,instagc,0.9097,18960682,GBR,,,86.29.147.112,no_relation,66,92,,74,140,causes,0.529812942826018,902928-FS1-4,"A 61 yr old woman with gallbladder stones, diabetes, weight loss, DIARRHEA and steatorrhea, IMMUNOHISTOCHEMICAL DIAGNOSIS OF SOMATOSTATINOMA (liver biopsy) and high plasma values of somatostatin was studied by somatostatin receptor scintigraphy.",DIARRHEA,IMMUNOHISTOCHEMICAL DIAGNOSIS OF SOMATOSTATINOMA,RO-disease_may_have_finding
502808404,7/13/2014 14:23:19,,1321909385,7/13/2014 14:22:35,instagc,0.7389,19686223,CAN,BC,Surrey,154.20.155.106,no_relation,66,92,,74,140,causes,0.529812942826018,902928-FS1-4,"A 61 yr old woman with gallbladder stones, diabetes, weight loss, DIARRHEA and steatorrhea, IMMUNOHISTOCHEMICAL DIAGNOSIS OF SOMATOSTATINOMA (liver biopsy) and high plasma values of somatostatin was studied by somatostatin receptor scintigraphy.",DIARRHEA,IMMUNOHISTOCHEMICAL DIAGNOSIS OF SOMATOSTATINOMA,RO-disease_may_have_finding
502808404,7/13/2014 15:04:38,,1321930579,7/13/2014 15:04:10,prodege,0.6014,27979711,CAN,ON,Stouffville,99.247.121.227,no_relation,66,92,,74,140,causes,0.529812942826018,902928-FS1-4,"A 61 yr old woman with gallbladder stones, diabetes, weight loss, DIARRHEA and steatorrhea, IMMUNOHISTOCHEMICAL DIAGNOSIS OF SOMATOSTATINOMA (liver biopsy) and high plasma values of somatostatin was studied by somatostatin receptor scintigraphy.",DIARRHEA,IMMUNOHISTOCHEMICAL DIAGNOSIS OF SOMATOSTATINOMA,RO-disease_may_have_finding
502808404,7/13/2014 16:05:01,,1321954340,7/13/2014 16:04:27,pedtoclick,0.5837,20864559,GBR,B8,Bromley,213.106.94.78,no_relation,66,92,,74,140,causes,0.529812942826018,902928-FS1-4,"A 61 yr old woman with gallbladder stones, diabetes, weight loss, DIARRHEA and steatorrhea, IMMUNOHISTOCHEMICAL DIAGNOSIS OF SOMATOSTATINOMA (liver biopsy) and high plasma values of somatostatin was studied by somatostatin receptor scintigraphy.",DIARRHEA,IMMUNOHISTOCHEMICAL DIAGNOSIS OF SOMATOSTATINOMA,RO-disease_may_have_finding
502808407,7/13/2014 13:56:25,,1321896563,7/13/2014 13:55:56,elite,1.0,28322695,GBR,H3,Leeds,109.157.255.113,no_relation,147,49,,171,81,causes,0.514495755427526,903802-FS1-4,A selected review is presented of the history of GROUP B STREPTOCOCCAL INFECTIONS and the laboratory tests used to identify Group B streptococcus (STREPTOCOCCUS AGALACTIAE an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups.,STREPTOCOCCUS AGALACTIAE,GROUP B STREPTOCOCCAL INFECTIONS,RO-has_causative_agent
502808407,7/13/2014 13:56:27,,1321896567,7/13/2014 13:56:21,neodev,0.875,25224036,CAN,ON,Sudbury,67.204.218.187,GROUP B STREPTOCOCCAL INFECTIONS causes STREPTOCOCCUS AGALACTIAE,147,49,,171,81,causes,0.514495755427526,903802-FS1-4,A selected review is presented of the history of GROUP B STREPTOCOCCAL INFECTIONS and the laboratory tests used to identify Group B streptococcus (STREPTOCOCCUS AGALACTIAE an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups.,STREPTOCOCCUS AGALACTIAE,GROUP B STREPTOCOCCAL INFECTIONS,RO-has_causative_agent
502808407,7/13/2014 14:01:23,,1321898873,7/13/2014 14:00:56,tremorgames,0.8611,24449707,CAN,QC,Laval,96.21.249.72,no_relation,147,49,,171,81,causes,0.514495755427526,903802-FS1-4,A selected review is presented of the history of GROUP B STREPTOCOCCAL INFECTIONS and the laboratory tests used to identify Group B streptococcus (STREPTOCOCCUS AGALACTIAE an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups.,STREPTOCOCCUS AGALACTIAE,GROUP B STREPTOCOCCAL INFECTIONS,RO-has_causative_agent
502808407,7/13/2014 14:24:11,,1321909780,7/13/2014 14:23:21,instagc,0.7389,19686223,CAN,BC,Surrey,154.20.155.106,no_relation,147,49,,171,81,causes,0.514495755427526,903802-FS1-4,A selected review is presented of the history of GROUP B STREPTOCOCCAL INFECTIONS and the laboratory tests used to identify Group B streptococcus (STREPTOCOCCUS AGALACTIAE an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups.,STREPTOCOCCUS AGALACTIAE,GROUP B STREPTOCOCCAL INFECTIONS,RO-has_causative_agent
502808407,7/13/2014 15:59:35,,1321952335,7/13/2014 15:58:39,prodege,0.596,27934334,GBR,E4,Loughton,86.162.38.12,STREPTOCOCCUS AGALACTIAE causes GROUP B STREPTOCOCCAL INFECTIONS,147,49,,171,81,causes,0.514495755427526,903802-FS1-4,A selected review is presented of the history of GROUP B STREPTOCOCCAL INFECTIONS and the laboratory tests used to identify Group B streptococcus (STREPTOCOCCUS AGALACTIAE an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups.,STREPTOCOCCUS AGALACTIAE,GROUP B STREPTOCOCCAL INFECTIONS,RO-has_causative_agent
502808407,7/13/2014 16:14:13,,1321958001,7/13/2014 16:14:09,bitcoinget,0.5274,27786287,USA,FL,Jacksonville,76.106.186.209,no_relation,147,49,,171,81,causes,0.514495755427526,903802-FS1-4,A selected review is presented of the history of GROUP B STREPTOCOCCAL INFECTIONS and the laboratory tests used to identify Group B streptococcus (STREPTOCOCCUS AGALACTIAE an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups.,STREPTOCOCCUS AGALACTIAE,GROUP B STREPTOCOCCAL INFECTIONS,RO-has_causative_agent
502808407,7/13/2014 16:41:06,,1321968682,7/13/2014 16:40:06,instagc,0.7262,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,147,49,,171,81,causes,0.514495755427526,903802-FS1-4,A selected review is presented of the history of GROUP B STREPTOCOCCAL INFECTIONS and the laboratory tests used to identify Group B streptococcus (STREPTOCOCCUS AGALACTIAE an opportunistic pathogen which causes serious infections in newborn infants and compromised patients in other age groups.,STREPTOCOCCUS AGALACTIAE,GROUP B STREPTOCOCCAL INFECTIONS,RO-has_causative_agent
502808408,7/13/2014 13:56:25,,1321896555,7/13/2014 13:55:56,elite,1.0,28322695,GBR,H3,Leeds,109.157.255.113,PHEOCHROMOCYTOMA causes HYPERTENSION,42,11,,54,27,causes,0.34188172937891403,902598-FS1-4,Removal of PHEOCHROMOCYTOMA may also cure HYPERTENSION ( 77.,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
502808408,7/13/2014 14:37:35,,1321916088,7/13/2014 14:37:21,instagc,0.7431,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,42,11,,54,27,causes,0.34188172937891403,902598-FS1-4,Removal of PHEOCHROMOCYTOMA may also cure HYPERTENSION ( 77.,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
502808408,7/13/2014 15:14:39,,1321934732,7/13/2014 15:14:04,uniquerewards,0.8194,20281752,GBR,M1,Slough,86.136.105.36,PHEOCHROMOCYTOMA causes HYPERTENSION,42,11,,54,27,causes,0.34188172937891403,902598-FS1-4,Removal of PHEOCHROMOCYTOMA may also cure HYPERTENSION ( 77.,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
502808408,7/13/2014 16:14:13,,1321958003,7/13/2014 16:14:09,bitcoinget,0.5274,27786287,USA,FL,Jacksonville,76.106.186.209,no_relation,42,11,,54,27,causes,0.34188172937891403,902598-FS1-4,Removal of PHEOCHROMOCYTOMA may also cure HYPERTENSION ( 77.,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
502808408,7/13/2014 16:56:29,,1321973940,7/13/2014 16:56:14,clixsense,0.6639,28037714,GBR,I4,Mitcham,94.4.232.118,PHEOCHROMOCYTOMA causes HYPERTENSION,42,11,,54,27,causes,0.34188172937891403,902598-FS1-4,Removal of PHEOCHROMOCYTOMA may also cure HYPERTENSION ( 77.,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
502808408,7/13/2014 16:59:35,,1321975076,7/13/2014 16:58:39,prodege,0.6048,28255346,GBR,L9,Sheffield,2.125.183.137,no_relation,42,11,,54,27,causes,0.34188172937891403,902598-FS1-4,Removal of PHEOCHROMOCYTOMA may also cure HYPERTENSION ( 77.,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
502808408,7/13/2014 17:14:02,,1321979646,7/13/2014 17:13:26,prodege,0.6151,2422962,USA,IA,Honey Creek,12.73.110.97,PHEOCHROMOCYTOMA causes HYPERTENSION,42,11,,54,27,causes,0.34188172937891403,902598-FS1-4,Removal of PHEOCHROMOCYTOMA may also cure HYPERTENSION ( 77.,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
502813470,7/13/2014 15:34:36,,1321942723,7/13/2014 15:34:29,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,HAEMATURIA causes RENAL CELL CARCINOMA,72,50,,82,70,causes,0.927172649945531,902711-FS1-4,The major symptoms are the same as in the classic RENAL CELL CARCINOMA: HAEMATURIA and flank pain.,HAEMATURIA,RENAL CELL CARCINOMA,RO-disease_may_have_finding
502813470,7/13/2014 15:37:47,,1321944045,7/13/2014 15:37:10,clixsense,0.7361,27871219,NLD,07,Amsterdam,87.210.207.223,RENAL CELL CARCINOMA causes HAEMATURIA,72,50,,82,70,causes,0.927172649945531,902711-FS1-4,The major symptoms are the same as in the classic RENAL CELL CARCINOMA: HAEMATURIA and flank pain.,HAEMATURIA,RENAL CELL CARCINOMA,RO-disease_may_have_finding
502813470,7/13/2014 15:58:28,,1321951878,7/13/2014 15:58:16,clixsense,0.6639,27793793,GBR,C5,Chester,151.230.27.155,RENAL CELL CARCINOMA causes HAEMATURIA,72,50,,82,70,causes,0.927172649945531,902711-FS1-4,The major symptoms are the same as in the classic RENAL CELL CARCINOMA: HAEMATURIA and flank pain.,HAEMATURIA,RENAL CELL CARCINOMA,RO-disease_may_have_finding
502813470,7/13/2014 16:11:02,,1321956654,7/13/2014 16:10:58,bitcoinget,0.4236,27786287,USA,FL,Jacksonville,76.106.186.209,no_relation,72,50,,82,70,causes,0.927172649945531,902711-FS1-4,The major symptoms are the same as in the classic RENAL CELL CARCINOMA: HAEMATURIA and flank pain.,HAEMATURIA,RENAL CELL CARCINOMA,RO-disease_may_have_finding
502813470,7/13/2014 16:14:29,,1321958139,7/13/2014 16:14:10,neodev,0.6407,14861092,GBR,I2,Manchester,90.194.137.76,no_relation,72,50,,82,70,causes,0.927172649945531,902711-FS1-4,The major symptoms are the same as in the classic RENAL CELL CARCINOMA: HAEMATURIA and flank pain.,HAEMATURIA,RENAL CELL CARCINOMA,RO-disease_may_have_finding
502813470,7/13/2014 16:26:08,,1321962398,7/13/2014 16:25:40,prodege,0.675,19192508,USA,OK,Broken Arrow,70.177.111.89,RENAL CELL CARCINOMA causes HAEMATURIA,72,50,,82,70,causes,0.927172649945531,902711-FS1-4,The major symptoms are the same as in the classic RENAL CELL CARCINOMA: HAEMATURIA and flank pain.,HAEMATURIA,RENAL CELL CARCINOMA,RO-disease_may_have_finding
502813470,7/13/2014 16:39:39,,1321968141,7/13/2014 16:39:21,instagc,0.5571,20183814,USA,,,166.182.83.213,RENAL CELL CARCINOMA causes HAEMATURIA,72,50,,82,70,causes,0.927172649945531,902711-FS1-4,The major symptoms are the same as in the classic RENAL CELL CARCINOMA: HAEMATURIA and flank pain.,HAEMATURIA,RENAL CELL CARCINOMA,RO-disease_may_have_finding
502813475,7/13/2014 15:36:23,,1321943504,7/13/2014 15:35:56,clixsense,0.7361,27871219,NLD,07,Amsterdam,87.210.207.223,HANTAVIRUS causes HANTAVIRUS PULMONARY SYNDROME,0,0,,10,29,causes,0.9438798074485389,903801-FS1-4,HANTAVIRUS PULMONARY SYNDROME (HPS) is a viral infection from a new strain of HANTAVIRUS,HANTAVIRUS,HANTAVIRUS PULMONARY SYNDROME,RO-has_causative_agent
502813475,7/13/2014 15:37:01,,1321943730,7/13/2014 15:36:54,neodev,0.5278,25224036,CAN,ON,Sudbury,67.204.218.187,HANTAVIRUS PULMONARY SYNDROME causes HANTAVIRUS,0,0,,10,29,causes,0.9438798074485389,903801-FS1-4,HANTAVIRUS PULMONARY SYNDROME (HPS) is a viral infection from a new strain of HANTAVIRUS,HANTAVIRUS,HANTAVIRUS PULMONARY SYNDROME,RO-has_causative_agent
502813475,7/13/2014 15:39:51,,1321944842,7/13/2014 15:39:33,instagc,0.7153,18960682,GBR,,,86.29.147.112,HANTAVIRUS causes HANTAVIRUS PULMONARY SYNDROME,0,0,,10,29,causes,0.9438798074485389,903801-FS1-4,HANTAVIRUS PULMONARY SYNDROME (HPS) is a viral infection from a new strain of HANTAVIRUS,HANTAVIRUS,HANTAVIRUS PULMONARY SYNDROME,RO-has_causative_agent
502813475,7/13/2014 16:10:23,,1321956460,7/13/2014 16:10:03,bitcoinget,0.4236,27786287,USA,FL,Jacksonville,76.106.186.209,HANTAVIRUS causes HANTAVIRUS PULMONARY SYNDROME,0,0,,10,29,causes,0.9438798074485389,903801-FS1-4,HANTAVIRUS PULMONARY SYNDROME (HPS) is a viral infection from a new strain of HANTAVIRUS,HANTAVIRUS,HANTAVIRUS PULMONARY SYNDROME,RO-has_causative_agent
502813475,7/13/2014 16:21:21,,1321960507,7/13/2014 16:20:34,rewardsspot,0.5812,24482174,GBR,H9,London,46.23.68.180,HANTAVIRUS PULMONARY SYNDROME causes HANTAVIRUS,0,0,,10,29,causes,0.9438798074485389,903801-FS1-4,HANTAVIRUS PULMONARY SYNDROME (HPS) is a viral infection from a new strain of HANTAVIRUS,HANTAVIRUS,HANTAVIRUS PULMONARY SYNDROME,RO-has_causative_agent
502813475,7/13/2014 16:23:31,,1321961256,7/13/2014 16:22:57,prodege,0.6149,28039757,GBR,L8,Southport,109.155.158.54,HANTAVIRUS causes HANTAVIRUS PULMONARY SYNDROME,0,0,,10,29,causes,0.9438798074485389,903801-FS1-4,HANTAVIRUS PULMONARY SYNDROME (HPS) is a viral infection from a new strain of HANTAVIRUS,HANTAVIRUS,HANTAVIRUS PULMONARY SYNDROME,RO-has_causative_agent
502813475,7/13/2014 16:36:09,,1321966812,7/13/2014 16:35:56,instagc,0.4853,25990856,USA,NV,Las Vegas,68.108.98.78,no_relation,0,0,,10,29,causes,0.9438798074485389,903801-FS1-4,HANTAVIRUS PULMONARY SYNDROME (HPS) is a viral infection from a new strain of HANTAVIRUS,HANTAVIRUS,HANTAVIRUS PULMONARY SYNDROME,RO-has_causative_agent
502813483,7/13/2014 15:38:40,,1321944391,7/13/2014 15:38:22,instagc,0.7153,18960682,GBR,,,86.29.147.112,no_relation,64,8,,95,40,causes,0.625543242171224,901949-FS1-4,Primary (ESSENTIAL THROMBOCYTHAEMIA (PT) is one of the forms of PRIMARY ACQUIRED THROMBOCYTOSES,PRIMARY ACQUIRED THROMBOCYTOSES,(ESSENTIAL THROMBOCYTHAEMIA (PT),RO-disease_has_finding
502813483,7/13/2014 15:58:44,,1321951994,7/13/2014 15:58:30,clixsense,0.6639,27793793,GBR,C5,Chester,151.230.27.155,no_relation,64,8,,95,40,causes,0.625543242171224,901949-FS1-4,Primary (ESSENTIAL THROMBOCYTHAEMIA (PT) is one of the forms of PRIMARY ACQUIRED THROMBOCYTOSES,PRIMARY ACQUIRED THROMBOCYTOSES,(ESSENTIAL THROMBOCYTHAEMIA (PT),RO-disease_has_finding
502813483,7/13/2014 16:01:11,,1321952957,7/13/2014 16:00:49,clixsense,0.6083,25402344,CAN,ON,Wawa,24.109.124.45,PRIMARY ACQUIRED THROMBOCYTOSES causes (ESSENTIAL THROMBOCYTHAEMIA (PT),64,8,,95,40,causes,0.625543242171224,901949-FS1-4,Primary (ESSENTIAL THROMBOCYTHAEMIA (PT) is one of the forms of PRIMARY ACQUIRED THROMBOCYTOSES,PRIMARY ACQUIRED THROMBOCYTOSES,(ESSENTIAL THROMBOCYTHAEMIA (PT),RO-disease_has_finding
502813483,7/13/2014 16:21:47,,1321960662,7/13/2014 16:21:14,prodege,0.6149,28039757,GBR,L8,Southport,109.155.158.54,no_relation,64,8,,95,40,causes,0.625543242171224,901949-FS1-4,Primary (ESSENTIAL THROMBOCYTHAEMIA (PT) is one of the forms of PRIMARY ACQUIRED THROMBOCYTOSES,PRIMARY ACQUIRED THROMBOCYTOSES,(ESSENTIAL THROMBOCYTHAEMIA (PT),RO-disease_has_finding
502813483,7/13/2014 16:24:50,,1321961876,7/13/2014 16:23:56,rewardsspot,0.5812,24482174,GBR,H9,London,46.23.68.180,no_relation,64,8,,95,40,causes,0.625543242171224,901949-FS1-4,Primary (ESSENTIAL THROMBOCYTHAEMIA (PT) is one of the forms of PRIMARY ACQUIRED THROMBOCYTOSES,PRIMARY ACQUIRED THROMBOCYTOSES,(ESSENTIAL THROMBOCYTHAEMIA (PT),RO-disease_has_finding
502813483,7/13/2014 16:28:50,,1321963611,7/13/2014 16:27:56,elite,0.304,28276268,USA,CA,San Diego,76.88.95.100,(ESSENTIAL THROMBOCYTHAEMIA (PT) causes PRIMARY ACQUIRED THROMBOCYTOSES,64,8,,95,40,causes,0.625543242171224,901949-FS1-4,Primary (ESSENTIAL THROMBOCYTHAEMIA (PT) is one of the forms of PRIMARY ACQUIRED THROMBOCYTOSES,PRIMARY ACQUIRED THROMBOCYTOSES,(ESSENTIAL THROMBOCYTHAEMIA (PT),RO-disease_has_finding
502813483,7/13/2014 16:39:39,,1321968133,7/13/2014 16:39:21,instagc,0.5571,20183814,USA,,,166.182.83.213,PRIMARY ACQUIRED THROMBOCYTOSES causes (ESSENTIAL THROMBOCYTHAEMIA (PT),64,8,,95,40,causes,0.625543242171224,901949-FS1-4,Primary (ESSENTIAL THROMBOCYTHAEMIA (PT) is one of the forms of PRIMARY ACQUIRED THROMBOCYTOSES,PRIMARY ACQUIRED THROMBOCYTOSES,(ESSENTIAL THROMBOCYTHAEMIA (PT),RO-disease_has_finding
502813484,7/13/2014 15:36:46,,1321943660,7/13/2014 15:36:40,neodev,0.5278,25224036,CAN,ON,Sudbury,67.204.218.187,TINEA PEDIS treats SULCONAZOLE NITRATE 1% CREAM,36,53,,47,81,treats,0.993883734673619,907886-FS1-2,"Woscoff A, Carabeli S. Treatment of TINEA PEDIS with SULCONAZOLE NITRATE 1% CREAM or miconazole nitrate 2% cream.",TINEA PEDIS,SULCONAZOLE NITRATE 1% CREAM,RO-may_treat
502813484,7/13/2014 15:41:09,,1321945332,7/13/2014 15:40:31,instagc,0.7889,28301350,GBR,K4,Plymouth,89.241.102.134,SULCONAZOLE NITRATE 1% CREAM treats TINEA PEDIS,36,53,,47,81,treats,0.993883734673619,907886-FS1-2,"Woscoff A, Carabeli S. Treatment of TINEA PEDIS with SULCONAZOLE NITRATE 1% CREAM or miconazole nitrate 2% cream.",TINEA PEDIS,SULCONAZOLE NITRATE 1% CREAM,RO-may_treat
502813484,7/13/2014 15:45:42,,1321946999,7/13/2014 15:45:10,prodege,0.6736,27096445,GBR,H9,London,86.186.168.254,SULCONAZOLE NITRATE 1% CREAM treats TINEA PEDIS,36,53,,47,81,treats,0.993883734673619,907886-FS1-2,"Woscoff A, Carabeli S. Treatment of TINEA PEDIS with SULCONAZOLE NITRATE 1% CREAM or miconazole nitrate 2% cream.",TINEA PEDIS,SULCONAZOLE NITRATE 1% CREAM,RO-may_treat
502813484,7/13/2014 15:50:04,,1321948521,7/13/2014 15:49:31,uniquerewards,0.6917,20281752,GBR,M1,Slough,86.136.105.36,SULCONAZOLE NITRATE 1% CREAM treats TINEA PEDIS,36,53,,47,81,treats,0.993883734673619,907886-FS1-2,"Woscoff A, Carabeli S. Treatment of TINEA PEDIS with SULCONAZOLE NITRATE 1% CREAM or miconazole nitrate 2% cream.",TINEA PEDIS,SULCONAZOLE NITRATE 1% CREAM,RO-may_treat
502813484,7/13/2014 15:58:01,,1321951692,7/13/2014 15:57:48,clixsense,0.6639,27793793,GBR,C5,Chester,151.230.27.155,SULCONAZOLE NITRATE 1% CREAM treats TINEA PEDIS,36,53,,47,81,treats,0.993883734673619,907886-FS1-2,"Woscoff A, Carabeli S. Treatment of TINEA PEDIS with SULCONAZOLE NITRATE 1% CREAM or miconazole nitrate 2% cream.",TINEA PEDIS,SULCONAZOLE NITRATE 1% CREAM,RO-may_treat
502813484,7/13/2014 16:01:39,,1321953154,7/13/2014 16:01:12,clixsense,0.6083,25402344,CAN,ON,Wawa,24.109.124.45,SULCONAZOLE NITRATE 1% CREAM treats TINEA PEDIS,36,53,,47,81,treats,0.993883734673619,907886-FS1-2,"Woscoff A, Carabeli S. Treatment of TINEA PEDIS with SULCONAZOLE NITRATE 1% CREAM or miconazole nitrate 2% cream.",TINEA PEDIS,SULCONAZOLE NITRATE 1% CREAM,RO-may_treat
502813484,7/13/2014 16:09:01,,1321955916,7/13/2014 16:07:46,bitcoinget,0.4236,27786287,USA,FL,Jacksonville,76.106.186.209,SULCONAZOLE NITRATE 1% CREAM treats TINEA PEDIS,36,53,,47,81,treats,0.993883734673619,907886-FS1-2,"Woscoff A, Carabeli S. Treatment of TINEA PEDIS with SULCONAZOLE NITRATE 1% CREAM or miconazole nitrate 2% cream.",TINEA PEDIS,SULCONAZOLE NITRATE 1% CREAM,RO-may_treat
502813487,7/13/2014 15:28:38,,1321940276,7/13/2014 15:28:02,clixsense,0.9167,15189335,GBR,K3,Peterborough,81.156.166.189,WORK RELATED ALLERGY causes DELAYED TYPE HYPERSENSITIVITIES,61,106,,81,137,causes,0.42426406871192895,900222-FS1-4,"In this chapter, various methods of protecting a worker from WORK RELATED ALLERGY including immediate and DELAYED TYPE HYPERSENSITIVITIES are considered and reviewed.",WORK RELATED ALLERGY,DELAYED TYPE HYPERSENSITIVITIES,RO-cause_of
502813487,7/13/2014 15:37:09,,1321943817,7/13/2014 15:36:24,clixsense,0.7361,27871219,NLD,07,Amsterdam,87.210.207.223,WORK RELATED ALLERGY causes DELAYED TYPE HYPERSENSITIVITIES,61,106,,81,137,causes,0.42426406871192895,900222-FS1-4,"In this chapter, various methods of protecting a worker from WORK RELATED ALLERGY including immediate and DELAYED TYPE HYPERSENSITIVITIES are considered and reviewed.",WORK RELATED ALLERGY,DELAYED TYPE HYPERSENSITIVITIES,RO-cause_of
502813487,7/13/2014 15:52:04,,1321949343,7/13/2014 15:51:25,uniquerewards,0.6917,20281752,GBR,M1,Slough,86.136.105.36,DELAYED TYPE HYPERSENSITIVITIES causes WORK RELATED ALLERGY,61,106,,81,137,causes,0.42426406871192895,900222-FS1-4,"In this chapter, various methods of protecting a worker from WORK RELATED ALLERGY including immediate and DELAYED TYPE HYPERSENSITIVITIES are considered and reviewed.",WORK RELATED ALLERGY,DELAYED TYPE HYPERSENSITIVITIES,RO-cause_of
502813487,7/13/2014 16:10:58,,1321956641,7/13/2014 16:10:43,bitcoinget,0.4236,27786287,USA,FL,Jacksonville,76.106.186.209,no_relation,61,106,,81,137,causes,0.42426406871192895,900222-FS1-4,"In this chapter, various methods of protecting a worker from WORK RELATED ALLERGY including immediate and DELAYED TYPE HYPERSENSITIVITIES are considered and reviewed.",WORK RELATED ALLERGY,DELAYED TYPE HYPERSENSITIVITIES,RO-cause_of
502813487,7/13/2014 16:19:28,,1321959984,7/13/2014 16:18:29,clixsense,0.2,25595227,CAN,SK,North Battleford,24.72.96.119,no_relation,61,106,,81,137,causes,0.42426406871192895,900222-FS1-4,"In this chapter, various methods of protecting a worker from WORK RELATED ALLERGY including immediate and DELAYED TYPE HYPERSENSITIVITIES are considered and reviewed.",WORK RELATED ALLERGY,DELAYED TYPE HYPERSENSITIVITIES,RO-cause_of
502813487,7/13/2014 16:35:34,,1321966481,7/13/2014 16:35:21,instagc,0.4853,25990856,USA,NV,Las Vegas,68.108.98.78,no_relation,61,106,,81,137,causes,0.42426406871192895,900222-FS1-4,"In this chapter, various methods of protecting a worker from WORK RELATED ALLERGY including immediate and DELAYED TYPE HYPERSENSITIVITIES are considered and reviewed.",WORK RELATED ALLERGY,DELAYED TYPE HYPERSENSITIVITIES,RO-cause_of
502813487,7/13/2014 16:39:20,,1321968061,7/13/2014 16:38:55,instagc,0.5571,20183814,USA,,,166.182.83.213,WORK RELATED ALLERGY causes DELAYED TYPE HYPERSENSITIVITIES,61,106,,81,137,causes,0.42426406871192895,900222-FS1-4,"In this chapter, various methods of protecting a worker from WORK RELATED ALLERGY including immediate and DELAYED TYPE HYPERSENSITIVITIES are considered and reviewed.",WORK RELATED ALLERGY,DELAYED TYPE HYPERSENSITIVITIES,RO-cause_of
502813489,7/13/2014 15:34:16,,1321942634,7/13/2014 15:34:06,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,PURTSCHER'S RETINOPATHY causes TRAUMA,0,80,,23,86,causes,0.843274042711568,900463-FS1-4,"PURTSCHER'S RETINOPATHY is a rare condition, seen in patients with a history of TRAUMA",PURTSCHER'S RETINOPATHY,TRAUMA,RO-cause_of
502813489,7/13/2014 15:35:16,,1321942982,7/13/2014 15:34:54,clixsense,0.9167,15189335,GBR,K3,Peterborough,81.156.166.189,TRAUMA causes PURTSCHER'S RETINOPATHY,0,80,,23,86,causes,0.843274042711568,900463-FS1-4,"PURTSCHER'S RETINOPATHY is a rare condition, seen in patients with a history of TRAUMA",PURTSCHER'S RETINOPATHY,TRAUMA,RO-cause_of
502813489,7/13/2014 15:36:48,,1321943668,7/13/2014 15:36:25,neodev,0.7292,28336203,USA,PA,Harrisburg,50.149.53.150,no_relation,0,80,,23,86,causes,0.843274042711568,900463-FS1-4,"PURTSCHER'S RETINOPATHY is a rare condition, seen in patients with a history of TRAUMA",PURTSCHER'S RETINOPATHY,TRAUMA,RO-cause_of
502813489,7/13/2014 15:37:17,,1321943907,7/13/2014 15:37:10,neodev,0.5278,25224036,CAN,ON,Sudbury,67.204.218.187,TRAUMA causes PURTSCHER'S RETINOPATHY,0,80,,23,86,causes,0.843274042711568,900463-FS1-4,"PURTSCHER'S RETINOPATHY is a rare condition, seen in patients with a history of TRAUMA",PURTSCHER'S RETINOPATHY,TRAUMA,RO-cause_of
502813489,7/13/2014 15:38:46,,1321944437,7/13/2014 15:38:14,clixsense,0.7361,27871219,NLD,07,Amsterdam,87.210.207.223,TRAUMA causes PURTSCHER'S RETINOPATHY,0,80,,23,86,causes,0.843274042711568,900463-FS1-4,"PURTSCHER'S RETINOPATHY is a rare condition, seen in patients with a history of TRAUMA",PURTSCHER'S RETINOPATHY,TRAUMA,RO-cause_of
502813489,7/13/2014 15:40:30,,1321945067,7/13/2014 15:39:53,instagc,0.7889,28301350,GBR,K4,Plymouth,89.241.102.134,TRAUMA causes PURTSCHER'S RETINOPATHY,0,80,,23,86,causes,0.843274042711568,900463-FS1-4,"PURTSCHER'S RETINOPATHY is a rare condition, seen in patients with a history of TRAUMA",PURTSCHER'S RETINOPATHY,TRAUMA,RO-cause_of
502813489,7/13/2014 15:41:57,,1321945665,7/13/2014 15:41:44,neodev,0.6488,17610000,GBR,I2,Manchester,90.200.140.201,PURTSCHER'S RETINOPATHY causes TRAUMA,0,80,,23,86,causes,0.843274042711568,900463-FS1-4,"PURTSCHER'S RETINOPATHY is a rare condition, seen in patients with a history of TRAUMA",PURTSCHER'S RETINOPATHY,TRAUMA,RO-cause_of
502813496,7/13/2014 15:34:05,,1321942552,7/13/2014 15:33:56,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,FVIII treats HEMOPHILIA A,76,26,,88,31,treats,0.962250448649376,906015-FS1-2,"Replacement therapy using FVIII is the leading therapy in the management of HEMOPHILIA A However, approximately 15% to 30% of patients develop inhibitory antibodies that neutralize the activity of the protein.",HEMOPHILIA A,FVIII,RO-has_manifestation
502813496,7/13/2014 15:34:53,,1321942798,7/13/2014 15:34:23,clixsense,0.9167,15189335,GBR,K3,Peterborough,81.156.166.189,FVIII treats HEMOPHILIA A,76,26,,88,31,treats,0.962250448649376,906015-FS1-2,"Replacement therapy using FVIII is the leading therapy in the management of HEMOPHILIA A However, approximately 15% to 30% of patients develop inhibitory antibodies that neutralize the activity of the protein.",HEMOPHILIA A,FVIII,RO-has_manifestation
502813496,7/13/2014 15:36:23,,1321943505,7/13/2014 15:35:56,clixsense,0.7361,27871219,NLD,07,Amsterdam,87.210.207.223,FVIII treats HEMOPHILIA A,76,26,,88,31,treats,0.962250448649376,906015-FS1-2,"Replacement therapy using FVIII is the leading therapy in the management of HEMOPHILIA A However, approximately 15% to 30% of patients develop inhibitory antibodies that neutralize the activity of the protein.",HEMOPHILIA A,FVIII,RO-has_manifestation
502813496,7/13/2014 16:10:42,,1321956574,7/13/2014 16:10:24,bitcoinget,0.4236,27786287,USA,FL,Jacksonville,76.106.186.209,FVIII treats HEMOPHILIA A,76,26,,88,31,treats,0.962250448649376,906015-FS1-2,"Replacement therapy using FVIII is the leading therapy in the management of HEMOPHILIA A However, approximately 15% to 30% of patients develop inhibitory antibodies that neutralize the activity of the protein.",HEMOPHILIA A,FVIII,RO-has_manifestation
502813496,7/13/2014 16:26:13,,1321962425,7/13/2014 16:25:35,rewardsspot,0.5812,24482174,GBR,H9,London,46.23.68.180,HEMOPHILIA A treats FVIII,76,26,,88,31,treats,0.962250448649376,906015-FS1-2,"Replacement therapy using FVIII is the leading therapy in the management of HEMOPHILIA A However, approximately 15% to 30% of patients develop inhibitory antibodies that neutralize the activity of the protein.",HEMOPHILIA A,FVIII,RO-has_manifestation
502813496,7/13/2014 16:34:40,,1321966134,7/13/2014 16:34:17,instagc,0.4853,25990856,USA,NV,Las Vegas,68.108.98.78,FVIII treats HEMOPHILIA A,76,26,,88,31,treats,0.962250448649376,906015-FS1-2,"Replacement therapy using FVIII is the leading therapy in the management of HEMOPHILIA A However, approximately 15% to 30% of patients develop inhibitory antibodies that neutralize the activity of the protein.",HEMOPHILIA A,FVIII,RO-has_manifestation
502813496,7/13/2014 16:47:14,,1321970811,7/13/2014 16:46:46,instagc,0.5933,24252915,GBR,B7,Bristol,77.98.139.82,FVIII treats HEMOPHILIA A,76,26,,88,31,treats,0.962250448649376,906015-FS1-2,"Replacement therapy using FVIII is the leading therapy in the management of HEMOPHILIA A However, approximately 15% to 30% of patients develop inhibitory antibodies that neutralize the activity of the protein.",HEMOPHILIA A,FVIII,RO-has_manifestation
502813498,7/13/2014 15:36:04,,1321943328,7/13/2014 15:35:57,neodev,0.7292,28336203,USA,PA,Harrisburg,50.149.53.150,ATOPIC causes ATOPIC DERMATITIS,77,77,,94,83,causes,0.625543242171224,900177-FS1-4,Sensitization to allergens of Japanese cedar pollen is known to cause canine ATOPIC DERMATITIS as approximately 10% of ATOPIC dogs in Japan were positive to the pollen allergen.,ATOPIC DERMATITIS,ATOPIC,RO-cause_of
502813498,7/13/2014 15:39:19,,1321944663,7/13/2014 15:38:51,instagc,0.7889,28301350,GBR,K4,Plymouth,89.241.102.134,no_relation,77,77,,94,83,causes,0.625543242171224,900177-FS1-4,Sensitization to allergens of Japanese cedar pollen is known to cause canine ATOPIC DERMATITIS as approximately 10% of ATOPIC dogs in Japan were positive to the pollen allergen.,ATOPIC DERMATITIS,ATOPIC,RO-cause_of
502813498,7/13/2014 15:50:53,,1321948830,7/13/2014 15:50:05,uniquerewards,0.6917,20281752,GBR,M1,Slough,86.136.105.36,no_relation,77,77,,94,83,causes,0.625543242171224,900177-FS1-4,Sensitization to allergens of Japanese cedar pollen is known to cause canine ATOPIC DERMATITIS as approximately 10% of ATOPIC dogs in Japan were positive to the pollen allergen.,ATOPIC DERMATITIS,ATOPIC,RO-cause_of
502813498,7/13/2014 16:01:39,,1321953149,7/13/2014 16:01:12,clixsense,0.6083,25402344,CAN,ON,Wawa,24.109.124.45,ATOPIC causes ATOPIC DERMATITIS,77,77,,94,83,causes,0.625543242171224,900177-FS1-4,Sensitization to allergens of Japanese cedar pollen is known to cause canine ATOPIC DERMATITIS as approximately 10% of ATOPIC dogs in Japan were positive to the pollen allergen.,ATOPIC DERMATITIS,ATOPIC,RO-cause_of
502813498,7/13/2014 16:38:38,,1321967782,7/13/2014 16:38:16,instagc,0.5571,20183814,USA,,,166.182.83.213,no_relation,77,77,,94,83,causes,0.625543242171224,900177-FS1-4,Sensitization to allergens of Japanese cedar pollen is known to cause canine ATOPIC DERMATITIS as approximately 10% of ATOPIC dogs in Japan were positive to the pollen allergen.,ATOPIC DERMATITIS,ATOPIC,RO-cause_of
502813498,7/13/2014 16:44:23,,1321969624,7/13/2014 16:44:00,instagc,0.5933,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,77,77,,94,83,causes,0.625543242171224,900177-FS1-4,Sensitization to allergens of Japanese cedar pollen is known to cause canine ATOPIC DERMATITIS as approximately 10% of ATOPIC dogs in Japan were positive to the pollen allergen.,ATOPIC DERMATITIS,ATOPIC,RO-cause_of
502813498,7/13/2014 16:49:11,,1321971506,7/13/2014 16:48:41,neodev,0.7345,27597779,CAN,AB,Calgary,68.146.86.137,no_relation,77,77,,94,83,causes,0.625543242171224,900177-FS1-4,Sensitization to allergens of Japanese cedar pollen is known to cause canine ATOPIC DERMATITIS as approximately 10% of ATOPIC dogs in Japan were positive to the pollen allergen.,ATOPIC DERMATITIS,ATOPIC,RO-cause_of
502813501,7/13/2014 15:34:16,,1321942633,7/13/2014 15:34:06,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,NONTHROMBOCYTIC PURPURA diagnosed by HENOCH SCHONLEIN PURPURA,18,84,,41,108,diagnosed by,0.39391929857916796,904727-FS1-13,The appearance of NONTHROMBOCYTIC PURPURA is an important clue for the diagnosis of HENOCH SCHONLEIN PURPURA (HSP.,NONTHROMBOCYTIC PURPURA,HENOCH SCHONLEIN PURPURA,RO-has_definitional_manifestation
502813501,7/13/2014 15:34:53,,1321942799,7/13/2014 15:34:23,clixsense,0.9167,15189335,GBR,K3,Peterborough,81.156.166.189,HENOCH SCHONLEIN PURPURA diagnosed by NONTHROMBOCYTIC PURPURA,18,84,,41,108,diagnosed by,0.39391929857916796,904727-FS1-13,The appearance of NONTHROMBOCYTIC PURPURA is an important clue for the diagnosis of HENOCH SCHONLEIN PURPURA (HSP.,NONTHROMBOCYTIC PURPURA,HENOCH SCHONLEIN PURPURA,RO-has_definitional_manifestation
502813501,7/13/2014 15:36:25,,1321943513,7/13/2014 15:36:15,neodev,0.7292,28336203,USA,PA,Harrisburg,50.149.53.150,HENOCH SCHONLEIN PURPURA diagnosed by NONTHROMBOCYTIC PURPURA,18,84,,41,108,diagnosed by,0.39391929857916796,904727-FS1-13,The appearance of NONTHROMBOCYTIC PURPURA is an important clue for the diagnosis of HENOCH SCHONLEIN PURPURA (HSP.,NONTHROMBOCYTIC PURPURA,HENOCH SCHONLEIN PURPURA,RO-has_definitional_manifestation
502813501,7/13/2014 15:38:57,,1321944512,7/13/2014 15:38:42,instagc,0.7153,18960682,GBR,,,86.29.147.112,HENOCH SCHONLEIN PURPURA diagnosed by NONTHROMBOCYTIC PURPURA,18,84,,41,108,diagnosed by,0.39391929857916796,904727-FS1-13,The appearance of NONTHROMBOCYTIC PURPURA is an important clue for the diagnosis of HENOCH SCHONLEIN PURPURA (HSP.,NONTHROMBOCYTIC PURPURA,HENOCH SCHONLEIN PURPURA,RO-has_definitional_manifestation
502813501,7/13/2014 15:44:36,,1321946668,7/13/2014 15:43:56,prodege,0.6736,27096445,GBR,H9,London,86.186.168.254,HENOCH SCHONLEIN PURPURA diagnosed by NONTHROMBOCYTIC PURPURA,18,84,,41,108,diagnosed by,0.39391929857916796,904727-FS1-13,The appearance of NONTHROMBOCYTIC PURPURA is an important clue for the diagnosis of HENOCH SCHONLEIN PURPURA (HSP.,NONTHROMBOCYTIC PURPURA,HENOCH SCHONLEIN PURPURA,RO-has_definitional_manifestation
502813501,7/13/2014 15:52:39,,1321949561,7/13/2014 15:52:05,uniquerewards,0.6917,20281752,GBR,M1,Slough,86.136.105.36,HENOCH SCHONLEIN PURPURA diagnosed by NONTHROMBOCYTIC PURPURA,18,84,,41,108,diagnosed by,0.39391929857916796,904727-FS1-13,The appearance of NONTHROMBOCYTIC PURPURA is an important clue for the diagnosis of HENOCH SCHONLEIN PURPURA (HSP.,NONTHROMBOCYTIC PURPURA,HENOCH SCHONLEIN PURPURA,RO-has_definitional_manifestation
502813501,7/13/2014 15:58:44,,1321951993,7/13/2014 15:58:30,clixsense,0.6639,27793793,GBR,C5,Chester,151.230.27.155,HENOCH SCHONLEIN PURPURA diagnosed by NONTHROMBOCYTIC PURPURA,18,84,,41,108,diagnosed by,0.39391929857916796,904727-FS1-13,The appearance of NONTHROMBOCYTIC PURPURA is an important clue for the diagnosis of HENOCH SCHONLEIN PURPURA (HSP.,NONTHROMBOCYTIC PURPURA,HENOCH SCHONLEIN PURPURA,RO-has_definitional_manifestation
502833443,7/13/2014 18:43:31,,1322046316,7/13/2014 18:43:22,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,CF causes BRONCHIECTASIS,78,127,,92,129,causes,0.981980506061966,906010-FS1-4,"DIFFERENTIAL DIAGNOSIS  In the differential diagnosis of PCD, other causes of BRONCHIECTASIS must be considered; these include CF immune deficiencies, severe respiratory illness in childhood, nontuberculous mycobacterial infection, and allergic bronchopulmonary aspergillosis.",BRONCHIECTASIS,CF,RO-has_manifestation
502833443,7/13/2014 19:00:47,,1322054459,7/13/2014 19:00:40,neodev,0.8333,17610000,GBR,I2,Manchester,90.200.140.201,BRONCHIECTASIS causes CF,78,127,,92,129,causes,0.981980506061966,906010-FS1-4,"DIFFERENTIAL DIAGNOSIS  In the differential diagnosis of PCD, other causes of BRONCHIECTASIS must be considered; these include CF immune deficiencies, severe respiratory illness in childhood, nontuberculous mycobacterial infection, and allergic bronchopulmonary aspergillosis.",BRONCHIECTASIS,CF,RO-has_manifestation
502833443,7/13/2014 19:16:02,,1322060978,7/13/2014 19:15:27,rewardsspot,0.6111,24482174,GBR,H9,London,46.23.68.180,no_relation,78,127,,92,129,causes,0.981980506061966,906010-FS1-4,"DIFFERENTIAL DIAGNOSIS  In the differential diagnosis of PCD, other causes of BRONCHIECTASIS must be considered; these include CF immune deficiencies, severe respiratory illness in childhood, nontuberculous mycobacterial infection, and allergic bronchopulmonary aspergillosis.",BRONCHIECTASIS,CF,RO-has_manifestation
502833443,7/13/2014 19:21:07,,1322062985,7/13/2014 19:20:57,prodege,0.6403,6011370,CAN,BC,Richmond,70.79.45.148,BRONCHIECTASIS causes CF,78,127,,92,129,causes,0.981980506061966,906010-FS1-4,"DIFFERENTIAL DIAGNOSIS  In the differential diagnosis of PCD, other causes of BRONCHIECTASIS must be considered; these include CF immune deficiencies, severe respiratory illness in childhood, nontuberculous mycobacterial infection, and allergic bronchopulmonary aspergillosis.",BRONCHIECTASIS,CF,RO-has_manifestation
502833443,7/13/2014 19:30:56,,1322066561,7/13/2014 19:30:51,clixsense,0.6319,25419319,GBR,H8,Liverpool,94.4.192.228,BRONCHIECTASIS causes CF,78,127,,92,129,causes,0.981980506061966,906010-FS1-4,"DIFFERENTIAL DIAGNOSIS  In the differential diagnosis of PCD, other causes of BRONCHIECTASIS must be considered; these include CF immune deficiencies, severe respiratory illness in childhood, nontuberculous mycobacterial infection, and allergic bronchopulmonary aspergillosis.",BRONCHIECTASIS,CF,RO-has_manifestation
502833443,7/13/2014 19:39:31,,1322069689,7/13/2014 19:38:50,vivatic,0.5806,25451531,GBR,,,83.67.28.193,CF causes BRONCHIECTASIS,78,127,,92,129,causes,0.981980506061966,906010-FS1-4,"DIFFERENTIAL DIAGNOSIS  In the differential diagnosis of PCD, other causes of BRONCHIECTASIS must be considered; these include CF immune deficiencies, severe respiratory illness in childhood, nontuberculous mycobacterial infection, and allergic bronchopulmonary aspergillosis.",BRONCHIECTASIS,CF,RO-has_manifestation
502833443,7/13/2014 19:42:41,,1322071350,7/13/2014 19:42:01,sendearnings,0.5385,11896941,USA,FL,Seminole,97.106.105.251,CF causes BRONCHIECTASIS,78,127,,92,129,causes,0.981980506061966,906010-FS1-4,"DIFFERENTIAL DIAGNOSIS  In the differential diagnosis of PCD, other causes of BRONCHIECTASIS must be considered; these include CF immune deficiencies, severe respiratory illness in childhood, nontuberculous mycobacterial infection, and allergic bronchopulmonary aspergillosis.",BRONCHIECTASIS,CF,RO-has_manifestation
502833445,7/13/2014 18:57:54,,1322053168,7/13/2014 18:57:49,neodev,0.8333,25224036,CAN,ON,Sudbury,67.204.218.187,BREAST CANCERS causes SUBSET,109,119,,115,133,causes,0.516397779494322,906171-FS1-4,Inactivation of the breast cancer susceptibility gene BRCA1 plays a significant role in the development of a SUBSET of BREAST CANCERS although the major tumor suppressor function of this gene remains unclear.,SUBSET,BREAST CANCERS,RO-has_manifestation
502833445,7/13/2014 19:11:34,,1322059200,7/13/2014 19:11:18,neodev,0.7917,18517457,GBR,,,86.29.147.112,no_relation,109,119,,115,133,causes,0.516397779494322,906171-FS1-4,Inactivation of the breast cancer susceptibility gene BRCA1 plays a significant role in the development of a SUBSET of BREAST CANCERS although the major tumor suppressor function of this gene remains unclear.,SUBSET,BREAST CANCERS,RO-has_manifestation
502833445,7/13/2014 19:42:00,,1322070951,7/13/2014 19:41:18,sendearnings,0.5385,11896941,USA,FL,Seminole,97.106.105.251,SUBSET causes BREAST CANCERS,109,119,,115,133,causes,0.516397779494322,906171-FS1-4,Inactivation of the breast cancer susceptibility gene BRCA1 plays a significant role in the development of a SUBSET of BREAST CANCERS although the major tumor suppressor function of this gene remains unclear.,SUBSET,BREAST CANCERS,RO-has_manifestation
502833445,7/13/2014 20:39:41,,1322122900,7/13/2014 20:38:52,tremorgames,0.5373,28013393,USA,CA,Rancho Cordova,71.197.67.37,no_relation,109,119,,115,133,causes,0.516397779494322,906171-FS1-4,Inactivation of the breast cancer susceptibility gene BRCA1 plays a significant role in the development of a SUBSET of BREAST CANCERS although the major tumor suppressor function of this gene remains unclear.,SUBSET,BREAST CANCERS,RO-has_manifestation
502833445,7/13/2014 20:41:37,,1322124471,7/13/2014 20:41:05,prodege,0.4776,1852770,USA,TX,Abilene,76.198.102.54,no_relation,109,119,,115,133,causes,0.516397779494322,906171-FS1-4,Inactivation of the breast cancer susceptibility gene BRCA1 plays a significant role in the development of a SUBSET of BREAST CANCERS although the major tumor suppressor function of this gene remains unclear.,SUBSET,BREAST CANCERS,RO-has_manifestation
502833445,7/13/2014 20:54:28,,1322135371,7/13/2014 20:54:21,instagc,0.4274,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,109,119,,115,133,causes,0.516397779494322,906171-FS1-4,Inactivation of the breast cancer susceptibility gene BRCA1 plays a significant role in the development of a SUBSET of BREAST CANCERS although the major tumor suppressor function of this gene remains unclear.,SUBSET,BREAST CANCERS,RO-has_manifestation
502833445,7/13/2014 21:28:46,,1322164517,7/13/2014 21:28:05,instagc,0.5667,20183814,USA,,,166.182.81.241,no_relation,109,119,,115,133,causes,0.516397779494322,906171-FS1-4,Inactivation of the breast cancer susceptibility gene BRCA1 plays a significant role in the development of a SUBSET of BREAST CANCERS although the major tumor suppressor function of this gene remains unclear.,SUBSET,BREAST CANCERS,RO-has_manifestation
502833448,7/13/2014 19:00:32,,1322054375,7/13/2014 19:00:26,neodev,0.8333,17610000,GBR,I2,Manchester,90.200.140.201,BRONCHIAL HYPERREACTIVITY causes METHACHOLINE,0,29,,25,41,causes,0.5962847939999439,906702-FS1-4,BRONCHIAL HYPERREACTIVITY to METHACHOLINE was confirmed at a pretrial bronchial challenge.,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,RO-may_diagnose
502833448,7/13/2014 19:40:11,,1322069950,7/13/2014 19:39:32,vivatic,0.5806,25451531,GBR,,,83.67.28.193,METHACHOLINE causes BRONCHIAL HYPERREACTIVITY,0,29,,25,41,causes,0.5962847939999439,906702-FS1-4,BRONCHIAL HYPERREACTIVITY to METHACHOLINE was confirmed at a pretrial bronchial challenge.,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,RO-may_diagnose
502833448,7/13/2014 19:40:40,,1322070192,7/13/2014 19:39:57,sendearnings,0.5385,11896941,USA,FL,Seminole,97.106.105.251,METHACHOLINE causes BRONCHIAL HYPERREACTIVITY,0,29,,25,41,causes,0.5962847939999439,906702-FS1-4,BRONCHIAL HYPERREACTIVITY to METHACHOLINE was confirmed at a pretrial bronchial challenge.,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,RO-may_diagnose
502833448,7/13/2014 19:41:06,,1322070390,7/13/2014 19:40:49,elite,0.5556,28276268,USA,CA,San Diego,76.88.95.100,BRONCHIAL HYPERREACTIVITY causes METHACHOLINE,0,29,,25,41,causes,0.5962847939999439,906702-FS1-4,BRONCHIAL HYPERREACTIVITY to METHACHOLINE was confirmed at a pretrial bronchial challenge.,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,RO-may_diagnose
502833448,7/13/2014 19:42:41,,1322071351,7/13/2014 19:42:26,neodev,0.4395,27756039,CAN,ON,Toronto,174.119.96.184,no_relation,0,29,,25,41,causes,0.5962847939999439,906702-FS1-4,BRONCHIAL HYPERREACTIVITY to METHACHOLINE was confirmed at a pretrial bronchial challenge.,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,RO-may_diagnose
502833448,7/13/2014 19:43:04,,1322071711,7/13/2014 19:42:34,instagc,0.5111,19686223,CAN,BC,Surrey,154.20.155.106,no_relation,0,29,,25,41,causes,0.5962847939999439,906702-FS1-4,BRONCHIAL HYPERREACTIVITY to METHACHOLINE was confirmed at a pretrial bronchial challenge.,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,RO-may_diagnose
502833448,7/13/2014 19:55:12,,1322081921,7/13/2014 19:54:43,prodege,0.4734,7664351,USA,NY,Cicero,74.111.0.21,no_relation,0,29,,25,41,causes,0.5962847939999439,906702-FS1-4,BRONCHIAL HYPERREACTIVITY to METHACHOLINE was confirmed at a pretrial bronchial challenge.,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,RO-may_diagnose
502833451,7/13/2014 19:00:53,,1322054519,7/13/2014 19:00:47,neodev,0.8333,17610000,GBR,I2,Manchester,90.200.140.201,FUNGI causes SUPERFICIAL MYCOSES,146,53,,151,72,causes,0.64018439966448,903797-FS1-4,"Although dermatophytes are the most common agents of SUPERFICIAL MYCOSES in humans and animals, the molecular basis of the pathogenicity of these FUNGI is largely unknown.",FUNGI,SUPERFICIAL MYCOSES,RO-has_causative_agent
502833451,7/13/2014 19:12:39,,1322059692,7/13/2014 19:12:18,neodev,0.7917,18517457,GBR,,,86.29.147.112,FUNGI causes SUPERFICIAL MYCOSES,146,53,,151,72,causes,0.64018439966448,903797-FS1-4,"Although dermatophytes are the most common agents of SUPERFICIAL MYCOSES in humans and animals, the molecular basis of the pathogenicity of these FUNGI is largely unknown.",FUNGI,SUPERFICIAL MYCOSES,RO-has_causative_agent
502833451,7/13/2014 19:14:07,,1322060247,7/13/2014 19:13:34,rewardsspot,0.6111,24482174,GBR,H9,London,46.23.68.180,FUNGI causes SUPERFICIAL MYCOSES,146,53,,151,72,causes,0.64018439966448,903797-FS1-4,"Although dermatophytes are the most common agents of SUPERFICIAL MYCOSES in humans and animals, the molecular basis of the pathogenicity of these FUNGI is largely unknown.",FUNGI,SUPERFICIAL MYCOSES,RO-has_causative_agent
502833451,7/13/2014 20:40:54,,1322123937,7/13/2014 20:40:29,tremorgames,0.5373,28013393,USA,CA,Rancho Cordova,71.197.67.37,SUPERFICIAL MYCOSES causes FUNGI,146,53,,151,72,causes,0.64018439966448,903797-FS1-4,"Although dermatophytes are the most common agents of SUPERFICIAL MYCOSES in humans and animals, the molecular basis of the pathogenicity of these FUNGI is largely unknown.",FUNGI,SUPERFICIAL MYCOSES,RO-has_causative_agent
502833451,7/13/2014 20:42:07,,1322124799,7/13/2014 20:41:38,prodege,0.4776,1852770,USA,TX,Abilene,76.198.102.54,no_relation,146,53,,151,72,causes,0.64018439966448,903797-FS1-4,"Although dermatophytes are the most common agents of SUPERFICIAL MYCOSES in humans and animals, the molecular basis of the pathogenicity of these FUNGI is largely unknown.",FUNGI,SUPERFICIAL MYCOSES,RO-has_causative_agent
502833451,7/13/2014 20:53:43,,1322134592,7/13/2014 20:53:25,instagc,0.4274,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,146,53,,151,72,causes,0.64018439966448,903797-FS1-4,"Although dermatophytes are the most common agents of SUPERFICIAL MYCOSES in humans and animals, the molecular basis of the pathogenicity of these FUNGI is largely unknown.",FUNGI,SUPERFICIAL MYCOSES,RO-has_causative_agent
502833451,7/13/2014 22:37:04,,1322221410,7/13/2014 22:36:09,elite,0.6571,28397222,GBR,,,31.49.231.211,FUNGI causes SUPERFICIAL MYCOSES,146,53,,151,72,causes,0.64018439966448,903797-FS1-4,"Although dermatophytes are the most common agents of SUPERFICIAL MYCOSES in humans and animals, the molecular basis of the pathogenicity of these FUNGI is largely unknown.",FUNGI,SUPERFICIAL MYCOSES,RO-has_causative_agent
502833456,7/13/2014 18:43:13,,1322046131,7/13/2014 18:43:06,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,MATERNAL THROMBOCYTOPENIA causes AUTOIMMUNE THROMBOCYTOPENIA,35,111,,60,138,causes,0.9878291611472622,904798-FS1-4,The clinically important causes of MATERNAL THROMBOCYTOPENIA in pregnancy are gestational thrombocytopenia and AUTOIMMUNE THROMBOCYTOPENIA,MATERNAL THROMBOCYTOPENIA,AUTOIMMUNE THROMBOCYTOPENIA,RO-has_definitional_manifestation
502833456,7/13/2014 18:57:26,,1322052930,7/13/2014 18:57:20,neodev,0.8333,25224036,CAN,ON,Sudbury,67.204.218.187,MATERNAL THROMBOCYTOPENIA causes AUTOIMMUNE THROMBOCYTOPENIA,35,111,,60,138,causes,0.9878291611472622,904798-FS1-4,The clinically important causes of MATERNAL THROMBOCYTOPENIA in pregnancy are gestational thrombocytopenia and AUTOIMMUNE THROMBOCYTOPENIA,MATERNAL THROMBOCYTOPENIA,AUTOIMMUNE THROMBOCYTOPENIA,RO-has_definitional_manifestation
502833456,7/13/2014 19:38:49,,1322069411,7/13/2014 19:38:17,vivatic,0.5806,25451531,GBR,,,83.67.28.193,AUTOIMMUNE THROMBOCYTOPENIA causes MATERNAL THROMBOCYTOPENIA,35,111,,60,138,causes,0.9878291611472622,904798-FS1-4,The clinically important causes of MATERNAL THROMBOCYTOPENIA in pregnancy are gestational thrombocytopenia and AUTOIMMUNE THROMBOCYTOPENIA,MATERNAL THROMBOCYTOPENIA,AUTOIMMUNE THROMBOCYTOPENIA,RO-has_definitional_manifestation
502833456,7/13/2014 19:42:24,,1322071154,7/13/2014 19:41:46,neodev,0.4395,27756039,CAN,ON,Toronto,174.119.96.184,AUTOIMMUNE THROMBOCYTOPENIA causes MATERNAL THROMBOCYTOPENIA,35,111,,60,138,causes,0.9878291611472622,904798-FS1-4,The clinically important causes of MATERNAL THROMBOCYTOPENIA in pregnancy are gestational thrombocytopenia and AUTOIMMUNE THROMBOCYTOPENIA,MATERNAL THROMBOCYTOPENIA,AUTOIMMUNE THROMBOCYTOPENIA,RO-has_definitional_manifestation
502833456,7/13/2014 20:54:46,,1322135557,7/13/2014 20:54:30,instagc,0.4274,15445601,USA,FL,Jacksonville,24.129.68.254,AUTOIMMUNE THROMBOCYTOPENIA causes MATERNAL THROMBOCYTOPENIA,35,111,,60,138,causes,0.9878291611472622,904798-FS1-4,The clinically important causes of MATERNAL THROMBOCYTOPENIA in pregnancy are gestational thrombocytopenia and AUTOIMMUNE THROMBOCYTOPENIA,MATERNAL THROMBOCYTOPENIA,AUTOIMMUNE THROMBOCYTOPENIA,RO-has_definitional_manifestation
502833456,7/13/2014 21:37:09,,1322170374,7/13/2014 21:36:51,fusioncash,0.5768,22139728,USA,,,66.67.91.242,no_relation,35,111,,60,138,causes,0.9878291611472622,904798-FS1-4,The clinically important causes of MATERNAL THROMBOCYTOPENIA in pregnancy are gestational thrombocytopenia and AUTOIMMUNE THROMBOCYTOPENIA,MATERNAL THROMBOCYTOPENIA,AUTOIMMUNE THROMBOCYTOPENIA,RO-has_definitional_manifestation
502833456,7/13/2014 22:35:26,,1322220177,7/13/2014 22:34:43,elite,0.6571,28397222,GBR,,,31.49.231.211,AUTOIMMUNE THROMBOCYTOPENIA causes MATERNAL THROMBOCYTOPENIA,35,111,,60,138,causes,0.9878291611472622,904798-FS1-4,The clinically important causes of MATERNAL THROMBOCYTOPENIA in pregnancy are gestational thrombocytopenia and AUTOIMMUNE THROMBOCYTOPENIA,MATERNAL THROMBOCYTOPENIA,AUTOIMMUNE THROMBOCYTOPENIA,RO-has_definitional_manifestation
502833459,7/13/2014 19:12:34,,1322059677,7/13/2014 19:11:56,rewardsspot,0.6111,24482174,GBR,H9,London,46.23.68.180,MICROCALCIFICATIONS causes IN SITU (DCIS),241,180,,260,194,causes,0.35921060405355,902656-FS1-4,"This retrospective study correlated the mammographic manifestations and averaged nuclear grades using Holland, Van Nuys, and Lagios classifications in 37 cases of ductal carcinoma IN SITU (DCIS; microcalcifications alone were seen in 59.4%, MICROCALCIFICATIONS with associated mass in 19%, and mass alone in 21.6%.",MICROCALCIFICATIONS,IN SITU (DCIS),RO-disease_may_have_finding
502833459,7/13/2014 19:41:40,,1322070783,7/13/2014 19:40:56,instagc,0.5111,19686223,CAN,BC,Surrey,154.20.155.106,no_relation,241,180,,260,194,causes,0.35921060405355,902656-FS1-4,"This retrospective study correlated the mammographic manifestations and averaged nuclear grades using Holland, Van Nuys, and Lagios classifications in 37 cases of ductal carcinoma IN SITU (DCIS; microcalcifications alone were seen in 59.4%, MICROCALCIFICATIONS with associated mass in 19%, and mass alone in 21.6%.",MICROCALCIFICATIONS,IN SITU (DCIS),RO-disease_may_have_finding
502833459,7/13/2014 20:24:04,,1322109716,7/13/2014 20:23:30,elite,0.6726,28503042,USA,OK,Oakwood,64.250.220.169,no_relation,241,180,,260,194,causes,0.35921060405355,902656-FS1-4,"This retrospective study correlated the mammographic manifestations and averaged nuclear grades using Holland, Van Nuys, and Lagios classifications in 37 cases of ductal carcinoma IN SITU (DCIS; microcalcifications alone were seen in 59.4%, MICROCALCIFICATIONS with associated mass in 19%, and mass alone in 21.6%.",MICROCALCIFICATIONS,IN SITU (DCIS),RO-disease_may_have_finding
502833459,7/13/2014 20:36:18,,1322120058,7/13/2014 20:35:21,inboxpounds,0.65,27394419,GBR,E6,Gloucester,94.195.150.99,no_relation,241,180,,260,194,causes,0.35921060405355,902656-FS1-4,"This retrospective study correlated the mammographic manifestations and averaged nuclear grades using Holland, Van Nuys, and Lagios classifications in 37 cases of ductal carcinoma IN SITU (DCIS; microcalcifications alone were seen in 59.4%, MICROCALCIFICATIONS with associated mass in 19%, and mass alone in 21.6%.",MICROCALCIFICATIONS,IN SITU (DCIS),RO-disease_may_have_finding
502833459,7/13/2014 20:43:28,,1322125900,7/13/2014 20:43:01,prodege,0.4776,1852770,USA,TX,Abilene,76.198.102.54,no_relation,241,180,,260,194,causes,0.35921060405355,902656-FS1-4,"This retrospective study correlated the mammographic manifestations and averaged nuclear grades using Holland, Van Nuys, and Lagios classifications in 37 cases of ductal carcinoma IN SITU (DCIS; microcalcifications alone were seen in 59.4%, MICROCALCIFICATIONS with associated mass in 19%, and mass alone in 21.6%.",MICROCALCIFICATIONS,IN SITU (DCIS),RO-disease_may_have_finding
502833459,7/13/2014 20:57:52,,1322138365,7/13/2014 20:57:28,neodev,0.526,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,241,180,,260,194,causes,0.35921060405355,902656-FS1-4,"This retrospective study correlated the mammographic manifestations and averaged nuclear grades using Holland, Van Nuys, and Lagios classifications in 37 cases of ductal carcinoma IN SITU (DCIS; microcalcifications alone were seen in 59.4%, MICROCALCIFICATIONS with associated mass in 19%, and mass alone in 21.6%.",MICROCALCIFICATIONS,IN SITU (DCIS),RO-disease_may_have_finding
502833459,7/13/2014 21:30:00,,1322165345,7/13/2014 21:29:02,instagc,0.5667,20183814,USA,,,166.182.81.241,IN SITU (DCIS) causes MICROCALCIFICATIONS,241,180,,260,194,causes,0.35921060405355,902656-FS1-4,"This retrospective study correlated the mammographic manifestations and averaged nuclear grades using Holland, Van Nuys, and Lagios classifications in 37 cases of ductal carcinoma IN SITU (DCIS; microcalcifications alone were seen in 59.4%, MICROCALCIFICATIONS with associated mass in 19%, and mass alone in 21.6%.",MICROCALCIFICATIONS,IN SITU (DCIS),RO-disease_may_have_finding
502833462,7/13/2014 18:43:31,,1322046317,7/13/2014 18:43:22,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,ANEMIA treats EPOETIN ALFA,68,0,,74,12,treats,0.997054485501582,908038-FS1-2,"EPOETIN ALFA is, therefore, effective and safe in the management of ANEMIA in patients with breast cancer treated with chemotherapy.",ANEMIA,EPOETIN ALFA,RO-may_treat
502833462,7/13/2014 19:00:17,,1322054274,7/13/2014 19:00:08,neodev,0.8333,17610000,GBR,I2,Manchester,90.200.140.201,ANEMIA treats EPOETIN ALFA,68,0,,74,12,treats,0.997054485501582,908038-FS1-2,"EPOETIN ALFA is, therefore, effective and safe in the management of ANEMIA in patients with breast cancer treated with chemotherapy.",ANEMIA,EPOETIN ALFA,RO-may_treat
502833462,7/13/2014 19:20:56,,1322062926,7/13/2014 19:20:46,prodege,0.6403,6011370,CAN,BC,Richmond,70.79.45.148,EPOETIN ALFA treats ANEMIA,68,0,,74,12,treats,0.997054485501582,908038-FS1-2,"EPOETIN ALFA is, therefore, effective and safe in the management of ANEMIA in patients with breast cancer treated with chemotherapy.",ANEMIA,EPOETIN ALFA,RO-may_treat
502833462,7/13/2014 19:34:01,,1322067551,7/13/2014 19:33:22,clixsense,0.6278,15189335,GBR,K3,Peterborough,81.156.166.189,EPOETIN ALFA treats ANEMIA,68,0,,74,12,treats,0.997054485501582,908038-FS1-2,"EPOETIN ALFA is, therefore, effective and safe in the management of ANEMIA in patients with breast cancer treated with chemotherapy.",ANEMIA,EPOETIN ALFA,RO-may_treat
502833462,7/13/2014 19:39:12,,1322069522,7/13/2014 19:38:53,elite,0.5556,28276268,USA,CA,San Diego,76.88.95.100,EPOETIN ALFA treats ANEMIA,68,0,,74,12,treats,0.997054485501582,908038-FS1-2,"EPOETIN ALFA is, therefore, effective and safe in the management of ANEMIA in patients with breast cancer treated with chemotherapy.",ANEMIA,EPOETIN ALFA,RO-may_treat
502833462,7/13/2014 19:48:47,,1322076029,7/13/2014 19:48:01,instagc,0.475,27770607,USA,TX,El Paso,72.183.244.51,EPOETIN ALFA treats ANEMIA,68,0,,74,12,treats,0.997054485501582,908038-FS1-2,"EPOETIN ALFA is, therefore, effective and safe in the management of ANEMIA in patients with breast cancer treated with chemotherapy.",ANEMIA,EPOETIN ALFA,RO-may_treat
502833462,7/13/2014 21:37:09,,1322170375,7/13/2014 21:36:51,fusioncash,0.5768,22139728,USA,,,66.67.91.242,EPOETIN ALFA treats ANEMIA,68,0,,74,12,treats,0.997054485501582,908038-FS1-2,"EPOETIN ALFA is, therefore, effective and safe in the management of ANEMIA in patients with breast cancer treated with chemotherapy.",ANEMIA,EPOETIN ALFA,RO-may_treat
502833472,7/13/2014 18:50:16,,1322049481,7/13/2014 18:49:45,clixsense,0.875,27871219,NLD,07,Amsterdam,87.210.207.223,no_relation,73,88,,81,120,causes,0.42008402520840293,902725-FS1-4,"A case of a 73 years old man with macronodular liver cirrhosis, ascites, JAUNDICE and a PRIMARY HEPATOCELLULAR CARCINOMA is presented.",JAUNDICE,PRIMARY HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
502833472,7/13/2014 18:57:54,,1322053163,7/13/2014 18:57:49,neodev,0.8333,25224036,CAN,ON,Sudbury,67.204.218.187,PRIMARY HEPATOCELLULAR CARCINOMA causes JAUNDICE,73,88,,81,120,causes,0.42008402520840293,902725-FS1-4,"A case of a 73 years old man with macronodular liver cirrhosis, ascites, JAUNDICE and a PRIMARY HEPATOCELLULAR CARCINOMA is presented.",JAUNDICE,PRIMARY HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
502833472,7/13/2014 19:09:26,,1322058325,7/13/2014 19:09:09,clixsense,0.6806,19803139,NLD,11,Leiden,82.139.76.131,no_relation,73,88,,81,120,causes,0.42008402520840293,902725-FS1-4,"A case of a 73 years old man with macronodular liver cirrhosis, ascites, JAUNDICE and a PRIMARY HEPATOCELLULAR CARCINOMA is presented.",JAUNDICE,PRIMARY HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
502833472,7/13/2014 19:31:09,,1322066618,7/13/2014 19:30:38,clixsense,0.6278,15189335,GBR,K3,Peterborough,81.156.166.189,PRIMARY HEPATOCELLULAR CARCINOMA causes JAUNDICE,73,88,,81,120,causes,0.42008402520840293,902725-FS1-4,"A case of a 73 years old man with macronodular liver cirrhosis, ascites, JAUNDICE and a PRIMARY HEPATOCELLULAR CARCINOMA is presented.",JAUNDICE,PRIMARY HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
502833472,7/13/2014 19:40:51,,1322070285,7/13/2014 19:40:12,vivatic,0.5806,25451531,GBR,,,83.67.28.193,no_relation,73,88,,81,120,causes,0.42008402520840293,902725-FS1-4,"A case of a 73 years old man with macronodular liver cirrhosis, ascites, JAUNDICE and a PRIMARY HEPATOCELLULAR CARCINOMA is presented.",JAUNDICE,PRIMARY HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
502833472,7/13/2014 19:47:06,,1322074648,7/13/2014 19:46:26,instagc,0.475,27770607,USA,TX,El Paso,72.183.244.51,no_relation,73,88,,81,120,causes,0.42008402520840293,902725-FS1-4,"A case of a 73 years old man with macronodular liver cirrhosis, ascites, JAUNDICE and a PRIMARY HEPATOCELLULAR CARCINOMA is presented.",JAUNDICE,PRIMARY HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
502833472,7/13/2014 20:41:04,,1322124064,7/13/2014 20:40:32,prodege,0.4776,1852770,USA,TX,Abilene,76.198.102.54,no_relation,73,88,,81,120,causes,0.42008402520840293,902725-FS1-4,"A case of a 73 years old man with macronodular liver cirrhosis, ascites, JAUNDICE and a PRIMARY HEPATOCELLULAR CARCINOMA is presented.",JAUNDICE,PRIMARY HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
502833475,7/13/2014 18:49:09,,1322049049,7/13/2014 18:48:28,clixsense,0.875,27871219,NLD,07,Amsterdam,87.210.207.223,BONE MARROW is location of MYELODYSPLASTIC SYNDROME,134,149,,145,173,is location of,0.5,905277-FS1-9,Apoptosis and its dysregulation have been implicated in dysplastic and ineffective hematopoiesis and the neoplastic transformation of BONE MARROW in MYELODYSPLASTIC SYNDROME (MDS.,BONE MARROW,MYELODYSPLASTIC SYNDROME,RO-has_finding_site
502833475,7/13/2014 19:21:24,,1322063063,7/13/2014 19:21:08,prodege,0.6403,6011370,CAN,BC,Richmond,70.79.45.148,BONE MARROW is location of MYELODYSPLASTIC SYNDROME,134,149,,145,173,is location of,0.5,905277-FS1-9,Apoptosis and its dysregulation have been implicated in dysplastic and ineffective hematopoiesis and the neoplastic transformation of BONE MARROW in MYELODYSPLASTIC SYNDROME (MDS.,BONE MARROW,MYELODYSPLASTIC SYNDROME,RO-has_finding_site
502833475,7/13/2014 19:39:56,,1322069889,7/13/2014 19:39:20,sendearnings,0.5385,11896941,USA,FL,Seminole,97.106.105.251,MYELODYSPLASTIC SYNDROME is location of BONE MARROW,134,149,,145,173,is location of,0.5,905277-FS1-9,Apoptosis and its dysregulation have been implicated in dysplastic and ineffective hematopoiesis and the neoplastic transformation of BONE MARROW in MYELODYSPLASTIC SYNDROME (MDS.,BONE MARROW,MYELODYSPLASTIC SYNDROME,RO-has_finding_site
502833475,7/13/2014 19:48:47,,1322076030,7/13/2014 19:48:01,instagc,0.475,27770607,USA,TX,El Paso,72.183.244.51,no_relation,134,149,,145,173,is location of,0.5,905277-FS1-9,Apoptosis and its dysregulation have been implicated in dysplastic and ineffective hematopoiesis and the neoplastic transformation of BONE MARROW in MYELODYSPLASTIC SYNDROME (MDS.,BONE MARROW,MYELODYSPLASTIC SYNDROME,RO-has_finding_site
502833475,7/13/2014 20:20:47,,1322106866,7/13/2014 20:20:13,superrewards,0.4583,26561650,NLD,,,81.205.191.81,MYELODYSPLASTIC SYNDROME is location of BONE MARROW,134,149,,145,173,is location of,0.5,905277-FS1-9,Apoptosis and its dysregulation have been implicated in dysplastic and ineffective hematopoiesis and the neoplastic transformation of BONE MARROW in MYELODYSPLASTIC SYNDROME (MDS.,BONE MARROW,MYELODYSPLASTIC SYNDROME,RO-has_finding_site
502833475,7/13/2014 20:25:50,,1322111280,7/13/2014 20:25:29,gifthulk,0.6079,21916793,GBR,,,87.113.87.199,BONE MARROW is location of MYELODYSPLASTIC SYNDROME,134,149,,145,173,is location of,0.5,905277-FS1-9,Apoptosis and its dysregulation have been implicated in dysplastic and ineffective hematopoiesis and the neoplastic transformation of BONE MARROW in MYELODYSPLASTIC SYNDROME (MDS.,BONE MARROW,MYELODYSPLASTIC SYNDROME,RO-has_finding_site
502833475,7/13/2014 20:36:18,,1322120056,7/13/2014 20:35:21,inboxpounds,0.65,27394419,GBR,E6,Gloucester,94.195.150.99,BONE MARROW is location of MYELODYSPLASTIC SYNDROME,134,149,,145,173,is location of,0.5,905277-FS1-9,Apoptosis and its dysregulation have been implicated in dysplastic and ineffective hematopoiesis and the neoplastic transformation of BONE MARROW in MYELODYSPLASTIC SYNDROME (MDS.,BONE MARROW,MYELODYSPLASTIC SYNDROME,RO-has_finding_site
502833482,7/13/2014 18:43:55,,1322046539,7/13/2014 18:43:47,prodege,1.0,2143114,CAN,BC,Vancouver,24.84.160.12,FACTOR VIII (FVIII causes VON WILLEBRAND'S DISEASE,30,110,,54,128,causes,0.416025147168922,908082-FS1-4,"Patients with severe forms of VON WILLEBRAND'S DISEASE (VWD) may have frequent haemarthroses, especially when FACTOR VIII (FVIII) levels are below 10 U/dL, so that some of them develop target joints like patients with severe haemophilia A. Some patients have recurrent gastrointestinal bleeding, often without lesions in the gastrointestinal tract, and need treatment every day or every other day.",VON WILLEBRAND'S DISEASE,FACTOR VIII (FVIII,RO-may_treat
502833482,7/13/2014 18:49:43,,1322049234,7/13/2014 18:49:11,clixsense,0.875,27871219,NLD,07,Amsterdam,87.210.207.223,no_relation,30,110,,54,128,causes,0.416025147168922,908082-FS1-4,"Patients with severe forms of VON WILLEBRAND'S DISEASE (VWD) may have frequent haemarthroses, especially when FACTOR VIII (FVIII) levels are below 10 U/dL, so that some of them develop target joints like patients with severe haemophilia A. Some patients have recurrent gastrointestinal bleeding, often without lesions in the gastrointestinal tract, and need treatment every day or every other day.",VON WILLEBRAND'S DISEASE,FACTOR VIII (FVIII,RO-may_treat
502833482,7/13/2014 18:57:40,,1322053043,7/13/2014 18:57:34,neodev,0.8333,25224036,CAN,ON,Sudbury,67.204.218.187,VON WILLEBRAND'S DISEASE causes FACTOR VIII (FVIII,30,110,,54,128,causes,0.416025147168922,908082-FS1-4,"Patients with severe forms of VON WILLEBRAND'S DISEASE (VWD) may have frequent haemarthroses, especially when FACTOR VIII (FVIII) levels are below 10 U/dL, so that some of them develop target joints like patients with severe haemophilia A. Some patients have recurrent gastrointestinal bleeding, often without lesions in the gastrointestinal tract, and need treatment every day or every other day.",VON WILLEBRAND'S DISEASE,FACTOR VIII (FVIII,RO-may_treat
502833482,7/13/2014 19:07:54,,1322057639,7/13/2014 19:07:29,clixsense,0.6806,19803139,NLD,11,Leiden,82.139.76.131,VON WILLEBRAND'S DISEASE causes FACTOR VIII (FVIII,30,110,,54,128,causes,0.416025147168922,908082-FS1-4,"Patients with severe forms of VON WILLEBRAND'S DISEASE (VWD) may have frequent haemarthroses, especially when FACTOR VIII (FVIII) levels are below 10 U/dL, so that some of them develop target joints like patients with severe haemophilia A. Some patients have recurrent gastrointestinal bleeding, often without lesions in the gastrointestinal tract, and need treatment every day or every other day.",VON WILLEBRAND'S DISEASE,FACTOR VIII (FVIII,RO-may_treat
502833482,7/13/2014 19:42:24,,1322071151,7/13/2014 19:41:46,neodev,0.4395,27756039,CAN,ON,Toronto,174.119.96.184,no_relation,30,110,,54,128,causes,0.416025147168922,908082-FS1-4,"Patients with severe forms of VON WILLEBRAND'S DISEASE (VWD) may have frequent haemarthroses, especially when FACTOR VIII (FVIII) levels are below 10 U/dL, so that some of them develop target joints like patients with severe haemophilia A. Some patients have recurrent gastrointestinal bleeding, often without lesions in the gastrointestinal tract, and need treatment every day or every other day.",VON WILLEBRAND'S DISEASE,FACTOR VIII (FVIII,RO-may_treat
502833482,7/13/2014 19:42:33,,1322071267,7/13/2014 19:41:41,instagc,0.5111,19686223,CAN,BC,Surrey,154.20.155.106,FACTOR VIII (FVIII causes VON WILLEBRAND'S DISEASE,30,110,,54,128,causes,0.416025147168922,908082-FS1-4,"Patients with severe forms of VON WILLEBRAND'S DISEASE (VWD) may have frequent haemarthroses, especially when FACTOR VIII (FVIII) levels are below 10 U/dL, so that some of them develop target joints like patients with severe haemophilia A. Some patients have recurrent gastrointestinal bleeding, often without lesions in the gastrointestinal tract, and need treatment every day or every other day.",VON WILLEBRAND'S DISEASE,FACTOR VIII (FVIII,RO-may_treat
502833482,7/13/2014 19:49:29,,1322076549,7/13/2014 19:48:48,instagc,0.475,27770607,USA,TX,El Paso,72.183.244.51,no_relation,30,110,,54,128,causes,0.416025147168922,908082-FS1-4,"Patients with severe forms of VON WILLEBRAND'S DISEASE (VWD) may have frequent haemarthroses, especially when FACTOR VIII (FVIII) levels are below 10 U/dL, so that some of them develop target joints like patients with severe haemophilia A. Some patients have recurrent gastrointestinal bleeding, often without lesions in the gastrointestinal tract, and need treatment every day or every other day.",VON WILLEBRAND'S DISEASE,FACTOR VIII (FVIII,RO-may_treat
502833483,7/13/2014 19:12:17,,1322059533,7/13/2014 19:11:56,neodev,0.7917,18517457,GBR,,,86.29.147.112,LIVERS is location of CHRONIC HEPATITIS,87,38,,93,55,is location of,0.9615239476408229,902285-FS1-9,A variety of liver diseases including CHRONIC HEPATITIS and cirrhosis were seen in the LIVERS of a majority of the ducks from Chi tung.,LIVERS,CHRONIC HEPATITIS,RO-disease_has_primary_anatomic_site
502833483,7/13/2014 19:13:28,,1322059959,7/13/2014 19:12:39,rewardsspot,0.6111,24482174,GBR,H9,London,46.23.68.180,CHRONIC HEPATITIS is location of LIVERS,87,38,,93,55,is location of,0.9615239476408229,902285-FS1-9,A variety of liver diseases including CHRONIC HEPATITIS and cirrhosis were seen in the LIVERS of a majority of the ducks from Chi tung.,LIVERS,CHRONIC HEPATITIS,RO-disease_has_primary_anatomic_site
502833483,7/13/2014 19:21:54,,1322063247,7/13/2014 19:21:48,prodege,0.6403,6011370,CAN,BC,Richmond,70.79.45.148,LIVERS is location of CHRONIC HEPATITIS,87,38,,93,55,is location of,0.9615239476408229,902285-FS1-9,A variety of liver diseases including CHRONIC HEPATITIS and cirrhosis were seen in the LIVERS of a majority of the ducks from Chi tung.,LIVERS,CHRONIC HEPATITIS,RO-disease_has_primary_anatomic_site
502833483,7/13/2014 19:47:06,,1322074646,7/13/2014 19:46:26,instagc,0.475,27770607,USA,TX,El Paso,72.183.244.51,LIVERS is location of CHRONIC HEPATITIS,87,38,,93,55,is location of,0.9615239476408229,902285-FS1-9,A variety of liver diseases including CHRONIC HEPATITIS and cirrhosis were seen in the LIVERS of a majority of the ducks from Chi tung.,LIVERS,CHRONIC HEPATITIS,RO-disease_has_primary_anatomic_site
502833483,7/13/2014 20:41:41,,1322124506,7/13/2014 20:41:13,tremorgames,0.5373,28013393,USA,CA,Rancho Cordova,71.197.67.37,LIVERS is location of CHRONIC HEPATITIS,87,38,,93,55,is location of,0.9615239476408229,902285-FS1-9,A variety of liver diseases including CHRONIC HEPATITIS and cirrhosis were seen in the LIVERS of a majority of the ducks from Chi tung.,LIVERS,CHRONIC HEPATITIS,RO-disease_has_primary_anatomic_site
502833483,7/13/2014 20:54:28,,1322135372,7/13/2014 20:54:21,instagc,0.4274,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,87,38,,93,55,is location of,0.9615239476408229,902285-FS1-9,A variety of liver diseases including CHRONIC HEPATITIS and cirrhosis were seen in the LIVERS of a majority of the ducks from Chi tung.,LIVERS,CHRONIC HEPATITIS,RO-disease_has_primary_anatomic_site
502833483,7/13/2014 21:37:52,,1322170947,7/13/2014 21:37:39,fusioncash,0.5768,22139728,USA,,,66.67.91.242,LIVERS is location of CHRONIC HEPATITIS,87,38,,93,55,is location of,0.9615239476408229,902285-FS1-9,A variety of liver diseases including CHRONIC HEPATITIS and cirrhosis were seen in the LIVERS of a majority of the ducks from Chi tung.,LIVERS,CHRONIC HEPATITIS,RO-disease_has_primary_anatomic_site
502833489,7/13/2014 19:11:55,,1322059370,7/13/2014 19:11:35,neodev,0.7917,18517457,GBR,,,86.29.147.112,GASTROINTESTINAL TRACT causes DIARRHEA,17,88,,39,96,causes,0.9434563530497259,905080-FS1-4,"All patients had GASTROINTESTINAL TRACT symptoms, with 30 patients (91%) complaining of DIARRHEA and 23 patients (70%) complaining of vomiting; these symptoms occurred early in the disease and were of short duration.",GASTROINTESTINAL TRACT,DIARRHEA,RO-has_finding_site
502833489,7/13/2014 19:21:46,,1322063216,7/13/2014 19:21:38,prodege,0.6403,6011370,CAN,BC,Richmond,70.79.45.148,GASTROINTESTINAL TRACT causes DIARRHEA,17,88,,39,96,causes,0.9434563530497259,905080-FS1-4,"All patients had GASTROINTESTINAL TRACT symptoms, with 30 patients (91%) complaining of DIARRHEA and 23 patients (70%) complaining of vomiting; these symptoms occurred early in the disease and were of short duration.",GASTROINTESTINAL TRACT,DIARRHEA,RO-has_finding_site
502833489,7/13/2014 19:39:56,,1322069888,7/13/2014 19:39:20,sendearnings,0.5385,11896941,USA,FL,Seminole,97.106.105.251,GASTROINTESTINAL TRACT causes DIARRHEA,17,88,,39,96,causes,0.9434563530497259,905080-FS1-4,"All patients had GASTROINTESTINAL TRACT symptoms, with 30 patients (91%) complaining of DIARRHEA and 23 patients (70%) complaining of vomiting; these symptoms occurred early in the disease and were of short duration.",GASTROINTESTINAL TRACT,DIARRHEA,RO-has_finding_site
502833489,7/13/2014 20:26:24,,1322111730,7/13/2014 20:26:07,elite,0.6726,28503042,USA,OK,Oakwood,64.250.220.169,GASTROINTESTINAL TRACT causes DIARRHEA,17,88,,39,96,causes,0.9434563530497259,905080-FS1-4,"All patients had GASTROINTESTINAL TRACT symptoms, with 30 patients (91%) complaining of DIARRHEA and 23 patients (70%) complaining of vomiting; these symptoms occurred early in the disease and were of short duration.",GASTROINTESTINAL TRACT,DIARRHEA,RO-has_finding_site
502833489,7/13/2014 20:41:04,,1322124065,7/13/2014 20:40:32,prodege,0.4776,1852770,USA,TX,Abilene,76.198.102.54,no_relation,17,88,,39,96,causes,0.9434563530497259,905080-FS1-4,"All patients had GASTROINTESTINAL TRACT symptoms, with 30 patients (91%) complaining of DIARRHEA and 23 patients (70%) complaining of vomiting; these symptoms occurred early in the disease and were of short duration.",GASTROINTESTINAL TRACT,DIARRHEA,RO-has_finding_site
502833489,7/13/2014 20:54:20,,1322135241,7/13/2014 20:54:04,instagc,0.4274,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,17,88,,39,96,causes,0.9434563530497259,905080-FS1-4,"All patients had GASTROINTESTINAL TRACT symptoms, with 30 patients (91%) complaining of DIARRHEA and 23 patients (70%) complaining of vomiting; these symptoms occurred early in the disease and were of short duration.",GASTROINTESTINAL TRACT,DIARRHEA,RO-has_finding_site
502833489,7/13/2014 21:02:38,,1322142603,7/13/2014 21:02:19,neodev,0.526,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,17,88,,39,96,causes,0.9434563530497259,905080-FS1-4,"All patients had GASTROINTESTINAL TRACT symptoms, with 30 patients (91%) complaining of DIARRHEA and 23 patients (70%) complaining of vomiting; these symptoms occurred early in the disease and were of short duration.",GASTROINTESTINAL TRACT,DIARRHEA,RO-has_finding_site
502904667,7/14/2014 10:21:52,,1322711917,7/14/2014 10:21:26,prodege,0.6625,27934334,GBR,Q2,Wokingham,86.166.73.21,no_relation,98,26,,102,57,diagnosed by,0.693375245281537,905265-FS1-13,The standard radiological DIAGNOSIS OF ADVANCED SCOLIOSIS consists of roentgenograms of the total SPINE in anterior posterior and lateral views.,SPINE,DIAGNOSIS OF ADVANCED SCOLIOSIS,RO-has_finding_site
502904667,7/14/2014 10:27:31,,1322715925,7/14/2014 10:27:25,instagc,0.7986,27753923,GBR,,,188.30.192.65,DIAGNOSIS OF ADVANCED SCOLIOSIS diagnosed by SPINE,98,26,,102,57,diagnosed by,0.693375245281537,905265-FS1-13,The standard radiological DIAGNOSIS OF ADVANCED SCOLIOSIS consists of roentgenograms of the total SPINE in anterior posterior and lateral views.,SPINE,DIAGNOSIS OF ADVANCED SCOLIOSIS,RO-has_finding_site
502904667,7/14/2014 10:53:23,,1322734568,7/14/2014 10:53:07,clixsense,0.5597,27793793,GBR,C5,Chester,151.230.27.155,no_relation,98,26,,102,57,diagnosed by,0.693375245281537,905265-FS1-13,The standard radiological DIAGNOSIS OF ADVANCED SCOLIOSIS consists of roentgenograms of the total SPINE in anterior posterior and lateral views.,SPINE,DIAGNOSIS OF ADVANCED SCOLIOSIS,RO-has_finding_site
502904667,7/14/2014 10:59:33,,1322738671,7/14/2014 10:59:12,instagc,0.5532,28301350,GBR,K4,Plymouth,78.145.138.150,no_relation,98,26,,102,57,diagnosed by,0.693375245281537,905265-FS1-13,The standard radiological DIAGNOSIS OF ADVANCED SCOLIOSIS consists of roentgenograms of the total SPINE in anterior posterior and lateral views.,SPINE,DIAGNOSIS OF ADVANCED SCOLIOSIS,RO-has_finding_site
502904667,7/14/2014 11:01:15,,1322739789,7/14/2014 11:00:29,instagc,0.4815,23149109,USA,NC,Durham,75.189.206.205,no_relation,98,26,,102,57,diagnosed by,0.693375245281537,905265-FS1-13,The standard radiological DIAGNOSIS OF ADVANCED SCOLIOSIS consists of roentgenograms of the total SPINE in anterior posterior and lateral views.,SPINE,DIAGNOSIS OF ADVANCED SCOLIOSIS,RO-has_finding_site
502904667,7/14/2014 11:03:37,,1322741188,7/14/2014 11:03:13,gifthulk,0.7087,21916793,GBR,,,87.113.87.199,no_relation,98,26,,102,57,diagnosed by,0.693375245281537,905265-FS1-13,The standard radiological DIAGNOSIS OF ADVANCED SCOLIOSIS consists of roentgenograms of the total SPINE in anterior posterior and lateral views.,SPINE,DIAGNOSIS OF ADVANCED SCOLIOSIS,RO-has_finding_site
502904667,7/14/2014 11:35:23,,1322764326,7/14/2014 11:34:43,clixsense,0.4976,21689102,CAN,ON,Oshawa,70.24.112.89,DIAGNOSIS OF ADVANCED SCOLIOSIS diagnosed by SPINE,98,26,,102,57,diagnosed by,0.693375245281537,905265-FS1-13,The standard radiological DIAGNOSIS OF ADVANCED SCOLIOSIS consists of roentgenograms of the total SPINE in anterior posterior and lateral views.,SPINE,DIAGNOSIS OF ADVANCED SCOLIOSIS,RO-has_finding_site
502904668,7/14/2014 10:08:02,,1322701990,7/14/2014 10:07:22,instagc,0.8889,25901556,GBR,C3,Saint Ives,82.9.129.2,no_relation,86,21,,103,51,causes,0.442325868464691,901775-FS1-4,Three primary and 16 METASTATIC MELANOMA CELL LINES were established from primary and METASTATIC LESIONS of 4 patients with malignant melanoma.,METASTATIC LESIONS,METASTATIC MELANOMA CELL LINES,RO-disease_has_finding
502904668,7/14/2014 10:08:38,,1322702541,7/14/2014 10:08:15,clixsense,0.8056,19803139,NLD,11,Leiden,82.139.76.131,no_relation,86,21,,103,51,causes,0.442325868464691,901775-FS1-4,Three primary and 16 METASTATIC MELANOMA CELL LINES were established from primary and METASTATIC LESIONS of 4 patients with malignant melanoma.,METASTATIC LESIONS,METASTATIC MELANOMA CELL LINES,RO-disease_has_finding
502904668,7/14/2014 10:41:38,,1322725946,7/14/2014 10:40:42,prodege,0.5958,24403612,CAN,ON,Ajax,99.242.234.239,no_relation,86,21,,103,51,causes,0.442325868464691,901775-FS1-4,Three primary and 16 METASTATIC MELANOMA CELL LINES were established from primary and METASTATIC LESIONS of 4 patients with malignant melanoma.,METASTATIC LESIONS,METASTATIC MELANOMA CELL LINES,RO-disease_has_finding
502904668,7/14/2014 10:48:44,,1322731313,7/14/2014 10:47:47,elite,0.6026,28397222,GBR,Y4,Usk,31.50.223.75,METASTATIC MELANOMA CELL LINES causes METASTATIC LESIONS,86,21,,103,51,causes,0.442325868464691,901775-FS1-4,Three primary and 16 METASTATIC MELANOMA CELL LINES were established from primary and METASTATIC LESIONS of 4 patients with malignant melanoma.,METASTATIC LESIONS,METASTATIC MELANOMA CELL LINES,RO-disease_has_finding
502904668,7/14/2014 10:59:37,,1322738695,7/14/2014 10:58:52,instagc,0.4815,23149109,USA,NC,Durham,75.189.206.205,METASTATIC MELANOMA CELL LINES causes METASTATIC LESIONS,86,21,,103,51,causes,0.442325868464691,901775-FS1-4,Three primary and 16 METASTATIC MELANOMA CELL LINES were established from primary and METASTATIC LESIONS of 4 patients with malignant melanoma.,METASTATIC LESIONS,METASTATIC MELANOMA CELL LINES,RO-disease_has_finding
502904668,7/14/2014 11:37:54,,1322766120,7/14/2014 11:37:31,instagc,0.4613,15445601,USA,FL,Jacksonville,24.129.68.254,METASTATIC MELANOMA CELL LINES causes METASTATIC LESIONS,86,21,,103,51,causes,0.442325868464691,901775-FS1-4,Three primary and 16 METASTATIC MELANOMA CELL LINES were established from primary and METASTATIC LESIONS of 4 patients with malignant melanoma.,METASTATIC LESIONS,METASTATIC MELANOMA CELL LINES,RO-disease_has_finding
502904668,7/14/2014 11:45:47,,1322771682,7/14/2014 11:45:17,rewardsspot,0.5710000000000001,24482174,GBR,H9,London,46.23.68.180,METASTATIC MELANOMA CELL LINES causes METASTATIC LESIONS,86,21,,103,51,causes,0.442325868464691,901775-FS1-4,Three primary and 16 METASTATIC MELANOMA CELL LINES were established from primary and METASTATIC LESIONS of 4 patients with malignant melanoma.,METASTATIC LESIONS,METASTATIC MELANOMA CELL LINES,RO-disease_has_finding
502904692,7/14/2014 10:03:37,,1322698524,7/14/2014 10:02:49,clixsense,0.9722,15189335,GBR,K3,Peterborough,81.156.166.189,SPINE is location of DIAGNOSIS OF ADVANCED SCOLIOSIS,98,26,,102,57,is location of,0.693375245281537,905265-FS1-9,The standard radiological DIAGNOSIS OF ADVANCED SCOLIOSIS consists of roentgenograms of the total SPINE in anterior posterior and lateral views.,SPINE,DIAGNOSIS OF ADVANCED SCOLIOSIS,RO-has_finding_site
502904692,7/14/2014 10:09:44,,1322703324,7/14/2014 10:09:30,clixsense,0.8056,19803139,NLD,11,Leiden,82.139.76.131,SPINE is location of DIAGNOSIS OF ADVANCED SCOLIOSIS,98,26,,102,57,is location of,0.693375245281537,905265-FS1-9,The standard radiological DIAGNOSIS OF ADVANCED SCOLIOSIS consists of roentgenograms of the total SPINE in anterior posterior and lateral views.,SPINE,DIAGNOSIS OF ADVANCED SCOLIOSIS,RO-has_finding_site
502904692,7/14/2014 10:21:55,,1322711927,7/14/2014 10:21:39,clixsense,0.7139,27871219,NLD,07,Amsterdam,87.210.207.223,SPINE is location of DIAGNOSIS OF ADVANCED SCOLIOSIS,98,26,,102,57,is location of,0.693375245281537,905265-FS1-9,The standard radiological DIAGNOSIS OF ADVANCED SCOLIOSIS consists of roentgenograms of the total SPINE in anterior posterior and lateral views.,SPINE,DIAGNOSIS OF ADVANCED SCOLIOSIS,RO-has_finding_site
502904692,7/14/2014 10:27:24,,1322715826,7/14/2014 10:27:19,instagc,0.7986,27753923,GBR,,,188.30.192.65,SPINE is location of DIAGNOSIS OF ADVANCED SCOLIOSIS,98,26,,102,57,is location of,0.693375245281537,905265-FS1-9,The standard radiological DIAGNOSIS OF ADVANCED SCOLIOSIS consists of roentgenograms of the total SPINE in anterior posterior and lateral views.,SPINE,DIAGNOSIS OF ADVANCED SCOLIOSIS,RO-has_finding_site
502904692,7/14/2014 11:08:43,,1322744819,7/14/2014 11:07:57,bitcoinget,0.3,28371854,GBR,K9,Middlesbrough,79.170.75.76,DIAGNOSIS OF ADVANCED SCOLIOSIS is location of SPINE,98,26,,102,57,is location of,0.693375245281537,905265-FS1-9,The standard radiological DIAGNOSIS OF ADVANCED SCOLIOSIS consists of roentgenograms of the total SPINE in anterior posterior and lateral views.,SPINE,DIAGNOSIS OF ADVANCED SCOLIOSIS,RO-has_finding_site
502904692,7/14/2014 11:50:22,,1322775027,7/14/2014 11:50:05,clixsense,0.3881,24763049,GBR,,,86.133.47.213,SPINE is location of DIAGNOSIS OF ADVANCED SCOLIOSIS,98,26,,102,57,is location of,0.693375245281537,905265-FS1-9,The standard radiological DIAGNOSIS OF ADVANCED SCOLIOSIS consists of roentgenograms of the total SPINE in anterior posterior and lateral views.,SPINE,DIAGNOSIS OF ADVANCED SCOLIOSIS,RO-has_finding_site
502904692,7/14/2014 11:50:37,,1322775129,7/14/2014 11:49:57,elite,0.6935,28322695,GBR,A3,Barnsley,217.44.205.195,SPINE is location of DIAGNOSIS OF ADVANCED SCOLIOSIS,98,26,,102,57,is location of,0.693375245281537,905265-FS1-9,The standard radiological DIAGNOSIS OF ADVANCED SCOLIOSIS consists of roentgenograms of the total SPINE in anterior posterior and lateral views.,SPINE,DIAGNOSIS OF ADVANCED SCOLIOSIS,RO-has_finding_site
502904698,7/14/2014 10:08:56,,1322702719,7/14/2014 10:08:02,instagc,0.8889,25901556,GBR,C3,Saint Ives,82.9.129.2,EPINEPHRINE treats VENTRICULAR FIBRILLATION,84,279,,107,290,treats,0.975900072948533,907970-FS1-2,"The study demonstrated that vasopressin is similar to epinephrine for OOH CA due to VENTRICULAR FIBRILLATION or pulseless electrical activity, and superior to epinephrine for the initial treatment of asystolic arrest; it also demonstrated that the combination of vasopressin and EPINEPHRINE is superior to epinephrine alone in the treatment of refractory, out of hospital cardiac arrest.",VENTRICULAR FIBRILLATION,EPINEPHRINE,RO-may_treat
502904698,7/14/2014 10:09:18,,1322702918,7/14/2014 10:08:57,clixsense,0.9722,15189335,GBR,K3,Peterborough,81.156.166.189,EPINEPHRINE treats VENTRICULAR FIBRILLATION,84,279,,107,290,treats,0.975900072948533,907970-FS1-2,"The study demonstrated that vasopressin is similar to epinephrine for OOH CA due to VENTRICULAR FIBRILLATION or pulseless electrical activity, and superior to epinephrine for the initial treatment of asystolic arrest; it also demonstrated that the combination of vasopressin and EPINEPHRINE is superior to epinephrine alone in the treatment of refractory, out of hospital cardiac arrest.",VENTRICULAR FIBRILLATION,EPINEPHRINE,RO-may_treat
502904698,7/14/2014 10:11:09,,1322704476,7/14/2014 10:10:04,prodege,0.8056,21891314,AUS,07,Glen Iris,58.6.248.249,no_relation,84,279,,107,290,treats,0.975900072948533,907970-FS1-2,"The study demonstrated that vasopressin is similar to epinephrine for OOH CA due to VENTRICULAR FIBRILLATION or pulseless electrical activity, and superior to epinephrine for the initial treatment of asystolic arrest; it also demonstrated that the combination of vasopressin and EPINEPHRINE is superior to epinephrine alone in the treatment of refractory, out of hospital cardiac arrest.",VENTRICULAR FIBRILLATION,EPINEPHRINE,RO-may_treat
502904698,7/14/2014 10:13:22,,1322705956,7/14/2014 10:13:16,neodev,0.6944,17610000,GBR,I2,Manchester,90.200.140.201,VENTRICULAR FIBRILLATION treats EPINEPHRINE,84,279,,107,290,treats,0.975900072948533,907970-FS1-2,"The study demonstrated that vasopressin is similar to epinephrine for OOH CA due to VENTRICULAR FIBRILLATION or pulseless electrical activity, and superior to epinephrine for the initial treatment of asystolic arrest; it also demonstrated that the combination of vasopressin and EPINEPHRINE is superior to epinephrine alone in the treatment of refractory, out of hospital cardiac arrest.",VENTRICULAR FIBRILLATION,EPINEPHRINE,RO-may_treat
502904698,7/14/2014 10:13:29,,1322706084,7/14/2014 10:12:29,instagc,0.7903,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,84,279,,107,290,treats,0.975900072948533,907970-FS1-2,"The study demonstrated that vasopressin is similar to epinephrine for OOH CA due to VENTRICULAR FIBRILLATION or pulseless electrical activity, and superior to epinephrine for the initial treatment of asystolic arrest; it also demonstrated that the combination of vasopressin and EPINEPHRINE is superior to epinephrine alone in the treatment of refractory, out of hospital cardiac arrest.",VENTRICULAR FIBRILLATION,EPINEPHRINE,RO-may_treat
502904698,7/14/2014 10:48:44,,1322731371,7/14/2014 10:47:47,elite,0.6026,28397222,GBR,Y4,Usk,31.50.223.75,no_relation,84,279,,107,290,treats,0.975900072948533,907970-FS1-2,"The study demonstrated that vasopressin is similar to epinephrine for OOH CA due to VENTRICULAR FIBRILLATION or pulseless electrical activity, and superior to epinephrine for the initial treatment of asystolic arrest; it also demonstrated that the combination of vasopressin and EPINEPHRINE is superior to epinephrine alone in the treatment of refractory, out of hospital cardiac arrest.",VENTRICULAR FIBRILLATION,EPINEPHRINE,RO-may_treat
502904698,7/14/2014 11:02:46,,1322740673,7/14/2014 11:01:57,instagc,0.4815,23149109,USA,NC,Durham,75.189.206.205,EPINEPHRINE treats VENTRICULAR FIBRILLATION,84,279,,107,290,treats,0.975900072948533,907970-FS1-2,"The study demonstrated that vasopressin is similar to epinephrine for OOH CA due to VENTRICULAR FIBRILLATION or pulseless electrical activity, and superior to epinephrine for the initial treatment of asystolic arrest; it also demonstrated that the combination of vasopressin and EPINEPHRINE is superior to epinephrine alone in the treatment of refractory, out of hospital cardiac arrest.",VENTRICULAR FIBRILLATION,EPINEPHRINE,RO-may_treat
502904702,7/14/2014 10:10:40,,1322704020,7/14/2014 10:10:05,instagc,0.8889,25901556,GBR,C3,Saint Ives,82.9.129.2,no_relation,110,153,,129,203,diagnosed by,0.353553390593274,907453-FS1-13,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of VITAMIN A DEFICIENCY but instead reflect a DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER.,VITAMIN A DEFICIENCY,DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER,RO-may_prevent
502904702,7/14/2014 10:50:32,,1322732574,7/14/2014 10:50:07,prodege,0.5599,15439740,AUS,02,Jannali,27.96.208.89,DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER diagnosed by VITAMIN A DEFICIENCY,110,153,,129,203,diagnosed by,0.353553390593274,907453-FS1-13,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of VITAMIN A DEFICIENCY but instead reflect a DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER.,VITAMIN A DEFICIENCY,DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER,RO-may_prevent
502904702,7/14/2014 10:51:27,,1322733170,7/14/2014 10:50:32,elite,0.6026,28397222,GBR,Y4,Usk,31.50.223.75,no_relation,110,153,,129,203,diagnosed by,0.353553390593274,907453-FS1-13,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of VITAMIN A DEFICIENCY but instead reflect a DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER.,VITAMIN A DEFICIENCY,DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER,RO-may_prevent
502904702,7/14/2014 11:06:25,,1322743267,7/14/2014 11:05:48,clixsense,0.5853,27969116,NLD,,,91.213.37.165,no_relation,110,153,,129,203,diagnosed by,0.353553390593274,907453-FS1-13,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of VITAMIN A DEFICIENCY but instead reflect a DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER.,VITAMIN A DEFICIENCY,DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER,RO-may_prevent
502904702,7/14/2014 11:38:01,,1322766187,7/14/2014 11:37:55,instagc,0.4613,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,110,153,,129,203,diagnosed by,0.353553390593274,907453-FS1-13,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of VITAMIN A DEFICIENCY but instead reflect a DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER.,VITAMIN A DEFICIENCY,DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER,RO-may_prevent
502904702,7/14/2014 11:48:33,,1322773696,7/14/2014 11:47:53,rewardsspot,0.5710000000000001,24482174,GBR,H9,London,46.23.68.180,VITAMIN A DEFICIENCY diagnosed by DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER,110,153,,129,203,diagnosed by,0.353553390593274,907453-FS1-13,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of VITAMIN A DEFICIENCY but instead reflect a DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER.,VITAMIN A DEFICIENCY,DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER,RO-may_prevent
502904702,7/14/2014 11:50:22,,1322775024,7/14/2014 11:50:05,clixsense,0.3881,24763049,GBR,,,86.133.47.213,DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER diagnosed by VITAMIN A DEFICIENCY,110,153,,129,203,diagnosed by,0.353553390593274,907453-FS1-13,The results suggest that the low serum vitamin A levels in primary biliary cirrhosis are not a consequence of VITAMIN A DEFICIENCY but instead reflect a DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER.,VITAMIN A DEFICIENCY,DEFECTIVE MOBILIZATION OF VITAMIN A FROM THE LIVER,RO-may_prevent
502904704,7/14/2014 10:05:40,,1322700189,7/14/2014 10:04:39,prodege,0.8056,21891314,AUS,07,Glen Iris,58.6.248.249,no_relation,276,323,,298,338,causes,0.384110639798688,906151-FS1-4,"ANT1, TWINKLE and POLG genes affect mtDNA stability and are involved in autosomal dominant PEO, while mutations in POLG are responsible for numerous clinical presentations, including autosomal recessive PEO, sensory ataxic neuropathy, dysarthria and ophthalmoparesis (SANDO), SPINO CEREBELLAR ATAXIA and epilepsy (SCAE) or ALPERS SYNDROME",SPINO CEREBELLAR ATAXIA,ALPERS SYNDROME,RO-has_manifestation
502904704,7/14/2014 10:50:28,,1322732550,7/14/2014 10:49:56,vivatic,0.5,19526833,GBR,K2,Oxford,86.24.196.187,no_relation,276,323,,298,338,causes,0.384110639798688,906151-FS1-4,"ANT1, TWINKLE and POLG genes affect mtDNA stability and are involved in autosomal dominant PEO, while mutations in POLG are responsible for numerous clinical presentations, including autosomal recessive PEO, sensory ataxic neuropathy, dysarthria and ophthalmoparesis (SANDO), SPINO CEREBELLAR ATAXIA and epilepsy (SCAE) or ALPERS SYNDROME",SPINO CEREBELLAR ATAXIA,ALPERS SYNDROME,RO-has_manifestation
502904704,7/14/2014 11:49:19,,1322774207,7/14/2014 11:48:39,rewardsspot,0.5710000000000001,24482174,GBR,H9,London,46.23.68.180,ALPERS SYNDROME causes SPINO CEREBELLAR ATAXIA,276,323,,298,338,causes,0.384110639798688,906151-FS1-4,"ANT1, TWINKLE and POLG genes affect mtDNA stability and are involved in autosomal dominant PEO, while mutations in POLG are responsible for numerous clinical presentations, including autosomal recessive PEO, sensory ataxic neuropathy, dysarthria and ophthalmoparesis (SANDO), SPINO CEREBELLAR ATAXIA and epilepsy (SCAE) or ALPERS SYNDROME",SPINO CEREBELLAR ATAXIA,ALPERS SYNDROME,RO-has_manifestation
502904704,7/14/2014 12:06:03,,1322785136,7/14/2014 12:05:34,prodege,0.4702,28039757,GBR,L8,Southport,109.155.158.54,no_relation,276,323,,298,338,causes,0.384110639798688,906151-FS1-4,"ANT1, TWINKLE and POLG genes affect mtDNA stability and are involved in autosomal dominant PEO, while mutations in POLG are responsible for numerous clinical presentations, including autosomal recessive PEO, sensory ataxic neuropathy, dysarthria and ophthalmoparesis (SANDO), SPINO CEREBELLAR ATAXIA and epilepsy (SCAE) or ALPERS SYNDROME",SPINO CEREBELLAR ATAXIA,ALPERS SYNDROME,RO-has_manifestation
502904704,7/14/2014 12:14:55,,1322790893,7/14/2014 12:14:12,clixsense,0.6319,8100278,USA,FL,Orlando,98.70.77.97,no_relation,276,323,,298,338,causes,0.384110639798688,906151-FS1-4,"ANT1, TWINKLE and POLG genes affect mtDNA stability and are involved in autosomal dominant PEO, while mutations in POLG are responsible for numerous clinical presentations, including autosomal recessive PEO, sensory ataxic neuropathy, dysarthria and ophthalmoparesis (SANDO), SPINO CEREBELLAR ATAXIA and epilepsy (SCAE) or ALPERS SYNDROME",SPINO CEREBELLAR ATAXIA,ALPERS SYNDROME,RO-has_manifestation
502904704,7/14/2014 12:44:42,,1322811156,7/14/2014 12:44:36,clixsense,0.4054,25419319,GBR,H8,Liverpool,94.4.192.228,SPINO CEREBELLAR ATAXIA causes ALPERS SYNDROME,276,323,,298,338,causes,0.384110639798688,906151-FS1-4,"ANT1, TWINKLE and POLG genes affect mtDNA stability and are involved in autosomal dominant PEO, while mutations in POLG are responsible for numerous clinical presentations, including autosomal recessive PEO, sensory ataxic neuropathy, dysarthria and ophthalmoparesis (SANDO), SPINO CEREBELLAR ATAXIA and epilepsy (SCAE) or ALPERS SYNDROME",SPINO CEREBELLAR ATAXIA,ALPERS SYNDROME,RO-has_manifestation
502904704,7/14/2014 12:57:09,,1322819580,7/14/2014 12:56:30,instagc,0.72,16334880,USA,PA,Saint Marys,98.21.77.53,no_relation,276,323,,298,338,causes,0.384110639798688,906151-FS1-4,"ANT1, TWINKLE and POLG genes affect mtDNA stability and are involved in autosomal dominant PEO, while mutations in POLG are responsible for numerous clinical presentations, including autosomal recessive PEO, sensory ataxic neuropathy, dysarthria and ophthalmoparesis (SANDO), SPINO CEREBELLAR ATAXIA and epilepsy (SCAE) or ALPERS SYNDROME",SPINO CEREBELLAR ATAXIA,ALPERS SYNDROME,RO-has_manifestation
502904705,7/14/2014 10:27:38,,1322715988,7/14/2014 10:27:32,instagc,0.7986,27753923,GBR,,,188.30.192.65,TYPE 1 DIABETES treats INSULIN PEPTIDE B9 23,48,0,,62,21,treats,0.875,908088-FS1-2,INSULIN PEPTIDE B9 23 is a major autoantigen in TYPE 1 DIABETES,TYPE 1 DIABETES,INSULIN PEPTIDE B9 23,RO-may_treat
502904705,7/14/2014 10:51:27,,1322733169,7/14/2014 10:50:32,elite,0.6026,28397222,GBR,Y4,Usk,31.50.223.75,no_relation,48,0,,62,21,treats,0.875,908088-FS1-2,INSULIN PEPTIDE B9 23 is a major autoantigen in TYPE 1 DIABETES,TYPE 1 DIABETES,INSULIN PEPTIDE B9 23,RO-may_treat
502904705,7/14/2014 10:59:48,,1322738832,7/14/2014 10:59:35,instagc,0.5532,28301350,GBR,K4,Plymouth,78.145.138.150,INSULIN PEPTIDE B9 23 treats TYPE 1 DIABETES,48,0,,62,21,treats,0.875,908088-FS1-2,INSULIN PEPTIDE B9 23 is a major autoantigen in TYPE 1 DIABETES,TYPE 1 DIABETES,INSULIN PEPTIDE B9 23,RO-may_treat
502904705,7/14/2014 11:47:47,,1322773066,7/14/2014 11:47:20,rewardsspot,0.5710000000000001,24482174,GBR,H9,London,46.23.68.180,INSULIN PEPTIDE B9 23 treats TYPE 1 DIABETES,48,0,,62,21,treats,0.875,908088-FS1-2,INSULIN PEPTIDE B9 23 is a major autoantigen in TYPE 1 DIABETES,TYPE 1 DIABETES,INSULIN PEPTIDE B9 23,RO-may_treat
502904705,7/14/2014 11:49:13,,1322774115,7/14/2014 11:48:56,clixsense,0.3881,24763049,GBR,,,86.133.47.213,INSULIN PEPTIDE B9 23 treats TYPE 1 DIABETES,48,0,,62,21,treats,0.875,908088-FS1-2,INSULIN PEPTIDE B9 23 is a major autoantigen in TYPE 1 DIABETES,TYPE 1 DIABETES,INSULIN PEPTIDE B9 23,RO-may_treat
502904705,7/14/2014 12:08:26,,1322786677,7/14/2014 12:07:54,prodege,0.4702,28039757,GBR,L8,Southport,109.155.158.54,no_relation,48,0,,62,21,treats,0.875,908088-FS1-2,INSULIN PEPTIDE B9 23 is a major autoantigen in TYPE 1 DIABETES,TYPE 1 DIABETES,INSULIN PEPTIDE B9 23,RO-may_treat
502904705,7/14/2014 12:14:11,,1322790394,7/14/2014 12:13:07,clixsense,0.6319,8100278,USA,FL,Orlando,98.70.77.97,no_relation,48,0,,62,21,treats,0.875,908088-FS1-2,INSULIN PEPTIDE B9 23 is a major autoantigen in TYPE 1 DIABETES,TYPE 1 DIABETES,INSULIN PEPTIDE B9 23,RO-may_treat
502912459,7/14/2014 12:34:49,,1322804466,7/14/2014 12:34:43,neodev,0.9583,17610000,GBR,I2,Manchester,90.200.140.201,ESOPHAGUS is location of ESOPHAGEAL CANCER,122,32,,130,49,is location of,0.875113012593303,902460-FS1-9,"Since 1982, three patients with ESOPHAGEAL CANCER complicated with pulmonary bullae have been treated by operation on the ESOPHAGUS and lung in one performance: In all the patients, the bullae were on the same side of the operation.",ESOPHAGUS,ESOPHAGEAL CANCER,RO-disease_has_primary_anatomic_site
502912459,7/14/2014 12:43:20,,1322810290,7/14/2014 12:43:13,clixsense,0.875,25419319,GBR,H8,Liverpool,94.4.192.228,ESOPHAGUS is location of ESOPHAGEAL CANCER,122,32,,130,49,is location of,0.875113012593303,902460-FS1-9,"Since 1982, three patients with ESOPHAGEAL CANCER complicated with pulmonary bullae have been treated by operation on the ESOPHAGUS and lung in one performance: In all the patients, the bullae were on the same side of the operation.",ESOPHAGUS,ESOPHAGEAL CANCER,RO-disease_has_primary_anatomic_site
502912459,7/14/2014 12:51:41,,1322815922,7/14/2014 12:50:47,clixsense,0.8194,15189335,GBR,K3,Peterborough,81.156.166.189,ESOPHAGUS is location of ESOPHAGEAL CANCER,122,32,,130,49,is location of,0.875113012593303,902460-FS1-9,"Since 1982, three patients with ESOPHAGEAL CANCER complicated with pulmonary bullae have been treated by operation on the ESOPHAGUS and lung in one performance: In all the patients, the bullae were on the same side of the operation.",ESOPHAGUS,ESOPHAGEAL CANCER,RO-disease_has_primary_anatomic_site
502912459,7/14/2014 12:59:57,,1322821427,7/14/2014 12:59:34,prodege,0.7639,7664351,USA,NY,Cicero,74.111.0.21,ESOPHAGUS is location of ESOPHAGEAL CANCER,122,32,,130,49,is location of,0.875113012593303,902460-FS1-9,"Since 1982, three patients with ESOPHAGEAL CANCER complicated with pulmonary bullae have been treated by operation on the ESOPHAGUS and lung in one performance: In all the patients, the bullae were on the same side of the operation.",ESOPHAGUS,ESOPHAGEAL CANCER,RO-disease_has_primary_anatomic_site
502912459,7/14/2014 13:21:16,,1322835773,7/14/2014 13:20:17,clixsense,0.7,24896327,GBR,V2,Glasgow,94.2.231.4,ESOPHAGUS is location of ESOPHAGEAL CANCER,122,32,,130,49,is location of,0.875113012593303,902460-FS1-9,"Since 1982, three patients with ESOPHAGEAL CANCER complicated with pulmonary bullae have been treated by operation on the ESOPHAGUS and lung in one performance: In all the patients, the bullae were on the same side of the operation.",ESOPHAGUS,ESOPHAGEAL CANCER,RO-disease_has_primary_anatomic_site
502912459,7/14/2014 14:26:51,,1322881732,7/14/2014 14:26:23,neodev,0.4306,21515166,NLD,11,Nootdorp,83.86.58.179,ESOPHAGEAL CANCER is location of ESOPHAGUS,122,32,,130,49,is location of,0.875113012593303,902460-FS1-9,"Since 1982, three patients with ESOPHAGEAL CANCER complicated with pulmonary bullae have been treated by operation on the ESOPHAGUS and lung in one performance: In all the patients, the bullae were on the same side of the operation.",ESOPHAGUS,ESOPHAGEAL CANCER,RO-disease_has_primary_anatomic_site
502912459,7/14/2014 14:49:01,,1322896781,7/14/2014 14:48:50,clixsense,0.5125,7415230,GBR,A7,Birmingham,147.188.47.242,no_relation,122,32,,130,49,is location of,0.875113012593303,902460-FS1-9,"Since 1982, three patients with ESOPHAGEAL CANCER complicated with pulmonary bullae have been treated by operation on the ESOPHAGUS and lung in one performance: In all the patients, the bullae were on the same side of the operation.",ESOPHAGUS,ESOPHAGEAL CANCER,RO-disease_has_primary_anatomic_site
502912460,7/14/2014 12:34:28,,1322804272,7/14/2014 12:34:23,neodev,0.9583,17610000,GBR,I2,Manchester,90.200.140.201,BONE causes PSEUDARTHROSIS,15,90,,18,104,causes,0.9285878790409641,905494-FS1-4,Instability of BONE fragments is regarded as the most important factor in pathogenesis of PSEUDARTHROSIS,BONE,PSEUDARTHROSIS,RO-has_finding_site
502912460,7/14/2014 12:36:18,,1322805375,7/14/2014 12:35:56,prodege,0.8889,27934334,GBR,Q2,Wokingham,86.166.73.21,no_relation,15,90,,18,104,causes,0.9285878790409641,905494-FS1-4,Instability of BONE fragments is regarded as the most important factor in pathogenesis of PSEUDARTHROSIS,BONE,PSEUDARTHROSIS,RO-has_finding_site
502912460,7/14/2014 15:04:46,,1322906337,7/14/2014 15:04:29,neodev,0.7190000000000001,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,15,90,,18,104,causes,0.9285878790409641,905494-FS1-4,Instability of BONE fragments is regarded as the most important factor in pathogenesis of PSEUDARTHROSIS,BONE,PSEUDARTHROSIS,RO-has_finding_site
502912460,7/14/2014 15:11:07,,1322909632,7/14/2014 15:10:38,clixsense,0.5718,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,15,90,,18,104,causes,0.9285878790409641,905494-FS1-4,Instability of BONE fragments is regarded as the most important factor in pathogenesis of PSEUDARTHROSIS,BONE,PSEUDARTHROSIS,RO-has_finding_site
502912460,7/14/2014 15:30:36,,1322920619,7/14/2014 15:30:28,prodege,0.5494,2143114,CAN,BC,Vancouver,24.84.160.12,BONE causes PSEUDARTHROSIS,15,90,,18,104,causes,0.9285878790409641,905494-FS1-4,Instability of BONE fragments is regarded as the most important factor in pathogenesis of PSEUDARTHROSIS,BONE,PSEUDARTHROSIS,RO-has_finding_site
502912460,7/14/2014 15:53:42,,1322933698,7/14/2014 15:53:19,clixsense,0.573,22177255,USA,CA,San Francisco,73.32.39.90,no_relation,15,90,,18,104,causes,0.9285878790409641,905494-FS1-4,Instability of BONE fragments is regarded as the most important factor in pathogenesis of PSEUDARTHROSIS,BONE,PSEUDARTHROSIS,RO-has_finding_site
502912460,7/14/2014 15:58:55,,1322936657,7/14/2014 15:58:25,prodege,0.5,28039757,GBR,L8,Southport,109.155.158.54,no_relation,15,90,,18,104,causes,0.9285878790409641,905494-FS1-4,Instability of BONE fragments is regarded as the most important factor in pathogenesis of PSEUDARTHROSIS,BONE,PSEUDARTHROSIS,RO-has_finding_site
502912462,7/14/2014 12:43:32,,1322810461,7/14/2014 12:43:28,clixsense,0.875,25419319,GBR,H8,Liverpool,94.4.192.228,CHRONIC HEPATITIS causes LIVER BIOPSY SPECIMEN,100,142,,120,159,causes,0.307793505625546,902294-FS1-4,"In addition to the characterization of the degree of inflammation and fibrosis, the evaluation of a LIVER BIOPSY SPECIMEN from a patient with CHRONIC HEPATITIS includes a description of all of the findings present (e.g., steatosis, bile duct changes, granulomas, type of inflammatory cells, presence of iron, and Mallory hyaline) or a notation of their absence.",LIVER BIOPSY SPECIMEN,CHRONIC HEPATITIS,RO-disease_has_primary_anatomic_site
502912462,7/14/2014 13:07:39,,1322826518,7/14/2014 13:07:25,prodege,0.6278,11616695,GBR,P7,Wigan,92.29.199.166,no_relation,100,142,,120,159,causes,0.307793505625546,902294-FS1-4,"In addition to the characterization of the degree of inflammation and fibrosis, the evaluation of a LIVER BIOPSY SPECIMEN from a patient with CHRONIC HEPATITIS includes a description of all of the findings present (e.g., steatosis, bile duct changes, granulomas, type of inflammatory cells, presence of iron, and Mallory hyaline) or a notation of their absence.",LIVER BIOPSY SPECIMEN,CHRONIC HEPATITIS,RO-disease_has_primary_anatomic_site
502912462,7/14/2014 13:39:49,,1322848950,7/14/2014 13:39:00,prodege,0.6181,17982533,GBR,H3,Leeds,90.193.39.185,no_relation,100,142,,120,159,causes,0.307793505625546,902294-FS1-4,"In addition to the characterization of the degree of inflammation and fibrosis, the evaluation of a LIVER BIOPSY SPECIMEN from a patient with CHRONIC HEPATITIS includes a description of all of the findings present (e.g., steatosis, bile duct changes, granulomas, type of inflammatory cells, presence of iron, and Mallory hyaline) or a notation of their absence.",LIVER BIOPSY SPECIMEN,CHRONIC HEPATITIS,RO-disease_has_primary_anatomic_site
502912462,7/14/2014 13:51:11,,1322857346,7/14/2014 13:50:46,clixsense,0.4042,25402344,CAN,ON,Wawa,24.109.124.45,CHRONIC HEPATITIS causes LIVER BIOPSY SPECIMEN,100,142,,120,159,causes,0.307793505625546,902294-FS1-4,"In addition to the characterization of the degree of inflammation and fibrosis, the evaluation of a LIVER BIOPSY SPECIMEN from a patient with CHRONIC HEPATITIS includes a description of all of the findings present (e.g., steatosis, bile duct changes, granulomas, type of inflammatory cells, presence of iron, and Mallory hyaline) or a notation of their absence.",LIVER BIOPSY SPECIMEN,CHRONIC HEPATITIS,RO-disease_has_primary_anatomic_site
502912462,7/14/2014 13:54:46,,1322859810,7/14/2014 13:54:29,zoombucks,0.7764,5919735,USA,PA,Doylestown,173.49.91.231,no_relation,100,142,,120,159,causes,0.307793505625546,902294-FS1-4,"In addition to the characterization of the degree of inflammation and fibrosis, the evaluation of a LIVER BIOPSY SPECIMEN from a patient with CHRONIC HEPATITIS includes a description of all of the findings present (e.g., steatosis, bile duct changes, granulomas, type of inflammatory cells, presence of iron, and Mallory hyaline) or a notation of their absence.",LIVER BIOPSY SPECIMEN,CHRONIC HEPATITIS,RO-disease_has_primary_anatomic_site
502912462,7/14/2014 14:23:09,,1322878961,7/14/2014 14:23:01,neodev,0.3792,25224036,CAN,ON,Sudbury,67.204.218.187,CHRONIC HEPATITIS causes LIVER BIOPSY SPECIMEN,100,142,,120,159,causes,0.307793505625546,902294-FS1-4,"In addition to the characterization of the degree of inflammation and fibrosis, the evaluation of a LIVER BIOPSY SPECIMEN from a patient with CHRONIC HEPATITIS includes a description of all of the findings present (e.g., steatosis, bile duct changes, granulomas, type of inflammatory cells, presence of iron, and Mallory hyaline) or a notation of their absence.",LIVER BIOPSY SPECIMEN,CHRONIC HEPATITIS,RO-disease_has_primary_anatomic_site
502912462,7/14/2014 14:57:16,,1322901865,7/14/2014 14:57:00,instagc,0.6593,13763729,USA,,,75.182.89.225,no_relation,100,142,,120,159,causes,0.307793505625546,902294-FS1-4,"In addition to the characterization of the degree of inflammation and fibrosis, the evaluation of a LIVER BIOPSY SPECIMEN from a patient with CHRONIC HEPATITIS includes a description of all of the findings present (e.g., steatosis, bile duct changes, granulomas, type of inflammatory cells, presence of iron, and Mallory hyaline) or a notation of their absence.",LIVER BIOPSY SPECIMEN,CHRONIC HEPATITIS,RO-disease_has_primary_anatomic_site
502912472,7/14/2014 12:35:19,,1322804783,7/14/2014 12:34:50,prodege,0.8889,27934334,GBR,Q2,Wokingham,86.166.73.21,no_relation,215,118,,230,153,causes,0.802955068546966,904858-FS1-4,"Acute idiopathic thrombocytopenic purpura is the most common cause of thrombocytopenia in childhood, and diagnosis of IDIOPATHIC THROMBOCYTOPENIC PURPURA is made clinically based on the exclusion of other causes of THROMBOCYTOPENIA.",THROMBOCYTOPENIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA,RO-has_definitional_manifestation
502912472,7/14/2014 14:23:23,,1322879150,7/14/2014 14:23:18,neodev,0.3792,25224036,CAN,ON,Sudbury,67.204.218.187,IDIOPATHIC THROMBOCYTOPENIC PURPURA causes THROMBOCYTOPENIA,215,118,,230,153,causes,0.802955068546966,904858-FS1-4,"Acute idiopathic thrombocytopenic purpura is the most common cause of thrombocytopenia in childhood, and diagnosis of IDIOPATHIC THROMBOCYTOPENIC PURPURA is made clinically based on the exclusion of other causes of THROMBOCYTOPENIA.",THROMBOCYTOPENIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA,RO-has_definitional_manifestation
502912472,7/14/2014 14:25:52,,1322881032,7/14/2014 14:25:18,neodev,0.4306,21515166,NLD,11,Nootdorp,83.86.58.179,IDIOPATHIC THROMBOCYTOPENIC PURPURA causes THROMBOCYTOPENIA,215,118,,230,153,causes,0.802955068546966,904858-FS1-4,"Acute idiopathic thrombocytopenic purpura is the most common cause of thrombocytopenia in childhood, and diagnosis of IDIOPATHIC THROMBOCYTOPENIC PURPURA is made clinically based on the exclusion of other causes of THROMBOCYTOPENIA.",THROMBOCYTOPENIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA,RO-has_definitional_manifestation
502912472,7/14/2014 14:31:12,,1322884974,7/14/2014 14:31:00,instagc,0.644,15445601,USA,FL,Jacksonville,24.129.68.254,IDIOPATHIC THROMBOCYTOPENIC PURPURA causes THROMBOCYTOPENIA,215,118,,230,153,causes,0.802955068546966,904858-FS1-4,"Acute idiopathic thrombocytopenic purpura is the most common cause of thrombocytopenia in childhood, and diagnosis of IDIOPATHIC THROMBOCYTOPENIC PURPURA is made clinically based on the exclusion of other causes of THROMBOCYTOPENIA.",THROMBOCYTOPENIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA,RO-has_definitional_manifestation
502912472,7/14/2014 14:45:33,,1322894785,7/14/2014 14:45:29,instagc,0.4611,27753923,GBR,,,188.30.192.65,THROMBOCYTOPENIA causes IDIOPATHIC THROMBOCYTOPENIC PURPURA,215,118,,230,153,causes,0.802955068546966,904858-FS1-4,"Acute idiopathic thrombocytopenic purpura is the most common cause of thrombocytopenia in childhood, and diagnosis of IDIOPATHIC THROMBOCYTOPENIC PURPURA is made clinically based on the exclusion of other causes of THROMBOCYTOPENIA.",THROMBOCYTOPENIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA,RO-has_definitional_manifestation
502912472,7/14/2014 15:00:49,,1322904039,7/14/2014 15:00:28,instagc,0.5536,18960682,GBR,,,86.29.147.112,THROMBOCYTOPENIA causes IDIOPATHIC THROMBOCYTOPENIC PURPURA,215,118,,230,153,causes,0.802955068546966,904858-FS1-4,"Acute idiopathic thrombocytopenic purpura is the most common cause of thrombocytopenia in childhood, and diagnosis of IDIOPATHIC THROMBOCYTOPENIC PURPURA is made clinically based on the exclusion of other causes of THROMBOCYTOPENIA.",THROMBOCYTOPENIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA,RO-has_definitional_manifestation
502912472,7/14/2014 15:04:04,,1322905948,7/14/2014 15:03:13,vivatic,0.5339,25451531,GBR,,,83.67.28.193,IDIOPATHIC THROMBOCYTOPENIC PURPURA causes THROMBOCYTOPENIA,215,118,,230,153,causes,0.802955068546966,904858-FS1-4,"Acute idiopathic thrombocytopenic purpura is the most common cause of thrombocytopenia in childhood, and diagnosis of IDIOPATHIC THROMBOCYTOPENIC PURPURA is made clinically based on the exclusion of other causes of THROMBOCYTOPENIA.",THROMBOCYTOPENIA,IDIOPATHIC THROMBOCYTOPENIC PURPURA,RO-has_definitional_manifestation
502912473,7/14/2014 12:34:14,,1322804071,7/14/2014 12:34:08,neodev,0.9583,17610000,GBR,I2,Manchester,90.200.140.201,HYPERTENSION causes NEPHROBLASTOMA,65,0,,76,14,causes,0.6837634587578281,902706-FS1-4,"NEPHROBLASTOMA must be included in the differential diagnosis of HYPERTENSION associated with increased renin concentrations, even in the absence of an abdominal mass..",HYPERTENSION,NEPHROBLASTOMA,RO-disease_may_have_finding
502912473,7/14/2014 12:54:56,,1322818150,7/14/2014 12:54:37,clixsense,0.8194,15189335,GBR,K3,Peterborough,81.156.166.189,HYPERTENSION causes NEPHROBLASTOMA,65,0,,76,14,causes,0.6837634587578281,902706-FS1-4,"NEPHROBLASTOMA must be included in the differential diagnosis of HYPERTENSION associated with increased renin concentrations, even in the absence of an abdominal mass..",HYPERTENSION,NEPHROBLASTOMA,RO-disease_may_have_finding
502912473,7/14/2014 13:18:19,,1322833772,7/14/2014 13:17:21,clixsense,0.7,24896327,GBR,V2,Glasgow,94.2.231.4,no_relation,65,0,,76,14,causes,0.6837634587578281,902706-FS1-4,"NEPHROBLASTOMA must be included in the differential diagnosis of HYPERTENSION associated with increased renin concentrations, even in the absence of an abdominal mass..",HYPERTENSION,NEPHROBLASTOMA,RO-disease_may_have_finding
502912473,7/14/2014 13:41:39,,1322850190,7/14/2014 13:41:12,prodege,0.6181,17982533,GBR,H3,Leeds,90.193.39.185,no_relation,65,0,,76,14,causes,0.6837634587578281,902706-FS1-4,"NEPHROBLASTOMA must be included in the differential diagnosis of HYPERTENSION associated with increased renin concentrations, even in the absence of an abdominal mass..",HYPERTENSION,NEPHROBLASTOMA,RO-disease_may_have_finding
502912473,7/14/2014 14:23:37,,1322879299,7/14/2014 14:23:31,neodev,0.3792,25224036,CAN,ON,Sudbury,67.204.218.187,NEPHROBLASTOMA causes HYPERTENSION,65,0,,76,14,causes,0.6837634587578281,902706-FS1-4,"NEPHROBLASTOMA must be included in the differential diagnosis of HYPERTENSION associated with increased renin concentrations, even in the absence of an abdominal mass..",HYPERTENSION,NEPHROBLASTOMA,RO-disease_may_have_finding
502912473,7/14/2014 14:57:55,,1322902292,7/14/2014 14:57:28,elite,0.4302,28276268,USA,MI,Taylor,67.149.247.166,NEPHROBLASTOMA causes HYPERTENSION,65,0,,76,14,causes,0.6837634587578281,902706-FS1-4,"NEPHROBLASTOMA must be included in the differential diagnosis of HYPERTENSION associated with increased renin concentrations, even in the absence of an abdominal mass..",HYPERTENSION,NEPHROBLASTOMA,RO-disease_may_have_finding
502912473,7/14/2014 15:27:02,,1322918423,7/14/2014 15:26:47,instagc,0.3552,19004168,GBR,H2,Accrington,80.47.185.52,no_relation,65,0,,76,14,causes,0.6837634587578281,902706-FS1-4,"NEPHROBLASTOMA must be included in the differential diagnosis of HYPERTENSION associated with increased renin concentrations, even in the absence of an abdominal mass..",HYPERTENSION,NEPHROBLASTOMA,RO-disease_may_have_finding
502912489,7/14/2014 13:00:42,,1322821947,7/14/2014 13:00:09,rewardsspot,0.7153,24482174,GBR,H9,London,46.23.68.180,INTRAEPITHELIAL LESION (HSIL) causes DYSPLASIA,169,96,,177,125,causes,0.7947194142390258,901923-FS1-4,Pap smears were reliable in screening for CIN; 75% of patients with CIN had high grade squamous INTRAEPITHELIAL LESION (HSIL) or LSIL in Pap smears taken at the time of DYSPLASIA,DYSPLASIA,INTRAEPITHELIAL LESION (HSIL),RO-disease_has_finding
502912489,7/14/2014 13:00:59,,1322822145,7/14/2014 13:00:28,prodege,0.7639,7664351,USA,NY,Cicero,74.111.0.21,no_relation,169,96,,177,125,causes,0.7947194142390258,901923-FS1-4,Pap smears were reliable in screening for CIN; 75% of patients with CIN had high grade squamous INTRAEPITHELIAL LESION (HSIL) or LSIL in Pap smears taken at the time of DYSPLASIA,DYSPLASIA,INTRAEPITHELIAL LESION (HSIL),RO-disease_has_finding
502912489,7/14/2014 13:23:13,,1322837395,7/14/2014 13:22:19,neodev,0.6667,19004420,GBR,M3,Bridgwater,86.160.70.204,INTRAEPITHELIAL LESION (HSIL) causes DYSPLASIA,169,96,,177,125,causes,0.7947194142390258,901923-FS1-4,Pap smears were reliable in screening for CIN; 75% of patients with CIN had high grade squamous INTRAEPITHELIAL LESION (HSIL) or LSIL in Pap smears taken at the time of DYSPLASIA,DYSPLASIA,INTRAEPITHELIAL LESION (HSIL),RO-disease_has_finding
502912489,7/14/2014 13:49:47,,1322856257,7/14/2014 13:49:22,clixsense,0.4042,25402344,CAN,ON,Wawa,24.109.124.45,DYSPLASIA causes INTRAEPITHELIAL LESION (HSIL),169,96,,177,125,causes,0.7947194142390258,901923-FS1-4,Pap smears were reliable in screening for CIN; 75% of patients with CIN had high grade squamous INTRAEPITHELIAL LESION (HSIL) or LSIL in Pap smears taken at the time of DYSPLASIA,DYSPLASIA,INTRAEPITHELIAL LESION (HSIL),RO-disease_has_finding
502912489,7/14/2014 14:31:46,,1322885441,7/14/2014 14:31:33,clixsense,0.5125,7415230,GBR,A7,Birmingham,147.188.47.242,no_relation,169,96,,177,125,causes,0.7947194142390258,901923-FS1-4,Pap smears were reliable in screening for CIN; 75% of patients with CIN had high grade squamous INTRAEPITHELIAL LESION (HSIL) or LSIL in Pap smears taken at the time of DYSPLASIA,DYSPLASIA,INTRAEPITHELIAL LESION (HSIL),RO-disease_has_finding
502912489,7/14/2014 14:56:09,,1322901093,7/14/2014 14:55:52,elite,0.4302,28276268,USA,MI,Taylor,67.149.247.166,INTRAEPITHELIAL LESION (HSIL) causes DYSPLASIA,169,96,,177,125,causes,0.7947194142390258,901923-FS1-4,Pap smears were reliable in screening for CIN; 75% of patients with CIN had high grade squamous INTRAEPITHELIAL LESION (HSIL) or LSIL in Pap smears taken at the time of DYSPLASIA,DYSPLASIA,INTRAEPITHELIAL LESION (HSIL),RO-disease_has_finding
502912489,7/14/2014 15:00:01,,1322903522,7/14/2014 14:59:43,instagc,0.5536,18960682,GBR,,,86.29.147.112,DYSPLASIA causes INTRAEPITHELIAL LESION (HSIL),169,96,,177,125,causes,0.7947194142390258,901923-FS1-4,Pap smears were reliable in screening for CIN; 75% of patients with CIN had high grade squamous INTRAEPITHELIAL LESION (HSIL) or LSIL in Pap smears taken at the time of DYSPLASIA,DYSPLASIA,INTRAEPITHELIAL LESION (HSIL),RO-disease_has_finding
502912495,7/14/2014 12:34:42,,1322804404,7/14/2014 12:34:37,neodev,0.9583,17610000,GBR,I2,Manchester,90.200.140.201,DYSPLASIA diagnosed by INTRAEPITHELIAL LESION (HSIL),169,96,,177,125,diagnosed by,0.3973597071195129,901923-FS1-13,Pap smears were reliable in screening for CIN; 75% of patients with CIN had high grade squamous INTRAEPITHELIAL LESION (HSIL) or LSIL in Pap smears taken at the time of DYSPLASIA,DYSPLASIA,INTRAEPITHELIAL LESION (HSIL),RO-disease_has_finding
502912495,7/14/2014 13:04:30,,1322824382,7/14/2014 13:04:20,clixsense,0.7708,27793793,GBR,C5,Chester,151.230.27.155,INTRAEPITHELIAL LESION (HSIL) diagnosed by DYSPLASIA,169,96,,177,125,diagnosed by,0.3973597071195129,901923-FS1-13,Pap smears were reliable in screening for CIN; 75% of patients with CIN had high grade squamous INTRAEPITHELIAL LESION (HSIL) or LSIL in Pap smears taken at the time of DYSPLASIA,DYSPLASIA,INTRAEPITHELIAL LESION (HSIL),RO-disease_has_finding
502912495,7/14/2014 14:23:48,,1322879456,7/14/2014 14:23:41,neodev,0.3792,25224036,CAN,ON,Sudbury,67.204.218.187,INTRAEPITHELIAL LESION (HSIL) diagnosed by DYSPLASIA,169,96,,177,125,diagnosed by,0.3973597071195129,901923-FS1-13,Pap smears were reliable in screening for CIN; 75% of patients with CIN had high grade squamous INTRAEPITHELIAL LESION (HSIL) or LSIL in Pap smears taken at the time of DYSPLASIA,DYSPLASIA,INTRAEPITHELIAL LESION (HSIL),RO-disease_has_finding
502912495,7/14/2014 14:56:25,,1322901236,7/14/2014 14:55:54,instagc,0.6593,13763729,USA,,,75.182.89.225,DYSPLASIA diagnosed by INTRAEPITHELIAL LESION (HSIL),169,96,,177,125,diagnosed by,0.3973597071195129,901923-FS1-13,Pap smears were reliable in screening for CIN; 75% of patients with CIN had high grade squamous INTRAEPITHELIAL LESION (HSIL) or LSIL in Pap smears taken at the time of DYSPLASIA,DYSPLASIA,INTRAEPITHELIAL LESION (HSIL),RO-disease_has_finding
502912495,7/14/2014 15:07:32,,1322907767,7/14/2014 15:06:52,instagc,0.7125,28519532,USA,IA,Honey Creek,12.73.110.26,DYSPLASIA diagnosed by INTRAEPITHELIAL LESION (HSIL),169,96,,177,125,diagnosed by,0.3973597071195129,901923-FS1-13,Pap smears were reliable in screening for CIN; 75% of patients with CIN had high grade squamous INTRAEPITHELIAL LESION (HSIL) or LSIL in Pap smears taken at the time of DYSPLASIA,DYSPLASIA,INTRAEPITHELIAL LESION (HSIL),RO-disease_has_finding
502912495,7/14/2014 15:37:31,,1322924786,7/14/2014 15:36:54,clixsense,0.6484,19638651,USA,,,173.23.121.63,DYSPLASIA diagnosed by INTRAEPITHELIAL LESION (HSIL),169,96,,177,125,diagnosed by,0.3973597071195129,901923-FS1-13,Pap smears were reliable in screening for CIN; 75% of patients with CIN had high grade squamous INTRAEPITHELIAL LESION (HSIL) or LSIL in Pap smears taken at the time of DYSPLASIA,DYSPLASIA,INTRAEPITHELIAL LESION (HSIL),RO-disease_has_finding
502912495,7/14/2014 15:54:58,,1322934481,7/14/2014 15:54:16,clixsense,0.573,22177255,USA,CA,San Francisco,73.32.39.90,no_relation,169,96,,177,125,diagnosed by,0.3973597071195129,901923-FS1-13,Pap smears were reliable in screening for CIN; 75% of patients with CIN had high grade squamous INTRAEPITHELIAL LESION (HSIL) or LSIL in Pap smears taken at the time of DYSPLASIA,DYSPLASIA,INTRAEPITHELIAL LESION (HSIL),RO-disease_has_finding
502912496,7/14/2014 12:34:48,,1322804460,7/14/2014 12:34:12,prodege,0.8889,27934334,GBR,Q2,Wokingham,86.166.73.21,SODIUM FLUORIDE treats DENTAL CARIES,181,69,,193,84,treats,0.5656854249492379,907106-FS1-2,"A sample of 1,824 schoolchildren was randomly assigned to either the SODIUM FLUORIDE dentifrice or the stannous fluoride dentifrice and examined clinically and radiographically for DENTAL CARIES initially and after one, two, and three years of dentifrice usage.",DENTAL CARIES,SODIUM FLUORIDE,RO-may_prevent
502912496,7/14/2014 13:54:07,,1322859335,7/14/2014 13:53:46,zoombucks,0.7764,5919735,USA,PA,Doylestown,173.49.91.231,SODIUM FLUORIDE treats DENTAL CARIES,181,69,,193,84,treats,0.5656854249492379,907106-FS1-2,"A sample of 1,824 schoolchildren was randomly assigned to either the SODIUM FLUORIDE dentifrice or the stannous fluoride dentifrice and examined clinically and radiographically for DENTAL CARIES initially and after one, two, and three years of dentifrice usage.",DENTAL CARIES,SODIUM FLUORIDE,RO-may_prevent
502912496,7/14/2014 14:09:54,,1322869870,7/14/2014 14:09:45,clixsense,0.7708,27793793,GBR,C5,Chester,151.230.27.155,SODIUM FLUORIDE treats DENTAL CARIES,181,69,,193,84,treats,0.5656854249492379,907106-FS1-2,"A sample of 1,824 schoolchildren was randomly assigned to either the SODIUM FLUORIDE dentifrice or the stannous fluoride dentifrice and examined clinically and radiographically for DENTAL CARIES initially and after one, two, and three years of dentifrice usage.",DENTAL CARIES,SODIUM FLUORIDE,RO-may_prevent
502912496,7/14/2014 14:11:18,,1322870783,7/14/2014 14:10:55,clixsense,0.5125,7415230,GBR,A7,Birmingham,147.188.47.242,no_relation,181,69,,193,84,treats,0.5656854249492379,907106-FS1-2,"A sample of 1,824 schoolchildren was randomly assigned to either the SODIUM FLUORIDE dentifrice or the stannous fluoride dentifrice and examined clinically and radiographically for DENTAL CARIES initially and after one, two, and three years of dentifrice usage.",DENTAL CARIES,SODIUM FLUORIDE,RO-may_prevent
502912496,7/14/2014 14:31:25,,1322885181,7/14/2014 14:31:13,instagc,0.644,15445601,USA,FL,Jacksonville,24.129.68.254,SODIUM FLUORIDE treats DENTAL CARIES,181,69,,193,84,treats,0.5656854249492379,907106-FS1-2,"A sample of 1,824 schoolchildren was randomly assigned to either the SODIUM FLUORIDE dentifrice or the stannous fluoride dentifrice and examined clinically and radiographically for DENTAL CARIES initially and after one, two, and three years of dentifrice usage.",DENTAL CARIES,SODIUM FLUORIDE,RO-may_prevent
502912496,7/14/2014 14:35:20,,1322887833,7/14/2014 14:35:01,rewardsspot,0.57,17763704,USA,IL,Chicago,67.212.175.123,SODIUM FLUORIDE treats DENTAL CARIES,181,69,,193,84,treats,0.5656854249492379,907106-FS1-2,"A sample of 1,824 schoolchildren was randomly assigned to either the SODIUM FLUORIDE dentifrice or the stannous fluoride dentifrice and examined clinically and radiographically for DENTAL CARIES initially and after one, two, and three years of dentifrice usage.",DENTAL CARIES,SODIUM FLUORIDE,RO-may_prevent
502912496,7/14/2014 15:02:22,,1322904878,7/14/2014 15:01:42,vivatic,0.5339,25451531,GBR,,,83.67.28.193,no_relation,181,69,,193,84,treats,0.5656854249492379,907106-FS1-2,"A sample of 1,824 schoolchildren was randomly assigned to either the SODIUM FLUORIDE dentifrice or the stannous fluoride dentifrice and examined clinically and radiographically for DENTAL CARIES initially and after one, two, and three years of dentifrice usage.",DENTAL CARIES,SODIUM FLUORIDE,RO-may_prevent
502912500,7/14/2014 12:35:54,,1322805145,7/14/2014 12:35:20,prodege,0.8889,27934334,GBR,Q2,Wokingham,86.166.73.21,no_relation,191,133,,197,141,is location of,0.41099746826339295,905412-FS1-9,Lacunes consist of small vascular lesions with a volume of between 2 and about 30 mm. These lacunar infarctions are determined by an ISCHEMIA caused by obstructive diseases of small terminal VESSELS in the deep areas of the brain.,VESSELS,ISCHEMIA,RO-has_finding_site
502912500,7/14/2014 12:49:09,,1322814086,7/14/2014 12:48:19,elite,0.75,27433978,AUS,05,Plympton,110.174.120.88,no_relation,191,133,,197,141,is location of,0.41099746826339295,905412-FS1-9,Lacunes consist of small vascular lesions with a volume of between 2 and about 30 mm. These lacunar infarctions are determined by an ISCHEMIA caused by obstructive diseases of small terminal VESSELS in the deep areas of the brain.,VESSELS,ISCHEMIA,RO-has_finding_site
502912500,7/14/2014 13:54:46,,1322859811,7/14/2014 13:54:29,zoombucks,0.7764,5919735,USA,PA,Doylestown,173.49.91.231,no_relation,191,133,,197,141,is location of,0.41099746826339295,905412-FS1-9,Lacunes consist of small vascular lesions with a volume of between 2 and about 30 mm. These lacunar infarctions are determined by an ISCHEMIA caused by obstructive diseases of small terminal VESSELS in the deep areas of the brain.,VESSELS,ISCHEMIA,RO-has_finding_site
502912500,7/14/2014 14:25:17,,1322880608,7/14/2014 14:24:41,neodev,0.4306,21515166,NLD,11,Nootdorp,83.86.58.179,VESSELS is location of ISCHEMIA,191,133,,197,141,is location of,0.41099746826339295,905412-FS1-9,Lacunes consist of small vascular lesions with a volume of between 2 and about 30 mm. These lacunar infarctions are determined by an ISCHEMIA caused by obstructive diseases of small terminal VESSELS in the deep areas of the brain.,VESSELS,ISCHEMIA,RO-has_finding_site
502912500,7/14/2014 14:34:59,,1322887518,7/14/2014 14:34:43,rewardsspot,0.57,17763704,USA,IL,Chicago,67.212.175.123,VESSELS is location of ISCHEMIA,191,133,,197,141,is location of,0.41099746826339295,905412-FS1-9,Lacunes consist of small vascular lesions with a volume of between 2 and about 30 mm. These lacunar infarctions are determined by an ISCHEMIA caused by obstructive diseases of small terminal VESSELS in the deep areas of the brain.,VESSELS,ISCHEMIA,RO-has_finding_site
502912500,7/14/2014 14:56:26,,1322901237,7/14/2014 14:56:11,elite,0.4302,28276268,USA,MI,Taylor,67.149.247.166,ISCHEMIA is location of VESSELS,191,133,,197,141,is location of,0.41099746826339295,905412-FS1-9,Lacunes consist of small vascular lesions with a volume of between 2 and about 30 mm. These lacunar infarctions are determined by an ISCHEMIA caused by obstructive diseases of small terminal VESSELS in the deep areas of the brain.,VESSELS,ISCHEMIA,RO-has_finding_site
502912500,7/14/2014 15:03:11,,1322905352,7/14/2014 15:02:23,vivatic,0.5339,25451531,GBR,,,83.67.28.193,VESSELS is location of ISCHEMIA,191,133,,197,141,is location of,0.41099746826339295,905412-FS1-9,Lacunes consist of small vascular lesions with a volume of between 2 and about 30 mm. These lacunar infarctions are determined by an ISCHEMIA caused by obstructive diseases of small terminal VESSELS in the deep areas of the brain.,VESSELS,ISCHEMIA,RO-has_finding_site
502912506,7/14/2014 12:43:46,,1322810605,7/14/2014 12:43:41,clixsense,0.875,25419319,GBR,H8,Liverpool,94.4.192.228,HEPATITIS A causes HEPATITIS A VIRUS,52,22,,68,33,causes,0.9,903786-FS1-4,Update: Prevention of HEPATITIS A after exposure to HEPATITIS A VIRUS and in international travelers.,HEPATITIS A VIRUS,HEPATITIS A,RO-has_causative_agent
502912506,7/14/2014 12:46:36,,1322812400,7/14/2014 12:45:53,elite,0.75,27433978,AUS,05,Plympton,110.174.120.88,HEPATITIS A VIRUS causes HEPATITIS A,52,22,,68,33,causes,0.9,903786-FS1-4,Update: Prevention of HEPATITIS A after exposure to HEPATITIS A VIRUS and in international travelers.,HEPATITIS A VIRUS,HEPATITIS A,RO-has_causative_agent
502912506,7/14/2014 13:06:57,,1322826000,7/14/2014 13:06:28,prodege,0.6278,11616695,GBR,P7,Wigan,92.29.199.166,HEPATITIS A VIRUS causes HEPATITIS A,52,22,,68,33,causes,0.9,903786-FS1-4,Update: Prevention of HEPATITIS A after exposure to HEPATITIS A VIRUS and in international travelers.,HEPATITIS A VIRUS,HEPATITIS A,RO-has_causative_agent
502912506,7/14/2014 14:10:21,,1322870120,7/14/2014 14:10:07,clixsense,0.7708,27793793,GBR,C5,Chester,151.230.27.155,HEPATITIS A VIRUS causes HEPATITIS A,52,22,,68,33,causes,0.9,903786-FS1-4,Update: Prevention of HEPATITIS A after exposure to HEPATITIS A VIRUS and in international travelers.,HEPATITIS A VIRUS,HEPATITIS A,RO-has_causative_agent
502912506,7/14/2014 15:18:32,,1322913413,7/14/2014 15:17:59,prodege,0.639,27996604,CAN,QC,Boucherville,24.201.21.27,HEPATITIS A VIRUS causes HEPATITIS A,52,22,,68,33,causes,0.9,903786-FS1-4,Update: Prevention of HEPATITIS A after exposure to HEPATITIS A VIRUS and in international travelers.,HEPATITIS A VIRUS,HEPATITIS A,RO-has_causative_agent
502912506,7/14/2014 15:31:44,,1322921309,7/14/2014 15:31:09,gifthulk,0.6484,21916793,GBR,,,87.113.87.199,HEPATITIS A VIRUS causes HEPATITIS A,52,22,,68,33,causes,0.9,903786-FS1-4,Update: Prevention of HEPATITIS A after exposure to HEPATITIS A VIRUS and in international travelers.,HEPATITIS A VIRUS,HEPATITIS A,RO-has_causative_agent
502912506,7/14/2014 15:36:32,,1322924180,7/14/2014 15:36:03,clixsense,0.6484,19638651,USA,,,173.23.121.63,HEPATITIS A VIRUS causes HEPATITIS A,52,22,,68,33,causes,0.9,903786-FS1-4,Update: Prevention of HEPATITIS A after exposure to HEPATITIS A VIRUS and in international travelers.,HEPATITIS A VIRUS,HEPATITIS A,RO-has_causative_agent
502912512,7/14/2014 12:43:27,,1322810393,7/14/2014 12:43:20,clixsense,0.875,25419319,GBR,H8,Liverpool,94.4.192.228,ALLERGIC REACTION causes CHRONIC ALLERGIC STATE,52,90,,68,112,causes,0.9897433186107869,900317-FS1-4,This results in the amplification of any subsequent ALLERGIC REACTION contributing to the CHRONIC ALLERGIC STATE,ALLERGIC REACTION,CHRONIC ALLERGIC STATE,RO-cause_of
502912512,7/14/2014 13:01:34,,1322822524,7/14/2014 13:00:59,prodege,0.7639,7664351,USA,NY,Cicero,74.111.0.21,ALLERGIC REACTION causes CHRONIC ALLERGIC STATE,52,90,,68,112,causes,0.9897433186107869,900317-FS1-4,This results in the amplification of any subsequent ALLERGIC REACTION contributing to the CHRONIC ALLERGIC STATE,ALLERGIC REACTION,CHRONIC ALLERGIC STATE,RO-cause_of
502912512,7/14/2014 13:08:06,,1322826853,7/14/2014 13:07:40,prodege,0.6278,11616695,GBR,P7,Wigan,92.29.199.166,ALLERGIC REACTION causes CHRONIC ALLERGIC STATE,52,90,,68,112,causes,0.9897433186107869,900317-FS1-4,This results in the amplification of any subsequent ALLERGIC REACTION contributing to the CHRONIC ALLERGIC STATE,ALLERGIC REACTION,CHRONIC ALLERGIC STATE,RO-cause_of
502912512,7/14/2014 14:17:14,,1322874893,7/14/2014 14:16:59,clixsense,0.5125,7415230,GBR,A7,Birmingham,147.188.47.242,ALLERGIC REACTION causes CHRONIC ALLERGIC STATE,52,90,,68,112,causes,0.9897433186107869,900317-FS1-4,This results in the amplification of any subsequent ALLERGIC REACTION contributing to the CHRONIC ALLERGIC STATE,ALLERGIC REACTION,CHRONIC ALLERGIC STATE,RO-cause_of
502912512,7/14/2014 14:31:25,,1322885179,7/14/2014 14:31:13,instagc,0.644,15445601,USA,FL,Jacksonville,24.129.68.254,ALLERGIC REACTION causes CHRONIC ALLERGIC STATE,52,90,,68,112,causes,0.9897433186107869,900317-FS1-4,This results in the amplification of any subsequent ALLERGIC REACTION contributing to the CHRONIC ALLERGIC STATE,ALLERGIC REACTION,CHRONIC ALLERGIC STATE,RO-cause_of
502912512,7/14/2014 14:35:40,,1322888027,7/14/2014 14:35:22,rewardsspot,0.57,17763704,USA,IL,Chicago,67.212.175.123,ALLERGIC REACTION causes CHRONIC ALLERGIC STATE,52,90,,68,112,causes,0.9897433186107869,900317-FS1-4,This results in the amplification of any subsequent ALLERGIC REACTION contributing to the CHRONIC ALLERGIC STATE,ALLERGIC REACTION,CHRONIC ALLERGIC STATE,RO-cause_of
502912512,7/14/2014 14:45:50,,1322894888,7/14/2014 14:45:46,instagc,0.4611,27753923,GBR,,,188.30.192.65,ALLERGIC REACTION causes CHRONIC ALLERGIC STATE,52,90,,68,112,causes,0.9897433186107869,900317-FS1-4,This results in the amplification of any subsequent ALLERGIC REACTION contributing to the CHRONIC ALLERGIC STATE,ALLERGIC REACTION,CHRONIC ALLERGIC STATE,RO-cause_of
502932174,7/14/2014 17:13:51,,1322970112,7/14/2014 17:13:08,prodege,0.7431,2767509,CAN,BC,Victoria,96.54.172.117,no_relation,59,98,,70,113,treats,0.824163383692134,906772-FS1-2,In a comparison group of 70 dogs without knwon exposure to TUBERCULOSIS two positive responses to USDA TUBERCULIN were demonstrated and none to PPD.,TUBERCULOSIS,USDA TUBERCULIN,RO-may_diagnose
502932174,7/14/2014 17:26:00,,1322976554,7/14/2014 17:25:51,pokerowned,0.5625,18747884,USA,MI,Snover,209.40.219.170,USDA TUBERCULIN treats TUBERCULOSIS,59,98,,70,113,treats,0.824163383692134,906772-FS1-2,In a comparison group of 70 dogs without knwon exposure to TUBERCULOSIS two positive responses to USDA TUBERCULIN were demonstrated and none to PPD.,TUBERCULOSIS,USDA TUBERCULIN,RO-may_diagnose
502932174,7/14/2014 17:48:37,,1322996061,7/14/2014 17:48:27,clixsense,0.5792,19803139,NLD,06,Veldhoven,212.61.84.196,USDA TUBERCULIN treats TUBERCULOSIS,59,98,,70,113,treats,0.824163383692134,906772-FS1-2,In a comparison group of 70 dogs without knwon exposure to TUBERCULOSIS two positive responses to USDA TUBERCULIN were demonstrated and none to PPD.,TUBERCULOSIS,USDA TUBERCULIN,RO-may_diagnose
502932174,7/14/2014 18:14:18,,1323009211,7/14/2014 18:13:46,vivatic,0.5669,25451531,GBR,,,83.67.28.193,USDA TUBERCULIN treats TUBERCULOSIS,59,98,,70,113,treats,0.824163383692134,906772-FS1-2,In a comparison group of 70 dogs without knwon exposure to TUBERCULOSIS two positive responses to USDA TUBERCULIN were demonstrated and none to PPD.,TUBERCULOSIS,USDA TUBERCULIN,RO-may_diagnose
502932174,7/14/2014 18:34:39,,1323017843,7/14/2014 18:34:29,clixsense,0.5347,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,59,98,,70,113,treats,0.824163383692134,906772-FS1-2,In a comparison group of 70 dogs without knwon exposure to TUBERCULOSIS two positive responses to USDA TUBERCULIN were demonstrated and none to PPD.,TUBERCULOSIS,USDA TUBERCULIN,RO-may_diagnose
502932174,7/14/2014 18:50:06,,1323025334,7/14/2014 18:50:01,clixsense,0.2853,19162475,GBR,M3,Frome,82.33.126.30,TUBERCULOSIS treats USDA TUBERCULIN,59,98,,70,113,treats,0.824163383692134,906772-FS1-2,In a comparison group of 70 dogs without knwon exposure to TUBERCULOSIS two positive responses to USDA TUBERCULIN were demonstrated and none to PPD.,TUBERCULOSIS,USDA TUBERCULIN,RO-may_diagnose
502932174,7/14/2014 19:15:59,,1323040732,7/14/2014 19:14:59,clixsense,0.4911,25595227,CAN,SK,North Battleford,24.72.96.119,USDA TUBERCULIN treats TUBERCULOSIS,59,98,,70,113,treats,0.824163383692134,906772-FS1-2,In a comparison group of 70 dogs without knwon exposure to TUBERCULOSIS two positive responses to USDA TUBERCULIN were demonstrated and none to PPD.,TUBERCULOSIS,USDA TUBERCULIN,RO-may_diagnose
502932183,7/14/2014 17:14:54,,1322970681,7/14/2014 17:14:30,prodege,0.7431,2767509,CAN,BC,Victoria,96.54.172.117,no_relation,106,123,,116,163,treats,0.43759497449368395,907161-FS1-2,The most significant results of this study are the level of hydration of the PC headgroup and the lack of DEHYDRATION with INCREASING TEMPERATURE AND SALT ADDITION.,DEHYDRATION,INCREASING TEMPERATURE AND SALT ADDITION,RO-may_prevent
502932183,7/14/2014 17:46:46,,1322995219,7/14/2014 17:46:13,fusioncash,0.3958,10190857,USA,OH,Clarksville,50.41.69.118,DEHYDRATION treats INCREASING TEMPERATURE AND SALT ADDITION,106,123,,116,163,treats,0.43759497449368395,907161-FS1-2,The most significant results of this study are the level of hydration of the PC headgroup and the lack of DEHYDRATION with INCREASING TEMPERATURE AND SALT ADDITION.,DEHYDRATION,INCREASING TEMPERATURE AND SALT ADDITION,RO-may_prevent
502932183,7/14/2014 17:48:15,,1322995864,7/14/2014 17:47:57,prodege,0.4458,2143114,CAN,BC,Vancouver,24.84.160.12,INCREASING TEMPERATURE AND SALT ADDITION treats DEHYDRATION,106,123,,116,163,treats,0.43759497449368395,907161-FS1-2,The most significant results of this study are the level of hydration of the PC headgroup and the lack of DEHYDRATION with INCREASING TEMPERATURE AND SALT ADDITION.,DEHYDRATION,INCREASING TEMPERATURE AND SALT ADDITION,RO-may_prevent
502932183,7/14/2014 18:02:48,,1323002461,7/14/2014 18:02:29,prodege,0.4377,12944140,GBR,I4,Mitcham,92.21.55.247,no_relation,106,123,,116,163,treats,0.43759497449368395,907161-FS1-2,The most significant results of this study are the level of hydration of the PC headgroup and the lack of DEHYDRATION with INCREASING TEMPERATURE AND SALT ADDITION.,DEHYDRATION,INCREASING TEMPERATURE AND SALT ADDITION,RO-may_prevent
502932183,7/14/2014 18:23:32,,1323013120,7/14/2014 18:23:11,neodev,0.4456,21515166,NLD,11,Nootdorp,83.86.58.179,DEHYDRATION treats INCREASING TEMPERATURE AND SALT ADDITION,106,123,,116,163,treats,0.43759497449368395,907161-FS1-2,The most significant results of this study are the level of hydration of the PC headgroup and the lack of DEHYDRATION with INCREASING TEMPERATURE AND SALT ADDITION.,DEHYDRATION,INCREASING TEMPERATURE AND SALT ADDITION,RO-may_prevent
502932183,7/14/2014 18:38:48,,1323019670,7/14/2014 18:37:55,instagc,0.5702,28524232,CAN,ON,Toronto,99.244.116.246,no_relation,106,123,,116,163,treats,0.43759497449368395,907161-FS1-2,The most significant results of this study are the level of hydration of the PC headgroup and the lack of DEHYDRATION with INCREASING TEMPERATURE AND SALT ADDITION.,DEHYDRATION,INCREASING TEMPERATURE AND SALT ADDITION,RO-may_prevent
502932183,7/14/2014 19:03:39,,1323034011,7/14/2014 19:03:09,instagc,0.6101,19686223,CAN,BC,Surrey,184.65.16.6,no_relation,106,123,,116,163,treats,0.43759497449368395,907161-FS1-2,The most significant results of this study are the level of hydration of the PC headgroup and the lack of DEHYDRATION with INCREASING TEMPERATURE AND SALT ADDITION.,DEHYDRATION,INCREASING TEMPERATURE AND SALT ADDITION,RO-may_prevent
502932191,7/14/2014 17:06:32,,1322966294,7/14/2014 17:06:14,instagc,0.8889,19636746,USA,NY,Andover,192.182.216.225,no_relation,109,28,,127,47,causes,0.625543242171224,900348-FS1-4,"A case of a typical form of SEXUAL ASPHYXIATION is described, involving a young man hanging, in a context of AUTOEROTIC ASPHYXIA",AUTOEROTIC ASPHYXIA,SEXUAL ASPHYXIATION,RO-cause_of
502932191,7/14/2014 17:25:05,,1322975990,7/14/2014 17:24:51,pokerowned,0.5625,18747884,USA,MI,Snover,209.40.219.170,SEXUAL ASPHYXIATION causes AUTOEROTIC ASPHYXIA,109,28,,127,47,causes,0.625543242171224,900348-FS1-4,"A case of a typical form of SEXUAL ASPHYXIATION is described, involving a young man hanging, in a context of AUTOEROTIC ASPHYXIA",AUTOEROTIC ASPHYXIA,SEXUAL ASPHYXIATION,RO-cause_of
502932191,7/14/2014 17:48:37,,1322996064,7/14/2014 17:48:28,prodege,0.4458,2143114,CAN,BC,Vancouver,24.84.160.12,AUTOEROTIC ASPHYXIA causes SEXUAL ASPHYXIATION,109,28,,127,47,causes,0.625543242171224,900348-FS1-4,"A case of a typical form of SEXUAL ASPHYXIATION is described, involving a young man hanging, in a context of AUTOEROTIC ASPHYXIA",AUTOEROTIC ASPHYXIA,SEXUAL ASPHYXIATION,RO-cause_of
502932191,7/14/2014 18:03:02,,1323002577,7/14/2014 18:02:23,eup_slw,0.6014,20818028,GBR,A7,Birmingham,92.232.139.254,AUTOEROTIC ASPHYXIA causes SEXUAL ASPHYXIATION,109,28,,127,47,causes,0.625543242171224,900348-FS1-4,"A case of a typical form of SEXUAL ASPHYXIATION is described, involving a young man hanging, in a context of AUTOEROTIC ASPHYXIA",AUTOEROTIC ASPHYXIA,SEXUAL ASPHYXIATION,RO-cause_of
502932191,7/14/2014 18:10:57,,1323007681,7/14/2014 18:10:20,quickrewards,0.7448,20452113,USA,NY,Port Henry,108.176.206.207,no_relation,109,28,,127,47,causes,0.625543242171224,900348-FS1-4,"A case of a typical form of SEXUAL ASPHYXIATION is described, involving a young man hanging, in a context of AUTOEROTIC ASPHYXIA",AUTOEROTIC ASPHYXIA,SEXUAL ASPHYXIATION,RO-cause_of
502932191,7/14/2014 18:23:52,,1323013248,7/14/2014 18:23:32,neodev,0.4456,21515166,NLD,11,Nootdorp,83.86.58.179,AUTOEROTIC ASPHYXIA causes SEXUAL ASPHYXIATION,109,28,,127,47,causes,0.625543242171224,900348-FS1-4,"A case of a typical form of SEXUAL ASPHYXIATION is described, involving a young man hanging, in a context of AUTOEROTIC ASPHYXIA",AUTOEROTIC ASPHYXIA,SEXUAL ASPHYXIATION,RO-cause_of
502932191,7/14/2014 18:37:54,,1323019213,7/14/2014 18:37:33,instagc,0.5702,28524232,CAN,ON,Toronto,99.244.116.246,SEXUAL ASPHYXIATION causes AUTOEROTIC ASPHYXIA,109,28,,127,47,causes,0.625543242171224,900348-FS1-4,"A case of a typical form of SEXUAL ASPHYXIATION is described, involving a young man hanging, in a context of AUTOEROTIC ASPHYXIA",AUTOEROTIC ASPHYXIA,SEXUAL ASPHYXIATION,RO-cause_of
502932207,7/14/2014 17:05:03,,1322965507,7/14/2014 17:04:27,clixsense,0.7639,27871219,NLD,07,Amsterdam,87.210.207.223,PREGNANCY contraindicates WARFARIN,165,101,,173,109,contraindicates,0.9284766908852591,901070-FS1-10,"When patients receive long term treatment with warfarin, pregnancy should be avoided or planned, and WARFARIN should be discontinued before conception or as soon as PREGNANCY is confirmed and before 6 weeks' gestation.",PREGNANCY,WARFARIN,RO-contraindicated_drug
502932207,7/14/2014 17:07:43,,1322966890,7/14/2014 17:07:37,neodev,0.6806,25224036,CAN,ON,Sudbury,67.204.218.187,WARFARIN contraindicates PREGNANCY,165,101,,173,109,contraindicates,0.9284766908852591,901070-FS1-10,"When patients receive long term treatment with warfarin, pregnancy should be avoided or planned, and WARFARIN should be discontinued before conception or as soon as PREGNANCY is confirmed and before 6 weeks' gestation.",PREGNANCY,WARFARIN,RO-contraindicated_drug
502932207,7/14/2014 18:23:10,,1323012998,7/14/2014 18:22:48,neodev,0.4456,21515166,NLD,11,Nootdorp,83.86.58.179,no_relation,165,101,,173,109,contraindicates,0.9284766908852591,901070-FS1-10,"When patients receive long term treatment with warfarin, pregnancy should be avoided or planned, and WARFARIN should be discontinued before conception or as soon as PREGNANCY is confirmed and before 6 weeks' gestation.",PREGNANCY,WARFARIN,RO-contraindicated_drug
502932207,7/14/2014 18:35:14,,1323018118,7/14/2014 18:35:04,clixsense,0.5347,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,165,101,,173,109,contraindicates,0.9284766908852591,901070-FS1-10,"When patients receive long term treatment with warfarin, pregnancy should be avoided or planned, and WARFARIN should be discontinued before conception or as soon as PREGNANCY is confirmed and before 6 weeks' gestation.",PREGNANCY,WARFARIN,RO-contraindicated_drug
502932207,7/14/2014 19:26:41,,1323047233,7/14/2014 19:26:23,neodev,0.4529,14861092,GBR,I2,Manchester,90.194.137.76,PREGNANCY contraindicates WARFARIN,165,101,,173,109,contraindicates,0.9284766908852591,901070-FS1-10,"When patients receive long term treatment with warfarin, pregnancy should be avoided or planned, and WARFARIN should be discontinued before conception or as soon as PREGNANCY is confirmed and before 6 weeks' gestation.",PREGNANCY,WARFARIN,RO-contraindicated_drug
502932207,7/14/2014 19:28:20,,1323048424,7/14/2014 19:28:01,clixsense,0.3805,15189335,GBR,A7,Birmingham,94.197.121.232,PREGNANCY contraindicates WARFARIN,165,101,,173,109,contraindicates,0.9284766908852591,901070-FS1-10,"When patients receive long term treatment with warfarin, pregnancy should be avoided or planned, and WARFARIN should be discontinued before conception or as soon as PREGNANCY is confirmed and before 6 weeks' gestation.",PREGNANCY,WARFARIN,RO-contraindicated_drug
502932207,7/14/2014 19:36:42,,1323053738,7/14/2014 19:35:53,prodege,0.3393,22360212,GBR,I1,Luton,82.6.41.191,no_relation,165,101,,173,109,contraindicates,0.9284766908852591,901070-FS1-10,"When patients receive long term treatment with warfarin, pregnancy should be avoided or planned, and WARFARIN should be discontinued before conception or as soon as PREGNANCY is confirmed and before 6 weeks' gestation.",PREGNANCY,WARFARIN,RO-contraindicated_drug
502932220,7/14/2014 17:00:42,,1322963418,7/14/2014 17:00:36,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,MECONIUM DOSE DEPENDENT RESPONSE causes MECONIUM ASPIRATION SYNDROME,169,85,,200,113,causes,0.577350269189626,903672-FS1-4,To better understand the mechanisms contributing to altered airway reactivity in the MECONIUM ASPIRATION SYNDROME in this study we investigated whether there could be a MECONIUM DOSE DEPENDENT RESPONSE of tracheal smooth muscle and lung tissue reactivity to histamine and acetylcholine in vitro.,MECONIUM DOSE DEPENDENT RESPONSE,MECONIUM ASPIRATION SYNDROME,RO-has_causative_agent
502932220,7/14/2014 17:16:16,,1322971389,7/14/2014 17:15:31,prodege,0.7431,2767509,CAN,BC,Victoria,96.54.172.117,no_relation,169,85,,200,113,causes,0.577350269189626,903672-FS1-4,To better understand the mechanisms contributing to altered airway reactivity in the MECONIUM ASPIRATION SYNDROME in this study we investigated whether there could be a MECONIUM DOSE DEPENDENT RESPONSE of tracheal smooth muscle and lung tissue reactivity to histamine and acetylcholine in vitro.,MECONIUM DOSE DEPENDENT RESPONSE,MECONIUM ASPIRATION SYNDROME,RO-has_causative_agent
502932220,7/14/2014 17:48:27,,1322995972,7/14/2014 17:48:16,prodege,0.4458,2143114,CAN,BC,Vancouver,24.84.160.12,MECONIUM ASPIRATION SYNDROME causes MECONIUM DOSE DEPENDENT RESPONSE,169,85,,200,113,causes,0.577350269189626,903672-FS1-4,To better understand the mechanisms contributing to altered airway reactivity in the MECONIUM ASPIRATION SYNDROME in this study we investigated whether there could be a MECONIUM DOSE DEPENDENT RESPONSE of tracheal smooth muscle and lung tissue reactivity to histamine and acetylcholine in vitro.,MECONIUM DOSE DEPENDENT RESPONSE,MECONIUM ASPIRATION SYNDROME,RO-has_causative_agent
502932220,7/14/2014 19:16:11,,1323040867,7/14/2014 19:15:43,elite,0.5323,28503042,USA,NJ,Woodbridge,54.191.150.115,MECONIUM ASPIRATION SYNDROME causes MECONIUM DOSE DEPENDENT RESPONSE,169,85,,200,113,causes,0.577350269189626,903672-FS1-4,To better understand the mechanisms contributing to altered airway reactivity in the MECONIUM ASPIRATION SYNDROME in this study we investigated whether there could be a MECONIUM DOSE DEPENDENT RESPONSE of tracheal smooth muscle and lung tissue reactivity to histamine and acetylcholine in vitro.,MECONIUM DOSE DEPENDENT RESPONSE,MECONIUM ASPIRATION SYNDROME,RO-has_causative_agent
502932220,7/14/2014 19:18:58,,1323042642,7/14/2014 19:17:57,clixsense,0.4911,25595227,CAN,SK,North Battleford,24.72.96.119,no_relation,169,85,,200,113,causes,0.577350269189626,903672-FS1-4,To better understand the mechanisms contributing to altered airway reactivity in the MECONIUM ASPIRATION SYNDROME in this study we investigated whether there could be a MECONIUM DOSE DEPENDENT RESPONSE of tracheal smooth muscle and lung tissue reactivity to histamine and acetylcholine in vitro.,MECONIUM DOSE DEPENDENT RESPONSE,MECONIUM ASPIRATION SYNDROME,RO-has_causative_agent
502932220,7/14/2014 19:28:40,,1323048595,7/14/2014 19:28:03,neodev,0.4529,14861092,GBR,I2,Manchester,90.194.137.76,no_relation,169,85,,200,113,causes,0.577350269189626,903672-FS1-4,To better understand the mechanisms contributing to altered airway reactivity in the MECONIUM ASPIRATION SYNDROME in this study we investigated whether there could be a MECONIUM DOSE DEPENDENT RESPONSE of tracheal smooth muscle and lung tissue reactivity to histamine and acetylcholine in vitro.,MECONIUM DOSE DEPENDENT RESPONSE,MECONIUM ASPIRATION SYNDROME,RO-has_causative_agent
502932220,7/14/2014 19:28:41,,1323048631,7/14/2014 19:28:23,clixsense,0.3805,15189335,GBR,A7,Birmingham,94.197.121.232,MECONIUM ASPIRATION SYNDROME causes MECONIUM DOSE DEPENDENT RESPONSE,169,85,,200,113,causes,0.577350269189626,903672-FS1-4,To better understand the mechanisms contributing to altered airway reactivity in the MECONIUM ASPIRATION SYNDROME in this study we investigated whether there could be a MECONIUM DOSE DEPENDENT RESPONSE of tracheal smooth muscle and lung tissue reactivity to histamine and acetylcholine in vitro.,MECONIUM DOSE DEPENDENT RESPONSE,MECONIUM ASPIRATION SYNDROME,RO-has_causative_agent
502934677,7/14/2014 17:02:41,,1322964497,7/14/2014 17:02:32,clixsense,0.8194,27793793,GBR,C5,Chester,151.230.27.155,900 MG OF IBUPROFEN treats PAIN RELATED TO OSTEOARTHROSIS,108,71,,137,90,treats,0.9958932064677041,907332-FS1-2,Indoprofen at the daily dose of 600 mg was comparable in efficacy with 900 MG OF IBUPROFEN in the relief of PAIN RELATED TO OSTEOARTHROSIS.,PAIN RELATED TO OSTEOARTHROSIS,900 MG OF IBUPROFEN,RO-may_prevent
502934677,7/14/2014 17:08:31,,1322967285,7/14/2014 17:08:26,neodev,0.6389,25224036,CAN,ON,Sudbury,67.204.218.187,900 MG OF IBUPROFEN treats PAIN RELATED TO OSTEOARTHROSIS,108,71,,137,90,treats,0.9958932064677041,907332-FS1-2,Indoprofen at the daily dose of 600 mg was comparable in efficacy with 900 MG OF IBUPROFEN in the relief of PAIN RELATED TO OSTEOARTHROSIS.,PAIN RELATED TO OSTEOARTHROSIS,900 MG OF IBUPROFEN,RO-may_prevent
502934677,7/14/2014 17:23:48,,1322975119,7/14/2014 17:23:33,instagc,0.8125,18960682,GBR,,,86.29.147.112,900 MG OF IBUPROFEN treats PAIN RELATED TO OSTEOARTHROSIS,108,71,,137,90,treats,0.9958932064677041,907332-FS1-2,Indoprofen at the daily dose of 600 mg was comparable in efficacy with 900 MG OF IBUPROFEN in the relief of PAIN RELATED TO OSTEOARTHROSIS.,PAIN RELATED TO OSTEOARTHROSIS,900 MG OF IBUPROFEN,RO-may_prevent
502934677,7/14/2014 18:02:16,,1323002249,7/14/2014 18:01:58,prodege,0.4264,12944140,GBR,I4,Mitcham,92.21.55.247,900 MG OF IBUPROFEN treats PAIN RELATED TO OSTEOARTHROSIS,108,71,,137,90,treats,0.9958932064677041,907332-FS1-2,Indoprofen at the daily dose of 600 mg was comparable in efficacy with 900 MG OF IBUPROFEN in the relief of PAIN RELATED TO OSTEOARTHROSIS.,PAIN RELATED TO OSTEOARTHROSIS,900 MG OF IBUPROFEN,RO-may_prevent
502934677,7/14/2014 18:09:10,,1323006776,7/14/2014 18:08:22,prodege,0.5502,7899370,USA,MI,Bay City,71.13.81.162,900 MG OF IBUPROFEN treats PAIN RELATED TO OSTEOARTHROSIS,108,71,,137,90,treats,0.9958932064677041,907332-FS1-2,Indoprofen at the daily dose of 600 mg was comparable in efficacy with 900 MG OF IBUPROFEN in the relief of PAIN RELATED TO OSTEOARTHROSIS.,PAIN RELATED TO OSTEOARTHROSIS,900 MG OF IBUPROFEN,RO-may_prevent
502934677,7/14/2014 18:32:49,,1323017092,7/14/2014 18:32:30,clixsense,0.7071,16827630,GBR,A7,Birmingham,86.146.169.103,900 MG OF IBUPROFEN treats PAIN RELATED TO OSTEOARTHROSIS,108,71,,137,90,treats,0.9958932064677041,907332-FS1-2,Indoprofen at the daily dose of 600 mg was comparable in efficacy with 900 MG OF IBUPROFEN in the relief of PAIN RELATED TO OSTEOARTHROSIS.,PAIN RELATED TO OSTEOARTHROSIS,900 MG OF IBUPROFEN,RO-may_prevent
502934677,7/14/2014 18:47:10,,1323023816,7/14/2014 18:47:04,clixsense,0.4121,19162475,GBR,M3,Frome,82.33.126.30,900 MG OF IBUPROFEN treats PAIN RELATED TO OSTEOARTHROSIS,108,71,,137,90,treats,0.9958932064677041,907332-FS1-2,Indoprofen at the daily dose of 600 mg was comparable in efficacy with 900 MG OF IBUPROFEN in the relief of PAIN RELATED TO OSTEOARTHROSIS.,PAIN RELATED TO OSTEOARTHROSIS,900 MG OF IBUPROFEN,RO-may_prevent
502934683,7/14/2014 16:59:39,,1322962845,7/14/2014 16:59:28,instagc,1.0,27753923,GBR,,,94.196.229.196,JOINTS is location of ARTHRITIS,27,0,,32,9,is location of,0.8660254037844392,902293-FS1-9,ARTHRITIS developed in all JOINTS in which the prosthesis elongated or broke.,JOINTS,ARTHRITIS,RO-disease_has_primary_anatomic_site
502934683,7/14/2014 17:01:02,,1322963648,7/14/2014 17:00:56,neodev,0.875,17610000,GBR,I2,Manchester,90.200.140.201,JOINTS is location of ARTHRITIS,27,0,,32,9,is location of,0.8660254037844392,902293-FS1-9,ARTHRITIS developed in all JOINTS in which the prosthesis elongated or broke.,JOINTS,ARTHRITIS,RO-disease_has_primary_anatomic_site
502934683,7/14/2014 17:58:39,,1323000666,7/14/2014 17:58:04,neodev,0.6641,28269997,GBR,H9,London,151.224.171.48,JOINTS is location of ARTHRITIS,27,0,,32,9,is location of,0.8660254037844392,902293-FS1-9,ARTHRITIS developed in all JOINTS in which the prosthesis elongated or broke.,JOINTS,ARTHRITIS,RO-disease_has_primary_anatomic_site
502934683,7/14/2014 18:10:47,,1323007584,7/14/2014 18:10:19,vivatic,0.605,25451531,GBR,,,83.67.28.193,JOINTS is location of ARTHRITIS,27,0,,32,9,is location of,0.8660254037844392,902293-FS1-9,ARTHRITIS developed in all JOINTS in which the prosthesis elongated or broke.,JOINTS,ARTHRITIS,RO-disease_has_primary_anatomic_site
502934683,7/14/2014 19:19:23,,1323042893,7/14/2014 19:18:53,instagc,0.7278,13763729,USA,,,75.182.89.225,JOINTS is location of ARTHRITIS,27,0,,32,9,is location of,0.8660254037844392,902293-FS1-9,ARTHRITIS developed in all JOINTS in which the prosthesis elongated or broke.,JOINTS,ARTHRITIS,RO-disease_has_primary_anatomic_site
502934683,7/14/2014 19:29:19,,1323048982,7/14/2014 19:29:03,neodev,0.6472,14861092,GBR,I2,Manchester,90.194.137.76,JOINTS is location of ARTHRITIS,27,0,,32,9,is location of,0.8660254037844392,902293-FS1-9,ARTHRITIS developed in all JOINTS in which the prosthesis elongated or broke.,JOINTS,ARTHRITIS,RO-disease_has_primary_anatomic_site
502934683,7/14/2014 19:33:31,,1323051742,7/14/2014 19:33:08,neodev,0.7222,21752395,USA,,,173.23.121.63,JOINTS is location of ARTHRITIS,27,0,,32,9,is location of,0.8660254037844392,902293-FS1-9,ARTHRITIS developed in all JOINTS in which the prosthesis elongated or broke.,JOINTS,ARTHRITIS,RO-disease_has_primary_anatomic_site
502934684,7/14/2014 17:01:11,,1322963776,7/14/2014 17:01:00,clixsense,0.8194,27793793,GBR,C5,Chester,151.230.27.155,ANTIEPILEPTIC DRUGS (AEDS) treats DRUG RESISTANT EPILEPSY,94,32,,116,58,treats,0.6741998624632421,908168-FS1-2,"In spite of the large number of ANTIEPILEPTIC DRUGS (AEDS) actually available, the problem of DRUG RESISTANT EPILEPSY has not been solved.",DRUG RESISTANT EPILEPSY,ANTIEPILEPTIC DRUGS (AEDS),RO-may_treat
502934684,7/14/2014 17:49:32,,1322996466,7/14/2014 17:49:23,prodege,0.6667,2143114,CAN,BC,Vancouver,24.84.160.12,ANTIEPILEPTIC DRUGS (AEDS) treats DRUG RESISTANT EPILEPSY,94,32,,116,58,treats,0.6741998624632421,908168-FS1-2,"In spite of the large number of ANTIEPILEPTIC DRUGS (AEDS) actually available, the problem of DRUG RESISTANT EPILEPSY has not been solved.",DRUG RESISTANT EPILEPSY,ANTIEPILEPTIC DRUGS (AEDS),RO-may_treat
502934684,7/14/2014 18:02:16,,1323002248,7/14/2014 18:01:58,prodege,0.4264,12944140,GBR,I4,Mitcham,92.21.55.247,no_relation,94,32,,116,58,treats,0.6741998624632421,908168-FS1-2,"In spite of the large number of ANTIEPILEPTIC DRUGS (AEDS) actually available, the problem of DRUG RESISTANT EPILEPSY has not been solved.",DRUG RESISTANT EPILEPSY,ANTIEPILEPTIC DRUGS (AEDS),RO-may_treat
502934684,7/14/2014 18:34:16,,1323017615,7/14/2014 18:33:55,clixsense,0.7071,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,94,32,,116,58,treats,0.6741998624632421,908168-FS1-2,"In spite of the large number of ANTIEPILEPTIC DRUGS (AEDS) actually available, the problem of DRUG RESISTANT EPILEPSY has not been solved.",DRUG RESISTANT EPILEPSY,ANTIEPILEPTIC DRUGS (AEDS),RO-may_treat
502934684,7/14/2014 18:55:56,,1323028674,7/14/2014 18:55:00,instagc,0.5877,19686223,CAN,BC,Surrey,184.65.16.6,ANTIEPILEPTIC DRUGS (AEDS) treats DRUG RESISTANT EPILEPSY,94,32,,116,58,treats,0.6741998624632421,908168-FS1-2,"In spite of the large number of ANTIEPILEPTIC DRUGS (AEDS) actually available, the problem of DRUG RESISTANT EPILEPSY has not been solved.",DRUG RESISTANT EPILEPSY,ANTIEPILEPTIC DRUGS (AEDS),RO-may_treat
502934684,7/14/2014 19:13:38,,1323039435,7/14/2014 19:13:12,elite,0.6234,28503042,USA,NJ,Woodbridge,54.191.150.115,ANTIEPILEPTIC DRUGS (AEDS) treats DRUG RESISTANT EPILEPSY,94,32,,116,58,treats,0.6741998624632421,908168-FS1-2,"In spite of the large number of ANTIEPILEPTIC DRUGS (AEDS) actually available, the problem of DRUG RESISTANT EPILEPSY has not been solved.",DRUG RESISTANT EPILEPSY,ANTIEPILEPTIC DRUGS (AEDS),RO-may_treat
502934684,7/14/2014 19:29:58,,1323049396,7/14/2014 19:29:21,neodev,0.6472,14861092,GBR,I2,Manchester,90.194.137.76,ANTIEPILEPTIC DRUGS (AEDS) treats DRUG RESISTANT EPILEPSY,94,32,,116,58,treats,0.6741998624632421,908168-FS1-2,"In spite of the large number of ANTIEPILEPTIC DRUGS (AEDS) actually available, the problem of DRUG RESISTANT EPILEPSY has not been solved.",DRUG RESISTANT EPILEPSY,ANTIEPILEPTIC DRUGS (AEDS),RO-may_treat
502934686,7/14/2014 17:02:31,,1322964447,7/14/2014 17:02:14,clixsense,0.8194,27793793,GBR,C5,Chester,151.230.27.155,MILD TRANSIENT RESPIRATORY DISTRESS causes RESPIRATORY DISTRESS SYNDROME,122,209,,156,238,causes,0.635000635000953,901937-FS1-4,The association was not explained by 1) improper timing of elective Cesarean deliveries; 2) misclassification of cases of MILD TRANSIENT RESPIRATORY DISTRESS (which may be more common after Cesarean birth) as RESPIRATORY DISTRESS SYNDROME; or 3) the differences in the occurrence of pregnancy complications preceding Cesarean births compared with vaginal births.,MILD TRANSIENT RESPIRATORY DISTRESS,RESPIRATORY DISTRESS SYNDROME,RO-disease_has_finding
502934686,7/14/2014 18:03:40,,1323002872,7/14/2014 18:03:21,prodege,0.4264,12944140,GBR,I4,Mitcham,92.21.55.247,no_relation,122,209,,156,238,causes,0.635000635000953,901937-FS1-4,The association was not explained by 1) improper timing of elective Cesarean deliveries; 2) misclassification of cases of MILD TRANSIENT RESPIRATORY DISTRESS (which may be more common after Cesarean birth) as RESPIRATORY DISTRESS SYNDROME; or 3) the differences in the occurrence of pregnancy complications preceding Cesarean births compared with vaginal births.,MILD TRANSIENT RESPIRATORY DISTRESS,RESPIRATORY DISTRESS SYNDROME,RO-disease_has_finding
502934686,7/14/2014 18:30:41,,1323016169,7/14/2014 18:30:00,instagc,0.6187,28524232,CAN,ON,Toronto,99.244.116.246,no_relation,122,209,,156,238,causes,0.635000635000953,901937-FS1-4,The association was not explained by 1) improper timing of elective Cesarean deliveries; 2) misclassification of cases of MILD TRANSIENT RESPIRATORY DISTRESS (which may be more common after Cesarean birth) as RESPIRATORY DISTRESS SYNDROME; or 3) the differences in the occurrence of pregnancy complications preceding Cesarean births compared with vaginal births.,MILD TRANSIENT RESPIRATORY DISTRESS,RESPIRATORY DISTRESS SYNDROME,RO-disease_has_finding
502934686,7/14/2014 18:58:01,,1323030192,7/14/2014 18:57:06,instagc,0.5877,19686223,CAN,BC,Surrey,184.65.16.6,MILD TRANSIENT RESPIRATORY DISTRESS causes RESPIRATORY DISTRESS SYNDROME,122,209,,156,238,causes,0.635000635000953,901937-FS1-4,The association was not explained by 1) improper timing of elective Cesarean deliveries; 2) misclassification of cases of MILD TRANSIENT RESPIRATORY DISTRESS (which may be more common after Cesarean birth) as RESPIRATORY DISTRESS SYNDROME; or 3) the differences in the occurrence of pregnancy complications preceding Cesarean births compared with vaginal births.,MILD TRANSIENT RESPIRATORY DISTRESS,RESPIRATORY DISTRESS SYNDROME,RO-disease_has_finding
502934686,7/14/2014 19:19:23,,1323042894,7/14/2014 19:18:53,instagc,0.7278,13763729,USA,,,75.182.89.225,no_relation,122,209,,156,238,causes,0.635000635000953,901937-FS1-4,The association was not explained by 1) improper timing of elective Cesarean deliveries; 2) misclassification of cases of MILD TRANSIENT RESPIRATORY DISTRESS (which may be more common after Cesarean birth) as RESPIRATORY DISTRESS SYNDROME; or 3) the differences in the occurrence of pregnancy complications preceding Cesarean births compared with vaginal births.,MILD TRANSIENT RESPIRATORY DISTRESS,RESPIRATORY DISTRESS SYNDROME,RO-disease_has_finding
502934686,7/14/2014 19:30:23,,1323049719,7/14/2014 19:29:59,neodev,0.6472,14861092,GBR,I2,Manchester,90.194.137.76,no_relation,122,209,,156,238,causes,0.635000635000953,901937-FS1-4,The association was not explained by 1) improper timing of elective Cesarean deliveries; 2) misclassification of cases of MILD TRANSIENT RESPIRATORY DISTRESS (which may be more common after Cesarean birth) as RESPIRATORY DISTRESS SYNDROME; or 3) the differences in the occurrence of pregnancy complications preceding Cesarean births compared with vaginal births.,MILD TRANSIENT RESPIRATORY DISTRESS,RESPIRATORY DISTRESS SYNDROME,RO-disease_has_finding
502934686,7/14/2014 19:32:08,,1323050955,7/14/2014 19:31:23,clixsense,0.3921,15189335,GBR,A7,Birmingham,94.197.121.232,RESPIRATORY DISTRESS SYNDROME causes MILD TRANSIENT RESPIRATORY DISTRESS,122,209,,156,238,causes,0.635000635000953,901937-FS1-4,The association was not explained by 1) improper timing of elective Cesarean deliveries; 2) misclassification of cases of MILD TRANSIENT RESPIRATORY DISTRESS (which may be more common after Cesarean birth) as RESPIRATORY DISTRESS SYNDROME; or 3) the differences in the occurrence of pregnancy complications preceding Cesarean births compared with vaginal births.,MILD TRANSIENT RESPIRATORY DISTRESS,RESPIRATORY DISTRESS SYNDROME,RO-disease_has_finding
502934688,7/14/2014 16:59:46,,1322962877,7/14/2014 16:59:41,instagc,1.0,27753923,GBR,,,94.196.229.196,HEPATOMA treats ASCITES FLUID,74,106,,86,114,treats,0.338061701891407,902852-FS1-2,"Human alpha fetoproteins were purified from umbilical cord serum and from ASCITES FLUID of a patient with HEPATOMA by affinity chromatography, and their chemical compositions and terminal sequences were compared.",ASCITES FLUID,HEPATOMA,RO-disease_may_have_finding
502934688,7/14/2014 17:49:32,,1322996462,7/14/2014 17:49:19,clixsense,0.6389,19803139,NLD,06,Veldhoven,212.61.84.196,ASCITES FLUID treats HEPATOMA,74,106,,86,114,treats,0.338061701891407,902852-FS1-2,"Human alpha fetoproteins were purified from umbilical cord serum and from ASCITES FLUID of a patient with HEPATOMA by affinity chromatography, and their chemical compositions and terminal sequences were compared.",ASCITES FLUID,HEPATOMA,RO-disease_may_have_finding
502934688,7/14/2014 18:22:39,,1323012800,7/14/2014 18:21:55,instagc,0.6187,28524232,CAN,ON,Toronto,99.244.116.246,no_relation,74,106,,86,114,treats,0.338061701891407,902852-FS1-2,"Human alpha fetoproteins were purified from umbilical cord serum and from ASCITES FLUID of a patient with HEPATOMA by affinity chromatography, and their chemical compositions and terminal sequences were compared.",ASCITES FLUID,HEPATOMA,RO-disease_may_have_finding
502934688,7/14/2014 18:33:40,,1323017392,7/14/2014 18:33:24,clixsense,0.7071,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,74,106,,86,114,treats,0.338061701891407,902852-FS1-2,"Human alpha fetoproteins were purified from umbilical cord serum and from ASCITES FLUID of a patient with HEPATOMA by affinity chromatography, and their chemical compositions and terminal sequences were compared.",ASCITES FLUID,HEPATOMA,RO-disease_may_have_finding
502934688,7/14/2014 18:49:07,,1323024788,7/14/2014 18:48:52,instagc,0.5869,25990856,USA,NV,Las Vegas,68.108.98.78,no_relation,74,106,,86,114,treats,0.338061701891407,902852-FS1-2,"Human alpha fetoproteins were purified from umbilical cord serum and from ASCITES FLUID of a patient with HEPATOMA by affinity chromatography, and their chemical compositions and terminal sequences were compared.",ASCITES FLUID,HEPATOMA,RO-disease_may_have_finding
502934688,7/14/2014 18:49:35,,1323025063,7/14/2014 18:49:25,clixsense,0.4121,19162475,GBR,M3,Frome,82.33.126.30,HEPATOMA treats ASCITES FLUID,74,106,,86,114,treats,0.338061701891407,902852-FS1-2,"Human alpha fetoproteins were purified from umbilical cord serum and from ASCITES FLUID of a patient with HEPATOMA by affinity chromatography, and their chemical compositions and terminal sequences were compared.",ASCITES FLUID,HEPATOMA,RO-disease_may_have_finding
502934688,7/14/2014 18:55:56,,1323028675,7/14/2014 18:55:00,instagc,0.5877,19686223,CAN,BC,Surrey,184.65.16.6,ASCITES FLUID treats HEPATOMA,74,106,,86,114,treats,0.338061701891407,902852-FS1-2,"Human alpha fetoproteins were purified from umbilical cord serum and from ASCITES FLUID of a patient with HEPATOMA by affinity chromatography, and their chemical compositions and terminal sequences were compared.",ASCITES FLUID,HEPATOMA,RO-disease_may_have_finding
502934689,7/14/2014 16:59:00,,1322962575,7/14/2014 16:58:55,instagc,1.0,27753923,GBR,,,94.196.229.196,IRON DEFICIENCY ANEMIA treats EPOETIN ALFA THERAPY,210,268,,231,288,treats,0.980196058819607,907636-FS1-2,Class:  Iron Preparations 20:04.04  Synonyms:  Iron Saccharate; Iron Sucron Complex; Saccharated Ferric Oxide  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of IRON DEFICIENCY ANEMIA in hemodialysis patients receiving EPOETIN ALFA THERAPY.,IRON DEFICIENCY ANEMIA,EPOETIN ALFA THERAPY,RO-may_treat
502934689,7/14/2014 17:08:47,,1322967438,7/14/2014 17:08:42,neodev,0.6389,25224036,CAN,ON,Sudbury,67.204.218.187,EPOETIN ALFA THERAPY treats IRON DEFICIENCY ANEMIA,210,268,,231,288,treats,0.980196058819607,907636-FS1-2,Class:  Iron Preparations 20:04.04  Synonyms:  Iron Saccharate; Iron Sucron Complex; Saccharated Ferric Oxide  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of IRON DEFICIENCY ANEMIA in hemodialysis patients receiving EPOETIN ALFA THERAPY.,IRON DEFICIENCY ANEMIA,EPOETIN ALFA THERAPY,RO-may_treat
502934689,7/14/2014 17:22:36,,1322974312,7/14/2014 17:22:25,instagc,0.8125,18960682,GBR,,,86.29.147.112,EPOETIN ALFA THERAPY treats IRON DEFICIENCY ANEMIA,210,268,,231,288,treats,0.980196058819607,907636-FS1-2,Class:  Iron Preparations 20:04.04  Synonyms:  Iron Saccharate; Iron Sucron Complex; Saccharated Ferric Oxide  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of IRON DEFICIENCY ANEMIA in hemodialysis patients receiving EPOETIN ALFA THERAPY.,IRON DEFICIENCY ANEMIA,EPOETIN ALFA THERAPY,RO-may_treat
502934689,7/14/2014 18:06:59,,1323005728,7/14/2014 18:05:53,prodege,0.5502,7899370,USA,MI,Bay City,71.13.81.162,EPOETIN ALFA THERAPY treats IRON DEFICIENCY ANEMIA,210,268,,231,288,treats,0.980196058819607,907636-FS1-2,Class:  Iron Preparations 20:04.04  Synonyms:  Iron Saccharate; Iron Sucron Complex; Saccharated Ferric Oxide  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of IRON DEFICIENCY ANEMIA in hemodialysis patients receiving EPOETIN ALFA THERAPY.,IRON DEFICIENCY ANEMIA,EPOETIN ALFA THERAPY,RO-may_treat
502934689,7/14/2014 18:31:19,,1323016425,7/14/2014 18:30:42,instagc,0.6187,28524232,CAN,ON,Toronto,99.244.116.246,EPOETIN ALFA THERAPY treats IRON DEFICIENCY ANEMIA,210,268,,231,288,treats,0.980196058819607,907636-FS1-2,Class:  Iron Preparations 20:04.04  Synonyms:  Iron Saccharate; Iron Sucron Complex; Saccharated Ferric Oxide  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of IRON DEFICIENCY ANEMIA in hemodialysis patients receiving EPOETIN ALFA THERAPY.,IRON DEFICIENCY ANEMIA,EPOETIN ALFA THERAPY,RO-may_treat
502934689,7/14/2014 18:46:23,,1323023344,7/14/2014 18:46:14,clixsense,0.4121,19162475,GBR,M3,Frome,82.33.126.30,EPOETIN ALFA THERAPY treats IRON DEFICIENCY ANEMIA,210,268,,231,288,treats,0.980196058819607,907636-FS1-2,Class:  Iron Preparations 20:04.04  Synonyms:  Iron Saccharate; Iron Sucron Complex; Saccharated Ferric Oxide  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of IRON DEFICIENCY ANEMIA in hemodialysis patients receiving EPOETIN ALFA THERAPY.,IRON DEFICIENCY ANEMIA,EPOETIN ALFA THERAPY,RO-may_treat
502934689,7/14/2014 19:31:01,,1323050047,7/14/2014 19:30:45,neodev,0.6472,14861092,GBR,I2,Manchester,90.194.137.76,EPOETIN ALFA THERAPY treats IRON DEFICIENCY ANEMIA,210,268,,231,288,treats,0.980196058819607,907636-FS1-2,Class:  Iron Preparations 20:04.04  Synonyms:  Iron Saccharate; Iron Sucron Complex; Saccharated Ferric Oxide  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of IRON DEFICIENCY ANEMIA in hemodialysis patients receiving EPOETIN ALFA THERAPY.,IRON DEFICIENCY ANEMIA,EPOETIN ALFA THERAPY,RO-may_treat
502934690,7/14/2014 17:01:11,,1322963777,7/14/2014 17:01:00,clixsense,0.8194,27793793,GBR,C5,Chester,151.230.27.155,PREECLAMPSIA causes PREGNANCY COMPLICATIONS,81,113,,103,125,causes,0.8219949365267859,901889-FS1-4,We also discuss a potential role for PLAC1 as a biomarker predictive of specific PREGNANCY COMPLICATIONS such as PREECLAMPSIA,PREGNANCY COMPLICATIONS,PREECLAMPSIA,RO-disease_has_finding
502934690,7/14/2014 17:11:16,,1322968814,7/14/2014 17:10:50,instagc,0.5208,19636746,USA,NY,Andover,192.182.216.225,no_relation,81,113,,103,125,causes,0.8219949365267859,901889-FS1-4,We also discuss a potential role for PLAC1 as a biomarker predictive of specific PREGNANCY COMPLICATIONS such as PREECLAMPSIA,PREGNANCY COMPLICATIONS,PREECLAMPSIA,RO-disease_has_finding
502934690,7/14/2014 17:26:40,,1322977026,7/14/2014 17:26:26,pokerowned,0.5639,18747884,USA,MI,Snover,209.40.219.170,PREECLAMPSIA causes PREGNANCY COMPLICATIONS,81,113,,103,125,causes,0.8219949365267859,901889-FS1-4,We also discuss a potential role for PLAC1 as a biomarker predictive of specific PREGNANCY COMPLICATIONS such as PREECLAMPSIA,PREGNANCY COMPLICATIONS,PREECLAMPSIA,RO-disease_has_finding
502934690,7/14/2014 17:29:09,,1322978912,7/14/2014 17:28:15,elite,0.5833,28276268,USA,MI,Taylor,67.149.247.166,PREECLAMPSIA causes PREGNANCY COMPLICATIONS,81,113,,103,125,causes,0.8219949365267859,901889-FS1-4,We also discuss a potential role for PLAC1 as a biomarker predictive of specific PREGNANCY COMPLICATIONS such as PREECLAMPSIA,PREGNANCY COMPLICATIONS,PREECLAMPSIA,RO-disease_has_finding
502934690,7/14/2014 18:10:17,,1323007283,7/14/2014 18:09:43,vivatic,0.605,25451531,GBR,,,83.67.28.193,no_relation,81,113,,103,125,causes,0.8219949365267859,901889-FS1-4,We also discuss a potential role for PLAC1 as a biomarker predictive of specific PREGNANCY COMPLICATIONS such as PREECLAMPSIA,PREGNANCY COMPLICATIONS,PREECLAMPSIA,RO-disease_has_finding
502934690,7/14/2014 18:28:33,,1323015274,7/14/2014 18:28:13,neodev,0.6095,21515166,NLD,11,Nootdorp,83.86.58.179,PREECLAMPSIA causes PREGNANCY COMPLICATIONS,81,113,,103,125,causes,0.8219949365267859,901889-FS1-4,We also discuss a potential role for PLAC1 as a biomarker predictive of specific PREGNANCY COMPLICATIONS such as PREECLAMPSIA,PREGNANCY COMPLICATIONS,PREECLAMPSIA,RO-disease_has_finding
502934690,7/14/2014 18:33:07,,1323017192,7/14/2014 18:32:50,clixsense,0.7071,16827630,GBR,A7,Birmingham,86.146.169.103,PREECLAMPSIA causes PREGNANCY COMPLICATIONS,81,113,,103,125,causes,0.8219949365267859,901889-FS1-4,We also discuss a potential role for PLAC1 as a biomarker predictive of specific PREGNANCY COMPLICATIONS such as PREECLAMPSIA,PREGNANCY COMPLICATIONS,PREECLAMPSIA,RO-disease_has_finding
502934691,7/14/2014 17:01:55,,1322964194,7/14/2014 17:01:24,clixsense,0.8611,27871219,NLD,07,Amsterdam,87.210.207.223,POLYPOID LESION diagnosed by GASTRO INTESTINAL POLYPS,106,33,,120,57,diagnosed by,0.38490017945974997,901529-FS1-13,"Although, according to T.Yamada, GASTRO INTESTINAL POLYPS are described with respect to shape and size of POLYPOID LESION only, microscopic structure of polyps manages to find its reflection to a considerable degree too: type I predominantly embraces hypertrophic folds of mucosa as well as non tumor polyps, both hyperplastic and inflammatory, while, at more advanced stages (II IV), tubular and tubulo villose adenomas and villose tumors prevail.",POLYPOID LESION,GASTRO INTESTINAL POLYPS,RO-disease_has_finding
502934691,7/14/2014 17:50:57,,1322997096,7/14/2014 17:50:32,clixsense,0.6389,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,106,33,,120,57,diagnosed by,0.38490017945974997,901529-FS1-13,"Although, according to T.Yamada, GASTRO INTESTINAL POLYPS are described with respect to shape and size of POLYPOID LESION only, microscopic structure of polyps manages to find its reflection to a considerable degree too: type I predominantly embraces hypertrophic folds of mucosa as well as non tumor polyps, both hyperplastic and inflammatory, while, at more advanced stages (II IV), tubular and tubulo villose adenomas and villose tumors prevail.",POLYPOID LESION,GASTRO INTESTINAL POLYPS,RO-disease_has_finding
502934691,7/14/2014 18:02:58,,1323002569,7/14/2014 18:02:46,prodege,0.4264,12944140,GBR,I4,Mitcham,92.21.55.247,no_relation,106,33,,120,57,diagnosed by,0.38490017945974997,901529-FS1-13,"Although, according to T.Yamada, GASTRO INTESTINAL POLYPS are described with respect to shape and size of POLYPOID LESION only, microscopic structure of polyps manages to find its reflection to a considerable degree too: type I predominantly embraces hypertrophic folds of mucosa as well as non tumor polyps, both hyperplastic and inflammatory, while, at more advanced stages (II IV), tubular and tubulo villose adenomas and villose tumors prevail.",POLYPOID LESION,GASTRO INTESTINAL POLYPS,RO-disease_has_finding
502934691,7/14/2014 18:09:47,,1323007061,7/14/2014 18:09:18,instagc,0.4639,28519532,USA,IA,Honey Creek,12.73.110.131,GASTRO INTESTINAL POLYPS diagnosed by POLYPOID LESION,106,33,,120,57,diagnosed by,0.38490017945974997,901529-FS1-13,"Although, according to T.Yamada, GASTRO INTESTINAL POLYPS are described with respect to shape and size of POLYPOID LESION only, microscopic structure of polyps manages to find its reflection to a considerable degree too: type I predominantly embraces hypertrophic folds of mucosa as well as non tumor polyps, both hyperplastic and inflammatory, while, at more advanced stages (II IV), tubular and tubulo villose adenomas and villose tumors prevail.",POLYPOID LESION,GASTRO INTESTINAL POLYPS,RO-disease_has_finding
502934691,7/14/2014 18:46:53,,1323023628,7/14/2014 18:46:24,clixsense,0.4121,19162475,GBR,M3,Frome,82.33.126.30,GASTRO INTESTINAL POLYPS diagnosed by POLYPOID LESION,106,33,,120,57,diagnosed by,0.38490017945974997,901529-FS1-13,"Although, according to T.Yamada, GASTRO INTESTINAL POLYPS are described with respect to shape and size of POLYPOID LESION only, microscopic structure of polyps manages to find its reflection to a considerable degree too: type I predominantly embraces hypertrophic folds of mucosa as well as non tumor polyps, both hyperplastic and inflammatory, while, at more advanced stages (II IV), tubular and tubulo villose adenomas and villose tumors prevail.",POLYPOID LESION,GASTRO INTESTINAL POLYPS,RO-disease_has_finding
502934691,7/14/2014 19:20:21,,1323043507,7/14/2014 19:19:24,instagc,0.7278,13763729,USA,,,75.182.89.225,GASTRO INTESTINAL POLYPS diagnosed by POLYPOID LESION,106,33,,120,57,diagnosed by,0.38490017945974997,901529-FS1-13,"Although, according to T.Yamada, GASTRO INTESTINAL POLYPS are described with respect to shape and size of POLYPOID LESION only, microscopic structure of polyps manages to find its reflection to a considerable degree too: type I predominantly embraces hypertrophic folds of mucosa as well as non tumor polyps, both hyperplastic and inflammatory, while, at more advanced stages (II IV), tubular and tubulo villose adenomas and villose tumors prevail.",POLYPOID LESION,GASTRO INTESTINAL POLYPS,RO-disease_has_finding
502934691,7/14/2014 19:29:19,,1323048975,7/14/2014 19:29:03,neodev,0.6472,14861092,GBR,I2,Manchester,90.194.137.76,GASTRO INTESTINAL POLYPS diagnosed by POLYPOID LESION,106,33,,120,57,diagnosed by,0.38490017945974997,901529-FS1-13,"Although, according to T.Yamada, GASTRO INTESTINAL POLYPS are described with respect to shape and size of POLYPOID LESION only, microscopic structure of polyps manages to find its reflection to a considerable degree too: type I predominantly embraces hypertrophic folds of mucosa as well as non tumor polyps, both hyperplastic and inflammatory, while, at more advanced stages (II IV), tubular and tubulo villose adenomas and villose tumors prevail.",POLYPOID LESION,GASTRO INTESTINAL POLYPS,RO-disease_has_finding
502934692,7/14/2014 17:01:37,,1322964051,7/14/2014 17:01:31,neodev,0.875,17610000,GBR,I2,Manchester,90.200.140.201,PELVIC PAIN causes ENDOMETRIOSIS,64,86,,74,99,causes,0.9958932064677041,904571-FS1-4,45   Aromatase inhibitors are not approved for the treatment of PELVIC PAIN caused by ENDOMETRIOSIS,PELVIC PAIN,ENDOMETRIOSIS,RO-has_definitional_manifestation
502934692,7/14/2014 18:10:16,,1323007273,7/14/2014 18:09:58,prodege,0.5502,7899370,USA,MI,Bay City,71.13.81.162,ENDOMETRIOSIS causes PELVIC PAIN,64,86,,74,99,causes,0.9958932064677041,904571-FS1-4,45   Aromatase inhibitors are not approved for the treatment of PELVIC PAIN caused by ENDOMETRIOSIS,PELVIC PAIN,ENDOMETRIOSIS,RO-has_definitional_manifestation
502934692,7/14/2014 18:14:37,,1323009339,7/14/2014 18:13:55,instagc,0.4639,28519532,USA,IA,Honey Creek,12.73.110.131,ENDOMETRIOSIS causes PELVIC PAIN,64,86,,74,99,causes,0.9958932064677041,904571-FS1-4,45   Aromatase inhibitors are not approved for the treatment of PELVIC PAIN caused by ENDOMETRIOSIS,PELVIC PAIN,ENDOMETRIOSIS,RO-has_definitional_manifestation
502934692,7/14/2014 18:28:13,,1323015101,7/14/2014 18:27:58,neodev,0.6095,21515166,NLD,11,Nootdorp,83.86.58.179,ENDOMETRIOSIS causes PELVIC PAIN,64,86,,74,99,causes,0.9958932064677041,904571-FS1-4,45   Aromatase inhibitors are not approved for the treatment of PELVIC PAIN caused by ENDOMETRIOSIS,PELVIC PAIN,ENDOMETRIOSIS,RO-has_definitional_manifestation
502934692,7/14/2014 18:33:53,,1323017433,7/14/2014 18:33:41,clixsense,0.7071,16827630,GBR,A7,Birmingham,86.146.169.103,ENDOMETRIOSIS causes PELVIC PAIN,64,86,,74,99,causes,0.9958932064677041,904571-FS1-4,45   Aromatase inhibitors are not approved for the treatment of PELVIC PAIN caused by ENDOMETRIOSIS,PELVIC PAIN,ENDOMETRIOSIS,RO-has_definitional_manifestation
502934692,7/14/2014 19:18:52,,1323042560,7/14/2014 19:18:28,instagc,0.7278,13763729,USA,,,75.182.89.225,ENDOMETRIOSIS causes PELVIC PAIN,64,86,,74,99,causes,0.9958932064677041,904571-FS1-4,45   Aromatase inhibitors are not approved for the treatment of PELVIC PAIN caused by ENDOMETRIOSIS,PELVIC PAIN,ENDOMETRIOSIS,RO-has_definitional_manifestation
502934692,7/14/2014 19:29:02,,1323048812,7/14/2014 19:28:47,neodev,0.6472,14861092,GBR,I2,Manchester,90.194.137.76,ENDOMETRIOSIS causes PELVIC PAIN,64,86,,74,99,causes,0.9958932064677041,904571-FS1-4,45   Aromatase inhibitors are not approved for the treatment of PELVIC PAIN caused by ENDOMETRIOSIS,PELVIC PAIN,ENDOMETRIOSIS,RO-has_definitional_manifestation
502934694,7/14/2014 17:22:48,,1322974430,7/14/2014 17:22:38,instagc,0.8125,18960682,GBR,,,86.29.147.112,BACILLUS ANTHRACIS causes ANTHRAX,0,78,,17,85,causes,0.9950371902099889,903926-FS1-4,BACILLUS ANTHRACIS is a Gram positive bacillus that is the causative agent of ANTHRAX,BACILLUS ANTHRACIS,ANTHRAX,RO-has_causative_agent
502934694,7/14/2014 18:49:07,,1323024806,7/14/2014 18:48:52,instagc,0.5869,25990856,USA,NV,Las Vegas,68.108.98.78,BACILLUS ANTHRACIS causes ANTHRAX,0,78,,17,85,causes,0.9950371902099889,903926-FS1-4,BACILLUS ANTHRACIS is a Gram positive bacillus that is the causative agent of ANTHRAX,BACILLUS ANTHRACIS,ANTHRAX,RO-has_causative_agent
502934694,7/14/2014 18:59:02,,1323030871,7/14/2014 18:58:03,instagc,0.5877,19686223,CAN,BC,Surrey,184.65.16.6,BACILLUS ANTHRACIS causes ANTHRAX,0,78,,17,85,causes,0.9950371902099889,903926-FS1-4,BACILLUS ANTHRACIS is a Gram positive bacillus that is the causative agent of ANTHRAX,BACILLUS ANTHRACIS,ANTHRAX,RO-has_causative_agent
502934694,7/14/2014 19:17:58,,1323041967,7/14/2014 19:17:33,instagc,0.7278,13763729,USA,,,75.182.89.225,BACILLUS ANTHRACIS causes ANTHRAX,0,78,,17,85,causes,0.9950371902099889,903926-FS1-4,BACILLUS ANTHRACIS is a Gram positive bacillus that is the causative agent of ANTHRAX,BACILLUS ANTHRACIS,ANTHRAX,RO-has_causative_agent
502934694,7/14/2014 19:30:28,,1323049744,7/14/2014 19:30:15,clixsense,0.3921,15189335,GBR,A7,Birmingham,94.197.121.232,ANTHRAX causes BACILLUS ANTHRACIS,0,78,,17,85,causes,0.9950371902099889,903926-FS1-4,BACILLUS ANTHRACIS is a Gram positive bacillus that is the causative agent of ANTHRAX,BACILLUS ANTHRACIS,ANTHRAX,RO-has_causative_agent
502934694,7/14/2014 19:32:39,,1323051261,7/14/2014 19:32:17,eup_slw,0.5952,20818028,GBR,A7,Birmingham,92.232.139.254,BACILLUS ANTHRACIS causes ANTHRAX,0,78,,17,85,causes,0.9950371902099889,903926-FS1-4,BACILLUS ANTHRACIS is a Gram positive bacillus that is the causative agent of ANTHRAX,BACILLUS ANTHRACIS,ANTHRAX,RO-has_causative_agent
502934694,7/14/2014 19:33:41,,1323051861,7/14/2014 19:33:32,neodev,0.7222,21752395,USA,,,173.23.121.63,BACILLUS ANTHRACIS causes ANTHRAX,0,78,,17,85,causes,0.9950371902099889,903926-FS1-4,BACILLUS ANTHRACIS is a Gram positive bacillus that is the causative agent of ANTHRAX,BACILLUS ANTHRACIS,ANTHRAX,RO-has_causative_agent
502934698,7/14/2014 17:02:31,,1322964445,7/14/2014 17:02:14,clixsense,0.8194,27793793,GBR,C5,Chester,151.230.27.155,FRUCTOSE INTOLERANCE causes DEFICIT OF THE LIVER,36,0,,55,20,causes,1.0,906249-FS1-4,FRUCTOSE INTOLERANCE is caused by a DEFICIT OF THE LIVER aldolase B enzyme.,DEFICIT OF THE LIVER,FRUCTOSE INTOLERANCE,RO-has_manifestation
502934698,7/14/2014 17:08:47,,1322967440,7/14/2014 17:08:42,neodev,0.6389,25224036,CAN,ON,Sudbury,67.204.218.187,FRUCTOSE INTOLERANCE causes DEFICIT OF THE LIVER,36,0,,55,20,causes,1.0,906249-FS1-4,FRUCTOSE INTOLERANCE is caused by a DEFICIT OF THE LIVER aldolase B enzyme.,DEFICIT OF THE LIVER,FRUCTOSE INTOLERANCE,RO-has_manifestation
502934698,7/14/2014 17:49:32,,1322996464,7/14/2014 17:49:23,prodege,0.6667,2143114,CAN,BC,Vancouver,24.84.160.12,FRUCTOSE INTOLERANCE causes DEFICIT OF THE LIVER,36,0,,55,20,causes,1.0,906249-FS1-4,FRUCTOSE INTOLERANCE is caused by a DEFICIT OF THE LIVER aldolase B enzyme.,DEFICIT OF THE LIVER,FRUCTOSE INTOLERANCE,RO-has_manifestation
502934698,7/14/2014 18:08:46,,1323006557,7/14/2014 18:08:18,vivatic,0.605,25451531,GBR,,,83.67.28.193,DEFICIT OF THE LIVER causes FRUCTOSE INTOLERANCE,36,0,,55,20,causes,1.0,906249-FS1-4,FRUCTOSE INTOLERANCE is caused by a DEFICIT OF THE LIVER aldolase B enzyme.,DEFICIT OF THE LIVER,FRUCTOSE INTOLERANCE,RO-has_manifestation
502934698,7/14/2014 19:15:10,,1323040244,7/14/2014 19:14:43,elite,0.6234,28503042,USA,NJ,Woodbridge,54.191.150.115,FRUCTOSE INTOLERANCE causes DEFICIT OF THE LIVER,36,0,,55,20,causes,1.0,906249-FS1-4,FRUCTOSE INTOLERANCE is caused by a DEFICIT OF THE LIVER aldolase B enzyme.,DEFICIT OF THE LIVER,FRUCTOSE INTOLERANCE,RO-has_manifestation
502934698,7/14/2014 19:29:02,,1323048817,7/14/2014 19:28:47,neodev,0.6472,14861092,GBR,I2,Manchester,90.194.137.76,DEFICIT OF THE LIVER causes FRUCTOSE INTOLERANCE,36,0,,55,20,causes,1.0,906249-FS1-4,FRUCTOSE INTOLERANCE is caused by a DEFICIT OF THE LIVER aldolase B enzyme.,DEFICIT OF THE LIVER,FRUCTOSE INTOLERANCE,RO-has_manifestation
502934698,7/14/2014 19:29:48,,1323049322,7/14/2014 19:29:22,clixsense,0.3921,15189335,GBR,A7,Birmingham,94.197.121.232,DEFICIT OF THE LIVER causes FRUCTOSE INTOLERANCE,36,0,,55,20,causes,1.0,906249-FS1-4,FRUCTOSE INTOLERANCE is caused by a DEFICIT OF THE LIVER aldolase B enzyme.,DEFICIT OF THE LIVER,FRUCTOSE INTOLERANCE,RO-has_manifestation
502934702,7/14/2014 17:01:37,,1322964052,7/14/2014 17:01:31,neodev,0.875,17610000,GBR,I2,Manchester,90.200.140.201,LONG TERM MEDICATION WITH TYPICAL NEUROLEPTICS causes TARDIVE DYSKINESIA,51,0,,96,18,causes,0.99654575824488,903749-FS1-4,TARDIVE DYSKINESIA (TD) is a common side effect of LONG TERM MEDICATION WITH TYPICAL NEUROLEPTICS.,LONG TERM MEDICATION WITH TYPICAL NEUROLEPTICS,TARDIVE DYSKINESIA,RO-has_causative_agent
502934702,7/14/2014 17:08:38,,1322967359,7/14/2014 17:08:32,neodev,0.6389,25224036,CAN,ON,Sudbury,67.204.218.187,LONG TERM MEDICATION WITH TYPICAL NEUROLEPTICS causes TARDIVE DYSKINESIA,51,0,,96,18,causes,0.99654575824488,903749-FS1-4,TARDIVE DYSKINESIA (TD) is a common side effect of LONG TERM MEDICATION WITH TYPICAL NEUROLEPTICS.,LONG TERM MEDICATION WITH TYPICAL NEUROLEPTICS,TARDIVE DYSKINESIA,RO-has_causative_agent
502934702,7/14/2014 17:13:01,,1322969728,7/14/2014 17:12:38,instagc,0.5208,19636746,USA,NY,Andover,192.182.216.225,LONG TERM MEDICATION WITH TYPICAL NEUROLEPTICS causes TARDIVE DYSKINESIA,51,0,,96,18,causes,0.99654575824488,903749-FS1-4,TARDIVE DYSKINESIA (TD) is a common side effect of LONG TERM MEDICATION WITH TYPICAL NEUROLEPTICS.,LONG TERM MEDICATION WITH TYPICAL NEUROLEPTICS,TARDIVE DYSKINESIA,RO-has_causative_agent
502934702,7/14/2014 17:27:21,,1322977560,7/14/2014 17:27:08,pokerowned,0.5639,18747884,USA,MI,Snover,209.40.219.170,LONG TERM MEDICATION WITH TYPICAL NEUROLEPTICS causes TARDIVE DYSKINESIA,51,0,,96,18,causes,0.99654575824488,903749-FS1-4,TARDIVE DYSKINESIA (TD) is a common side effect of LONG TERM MEDICATION WITH TYPICAL NEUROLEPTICS.,LONG TERM MEDICATION WITH TYPICAL NEUROLEPTICS,TARDIVE DYSKINESIA,RO-has_causative_agent
502934702,7/14/2014 17:51:19,,1322997293,7/14/2014 17:50:59,clixsense,0.6389,19803139,NLD,06,Veldhoven,212.61.84.196,LONG TERM MEDICATION WITH TYPICAL NEUROLEPTICS causes TARDIVE DYSKINESIA,51,0,,96,18,causes,0.99654575824488,903749-FS1-4,TARDIVE DYSKINESIA (TD) is a common side effect of LONG TERM MEDICATION WITH TYPICAL NEUROLEPTICS.,LONG TERM MEDICATION WITH TYPICAL NEUROLEPTICS,TARDIVE DYSKINESIA,RO-has_causative_agent
502934702,7/14/2014 18:03:20,,1323002686,7/14/2014 18:03:07,prodege,0.4264,12944140,GBR,I4,Mitcham,92.21.55.247,no_relation,51,0,,96,18,causes,0.99654575824488,903749-FS1-4,TARDIVE DYSKINESIA (TD) is a common side effect of LONG TERM MEDICATION WITH TYPICAL NEUROLEPTICS.,LONG TERM MEDICATION WITH TYPICAL NEUROLEPTICS,TARDIVE DYSKINESIA,RO-has_causative_agent
502934702,7/14/2014 18:08:46,,1323006556,7/14/2014 18:08:18,vivatic,0.605,25451531,GBR,,,83.67.28.193,TARDIVE DYSKINESIA causes LONG TERM MEDICATION WITH TYPICAL NEUROLEPTICS,51,0,,96,18,causes,0.99654575824488,903749-FS1-4,TARDIVE DYSKINESIA (TD) is a common side effect of LONG TERM MEDICATION WITH TYPICAL NEUROLEPTICS.,LONG TERM MEDICATION WITH TYPICAL NEUROLEPTICS,TARDIVE DYSKINESIA,RO-has_causative_agent
502934703,7/14/2014 17:01:08,,1322963745,7/14/2014 17:01:03,neodev,0.875,17610000,GBR,I2,Manchester,90.200.140.201,HYPERTENSION causes WILMS' TUMOR,0,68,,11,80,causes,0.9704949588309459,902898-FS1-4,HYPERTENSION is a very frequent finding in patients presenting with WILMS' TUMOR,HYPERTENSION,WILMS' TUMOR,RO-disease_may_have_finding
502934703,7/14/2014 17:01:32,,1322964004,7/14/2014 17:01:12,clixsense,0.8194,27793793,GBR,C5,Chester,151.230.27.155,WILMS' TUMOR causes HYPERTENSION,0,68,,11,80,causes,0.9704949588309459,902898-FS1-4,HYPERTENSION is a very frequent finding in patients presenting with WILMS' TUMOR,HYPERTENSION,WILMS' TUMOR,RO-disease_may_have_finding
502934703,7/14/2014 17:08:25,,1322967228,7/14/2014 17:08:20,neodev,0.6389,25224036,CAN,ON,Sudbury,67.204.218.187,HYPERTENSION causes WILMS' TUMOR,0,68,,11,80,causes,0.9704949588309459,902898-FS1-4,HYPERTENSION is a very frequent finding in patients presenting with WILMS' TUMOR,HYPERTENSION,WILMS' TUMOR,RO-disease_may_have_finding
502934703,7/14/2014 17:26:52,,1322977181,7/14/2014 17:26:41,pokerowned,0.5639,18747884,USA,MI,Snover,209.40.219.170,HYPERTENSION causes WILMS' TUMOR,0,68,,11,80,causes,0.9704949588309459,902898-FS1-4,HYPERTENSION is a very frequent finding in patients presenting with WILMS' TUMOR,HYPERTENSION,WILMS' TUMOR,RO-disease_may_have_finding
502934703,7/14/2014 18:03:05,,1323002592,7/14/2014 18:02:59,prodege,0.4264,12944140,GBR,I4,Mitcham,92.21.55.247,no_relation,0,68,,11,80,causes,0.9704949588309459,902898-FS1-4,HYPERTENSION is a very frequent finding in patients presenting with WILMS' TUMOR,HYPERTENSION,WILMS' TUMOR,RO-disease_may_have_finding
502934703,7/14/2014 18:07:57,,1323006138,7/14/2014 18:07:31,instagc,0.4639,28519532,USA,IA,Honey Creek,12.73.110.131,no_relation,0,68,,11,80,causes,0.9704949588309459,902898-FS1-4,HYPERTENSION is a very frequent finding in patients presenting with WILMS' TUMOR,HYPERTENSION,WILMS' TUMOR,RO-disease_may_have_finding
502934703,7/14/2014 18:08:17,,1323006335,7/14/2014 18:07:42,vivatic,0.605,25451531,GBR,,,83.67.28.193,no_relation,0,68,,11,80,causes,0.9704949588309459,902898-FS1-4,HYPERTENSION is a very frequent finding in patients presenting with WILMS' TUMOR,HYPERTENSION,WILMS' TUMOR,RO-disease_may_have_finding
502934716,7/14/2014 17:08:18,,1322967169,7/14/2014 17:07:23,neodev,0.6389,25224036,CAN,ON,Sudbury,67.204.218.187,CARBAMAZEPINE treats TRIGEMINAL NEURALGIA,83,35,,102,48,treats,0.98058067569092,907754-FS1-2,Other trials studied chronic pain: CARBAMAZEPINE was effective in 3 of 4 trials in TRIGEMINAL NEURALGIA and lamotrigine was no more effective than placebo in 1 trial (Table.,TRIGEMINAL NEURALGIA,CARBAMAZEPINE,RO-may_treat
502934716,7/14/2014 17:10:50,,1322968584,7/14/2014 17:10:29,instagc,0.5208,19636746,USA,NY,Andover,192.182.216.225,CARBAMAZEPINE treats TRIGEMINAL NEURALGIA,83,35,,102,48,treats,0.98058067569092,907754-FS1-2,Other trials studied chronic pain: CARBAMAZEPINE was effective in 3 of 4 trials in TRIGEMINAL NEURALGIA and lamotrigine was no more effective than placebo in 1 trial (Table.,TRIGEMINAL NEURALGIA,CARBAMAZEPINE,RO-may_treat
502934716,7/14/2014 17:50:31,,1322996903,7/14/2014 17:50:12,clixsense,0.6389,19803139,NLD,06,Veldhoven,212.61.84.196,CARBAMAZEPINE treats TRIGEMINAL NEURALGIA,83,35,,102,48,treats,0.98058067569092,907754-FS1-2,Other trials studied chronic pain: CARBAMAZEPINE was effective in 3 of 4 trials in TRIGEMINAL NEURALGIA and lamotrigine was no more effective than placebo in 1 trial (Table.,TRIGEMINAL NEURALGIA,CARBAMAZEPINE,RO-may_treat
502934716,7/14/2014 18:29:18,,1323015542,7/14/2014 18:28:56,instagc,0.6187,28524232,CAN,ON,Toronto,99.244.116.246,CARBAMAZEPINE treats TRIGEMINAL NEURALGIA,83,35,,102,48,treats,0.98058067569092,907754-FS1-2,Other trials studied chronic pain: CARBAMAZEPINE was effective in 3 of 4 trials in TRIGEMINAL NEURALGIA and lamotrigine was no more effective than placebo in 1 trial (Table.,TRIGEMINAL NEURALGIA,CARBAMAZEPINE,RO-may_treat
502934716,7/14/2014 18:49:21,,1323024917,7/14/2014 18:49:09,instagc,0.5869,25990856,USA,NV,Las Vegas,68.108.98.78,CARBAMAZEPINE treats TRIGEMINAL NEURALGIA,83,35,,102,48,treats,0.98058067569092,907754-FS1-2,Other trials studied chronic pain: CARBAMAZEPINE was effective in 3 of 4 trials in TRIGEMINAL NEURALGIA and lamotrigine was no more effective than placebo in 1 trial (Table.,TRIGEMINAL NEURALGIA,CARBAMAZEPINE,RO-may_treat
502934716,7/14/2014 19:32:08,,1323050962,7/14/2014 19:31:23,clixsense,0.3921,15189335,GBR,A7,Birmingham,94.197.121.232,CARBAMAZEPINE treats TRIGEMINAL NEURALGIA,83,35,,102,48,treats,0.98058067569092,907754-FS1-2,Other trials studied chronic pain: CARBAMAZEPINE was effective in 3 of 4 trials in TRIGEMINAL NEURALGIA and lamotrigine was no more effective than placebo in 1 trial (Table.,TRIGEMINAL NEURALGIA,CARBAMAZEPINE,RO-may_treat
502934716,7/14/2014 19:32:39,,1323051250,7/14/2014 19:31:35,neodev,0.7222,21752395,USA,,,173.23.121.63,CARBAMAZEPINE treats TRIGEMINAL NEURALGIA,83,35,,102,48,treats,0.98058067569092,907754-FS1-2,Other trials studied chronic pain: CARBAMAZEPINE was effective in 3 of 4 trials in TRIGEMINAL NEURALGIA and lamotrigine was no more effective than placebo in 1 trial (Table.,TRIGEMINAL NEURALGIA,CARBAMAZEPINE,RO-may_treat
502934719,7/14/2014 16:59:00,,1322962574,7/14/2014 16:58:55,instagc,1.0,27753923,GBR,,,94.196.229.196,FLUCTUATING PARKINSON'S DISEASE treats LEVODOPA/DDCI,52,102,,82,115,treats,0.987878339907213,908084-FS1-2,"Thus, tolcapone is a useful option in patients with FLUCTUATING PARKINSON'S DISEASE who are receiving LEVODOPA/DDCI and are not responding to, or are not candidates for, other adjunctive treatments.",FLUCTUATING PARKINSON'S DISEASE,LEVODOPA/DDCI,RO-may_treat
502934719,7/14/2014 17:11:45,,1322969094,7/14/2014 17:11:17,instagc,0.5208,19636746,USA,NY,Andover,192.182.216.225,LEVODOPA/DDCI treats FLUCTUATING PARKINSON'S DISEASE,52,102,,82,115,treats,0.987878339907213,908084-FS1-2,"Thus, tolcapone is a useful option in patients with FLUCTUATING PARKINSON'S DISEASE who are receiving LEVODOPA/DDCI and are not responding to, or are not candidates for, other adjunctive treatments.",FLUCTUATING PARKINSON'S DISEASE,LEVODOPA/DDCI,RO-may_treat
502934719,7/14/2014 17:28:13,,1322978206,7/14/2014 17:27:31,elite,0.5833,28276268,USA,MI,Taylor,67.149.247.166,LEVODOPA/DDCI treats FLUCTUATING PARKINSON'S DISEASE,52,102,,82,115,treats,0.987878339907213,908084-FS1-2,"Thus, tolcapone is a useful option in patients with FLUCTUATING PARKINSON'S DISEASE who are receiving LEVODOPA/DDCI and are not responding to, or are not candidates for, other adjunctive treatments.",FLUCTUATING PARKINSON'S DISEASE,LEVODOPA/DDCI,RO-may_treat
502934719,7/14/2014 17:49:56,,1322996620,7/14/2014 17:49:45,prodege,0.6667,2143114,CAN,BC,Vancouver,24.84.160.12,LEVODOPA/DDCI treats FLUCTUATING PARKINSON'S DISEASE,52,102,,82,115,treats,0.987878339907213,908084-FS1-2,"Thus, tolcapone is a useful option in patients with FLUCTUATING PARKINSON'S DISEASE who are receiving LEVODOPA/DDCI and are not responding to, or are not candidates for, other adjunctive treatments.",FLUCTUATING PARKINSON'S DISEASE,LEVODOPA/DDCI,RO-may_treat
502934719,7/14/2014 18:09:47,,1323007062,7/14/2014 18:09:18,instagc,0.4639,28519532,USA,IA,Honey Creek,12.73.110.131,LEVODOPA/DDCI treats FLUCTUATING PARKINSON'S DISEASE,52,102,,82,115,treats,0.987878339907213,908084-FS1-2,"Thus, tolcapone is a useful option in patients with FLUCTUATING PARKINSON'S DISEASE who are receiving LEVODOPA/DDCI and are not responding to, or are not candidates for, other adjunctive treatments.",FLUCTUATING PARKINSON'S DISEASE,LEVODOPA/DDCI,RO-may_treat
502934719,7/14/2014 18:22:39,,1323012801,7/14/2014 18:21:55,instagc,0.6187,28524232,CAN,ON,Toronto,99.244.116.246,no_relation,52,102,,82,115,treats,0.987878339907213,908084-FS1-2,"Thus, tolcapone is a useful option in patients with FLUCTUATING PARKINSON'S DISEASE who are receiving LEVODOPA/DDCI and are not responding to, or are not candidates for, other adjunctive treatments.",FLUCTUATING PARKINSON'S DISEASE,LEVODOPA/DDCI,RO-may_treat
502934719,7/14/2014 18:27:37,,1323014793,7/14/2014 18:27:17,neodev,0.6095,21515166,NLD,11,Nootdorp,83.86.58.179,LEVODOPA/DDCI treats FLUCTUATING PARKINSON'S DISEASE,52,102,,82,115,treats,0.987878339907213,908084-FS1-2,"Thus, tolcapone is a useful option in patients with FLUCTUATING PARKINSON'S DISEASE who are receiving LEVODOPA/DDCI and are not responding to, or are not candidates for, other adjunctive treatments.",FLUCTUATING PARKINSON'S DISEASE,LEVODOPA/DDCI,RO-may_treat
502934720,7/14/2014 17:01:14,,1322963823,7/14/2014 17:01:09,neodev,0.875,17610000,GBR,I2,Manchester,90.200.140.201,THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA diagnosed by POLYCYTHAEMIA VERA,132,85,,173,103,diagnosed by,0.36514837167011105,906409-FS1-13,These endogenous erythroid colonies (EEC) are seen in the great majority of cases of POLYCYTHAEMIA VERA as well as in some cases of THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA and idiopathic myelofibrosis.,THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA,POLYCYTHAEMIA VERA,RO-has_manifestation
502934720,7/14/2014 17:01:32,,1322963999,7/14/2014 17:01:12,clixsense,0.8194,27793793,GBR,C5,Chester,151.230.27.155,no_relation,132,85,,173,103,diagnosed by,0.36514837167011105,906409-FS1-13,These endogenous erythroid colonies (EEC) are seen in the great majority of cases of POLYCYTHAEMIA VERA as well as in some cases of THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA and idiopathic myelofibrosis.,THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA,POLYCYTHAEMIA VERA,RO-has_manifestation
502934720,7/14/2014 17:01:55,,1322964193,7/14/2014 17:01:24,clixsense,0.8611,27871219,NLD,07,Amsterdam,87.210.207.223,no_relation,132,85,,173,103,diagnosed by,0.36514837167011105,906409-FS1-13,These endogenous erythroid colonies (EEC) are seen in the great majority of cases of POLYCYTHAEMIA VERA as well as in some cases of THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA and idiopathic myelofibrosis.,THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA,POLYCYTHAEMIA VERA,RO-has_manifestation
502934720,7/14/2014 17:22:36,,1322974314,7/14/2014 17:22:25,instagc,0.8125,18960682,GBR,,,86.29.147.112,no_relation,132,85,,173,103,diagnosed by,0.36514837167011105,906409-FS1-13,These endogenous erythroid colonies (EEC) are seen in the great majority of cases of POLYCYTHAEMIA VERA as well as in some cases of THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA and idiopathic myelofibrosis.,THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA,POLYCYTHAEMIA VERA,RO-has_manifestation
502934720,7/14/2014 17:29:49,,1322979548,7/14/2014 17:29:11,elite,0.5833,28276268,USA,MI,Taylor,67.149.247.166,POLYCYTHAEMIA VERA diagnosed by THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA,132,85,,173,103,diagnosed by,0.36514837167011105,906409-FS1-13,These endogenous erythroid colonies (EEC) are seen in the great majority of cases of POLYCYTHAEMIA VERA as well as in some cases of THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA and idiopathic myelofibrosis.,THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA,POLYCYTHAEMIA VERA,RO-has_manifestation
502934720,7/14/2014 17:50:57,,1322997097,7/14/2014 17:50:32,clixsense,0.6389,19803139,NLD,06,Veldhoven,212.61.84.196,THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA diagnosed by POLYCYTHAEMIA VERA,132,85,,173,103,diagnosed by,0.36514837167011105,906409-FS1-13,These endogenous erythroid colonies (EEC) are seen in the great majority of cases of POLYCYTHAEMIA VERA as well as in some cases of THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA and idiopathic myelofibrosis.,THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA,POLYCYTHAEMIA VERA,RO-has_manifestation
502934720,7/14/2014 18:01:00,,1323001721,7/14/2014 18:00:33,neodev,0.6641,28269997,GBR,H9,London,151.224.171.48,no_relation,132,85,,173,103,diagnosed by,0.36514837167011105,906409-FS1-13,These endogenous erythroid colonies (EEC) are seen in the great majority of cases of POLYCYTHAEMIA VERA as well as in some cases of THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA and idiopathic myelofibrosis.,THROMBOCYTHAEMIA CHRONIC MYELOID LEUKAEMIA,POLYCYTHAEMIA VERA,RO-has_manifestation
503007617,7/14/2014 21:11:23,,1323101801,7/14/2014 21:10:37,elite,0.8694,28276268,USA,MI,Taylor,67.149.247.166,DISSECTION OF AORTA is location of AORTA,51,37,,55,56,is location of,0.960768922830523,905375-FS1-9,Cjest computerized tomography showed DISSECTION OF AORTA from ascending to descendig aorta and hemorrhage around ascending AORTA.,AORTA,DISSECTION OF AORTA,RO-has_finding_site
503007617,7/14/2014 21:15:25,,1323103657,7/14/2014 21:14:40,prodege,0.7639,28255346,GBR,L9,Sheffield,2.125.183.137,DISSECTION OF AORTA is location of AORTA,51,37,,55,56,is location of,0.960768922830523,905375-FS1-9,Cjest computerized tomography showed DISSECTION OF AORTA from ascending to descendig aorta and hemorrhage around ascending AORTA.,AORTA,DISSECTION OF AORTA,RO-has_finding_site
503007617,7/14/2014 21:24:28,,1323107650,7/14/2014 21:24:18,clixsense,0.5625,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,51,37,,55,56,is location of,0.960768922830523,905375-FS1-9,Cjest computerized tomography showed DISSECTION OF AORTA from ascending to descendig aorta and hemorrhage around ascending AORTA.,AORTA,DISSECTION OF AORTA,RO-has_finding_site
503007617,7/14/2014 21:36:19,,1323114176,7/14/2014 21:35:54,clixsense,0.5974,19803139,NLD,06,Veldhoven,212.61.84.196,AORTA is location of DISSECTION OF AORTA,51,37,,55,56,is location of,0.960768922830523,905375-FS1-9,Cjest computerized tomography showed DISSECTION OF AORTA from ascending to descendig aorta and hemorrhage around ascending AORTA.,AORTA,DISSECTION OF AORTA,RO-has_finding_site
503007617,7/14/2014 21:43:59,,1323119788,7/14/2014 21:43:11,neodev,0.6153,27597779,CAN,AB,Calgary,72.29.251.209,AORTA is location of DISSECTION OF AORTA,51,37,,55,56,is location of,0.960768922830523,905375-FS1-9,Cjest computerized tomography showed DISSECTION OF AORTA from ascending to descendig aorta and hemorrhage around ascending AORTA.,AORTA,DISSECTION OF AORTA,RO-has_finding_site
503007617,7/14/2014 22:28:11,,1323145288,7/14/2014 22:27:28,clixsense,0.5752,15189335,GBR,K3,Peterborough,81.156.166.189,AORTA is location of DISSECTION OF AORTA,51,37,,55,56,is location of,0.960768922830523,905375-FS1-9,Cjest computerized tomography showed DISSECTION OF AORTA from ascending to descendig aorta and hemorrhage around ascending AORTA.,AORTA,DISSECTION OF AORTA,RO-has_finding_site
503007617,7/14/2014 22:32:08,,1323146952,7/14/2014 22:32:03,clixsense,0.3016,25419319,GBR,H8,Liverpool,94.4.192.228,AORTA is location of DISSECTION OF AORTA,51,37,,55,56,is location of,0.960768922830523,905375-FS1-9,Cjest computerized tomography showed DISSECTION OF AORTA from ascending to descendig aorta and hemorrhage around ascending AORTA.,AORTA,DISSECTION OF AORTA,RO-has_finding_site
503007618,7/14/2014 21:45:21,,1323120885,7/14/2014 21:45:11,prodege,0.5819,2143114,CAN,BC,Vancouver,24.84.160.12,PHEOCHROMOCYTOMA treats ARTERIAL HYPERTENSION,27,66,,47,82,treats,0.960768922830523,902920-FS1-2,2]  Dimopoulos C. [Cure of ARTERIAL HYPERTENSION by excision of a PHEOCHROMOCYTOMA (2 cases.,ARTERIAL HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503007618,7/14/2014 21:46:57,,1323122213,7/14/2014 21:46:17,instagc,0.6292,21551272,GBR,E6,Chipping Campden,78.145.193.123,no_relation,27,66,,47,82,treats,0.960768922830523,902920-FS1-2,2]  Dimopoulos C. [Cure of ARTERIAL HYPERTENSION by excision of a PHEOCHROMOCYTOMA (2 cases.,ARTERIAL HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503007618,7/14/2014 21:49:06,,1323123424,7/14/2014 21:48:39,clixsense,0.5155,26889820,GBR,C3,Shelford,92.18.120.203,no_relation,27,66,,47,82,treats,0.960768922830523,902920-FS1-2,2]  Dimopoulos C. [Cure of ARTERIAL HYPERTENSION by excision of a PHEOCHROMOCYTOMA (2 cases.,ARTERIAL HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503007618,7/14/2014 22:07:17,,1323132246,7/14/2014 22:06:56,instagc,0.5915,18960682,GBR,,,86.29.147.112,PHEOCHROMOCYTOMA treats ARTERIAL HYPERTENSION,27,66,,47,82,treats,0.960768922830523,902920-FS1-2,2]  Dimopoulos C. [Cure of ARTERIAL HYPERTENSION by excision of a PHEOCHROMOCYTOMA (2 cases.,ARTERIAL HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503007618,7/14/2014 22:30:05,,1323146018,7/14/2014 22:29:28,instagc,0.5867,23149109,USA,NC,Durham,75.189.206.205,PHEOCHROMOCYTOMA treats ARTERIAL HYPERTENSION,27,66,,47,82,treats,0.960768922830523,902920-FS1-2,2]  Dimopoulos C. [Cure of ARTERIAL HYPERTENSION by excision of a PHEOCHROMOCYTOMA (2 cases.,ARTERIAL HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503007618,7/14/2014 22:32:32,,1323147103,7/14/2014 22:32:27,clixsense,0.3016,25419319,GBR,H8,Liverpool,94.4.192.228,ARTERIAL HYPERTENSION treats PHEOCHROMOCYTOMA,27,66,,47,82,treats,0.960768922830523,902920-FS1-2,2]  Dimopoulos C. [Cure of ARTERIAL HYPERTENSION by excision of a PHEOCHROMOCYTOMA (2 cases.,ARTERIAL HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503007618,7/14/2014 22:51:45,,1323154699,7/14/2014 22:51:27,instagc,0.6238,19686223,CAN,BC,Surrey,184.65.16.6,PHEOCHROMOCYTOMA treats ARTERIAL HYPERTENSION,27,66,,47,82,treats,0.960768922830523,902920-FS1-2,2]  Dimopoulos C. [Cure of ARTERIAL HYPERTENSION by excision of a PHEOCHROMOCYTOMA (2 cases.,ARTERIAL HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503007620,7/14/2014 20:34:42,,1323082997,7/14/2014 20:34:17,clixsense,0.9583,27871219,NLD,07,Amsterdam,87.210.207.223,INTERFERON treats MULTIPLE MYELOMA,76,35,,91,45,treats,0.625543242171224,907872-FS1-2,"Einhorn S, Ahre A, Blomgren H et alINTERFERON and naturl killer activity in MULTIPLE MYELOMA",MULTIPLE MYELOMA,INTERFERON,RO-may_treat
503007620,7/14/2014 20:46:04,,1323088758,7/14/2014 20:46:01,instagc,0.6111,25990856,USA,NV,Las Vegas,68.108.98.78,no_relation,76,35,,91,45,treats,0.625543242171224,907872-FS1-2,"Einhorn S, Ahre A, Blomgren H et alINTERFERON and naturl killer activity in MULTIPLE MYELOMA",MULTIPLE MYELOMA,INTERFERON,RO-may_treat
503007620,7/14/2014 21:24:02,,1323107440,7/14/2014 21:22:59,prodege,0.7639,28255346,GBR,L9,Sheffield,2.125.183.137,INTERFERON treats MULTIPLE MYELOMA,76,35,,91,45,treats,0.625543242171224,907872-FS1-2,"Einhorn S, Ahre A, Blomgren H et alINTERFERON and naturl killer activity in MULTIPLE MYELOMA",MULTIPLE MYELOMA,INTERFERON,RO-may_treat
503007620,7/14/2014 21:26:26,,1323108718,7/14/2014 21:26:17,prodege,0.7306,23541832,USA,AZ,Tempe,149.169.129.225,INTERFERON treats MULTIPLE MYELOMA,76,35,,91,45,treats,0.625543242171224,907872-FS1-2,"Einhorn S, Ahre A, Blomgren H et alINTERFERON and naturl killer activity in MULTIPLE MYELOMA",MULTIPLE MYELOMA,INTERFERON,RO-may_treat
503007620,7/14/2014 21:30:43,,1323111117,7/14/2014 21:30:07,instagc,0.6498,19602039,USA,WA,Bellevue,50.135.214.140,INTERFERON treats MULTIPLE MYELOMA,76,35,,91,45,treats,0.625543242171224,907872-FS1-2,"Einhorn S, Ahre A, Blomgren H et alINTERFERON and naturl killer activity in MULTIPLE MYELOMA",MULTIPLE MYELOMA,INTERFERON,RO-may_treat
503007620,7/14/2014 21:31:38,,1323111637,7/14/2014 21:31:09,tremorgames,0.5903,28013393,USA,CA,Rancho Cordova,71.197.67.37,no_relation,76,35,,91,45,treats,0.625543242171224,907872-FS1-2,"Einhorn S, Ahre A, Blomgren H et alINTERFERON and naturl killer activity in MULTIPLE MYELOMA",MULTIPLE MYELOMA,INTERFERON,RO-may_treat
503007620,7/14/2014 21:37:29,,1323114863,7/14/2014 21:37:06,clixsense,0.5974,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,76,35,,91,45,treats,0.625543242171224,907872-FS1-2,"Einhorn S, Ahre A, Blomgren H et alINTERFERON and naturl killer activity in MULTIPLE MYELOMA",MULTIPLE MYELOMA,INTERFERON,RO-may_treat
503007621,7/14/2014 20:34:10,,1323082732,7/14/2014 20:33:45,neodev,0.9583,21515166,NLD,11,Nootdorp,83.86.58.179,INSULIN treats HYPERGLYCEMIA,71,0,,83,7,treats,0.992277876713668,907972-FS1-2,INSULIN and fluid and electrolyte therapy are initiated to control the HYPERGLYCEMIA and prevent shock and further complications.,HYPERGLYCEMIA,INSULIN,RO-may_treat
503007621,7/14/2014 20:42:56,,1323087138,7/14/2014 20:42:41,elite,0.875,28503042,USA,NJ,Woodbridge,54.191.150.115,INSULIN treats HYPERGLYCEMIA,71,0,,83,7,treats,0.992277876713668,907972-FS1-2,INSULIN and fluid and electrolyte therapy are initiated to control the HYPERGLYCEMIA and prevent shock and further complications.,HYPERGLYCEMIA,INSULIN,RO-may_treat
503007621,7/14/2014 21:12:35,,1323102356,7/14/2014 21:12:15,elite,0.8694,28276268,USA,MI,Taylor,67.149.247.166,INSULIN treats HYPERGLYCEMIA,71,0,,83,7,treats,0.992277876713668,907972-FS1-2,INSULIN and fluid and electrolyte therapy are initiated to control the HYPERGLYCEMIA and prevent shock and further complications.,HYPERGLYCEMIA,INSULIN,RO-may_treat
503007621,7/14/2014 21:32:21,,1323111975,7/14/2014 21:32:07,tremorgames,0.5903,28013393,USA,CA,Rancho Cordova,71.197.67.37,INSULIN treats HYPERGLYCEMIA,71,0,,83,7,treats,0.992277876713668,907972-FS1-2,INSULIN and fluid and electrolyte therapy are initiated to control the HYPERGLYCEMIA and prevent shock and further complications.,HYPERGLYCEMIA,INSULIN,RO-may_treat
503007621,7/14/2014 21:35:54,,1323113924,7/14/2014 21:35:30,clixsense,0.5974,19803139,NLD,06,Veldhoven,212.61.84.196,INSULIN treats HYPERGLYCEMIA,71,0,,83,7,treats,0.992277876713668,907972-FS1-2,INSULIN and fluid and electrolyte therapy are initiated to control the HYPERGLYCEMIA and prevent shock and further complications.,HYPERGLYCEMIA,INSULIN,RO-may_treat
503007621,7/14/2014 21:40:17,,1323116795,7/14/2014 21:39:59,instagc,0.7958,28301350,GBR,K4,Plymouth,92.28.215.248,INSULIN treats HYPERGLYCEMIA,71,0,,83,7,treats,0.992277876713668,907972-FS1-2,INSULIN and fluid and electrolyte therapy are initiated to control the HYPERGLYCEMIA and prevent shock and further complications.,HYPERGLYCEMIA,INSULIN,RO-may_treat
503007621,7/14/2014 21:44:31,,1323120251,7/14/2014 21:44:03,instagc,0.6292,21551272,GBR,E6,Chipping Campden,78.145.193.123,INSULIN treats HYPERGLYCEMIA,71,0,,83,7,treats,0.992277876713668,907972-FS1-2,INSULIN and fluid and electrolyte therapy are initiated to control the HYPERGLYCEMIA and prevent shock and further complications.,HYPERGLYCEMIA,INSULIN,RO-may_treat
503007627,7/14/2014 20:33:05,,1323082231,7/14/2014 20:32:48,clixsense,0.9583,27871219,NLD,07,Amsterdam,87.210.207.223,INTERFERON causes MULTIPLE MYELOMA,76,35,,91,45,causes,0.41702882811415004,907872-FS1-4,"Einhorn S, Ahre A, Blomgren H et alINTERFERON and naturl killer activity in MULTIPLE MYELOMA",MULTIPLE MYELOMA,INTERFERON,RO-may_treat
503007627,7/14/2014 21:23:27,,1323107191,7/14/2014 21:23:12,clixsense,0.5625,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,76,35,,91,45,causes,0.41702882811415004,907872-FS1-4,"Einhorn S, Ahre A, Blomgren H et alINTERFERON and naturl killer activity in MULTIPLE MYELOMA",MULTIPLE MYELOMA,INTERFERON,RO-may_treat
503007627,7/14/2014 21:39:12,,1323115982,7/14/2014 21:38:57,instagc,0.7958,28301350,GBR,K4,Plymouth,92.28.215.248,no_relation,76,35,,91,45,causes,0.41702882811415004,907872-FS1-4,"Einhorn S, Ahre A, Blomgren H et alINTERFERON and naturl killer activity in MULTIPLE MYELOMA",MULTIPLE MYELOMA,INTERFERON,RO-may_treat
503007627,7/14/2014 21:48:38,,1323123148,7/14/2014 21:48:15,clixsense,0.5155,26889820,GBR,C3,Shelford,92.18.120.203,no_relation,76,35,,91,45,causes,0.41702882811415004,907872-FS1-4,"Einhorn S, Ahre A, Blomgren H et alINTERFERON and naturl killer activity in MULTIPLE MYELOMA",MULTIPLE MYELOMA,INTERFERON,RO-may_treat
503007627,7/14/2014 22:28:11,,1323145290,7/14/2014 22:27:28,clixsense,0.5752,15189335,GBR,K3,Peterborough,81.156.166.189,no_relation,76,35,,91,45,causes,0.41702882811415004,907872-FS1-4,"Einhorn S, Ahre A, Blomgren H et alINTERFERON and naturl killer activity in MULTIPLE MYELOMA",MULTIPLE MYELOMA,INTERFERON,RO-may_treat
503007627,7/14/2014 22:30:29,,1323146168,7/14/2014 22:30:06,instagc,0.5867,23149109,USA,NC,Durham,75.189.206.205,INTERFERON causes MULTIPLE MYELOMA,76,35,,91,45,causes,0.41702882811415004,907872-FS1-4,"Einhorn S, Ahre A, Blomgren H et alINTERFERON and naturl killer activity in MULTIPLE MYELOMA",MULTIPLE MYELOMA,INTERFERON,RO-may_treat
503007627,7/14/2014 22:32:02,,1323146860,7/14/2014 22:31:26,clixsense,0.3016,25419319,GBR,H8,Liverpool,94.4.192.228,INTERFERON causes MULTIPLE MYELOMA,76,35,,91,45,causes,0.41702882811415004,907872-FS1-4,"Einhorn S, Ahre A, Blomgren H et alINTERFERON and naturl killer activity in MULTIPLE MYELOMA",MULTIPLE MYELOMA,INTERFERON,RO-may_treat
503007630,7/14/2014 20:33:25,,1323082415,7/14/2014 20:33:07,clixsense,0.9583,27871219,NLD,07,Amsterdam,87.210.207.223,MIDDLE EAR is location of ACUTE OTITIS MEDIA,94,27,,103,45,is location of,0.9761870601839531,905496-FS1-9,The role of antibiotics in ACUTE OTITIS MEDIA is to eradicate the causative pathogen from the MIDDLE EAR,MIDDLE EAR,ACUTE OTITIS MEDIA,RO-has_finding_site
503007630,7/14/2014 20:41:25,,1323086460,7/14/2014 20:41:04,elite,0.875,28503042,USA,NJ,Woodbridge,54.191.150.115,no_relation,94,27,,103,45,is location of,0.9761870601839531,905496-FS1-9,The role of antibiotics in ACUTE OTITIS MEDIA is to eradicate the causative pathogen from the MIDDLE EAR,MIDDLE EAR,ACUTE OTITIS MEDIA,RO-has_finding_site
503007630,7/14/2014 21:44:37,,1323120385,7/14/2014 21:44:21,neodev,0.6153,27597779,CAN,AB,Calgary,72.29.251.209,MIDDLE EAR is location of ACUTE OTITIS MEDIA,94,27,,103,45,is location of,0.9761870601839531,905496-FS1-9,The role of antibiotics in ACUTE OTITIS MEDIA is to eradicate the causative pathogen from the MIDDLE EAR,MIDDLE EAR,ACUTE OTITIS MEDIA,RO-has_finding_site
503007630,7/14/2014 21:45:30,,1323121026,7/14/2014 21:44:24,clixsense,0.6786,13328793,GBR,G5,Maidstone,2.103.33.237,no_relation,94,27,,103,45,is location of,0.9761870601839531,905496-FS1-9,The role of antibiotics in ACUTE OTITIS MEDIA is to eradicate the causative pathogen from the MIDDLE EAR,MIDDLE EAR,ACUTE OTITIS MEDIA,RO-has_finding_site
503007630,7/14/2014 22:07:49,,1323132653,7/14/2014 22:07:32,instagc,0.5915,18960682,GBR,,,86.29.147.112,MIDDLE EAR is location of ACUTE OTITIS MEDIA,94,27,,103,45,is location of,0.9761870601839531,905496-FS1-9,The role of antibiotics in ACUTE OTITIS MEDIA is to eradicate the causative pathogen from the MIDDLE EAR,MIDDLE EAR,ACUTE OTITIS MEDIA,RO-has_finding_site
503007630,7/14/2014 22:29:55,,1323145978,7/14/2014 22:29:20,clixsense,0.5752,15189335,GBR,K3,Peterborough,81.156.166.189,MIDDLE EAR is location of ACUTE OTITIS MEDIA,94,27,,103,45,is location of,0.9761870601839531,905496-FS1-9,The role of antibiotics in ACUTE OTITIS MEDIA is to eradicate the causative pathogen from the MIDDLE EAR,MIDDLE EAR,ACUTE OTITIS MEDIA,RO-has_finding_site
503007630,7/14/2014 22:32:26,,1323147079,7/14/2014 22:32:21,clixsense,0.3016,25419319,GBR,H8,Liverpool,94.4.192.228,MIDDLE EAR is location of ACUTE OTITIS MEDIA,94,27,,103,45,is location of,0.9761870601839531,905496-FS1-9,The role of antibiotics in ACUTE OTITIS MEDIA is to eradicate the causative pathogen from the MIDDLE EAR,MIDDLE EAR,ACUTE OTITIS MEDIA,RO-has_finding_site
503007637,7/14/2014 20:32:47,,1323082104,7/14/2014 20:32:15,clixsense,0.9583,27871219,NLD,07,Amsterdam,87.210.207.223,DIC causes APL,79,3,,81,6,causes,0.328797974610715,902646-FS1-4,"In APL with the translocation t(15;17), all  trans  retinoic acid corrects the DIC in 2 to 5 days; combined with daunorubicin or idarubicin, this regimen can induce remission in 80 to 90% of patients, and long term survival in 65 to 70%.",DIC,APL,RO-disease_may_have_finding
503007637,7/14/2014 21:13:47,,1323102829,7/14/2014 21:13:10,elite,0.8694,28276268,USA,MI,Taylor,67.149.247.166,APL causes DIC,79,3,,81,6,causes,0.328797974610715,902646-FS1-4,"In APL with the translocation t(15;17), all  trans  retinoic acid corrects the DIC in 2 to 5 days; combined with daunorubicin or idarubicin, this regimen can induce remission in 80 to 90% of patients, and long term survival in 65 to 70%.",DIC,APL,RO-disease_may_have_finding
503007637,7/14/2014 21:33:05,,1323112406,7/14/2014 21:32:45,tremorgames,0.5903,28013393,USA,CA,Rancho Cordova,71.197.67.37,APL causes DIC,79,3,,81,6,causes,0.328797974610715,902646-FS1-4,"In APL with the translocation t(15;17), all  trans  retinoic acid corrects the DIC in 2 to 5 days; combined with daunorubicin or idarubicin, this regimen can induce remission in 80 to 90% of patients, and long term survival in 65 to 70%.",DIC,APL,RO-disease_may_have_finding
503007637,7/14/2014 21:39:58,,1323116459,7/14/2014 21:39:34,instagc,0.7958,28301350,GBR,K4,Plymouth,92.28.215.248,no_relation,79,3,,81,6,causes,0.328797974610715,902646-FS1-4,"In APL with the translocation t(15;17), all  trans  retinoic acid corrects the DIC in 2 to 5 days; combined with daunorubicin or idarubicin, this regimen can induce remission in 80 to 90% of patients, and long term survival in 65 to 70%.",DIC,APL,RO-disease_may_have_finding
503007637,7/14/2014 21:45:22,,1323120902,7/14/2014 21:44:38,neodev,0.6153,27597779,CAN,AB,Calgary,72.29.251.209,no_relation,79,3,,81,6,causes,0.328797974610715,902646-FS1-4,"In APL with the translocation t(15;17), all  trans  retinoic acid corrects the DIC in 2 to 5 days; combined with daunorubicin or idarubicin, this regimen can induce remission in 80 to 90% of patients, and long term survival in 65 to 70%.",DIC,APL,RO-disease_may_have_finding
503007637,7/14/2014 22:30:47,,1323146324,7/14/2014 22:30:31,instagc,0.5867,23149109,USA,NC,Durham,75.189.206.205,APL causes DIC,79,3,,81,6,causes,0.328797974610715,902646-FS1-4,"In APL with the translocation t(15;17), all  trans  retinoic acid corrects the DIC in 2 to 5 days; combined with daunorubicin or idarubicin, this regimen can induce remission in 80 to 90% of patients, and long term survival in 65 to 70%.",DIC,APL,RO-disease_may_have_finding
503007637,7/14/2014 22:32:15,,1323146976,7/14/2014 22:32:10,clixsense,0.3016,25419319,GBR,H8,Liverpool,94.4.192.228,DIC causes APL,79,3,,81,6,causes,0.328797974610715,902646-FS1-4,"In APL with the translocation t(15;17), all  trans  retinoic acid corrects the DIC in 2 to 5 days; combined with daunorubicin or idarubicin, this regimen can induce remission in 80 to 90% of patients, and long term survival in 65 to 70%.",DIC,APL,RO-disease_may_have_finding
503007639,7/14/2014 20:33:44,,1323082577,7/14/2014 20:33:23,neodev,0.9583,21515166,NLD,11,Nootdorp,83.86.58.179,CADMIUM causes ITAI ITAI DISEASE,155,206,,161,223,causes,0.9701425001453321,903720-FS1-4,"In view of these data, the length of cadmium exposure and the life span of animals as well as epidemiological data published elsewhere, factors other than CADMIUM may also be involved in the development of ITAI ITAI DISEASE.",CADMIUM,ITAI ITAI DISEASE,RO-has_causative_agent
503007639,7/14/2014 20:49:22,,1323090396,7/14/2014 20:49:01,zoombucks,0.875,28232452,USA,NC,Cary,174.97.217.113,CADMIUM causes ITAI ITAI DISEASE,155,206,,161,223,causes,0.9701425001453321,903720-FS1-4,"In view of these data, the length of cadmium exposure and the life span of animals as well as epidemiological data published elsewhere, factors other than CADMIUM may also be involved in the development of ITAI ITAI DISEASE.",CADMIUM,ITAI ITAI DISEASE,RO-has_causative_agent
503007639,7/14/2014 21:24:16,,1323107560,7/14/2014 21:24:03,clixsense,0.5625,16827630,GBR,A7,Birmingham,86.146.169.103,CADMIUM causes ITAI ITAI DISEASE,155,206,,161,223,causes,0.9701425001453321,903720-FS1-4,"In view of these data, the length of cadmium exposure and the life span of animals as well as epidemiological data published elsewhere, factors other than CADMIUM may also be involved in the development of ITAI ITAI DISEASE.",CADMIUM,ITAI ITAI DISEASE,RO-has_causative_agent
503007639,7/14/2014 21:30:53,,1323111224,7/14/2014 21:30:27,neodev,0.7333,18755947,GBR,H2,Accrington,80.47.185.52,CADMIUM causes ITAI ITAI DISEASE,155,206,,161,223,causes,0.9701425001453321,903720-FS1-4,"In view of these data, the length of cadmium exposure and the life span of animals as well as epidemiological data published elsewhere, factors other than CADMIUM may also be involved in the development of ITAI ITAI DISEASE.",CADMIUM,ITAI ITAI DISEASE,RO-has_causative_agent
503007639,7/14/2014 21:37:54,,1323115129,7/14/2014 21:37:30,clixsense,0.5974,19803139,NLD,06,Veldhoven,212.61.84.196,CADMIUM causes ITAI ITAI DISEASE,155,206,,161,223,causes,0.9701425001453321,903720-FS1-4,"In view of these data, the length of cadmium exposure and the life span of animals as well as epidemiological data published elsewhere, factors other than CADMIUM may also be involved in the development of ITAI ITAI DISEASE.",CADMIUM,ITAI ITAI DISEASE,RO-has_causative_agent
503007639,7/14/2014 21:39:12,,1323115981,7/14/2014 21:38:57,instagc,0.7958,28301350,GBR,K4,Plymouth,92.28.215.248,CADMIUM causes ITAI ITAI DISEASE,155,206,,161,223,causes,0.9701425001453321,903720-FS1-4,"In view of these data, the length of cadmium exposure and the life span of animals as well as epidemiological data published elsewhere, factors other than CADMIUM may also be involved in the development of ITAI ITAI DISEASE.",CADMIUM,ITAI ITAI DISEASE,RO-has_causative_agent
503007639,7/14/2014 21:45:10,,1323120740,7/14/2014 21:45:03,prodege,0.5819,2143114,CAN,BC,Vancouver,24.84.160.12,CADMIUM causes ITAI ITAI DISEASE,155,206,,161,223,causes,0.9701425001453321,903720-FS1-4,"In view of these data, the length of cadmium exposure and the life span of animals as well as epidemiological data published elsewhere, factors other than CADMIUM may also be involved in the development of ITAI ITAI DISEASE.",CADMIUM,ITAI ITAI DISEASE,RO-has_causative_agent
503007643,7/14/2014 20:34:42,,1323082998,7/14/2014 20:34:17,clixsense,0.9583,27871219,NLD,07,Amsterdam,87.210.207.223,OSTEOMYELITIS diagnosed by BONE,99,66,,102,79,diagnosed by,0.549442255794756,902221-FS1-13,"In a 5 1/2 year retrospective study of hospitalized children with OSTEOMYELITIS who had technetium BONE scans, we found that 32 of 38 (84%) had increased radionuclide uptake, 4 (11%) had normal uptake and 2 (5%) had decreased uptake.",BONE,OSTEOMYELITIS,RO-disease_has_primary_anatomic_site
503007643,7/14/2014 21:13:47,,1323102830,7/14/2014 21:13:10,elite,0.8694,28276268,USA,MI,Taylor,67.149.247.166,OSTEOMYELITIS diagnosed by BONE,99,66,,102,79,diagnosed by,0.549442255794756,902221-FS1-13,"In a 5 1/2 year retrospective study of hospitalized children with OSTEOMYELITIS who had technetium BONE scans, we found that 32 of 38 (84%) had increased radionuclide uptake, 4 (11%) had normal uptake and 2 (5%) had decreased uptake.",BONE,OSTEOMYELITIS,RO-disease_has_primary_anatomic_site
503007643,7/14/2014 21:23:49,,1323107337,7/14/2014 21:23:38,clixsense,0.5625,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,99,66,,102,79,diagnosed by,0.549442255794756,902221-FS1-13,"In a 5 1/2 year retrospective study of hospitalized children with OSTEOMYELITIS who had technetium BONE scans, we found that 32 of 38 (84%) had increased radionuclide uptake, 4 (11%) had normal uptake and 2 (5%) had decreased uptake.",BONE,OSTEOMYELITIS,RO-disease_has_primary_anatomic_site
503007643,7/14/2014 21:37:26,,1323114840,7/14/2014 21:37:22,clixsense,0.4925,19162475,GBR,M3,Frome,82.33.126.30,OSTEOMYELITIS diagnosed by BONE,99,66,,102,79,diagnosed by,0.549442255794756,902221-FS1-13,"In a 5 1/2 year retrospective study of hospitalized children with OSTEOMYELITIS who had technetium BONE scans, we found that 32 of 38 (84%) had increased radionuclide uptake, 4 (11%) had normal uptake and 2 (5%) had decreased uptake.",BONE,OSTEOMYELITIS,RO-disease_has_primary_anatomic_site
503007643,7/14/2014 21:37:54,,1323115125,7/14/2014 21:37:30,clixsense,0.5974,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,99,66,,102,79,diagnosed by,0.549442255794756,902221-FS1-13,"In a 5 1/2 year retrospective study of hospitalized children with OSTEOMYELITIS who had technetium BONE scans, we found that 32 of 38 (84%) had increased radionuclide uptake, 4 (11%) had normal uptake and 2 (5%) had decreased uptake.",BONE,OSTEOMYELITIS,RO-disease_has_primary_anatomic_site
503007643,7/14/2014 21:44:48,,1323120491,7/14/2014 21:44:34,prodege,0.5819,2143114,CAN,BC,Vancouver,24.84.160.12,BONE diagnosed by OSTEOMYELITIS,99,66,,102,79,diagnosed by,0.549442255794756,902221-FS1-13,"In a 5 1/2 year retrospective study of hospitalized children with OSTEOMYELITIS who had technetium BONE scans, we found that 32 of 38 (84%) had increased radionuclide uptake, 4 (11%) had normal uptake and 2 (5%) had decreased uptake.",BONE,OSTEOMYELITIS,RO-disease_has_primary_anatomic_site
503007643,7/14/2014 22:30:44,,1323146298,7/14/2014 22:29:58,clixsense,0.5752,15189335,GBR,K3,Peterborough,81.156.166.189,no_relation,99,66,,102,79,diagnosed by,0.549442255794756,902221-FS1-13,"In a 5 1/2 year retrospective study of hospitalized children with OSTEOMYELITIS who had technetium BONE scans, we found that 32 of 38 (84%) had increased radionuclide uptake, 4 (11%) had normal uptake and 2 (5%) had decreased uptake.",BONE,OSTEOMYELITIS,RO-disease_has_primary_anatomic_site
503007644,7/14/2014 20:34:29,,1323082911,7/14/2014 20:34:11,neodev,0.9583,21515166,NLD,11,Nootdorp,83.86.58.179,ALBUTEROL treats ASTHMA,181,201,,186,210,treats,0.9707253433941508,907668-FS1-2,"CONCLUSION  In mild asthma, patients with the Gly/Gly genotype had better asthma control with albuterol than when it was withdrawn, and patients with the Arg/Arg genotype had worse ASTHMA control with ALBUTEROL than when it was withdrawn.",ASTHMA,ALBUTEROL,RO-may_treat
503007644,7/14/2014 20:42:56,,1323087146,7/14/2014 20:42:41,elite,0.875,28503042,USA,NJ,Woodbridge,54.191.150.115,ASTHMA treats ALBUTEROL,181,201,,186,210,treats,0.9707253433941508,907668-FS1-2,"CONCLUSION  In mild asthma, patients with the Gly/Gly genotype had better asthma control with albuterol than when it was withdrawn, and patients with the Arg/Arg genotype had worse ASTHMA control with ALBUTEROL than when it was withdrawn.",ASTHMA,ALBUTEROL,RO-may_treat
503007644,7/14/2014 20:49:38,,1323090595,7/14/2014 20:49:23,zoombucks,0.875,28232452,USA,NC,Cary,174.97.217.113,ALBUTEROL treats ASTHMA,181,201,,186,210,treats,0.9707253433941508,907668-FS1-2,"CONCLUSION  In mild asthma, patients with the Gly/Gly genotype had better asthma control with albuterol than when it was withdrawn, and patients with the Arg/Arg genotype had worse ASTHMA control with ALBUTEROL than when it was withdrawn.",ASTHMA,ALBUTEROL,RO-may_treat
503007644,7/14/2014 21:23:37,,1323107252,7/14/2014 21:23:27,clixsense,0.5625,16827630,GBR,A7,Birmingham,86.146.169.103,ALBUTEROL treats ASTHMA,181,201,,186,210,treats,0.9707253433941508,907668-FS1-2,"CONCLUSION  In mild asthma, patients with the Gly/Gly genotype had better asthma control with albuterol than when it was withdrawn, and patients with the Arg/Arg genotype had worse ASTHMA control with ALBUTEROL than when it was withdrawn.",ASTHMA,ALBUTEROL,RO-may_treat
503007644,7/14/2014 21:26:16,,1323108638,7/14/2014 21:26:06,prodege,0.7306,23541832,USA,AZ,Tempe,149.169.129.225,ALBUTEROL treats ASTHMA,181,201,,186,210,treats,0.9707253433941508,907668-FS1-2,"CONCLUSION  In mild asthma, patients with the Gly/Gly genotype had better asthma control with albuterol than when it was withdrawn, and patients with the Arg/Arg genotype had worse ASTHMA control with ALBUTEROL than when it was withdrawn.",ASTHMA,ALBUTEROL,RO-may_treat
503007644,7/14/2014 21:31:50,,1323111738,7/14/2014 21:31:15,instagc,0.6498,19602039,USA,WA,Bellevue,50.135.214.140,ALBUTEROL treats ASTHMA,181,201,,186,210,treats,0.9707253433941508,907668-FS1-2,"CONCLUSION  In mild asthma, patients with the Gly/Gly genotype had better asthma control with albuterol than when it was withdrawn, and patients with the Arg/Arg genotype had worse ASTHMA control with ALBUTEROL than when it was withdrawn.",ASTHMA,ALBUTEROL,RO-may_treat
503007644,7/14/2014 21:35:15,,1323113557,7/14/2014 21:34:23,neodev,0.7333,18755947,GBR,H2,Accrington,80.47.185.52,ALBUTEROL treats ASTHMA,181,201,,186,210,treats,0.9707253433941508,907668-FS1-2,"CONCLUSION  In mild asthma, patients with the Gly/Gly genotype had better asthma control with albuterol than when it was withdrawn, and patients with the Arg/Arg genotype had worse ASTHMA control with ALBUTEROL than when it was withdrawn.",ASTHMA,ALBUTEROL,RO-may_treat
503007645,7/14/2014 20:49:01,,1323090216,7/14/2014 20:48:42,zoombucks,0.875,28232452,USA,NC,Cary,174.97.217.113,OVARIAN MUCINOUS ADENOCARCINOMAS diagnosed by ASCITES,141,63,,147,95,diagnosed by,0.353553390593274,902909-FS1-13,"On cytology it was found that cancer cells in the ascites from OVARIAN MUCINOUS ADENOCARCINOMAS were HNF4 alpha positive, but tumor cells in ASCITES from other types of ovarian carcinomas were negative for HNF4 alpha.",ASCITES,OVARIAN MUCINOUS ADENOCARCINOMAS,RO-disease_may_have_finding
503007645,7/14/2014 21:24:01,,1323107436,7/14/2014 21:23:50,clixsense,0.5625,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,141,63,,147,95,diagnosed by,0.353553390593274,902909-FS1-13,"On cytology it was found that cancer cells in the ascites from OVARIAN MUCINOUS ADENOCARCINOMAS were HNF4 alpha positive, but tumor cells in ASCITES from other types of ovarian carcinomas were negative for HNF4 alpha.",ASCITES,OVARIAN MUCINOUS ADENOCARCINOMAS,RO-disease_may_have_finding
503007645,7/14/2014 21:32:44,,1323112194,7/14/2014 21:32:22,tremorgames,0.5903,28013393,USA,CA,Rancho Cordova,71.197.67.37,OVARIAN MUCINOUS ADENOCARCINOMAS diagnosed by ASCITES,141,63,,147,95,diagnosed by,0.353553390593274,902909-FS1-13,"On cytology it was found that cancer cells in the ascites from OVARIAN MUCINOUS ADENOCARCINOMAS were HNF4 alpha positive, but tumor cells in ASCITES from other types of ovarian carcinomas were negative for HNF4 alpha.",ASCITES,OVARIAN MUCINOUS ADENOCARCINOMAS,RO-disease_may_have_finding
503007645,7/14/2014 21:37:13,,1323114653,7/14/2014 21:37:07,clixsense,0.4925,19162475,GBR,M3,Frome,82.33.126.30,ASCITES diagnosed by OVARIAN MUCINOUS ADENOCARCINOMAS,141,63,,147,95,diagnosed by,0.353553390593274,902909-FS1-13,"On cytology it was found that cancer cells in the ascites from OVARIAN MUCINOUS ADENOCARCINOMAS were HNF4 alpha positive, but tumor cells in ASCITES from other types of ovarian carcinomas were negative for HNF4 alpha.",ASCITES,OVARIAN MUCINOUS ADENOCARCINOMAS,RO-disease_may_have_finding
503007645,7/14/2014 21:45:01,,1323120636,7/14/2014 21:44:49,prodege,0.5819,2143114,CAN,BC,Vancouver,24.84.160.12,OVARIAN MUCINOUS ADENOCARCINOMAS diagnosed by ASCITES,141,63,,147,95,diagnosed by,0.353553390593274,902909-FS1-13,"On cytology it was found that cancer cells in the ascites from OVARIAN MUCINOUS ADENOCARCINOMAS were HNF4 alpha positive, but tumor cells in ASCITES from other types of ovarian carcinomas were negative for HNF4 alpha.",ASCITES,OVARIAN MUCINOUS ADENOCARCINOMAS,RO-disease_may_have_finding
503007645,7/14/2014 22:08:26,,1323133039,7/14/2014 22:08:08,instagc,0.5915,18960682,GBR,,,86.29.147.112,OVARIAN MUCINOUS ADENOCARCINOMAS diagnosed by ASCITES,141,63,,147,95,diagnosed by,0.353553390593274,902909-FS1-13,"On cytology it was found that cancer cells in the ascites from OVARIAN MUCINOUS ADENOCARCINOMAS were HNF4 alpha positive, but tumor cells in ASCITES from other types of ovarian carcinomas were negative for HNF4 alpha.",ASCITES,OVARIAN MUCINOUS ADENOCARCINOMAS,RO-disease_may_have_finding
503007645,7/14/2014 22:31:13,,1323146516,7/14/2014 22:30:48,instagc,0.5867,23149109,USA,NC,Durham,75.189.206.205,OVARIAN MUCINOUS ADENOCARCINOMAS diagnosed by ASCITES,141,63,,147,95,diagnosed by,0.353553390593274,902909-FS1-13,"On cytology it was found that cancer cells in the ascites from OVARIAN MUCINOUS ADENOCARCINOMAS were HNF4 alpha positive, but tumor cells in ASCITES from other types of ovarian carcinomas were negative for HNF4 alpha.",ASCITES,OVARIAN MUCINOUS ADENOCARCINOMAS,RO-disease_may_have_finding
503007647,7/14/2014 20:34:46,,1323083030,7/14/2014 20:34:31,neodev,0.9583,21515166,NLD,11,Nootdorp,83.86.58.179,TRIGEMINAL NEURALGIA causes PAIN,21,71,,24,91,causes,0.993883734673619,904802-FS1-4,Predictive model for PAIN recurrence after posterior fossa surgery for TRIGEMINAL NEURALGIA,PAIN,TRIGEMINAL NEURALGIA,RO-has_definitional_manifestation
503007647,7/14/2014 20:48:41,,1323090057,7/14/2014 20:48:21,zoombucks,0.875,28232452,USA,NC,Cary,174.97.217.113,TRIGEMINAL NEURALGIA causes PAIN,21,71,,24,91,causes,0.993883734673619,904802-FS1-4,Predictive model for PAIN recurrence after posterior fossa surgery for TRIGEMINAL NEURALGIA,PAIN,TRIGEMINAL NEURALGIA,RO-has_definitional_manifestation
503007647,7/14/2014 21:15:25,,1323103659,7/14/2014 21:14:40,prodege,0.7639,28255346,GBR,L9,Sheffield,2.125.183.137,TRIGEMINAL NEURALGIA causes PAIN,21,71,,24,91,causes,0.993883734673619,904802-FS1-4,Predictive model for PAIN recurrence after posterior fossa surgery for TRIGEMINAL NEURALGIA,PAIN,TRIGEMINAL NEURALGIA,RO-has_definitional_manifestation
503007647,7/14/2014 21:23:27,,1323107192,7/14/2014 21:23:12,clixsense,0.5625,16827630,GBR,A7,Birmingham,86.146.169.103,TRIGEMINAL NEURALGIA causes PAIN,21,71,,24,91,causes,0.993883734673619,904802-FS1-4,Predictive model for PAIN recurrence after posterior fossa surgery for TRIGEMINAL NEURALGIA,PAIN,TRIGEMINAL NEURALGIA,RO-has_definitional_manifestation
503007647,7/14/2014 21:27:02,,1323109030,7/14/2014 21:26:43,prodege,0.7306,23541832,USA,AZ,Tempe,149.169.129.225,TRIGEMINAL NEURALGIA causes PAIN,21,71,,24,91,causes,0.993883734673619,904802-FS1-4,Predictive model for PAIN recurrence after posterior fossa surgery for TRIGEMINAL NEURALGIA,PAIN,TRIGEMINAL NEURALGIA,RO-has_definitional_manifestation
503007647,7/14/2014 21:31:50,,1323111737,7/14/2014 21:31:15,instagc,0.6498,19602039,USA,WA,Bellevue,50.135.214.140,TRIGEMINAL NEURALGIA causes PAIN,21,71,,24,91,causes,0.993883734673619,904802-FS1-4,Predictive model for PAIN recurrence after posterior fossa surgery for TRIGEMINAL NEURALGIA,PAIN,TRIGEMINAL NEURALGIA,RO-has_definitional_manifestation
503007647,7/14/2014 21:36:40,,1323114381,7/14/2014 21:36:19,clixsense,0.5974,19803139,NLD,06,Veldhoven,212.61.84.196,TRIGEMINAL NEURALGIA causes PAIN,21,71,,24,91,causes,0.993883734673619,904802-FS1-4,Predictive model for PAIN recurrence after posterior fossa surgery for TRIGEMINAL NEURALGIA,PAIN,TRIGEMINAL NEURALGIA,RO-has_definitional_manifestation
503223349,7/15/2014 11:04:22,,1323512191,7/15/2014 11:03:56,prodege,0.6528,28039757,GBR,L8,Southport,109.155.158.54,no_relation,78,135,,104,146,treats,0.753778361444409,907406-FS1-2,51   The identification of neurotransmitter pathways involved in chemotherapy INDUCED NAUSEA AND VOMITING led to development of potent ANTIEMETICS such as the serotonin antagonists ondansetron and granisetron.,INDUCED NAUSEA AND VOMITING,ANTIEMETICS,RO-may_prevent
503223349,7/15/2014 11:26:31,,1323527404,7/15/2014 11:26:15,instagc,0.7611,28301350,GBR,K4,Plymouth,92.28.215.248,ANTIEMETICS treats INDUCED NAUSEA AND VOMITING,78,135,,104,146,treats,0.753778361444409,907406-FS1-2,51   The identification of neurotransmitter pathways involved in chemotherapy INDUCED NAUSEA AND VOMITING led to development of potent ANTIEMETICS such as the serotonin antagonists ondansetron and granisetron.,INDUCED NAUSEA AND VOMITING,ANTIEMETICS,RO-may_prevent
503223349,7/15/2014 11:51:46,,1323542308,7/15/2014 11:51:12,neodev,0.6736,24578640,USA,IL,Chicago,65.60.20.66,INDUCED NAUSEA AND VOMITING treats ANTIEMETICS,78,135,,104,146,treats,0.753778361444409,907406-FS1-2,51   The identification of neurotransmitter pathways involved in chemotherapy INDUCED NAUSEA AND VOMITING led to development of potent ANTIEMETICS such as the serotonin antagonists ondansetron and granisetron.,INDUCED NAUSEA AND VOMITING,ANTIEMETICS,RO-may_prevent
503223349,7/15/2014 12:38:45,,1323561278,7/15/2014 12:38:12,prodege,0.5236,1852770,USA,TX,Abilene,76.198.102.54,no_relation,78,135,,104,146,treats,0.753778361444409,907406-FS1-2,51   The identification of neurotransmitter pathways involved in chemotherapy INDUCED NAUSEA AND VOMITING led to development of potent ANTIEMETICS such as the serotonin antagonists ondansetron and granisetron.,INDUCED NAUSEA AND VOMITING,ANTIEMETICS,RO-may_prevent
503223349,7/15/2014 12:39:40,,1323561668,7/15/2014 12:39:23,instagc,0.7472,18960682,GBR,,,86.29.147.112,INDUCED NAUSEA AND VOMITING treats ANTIEMETICS,78,135,,104,146,treats,0.753778361444409,907406-FS1-2,51   The identification of neurotransmitter pathways involved in chemotherapy INDUCED NAUSEA AND VOMITING led to development of potent ANTIEMETICS such as the serotonin antagonists ondansetron and granisetron.,INDUCED NAUSEA AND VOMITING,ANTIEMETICS,RO-may_prevent
503223349,7/15/2014 13:04:24,,1323571485,7/15/2014 13:04:16,clixsense,0.601,20614047,USA,ID,Priest River,174.32.160.124,no_relation,78,135,,104,146,treats,0.753778361444409,907406-FS1-2,51   The identification of neurotransmitter pathways involved in chemotherapy INDUCED NAUSEA AND VOMITING led to development of potent ANTIEMETICS such as the serotonin antagonists ondansetron and granisetron.,INDUCED NAUSEA AND VOMITING,ANTIEMETICS,RO-may_prevent
503223349,7/15/2014 13:11:59,,1323574241,7/15/2014 13:11:44,neodev,0.4365,28336203,USA,PA,Harrisburg,50.149.53.150,ANTIEMETICS treats INDUCED NAUSEA AND VOMITING,78,135,,104,146,treats,0.753778361444409,907406-FS1-2,51   The identification of neurotransmitter pathways involved in chemotherapy INDUCED NAUSEA AND VOMITING led to development of potent ANTIEMETICS such as the serotonin antagonists ondansetron and granisetron.,INDUCED NAUSEA AND VOMITING,ANTIEMETICS,RO-may_prevent
503223354,7/15/2014 10:50:56,,1323503684,7/15/2014 10:50:40,clixsense,0.8486,27793793,GBR,C5,Chester,151.230.27.155,no_relation,52,5,,79,26,causes,0.3779644730092271,900137-FS1-4,"Both DIABETIC KETOACIDOSIS (DKA) and hyperglycemic, HYPEROSMOLAR NONKETOTIC COMA (HHNC) are stressful metabolic occurrences brought about by the orchestration of numerous events.",HYPEROSMOLAR NONKETOTIC COMA,DIABETIC KETOACIDOSIS,RO-cause_of
503223354,7/15/2014 10:52:13,,1323504641,7/15/2014 10:51:52,rewardsspot,0.6319,17763704,USA,VA,Manassas,198.7.62.204,HYPEROSMOLAR NONKETOTIC COMA causes DIABETIC KETOACIDOSIS,52,5,,79,26,causes,0.3779644730092271,900137-FS1-4,"Both DIABETIC KETOACIDOSIS (DKA) and hyperglycemic, HYPEROSMOLAR NONKETOTIC COMA (HHNC) are stressful metabolic occurrences brought about by the orchestration of numerous events.",HYPEROSMOLAR NONKETOTIC COMA,DIABETIC KETOACIDOSIS,RO-cause_of
503223354,7/15/2014 11:11:43,,1323518570,7/15/2014 11:11:05,elite,0.7417,28397222,GBR,Y4,Usk,31.50.223.75,no_relation,52,5,,79,26,causes,0.3779644730092271,900137-FS1-4,"Both DIABETIC KETOACIDOSIS (DKA) and hyperglycemic, HYPEROSMOLAR NONKETOTIC COMA (HHNC) are stressful metabolic occurrences brought about by the orchestration of numerous events.",HYPEROSMOLAR NONKETOTIC COMA,DIABETIC KETOACIDOSIS,RO-cause_of
503223354,7/15/2014 11:14:47,,1323520518,7/15/2014 11:14:19,prodege,0.7681,11864493,GBR,Z4,Wrexham,212.219.196.69,no_relation,52,5,,79,26,causes,0.3779644730092271,900137-FS1-4,"Both DIABETIC KETOACIDOSIS (DKA) and hyperglycemic, HYPEROSMOLAR NONKETOTIC COMA (HHNC) are stressful metabolic occurrences brought about by the orchestration of numerous events.",HYPEROSMOLAR NONKETOTIC COMA,DIABETIC KETOACIDOSIS,RO-cause_of
503223354,7/15/2014 13:32:04,,1323580874,7/15/2014 13:31:06,instagc,0.5063,23149109,USA,NC,Cary,24.206.38.18,DIABETIC KETOACIDOSIS causes HYPEROSMOLAR NONKETOTIC COMA,52,5,,79,26,causes,0.3779644730092271,900137-FS1-4,"Both DIABETIC KETOACIDOSIS (DKA) and hyperglycemic, HYPEROSMOLAR NONKETOTIC COMA (HHNC) are stressful metabolic occurrences brought about by the orchestration of numerous events.",HYPEROSMOLAR NONKETOTIC COMA,DIABETIC KETOACIDOSIS,RO-cause_of
503223354,7/15/2014 14:32:49,,1323599081,7/15/2014 14:32:43,neodev,0.3913,25224036,CAN,ON,Sudbury,67.204.218.187,DIABETIC KETOACIDOSIS causes HYPEROSMOLAR NONKETOTIC COMA,52,5,,79,26,causes,0.3779644730092271,900137-FS1-4,"Both DIABETIC KETOACIDOSIS (DKA) and hyperglycemic, HYPEROSMOLAR NONKETOTIC COMA (HHNC) are stressful metabolic occurrences brought about by the orchestration of numerous events.",HYPEROSMOLAR NONKETOTIC COMA,DIABETIC KETOACIDOSIS,RO-cause_of
503223354,7/15/2014 16:24:47,,1323671019,7/15/2014 16:24:00,clixsense,0.475,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,52,5,,79,26,causes,0.3779644730092271,900137-FS1-4,"Both DIABETIC KETOACIDOSIS (DKA) and hyperglycemic, HYPEROSMOLAR NONKETOTIC COMA (HHNC) are stressful metabolic occurrences brought about by the orchestration of numerous events.",HYPEROSMOLAR NONKETOTIC COMA,DIABETIC KETOACIDOSIS,RO-cause_of
503223361,7/15/2014 10:24:47,,1323485703,7/15/2014 10:24:06,rewardsspot,0.8889,24482174,GBR,H9,London,46.23.68.180,MELPHALAN treats MULTIPLE MYELOMA,75,32,,90,41,treats,0.9704949588309459,907938-FS1-2,"Combination chemotherapy versus MELPHALAN plus prednisone as treatment for MULTIPLE MYELOMA: an overview of 6,633 patients from 27 randomized trials.",MULTIPLE MYELOMA,MELPHALAN,RO-may_treat
503223361,7/15/2014 11:27:19,,1323527951,7/15/2014 11:26:47,elite,0.7417,28397222,GBR,Y4,Usk,31.50.223.75,MELPHALAN treats MULTIPLE MYELOMA,75,32,,90,41,treats,0.9704949588309459,907938-FS1-2,"Combination chemotherapy versus MELPHALAN plus prednisone as treatment for MULTIPLE MYELOMA: an overview of 6,633 patients from 27 randomized trials.",MULTIPLE MYELOMA,MELPHALAN,RO-may_treat
503223361,7/15/2014 11:50:29,,1323541441,7/15/2014 11:50:12,neodev,0.6637,21515166,NLD,11,Nootdorp,83.86.58.179,MELPHALAN treats MULTIPLE MYELOMA,75,32,,90,41,treats,0.9704949588309459,907938-FS1-2,"Combination chemotherapy versus MELPHALAN plus prednisone as treatment for MULTIPLE MYELOMA: an overview of 6,633 patients from 27 randomized trials.",MULTIPLE MYELOMA,MELPHALAN,RO-may_treat
503223361,7/15/2014 13:48:47,,1323586485,7/15/2014 13:48:17,prodege,0.6706,13795372,CAN,NS,Dartmouth,142.68.155.182,MELPHALAN treats MULTIPLE MYELOMA,75,32,,90,41,treats,0.9704949588309459,907938-FS1-2,"Combination chemotherapy versus MELPHALAN plus prednisone as treatment for MULTIPLE MYELOMA: an overview of 6,633 patients from 27 randomized trials.",MULTIPLE MYELOMA,MELPHALAN,RO-may_treat
503223361,7/15/2014 13:51:07,,1323587098,7/15/2014 13:50:45,neodev,0.4671,18339121,USA,SC,Sumter,173.93.188.194,MELPHALAN treats MULTIPLE MYELOMA,75,32,,90,41,treats,0.9704949588309459,907938-FS1-2,"Combination chemotherapy versus MELPHALAN plus prednisone as treatment for MULTIPLE MYELOMA: an overview of 6,633 patients from 27 randomized trials.",MULTIPLE MYELOMA,MELPHALAN,RO-may_treat
503223361,7/15/2014 15:49:07,,1323640573,7/15/2014 15:48:52,clixsense,0.6403,7265596,USA,IA,Neola,199.120.116.136,MELPHALAN treats MULTIPLE MYELOMA,75,32,,90,41,treats,0.9704949588309459,907938-FS1-2,"Combination chemotherapy versus MELPHALAN plus prednisone as treatment for MULTIPLE MYELOMA: an overview of 6,633 patients from 27 randomized trials.",MULTIPLE MYELOMA,MELPHALAN,RO-may_treat
503223361,7/15/2014 15:53:00,,1323643543,7/15/2014 15:52:38,neodev,0.624,14861092,GBR,I2,Manchester,90.194.137.76,MELPHALAN treats MULTIPLE MYELOMA,75,32,,90,41,treats,0.9704949588309459,907938-FS1-2,"Combination chemotherapy versus MELPHALAN plus prednisone as treatment for MULTIPLE MYELOMA: an overview of 6,633 patients from 27 randomized trials.",MULTIPLE MYELOMA,MELPHALAN,RO-may_treat
503223362,7/15/2014 10:31:44,,1323490374,7/15/2014 10:31:37,clixsense,0.6875,19162475,GBR,M3,Frome,82.33.126.30,PANIC DISORDER causes PANIC ATTACKS,64,166,,76,180,causes,0.738548945875996,904519-FS1-4,"Hyperventilation syndrome is separate from panic disorder (see  PANIC ATTACKS and Panic Disorder ), although the 2 conditions overlap; about  1 / 2  of patients with PANIC DISORDER have hyperventilation syndrome and  1 / 4  of patients with hyperventilation syndrome have panic disorder.",PANIC ATTACKS,PANIC DISORDER,RO-has_definitional_manifestation
503223362,7/15/2014 11:14:57,,1323520643,7/15/2014 11:14:11,prodege,0.6058,27934334,GBR,B9,High Wycombe,86.166.72.139,no_relation,64,166,,76,180,causes,0.738548945875996,904519-FS1-4,"Hyperventilation syndrome is separate from panic disorder (see  PANIC ATTACKS and Panic Disorder ), although the 2 conditions overlap; about  1 / 2  of patients with PANIC DISORDER have hyperventilation syndrome and  1 / 4  of patients with hyperventilation syndrome have panic disorder.",PANIC ATTACKS,PANIC DISORDER,RO-has_definitional_manifestation
503223362,7/15/2014 12:04:58,,1323548697,7/15/2014 12:04:31,prodege,0.35,7664351,USA,NY,Cicero,74.111.0.21,PANIC DISORDER causes PANIC ATTACKS,64,166,,76,180,causes,0.738548945875996,904519-FS1-4,"Hyperventilation syndrome is separate from panic disorder (see  PANIC ATTACKS and Panic Disorder ), although the 2 conditions overlap; about  1 / 2  of patients with PANIC DISORDER have hyperventilation syndrome and  1 / 4  of patients with hyperventilation syndrome have panic disorder.",PANIC ATTACKS,PANIC DISORDER,RO-has_definitional_manifestation
503223362,7/15/2014 12:58:53,,1323569288,7/15/2014 12:58:40,elite,0.8028,28503042,USA,NJ,Woodbridge,54.191.150.115,PANIC DISORDER causes PANIC ATTACKS,64,166,,76,180,causes,0.738548945875996,904519-FS1-4,"Hyperventilation syndrome is separate from panic disorder (see  PANIC ATTACKS and Panic Disorder ), although the 2 conditions overlap; about  1 / 2  of patients with PANIC DISORDER have hyperventilation syndrome and  1 / 4  of patients with hyperventilation syndrome have panic disorder.",PANIC ATTACKS,PANIC DISORDER,RO-has_definitional_manifestation
503223362,7/15/2014 15:49:20,,1323640785,7/15/2014 15:49:08,clixsense,0.6403,7265596,USA,IA,Neola,199.120.116.136,PANIC DISORDER causes PANIC ATTACKS,64,166,,76,180,causes,0.738548945875996,904519-FS1-4,"Hyperventilation syndrome is separate from panic disorder (see  PANIC ATTACKS and Panic Disorder ), although the 2 conditions overlap; about  1 / 2  of patients with PANIC DISORDER have hyperventilation syndrome and  1 / 4  of patients with hyperventilation syndrome have panic disorder.",PANIC ATTACKS,PANIC DISORDER,RO-has_definitional_manifestation
503223362,7/15/2014 16:59:40,,1323711846,7/15/2014 16:59:26,neodev,0.6701,18755947,GBR,H2,Accrington,80.47.185.52,PANIC DISORDER causes PANIC ATTACKS,64,166,,76,180,causes,0.738548945875996,904519-FS1-4,"Hyperventilation syndrome is separate from panic disorder (see  PANIC ATTACKS and Panic Disorder ), although the 2 conditions overlap; about  1 / 2  of patients with PANIC DISORDER have hyperventilation syndrome and  1 / 4  of patients with hyperventilation syndrome have panic disorder.",PANIC ATTACKS,PANIC DISORDER,RO-has_definitional_manifestation
503223362,7/15/2014 17:06:39,,1323718638,7/15/2014 17:06:21,instagc,0.9286,19004168,GBR,H2,Accrington,80.47.185.52,PANIC DISORDER causes PANIC ATTACKS,64,166,,76,180,causes,0.738548945875996,904519-FS1-4,"Hyperventilation syndrome is separate from panic disorder (see  PANIC ATTACKS and Panic Disorder ), although the 2 conditions overlap; about  1 / 2  of patients with PANIC DISORDER have hyperventilation syndrome and  1 / 4  of patients with hyperventilation syndrome have panic disorder.",PANIC ATTACKS,PANIC DISORDER,RO-has_definitional_manifestation
503223366,7/15/2014 10:07:22,,1323475110,7/15/2014 10:06:51,eup_slw,0.9167,20818028,GBR,A7,Birmingham,92.232.139.254,no_relation,124,48,,148,86,causes,0.875189948987367,901512-FS1-4,Late postpartum eclampsia without the classical PRE ECLAMPTIC SIGNS OEDEMA PROTEINURIA and hypertension is a rarely noticed COMPLICATION OF PREGNANCY,COMPLICATION OF PREGNANCY,PRE ECLAMPTIC SIGNS OEDEMA PROTEINURIA,RO-disease_has_finding
503223366,7/15/2014 10:30:29,,1323489449,7/15/2014 10:29:47,vivatic,0.8056,25451531,GBR,,,83.67.28.193,no_relation,124,48,,148,86,causes,0.875189948987367,901512-FS1-4,Late postpartum eclampsia without the classical PRE ECLAMPTIC SIGNS OEDEMA PROTEINURIA and hypertension is a rarely noticed COMPLICATION OF PREGNANCY,COMPLICATION OF PREGNANCY,PRE ECLAMPTIC SIGNS OEDEMA PROTEINURIA,RO-disease_has_finding
503223366,7/15/2014 11:14:29,,1323520379,7/15/2014 11:13:54,clixsense,0.8306,27871219,NLD,07,Amsterdam,87.210.207.223,PRE ECLAMPTIC SIGNS OEDEMA PROTEINURIA causes COMPLICATION OF PREGNANCY,124,48,,148,86,causes,0.875189948987367,901512-FS1-4,Late postpartum eclampsia without the classical PRE ECLAMPTIC SIGNS OEDEMA PROTEINURIA and hypertension is a rarely noticed COMPLICATION OF PREGNANCY,COMPLICATION OF PREGNANCY,PRE ECLAMPTIC SIGNS OEDEMA PROTEINURIA,RO-disease_has_finding
503223366,7/15/2014 11:14:57,,1323520647,7/15/2014 11:14:11,prodege,0.6058,27934334,GBR,B9,High Wycombe,86.166.72.139,PRE ECLAMPTIC SIGNS OEDEMA PROTEINURIA causes COMPLICATION OF PREGNANCY,124,48,,148,86,causes,0.875189948987367,901512-FS1-4,Late postpartum eclampsia without the classical PRE ECLAMPTIC SIGNS OEDEMA PROTEINURIA and hypertension is a rarely noticed COMPLICATION OF PREGNANCY,COMPLICATION OF PREGNANCY,PRE ECLAMPTIC SIGNS OEDEMA PROTEINURIA,RO-disease_has_finding
503223366,7/15/2014 15:22:06,,1323620924,7/15/2014 15:21:12,prodege,0.5683,7899370,USA,MI,Bay City,71.13.81.162,PRE ECLAMPTIC SIGNS OEDEMA PROTEINURIA causes COMPLICATION OF PREGNANCY,124,48,,148,86,causes,0.875189948987367,901512-FS1-4,Late postpartum eclampsia without the classical PRE ECLAMPTIC SIGNS OEDEMA PROTEINURIA and hypertension is a rarely noticed COMPLICATION OF PREGNANCY,COMPLICATION OF PREGNANCY,PRE ECLAMPTIC SIGNS OEDEMA PROTEINURIA,RO-disease_has_finding
503223366,7/15/2014 15:52:08,,1323642974,7/15/2014 15:51:48,neodev,0.624,14861092,GBR,I2,Manchester,90.194.137.76,COMPLICATION OF PREGNANCY causes PRE ECLAMPTIC SIGNS OEDEMA PROTEINURIA,124,48,,148,86,causes,0.875189948987367,901512-FS1-4,Late postpartum eclampsia without the classical PRE ECLAMPTIC SIGNS OEDEMA PROTEINURIA and hypertension is a rarely noticed COMPLICATION OF PREGNANCY,COMPLICATION OF PREGNANCY,PRE ECLAMPTIC SIGNS OEDEMA PROTEINURIA,RO-disease_has_finding
503223366,7/15/2014 16:50:09,,1323701029,7/15/2014 16:49:28,prodege,0.5758,23541832,USA,AZ,Tempe,149.169.145.144,no_relation,124,48,,148,86,causes,0.875189948987367,901512-FS1-4,Late postpartum eclampsia without the classical PRE ECLAMPTIC SIGNS OEDEMA PROTEINURIA and hypertension is a rarely noticed COMPLICATION OF PREGNANCY,COMPLICATION OF PREGNANCY,PRE ECLAMPTIC SIGNS OEDEMA PROTEINURIA,RO-disease_has_finding
503223376,7/15/2014 10:08:30,,1323475791,7/15/2014 10:08:04,clixsense,0.875,15189335,GBR,E4,Colchester,5.67.141.89,TACHYCARDIA causes SUSTAINED VENTRICULAR TACHYCARDIA,208,248,,218,281,causes,0.4472135954999579,904545-FS1-4,"To determine if termination of hemodynamically tolerated, sustained ventricular tachycardia during intravenous infusion of procainamide predicts the success of procainamide therapy in preventing induction of TACHYCARDIA 15 patients with inducible, SUSTAINED VENTRICULAR TACHYCARDIA in the setting of chronic coronary artery disease were studied.",TACHYCARDIA,SUSTAINED VENTRICULAR TACHYCARDIA,RO-has_definitional_manifestation
503223376,7/15/2014 11:52:08,,1323542654,7/15/2014 11:51:48,neodev,0.6736,24578640,USA,IL,Chicago,65.60.20.66,TACHYCARDIA causes SUSTAINED VENTRICULAR TACHYCARDIA,208,248,,218,281,causes,0.4472135954999579,904545-FS1-4,"To determine if termination of hemodynamically tolerated, sustained ventricular tachycardia during intravenous infusion of procainamide predicts the success of procainamide therapy in preventing induction of TACHYCARDIA 15 patients with inducible, SUSTAINED VENTRICULAR TACHYCARDIA in the setting of chronic coronary artery disease were studied.",TACHYCARDIA,SUSTAINED VENTRICULAR TACHYCARDIA,RO-has_definitional_manifestation
503223376,7/15/2014 12:12:36,,1323551381,7/15/2014 12:12:15,paiddailysurveys,0.6127,11786001,USA,NC,Charlotte,71.28.89.238,TACHYCARDIA causes SUSTAINED VENTRICULAR TACHYCARDIA,208,248,,218,281,causes,0.4472135954999579,904545-FS1-4,"To determine if termination of hemodynamically tolerated, sustained ventricular tachycardia during intravenous infusion of procainamide predicts the success of procainamide therapy in preventing induction of TACHYCARDIA 15 patients with inducible, SUSTAINED VENTRICULAR TACHYCARDIA in the setting of chronic coronary artery disease were studied.",TACHYCARDIA,SUSTAINED VENTRICULAR TACHYCARDIA,RO-has_definitional_manifestation
503223376,7/15/2014 13:50:36,,1323586885,7/15/2014 13:49:58,neodev,0.4671,18339121,USA,SC,Sumter,173.93.188.194,TACHYCARDIA causes SUSTAINED VENTRICULAR TACHYCARDIA,208,248,,218,281,causes,0.4472135954999579,904545-FS1-4,"To determine if termination of hemodynamically tolerated, sustained ventricular tachycardia during intravenous infusion of procainamide predicts the success of procainamide therapy in preventing induction of TACHYCARDIA 15 patients with inducible, SUSTAINED VENTRICULAR TACHYCARDIA in the setting of chronic coronary artery disease were studied.",TACHYCARDIA,SUSTAINED VENTRICULAR TACHYCARDIA,RO-has_definitional_manifestation
503223376,7/15/2014 14:19:40,,1323595117,7/15/2014 14:19:09,instagc,0.6554,19636746,USA,NY,Andover,192.182.216.225,no_relation,208,248,,218,281,causes,0.4472135954999579,904545-FS1-4,"To determine if termination of hemodynamically tolerated, sustained ventricular tachycardia during intravenous infusion of procainamide predicts the success of procainamide therapy in preventing induction of TACHYCARDIA 15 patients with inducible, SUSTAINED VENTRICULAR TACHYCARDIA in the setting of chronic coronary artery disease were studied.",TACHYCARDIA,SUSTAINED VENTRICULAR TACHYCARDIA,RO-has_definitional_manifestation
503223376,7/15/2014 16:46:08,,1323696628,7/15/2014 16:46:02,prodege,0.474,2143114,CAN,BC,Vancouver,24.84.160.12,TACHYCARDIA causes SUSTAINED VENTRICULAR TACHYCARDIA,208,248,,218,281,causes,0.4472135954999579,904545-FS1-4,"To determine if termination of hemodynamically tolerated, sustained ventricular tachycardia during intravenous infusion of procainamide predicts the success of procainamide therapy in preventing induction of TACHYCARDIA 15 patients with inducible, SUSTAINED VENTRICULAR TACHYCARDIA in the setting of chronic coronary artery disease were studied.",TACHYCARDIA,SUSTAINED VENTRICULAR TACHYCARDIA,RO-has_definitional_manifestation
503223376,7/15/2014 16:51:16,,1323702177,7/15/2014 16:50:51,prodege,0.5758,23541832,USA,AZ,Tempe,149.169.145.144,no_relation,208,248,,218,281,causes,0.4472135954999579,904545-FS1-4,"To determine if termination of hemodynamically tolerated, sustained ventricular tachycardia during intravenous infusion of procainamide predicts the success of procainamide therapy in preventing induction of TACHYCARDIA 15 patients with inducible, SUSTAINED VENTRICULAR TACHYCARDIA in the setting of chronic coronary artery disease were studied.",TACHYCARDIA,SUSTAINED VENTRICULAR TACHYCARDIA,RO-has_definitional_manifestation
503223378,7/15/2014 10:51:38,,1323504285,7/15/2014 10:51:24,clixsense,0.8486,27793793,GBR,C5,Chester,151.230.27.155,no_relation,37,108,,90,120,is location of,0.353553390593274,902461-FS1-9,"The alterations found in bone matrix CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS suggest that in OSTEOPOROSIS and fractures, not only bone mass changes, but also bone quality changes play a role in bone strength.",CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
503223378,7/15/2014 12:57:58,,1323568820,7/15/2014 12:57:35,elite,0.8028,28503042,USA,NJ,Woodbridge,54.191.150.115,no_relation,37,108,,90,120,is location of,0.353553390593274,902461-FS1-9,"The alterations found in bone matrix CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS suggest that in OSTEOPOROSIS and fractures, not only bone mass changes, but also bone quality changes play a role in bone strength.",CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
503223378,7/15/2014 13:04:24,,1323571478,7/15/2014 13:04:16,clixsense,0.601,20614047,USA,ID,Priest River,174.32.160.124,CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS is location of OSTEOPOROSIS,37,108,,90,120,is location of,0.353553390593274,902461-FS1-9,"The alterations found in bone matrix CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS suggest that in OSTEOPOROSIS and fractures, not only bone mass changes, but also bone quality changes play a role in bone strength.",CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
503223378,7/15/2014 15:51:26,,1323642418,7/15/2014 15:51:01,neodev,0.624,14861092,GBR,I2,Manchester,90.194.137.76,CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS is location of OSTEOPOROSIS,37,108,,90,120,is location of,0.353553390593274,902461-FS1-9,"The alterations found in bone matrix CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS suggest that in OSTEOPOROSIS and fractures, not only bone mass changes, but also bone quality changes play a role in bone strength.",CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
503223378,7/15/2014 16:45:49,,1323696291,7/15/2014 16:45:39,prodege,0.474,2143114,CAN,BC,Vancouver,24.84.160.12,CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS is location of OSTEOPOROSIS,37,108,,90,120,is location of,0.353553390593274,902461-FS1-9,"The alterations found in bone matrix CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS suggest that in OSTEOPOROSIS and fractures, not only bone mass changes, but also bone quality changes play a role in bone strength.",CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
503223378,7/15/2014 16:50:33,,1323701457,7/15/2014 16:50:09,prodege,0.5758,23541832,USA,AZ,Tempe,149.169.145.144,no_relation,37,108,,90,120,is location of,0.353553390593274,902461-FS1-9,"The alterations found in bone matrix CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS suggest that in OSTEOPOROSIS and fractures, not only bone mass changes, but also bone quality changes play a role in bone strength.",CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
503223378,7/15/2014 16:54:14,,1323705321,7/15/2014 16:53:40,prodege,0.5952,9525153,CAN,ON,Toronto,65.95.187.40,CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS is location of OSTEOPOROSIS,37,108,,90,120,is location of,0.353553390593274,902461-FS1-9,"The alterations found in bone matrix CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS suggest that in OSTEOPOROSIS and fractures, not only bone mass changes, but also bone quality changes play a role in bone strength.",CONSTITUENTS IN OSTEOPOROTIC BONE RELATIVE TO CONTROLS,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
503223386,7/15/2014 11:12:25,,1323519098,7/15/2014 11:11:59,prodege,0.7681,11864493,GBR,Z4,Wrexham,212.219.196.69,no_relation,66,103,,70,111,causes,0.7947194142390258,902366-FS1-4,"In the present study, the influence of organic alterations in the BRAIN on the age of manifestation of EPILEPSY was investigated by means of cranial computer tomography (CCT) in 307 children and adolescents.",BRAIN,EPILEPSY,RO-disease_has_primary_anatomic_site
503223386,7/15/2014 11:14:29,,1323520381,7/15/2014 11:13:54,clixsense,0.8306,27871219,NLD,07,Amsterdam,87.210.207.223,no_relation,66,103,,70,111,causes,0.7947194142390258,902366-FS1-4,"In the present study, the influence of organic alterations in the BRAIN on the age of manifestation of EPILEPSY was investigated by means of cranial computer tomography (CCT) in 307 children and adolescents.",BRAIN,EPILEPSY,RO-disease_has_primary_anatomic_site
503223386,7/15/2014 12:23:52,,1323555746,7/15/2014 12:23:23,paiddailysurveys,0.6127,11786001,USA,NC,Charlotte,71.28.89.238,BRAIN causes EPILEPSY,66,103,,70,111,causes,0.7947194142390258,902366-FS1-4,"In the present study, the influence of organic alterations in the BRAIN on the age of manifestation of EPILEPSY was investigated by means of cranial computer tomography (CCT) in 307 children and adolescents.",BRAIN,EPILEPSY,RO-disease_has_primary_anatomic_site
503223386,7/15/2014 15:52:37,,1323643304,7/15/2014 15:52:09,neodev,0.624,14861092,GBR,I2,Manchester,90.194.137.76,no_relation,66,103,,70,111,causes,0.7947194142390258,902366-FS1-4,"In the present study, the influence of organic alterations in the BRAIN on the age of manifestation of EPILEPSY was investigated by means of cranial computer tomography (CCT) in 307 children and adolescents.",BRAIN,EPILEPSY,RO-disease_has_primary_anatomic_site
503223386,7/15/2014 16:46:01,,1323696495,7/15/2014 16:45:51,prodege,0.474,2143114,CAN,BC,Vancouver,24.84.160.12,BRAIN causes EPILEPSY,66,103,,70,111,causes,0.7947194142390258,902366-FS1-4,"In the present study, the influence of organic alterations in the BRAIN on the age of manifestation of EPILEPSY was investigated by means of cranial computer tomography (CCT) in 307 children and adolescents.",BRAIN,EPILEPSY,RO-disease_has_primary_anatomic_site
503223386,7/15/2014 16:47:00,,1323697670,7/15/2014 16:46:14,clixsense,0.8809999999999999,6455807,CAN,BC,Victoria,96.54.172.117,no_relation,66,103,,70,111,causes,0.7947194142390258,902366-FS1-4,"In the present study, the influence of organic alterations in the BRAIN on the age of manifestation of EPILEPSY was investigated by means of cranial computer tomography (CCT) in 307 children and adolescents.",BRAIN,EPILEPSY,RO-disease_has_primary_anatomic_site
503223386,7/15/2014 16:50:50,,1323701800,7/15/2014 16:50:33,prodege,0.5758,23541832,USA,AZ,Tempe,149.169.145.144,no_relation,66,103,,70,111,causes,0.7947194142390258,902366-FS1-4,"In the present study, the influence of organic alterations in the BRAIN on the age of manifestation of EPILEPSY was investigated by means of cranial computer tomography (CCT) in 307 children and adolescents.",BRAIN,EPILEPSY,RO-disease_has_primary_anatomic_site
503223407,7/15/2014 10:09:04,,1323476118,7/15/2014 10:08:20,eup_slw,0.9167,20818028,GBR,A7,Birmingham,92.232.139.254,no_relation,0,88,,16,111,is location of,0.9191450300180579,905462-FS1-9,"PERIPHERAL NERVES show spontaneous regenerative responses, but recovery after injury or PERIPHERAL NEUROPATHIES (toxic, diabetic, or chronic inflammatory demyelinating polyneuropathy syndromes) is slow and often incomplete, and at present no efficient treatment is available.",PERIPHERAL NERVES,PERIPHERAL NEUROPATHIES,RO-has_finding_site
503223407,7/15/2014 10:25:31,,1323486233,7/15/2014 10:24:56,rewardsspot,0.8889,24482174,GBR,H9,London,46.23.68.180,PERIPHERAL NERVES is location of PERIPHERAL NEUROPATHIES,0,88,,16,111,is location of,0.9191450300180579,905462-FS1-9,"PERIPHERAL NERVES show spontaneous regenerative responses, but recovery after injury or PERIPHERAL NEUROPATHIES (toxic, diabetic, or chronic inflammatory demyelinating polyneuropathy syndromes) is slow and often incomplete, and at present no efficient treatment is available.",PERIPHERAL NERVES,PERIPHERAL NEUROPATHIES,RO-has_finding_site
503223407,7/15/2014 10:28:25,,1323488195,7/15/2014 10:27:44,vivatic,0.8056,25451531,GBR,,,83.67.28.193,PERIPHERAL NERVES is location of PERIPHERAL NEUROPATHIES,0,88,,16,111,is location of,0.9191450300180579,905462-FS1-9,"PERIPHERAL NERVES show spontaneous regenerative responses, but recovery after injury or PERIPHERAL NEUROPATHIES (toxic, diabetic, or chronic inflammatory demyelinating polyneuropathy syndromes) is slow and often incomplete, and at present no efficient treatment is available.",PERIPHERAL NERVES,PERIPHERAL NEUROPATHIES,RO-has_finding_site
503223407,7/15/2014 11:37:24,,1323533712,7/15/2014 11:36:06,clixsense,0.5726,23233834,GBR,N6,Sunderland,86.17.58.181,PERIPHERAL NERVES is location of PERIPHERAL NEUROPATHIES,0,88,,16,111,is location of,0.9191450300180579,905462-FS1-9,"PERIPHERAL NERVES show spontaneous regenerative responses, but recovery after injury or PERIPHERAL NEUROPATHIES (toxic, diabetic, or chronic inflammatory demyelinating polyneuropathy syndromes) is slow and often incomplete, and at present no efficient treatment is available.",PERIPHERAL NERVES,PERIPHERAL NEUROPATHIES,RO-has_finding_site
503223407,7/15/2014 11:52:04,,1323542592,7/15/2014 11:51:08,instagc,0.4583,21551272,GBR,Q3,Wolverhampton,2.103.57.104,no_relation,0,88,,16,111,is location of,0.9191450300180579,905462-FS1-9,"PERIPHERAL NERVES show spontaneous regenerative responses, but recovery after injury or PERIPHERAL NEUROPATHIES (toxic, diabetic, or chronic inflammatory demyelinating polyneuropathy syndromes) is slow and often incomplete, and at present no efficient treatment is available.",PERIPHERAL NERVES,PERIPHERAL NEUROPATHIES,RO-has_finding_site
503223407,7/15/2014 12:38:52,,1323561348,7/15/2014 12:38:38,instagc,0.7472,18960682,GBR,,,86.29.147.112,PERIPHERAL NERVES is location of PERIPHERAL NEUROPATHIES,0,88,,16,111,is location of,0.9191450300180579,905462-FS1-9,"PERIPHERAL NERVES show spontaneous regenerative responses, but recovery after injury or PERIPHERAL NEUROPATHIES (toxic, diabetic, or chronic inflammatory demyelinating polyneuropathy syndromes) is slow and often incomplete, and at present no efficient treatment is available.",PERIPHERAL NERVES,PERIPHERAL NEUROPATHIES,RO-has_finding_site
503223407,7/15/2014 13:10:04,,1323573540,7/15/2014 13:09:33,neodev,0.4365,28336203,USA,PA,Harrisburg,50.149.53.150,PERIPHERAL NEUROPATHIES is location of PERIPHERAL NERVES,0,88,,16,111,is location of,0.9191450300180579,905462-FS1-9,"PERIPHERAL NERVES show spontaneous regenerative responses, but recovery after injury or PERIPHERAL NEUROPATHIES (toxic, diabetic, or chronic inflammatory demyelinating polyneuropathy syndromes) is slow and often incomplete, and at present no efficient treatment is available.",PERIPHERAL NERVES,PERIPHERAL NEUROPATHIES,RO-has_finding_site
503223450,7/15/2014 10:27:33,,1323487480,7/15/2014 10:26:57,rewardsspot,0.8889,24482174,GBR,H9,London,46.23.68.180,SUPPLEMENTARY FLUORIDE treats CARIES PROPHYLACTIC PURPOSE,176,135,,202,157,treats,0.9950371902099889,907269-FS1-2,The results show that high F groundwater is prevalent and emphasize that information on domestic water supply must be available before SUPPLEMENTARY FLUORIDE is prescribed for CARIES PROPHYLACTIC PURPOSE.,CARIES PROPHYLACTIC PURPOSE,SUPPLEMENTARY FLUORIDE,RO-may_prevent
503223450,7/15/2014 10:55:52,,1323506985,7/15/2014 10:55:30,rewardsspot,0.8542,17763704,USA,VA,Manassas,198.7.62.204,SUPPLEMENTARY FLUORIDE treats CARIES PROPHYLACTIC PURPOSE,176,135,,202,157,treats,0.9950371902099889,907269-FS1-2,The results show that high F groundwater is prevalent and emphasize that information on domestic water supply must be available before SUPPLEMENTARY FLUORIDE is prescribed for CARIES PROPHYLACTIC PURPOSE.,CARIES PROPHYLACTIC PURPOSE,SUPPLEMENTARY FLUORIDE,RO-may_prevent
503223450,7/15/2014 11:22:05,,1323525004,7/15/2014 11:21:46,instagc,0.9417,13763729,USA,,,75.182.89.225,SUPPLEMENTARY FLUORIDE treats CARIES PROPHYLACTIC PURPOSE,176,135,,202,157,treats,0.9950371902099889,907269-FS1-2,The results show that high F groundwater is prevalent and emphasize that information on domestic water supply must be available before SUPPLEMENTARY FLUORIDE is prescribed for CARIES PROPHYLACTIC PURPOSE.,CARIES PROPHYLACTIC PURPOSE,SUPPLEMENTARY FLUORIDE,RO-may_prevent
503223450,7/15/2014 12:40:32,,1323561891,7/15/2014 12:40:21,instagc,0.7417,18960682,GBR,,,86.29.147.112,SUPPLEMENTARY FLUORIDE treats CARIES PROPHYLACTIC PURPOSE,176,135,,202,157,treats,0.9950371902099889,907269-FS1-2,The results show that high F groundwater is prevalent and emphasize that information on domestic water supply must be available before SUPPLEMENTARY FLUORIDE is prescribed for CARIES PROPHYLACTIC PURPOSE.,CARIES PROPHYLACTIC PURPOSE,SUPPLEMENTARY FLUORIDE,RO-may_prevent
503223450,7/15/2014 12:55:55,,1323567998,7/15/2014 12:55:30,elite,0.75,28503042,USA,NJ,Woodbridge,54.191.150.115,SUPPLEMENTARY FLUORIDE treats CARIES PROPHYLACTIC PURPOSE,176,135,,202,157,treats,0.9950371902099889,907269-FS1-2,The results show that high F groundwater is prevalent and emphasize that information on domestic water supply must be available before SUPPLEMENTARY FLUORIDE is prescribed for CARIES PROPHYLACTIC PURPOSE.,CARIES PROPHYLACTIC PURPOSE,SUPPLEMENTARY FLUORIDE,RO-may_prevent
503223450,7/15/2014 14:22:48,,1323596011,7/15/2014 14:22:22,instagc,0.7347,19636746,USA,NY,Andover,192.182.216.225,SUPPLEMENTARY FLUORIDE treats CARIES PROPHYLACTIC PURPOSE,176,135,,202,157,treats,0.9950371902099889,907269-FS1-2,The results show that high F groundwater is prevalent and emphasize that information on domestic water supply must be available before SUPPLEMENTARY FLUORIDE is prescribed for CARIES PROPHYLACTIC PURPOSE.,CARIES PROPHYLACTIC PURPOSE,SUPPLEMENTARY FLUORIDE,RO-may_prevent
503223450,7/15/2014 15:57:18,,1323646877,7/15/2014 15:56:51,instagc,0.628,25901556,GBR,C3,Saint Ives,82.9.129.2,SUPPLEMENTARY FLUORIDE treats CARIES PROPHYLACTIC PURPOSE,176,135,,202,157,treats,0.9950371902099889,907269-FS1-2,The results show that high F groundwater is prevalent and emphasize that information on domestic water supply must be available before SUPPLEMENTARY FLUORIDE is prescribed for CARIES PROPHYLACTIC PURPOSE.,CARIES PROPHYLACTIC PURPOSE,SUPPLEMENTARY FLUORIDE,RO-may_prevent
503223452,7/15/2014 11:12:19,,1323518998,7/15/2014 11:11:54,instagc,0.7778,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,3,35,,8,49,causes,0.34412360080584303,907148-FS1-4,"No CARIES protective effect of the FETAL FLUORIDE however, has been substantiated by pertinent research.",CARIES,FETAL FLUORIDE,RO-may_prevent
503223452,7/15/2014 11:21:46,,1323524860,7/15/2014 11:21:23,instagc,0.9417,13763729,USA,,,75.182.89.225,no_relation,3,35,,8,49,causes,0.34412360080584303,907148-FS1-4,"No CARIES protective effect of the FETAL FLUORIDE however, has been substantiated by pertinent research.",CARIES,FETAL FLUORIDE,RO-may_prevent
503223452,7/15/2014 14:23:15,,1323596115,7/15/2014 14:22:51,instagc,0.7347,19636746,USA,NY,Andover,192.182.216.225,no_relation,3,35,,8,49,causes,0.34412360080584303,907148-FS1-4,"No CARIES protective effect of the FETAL FLUORIDE however, has been substantiated by pertinent research.",CARIES,FETAL FLUORIDE,RO-may_prevent
503223452,7/15/2014 14:34:03,,1323599519,7/15/2014 14:33:58,neodev,0.5833,25224036,CAN,ON,Sudbury,67.204.218.187,CARIES causes FETAL FLUORIDE,3,35,,8,49,causes,0.34412360080584303,907148-FS1-4,"No CARIES protective effect of the FETAL FLUORIDE however, has been substantiated by pertinent research.",CARIES,FETAL FLUORIDE,RO-may_prevent
503223452,7/15/2014 16:24:54,,1323671153,7/15/2014 16:24:37,clixsense,0.6252,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,3,35,,8,49,causes,0.34412360080584303,907148-FS1-4,"No CARIES protective effect of the FETAL FLUORIDE however, has been substantiated by pertinent research.",CARIES,FETAL FLUORIDE,RO-may_prevent
503223452,7/15/2014 17:10:50,,1323722046,7/15/2014 17:10:08,clixsense,0.5345,6574199,USA,TX,San Antonio,207.230.144.242,no_relation,3,35,,8,49,causes,0.34412360080584303,907148-FS1-4,"No CARIES protective effect of the FETAL FLUORIDE however, has been substantiated by pertinent research.",CARIES,FETAL FLUORIDE,RO-may_prevent
503223452,7/15/2014 20:34:35,,1323828308,7/15/2014 20:33:56,prodege,0.5694,28255346,GBR,L9,Sheffield,2.125.183.137,no_relation,3,35,,8,49,causes,0.34412360080584303,907148-FS1-4,"No CARIES protective effect of the FETAL FLUORIDE however, has been substantiated by pertinent research.",CARIES,FETAL FLUORIDE,RO-may_prevent
503223459,7/15/2014 10:31:20,,1323490092,7/15/2014 10:31:01,clixsense,0.9722,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,170,217,,192,240,causes,0.703526470681448,907152-FS1-4,The principal differences between these vaccines are the transmission of live vaccine viruses from recipieits to their contacts and the occurrence of occasional cases of PARALYTIC POLIOMYELITIS associated with use of LIVE POLIOVIRUS VACCINE,PARALYTIC POLIOMYELITIS,LIVE POLIOVIRUS VACCINE,RO-may_prevent
503223459,7/15/2014 11:23:00,,1323525538,7/15/2014 11:22:34,instagc,0.9417,13763729,USA,,,75.182.89.225,LIVE POLIOVIRUS VACCINE causes PARALYTIC POLIOMYELITIS,170,217,,192,240,causes,0.703526470681448,907152-FS1-4,The principal differences between these vaccines are the transmission of live vaccine viruses from recipieits to their contacts and the occurrence of occasional cases of PARALYTIC POLIOMYELITIS associated with use of LIVE POLIOVIRUS VACCINE,PARALYTIC POLIOMYELITIS,LIVE POLIOVIRUS VACCINE,RO-may_prevent
503223459,7/15/2014 11:27:25,,1323528006,7/15/2014 11:27:07,prodege,0.6917,15439740,AUS,02,Jannali,27.96.208.89,no_relation,170,217,,192,240,causes,0.703526470681448,907152-FS1-4,The principal differences between these vaccines are the transmission of live vaccine viruses from recipieits to their contacts and the occurrence of occasional cases of PARALYTIC POLIOMYELITIS associated with use of LIVE POLIOVIRUS VACCINE,PARALYTIC POLIOMYELITIS,LIVE POLIOVIRUS VACCINE,RO-may_prevent
503223459,7/15/2014 12:41:41,,1323562285,7/15/2014 12:41:17,instagc,0.7417,18960682,GBR,,,86.29.147.112,LIVE POLIOVIRUS VACCINE causes PARALYTIC POLIOMYELITIS,170,217,,192,240,causes,0.703526470681448,907152-FS1-4,The principal differences between these vaccines are the transmission of live vaccine viruses from recipieits to their contacts and the occurrence of occasional cases of PARALYTIC POLIOMYELITIS associated with use of LIVE POLIOVIRUS VACCINE,PARALYTIC POLIOMYELITIS,LIVE POLIOVIRUS VACCINE,RO-may_prevent
503223459,7/15/2014 15:32:24,,1323628139,7/15/2014 15:32:07,tremorgames,0.8357,24449707,CAN,QC,Laval,96.21.249.72,LIVE POLIOVIRUS VACCINE causes PARALYTIC POLIOMYELITIS,170,217,,192,240,causes,0.703526470681448,907152-FS1-4,The principal differences between these vaccines are the transmission of live vaccine viruses from recipieits to their contacts and the occurrence of occasional cases of PARALYTIC POLIOMYELITIS associated with use of LIVE POLIOVIRUS VACCINE,PARALYTIC POLIOMYELITIS,LIVE POLIOVIRUS VACCINE,RO-may_prevent
503223459,7/15/2014 16:24:36,,1323670861,7/15/2014 16:24:26,clixsense,0.6252,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,170,217,,192,240,causes,0.703526470681448,907152-FS1-4,The principal differences between these vaccines are the transmission of live vaccine viruses from recipieits to their contacts and the occurrence of occasional cases of PARALYTIC POLIOMYELITIS associated with use of LIVE POLIOVIRUS VACCINE,PARALYTIC POLIOMYELITIS,LIVE POLIOVIRUS VACCINE,RO-may_prevent
503223459,7/15/2014 18:46:21,,1323780236,7/15/2014 18:45:34,clixsense,0.7143,6355977,NLD,07,Amsterdam,46.129.42.165,LIVE POLIOVIRUS VACCINE causes PARALYTIC POLIOMYELITIS,170,217,,192,240,causes,0.703526470681448,907152-FS1-4,The principal differences between these vaccines are the transmission of live vaccine viruses from recipieits to their contacts and the occurrence of occasional cases of PARALYTIC POLIOMYELITIS associated with use of LIVE POLIOVIRUS VACCINE,PARALYTIC POLIOMYELITIS,LIVE POLIOVIRUS VACCINE,RO-may_prevent
503223464,7/15/2014 10:11:10,,1323477154,7/15/2014 10:10:41,eup_slw,0.9583,20818028,GBR,A7,Birmingham,92.232.139.254,CITRATE treats RENAL STONE DISEASE,190,118,,208,125,treats,0.9722718241315029,907076-FS1-2,"Urinary citrate is an important determinant for crystallization of calcium salts, and recently oral administration of CITRATE has been suggested to be clinically useful in the management of RENAL STONE DISEASE.",RENAL STONE DISEASE,CITRATE,RO-may_prevent
503223464,7/15/2014 10:30:12,,1323489260,7/15/2014 10:30:04,clixsense,0.9583,19162475,GBR,M3,Frome,82.33.126.30,CITRATE treats RENAL STONE DISEASE,190,118,,208,125,treats,0.9722718241315029,907076-FS1-2,"Urinary citrate is an important determinant for crystallization of calcium salts, and recently oral administration of CITRATE has been suggested to be clinically useful in the management of RENAL STONE DISEASE.",RENAL STONE DISEASE,CITRATE,RO-may_prevent
503223464,7/15/2014 11:28:25,,1323528630,7/15/2014 11:28:02,prodege,0.6917,15439740,AUS,02,Jannali,27.96.208.89,CITRATE treats RENAL STONE DISEASE,190,118,,208,125,treats,0.9722718241315029,907076-FS1-2,"Urinary citrate is an important determinant for crystallization of calcium salts, and recently oral administration of CITRATE has been suggested to be clinically useful in the management of RENAL STONE DISEASE.",RENAL STONE DISEASE,CITRATE,RO-may_prevent
503223464,7/15/2014 11:52:44,,1323543131,7/15/2014 11:52:18,neodev,0.6528,21515166,NLD,11,Nootdorp,83.86.58.179,CITRATE treats RENAL STONE DISEASE,190,118,,208,125,treats,0.9722718241315029,907076-FS1-2,"Urinary citrate is an important determinant for crystallization of calcium salts, and recently oral administration of CITRATE has been suggested to be clinically useful in the management of RENAL STONE DISEASE.",RENAL STONE DISEASE,CITRATE,RO-may_prevent
503223464,7/15/2014 12:16:46,,1323552955,7/15/2014 12:16:14,paiddailysurveys,0.6292,11786001,USA,NC,Charlotte,71.28.89.238,CITRATE treats RENAL STONE DISEASE,190,118,,208,125,treats,0.9722718241315029,907076-FS1-2,"Urinary citrate is an important determinant for crystallization of calcium salts, and recently oral administration of CITRATE has been suggested to be clinically useful in the management of RENAL STONE DISEASE.",RENAL STONE DISEASE,CITRATE,RO-may_prevent
503223464,7/15/2014 17:16:03,,1323725235,7/15/2014 17:15:38,instagc,0.531,28519532,USA,IA,Honey Creek,12.73.110.41,CITRATE treats RENAL STONE DISEASE,190,118,,208,125,treats,0.9722718241315029,907076-FS1-2,"Urinary citrate is an important determinant for crystallization of calcium salts, and recently oral administration of CITRATE has been suggested to be clinically useful in the management of RENAL STONE DISEASE.",RENAL STONE DISEASE,CITRATE,RO-may_prevent
503223464,7/15/2014 19:37:04,,1323805547,7/15/2014 19:36:47,gifthulk,0.6774,21916793,GBR,,,87.113.87.199,CITRATE treats RENAL STONE DISEASE,190,118,,208,125,treats,0.9722718241315029,907076-FS1-2,"Urinary citrate is an important determinant for crystallization of calcium salts, and recently oral administration of CITRATE has been suggested to be clinically useful in the management of RENAL STONE DISEASE.",RENAL STONE DISEASE,CITRATE,RO-may_prevent
503223465,7/15/2014 10:10:39,,1323476918,7/15/2014 10:10:16,eup_slw,0.9583,20818028,GBR,A7,Birmingham,92.232.139.254,PHAEOCHROMOCYTOMA causes FEVER,0,25,,4,42,causes,0.913811548620257,902821-FS1-4,FEVER was secondary to a PHAEOCHROMOCYTOMA in one patient and sepsis in the other.,FEVER,PHAEOCHROMOCYTOMA,RO-disease_may_have_finding
503223465,7/15/2014 11:23:38,,1323525869,7/15/2014 11:23:26,instagc,0.9417,13763729,USA,,,75.182.89.225,PHAEOCHROMOCYTOMA causes FEVER,0,25,,4,42,causes,0.913811548620257,902821-FS1-4,FEVER was secondary to a PHAEOCHROMOCYTOMA in one patient and sepsis in the other.,FEVER,PHAEOCHROMOCYTOMA,RO-disease_may_have_finding
503223465,7/15/2014 14:33:28,,1323599324,7/15/2014 14:33:21,neodev,0.5833,25224036,CAN,ON,Sudbury,67.204.218.187,FEVER causes PHAEOCHROMOCYTOMA,0,25,,4,42,causes,0.913811548620257,902821-FS1-4,FEVER was secondary to a PHAEOCHROMOCYTOMA in one patient and sepsis in the other.,FEVER,PHAEOCHROMOCYTOMA,RO-disease_may_have_finding
503223465,7/15/2014 15:24:48,,1323622776,7/15/2014 15:24:32,prodege,0.7167,7899370,USA,MI,Bay City,71.13.81.162,no_relation,0,25,,4,42,causes,0.913811548620257,902821-FS1-4,FEVER was secondary to a PHAEOCHROMOCYTOMA in one patient and sepsis in the other.,FEVER,PHAEOCHROMOCYTOMA,RO-disease_may_have_finding
503223465,7/15/2014 15:56:50,,1323646493,7/15/2014 15:56:25,instagc,0.628,25901556,GBR,C3,Saint Ives,82.9.129.2,PHAEOCHROMOCYTOMA causes FEVER,0,25,,4,42,causes,0.913811548620257,902821-FS1-4,FEVER was secondary to a PHAEOCHROMOCYTOMA in one patient and sepsis in the other.,FEVER,PHAEOCHROMOCYTOMA,RO-disease_may_have_finding
503223465,7/15/2014 18:48:22,,1323781293,7/15/2014 18:47:49,clixsense,0.7143,6355977,NLD,07,Amsterdam,46.129.42.165,PHAEOCHROMOCYTOMA causes FEVER,0,25,,4,42,causes,0.913811548620257,902821-FS1-4,FEVER was secondary to a PHAEOCHROMOCYTOMA in one patient and sepsis in the other.,FEVER,PHAEOCHROMOCYTOMA,RO-disease_may_have_finding
503223465,7/15/2014 19:06:36,,1323791226,7/15/2014 19:05:56,prodege,0.5528,17932518,GBR,L5,Salford,95.151.167.238,PHAEOCHROMOCYTOMA causes FEVER,0,25,,4,42,causes,0.913811548620257,902821-FS1-4,FEVER was secondary to a PHAEOCHROMOCYTOMA in one patient and sepsis in the other.,FEVER,PHAEOCHROMOCYTOMA,RO-disease_may_have_finding
503223468,7/15/2014 10:33:58,,1323491769,7/15/2014 10:33:20,vivatic,0.7917,25451531,GBR,,,83.67.28.193,no_relation,44,24,,73,39,is location of,0.42426406871192895,901939-FS1-9,In the case of multiple BONE METASTASES the METASTATIC LESION OF THE SKULL was clearly demonstrated by Tl 201 but not by Ga 67.,METASTATIC LESION OF THE SKULL,BONE METASTASES,RO-disease_has_finding
503223468,7/15/2014 13:14:16,,1323574916,7/15/2014 13:13:26,prodege,0.6865,21891314,AUS,07,Glen Iris,58.6.248.249,BONE METASTASES is location of METASTATIC LESION OF THE SKULL,44,24,,73,39,is location of,0.42426406871192895,901939-FS1-9,In the case of multiple BONE METASTASES the METASTATIC LESION OF THE SKULL was clearly demonstrated by Tl 201 but not by Ga 67.,METASTATIC LESION OF THE SKULL,BONE METASTASES,RO-disease_has_finding
503223468,7/15/2014 14:24:56,,1323596633,7/15/2014 14:24:11,instagc,0.7347,19636746,USA,NY,Andover,192.182.216.225,METASTATIC LESION OF THE SKULL is location of BONE METASTASES,44,24,,73,39,is location of,0.42426406871192895,901939-FS1-9,In the case of multiple BONE METASTASES the METASTATIC LESION OF THE SKULL was clearly demonstrated by Tl 201 but not by Ga 67.,METASTATIC LESION OF THE SKULL,BONE METASTASES,RO-disease_has_finding
503223468,7/15/2014 16:57:41,,1323709363,7/15/2014 16:57:23,prodege,0.544,9525153,CAN,ON,Toronto,65.95.187.40,BONE METASTASES is location of METASTATIC LESION OF THE SKULL,44,24,,73,39,is location of,0.42426406871192895,901939-FS1-9,In the case of multiple BONE METASTASES the METASTATIC LESION OF THE SKULL was clearly demonstrated by Tl 201 but not by Ga 67.,METASTATIC LESION OF THE SKULL,BONE METASTASES,RO-disease_has_finding
503223468,7/15/2014 18:51:05,,1323782741,7/15/2014 18:51:02,instagc,0.578,25990856,USA,NV,Las Vegas,68.108.98.78,METASTATIC LESION OF THE SKULL is location of BONE METASTASES,44,24,,73,39,is location of,0.42426406871192895,901939-FS1-9,In the case of multiple BONE METASTASES the METASTATIC LESION OF THE SKULL was clearly demonstrated by Tl 201 but not by Ga 67.,METASTATIC LESION OF THE SKULL,BONE METASTASES,RO-disease_has_finding
503223468,7/15/2014 18:54:38,,1323784681,7/15/2014 18:54:34,prodege,0.4899,12944140,GBR,C8,Thornton Heath,92.21.6.167,METASTATIC LESION OF THE SKULL is location of BONE METASTASES,44,24,,73,39,is location of,0.42426406871192895,901939-FS1-9,In the case of multiple BONE METASTASES the METASTATIC LESION OF THE SKULL was clearly demonstrated by Tl 201 but not by Ga 67.,METASTATIC LESION OF THE SKULL,BONE METASTASES,RO-disease_has_finding
503223468,7/15/2014 19:12:37,,1323794450,7/15/2014 19:11:51,prodege,0.5528,17932518,GBR,L5,Salford,95.151.167.238,BONE METASTASES is location of METASTATIC LESION OF THE SKULL,44,24,,73,39,is location of,0.42426406871192895,901939-FS1-9,In the case of multiple BONE METASTASES the METASTATIC LESION OF THE SKULL was clearly demonstrated by Tl 201 but not by Ga 67.,METASTATIC LESION OF THE SKULL,BONE METASTASES,RO-disease_has_finding
503223471,7/15/2014 13:34:49,,1323581929,7/15/2014 13:34:27,instagc,0.6153,23149109,USA,NC,Cary,24.206.38.18,FALLOPIAN TUBES is location of FALLOPIAN TUBE INFECTION,64,14,,78,38,is location of,0.975900072948533,905312-FS1-9,The parasitic FALLOPIAN TUBE INFECTION may have predisposed the FALLOPIAN TUBES to a microbial tuboovarian abscess.,FALLOPIAN TUBES,FALLOPIAN TUBE INFECTION,RO-has_finding_site
503223471,7/15/2014 14:33:28,,1323599323,7/15/2014 14:33:21,neodev,0.5833,25224036,CAN,ON,Sudbury,67.204.218.187,FALLOPIAN TUBE INFECTION is location of FALLOPIAN TUBES,64,14,,78,38,is location of,0.975900072948533,905312-FS1-9,The parasitic FALLOPIAN TUBE INFECTION may have predisposed the FALLOPIAN TUBES to a microbial tuboovarian abscess.,FALLOPIAN TUBES,FALLOPIAN TUBE INFECTION,RO-has_finding_site
503223471,7/15/2014 15:48:52,,1323640414,7/15/2014 15:48:31,elite,0.4948,28276268,USA,MI,Taylor,67.149.247.166,FALLOPIAN TUBE INFECTION is location of FALLOPIAN TUBES,64,14,,78,38,is location of,0.975900072948533,905312-FS1-9,The parasitic FALLOPIAN TUBE INFECTION may have predisposed the FALLOPIAN TUBES to a microbial tuboovarian abscess.,FALLOPIAN TUBES,FALLOPIAN TUBE INFECTION,RO-has_finding_site
503223471,7/15/2014 15:54:49,,1323644966,7/15/2014 15:54:33,neodev,0.4345,14861092,GBR,I2,Manchester,90.194.137.76,FALLOPIAN TUBES is location of FALLOPIAN TUBE INFECTION,64,14,,78,38,is location of,0.975900072948533,905312-FS1-9,The parasitic FALLOPIAN TUBE INFECTION may have predisposed the FALLOPIAN TUBES to a microbial tuboovarian abscess.,FALLOPIAN TUBES,FALLOPIAN TUBE INFECTION,RO-has_finding_site
503223471,7/15/2014 18:54:57,,1323784835,7/15/2014 18:54:53,prodege,0.4899,12944140,GBR,C8,Thornton Heath,92.21.6.167,no_relation,64,14,,78,38,is location of,0.975900072948533,905312-FS1-9,The parasitic FALLOPIAN TUBE INFECTION may have predisposed the FALLOPIAN TUBES to a microbial tuboovarian abscess.,FALLOPIAN TUBES,FALLOPIAN TUBE INFECTION,RO-has_finding_site
503223471,7/15/2014 19:34:09,,1323804294,7/15/2014 19:33:56,gifthulk,0.6774,21916793,GBR,,,87.113.87.199,FALLOPIAN TUBES is location of FALLOPIAN TUBE INFECTION,64,14,,78,38,is location of,0.975900072948533,905312-FS1-9,The parasitic FALLOPIAN TUBE INFECTION may have predisposed the FALLOPIAN TUBES to a microbial tuboovarian abscess.,FALLOPIAN TUBES,FALLOPIAN TUBE INFECTION,RO-has_finding_site
503223471,7/15/2014 20:37:46,,1323829576,7/15/2014 20:37:15,prodege,0.5694,28255346,GBR,L9,Sheffield,2.125.183.137,FALLOPIAN TUBES is location of FALLOPIAN TUBE INFECTION,64,14,,78,38,is location of,0.975900072948533,905312-FS1-9,The parasitic FALLOPIAN TUBE INFECTION may have predisposed the FALLOPIAN TUBES to a microbial tuboovarian abscess.,FALLOPIAN TUBES,FALLOPIAN TUBE INFECTION,RO-has_finding_site
503223473,7/15/2014 18:50:40,,1323782533,7/15/2014 18:50:32,instagc,0.578,25990856,USA,NV,Las Vegas,68.108.98.78,PRIMARY MELANOMA is location of CUTANEOUS MELANOMA,38,135,,53,153,is location of,0.328797974610715,906492-FS1-9,Depending on the Breslow depth of the PRIMARY MELANOMA sentinel lymph node biopsy is considered as standard of care for the staging of CUTANEOUS MELANOMA and is one of the most important prognostic factors.,PRIMARY MELANOMA,CUTANEOUS MELANOMA,RO-has_manifestation
503223473,7/15/2014 19:53:33,,1323811606,7/15/2014 19:52:47,clixsense,0.4819,6714657,USA,CT,Groton,71.235.184.32,no_relation,38,135,,53,153,is location of,0.328797974610715,906492-FS1-9,Depending on the Breslow depth of the PRIMARY MELANOMA sentinel lymph node biopsy is considered as standard of care for the staging of CUTANEOUS MELANOMA and is one of the most important prognostic factors.,PRIMARY MELANOMA,CUTANEOUS MELANOMA,RO-has_manifestation
503223473,7/15/2014 22:40:02,,1323881071,7/15/2014 22:39:46,instagc,0.4595,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,38,135,,53,153,is location of,0.328797974610715,906492-FS1-9,Depending on the Breslow depth of the PRIMARY MELANOMA sentinel lymph node biopsy is considered as standard of care for the staging of CUTANEOUS MELANOMA and is one of the most important prognostic factors.,PRIMARY MELANOMA,CUTANEOUS MELANOMA,RO-has_manifestation
503223473,7/16/2014 02:17:48,,1323996238,7/16/2014 02:17:26,neodev,0.523,22098386,USA,NY,Greenwich,67.248.253.125,CUTANEOUS MELANOMA is location of PRIMARY MELANOMA,38,135,,53,153,is location of,0.328797974610715,906492-FS1-9,Depending on the Breslow depth of the PRIMARY MELANOMA sentinel lymph node biopsy is considered as standard of care for the staging of CUTANEOUS MELANOMA and is one of the most important prognostic factors.,PRIMARY MELANOMA,CUTANEOUS MELANOMA,RO-has_manifestation
503223473,7/16/2014 02:36:34,,1324003453,7/16/2014 02:36:07,zoombucks,0.6939,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,38,135,,53,153,is location of,0.328797974610715,906492-FS1-9,Depending on the Breslow depth of the PRIMARY MELANOMA sentinel lymph node biopsy is considered as standard of care for the staging of CUTANEOUS MELANOMA and is one of the most important prognostic factors.,PRIMARY MELANOMA,CUTANEOUS MELANOMA,RO-has_manifestation
503223473,7/16/2014 03:59:13,,1324034325,7/16/2014 03:58:38,clixsense,0.381,6330991,USA,NJ,Belvidere,69.141.104.97,no_relation,38,135,,53,153,is location of,0.328797974610715,906492-FS1-9,Depending on the Breslow depth of the PRIMARY MELANOMA sentinel lymph node biopsy is considered as standard of care for the staging of CUTANEOUS MELANOMA and is one of the most important prognostic factors.,PRIMARY MELANOMA,CUTANEOUS MELANOMA,RO-has_manifestation
503223473,7/16/2014 05:00:18,,1324057714,7/16/2014 04:59:41,instagc,0.5714,27770607,USA,TX,El Paso,72.183.248.75,no_relation,38,135,,53,153,is location of,0.328797974610715,906492-FS1-9,Depending on the Breslow depth of the PRIMARY MELANOMA sentinel lymph node biopsy is considered as standard of care for the staging of CUTANEOUS MELANOMA and is one of the most important prognostic factors.,PRIMARY MELANOMA,CUTANEOUS MELANOMA,RO-has_manifestation
503223477,7/15/2014 10:31:00,,1323489828,7/15/2014 10:30:32,clixsense,0.9722,19803139,NLD,06,Veldhoven,212.61.84.196,THE BASAL JOINT OF THE THUMB is location of ARTHRITIS,82,69,,109,78,is location of,0.985329278164293,902328-FS1-9,The senior author has performed the Swanson implant arthroplasty for ARTHRITIS of THE BASAL JOINT OF THE THUMB for the past 12 years.,THE BASAL JOINT OF THE THUMB,ARTHRITIS,RO-disease_has_primary_anatomic_site
503223477,7/15/2014 11:01:17,,1323510229,7/15/2014 11:00:49,rewardsspot,0.8542,17763704,USA,VA,Manassas,198.7.62.204,THE BASAL JOINT OF THE THUMB is location of ARTHRITIS,82,69,,109,78,is location of,0.985329278164293,902328-FS1-9,The senior author has performed the Swanson implant arthroplasty for ARTHRITIS of THE BASAL JOINT OF THE THUMB for the past 12 years.,THE BASAL JOINT OF THE THUMB,ARTHRITIS,RO-disease_has_primary_anatomic_site
503223477,7/15/2014 11:28:00,,1323528314,7/15/2014 11:27:41,prodege,0.6917,15439740,AUS,02,Jannali,27.96.208.89,THE BASAL JOINT OF THE THUMB is location of ARTHRITIS,82,69,,109,78,is location of,0.985329278164293,902328-FS1-9,The senior author has performed the Swanson implant arthroplasty for ARTHRITIS of THE BASAL JOINT OF THE THUMB for the past 12 years.,THE BASAL JOINT OF THE THUMB,ARTHRITIS,RO-disease_has_primary_anatomic_site
503223477,7/15/2014 11:33:53,,1323531732,7/15/2014 11:33:29,prodege,0.6514,28039757,GBR,L8,Southport,109.155.158.54,ARTHRITIS is location of THE BASAL JOINT OF THE THUMB,82,69,,109,78,is location of,0.985329278164293,902328-FS1-9,The senior author has performed the Swanson implant arthroplasty for ARTHRITIS of THE BASAL JOINT OF THE THUMB for the past 12 years.,THE BASAL JOINT OF THE THUMB,ARTHRITIS,RO-disease_has_primary_anatomic_site
503223477,7/15/2014 11:34:46,,1323532258,7/15/2014 11:34:12,clixsense,0.8514,8888883,USA,FL,Orlando,76.26.232.146,THE BASAL JOINT OF THE THUMB is location of ARTHRITIS,82,69,,109,78,is location of,0.985329278164293,902328-FS1-9,The senior author has performed the Swanson implant arthroplasty for ARTHRITIS of THE BASAL JOINT OF THE THUMB for the past 12 years.,THE BASAL JOINT OF THE THUMB,ARTHRITIS,RO-disease_has_primary_anatomic_site
503223477,7/15/2014 12:41:15,,1323562163,7/15/2014 12:40:55,instagc,0.7417,18960682,GBR,,,86.29.147.112,THE BASAL JOINT OF THE THUMB is location of ARTHRITIS,82,69,,109,78,is location of,0.985329278164293,902328-FS1-9,The senior author has performed the Swanson implant arthroplasty for ARTHRITIS of THE BASAL JOINT OF THE THUMB for the past 12 years.,THE BASAL JOINT OF THE THUMB,ARTHRITIS,RO-disease_has_primary_anatomic_site
503223477,7/15/2014 15:19:45,,1323619367,7/15/2014 15:19:16,prodege,0.7067,27934334,GBR,B9,High Wycombe,86.166.72.139,THE BASAL JOINT OF THE THUMB is location of ARTHRITIS,82,69,,109,78,is location of,0.985329278164293,902328-FS1-9,The senior author has performed the Swanson implant arthroplasty for ARTHRITIS of THE BASAL JOINT OF THE THUMB for the past 12 years.,THE BASAL JOINT OF THE THUMB,ARTHRITIS,RO-disease_has_primary_anatomic_site
503223479,7/15/2014 10:57:31,,1323507901,7/15/2014 10:56:50,rewardsspot,0.8542,17763704,USA,VA,Manassas,198.7.62.204,DEXTROSE treats HYPOGLYCEMIA,67,25,,78,33,treats,0.625,907545-FS1-2,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223479,7/15/2014 15:24:31,,1323622565,7/15/2014 15:24:15,prodege,0.7167,7899370,USA,MI,Bay City,71.13.81.162,DEXTROSE treats HYPOGLYCEMIA,67,25,,78,33,treats,0.625,907545-FS1-2,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223479,7/15/2014 15:32:52,,1323628519,7/15/2014 15:32:42,tremorgames,0.8357,24449707,CAN,QC,Laval,96.21.249.72,DEXTROSE treats HYPOGLYCEMIA,67,25,,78,33,treats,0.625,907545-FS1-2,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223479,7/15/2014 15:48:30,,1323640127,7/15/2014 15:48:03,elite,0.4948,28276268,USA,MI,Taylor,67.149.247.166,DEXTROSE treats HYPOGLYCEMIA,67,25,,78,33,treats,0.625,907545-FS1-2,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223479,7/15/2014 15:53:39,,1323644027,7/15/2014 15:53:22,neodev,0.4345,14861092,GBR,I2,Manchester,90.194.137.76,no_relation,67,25,,78,33,treats,0.625,907545-FS1-2,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223479,7/15/2014 17:09:13,,1323720854,7/15/2014 17:08:33,clixsense,0.5345,6574199,USA,TX,San Antonio,207.230.144.242,no_relation,67,25,,78,33,treats,0.625,907545-FS1-2,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223479,7/15/2014 18:54:32,,1323784625,7/15/2014 18:54:16,prodege,0.4899,12944140,GBR,C8,Thornton Heath,92.21.6.167,DEXTROSE treats HYPOGLYCEMIA,67,25,,78,33,treats,0.625,907545-FS1-2,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223485,7/15/2014 10:10:32,,1323476844,7/15/2014 10:10:13,clixsense,0.9583,15189335,GBR,E4,Colchester,5.67.141.89,PHEOCHROMOCYTOMA diagnosed by HYPERTENSION,64,131,,75,147,diagnosed by,0.6741998624632421,902674-FS1-13,C]  4.1 Consider consulting an endocrinologist or specialist in HYPERTENSION to assist in confirming or excluding the diagnosis of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503223485,7/15/2014 11:35:41,,1323532763,7/15/2014 11:35:17,clixsense,0.8514,8888883,USA,FL,Orlando,76.26.232.146,HYPERTENSION diagnosed by PHEOCHROMOCYTOMA,64,131,,75,147,diagnosed by,0.6741998624632421,902674-FS1-13,C]  4.1 Consider consulting an endocrinologist or specialist in HYPERTENSION to assist in confirming or excluding the diagnosis of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503223485,7/15/2014 12:16:13,,1323552767,7/15/2014 12:15:28,paiddailysurveys,0.6292,11786001,USA,NC,Charlotte,71.28.89.238,HYPERTENSION diagnosed by PHEOCHROMOCYTOMA,64,131,,75,147,diagnosed by,0.6741998624632421,902674-FS1-13,C]  4.1 Consider consulting an endocrinologist or specialist in HYPERTENSION to assist in confirming or excluding the diagnosis of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503223485,7/15/2014 13:15:51,,1323575486,7/15/2014 13:15:10,prodege,0.6865,21891314,AUS,07,Glen Iris,58.6.248.249,PHEOCHROMOCYTOMA diagnosed by HYPERTENSION,64,131,,75,147,diagnosed by,0.6741998624632421,902674-FS1-13,C]  4.1 Consider consulting an endocrinologist or specialist in HYPERTENSION to assist in confirming or excluding the diagnosis of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503223485,7/15/2014 13:56:04,,1323588496,7/15/2014 13:55:43,neodev,0.4998,18339121,USA,SC,Sumter,173.93.188.194,PHEOCHROMOCYTOMA diagnosed by HYPERTENSION,64,131,,75,147,diagnosed by,0.6741998624632421,902674-FS1-13,C]  4.1 Consider consulting an endocrinologist or specialist in HYPERTENSION to assist in confirming or excluding the diagnosis of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503223485,7/15/2014 16:52:15,,1323703330,7/15/2014 16:51:45,clixsense,0.6852,6455807,CAN,BC,Victoria,96.54.172.117,PHEOCHROMOCYTOMA diagnosed by HYPERTENSION,64,131,,75,147,diagnosed by,0.6741998624632421,902674-FS1-13,C]  4.1 Consider consulting an endocrinologist or specialist in HYPERTENSION to assist in confirming or excluding the diagnosis of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503223485,7/15/2014 18:47:47,,1323780941,7/15/2014 18:46:55,clixsense,0.7143,6355977,NLD,07,Amsterdam,46.129.42.165,PHEOCHROMOCYTOMA diagnosed by HYPERTENSION,64,131,,75,147,diagnosed by,0.6741998624632421,902674-FS1-13,C]  4.1 Consider consulting an endocrinologist or specialist in HYPERTENSION to assist in confirming or excluding the diagnosis of PHEOCHROMOCYTOMA,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
503223488,7/15/2014 16:49:58,,1323700860,7/15/2014 16:49:25,clixsense,0.6852,6455807,CAN,BC,Victoria,96.54.172.117,SPINE is location of SCOLIOSIS,65,88,,69,97,is location of,0.848874687627165,905141-FS1-9,"Hence, when analysing the biomechanics of the growing adolescent SPINE (for instance in SCOLIOSIS research), the inclusion of depth and width changes, in addition to the usually implemented height change, is essential.",SPINE,SCOLIOSIS,RO-has_finding_site
503223488,7/15/2014 17:00:57,,1323713201,7/15/2014 17:00:45,neodev,0.7097,18755947,GBR,H2,Accrington,80.47.185.52,SPINE is location of SCOLIOSIS,65,88,,69,97,is location of,0.848874687627165,905141-FS1-9,"Hence, when analysing the biomechanics of the growing adolescent SPINE (for instance in SCOLIOSIS research), the inclusion of depth and width changes, in addition to the usually implemented height change, is essential.",SPINE,SCOLIOSIS,RO-has_finding_site
503223488,7/15/2014 19:41:42,,1323807566,7/15/2014 19:41:19,clixsense,0.6984,24429778,AUS,,,121.211.19.218,SPINE is location of SCOLIOSIS,65,88,,69,97,is location of,0.848874687627165,905141-FS1-9,"Hence, when analysing the biomechanics of the growing adolescent SPINE (for instance in SCOLIOSIS research), the inclusion of depth and width changes, in addition to the usually implemented height change, is essential.",SPINE,SCOLIOSIS,RO-has_finding_site
503223488,7/15/2014 19:52:47,,1323811335,7/15/2014 19:52:04,clixsense,0.4819,6714657,USA,CT,Groton,71.235.184.32,no_relation,65,88,,69,97,is location of,0.848874687627165,905141-FS1-9,"Hence, when analysing the biomechanics of the growing adolescent SPINE (for instance in SCOLIOSIS research), the inclusion of depth and width changes, in addition to the usually implemented height change, is essential.",SPINE,SCOLIOSIS,RO-has_finding_site
503223488,7/16/2014 01:09:25,,1323962342,7/16/2014 01:09:04,bitcoinget,0.6825,28377798,GBR,,,195.166.117.126,SPINE is location of SCOLIOSIS,65,88,,69,97,is location of,0.848874687627165,905141-FS1-9,"Hence, when analysing the biomechanics of the growing adolescent SPINE (for instance in SCOLIOSIS research), the inclusion of depth and width changes, in addition to the usually implemented height change, is essential.",SPINE,SCOLIOSIS,RO-has_finding_site
503223488,7/16/2014 01:44:06,,1323979743,7/16/2014 01:43:46,clixsense,0.7798,19638651,USA,,,173.23.121.63,SPINE is location of SCOLIOSIS,65,88,,69,97,is location of,0.848874687627165,905141-FS1-9,"Hence, when analysing the biomechanics of the growing adolescent SPINE (for instance in SCOLIOSIS research), the inclusion of depth and width changes, in addition to the usually implemented height change, is essential.",SPINE,SCOLIOSIS,RO-has_finding_site
503223488,7/16/2014 02:17:48,,1323996239,7/16/2014 02:17:26,neodev,0.523,22098386,USA,NY,Greenwich,67.248.253.125,SPINE is location of SCOLIOSIS,65,88,,69,97,is location of,0.848874687627165,905141-FS1-9,"Hence, when analysing the biomechanics of the growing adolescent SPINE (for instance in SCOLIOSIS research), the inclusion of depth and width changes, in addition to the usually implemented height change, is essential.",SPINE,SCOLIOSIS,RO-has_finding_site
503223491,7/15/2014 10:52:21,,1323504724,7/15/2014 10:52:13,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,HAEMOPHAGOCYTOSIS causes HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,161,113,,177,148,causes,0.4472135954999579,901841-FS1-4,Post mortem analyses in affected patients have revealed haemophagocytosis similar to that found in patients with HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH); such HAEMOPHAGOCYTOSIS could be a very prominent post mortem feature in H5N1 infection.,HAEMOPHAGOCYTOSIS,HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,RO-disease_has_finding
503223491,7/15/2014 11:33:27,,1323531431,7/15/2014 11:33:04,prodege,0.6514,28039757,GBR,L8,Southport,109.155.158.54,no_relation,161,113,,177,148,causes,0.4472135954999579,901841-FS1-4,Post mortem analyses in affected patients have revealed haemophagocytosis similar to that found in patients with HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH); such HAEMOPHAGOCYTOSIS could be a very prominent post mortem feature in H5N1 infection.,HAEMOPHAGOCYTOSIS,HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,RO-disease_has_finding
503223491,7/15/2014 11:51:23,,1323542058,7/15/2014 11:51:07,neodev,0.6528,21515166,NLD,11,Nootdorp,83.86.58.179,HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS causes HAEMOPHAGOCYTOSIS,161,113,,177,148,causes,0.4472135954999579,901841-FS1-4,Post mortem analyses in affected patients have revealed haemophagocytosis similar to that found in patients with HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH); such HAEMOPHAGOCYTOSIS could be a very prominent post mortem feature in H5N1 infection.,HAEMOPHAGOCYTOSIS,HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,RO-disease_has_finding
503223491,7/15/2014 12:16:13,,1323552765,7/15/2014 12:15:28,paiddailysurveys,0.6292,11786001,USA,NC,Charlotte,71.28.89.238,HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS causes HAEMOPHAGOCYTOSIS,161,113,,177,148,causes,0.4472135954999579,901841-FS1-4,Post mortem analyses in affected patients have revealed haemophagocytosis similar to that found in patients with HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH); such HAEMOPHAGOCYTOSIS could be a very prominent post mortem feature in H5N1 infection.,HAEMOPHAGOCYTOSIS,HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,RO-disease_has_finding
503223491,7/15/2014 13:54:25,,1323588015,7/15/2014 13:53:25,clixsense,0.5419,6334612,USA,OH,Cleveland,108.225.254.58,HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS causes HAEMOPHAGOCYTOSIS,161,113,,177,148,causes,0.4472135954999579,901841-FS1-4,Post mortem analyses in affected patients have revealed haemophagocytosis similar to that found in patients with HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH); such HAEMOPHAGOCYTOSIS could be a very prominent post mortem feature in H5N1 infection.,HAEMOPHAGOCYTOSIS,HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,RO-disease_has_finding
503223491,7/15/2014 16:47:27,,1323698055,7/15/2014 16:47:19,prodege,0.5014,2143114,CAN,BC,Vancouver,24.84.160.12,HAEMOPHAGOCYTOSIS causes HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,161,113,,177,148,causes,0.4472135954999579,901841-FS1-4,Post mortem analyses in affected patients have revealed haemophagocytosis similar to that found in patients with HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH); such HAEMOPHAGOCYTOSIS could be a very prominent post mortem feature in H5N1 infection.,HAEMOPHAGOCYTOSIS,HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,RO-disease_has_finding
503223491,7/15/2014 17:56:16,,1323759061,7/15/2014 17:55:53,tremorgames,0.5768,28013393,USA,CA,Rancho Cordova,71.197.67.37,HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS causes HAEMOPHAGOCYTOSIS,161,113,,177,148,causes,0.4472135954999579,901841-FS1-4,Post mortem analyses in affected patients have revealed haemophagocytosis similar to that found in patients with HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH); such HAEMOPHAGOCYTOSIS could be a very prominent post mortem feature in H5N1 infection.,HAEMOPHAGOCYTOSIS,HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,RO-disease_has_finding
503223504,7/15/2014 14:24:03,,1323596450,7/15/2014 14:23:21,instagc,0.7347,19636746,USA,NY,Andover,192.182.216.225,DEXTROSE contraindicates HYPOGLYCEMIA,67,25,,78,33,contraindicates,0.625,907545-FS1-10,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223504,7/15/2014 15:24:48,,1323622783,7/15/2014 15:24:32,prodege,0.7167,7899370,USA,MI,Bay City,71.13.81.162,DEXTROSE contraindicates HYPOGLYCEMIA,67,25,,78,33,contraindicates,0.625,907545-FS1-10,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223504,7/15/2014 15:44:18,,1323637081,7/15/2014 15:43:57,clixsense,0.6496,7265596,USA,IA,Neola,199.120.116.136,no_relation,67,25,,78,33,contraindicates,0.625,907545-FS1-10,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223504,7/15/2014 17:00:27,,1323712657,7/15/2014 17:00:07,neodev,0.7097,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,67,25,,78,33,contraindicates,0.625,907545-FS1-10,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223504,7/15/2014 17:58:06,,1323760755,7/15/2014 17:57:51,clixsense,0.4097,17722340,CAN,BC,Mission,50.98.185.25,HYPOGLYCEMIA contraindicates DEXTROSE,67,25,,78,33,contraindicates,0.625,907545-FS1-10,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223504,7/15/2014 17:58:54,,1323761261,7/15/2014 17:58:43,tremorgames,0.5768,28013393,USA,CA,Rancho Cordova,71.197.67.37,HYPOGLYCEMIA contraindicates DEXTROSE,67,25,,78,33,contraindicates,0.625,907545-FS1-10,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223504,7/15/2014 18:54:42,,1323784729,7/15/2014 18:54:39,prodege,0.4899,12944140,GBR,C8,Thornton Heath,92.21.6.167,no_relation,67,25,,78,33,contraindicates,0.625,907545-FS1-10,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
503223508,7/15/2014 11:11:53,,1323518705,7/15/2014 11:11:22,instagc,0.7778,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,113,0,,116,33,is location of,0.9878291611472622,902325-FS1-9,"BENIGN MUCOUS MEMBRANE PEMPHIGOID (BMMP) is characterized by immunoglobulin deposits along the basal zone of the SKIN and mucous membranes, leading to blistering erosions of the involved regions.",SKIN,BENIGN MUCOUS MEMBRANE PEMPHIGOID,RO-disease_has_primary_anatomic_site
503223508,7/15/2014 11:17:59,,1323522664,7/15/2014 11:17:43,clixsense,0.7361,27871219,NLD,07,Amsterdam,87.210.207.223,SKIN is location of BENIGN MUCOUS MEMBRANE PEMPHIGOID,113,0,,116,33,is location of,0.9878291611472622,902325-FS1-9,"BENIGN MUCOUS MEMBRANE PEMPHIGOID (BMMP) is characterized by immunoglobulin deposits along the basal zone of the SKIN and mucous membranes, leading to blistering erosions of the involved regions.",SKIN,BENIGN MUCOUS MEMBRANE PEMPHIGOID,RO-disease_has_primary_anatomic_site
503223508,7/15/2014 11:52:17,,1323542778,7/15/2014 11:51:58,neodev,0.6528,21515166,NLD,11,Nootdorp,83.86.58.179,SKIN is location of BENIGN MUCOUS MEMBRANE PEMPHIGOID,113,0,,116,33,is location of,0.9878291611472622,902325-FS1-9,"BENIGN MUCOUS MEMBRANE PEMPHIGOID (BMMP) is characterized by immunoglobulin deposits along the basal zone of the SKIN and mucous membranes, leading to blistering erosions of the involved regions.",SKIN,BENIGN MUCOUS MEMBRANE PEMPHIGOID,RO-disease_has_primary_anatomic_site
503223508,7/15/2014 12:39:40,,1323561662,7/15/2014 12:39:23,prodege,0.7631,1852770,USA,TX,Abilene,76.198.102.54,SKIN is location of BENIGN MUCOUS MEMBRANE PEMPHIGOID,113,0,,116,33,is location of,0.9878291611472622,902325-FS1-9,"BENIGN MUCOUS MEMBRANE PEMPHIGOID (BMMP) is characterized by immunoglobulin deposits along the basal zone of the SKIN and mucous membranes, leading to blistering erosions of the involved regions.",SKIN,BENIGN MUCOUS MEMBRANE PEMPHIGOID,RO-disease_has_primary_anatomic_site
503223508,7/15/2014 13:03:42,,1323571227,7/15/2014 13:03:06,prodege,0.875,19192508,USA,OK,Broken Arrow,70.177.111.89,SKIN is location of BENIGN MUCOUS MEMBRANE PEMPHIGOID,113,0,,116,33,is location of,0.9878291611472622,902325-FS1-9,"BENIGN MUCOUS MEMBRANE PEMPHIGOID (BMMP) is characterized by immunoglobulin deposits along the basal zone of the SKIN and mucous membranes, leading to blistering erosions of the involved regions.",SKIN,BENIGN MUCOUS MEMBRANE PEMPHIGOID,RO-disease_has_primary_anatomic_site
503223508,7/15/2014 15:43:29,,1323636355,7/15/2014 15:43:01,clixsense,0.6496,7265596,USA,IA,Neola,199.120.116.136,SKIN is location of BENIGN MUCOUS MEMBRANE PEMPHIGOID,113,0,,116,33,is location of,0.9878291611472622,902325-FS1-9,"BENIGN MUCOUS MEMBRANE PEMPHIGOID (BMMP) is characterized by immunoglobulin deposits along the basal zone of the SKIN and mucous membranes, leading to blistering erosions of the involved regions.",SKIN,BENIGN MUCOUS MEMBRANE PEMPHIGOID,RO-disease_has_primary_anatomic_site
503223508,7/15/2014 15:57:18,,1323646848,7/15/2014 15:56:51,instagc,0.628,25901556,GBR,C3,Saint Ives,82.9.129.2,SKIN is location of BENIGN MUCOUS MEMBRANE PEMPHIGOID,113,0,,116,33,is location of,0.9878291611472622,902325-FS1-9,"BENIGN MUCOUS MEMBRANE PEMPHIGOID (BMMP) is characterized by immunoglobulin deposits along the basal zone of the SKIN and mucous membranes, leading to blistering erosions of the involved regions.",SKIN,BENIGN MUCOUS MEMBRANE PEMPHIGOID,RO-disease_has_primary_anatomic_site
503223512,7/15/2014 10:12:19,,1323477811,7/15/2014 10:11:31,clixsense,0.9583,15189335,GBR,E4,Colchester,5.67.141.89,CAFFEINE treats APNOEA,22,80,,27,88,treats,0.9578262852211508,908015-FS1-2,Episodes of prolonged APNOEA disappeared in all infants after administration of CAFFEINE and in 11 infants all pneumogram abnormalities resolved.,APNOEA,CAFFEINE,RO-may_treat
503223512,7/15/2014 11:12:19,,1323519027,7/15/2014 11:11:54,instagc,0.7778,24252915,GBR,B7,Bristol,77.98.139.82,CAFFEINE treats APNOEA,22,80,,27,88,treats,0.9578262852211508,908015-FS1-2,Episodes of prolonged APNOEA disappeared in all infants after administration of CAFFEINE and in 11 infants all pneumogram abnormalities resolved.,APNOEA,CAFFEINE,RO-may_treat
503223512,7/15/2014 11:20:36,,1323524249,7/15/2014 11:20:10,clixsense,0.1667,24896327,GBR,V2,Glasgow,94.2.231.4,no_relation,22,80,,27,88,treats,0.9578262852211508,908015-FS1-2,Episodes of prolonged APNOEA disappeared in all infants after administration of CAFFEINE and in 11 infants all pneumogram abnormalities resolved.,APNOEA,CAFFEINE,RO-may_treat
503223512,7/15/2014 11:33:14,,1323531278,7/15/2014 11:32:25,clixsense,0.8514,8888883,USA,FL,Orlando,76.26.232.146,CAFFEINE treats APNOEA,22,80,,27,88,treats,0.9578262852211508,908015-FS1-2,Episodes of prolonged APNOEA disappeared in all infants after administration of CAFFEINE and in 11 infants all pneumogram abnormalities resolved.,APNOEA,CAFFEINE,RO-may_treat
503223512,7/15/2014 13:54:35,,1323588093,7/15/2014 13:54:16,neodev,0.4998,18339121,USA,SC,Sumter,173.93.188.194,APNOEA treats CAFFEINE,22,80,,27,88,treats,0.9578262852211508,908015-FS1-2,Episodes of prolonged APNOEA disappeared in all infants after administration of CAFFEINE and in 11 infants all pneumogram abnormalities resolved.,APNOEA,CAFFEINE,RO-may_treat
503223512,7/15/2014 13:57:40,,1323589010,7/15/2014 13:56:46,clixsense,0.5419,6334612,USA,OH,Cleveland,108.225.254.58,CAFFEINE treats APNOEA,22,80,,27,88,treats,0.9578262852211508,908015-FS1-2,Episodes of prolonged APNOEA disappeared in all infants after administration of CAFFEINE and in 11 infants all pneumogram abnormalities resolved.,APNOEA,CAFFEINE,RO-may_treat
503223512,7/15/2014 15:55:10,,1323645262,7/15/2014 15:54:50,neodev,0.4345,14861092,GBR,I2,Manchester,90.194.137.76,CAFFEINE treats APNOEA,22,80,,27,88,treats,0.9578262852211508,908015-FS1-2,Episodes of prolonged APNOEA disappeared in all infants after administration of CAFFEINE and in 11 infants all pneumogram abnormalities resolved.,APNOEA,CAFFEINE,RO-may_treat
503223538,7/15/2014 10:10:55,,1323477054,7/15/2014 10:10:34,clixsense,0.9583,15189335,GBR,E4,Colchester,5.67.141.89,DIABETES diagnosed by ISLET CELLS,100,155,,110,163,diagnosed by,0.7715167498104591,902036-FS1-13,"We propose, therefore, that the preferential impairment of the oxidative and secretory responses of ISLET CELLS to D glucose in this experimental model of DIABETES may be at least partly attributable to an altered transfer of reducing equivalents into the mitochondria as mediated by the glycerol phosphate shuttle.",ISLET CELLS,DIABETES,RO-disease_has_primary_anatomic_site
503223538,7/15/2014 11:25:02,,1323526697,7/15/2014 11:24:09,elite,0.8264,28397222,GBR,Y4,Usk,31.50.223.75,DIABETES diagnosed by ISLET CELLS,100,155,,110,163,diagnosed by,0.7715167498104591,902036-FS1-13,"We propose, therefore, that the preferential impairment of the oxidative and secretory responses of ISLET CELLS to D glucose in this experimental model of DIABETES may be at least partly attributable to an altered transfer of reducing equivalents into the mitochondria as mediated by the glycerol phosphate shuttle.",ISLET CELLS,DIABETES,RO-disease_has_primary_anatomic_site
503223538,7/15/2014 11:51:40,,1323542249,7/15/2014 11:51:24,neodev,0.6528,21515166,NLD,11,Nootdorp,83.86.58.179,DIABETES diagnosed by ISLET CELLS,100,155,,110,163,diagnosed by,0.7715167498104591,902036-FS1-13,"We propose, therefore, that the preferential impairment of the oxidative and secretory responses of ISLET CELLS to D glucose in this experimental model of DIABETES may be at least partly attributable to an altered transfer of reducing equivalents into the mitochondria as mediated by the glycerol phosphate shuttle.",ISLET CELLS,DIABETES,RO-disease_has_primary_anatomic_site
503223538,7/15/2014 14:24:56,,1323596657,7/15/2014 14:24:11,instagc,0.7347,19636746,USA,NY,Andover,192.182.216.225,no_relation,100,155,,110,163,diagnosed by,0.7715167498104591,902036-FS1-13,"We propose, therefore, that the preferential impairment of the oxidative and secretory responses of ISLET CELLS to D glucose in this experimental model of DIABETES may be at least partly attributable to an altered transfer of reducing equivalents into the mitochondria as mediated by the glycerol phosphate shuttle.",ISLET CELLS,DIABETES,RO-disease_has_primary_anatomic_site
503223538,7/15/2014 15:48:30,,1323640144,7/15/2014 15:48:03,elite,0.4948,28276268,USA,MI,Taylor,67.149.247.166,ISLET CELLS diagnosed by DIABETES,100,155,,110,163,diagnosed by,0.7715167498104591,902036-FS1-13,"We propose, therefore, that the preferential impairment of the oxidative and secretory responses of ISLET CELLS to D glucose in this experimental model of DIABETES may be at least partly attributable to an altered transfer of reducing equivalents into the mitochondria as mediated by the glycerol phosphate shuttle.",ISLET CELLS,DIABETES,RO-disease_has_primary_anatomic_site
503223538,7/15/2014 15:55:17,,1323645348,7/15/2014 15:54:47,instagc,0.628,25901556,GBR,C3,Saint Ives,82.9.129.2,DIABETES diagnosed by ISLET CELLS,100,155,,110,163,diagnosed by,0.7715167498104591,902036-FS1-13,"We propose, therefore, that the preferential impairment of the oxidative and secretory responses of ISLET CELLS to D glucose in this experimental model of DIABETES may be at least partly attributable to an altered transfer of reducing equivalents into the mitochondria as mediated by the glycerol phosphate shuttle.",ISLET CELLS,DIABETES,RO-disease_has_primary_anatomic_site
503223538,7/15/2014 16:54:22,,1323705471,7/15/2014 16:54:06,prodege,0.7147,23541832,USA,AZ,Tempe,149.169.145.144,DIABETES diagnosed by ISLET CELLS,100,155,,110,163,diagnosed by,0.7715167498104591,902036-FS1-13,"We propose, therefore, that the preferential impairment of the oxidative and secretory responses of ISLET CELLS to D glucose in this experimental model of DIABETES may be at least partly attributable to an altered transfer of reducing equivalents into the mitochondria as mediated by the glycerol phosphate shuttle.",ISLET CELLS,DIABETES,RO-disease_has_primary_anatomic_site
503223542,7/15/2014 10:12:47,,1323478036,7/15/2014 10:12:12,eup_slw,0.9583,20818028,GBR,A7,Birmingham,92.232.139.254,ISLET CELLS is location of ISLET CELL TUMORS,62,150,,72,167,is location of,0.964901281354015,902422-FS1-9,"Neuron specific enolase was localized in nerve fibers, normal ISLET CELLS and islet cell tumors; its concentration was elevated only in the tissue of ISLET CELL TUMORS and in serum from patients with insulinoma.",ISLET CELLS,ISLET CELL TUMORS,RO-disease_has_primary_anatomic_site
503223542,7/15/2014 10:30:03,,1323489195,7/15/2014 10:29:55,clixsense,0.9583,19162475,GBR,M3,Frome,82.33.126.30,ISLET CELLS is location of ISLET CELL TUMORS,62,150,,72,167,is location of,0.964901281354015,902422-FS1-9,"Neuron specific enolase was localized in nerve fibers, normal ISLET CELLS and islet cell tumors; its concentration was elevated only in the tissue of ISLET CELL TUMORS and in serum from patients with insulinoma.",ISLET CELLS,ISLET CELL TUMORS,RO-disease_has_primary_anatomic_site
503223542,7/15/2014 10:32:00,,1323490517,7/15/2014 10:31:40,clixsense,0.9722,19803139,NLD,06,Veldhoven,212.61.84.196,ISLET CELLS is location of ISLET CELL TUMORS,62,150,,72,167,is location of,0.964901281354015,902422-FS1-9,"Neuron specific enolase was localized in nerve fibers, normal ISLET CELLS and islet cell tumors; its concentration was elevated only in the tissue of ISLET CELL TUMORS and in serum from patients with insulinoma.",ISLET CELLS,ISLET CELL TUMORS,RO-disease_has_primary_anatomic_site
503223542,7/15/2014 10:56:48,,1323507504,7/15/2014 10:55:54,rewardsspot,0.8542,17763704,USA,VA,Manassas,198.7.62.204,ISLET CELL TUMORS is location of ISLET CELLS,62,150,,72,167,is location of,0.964901281354015,902422-FS1-9,"Neuron specific enolase was localized in nerve fibers, normal ISLET CELLS and islet cell tumors; its concentration was elevated only in the tissue of ISLET CELL TUMORS and in serum from patients with insulinoma.",ISLET CELLS,ISLET CELL TUMORS,RO-disease_has_primary_anatomic_site
503223542,7/15/2014 11:54:03,,1323543939,7/15/2014 11:53:45,neodev,0.7083,24578640,USA,IL,Chicago,65.60.20.66,ISLET CELL TUMORS is location of ISLET CELLS,62,150,,72,167,is location of,0.964901281354015,902422-FS1-9,"Neuron specific enolase was localized in nerve fibers, normal ISLET CELLS and islet cell tumors; its concentration was elevated only in the tissue of ISLET CELL TUMORS and in serum from patients with insulinoma.",ISLET CELLS,ISLET CELL TUMORS,RO-disease_has_primary_anatomic_site
503223542,7/15/2014 13:36:14,,1323582461,7/15/2014 13:36:01,instagc,0.6153,23149109,USA,NC,Cary,24.206.38.18,ISLET CELLS is location of ISLET CELL TUMORS,62,150,,72,167,is location of,0.964901281354015,902422-FS1-9,"Neuron specific enolase was localized in nerve fibers, normal ISLET CELLS and islet cell tumors; its concentration was elevated only in the tissue of ISLET CELL TUMORS and in serum from patients with insulinoma.",ISLET CELLS,ISLET CELL TUMORS,RO-disease_has_primary_anatomic_site
503223542,7/15/2014 15:43:56,,1323636782,7/15/2014 15:43:30,clixsense,0.6496,7265596,USA,IA,Neola,199.120.116.136,ISLET CELL TUMORS is location of ISLET CELLS,62,150,,72,167,is location of,0.964901281354015,902422-FS1-9,"Neuron specific enolase was localized in nerve fibers, normal ISLET CELLS and islet cell tumors; its concentration was elevated only in the tissue of ISLET CELL TUMORS and in serum from patients with insulinoma.",ISLET CELLS,ISLET CELL TUMORS,RO-disease_has_primary_anatomic_site
503223544,7/15/2014 11:34:11,,1323531917,7/15/2014 11:33:42,clixsense,0.8514,8888883,USA,FL,Orlando,76.26.232.146,no_relation,13,31,,26,62,causes,0.788263422531435,902947-FS1-4,"However, the HYPERVISCOSITY in WALDENSTROM'S MACROGLOBULINEMIA is an ideal representative of a venous stasis that is without associated vascular pathology.",HYPERVISCOSITY,WALDENSTROM'S MACROGLOBULINEMIA,RO-disease_may_have_finding
503223544,7/15/2014 11:51:06,,1323541797,7/15/2014 11:50:40,neodev,0.6528,21515166,NLD,11,Nootdorp,83.86.58.179,WALDENSTROM'S MACROGLOBULINEMIA causes HYPERVISCOSITY,13,31,,26,62,causes,0.788263422531435,902947-FS1-4,"However, the HYPERVISCOSITY in WALDENSTROM'S MACROGLOBULINEMIA is an ideal representative of a venous stasis that is without associated vascular pathology.",HYPERVISCOSITY,WALDENSTROM'S MACROGLOBULINEMIA,RO-disease_may_have_finding
503223544,7/15/2014 11:54:33,,1323544094,7/15/2014 11:54:17,neodev,0.7083,24578640,USA,IL,Chicago,65.60.20.66,WALDENSTROM'S MACROGLOBULINEMIA causes HYPERVISCOSITY,13,31,,26,62,causes,0.788263422531435,902947-FS1-4,"However, the HYPERVISCOSITY in WALDENSTROM'S MACROGLOBULINEMIA is an ideal representative of a venous stasis that is without associated vascular pathology.",HYPERVISCOSITY,WALDENSTROM'S MACROGLOBULINEMIA,RO-disease_may_have_finding
503223544,7/15/2014 12:14:57,,1323552351,7/15/2014 12:14:26,paiddailysurveys,0.6292,11786001,USA,NC,Charlotte,71.28.89.238,HYPERVISCOSITY causes WALDENSTROM'S MACROGLOBULINEMIA,13,31,,26,62,causes,0.788263422531435,902947-FS1-4,"However, the HYPERVISCOSITY in WALDENSTROM'S MACROGLOBULINEMIA is an ideal representative of a venous stasis that is without associated vascular pathology.",HYPERVISCOSITY,WALDENSTROM'S MACROGLOBULINEMIA,RO-disease_may_have_finding
503223544,7/15/2014 12:40:42,,1323561959,7/15/2014 12:40:33,instagc,0.7417,18960682,GBR,,,86.29.147.112,no_relation,13,31,,26,62,causes,0.788263422531435,902947-FS1-4,"However, the HYPERVISCOSITY in WALDENSTROM'S MACROGLOBULINEMIA is an ideal representative of a venous stasis that is without associated vascular pathology.",HYPERVISCOSITY,WALDENSTROM'S MACROGLOBULINEMIA,RO-disease_may_have_finding
503223544,7/15/2014 14:15:38,,1323593874,7/15/2014 14:15:21,neodev,0.8179,28336203,USA,PA,Harrisburg,50.149.53.150,no_relation,13,31,,26,62,causes,0.788263422531435,902947-FS1-4,"However, the HYPERVISCOSITY in WALDENSTROM'S MACROGLOBULINEMIA is an ideal representative of a venous stasis that is without associated vascular pathology.",HYPERVISCOSITY,WALDENSTROM'S MACROGLOBULINEMIA,RO-disease_may_have_finding
503223544,7/15/2014 16:24:15,,1323670438,7/15/2014 16:23:59,clixsense,0.6252,16827630,GBR,A7,Birmingham,86.146.169.103,WALDENSTROM'S MACROGLOBULINEMIA causes HYPERVISCOSITY,13,31,,26,62,causes,0.788263422531435,902947-FS1-4,"However, the HYPERVISCOSITY in WALDENSTROM'S MACROGLOBULINEMIA is an ideal representative of a venous stasis that is without associated vascular pathology.",HYPERVISCOSITY,WALDENSTROM'S MACROGLOBULINEMIA,RO-disease_may_have_finding
503223546,7/15/2014 16:25:23,,1323671767,7/15/2014 16:25:11,clixsense,0.6252,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,60,74,,64,87,causes,0.312771621085612,902160-FS1-4,"Protoporphyrins sometimes accumulate to toxic levels in the LIVER causing LIVER FAILURE; if this occurs, a liver transplant becomes necessary.",LIVER,LIVER FAILURE,RO-disease_has_primary_anatomic_site
503223546,7/15/2014 18:50:45,,1323782571,7/15/2014 18:50:41,instagc,0.578,25990856,USA,NV,Las Vegas,68.108.98.78,LIVER causes LIVER FAILURE,60,74,,64,87,causes,0.312771621085612,902160-FS1-4,"Protoporphyrins sometimes accumulate to toxic levels in the LIVER causing LIVER FAILURE; if this occurs, a liver transplant becomes necessary.",LIVER,LIVER FAILURE,RO-disease_has_primary_anatomic_site
503223546,7/15/2014 20:25:38,,1323824481,7/15/2014 20:24:43,clixsense,0.5208,25399403,GBR,,,188.29.96.57,no_relation,60,74,,64,87,causes,0.312771621085612,902160-FS1-4,"Protoporphyrins sometimes accumulate to toxic levels in the LIVER causing LIVER FAILURE; if this occurs, a liver transplant becomes necessary.",LIVER,LIVER FAILURE,RO-disease_has_primary_anatomic_site
503223546,7/15/2014 20:36:35,,1323829056,7/15/2014 20:35:33,prodege,0.5694,28255346,GBR,L9,Sheffield,2.125.183.137,no_relation,60,74,,64,87,causes,0.312771621085612,902160-FS1-4,"Protoporphyrins sometimes accumulate to toxic levels in the LIVER causing LIVER FAILURE; if this occurs, a liver transplant becomes necessary.",LIVER,LIVER FAILURE,RO-disease_has_primary_anatomic_site
503223546,7/16/2014 01:08:23,,1323961669,7/16/2014 01:07:59,bitcoinget,0.6825,28377798,GBR,,,195.166.117.126,no_relation,60,74,,64,87,causes,0.312771621085612,902160-FS1-4,"Protoporphyrins sometimes accumulate to toxic levels in the LIVER causing LIVER FAILURE; if this occurs, a liver transplant becomes necessary.",LIVER,LIVER FAILURE,RO-disease_has_primary_anatomic_site
503223546,7/16/2014 01:36:36,,1323977065,7/16/2014 01:35:59,clixsense,0.5345,6574199,USA,NJ,Mount Laurel,72.82.165.96,LIVER causes LIVER FAILURE,60,74,,64,87,causes,0.312771621085612,902160-FS1-4,"Protoporphyrins sometimes accumulate to toxic levels in the LIVER causing LIVER FAILURE; if this occurs, a liver transplant becomes necessary.",LIVER,LIVER FAILURE,RO-disease_has_primary_anatomic_site
503223546,7/16/2014 01:44:06,,1323979744,7/16/2014 01:43:46,clixsense,0.7798,19638651,USA,,,173.23.121.63,no_relation,60,74,,64,87,causes,0.312771621085612,902160-FS1-4,"Protoporphyrins sometimes accumulate to toxic levels in the LIVER causing LIVER FAILURE; if this occurs, a liver transplant becomes necessary.",LIVER,LIVER FAILURE,RO-disease_has_primary_anatomic_site
503223549,7/15/2014 11:17:59,,1323522675,7/15/2014 11:17:43,clixsense,0.7361,27871219,NLD,07,Amsterdam,87.210.207.223,PITUITARY ADENOMAS causes TUBERCULOUS INVOLVEMENT OF PITUITARY,0,103,,35,121,causes,0.34815531191139604,905046-FS1-4,TUBERCULOUS INVOLVEMENT OF PITUITARY is extremely rare and is usually not suspected while dealing with PITUITARY ADENOMAS even in patients with history of systemic tuberculosis.,TUBERCULOUS INVOLVEMENT OF PITUITARY,PITUITARY ADENOMAS,RO-has_finding_site
503223549,7/15/2014 11:40:19,,1323535442,7/15/2014 11:39:53,clixsense,0.5,23233834,GBR,N6,Sunderland,86.17.58.181,TUBERCULOUS INVOLVEMENT OF PITUITARY causes PITUITARY ADENOMAS,0,103,,35,121,causes,0.34815531191139604,905046-FS1-4,TUBERCULOUS INVOLVEMENT OF PITUITARY is extremely rare and is usually not suspected while dealing with PITUITARY ADENOMAS even in patients with history of systemic tuberculosis.,TUBERCULOUS INVOLVEMENT OF PITUITARY,PITUITARY ADENOMAS,RO-has_finding_site
503223549,7/15/2014 13:56:04,,1323588494,7/15/2014 13:55:43,neodev,0.4998,18339121,USA,SC,Sumter,173.93.188.194,PITUITARY ADENOMAS causes TUBERCULOUS INVOLVEMENT OF PITUITARY,0,103,,35,121,causes,0.34815531191139604,905046-FS1-4,TUBERCULOUS INVOLVEMENT OF PITUITARY is extremely rare and is usually not suspected while dealing with PITUITARY ADENOMAS even in patients with history of systemic tuberculosis.,TUBERCULOUS INVOLVEMENT OF PITUITARY,PITUITARY ADENOMAS,RO-has_finding_site
503223549,7/15/2014 15:56:23,,1323646173,7/15/2014 15:55:50,instagc,0.628,25901556,GBR,C3,Saint Ives,82.9.129.2,no_relation,0,103,,35,121,causes,0.34815531191139604,905046-FS1-4,TUBERCULOUS INVOLVEMENT OF PITUITARY is extremely rare and is usually not suspected while dealing with PITUITARY ADENOMAS even in patients with history of systemic tuberculosis.,TUBERCULOUS INVOLVEMENT OF PITUITARY,PITUITARY ADENOMAS,RO-has_finding_site
503223549,7/15/2014 16:53:06,,1323704138,7/15/2014 16:52:23,prodege,0.7147,23541832,USA,AZ,Tempe,149.169.145.144,PITUITARY ADENOMAS causes TUBERCULOUS INVOLVEMENT OF PITUITARY,0,103,,35,121,causes,0.34815531191139604,905046-FS1-4,TUBERCULOUS INVOLVEMENT OF PITUITARY is extremely rare and is usually not suspected while dealing with PITUITARY ADENOMAS even in patients with history of systemic tuberculosis.,TUBERCULOUS INVOLVEMENT OF PITUITARY,PITUITARY ADENOMAS,RO-has_finding_site
503223549,7/15/2014 17:09:41,,1323721165,7/15/2014 17:09:16,clixsense,0.5345,6574199,USA,TX,San Antonio,207.230.144.242,no_relation,0,103,,35,121,causes,0.34815531191139604,905046-FS1-4,TUBERCULOUS INVOLVEMENT OF PITUITARY is extremely rare and is usually not suspected while dealing with PITUITARY ADENOMAS even in patients with history of systemic tuberculosis.,TUBERCULOUS INVOLVEMENT OF PITUITARY,PITUITARY ADENOMAS,RO-has_finding_site
503223549,7/15/2014 17:14:50,,1323724648,7/15/2014 17:14:20,instagc,0.531,28519532,USA,IA,Honey Creek,12.73.110.41,no_relation,0,103,,35,121,causes,0.34815531191139604,905046-FS1-4,TUBERCULOUS INVOLVEMENT OF PITUITARY is extremely rare and is usually not suspected while dealing with PITUITARY ADENOMAS even in patients with history of systemic tuberculosis.,TUBERCULOUS INVOLVEMENT OF PITUITARY,PITUITARY ADENOMAS,RO-has_finding_site
503335433,7/15/2014 20:57:00,,1323837050,7/15/2014 20:56:30,clixsense,0.9583,15189335,GBR,H9,London,188.29.165.120,PRIMARY HEADACHE CONDITIONS causes CLUSTER HEADACHE,36,0,,62,16,causes,0.337526370277807,904591-FS1-4,"CLUSTER HEADACHE the most severe of PRIMARY HEADACHE CONDITIONS for functional and social impairment it provokes, has been recently the object of a great amount of clinical, physiopathological, surgical and functional neuroradiological studies aimed to uncover the real mechanisms which underlie its disabling manifestations.",PRIMARY HEADACHE CONDITIONS,CLUSTER HEADACHE,RO-has_definitional_manifestation
503335433,7/15/2014 21:14:51,,1323845178,7/15/2014 21:14:28,elite,0.6944,28503042,USA,NJ,Woodbridge,54.191.150.115,no_relation,36,0,,62,16,causes,0.337526370277807,904591-FS1-4,"CLUSTER HEADACHE the most severe of PRIMARY HEADACHE CONDITIONS for functional and social impairment it provokes, has been recently the object of a great amount of clinical, physiopathological, surgical and functional neuroradiological studies aimed to uncover the real mechanisms which underlie its disabling manifestations.",PRIMARY HEADACHE CONDITIONS,CLUSTER HEADACHE,RO-has_definitional_manifestation
503335433,7/15/2014 21:47:20,,1323857108,7/15/2014 21:46:59,clixsense,0.6875,19638651,USA,,,173.23.121.63,no_relation,36,0,,62,16,causes,0.337526370277807,904591-FS1-4,"CLUSTER HEADACHE the most severe of PRIMARY HEADACHE CONDITIONS for functional and social impairment it provokes, has been recently the object of a great amount of clinical, physiopathological, surgical and functional neuroradiological studies aimed to uncover the real mechanisms which underlie its disabling manifestations.",PRIMARY HEADACHE CONDITIONS,CLUSTER HEADACHE,RO-has_definitional_manifestation
503335433,7/15/2014 21:59:17,,1323861674,7/15/2014 21:58:27,prodege,0.7389,28255346,GBR,L9,Sheffield,2.125.183.137,CLUSTER HEADACHE causes PRIMARY HEADACHE CONDITIONS,36,0,,62,16,causes,0.337526370277807,904591-FS1-4,"CLUSTER HEADACHE the most severe of PRIMARY HEADACHE CONDITIONS for functional and social impairment it provokes, has been recently the object of a great amount of clinical, physiopathological, surgical and functional neuroradiological studies aimed to uncover the real mechanisms which underlie its disabling manifestations.",PRIMARY HEADACHE CONDITIONS,CLUSTER HEADACHE,RO-has_definitional_manifestation
503335433,7/15/2014 22:14:27,,1323868513,7/15/2014 22:14:07,instagc,0.4861,26706653,USA,IL,Elk Grove Village,99.99.9.247,CLUSTER HEADACHE causes PRIMARY HEADACHE CONDITIONS,36,0,,62,16,causes,0.337526370277807,904591-FS1-4,"CLUSTER HEADACHE the most severe of PRIMARY HEADACHE CONDITIONS for functional and social impairment it provokes, has been recently the object of a great amount of clinical, physiopathological, surgical and functional neuroradiological studies aimed to uncover the real mechanisms which underlie its disabling manifestations.",PRIMARY HEADACHE CONDITIONS,CLUSTER HEADACHE,RO-has_definitional_manifestation
503335433,7/16/2014 01:04:23,,1323959141,7/16/2014 01:03:19,bitcoinget,0.6514,28377798,GBR,,,195.166.117.126,no_relation,36,0,,62,16,causes,0.337526370277807,904591-FS1-4,"CLUSTER HEADACHE the most severe of PRIMARY HEADACHE CONDITIONS for functional and social impairment it provokes, has been recently the object of a great amount of clinical, physiopathological, surgical and functional neuroradiological studies aimed to uncover the real mechanisms which underlie its disabling manifestations.",PRIMARY HEADACHE CONDITIONS,CLUSTER HEADACHE,RO-has_definitional_manifestation
503335433,7/16/2014 04:21:30,,1324044720,7/16/2014 04:20:57,instagc,0.6288,27770607,USA,TX,El Paso,72.183.248.75,no_relation,36,0,,62,16,causes,0.337526370277807,904591-FS1-4,"CLUSTER HEADACHE the most severe of PRIMARY HEADACHE CONDITIONS for functional and social impairment it provokes, has been recently the object of a great amount of clinical, physiopathological, surgical and functional neuroradiological studies aimed to uncover the real mechanisms which underlie its disabling manifestations.",PRIMARY HEADACHE CONDITIONS,CLUSTER HEADACHE,RO-has_definitional_manifestation
503335434,7/15/2014 21:06:22,,1323841496,7/15/2014 21:05:40,clixsense,0.7153,6564572,USA,MI,Kalamazoo,173.46.248.170,MPS II causes WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,16,71,,56,77,causes,0.3779644730092271,906479-FS1-4,"We report a boy WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosis of MPS II was proved by demonstrating a severe deficiency of serum and leucocyte iduronate sulphate sulphatase and an accelerated incorporation of radiosulphate into his cultured fibroblast glycosaminoglycans, which could not be corrected by the product of other typed reference MPS II cells.",WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,MPS II,RO-has_manifestation
503335434,7/15/2014 21:57:02,,1323860599,7/15/2014 21:56:21,prodege,0.7389,28255346,GBR,L9,Sheffield,2.125.183.137,MPS II causes WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,16,71,,56,77,causes,0.3779644730092271,906479-FS1-4,"We report a boy WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosis of MPS II was proved by demonstrating a severe deficiency of serum and leucocyte iduronate sulphate sulphatase and an accelerated incorporation of radiosulphate into his cultured fibroblast glycosaminoglycans, which could not be corrected by the product of other typed reference MPS II cells.",WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,MPS II,RO-has_manifestation
503335434,7/16/2014 00:40:05,,1323945877,7/16/2014 00:39:20,neodev,0.7873,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,16,71,,56,77,causes,0.3779644730092271,906479-FS1-4,"We report a boy WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosis of MPS II was proved by demonstrating a severe deficiency of serum and leucocyte iduronate sulphate sulphatase and an accelerated incorporation of radiosulphate into his cultured fibroblast glycosaminoglycans, which could not be corrected by the product of other typed reference MPS II cells.",WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,MPS II,RO-has_manifestation
503335434,7/16/2014 01:07:14,,1323960782,7/16/2014 01:06:47,bitcoinget,0.6514,28377798,GBR,,,195.166.117.126,no_relation,16,71,,56,77,causes,0.3779644730092271,906479-FS1-4,"We report a boy WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosis of MPS II was proved by demonstrating a severe deficiency of serum and leucocyte iduronate sulphate sulphatase and an accelerated incorporation of radiosulphate into his cultured fibroblast glycosaminoglycans, which could not be corrected by the product of other typed reference MPS II cells.",WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,MPS II,RO-has_manifestation
503335434,7/16/2014 02:26:04,,1323999676,7/16/2014 02:25:55,clixsense,0.6681,27793793,GBR,C5,Chester,151.230.27.155,MPS II causes WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,16,71,,56,77,causes,0.3779644730092271,906479-FS1-4,"We report a boy WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosis of MPS II was proved by demonstrating a severe deficiency of serum and leucocyte iduronate sulphate sulphatase and an accelerated incorporation of radiosulphate into his cultured fibroblast glycosaminoglycans, which could not be corrected by the product of other typed reference MPS II cells.",WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,MPS II,RO-has_manifestation
503335434,7/16/2014 02:28:05,,1324000476,7/16/2014 02:27:34,instagc,0.7429,28519532,USA,IA,Honey Creek,12.73.110.156,no_relation,16,71,,56,77,causes,0.3779644730092271,906479-FS1-4,"We report a boy WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosis of MPS II was proved by demonstrating a severe deficiency of serum and leucocyte iduronate sulphate sulphatase and an accelerated incorporation of radiosulphate into his cultured fibroblast glycosaminoglycans, which could not be corrected by the product of other typed reference MPS II cells.",WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,MPS II,RO-has_manifestation
503335434,7/16/2014 04:21:30,,1324044721,7/16/2014 04:20:57,instagc,0.6288,27770607,USA,TX,El Paso,72.183.248.75,no_relation,16,71,,56,77,causes,0.3779644730092271,906479-FS1-4,"We report a boy WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosis of MPS II was proved by demonstrating a severe deficiency of serum and leucocyte iduronate sulphate sulphatase and an accelerated incorporation of radiosulphate into his cultured fibroblast glycosaminoglycans, which could not be corrected by the product of other typed reference MPS II cells.",WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,MPS II,RO-has_manifestation
503335437,7/15/2014 20:57:15,,1323837131,7/15/2014 20:57:02,clixsense,0.9583,15189335,GBR,H9,London,188.29.165.120,EPILEPSY causes SEIZURES,123,75,,130,83,causes,0.520755643923296,904640-FS1-4,"Studies of human patients with temporal lobe epilepsy and animal models of EPILEPSY have established relationships between SEIZURES excitotoxic hippocampal damage, and memory impairment.",SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503335437,7/15/2014 21:46:27,,1323856818,7/15/2014 21:45:53,clixsense,0.6875,19638651,USA,,,173.23.121.63,no_relation,123,75,,130,83,causes,0.520755643923296,904640-FS1-4,"Studies of human patients with temporal lobe epilepsy and animal models of EPILEPSY have established relationships between SEIZURES excitotoxic hippocampal damage, and memory impairment.",SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503335437,7/16/2014 00:10:32,,1323930139,7/16/2014 00:09:58,clixsense,0.4942,20614047,USA,MO,Maryville,174.32.162.147,SEIZURES causes EPILEPSY,123,75,,130,83,causes,0.520755643923296,904640-FS1-4,"Studies of human patients with temporal lobe epilepsy and animal models of EPILEPSY have established relationships between SEIZURES excitotoxic hippocampal damage, and memory impairment.",SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503335437,7/16/2014 00:38:38,,1323945155,7/16/2014 00:37:59,neodev,0.7873,11460728,CAN,BC,Burnaby,70.79.16.165,EPILEPSY causes SEIZURES,123,75,,130,83,causes,0.520755643923296,904640-FS1-4,"Studies of human patients with temporal lobe epilepsy and animal models of EPILEPSY have established relationships between SEIZURES excitotoxic hippocampal damage, and memory impairment.",SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503335437,7/16/2014 02:25:54,,1323999607,7/16/2014 02:25:43,clixsense,0.6681,27793793,GBR,C5,Chester,151.230.27.155,EPILEPSY causes SEIZURES,123,75,,130,83,causes,0.520755643923296,904640-FS1-4,"Studies of human patients with temporal lobe epilepsy and animal models of EPILEPSY have established relationships between SEIZURES excitotoxic hippocampal damage, and memory impairment.",SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503335437,7/16/2014 02:47:31,,1324007039,7/16/2014 02:46:51,clixsense,0.5768,23398628,USA,WA,Spanaway,50.149.99.43,EPILEPSY causes SEIZURES,123,75,,130,83,causes,0.520755643923296,904640-FS1-4,"Studies of human patients with temporal lobe epilepsy and animal models of EPILEPSY have established relationships between SEIZURES excitotoxic hippocampal damage, and memory impairment.",SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503335437,7/16/2014 06:16:00,,1324081369,7/16/2014 06:15:41,clixsense,0.6893,15117831,GBR,H9,London,90.194.156.173,SEIZURES causes EPILEPSY,123,75,,130,83,causes,0.520755643923296,904640-FS1-4,"Studies of human patients with temporal lobe epilepsy and animal models of EPILEPSY have established relationships between SEIZURES excitotoxic hippocampal damage, and memory impairment.",SEIZURES,EPILEPSY,RO-has_definitional_manifestation
503335439,7/15/2014 21:06:45,,1323841683,7/15/2014 21:06:37,prodege,0.9167,2143114,CAN,BC,Vancouver,24.84.160.12,CHRONIC NEUROGENIC BLADDERS treats PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,126,211,,152,251,treats,0.304997140665209,906758-FS1-2,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335439,7/15/2014 21:18:59,,1323846805,7/15/2014 21:18:44,clixsense,0.75,16827630,GBR,A7,Birmingham,86.146.169.103,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE treats CHRONIC NEUROGENIC BLADDERS,126,211,,152,251,treats,0.304997140665209,906758-FS1-2,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335439,7/15/2014 21:27:23,,1323850387,7/15/2014 21:26:40,neodev,0.8056,18755947,GBR,H2,Accrington,80.47.185.52,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE treats CHRONIC NEUROGENIC BLADDERS,126,211,,152,251,treats,0.304997140665209,906758-FS1-2,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335439,7/15/2014 21:59:33,,1323861821,7/15/2014 21:58:36,elite,0.5972,28465503,CAN,QC,Boucherville,24.201.21.27,CHRONIC NEUROGENIC BLADDERS treats PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,126,211,,152,251,treats,0.304997140665209,906758-FS1-2,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335439,7/16/2014 01:33:39,,1323975945,7/16/2014 01:33:23,rewardsspot,0.5907,17763704,USA,VA,Manassas,198.7.62.204,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE treats CHRONIC NEUROGENIC BLADDERS,126,211,,152,251,treats,0.304997140665209,906758-FS1-2,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335439,7/16/2014 01:39:56,,1323978348,7/16/2014 01:39:37,instagc,0.5153,23149109,USA,NC,Durham,75.189.206.205,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE treats CHRONIC NEUROGENIC BLADDERS,126,211,,152,251,treats,0.304997140665209,906758-FS1-2,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335439,7/16/2014 05:41:05,,1324070540,7/16/2014 05:40:23,sendearnings,0.5972,20717796,USA,CA,San Jose,99.27.90.128,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE treats CHRONIC NEUROGENIC BLADDERS,126,211,,152,251,treats,0.304997140665209,906758-FS1-2,The response of urethral pressure to administration of an alpha stimulant was compared between a group of eight patients with CHRONIC NEUROGENIC BLADDERS as evidenced by positive denervation supersensitivity to PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE and a group of ten control patients.,CHRONIC NEUROGENIC BLADDERS,PARASYMPATHOMIMETIC BETHANECHOL CHLORIDE,RO-may_diagnose
503335442,7/15/2014 21:06:45,,1323841684,7/15/2014 21:06:37,prodege,0.9167,2143114,CAN,BC,Vancouver,24.84.160.12,EXTRACTION OF BOTH LENSES treats SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,75,20,,99,64,treats,0.650944554904119,905467-FS1-2,He had a history of SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS requiring EXTRACTION OF BOTH LENSES and operatively corrected genu valgum on both sides.,EXTRACTION OF BOTH LENSES,SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,RO-has_finding_site
503335442,7/15/2014 21:35:28,,1323853233,7/15/2014 21:34:56,clixsense,0.8861,25595227,CAN,SK,North Battleford,24.72.96.119,EXTRACTION OF BOTH LENSES treats SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,75,20,,99,64,treats,0.650944554904119,905467-FS1-2,He had a history of SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS requiring EXTRACTION OF BOTH LENSES and operatively corrected genu valgum on both sides.,EXTRACTION OF BOTH LENSES,SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,RO-has_finding_site
503335442,7/15/2014 22:09:31,,1323866375,7/15/2014 22:08:58,neodev,0.6528,11087793,GBR,K6,Southsea,82.24.115.185,EXTRACTION OF BOTH LENSES treats SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,75,20,,99,64,treats,0.650944554904119,905467-FS1-2,He had a history of SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS requiring EXTRACTION OF BOTH LENSES and operatively corrected genu valgum on both sides.,EXTRACTION OF BOTH LENSES,SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,RO-has_finding_site
503335442,7/15/2014 22:39:23,,1323880718,7/15/2014 22:38:58,instagc,0.6089,13763729,USA,,,75.182.89.225,EXTRACTION OF BOTH LENSES treats SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,75,20,,99,64,treats,0.650944554904119,905467-FS1-2,He had a history of SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS requiring EXTRACTION OF BOTH LENSES and operatively corrected genu valgum on both sides.,EXTRACTION OF BOTH LENSES,SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,RO-has_finding_site
503335442,7/16/2014 00:39:19,,1323945501,7/16/2014 00:38:40,neodev,0.7873,11460728,CAN,BC,Burnaby,70.79.16.165,EXTRACTION OF BOTH LENSES treats SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,75,20,,99,64,treats,0.650944554904119,905467-FS1-2,He had a history of SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS requiring EXTRACTION OF BOTH LENSES and operatively corrected genu valgum on both sides.,EXTRACTION OF BOTH LENSES,SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,RO-has_finding_site
503335442,7/16/2014 01:07:14,,1323960785,7/16/2014 01:06:47,bitcoinget,0.6514,28377798,GBR,,,195.166.117.126,EXTRACTION OF BOTH LENSES treats SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,75,20,,99,64,treats,0.650944554904119,905467-FS1-2,He had a history of SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS requiring EXTRACTION OF BOTH LENSES and operatively corrected genu valgum on both sides.,EXTRACTION OF BOTH LENSES,SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,RO-has_finding_site
503335442,7/16/2014 02:17:59,,1323996315,7/16/2014 02:17:45,neodev,0.4899,22098386,USA,NY,Greenwich,67.248.253.125,SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS treats EXTRACTION OF BOTH LENSES,75,20,,99,64,treats,0.650944554904119,905467-FS1-2,He had a history of SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS requiring EXTRACTION OF BOTH LENSES and operatively corrected genu valgum on both sides.,EXTRACTION OF BOTH LENSES,SEVERE OLIGOPHRENIA BILATERAL ECTOPIA LENTIS,RO-has_finding_site
503335453,7/15/2014 21:06:35,,1323841603,7/15/2014 21:06:28,prodege,0.9167,2143114,CAN,BC,Vancouver,24.84.160.12,ERECTILE DYSFUNCTION diagnosed by PAPAVERINE,3,140,,22,150,diagnosed by,0.43643578047198495,906641-FS1-13,"In ERECTILE DYSFUNCTION formerly, for both diagnostic and therapeutic purposes, intracavernous injections of papaverine and the combination PAPAVERINE/phentolamine were employed.",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
503335453,7/16/2014 01:39:56,,1323978347,7/16/2014 01:39:37,instagc,0.5153,23149109,USA,NC,Durham,75.189.206.205,ERECTILE DYSFUNCTION diagnosed by PAPAVERINE,3,140,,22,150,diagnosed by,0.43643578047198495,906641-FS1-13,"In ERECTILE DYSFUNCTION formerly, for both diagnostic and therapeutic purposes, intracavernous injections of papaverine and the combination PAPAVERINE/phentolamine were employed.",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
503335453,7/16/2014 06:23:10,,1324083903,7/16/2014 06:22:54,clixsense,0.4766,17722340,CAN,BC,Mission,50.98.185.25,PAPAVERINE diagnosed by ERECTILE DYSFUNCTION,3,140,,22,150,diagnosed by,0.43643578047198495,906641-FS1-13,"In ERECTILE DYSFUNCTION formerly, for both diagnostic and therapeutic purposes, intracavernous injections of papaverine and the combination PAPAVERINE/phentolamine were employed.",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
503335453,7/16/2014 07:52:12,,1324112800,7/16/2014 07:51:42,prodege,0.5324,9559045,USA,TX,Katy,107.204.186.172,no_relation,3,140,,22,150,diagnosed by,0.43643578047198495,906641-FS1-13,"In ERECTILE DYSFUNCTION formerly, for both diagnostic and therapeutic purposes, intracavernous injections of papaverine and the combination PAPAVERINE/phentolamine were employed.",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
503335453,7/16/2014 08:26:50,,1324123539,7/16/2014 08:25:46,cotter,0.54,7461147,USA,VA,Saluda,71.253.203.209,ERECTILE DYSFUNCTION diagnosed by PAPAVERINE,3,140,,22,150,diagnosed by,0.43643578047198495,906641-FS1-13,"In ERECTILE DYSFUNCTION formerly, for both diagnostic and therapeutic purposes, intracavernous injections of papaverine and the combination PAPAVERINE/phentolamine were employed.",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
503335453,7/16/2014 09:04:21,,1324133782,7/16/2014 09:04:16,clixsense,0.4962,19162475,GBR,M3,Frome,82.33.126.30,ERECTILE DYSFUNCTION diagnosed by PAPAVERINE,3,140,,22,150,diagnosed by,0.43643578047198495,906641-FS1-13,"In ERECTILE DYSFUNCTION formerly, for both diagnostic and therapeutic purposes, intracavernous injections of papaverine and the combination PAPAVERINE/phentolamine were employed.",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
503335453,7/16/2014 09:17:28,,1324138436,7/16/2014 09:16:23,clixsense,0.6071,27969116,NLD,04,Veendam,185.12.216.74,ERECTILE DYSFUNCTION diagnosed by PAPAVERINE,3,140,,22,150,diagnosed by,0.43643578047198495,906641-FS1-13,"In ERECTILE DYSFUNCTION formerly, for both diagnostic and therapeutic purposes, intracavernous injections of papaverine and the combination PAPAVERINE/phentolamine were employed.",ERECTILE DYSFUNCTION,PAPAVERINE,RO-may_diagnose
503335454,7/15/2014 20:57:15,,1323837134,7/15/2014 20:57:02,clixsense,0.9583,15189335,GBR,H9,London,188.29.165.120,SKIN is location of ACUTE CONTACT DERMATITIS,66,4,,69,28,is location of,0.855186110494136,905031-FS1-9,The ACUTE CONTACT DERMATITIS causes many different lesions on the SKIN,SKIN,ACUTE CONTACT DERMATITIS,RO-has_finding_site
503335454,7/15/2014 21:01:27,,1323839119,7/15/2014 21:01:19,neodev,0.875,25224036,CAN,ON,Sudbury,67.204.218.187,SKIN is location of ACUTE CONTACT DERMATITIS,66,4,,69,28,is location of,0.855186110494136,905031-FS1-9,The ACUTE CONTACT DERMATITIS causes many different lesions on the SKIN,SKIN,ACUTE CONTACT DERMATITIS,RO-has_finding_site
503335454,7/15/2014 21:07:14,,1323841843,7/15/2014 21:07:07,instagc,0.6944,25990856,USA,NV,Las Vegas,68.108.98.78,no_relation,66,4,,69,28,is location of,0.855186110494136,905031-FS1-9,The ACUTE CONTACT DERMATITIS causes many different lesions on the SKIN,SKIN,ACUTE CONTACT DERMATITIS,RO-has_finding_site
503335454,7/15/2014 21:24:58,,1323849342,7/15/2014 21:24:31,clixsense,0.7986,19803139,NLD,06,Veldhoven,212.61.84.196,SKIN is location of ACUTE CONTACT DERMATITIS,66,4,,69,28,is location of,0.855186110494136,905031-FS1-9,The ACUTE CONTACT DERMATITIS causes many different lesions on the SKIN,SKIN,ACUTE CONTACT DERMATITIS,RO-has_finding_site
503335454,7/15/2014 22:03:15,,1323863549,7/15/2014 22:02:17,elite,0.5972,28465503,CAN,QC,Boucherville,24.201.21.27,no_relation,66,4,,69,28,is location of,0.855186110494136,905031-FS1-9,The ACUTE CONTACT DERMATITIS causes many different lesions on the SKIN,SKIN,ACUTE CONTACT DERMATITIS,RO-has_finding_site
503335454,7/16/2014 00:31:36,,1323941910,7/16/2014 00:31:15,prodege,0.6712,15439740,AUS,02,Jannali,27.96.208.89,SKIN is location of ACUTE CONTACT DERMATITIS,66,4,,69,28,is location of,0.855186110494136,905031-FS1-9,The ACUTE CONTACT DERMATITIS causes many different lesions on the SKIN,SKIN,ACUTE CONTACT DERMATITIS,RO-has_finding_site
503335454,7/16/2014 02:20:22,,1323997346,7/16/2014 02:20:06,zoombucks,0.5502,4688131,CAN,BC,Vancouver,108.180.143.28,SKIN is location of ACUTE CONTACT DERMATITIS,66,4,,69,28,is location of,0.855186110494136,905031-FS1-9,The ACUTE CONTACT DERMATITIS causes many different lesions on the SKIN,SKIN,ACUTE CONTACT DERMATITIS,RO-has_finding_site
503335457,7/15/2014 20:53:58,,1323835861,7/15/2014 20:53:25,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,65,145,,84,157,diagnosed by,0.557086014531156,903632-FS1-13,The results of the study of the prevalence of antibodies against BORRELIA BURGDORFERI in three categories of subjects from the endemic region of LYME DISEASE in the northeast Croatia are reported.,BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
503335457,7/15/2014 20:55:03,,1323836315,7/15/2014 20:54:43,clixsense,0.9583,15189335,GBR,H9,London,188.29.165.120,LYME DISEASE diagnosed by BORRELIA BURGDORFERI,65,145,,84,157,diagnosed by,0.557086014531156,903632-FS1-13,The results of the study of the prevalence of antibodies against BORRELIA BURGDORFERI in three categories of subjects from the endemic region of LYME DISEASE in the northeast Croatia are reported.,BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
503335457,7/15/2014 21:31:32,,1323852000,7/15/2014 21:31:12,instagc,0.6917,28301350,GBR,O4,Torquay,89.241.101.166,no_relation,65,145,,84,157,diagnosed by,0.557086014531156,903632-FS1-13,The results of the study of the prevalence of antibodies against BORRELIA BURGDORFERI in three categories of subjects from the endemic region of LYME DISEASE in the northeast Croatia are reported.,BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
503335457,7/15/2014 21:39:03,,1323854412,7/15/2014 21:38:41,tremorgames,0.6875,24449707,CAN,QC,Laval,96.21.249.72,no_relation,65,145,,84,157,diagnosed by,0.557086014531156,903632-FS1-13,The results of the study of the prevalence of antibodies against BORRELIA BURGDORFERI in three categories of subjects from the endemic region of LYME DISEASE in the northeast Croatia are reported.,BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
503335457,7/15/2014 22:42:25,,1323882093,7/15/2014 22:42:19,instagc,0.6708,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,65,145,,84,157,diagnosed by,0.557086014531156,903632-FS1-13,The results of the study of the prevalence of antibodies against BORRELIA BURGDORFERI in three categories of subjects from the endemic region of LYME DISEASE in the northeast Croatia are reported.,BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
503335457,7/15/2014 23:31:43,,1323908590,7/15/2014 23:30:47,elite,0.6665,28397222,GBR,Y4,Usk,31.50.223.75,LYME DISEASE diagnosed by BORRELIA BURGDORFERI,65,145,,84,157,diagnosed by,0.557086014531156,903632-FS1-13,The results of the study of the prevalence of antibodies against BORRELIA BURGDORFERI in three categories of subjects from the endemic region of LYME DISEASE in the northeast Croatia are reported.,BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
503335457,7/16/2014 01:24:49,,1323971856,7/16/2014 01:24:42,tremorgames,0.6371,28013393,USA,CA,Rancho Cordova,71.197.67.37,LYME DISEASE diagnosed by BORRELIA BURGDORFERI,65,145,,84,157,diagnosed by,0.557086014531156,903632-FS1-13,The results of the study of the prevalence of antibodies against BORRELIA BURGDORFERI in three categories of subjects from the endemic region of LYME DISEASE in the northeast Croatia are reported.,BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
503335458,7/15/2014 20:54:32,,1323836089,7/15/2014 20:54:01,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,TOTAL THYROXINE treats THYROID DISEASE,154,203,,168,218,treats,0.629940788348712,906870-FS1-2,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
503335458,7/15/2014 21:31:32,,1323851993,7/15/2014 21:31:12,instagc,0.6917,28301350,GBR,O4,Torquay,89.241.101.166,TOTAL THYROXINE treats THYROID DISEASE,154,203,,168,218,treats,0.629940788348712,906870-FS1-2,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
503335458,7/16/2014 05:40:22,,1324070332,7/16/2014 05:39:38,sendearnings,0.5972,20717796,USA,CA,San Jose,99.27.90.128,TOTAL THYROXINE treats THYROID DISEASE,154,203,,168,218,treats,0.629940788348712,906870-FS1-2,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
503335458,7/16/2014 06:17:11,,1324081893,7/16/2014 06:16:47,clixsense,0.6893,15117831,GBR,H9,London,90.194.156.173,TOTAL THYROXINE treats THYROID DISEASE,154,203,,168,218,treats,0.629940788348712,906870-FS1-2,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
503335458,7/16/2014 07:10:15,,1324100760,7/16/2014 07:09:58,instagc,0.6093,18960682,GBR,,,86.29.147.112,TOTAL THYROXINE treats THYROID DISEASE,154,203,,168,218,treats,0.629940788348712,906870-FS1-2,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
503335458,7/16/2014 08:34:36,,1324125553,7/16/2014 08:33:55,eup_slw,0.6377,20818028,GBR,A7,Birmingham,92.232.139.254,TOTAL THYROXINE treats THYROID DISEASE,154,203,,168,218,treats,0.629940788348712,906870-FS1-2,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
503335458,7/16/2014 09:29:29,,1324148817,7/16/2014 09:28:58,prodege,0.7222,27934334,GBR,Q2,Wokingham,86.166.73.7,no_relation,154,203,,168,218,treats,0.629940788348712,906870-FS1-2,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
503335474,7/15/2014 22:13:59,,1323868302,7/15/2014 22:13:55,instagc,0.4861,26706653,USA,IL,Elk Grove Village,99.99.9.247,GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS causes CYCLOSPORINE,0,117,,43,129,causes,0.371390676354104,907100-FS1-4,"GRAFT VERSUS HOST DISEASE (GVHD PROPHYLAXIS was methotrexate (1 patient), cyclosporine (2 patients), methotrexate + CYCLOSPORINE (3 patients), cyclosporine + physical removal of T cells (2 patients.",GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS,CYCLOSPORINE,RO-may_prevent
503335474,7/15/2014 22:37:02,,1323879509,7/15/2014 22:36:39,instagc,0.6089,13763729,USA,,,75.182.89.225,no_relation,0,117,,43,129,causes,0.371390676354104,907100-FS1-4,"GRAFT VERSUS HOST DISEASE (GVHD PROPHYLAXIS was methotrexate (1 patient), cyclosporine (2 patients), methotrexate + CYCLOSPORINE (3 patients), cyclosporine + physical removal of T cells (2 patients.",GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS,CYCLOSPORINE,RO-may_prevent
503335474,7/16/2014 10:30:10,,1324184648,7/16/2014 10:29:24,superrewards,0.4901,26561650,NLD,06,Tilburg,84.87.179.65,no_relation,0,117,,43,129,causes,0.371390676354104,907100-FS1-4,"GRAFT VERSUS HOST DISEASE (GVHD PROPHYLAXIS was methotrexate (1 patient), cyclosporine (2 patients), methotrexate + CYCLOSPORINE (3 patients), cyclosporine + physical removal of T cells (2 patients.",GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS,CYCLOSPORINE,RO-may_prevent
503335474,7/16/2014 10:55:50,,1324195912,7/16/2014 10:55:09,clixsense,0.6653,24896327,GBR,V2,Glasgow,94.2.231.4,no_relation,0,117,,43,129,causes,0.371390676354104,907100-FS1-4,"GRAFT VERSUS HOST DISEASE (GVHD PROPHYLAXIS was methotrexate (1 patient), cyclosporine (2 patients), methotrexate + CYCLOSPORINE (3 patients), cyclosporine + physical removal of T cells (2 patients.",GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS,CYCLOSPORINE,RO-may_prevent
503335474,7/16/2014 11:29:10,,1324207284,7/16/2014 11:28:41,vivatic,0.4931,24842942,GBR,H9,London,149.254.51.63,no_relation,0,117,,43,129,causes,0.371390676354104,907100-FS1-4,"GRAFT VERSUS HOST DISEASE (GVHD PROPHYLAXIS was methotrexate (1 patient), cyclosporine (2 patients), methotrexate + CYCLOSPORINE (3 patients), cyclosporine + physical removal of T cells (2 patients.",GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS,CYCLOSPORINE,RO-may_prevent
503335474,7/16/2014 11:48:02,,1324213852,7/16/2014 11:47:34,prodege,0.5516,28039757,GBR,L8,Southport,109.155.158.54,no_relation,0,117,,43,129,causes,0.371390676354104,907100-FS1-4,"GRAFT VERSUS HOST DISEASE (GVHD PROPHYLAXIS was methotrexate (1 patient), cyclosporine (2 patients), methotrexate + CYCLOSPORINE (3 patients), cyclosporine + physical removal of T cells (2 patients.",GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS,CYCLOSPORINE,RO-may_prevent
503335474,7/16/2014 12:32:20,,1324229202,7/16/2014 12:32:13,neodev,0.0,11043386,CAN,,,162.156.205.17,CYCLOSPORINE causes GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS,0,117,,43,129,causes,0.371390676354104,907100-FS1-4,"GRAFT VERSUS HOST DISEASE (GVHD PROPHYLAXIS was methotrexate (1 patient), cyclosporine (2 patients), methotrexate + CYCLOSPORINE (3 patients), cyclosporine + physical removal of T cells (2 patients.",GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS,CYCLOSPORINE,RO-may_prevent
503335477,7/15/2014 20:53:05,,1323835595,7/15/2014 20:52:47,clixsense,1.0,27871219,NLD,07,Amsterdam,87.210.207.223,FUROSEMIDE treats OVERT CONGESTIVE HEART FAILURE,25,111,,54,121,treats,0.986393923832143,908068-FS1-2,"A 51 year old woman with OVERT CONGESTIVE HEART FAILURE with pleural and pericardial effusion was treated with FUROSEMIDE and nifedipine, leading to improvement in her condition and a decrease in effusions.",OVERT CONGESTIVE HEART FAILURE,FUROSEMIDE,RO-may_treat
503335477,7/15/2014 21:26:38,,1323850101,7/15/2014 21:26:14,neodev,0.8056,18755947,GBR,H2,Accrington,80.47.185.52,FUROSEMIDE treats OVERT CONGESTIVE HEART FAILURE,25,111,,54,121,treats,0.986393923832143,908068-FS1-2,"A 51 year old woman with OVERT CONGESTIVE HEART FAILURE with pleural and pericardial effusion was treated with FUROSEMIDE and nifedipine, leading to improvement in her condition and a decrease in effusions.",OVERT CONGESTIVE HEART FAILURE,FUROSEMIDE,RO-may_treat
503335477,7/16/2014 00:08:50,,1323928904,7/16/2014 00:08:40,clixsense,0.4942,20614047,USA,MO,Maryville,174.32.162.147,OVERT CONGESTIVE HEART FAILURE treats FUROSEMIDE,25,111,,54,121,treats,0.986393923832143,908068-FS1-2,"A 51 year old woman with OVERT CONGESTIVE HEART FAILURE with pleural and pericardial effusion was treated with FUROSEMIDE and nifedipine, leading to improvement in her condition and a decrease in effusions.",OVERT CONGESTIVE HEART FAILURE,FUROSEMIDE,RO-may_treat
503335477,7/16/2014 01:24:56,,1323971883,7/16/2014 01:24:49,tremorgames,0.6371,28013393,USA,CA,Rancho Cordova,71.197.67.37,FUROSEMIDE treats OVERT CONGESTIVE HEART FAILURE,25,111,,54,121,treats,0.986393923832143,908068-FS1-2,"A 51 year old woman with OVERT CONGESTIVE HEART FAILURE with pleural and pericardial effusion was treated with FUROSEMIDE and nifedipine, leading to improvement in her condition and a decrease in effusions.",OVERT CONGESTIVE HEART FAILURE,FUROSEMIDE,RO-may_treat
503335477,7/16/2014 01:31:59,,1323975330,7/16/2014 01:31:23,rewardsspot,0.5907,17763704,USA,VA,Manassas,198.7.62.204,FUROSEMIDE treats OVERT CONGESTIVE HEART FAILURE,25,111,,54,121,treats,0.986393923832143,908068-FS1-2,"A 51 year old woman with OVERT CONGESTIVE HEART FAILURE with pleural and pericardial effusion was treated with FUROSEMIDE and nifedipine, leading to improvement in her condition and a decrease in effusions.",OVERT CONGESTIVE HEART FAILURE,FUROSEMIDE,RO-may_treat
503335477,7/16/2014 02:18:04,,1323996353,7/16/2014 02:18:00,neodev,0.4899,22098386,USA,NY,Greenwich,67.248.253.125,OVERT CONGESTIVE HEART FAILURE treats FUROSEMIDE,25,111,,54,121,treats,0.986393923832143,908068-FS1-2,"A 51 year old woman with OVERT CONGESTIVE HEART FAILURE with pleural and pericardial effusion was treated with FUROSEMIDE and nifedipine, leading to improvement in her condition and a decrease in effusions.",OVERT CONGESTIVE HEART FAILURE,FUROSEMIDE,RO-may_treat
503335477,7/16/2014 02:45:53,,1324006539,7/16/2014 02:45:17,rewardsspot,0.7526,24482174,GBR,H9,London,46.23.68.180,FUROSEMIDE treats OVERT CONGESTIVE HEART FAILURE,25,111,,54,121,treats,0.986393923832143,908068-FS1-2,"A 51 year old woman with OVERT CONGESTIVE HEART FAILURE with pleural and pericardial effusion was treated with FUROSEMIDE and nifedipine, leading to improvement in her condition and a decrease in effusions.",OVERT CONGESTIVE HEART FAILURE,FUROSEMIDE,RO-may_treat
503335478,7/15/2014 21:01:58,,1323839404,7/15/2014 21:01:50,neodev,0.875,25224036,CAN,ON,Sudbury,67.204.218.187,MPS II diagnosed by WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,16,71,,56,77,diagnosed by,0.881917103688197,906479-FS1-13,"We report a boy WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosis of MPS II was proved by demonstrating a severe deficiency of serum and leucocyte iduronate sulphate sulphatase and an accelerated incorporation of radiosulphate into his cultured fibroblast glycosaminoglycans, which could not be corrected by the product of other typed reference MPS II cells.",WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,MPS II,RO-has_manifestation
503335478,7/15/2014 21:18:23,,1323846537,7/15/2014 21:18:00,clixsense,0.75,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,16,71,,56,77,diagnosed by,0.881917103688197,906479-FS1-13,"We report a boy WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosis of MPS II was proved by demonstrating a severe deficiency of serum and leucocyte iduronate sulphate sulphatase and an accelerated incorporation of radiosulphate into his cultured fibroblast glycosaminoglycans, which could not be corrected by the product of other typed reference MPS II cells.",WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,MPS II,RO-has_manifestation
503335478,7/15/2014 21:21:05,,1323847570,7/15/2014 21:20:39,neodev,0.6597,21515166,NLD,11,Nootdorp,83.86.58.179,MPS II diagnosed by WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,16,71,,56,77,diagnosed by,0.881917103688197,906479-FS1-13,"We report a boy WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosis of MPS II was proved by demonstrating a severe deficiency of serum and leucocyte iduronate sulphate sulphatase and an accelerated incorporation of radiosulphate into his cultured fibroblast glycosaminoglycans, which could not be corrected by the product of other typed reference MPS II cells.",WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,MPS II,RO-has_manifestation
503335478,7/15/2014 21:22:55,,1323848447,7/15/2014 21:22:38,elite,0.8125,28276268,USA,MI,Taylor,67.149.247.166,WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosed by MPS II,16,71,,56,77,diagnosed by,0.881917103688197,906479-FS1-13,"We report a boy WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosis of MPS II was proved by demonstrating a severe deficiency of serum and leucocyte iduronate sulphate sulphatase and an accelerated incorporation of radiosulphate into his cultured fibroblast glycosaminoglycans, which could not be corrected by the product of other typed reference MPS II cells.",WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,MPS II,RO-has_manifestation
503335478,7/16/2014 05:42:06,,1324070809,7/16/2014 05:41:44,sendearnings,0.5972,20717796,USA,CA,San Jose,99.27.90.128,WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosed by MPS II,16,71,,56,77,diagnosed by,0.881917103688197,906479-FS1-13,"We report a boy WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosis of MPS II was proved by demonstrating a severe deficiency of serum and leucocyte iduronate sulphate sulphatase and an accelerated incorporation of radiosulphate into his cultured fibroblast glycosaminoglycans, which could not be corrected by the product of other typed reference MPS II cells.",WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,MPS II,RO-has_manifestation
503335478,7/16/2014 08:08:20,,1324117830,7/16/2014 08:07:45,instagc,0.6736,20183814,USA,,,166.182.83.84,no_relation,16,71,,56,77,diagnosed by,0.881917103688197,906479-FS1-13,"We report a boy WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosis of MPS II was proved by demonstrating a severe deficiency of serum and leucocyte iduronate sulphate sulphatase and an accelerated incorporation of radiosulphate into his cultured fibroblast glycosaminoglycans, which could not be corrected by the product of other typed reference MPS II cells.",WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,MPS II,RO-has_manifestation
503335478,7/16/2014 08:33:26,,1324125283,7/16/2014 08:32:54,eup_slw,0.6377,20818028,GBR,A7,Birmingham,92.232.139.254,WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosed by MPS II,16,71,,56,77,diagnosed by,0.881917103688197,906479-FS1-13,"We report a boy WITH MARKED CLINICAL KYPHOSIS IN WHOM THE diagnosis of MPS II was proved by demonstrating a severe deficiency of serum and leucocyte iduronate sulphate sulphatase and an accelerated incorporation of radiosulphate into his cultured fibroblast glycosaminoglycans, which could not be corrected by the product of other typed reference MPS II cells.",WITH MARKED CLINICAL KYPHOSIS IN WHOM THE,MPS II,RO-has_manifestation
503335482,7/15/2014 21:13:33,,1323844583,7/15/2014 21:13:12,elite,0.6944,28503042,USA,NJ,Woodbridge,54.191.150.115,OSTEOID OSTEOMA diagnosed by PAIN,59,20,,62,35,diagnosed by,0.474712663277541,901848-FS1-13,In the diagnosis of OSTEOID OSTEOMA a history of relief of PAIN with aspirin is important.,PAIN,OSTEOID OSTEOMA,RO-disease_has_finding
503335482,7/15/2014 22:01:24,,1323862759,7/15/2014 22:00:35,elite,0.5972,28465503,CAN,QC,Boucherville,24.201.21.27,no_relation,59,20,,62,35,diagnosed by,0.474712663277541,901848-FS1-13,In the diagnosis of OSTEOID OSTEOMA a history of relief of PAIN with aspirin is important.,PAIN,OSTEOID OSTEOMA,RO-disease_has_finding
503335482,7/15/2014 22:10:32,,1323866868,7/15/2014 22:09:59,neodev,0.6528,11087793,GBR,K6,Southsea,82.24.115.185,no_relation,59,20,,62,35,diagnosed by,0.474712663277541,901848-FS1-13,In the diagnosis of OSTEOID OSTEOMA a history of relief of PAIN with aspirin is important.,PAIN,OSTEOID OSTEOMA,RO-disease_has_finding
503335482,7/15/2014 22:38:33,,1323880327,7/15/2014 22:38:03,instagc,0.6089,13763729,USA,,,75.182.89.225,OSTEOID OSTEOMA diagnosed by PAIN,59,20,,62,35,diagnosed by,0.474712663277541,901848-FS1-13,In the diagnosis of OSTEOID OSTEOMA a history of relief of PAIN with aspirin is important.,PAIN,OSTEOID OSTEOMA,RO-disease_has_finding
503335482,7/16/2014 01:06:11,,1323960187,7/16/2014 01:05:25,bitcoinget,0.6514,28377798,GBR,,,195.166.117.126,OSTEOID OSTEOMA diagnosed by PAIN,59,20,,62,35,diagnosed by,0.474712663277541,901848-FS1-13,In the diagnosis of OSTEOID OSTEOMA a history of relief of PAIN with aspirin is important.,PAIN,OSTEOID OSTEOMA,RO-disease_has_finding
503335482,7/16/2014 02:17:29,,1323996042,7/16/2014 02:16:55,neodev,0.4899,22098386,USA,NY,Greenwich,67.248.253.125,PAIN diagnosed by OSTEOID OSTEOMA,59,20,,62,35,diagnosed by,0.474712663277541,901848-FS1-13,In the diagnosis of OSTEOID OSTEOMA a history of relief of PAIN with aspirin is important.,PAIN,OSTEOID OSTEOMA,RO-disease_has_finding
503335482,7/16/2014 02:55:02,,1324009333,7/16/2014 02:54:16,clixsense,0.5768,23398628,USA,WA,Spanaway,50.149.99.43,OSTEOID OSTEOMA diagnosed by PAIN,59,20,,62,35,diagnosed by,0.474712663277541,901848-FS1-13,In the diagnosis of OSTEOID OSTEOMA a history of relief of PAIN with aspirin is important.,PAIN,OSTEOID OSTEOMA,RO-disease_has_finding
503335483,7/15/2014 21:18:23,,1323846542,7/15/2014 21:18:00,clixsense,0.75,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,32,59,,35,77,diagnosed by,0.5488212999484521,905296-FS1-13,Histological examination of the SKIN was consistent with a LICHENOID ERUPTION in all cases.,SKIN,LICHENOID ERUPTION,RO-has_finding_site
503335483,7/15/2014 21:57:35,,1323860855,7/15/2014 21:57:03,prodege,0.7389,28255346,GBR,L9,Sheffield,2.125.183.137,no_relation,32,59,,35,77,diagnosed by,0.5488212999484521,905296-FS1-13,Histological examination of the SKIN was consistent with a LICHENOID ERUPTION in all cases.,SKIN,LICHENOID ERUPTION,RO-has_finding_site
503335483,7/15/2014 22:08:15,,1323865867,7/15/2014 22:07:25,neodev,0.6528,11087793,GBR,K6,Southsea,82.24.115.185,LICHENOID ERUPTION diagnosed by SKIN,32,59,,35,77,diagnosed by,0.5488212999484521,905296-FS1-13,Histological examination of the SKIN was consistent with a LICHENOID ERUPTION in all cases.,SKIN,LICHENOID ERUPTION,RO-has_finding_site
503335483,7/15/2014 22:38:57,,1323880526,7/15/2014 22:38:35,instagc,0.6089,13763729,USA,,,75.182.89.225,SKIN diagnosed by LICHENOID ERUPTION,32,59,,35,77,diagnosed by,0.5488212999484521,905296-FS1-13,Histological examination of the SKIN was consistent with a LICHENOID ERUPTION in all cases.,SKIN,LICHENOID ERUPTION,RO-has_finding_site
503335483,7/16/2014 01:39:06,,1323978048,7/16/2014 01:38:46,instagc,0.5153,23149109,USA,NC,Durham,75.189.206.205,SKIN diagnosed by LICHENOID ERUPTION,32,59,,35,77,diagnosed by,0.5488212999484521,905296-FS1-13,Histological examination of the SKIN was consistent with a LICHENOID ERUPTION in all cases.,SKIN,LICHENOID ERUPTION,RO-has_finding_site
503335483,7/16/2014 02:46:54,,1324006855,7/16/2014 02:46:28,rewardsspot,0.7526,24482174,GBR,H9,London,46.23.68.180,no_relation,32,59,,35,77,diagnosed by,0.5488212999484521,905296-FS1-13,Histological examination of the SKIN was consistent with a LICHENOID ERUPTION in all cases.,SKIN,LICHENOID ERUPTION,RO-has_finding_site
503335483,7/16/2014 02:52:46,,1324008630,7/16/2014 02:51:59,clixsense,0.5768,23398628,USA,WA,Spanaway,50.149.99.43,no_relation,32,59,,35,77,diagnosed by,0.5488212999484521,905296-FS1-13,Histological examination of the SKIN was consistent with a LICHENOID ERUPTION in all cases.,SKIN,LICHENOID ERUPTION,RO-has_finding_site
503335490,7/15/2014 21:23:48,,1323848862,7/15/2014 21:23:06,clixsense,0.7986,19803139,NLD,06,Veldhoven,212.61.84.196,HYDROCORTISONE treats INFLAMMATION,158,124,,169,138,treats,0.9838699100999069,908222-FS1-2,Daktacort treatment induced a significant improvement of all symptoms within 1 week and was superior to both miconazole and HYDROCORTISONE in suppressing the INFLAMMATION,INFLAMMATION,HYDROCORTISONE,RO-may_treat
503335490,7/15/2014 21:24:12,,1323849011,7/15/2014 21:23:54,elite,0.8125,28276268,USA,MI,Taylor,67.149.247.166,HYDROCORTISONE treats INFLAMMATION,158,124,,169,138,treats,0.9838699100999069,908222-FS1-2,Daktacort treatment induced a significant improvement of all symptoms within 1 week and was superior to both miconazole and HYDROCORTISONE in suppressing the INFLAMMATION,INFLAMMATION,HYDROCORTISONE,RO-may_treat
503335490,7/15/2014 21:36:26,,1323853576,7/15/2014 21:36:09,clixsense,0.8861,25595227,CAN,SK,North Battleford,24.72.96.119,HYDROCORTISONE treats INFLAMMATION,158,124,,169,138,treats,0.9838699100999069,908222-FS1-2,Daktacort treatment induced a significant improvement of all symptoms within 1 week and was superior to both miconazole and HYDROCORTISONE in suppressing the INFLAMMATION,INFLAMMATION,HYDROCORTISONE,RO-may_treat
503335490,7/15/2014 21:40:09,,1323854711,7/15/2014 21:39:54,tremorgames,0.6875,24449707,CAN,QC,Laval,96.21.249.72,HYDROCORTISONE treats INFLAMMATION,158,124,,169,138,treats,0.9838699100999069,908222-FS1-2,Daktacort treatment induced a significant improvement of all symptoms within 1 week and was superior to both miconazole and HYDROCORTISONE in suppressing the INFLAMMATION,INFLAMMATION,HYDROCORTISONE,RO-may_treat
503335490,7/16/2014 02:46:54,,1324006856,7/16/2014 02:46:28,rewardsspot,0.7526,24482174,GBR,H9,London,46.23.68.180,HYDROCORTISONE treats INFLAMMATION,158,124,,169,138,treats,0.9838699100999069,908222-FS1-2,Daktacort treatment induced a significant improvement of all symptoms within 1 week and was superior to both miconazole and HYDROCORTISONE in suppressing the INFLAMMATION,INFLAMMATION,HYDROCORTISONE,RO-may_treat
503335490,7/16/2014 04:21:53,,1324044843,7/16/2014 04:21:31,instagc,0.6288,27770607,USA,TX,El Paso,72.183.248.75,HYDROCORTISONE treats INFLAMMATION,158,124,,169,138,treats,0.9838699100999069,908222-FS1-2,Daktacort treatment induced a significant improvement of all symptoms within 1 week and was superior to both miconazole and HYDROCORTISONE in suppressing the INFLAMMATION,INFLAMMATION,HYDROCORTISONE,RO-may_treat
503335490,7/16/2014 06:24:27,,1324084357,7/16/2014 06:24:09,clixsense,0.4766,17722340,CAN,BC,Mission,50.98.185.25,HYDROCORTISONE treats INFLAMMATION,158,124,,169,138,treats,0.9838699100999069,908222-FS1-2,Daktacort treatment induced a significant improvement of all symptoms within 1 week and was superior to both miconazole and HYDROCORTISONE in suppressing the INFLAMMATION,INFLAMMATION,HYDROCORTISONE,RO-may_treat
503335500,7/15/2014 21:59:33,,1323861815,7/15/2014 21:58:36,elite,0.5972,28465503,CAN,QC,Boucherville,24.201.21.27,no_relation,248,224,,264,240,diagnosed by,0.338061701891407,907823-FS1-13,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
503335500,7/16/2014 00:32:26,,1323942297,7/16/2014 00:31:38,prodege,0.6712,15439740,AUS,02,Jannali,27.96.208.89,no_relation,248,224,,264,240,diagnosed by,0.338061701891407,907823-FS1-13,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
503335500,7/16/2014 02:25:20,,1323999381,7/16/2014 02:24:28,instagc,0.7429,28519532,USA,IA,Honey Creek,12.73.110.156,no_relation,248,224,,264,240,diagnosed by,0.338061701891407,907823-FS1-13,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
503335500,7/16/2014 06:16:27,,1324081584,7/16/2014 06:16:01,clixsense,0.6893,15117831,GBR,H9,London,90.194.156.173,no_relation,248,224,,264,240,diagnosed by,0.338061701891407,907823-FS1-13,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
503335500,7/16/2014 07:10:56,,1324100979,7/16/2014 07:10:32,instagc,0.6093,18960682,GBR,,,86.29.147.112,no_relation,248,224,,264,240,diagnosed by,0.338061701891407,907823-FS1-13,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
503335500,7/16/2014 07:28:59,,1324106780,7/16/2014 07:28:06,vivatic,0.6569,25451531,GBR,,,83.67.28.193,no_relation,248,224,,264,240,diagnosed by,0.338061701891407,907823-FS1-13,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
503335500,7/16/2014 10:29:23,,1324184326,7/16/2014 10:28:34,superrewards,0.4901,26561650,NLD,06,Tilburg,84.87.179.65,AGENTS (ATROPINE diagnosed by ARREST ARRHYTHMIA,248,224,,264,240,diagnosed by,0.338061701891407,907823-FS1-13,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
503335507,7/15/2014 20:56:29,,1323836849,7/15/2014 20:55:28,clixsense,0.9583,15189335,GBR,H9,London,188.29.165.120,no_relation,62,0,,96,16,causes,0.979957887012223,901643-FS1-4,OSTEOID OSTEOMAS are characterized clinically by a pattern of NOCTURNAL PAIN WHICH IS EXQUISITELY sensitive to salicylates.,NOCTURNAL PAIN WHICH IS EXQUISITELY,OSTEOID OSTEOMAS,RO-disease_has_finding
503335507,7/15/2014 21:18:39,,1323846656,7/15/2014 21:18:25,elite,0.6944,28503042,USA,NJ,Woodbridge,54.191.150.115,OSTEOID OSTEOMAS causes NOCTURNAL PAIN WHICH IS EXQUISITELY,62,0,,96,16,causes,0.979957887012223,901643-FS1-4,OSTEOID OSTEOMAS are characterized clinically by a pattern of NOCTURNAL PAIN WHICH IS EXQUISITELY sensitive to salicylates.,NOCTURNAL PAIN WHICH IS EXQUISITELY,OSTEOID OSTEOMAS,RO-disease_has_finding
503335507,7/15/2014 21:20:38,,1323847424,7/15/2014 21:20:02,neodev,0.6597,21515166,NLD,11,Nootdorp,83.86.58.179,OSTEOID OSTEOMAS causes NOCTURNAL PAIN WHICH IS EXQUISITELY,62,0,,96,16,causes,0.979957887012223,901643-FS1-4,OSTEOID OSTEOMAS are characterized clinically by a pattern of NOCTURNAL PAIN WHICH IS EXQUISITELY sensitive to salicylates.,NOCTURNAL PAIN WHICH IS EXQUISITELY,OSTEOID OSTEOMAS,RO-disease_has_finding
503335507,7/15/2014 22:27:34,,1323874567,7/15/2014 22:27:26,clixsense,0.7236,7265596,USA,IA,Neola,199.120.116.136,OSTEOID OSTEOMAS causes NOCTURNAL PAIN WHICH IS EXQUISITELY,62,0,,96,16,causes,0.979957887012223,901643-FS1-4,OSTEOID OSTEOMAS are characterized clinically by a pattern of NOCTURNAL PAIN WHICH IS EXQUISITELY sensitive to salicylates.,NOCTURNAL PAIN WHICH IS EXQUISITELY,OSTEOID OSTEOMAS,RO-disease_has_finding
503335507,7/16/2014 00:40:05,,1323945878,7/16/2014 00:39:20,neodev,0.7873,11460728,CAN,BC,Burnaby,70.79.16.165,OSTEOID OSTEOMAS causes NOCTURNAL PAIN WHICH IS EXQUISITELY,62,0,,96,16,causes,0.979957887012223,901643-FS1-4,OSTEOID OSTEOMAS are characterized clinically by a pattern of NOCTURNAL PAIN WHICH IS EXQUISITELY sensitive to salicylates.,NOCTURNAL PAIN WHICH IS EXQUISITELY,OSTEOID OSTEOMAS,RO-disease_has_finding
503335507,7/16/2014 01:05:23,,1323959739,7/16/2014 01:04:55,bitcoinget,0.6514,28377798,GBR,,,195.166.117.126,OSTEOID OSTEOMAS causes NOCTURNAL PAIN WHICH IS EXQUISITELY,62,0,,96,16,causes,0.979957887012223,901643-FS1-4,OSTEOID OSTEOMAS are characterized clinically by a pattern of NOCTURNAL PAIN WHICH IS EXQUISITELY sensitive to salicylates.,NOCTURNAL PAIN WHICH IS EXQUISITELY,OSTEOID OSTEOMAS,RO-disease_has_finding
503335507,7/16/2014 05:08:20,,1324060832,7/16/2014 05:07:43,eup_slw,0.7258,28186528,USA,IN,Bloomington,74.204.124.9,OSTEOID OSTEOMAS causes NOCTURNAL PAIN WHICH IS EXQUISITELY,62,0,,96,16,causes,0.979957887012223,901643-FS1-4,OSTEOID OSTEOMAS are characterized clinically by a pattern of NOCTURNAL PAIN WHICH IS EXQUISITELY sensitive to salicylates.,NOCTURNAL PAIN WHICH IS EXQUISITELY,OSTEOID OSTEOMAS,RO-disease_has_finding
503335513,7/15/2014 20:55:25,,1323836439,7/15/2014 20:54:41,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,236,297,,265,300,causes,0.468521285665818,902931-FS1-4,"The M3 subtype of AML, also known as acute promyelocytic leukemia, is almost universally treated with the drug ATRA (all trans retinoic acid) in addition to induction chemotherapy.[36][37][38] Care must be taken to prevent disseminated INTRAVASCULAR COAGULATION (DIC complicating the treatment of APL when the promyelocytes release the contents of their granules into the peripheral circulation.",INTRAVASCULAR COAGULATION (DIC,APL,RO-disease_may_have_finding
503335513,7/15/2014 21:14:04,,1323844818,7/15/2014 21:13:34,elite,0.6944,28503042,USA,NJ,Woodbridge,54.191.150.115,APL causes INTRAVASCULAR COAGULATION (DIC,236,297,,265,300,causes,0.468521285665818,902931-FS1-4,"The M3 subtype of AML, also known as acute promyelocytic leukemia, is almost universally treated with the drug ATRA (all trans retinoic acid) in addition to induction chemotherapy.[36][37][38] Care must be taken to prevent disseminated INTRAVASCULAR COAGULATION (DIC complicating the treatment of APL when the promyelocytes release the contents of their granules into the peripheral circulation.",INTRAVASCULAR COAGULATION (DIC,APL,RO-disease_may_have_finding
503335513,7/16/2014 00:10:32,,1323930132,7/16/2014 00:09:58,clixsense,0.4942,20614047,USA,MO,Maryville,174.32.162.147,INTRAVASCULAR COAGULATION (DIC causes APL,236,297,,265,300,causes,0.468521285665818,902931-FS1-4,"The M3 subtype of AML, also known as acute promyelocytic leukemia, is almost universally treated with the drug ATRA (all trans retinoic acid) in addition to induction chemotherapy.[36][37][38] Care must be taken to prevent disseminated INTRAVASCULAR COAGULATION (DIC complicating the treatment of APL when the promyelocytes release the contents of their granules into the peripheral circulation.",INTRAVASCULAR COAGULATION (DIC,APL,RO-disease_may_have_finding
503335513,7/16/2014 05:41:43,,1324070716,7/16/2014 05:41:06,sendearnings,0.5972,20717796,USA,CA,San Jose,99.27.90.128,INTRAVASCULAR COAGULATION (DIC causes APL,236,297,,265,300,causes,0.468521285665818,902931-FS1-4,"The M3 subtype of AML, also known as acute promyelocytic leukemia, is almost universally treated with the drug ATRA (all trans retinoic acid) in addition to induction chemotherapy.[36][37][38] Care must be taken to prevent disseminated INTRAVASCULAR COAGULATION (DIC complicating the treatment of APL when the promyelocytes release the contents of their granules into the peripheral circulation.",INTRAVASCULAR COAGULATION (DIC,APL,RO-disease_may_have_finding
503335513,7/16/2014 09:04:21,,1324133784,7/16/2014 09:04:16,clixsense,0.4962,19162475,GBR,M3,Frome,82.33.126.30,APL causes INTRAVASCULAR COAGULATION (DIC,236,297,,265,300,causes,0.468521285665818,902931-FS1-4,"The M3 subtype of AML, also known as acute promyelocytic leukemia, is almost universally treated with the drug ATRA (all trans retinoic acid) in addition to induction chemotherapy.[36][37][38] Care must be taken to prevent disseminated INTRAVASCULAR COAGULATION (DIC complicating the treatment of APL when the promyelocytes release the contents of their granules into the peripheral circulation.",INTRAVASCULAR COAGULATION (DIC,APL,RO-disease_may_have_finding
503335513,7/16/2014 10:34:07,,1324185942,7/16/2014 10:33:19,prodege,0.6647,23999031,AUS,08,Perth,203.59.238.194,no_relation,236,297,,265,300,causes,0.468521285665818,902931-FS1-4,"The M3 subtype of AML, also known as acute promyelocytic leukemia, is almost universally treated with the drug ATRA (all trans retinoic acid) in addition to induction chemotherapy.[36][37][38] Care must be taken to prevent disseminated INTRAVASCULAR COAGULATION (DIC complicating the treatment of APL when the promyelocytes release the contents of their granules into the peripheral circulation.",INTRAVASCULAR COAGULATION (DIC,APL,RO-disease_may_have_finding
503335513,7/16/2014 11:31:19,,1324208012,7/16/2014 11:31:01,vivatic,0.4931,24842942,GBR,H9,London,149.254.51.63,no_relation,236,297,,265,300,causes,0.468521285665818,902931-FS1-4,"The M3 subtype of AML, also known as acute promyelocytic leukemia, is almost universally treated with the drug ATRA (all trans retinoic acid) in addition to induction chemotherapy.[36][37][38] Care must be taken to prevent disseminated INTRAVASCULAR COAGULATION (DIC complicating the treatment of APL when the promyelocytes release the contents of their granules into the peripheral circulation.",INTRAVASCULAR COAGULATION (DIC,APL,RO-disease_may_have_finding
503460424,7/16/2014 13:10:48,,1324245660,7/16/2014 13:10:38,clixsense,0.9167,20614047,USA,MO,Maryville,174.32.162.147,SYPHILIS treats ERYTHROMYCIN,41,0,,48,12,treats,0.9630868246861541,907476-FS1-2,ERYTHROMYCIN failure in the treatment of SYPHILIS in a pregnant woman.,SYPHILIS,ERYTHROMYCIN,RO-may_treat
503460424,7/16/2014 13:13:06,,1324246568,7/16/2014 13:12:26,instagc,0.7222,14378608,USA,NY,Brooklyn,24.189.101.95,no_relation,41,0,,48,12,treats,0.9630868246861541,907476-FS1-2,ERYTHROMYCIN failure in the treatment of SYPHILIS in a pregnant woman.,SYPHILIS,ERYTHROMYCIN,RO-may_treat
503460424,7/16/2014 13:30:14,,1324253586,7/16/2014 13:29:08,rewardsspot,0.5306,24482174,GBR,H9,London,46.23.68.180,ERYTHROMYCIN treats SYPHILIS,41,0,,48,12,treats,0.9630868246861541,907476-FS1-2,ERYTHROMYCIN failure in the treatment of SYPHILIS in a pregnant woman.,SYPHILIS,ERYTHROMYCIN,RO-may_treat
503460424,7/16/2014 13:32:56,,1324254844,7/16/2014 13:31:54,inboxpounds,0.65,22207998,GBR,N7,Banstead,86.3.88.5,ERYTHROMYCIN treats SYPHILIS,41,0,,48,12,treats,0.9630868246861541,907476-FS1-2,ERYTHROMYCIN failure in the treatment of SYPHILIS in a pregnant woman.,SYPHILIS,ERYTHROMYCIN,RO-may_treat
503460424,7/16/2014 15:09:47,,1324291899,7/16/2014 15:09:42,clixsense,0.6313,19162475,GBR,M3,Frome,82.33.126.30,ERYTHROMYCIN treats SYPHILIS,41,0,,48,12,treats,0.9630868246861541,907476-FS1-2,ERYTHROMYCIN failure in the treatment of SYPHILIS in a pregnant woman.,SYPHILIS,ERYTHROMYCIN,RO-may_treat
503460424,7/16/2014 15:39:35,,1324301791,7/16/2014 15:39:21,prodege,0.5256,15220325,USA,PA,Troy,24.229.175.37,no_relation,41,0,,48,12,treats,0.9630868246861541,907476-FS1-2,ERYTHROMYCIN failure in the treatment of SYPHILIS in a pregnant woman.,SYPHILIS,ERYTHROMYCIN,RO-may_treat
503460424,7/16/2014 15:49:30,,1324305999,7/16/2014 15:49:09,clixsense,0.58,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,41,0,,48,12,treats,0.9630868246861541,907476-FS1-2,ERYTHROMYCIN failure in the treatment of SYPHILIS in a pregnant woman.,SYPHILIS,ERYTHROMYCIN,RO-may_treat
503460425,7/16/2014 13:16:44,,1324248052,7/16/2014 13:16:10,instagc,0.7222,14378608,USA,NY,Brooklyn,24.189.101.95,BCL 2 GENE is location of FOLLICULAR LYMPHOMAS,230,207,,249,217,is location of,0.617213399848368,906095-FS1-9,"This growth enhancement was also seen in cells transfected with the BCL 2 gene with its own promoter juxtaposed to the immunoglobulin heavy chain gene enhancer, which represents the translocated form of the BCL 2 GENE observed in FOLLICULAR LYMPHOMAS with the t(14;18) translocation.",FOLLICULAR LYMPHOMAS,BCL 2 GENE,RO-has_manifestation
503460425,7/16/2014 13:19:39,,1324249173,7/16/2014 13:19:25,neodev,0.7833,25804244,USA,IL,Chicago,99.198.108.116,FOLLICULAR LYMPHOMAS is location of BCL 2 GENE,230,207,,249,217,is location of,0.617213399848368,906095-FS1-9,"This growth enhancement was also seen in cells transfected with the BCL 2 gene with its own promoter juxtaposed to the immunoglobulin heavy chain gene enhancer, which represents the translocated form of the BCL 2 GENE observed in FOLLICULAR LYMPHOMAS with the t(14;18) translocation.",FOLLICULAR LYMPHOMAS,BCL 2 GENE,RO-has_manifestation
503460425,7/16/2014 13:24:47,,1324251211,7/16/2014 13:24:13,neodev,0.6722,12115558,USA,OH,Twinsburg,75.187.196.41,FOLLICULAR LYMPHOMAS is location of BCL 2 GENE,230,207,,249,217,is location of,0.617213399848368,906095-FS1-9,"This growth enhancement was also seen in cells transfected with the BCL 2 gene with its own promoter juxtaposed to the immunoglobulin heavy chain gene enhancer, which represents the translocated form of the BCL 2 GENE observed in FOLLICULAR LYMPHOMAS with the t(14;18) translocation.",FOLLICULAR LYMPHOMAS,BCL 2 GENE,RO-has_manifestation
503460425,7/16/2014 13:27:24,,1324252435,7/16/2014 13:26:51,rewardsspot,0.5306,24482174,GBR,H9,London,46.23.68.180,no_relation,230,207,,249,217,is location of,0.617213399848368,906095-FS1-9,"This growth enhancement was also seen in cells transfected with the BCL 2 gene with its own promoter juxtaposed to the immunoglobulin heavy chain gene enhancer, which represents the translocated form of the BCL 2 GENE observed in FOLLICULAR LYMPHOMAS with the t(14;18) translocation.",FOLLICULAR LYMPHOMAS,BCL 2 GENE,RO-has_manifestation
503460425,7/16/2014 13:32:17,,1324254619,7/16/2014 13:31:33,clixsense,0.7708,6564572,USA,MI,Kalamazoo,173.46.248.170,BCL 2 GENE is location of FOLLICULAR LYMPHOMAS,230,207,,249,217,is location of,0.617213399848368,906095-FS1-9,"This growth enhancement was also seen in cells transfected with the BCL 2 gene with its own promoter juxtaposed to the immunoglobulin heavy chain gene enhancer, which represents the translocated form of the BCL 2 GENE observed in FOLLICULAR LYMPHOMAS with the t(14;18) translocation.",FOLLICULAR LYMPHOMAS,BCL 2 GENE,RO-has_manifestation
503460425,7/16/2014 13:35:30,,1324256005,7/16/2014 13:34:54,clixsense,0.7278,24896327,GBR,V2,Glasgow,94.2.231.4,BCL 2 GENE is location of FOLLICULAR LYMPHOMAS,230,207,,249,217,is location of,0.617213399848368,906095-FS1-9,"This growth enhancement was also seen in cells transfected with the BCL 2 gene with its own promoter juxtaposed to the immunoglobulin heavy chain gene enhancer, which represents the translocated form of the BCL 2 GENE observed in FOLLICULAR LYMPHOMAS with the t(14;18) translocation.",FOLLICULAR LYMPHOMAS,BCL 2 GENE,RO-has_manifestation
503460425,7/16/2014 14:17:04,,1324272332,7/16/2014 14:16:43,instagc,0.7677,28301350,GBR,K4,Plymouth,92.28.208.109,FOLLICULAR LYMPHOMAS is location of BCL 2 GENE,230,207,,249,217,is location of,0.617213399848368,906095-FS1-9,"This growth enhancement was also seen in cells transfected with the BCL 2 gene with its own promoter juxtaposed to the immunoglobulin heavy chain gene enhancer, which represents the translocated form of the BCL 2 GENE observed in FOLLICULAR LYMPHOMAS with the t(14;18) translocation.",FOLLICULAR LYMPHOMAS,BCL 2 GENE,RO-has_manifestation
503460426,7/16/2014 13:06:44,,1324244029,7/16/2014 13:06:25,clixsense,0.9583,27871219,NLD,07,Amsterdam,87.210.207.223,PREECLAMPSIA causes COMPLICATIONS OF PREGNANCY,50,134,,75,146,causes,0.722315118514615,901860-FS1-4,"This article examines the recurrence risk of four COMPLICATIONS OF PREGNANCY: gestational diabetes, preterm delivery, stillbirth, and PREECLAMPSIA",COMPLICATIONS OF PREGNANCY,PREECLAMPSIA,RO-disease_has_finding
503460426,7/16/2014 14:18:43,,1324273033,7/16/2014 14:18:25,instagc,0.7677,28301350,GBR,K4,Plymouth,92.28.208.109,PREECLAMPSIA causes COMPLICATIONS OF PREGNANCY,50,134,,75,146,causes,0.722315118514615,901860-FS1-4,"This article examines the recurrence risk of four COMPLICATIONS OF PREGNANCY: gestational diabetes, preterm delivery, stillbirth, and PREECLAMPSIA",COMPLICATIONS OF PREGNANCY,PREECLAMPSIA,RO-disease_has_finding
503460426,7/16/2014 16:53:33,,1324335889,7/16/2014 16:52:49,clixsense,0.4786,6497991,USA,NC,Clinton,204.211.52.144,COMPLICATIONS OF PREGNANCY causes PREECLAMPSIA,50,134,,75,146,causes,0.722315118514615,901860-FS1-4,"This article examines the recurrence risk of four COMPLICATIONS OF PREGNANCY: gestational diabetes, preterm delivery, stillbirth, and PREECLAMPSIA",COMPLICATIONS OF PREGNANCY,PREECLAMPSIA,RO-disease_has_finding
503460426,7/16/2014 18:01:51,,1324379689,7/16/2014 18:01:29,instagc,0.5512,28157545,USA,OR,Mcminnville,76.115.153.186,PREECLAMPSIA causes COMPLICATIONS OF PREGNANCY,50,134,,75,146,causes,0.722315118514615,901860-FS1-4,"This article examines the recurrence risk of four COMPLICATIONS OF PREGNANCY: gestational diabetes, preterm delivery, stillbirth, and PREECLAMPSIA",COMPLICATIONS OF PREGNANCY,PREECLAMPSIA,RO-disease_has_finding
503460426,7/16/2014 18:22:19,,1324398974,7/16/2014 18:22:03,gifthulk,0.6992,21916793,GBR,,,87.113.87.199,no_relation,50,134,,75,146,causes,0.722315118514615,901860-FS1-4,"This article examines the recurrence risk of four COMPLICATIONS OF PREGNANCY: gestational diabetes, preterm delivery, stillbirth, and PREECLAMPSIA",COMPLICATIONS OF PREGNANCY,PREECLAMPSIA,RO-disease_has_finding
503460426,7/16/2014 18:47:19,,1324410909,7/16/2014 18:46:44,eup_slw,0.5873,28186528,USA,IN,Bloomington,74.204.124.9,PREECLAMPSIA causes COMPLICATIONS OF PREGNANCY,50,134,,75,146,causes,0.722315118514615,901860-FS1-4,"This article examines the recurrence risk of four COMPLICATIONS OF PREGNANCY: gestational diabetes, preterm delivery, stillbirth, and PREECLAMPSIA",COMPLICATIONS OF PREGNANCY,PREECLAMPSIA,RO-disease_has_finding
503460426,7/16/2014 19:29:04,,1324434075,7/16/2014 19:28:24,clixsense,0.5333,6714657,USA,CT,Groton,71.235.184.32,PREECLAMPSIA causes COMPLICATIONS OF PREGNANCY,50,134,,75,146,causes,0.722315118514615,901860-FS1-4,"This article examines the recurrence risk of four COMPLICATIONS OF PREGNANCY: gestational diabetes, preterm delivery, stillbirth, and PREECLAMPSIA",COMPLICATIONS OF PREGNANCY,PREECLAMPSIA,RO-disease_has_finding
503460428,7/16/2014 13:22:23,,1324250288,7/16/2014 13:22:13,clixsense,0.7208,27793793,GBR,C5,Chester,151.230.27.155,QUININE SULPHATE treats MUSCLE CRAMPS,57,89,,69,105,treats,0.9918365981341758,907060-FS1-2,Nine patients on maintenance haemodialysis with frequent MUSCLE CRAMPS were given 320 mg QUININE SULPHATE or placebo (in an identical gelatin capsule) at the beginning of each dialysis for a period of 12 weeks.,MUSCLE CRAMPS,QUININE SULPHATE,RO-may_prevent
503460428,7/16/2014 13:24:19,,1324251004,7/16/2014 13:23:56,neodev,0.8806,21515166,NLD,11,Nootdorp,83.86.58.179,QUININE SULPHATE treats MUSCLE CRAMPS,57,89,,69,105,treats,0.9918365981341758,907060-FS1-2,Nine patients on maintenance haemodialysis with frequent MUSCLE CRAMPS were given 320 mg QUININE SULPHATE or placebo (in an identical gelatin capsule) at the beginning of each dialysis for a period of 12 weeks.,MUSCLE CRAMPS,QUININE SULPHATE,RO-may_prevent
503460428,7/16/2014 13:27:24,,1324252434,7/16/2014 13:26:51,rewardsspot,0.5306,24482174,GBR,H9,London,46.23.68.180,QUININE SULPHATE treats MUSCLE CRAMPS,57,89,,69,105,treats,0.9918365981341758,907060-FS1-2,Nine patients on maintenance haemodialysis with frequent MUSCLE CRAMPS were given 320 mg QUININE SULPHATE or placebo (in an identical gelatin capsule) at the beginning of each dialysis for a period of 12 weeks.,MUSCLE CRAMPS,QUININE SULPHATE,RO-may_prevent
503460428,7/16/2014 14:21:26,,1324274137,7/16/2014 14:20:34,fusioncash,0.6587,7012325,USA,CT,Stamford,24.185.182.15,QUININE SULPHATE treats MUSCLE CRAMPS,57,89,,69,105,treats,0.9918365981341758,907060-FS1-2,Nine patients on maintenance haemodialysis with frequent MUSCLE CRAMPS were given 320 mg QUININE SULPHATE or placebo (in an identical gelatin capsule) at the beginning of each dialysis for a period of 12 weeks.,MUSCLE CRAMPS,QUININE SULPHATE,RO-may_prevent
503460428,7/16/2014 15:34:34,,1324299857,7/16/2014 15:34:18,instagc,0.7538,19636746,USA,NY,Andover,192.182.216.225,QUININE SULPHATE treats MUSCLE CRAMPS,57,89,,69,105,treats,0.9918365981341758,907060-FS1-2,Nine patients on maintenance haemodialysis with frequent MUSCLE CRAMPS were given 320 mg QUININE SULPHATE or placebo (in an identical gelatin capsule) at the beginning of each dialysis for a period of 12 weeks.,MUSCLE CRAMPS,QUININE SULPHATE,RO-may_prevent
503460428,7/16/2014 15:36:09,,1324300393,7/16/2014 15:35:58,prodege,0.5498,23541832,USA,AZ,Tempe,149.169.143.104,QUININE SULPHATE treats MUSCLE CRAMPS,57,89,,69,105,treats,0.9918365981341758,907060-FS1-2,Nine patients on maintenance haemodialysis with frequent MUSCLE CRAMPS were given 320 mg QUININE SULPHATE or placebo (in an identical gelatin capsule) at the beginning of each dialysis for a period of 12 weeks.,MUSCLE CRAMPS,QUININE SULPHATE,RO-may_prevent
503460428,7/16/2014 15:43:52,,1324303638,7/16/2014 15:43:37,neodev,0.6659,27597779,CAN,AB,Calgary,72.29.251.209,QUININE SULPHATE treats MUSCLE CRAMPS,57,89,,69,105,treats,0.9918365981341758,907060-FS1-2,Nine patients on maintenance haemodialysis with frequent MUSCLE CRAMPS were given 320 mg QUININE SULPHATE or placebo (in an identical gelatin capsule) at the beginning of each dialysis for a period of 12 weeks.,MUSCLE CRAMPS,QUININE SULPHATE,RO-may_prevent
503460433,7/16/2014 13:15:51,,1324247699,7/16/2014 13:15:34,prodege,0.7917,9525153,CAN,ON,Toronto,65.95.94.44,COLESTIPOL treats SEVERE HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,57,31,,105,41,treats,0.9958932064677041,907609-FS1-2,Illingworth DR. Mevinolin plus COLESTIPOL in therapy for SEVERE HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,SEVERE HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,COLESTIPOL,RO-may_treat
503460433,7/16/2014 13:20:52,,1324249680,7/16/2014 13:20:33,prodege,0.6875,22031444,GBR,B7,Bristol,77.98.139.82,COLESTIPOL treats SEVERE HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,57,31,,105,41,treats,0.9958932064677041,907609-FS1-2,Illingworth DR. Mevinolin plus COLESTIPOL in therapy for SEVERE HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,SEVERE HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,COLESTIPOL,RO-may_treat
503460433,7/16/2014 13:27:26,,1324252444,7/16/2014 13:26:48,clixsense,0.8056,15189335,GBR,I9,Bury Saint Edmunds,81.155.129.231,COLESTIPOL treats SEVERE HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,57,31,,105,41,treats,0.9958932064677041,907609-FS1-2,Illingworth DR. Mevinolin plus COLESTIPOL in therapy for SEVERE HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,SEVERE HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,COLESTIPOL,RO-may_treat
503460433,7/16/2014 13:33:56,,1324255333,7/16/2014 13:32:57,inboxpounds,0.65,22207998,GBR,N7,Banstead,86.3.88.5,COLESTIPOL treats SEVERE HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,57,31,,105,41,treats,0.9958932064677041,907609-FS1-2,Illingworth DR. Mevinolin plus COLESTIPOL in therapy for SEVERE HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,SEVERE HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,COLESTIPOL,RO-may_treat
503460433,7/16/2014 14:21:47,,1324274289,7/16/2014 14:21:27,fusioncash,0.6587,7012325,USA,CT,Stamford,24.185.182.15,COLESTIPOL treats SEVERE HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,57,31,,105,41,treats,0.9958932064677041,907609-FS1-2,Illingworth DR. Mevinolin plus COLESTIPOL in therapy for SEVERE HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,SEVERE HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,COLESTIPOL,RO-may_treat
503460433,7/16/2014 14:53:37,,1324285576,7/16/2014 14:53:00,prodege,0.505,28039757,GBR,L8,Southport,109.155.158.54,COLESTIPOL treats SEVERE HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,57,31,,105,41,treats,0.9958932064677041,907609-FS1-2,Illingworth DR. Mevinolin plus COLESTIPOL in therapy for SEVERE HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,SEVERE HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,COLESTIPOL,RO-may_treat
503460433,7/16/2014 16:39:06,,1324330155,7/16/2014 16:38:57,prodege,0.5183,2143114,CAN,BC,Vancouver,24.84.160.12,SEVERE HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA treats COLESTIPOL,57,31,,105,41,treats,0.9958932064677041,907609-FS1-2,Illingworth DR. Mevinolin plus COLESTIPOL in therapy for SEVERE HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,SEVERE HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,COLESTIPOL,RO-may_treat
503460438,7/16/2014 13:31:29,,1324254202,7/16/2014 13:30:49,clixsense,0.7708,6564572,USA,MI,Kalamazoo,173.46.248.170,ERYTHROMYCIN treats PERTUSSIS,95,110,,103,122,treats,0.987878339907213,907514-FS1-2,Hoppe JE: Comparison of erythromycin estolate and erythromycin ethylsuccinate for treatment of PERTUSSIS: the ERYTHROMYCIN Study Group.,PERTUSSIS,ERYTHROMYCIN,RO-may_treat
503460438,7/16/2014 13:35:46,,1324256064,7/16/2014 13:35:32,clixsense,0.7278,24896327,GBR,V2,Glasgow,94.2.231.4,ERYTHROMYCIN treats PERTUSSIS,95,110,,103,122,treats,0.987878339907213,907514-FS1-2,Hoppe JE: Comparison of erythromycin estolate and erythromycin ethylsuccinate for treatment of PERTUSSIS: the ERYTHROMYCIN Study Group.,PERTUSSIS,ERYTHROMYCIN,RO-may_treat
503460438,7/16/2014 15:02:09,,1324288888,7/16/2014 15:01:19,prodege,0.6956,17780691,CAN,ON,Toronto,24.114.226.82,ERYTHROMYCIN treats PERTUSSIS,95,110,,103,122,treats,0.987878339907213,907514-FS1-2,Hoppe JE: Comparison of erythromycin estolate and erythromycin ethylsuccinate for treatment of PERTUSSIS: the ERYTHROMYCIN Study Group.,PERTUSSIS,ERYTHROMYCIN,RO-may_treat
503460438,7/16/2014 15:35:07,,1324300047,7/16/2014 15:34:35,instagc,0.7538,19636746,USA,NY,Andover,192.182.216.225,ERYTHROMYCIN treats PERTUSSIS,95,110,,103,122,treats,0.987878339907213,907514-FS1-2,Hoppe JE: Comparison of erythromycin estolate and erythromycin ethylsuccinate for treatment of PERTUSSIS: the ERYTHROMYCIN Study Group.,PERTUSSIS,ERYTHROMYCIN,RO-may_treat
503460438,7/16/2014 17:18:03,,1324343863,7/16/2014 17:17:32,clixsense,0.6583,25595227,CAN,SK,North Battleford,24.72.96.119,ERYTHROMYCIN treats PERTUSSIS,95,110,,103,122,treats,0.987878339907213,907514-FS1-2,Hoppe JE: Comparison of erythromycin estolate and erythromycin ethylsuccinate for treatment of PERTUSSIS: the ERYTHROMYCIN Study Group.,PERTUSSIS,ERYTHROMYCIN,RO-may_treat
503460438,7/16/2014 18:22:36,,1324399026,7/16/2014 18:22:20,gifthulk,0.6992,21916793,GBR,,,87.113.87.199,ERYTHROMYCIN treats PERTUSSIS,95,110,,103,122,treats,0.987878339907213,907514-FS1-2,Hoppe JE: Comparison of erythromycin estolate and erythromycin ethylsuccinate for treatment of PERTUSSIS: the ERYTHROMYCIN Study Group.,PERTUSSIS,ERYTHROMYCIN,RO-may_treat
503460438,7/16/2014 18:34:12,,1324404150,7/16/2014 18:34:02,instagc,0.4563,15445601,USA,FL,Jacksonville,24.129.68.254,ERYTHROMYCIN treats PERTUSSIS,95,110,,103,122,treats,0.987878339907213,907514-FS1-2,Hoppe JE: Comparison of erythromycin estolate and erythromycin ethylsuccinate for treatment of PERTUSSIS: the ERYTHROMYCIN Study Group.,PERTUSSIS,ERYTHROMYCIN,RO-may_treat
503460439,7/16/2014 13:08:23,,1324244725,7/16/2014 13:08:03,prodege,0.9167,7664351,USA,NY,Cicero,74.111.0.21,BRAIN is location of STROKE,84,28,,88,34,is location of,0.9630868246861541,902042-FS1-9,In most of the patients the STROKE came as a debut of vascular abnormalities in the BRAIN,BRAIN,STROKE,RO-disease_has_primary_anatomic_site
503460439,7/16/2014 13:19:58,,1324249312,7/16/2014 13:19:51,neodev,0.7833,25804244,USA,IL,Chicago,99.198.108.116,BRAIN is location of STROKE,84,28,,88,34,is location of,0.9630868246861541,902042-FS1-9,In most of the patients the STROKE came as a debut of vascular abnormalities in the BRAIN,BRAIN,STROKE,RO-disease_has_primary_anatomic_site
503460439,7/16/2014 13:23:49,,1324250779,7/16/2014 13:23:25,clixsense,0.8056,15189335,GBR,I9,Bury Saint Edmunds,81.155.129.231,BRAIN is location of STROKE,84,28,,88,34,is location of,0.9630868246861541,902042-FS1-9,In most of the patients the STROKE came as a debut of vascular abnormalities in the BRAIN,BRAIN,STROKE,RO-disease_has_primary_anatomic_site
503460439,7/16/2014 13:30:58,,1324253975,7/16/2014 13:30:20,rewardsspot,0.5306,24482174,GBR,H9,London,46.23.68.180,BRAIN is location of STROKE,84,28,,88,34,is location of,0.9630868246861541,902042-FS1-9,In most of the patients the STROKE came as a debut of vascular abnormalities in the BRAIN,BRAIN,STROKE,RO-disease_has_primary_anatomic_site
503460439,7/16/2014 14:54:22,,1324285798,7/16/2014 14:53:58,prodege,0.505,28039757,GBR,L8,Southport,109.155.158.54,BRAIN is location of STROKE,84,28,,88,34,is location of,0.9630868246861541,902042-FS1-9,In most of the patients the STROKE came as a debut of vascular abnormalities in the BRAIN,BRAIN,STROKE,RO-disease_has_primary_anatomic_site
503460439,7/16/2014 16:38:36,,1324329833,7/16/2014 16:38:25,neodev,0.5359,14861092,GBR,H9,London,90.194.156.173,BRAIN is location of STROKE,84,28,,88,34,is location of,0.9630868246861541,902042-FS1-9,In most of the patients the STROKE came as a debut of vascular abnormalities in the BRAIN,BRAIN,STROKE,RO-disease_has_primary_anatomic_site
503460439,7/16/2014 16:38:56,,1324330049,7/16/2014 16:38:45,prodege,0.5183,2143114,CAN,BC,Vancouver,24.84.160.12,STROKE is location of BRAIN,84,28,,88,34,is location of,0.9630868246861541,902042-FS1-9,In most of the patients the STROKE came as a debut of vascular abnormalities in the BRAIN,BRAIN,STROKE,RO-disease_has_primary_anatomic_site
503460451,7/16/2014 13:27:26,,1324252442,7/16/2014 13:26:48,clixsense,0.8056,15189335,GBR,I9,Bury Saint Edmunds,81.155.129.231,MONTELUKAST treats ASTHMA,53,135,,58,146,treats,0.9539980920057242,907799-FS1-2,Because montelukast is efficacious for patients with ASTHMA selected patients with mild asthma and rhinitis may be good candidates for MONTELUKAST.,ASTHMA,MONTELUKAST,RO-may_treat
503460451,7/16/2014 14:25:37,,1324275797,7/16/2014 14:25:16,rewardsspot,0.6855,17763704,USA,VA,Manassas,198.7.62.204,MONTELUKAST treats ASTHMA,53,135,,58,146,treats,0.9539980920057242,907799-FS1-2,Because montelukast is efficacious for patients with ASTHMA selected patients with mild asthma and rhinitis may be good candidates for MONTELUKAST.,ASTHMA,MONTELUKAST,RO-may_treat
503460451,7/16/2014 15:14:24,,1324293440,7/16/2014 15:13:29,elite,0.5194,28276268,USA,MI,Fenton,68.188.185.225,ASTHMA treats MONTELUKAST,53,135,,58,146,treats,0.9539980920057242,907799-FS1-2,Because montelukast is efficacious for patients with ASTHMA selected patients with mild asthma and rhinitis may be good candidates for MONTELUKAST.,ASTHMA,MONTELUKAST,RO-may_treat
503460451,7/16/2014 15:48:57,,1324305765,7/16/2014 15:48:35,clixsense,0.58,16827630,GBR,A7,Birmingham,86.146.169.103,MONTELUKAST treats ASTHMA,53,135,,58,146,treats,0.9539980920057242,907799-FS1-2,Because montelukast is efficacious for patients with ASTHMA selected patients with mild asthma and rhinitis may be good candidates for MONTELUKAST.,ASTHMA,MONTELUKAST,RO-may_treat
503460451,7/16/2014 17:19:28,,1324344230,7/16/2014 17:18:47,prodege,0.521,19026375,GBR,Z1,Swansea,92.26.69.100,MONTELUKAST treats ASTHMA,53,135,,58,146,treats,0.9539980920057242,907799-FS1-2,Because montelukast is efficacious for patients with ASTHMA selected patients with mild asthma and rhinitis may be good candidates for MONTELUKAST.,ASTHMA,MONTELUKAST,RO-may_treat
503460451,7/16/2014 17:27:09,,1324347279,7/16/2014 17:26:49,clixsense,0.6583,25595227,CAN,SK,North Battleford,24.72.96.119,MONTELUKAST treats ASTHMA,53,135,,58,146,treats,0.9539980920057242,907799-FS1-2,Because montelukast is efficacious for patients with ASTHMA selected patients with mild asthma and rhinitis may be good candidates for MONTELUKAST.,ASTHMA,MONTELUKAST,RO-may_treat
503460451,7/16/2014 17:44:40,,1324361623,7/16/2014 17:44:09,clixsense,0.6621,23398628,USA,WA,Spanaway,50.149.99.43,MONTELUKAST treats ASTHMA,53,135,,58,146,treats,0.9539980920057242,907799-FS1-2,Because montelukast is efficacious for patients with ASTHMA selected patients with mild asthma and rhinitis may be good candidates for MONTELUKAST.,ASTHMA,MONTELUKAST,RO-may_treat
503460453,7/16/2014 13:33:23,,1324255067,7/16/2014 13:32:52,clixsense,0.7708,6564572,USA,MI,Kalamazoo,173.46.248.170,FLUORIDE treats CARIES,243,188,,248,196,treats,0.9761870601839531,907105-FS1-2,"This paper reviewed clinical studies and found that fluoride varnish's effectiveness in caries prevention, ease of application, and safety give it an advantage over other types of topical FLUORIDE treatments (such as gels and rinses) or other CARIES management methods.",CARIES,FLUORIDE,RO-may_prevent
503460453,7/16/2014 15:43:52,,1324303639,7/16/2014 15:43:37,neodev,0.6659,27597779,CAN,AB,Calgary,72.29.251.209,no_relation,243,188,,248,196,treats,0.9761870601839531,907105-FS1-2,"This paper reviewed clinical studies and found that fluoride varnish's effectiveness in caries prevention, ease of application, and safety give it an advantage over other types of topical FLUORIDE treatments (such as gels and rinses) or other CARIES management methods.",CARIES,FLUORIDE,RO-may_prevent
503460453,7/16/2014 15:50:03,,1324306232,7/16/2014 15:49:49,clixsense,0.58,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,243,188,,248,196,treats,0.9761870601839531,907105-FS1-2,"This paper reviewed clinical studies and found that fluoride varnish's effectiveness in caries prevention, ease of application, and safety give it an advantage over other types of topical FLUORIDE treatments (such as gels and rinses) or other CARIES management methods.",CARIES,FLUORIDE,RO-may_prevent
503460453,7/16/2014 16:54:23,,1324336123,7/16/2014 16:53:34,clixsense,0.4786,6497991,USA,NC,Clinton,204.211.52.144,FLUORIDE treats CARIES,243,188,,248,196,treats,0.9761870601839531,907105-FS1-2,"This paper reviewed clinical studies and found that fluoride varnish's effectiveness in caries prevention, ease of application, and safety give it an advantage over other types of topical FLUORIDE treatments (such as gels and rinses) or other CARIES management methods.",CARIES,FLUORIDE,RO-may_prevent
503460453,7/16/2014 16:56:11,,1324336773,7/16/2014 16:55:13,instagc,0.6306,14941596,USA,KY,Erlanger,74.140.124.145,FLUORIDE treats CARIES,243,188,,248,196,treats,0.9761870601839531,907105-FS1-2,"This paper reviewed clinical studies and found that fluoride varnish's effectiveness in caries prevention, ease of application, and safety give it an advantage over other types of topical FLUORIDE treatments (such as gels and rinses) or other CARIES management methods.",CARIES,FLUORIDE,RO-may_prevent
503460453,7/16/2014 18:34:02,,1324404051,7/16/2014 18:33:49,instagc,0.4563,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,243,188,,248,196,treats,0.9761870601839531,907105-FS1-2,"This paper reviewed clinical studies and found that fluoride varnish's effectiveness in caries prevention, ease of application, and safety give it an advantage over other types of topical FLUORIDE treatments (such as gels and rinses) or other CARIES management methods.",CARIES,FLUORIDE,RO-may_prevent
503460453,7/16/2014 18:46:43,,1324410565,7/16/2014 18:45:58,eup_slw,0.5873,28186528,USA,IN,Bloomington,74.204.124.9,no_relation,243,188,,248,196,treats,0.9761870601839531,907105-FS1-2,"This paper reviewed clinical studies and found that fluoride varnish's effectiveness in caries prevention, ease of application, and safety give it an advantage over other types of topical FLUORIDE treatments (such as gels and rinses) or other CARIES management methods.",CARIES,FLUORIDE,RO-may_prevent
503460454,7/16/2014 13:08:02,,1324244549,7/16/2014 13:07:30,prodege,0.9167,7664351,USA,NY,Cicero,74.111.0.21,MYASTHENIA GRAVIS diagnosed by NEOSTIGMINE,0,46,,16,57,diagnosed by,0.997054485501582,906866-FS1-13,MYASTHENIA GRAVIS was confirmed by a positive NEOSTIGMINE test.,MYASTHENIA GRAVIS,NEOSTIGMINE,RO-may_diagnose
503460454,7/16/2014 13:24:52,,1324251253,7/16/2014 13:24:24,neodev,0.8806,21515166,NLD,11,Nootdorp,83.86.58.179,MYASTHENIA GRAVIS diagnosed by NEOSTIGMINE,0,46,,16,57,diagnosed by,0.997054485501582,906866-FS1-13,MYASTHENIA GRAVIS was confirmed by a positive NEOSTIGMINE test.,MYASTHENIA GRAVIS,NEOSTIGMINE,RO-may_diagnose
503460454,7/16/2014 14:30:12,,1324277684,7/16/2014 14:29:34,vivatic,0.5899,25451531,GBR,,,83.67.28.193,MYASTHENIA GRAVIS diagnosed by NEOSTIGMINE,0,46,,16,57,diagnosed by,0.997054485501582,906866-FS1-13,MYASTHENIA GRAVIS was confirmed by a positive NEOSTIGMINE test.,MYASTHENIA GRAVIS,NEOSTIGMINE,RO-may_diagnose
503460454,7/16/2014 15:00:10,,1324288005,7/16/2014 14:59:13,prodege,0.6956,17780691,CAN,ON,Toronto,24.114.226.82,MYASTHENIA GRAVIS diagnosed by NEOSTIGMINE,0,46,,16,57,diagnosed by,0.997054485501582,906866-FS1-13,MYASTHENIA GRAVIS was confirmed by a positive NEOSTIGMINE test.,MYASTHENIA GRAVIS,NEOSTIGMINE,RO-may_diagnose
503460454,7/16/2014 15:36:18,,1324300477,7/16/2014 15:35:51,instagc,0.7538,19636746,USA,NY,Andover,192.182.216.225,MYASTHENIA GRAVIS diagnosed by NEOSTIGMINE,0,46,,16,57,diagnosed by,0.997054485501582,906866-FS1-13,MYASTHENIA GRAVIS was confirmed by a positive NEOSTIGMINE test.,MYASTHENIA GRAVIS,NEOSTIGMINE,RO-may_diagnose
503460454,7/16/2014 16:56:52,,1324336999,7/16/2014 16:56:12,instagc,0.6306,14941596,USA,KY,Erlanger,74.140.124.145,MYASTHENIA GRAVIS diagnosed by NEOSTIGMINE,0,46,,16,57,diagnosed by,0.997054485501582,906866-FS1-13,MYASTHENIA GRAVIS was confirmed by a positive NEOSTIGMINE test.,MYASTHENIA GRAVIS,NEOSTIGMINE,RO-may_diagnose
503460454,7/16/2014 17:05:26,,1324339837,7/16/2014 17:05:00,instagc,0.5901,23149109,USA,NC,Cary,24.206.38.18,MYASTHENIA GRAVIS diagnosed by NEOSTIGMINE,0,46,,16,57,diagnosed by,0.997054485501582,906866-FS1-13,MYASTHENIA GRAVIS was confirmed by a positive NEOSTIGMINE test.,MYASTHENIA GRAVIS,NEOSTIGMINE,RO-may_diagnose
503460466,7/16/2014 13:08:55,,1324244924,7/16/2014 13:08:30,tremorgames,0.8889,24449707,CAN,QC,Laval,96.21.249.72,EXTRASKELETAL OSTEOCHONDROMA diagnosed by CALCIUM DEPOSITS,13,91,,28,119,diagnosed by,0.617213399848368,902718-FS1-13,"Two isolated CALCIUM DEPOSITS formed an encapsulated mass in the iliopsoas muscle, and the EXTRASKELETAL OSTEOCHONDROMA was diagnosed.",CALCIUM DEPOSITS,EXTRASKELETAL OSTEOCHONDROMA,RO-disease_may_have_finding
503460466,7/16/2014 13:25:28,,1324251568,7/16/2014 13:25:05,neodev,0.6722,12115558,USA,OH,Twinsburg,75.187.196.41,EXTRASKELETAL OSTEOCHONDROMA diagnosed by CALCIUM DEPOSITS,13,91,,28,119,diagnosed by,0.617213399848368,902718-FS1-13,"Two isolated CALCIUM DEPOSITS formed an encapsulated mass in the iliopsoas muscle, and the EXTRASKELETAL OSTEOCHONDROMA was diagnosed.",CALCIUM DEPOSITS,EXTRASKELETAL OSTEOCHONDROMA,RO-disease_may_have_finding
503460466,7/16/2014 14:17:57,,1324272697,7/16/2014 14:17:28,instagc,0.7677,28301350,GBR,K4,Plymouth,92.28.208.109,EXTRASKELETAL OSTEOCHONDROMA diagnosed by CALCIUM DEPOSITS,13,91,,28,119,diagnosed by,0.617213399848368,902718-FS1-13,"Two isolated CALCIUM DEPOSITS formed an encapsulated mass in the iliopsoas muscle, and the EXTRASKELETAL OSTEOCHONDROMA was diagnosed.",CALCIUM DEPOSITS,EXTRASKELETAL OSTEOCHONDROMA,RO-disease_may_have_finding
503460466,7/16/2014 14:25:37,,1324275800,7/16/2014 14:25:16,rewardsspot,0.6855,17763704,USA,VA,Manassas,198.7.62.204,CALCIUM DEPOSITS diagnosed by EXTRASKELETAL OSTEOCHONDROMA,13,91,,28,119,diagnosed by,0.617213399848368,902718-FS1-13,"Two isolated CALCIUM DEPOSITS formed an encapsulated mass in the iliopsoas muscle, and the EXTRASKELETAL OSTEOCHONDROMA was diagnosed.",CALCIUM DEPOSITS,EXTRASKELETAL OSTEOCHONDROMA,RO-disease_may_have_finding
503460466,7/16/2014 14:44:55,,1324282968,7/16/2014 14:44:21,clixsense,0.6742,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,EXTRASKELETAL OSTEOCHONDROMA diagnosed by CALCIUM DEPOSITS,13,91,,28,119,diagnosed by,0.617213399848368,902718-FS1-13,"Two isolated CALCIUM DEPOSITS formed an encapsulated mass in the iliopsoas muscle, and the EXTRASKELETAL OSTEOCHONDROMA was diagnosed.",CALCIUM DEPOSITS,EXTRASKELETAL OSTEOCHONDROMA,RO-disease_may_have_finding
503460466,7/16/2014 17:05:50,,1324339884,7/16/2014 17:05:27,instagc,0.5901,23149109,USA,NC,Cary,24.206.38.18,EXTRASKELETAL OSTEOCHONDROMA diagnosed by CALCIUM DEPOSITS,13,91,,28,119,diagnosed by,0.617213399848368,902718-FS1-13,"Two isolated CALCIUM DEPOSITS formed an encapsulated mass in the iliopsoas muscle, and the EXTRASKELETAL OSTEOCHONDROMA was diagnosed.",CALCIUM DEPOSITS,EXTRASKELETAL OSTEOCHONDROMA,RO-disease_may_have_finding
503460466,7/16/2014 17:47:16,,1324364502,7/16/2014 17:46:53,clixsense,0.6621,23398628,USA,WA,Spanaway,50.149.99.43,EXTRASKELETAL OSTEOCHONDROMA diagnosed by CALCIUM DEPOSITS,13,91,,28,119,diagnosed by,0.617213399848368,902718-FS1-13,"Two isolated CALCIUM DEPOSITS formed an encapsulated mass in the iliopsoas muscle, and the EXTRASKELETAL OSTEOCHONDROMA was diagnosed.",CALCIUM DEPOSITS,EXTRASKELETAL OSTEOCHONDROMA,RO-disease_may_have_finding
503460468,7/16/2014 13:07:17,,1324244203,7/16/2014 13:06:48,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,HEPATOMA causes ASCITES,93,0,,99,8,causes,0.42008402520840293,902957-FS1-4,"HEPATOMA in one patient was correctly identified by both methods, as well as the presence of ASCITES",ASCITES,HEPATOMA,RO-disease_may_have_finding
503460468,7/16/2014 13:14:46,,1324247315,7/16/2014 13:14:31,instagc,0.7083,18960682,GBR,,,86.29.147.112,no_relation,93,0,,99,8,causes,0.42008402520840293,902957-FS1-4,"HEPATOMA in one patient was correctly identified by both methods, as well as the presence of ASCITES",ASCITES,HEPATOMA,RO-disease_may_have_finding
503460468,7/16/2014 14:33:07,,1324278834,7/16/2014 14:32:44,clixsense,0.6486,17722340,CAN,BC,Mission,50.98.185.25,ASCITES causes HEPATOMA,93,0,,99,8,causes,0.42008402520840293,902957-FS1-4,"HEPATOMA in one patient was correctly identified by both methods, as well as the presence of ASCITES",ASCITES,HEPATOMA,RO-disease_may_have_finding
503460468,7/16/2014 15:39:20,,1324301733,7/16/2014 15:38:21,prodege,0.5256,15220325,USA,PA,Troy,24.229.175.37,no_relation,93,0,,99,8,causes,0.42008402520840293,902957-FS1-4,"HEPATOMA in one patient was correctly identified by both methods, as well as the presence of ASCITES",ASCITES,HEPATOMA,RO-disease_may_have_finding
503460468,7/16/2014 15:44:01,,1324303698,7/16/2014 15:43:53,neodev,0.6659,27597779,CAN,AB,Calgary,72.29.251.209,ASCITES causes HEPATOMA,93,0,,99,8,causes,0.42008402520840293,902957-FS1-4,"HEPATOMA in one patient was correctly identified by both methods, as well as the presence of ASCITES",ASCITES,HEPATOMA,RO-disease_may_have_finding
503460468,7/16/2014 16:54:23,,1324336139,7/16/2014 16:53:34,clixsense,0.4786,6497991,USA,NC,Clinton,204.211.52.144,no_relation,93,0,,99,8,causes,0.42008402520840293,902957-FS1-4,"HEPATOMA in one patient was correctly identified by both methods, as well as the presence of ASCITES",ASCITES,HEPATOMA,RO-disease_may_have_finding
503460468,7/16/2014 17:06:30,,1324340098,7/16/2014 17:06:21,prodege,0.4233,12944140,GBR,C8,Croydon,92.21.8.174,ASCITES causes HEPATOMA,93,0,,99,8,causes,0.42008402520840293,902957-FS1-4,"HEPATOMA in one patient was correctly identified by both methods, as well as the presence of ASCITES",ASCITES,HEPATOMA,RO-disease_may_have_finding
503460469,7/16/2014 13:10:10,,1324245401,7/16/2014 13:09:49,neodev,0.8194,18339121,USA,SC,Sumter,173.93.188.194,MOTION SICKNESS treats SCOPOLAMINE,45,116,,59,127,treats,0.8660254037844392,907382-FS1-2,"Transdermal scopolamine provides significant MOTION SICKNESS protection, similar in extent to that provided by oral SCOPOLAMINE or dimenhydrinate.",MOTION SICKNESS,SCOPOLAMINE,RO-may_prevent
503460469,7/16/2014 13:16:08,,1324247776,7/16/2014 13:15:45,instagc,0.7222,14378608,USA,NY,Brooklyn,24.189.101.95,no_relation,45,116,,59,127,treats,0.8660254037844392,907382-FS1-2,"Transdermal scopolamine provides significant MOTION SICKNESS protection, similar in extent to that provided by oral SCOPOLAMINE or dimenhydrinate.",MOTION SICKNESS,SCOPOLAMINE,RO-may_prevent
503460469,7/16/2014 15:43:36,,1324303494,7/16/2014 15:43:18,neodev,0.6659,27597779,CAN,AB,Calgary,72.29.251.209,SCOPOLAMINE treats MOTION SICKNESS,45,116,,59,127,treats,0.8660254037844392,907382-FS1-2,"Transdermal scopolamine provides significant MOTION SICKNESS protection, similar in extent to that provided by oral SCOPOLAMINE or dimenhydrinate.",MOTION SICKNESS,SCOPOLAMINE,RO-may_prevent
503460469,7/16/2014 16:38:18,,1324329609,7/16/2014 16:38:01,prodege,0.5183,2143114,CAN,BC,Vancouver,24.84.160.12,SCOPOLAMINE treats MOTION SICKNESS,45,116,,59,127,treats,0.8660254037844392,907382-FS1-2,"Transdermal scopolamine provides significant MOTION SICKNESS protection, similar in extent to that provided by oral SCOPOLAMINE or dimenhydrinate.",MOTION SICKNESS,SCOPOLAMINE,RO-may_prevent
503460469,7/16/2014 17:27:09,,1324347277,7/16/2014 17:26:49,clixsense,0.6583,25595227,CAN,SK,North Battleford,24.72.96.119,SCOPOLAMINE treats MOTION SICKNESS,45,116,,59,127,treats,0.8660254037844392,907382-FS1-2,"Transdermal scopolamine provides significant MOTION SICKNESS protection, similar in extent to that provided by oral SCOPOLAMINE or dimenhydrinate.",MOTION SICKNESS,SCOPOLAMINE,RO-may_prevent
503460469,7/16/2014 17:46:52,,1324364020,7/16/2014 17:46:31,clixsense,0.6621,23398628,USA,WA,Spanaway,50.149.99.43,SCOPOLAMINE treats MOTION SICKNESS,45,116,,59,127,treats,0.8660254037844392,907382-FS1-2,"Transdermal scopolamine provides significant MOTION SICKNESS protection, similar in extent to that provided by oral SCOPOLAMINE or dimenhydrinate.",MOTION SICKNESS,SCOPOLAMINE,RO-may_prevent
503460469,7/16/2014 18:01:51,,1324379718,7/16/2014 18:01:29,instagc,0.5512,28157545,USA,OR,Mcminnville,76.115.153.186,SCOPOLAMINE treats MOTION SICKNESS,45,116,,59,127,treats,0.8660254037844392,907382-FS1-2,"Transdermal scopolamine provides significant MOTION SICKNESS protection, similar in extent to that provided by oral SCOPOLAMINE or dimenhydrinate.",MOTION SICKNESS,SCOPOLAMINE,RO-may_prevent
503460470,7/16/2014 13:18:28,,1324248715,7/16/2014 13:18:13,elite,0.7917,28503042,USA,NJ,Woodbridge,54.191.150.115,LOW MOLECULAR WEIGHT HEPARIN treats UNSTABLE ANGINA,77,45,,91,73,treats,0.9761870601839531,908115-FS1-2,The indications and length of treatment with LOW MOLECULAR WEIGHT HEPARIN in UNSTABLE ANGINA patients have to be appropriate and the perioperative management of these patients has to address the bleeding tendency.,UNSTABLE ANGINA,LOW MOLECULAR WEIGHT HEPARIN,RO-may_treat
503460470,7/16/2014 13:23:49,,1324250780,7/16/2014 13:23:25,clixsense,0.8056,15189335,GBR,I9,Bury Saint Edmunds,81.155.129.231,LOW MOLECULAR WEIGHT HEPARIN treats UNSTABLE ANGINA,77,45,,91,73,treats,0.9761870601839531,908115-FS1-2,The indications and length of treatment with LOW MOLECULAR WEIGHT HEPARIN in UNSTABLE ANGINA patients have to be appropriate and the perioperative management of these patients has to address the bleeding tendency.,UNSTABLE ANGINA,LOW MOLECULAR WEIGHT HEPARIN,RO-may_treat
503460470,7/16/2014 14:27:21,,1324276390,7/16/2014 14:26:57,rewardsspot,0.6855,17763704,USA,VA,Manassas,198.7.62.204,UNSTABLE ANGINA treats LOW MOLECULAR WEIGHT HEPARIN,77,45,,91,73,treats,0.9761870601839531,908115-FS1-2,The indications and length of treatment with LOW MOLECULAR WEIGHT HEPARIN in UNSTABLE ANGINA patients have to be appropriate and the perioperative management of these patients has to address the bleeding tendency.,UNSTABLE ANGINA,LOW MOLECULAR WEIGHT HEPARIN,RO-may_treat
503460470,7/16/2014 14:45:58,,1324283205,7/16/2014 14:45:33,clixsense,0.6742,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,LOW MOLECULAR WEIGHT HEPARIN treats UNSTABLE ANGINA,77,45,,91,73,treats,0.9761870601839531,908115-FS1-2,The indications and length of treatment with LOW MOLECULAR WEIGHT HEPARIN in UNSTABLE ANGINA patients have to be appropriate and the perioperative management of these patients has to address the bleeding tendency.,UNSTABLE ANGINA,LOW MOLECULAR WEIGHT HEPARIN,RO-may_treat
503460470,7/16/2014 17:05:50,,1324339883,7/16/2014 17:05:27,instagc,0.5901,23149109,USA,NC,Cary,24.206.38.18,UNSTABLE ANGINA treats LOW MOLECULAR WEIGHT HEPARIN,77,45,,91,73,treats,0.9761870601839531,908115-FS1-2,The indications and length of treatment with LOW MOLECULAR WEIGHT HEPARIN in UNSTABLE ANGINA patients have to be appropriate and the perioperative management of these patients has to address the bleeding tendency.,UNSTABLE ANGINA,LOW MOLECULAR WEIGHT HEPARIN,RO-may_treat
503460470,7/16/2014 17:06:20,,1324340008,7/16/2014 17:06:14,prodege,0.4233,12944140,GBR,C8,Croydon,92.21.8.174,UNSTABLE ANGINA treats LOW MOLECULAR WEIGHT HEPARIN,77,45,,91,73,treats,0.9761870601839531,908115-FS1-2,The indications and length of treatment with LOW MOLECULAR WEIGHT HEPARIN in UNSTABLE ANGINA patients have to be appropriate and the perioperative management of these patients has to address the bleeding tendency.,UNSTABLE ANGINA,LOW MOLECULAR WEIGHT HEPARIN,RO-may_treat
503460470,7/16/2014 17:47:16,,1324364503,7/16/2014 17:46:53,clixsense,0.6621,23398628,USA,WA,Spanaway,50.149.99.43,LOW MOLECULAR WEIGHT HEPARIN treats UNSTABLE ANGINA,77,45,,91,73,treats,0.9761870601839531,908115-FS1-2,The indications and length of treatment with LOW MOLECULAR WEIGHT HEPARIN in UNSTABLE ANGINA patients have to be appropriate and the perioperative management of these patients has to address the bleeding tendency.,UNSTABLE ANGINA,LOW MOLECULAR WEIGHT HEPARIN,RO-may_treat
503460472,7/16/2014 13:07:09,,1324244162,7/16/2014 13:06:45,clixsense,0.9583,27871219,NLD,07,Amsterdam,87.210.207.223,SPINAL METASTASES causes PATHOLOGICAL FRACTURE,61,121,,81,138,causes,0.9383148632568359,902720-FS1-4,"However, radiotherapy alone could not resolve the problem of PATHOLOGICAL FRACTURE which is an important complication of SPINAL METASTASES",PATHOLOGICAL FRACTURE,SPINAL METASTASES,RO-disease_may_have_finding
503460472,7/16/2014 13:38:24,,1324257035,7/16/2014 13:38:01,prodege,0.5958,1852770,USA,TX,Abilene,76.198.102.54,SPINAL METASTASES causes PATHOLOGICAL FRACTURE,61,121,,81,138,causes,0.9383148632568359,902720-FS1-4,"However, radiotherapy alone could not resolve the problem of PATHOLOGICAL FRACTURE which is an important complication of SPINAL METASTASES",PATHOLOGICAL FRACTURE,SPINAL METASTASES,RO-disease_may_have_finding
503460472,7/16/2014 13:52:46,,1324262110,7/16/2014 13:52:18,instagc,0.7333,13763729,USA,,,75.182.89.225,SPINAL METASTASES causes PATHOLOGICAL FRACTURE,61,121,,81,138,causes,0.9383148632568359,902720-FS1-4,"However, radiotherapy alone could not resolve the problem of PATHOLOGICAL FRACTURE which is an important complication of SPINAL METASTASES",PATHOLOGICAL FRACTURE,SPINAL METASTASES,RO-disease_may_have_finding
503460472,7/16/2014 14:46:27,,1324283368,7/16/2014 14:45:59,clixsense,0.6742,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,SPINAL METASTASES causes PATHOLOGICAL FRACTURE,61,121,,81,138,causes,0.9383148632568359,902720-FS1-4,"However, radiotherapy alone could not resolve the problem of PATHOLOGICAL FRACTURE which is an important complication of SPINAL METASTASES",PATHOLOGICAL FRACTURE,SPINAL METASTASES,RO-disease_may_have_finding
503460472,7/16/2014 15:43:36,,1324303490,7/16/2014 15:43:18,neodev,0.6659,27597779,CAN,AB,Calgary,72.29.251.209,SPINAL METASTASES causes PATHOLOGICAL FRACTURE,61,121,,81,138,causes,0.9383148632568359,902720-FS1-4,"However, radiotherapy alone could not resolve the problem of PATHOLOGICAL FRACTURE which is an important complication of SPINAL METASTASES",PATHOLOGICAL FRACTURE,SPINAL METASTASES,RO-disease_may_have_finding
503460472,7/16/2014 16:38:56,,1324330048,7/16/2014 16:38:45,prodege,0.5183,2143114,CAN,BC,Vancouver,24.84.160.12,SPINAL METASTASES causes PATHOLOGICAL FRACTURE,61,121,,81,138,causes,0.9383148632568359,902720-FS1-4,"However, radiotherapy alone could not resolve the problem of PATHOLOGICAL FRACTURE which is an important complication of SPINAL METASTASES",PATHOLOGICAL FRACTURE,SPINAL METASTASES,RO-disease_may_have_finding
503460472,7/16/2014 16:39:49,,1324330523,7/16/2014 16:39:26,neodev,0.5359,14861092,GBR,H9,London,90.194.156.173,SPINAL METASTASES causes PATHOLOGICAL FRACTURE,61,121,,81,138,causes,0.9383148632568359,902720-FS1-4,"However, radiotherapy alone could not resolve the problem of PATHOLOGICAL FRACTURE which is an important complication of SPINAL METASTASES",PATHOLOGICAL FRACTURE,SPINAL METASTASES,RO-disease_may_have_finding
503460473,7/16/2014 13:12:25,,1324246289,7/16/2014 13:11:55,instagc,0.7222,14378608,USA,NY,Brooklyn,24.189.101.95,no_relation,22,22,,43,54,causes,0.7715167498104591,903703-FS1-4,Serologic evidence of VARICELLA ZOSTER VIRUS INFECTION was measured by enzyme immunoassay of VARICELLA ZOSTER VIRUS specific IgG antibody.,VARICELLA ZOSTER VIRUS,VARICELLA ZOSTER VIRUS INFECTION,RO-has_causative_agent
503460473,7/16/2014 13:23:23,,1324250610,7/16/2014 13:23:03,clixsense,0.8056,15189335,GBR,I9,Bury Saint Edmunds,81.155.129.231,VARICELLA ZOSTER VIRUS causes VARICELLA ZOSTER VIRUS INFECTION,22,22,,43,54,causes,0.7715167498104591,903703-FS1-4,Serologic evidence of VARICELLA ZOSTER VIRUS INFECTION was measured by enzyme immunoassay of VARICELLA ZOSTER VIRUS specific IgG antibody.,VARICELLA ZOSTER VIRUS,VARICELLA ZOSTER VIRUS INFECTION,RO-has_causative_agent
503460473,7/16/2014 13:52:17,,1324261890,7/16/2014 13:51:55,instagc,0.7333,13763729,USA,,,75.182.89.225,VARICELLA ZOSTER VIRUS causes VARICELLA ZOSTER VIRUS INFECTION,22,22,,43,54,causes,0.7715167498104591,903703-FS1-4,Serologic evidence of VARICELLA ZOSTER VIRUS INFECTION was measured by enzyme immunoassay of VARICELLA ZOSTER VIRUS specific IgG antibody.,VARICELLA ZOSTER VIRUS,VARICELLA ZOSTER VIRUS INFECTION,RO-has_causative_agent
503460473,7/16/2014 14:17:04,,1324272333,7/16/2014 14:16:43,instagc,0.7677,28301350,GBR,K4,Plymouth,92.28.208.109,no_relation,22,22,,43,54,causes,0.7715167498104591,903703-FS1-4,Serologic evidence of VARICELLA ZOSTER VIRUS INFECTION was measured by enzyme immunoassay of VARICELLA ZOSTER VIRUS specific IgG antibody.,VARICELLA ZOSTER VIRUS,VARICELLA ZOSTER VIRUS INFECTION,RO-has_causative_agent
503460473,7/16/2014 14:26:21,,1324276075,7/16/2014 14:25:22,fusioncash,0.6587,7012325,USA,CT,Stamford,24.185.182.15,VARICELLA ZOSTER VIRUS causes VARICELLA ZOSTER VIRUS INFECTION,22,22,,43,54,causes,0.7715167498104591,903703-FS1-4,Serologic evidence of VARICELLA ZOSTER VIRUS INFECTION was measured by enzyme immunoassay of VARICELLA ZOSTER VIRUS specific IgG antibody.,VARICELLA ZOSTER VIRUS,VARICELLA ZOSTER VIRUS INFECTION,RO-has_causative_agent
503460473,7/16/2014 14:45:58,,1324283210,7/16/2014 14:45:33,clixsense,0.6742,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,VARICELLA ZOSTER VIRUS causes VARICELLA ZOSTER VIRUS INFECTION,22,22,,43,54,causes,0.7715167498104591,903703-FS1-4,Serologic evidence of VARICELLA ZOSTER VIRUS INFECTION was measured by enzyme immunoassay of VARICELLA ZOSTER VIRUS specific IgG antibody.,VARICELLA ZOSTER VIRUS,VARICELLA ZOSTER VIRUS INFECTION,RO-has_causative_agent
503460473,7/16/2014 15:09:33,,1324291833,7/16/2014 15:09:22,clixsense,0.6313,19162475,GBR,M3,Frome,82.33.126.30,VARICELLA ZOSTER VIRUS INFECTION causes VARICELLA ZOSTER VIRUS,22,22,,43,54,causes,0.7715167498104591,903703-FS1-4,Serologic evidence of VARICELLA ZOSTER VIRUS INFECTION was measured by enzyme immunoassay of VARICELLA ZOSTER VIRUS specific IgG antibody.,VARICELLA ZOSTER VIRUS,VARICELLA ZOSTER VIRUS INFECTION,RO-has_causative_agent
503460475,7/16/2014 13:29:24,,1324253261,7/16/2014 13:28:25,clixsense,0.7708,6564572,USA,MI,Kalamazoo,173.46.248.170,PAROXETINE treats MAJOR DEPRESSION,36,118,,51,128,treats,0.997054485501582,907618-FS1-2,"CONCLUSIONS  In older patients with MAJOR DEPRESSION who responded to treatment, long term maintenance treatment with PAROXETINE prevented recurrence of depression.",MAJOR DEPRESSION,PAROXETINE,RO-may_treat
503460475,7/16/2014 13:32:56,,1324254846,7/16/2014 13:31:54,inboxpounds,0.65,22207998,GBR,N7,Banstead,86.3.88.5,PAROXETINE treats MAJOR DEPRESSION,36,118,,51,128,treats,0.997054485501582,907618-FS1-2,"CONCLUSIONS  In older patients with MAJOR DEPRESSION who responded to treatment, long term maintenance treatment with PAROXETINE prevented recurrence of depression.",MAJOR DEPRESSION,PAROXETINE,RO-may_treat
503460475,7/16/2014 13:34:20,,1324255517,7/16/2014 13:33:44,clixsense,0.7278,24896327,GBR,V2,Glasgow,94.2.231.4,PAROXETINE treats MAJOR DEPRESSION,36,118,,51,128,treats,0.997054485501582,907618-FS1-2,"CONCLUSIONS  In older patients with MAJOR DEPRESSION who responded to treatment, long term maintenance treatment with PAROXETINE prevented recurrence of depression.",MAJOR DEPRESSION,PAROXETINE,RO-may_treat
503460475,7/16/2014 13:34:39,,1324255685,7/16/2014 13:34:23,prodege,0.5958,1852770,USA,TX,Abilene,76.198.102.54,PAROXETINE treats MAJOR DEPRESSION,36,118,,51,128,treats,0.997054485501582,907618-FS1-2,"CONCLUSIONS  In older patients with MAJOR DEPRESSION who responded to treatment, long term maintenance treatment with PAROXETINE prevented recurrence of depression.",MAJOR DEPRESSION,PAROXETINE,RO-may_treat
503460475,7/16/2014 14:26:02,,1324275954,7/16/2014 14:25:39,rewardsspot,0.6855,17763704,USA,VA,Manassas,198.7.62.204,PAROXETINE treats MAJOR DEPRESSION,36,118,,51,128,treats,0.997054485501582,907618-FS1-2,"CONCLUSIONS  In older patients with MAJOR DEPRESSION who responded to treatment, long term maintenance treatment with PAROXETINE prevented recurrence of depression.",MAJOR DEPRESSION,PAROXETINE,RO-may_treat
503460475,7/16/2014 14:53:56,,1324285678,7/16/2014 14:53:38,prodege,0.505,28039757,GBR,L8,Southport,109.155.158.54,no_relation,36,118,,51,128,treats,0.997054485501582,907618-FS1-2,"CONCLUSIONS  In older patients with MAJOR DEPRESSION who responded to treatment, long term maintenance treatment with PAROXETINE prevented recurrence of depression.",MAJOR DEPRESSION,PAROXETINE,RO-may_treat
503460475,7/16/2014 15:34:16,,1324299722,7/16/2014 15:33:48,instagc,0.7538,19636746,USA,NY,Andover,192.182.216.225,PAROXETINE treats MAJOR DEPRESSION,36,118,,51,128,treats,0.997054485501582,907618-FS1-2,"CONCLUSIONS  In older patients with MAJOR DEPRESSION who responded to treatment, long term maintenance treatment with PAROXETINE prevented recurrence of depression.",MAJOR DEPRESSION,PAROXETINE,RO-may_treat
503460476,7/16/2014 13:06:47,,1324244039,7/16/2014 13:06:27,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,BONE is location of OSTEOPOROSIS,56,0,,59,12,is location of,0.9438798074485389,902388-FS1-9,OSTEOPOROSIS medications can exert favorable effects on BONE size and cortical thickness.,BONE,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
503460476,7/16/2014 13:08:08,,1324244605,7/16/2014 13:07:38,neodev,0.8194,18339121,USA,SC,Sumter,173.93.188.194,OSTEOPOROSIS is location of BONE,56,0,,59,12,is location of,0.9438798074485389,902388-FS1-9,OSTEOPOROSIS medications can exert favorable effects on BONE size and cortical thickness.,BONE,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
503460476,7/16/2014 14:32:43,,1324278714,7/16/2014 14:32:08,clixsense,0.6486,17722340,CAN,BC,Mission,50.98.185.25,OSTEOPOROSIS is location of BONE,56,0,,59,12,is location of,0.9438798074485389,902388-FS1-9,OSTEOPOROSIS medications can exert favorable effects on BONE size and cortical thickness.,BONE,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
503460476,7/16/2014 15:37:19,,1324300849,7/16/2014 15:37:08,prodege,0.5498,23541832,USA,AZ,Tempe,149.169.143.104,BONE is location of OSTEOPOROSIS,56,0,,59,12,is location of,0.9438798074485389,902388-FS1-9,OSTEOPOROSIS medications can exert favorable effects on BONE size and cortical thickness.,BONE,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
503460476,7/16/2014 15:44:18,,1324303810,7/16/2014 15:44:02,neodev,0.6659,27597779,CAN,AB,Calgary,72.29.251.209,BONE is location of OSTEOPOROSIS,56,0,,59,12,is location of,0.9438798074485389,902388-FS1-9,OSTEOPOROSIS medications can exert favorable effects on BONE size and cortical thickness.,BONE,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
503460476,7/16/2014 17:09:43,,1324341288,7/16/2014 17:09:08,clixsense,0.5952,19638651,USA,,,173.23.121.63,BONE is location of OSTEOPOROSIS,56,0,,59,12,is location of,0.9438798074485389,902388-FS1-9,OSTEOPOROSIS medications can exert favorable effects on BONE size and cortical thickness.,BONE,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
503460476,7/16/2014 18:02:11,,1324380029,7/16/2014 18:01:51,instagc,0.5512,28157545,USA,OR,Mcminnville,76.115.153.186,BONE is location of OSTEOPOROSIS,56,0,,59,12,is location of,0.9438798074485389,902388-FS1-9,OSTEOPOROSIS medications can exert favorable effects on BONE size and cortical thickness.,BONE,OSTEOPOROSIS,RO-disease_has_primary_anatomic_site
503460477,7/16/2014 13:18:13,,1324248629,7/16/2014 13:17:32,elite,0.7917,28503042,USA,NJ,Woodbridge,54.191.150.115,LSIL causes HIGH GRADE CERVICAL DYSPLASIA,96,69,,124,73,causes,0.721687836487032,901864-FS1-4,"More recent evidence suggests that HIV positive women with ASC US or LSIL have similar rates of HIGH GRADE CERVICAL DYSPLASIA to HIV negative women, although a trend towards increased rates of CIN II or worse was observed among women with worsening immunosuppression ( 74.",HIGH GRADE CERVICAL DYSPLASIA,LSIL,RO-disease_has_finding
503460477,7/16/2014 13:23:02,,1324250492,7/16/2014 13:22:08,clixsense,0.8056,15189335,GBR,I9,Bury Saint Edmunds,81.155.129.231,LSIL causes HIGH GRADE CERVICAL DYSPLASIA,96,69,,124,73,causes,0.721687836487032,901864-FS1-4,"More recent evidence suggests that HIV positive women with ASC US or LSIL have similar rates of HIGH GRADE CERVICAL DYSPLASIA to HIV negative women, although a trend towards increased rates of CIN II or worse was observed among women with worsening immunosuppression ( 74.",HIGH GRADE CERVICAL DYSPLASIA,LSIL,RO-disease_has_finding
503460477,7/16/2014 13:31:31,,1324254211,7/16/2014 13:31:04,rewardsspot,0.5306,24482174,GBR,H9,London,46.23.68.180,LSIL causes HIGH GRADE CERVICAL DYSPLASIA,96,69,,124,73,causes,0.721687836487032,901864-FS1-4,"More recent evidence suggests that HIV positive women with ASC US or LSIL have similar rates of HIGH GRADE CERVICAL DYSPLASIA to HIV negative women, although a trend towards increased rates of CIN II or worse was observed among women with worsening immunosuppression ( 74.",HIGH GRADE CERVICAL DYSPLASIA,LSIL,RO-disease_has_finding
503460477,7/16/2014 14:55:44,,1324286316,7/16/2014 14:55:12,prodege,0.505,28039757,GBR,L8,Southport,109.155.158.54,no_relation,96,69,,124,73,causes,0.721687836487032,901864-FS1-4,"More recent evidence suggests that HIV positive women with ASC US or LSIL have similar rates of HIGH GRADE CERVICAL DYSPLASIA to HIV negative women, although a trend towards increased rates of CIN II or worse was observed among women with worsening immunosuppression ( 74.",HIGH GRADE CERVICAL DYSPLASIA,LSIL,RO-disease_has_finding
503460477,7/16/2014 17:06:15,,1324339982,7/16/2014 17:05:50,instagc,0.5901,23149109,USA,NC,Cary,24.206.38.18,LSIL causes HIGH GRADE CERVICAL DYSPLASIA,96,69,,124,73,causes,0.721687836487032,901864-FS1-4,"More recent evidence suggests that HIV positive women with ASC US or LSIL have similar rates of HIGH GRADE CERVICAL DYSPLASIA to HIV negative women, although a trend towards increased rates of CIN II or worse was observed among women with worsening immunosuppression ( 74.",HIGH GRADE CERVICAL DYSPLASIA,LSIL,RO-disease_has_finding
503460477,7/16/2014 17:18:45,,1324344019,7/16/2014 17:17:45,prodege,0.521,19026375,GBR,Z1,Swansea,92.26.69.100,HIGH GRADE CERVICAL DYSPLASIA causes LSIL,96,69,,124,73,causes,0.721687836487032,901864-FS1-4,"More recent evidence suggests that HIV positive women with ASC US or LSIL have similar rates of HIGH GRADE CERVICAL DYSPLASIA to HIV negative women, although a trend towards increased rates of CIN II or worse was observed among women with worsening immunosuppression ( 74.",HIGH GRADE CERVICAL DYSPLASIA,LSIL,RO-disease_has_finding
503460477,7/16/2014 17:44:40,,1324361620,7/16/2014 17:44:09,clixsense,0.6621,23398628,USA,WA,Spanaway,50.149.99.43,LSIL causes HIGH GRADE CERVICAL DYSPLASIA,96,69,,124,73,causes,0.721687836487032,901864-FS1-4,"More recent evidence suggests that HIV positive women with ASC US or LSIL have similar rates of HIGH GRADE CERVICAL DYSPLASIA to HIV negative women, although a trend towards increased rates of CIN II or worse was observed among women with worsening immunosuppression ( 74.",HIGH GRADE CERVICAL DYSPLASIA,LSIL,RO-disease_has_finding
503460483,7/16/2014 13:08:30,,1324244753,7/16/2014 13:07:55,tremorgames,0.8889,24449707,CAN,QC,Laval,96.21.249.72,RENAL LYMPHOMA causes PRIMARY LESION,108,157,,121,171,causes,0.522232967867094,901633-FS1-4,From these cases three conclusions have been drawn: it is reasonable to assume that renal lymphoma can be a PRIMARY LESION; almost all patients with primary RENAL LYMPHOMA will develop extrarenal lymphomatous disease shortly after diagnosis of their renal tumor; and survival for more than 1 year after diagnosis is rare.,PRIMARY LESION,RENAL LYMPHOMA,RO-disease_has_finding
503460483,7/16/2014 13:24:19,,1324251007,7/16/2014 13:23:56,neodev,0.8806,21515166,NLD,11,Nootdorp,83.86.58.179,RENAL LYMPHOMA causes PRIMARY LESION,108,157,,121,171,causes,0.522232967867094,901633-FS1-4,From these cases three conclusions have been drawn: it is reasonable to assume that renal lymphoma can be a PRIMARY LESION; almost all patients with primary RENAL LYMPHOMA will develop extrarenal lymphomatous disease shortly after diagnosis of their renal tumor; and survival for more than 1 year after diagnosis is rare.,PRIMARY LESION,RENAL LYMPHOMA,RO-disease_has_finding
503460483,7/16/2014 14:30:30,,1324277855,7/16/2014 14:29:50,clixsense,0.6486,17722340,CAN,BC,Mission,50.98.185.25,RENAL LYMPHOMA causes PRIMARY LESION,108,157,,121,171,causes,0.522232967867094,901633-FS1-4,From these cases three conclusions have been drawn: it is reasonable to assume that renal lymphoma can be a PRIMARY LESION; almost all patients with primary RENAL LYMPHOMA will develop extrarenal lymphomatous disease shortly after diagnosis of their renal tumor; and survival for more than 1 year after diagnosis is rare.,PRIMARY LESION,RENAL LYMPHOMA,RO-disease_has_finding
503460483,7/16/2014 15:09:47,,1324291898,7/16/2014 15:09:42,clixsense,0.6313,19162475,GBR,M3,Frome,82.33.126.30,RENAL LYMPHOMA causes PRIMARY LESION,108,157,,121,171,causes,0.522232967867094,901633-FS1-4,From these cases three conclusions have been drawn: it is reasonable to assume that renal lymphoma can be a PRIMARY LESION; almost all patients with primary RENAL LYMPHOMA will develop extrarenal lymphomatous disease shortly after diagnosis of their renal tumor; and survival for more than 1 year after diagnosis is rare.,PRIMARY LESION,RENAL LYMPHOMA,RO-disease_has_finding
503460483,7/16/2014 15:36:47,,1324300658,7/16/2014 15:36:25,prodege,0.5498,23541832,USA,AZ,Tempe,149.169.143.104,no_relation,108,157,,121,171,causes,0.522232967867094,901633-FS1-4,From these cases three conclusions have been drawn: it is reasonable to assume that renal lymphoma can be a PRIMARY LESION; almost all patients with primary RENAL LYMPHOMA will develop extrarenal lymphomatous disease shortly after diagnosis of their renal tumor; and survival for more than 1 year after diagnosis is rare.,PRIMARY LESION,RENAL LYMPHOMA,RO-disease_has_finding
503460483,7/16/2014 15:39:20,,1324301732,7/16/2014 15:38:21,prodege,0.5256,15220325,USA,PA,Troy,24.229.175.37,no_relation,108,157,,121,171,causes,0.522232967867094,901633-FS1-4,From these cases three conclusions have been drawn: it is reasonable to assume that renal lymphoma can be a PRIMARY LESION; almost all patients with primary RENAL LYMPHOMA will develop extrarenal lymphomatous disease shortly after diagnosis of their renal tumor; and survival for more than 1 year after diagnosis is rare.,PRIMARY LESION,RENAL LYMPHOMA,RO-disease_has_finding
503460483,7/16/2014 15:49:30,,1324306004,7/16/2014 15:49:09,clixsense,0.58,16827630,GBR,A7,Birmingham,86.146.169.103,RENAL LYMPHOMA causes PRIMARY LESION,108,157,,121,171,causes,0.522232967867094,901633-FS1-4,From these cases three conclusions have been drawn: it is reasonable to assume that renal lymphoma can be a PRIMARY LESION; almost all patients with primary RENAL LYMPHOMA will develop extrarenal lymphomatous disease shortly after diagnosis of their renal tumor; and survival for more than 1 year after diagnosis is rare.,PRIMARY LESION,RENAL LYMPHOMA,RO-disease_has_finding
503460485,7/16/2014 13:07:29,,1324244279,7/16/2014 13:06:41,prodege,0.9167,7664351,USA,NY,Cicero,74.111.0.21,VARICELLA ZOSTER VIRUS diagnosed by VARICELLA ZOSTER VIRUS INFECTION,22,22,,43,54,diagnosed by,0.617213399848368,903703-FS1-13,Serologic evidence of VARICELLA ZOSTER VIRUS INFECTION was measured by enzyme immunoassay of VARICELLA ZOSTER VIRUS specific IgG antibody.,VARICELLA ZOSTER VIRUS,VARICELLA ZOSTER VIRUS INFECTION,RO-has_causative_agent
503460485,7/16/2014 13:19:05,,1324248948,7/16/2014 13:18:59,neodev,0.7833,25804244,USA,IL,Chicago,99.198.108.116,VARICELLA ZOSTER VIRUS INFECTION diagnosed by VARICELLA ZOSTER VIRUS,22,22,,43,54,diagnosed by,0.617213399848368,903703-FS1-13,Serologic evidence of VARICELLA ZOSTER VIRUS INFECTION was measured by enzyme immunoassay of VARICELLA ZOSTER VIRUS specific IgG antibody.,VARICELLA ZOSTER VIRUS,VARICELLA ZOSTER VIRUS INFECTION,RO-has_causative_agent
503460485,7/16/2014 13:26:17,,1324251884,7/16/2014 13:25:35,clixsense,0.8056,15189335,GBR,I9,Bury Saint Edmunds,81.155.129.231,VARICELLA ZOSTER VIRUS diagnosed by VARICELLA ZOSTER VIRUS INFECTION,22,22,,43,54,diagnosed by,0.617213399848368,903703-FS1-13,Serologic evidence of VARICELLA ZOSTER VIRUS INFECTION was measured by enzyme immunoassay of VARICELLA ZOSTER VIRUS specific IgG antibody.,VARICELLA ZOSTER VIRUS,VARICELLA ZOSTER VIRUS INFECTION,RO-has_causative_agent
503460485,7/16/2014 13:32:17,,1324254606,7/16/2014 13:31:33,clixsense,0.7708,6564572,USA,MI,Kalamazoo,173.46.248.170,VARICELLA ZOSTER VIRUS INFECTION diagnosed by VARICELLA ZOSTER VIRUS,22,22,,43,54,diagnosed by,0.617213399848368,903703-FS1-13,Serologic evidence of VARICELLA ZOSTER VIRUS INFECTION was measured by enzyme immunoassay of VARICELLA ZOSTER VIRUS specific IgG antibody.,VARICELLA ZOSTER VIRUS,VARICELLA ZOSTER VIRUS INFECTION,RO-has_causative_agent
503460485,7/16/2014 14:44:19,,1324282834,7/16/2014 14:43:50,clixsense,0.6742,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,VARICELLA ZOSTER VIRUS INFECTION diagnosed by VARICELLA ZOSTER VIRUS,22,22,,43,54,diagnosed by,0.617213399848368,903703-FS1-13,Serologic evidence of VARICELLA ZOSTER VIRUS INFECTION was measured by enzyme immunoassay of VARICELLA ZOSTER VIRUS specific IgG antibody.,VARICELLA ZOSTER VIRUS,VARICELLA ZOSTER VIRUS INFECTION,RO-has_causative_agent
503460485,7/16/2014 14:55:11,,1324286105,7/16/2014 14:54:46,prodege,0.505,28039757,GBR,L8,Southport,109.155.158.54,VARICELLA ZOSTER VIRUS diagnosed by VARICELLA ZOSTER VIRUS INFECTION,22,22,,43,54,diagnosed by,0.617213399848368,903703-FS1-13,Serologic evidence of VARICELLA ZOSTER VIRUS INFECTION was measured by enzyme immunoassay of VARICELLA ZOSTER VIRUS specific IgG antibody.,VARICELLA ZOSTER VIRUS,VARICELLA ZOSTER VIRUS INFECTION,RO-has_causative_agent
503460485,7/16/2014 15:35:50,,1324300296,7/16/2014 15:35:07,instagc,0.7538,19636746,USA,NY,Andover,192.182.216.225,no_relation,22,22,,43,54,diagnosed by,0.617213399848368,903703-FS1-13,Serologic evidence of VARICELLA ZOSTER VIRUS INFECTION was measured by enzyme immunoassay of VARICELLA ZOSTER VIRUS specific IgG antibody.,VARICELLA ZOSTER VIRUS,VARICELLA ZOSTER VIRUS INFECTION,RO-has_causative_agent
503460486,7/16/2014 14:17:26,,1324272494,7/16/2014 14:17:06,instagc,0.7677,28301350,GBR,K4,Plymouth,92.28.208.109,no_relation,58,75,,64,83,causes,0.312347523777212,902643-FS1-4,The activities of nucleoside diphosphatase in various rat ASCITES cells of HEPATOMA and fetal and neonatal rat liver were much lower than that of normal adult rat liver.,ASCITES,HEPATOMA,RO-disease_may_have_finding
503460486,7/16/2014 14:47:36,,1324283732,7/16/2014 14:46:28,clixsense,0.6742,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,HEPATOMA causes ASCITES,58,75,,64,83,causes,0.312347523777212,902643-FS1-4,The activities of nucleoside diphosphatase in various rat ASCITES cells of HEPATOMA and fetal and neonatal rat liver were much lower than that of normal adult rat liver.,ASCITES,HEPATOMA,RO-disease_may_have_finding
503460486,7/16/2014 15:15:03,,1324293618,7/16/2014 15:14:50,elite,0.5194,28276268,USA,MI,Fenton,68.188.185.225,ASCITES causes HEPATOMA,58,75,,64,83,causes,0.312347523777212,902643-FS1-4,The activities of nucleoside diphosphatase in various rat ASCITES cells of HEPATOMA and fetal and neonatal rat liver were much lower than that of normal adult rat liver.,ASCITES,HEPATOMA,RO-disease_may_have_finding
503460486,7/16/2014 17:04:50,,1324339705,7/16/2014 17:04:22,prodege,0.4233,12944140,GBR,C8,Croydon,92.21.8.174,ASCITES causes HEPATOMA,58,75,,64,83,causes,0.312347523777212,902643-FS1-4,The activities of nucleoside diphosphatase in various rat ASCITES cells of HEPATOMA and fetal and neonatal rat liver were much lower than that of normal adult rat liver.,ASCITES,HEPATOMA,RO-disease_may_have_finding
503460486,7/16/2014 17:17:31,,1324343695,7/16/2014 17:17:10,clixsense,0.6583,25595227,CAN,SK,North Battleford,24.72.96.119,HEPATOMA causes ASCITES,58,75,,64,83,causes,0.312347523777212,902643-FS1-4,The activities of nucleoside diphosphatase in various rat ASCITES cells of HEPATOMA and fetal and neonatal rat liver were much lower than that of normal adult rat liver.,ASCITES,HEPATOMA,RO-disease_may_have_finding
503460486,7/16/2014 18:01:28,,1324379287,7/16/2014 18:00:40,instagc,0.5512,28157545,USA,OR,Mcminnville,76.115.153.186,ASCITES causes HEPATOMA,58,75,,64,83,causes,0.312347523777212,902643-FS1-4,The activities of nucleoside diphosphatase in various rat ASCITES cells of HEPATOMA and fetal and neonatal rat liver were much lower than that of normal adult rat liver.,ASCITES,HEPATOMA,RO-disease_may_have_finding
503460486,7/16/2014 18:07:59,,1324385883,7/16/2014 18:07:28,clixsense,0.4083,6451515,USA,MN,Minneapolis,75.144.36.177,HEPATOMA causes ASCITES,58,75,,64,83,causes,0.312347523777212,902643-FS1-4,The activities of nucleoside diphosphatase in various rat ASCITES cells of HEPATOMA and fetal and neonatal rat liver were much lower than that of normal adult rat liver.,ASCITES,HEPATOMA,RO-disease_may_have_finding
503460488,7/16/2014 13:06:04,,1324243782,7/16/2014 13:05:50,clixsense,1.0,19803139,NLD,06,Veldhoven,212.61.84.196,SKIN is location of INTRADERMAL NEVUS,86,111,,89,128,is location of,0.5669467095138411,905150-FS1-9,"Images include pigmented skin sites (freckle, tattoo, pigmented nevi) and unpigmented SKIN sites [nonpigmented INTRADERMAL NEVUS neurofibroma, actinic keratosis, malignant basal cell carcinoma, squamous cell carcinoma, vascular abnormality (venous lake), burn scar.",SKIN,INTRADERMAL NEVUS,RO-has_finding_site
503460488,7/16/2014 13:07:57,,1324244523,7/16/2014 13:07:36,clixsense,0.9583,27871219,NLD,07,Amsterdam,87.210.207.223,SKIN is location of INTRADERMAL NEVUS,86,111,,89,128,is location of,0.5669467095138411,905150-FS1-9,"Images include pigmented skin sites (freckle, tattoo, pigmented nevi) and unpigmented SKIN sites [nonpigmented INTRADERMAL NEVUS neurofibroma, actinic keratosis, malignant basal cell carcinoma, squamous cell carcinoma, vascular abnormality (venous lake), burn scar.",SKIN,INTRADERMAL NEVUS,RO-has_finding_site
503460488,7/16/2014 13:10:48,,1324245659,7/16/2014 13:10:38,clixsense,0.9167,20614047,USA,MO,Maryville,174.32.162.147,SKIN is location of INTRADERMAL NEVUS,86,111,,89,128,is location of,0.5669467095138411,905150-FS1-9,"Images include pigmented skin sites (freckle, tattoo, pigmented nevi) and unpigmented SKIN sites [nonpigmented INTRADERMAL NEVUS neurofibroma, actinic keratosis, malignant basal cell carcinoma, squamous cell carcinoma, vascular abnormality (venous lake), burn scar.",SKIN,INTRADERMAL NEVUS,RO-has_finding_site
503460488,7/16/2014 13:26:02,,1324251765,7/16/2014 13:25:31,neodev,0.8806,21515166,NLD,11,Nootdorp,83.86.58.179,SKIN is location of INTRADERMAL NEVUS,86,111,,89,128,is location of,0.5669467095138411,905150-FS1-9,"Images include pigmented skin sites (freckle, tattoo, pigmented nevi) and unpigmented SKIN sites [nonpigmented INTRADERMAL NEVUS neurofibroma, actinic keratosis, malignant basal cell carcinoma, squamous cell carcinoma, vascular abnormality (venous lake), burn scar.",SKIN,INTRADERMAL NEVUS,RO-has_finding_site
503460488,7/16/2014 14:32:07,,1324278486,7/16/2014 14:31:45,clixsense,0.6486,17722340,CAN,BC,Mission,50.98.185.25,INTRADERMAL NEVUS is location of SKIN,86,111,,89,128,is location of,0.5669467095138411,905150-FS1-9,"Images include pigmented skin sites (freckle, tattoo, pigmented nevi) and unpigmented SKIN sites [nonpigmented INTRADERMAL NEVUS neurofibroma, actinic keratosis, malignant basal cell carcinoma, squamous cell carcinoma, vascular abnormality (venous lake), burn scar.",SKIN,INTRADERMAL NEVUS,RO-has_finding_site
503460488,7/16/2014 15:40:15,,1324302083,7/16/2014 15:39:35,prodege,0.5256,15220325,USA,PA,Troy,24.229.175.37,INTRADERMAL NEVUS is location of SKIN,86,111,,89,128,is location of,0.5669467095138411,905150-FS1-9,"Images include pigmented skin sites (freckle, tattoo, pigmented nevi) and unpigmented SKIN sites [nonpigmented INTRADERMAL NEVUS neurofibroma, actinic keratosis, malignant basal cell carcinoma, squamous cell carcinoma, vascular abnormality (venous lake), burn scar.",SKIN,INTRADERMAL NEVUS,RO-has_finding_site
503460488,7/16/2014 16:52:48,,1324335605,7/16/2014 16:51:39,clixsense,0.4786,6497991,USA,NC,Clinton,204.211.52.144,INTRADERMAL NEVUS is location of SKIN,86,111,,89,128,is location of,0.5669467095138411,905150-FS1-9,"Images include pigmented skin sites (freckle, tattoo, pigmented nevi) and unpigmented SKIN sites [nonpigmented INTRADERMAL NEVUS neurofibroma, actinic keratosis, malignant basal cell carcinoma, squamous cell carcinoma, vascular abnormality (venous lake), burn scar.",SKIN,INTRADERMAL NEVUS,RO-has_finding_site
503460494,7/16/2014 13:20:31,,1324249498,7/16/2014 13:20:06,prodege,0.6875,22031444,GBR,B7,Bristol,77.98.139.82,no_relation,91,63,,109,73,is location of,0.42426406871192895,906133-FS1-9,This study expands the geographical map of the distribution of BCL 2 GENE rearrangement in FOLLICULAR LYMPHOMA patients in the Middle East region.,FOLLICULAR LYMPHOMA,BCL 2 GENE,RO-has_manifestation
503460494,7/16/2014 13:24:12,,1324250965,7/16/2014 13:23:29,neodev,0.6722,12115558,USA,OH,Twinsburg,75.187.196.41,BCL 2 GENE is location of FOLLICULAR LYMPHOMA,91,63,,109,73,is location of,0.42426406871192895,906133-FS1-9,This study expands the geographical map of the distribution of BCL 2 GENE rearrangement in FOLLICULAR LYMPHOMA patients in the Middle East region.,FOLLICULAR LYMPHOMA,BCL 2 GENE,RO-has_manifestation
503460494,7/16/2014 13:33:55,,1324255329,7/16/2014 13:33:25,clixsense,0.7708,6564572,USA,MI,Kalamazoo,173.46.248.170,BCL 2 GENE is location of FOLLICULAR LYMPHOMA,91,63,,109,73,is location of,0.42426406871192895,906133-FS1-9,This study expands the geographical map of the distribution of BCL 2 GENE rearrangement in FOLLICULAR LYMPHOMA patients in the Middle East region.,FOLLICULAR LYMPHOMA,BCL 2 GENE,RO-has_manifestation
503460494,7/16/2014 15:50:03,,1324306236,7/16/2014 15:49:49,clixsense,0.58,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,91,63,,109,73,is location of,0.42426406871192895,906133-FS1-9,This study expands the geographical map of the distribution of BCL 2 GENE rearrangement in FOLLICULAR LYMPHOMA patients in the Middle East region.,FOLLICULAR LYMPHOMA,BCL 2 GENE,RO-has_manifestation
503460494,7/16/2014 16:37:59,,1324329370,7/16/2014 16:37:26,prodege,0.5183,2143114,CAN,BC,Vancouver,24.84.160.12,BCL 2 GENE is location of FOLLICULAR LYMPHOMA,91,63,,109,73,is location of,0.42426406871192895,906133-FS1-9,This study expands the geographical map of the distribution of BCL 2 GENE rearrangement in FOLLICULAR LYMPHOMA patients in the Middle East region.,FOLLICULAR LYMPHOMA,BCL 2 GENE,RO-has_manifestation
503460494,7/16/2014 17:46:31,,1324363702,7/16/2014 17:45:39,clixsense,0.6621,23398628,USA,WA,Spanaway,50.149.99.43,no_relation,91,63,,109,73,is location of,0.42426406871192895,906133-FS1-9,This study expands the geographical map of the distribution of BCL 2 GENE rearrangement in FOLLICULAR LYMPHOMA patients in the Middle East region.,FOLLICULAR LYMPHOMA,BCL 2 GENE,RO-has_manifestation
503460494,7/16/2014 18:00:01,,1324377894,7/16/2014 17:59:27,instagc,0.5512,28157545,USA,OR,Mcminnville,76.115.153.186,BCL 2 GENE is location of FOLLICULAR LYMPHOMA,91,63,,109,73,is location of,0.42426406871192895,906133-FS1-9,This study expands the geographical map of the distribution of BCL 2 GENE rearrangement in FOLLICULAR LYMPHOMA patients in the Middle East region.,FOLLICULAR LYMPHOMA,BCL 2 GENE,RO-has_manifestation
503460495,7/16/2014 13:07:35,,1324244340,7/16/2014 13:07:09,clixsense,0.9583,27871219,NLD,07,Amsterdam,87.210.207.223,NEUROENDOCRINE DIFFERENTIATION causes SMALL CELL LUNG CANCER (SCLC),66,119,,95,148,causes,0.9615239476408229,901631-FS1-4,"A radioimmunoassay for neuron specific enolase (NSE), a marker of NEUROENDOCRINE DIFFERENTIATION has been evaluated in SMALL CELL LUNG CANCER (SCLC).",NEUROENDOCRINE DIFFERENTIATION,SMALL CELL LUNG CANCER (SCLC),RO-disease_has_finding
503460495,7/16/2014 13:25:30,,1324251559,7/16/2014 13:25:00,neodev,0.8806,21515166,NLD,11,Nootdorp,83.86.58.179,SMALL CELL LUNG CANCER (SCLC) causes NEUROENDOCRINE DIFFERENTIATION,66,119,,95,148,causes,0.9615239476408229,901631-FS1-4,"A radioimmunoassay for neuron specific enolase (NSE), a marker of NEUROENDOCRINE DIFFERENTIATION has been evaluated in SMALL CELL LUNG CANCER (SCLC).",NEUROENDOCRINE DIFFERENTIATION,SMALL CELL LUNG CANCER (SCLC),RO-disease_has_finding
503460495,7/16/2014 13:33:56,,1324255337,7/16/2014 13:33:15,prodege,0.5958,1852770,USA,TX,Abilene,76.198.102.54,no_relation,66,119,,95,148,causes,0.9615239476408229,901631-FS1-4,"A radioimmunoassay for neuron specific enolase (NSE), a marker of NEUROENDOCRINE DIFFERENTIATION has been evaluated in SMALL CELL LUNG CANCER (SCLC).",NEUROENDOCRINE DIFFERENTIATION,SMALL CELL LUNG CANCER (SCLC),RO-disease_has_finding
503460495,7/16/2014 14:55:11,,1324286101,7/16/2014 14:54:46,prodege,0.505,28039757,GBR,L8,Southport,109.155.158.54,no_relation,66,119,,95,148,causes,0.9615239476408229,901631-FS1-4,"A radioimmunoassay for neuron specific enolase (NSE), a marker of NEUROENDOCRINE DIFFERENTIATION has been evaluated in SMALL CELL LUNG CANCER (SCLC).",NEUROENDOCRINE DIFFERENTIATION,SMALL CELL LUNG CANCER (SCLC),RO-disease_has_finding
503460495,7/16/2014 15:40:41,,1324302244,7/16/2014 15:40:17,prodege,0.5256,15220325,USA,PA,Troy,24.229.175.37,no_relation,66,119,,95,148,causes,0.9615239476408229,901631-FS1-4,"A radioimmunoassay for neuron specific enolase (NSE), a marker of NEUROENDOCRINE DIFFERENTIATION has been evaluated in SMALL CELL LUNG CANCER (SCLC).",NEUROENDOCRINE DIFFERENTIATION,SMALL CELL LUNG CANCER (SCLC),RO-disease_has_finding
503460495,7/16/2014 17:20:29,,1324344476,7/16/2014 17:19:29,prodege,0.521,19026375,GBR,Z1,Swansea,92.26.69.100,NEUROENDOCRINE DIFFERENTIATION causes SMALL CELL LUNG CANCER (SCLC),66,119,,95,148,causes,0.9615239476408229,901631-FS1-4,"A radioimmunoassay for neuron specific enolase (NSE), a marker of NEUROENDOCRINE DIFFERENTIATION has been evaluated in SMALL CELL LUNG CANCER (SCLC).",NEUROENDOCRINE DIFFERENTIATION,SMALL CELL LUNG CANCER (SCLC),RO-disease_has_finding
503460495,7/16/2014 18:00:38,,1324378477,7/16/2014 18:00:03,instagc,0.5512,28157545,USA,OR,Mcminnville,76.115.153.186,SMALL CELL LUNG CANCER (SCLC) causes NEUROENDOCRINE DIFFERENTIATION,66,119,,95,148,causes,0.9615239476408229,901631-FS1-4,"A radioimmunoassay for neuron specific enolase (NSE), a marker of NEUROENDOCRINE DIFFERENTIATION has been evaluated in SMALL CELL LUNG CANCER (SCLC).",NEUROENDOCRINE DIFFERENTIATION,SMALL CELL LUNG CANCER (SCLC),RO-disease_has_finding
503460497,7/16/2014 13:16:14,,1324247803,7/16/2014 13:15:51,prodege,0.7917,9525153,CAN,ON,Toronto,65.95.94.44,GANCICLOVIR treats CMV INFECTION,123,93,,135,104,treats,0.9958932064677041,907219-FS1-2,An example of AIDS research being helpful in the treatment of other conditions is the use of GANCICLOVIR for prevention of CMV INFECTION in transplant patients  who are vulnerable to infections because of the immune suppressive drugs they must take.,CMV INFECTION,GANCICLOVIR,RO-may_prevent
503460497,7/16/2014 15:36:18,,1324300476,7/16/2014 15:35:51,instagc,0.7538,19636746,USA,NY,Andover,192.182.216.225,GANCICLOVIR treats CMV INFECTION,123,93,,135,104,treats,0.9958932064677041,907219-FS1-2,An example of AIDS research being helpful in the treatment of other conditions is the use of GANCICLOVIR for prevention of CMV INFECTION in transplant patients  who are vulnerable to infections because of the immune suppressive drugs they must take.,CMV INFECTION,GANCICLOVIR,RO-may_prevent
503460497,7/16/2014 15:37:07,,1324300776,7/16/2014 15:36:48,prodege,0.5498,23541832,USA,AZ,Tempe,149.169.143.104,no_relation,123,93,,135,104,treats,0.9958932064677041,907219-FS1-2,An example of AIDS research being helpful in the treatment of other conditions is the use of GANCICLOVIR for prevention of CMV INFECTION in transplant patients  who are vulnerable to infections because of the immune suppressive drugs they must take.,CMV INFECTION,GANCICLOVIR,RO-may_prevent
503460497,7/16/2014 15:41:25,,1324302590,7/16/2014 15:40:41,prodege,0.5256,15220325,USA,PA,Troy,24.229.175.37,GANCICLOVIR treats CMV INFECTION,123,93,,135,104,treats,0.9958932064677041,907219-FS1-2,An example of AIDS research being helpful in the treatment of other conditions is the use of GANCICLOVIR for prevention of CMV INFECTION in transplant patients  who are vulnerable to infections because of the immune suppressive drugs they must take.,CMV INFECTION,GANCICLOVIR,RO-may_prevent
503460497,7/16/2014 16:37:24,,1324329001,7/16/2014 16:37:07,prodege,0.5183,2143114,CAN,BC,Vancouver,24.84.160.12,GANCICLOVIR treats CMV INFECTION,123,93,,135,104,treats,0.9958932064677041,907219-FS1-2,An example of AIDS research being helpful in the treatment of other conditions is the use of GANCICLOVIR for prevention of CMV INFECTION in transplant patients  who are vulnerable to infections because of the immune suppressive drugs they must take.,CMV INFECTION,GANCICLOVIR,RO-may_prevent
503460497,7/16/2014 17:04:58,,1324339727,7/16/2014 17:04:54,prodege,0.4233,12944140,GBR,C8,Croydon,92.21.8.174,CMV INFECTION treats GANCICLOVIR,123,93,,135,104,treats,0.9958932064677041,907219-FS1-2,An example of AIDS research being helpful in the treatment of other conditions is the use of GANCICLOVIR for prevention of CMV INFECTION in transplant patients  who are vulnerable to infections because of the immune suppressive drugs they must take.,CMV INFECTION,GANCICLOVIR,RO-may_prevent
503460497,7/16/2014 17:09:07,,1324341090,7/16/2014 17:08:43,clixsense,0.5952,19638651,USA,,,173.23.121.63,GANCICLOVIR treats CMV INFECTION,123,93,,135,104,treats,0.9958932064677041,907219-FS1-2,An example of AIDS research being helpful in the treatment of other conditions is the use of GANCICLOVIR for prevention of CMV INFECTION in transplant patients  who are vulnerable to infections because of the immune suppressive drugs they must take.,CMV INFECTION,GANCICLOVIR,RO-may_prevent
503460505,7/16/2014 13:08:20,,1324244705,7/16/2014 13:07:58,clixsense,0.9583,27871219,NLD,07,Amsterdam,87.210.207.223,TUBERCULOSIS diagnosed by TUBERCULIN,91,44,,102,54,diagnosed by,0.927172649945531,906806-FS1-13,2 of 16 patients with kala azar tested with TUBERCULIN were positive; one was diagnosed as TUBERCULOSIS,TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
503460505,7/16/2014 13:11:35,,1324245933,7/16/2014 13:11:22,clixsense,0.9167,20614047,USA,MO,Maryville,174.32.162.147,TUBERCULOSIS diagnosed by TUBERCULIN,91,44,,102,54,diagnosed by,0.927172649945531,906806-FS1-13,2 of 16 patients with kala azar tested with TUBERCULIN were positive; one was diagnosed as TUBERCULOSIS,TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
503460505,7/16/2014 13:21:38,,1324249993,7/16/2014 13:21:26,clixsense,0.7208,27793793,GBR,C5,Chester,151.230.27.155,TUBERCULIN diagnosed by TUBERCULOSIS,91,44,,102,54,diagnosed by,0.927172649945531,906806-FS1-13,2 of 16 patients with kala azar tested with TUBERCULIN were positive; one was diagnosed as TUBERCULOSIS,TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
503460505,7/16/2014 17:20:29,,1324344477,7/16/2014 17:19:29,prodege,0.521,19026375,GBR,Z1,Swansea,92.26.69.100,TUBERCULIN diagnosed by TUBERCULOSIS,91,44,,102,54,diagnosed by,0.927172649945531,906806-FS1-13,2 of 16 patients with kala azar tested with TUBERCULIN were positive; one was diagnosed as TUBERCULOSIS,TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
503460505,7/16/2014 17:46:31,,1324363701,7/16/2014 17:45:39,clixsense,0.6621,23398628,USA,WA,Spanaway,50.149.99.43,TUBERCULOSIS diagnosed by TUBERCULIN,91,44,,102,54,diagnosed by,0.927172649945531,906806-FS1-13,2 of 16 patients with kala azar tested with TUBERCULIN were positive; one was diagnosed as TUBERCULOSIS,TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
503460505,7/16/2014 18:00:38,,1324378478,7/16/2014 18:00:03,instagc,0.5512,28157545,USA,OR,Mcminnville,76.115.153.186,TUBERCULOSIS diagnosed by TUBERCULIN,91,44,,102,54,diagnosed by,0.927172649945531,906806-FS1-13,2 of 16 patients with kala azar tested with TUBERCULIN were positive; one was diagnosed as TUBERCULOSIS,TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
503460505,7/16/2014 18:23:20,,1324399335,7/16/2014 18:23:01,gifthulk,0.6992,21916793,GBR,,,87.113.87.199,TUBERCULOSIS diagnosed by TUBERCULIN,91,44,,102,54,diagnosed by,0.927172649945531,906806-FS1-13,2 of 16 patients with kala azar tested with TUBERCULIN were positive; one was diagnosed as TUBERCULOSIS,TUBERCULOSIS,TUBERCULIN,RO-may_diagnose
503468984,7/16/2014 15:39:09,,1324301689,7/16/2014 15:38:49,clixsense,0.8333,15189335,GBR,I9,Bury Saint Edmunds,81.155.129.231,STATUS EPILEPTICUS diagnosed by DIAZEPAM,131,55,,148,63,diagnosed by,0.351123441588392,908055-FS1-13,The effect of nimodipine alone and in combination with DIAZEPAM or phenytoin was tested in the electroshock induced mouse model of STATUS EPILEPTICUS,STATUS EPILEPTICUS,DIAZEPAM,RO-may_treat
503468984,7/16/2014 16:21:37,,1324322634,7/16/2014 16:21:08,instagc,0.5972,19436046,GBR,U3,Dundee,82.36.106.184,no_relation,131,55,,148,63,diagnosed by,0.351123441588392,908055-FS1-13,The effect of nimodipine alone and in combination with DIAZEPAM or phenytoin was tested in the electroshock induced mouse model of STATUS EPILEPTICUS,STATUS EPILEPTICUS,DIAZEPAM,RO-may_treat
503468984,7/16/2014 20:03:02,,1324449660,7/16/2014 20:02:40,neodev,0.6433,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,131,55,,148,63,diagnosed by,0.351123441588392,908055-FS1-13,The effect of nimodipine alone and in combination with DIAZEPAM or phenytoin was tested in the electroshock induced mouse model of STATUS EPILEPTICUS,STATUS EPILEPTICUS,DIAZEPAM,RO-may_treat
503468984,7/16/2014 21:39:18,,1324493666,7/16/2014 21:39:01,clixsense,0.7516,24896327,GBR,V2,Glasgow,94.2.231.4,no_relation,131,55,,148,63,diagnosed by,0.351123441588392,908055-FS1-13,The effect of nimodipine alone and in combination with DIAZEPAM or phenytoin was tested in the electroshock induced mouse model of STATUS EPILEPTICUS,STATUS EPILEPTICUS,DIAZEPAM,RO-may_treat
503468984,7/16/2014 22:02:02,,1324502488,7/16/2014 22:01:24,clixsense,0.6754,6472283,USA,WI,Oak Creek,99.107.184.156,STATUS EPILEPTICUS diagnosed by DIAZEPAM,131,55,,148,63,diagnosed by,0.351123441588392,908055-FS1-13,The effect of nimodipine alone and in combination with DIAZEPAM or phenytoin was tested in the electroshock induced mouse model of STATUS EPILEPTICUS,STATUS EPILEPTICUS,DIAZEPAM,RO-may_treat
503468984,7/16/2014 23:11:30,,1324529240,7/16/2014 23:10:51,instagc,0.6728,19636746,USA,NY,Andover,192.182.216.225,no_relation,131,55,,148,63,diagnosed by,0.351123441588392,908055-FS1-13,The effect of nimodipine alone and in combination with DIAZEPAM or phenytoin was tested in the electroshock induced mouse model of STATUS EPILEPTICUS,STATUS EPILEPTICUS,DIAZEPAM,RO-may_treat
503468984,7/16/2014 23:33:13,,1324538966,7/16/2014 23:32:41,neodev,0.6766,15848372,AUS,02,Jannali,27.96.208.89,no_relation,131,55,,148,63,diagnosed by,0.351123441588392,908055-FS1-13,The effect of nimodipine alone and in combination with DIAZEPAM or phenytoin was tested in the electroshock induced mouse model of STATUS EPILEPTICUS,STATUS EPILEPTICUS,DIAZEPAM,RO-may_treat
503468987,7/16/2014 15:26:15,,1324297153,7/16/2014 15:25:57,clixsense,0.9028,20614047,USA,MO,Maryville,174.32.162.147,SKIN is location of PETECHIAE,337,372,,340,381,is location of,0.5962847939999439,905203-FS1-9,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  SKIN exam  Look for ecchymosis and PETECHIAE   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",SKIN,PETECHIAE,RO-has_finding_site
503468987,7/16/2014 15:43:10,,1324303261,7/16/2014 15:42:56,instagc,0.8194,18960682,GBR,,,86.29.147.112,SKIN is location of PETECHIAE,337,372,,340,381,is location of,0.5962847939999439,905203-FS1-9,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  SKIN exam  Look for ecchymosis and PETECHIAE   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",SKIN,PETECHIAE,RO-has_finding_site
503468987,7/16/2014 16:50:48,,1324334904,7/16/2014 16:50:08,rewardsspot,0.6597,17763704,USA,VA,Manassas,198.7.62.204,SKIN is location of PETECHIAE,337,372,,340,381,is location of,0.5962847939999439,905203-FS1-9,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  SKIN exam  Look for ecchymosis and PETECHIAE   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",SKIN,PETECHIAE,RO-has_finding_site
503468987,7/16/2014 17:25:39,,1324346438,7/16/2014 17:24:40,prodege,0.7014,19026375,GBR,Z1,Swansea,92.26.69.100,PETECHIAE is location of SKIN,337,372,,340,381,is location of,0.5962847939999439,905203-FS1-9,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  SKIN exam  Look for ecchymosis and PETECHIAE   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",SKIN,PETECHIAE,RO-has_finding_site
503468987,7/16/2014 22:18:45,,1324508464,7/16/2014 22:17:35,clixsense,0.6101,19294877,USA,MA,Boston,96.233.18.114,no_relation,337,372,,340,381,is location of,0.5962847939999439,905203-FS1-9,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  SKIN exam  Look for ecchymosis and PETECHIAE   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",SKIN,PETECHIAE,RO-has_finding_site
503468987,7/16/2014 23:10:46,,1324528949,7/16/2014 23:10:15,eup_slw,0.7077,20818028,GBR,A7,Birmingham,92.232.139.254,SKIN is location of PETECHIAE,337,372,,340,381,is location of,0.5962847939999439,905203-FS1-9,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  SKIN exam  Look for ecchymosis and PETECHIAE   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",SKIN,PETECHIAE,RO-has_finding_site
503468987,7/17/2014 02:18:33,,1324670518,7/17/2014 02:17:42,pokerowned,0.5583,18747884,USA,MI,Saginaw,74.85.192.98,PETECHIAE is location of SKIN,337,372,,340,381,is location of,0.5962847939999439,905203-FS1-9,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  SKIN exam  Look for ecchymosis and PETECHIAE   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",SKIN,PETECHIAE,RO-has_finding_site
503468994,7/16/2014 15:38:34,,1324301371,7/16/2014 15:38:14,instagc,0.9028,13763729,USA,,,75.182.89.225,JOINTS is location of RHEUMATOID ARTHRITIS,57,81,,62,101,is location of,0.948683298050514,902088-FS1-9,Intra articular application of Placenta in the arthritis JOINTS of patients with RHEUMATOID ARTHRITIS results in a significant improvement as compared with placebo.,JOINTS,RHEUMATOID ARTHRITIS,RO-disease_has_primary_anatomic_site
503468994,7/16/2014 16:22:46,,1324323016,7/16/2014 16:22:32,neodev,0.5486,21515166,NLD,11,Nootdorp,83.86.58.179,JOINTS is location of RHEUMATOID ARTHRITIS,57,81,,62,101,is location of,0.948683298050514,902088-FS1-9,Intra articular application of Placenta in the arthritis JOINTS of patients with RHEUMATOID ARTHRITIS results in a significant improvement as compared with placebo.,JOINTS,RHEUMATOID ARTHRITIS,RO-disease_has_primary_anatomic_site
503468994,7/16/2014 17:24:03,,1324345735,7/16/2014 17:23:25,prodege,0.7014,19026375,GBR,Z1,Swansea,92.26.69.100,JOINTS is location of RHEUMATOID ARTHRITIS,57,81,,62,101,is location of,0.948683298050514,902088-FS1-9,Intra articular application of Placenta in the arthritis JOINTS of patients with RHEUMATOID ARTHRITIS results in a significant improvement as compared with placebo.,JOINTS,RHEUMATOID ARTHRITIS,RO-disease_has_primary_anatomic_site
503468994,7/16/2014 17:30:38,,1324349786,7/16/2014 17:30:22,clixsense,0.6083,25595227,CAN,SK,North Battleford,24.72.96.119,JOINTS is location of RHEUMATOID ARTHRITIS,57,81,,62,101,is location of,0.948683298050514,902088-FS1-9,Intra articular application of Placenta in the arthritis JOINTS of patients with RHEUMATOID ARTHRITIS results in a significant improvement as compared with placebo.,JOINTS,RHEUMATOID ARTHRITIS,RO-disease_has_primary_anatomic_site
503468994,7/16/2014 17:44:50,,1324361816,7/16/2014 17:44:36,gifthulk,0.7524,21916793,GBR,,,87.113.87.199,JOINTS is location of RHEUMATOID ARTHRITIS,57,81,,62,101,is location of,0.948683298050514,902088-FS1-9,Intra articular application of Placenta in the arthritis JOINTS of patients with RHEUMATOID ARTHRITIS results in a significant improvement as compared with placebo.,JOINTS,RHEUMATOID ARTHRITIS,RO-disease_has_primary_anatomic_site
503468994,7/16/2014 19:24:18,,1324431640,7/16/2014 19:23:20,clixsense,0.5444,6714657,USA,CT,Groton,71.235.184.32,RHEUMATOID ARTHRITIS is location of JOINTS,57,81,,62,101,is location of,0.948683298050514,902088-FS1-9,Intra articular application of Placenta in the arthritis JOINTS of patients with RHEUMATOID ARTHRITIS results in a significant improvement as compared with placebo.,JOINTS,RHEUMATOID ARTHRITIS,RO-disease_has_primary_anatomic_site
503468994,7/16/2014 20:10:25,,1324452948,7/16/2014 20:10:19,tremorgames,0.6605,28013393,USA,CA,Rancho Cordova,71.197.67.37,JOINTS is location of RHEUMATOID ARTHRITIS,57,81,,62,101,is location of,0.948683298050514,902088-FS1-9,Intra articular application of Placenta in the arthritis JOINTS of patients with RHEUMATOID ARTHRITIS results in a significant improvement as compared with placebo.,JOINTS,RHEUMATOID ARTHRITIS,RO-disease_has_primary_anatomic_site
503469012,7/16/2014 15:26:32,,1324297228,7/16/2014 15:26:19,clixsense,0.9028,20614047,USA,MO,Maryville,174.32.162.147,IRON treats IRON DEFICIENCY ANEMIA,96,96,,117,100,treats,0.848874687627165,907379-FS1-2,"? Adherence to a gluten free diet in patients with celiac disease can lead to the correction of IRON DEFICIENCY ANEMIA and the replacement of iron stores, and it can prevent the recurrence of IRON deficiency.",IRON DEFICIENCY ANEMIA,IRON,RO-may_prevent
503469012,7/16/2014 15:55:46,,1324308654,7/16/2014 15:55:10,rewardsspot,0.65,24482174,GBR,H9,London,46.23.68.180,no_relation,96,96,,117,100,treats,0.848874687627165,907379-FS1-2,"? Adherence to a gluten free diet in patients with celiac disease can lead to the correction of IRON DEFICIENCY ANEMIA and the replacement of iron stores, and it can prevent the recurrence of IRON deficiency.",IRON DEFICIENCY ANEMIA,IRON,RO-may_prevent
503469012,7/16/2014 16:18:46,,1324321557,7/16/2014 16:18:17,clixsense,0.7708,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,IRON treats IRON DEFICIENCY ANEMIA,96,96,,117,100,treats,0.848874687627165,907379-FS1-2,"? Adherence to a gluten free diet in patients with celiac disease can lead to the correction of IRON DEFICIENCY ANEMIA and the replacement of iron stores, and it can prevent the recurrence of IRON deficiency.",IRON DEFICIENCY ANEMIA,IRON,RO-may_prevent
503469012,7/16/2014 16:47:09,,1324333642,7/16/2014 16:47:02,clixsense,0.6125,19162475,GBR,M3,Frome,82.33.126.30,IRON treats IRON DEFICIENCY ANEMIA,96,96,,117,100,treats,0.848874687627165,907379-FS1-2,"? Adherence to a gluten free diet in patients with celiac disease can lead to the correction of IRON DEFICIENCY ANEMIA and the replacement of iron stores, and it can prevent the recurrence of IRON deficiency.",IRON DEFICIENCY ANEMIA,IRON,RO-may_prevent
503469012,7/16/2014 17:08:06,,1324340712,7/16/2014 17:07:36,instagc,0.6736,23149109,USA,NC,Cary,24.206.38.18,IRON treats IRON DEFICIENCY ANEMIA,96,96,,117,100,treats,0.848874687627165,907379-FS1-2,"? Adherence to a gluten free diet in patients with celiac disease can lead to the correction of IRON DEFICIENCY ANEMIA and the replacement of iron stores, and it can prevent the recurrence of IRON deficiency.",IRON DEFICIENCY ANEMIA,IRON,RO-may_prevent
503469012,7/16/2014 17:44:35,,1324361533,7/16/2014 17:44:11,gifthulk,0.7524,21916793,GBR,,,87.113.87.199,IRON treats IRON DEFICIENCY ANEMIA,96,96,,117,100,treats,0.848874687627165,907379-FS1-2,"? Adherence to a gluten free diet in patients with celiac disease can lead to the correction of IRON DEFICIENCY ANEMIA and the replacement of iron stores, and it can prevent the recurrence of IRON deficiency.",IRON DEFICIENCY ANEMIA,IRON,RO-may_prevent
503469012,7/16/2014 20:10:25,,1324452947,7/16/2014 20:10:19,tremorgames,0.6605,28013393,USA,CA,Rancho Cordova,71.197.67.37,IRON treats IRON DEFICIENCY ANEMIA,96,96,,117,100,treats,0.848874687627165,907379-FS1-2,"? Adherence to a gluten free diet in patients with celiac disease can lead to the correction of IRON DEFICIENCY ANEMIA and the replacement of iron stores, and it can prevent the recurrence of IRON deficiency.",IRON DEFICIENCY ANEMIA,IRON,RO-may_prevent
503469015,7/16/2014 16:36:51,,1324328622,7/16/2014 16:36:28,neodev,0.8542,14861092,GBR,H9,London,90.194.156.173,HEPATOMA causes ASCITES,62,149,,68,157,causes,0.787838597158335,902723-FS1-4,Two early postoperative complications were noticed: transient ASCITES and pancreatic pseudocyst and a late development of a hepatic nodule (probably HEPATOMA,ASCITES,HEPATOMA,RO-disease_may_have_finding
503469015,7/16/2014 16:47:01,,1324333583,7/16/2014 16:46:46,clixsense,0.6125,19162475,GBR,M3,Frome,82.33.126.30,HEPATOMA causes ASCITES,62,149,,68,157,causes,0.787838597158335,902723-FS1-4,Two early postoperative complications were noticed: transient ASCITES and pancreatic pseudocyst and a late development of a hepatic nodule (probably HEPATOMA,ASCITES,HEPATOMA,RO-disease_may_have_finding
503469015,7/16/2014 17:04:33,,1324339554,7/16/2014 17:04:00,clixsense,0.5597,19638651,USA,,,173.23.121.63,no_relation,62,149,,68,157,causes,0.787838597158335,902723-FS1-4,Two early postoperative complications were noticed: transient ASCITES and pancreatic pseudocyst and a late development of a hepatic nodule (probably HEPATOMA,ASCITES,HEPATOMA,RO-disease_may_have_finding
503469015,7/16/2014 17:07:14,,1324340438,7/16/2014 17:06:46,instagc,0.6736,23149109,USA,NC,Cary,24.206.38.18,HEPATOMA causes ASCITES,62,149,,68,157,causes,0.787838597158335,902723-FS1-4,Two early postoperative complications were noticed: transient ASCITES and pancreatic pseudocyst and a late development of a hepatic nodule (probably HEPATOMA,ASCITES,HEPATOMA,RO-disease_may_have_finding
503469015,7/16/2014 18:03:10,,1324381092,7/16/2014 18:02:21,instagc,0.7462,28157545,USA,OR,Mcminnville,76.115.153.186,ASCITES causes HEPATOMA,62,149,,68,157,causes,0.787838597158335,902723-FS1-4,Two early postoperative complications were noticed: transient ASCITES and pancreatic pseudocyst and a late development of a hepatic nodule (probably HEPATOMA,ASCITES,HEPATOMA,RO-disease_may_have_finding
503469015,7/16/2014 19:27:40,,1324433322,7/16/2014 19:27:05,clixsense,0.6758,27871219,NLD,07,Amsterdam,87.210.207.223,no_relation,62,149,,68,157,causes,0.787838597158335,902723-FS1-4,Two early postoperative complications were noticed: transient ASCITES and pancreatic pseudocyst and a late development of a hepatic nodule (probably HEPATOMA,ASCITES,HEPATOMA,RO-disease_may_have_finding
503469015,7/16/2014 22:20:12,,1324509280,7/16/2014 22:19:41,clixsense,0.6101,19294877,USA,MA,Boston,96.233.18.114,no_relation,62,149,,68,157,causes,0.787838597158335,902723-FS1-4,Two early postoperative complications were noticed: transient ASCITES and pancreatic pseudocyst and a late development of a hepatic nodule (probably HEPATOMA,ASCITES,HEPATOMA,RO-disease_may_have_finding
503469021,7/16/2014 15:29:37,,1324298203,7/16/2014 15:29:30,clixsense,0.9306,27793793,GBR,C5,Chester,151.230.27.155,RANITIDINE treats DUODENAL ULCER DISEASE,191,102,,212,112,treats,0.993883734673619,907235-FS1-2,Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with RANITIDINE indicating the importance of overnight gastric acidity in the pathogenesis of DUODENAL ULCER DISEASE,DUODENAL ULCER DISEASE,RANITIDINE,RO-may_prevent
503469021,7/16/2014 15:51:30,,1324306866,7/16/2014 15:50:45,clixsense,0.775,27812714,NLD,06,Tilburg,84.31.160.155,no_relation,191,102,,212,112,treats,0.993883734673619,907235-FS1-2,Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with RANITIDINE indicating the importance of overnight gastric acidity in the pathogenesis of DUODENAL ULCER DISEASE,DUODENAL ULCER DISEASE,RANITIDINE,RO-may_prevent
503469021,7/16/2014 19:40:28,,1324439428,7/16/2014 19:39:54,fusioncash,0.506,7012325,USA,CT,Stamford,24.185.182.15,RANITIDINE treats DUODENAL ULCER DISEASE,191,102,,212,112,treats,0.993883734673619,907235-FS1-2,Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with RANITIDINE indicating the importance of overnight gastric acidity in the pathogenesis of DUODENAL ULCER DISEASE,DUODENAL ULCER DISEASE,RANITIDINE,RO-may_prevent
503469021,7/16/2014 19:54:07,,1324446176,7/16/2014 19:53:46,prodege,0.4306,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,191,102,,212,112,treats,0.993883734673619,907235-FS1-2,Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with RANITIDINE indicating the importance of overnight gastric acidity in the pathogenesis of DUODENAL ULCER DISEASE,DUODENAL ULCER DISEASE,RANITIDINE,RO-may_prevent
503469021,7/16/2014 20:00:52,,1324448871,7/16/2014 19:59:55,prodege,0.5917,15287417,CAN,ON,Mississauga,209.171.47.7,RANITIDINE treats DUODENAL ULCER DISEASE,191,102,,212,112,treats,0.993883734673619,907235-FS1-2,Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with RANITIDINE indicating the importance of overnight gastric acidity in the pathogenesis of DUODENAL ULCER DISEASE,DUODENAL ULCER DISEASE,RANITIDINE,RO-may_prevent
503469021,7/16/2014 23:09:29,,1324528494,7/16/2014 23:09:01,eup_slw,0.7077,20818028,GBR,A7,Birmingham,92.232.139.254,no_relation,191,102,,212,112,treats,0.993883734673619,907235-FS1-2,Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with RANITIDINE indicating the importance of overnight gastric acidity in the pathogenesis of DUODENAL ULCER DISEASE,DUODENAL ULCER DISEASE,RANITIDINE,RO-may_prevent
503469021,7/17/2014 00:27:47,,1324564038,7/17/2014 00:27:16,prodege,0.335,24403612,CAN,ON,Ajax,99.242.234.239,no_relation,191,102,,212,112,treats,0.993883734673619,907235-FS1-2,Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with RANITIDINE indicating the importance of overnight gastric acidity in the pathogenesis of DUODENAL ULCER DISEASE,DUODENAL ULCER DISEASE,RANITIDINE,RO-may_prevent
503469023,7/16/2014 16:22:46,,1324323017,7/16/2014 16:22:32,neodev,0.5486,21515166,NLD,11,Nootdorp,83.86.58.179,PROPRANOLOL treats ANGINA PECTORIS,162,116,,176,127,treats,1.0,907967-FS1-2,3 These results indicate that oxyfedrine is a safe and well tolerated drug with an efficacy comparable with that of PROPRANOLOL in the treatment of patients with ANGINA PECTORIS,ANGINA PECTORIS,PROPRANOLOL,RO-may_treat
503469023,7/16/2014 16:23:40,,1324323380,7/16/2014 16:23:09,prodege,0.6736,13300986,CAN,AB,Edmonton,68.150.33.230,PROPRANOLOL treats ANGINA PECTORIS,162,116,,176,127,treats,1.0,907967-FS1-2,3 These results indicate that oxyfedrine is a safe and well tolerated drug with an efficacy comparable with that of PROPRANOLOL in the treatment of patients with ANGINA PECTORIS,ANGINA PECTORIS,PROPRANOLOL,RO-may_treat
503469023,7/16/2014 16:47:33,,1324333768,7/16/2014 16:47:26,clixsense,0.6125,19162475,GBR,M3,Frome,82.33.126.30,no_relation,162,116,,176,127,treats,1.0,907967-FS1-2,3 These results indicate that oxyfedrine is a safe and well tolerated drug with an efficacy comparable with that of PROPRANOLOL in the treatment of patients with ANGINA PECTORIS,ANGINA PECTORIS,PROPRANOLOL,RO-may_treat
503469023,7/16/2014 19:09:25,,1324424230,7/16/2014 19:08:44,vivatic,0.6952,25451531,GBR,,,83.67.28.193,PROPRANOLOL treats ANGINA PECTORIS,162,116,,176,127,treats,1.0,907967-FS1-2,3 These results indicate that oxyfedrine is a safe and well tolerated drug with an efficacy comparable with that of PROPRANOLOL in the treatment of patients with ANGINA PECTORIS,ANGINA PECTORIS,PROPRANOLOL,RO-may_treat
503469023,7/16/2014 19:45:42,,1324442111,7/16/2014 19:45:21,prodege,0.4306,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,162,116,,176,127,treats,1.0,907967-FS1-2,3 These results indicate that oxyfedrine is a safe and well tolerated drug with an efficacy comparable with that of PROPRANOLOL in the treatment of patients with ANGINA PECTORIS,ANGINA PECTORIS,PROPRANOLOL,RO-may_treat
503469023,7/16/2014 21:38:58,,1324493528,7/16/2014 21:38:41,clixsense,0.7516,24896327,GBR,V2,Glasgow,94.2.231.4,PROPRANOLOL treats ANGINA PECTORIS,162,116,,176,127,treats,1.0,907967-FS1-2,3 These results indicate that oxyfedrine is a safe and well tolerated drug with an efficacy comparable with that of PROPRANOLOL in the treatment of patients with ANGINA PECTORIS,ANGINA PECTORIS,PROPRANOLOL,RO-may_treat
503469023,7/16/2014 22:49:46,,1324521157,7/16/2014 22:49:11,prodege,0.5665,28255346,GBR,L9,Sheffield,2.125.183.137,PROPRANOLOL treats ANGINA PECTORIS,162,116,,176,127,treats,1.0,907967-FS1-2,3 These results indicate that oxyfedrine is a safe and well tolerated drug with an efficacy comparable with that of PROPRANOLOL in the treatment of patients with ANGINA PECTORIS,ANGINA PECTORIS,PROPRANOLOL,RO-may_treat
503469026,7/16/2014 15:37:23,,1324300867,7/16/2014 15:37:00,instagc,0.9028,13763729,USA,,,75.182.89.225,PREGNANCY contraindicates WARFARIN,140,156,,147,165,contraindicates,0.36650833306891606,901253-FS1-10,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of WARFARIN during PREGNANCY,WARFARIN,PREGNANCY,RO-contraindicated_drug
503469026,7/16/2014 15:49:03,,1324305806,7/16/2014 15:48:47,clixsense,0.4792,16827630,GBR,A7,Birmingham,86.146.169.103,WARFARIN contraindicates PREGNANCY,140,156,,147,165,contraindicates,0.36650833306891606,901253-FS1-10,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of WARFARIN during PREGNANCY,WARFARIN,PREGNANCY,RO-contraindicated_drug
503469026,7/16/2014 15:49:33,,1324306025,7/16/2014 15:49:20,prodege,0.7083,9525153,CAN,ON,Toronto,65.95.94.44,PREGNANCY contraindicates WARFARIN,140,156,,147,165,contraindicates,0.36650833306891606,901253-FS1-10,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of WARFARIN during PREGNANCY,WARFARIN,PREGNANCY,RO-contraindicated_drug
503469026,7/16/2014 16:37:20,,1324328917,7/16/2014 16:37:07,neodev,0.8542,14861092,GBR,H9,London,90.194.156.173,PREGNANCY contraindicates WARFARIN,140,156,,147,165,contraindicates,0.36650833306891606,901253-FS1-10,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of WARFARIN during PREGNANCY,WARFARIN,PREGNANCY,RO-contraindicated_drug
503469026,7/16/2014 17:06:04,,1324339930,7/16/2014 17:05:26,clixsense,0.5597,19638651,USA,,,173.23.121.63,no_relation,140,156,,147,165,contraindicates,0.36650833306891606,901253-FS1-10,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of WARFARIN during PREGNANCY,WARFARIN,PREGNANCY,RO-contraindicated_drug
503469026,7/16/2014 19:39:53,,1324439060,7/16/2014 19:39:15,fusioncash,0.506,7012325,USA,CT,Stamford,24.185.182.15,no_relation,140,156,,147,165,contraindicates,0.36650833306891606,901253-FS1-10,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of WARFARIN during PREGNANCY,WARFARIN,PREGNANCY,RO-contraindicated_drug
503469026,7/16/2014 20:03:28,,1324449824,7/16/2014 20:03:03,neodev,0.6433,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,140,156,,147,165,contraindicates,0.36650833306891606,901253-FS1-10,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of WARFARIN during PREGNANCY,WARFARIN,PREGNANCY,RO-contraindicated_drug
503469030,7/16/2014 15:49:44,,1324306078,7/16/2014 15:49:34,prodege,0.7083,9525153,CAN,ON,Toronto,65.95.94.44,LAMELAR BONE causes BONE PAIN,113,91,,124,100,causes,0.589767824619588,905427-FS1-4,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and BONE PAIN with normal LAMELAR BONE",LAMELAR BONE,BONE PAIN,RO-has_finding_site
503469030,7/16/2014 15:50:19,,1324306362,7/16/2014 15:49:59,clixsense,0.4792,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,113,91,,124,100,causes,0.589767824619588,905427-FS1-4,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and BONE PAIN with normal LAMELAR BONE",LAMELAR BONE,BONE PAIN,RO-has_finding_site
503469030,7/16/2014 15:59:36,,1324310533,7/16/2014 15:59:21,clixsense,0.6111,17722340,CAN,BC,Mission,50.98.185.25,LAMELAR BONE causes BONE PAIN,113,91,,124,100,causes,0.589767824619588,905427-FS1-4,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and BONE PAIN with normal LAMELAR BONE",LAMELAR BONE,BONE PAIN,RO-has_finding_site
503469030,7/16/2014 16:23:40,,1324323382,7/16/2014 16:23:09,prodege,0.6736,13300986,CAN,AB,Edmonton,68.150.33.230,no_relation,113,91,,124,100,causes,0.589767824619588,905427-FS1-4,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and BONE PAIN with normal LAMELAR BONE",LAMELAR BONE,BONE PAIN,RO-has_finding_site
503469030,7/16/2014 16:38:20,,1324329625,7/16/2014 16:38:04,neodev,0.8542,14861092,GBR,H9,London,90.194.156.173,no_relation,113,91,,124,100,causes,0.589767824619588,905427-FS1-4,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and BONE PAIN with normal LAMELAR BONE",LAMELAR BONE,BONE PAIN,RO-has_finding_site
503469030,7/16/2014 17:07:43,,1324340610,7/16/2014 17:07:23,neodev,0.5903,18339121,USA,SC,Sumter,173.93.188.194,BONE PAIN causes LAMELAR BONE,113,91,,124,100,causes,0.589767824619588,905427-FS1-4,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and BONE PAIN with normal LAMELAR BONE",LAMELAR BONE,BONE PAIN,RO-has_finding_site
503469030,7/16/2014 18:17:32,,1324396298,7/16/2014 18:16:51,eup_slw,0.675,28186528,USA,IN,Bloomington,74.204.124.9,LAMELAR BONE causes BONE PAIN,113,91,,124,100,causes,0.589767824619588,905427-FS1-4,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and BONE PAIN with normal LAMELAR BONE",LAMELAR BONE,BONE PAIN,RO-has_finding_site
503469034,7/16/2014 15:30:41,,1324298575,7/16/2014 15:30:25,instagc,0.8611,24252915,GBR,B7,Bristol,77.98.139.82,TUBERCULIN diagnosed by TUBERCULOSIS INFECTION,143,104,,164,114,diagnosed by,0.979957887012223,906709-FS1-13,A new test that measures interferon gamma (IFN gamma) release in whole blood following stimulation with TUBERCULIN has the potential to detect TUBERCULOSIS INFECTION using a single blood draw.,TUBERCULOSIS INFECTION,TUBERCULIN,RO-may_diagnose
503469034,7/16/2014 15:38:48,,1324301470,7/16/2014 15:38:24,clixsense,0.8333,15189335,GBR,I9,Bury Saint Edmunds,81.155.129.231,TUBERCULIN diagnosed by TUBERCULOSIS INFECTION,143,104,,164,114,diagnosed by,0.979957887012223,906709-FS1-13,A new test that measures interferon gamma (IFN gamma) release in whole blood following stimulation with TUBERCULIN has the potential to detect TUBERCULOSIS INFECTION using a single blood draw.,TUBERCULOSIS INFECTION,TUBERCULIN,RO-may_diagnose
503469034,7/16/2014 16:21:52,,1324322713,7/16/2014 16:20:47,clixsense,0.7708,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,TUBERCULOSIS INFECTION diagnosed by TUBERCULIN,143,104,,164,114,diagnosed by,0.979957887012223,906709-FS1-13,A new test that measures interferon gamma (IFN gamma) release in whole blood following stimulation with TUBERCULIN has the potential to detect TUBERCULOSIS INFECTION using a single blood draw.,TUBERCULOSIS INFECTION,TUBERCULIN,RO-may_diagnose
503469034,7/16/2014 17:09:25,,1324341201,7/16/2014 17:09:01,neodev,0.5903,18339121,USA,SC,Sumter,173.93.188.194,TUBERCULIN diagnosed by TUBERCULOSIS INFECTION,143,104,,164,114,diagnosed by,0.979957887012223,906709-FS1-13,A new test that measures interferon gamma (IFN gamma) release in whole blood following stimulation with TUBERCULIN has the potential to detect TUBERCULOSIS INFECTION using a single blood draw.,TUBERCULOSIS INFECTION,TUBERCULIN,RO-may_diagnose
503469034,7/16/2014 17:18:52,,1324344046,7/16/2014 17:18:38,prodege,0.6046,23541832,USA,AZ,Tempe,149.169.143.104,TUBERCULOSIS INFECTION diagnosed by TUBERCULIN,143,104,,164,114,diagnosed by,0.979957887012223,906709-FS1-13,A new test that measures interferon gamma (IFN gamma) release in whole blood following stimulation with TUBERCULIN has the potential to detect TUBERCULOSIS INFECTION using a single blood draw.,TUBERCULOSIS INFECTION,TUBERCULIN,RO-may_diagnose
503469034,7/16/2014 17:30:38,,1324349809,7/16/2014 17:30:22,clixsense,0.6083,25595227,CAN,SK,North Battleford,24.72.96.119,TUBERCULOSIS INFECTION diagnosed by TUBERCULIN,143,104,,164,114,diagnosed by,0.979957887012223,906709-FS1-13,A new test that measures interferon gamma (IFN gamma) release in whole blood following stimulation with TUBERCULIN has the potential to detect TUBERCULOSIS INFECTION using a single blood draw.,TUBERCULOSIS INFECTION,TUBERCULIN,RO-may_diagnose
503469034,7/16/2014 17:43:50,,1324360820,7/16/2014 17:43:18,clixsense,0.5657,23398628,USA,WA,Spanaway,50.149.99.43,TUBERCULOSIS INFECTION diagnosed by TUBERCULIN,143,104,,164,114,diagnosed by,0.979957887012223,906709-FS1-13,A new test that measures interferon gamma (IFN gamma) release in whole blood following stimulation with TUBERCULIN has the potential to detect TUBERCULOSIS INFECTION using a single blood draw.,TUBERCULOSIS INFECTION,TUBERCULIN,RO-may_diagnose
503469037,7/16/2014 23:10:26,,1324528826,7/16/2014 23:10:02,instagc,0.6728,19636746,USA,NY,Andover,192.182.216.225,WARFARIN ANTICOAGULATION treats ATRIAL FIBRILLATION,54,88,,72,112,treats,0.9667364890456641,908209-FS1-2,Thromboembolism did not occur in patients who were in ATRIAL FIBRILLATION and receiving WARFARIN ANTICOAGULATION.,ATRIAL FIBRILLATION,WARFARIN ANTICOAGULATION,RO-may_treat
503469037,7/16/2014 23:29:28,,1324537409,7/16/2014 23:29:08,zoombucks,0.7409,4688131,CAN,BC,Vancouver,108.180.143.28,WARFARIN ANTICOAGULATION treats ATRIAL FIBRILLATION,54,88,,72,112,treats,0.9667364890456641,908209-FS1-2,Thromboembolism did not occur in patients who were in ATRIAL FIBRILLATION and receiving WARFARIN ANTICOAGULATION.,ATRIAL FIBRILLATION,WARFARIN ANTICOAGULATION,RO-may_treat
503469037,7/16/2014 23:33:33,,1324539069,7/16/2014 23:33:14,neodev,0.6766,15848372,AUS,02,Jannali,27.96.208.89,WARFARIN ANTICOAGULATION treats ATRIAL FIBRILLATION,54,88,,72,112,treats,0.9667364890456641,908209-FS1-2,Thromboembolism did not occur in patients who were in ATRIAL FIBRILLATION and receiving WARFARIN ANTICOAGULATION.,ATRIAL FIBRILLATION,WARFARIN ANTICOAGULATION,RO-may_treat
503469037,7/17/2014 00:28:35,,1324564768,7/17/2014 00:28:12,prodege,0.335,24403612,CAN,ON,Ajax,99.242.234.239,no_relation,54,88,,72,112,treats,0.9667364890456641,908209-FS1-2,Thromboembolism did not occur in patients who were in ATRIAL FIBRILLATION and receiving WARFARIN ANTICOAGULATION.,ATRIAL FIBRILLATION,WARFARIN ANTICOAGULATION,RO-may_treat
503469037,7/17/2014 02:18:49,,1324670853,7/17/2014 02:18:34,pokerowned,0.5583,18747884,USA,MI,Saginaw,74.85.192.98,WARFARIN ANTICOAGULATION treats ATRIAL FIBRILLATION,54,88,,72,112,treats,0.9667364890456641,908209-FS1-2,Thromboembolism did not occur in patients who were in ATRIAL FIBRILLATION and receiving WARFARIN ANTICOAGULATION.,ATRIAL FIBRILLATION,WARFARIN ANTICOAGULATION,RO-may_treat
503469037,7/17/2014 02:23:09,,1324675115,7/17/2014 02:22:14,clixsense,0.5607,6520576,USA,OH,Springfield,71.79.14.94,WARFARIN ANTICOAGULATION treats ATRIAL FIBRILLATION,54,88,,72,112,treats,0.9667364890456641,908209-FS1-2,Thromboembolism did not occur in patients who were in ATRIAL FIBRILLATION and receiving WARFARIN ANTICOAGULATION.,ATRIAL FIBRILLATION,WARFARIN ANTICOAGULATION,RO-may_treat
503469037,7/17/2014 03:07:37,,1324720203,7/17/2014 03:06:58,cotter,0.5675,7287927,USA,CA,San Jose,99.27.90.128,WARFARIN ANTICOAGULATION treats ATRIAL FIBRILLATION,54,88,,72,112,treats,0.9667364890456641,908209-FS1-2,Thromboembolism did not occur in patients who were in ATRIAL FIBRILLATION and receiving WARFARIN ANTICOAGULATION.,ATRIAL FIBRILLATION,WARFARIN ANTICOAGULATION,RO-may_treat
503469050,7/16/2014 15:31:50,,1324298979,7/16/2014 15:31:21,clixsense,0.9028,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,0,23,,21,36,causes,0.320256307610174,906399-FS1-4,"X LINKED HYDROCEPHALUS MASA SYNDROME X linked complicated Spastic Paraplegia Type I and X linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene.",X LINKED HYDROCEPHALUS,MASA SYNDROME,RO-has_manifestation
503469050,7/16/2014 16:16:34,,1324320682,7/16/2014 16:16:07,elite,0.7361,28276268,USA,MI,Fenton,68.188.185.225,X LINKED HYDROCEPHALUS causes MASA SYNDROME,0,23,,21,36,causes,0.320256307610174,906399-FS1-4,"X LINKED HYDROCEPHALUS MASA SYNDROME X linked complicated Spastic Paraplegia Type I and X linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene.",X LINKED HYDROCEPHALUS,MASA SYNDROME,RO-has_manifestation
503469050,7/16/2014 16:37:49,,1324329259,7/16/2014 16:37:21,neodev,0.8542,14861092,GBR,H9,London,90.194.156.173,no_relation,0,23,,21,36,causes,0.320256307610174,906399-FS1-4,"X LINKED HYDROCEPHALUS MASA SYNDROME X linked complicated Spastic Paraplegia Type I and X linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene.",X LINKED HYDROCEPHALUS,MASA SYNDROME,RO-has_manifestation
503469050,7/16/2014 17:02:07,,1324338852,7/16/2014 17:02:03,prodege,0.5583,12944140,GBR,C8,Croydon,92.21.8.174,MASA SYNDROME causes X LINKED HYDROCEPHALUS,0,23,,21,36,causes,0.320256307610174,906399-FS1-4,"X LINKED HYDROCEPHALUS MASA SYNDROME X linked complicated Spastic Paraplegia Type I and X linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene.",X LINKED HYDROCEPHALUS,MASA SYNDROME,RO-has_manifestation
503469050,7/16/2014 17:04:33,,1324339555,7/16/2014 17:04:00,clixsense,0.5597,19638651,USA,,,173.23.121.63,no_relation,0,23,,21,36,causes,0.320256307610174,906399-FS1-4,"X LINKED HYDROCEPHALUS MASA SYNDROME X linked complicated Spastic Paraplegia Type I and X linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene.",X LINKED HYDROCEPHALUS,MASA SYNDROME,RO-has_manifestation
503469050,7/16/2014 19:27:59,,1324433486,7/16/2014 19:27:18,clixsense,0.5444,6714657,USA,CT,Groton,71.235.184.32,no_relation,0,23,,21,36,causes,0.320256307610174,906399-FS1-4,"X LINKED HYDROCEPHALUS MASA SYNDROME X linked complicated Spastic Paraplegia Type I and X linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene.",X LINKED HYDROCEPHALUS,MASA SYNDROME,RO-has_manifestation
503469050,7/16/2014 22:01:23,,1324502238,7/16/2014 22:00:56,clixsense,0.6754,6472283,USA,WI,Oak Creek,99.107.184.156,MASA SYNDROME causes X LINKED HYDROCEPHALUS,0,23,,21,36,causes,0.320256307610174,906399-FS1-4,"X LINKED HYDROCEPHALUS MASA SYNDROME X linked complicated Spastic Paraplegia Type I and X linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene.",X LINKED HYDROCEPHALUS,MASA SYNDROME,RO-has_manifestation
503469054,7/16/2014 15:28:16,,1324297708,7/16/2014 15:27:36,elite,0.8472,28503042,USA,NJ,Woodbridge,54.191.150.115,no_relation,123,95,,126,118,causes,0.400891862868637,907870-FS1-4,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), PRO (B29 HUMAN INSULIN] in IDDM and NIDDM patients previously treated with insulin.",IDDM,PRO (B29) HUMAN INSULIN,RO-may_treat
503469054,7/16/2014 15:33:52,,1324299587,7/16/2014 15:33:37,neodev,0.8472,27597779,CAN,AB,Calgary,72.29.251.209,PRO (B29) HUMAN INSULIN causes IDDM,123,95,,126,118,causes,0.400891862868637,907870-FS1-4,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), PRO (B29 HUMAN INSULIN] in IDDM and NIDDM patients previously treated with insulin.",IDDM,PRO (B29) HUMAN INSULIN,RO-may_treat
503469054,7/16/2014 15:37:23,,1324300866,7/16/2014 15:37:00,instagc,0.9028,13763729,USA,,,75.182.89.225,no_relation,123,95,,126,118,causes,0.400891862868637,907870-FS1-4,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), PRO (B29 HUMAN INSULIN] in IDDM and NIDDM patients previously treated with insulin.",IDDM,PRO (B29) HUMAN INSULIN,RO-may_treat
503469054,7/16/2014 16:24:42,,1324323818,7/16/2014 16:24:15,neodev,0.5486,21515166,NLD,11,Nootdorp,83.86.58.179,PRO (B29) HUMAN INSULIN causes IDDM,123,95,,126,118,causes,0.400891862868637,907870-FS1-4,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), PRO (B29 HUMAN INSULIN] in IDDM and NIDDM patients previously treated with insulin.",IDDM,PRO (B29) HUMAN INSULIN,RO-may_treat
503469054,7/16/2014 20:34:56,,1324464172,7/16/2014 20:34:13,clixsense,0.4899,6574199,USA,TX,San Antonio,207.230.144.242,IDDM causes PRO (B29) HUMAN INSULIN,123,95,,126,118,causes,0.400891862868637,907870-FS1-4,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), PRO (B29 HUMAN INSULIN] in IDDM and NIDDM patients previously treated with insulin.",IDDM,PRO (B29) HUMAN INSULIN,RO-may_treat
503469054,7/16/2014 22:52:20,,1324522209,7/16/2014 22:51:36,prodege,0.5665,28255346,GBR,L9,Sheffield,2.125.183.137,no_relation,123,95,,126,118,causes,0.400891862868637,907870-FS1-4,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), PRO (B29 HUMAN INSULIN] in IDDM and NIDDM patients previously treated with insulin.",IDDM,PRO (B29) HUMAN INSULIN,RO-may_treat
503469054,7/16/2014 22:54:37,,1324523251,7/16/2014 22:54:07,prodege,0.7282,12971342,USA,CA,Los Angeles,198.101.91.82,no_relation,123,95,,126,118,causes,0.400891862868637,907870-FS1-4,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), PRO (B29 HUMAN INSULIN] in IDDM and NIDDM patients previously treated with insulin.",IDDM,PRO (B29) HUMAN INSULIN,RO-may_treat
503469061,7/16/2014 15:36:59,,1324300740,7/16/2014 15:36:41,instagc,0.9028,13763729,USA,,,75.182.89.225,RIGHT PARIETAL PARASAGITTAL MENINGIOMA causes SEIZURES,70,90,,77,128,causes,0.997054485501582,902637-FS1-4,The authors describe the case of a 58 year old man with an history of SEIZURES because of RIGHT PARIETAL PARASAGITTAL MENINGIOMA,SEIZURES,RIGHT PARIETAL PARASAGITTAL MENINGIOMA,RO-disease_may_have_finding
503469061,7/16/2014 16:22:10,,1324322830,7/16/2014 16:21:53,clixsense,0.7708,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,RIGHT PARIETAL PARASAGITTAL MENINGIOMA causes SEIZURES,70,90,,77,128,causes,0.997054485501582,902637-FS1-4,The authors describe the case of a 58 year old man with an history of SEIZURES because of RIGHT PARIETAL PARASAGITTAL MENINGIOMA,SEIZURES,RIGHT PARIETAL PARASAGITTAL MENINGIOMA,RO-disease_may_have_finding
503469061,7/16/2014 16:24:42,,1324323821,7/16/2014 16:24:15,neodev,0.5486,21515166,NLD,11,Nootdorp,83.86.58.179,SEIZURES causes RIGHT PARIETAL PARASAGITTAL MENINGIOMA,70,90,,77,128,causes,0.997054485501582,902637-FS1-4,The authors describe the case of a 58 year old man with an history of SEIZURES because of RIGHT PARIETAL PARASAGITTAL MENINGIOMA,SEIZURES,RIGHT PARIETAL PARASAGITTAL MENINGIOMA,RO-disease_may_have_finding
503469061,7/16/2014 16:50:04,,1324334674,7/16/2014 16:49:15,rewardsspot,0.6597,17763704,USA,VA,Manassas,198.7.62.204,RIGHT PARIETAL PARASAGITTAL MENINGIOMA causes SEIZURES,70,90,,77,128,causes,0.997054485501582,902637-FS1-4,The authors describe the case of a 58 year old man with an history of SEIZURES because of RIGHT PARIETAL PARASAGITTAL MENINGIOMA,SEIZURES,RIGHT PARIETAL PARASAGITTAL MENINGIOMA,RO-disease_may_have_finding
503469061,7/16/2014 17:04:00,,1324339422,7/16/2014 17:03:42,clixsense,0.5597,19638651,USA,,,173.23.121.63,RIGHT PARIETAL PARASAGITTAL MENINGIOMA causes SEIZURES,70,90,,77,128,causes,0.997054485501582,902637-FS1-4,The authors describe the case of a 58 year old man with an history of SEIZURES because of RIGHT PARIETAL PARASAGITTAL MENINGIOMA,SEIZURES,RIGHT PARIETAL PARASAGITTAL MENINGIOMA,RO-disease_may_have_finding
503469061,7/16/2014 17:22:38,,1324345158,7/16/2014 17:22:08,prodege,0.7014,19026375,GBR,Z1,Swansea,92.26.69.100,RIGHT PARIETAL PARASAGITTAL MENINGIOMA causes SEIZURES,70,90,,77,128,causes,0.997054485501582,902637-FS1-4,The authors describe the case of a 58 year old man with an history of SEIZURES because of RIGHT PARIETAL PARASAGITTAL MENINGIOMA,SEIZURES,RIGHT PARIETAL PARASAGITTAL MENINGIOMA,RO-disease_may_have_finding
503469061,7/16/2014 17:42:10,,1324359200,7/16/2014 17:41:47,clixsense,0.5657,23398628,USA,WA,Spanaway,50.149.99.43,SEIZURES causes RIGHT PARIETAL PARASAGITTAL MENINGIOMA,70,90,,77,128,causes,0.997054485501582,902637-FS1-4,The authors describe the case of a 58 year old man with an history of SEIZURES because of RIGHT PARIETAL PARASAGITTAL MENINGIOMA,SEIZURES,RIGHT PARIETAL PARASAGITTAL MENINGIOMA,RO-disease_may_have_finding
503469062,7/16/2014 17:43:17,,1324360279,7/16/2014 17:42:43,clixsense,0.5657,23398628,USA,WA,Spanaway,50.149.99.43,PROGERIA SYNDROME (HGPS) causes PREMATURE AGING,77,122,,91,146,causes,0.5393598899705939,906273-FS1-4,The most recently discovered diseases associated with LMNA mutations are the PREMATURE AGING disorders Hutchinson Gilford PROGERIA SYNDROME (HGPS) and atypical Werner's syndrome.,PREMATURE AGING,PROGERIA SYNDROME (HGPS),RO-has_manifestation
503469062,7/16/2014 19:10:39,,1324424829,7/16/2014 19:10:01,vivatic,0.6952,25451531,GBR,,,83.67.28.193,PREMATURE AGING causes PROGERIA SYNDROME (HGPS),77,122,,91,146,causes,0.5393598899705939,906273-FS1-4,The most recently discovered diseases associated with LMNA mutations are the PREMATURE AGING disorders Hutchinson Gilford PROGERIA SYNDROME (HGPS) and atypical Werner's syndrome.,PREMATURE AGING,PROGERIA SYNDROME (HGPS),RO-has_manifestation
503469062,7/16/2014 19:46:09,,1324442288,7/16/2014 19:45:43,prodege,0.4306,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,77,122,,91,146,causes,0.5393598899705939,906273-FS1-4,The most recently discovered diseases associated with LMNA mutations are the PREMATURE AGING disorders Hutchinson Gilford PROGERIA SYNDROME (HGPS) and atypical Werner's syndrome.,PREMATURE AGING,PROGERIA SYNDROME (HGPS),RO-has_manifestation
503469062,7/16/2014 22:56:58,,1324524240,7/16/2014 22:56:28,prodege,0.7282,12971342,USA,CA,Los Angeles,198.101.91.82,no_relation,77,122,,91,146,causes,0.5393598899705939,906273-FS1-4,The most recently discovered diseases associated with LMNA mutations are the PREMATURE AGING disorders Hutchinson Gilford PROGERIA SYNDROME (HGPS) and atypical Werner's syndrome.,PREMATURE AGING,PROGERIA SYNDROME (HGPS),RO-has_manifestation
503469062,7/16/2014 23:50:16,,1324545717,7/16/2014 23:50:04,clixsense,0.6734,23585686,GBR,H9,London,31.51.221.173,PROGERIA SYNDROME (HGPS) causes PREMATURE AGING,77,122,,91,146,causes,0.5393598899705939,906273-FS1-4,The most recently discovered diseases associated with LMNA mutations are the PREMATURE AGING disorders Hutchinson Gilford PROGERIA SYNDROME (HGPS) and atypical Werner's syndrome.,PREMATURE AGING,PROGERIA SYNDROME (HGPS),RO-has_manifestation
503469062,7/17/2014 00:28:11,,1324564393,7/17/2014 00:27:47,prodege,0.335,24403612,CAN,ON,Ajax,99.242.234.239,no_relation,77,122,,91,146,causes,0.5393598899705939,906273-FS1-4,The most recently discovered diseases associated with LMNA mutations are the PREMATURE AGING disorders Hutchinson Gilford PROGERIA SYNDROME (HGPS) and atypical Werner's syndrome.,PREMATURE AGING,PROGERIA SYNDROME (HGPS),RO-has_manifestation
503469062,7/17/2014 02:19:04,,1324671181,7/17/2014 02:18:49,pokerowned,0.5583,18747884,USA,MI,Saginaw,74.85.192.98,PREMATURE AGING causes PROGERIA SYNDROME (HGPS),77,122,,91,146,causes,0.5393598899705939,906273-FS1-4,The most recently discovered diseases associated with LMNA mutations are the PREMATURE AGING disorders Hutchinson Gilford PROGERIA SYNDROME (HGPS) and atypical Werner's syndrome.,PREMATURE AGING,PROGERIA SYNDROME (HGPS),RO-has_manifestation
503469086,7/16/2014 15:31:20,,1324298774,7/16/2014 15:30:46,clixsense,0.9028,19803139,NLD,06,Veldhoven,212.61.84.196,PRO (B29) HUMAN INSULIN treats IDDM,123,95,,126,118,treats,0.801783725737273,907870-FS1-2,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), PRO (B29 HUMAN INSULIN] in IDDM and NIDDM patients previously treated with insulin.",IDDM,PRO (B29) HUMAN INSULIN,RO-may_treat
503469086,7/16/2014 15:43:10,,1324303266,7/16/2014 15:42:56,instagc,0.8194,18960682,GBR,,,86.29.147.112,PRO (B29) HUMAN INSULIN treats IDDM,123,95,,126,118,treats,0.801783725737273,907870-FS1-2,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), PRO (B29 HUMAN INSULIN] in IDDM and NIDDM patients previously treated with insulin.",IDDM,PRO (B29) HUMAN INSULIN,RO-may_treat
503469086,7/16/2014 17:07:22,,1324340501,7/16/2014 17:06:11,neodev,0.5903,18339121,USA,SC,Sumter,173.93.188.194,IDDM treats PRO (B29) HUMAN INSULIN,123,95,,126,118,treats,0.801783725737273,907870-FS1-2,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), PRO (B29 HUMAN INSULIN] in IDDM and NIDDM patients previously treated with insulin.",IDDM,PRO (B29) HUMAN INSULIN,RO-may_treat
503469086,7/16/2014 19:12:02,,1324425475,7/16/2014 19:11:21,vivatic,0.6952,25451531,GBR,,,83.67.28.193,PRO (B29) HUMAN INSULIN treats IDDM,123,95,,126,118,treats,0.801783725737273,907870-FS1-2,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), PRO (B29 HUMAN INSULIN] in IDDM and NIDDM patients previously treated with insulin.",IDDM,PRO (B29) HUMAN INSULIN,RO-may_treat
503469086,7/16/2014 20:00:52,,1324448870,7/16/2014 19:59:55,prodege,0.5917,15287417,CAN,ON,Mississauga,209.171.47.7,no_relation,123,95,,126,118,treats,0.801783725737273,907870-FS1-2,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), PRO (B29 HUMAN INSULIN] in IDDM and NIDDM patients previously treated with insulin.",IDDM,PRO (B29) HUMAN INSULIN,RO-may_treat
503469086,7/16/2014 22:20:32,,1324509429,7/16/2014 22:20:14,clixsense,0.6101,19294877,USA,MA,Boston,96.233.18.114,PRO (B29) HUMAN INSULIN treats IDDM,123,95,,126,118,treats,0.801783725737273,907870-FS1-2,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), PRO (B29 HUMAN INSULIN] in IDDM and NIDDM patients previously treated with insulin.",IDDM,PRO (B29) HUMAN INSULIN,RO-may_treat
503469086,7/16/2014 22:51:34,,1324521891,7/16/2014 22:50:42,prodege,0.5665,28255346,GBR,L9,Sheffield,2.125.183.137,PRO (B29) HUMAN INSULIN treats IDDM,123,95,,126,118,treats,0.801783725737273,907870-FS1-2,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), PRO (B29 HUMAN INSULIN] in IDDM and NIDDM patients previously treated with insulin.",IDDM,PRO (B29) HUMAN INSULIN,RO-may_treat
503729619,7/16/2014 22:28:26,,1324512720,7/16/2014 22:28:00,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,139,43,,159,69,causes,0.7022468831767831,900071-FS1-4,Analysis of the mortality of children with INSULIN DEPENDENT DIABETES in Moscow in the eighties revealed a very high specific incidence of DIABETIC KETOACIDOSIS the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases.,DIABETIC KETOACIDOSIS,INSULIN DEPENDENT DIABETES,RO-cause_of
503729619,7/16/2014 23:09:47,,1324528606,7/16/2014 23:09:10,cotter,0.6014,7287927,USA,CA,San Jose,99.27.90.128,INSULIN DEPENDENT DIABETES causes DIABETIC KETOACIDOSIS,139,43,,159,69,causes,0.7022468831767831,900071-FS1-4,Analysis of the mortality of children with INSULIN DEPENDENT DIABETES in Moscow in the eighties revealed a very high specific incidence of DIABETIC KETOACIDOSIS the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases.,DIABETIC KETOACIDOSIS,INSULIN DEPENDENT DIABETES,RO-cause_of
503729619,7/17/2014 00:16:40,,1324557442,7/17/2014 00:16:19,prodege,0.555,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,139,43,,159,69,causes,0.7022468831767831,900071-FS1-4,Analysis of the mortality of children with INSULIN DEPENDENT DIABETES in Moscow in the eighties revealed a very high specific incidence of DIABETIC KETOACIDOSIS the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases.,DIABETIC KETOACIDOSIS,INSULIN DEPENDENT DIABETES,RO-cause_of
503729619,7/17/2014 00:48:57,,1324583326,7/17/2014 00:48:51,coinworker,0.4226,28394550,USA,PA,Marcus Hook,71.175.96.184,INSULIN DEPENDENT DIABETES causes DIABETIC KETOACIDOSIS,139,43,,159,69,causes,0.7022468831767831,900071-FS1-4,Analysis of the mortality of children with INSULIN DEPENDENT DIABETES in Moscow in the eighties revealed a very high specific incidence of DIABETIC KETOACIDOSIS the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases.,DIABETIC KETOACIDOSIS,INSULIN DEPENDENT DIABETES,RO-cause_of
503729619,7/17/2014 04:44:33,,1324810425,7/17/2014 04:44:16,clixsense,0.5202,27608125,CAN,AB,Calgary,68.146.86.137,INSULIN DEPENDENT DIABETES causes DIABETIC KETOACIDOSIS,139,43,,159,69,causes,0.7022468831767831,900071-FS1-4,Analysis of the mortality of children with INSULIN DEPENDENT DIABETES in Moscow in the eighties revealed a very high specific incidence of DIABETIC KETOACIDOSIS the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases.,DIABETIC KETOACIDOSIS,INSULIN DEPENDENT DIABETES,RO-cause_of
503729619,7/17/2014 04:57:06,,1324821413,7/17/2014 04:56:26,prodege,0.7105,27934334,GBR,,,86.130.153.15,INSULIN DEPENDENT DIABETES causes DIABETIC KETOACIDOSIS,139,43,,159,69,causes,0.7022468831767831,900071-FS1-4,Analysis of the mortality of children with INSULIN DEPENDENT DIABETES in Moscow in the eighties revealed a very high specific incidence of DIABETIC KETOACIDOSIS the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases.,DIABETIC KETOACIDOSIS,INSULIN DEPENDENT DIABETES,RO-cause_of
503729619,7/17/2014 06:39:30,,1324909279,7/17/2014 06:39:06,instagc,0.5978,18634892,USA,,,68.102.93.185,INSULIN DEPENDENT DIABETES causes DIABETIC KETOACIDOSIS,139,43,,159,69,causes,0.7022468831767831,900071-FS1-4,Analysis of the mortality of children with INSULIN DEPENDENT DIABETES in Moscow in the eighties revealed a very high specific incidence of DIABETIC KETOACIDOSIS the principal cause of lethal outcomes occurring in the period of the disease manifestation in more than a half of the analyzed cases.,DIABETIC KETOACIDOSIS,INSULIN DEPENDENT DIABETES,RO-cause_of
503729625,7/16/2014 22:28:41,,1324512798,7/16/2014 22:28:32,clixsense,0.9306,20614047,USA,MO,Maryville,174.32.162.147,EPILEPTIC SEIZURES causes SEIZURES,77,141,,84,159,causes,0.583459965991578,904933-FS1-4,The examined parameters included: the prevalence and the age of onset of the SEIZURES the clinical subgroup of cerebral palsy and subtype of EPILEPTIC SEIZURES,SEIZURES,EPILEPTIC SEIZURES,RO-has_definitional_manifestation
503729625,7/16/2014 23:55:16,,1324547693,7/16/2014 23:55:00,gifthulk,0.9056,21916793,GBR,,,87.115.178.12,EPILEPTIC SEIZURES causes SEIZURES,77,141,,84,159,causes,0.583459965991578,904933-FS1-4,The examined parameters included: the prevalence and the age of onset of the SEIZURES the clinical subgroup of cerebral palsy and subtype of EPILEPTIC SEIZURES,SEIZURES,EPILEPTIC SEIZURES,RO-has_definitional_manifestation
503729625,7/17/2014 03:42:18,,1324753711,7/17/2014 03:41:45,instagc,0.7319,20183814,USA,,,166.182.81.199,EPILEPTIC SEIZURES causes SEIZURES,77,141,,84,159,causes,0.583459965991578,904933-FS1-4,The examined parameters included: the prevalence and the age of onset of the SEIZURES the clinical subgroup of cerebral palsy and subtype of EPILEPTIC SEIZURES,SEIZURES,EPILEPTIC SEIZURES,RO-has_definitional_manifestation
503729625,7/17/2014 04:57:30,,1324821840,7/17/2014 04:57:07,prodege,0.7105,27934334,GBR,,,86.130.153.15,no_relation,77,141,,84,159,causes,0.583459965991578,904933-FS1-4,The examined parameters included: the prevalence and the age of onset of the SEIZURES the clinical subgroup of cerebral palsy and subtype of EPILEPTIC SEIZURES,SEIZURES,EPILEPTIC SEIZURES,RO-has_definitional_manifestation
503729625,7/17/2014 07:31:29,,1324964711,7/17/2014 07:30:39,instagc,0.8278,25901556,GBR,C3,Saint Ives,82.9.129.2,EPILEPTIC SEIZURES causes SEIZURES,77,141,,84,159,causes,0.583459965991578,904933-FS1-4,The examined parameters included: the prevalence and the age of onset of the SEIZURES the clinical subgroup of cerebral palsy and subtype of EPILEPTIC SEIZURES,SEIZURES,EPILEPTIC SEIZURES,RO-has_definitional_manifestation
503729625,7/17/2014 10:03:04,,1325115955,7/17/2014 10:02:38,prodege,0.7163,25949006,GBR,,,62.249.242.67,no_relation,77,141,,84,159,causes,0.583459965991578,904933-FS1-4,The examined parameters included: the prevalence and the age of onset of the SEIZURES the clinical subgroup of cerebral palsy and subtype of EPILEPTIC SEIZURES,SEIZURES,EPILEPTIC SEIZURES,RO-has_definitional_manifestation
503729625,7/17/2014 10:35:59,,1325143096,7/17/2014 10:35:41,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,SEIZURES causes EPILEPTIC SEIZURES,77,141,,84,159,causes,0.583459965991578,904933-FS1-4,The examined parameters included: the prevalence and the age of onset of the SEIZURES the clinical subgroup of cerebral palsy and subtype of EPILEPTIC SEIZURES,SEIZURES,EPILEPTIC SEIZURES,RO-has_definitional_manifestation
503729637,7/16/2014 22:24:01,,1324510746,7/16/2014 22:23:23,clixsense,1.0,21642428,NLD,11,Nootdorp,83.86.58.179,TUBERCULIN RESPONSE diagnosed by TUBERCULOSIS,120,4,,131,23,diagnosed by,0.442325868464691,906700-FS1-13,"The TUBERCULIN RESPONSE which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN RESPONSE,RO-may_diagnose
503729637,7/16/2014 22:37:24,,1324516565,7/16/2014 22:36:56,tremorgames,0.8403,24449707,CAN,QC,Laval,96.21.249.72,TUBERCULOSIS diagnosed by TUBERCULIN RESPONSE,120,4,,131,23,diagnosed by,0.442325868464691,906700-FS1-13,"The TUBERCULIN RESPONSE which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN RESPONSE,RO-may_diagnose
503729637,7/16/2014 23:25:01,,1324535535,7/16/2014 23:24:47,instagc,0.7639,13763729,USA,,,75.182.89.225,TUBERCULOSIS diagnosed by TUBERCULIN RESPONSE,120,4,,131,23,diagnosed by,0.442325868464691,906700-FS1-13,"The TUBERCULIN RESPONSE which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN RESPONSE,RO-may_diagnose
503729637,7/16/2014 23:38:09,,1324541210,7/16/2014 23:37:49,neodev,0.7056,15848372,AUS,02,Jannali,27.96.208.89,TUBERCULOSIS diagnosed by TUBERCULIN RESPONSE,120,4,,131,23,diagnosed by,0.442325868464691,906700-FS1-13,"The TUBERCULIN RESPONSE which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN RESPONSE,RO-may_diagnose
503729637,7/17/2014 06:05:27,,1324879277,7/17/2014 06:04:59,clixsense,0.6268,15117831,GBR,H9,London,90.194.156.173,TUBERCULOSIS diagnosed by TUBERCULIN RESPONSE,120,4,,131,23,diagnosed by,0.442325868464691,906700-FS1-13,"The TUBERCULIN RESPONSE which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN RESPONSE,RO-may_diagnose
503729637,7/17/2014 07:24:16,,1324956519,7/17/2014 07:23:17,clixsense,0.7143,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,TUBERCULOSIS diagnosed by TUBERCULIN RESPONSE,120,4,,131,23,diagnosed by,0.442325868464691,906700-FS1-13,"The TUBERCULIN RESPONSE which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN RESPONSE,RO-may_diagnose
503729637,7/17/2014 07:57:34,,1324992920,7/17/2014 07:57:02,prodege,0.4905,19466267,GBR,Z5,Bedford,82.29.157.23,no_relation,120,4,,131,23,diagnosed by,0.442325868464691,906700-FS1-13,"The TUBERCULIN RESPONSE which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN RESPONSE,RO-may_diagnose
503729640,7/16/2014 22:29:25,,1324513047,7/16/2014 22:29:16,clixsense,0.9306,20614047,USA,MO,Maryville,174.32.162.147,MEDULLARY CARCINOMA causes COLD NODULES,175,242,,186,261,causes,0.304997140665209,902601-FS1-4,"Affinity labelling with a 125I labelled photoactive derivative of TSH (HSAB TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) COLD NODULES; (2) autonomous nodules; (3) papillary carcinoma; (4) MEDULLARY CARCINOMA; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid.",COLD NODULES,MEDULLARY CARCINOMA,RO-disease_may_have_finding
503729640,7/16/2014 23:33:02,,1324538899,7/16/2014 23:32:22,zoombucks,0.7236,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,175,242,,186,261,causes,0.304997140665209,902601-FS1-4,"Affinity labelling with a 125I labelled photoactive derivative of TSH (HSAB TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) COLD NODULES; (2) autonomous nodules; (3) papillary carcinoma; (4) MEDULLARY CARCINOMA; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid.",COLD NODULES,MEDULLARY CARCINOMA,RO-disease_may_have_finding
503729640,7/16/2014 23:55:28,,1324547780,7/16/2014 23:55:18,gifthulk,0.9056,21916793,GBR,,,87.115.178.12,no_relation,175,242,,186,261,causes,0.304997140665209,902601-FS1-4,"Affinity labelling with a 125I labelled photoactive derivative of TSH (HSAB TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) COLD NODULES; (2) autonomous nodules; (3) papillary carcinoma; (4) MEDULLARY CARCINOMA; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid.",COLD NODULES,MEDULLARY CARCINOMA,RO-disease_may_have_finding
503729640,7/17/2014 00:18:27,,1324558259,7/17/2014 00:18:06,prodege,0.555,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,175,242,,186,261,causes,0.304997140665209,902601-FS1-4,"Affinity labelling with a 125I labelled photoactive derivative of TSH (HSAB TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) COLD NODULES; (2) autonomous nodules; (3) papillary carcinoma; (4) MEDULLARY CARCINOMA; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid.",COLD NODULES,MEDULLARY CARCINOMA,RO-disease_may_have_finding
503729640,7/17/2014 08:48:10,,1325044823,7/17/2014 08:47:48,neodev,0.5377,18339121,USA,SC,Sumter,173.93.188.194,COLD NODULES causes MEDULLARY CARCINOMA,175,242,,186,261,causes,0.304997140665209,902601-FS1-4,"Affinity labelling with a 125I labelled photoactive derivative of TSH (HSAB TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) COLD NODULES; (2) autonomous nodules; (3) papillary carcinoma; (4) MEDULLARY CARCINOMA; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid.",COLD NODULES,MEDULLARY CARCINOMA,RO-disease_may_have_finding
503729640,7/17/2014 09:30:55,,1325084826,7/17/2014 09:30:21,prodege,0.5512,27990290,GBR,I9,Bury Saint Edmunds,86.142.231.81,no_relation,175,242,,186,261,causes,0.304997140665209,902601-FS1-4,"Affinity labelling with a 125I labelled photoactive derivative of TSH (HSAB TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) COLD NODULES; (2) autonomous nodules; (3) papillary carcinoma; (4) MEDULLARY CARCINOMA; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid.",COLD NODULES,MEDULLARY CARCINOMA,RO-disease_may_have_finding
503729640,7/17/2014 10:03:04,,1325115958,7/17/2014 10:02:38,prodege,0.7163,25949006,GBR,,,62.249.242.67,no_relation,175,242,,186,261,causes,0.304997140665209,902601-FS1-4,"Affinity labelling with a 125I labelled photoactive derivative of TSH (HSAB TSH) was used to analyse TSH receptor size in the following specimens of human thyroid tissue: (1) COLD NODULES; (2) autonomous nodules; (3) papillary carcinoma; (4) MEDULLARY CARCINOMA; (5) metastasis of papillary carcinoma to lymph node; (6) anaplastic carcinoma, and (7) Graves' thyroid.",COLD NODULES,MEDULLARY CARCINOMA,RO-disease_may_have_finding
503729659,7/16/2014 23:08:38,,1324528216,7/16/2014 23:08:02,clixsense,0.6278,18647227,GBR,P3,Bulkington,2.216.185.243,no_relation,142,0,,153,30,is location of,0.8908708063747479,905340-FS1-9,OBSTRUCTIVE SLEEP APNOEA (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep related decrement in UPPER AIRWAY muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration.,UPPER AIRWAY,OBSTRUCTIVE SLEEP APNOEA (OSA),RO-has_finding_site
503729659,7/17/2014 00:27:08,,1324563441,7/17/2014 00:26:50,elite,0.675,28503042,USA,OK,Watonga,65.255.78.241,UPPER AIRWAY is location of OBSTRUCTIVE SLEEP APNOEA (OSA),142,0,,153,30,is location of,0.8908708063747479,905340-FS1-9,OBSTRUCTIVE SLEEP APNOEA (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep related decrement in UPPER AIRWAY muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration.,UPPER AIRWAY,OBSTRUCTIVE SLEEP APNOEA (OSA),RO-has_finding_site
503729659,7/17/2014 01:11:49,,1324604884,7/17/2014 01:11:24,prodege,0.649,2767509,CAN,BC,Victoria,96.54.172.117,UPPER AIRWAY is location of OBSTRUCTIVE SLEEP APNOEA (OSA),142,0,,153,30,is location of,0.8908708063747479,905340-FS1-9,OBSTRUCTIVE SLEEP APNOEA (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep related decrement in UPPER AIRWAY muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration.,UPPER AIRWAY,OBSTRUCTIVE SLEEP APNOEA (OSA),RO-has_finding_site
503729659,7/17/2014 01:38:50,,1324631741,7/17/2014 01:38:07,rewardsspot,0.6012,17763704,USA,IL,Chicago,67.212.175.123,UPPER AIRWAY is location of OBSTRUCTIVE SLEEP APNOEA (OSA),142,0,,153,30,is location of,0.8908708063747479,905340-FS1-9,OBSTRUCTIVE SLEEP APNOEA (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep related decrement in UPPER AIRWAY muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration.,UPPER AIRWAY,OBSTRUCTIVE SLEEP APNOEA (OSA),RO-has_finding_site
503729659,7/17/2014 03:41:05,,1324752619,7/17/2014 03:40:41,instagc,0.7319,20183814,USA,,,166.182.81.199,UPPER AIRWAY is location of OBSTRUCTIVE SLEEP APNOEA (OSA),142,0,,153,30,is location of,0.8908708063747479,905340-FS1-9,OBSTRUCTIVE SLEEP APNOEA (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep related decrement in UPPER AIRWAY muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration.,UPPER AIRWAY,OBSTRUCTIVE SLEEP APNOEA (OSA),RO-has_finding_site
503729659,7/17/2014 06:11:41,,1324884840,7/17/2014 06:11:26,clixsense,0.6401,17648398,GBR,O4,Torquay,92.23.66.130,UPPER AIRWAY is location of OBSTRUCTIVE SLEEP APNOEA (OSA),142,0,,153,30,is location of,0.8908708063747479,905340-FS1-9,OBSTRUCTIVE SLEEP APNOEA (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep related decrement in UPPER AIRWAY muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration.,UPPER AIRWAY,OBSTRUCTIVE SLEEP APNOEA (OSA),RO-has_finding_site
503729659,7/17/2014 07:24:16,,1324956517,7/17/2014 07:23:17,clixsense,0.7143,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,no_relation,142,0,,153,30,is location of,0.8908708063747479,905340-FS1-9,OBSTRUCTIVE SLEEP APNOEA (OSA) is characterised by repetitive collapse of the upper airway during sleep owing to a sleep related decrement in UPPER AIRWAY muscle activity with consequent failure of the pharyngeal dilator muscles to oppose the collapsing pressure that is generated by the diaphragm and accessory muscles during inspiration.,UPPER AIRWAY,OBSTRUCTIVE SLEEP APNOEA (OSA),RO-has_finding_site
503729661,7/16/2014 23:33:53,,1324539217,7/16/2014 23:33:37,zoombucks,0.7236,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,120,4,,131,23,treats,0.442325868464691,906700-FS1-2,"The TUBERCULIN RESPONSE which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN RESPONSE,RO-may_diagnose
503729661,7/16/2014 23:55:16,,1324547692,7/16/2014 23:55:00,gifthulk,0.9056,21916793,GBR,,,87.115.178.12,no_relation,120,4,,131,23,treats,0.442325868464691,906700-FS1-2,"The TUBERCULIN RESPONSE which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN RESPONSE,RO-may_diagnose
503729661,7/17/2014 00:02:37,,1324551650,7/17/2014 00:02:12,instagc,0.675,19636746,USA,NY,Andover,192.182.216.225,no_relation,120,4,,131,23,treats,0.442325868464691,906700-FS1-2,"The TUBERCULIN RESPONSE which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN RESPONSE,RO-may_diagnose
503729661,7/17/2014 03:09:28,,1324722081,7/17/2014 03:09:00,instagc,0.6704,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,120,4,,131,23,treats,0.442325868464691,906700-FS1-2,"The TUBERCULIN RESPONSE which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN RESPONSE,RO-may_diagnose
503729661,7/17/2014 07:25:49,,1324958270,7/17/2014 07:25:18,clixsense,0.7143,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,no_relation,120,4,,131,23,treats,0.442325868464691,906700-FS1-2,"The TUBERCULIN RESPONSE which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN RESPONSE,RO-may_diagnose
503729661,7/17/2014 10:03:33,,1325116452,7/17/2014 10:03:05,prodege,0.7163,25949006,GBR,,,62.249.242.67,no_relation,120,4,,131,23,treats,0.442325868464691,906700-FS1-2,"The TUBERCULIN RESPONSE which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN RESPONSE,RO-may_diagnose
503729661,7/17/2014 10:32:47,,1325140284,7/17/2014 10:32:38,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,TUBERCULIN RESPONSE treats TUBERCULOSIS,120,4,,131,23,treats,0.442325868464691,906700-FS1-2,"The TUBERCULIN RESPONSE which is a delayed hypersensitivity reaction, indicates the status of cellular immunity against TUBERCULOSIS",TUBERCULOSIS,TUBERCULIN RESPONSE,RO-may_diagnose
503729667,7/16/2014 22:28:59,,1324512881,7/16/2014 22:28:44,clixsense,0.9306,20614047,USA,MO,Maryville,174.32.162.147,no_relation,339,306,,366,317,treats,0.9918365981341758,908334-FS1-2,"Two hundred sixty five patients with head and neck cancer who had previously participated in either a fixed dose, dose titration, or dose ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36 month multicenter maintenance study to evaluate the long term safety and efficacy of oral PILOCARPINE for the treatment of RADIATION INDUCED XEROSTOMIA",RADIATION INDUCED XEROSTOMIA,PILOCARPINE,RO-may_treat
503729667,7/16/2014 23:26:51,,1324536292,7/16/2014 23:26:35,instagc,0.7639,13763729,USA,,,75.182.89.225,PILOCARPINE treats RADIATION INDUCED XEROSTOMIA,339,306,,366,317,treats,0.9918365981341758,908334-FS1-2,"Two hundred sixty five patients with head and neck cancer who had previously participated in either a fixed dose, dose titration, or dose ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36 month multicenter maintenance study to evaluate the long term safety and efficacy of oral PILOCARPINE for the treatment of RADIATION INDUCED XEROSTOMIA",RADIATION INDUCED XEROSTOMIA,PILOCARPINE,RO-may_treat
503729667,7/17/2014 01:14:26,,1324607198,7/17/2014 01:13:47,prodege,0.649,2767509,CAN,BC,Victoria,96.54.172.117,PILOCARPINE treats RADIATION INDUCED XEROSTOMIA,339,306,,366,317,treats,0.9918365981341758,908334-FS1-2,"Two hundred sixty five patients with head and neck cancer who had previously participated in either a fixed dose, dose titration, or dose ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36 month multicenter maintenance study to evaluate the long term safety and efficacy of oral PILOCARPINE for the treatment of RADIATION INDUCED XEROSTOMIA",RADIATION INDUCED XEROSTOMIA,PILOCARPINE,RO-may_treat
503729667,7/17/2014 06:38:33,,1324908402,7/17/2014 06:38:17,instagc,0.5978,18634892,USA,,,68.102.93.185,PILOCARPINE treats RADIATION INDUCED XEROSTOMIA,339,306,,366,317,treats,0.9918365981341758,908334-FS1-2,"Two hundred sixty five patients with head and neck cancer who had previously participated in either a fixed dose, dose titration, or dose ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36 month multicenter maintenance study to evaluate the long term safety and efficacy of oral PILOCARPINE for the treatment of RADIATION INDUCED XEROSTOMIA",RADIATION INDUCED XEROSTOMIA,PILOCARPINE,RO-may_treat
503729667,7/17/2014 08:47:47,,1325044357,7/17/2014 08:47:25,neodev,0.5377,18339121,USA,SC,Sumter,173.93.188.194,PILOCARPINE treats RADIATION INDUCED XEROSTOMIA,339,306,,366,317,treats,0.9918365981341758,908334-FS1-2,"Two hundred sixty five patients with head and neck cancer who had previously participated in either a fixed dose, dose titration, or dose ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36 month multicenter maintenance study to evaluate the long term safety and efficacy of oral PILOCARPINE for the treatment of RADIATION INDUCED XEROSTOMIA",RADIATION INDUCED XEROSTOMIA,PILOCARPINE,RO-may_treat
503729667,7/17/2014 09:32:33,,1325086782,7/17/2014 09:32:16,prodege,0.6687,28039757,GBR,L8,Southport,109.155.158.54,PILOCARPINE treats RADIATION INDUCED XEROSTOMIA,339,306,,366,317,treats,0.9918365981341758,908334-FS1-2,"Two hundred sixty five patients with head and neck cancer who had previously participated in either a fixed dose, dose titration, or dose ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36 month multicenter maintenance study to evaluate the long term safety and efficacy of oral PILOCARPINE for the treatment of RADIATION INDUCED XEROSTOMIA",RADIATION INDUCED XEROSTOMIA,PILOCARPINE,RO-may_treat
503729667,7/17/2014 10:35:40,,1325142870,7/17/2014 10:35:26,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,PILOCARPINE treats RADIATION INDUCED XEROSTOMIA,339,306,,366,317,treats,0.9918365981341758,908334-FS1-2,"Two hundred sixty five patients with head and neck cancer who had previously participated in either a fixed dose, dose titration, or dose ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36 month multicenter maintenance study to evaluate the long term safety and efficacy of oral PILOCARPINE for the treatment of RADIATION INDUCED XEROSTOMIA",RADIATION INDUCED XEROSTOMIA,PILOCARPINE,RO-may_treat
503729676,7/16/2014 22:31:09,,1324513771,7/16/2014 22:30:51,clixsense,0.9722,27871219,NLD,07,Amsterdam,87.210.207.223,INTRACTABLE EPILEPSY causes SEIZURES,89,59,,96,79,causes,0.8,904631-FS1-4,Twenty to 30% of patients with epilepsy develop chronic or INTRACTABLE EPILEPSY i.e. the SEIZURES persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs.,SEIZURES,INTRACTABLE EPILEPSY,RO-has_definitional_manifestation
503729676,7/16/2014 22:46:05,,1324519800,7/16/2014 22:45:50,elite,0.8333,28276268,USA,CA,Daly City,24.6.249.44,INTRACTABLE EPILEPSY causes SEIZURES,89,59,,96,79,causes,0.8,904631-FS1-4,Twenty to 30% of patients with epilepsy develop chronic or INTRACTABLE EPILEPSY i.e. the SEIZURES persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs.,SEIZURES,INTRACTABLE EPILEPSY,RO-has_definitional_manifestation
503729676,7/16/2014 22:52:36,,1324522313,7/16/2014 22:52:12,prodege,0.8194,12971342,USA,CA,Los Angeles,198.101.91.82,INTRACTABLE EPILEPSY causes SEIZURES,89,59,,96,79,causes,0.8,904631-FS1-4,Twenty to 30% of patients with epilepsy develop chronic or INTRACTABLE EPILEPSY i.e. the SEIZURES persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs.,SEIZURES,INTRACTABLE EPILEPSY,RO-has_definitional_manifestation
503729676,7/16/2014 23:33:36,,1324539073,7/16/2014 23:33:21,zoombucks,0.7236,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,89,59,,96,79,causes,0.8,904631-FS1-4,Twenty to 30% of patients with epilepsy develop chronic or INTRACTABLE EPILEPSY i.e. the SEIZURES persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs.,SEIZURES,INTRACTABLE EPILEPSY,RO-has_definitional_manifestation
503729676,7/17/2014 06:40:27,,1324910145,7/17/2014 06:39:56,instagc,0.5978,18634892,USA,,,68.102.93.185,INTRACTABLE EPILEPSY causes SEIZURES,89,59,,96,79,causes,0.8,904631-FS1-4,Twenty to 30% of patients with epilepsy develop chronic or INTRACTABLE EPILEPSY i.e. the SEIZURES persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs.,SEIZURES,INTRACTABLE EPILEPSY,RO-has_definitional_manifestation
503729676,7/17/2014 09:30:20,,1325084166,7/17/2014 09:29:32,prodege,0.5512,27990290,GBR,I9,Bury Saint Edmunds,86.142.231.81,no_relation,89,59,,96,79,causes,0.8,904631-FS1-4,Twenty to 30% of patients with epilepsy develop chronic or INTRACTABLE EPILEPSY i.e. the SEIZURES persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs.,SEIZURES,INTRACTABLE EPILEPSY,RO-has_definitional_manifestation
503729676,7/17/2014 10:36:17,,1325143288,7/17/2014 10:36:00,prodege,0.652,9525153,CAN,ON,Toronto,65.95.92.180,SEIZURES causes INTRACTABLE EPILEPSY,89,59,,96,79,causes,0.8,904631-FS1-4,Twenty to 30% of patients with epilepsy develop chronic or INTRACTABLE EPILEPSY i.e. the SEIZURES persist despite accurate diagnosis and carefully monitored treatment with antiepileptic drugs.,SEIZURES,INTRACTABLE EPILEPSY,RO-has_definitional_manifestation
503729678,7/16/2014 22:51:49,,1324522017,7/16/2014 22:51:31,prodege,0.8194,12971342,USA,CA,Los Angeles,198.101.91.82,ALLERGY causes HYPERSENSITIVITY,4,44,,19,51,causes,0.99654575824488,900099-FS1-4,"The HYPERSENSITIVITY proved to be due to an ALLERGY to a reaction product, and the simultaneous presence of the preservatives 1,3,5 trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction.",HYPERSENSITIVITY,ALLERGY,RO-cause_of
503729678,7/16/2014 22:51:51,,1324522021,7/16/2014 22:51:19,clixsense,0.75,17722340,CAN,BC,Mission,50.98.185.25,HYPERSENSITIVITY causes ALLERGY,4,44,,19,51,causes,0.99654575824488,900099-FS1-4,"The HYPERSENSITIVITY proved to be due to an ALLERGY to a reaction product, and the simultaneous presence of the preservatives 1,3,5 trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction.",HYPERSENSITIVITY,ALLERGY,RO-cause_of
503729678,7/17/2014 00:10:22,,1324555026,7/17/2014 00:09:56,instagc,0.675,19636746,USA,NY,Andover,192.182.216.225,ALLERGY causes HYPERSENSITIVITY,4,44,,19,51,causes,0.99654575824488,900099-FS1-4,"The HYPERSENSITIVITY proved to be due to an ALLERGY to a reaction product, and the simultaneous presence of the preservatives 1,3,5 trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction.",HYPERSENSITIVITY,ALLERGY,RO-cause_of
503729678,7/17/2014 01:26:14,,1324618360,7/17/2014 01:25:37,rewardsspot,0.5125,24482174,GBR,H9,London,46.23.68.180,ALLERGY causes HYPERSENSITIVITY,4,44,,19,51,causes,0.99654575824488,900099-FS1-4,"The HYPERSENSITIVITY proved to be due to an ALLERGY to a reaction product, and the simultaneous presence of the preservatives 1,3,5 trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction.",HYPERSENSITIVITY,ALLERGY,RO-cause_of
503729678,7/17/2014 01:38:04,,1324630885,7/17/2014 01:37:38,rewardsspot,0.6012,17763704,USA,IL,Chicago,67.212.175.123,ALLERGY causes HYPERSENSITIVITY,4,44,,19,51,causes,0.99654575824488,900099-FS1-4,"The HYPERSENSITIVITY proved to be due to an ALLERGY to a reaction product, and the simultaneous presence of the preservatives 1,3,5 trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction.",HYPERSENSITIVITY,ALLERGY,RO-cause_of
503729678,7/17/2014 10:02:37,,1325115468,7/17/2014 10:02:19,prodege,0.7163,25949006,GBR,,,62.249.242.67,ALLERGY causes HYPERSENSITIVITY,4,44,,19,51,causes,0.99654575824488,900099-FS1-4,"The HYPERSENSITIVITY proved to be due to an ALLERGY to a reaction product, and the simultaneous presence of the preservatives 1,3,5 trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction.",HYPERSENSITIVITY,ALLERGY,RO-cause_of
503729678,7/17/2014 10:32:47,,1325140305,7/17/2014 10:32:38,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,HYPERSENSITIVITY causes ALLERGY,4,44,,19,51,causes,0.99654575824488,900099-FS1-4,"The HYPERSENSITIVITY proved to be due to an ALLERGY to a reaction product, and the simultaneous presence of the preservatives 1,3,5 trihydroxyethylhexahydrotriazine and thymol was found to be necessary for the occurrence of a positive patch test reaction.",HYPERSENSITIVITY,ALLERGY,RO-cause_of
503729680,7/16/2014 22:56:41,,1324524111,7/16/2014 22:56:29,prodege,0.8194,28255346,GBR,L9,Sheffield,2.125.183.137,QUININE SULFATE treats NOCTURNAL CRAMPS,48,0,,63,15,treats,0.99654575824488,907323-FS1-2,QUININE SULFATE is a widely prescribed drug for NOCTURNAL CRAMPS,NOCTURNAL CRAMPS,QUININE SULFATE,RO-may_prevent
503729680,7/16/2014 23:24:34,,1324535328,7/16/2014 23:24:12,instagc,0.5714,23149109,USA,NC,Durham,75.189.206.205,QUININE SULFATE treats NOCTURNAL CRAMPS,48,0,,63,15,treats,0.99654575824488,907323-FS1-2,QUININE SULFATE is a widely prescribed drug for NOCTURNAL CRAMPS,NOCTURNAL CRAMPS,QUININE SULFATE,RO-may_prevent
503729680,7/17/2014 01:32:15,,1324624918,7/17/2014 01:32:10,tremorgames,0.6667,28013393,USA,CA,Rancho Cordova,71.197.67.37,QUININE SULFATE treats NOCTURNAL CRAMPS,48,0,,63,15,treats,0.99654575824488,907323-FS1-2,QUININE SULFATE is a widely prescribed drug for NOCTURNAL CRAMPS,NOCTURNAL CRAMPS,QUININE SULFATE,RO-may_prevent
503729680,7/17/2014 02:19:51,,1324671994,7/17/2014 02:19:14,pokerowned,0.6218,18747884,USA,MI,Saginaw,74.85.192.98,QUININE SULFATE treats NOCTURNAL CRAMPS,48,0,,63,15,treats,0.99654575824488,907323-FS1-2,QUININE SULFATE is a widely prescribed drug for NOCTURNAL CRAMPS,NOCTURNAL CRAMPS,QUININE SULFATE,RO-may_prevent
503729680,7/17/2014 02:36:48,,1324689313,7/17/2014 02:36:21,neodev,0.7234,11460728,CAN,BC,Burnaby,70.79.16.165,QUININE SULFATE treats NOCTURNAL CRAMPS,48,0,,63,15,treats,0.99654575824488,907323-FS1-2,QUININE SULFATE is a widely prescribed drug for NOCTURNAL CRAMPS,NOCTURNAL CRAMPS,QUININE SULFATE,RO-may_prevent
503729680,7/17/2014 06:03:06,,1324877515,7/17/2014 06:02:27,clixsense,0.6042,6472283,USA,WI,Oak Creek,99.107.184.156,QUININE SULFATE treats NOCTURNAL CRAMPS,48,0,,63,15,treats,0.99654575824488,907323-FS1-2,QUININE SULFATE is a widely prescribed drug for NOCTURNAL CRAMPS,NOCTURNAL CRAMPS,QUININE SULFATE,RO-may_prevent
503729680,7/17/2014 07:25:17,,1324957577,7/17/2014 07:25:05,clixsense,0.7143,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,QUININE SULFATE treats NOCTURNAL CRAMPS,48,0,,63,15,treats,0.99654575824488,907323-FS1-2,QUININE SULFATE is a widely prescribed drug for NOCTURNAL CRAMPS,NOCTURNAL CRAMPS,QUININE SULFATE,RO-may_prevent
503729682,7/16/2014 22:24:01,,1324510747,7/16/2014 22:23:23,clixsense,1.0,21642428,NLD,11,Nootdorp,83.86.58.179,DUODENAL SOMATOSTATINOMAS diagnosed by PSAMMOMA BODIES,28,77,,42,102,diagnosed by,0.8834522085987719,901958-FS1-13,The histological finding of PSAMMOMA BODIES is important in the diagnosis of DUODENAL SOMATOSTATINOMAS,PSAMMOMA BODIES,DUODENAL SOMATOSTATINOMAS,RO-disease_has_finding
503729682,7/16/2014 22:31:09,,1324513756,7/16/2014 22:30:51,clixsense,0.9722,27871219,NLD,07,Amsterdam,87.210.207.223,DUODENAL SOMATOSTATINOMAS diagnosed by PSAMMOMA BODIES,28,77,,42,102,diagnosed by,0.8834522085987719,901958-FS1-13,The histological finding of PSAMMOMA BODIES is important in the diagnosis of DUODENAL SOMATOSTATINOMAS,PSAMMOMA BODIES,DUODENAL SOMATOSTATINOMAS,RO-disease_has_finding
503729682,7/16/2014 22:52:36,,1324522312,7/16/2014 22:52:12,prodege,0.8194,12971342,USA,CA,Los Angeles,198.101.91.82,DUODENAL SOMATOSTATINOMAS diagnosed by PSAMMOMA BODIES,28,77,,42,102,diagnosed by,0.8834522085987719,901958-FS1-13,The histological finding of PSAMMOMA BODIES is important in the diagnosis of DUODENAL SOMATOSTATINOMAS,PSAMMOMA BODIES,DUODENAL SOMATOSTATINOMAS,RO-disease_has_finding
503729682,7/16/2014 23:36:51,,1324540630,7/16/2014 23:36:25,neodev,0.7056,15848372,AUS,02,Jannali,27.96.208.89,DUODENAL SOMATOSTATINOMAS diagnosed by PSAMMOMA BODIES,28,77,,42,102,diagnosed by,0.8834522085987719,901958-FS1-13,The histological finding of PSAMMOMA BODIES is important in the diagnosis of DUODENAL SOMATOSTATINOMAS,PSAMMOMA BODIES,DUODENAL SOMATOSTATINOMAS,RO-disease_has_finding
503729682,7/16/2014 23:44:20,,1324543537,7/16/2014 23:43:46,prodege,0.5722,2143114,CAN,BC,Vancouver,24.84.160.12,DUODENAL SOMATOSTATINOMAS diagnosed by PSAMMOMA BODIES,28,77,,42,102,diagnosed by,0.8834522085987719,901958-FS1-13,The histological finding of PSAMMOMA BODIES is important in the diagnosis of DUODENAL SOMATOSTATINOMAS,PSAMMOMA BODIES,DUODENAL SOMATOSTATINOMAS,RO-disease_has_finding
503729682,7/16/2014 23:54:45,,1324547498,7/16/2014 23:54:19,gifthulk,0.9056,21916793,GBR,,,87.115.178.12,DUODENAL SOMATOSTATINOMAS diagnosed by PSAMMOMA BODIES,28,77,,42,102,diagnosed by,0.8834522085987719,901958-FS1-13,The histological finding of PSAMMOMA BODIES is important in the diagnosis of DUODENAL SOMATOSTATINOMAS,PSAMMOMA BODIES,DUODENAL SOMATOSTATINOMAS,RO-disease_has_finding
503729682,7/17/2014 03:11:47,,1324724159,7/17/2014 03:11:26,instagc,0.6704,24252915,GBR,B7,Bristol,77.98.139.82,DUODENAL SOMATOSTATINOMAS diagnosed by PSAMMOMA BODIES,28,77,,42,102,diagnosed by,0.8834522085987719,901958-FS1-13,The histological finding of PSAMMOMA BODIES is important in the diagnosis of DUODENAL SOMATOSTATINOMAS,PSAMMOMA BODIES,DUODENAL SOMATOSTATINOMAS,RO-disease_has_finding
503729697,7/16/2014 22:49:09,,1324520921,7/16/2014 22:48:49,clixsense,0.75,17722340,CAN,BC,Mission,50.98.185.25,PATHOLOGIC FRACTURES is location of BONE METASTASES,48,32,,67,47,is location of,0.50709255283711,902836-FS1-9,"Outcomes:  Skeletal events (new BONE METASTASES PATHOLOGIC FRACTURES spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",PATHOLOGIC FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503729697,7/17/2014 00:32:24,,1324567744,7/17/2014 00:31:47,eup_slw,0.5788,28186528,USA,IN,Bloomington,74.204.124.9,BONE METASTASES is location of PATHOLOGIC FRACTURES,48,32,,67,47,is location of,0.50709255283711,902836-FS1-9,"Outcomes:  Skeletal events (new BONE METASTASES PATHOLOGIC FRACTURES spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",PATHOLOGIC FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503729697,7/17/2014 04:43:48,,1324809689,7/17/2014 04:43:18,clixsense,0.5202,27608125,CAN,AB,Calgary,68.146.86.137,no_relation,48,32,,67,47,is location of,0.50709255283711,902836-FS1-9,"Outcomes:  Skeletal events (new BONE METASTASES PATHOLOGIC FRACTURES spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",PATHOLOGIC FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503729697,7/17/2014 06:03:46,,1324878046,7/17/2014 06:03:06,clixsense,0.6042,6472283,USA,WI,Oak Creek,99.107.184.156,PATHOLOGIC FRACTURES is location of BONE METASTASES,48,32,,67,47,is location of,0.50709255283711,902836-FS1-9,"Outcomes:  Skeletal events (new BONE METASTASES PATHOLOGIC FRACTURES spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",PATHOLOGIC FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503729697,7/17/2014 07:04:37,,1324934072,7/17/2014 07:04:21,clixsense,0.5793,27793793,GBR,C5,Chester,151.230.27.155,no_relation,48,32,,67,47,is location of,0.50709255283711,902836-FS1-9,"Outcomes:  Skeletal events (new BONE METASTASES PATHOLOGIC FRACTURES spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",PATHOLOGIC FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503729697,7/17/2014 07:25:49,,1324958274,7/17/2014 07:25:18,clixsense,0.7143,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,BONE METASTASES is location of PATHOLOGIC FRACTURES,48,32,,67,47,is location of,0.50709255283711,902836-FS1-9,"Outcomes:  Skeletal events (new BONE METASTASES PATHOLOGIC FRACTURES spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",PATHOLOGIC FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503729697,7/17/2014 07:49:01,,1324984094,7/17/2014 07:48:15,vivatic,0.5413,25451531,GBR,,,83.67.28.193,BONE METASTASES is location of PATHOLOGIC FRACTURES,48,32,,67,47,is location of,0.50709255283711,902836-FS1-9,"Outcomes:  Skeletal events (new BONE METASTASES PATHOLOGIC FRACTURES spinal cord compression, irradiation of or surgery on bone, development or progression of bone pain [and, in some studies, hypercalcemia]), quality of life, and survival.",PATHOLOGIC FRACTURES,BONE METASTASES,RO-disease_may_have_finding
503729701,7/16/2014 22:26:01,,1324511487,7/16/2014 22:25:48,clixsense,1.0,24896327,GBR,V2,Glasgow,94.2.231.4,no_relation,115,202,,127,227,treats,0.304997140665209,903638-FS1-2,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,RO-has_causative_agent
503729701,7/16/2014 22:27:59,,1324512480,7/16/2014 22:27:41,clixsense,0.6636,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,115,202,,127,227,treats,0.304997140665209,903638-FS1-2,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,RO-has_causative_agent
503729701,7/16/2014 23:01:26,,1324525647,7/16/2014 23:01:04,instagc,0.7361,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,115,202,,127,227,treats,0.304997140665209,903638-FS1-2,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,RO-has_causative_agent
503729701,7/16/2014 23:25:01,,1324535536,7/16/2014 23:24:47,instagc,0.7639,13763729,USA,,,75.182.89.225,no_relation,115,202,,127,227,treats,0.304997140665209,903638-FS1-2,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,RO-has_causative_agent
503729701,7/16/2014 23:31:54,,1324538432,7/16/2014 23:31:15,zoombucks,0.7236,4688131,CAN,BC,Vancouver,108.180.143.28,no_relation,115,202,,127,227,treats,0.304997140665209,903638-FS1-2,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,RO-has_causative_agent
503729701,7/16/2014 23:54:45,,1324547497,7/16/2014 23:54:19,gifthulk,0.9056,21916793,GBR,,,87.115.178.12,no_relation,115,202,,127,227,treats,0.304997140665209,903638-FS1-2,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,RO-has_causative_agent
503729701,7/17/2014 04:43:48,,1324809691,7/17/2014 04:43:18,clixsense,0.5202,27608125,CAN,AB,Calgary,68.146.86.137,STAPHYLOCOCCI treats STAPHYLOCOCCAL INFECTIONS,115,202,,127,227,treats,0.304997140665209,903638-FS1-2,"1   If staphylococci resistant to penicillinase resistant penicillins (oxacillin resistant [methicillin resistant] STAPHYLOCOCCI are prevalent in the hospital or community, empiric therapy of suspected STAPHYLOCOCCAL INFECTIONS should include another appropriate anti infective (e.g., vancomycin.",STAPHYLOCOCCI,STAPHYLOCOCCAL INFECTIONS,RO-has_causative_agent
503729703,7/17/2014 00:18:05,,1324558016,7/17/2014 00:17:12,prodege,0.555,13391452,GBR,B7,Bristol,90.213.30.203,no_relation,18,104,,33,121,is location of,0.721687836487032,905367-FS1-9,"In three patients THROMBOSED VEINS were documented by venography and in all five cases, the presence of VENOUS THROMBOSIS was substantiated by the clinical findings.",THROMBOSED VEINS,VENOUS THROMBOSIS,RO-has_finding_site
503729703,7/17/2014 01:13:20,,1324606272,7/17/2014 01:12:52,prodege,0.649,2767509,CAN,BC,Victoria,96.54.172.117,THROMBOSED VEINS is location of VENOUS THROMBOSIS,18,104,,33,121,is location of,0.721687836487032,905367-FS1-9,"In three patients THROMBOSED VEINS were documented by venography and in all five cases, the presence of VENOUS THROMBOSIS was substantiated by the clinical findings.",THROMBOSED VEINS,VENOUS THROMBOSIS,RO-has_finding_site
503729703,7/17/2014 02:17:55,,1324669961,7/17/2014 02:17:41,pokerowned,0.6218,18747884,USA,MI,Saginaw,74.85.192.98,THROMBOSED VEINS is location of VENOUS THROMBOSIS,18,104,,33,121,is location of,0.721687836487032,905367-FS1-9,"In three patients THROMBOSED VEINS were documented by venography and in all five cases, the presence of VENOUS THROMBOSIS was substantiated by the clinical findings.",THROMBOSED VEINS,VENOUS THROMBOSIS,RO-has_finding_site
503729703,7/17/2014 03:09:57,,1324722460,7/17/2014 03:09:12,prodege,0.6565,6011370,CAN,BC,Richmond,70.79.45.148,THROMBOSED VEINS is location of VENOUS THROMBOSIS,18,104,,33,121,is location of,0.721687836487032,905367-FS1-9,"In three patients THROMBOSED VEINS were documented by venography and in all five cases, the presence of VENOUS THROMBOSIS was substantiated by the clinical findings.",THROMBOSED VEINS,VENOUS THROMBOSIS,RO-has_finding_site
503729703,7/17/2014 03:11:25,,1324723753,7/17/2014 03:10:46,instagc,0.6704,24252915,GBR,B7,Bristol,77.98.139.82,THROMBOSED VEINS is location of VENOUS THROMBOSIS,18,104,,33,121,is location of,0.721687836487032,905367-FS1-9,"In three patients THROMBOSED VEINS were documented by venography and in all five cases, the presence of VENOUS THROMBOSIS was substantiated by the clinical findings.",THROMBOSED VEINS,VENOUS THROMBOSIS,RO-has_finding_site
503729703,7/17/2014 03:41:44,,1324753171,7/17/2014 03:41:30,instagc,0.7319,20183814,USA,,,166.182.81.199,THROMBOSED VEINS is location of VENOUS THROMBOSIS,18,104,,33,121,is location of,0.721687836487032,905367-FS1-9,"In three patients THROMBOSED VEINS were documented by venography and in all five cases, the presence of VENOUS THROMBOSIS was substantiated by the clinical findings.",THROMBOSED VEINS,VENOUS THROMBOSIS,RO-has_finding_site
503729703,7/17/2014 06:04:58,,1324878978,7/17/2014 06:04:37,clixsense,0.6268,15117831,GBR,H9,London,90.194.156.173,THROMBOSED VEINS is location of VENOUS THROMBOSIS,18,104,,33,121,is location of,0.721687836487032,905367-FS1-9,"In three patients THROMBOSED VEINS were documented by venography and in all five cases, the presence of VENOUS THROMBOSIS was substantiated by the clinical findings.",THROMBOSED VEINS,VENOUS THROMBOSIS,RO-has_finding_site
503729713,7/16/2014 22:31:26,,1324513901,7/16/2014 22:30:48,clixsense,0.875,15189335,GBR,H9,London,188.29.165.175,no_relation,66,88,,86,119,causes,0.34815531191139604,901594-FS1-4,"Plasmapheresis and paraproteinemia: cryoprotein induced diseases, MONOCLONAL GAMMOPATHY WALDENSTROM'S MACROGLOBULINEMIA hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.",MONOCLONAL GAMMOPATHY,WALDENSTROM'S MACROGLOBULINEMIA,RO-disease_has_finding
503729713,7/17/2014 00:27:30,,1324563800,7/17/2014 00:27:08,elite,0.675,28503042,USA,OK,Watonga,65.255.78.241,no_relation,66,88,,86,119,causes,0.34815531191139604,901594-FS1-4,"Plasmapheresis and paraproteinemia: cryoprotein induced diseases, MONOCLONAL GAMMOPATHY WALDENSTROM'S MACROGLOBULINEMIA hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.",MONOCLONAL GAMMOPATHY,WALDENSTROM'S MACROGLOBULINEMIA,RO-disease_has_finding
503729713,7/17/2014 02:34:58,,1324687341,7/17/2014 02:34:21,neodev,0.7234,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,66,88,,86,119,causes,0.34815531191139604,901594-FS1-4,"Plasmapheresis and paraproteinemia: cryoprotein induced diseases, MONOCLONAL GAMMOPATHY WALDENSTROM'S MACROGLOBULINEMIA hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.",MONOCLONAL GAMMOPATHY,WALDENSTROM'S MACROGLOBULINEMIA,RO-disease_has_finding
503729713,7/17/2014 06:01:52,,1324876482,7/17/2014 06:01:26,clixsense,0.6042,6472283,USA,WI,Oak Creek,99.107.184.156,MONOCLONAL GAMMOPATHY causes WALDENSTROM'S MACROGLOBULINEMIA,66,88,,86,119,causes,0.34815531191139604,901594-FS1-4,"Plasmapheresis and paraproteinemia: cryoprotein induced diseases, MONOCLONAL GAMMOPATHY WALDENSTROM'S MACROGLOBULINEMIA hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.",MONOCLONAL GAMMOPATHY,WALDENSTROM'S MACROGLOBULINEMIA,RO-disease_has_finding
503729713,7/17/2014 07:25:03,,1324957272,7/17/2014 07:24:17,clixsense,0.7143,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,MONOCLONAL GAMMOPATHY causes WALDENSTROM'S MACROGLOBULINEMIA,66,88,,86,119,causes,0.34815531191139604,901594-FS1-4,"Plasmapheresis and paraproteinemia: cryoprotein induced diseases, MONOCLONAL GAMMOPATHY WALDENSTROM'S MACROGLOBULINEMIA hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.",MONOCLONAL GAMMOPATHY,WALDENSTROM'S MACROGLOBULINEMIA,RO-disease_has_finding
503729713,7/17/2014 07:45:29,,1324980189,7/17/2014 07:44:43,vivatic,0.5413,25451531,GBR,,,83.67.28.193,no_relation,66,88,,86,119,causes,0.34815531191139604,901594-FS1-4,"Plasmapheresis and paraproteinemia: cryoprotein induced diseases, MONOCLONAL GAMMOPATHY WALDENSTROM'S MACROGLOBULINEMIA hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.",MONOCLONAL GAMMOPATHY,WALDENSTROM'S MACROGLOBULINEMIA,RO-disease_has_finding
503729713,7/17/2014 07:58:20,,1324993575,7/17/2014 07:57:35,prodege,0.4905,19466267,GBR,Z5,Bedford,82.29.157.23,no_relation,66,88,,86,119,causes,0.34815531191139604,901594-FS1-4,"Plasmapheresis and paraproteinemia: cryoprotein induced diseases, MONOCLONAL GAMMOPATHY WALDENSTROM'S MACROGLOBULINEMIA hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.",MONOCLONAL GAMMOPATHY,WALDENSTROM'S MACROGLOBULINEMIA,RO-disease_has_finding
504169874,7/17/2014 10:21:17,,1325131140,7/17/2014 10:21:01,clixsense,0.8111,27793793,GBR,C5,Chester,151.230.27.155,ABNORMALITIES OF BONE TURNOVER STRUCTURE causes PAGET'S DISEASE,61,0,,100,15,causes,0.997054485501582,905143-FS1-4,PAGET'S DISEASE is a metabolic bone disease characterized by ABNORMALITIES OF BONE TURNOVER STRUCTURE AND architecture.,ABNORMALITIES OF BONE TURNOVER STRUCTURE,PAGET'S DISEASE,RO-has_finding_site
504169874,7/17/2014 11:15:27,,1325173432,7/17/2014 11:15:09,prodege,0.6456,15439740,AUS,02,Jannali,27.96.208.89,no_relation,61,0,,100,15,causes,0.997054485501582,905143-FS1-4,PAGET'S DISEASE is a metabolic bone disease characterized by ABNORMALITIES OF BONE TURNOVER STRUCTURE AND architecture.,ABNORMALITIES OF BONE TURNOVER STRUCTURE,PAGET'S DISEASE,RO-has_finding_site
504169874,7/17/2014 11:29:16,,1325183471,7/17/2014 11:28:41,fusioncash,0.6519,7012325,USA,CT,Stamford,24.185.182.15,PAGET'S DISEASE causes ABNORMALITIES OF BONE TURNOVER STRUCTURE,61,0,,100,15,causes,0.997054485501582,905143-FS1-4,PAGET'S DISEASE is a metabolic bone disease characterized by ABNORMALITIES OF BONE TURNOVER STRUCTURE AND architecture.,ABNORMALITIES OF BONE TURNOVER STRUCTURE,PAGET'S DISEASE,RO-has_finding_site
504169874,7/17/2014 11:32:17,,1325186309,7/17/2014 11:31:16,vivatic,0.5949,25451531,GBR,,,83.67.28.193,PAGET'S DISEASE causes ABNORMALITIES OF BONE TURNOVER STRUCTURE,61,0,,100,15,causes,0.997054485501582,905143-FS1-4,PAGET'S DISEASE is a metabolic bone disease characterized by ABNORMALITIES OF BONE TURNOVER STRUCTURE AND architecture.,ABNORMALITIES OF BONE TURNOVER STRUCTURE,PAGET'S DISEASE,RO-has_finding_site
504169874,7/17/2014 11:47:06,,1325198012,7/17/2014 11:46:43,instagc,0.6489,13763729,USA,,,75.182.89.225,no_relation,61,0,,100,15,causes,0.997054485501582,905143-FS1-4,PAGET'S DISEASE is a metabolic bone disease characterized by ABNORMALITIES OF BONE TURNOVER STRUCTURE AND architecture.,ABNORMALITIES OF BONE TURNOVER STRUCTURE,PAGET'S DISEASE,RO-has_finding_site
504169874,7/17/2014 11:56:16,,1325204367,7/17/2014 11:55:52,tremorgames,0.5999,24449707,CAN,QC,Laval,96.21.249.72,no_relation,61,0,,100,15,causes,0.997054485501582,905143-FS1-4,PAGET'S DISEASE is a metabolic bone disease characterized by ABNORMALITIES OF BONE TURNOVER STRUCTURE AND architecture.,ABNORMALITIES OF BONE TURNOVER STRUCTURE,PAGET'S DISEASE,RO-has_finding_site
504169874,7/17/2014 12:26:41,,1325227127,7/17/2014 12:26:12,prodege,0.7034,7664351,USA,NY,Cicero,74.111.0.21,PAGET'S DISEASE causes ABNORMALITIES OF BONE TURNOVER STRUCTURE,61,0,,100,15,causes,0.997054485501582,905143-FS1-4,PAGET'S DISEASE is a metabolic bone disease characterized by ABNORMALITIES OF BONE TURNOVER STRUCTURE AND architecture.,ABNORMALITIES OF BONE TURNOVER STRUCTURE,PAGET'S DISEASE,RO-has_finding_site
504169875,7/17/2014 10:21:53,,1325131600,7/17/2014 10:21:45,clixsense,0.8111,27793793,GBR,C5,Chester,151.230.27.155,no_relation,109,188,,136,220,causes,0.516397779494322,902125-FS1-4,The possibility that the distribution of skin lesions in some cutaneous diseases is due to variations in the ANTIGENIC PROPERTIES OF SKIN was investigated by mapping the expression of the SKIN SPECIFIC PEMPHIGUS VULGARIS and bullous pemphigoid antigens in different regions of the body.,ANTIGENIC PROPERTIES OF SKIN,SKIN SPECIFIC PEMPHIGUS VULGARIS,RO-disease_has_primary_anatomic_site
504169875,7/17/2014 10:43:38,,1325148918,7/17/2014 10:43:17,prodege,0.7444,9525153,CAN,ON,Toronto,65.95.92.180,SKIN SPECIFIC PEMPHIGUS VULGARIS causes ANTIGENIC PROPERTIES OF SKIN,109,188,,136,220,causes,0.516397779494322,902125-FS1-4,The possibility that the distribution of skin lesions in some cutaneous diseases is due to variations in the ANTIGENIC PROPERTIES OF SKIN was investigated by mapping the expression of the SKIN SPECIFIC PEMPHIGUS VULGARIS and bullous pemphigoid antigens in different regions of the body.,ANTIGENIC PROPERTIES OF SKIN,SKIN SPECIFIC PEMPHIGUS VULGARIS,RO-disease_has_primary_anatomic_site
504169875,7/17/2014 10:43:40,,1325148935,7/17/2014 10:43:14,clixsense,0.8083,19803139,NLD,06,Veldhoven,212.61.84.196,SKIN SPECIFIC PEMPHIGUS VULGARIS causes ANTIGENIC PROPERTIES OF SKIN,109,188,,136,220,causes,0.516397779494322,902125-FS1-4,The possibility that the distribution of skin lesions in some cutaneous diseases is due to variations in the ANTIGENIC PROPERTIES OF SKIN was investigated by mapping the expression of the SKIN SPECIFIC PEMPHIGUS VULGARIS and bullous pemphigoid antigens in different regions of the body.,ANTIGENIC PROPERTIES OF SKIN,SKIN SPECIFIC PEMPHIGUS VULGARIS,RO-disease_has_primary_anatomic_site
504169875,7/17/2014 11:07:27,,1325166701,7/17/2014 11:07:09,instagc,0.6656,23149109,USA,NC,Durham,75.189.206.205,no_relation,109,188,,136,220,causes,0.516397779494322,902125-FS1-4,The possibility that the distribution of skin lesions in some cutaneous diseases is due to variations in the ANTIGENIC PROPERTIES OF SKIN was investigated by mapping the expression of the SKIN SPECIFIC PEMPHIGUS VULGARIS and bullous pemphigoid antigens in different regions of the body.,ANTIGENIC PROPERTIES OF SKIN,SKIN SPECIFIC PEMPHIGUS VULGARIS,RO-disease_has_primary_anatomic_site
504169875,7/17/2014 11:08:33,,1325167671,7/17/2014 11:07:31,clixsense,0.6811,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,ANTIGENIC PROPERTIES OF SKIN causes SKIN SPECIFIC PEMPHIGUS VULGARIS,109,188,,136,220,causes,0.516397779494322,902125-FS1-4,The possibility that the distribution of skin lesions in some cutaneous diseases is due to variations in the ANTIGENIC PROPERTIES OF SKIN was investigated by mapping the expression of the SKIN SPECIFIC PEMPHIGUS VULGARIS and bullous pemphigoid antigens in different regions of the body.,ANTIGENIC PROPERTIES OF SKIN,SKIN SPECIFIC PEMPHIGUS VULGARIS,RO-disease_has_primary_anatomic_site
504169875,7/17/2014 12:11:07,,1325215177,7/17/2014 12:10:36,elite,0.6437,28503042,USA,NJ,Woodbridge,54.191.150.115,ANTIGENIC PROPERTIES OF SKIN causes SKIN SPECIFIC PEMPHIGUS VULGARIS,109,188,,136,220,causes,0.516397779494322,902125-FS1-4,The possibility that the distribution of skin lesions in some cutaneous diseases is due to variations in the ANTIGENIC PROPERTIES OF SKIN was investigated by mapping the expression of the SKIN SPECIFIC PEMPHIGUS VULGARIS and bullous pemphigoid antigens in different regions of the body.,ANTIGENIC PROPERTIES OF SKIN,SKIN SPECIFIC PEMPHIGUS VULGARIS,RO-disease_has_primary_anatomic_site
504169875,7/17/2014 12:27:29,,1325227798,7/17/2014 12:26:59,prodege,0.7034,7664351,USA,NY,Cicero,74.111.0.21,no_relation,109,188,,136,220,causes,0.516397779494322,902125-FS1-4,The possibility that the distribution of skin lesions in some cutaneous diseases is due to variations in the ANTIGENIC PROPERTIES OF SKIN was investigated by mapping the expression of the SKIN SPECIFIC PEMPHIGUS VULGARIS and bullous pemphigoid antigens in different regions of the body.,ANTIGENIC PROPERTIES OF SKIN,SKIN SPECIFIC PEMPHIGUS VULGARIS,RO-disease_has_primary_anatomic_site
504169879,7/17/2014 10:34:26,,1325141714,7/17/2014 10:34:15,clixsense,0.8111,27793793,GBR,C5,Chester,151.230.27.155,BOWEL PERFORATION causes MECONIUM PERITONITIS,0,70,,19,87,causes,0.9722718241315029,900224-FS1-4,MECONIUM PERITONITIS is a chemical peritonitis which occurs following BOWEL PERFORATION during fetal life.,MECONIUM PERITONITIS,BOWEL PERFORATION,RO-cause_of
504169879,7/17/2014 10:44:09,,1325149267,7/17/2014 10:43:38,prodege,0.7444,9525153,CAN,ON,Toronto,65.95.92.180,BOWEL PERFORATION causes MECONIUM PERITONITIS,0,70,,19,87,causes,0.9722718241315029,900224-FS1-4,MECONIUM PERITONITIS is a chemical peritonitis which occurs following BOWEL PERFORATION during fetal life.,MECONIUM PERITONITIS,BOWEL PERFORATION,RO-cause_of
504169879,7/17/2014 11:09:24,,1325168243,7/17/2014 11:09:13,instagc,0.6656,23149109,USA,NC,Durham,75.189.206.205,MECONIUM PERITONITIS causes BOWEL PERFORATION,0,70,,19,87,causes,0.9722718241315029,900224-FS1-4,MECONIUM PERITONITIS is a chemical peritonitis which occurs following BOWEL PERFORATION during fetal life.,MECONIUM PERITONITIS,BOWEL PERFORATION,RO-cause_of
504169879,7/17/2014 11:28:22,,1325182822,7/17/2014 11:28:08,gifthulk,0.71,21916793,GBR,,,87.115.178.12,BOWEL PERFORATION causes MECONIUM PERITONITIS,0,70,,19,87,causes,0.9722718241315029,900224-FS1-4,MECONIUM PERITONITIS is a chemical peritonitis which occurs following BOWEL PERFORATION during fetal life.,MECONIUM PERITONITIS,BOWEL PERFORATION,RO-cause_of
504169879,7/17/2014 11:48:02,,1325198703,7/17/2014 11:47:39,instagc,0.6489,13763729,USA,,,75.182.89.225,BOWEL PERFORATION causes MECONIUM PERITONITIS,0,70,,19,87,causes,0.9722718241315029,900224-FS1-4,MECONIUM PERITONITIS is a chemical peritonitis which occurs following BOWEL PERFORATION during fetal life.,MECONIUM PERITONITIS,BOWEL PERFORATION,RO-cause_of
504169879,7/17/2014 11:58:14,,1325205655,7/17/2014 11:57:40,tremorgames,0.5999,24449707,CAN,QC,Laval,96.21.249.72,MECONIUM PERITONITIS causes BOWEL PERFORATION,0,70,,19,87,causes,0.9722718241315029,900224-FS1-4,MECONIUM PERITONITIS is a chemical peritonitis which occurs following BOWEL PERFORATION during fetal life.,MECONIUM PERITONITIS,BOWEL PERFORATION,RO-cause_of
504169879,7/17/2014 12:10:19,,1325214484,7/17/2014 12:10:08,elite,0.6437,28503042,USA,NJ,Woodbridge,54.191.150.115,MECONIUM PERITONITIS causes BOWEL PERFORATION,0,70,,19,87,causes,0.9722718241315029,900224-FS1-4,MECONIUM PERITONITIS is a chemical peritonitis which occurs following BOWEL PERFORATION during fetal life.,MECONIUM PERITONITIS,BOWEL PERFORATION,RO-cause_of
504169883,7/17/2014 10:31:33,,1325139283,7/17/2014 10:31:19,instagc,0.8444,24252915,GBR,B7,Bristol,77.98.139.82,RENAL ARTERIES is location of FIBROMUSCULAR DYSPLASIA,48,17,,61,40,is location of,0.986393923832143,905441-FS1-9,Imaging revealed FIBROMUSCULAR DYSPLASIA of the RENAL ARTERIES and the superior mesentery artery.,RENAL ARTERIES,FIBROMUSCULAR DYSPLASIA,RO-has_finding_site
504169883,7/17/2014 10:42:21,,1325147821,7/17/2014 10:42:07,clixsense,0.8083,19803139,NLD,06,Veldhoven,212.61.84.196,RENAL ARTERIES is location of FIBROMUSCULAR DYSPLASIA,48,17,,61,40,is location of,0.986393923832143,905441-FS1-9,Imaging revealed FIBROMUSCULAR DYSPLASIA of the RENAL ARTERIES and the superior mesentery artery.,RENAL ARTERIES,FIBROMUSCULAR DYSPLASIA,RO-has_finding_site
504169883,7/17/2014 11:22:52,,1325179038,7/17/2014 11:22:29,prodege,0.5754,27934334,GBR,,,86.130.153.15,RENAL ARTERIES is location of FIBROMUSCULAR DYSPLASIA,48,17,,61,40,is location of,0.986393923832143,905441-FS1-9,Imaging revealed FIBROMUSCULAR DYSPLASIA of the RENAL ARTERIES and the superior mesentery artery.,RENAL ARTERIES,FIBROMUSCULAR DYSPLASIA,RO-has_finding_site
504169883,7/17/2014 12:56:10,,1325251546,7/17/2014 12:55:46,clixsense,0.7115,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,48,17,,61,40,is location of,0.986393923832143,905441-FS1-9,Imaging revealed FIBROMUSCULAR DYSPLASIA of the RENAL ARTERIES and the superior mesentery artery.,RENAL ARTERIES,FIBROMUSCULAR DYSPLASIA,RO-has_finding_site
504169883,7/17/2014 13:02:37,,1325257195,7/17/2014 13:02:10,neodev,0.6065,21515166,NLD,11,Nootdorp,83.86.58.179,RENAL ARTERIES is location of FIBROMUSCULAR DYSPLASIA,48,17,,61,40,is location of,0.986393923832143,905441-FS1-9,Imaging revealed FIBROMUSCULAR DYSPLASIA of the RENAL ARTERIES and the superior mesentery artery.,RENAL ARTERIES,FIBROMUSCULAR DYSPLASIA,RO-has_finding_site
504169883,7/17/2014 13:24:52,,1325276279,7/17/2014 13:24:22,clixsense,0.5029,6334612,USA,OH,Cleveland,108.225.254.58,no_relation,48,17,,61,40,is location of,0.986393923832143,905441-FS1-9,Imaging revealed FIBROMUSCULAR DYSPLASIA of the RENAL ARTERIES and the superior mesentery artery.,RENAL ARTERIES,FIBROMUSCULAR DYSPLASIA,RO-has_finding_site
504169883,7/17/2014 13:56:01,,1325306737,7/17/2014 13:55:30,clixsense,0.619,6579377,CAN,BC,Richmond,174.6.142.227,no_relation,48,17,,61,40,is location of,0.986393923832143,905441-FS1-9,Imaging revealed FIBROMUSCULAR DYSPLASIA of the RENAL ARTERIES and the superior mesentery artery.,RENAL ARTERIES,FIBROMUSCULAR DYSPLASIA,RO-has_finding_site
504169886,7/17/2014 10:32:10,,1325139802,7/17/2014 10:32:00,clixsense,0.8667,19162475,GBR,M3,Frome,82.33.126.30,GLUCAGON diagnosed by INSULIN INDUCED HYPOGLYCEMIA,45,4,,72,12,diagnosed by,0.3779644730092271,908243-FS1-13,"The GLUCAGON and norepinephrine responses to INSULIN INDUCED HYPOGLYCEMIA are blunted in late pregnancy in the dog, impacting on the magnitude of the metabolic responses to the fall in glucose.",INSULIN INDUCED HYPOGLYCEMIA,GLUCAGON,RO-may_treat
504169886,7/17/2014 10:42:18,,1325147796,7/17/2014 10:41:58,prodege,0.7444,9525153,CAN,ON,Toronto,65.95.92.180,no_relation,45,4,,72,12,diagnosed by,0.3779644730092271,908243-FS1-13,"The GLUCAGON and norepinephrine responses to INSULIN INDUCED HYPOGLYCEMIA are blunted in late pregnancy in the dog, impacting on the magnitude of the metabolic responses to the fall in glucose.",INSULIN INDUCED HYPOGLYCEMIA,GLUCAGON,RO-may_treat
504169886,7/17/2014 11:09:12,,1325168077,7/17/2014 11:09:05,instagc,0.6656,23149109,USA,NC,Durham,75.189.206.205,INSULIN INDUCED HYPOGLYCEMIA diagnosed by GLUCAGON,45,4,,72,12,diagnosed by,0.3779644730092271,908243-FS1-13,"The GLUCAGON and norepinephrine responses to INSULIN INDUCED HYPOGLYCEMIA are blunted in late pregnancy in the dog, impacting on the magnitude of the metabolic responses to the fall in glucose.",INSULIN INDUCED HYPOGLYCEMIA,GLUCAGON,RO-may_treat
504169886,7/17/2014 11:26:26,,1325181461,7/17/2014 11:25:53,prodege,0.5754,27934334,GBR,,,86.130.153.15,no_relation,45,4,,72,12,diagnosed by,0.3779644730092271,908243-FS1-13,"The GLUCAGON and norepinephrine responses to INSULIN INDUCED HYPOGLYCEMIA are blunted in late pregnancy in the dog, impacting on the magnitude of the metabolic responses to the fall in glucose.",INSULIN INDUCED HYPOGLYCEMIA,GLUCAGON,RO-may_treat
504169886,7/17/2014 11:34:35,,1325188702,7/17/2014 11:34:11,fusioncash,0.6519,7012325,USA,CT,Stamford,24.185.182.15,no_relation,45,4,,72,12,diagnosed by,0.3779644730092271,908243-FS1-13,"The GLUCAGON and norepinephrine responses to INSULIN INDUCED HYPOGLYCEMIA are blunted in late pregnancy in the dog, impacting on the magnitude of the metabolic responses to the fall in glucose.",INSULIN INDUCED HYPOGLYCEMIA,GLUCAGON,RO-may_treat
504169886,7/17/2014 12:00:15,,1325207004,7/17/2014 11:59:45,tremorgames,0.5999,24449707,CAN,QC,Laval,96.21.249.72,INSULIN INDUCED HYPOGLYCEMIA diagnosed by GLUCAGON,45,4,,72,12,diagnosed by,0.3779644730092271,908243-FS1-13,"The GLUCAGON and norepinephrine responses to INSULIN INDUCED HYPOGLYCEMIA are blunted in late pregnancy in the dog, impacting on the magnitude of the metabolic responses to the fall in glucose.",INSULIN INDUCED HYPOGLYCEMIA,GLUCAGON,RO-may_treat
504169886,7/17/2014 12:26:11,,1325226713,7/17/2014 12:25:48,prodege,0.7034,7664351,USA,NY,Cicero,74.111.0.21,INSULIN INDUCED HYPOGLYCEMIA diagnosed by GLUCAGON,45,4,,72,12,diagnosed by,0.3779644730092271,908243-FS1-13,"The GLUCAGON and norepinephrine responses to INSULIN INDUCED HYPOGLYCEMIA are blunted in late pregnancy in the dog, impacting on the magnitude of the metabolic responses to the fall in glucose.",INSULIN INDUCED HYPOGLYCEMIA,GLUCAGON,RO-may_treat
504169889,7/17/2014 10:39:44,,1325145842,7/17/2014 10:39:19,prodege,0.7444,9525153,CAN,ON,Toronto,65.95.92.180,ANXIETY causes OBSESSIVE COMPULSIVE NEUROSIS,79,106,,85,135,causes,0.78086880944303,904918-FS1-4,"Whereas anxiety responds independently to exposure therapy, and hence that the ANXIETY reduction model of OBSESSIVE COMPULSIVE NEUROSIS is inadequate.",ANXIETY,OBSESSIVE COMPULSIVE NEUROSIS,RO-has_definitional_manifestation
504169889,7/17/2014 10:41:19,,1325147100,7/17/2014 10:40:53,clixsense,0.8083,19803139,NLD,06,Veldhoven,212.61.84.196,OBSESSIVE COMPULSIVE NEUROSIS causes ANXIETY,79,106,,85,135,causes,0.78086880944303,904918-FS1-4,"Whereas anxiety responds independently to exposure therapy, and hence that the ANXIETY reduction model of OBSESSIVE COMPULSIVE NEUROSIS is inadequate.",ANXIETY,OBSESSIVE COMPULSIVE NEUROSIS,RO-has_definitional_manifestation
504169889,7/17/2014 11:07:52,,1325167081,7/17/2014 11:07:42,instagc,0.6656,23149109,USA,NC,Durham,75.189.206.205,OBSESSIVE COMPULSIVE NEUROSIS causes ANXIETY,79,106,,85,135,causes,0.78086880944303,904918-FS1-4,"Whereas anxiety responds independently to exposure therapy, and hence that the ANXIETY reduction model of OBSESSIVE COMPULSIVE NEUROSIS is inadequate.",ANXIETY,OBSESSIVE COMPULSIVE NEUROSIS,RO-has_definitional_manifestation
504169889,7/17/2014 11:34:10,,1325188225,7/17/2014 11:33:43,fusioncash,0.6519,7012325,USA,CT,Stamford,24.185.182.15,ANXIETY causes OBSESSIVE COMPULSIVE NEUROSIS,79,106,,85,135,causes,0.78086880944303,904918-FS1-4,"Whereas anxiety responds independently to exposure therapy, and hence that the ANXIETY reduction model of OBSESSIVE COMPULSIVE NEUROSIS is inadequate.",ANXIETY,OBSESSIVE COMPULSIVE NEUROSIS,RO-has_definitional_manifestation
504169889,7/17/2014 11:50:58,,1325200854,7/17/2014 11:50:32,instagc,0.6489,13763729,USA,,,75.182.89.225,no_relation,79,106,,85,135,causes,0.78086880944303,904918-FS1-4,"Whereas anxiety responds independently to exposure therapy, and hence that the ANXIETY reduction model of OBSESSIVE COMPULSIVE NEUROSIS is inadequate.",ANXIETY,OBSESSIVE COMPULSIVE NEUROSIS,RO-has_definitional_manifestation
504169889,7/17/2014 11:58:36,,1325205932,7/17/2014 11:58:15,tremorgames,0.5999,24449707,CAN,QC,Laval,96.21.249.72,no_relation,79,106,,85,135,causes,0.78086880944303,904918-FS1-4,"Whereas anxiety responds independently to exposure therapy, and hence that the ANXIETY reduction model of OBSESSIVE COMPULSIVE NEUROSIS is inadequate.",ANXIETY,OBSESSIVE COMPULSIVE NEUROSIS,RO-has_definitional_manifestation
504169889,7/17/2014 12:29:20,,1325229410,7/17/2014 12:28:52,prodege,0.7034,7664351,USA,NY,Cicero,74.111.0.21,OBSESSIVE COMPULSIVE NEUROSIS causes ANXIETY,79,106,,85,135,causes,0.78086880944303,904918-FS1-4,"Whereas anxiety responds independently to exposure therapy, and hence that the ANXIETY reduction model of OBSESSIVE COMPULSIVE NEUROSIS is inadequate.",ANXIETY,OBSESSIVE COMPULSIVE NEUROSIS,RO-has_definitional_manifestation
504169891,7/17/2014 10:31:08,,1325138818,7/17/2014 10:31:02,clixsense,0.8667,19162475,GBR,M3,Frome,82.33.126.30,NEOSTIGMINE treats MYASTHENIA GRAVIS,23,84,,39,95,treats,1.0,906775-FS1-2,A 52 year old man with MYASTHENIA GRAVIS and normal liver function was treated with NEOSTIGMINE prednisolone and azathioprine.,MYASTHENIA GRAVIS,NEOSTIGMINE,RO-may_diagnose
504169891,7/17/2014 10:44:38,,1325149625,7/17/2014 10:44:14,clixsense,0.8083,19803139,NLD,06,Veldhoven,212.61.84.196,NEOSTIGMINE treats MYASTHENIA GRAVIS,23,84,,39,95,treats,1.0,906775-FS1-2,A 52 year old man with MYASTHENIA GRAVIS and normal liver function was treated with NEOSTIGMINE prednisolone and azathioprine.,MYASTHENIA GRAVIS,NEOSTIGMINE,RO-may_diagnose
504169891,7/17/2014 11:09:42,,1325168567,7/17/2014 11:09:33,instagc,0.6656,23149109,USA,NC,Durham,75.189.206.205,NEOSTIGMINE treats MYASTHENIA GRAVIS,23,84,,39,95,treats,1.0,906775-FS1-2,A 52 year old man with MYASTHENIA GRAVIS and normal liver function was treated with NEOSTIGMINE prednisolone and azathioprine.,MYASTHENIA GRAVIS,NEOSTIGMINE,RO-may_diagnose
504169891,7/17/2014 11:15:07,,1325173141,7/17/2014 11:14:52,prodege,0.6456,15439740,AUS,02,Jannali,27.96.208.89,NEOSTIGMINE treats MYASTHENIA GRAVIS,23,84,,39,95,treats,1.0,906775-FS1-2,A 52 year old man with MYASTHENIA GRAVIS and normal liver function was treated with NEOSTIGMINE prednisolone and azathioprine.,MYASTHENIA GRAVIS,NEOSTIGMINE,RO-may_diagnose
504169891,7/17/2014 11:29:14,,1325183420,7/17/2014 11:28:23,gifthulk,0.71,21916793,GBR,,,87.115.178.12,NEOSTIGMINE treats MYASTHENIA GRAVIS,23,84,,39,95,treats,1.0,906775-FS1-2,A 52 year old man with MYASTHENIA GRAVIS and normal liver function was treated with NEOSTIGMINE prednisolone and azathioprine.,MYASTHENIA GRAVIS,NEOSTIGMINE,RO-may_diagnose
504169891,7/17/2014 11:30:54,,1325184992,7/17/2014 11:30:22,fusioncash,0.6519,7012325,USA,CT,Stamford,24.185.182.15,NEOSTIGMINE treats MYASTHENIA GRAVIS,23,84,,39,95,treats,1.0,906775-FS1-2,A 52 year old man with MYASTHENIA GRAVIS and normal liver function was treated with NEOSTIGMINE prednisolone and azathioprine.,MYASTHENIA GRAVIS,NEOSTIGMINE,RO-may_diagnose
504169891,7/17/2014 13:02:37,,1325257197,7/17/2014 13:02:10,neodev,0.6065,21515166,NLD,11,Nootdorp,83.86.58.179,NEOSTIGMINE treats MYASTHENIA GRAVIS,23,84,,39,95,treats,1.0,906775-FS1-2,A 52 year old man with MYASTHENIA GRAVIS and normal liver function was treated with NEOSTIGMINE prednisolone and azathioprine.,MYASTHENIA GRAVIS,NEOSTIGMINE,RO-may_diagnose
504169897,7/17/2014 10:39:18,,1325145471,7/17/2014 10:38:57,prodege,0.7444,9525153,CAN,ON,Toronto,65.95.92.180,EMESIS diagnosed by ONDANSETRON,23,46,,28,57,diagnosed by,0.881917103688197,907449-FS1-13,The lower incidence of EMESIS recorded by the ONDANSETRON groups compared with the droperidol group was not statistically significant.,EMESIS,ONDANSETRON,RO-may_prevent
504169897,7/17/2014 11:08:57,,1325167926,7/17/2014 11:08:34,clixsense,0.6811,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,EMESIS diagnosed by ONDANSETRON,23,46,,28,57,diagnosed by,0.881917103688197,907449-FS1-13,The lower incidence of EMESIS recorded by the ONDANSETRON groups compared with the droperidol group was not statistically significant.,EMESIS,ONDANSETRON,RO-may_prevent
504169897,7/17/2014 11:25:47,,1325180990,7/17/2014 11:25:19,gifthulk,0.71,21916793,GBR,,,87.115.178.12,EMESIS diagnosed by ONDANSETRON,23,46,,28,57,diagnosed by,0.881917103688197,907449-FS1-13,The lower incidence of EMESIS recorded by the ONDANSETRON groups compared with the droperidol group was not statistically significant.,EMESIS,ONDANSETRON,RO-may_prevent
504169897,7/17/2014 11:31:55,,1325185931,7/17/2014 11:31:29,fusioncash,0.6519,7012325,USA,CT,Stamford,24.185.182.15,EMESIS diagnosed by ONDANSETRON,23,46,,28,57,diagnosed by,0.881917103688197,907449-FS1-13,The lower incidence of EMESIS recorded by the ONDANSETRON groups compared with the droperidol group was not statistically significant.,EMESIS,ONDANSETRON,RO-may_prevent
504169897,7/17/2014 12:12:13,,1325216046,7/17/2014 12:11:49,elite,0.6437,28503042,USA,NJ,Woodbridge,54.191.150.115,no_relation,23,46,,28,57,diagnosed by,0.881917103688197,907449-FS1-13,The lower incidence of EMESIS recorded by the ONDANSETRON groups compared with the droperidol group was not statistically significant.,EMESIS,ONDANSETRON,RO-may_prevent
504169897,7/17/2014 12:57:24,,1325252420,7/17/2014 12:57:16,clixsense,0.7115,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,23,46,,28,57,diagnosed by,0.881917103688197,907449-FS1-13,The lower incidence of EMESIS recorded by the ONDANSETRON groups compared with the droperidol group was not statistically significant.,EMESIS,ONDANSETRON,RO-may_prevent
504169897,7/17/2014 13:20:59,,1325272700,7/17/2014 13:20:16,clixsense,0.5029,6334612,USA,OH,Cleveland,108.225.254.58,no_relation,23,46,,28,57,diagnosed by,0.881917103688197,907449-FS1-13,The lower incidence of EMESIS recorded by the ONDANSETRON groups compared with the droperidol group was not statistically significant.,EMESIS,ONDANSETRON,RO-may_prevent
504169899,7/17/2014 11:27:47,,1325182429,7/17/2014 11:27:29,gifthulk,0.71,21916793,GBR,,,87.115.178.12,AMOXICILLIN treats ACUTE MAXILLARY SINUSITIS,77,45,,101,56,treats,1.0,907639-FS1-2,Multicenter comparison of clarithromycin and AMOXICILLIN in the treatment of ACUTE MAXILLARY SINUSITIS,ACUTE MAXILLARY SINUSITIS,AMOXICILLIN,RO-may_treat
504169899,7/17/2014 11:35:16,,1325189290,7/17/2014 11:35:02,fusioncash,0.6519,7012325,USA,CT,Stamford,24.185.182.15,AMOXICILLIN treats ACUTE MAXILLARY SINUSITIS,77,45,,101,56,treats,1.0,907639-FS1-2,Multicenter comparison of clarithromycin and AMOXICILLIN in the treatment of ACUTE MAXILLARY SINUSITIS,ACUTE MAXILLARY SINUSITIS,AMOXICILLIN,RO-may_treat
504169899,7/17/2014 11:50:58,,1325200855,7/17/2014 11:50:32,instagc,0.6489,13763729,USA,,,75.182.89.225,AMOXICILLIN treats ACUTE MAXILLARY SINUSITIS,77,45,,101,56,treats,1.0,907639-FS1-2,Multicenter comparison of clarithromycin and AMOXICILLIN in the treatment of ACUTE MAXILLARY SINUSITIS,ACUTE MAXILLARY SINUSITIS,AMOXICILLIN,RO-may_treat
504169899,7/17/2014 11:59:05,,1325206383,7/17/2014 11:58:53,tremorgames,0.5999,24449707,CAN,QC,Laval,96.21.249.72,AMOXICILLIN treats ACUTE MAXILLARY SINUSITIS,77,45,,101,56,treats,1.0,907639-FS1-2,Multicenter comparison of clarithromycin and AMOXICILLIN in the treatment of ACUTE MAXILLARY SINUSITIS,ACUTE MAXILLARY SINUSITIS,AMOXICILLIN,RO-may_treat
504169899,7/17/2014 12:07:08,,1325212059,7/17/2014 12:06:52,elite,0.6437,28503042,USA,NJ,Woodbridge,54.191.150.115,AMOXICILLIN treats ACUTE MAXILLARY SINUSITIS,77,45,,101,56,treats,1.0,907639-FS1-2,Multicenter comparison of clarithromycin and AMOXICILLIN in the treatment of ACUTE MAXILLARY SINUSITIS,ACUTE MAXILLARY SINUSITIS,AMOXICILLIN,RO-may_treat
504169899,7/17/2014 12:26:11,,1325226724,7/17/2014 12:25:48,prodege,0.7034,7664351,USA,NY,Cicero,74.111.0.21,AMOXICILLIN treats ACUTE MAXILLARY SINUSITIS,77,45,,101,56,treats,1.0,907639-FS1-2,Multicenter comparison of clarithromycin and AMOXICILLIN in the treatment of ACUTE MAXILLARY SINUSITIS,ACUTE MAXILLARY SINUSITIS,AMOXICILLIN,RO-may_treat
504169899,7/17/2014 12:54:16,,1325250007,7/17/2014 12:54:04,clixsense,0.7115,16827630,GBR,A7,Birmingham,86.146.169.103,AMOXICILLIN treats ACUTE MAXILLARY SINUSITIS,77,45,,101,56,treats,1.0,907639-FS1-2,Multicenter comparison of clarithromycin and AMOXICILLIN in the treatment of ACUTE MAXILLARY SINUSITIS,ACUTE MAXILLARY SINUSITIS,AMOXICILLIN,RO-may_treat
504169902,7/17/2014 10:22:05,,1325131755,7/17/2014 10:21:55,clixsense,0.8111,27793793,GBR,C5,Chester,151.230.27.155,COLON CANCER causes FAMILIAL ADENOMATOUS POLYPOSIS,48,74,,59,104,causes,0.5892556509887901,906092-FS1-4,The risk of colon cancer is extreme in the rare COLON CANCER syndromes of FAMILIAL ADENOMATOUS POLYPOSIS and hereditary nonpolyposis colon cancer.,COLON CANCER,FAMILIAL ADENOMATOUS POLYPOSIS,RO-has_manifestation
504169902,7/17/2014 10:33:16,,1325140705,7/17/2014 10:32:34,instagc,0.8444,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,48,74,,59,104,causes,0.5892556509887901,906092-FS1-4,The risk of colon cancer is extreme in the rare COLON CANCER syndromes of FAMILIAL ADENOMATOUS POLYPOSIS and hereditary nonpolyposis colon cancer.,COLON CANCER,FAMILIAL ADENOMATOUS POLYPOSIS,RO-has_manifestation
504169902,7/17/2014 11:25:17,,1325180687,7/17/2014 11:24:52,gifthulk,0.71,21916793,GBR,,,87.115.178.12,FAMILIAL ADENOMATOUS POLYPOSIS causes COLON CANCER,48,74,,59,104,causes,0.5892556509887901,906092-FS1-4,The risk of colon cancer is extreme in the rare COLON CANCER syndromes of FAMILIAL ADENOMATOUS POLYPOSIS and hereditary nonpolyposis colon cancer.,COLON CANCER,FAMILIAL ADENOMATOUS POLYPOSIS,RO-has_manifestation
504169902,7/17/2014 11:31:28,,1325185537,7/17/2014 11:30:56,fusioncash,0.6519,7012325,USA,CT,Stamford,24.185.182.15,FAMILIAL ADENOMATOUS POLYPOSIS causes COLON CANCER,48,74,,59,104,causes,0.5892556509887901,906092-FS1-4,The risk of colon cancer is extreme in the rare COLON CANCER syndromes of FAMILIAL ADENOMATOUS POLYPOSIS and hereditary nonpolyposis colon cancer.,COLON CANCER,FAMILIAL ADENOMATOUS POLYPOSIS,RO-has_manifestation
504169902,7/17/2014 11:46:43,,1325197735,7/17/2014 11:46:11,instagc,0.6489,13763729,USA,,,75.182.89.225,FAMILIAL ADENOMATOUS POLYPOSIS causes COLON CANCER,48,74,,59,104,causes,0.5892556509887901,906092-FS1-4,The risk of colon cancer is extreme in the rare COLON CANCER syndromes of FAMILIAL ADENOMATOUS POLYPOSIS and hereditary nonpolyposis colon cancer.,COLON CANCER,FAMILIAL ADENOMATOUS POLYPOSIS,RO-has_manifestation
504169902,7/17/2014 12:08:11,,1325212776,7/17/2014 12:07:35,elite,0.6437,28503042,USA,NJ,Woodbridge,54.191.150.115,FAMILIAL ADENOMATOUS POLYPOSIS causes COLON CANCER,48,74,,59,104,causes,0.5892556509887901,906092-FS1-4,The risk of colon cancer is extreme in the rare COLON CANCER syndromes of FAMILIAL ADENOMATOUS POLYPOSIS and hereditary nonpolyposis colon cancer.,COLON CANCER,FAMILIAL ADENOMATOUS POLYPOSIS,RO-has_manifestation
504169902,7/17/2014 13:54:31,,1325305497,7/17/2014 13:53:59,clixsense,0.619,6579377,CAN,BC,Richmond,174.6.142.227,no_relation,48,74,,59,104,causes,0.5892556509887901,906092-FS1-4,The risk of colon cancer is extreme in the rare COLON CANCER syndromes of FAMILIAL ADENOMATOUS POLYPOSIS and hereditary nonpolyposis colon cancer.,COLON CANCER,FAMILIAL ADENOMATOUS POLYPOSIS,RO-has_manifestation
504169911,7/17/2014 10:31:30,,1325139233,7/17/2014 10:31:25,clixsense,0.8667,19162475,GBR,M3,Frome,82.33.126.30,LYME DISEASE causes SPIROCHETE BORRELIA BURGDORFERI,4,62,,34,74,causes,1.0,903501-FS1-4,The SPIROCHETE BORRELIA BURGDORFERI is the causative agent of LYME DISEASE the leading vector borne illness in the United States.,SPIROCHETE BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
504169911,7/17/2014 10:43:17,,1325148626,7/17/2014 10:42:53,prodege,0.7444,9525153,CAN,ON,Toronto,65.95.92.180,SPIROCHETE BORRELIA BURGDORFERI causes LYME DISEASE,4,62,,34,74,causes,1.0,903501-FS1-4,The SPIROCHETE BORRELIA BURGDORFERI is the causative agent of LYME DISEASE the leading vector borne illness in the United States.,SPIROCHETE BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
504169911,7/17/2014 11:09:24,,1325168260,7/17/2014 11:09:13,instagc,0.6656,23149109,USA,NC,Durham,75.189.206.205,SPIROCHETE BORRELIA BURGDORFERI causes LYME DISEASE,4,62,,34,74,causes,1.0,903501-FS1-4,The SPIROCHETE BORRELIA BURGDORFERI is the causative agent of LYME DISEASE the leading vector borne illness in the United States.,SPIROCHETE BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
504169911,7/17/2014 11:11:04,,1325169646,7/17/2014 11:10:44,clixsense,0.6811,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,SPIROCHETE BORRELIA BURGDORFERI causes LYME DISEASE,4,62,,34,74,causes,1.0,903501-FS1-4,The SPIROCHETE BORRELIA BURGDORFERI is the causative agent of LYME DISEASE the leading vector borne illness in the United States.,SPIROCHETE BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
504169911,7/17/2014 11:19:13,,1325176405,7/17/2014 11:18:57,prodege,0.6456,15439740,AUS,02,Jannali,27.96.208.89,SPIROCHETE BORRELIA BURGDORFERI causes LYME DISEASE,4,62,,34,74,causes,1.0,903501-FS1-4,The SPIROCHETE BORRELIA BURGDORFERI is the causative agent of LYME DISEASE the leading vector borne illness in the United States.,SPIROCHETE BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
504169911,7/17/2014 11:24:42,,1325180301,7/17/2014 11:23:56,prodege,0.5754,27934334,GBR,,,86.130.153.15,SPIROCHETE BORRELIA BURGDORFERI causes LYME DISEASE,4,62,,34,74,causes,1.0,903501-FS1-4,The SPIROCHETE BORRELIA BURGDORFERI is the causative agent of LYME DISEASE the leading vector borne illness in the United States.,SPIROCHETE BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
504169911,7/17/2014 12:26:57,,1325227326,7/17/2014 12:26:42,prodege,0.7034,7664351,USA,NY,Cicero,74.111.0.21,SPIROCHETE BORRELIA BURGDORFERI causes LYME DISEASE,4,62,,34,74,causes,1.0,903501-FS1-4,The SPIROCHETE BORRELIA BURGDORFERI is the causative agent of LYME DISEASE the leading vector borne illness in the United States.,SPIROCHETE BORRELIA BURGDORFERI,LYME DISEASE,RO-has_causative_agent
504169924,7/17/2014 10:30:37,,1325138417,7/17/2014 10:30:28,clixsense,0.8667,19162475,GBR,M3,Frome,82.33.126.30,TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY causes PRION PROTEIN,196,233,,208,272,causes,0.924500327042048,903808-FS1-4,The former is consistent with the concept of an agent with an independent genome while the latter is consistent with the concept that 'strain of agent' is another expression of the involvement of PRION PROTEIN in the pathogenesis of TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY,PRION PROTEIN,TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY,RO-has_causative_agent
504169924,7/17/2014 10:32:04,,1325139742,7/17/2014 10:31:34,instagc,0.8444,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,196,233,,208,272,causes,0.924500327042048,903808-FS1-4,The former is consistent with the concept of an agent with an independent genome while the latter is consistent with the concept that 'strain of agent' is another expression of the involvement of PRION PROTEIN in the pathogenesis of TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY,PRION PROTEIN,TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY,RO-has_causative_agent
504169924,7/17/2014 10:41:44,,1325147414,7/17/2014 10:41:12,prodege,0.7444,9525153,CAN,ON,Toronto,65.95.92.180,PRION PROTEIN causes TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY,196,233,,208,272,causes,0.924500327042048,903808-FS1-4,The former is consistent with the concept of an agent with an independent genome while the latter is consistent with the concept that 'strain of agent' is another expression of the involvement of PRION PROTEIN in the pathogenesis of TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY,PRION PROTEIN,TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY,RO-has_causative_agent
504169924,7/17/2014 11:05:10,,1325165106,7/17/2014 11:04:17,clixsense,0.6811,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,PRION PROTEIN causes TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY,196,233,,208,272,causes,0.924500327042048,903808-FS1-4,The former is consistent with the concept of an agent with an independent genome while the latter is consistent with the concept that 'strain of agent' is another expression of the involvement of PRION PROTEIN in the pathogenesis of TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY,PRION PROTEIN,TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY,RO-has_causative_agent
504169924,7/17/2014 12:11:09,,1325215225,7/17/2014 12:10:55,prodege,0.6851,24945126,GBR,F6,Romford,82.12.220.44,PRION PROTEIN causes TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY,196,233,,208,272,causes,0.924500327042048,903808-FS1-4,The former is consistent with the concept of an agent with an independent genome while the latter is consistent with the concept that 'strain of agent' is another expression of the involvement of PRION PROTEIN in the pathogenesis of TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY,PRION PROTEIN,TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY,RO-has_causative_agent
504169924,7/17/2014 12:12:28,,1325216239,7/17/2014 12:12:14,elite,0.6437,28503042,USA,NJ,Woodbridge,54.191.150.115,PRION PROTEIN causes TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY,196,233,,208,272,causes,0.924500327042048,903808-FS1-4,The former is consistent with the concept of an agent with an independent genome while the latter is consistent with the concept that 'strain of agent' is another expression of the involvement of PRION PROTEIN in the pathogenesis of TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY,PRION PROTEIN,TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY,RO-has_causative_agent
504169924,7/17/2014 13:56:01,,1325306741,7/17/2014 13:55:30,clixsense,0.619,6579377,CAN,BC,Richmond,174.6.142.227,PRION PROTEIN causes TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY,196,233,,208,272,causes,0.924500327042048,903808-FS1-4,The former is consistent with the concept of an agent with an independent genome while the latter is consistent with the concept that 'strain of agent' is another expression of the involvement of PRION PROTEIN in the pathogenesis of TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY,PRION PROTEIN,TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY,RO-has_causative_agent
504169927,7/17/2014 10:30:54,,1325138623,7/17/2014 10:30:45,clixsense,0.8667,19162475,GBR,M3,Frome,82.33.126.30,PHEOCHROMOCYTOMA causes HYPERTENSION,72,0,,83,16,causes,1.0,902691-FS1-4,PHEOCHROMOCYTOMA is a catecholamine producing tumor and a rare cause of HYPERTENSION,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
504169927,7/17/2014 10:34:38,,1325141904,7/17/2014 10:34:26,clixsense,0.8111,27793793,GBR,C5,Chester,151.230.27.155,PHEOCHROMOCYTOMA causes HYPERTENSION,72,0,,83,16,causes,1.0,902691-FS1-4,PHEOCHROMOCYTOMA is a catecholamine producing tumor and a rare cause of HYPERTENSION,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
504169927,7/17/2014 11:29:42,,1325183918,7/17/2014 11:28:58,vivatic,0.5949,25451531,GBR,,,83.67.28.193,PHEOCHROMOCYTOMA causes HYPERTENSION,72,0,,83,16,causes,1.0,902691-FS1-4,PHEOCHROMOCYTOMA is a catecholamine producing tumor and a rare cause of HYPERTENSION,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
504169927,7/17/2014 13:22:34,,1325274158,7/17/2014 13:21:51,clixsense,0.5029,6334612,USA,OH,Cleveland,108.225.254.58,no_relation,72,0,,83,16,causes,1.0,902691-FS1-4,PHEOCHROMOCYTOMA is a catecholamine producing tumor and a rare cause of HYPERTENSION,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
504169927,7/17/2014 13:32:39,,1325285695,7/17/2014 13:32:18,prodege,0.5459,28039757,GBR,L8,Southport,109.155.158.54,PHEOCHROMOCYTOMA causes HYPERTENSION,72,0,,83,16,causes,1.0,902691-FS1-4,PHEOCHROMOCYTOMA is a catecholamine producing tumor and a rare cause of HYPERTENSION,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
504169927,7/17/2014 13:51:59,,1325302966,7/17/2014 13:51:39,clixsense,0.619,6579377,CAN,BC,Richmond,174.6.142.227,PHEOCHROMOCYTOMA causes HYPERTENSION,72,0,,83,16,causes,1.0,902691-FS1-4,PHEOCHROMOCYTOMA is a catecholamine producing tumor and a rare cause of HYPERTENSION,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
504169927,7/17/2014 14:00:25,,1325311060,7/17/2014 14:00:03,clixsense,0.6306,15189335,GBR,T5,Aberdeen,90.218.222.164,PHEOCHROMOCYTOMA causes HYPERTENSION,72,0,,83,16,causes,1.0,902691-FS1-4,PHEOCHROMOCYTOMA is a catecholamine producing tumor and a rare cause of HYPERTENSION,HYPERTENSION,PHEOCHROMOCYTOMA,RO-disease_may_have_finding
504169933,7/17/2014 10:42:54,,1325148283,7/17/2014 10:42:38,clixsense,0.8083,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,48,118,,64,153,is location of,0.549442255794756,902058-FS1-9,Cytokines produced by immune cells infiltrating PANCREATIC ISLETS are important mediators of beta cell destruction in INSULIN DEPENDENT DIABETES MELLITUS,PANCREATIC ISLETS,INSULIN DEPENDENT DIABETES MELLITUS,RO-disease_has_primary_anatomic_site
504169933,7/17/2014 11:06:06,,1325165674,7/17/2014 11:05:38,clixsense,0.6811,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,no_relation,48,118,,64,153,is location of,0.549442255794756,902058-FS1-9,Cytokines produced by immune cells infiltrating PANCREATIC ISLETS are important mediators of beta cell destruction in INSULIN DEPENDENT DIABETES MELLITUS,PANCREATIC ISLETS,INSULIN DEPENDENT DIABETES MELLITUS,RO-disease_has_primary_anatomic_site
504169933,7/17/2014 11:19:45,,1325176695,7/17/2014 11:19:27,prodege,0.6456,15439740,AUS,02,Jannali,27.96.208.89,no_relation,48,118,,64,153,is location of,0.549442255794756,902058-FS1-9,Cytokines produced by immune cells infiltrating PANCREATIC ISLETS are important mediators of beta cell destruction in INSULIN DEPENDENT DIABETES MELLITUS,PANCREATIC ISLETS,INSULIN DEPENDENT DIABETES MELLITUS,RO-disease_has_primary_anatomic_site
504169933,7/17/2014 11:25:53,,1325181104,7/17/2014 11:25:11,prodege,0.5754,27934334,GBR,,,86.130.153.15,PANCREATIC ISLETS is location of INSULIN DEPENDENT DIABETES MELLITUS,48,118,,64,153,is location of,0.549442255794756,902058-FS1-9,Cytokines produced by immune cells infiltrating PANCREATIC ISLETS are important mediators of beta cell destruction in INSULIN DEPENDENT DIABETES MELLITUS,PANCREATIC ISLETS,INSULIN DEPENDENT DIABETES MELLITUS,RO-disease_has_primary_anatomic_site
504169933,7/17/2014 11:29:42,,1325183916,7/17/2014 11:28:58,vivatic,0.5949,25451531,GBR,,,83.67.28.193,PANCREATIC ISLETS is location of INSULIN DEPENDENT DIABETES MELLITUS,48,118,,64,153,is location of,0.549442255794756,902058-FS1-9,Cytokines produced by immune cells infiltrating PANCREATIC ISLETS are important mediators of beta cell destruction in INSULIN DEPENDENT DIABETES MELLITUS,PANCREATIC ISLETS,INSULIN DEPENDENT DIABETES MELLITUS,RO-disease_has_primary_anatomic_site
504169933,7/17/2014 11:36:14,,1325190311,7/17/2014 11:35:49,fusioncash,0.6519,7012325,USA,CT,Stamford,24.185.182.15,no_relation,48,118,,64,153,is location of,0.549442255794756,902058-FS1-9,Cytokines produced by immune cells infiltrating PANCREATIC ISLETS are important mediators of beta cell destruction in INSULIN DEPENDENT DIABETES MELLITUS,PANCREATIC ISLETS,INSULIN DEPENDENT DIABETES MELLITUS,RO-disease_has_primary_anatomic_site
504169933,7/17/2014 11:45:47,,1325197080,7/17/2014 11:45:16,instagc,0.6489,13763729,USA,,,75.182.89.225,PANCREATIC ISLETS is location of INSULIN DEPENDENT DIABETES MELLITUS,48,118,,64,153,is location of,0.549442255794756,902058-FS1-9,Cytokines produced by immune cells infiltrating PANCREATIC ISLETS are important mediators of beta cell destruction in INSULIN DEPENDENT DIABETES MELLITUS,PANCREATIC ISLETS,INSULIN DEPENDENT DIABETES MELLITUS,RO-disease_has_primary_anatomic_site
504169937,7/17/2014 11:02:20,,1325163112,7/17/2014 11:01:54,clixsense,0.6811,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,NAPROXEN treats OSTEOARTHRITIS OF THE HIP,170,141,,194,149,treats,0.997054485501582,908100-FS1-2,"In a double blind study, the efficacy and tolerability of S adenosylmethionine (SAMe) were evaluated in comparison with those of placebo and NAPROXEN in the treatment of OSTEOARTHRITIS OF THE HIP knee, spine, and hand.",OSTEOARTHRITIS OF THE HIP,NAPROXEN,RO-may_treat
504169937,7/17/2014 11:30:21,,1325184557,7/17/2014 11:29:49,fusioncash,0.6519,7012325,USA,CT,Stamford,24.185.182.15,no_relation,170,141,,194,149,treats,0.997054485501582,908100-FS1-2,"In a double blind study, the efficacy and tolerability of S adenosylmethionine (SAMe) were evaluated in comparison with those of placebo and NAPROXEN in the treatment of OSTEOARTHRITIS OF THE HIP knee, spine, and hand.",OSTEOARTHRITIS OF THE HIP,NAPROXEN,RO-may_treat
504169937,7/17/2014 11:31:19,,1325185325,7/17/2014 11:31:02,gifthulk,0.71,21916793,GBR,,,87.115.178.12,NAPROXEN treats OSTEOARTHRITIS OF THE HIP,170,141,,194,149,treats,0.997054485501582,908100-FS1-2,"In a double blind study, the efficacy and tolerability of S adenosylmethionine (SAMe) were evaluated in comparison with those of placebo and NAPROXEN in the treatment of OSTEOARTHRITIS OF THE HIP knee, spine, and hand.",OSTEOARTHRITIS OF THE HIP,NAPROXEN,RO-may_treat
504169937,7/17/2014 11:55:51,,1325204085,7/17/2014 11:55:21,tremorgames,0.5999,24449707,CAN,QC,Laval,96.21.249.72,NAPROXEN treats OSTEOARTHRITIS OF THE HIP,170,141,,194,149,treats,0.997054485501582,908100-FS1-2,"In a double blind study, the efficacy and tolerability of S adenosylmethionine (SAMe) were evaluated in comparison with those of placebo and NAPROXEN in the treatment of OSTEOARTHRITIS OF THE HIP knee, spine, and hand.",OSTEOARTHRITIS OF THE HIP,NAPROXEN,RO-may_treat
504169937,7/17/2014 12:11:27,,1325215440,7/17/2014 12:11:10,prodege,0.6851,24945126,GBR,F6,Romford,82.12.220.44,NAPROXEN treats OSTEOARTHRITIS OF THE HIP,170,141,,194,149,treats,0.997054485501582,908100-FS1-2,"In a double blind study, the efficacy and tolerability of S adenosylmethionine (SAMe) were evaluated in comparison with those of placebo and NAPROXEN in the treatment of OSTEOARTHRITIS OF THE HIP knee, spine, and hand.",OSTEOARTHRITIS OF THE HIP,NAPROXEN,RO-may_treat
504169937,7/17/2014 12:57:14,,1325252327,7/17/2014 12:57:07,clixsense,0.7115,16827630,GBR,A7,Birmingham,86.146.169.103,NAPROXEN treats OSTEOARTHRITIS OF THE HIP,170,141,,194,149,treats,0.997054485501582,908100-FS1-2,"In a double blind study, the efficacy and tolerability of S adenosylmethionine (SAMe) were evaluated in comparison with those of placebo and NAPROXEN in the treatment of OSTEOARTHRITIS OF THE HIP knee, spine, and hand.",OSTEOARTHRITIS OF THE HIP,NAPROXEN,RO-may_treat
504169937,7/17/2014 13:06:03,,1325260247,7/17/2014 13:05:30,neodev,0.6065,21515166,NLD,11,Nootdorp,83.86.58.179,NAPROXEN treats OSTEOARTHRITIS OF THE HIP,170,141,,194,149,treats,0.997054485501582,908100-FS1-2,"In a double blind study, the efficacy and tolerability of S adenosylmethionine (SAMe) were evaluated in comparison with those of placebo and NAPROXEN in the treatment of OSTEOARTHRITIS OF THE HIP knee, spine, and hand.",OSTEOARTHRITIS OF THE HIP,NAPROXEN,RO-may_treat
504169946,7/17/2014 10:34:26,,1325141713,7/17/2014 10:34:15,clixsense,0.8111,27793793,GBR,C5,Chester,151.230.27.155,no_relation,79,106,,85,135,diagnosed by,0.312347523777212,904918-FS1-13,"Whereas anxiety responds independently to exposure therapy, and hence that the ANXIETY reduction model of OBSESSIVE COMPULSIVE NEUROSIS is inadequate.",ANXIETY,OBSESSIVE COMPULSIVE NEUROSIS,RO-has_definitional_manifestation
504169946,7/17/2014 11:03:07,,1325163648,7/17/2014 11:02:22,clixsense,0.6811,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,OBSESSIVE COMPULSIVE NEUROSIS diagnosed by ANXIETY,79,106,,85,135,diagnosed by,0.312347523777212,904918-FS1-13,"Whereas anxiety responds independently to exposure therapy, and hence that the ANXIETY reduction model of OBSESSIVE COMPULSIVE NEUROSIS is inadequate.",ANXIETY,OBSESSIVE COMPULSIVE NEUROSIS,RO-has_definitional_manifestation
504169946,7/17/2014 11:19:25,,1325176476,7/17/2014 11:19:14,prodege,0.6456,15439740,AUS,02,Jannali,27.96.208.89,no_relation,79,106,,85,135,diagnosed by,0.312347523777212,904918-FS1-13,"Whereas anxiety responds independently to exposure therapy, and hence that the ANXIETY reduction model of OBSESSIVE COMPULSIVE NEUROSIS is inadequate.",ANXIETY,OBSESSIVE COMPULSIVE NEUROSIS,RO-has_definitional_manifestation
504169946,7/17/2014 11:55:20,,1325203699,7/17/2014 11:55:04,tremorgames,0.5999,24449707,CAN,QC,Laval,96.21.249.72,no_relation,79,106,,85,135,diagnosed by,0.312347523777212,904918-FS1-13,"Whereas anxiety responds independently to exposure therapy, and hence that the ANXIETY reduction model of OBSESSIVE COMPULSIVE NEUROSIS is inadequate.",ANXIETY,OBSESSIVE COMPULSIVE NEUROSIS,RO-has_definitional_manifestation
504169946,7/17/2014 12:11:48,,1325215798,7/17/2014 12:11:30,elite,0.6437,28503042,USA,NJ,Woodbridge,54.191.150.115,ANXIETY diagnosed by OBSESSIVE COMPULSIVE NEUROSIS,79,106,,85,135,diagnosed by,0.312347523777212,904918-FS1-13,"Whereas anxiety responds independently to exposure therapy, and hence that the ANXIETY reduction model of OBSESSIVE COMPULSIVE NEUROSIS is inadequate.",ANXIETY,OBSESSIVE COMPULSIVE NEUROSIS,RO-has_definitional_manifestation
504169946,7/17/2014 12:55:16,,1325250853,7/17/2014 12:54:58,clixsense,0.7115,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,79,106,,85,135,diagnosed by,0.312347523777212,904918-FS1-13,"Whereas anxiety responds independently to exposure therapy, and hence that the ANXIETY reduction model of OBSESSIVE COMPULSIVE NEUROSIS is inadequate.",ANXIETY,OBSESSIVE COMPULSIVE NEUROSIS,RO-has_definitional_manifestation
504169946,7/17/2014 13:05:29,,1325259812,7/17/2014 13:04:56,neodev,0.6065,21515166,NLD,11,Nootdorp,83.86.58.179,OBSESSIVE COMPULSIVE NEUROSIS diagnosed by ANXIETY,79,106,,85,135,diagnosed by,0.312347523777212,904918-FS1-13,"Whereas anxiety responds independently to exposure therapy, and hence that the ANXIETY reduction model of OBSESSIVE COMPULSIVE NEUROSIS is inadequate.",ANXIETY,OBSESSIVE COMPULSIVE NEUROSIS,RO-has_definitional_manifestation
504169949,7/17/2014 10:29:55,,1325137858,7/17/2014 10:29:38,instagc,0.8444,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,107,67,,124,88,causes,0.6741998624632421,900150-FS1-4,"To the best of our knowledge, this is the first reported case of a TONGUE BASE HAMARTOMA in a patient with TUBEROUS SCLEROSIS",TUBEROUS SCLEROSIS,TONGUE BASE HAMARTOMA,RO-cause_of
504169949,7/17/2014 11:07:42,,1325166929,7/17/2014 11:07:28,instagc,0.6656,23149109,USA,NC,Durham,75.189.206.205,TUBEROUS SCLEROSIS causes TONGUE BASE HAMARTOMA,107,67,,124,88,causes,0.6741998624632421,900150-FS1-4,"To the best of our knowledge, this is the first reported case of a TONGUE BASE HAMARTOMA in a patient with TUBEROUS SCLEROSIS",TUBEROUS SCLEROSIS,TONGUE BASE HAMARTOMA,RO-cause_of
504169949,7/17/2014 11:14:51,,1325172934,7/17/2014 11:14:34,prodege,0.6456,15439740,AUS,02,Jannali,27.96.208.89,no_relation,107,67,,124,88,causes,0.6741998624632421,900150-FS1-4,"To the best of our knowledge, this is the first reported case of a TONGUE BASE HAMARTOMA in a patient with TUBEROUS SCLEROSIS",TUBEROUS SCLEROSIS,TONGUE BASE HAMARTOMA,RO-cause_of
504169949,7/17/2014 11:27:28,,1325182140,7/17/2014 11:26:56,gifthulk,0.71,21916793,GBR,,,87.115.178.12,no_relation,107,67,,124,88,causes,0.6741998624632421,900150-FS1-4,"To the best of our knowledge, this is the first reported case of a TONGUE BASE HAMARTOMA in a patient with TUBEROUS SCLEROSIS",TUBEROUS SCLEROSIS,TONGUE BASE HAMARTOMA,RO-cause_of
504169949,7/17/2014 11:29:13,,1325183397,7/17/2014 11:28:33,prodege,0.5754,27934334,GBR,,,86.130.153.15,no_relation,107,67,,124,88,causes,0.6741998624632421,900150-FS1-4,"To the best of our knowledge, this is the first reported case of a TONGUE BASE HAMARTOMA in a patient with TUBEROUS SCLEROSIS",TUBEROUS SCLEROSIS,TONGUE BASE HAMARTOMA,RO-cause_of
504169949,7/17/2014 11:31:55,,1325185971,7/17/2014 11:31:29,fusioncash,0.6519,7012325,USA,CT,Stamford,24.185.182.15,no_relation,107,67,,124,88,causes,0.6741998624632421,900150-FS1-4,"To the best of our knowledge, this is the first reported case of a TONGUE BASE HAMARTOMA in a patient with TUBEROUS SCLEROSIS",TUBEROUS SCLEROSIS,TONGUE BASE HAMARTOMA,RO-cause_of
504169949,7/17/2014 12:28:51,,1325229041,7/17/2014 12:28:25,prodege,0.7034,7664351,USA,NY,Cicero,74.111.0.21,no_relation,107,67,,124,88,causes,0.6741998624632421,900150-FS1-4,"To the best of our knowledge, this is the first reported case of a TONGUE BASE HAMARTOMA in a patient with TUBEROUS SCLEROSIS",TUBEROUS SCLEROSIS,TONGUE BASE HAMARTOMA,RO-cause_of
504169950,7/17/2014 10:42:05,,1325147636,7/17/2014 10:41:39,clixsense,0.8083,19803139,NLD,06,Veldhoven,212.61.84.196,LYMPH NODE METASTASIS causes METASTATIC LESIONS,232,102,,249,123,causes,0.6454972243679029,901642-FS1-4,"When TM expression was compared between the primary and metastatic lesions in the 39 patients who had LYMPH NODE METASTASIS 26 (67%) showed decreased TM expression, 13 (33%) showed no change, and none (0%) showed an increase in the METASTATIC LESIONS.",METASTATIC LESIONS,LYMPH NODE METASTASIS,RO-disease_has_finding
504169950,7/17/2014 11:06:36,,1325166034,7/17/2014 11:06:07,clixsense,0.6811,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,LYMPH NODE METASTASIS causes METASTATIC LESIONS,232,102,,249,123,causes,0.6454972243679029,901642-FS1-4,"When TM expression was compared between the primary and metastatic lesions in the 39 patients who had LYMPH NODE METASTASIS 26 (67%) showed decreased TM expression, 13 (33%) showed no change, and none (0%) showed an increase in the METASTATIC LESIONS.",METASTATIC LESIONS,LYMPH NODE METASTASIS,RO-disease_has_finding
504169950,7/17/2014 11:30:54,,1325184993,7/17/2014 11:30:22,fusioncash,0.6519,7012325,USA,CT,Stamford,24.185.182.15,LYMPH NODE METASTASIS causes METASTATIC LESIONS,232,102,,249,123,causes,0.6454972243679029,901642-FS1-4,"When TM expression was compared between the primary and metastatic lesions in the 39 patients who had LYMPH NODE METASTASIS 26 (67%) showed decreased TM expression, 13 (33%) showed no change, and none (0%) showed an increase in the METASTATIC LESIONS.",METASTATIC LESIONS,LYMPH NODE METASTASIS,RO-disease_has_finding
504169950,7/17/2014 12:10:07,,1325214344,7/17/2014 12:09:27,elite,0.6437,28503042,USA,NJ,Woodbridge,54.191.150.115,no_relation,232,102,,249,123,causes,0.6454972243679029,901642-FS1-4,"When TM expression was compared between the primary and metastatic lesions in the 39 patients who had LYMPH NODE METASTASIS 26 (67%) showed decreased TM expression, 13 (33%) showed no change, and none (0%) showed an increase in the METASTATIC LESIONS.",METASTATIC LESIONS,LYMPH NODE METASTASIS,RO-disease_has_finding
504169950,7/17/2014 12:28:13,,1325228481,7/17/2014 12:27:30,prodege,0.7034,7664351,USA,NY,Cicero,74.111.0.21,METASTATIC LESIONS causes LYMPH NODE METASTASIS,232,102,,249,123,causes,0.6454972243679029,901642-FS1-4,"When TM expression was compared between the primary and metastatic lesions in the 39 patients who had LYMPH NODE METASTASIS 26 (67%) showed decreased TM expression, 13 (33%) showed no change, and none (0%) showed an increase in the METASTATIC LESIONS.",METASTATIC LESIONS,LYMPH NODE METASTASIS,RO-disease_has_finding
504169950,7/17/2014 13:07:46,,1325261599,7/17/2014 13:07:08,neodev,0.6065,21515166,NLD,11,Nootdorp,83.86.58.179,METASTATIC LESIONS causes LYMPH NODE METASTASIS,232,102,,249,123,causes,0.6454972243679029,901642-FS1-4,"When TM expression was compared between the primary and metastatic lesions in the 39 patients who had LYMPH NODE METASTASIS 26 (67%) showed decreased TM expression, 13 (33%) showed no change, and none (0%) showed an increase in the METASTATIC LESIONS.",METASTATIC LESIONS,LYMPH NODE METASTASIS,RO-disease_has_finding
504169950,7/17/2014 13:17:10,,1325269430,7/17/2014 13:16:27,clixsense,0.5029,6334612,USA,OH,Cleveland,108.225.254.58,no_relation,232,102,,249,123,causes,0.6454972243679029,901642-FS1-4,"When TM expression was compared between the primary and metastatic lesions in the 39 patients who had LYMPH NODE METASTASIS 26 (67%) showed decreased TM expression, 13 (33%) showed no change, and none (0%) showed an increase in the METASTATIC LESIONS.",METASTATIC LESIONS,LYMPH NODE METASTASIS,RO-disease_has_finding
504169956,7/17/2014 10:43:13,,1325148554,7/17/2014 10:42:56,clixsense,0.8083,19803139,NLD,06,Veldhoven,212.61.84.196,no_relation,0,80,,18,90,treats,0.843274042711568,908309-FS1-2,"SALMONELLA ISOLATES were found to be susceptible to chloramphenicol, kanamycin, AMPICILLIN and tetracycline.",SALMONELLA ISOLATES,AMPICILLIN,RO-may_treat
504169956,7/17/2014 11:05:10,,1325165116,7/17/2014 11:04:17,clixsense,0.6811,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,AMPICILLIN treats SALMONELLA ISOLATES,0,80,,18,90,treats,0.843274042711568,908309-FS1-2,"SALMONELLA ISOLATES were found to be susceptible to chloramphenicol, kanamycin, AMPICILLIN and tetracycline.",SALMONELLA ISOLATES,AMPICILLIN,RO-may_treat
504169956,7/17/2014 11:07:52,,1325167076,7/17/2014 11:07:42,instagc,0.6656,23149109,USA,NC,Durham,75.189.206.205,SALMONELLA ISOLATES treats AMPICILLIN,0,80,,18,90,treats,0.843274042711568,908309-FS1-2,"SALMONELLA ISOLATES were found to be susceptible to chloramphenicol, kanamycin, AMPICILLIN and tetracycline.",SALMONELLA ISOLATES,AMPICILLIN,RO-may_treat
504169956,7/17/2014 12:12:44,,1325216448,7/17/2014 12:12:30,elite,0.6437,28503042,USA,NJ,Woodbridge,54.191.150.115,AMPICILLIN treats SALMONELLA ISOLATES,0,80,,18,90,treats,0.843274042711568,908309-FS1-2,"SALMONELLA ISOLATES were found to be susceptible to chloramphenicol, kanamycin, AMPICILLIN and tetracycline.",SALMONELLA ISOLATES,AMPICILLIN,RO-may_treat
504169956,7/17/2014 13:24:21,,1325275701,7/17/2014 13:24:00,clixsense,0.5029,6334612,USA,OH,Cleveland,108.225.254.58,no_relation,0,80,,18,90,treats,0.843274042711568,908309-FS1-2,"SALMONELLA ISOLATES were found to be susceptible to chloramphenicol, kanamycin, AMPICILLIN and tetracycline.",SALMONELLA ISOLATES,AMPICILLIN,RO-may_treat
504169956,7/17/2014 13:33:49,,1325286705,7/17/2014 13:33:31,prodege,0.5459,28039757,GBR,L8,Southport,109.155.158.54,no_relation,0,80,,18,90,treats,0.843274042711568,908309-FS1-2,"SALMONELLA ISOLATES were found to be susceptible to chloramphenicol, kanamycin, AMPICILLIN and tetracycline.",SALMONELLA ISOLATES,AMPICILLIN,RO-may_treat
504169956,7/17/2014 14:02:16,,1325313062,7/17/2014 14:02:04,clixsense,0.6306,15189335,GBR,T5,Aberdeen,90.218.222.164,AMPICILLIN treats SALMONELLA ISOLATES,0,80,,18,90,treats,0.843274042711568,908309-FS1-2,"SALMONELLA ISOLATES were found to be susceptible to chloramphenicol, kanamycin, AMPICILLIN and tetracycline.",SALMONELLA ISOLATES,AMPICILLIN,RO-may_treat
504169961,7/17/2014 10:30:37,,1325138413,7/17/2014 10:30:28,clixsense,0.8667,19162475,GBR,M3,Frome,82.33.126.30,LEVODOPA treats PARKINSON'S DISEASE,27,65,,45,73,treats,0.997054485501582,908327-FS1-2,Eighty eight patients with PARKINSON'S DISEASE were treated with LEVODOPA,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
504169961,7/17/2014 10:31:33,,1325139278,7/17/2014 10:31:19,instagc,0.8444,24252915,GBR,B7,Bristol,77.98.139.82,LEVODOPA treats PARKINSON'S DISEASE,27,65,,45,73,treats,0.997054485501582,908327-FS1-2,Eighty eight patients with PARKINSON'S DISEASE were treated with LEVODOPA,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
504169961,7/17/2014 10:34:46,,1325141997,7/17/2014 10:34:39,clixsense,0.8111,27793793,GBR,C5,Chester,151.230.27.155,LEVODOPA treats PARKINSON'S DISEASE,27,65,,45,73,treats,0.997054485501582,908327-FS1-2,Eighty eight patients with PARKINSON'S DISEASE were treated with LEVODOPA,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
504169961,7/17/2014 10:42:37,,1325148054,7/17/2014 10:42:22,clixsense,0.8083,19803139,NLD,06,Veldhoven,212.61.84.196,LEVODOPA treats PARKINSON'S DISEASE,27,65,,45,73,treats,0.997054485501582,908327-FS1-2,Eighty eight patients with PARKINSON'S DISEASE were treated with LEVODOPA,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
504169961,7/17/2014 11:45:15,,1325196662,7/17/2014 11:44:53,instagc,0.6489,13763729,USA,,,75.182.89.225,LEVODOPA treats PARKINSON'S DISEASE,27,65,,45,73,treats,0.997054485501582,908327-FS1-2,Eighty eight patients with PARKINSON'S DISEASE were treated with LEVODOPA,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
504169961,7/17/2014 11:59:45,,1325206734,7/17/2014 11:59:27,tremorgames,0.5999,24449707,CAN,QC,Laval,96.21.249.72,LEVODOPA treats PARKINSON'S DISEASE,27,65,,45,73,treats,0.997054485501582,908327-FS1-2,Eighty eight patients with PARKINSON'S DISEASE were treated with LEVODOPA,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
504169961,7/17/2014 14:01:18,,1325312041,7/17/2014 14:01:10,clixsense,0.6306,15189335,GBR,T5,Aberdeen,90.218.222.164,LEVODOPA treats PARKINSON'S DISEASE,27,65,,45,73,treats,0.997054485501582,908327-FS1-2,Eighty eight patients with PARKINSON'S DISEASE were treated with LEVODOPA,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
504170003,7/17/2014 11:10:14,,1325168962,7/17/2014 11:10:05,instagc,0.6556,23149109,USA,NC,Durham,75.189.206.205,RELATED GENE (HERG) causes TORSADES DE POINTES,163,75,,181,94,causes,0.9838699100999069,906446-FS1-4,Unintended inhibition of the cardiac potassium channel human ether a go go RELATED GENE (HERG) is considered the main culprit in drug induced arrhythmias known as TORSADES DE POINTES,TORSADES DE POINTES,RELATED GENE (HERG),RO-has_manifestation
504170003,7/17/2014 11:53:19,,1325202477,7/17/2014 11:52:59,instagc,0.6653,13763729,USA,,,75.182.89.225,RELATED GENE (HERG) causes TORSADES DE POINTES,163,75,,181,94,causes,0.9838699100999069,906446-FS1-4,Unintended inhibition of the cardiac potassium channel human ether a go go RELATED GENE (HERG) is considered the main culprit in drug induced arrhythmias known as TORSADES DE POINTES,TORSADES DE POINTES,RELATED GENE (HERG),RO-has_manifestation
504170003,7/17/2014 14:06:03,,1325316419,7/17/2014 14:05:38,neodev,0.5669,18339121,USA,SC,Sumter,173.93.188.194,RELATED GENE (HERG) causes TORSADES DE POINTES,163,75,,181,94,causes,0.9838699100999069,906446-FS1-4,Unintended inhibition of the cardiac potassium channel human ether a go go RELATED GENE (HERG) is considered the main culprit in drug induced arrhythmias known as TORSADES DE POINTES,TORSADES DE POINTES,RELATED GENE (HERG),RO-has_manifestation
504170003,7/17/2014 14:31:56,,1325339901,7/17/2014 14:31:45,clixsense,0.4918,20614047,USA,MO,Maryville,174.32.162.147,RELATED GENE (HERG) causes TORSADES DE POINTES,163,75,,181,94,causes,0.9838699100999069,906446-FS1-4,Unintended inhibition of the cardiac potassium channel human ether a go go RELATED GENE (HERG) is considered the main culprit in drug induced arrhythmias known as TORSADES DE POINTES,TORSADES DE POINTES,RELATED GENE (HERG),RO-has_manifestation
504170003,7/17/2014 15:05:34,,1325370260,7/17/2014 15:05:11,elite,0.534,28276268,USA,MI,Taylor,67.149.247.166,RELATED GENE (HERG) causes TORSADES DE POINTES,163,75,,181,94,causes,0.9838699100999069,906446-FS1-4,Unintended inhibition of the cardiac potassium channel human ether a go go RELATED GENE (HERG) is considered the main culprit in drug induced arrhythmias known as TORSADES DE POINTES,TORSADES DE POINTES,RELATED GENE (HERG),RO-has_manifestation
504170003,7/17/2014 15:43:24,,1325404341,7/17/2014 15:43:06,prodege,0.4155,24403612,CAN,ON,Ajax,99.242.234.239,no_relation,163,75,,181,94,causes,0.9838699100999069,906446-FS1-4,Unintended inhibition of the cardiac potassium channel human ether a go go RELATED GENE (HERG) is considered the main culprit in drug induced arrhythmias known as TORSADES DE POINTES,TORSADES DE POINTES,RELATED GENE (HERG),RO-has_manifestation
504170003,7/17/2014 15:48:27,,1325408512,7/17/2014 15:48:08,prodege,0.754,23541832,USA,AZ,Tempe,149.169.145.152,RELATED GENE (HERG) causes TORSADES DE POINTES,163,75,,181,94,causes,0.9838699100999069,906446-FS1-4,Unintended inhibition of the cardiac potassium channel human ether a go go RELATED GENE (HERG) is considered the main culprit in drug induced arrhythmias known as TORSADES DE POINTES,TORSADES DE POINTES,RELATED GENE (HERG),RO-has_manifestation
504170010,7/17/2014 11:54:11,,1325203035,7/17/2014 11:54:01,gifthulk,0.8375,21916793,GBR,,,87.115.178.12,AMANTADINE treats PARKINSON'S DISEASE,31,0,,49,10,treats,1.0,907950-FS1-2,AMANTADINE in the treatment of PARKINSON'S DISEASE,PARKINSON'S DISEASE,AMANTADINE,RO-may_treat
504170010,7/17/2014 12:16:10,,1325219182,7/17/2014 12:15:52,elite,0.6262,28503042,USA,NJ,Woodbridge,54.191.150.115,AMANTADINE treats PARKINSON'S DISEASE,31,0,,49,10,treats,1.0,907950-FS1-2,AMANTADINE in the treatment of PARKINSON'S DISEASE,PARKINSON'S DISEASE,AMANTADINE,RO-may_treat
504170010,7/17/2014 13:23:50,,1325275236,7/17/2014 13:23:32,prodege,0.6909,24945126,GBR,F6,Romford,82.12.220.44,AMANTADINE treats PARKINSON'S DISEASE,31,0,,49,10,treats,1.0,907950-FS1-2,AMANTADINE in the treatment of PARKINSON'S DISEASE,PARKINSON'S DISEASE,AMANTADINE,RO-may_treat
504170010,7/17/2014 13:38:57,,1325291105,7/17/2014 13:38:39,clixsense,0.6825,6574199,USA,TX,San Antonio,207.230.144.242,AMANTADINE treats PARKINSON'S DISEASE,31,0,,49,10,treats,1.0,907950-FS1-2,AMANTADINE in the treatment of PARKINSON'S DISEASE,PARKINSON'S DISEASE,AMANTADINE,RO-may_treat
504170010,7/17/2014 13:59:40,,1325310307,7/17/2014 13:59:27,clixsense,0.6744,6579377,CAN,BC,Richmond,174.6.142.227,AMANTADINE treats PARKINSON'S DISEASE,31,0,,49,10,treats,1.0,907950-FS1-2,AMANTADINE in the treatment of PARKINSON'S DISEASE,PARKINSON'S DISEASE,AMANTADINE,RO-may_treat
504170010,7/17/2014 14:11:22,,1325321065,7/17/2014 14:11:06,clixsense,0.7183,27871219,NLD,07,Amsterdam,87.210.207.223,AMANTADINE treats PARKINSON'S DISEASE,31,0,,49,10,treats,1.0,907950-FS1-2,AMANTADINE in the treatment of PARKINSON'S DISEASE,PARKINSON'S DISEASE,AMANTADINE,RO-may_treat
504170010,7/17/2014 14:32:50,,1325340649,7/17/2014 14:32:42,clixsense,0.4918,20614047,USA,MO,Maryville,174.32.162.147,PARKINSON'S DISEASE treats AMANTADINE,31,0,,49,10,treats,1.0,907950-FS1-2,AMANTADINE in the treatment of PARKINSON'S DISEASE,PARKINSON'S DISEASE,AMANTADINE,RO-may_treat
504170012,7/17/2014 10:27:22,,1325135613,7/17/2014 10:27:06,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,PHEOCHROMOCYTOMA diagnosed by PHENTOLAMINE,106,84,,121,96,diagnosed by,0.6154574548966639,906704-FS1-13,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170012,7/17/2014 10:39:24,,1325145538,7/17/2014 10:38:56,clixsense,0.8958,19803139,NLD,06,Veldhoven,212.61.84.196,PHEOCHROMOCYTOMA diagnosed by PHENTOLAMINE,106,84,,121,96,diagnosed by,0.6154574548966639,906704-FS1-13,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170012,7/17/2014 11:10:14,,1325168973,7/17/2014 11:10:05,instagc,0.6556,23149109,USA,NC,Durham,75.189.206.205,PHENTOLAMINE diagnosed by PHEOCHROMOCYTOMA,106,84,,121,96,diagnosed by,0.6154574548966639,906704-FS1-13,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170012,7/17/2014 11:12:41,,1325171198,7/17/2014 11:12:17,clixsense,0.8958,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,PHEOCHROMOCYTOMA diagnosed by PHENTOLAMINE,106,84,,121,96,diagnosed by,0.6154574548966639,906704-FS1-13,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170012,7/17/2014 13:25:49,,1325277092,7/17/2014 13:25:16,prodege,0.6909,24945126,GBR,F6,Romford,82.12.220.44,no_relation,106,84,,121,96,diagnosed by,0.6154574548966639,906704-FS1-13,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170012,7/17/2014 13:37:53,,1325290043,7/17/2014 13:37:35,clixsense,0.6825,6574199,USA,TX,San Antonio,207.230.144.242,PHENTOLAMINE diagnosed by PHEOCHROMOCYTOMA,106,84,,121,96,diagnosed by,0.6154574548966639,906704-FS1-13,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170012,7/17/2014 14:01:11,,1325311902,7/17/2014 14:00:35,clixsense,0.6744,6579377,CAN,BC,Richmond,174.6.142.227,PHEOCHROMOCYTOMA diagnosed by PHENTOLAMINE,106,84,,121,96,diagnosed by,0.6154574548966639,906704-FS1-13,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170014,7/17/2014 11:28:18,,1325182756,7/17/2014 11:27:45,fusioncash,0.5583,7012325,USA,CT,Stamford,24.185.182.15,HYDROXYUREA treats POLYCYTHEMIA VERA,32,0,,48,11,treats,0.986393923832143,907569-FS1-2,HYDROXYUREA in the treatment of POLYCYTHEMIA VERA: a prospective study of 100 patients over a 20 year period.,POLYCYTHEMIA VERA,HYDROXYUREA,RO-may_treat
504170014,7/17/2014 11:52:58,,1325202193,7/17/2014 11:52:46,instagc,0.6653,13763729,USA,,,75.182.89.225,HYDROXYUREA treats POLYCYTHEMIA VERA,32,0,,48,11,treats,0.986393923832143,907569-FS1-2,HYDROXYUREA in the treatment of POLYCYTHEMIA VERA: a prospective study of 100 patients over a 20 year period.,POLYCYTHEMIA VERA,HYDROXYUREA,RO-may_treat
504170014,7/17/2014 12:14:13,,1325217527,7/17/2014 12:13:57,elite,0.6262,28503042,USA,NJ,Woodbridge,54.191.150.115,HYDROXYUREA treats POLYCYTHEMIA VERA,32,0,,48,11,treats,0.986393923832143,907569-FS1-2,HYDROXYUREA in the treatment of POLYCYTHEMIA VERA: a prospective study of 100 patients over a 20 year period.,POLYCYTHEMIA VERA,HYDROXYUREA,RO-may_treat
504170014,7/17/2014 12:54:23,,1325250086,7/17/2014 12:54:12,clixsense,0.7,16827630,GBR,A7,Birmingham,86.146.169.103,HYDROXYUREA treats POLYCYTHEMIA VERA,32,0,,48,11,treats,0.986393923832143,907569-FS1-2,HYDROXYUREA in the treatment of POLYCYTHEMIA VERA: a prospective study of 100 patients over a 20 year period.,POLYCYTHEMIA VERA,HYDROXYUREA,RO-may_treat
504170014,7/17/2014 14:04:28,,1325315004,7/17/2014 14:04:08,clixsense,0.5901,15189335,GBR,T5,Aberdeen,90.218.222.164,HYDROXYUREA treats POLYCYTHEMIA VERA,32,0,,48,11,treats,0.986393923832143,907569-FS1-2,HYDROXYUREA in the treatment of POLYCYTHEMIA VERA: a prospective study of 100 patients over a 20 year period.,POLYCYTHEMIA VERA,HYDROXYUREA,RO-may_treat
504170014,7/17/2014 14:32:38,,1325340480,7/17/2014 14:32:27,clixsense,0.4918,20614047,USA,MO,Maryville,174.32.162.147,POLYCYTHEMIA VERA treats HYDROXYUREA,32,0,,48,11,treats,0.986393923832143,907569-FS1-2,HYDROXYUREA in the treatment of POLYCYTHEMIA VERA: a prospective study of 100 patients over a 20 year period.,POLYCYTHEMIA VERA,HYDROXYUREA,RO-may_treat
504170014,7/17/2014 14:47:10,,1325353207,7/17/2014 14:46:08,clixsense,0.2,11764504,GBR,M5,Southend-on-sea,92.232.81.238,no_relation,32,0,,48,11,treats,0.986393923832143,907569-FS1-2,HYDROXYUREA in the treatment of POLYCYTHEMIA VERA: a prospective study of 100 patients over a 20 year period.,POLYCYTHEMIA VERA,HYDROXYUREA,RO-may_treat
504170020,7/17/2014 10:34:50,,1325142030,7/17/2014 10:34:31,clixsense,0.8472,19162475,GBR,M3,Frome,82.33.126.30,VIREMIA causes VIRUS EXPOSURE,99,45,,112,52,causes,0.9667364890456641,903998-FS1-4,Efficacious FeLV vaccines prevent persistent VIREMIA and development of FeLV related disease after VIRUS EXPOSURE but not minimal viral replication and a provirus positive state as recently demonstrated using sensitive real time PCR assays.,VIRUS EXPOSURE,VIREMIA,RO-has_causative_agent
504170020,7/17/2014 11:13:33,,1325171959,7/17/2014 11:13:18,clixsense,0.8958,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,VIREMIA causes VIRUS EXPOSURE,99,45,,112,52,causes,0.9667364890456641,903998-FS1-4,Efficacious FeLV vaccines prevent persistent VIREMIA and development of FeLV related disease after VIRUS EXPOSURE but not minimal viral replication and a provirus positive state as recently demonstrated using sensitive real time PCR assays.,VIRUS EXPOSURE,VIREMIA,RO-has_causative_agent
504170020,7/17/2014 12:15:07,,1325218272,7/17/2014 12:14:51,elite,0.6262,28503042,USA,NJ,Woodbridge,54.191.150.115,VIRUS EXPOSURE causes VIREMIA,99,45,,112,52,causes,0.9667364890456641,903998-FS1-4,Efficacious FeLV vaccines prevent persistent VIREMIA and development of FeLV related disease after VIRUS EXPOSURE but not minimal viral replication and a provirus positive state as recently demonstrated using sensitive real time PCR assays.,VIRUS EXPOSURE,VIREMIA,RO-has_causative_agent
504170020,7/17/2014 12:31:12,,1325230952,7/17/2014 12:30:56,prodege,0.6827,7664351,USA,NY,Cicero,74.111.0.21,VIRUS EXPOSURE causes VIREMIA,99,45,,112,52,causes,0.9667364890456641,903998-FS1-4,Efficacious FeLV vaccines prevent persistent VIREMIA and development of FeLV related disease after VIRUS EXPOSURE but not minimal viral replication and a provirus positive state as recently demonstrated using sensitive real time PCR assays.,VIRUS EXPOSURE,VIREMIA,RO-has_causative_agent
504170020,7/17/2014 14:06:03,,1325316434,7/17/2014 14:05:38,neodev,0.5669,18339121,USA,SC,Sumter,173.93.188.194,VIRUS EXPOSURE causes VIREMIA,99,45,,112,52,causes,0.9667364890456641,903998-FS1-4,Efficacious FeLV vaccines prevent persistent VIREMIA and development of FeLV related disease after VIRUS EXPOSURE but not minimal viral replication and a provirus positive state as recently demonstrated using sensitive real time PCR assays.,VIRUS EXPOSURE,VIREMIA,RO-has_causative_agent
504170020,7/17/2014 14:09:18,,1325319274,7/17/2014 14:08:53,clixsense,0.7183,27871219,NLD,07,Amsterdam,87.210.207.223,VIRUS EXPOSURE causes VIREMIA,99,45,,112,52,causes,0.9667364890456641,903998-FS1-4,Efficacious FeLV vaccines prevent persistent VIREMIA and development of FeLV related disease after VIRUS EXPOSURE but not minimal viral replication and a provirus positive state as recently demonstrated using sensitive real time PCR assays.,VIRUS EXPOSURE,VIREMIA,RO-has_causative_agent
504170020,7/17/2014 14:30:17,,1325338481,7/17/2014 14:29:25,clixsense,0.4167,21830510,USA,NC,Greensboro,75.177.52.45,no_relation,99,45,,112,52,causes,0.9667364890456641,903998-FS1-4,Efficacious FeLV vaccines prevent persistent VIREMIA and development of FeLV related disease after VIRUS EXPOSURE but not minimal viral replication and a provirus positive state as recently demonstrated using sensitive real time PCR assays.,VIRUS EXPOSURE,VIREMIA,RO-has_causative_agent
504170022,7/17/2014 10:27:44,,1325135971,7/17/2014 10:27:23,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,ALLERGY causes HYPERSENSITIVITY REACTION,93,7,,117,14,causes,0.7875615306482171,900292-FS1-4,SEE:   ALLERGY ;  anaphylaxis  ETIOLOGY: The condition is the result of a type I allergic or HYPERSENSITIVITY REACTION during which the allergen is absorbed into the blood directly or through the mucosa.,HYPERSENSITIVITY REACTION,ALLERGY,RO-cause_of
504170022,7/17/2014 10:38:54,,1325145117,7/17/2014 10:38:36,clixsense,0.8958,19803139,NLD,06,Veldhoven,212.61.84.196,ALLERGY causes HYPERSENSITIVITY REACTION,93,7,,117,14,causes,0.7875615306482171,900292-FS1-4,SEE:   ALLERGY ;  anaphylaxis  ETIOLOGY: The condition is the result of a type I allergic or HYPERSENSITIVITY REACTION during which the allergen is absorbed into the blood directly or through the mucosa.,HYPERSENSITIVITY REACTION,ALLERGY,RO-cause_of
504170022,7/17/2014 11:12:58,,1325171434,7/17/2014 11:12:42,clixsense,0.8958,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,ALLERGY causes HYPERSENSITIVITY REACTION,93,7,,117,14,causes,0.7875615306482171,900292-FS1-4,SEE:   ALLERGY ;  anaphylaxis  ETIOLOGY: The condition is the result of a type I allergic or HYPERSENSITIVITY REACTION during which the allergen is absorbed into the blood directly or through the mucosa.,HYPERSENSITIVITY REACTION,ALLERGY,RO-cause_of
504170022,7/17/2014 11:16:35,,1325174295,7/17/2014 11:16:00,prodege,0.6597,27934334,GBR,,,86.130.153.15,no_relation,93,7,,117,14,causes,0.7875615306482171,900292-FS1-4,SEE:   ALLERGY ;  anaphylaxis  ETIOLOGY: The condition is the result of a type I allergic or HYPERSENSITIVITY REACTION during which the allergen is absorbed into the blood directly or through the mucosa.,HYPERSENSITIVITY REACTION,ALLERGY,RO-cause_of
504170022,7/17/2014 11:25:40,,1325180930,7/17/2014 11:25:01,fusioncash,0.5583,7012325,USA,CT,Stamford,24.185.182.15,HYPERSENSITIVITY REACTION causes ALLERGY,93,7,,117,14,causes,0.7875615306482171,900292-FS1-4,SEE:   ALLERGY ;  anaphylaxis  ETIOLOGY: The condition is the result of a type I allergic or HYPERSENSITIVITY REACTION during which the allergen is absorbed into the blood directly or through the mucosa.,HYPERSENSITIVITY REACTION,ALLERGY,RO-cause_of
504170022,7/17/2014 11:51:28,,1325201134,7/17/2014 11:51:18,gifthulk,0.8375,21916793,GBR,,,87.115.178.12,ALLERGY causes HYPERSENSITIVITY REACTION,93,7,,117,14,causes,0.7875615306482171,900292-FS1-4,SEE:   ALLERGY ;  anaphylaxis  ETIOLOGY: The condition is the result of a type I allergic or HYPERSENSITIVITY REACTION during which the allergen is absorbed into the blood directly or through the mucosa.,HYPERSENSITIVITY REACTION,ALLERGY,RO-cause_of
504170022,7/17/2014 12:14:49,,1325218046,7/17/2014 12:14:14,elite,0.6262,28503042,USA,NJ,Woodbridge,54.191.150.115,ALLERGY causes HYPERSENSITIVITY REACTION,93,7,,117,14,causes,0.7875615306482171,900292-FS1-4,SEE:   ALLERGY ;  anaphylaxis  ETIOLOGY: The condition is the result of a type I allergic or HYPERSENSITIVITY REACTION during which the allergen is absorbed into the blood directly or through the mucosa.,HYPERSENSITIVITY REACTION,ALLERGY,RO-cause_of
504170026,7/17/2014 11:10:25,,1325169084,7/17/2014 11:10:16,instagc,0.6556,23149109,USA,NC,Durham,75.189.206.205,VARIOLA VIRUS causes SMALLPOX,77,104,,89,112,causes,0.9830783046228491,903571-FS1-4,Each comparison gave the same conclusion: CMPV is the closest known virus to VARIOLA VIRUS the cause of SMALLPOX,VARIOLA VIRUS,SMALLPOX,RO-has_causative_agent
504170026,7/17/2014 11:27:16,,1325182006,7/17/2014 11:26:59,fusioncash,0.5583,7012325,USA,CT,Stamford,24.185.182.15,VARIOLA VIRUS causes SMALLPOX,77,104,,89,112,causes,0.9830783046228491,903571-FS1-4,Each comparison gave the same conclusion: CMPV is the closest known virus to VARIOLA VIRUS the cause of SMALLPOX,VARIOLA VIRUS,SMALLPOX,RO-has_causative_agent
504170026,7/17/2014 14:11:22,,1325321052,7/17/2014 14:11:06,clixsense,0.7183,27871219,NLD,07,Amsterdam,87.210.207.223,VARIOLA VIRUS causes SMALLPOX,77,104,,89,112,causes,0.9830783046228491,903571-FS1-4,Each comparison gave the same conclusion: CMPV is the closest known virus to VARIOLA VIRUS the cause of SMALLPOX,VARIOLA VIRUS,SMALLPOX,RO-has_causative_agent
504170026,7/17/2014 14:32:38,,1325340474,7/17/2014 14:32:27,clixsense,0.4918,20614047,USA,MO,Maryville,174.32.162.147,SMALLPOX causes VARIOLA VIRUS,77,104,,89,112,causes,0.9830783046228491,903571-FS1-4,Each comparison gave the same conclusion: CMPV is the closest known virus to VARIOLA VIRUS the cause of SMALLPOX,VARIOLA VIRUS,SMALLPOX,RO-has_causative_agent
504170026,7/17/2014 15:05:34,,1325370256,7/17/2014 15:05:11,elite,0.534,28276268,USA,MI,Taylor,67.149.247.166,VARIOLA VIRUS causes SMALLPOX,77,104,,89,112,causes,0.9830783046228491,903571-FS1-4,Each comparison gave the same conclusion: CMPV is the closest known virus to VARIOLA VIRUS the cause of SMALLPOX,VARIOLA VIRUS,SMALLPOX,RO-has_causative_agent
504170026,7/17/2014 15:43:04,,1325404071,7/17/2014 15:42:43,prodege,0.4155,24403612,CAN,ON,Ajax,99.242.234.239,VARIOLA VIRUS causes SMALLPOX,77,104,,89,112,causes,0.9830783046228491,903571-FS1-4,Each comparison gave the same conclusion: CMPV is the closest known virus to VARIOLA VIRUS the cause of SMALLPOX,VARIOLA VIRUS,SMALLPOX,RO-has_causative_agent
504170026,7/17/2014 15:48:27,,1325408511,7/17/2014 15:48:08,prodege,0.754,23541832,USA,AZ,Tempe,149.169.145.152,VARIOLA VIRUS causes SMALLPOX,77,104,,89,112,causes,0.9830783046228491,903571-FS1-4,Each comparison gave the same conclusion: CMPV is the closest known virus to VARIOLA VIRUS the cause of SMALLPOX,VARIOLA VIRUS,SMALLPOX,RO-has_causative_agent
504170027,7/17/2014 10:22:31,,1325132085,7/17/2014 10:22:22,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,PARTIAL EPILEPSY causes SEIZURES,89,52,,96,68,causes,0.985329278164293,904841-FS1-4,During therapy of 40 patients (8 57 year olds) with PARTIAL EPILEPSY the severity of the SEIZURES as well as emotional and cognitive functions of the patients were evaluated.,SEIZURES,PARTIAL EPILEPSY,RO-has_definitional_manifestation
504170027,7/17/2014 11:13:33,,1325171958,7/17/2014 11:13:18,clixsense,0.8958,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,PARTIAL EPILEPSY causes SEIZURES,89,52,,96,68,causes,0.985329278164293,904841-FS1-4,During therapy of 40 patients (8 57 year olds) with PARTIAL EPILEPSY the severity of the SEIZURES as well as emotional and cognitive functions of the patients were evaluated.,SEIZURES,PARTIAL EPILEPSY,RO-has_definitional_manifestation
504170027,7/17/2014 11:21:57,,1325178420,7/17/2014 11:21:25,prodege,0.6181,15439740,AUS,02,Jannali,27.96.208.89,SEIZURES causes PARTIAL EPILEPSY,89,52,,96,68,causes,0.985329278164293,904841-FS1-4,During therapy of 40 patients (8 57 year olds) with PARTIAL EPILEPSY the severity of the SEIZURES as well as emotional and cognitive functions of the patients were evaluated.,SEIZURES,PARTIAL EPILEPSY,RO-has_definitional_manifestation
504170027,7/17/2014 11:56:27,,1325204459,7/17/2014 11:56:08,tremorgames,0.7111,24449707,CAN,QC,Laval,96.21.249.72,PARTIAL EPILEPSY causes SEIZURES,89,52,,96,68,causes,0.985329278164293,904841-FS1-4,During therapy of 40 patients (8 57 year olds) with PARTIAL EPILEPSY the severity of the SEIZURES as well as emotional and cognitive functions of the patients were evaluated.,SEIZURES,PARTIAL EPILEPSY,RO-has_definitional_manifestation
504170027,7/17/2014 12:55:04,,1325250655,7/17/2014 12:54:52,clixsense,0.7,16827630,GBR,A7,Birmingham,86.146.169.103,PARTIAL EPILEPSY causes SEIZURES,89,52,,96,68,causes,0.985329278164293,904841-FS1-4,During therapy of 40 patients (8 57 year olds) with PARTIAL EPILEPSY the severity of the SEIZURES as well as emotional and cognitive functions of the patients were evaluated.,SEIZURES,PARTIAL EPILEPSY,RO-has_definitional_manifestation
504170027,7/17/2014 13:38:57,,1325291109,7/17/2014 13:38:39,clixsense,0.6825,6574199,USA,TX,San Antonio,207.230.144.242,PARTIAL EPILEPSY causes SEIZURES,89,52,,96,68,causes,0.985329278164293,904841-FS1-4,During therapy of 40 patients (8 57 year olds) with PARTIAL EPILEPSY the severity of the SEIZURES as well as emotional and cognitive functions of the patients were evaluated.,SEIZURES,PARTIAL EPILEPSY,RO-has_definitional_manifestation
504170027,7/17/2014 13:39:06,,1325291277,7/17/2014 13:38:40,prodege,0.5202,28039757,GBR,L8,Southport,109.155.158.54,no_relation,89,52,,96,68,causes,0.985329278164293,904841-FS1-4,During therapy of 40 patients (8 57 year olds) with PARTIAL EPILEPSY the severity of the SEIZURES as well as emotional and cognitive functions of the patients were evaluated.,SEIZURES,PARTIAL EPILEPSY,RO-has_definitional_manifestation
504170028,7/17/2014 10:34:22,,1325141667,7/17/2014 10:33:52,clixsense,0.8472,19162475,GBR,M3,Frome,82.33.126.30,TOPICAL MINOXIDIL treats MALE PATTERN BALDNESS,64,99,,84,116,treats,0.99654575824488,907885-FS1-2,"Olsen EA, DeLong ER, Weiner MS. Long term follow up of men with MALE PATTERN BALDNESS treated with TOPICAL MINOXIDIL",MALE PATTERN BALDNESS,TOPICAL MINOXIDIL,RO-may_treat
504170028,7/17/2014 11:13:17,,1325171680,7/17/2014 11:12:59,clixsense,0.8958,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,TOPICAL MINOXIDIL treats MALE PATTERN BALDNESS,64,99,,84,116,treats,0.99654575824488,907885-FS1-2,"Olsen EA, DeLong ER, Weiner MS. Long term follow up of men with MALE PATTERN BALDNESS treated with TOPICAL MINOXIDIL",MALE PATTERN BALDNESS,TOPICAL MINOXIDIL,RO-may_treat
504170028,7/17/2014 11:16:35,,1325174296,7/17/2014 11:16:00,prodege,0.6597,27934334,GBR,,,86.130.153.15,TOPICAL MINOXIDIL treats MALE PATTERN BALDNESS,64,99,,84,116,treats,0.99654575824488,907885-FS1-2,"Olsen EA, DeLong ER, Weiner MS. Long term follow up of men with MALE PATTERN BALDNESS treated with TOPICAL MINOXIDIL",MALE PATTERN BALDNESS,TOPICAL MINOXIDIL,RO-may_treat
504170028,7/17/2014 12:31:12,,1325230955,7/17/2014 12:30:56,prodege,0.6827,7664351,USA,NY,Cicero,74.111.0.21,TOPICAL MINOXIDIL treats MALE PATTERN BALDNESS,64,99,,84,116,treats,0.99654575824488,907885-FS1-2,"Olsen EA, DeLong ER, Weiner MS. Long term follow up of men with MALE PATTERN BALDNESS treated with TOPICAL MINOXIDIL",MALE PATTERN BALDNESS,TOPICAL MINOXIDIL,RO-may_treat
504170028,7/17/2014 13:10:24,,1325263583,7/17/2014 13:09:44,neodev,0.7137,21515166,NLD,11,Nootdorp,83.86.58.179,TOPICAL MINOXIDIL treats MALE PATTERN BALDNESS,64,99,,84,116,treats,0.99654575824488,907885-FS1-2,"Olsen EA, DeLong ER, Weiner MS. Long term follow up of men with MALE PATTERN BALDNESS treated with TOPICAL MINOXIDIL",MALE PATTERN BALDNESS,TOPICAL MINOXIDIL,RO-may_treat
504170028,7/17/2014 13:39:24,,1325291543,7/17/2014 13:38:58,clixsense,0.6825,6574199,USA,TX,San Antonio,207.230.144.242,TOPICAL MINOXIDIL treats MALE PATTERN BALDNESS,64,99,,84,116,treats,0.99654575824488,907885-FS1-2,"Olsen EA, DeLong ER, Weiner MS. Long term follow up of men with MALE PATTERN BALDNESS treated with TOPICAL MINOXIDIL",MALE PATTERN BALDNESS,TOPICAL MINOXIDIL,RO-may_treat
504170028,7/17/2014 13:39:26,,1325291607,7/17/2014 13:39:06,prodege,0.5202,28039757,GBR,L8,Southport,109.155.158.54,TOPICAL MINOXIDIL treats MALE PATTERN BALDNESS,64,99,,84,116,treats,0.99654575824488,907885-FS1-2,"Olsen EA, DeLong ER, Weiner MS. Long term follow up of men with MALE PATTERN BALDNESS treated with TOPICAL MINOXIDIL",MALE PATTERN BALDNESS,TOPICAL MINOXIDIL,RO-may_treat
504170033,7/17/2014 10:22:21,,1325131950,7/17/2014 10:22:14,clixsense,1.0,27793793,GBR,C5,Chester,151.230.27.155,HODGKIN'S DISEASE treats VINCRISTINE,56,128,,72,139,treats,1.0,908106-FS1-2,"Seventy six patients with previously untreated advanced HODGKIN'S DISEASE have been treated with the MOPP/ABV (mechlorethamine, VINCRISTINE procarbazine, prednisone/doxorubicin, bleomycin, vincristine) hybrid program.",HODGKIN'S DISEASE,VINCRISTINE,RO-may_treat
504170033,7/17/2014 10:35:21,,1325142602,7/17/2014 10:35:15,clixsense,0.8472,19162475,GBR,M3,Frome,82.33.126.30,VINCRISTINE treats HODGKIN'S DISEASE,56,128,,72,139,treats,1.0,908106-FS1-2,"Seventy six patients with previously untreated advanced HODGKIN'S DISEASE have been treated with the MOPP/ABV (mechlorethamine, VINCRISTINE procarbazine, prednisone/doxorubicin, bleomycin, vincristine) hybrid program.",HODGKIN'S DISEASE,VINCRISTINE,RO-may_treat
504170033,7/17/2014 11:12:58,,1325171433,7/17/2014 11:12:42,clixsense,0.8958,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,VINCRISTINE treats HODGKIN'S DISEASE,56,128,,72,139,treats,1.0,908106-FS1-2,"Seventy six patients with previously untreated advanced HODGKIN'S DISEASE have been treated with the MOPP/ABV (mechlorethamine, VINCRISTINE procarbazine, prednisone/doxorubicin, bleomycin, vincristine) hybrid program.",HODGKIN'S DISEASE,VINCRISTINE,RO-may_treat
504170033,7/17/2014 11:22:15,,1325178657,7/17/2014 11:21:59,prodege,0.6181,15439740,AUS,02,Jannali,27.96.208.89,VINCRISTINE treats HODGKIN'S DISEASE,56,128,,72,139,treats,1.0,908106-FS1-2,"Seventy six patients with previously untreated advanced HODGKIN'S DISEASE have been treated with the MOPP/ABV (mechlorethamine, VINCRISTINE procarbazine, prednisone/doxorubicin, bleomycin, vincristine) hybrid program.",HODGKIN'S DISEASE,VINCRISTINE,RO-may_treat
504170033,7/17/2014 11:51:39,,1325201239,7/17/2014 11:51:29,gifthulk,0.8375,21916793,GBR,,,87.115.178.12,VINCRISTINE treats HODGKIN'S DISEASE,56,128,,72,139,treats,1.0,908106-FS1-2,"Seventy six patients with previously untreated advanced HODGKIN'S DISEASE have been treated with the MOPP/ABV (mechlorethamine, VINCRISTINE procarbazine, prednisone/doxorubicin, bleomycin, vincristine) hybrid program.",HODGKIN'S DISEASE,VINCRISTINE,RO-may_treat
504170033,7/17/2014 13:11:32,,1325264648,7/17/2014 13:11:19,neodev,0.7137,21515166,NLD,11,Nootdorp,83.86.58.179,VINCRISTINE treats HODGKIN'S DISEASE,56,128,,72,139,treats,1.0,908106-FS1-2,"Seventy six patients with previously untreated advanced HODGKIN'S DISEASE have been treated with the MOPP/ABV (mechlorethamine, VINCRISTINE procarbazine, prednisone/doxorubicin, bleomycin, vincristine) hybrid program.",HODGKIN'S DISEASE,VINCRISTINE,RO-may_treat
504170033,7/17/2014 14:00:34,,1325311249,7/17/2014 14:00:17,clixsense,0.6744,6579377,CAN,BC,Richmond,174.6.142.227,VINCRISTINE treats HODGKIN'S DISEASE,56,128,,72,139,treats,1.0,908106-FS1-2,"Seventy six patients with previously untreated advanced HODGKIN'S DISEASE have been treated with the MOPP/ABV (mechlorethamine, VINCRISTINE procarbazine, prednisone/doxorubicin, bleomycin, vincristine) hybrid program.",HODGKIN'S DISEASE,VINCRISTINE,RO-may_treat
504170035,7/17/2014 10:26:44,,1325135258,7/17/2014 10:26:20,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,0,0,,7,20,is location of,0.7504787743864558,903841-FS1-9,MECONIUM PERITONITIS occasionally occurs as a localized collection of MECONIUM contained in a cyst made of fibrous granulation tissue.,MECONIUM,MECONIUM PERITONITIS,RO-has_causative_agent
504170035,7/17/2014 11:11:01,,1325169610,7/17/2014 11:10:49,instagc,0.6556,23149109,USA,NC,Durham,75.189.206.205,MECONIUM is location of MECONIUM PERITONITIS,0,0,,7,20,is location of,0.7504787743864558,903841-FS1-9,MECONIUM PERITONITIS occasionally occurs as a localized collection of MECONIUM contained in a cyst made of fibrous granulation tissue.,MECONIUM,MECONIUM PERITONITIS,RO-has_causative_agent
504170035,7/17/2014 11:21:24,,1325177945,7/17/2014 11:21:10,prodege,0.6181,15439740,AUS,02,Jannali,27.96.208.89,no_relation,0,0,,7,20,is location of,0.7504787743864558,903841-FS1-9,MECONIUM PERITONITIS occasionally occurs as a localized collection of MECONIUM contained in a cyst made of fibrous granulation tissue.,MECONIUM,MECONIUM PERITONITIS,RO-has_causative_agent
504170035,7/17/2014 11:54:32,,1325203216,7/17/2014 11:54:01,instagc,0.6653,13763729,USA,,,75.182.89.225,no_relation,0,0,,7,20,is location of,0.7504787743864558,903841-FS1-9,MECONIUM PERITONITIS occasionally occurs as a localized collection of MECONIUM contained in a cyst made of fibrous granulation tissue.,MECONIUM,MECONIUM PERITONITIS,RO-has_causative_agent
504170035,7/17/2014 12:15:50,,1325218832,7/17/2014 12:15:28,elite,0.6262,28503042,USA,NJ,Woodbridge,54.191.150.115,MECONIUM PERITONITIS is location of MECONIUM,0,0,,7,20,is location of,0.7504787743864558,903841-FS1-9,MECONIUM PERITONITIS occasionally occurs as a localized collection of MECONIUM contained in a cyst made of fibrous granulation tissue.,MECONIUM,MECONIUM PERITONITIS,RO-has_causative_agent
504170035,7/17/2014 12:54:11,,1325249955,7/17/2014 12:53:54,clixsense,0.7,16827630,GBR,A7,Birmingham,86.146.169.103,no_relation,0,0,,7,20,is location of,0.7504787743864558,903841-FS1-9,MECONIUM PERITONITIS occasionally occurs as a localized collection of MECONIUM contained in a cyst made of fibrous granulation tissue.,MECONIUM,MECONIUM PERITONITIS,RO-has_causative_agent
504170035,7/17/2014 14:04:07,,1325314733,7/17/2014 14:03:48,clixsense,0.5901,15189335,GBR,T5,Aberdeen,90.218.222.164,no_relation,0,0,,7,20,is location of,0.7504787743864558,903841-FS1-9,MECONIUM PERITONITIS occasionally occurs as a localized collection of MECONIUM contained in a cyst made of fibrous granulation tissue.,MECONIUM,MECONIUM PERITONITIS,RO-has_causative_agent
504170039,7/17/2014 10:34:57,,1325142165,7/17/2014 10:34:51,clixsense,0.8472,19162475,GBR,M3,Frome,82.33.126.30,ATOPIC DERMATITIS diagnosed by ATOPIC WINTER FEET,150,171,,166,189,diagnosed by,0.363803437554499,900231-FS1-13,When comparing 1% hydrocortisone in a stabilized 10% urea cream with 0.1% betamethasone 17 valerate cream in a double blind study on 49 patients with ATOPIC DERMATITIS or ATOPIC WINTER FEET betamethasone cream was found to be the most potent.,ATOPIC DERMATITIS,ATOPIC WINTER FEET,RO-cause_of
504170039,7/17/2014 11:11:50,,1325170395,7/17/2014 11:11:22,clixsense,0.8958,28324391,NLD,11,Hazerswoude-rijndijk,94.208.82.215,ATOPIC DERMATITIS diagnosed by ATOPIC WINTER FEET,150,171,,166,189,diagnosed by,0.363803437554499,900231-FS1-13,When comparing 1% hydrocortisone in a stabilized 10% urea cream with 0.1% betamethasone 17 valerate cream in a double blind study on 49 patients with ATOPIC DERMATITIS or ATOPIC WINTER FEET betamethasone cream was found to be the most potent.,ATOPIC DERMATITIS,ATOPIC WINTER FEET,RO-cause_of
504170039,7/17/2014 11:26:58,,1325181781,7/17/2014 11:26:17,fusioncash,0.5583,7012325,USA,CT,Stamford,24.185.182.15,no_relation,150,171,,166,189,diagnosed by,0.363803437554499,900231-FS1-13,When comparing 1% hydrocortisone in a stabilized 10% urea cream with 0.1% betamethasone 17 valerate cream in a double blind study on 49 patients with ATOPIC DERMATITIS or ATOPIC WINTER FEET betamethasone cream was found to be the most potent.,ATOPIC DERMATITIS,ATOPIC WINTER FEET,RO-cause_of
504170039,7/17/2014 11:54:51,,1325203398,7/17/2014 11:54:33,instagc,0.6653,13763729,USA,,,75.182.89.225,no_relation,150,171,,166,189,diagnosed by,0.363803437554499,900231-FS1-13,When comparing 1% hydrocortisone in a stabilized 10% urea cream with 0.1% betamethasone 17 valerate cream in a double blind study on 49 patients with ATOPIC DERMATITIS or ATOPIC WINTER FEET betamethasone cream was found to be the most potent.,ATOPIC DERMATITIS,ATOPIC WINTER FEET,RO-cause_of
504170039,7/17/2014 12:14:49,,1325218056,7/17/2014 12:14:14,elite,0.6262,28503042,USA,NJ,Woodbridge,54.191.150.115,no_relation,150,171,,166,189,diagnosed by,0.363803437554499,900231-FS1-13,When comparing 1% hydrocortisone in a stabilized 10% urea cream with 0.1% betamethasone 17 valerate cream in a double blind study on 49 patients with ATOPIC DERMATITIS or ATOPIC WINTER FEET betamethasone cream was found to be the most potent.,ATOPIC DERMATITIS,ATOPIC WINTER FEET,RO-cause_of
504170039,7/17/2014 13:24:12,,1325275543,7/17/2014 13:23:51,prodege,0.6909,24945126,GBR,F6,Romford,82.12.220.44,no_relation,150,171,,166,189,diagnosed by,0.363803437554499,900231-FS1-13,When comparing 1% hydrocortisone in a stabilized 10% urea cream with 0.1% betamethasone 17 valerate cream in a double blind study on 49 patients with ATOPIC DERMATITIS or ATOPIC WINTER FEET betamethasone cream was found to be the most potent.,ATOPIC DERMATITIS,ATOPIC WINTER FEET,RO-cause_of
504170039,7/17/2014 13:40:42,,1325292777,7/17/2014 13:40:22,prodege,0.5202,28039757,GBR,L8,Southport,109.155.158.54,no_relation,150,171,,166,189,diagnosed by,0.363803437554499,900231-FS1-13,When comparing 1% hydrocortisone in a stabilized 10% urea cream with 0.1% betamethasone 17 valerate cream in a double blind study on 49 patients with ATOPIC DERMATITIS or ATOPIC WINTER FEET betamethasone cream was found to be the most potent.,ATOPIC DERMATITIS,ATOPIC WINTER FEET,RO-cause_of
504170043,7/17/2014 10:27:22,,1325135633,7/17/2014 10:27:06,instagc,0.9583,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,106,84,,121,96,causes,0.6154574548966639,906704-FS1-4,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170043,7/17/2014 10:46:14,,1325150877,7/17/2014 10:45:39,prodege,0.8333,9525153,CAN,ON,Toronto,65.95.92.180,PHENTOLAMINE causes PHEOCHROMOCYTOMA,106,84,,121,96,causes,0.6154574548966639,906704-FS1-4,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170043,7/17/2014 11:18:35,,1325175900,7/17/2014 11:17:59,prodege,0.6597,27934334,GBR,,,86.130.153.15,no_relation,106,84,,121,96,causes,0.6154574548966639,906704-FS1-4,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170043,7/17/2014 11:27:16,,1325182005,7/17/2014 11:26:59,fusioncash,0.5583,7012325,USA,CT,Stamford,24.185.182.15,no_relation,106,84,,121,96,causes,0.6154574548966639,906704-FS1-4,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170043,7/17/2014 11:53:19,,1325202476,7/17/2014 11:52:59,instagc,0.6653,13763729,USA,,,75.182.89.225,no_relation,106,84,,121,96,causes,0.6154574548966639,906704-FS1-4,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170043,7/17/2014 13:39:26,,1325291615,7/17/2014 13:39:06,prodege,0.5202,28039757,GBR,L8,Southport,109.155.158.54,no_relation,106,84,,121,96,causes,0.6154574548966639,906704-FS1-4,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170043,7/17/2014 13:40:04,,1325292185,7/17/2014 13:39:26,clixsense,0.6825,6574199,USA,TX,San Antonio,207.230.144.242,PHENTOLAMINE causes PHEOCHROMOCYTOMA,106,84,,121,96,causes,0.6154574548966639,906704-FS1-4,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170045,7/17/2014 10:47:29,,1325151862,7/17/2014 10:47:15,prodege,0.8333,9525153,CAN,ON,Toronto,65.95.92.180,PHENTOLAMINE treats PHEOCHROMOCYTOMA,106,84,,121,96,treats,0.492365963917331,906704-FS1-2,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170045,7/17/2014 11:17:58,,1325175503,7/17/2014 11:17:16,prodege,0.6597,27934334,GBR,,,86.130.153.15,no_relation,106,84,,121,96,treats,0.492365963917331,906704-FS1-2,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170045,7/17/2014 13:10:49,,1325263927,7/17/2014 13:10:25,neodev,0.7137,21515166,NLD,11,Nootdorp,83.86.58.179,PHENTOLAMINE treats PHEOCHROMOCYTOMA,106,84,,121,96,treats,0.492365963917331,906704-FS1-2,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170045,7/17/2014 13:40:42,,1325292778,7/17/2014 13:40:22,prodege,0.5202,28039757,GBR,L8,Southport,109.155.158.54,no_relation,106,84,,121,96,treats,0.492365963917331,906704-FS1-2,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170045,7/17/2014 14:04:07,,1325314734,7/17/2014 14:03:48,clixsense,0.5901,15189335,GBR,T5,Aberdeen,90.218.222.164,PHENTOLAMINE treats PHEOCHROMOCYTOMA,106,84,,121,96,treats,0.492365963917331,906704-FS1-2,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170045,7/17/2014 14:06:47,,1325317040,7/17/2014 14:06:29,neodev,0.5669,18339121,USA,SC,Sumter,173.93.188.194,PHENTOLAMINE treats PHEOCHROMOCYTOMA,106,84,,121,96,treats,0.492365963917331,906704-FS1-2,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170045,7/17/2014 14:09:18,,1325319277,7/17/2014 14:08:53,clixsense,0.7183,27871219,NLD,07,Amsterdam,87.210.207.223,PHENTOLAMINE treats PHEOCHROMOCYTOMA,106,84,,121,96,treats,0.492365963917331,906704-FS1-2,"177 ,   a  Sudden and marked reduction in BP following parenteral administration of PHENTOLAMINE suggests PHEOCHROMOCYTOMA;  a   however, false negative and false positive responses are frequent.",PHEOCHROMOCYTOMA,PHENTOLAMINE,RO-may_diagnose
504170046,7/17/2014 10:34:50,,1325142029,7/17/2014 10:34:31,clixsense,0.8472,19162475,GBR,M3,Frome,82.33.126.30,FLAT ADENOMAS causes HIGH GRADE DYSPLASIA,90,49,,109,62,causes,0.97439119569462,901798-FS1-4,"Compared with polypoid adenomas of similar size, FLAT ADENOMAS show a higher frequency of HIGH GRADE DYSPLASIA and rapid submucosal invasion.",HIGH GRADE DYSPLASIA,FLAT ADENOMAS,RO-disease_has_finding
504170046,7/17/2014 11:23:15,,1325179294,7/17/2014 11:22:31,prodege,0.6181,15439740,AUS,02,Jannali,27.96.208.89,no_relation,90,49,,109,62,causes,0.97439119569462,901798-FS1-4,"Compared with polypoid adenomas of similar size, FLAT ADENOMAS show a higher frequency of HIGH GRADE DYSPLASIA and rapid submucosal invasion.",HIGH GRADE DYSPLASIA,FLAT ADENOMAS,RO-disease_has_finding
504170046,7/17/2014 11:56:53,,1325204663,7/17/2014 11:56:28,tremorgames,0.7111,24449707,CAN,QC,Laval,96.21.249.72,FLAT ADENOMAS causes HIGH GRADE DYSPLASIA,90,49,,109,62,causes,0.97439119569462,901798-FS1-4,"Compared with polypoid adenomas of similar size, FLAT ADENOMAS show a higher frequency of HIGH GRADE DYSPLASIA and rapid submucosal invasion.",HIGH GRADE DYSPLASIA,FLAT ADENOMAS,RO-disease_has_finding
504170046,7/17/2014 13:12:14,,1325265408,7/17/2014 13:11:33,neodev,0.7137,21515166,NLD,11,Nootdorp,83.86.58.179,FLAT ADENOMAS causes HIGH GRADE DYSPLASIA,90,49,,109,62,causes,0.97439119569462,901798-FS1-4,"Compared with polypoid adenomas of similar size, FLAT ADENOMAS show a higher frequency of HIGH GRADE DYSPLASIA and rapid submucosal invasion.",HIGH GRADE DYSPLASIA,FLAT ADENOMAS,RO-disease_has_finding
504170046,7/17/2014 13:37:34,,1325289824,7/17/2014 13:36:57,clixsense,0.6825,6574199,USA,TX,San Antonio,207.230.144.242,FLAT ADENOMAS causes HIGH GRADE DYSPLASIA,90,49,,109,62,causes,0.97439119569462,901798-FS1-4,"Compared with polypoid adenomas of similar size, FLAT ADENOMAS show a higher frequency of HIGH GRADE DYSPLASIA and rapid submucosal invasion.",HIGH GRADE DYSPLASIA,FLAT ADENOMAS,RO-disease_has_finding
504170046,7/17/2014 14:03:47,,1325314441,7/17/2014 14:03:36,clixsense,0.5901,15189335,GBR,T5,Aberdeen,90.218.222.164,HIGH GRADE DYSPLASIA causes FLAT ADENOMAS,90,49,,109,62,causes,0.97439119569462,901798-FS1-4,"Compared with polypoid adenomas of similar size, FLAT ADENOMAS show a higher frequency of HIGH GRADE DYSPLASIA and rapid submucosal invasion.",HIGH GRADE DYSPLASIA,FLAT ADENOMAS,RO-disease_has_finding
504170046,7/17/2014 14:07:07,,1325317340,7/17/2014 14:06:48,neodev,0.5669,18339121,USA,SC,Sumter,173.93.188.194,FLAT ADENOMAS causes HIGH GRADE DYSPLASIA,90,49,,109,62,causes,0.97439119569462,901798-FS1-4,"Compared with polypoid adenomas of similar size, FLAT ADENOMAS show a higher frequency of HIGH GRADE DYSPLASIA and rapid submucosal invasion.",HIGH GRADE DYSPLASIA,FLAT ADENOMAS,RO-disease_has_finding
497762768,7/3/2014 10:26:32,,1313874091,7/3/2014 10:26:26,instagc,0.0,27753923,GBR,,,92.40.75.232,PETIT MAL causes SEIZURE,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/3/2014 10:36:12,,1313880794,7/3/2014 10:35:53,clixsense,0.0,15189335,GBR,I9,Dereham,86.157.163.112,PETIT MAL causes SEIZURE,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/3/2014 10:46:05,,1313887232,7/3/2014 10:45:09,vivatic,0.0,25451531,GBR,,,83.67.28.193,PETIT MAL causes SEIZURE,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/3/2014 14:20:40,,1313997484,7/3/2014 14:20:15,instagc,0.0,21838928,GBR,U1,Alloa,86.155.175.33,no_relation,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/3/2014 15:08:30,,1314034200,7/3/2014 15:07:56,instagc,0.0,20183814,USA,,,166.182.80.97,PETIT MAL causes SEIZURE,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/3/2014 15:10:04,,1314035471,7/3/2014 15:09:27,clixsense,0.0,27871219,NLD,7,Amsterdam,87.210.207.223,no_relation,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/3/2014 15:23:07,,1314045877,7/3/2014 15:22:51,neodev,0.0,21405167,USA,MD,Pasadena,69.243.35.97,PETIT MAL causes SEIZURE,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/3/2014 15:53:51,,1314071446,7/3/2014 15:53:25,clixsense,0.0,21917173,CAN,,,24.71.41.51,no_relation,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/3/2014 16:00:48,,1314077402,7/3/2014 16:00:26,superrewards,0.0,22638731,USA,IL,Carterville,50.40.185.175,PETIT MAL causes SEIZURE,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/3/2014 16:40:20,,1314110673,7/3/2014 16:40:09,prodege,0.0,2143114,CAN,BC,Vancouver,24.84.160.12,PETIT MAL causes SEIZURE,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/3/2014 17:00:30,,1314125695,7/3/2014 17:00:10,clixsense,0.0,17950689,GBR,X5,Cardiff,89.168.38.216,SEIZURE causes PETIT MAL,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/3/2014 17:00:44,,1314125891,7/3/2014 17:00:32,neodev,0.0,18517457,GBR,,,86.29.55.201,PETIT MAL causes SEIZURE,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/3/2014 17:19:07,,1314141439,7/3/2014 17:18:09,bitcoinget,0.0,26217831,GBR,H9,London,82.35.240.150,no_relation,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/3/2014 17:50:35,,1314172992,7/3/2014 17:50:19,instagc,0.0,19636746,USA,NY,Canandaigua,192.182.211.200,no_relation,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/3/2014 19:26:50,,1314250246,7/3/2014 19:26:32,clixsense,0.0,6331514,CAN,ON,Sault Sainte Marie,65.95.60.150,PETIT MAL causes SEIZURE,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/3/2014 19:49:17,,1314268058,7/3/2014 19:49:12,prodege,0.0,18960400,GBR,A2,Edgware,31.54.207.221,PETIT MAL causes SEIZURE,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/3/2014 20:19:52,,1314297737,7/3/2014 20:19:27,eup_slw,0.0,20818028,GBR,A7,Birmingham,92.232.139.254,no_relation,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/3/2014 21:38:04,,1314366265,7/3/2014 21:37:42,bitcoinget,0.0,21490602,USA,NJ,Bound Brook,68.193.36.186,no_relation,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/3/2014 21:49:02,,1314376207,7/3/2014 21:48:36,instagc,0.0,26801585,USA,WA,Everett,76.28.248.228,SEIZURE causes PETIT MAL,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/3/2014 22:54:35,,1314416019,7/3/2014 22:54:19,clixsense,0.0,19803139,NLD,6,Veldhoven,212.61.84.196,no_relation,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/3/2014 23:39:03,,1314439235,7/3/2014 23:38:26,neodev,0.0,25804244,USA,IL,Chicago,216.104.36.236,SEIZURE causes PETIT MAL,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/4/2014 01:02:18,,1314483276,7/4/2014 01:02:12,clixsense,0.0,17121874,GBR,U9,Falkirk,80.192.66.214,SEIZURE causes PETIT MAL,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/4/2014 02:02:23,,1314520456,7/4/2014 02:02:02,instagc,0.0,19686223,CAN,BC,Surrey,184.65.16.6,no_relation,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/4/2014 02:36:34,,1314541443,7/4/2014 02:35:56,zoombucks,0.0,28232452,USA,NC,Cary,174.97.217.113,no_relation,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/4/2014 02:43:56,,1314545156,7/4/2014 02:43:37,rewardsspot,0.0,24482174,GBR,H9,London,46.23.68.180,SEIZURE causes PETIT MAL,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/4/2014 02:48:45,,1314547673,7/4/2014 02:48:25,rewardsspot,0.0,17763704,USA,IL,Chicago,67.212.175.123,SEIZURE causes PETIT MAL,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/4/2014 03:38:34,,1314570270,7/4/2014 03:38:01,clixsense,0.0,17722340,CAN,BC,Mission,50.98.185.25,SEIZURE causes PETIT MAL,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/4/2014 04:40:28,,1314597449,7/4/2014 04:39:57,instagc,0.0,13846187,USA,MO,Chesterfield,63.137.150.235,PETIT MAL causes SEIZURE,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/4/2014 04:47:54,,1314601130,7/4/2014 04:47:46,gptbanks,0.0,18496428,USA,CA,Newhall,199.244.112.121,PETIT MAL causes SEIZURE,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/4/2014 05:07:21,,1314609906,7/4/2014 05:06:56,clixsense,0.0,24429778,AUS,2,Sydney,125.255.54.86,PETIT MAL causes SEIZURE,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/4/2014 06:53:52,,1314657600,7/4/2014 06:53:22,clixsense,0.0,27969116,NLD,,,91.213.37.165,SEIZURE causes PETIT MAL,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/4/2014 07:14:03,,1314670372,7/4/2014 07:13:48,clixsense,0.0,19190439,GBR,H9,London,86.15.32.131,no_relation,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/4/2014 08:09:15,,1314696203,7/4/2014 08:08:53,clixsense,0.0,23138831,NLD,,,77.174.95.58,no_relation,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/4/2014 08:40:13,,1314710744,7/4/2014 08:39:43,prodege,0.0,15439740,AUS,2,Jannali,27.96.208.89,no_relation,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762768,7/4/2014 09:12:49,,1314726603,7/4/2014 09:12:03,eup_slw,0.0,21338859,GBR,K6,Portsmouth,86.6.113.168,PETIT MAL causes SEIZURE,25,79,,32,88,causes,0.316227766,904762-FS1-4,"Distribution by types of SEIZURE was awakening grand mal, absence or myoclonic PETIT MAL in 24%, grand mal with no aura in 21%, grand mal during sleep in 23%, diffuse grand mal in 7%, grand mal with aura in 13%, psychomotor seizure in 9%, and focal seizure in 3%",SEIZURE,PETIT MAL,RO-has_definitional_manifestation
497762771,7/3/2014 10:26:32,,1313874089,7/3/2014 10:26:26,instagc,0.0,27753923,GBR,,,92.40.75.232,PAIN causes POLYMYALGIA RHEUMATICA,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/3/2014 10:36:12,,1313880793,7/3/2014 10:35:53,clixsense,0.0,15189335,GBR,I9,Dereham,86.157.163.112,POLYMYALGIA RHEUMATICA causes PAIN,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/3/2014 10:52:19,,1313891503,7/3/2014 10:51:52,vivatic,0.0,25451531,GBR,,,83.67.28.193,no_relation,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/3/2014 14:18:18,,1313996113,7/3/2014 14:17:59,instagc,0.0,21838928,GBR,U1,Alloa,86.155.175.33,no_relation,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/3/2014 15:09:48,,1314035241,7/3/2014 15:09:30,instagc,0.0,20183814,USA,,,166.182.80.97,POLYMYALGIA RHEUMATICA causes PAIN,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/3/2014 15:11:43,,1314036771,7/3/2014 15:10:55,clixsense,0.0,27871219,NLD,7,Amsterdam,87.210.207.223,no_relation,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/3/2014 15:21:34,,1314044554,7/3/2014 15:21:11,neodev,0.0,21405167,USA,MD,Pasadena,69.243.35.97,POLYMYALGIA RHEUMATICA causes PAIN,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/3/2014 15:46:04,,1314064727,7/3/2014 15:45:52,clixsense,0.0,17950689,GBR,X5,Cardiff,89.168.38.216,POLYMYALGIA RHEUMATICA causes PAIN,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/3/2014 16:04:18,,1314080449,7/3/2014 16:03:48,superrewards,0.0,22638731,USA,IL,Carterville,50.40.185.175,POLYMYALGIA RHEUMATICA causes PAIN,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/3/2014 16:39:23,,1314109995,7/3/2014 16:39:10,prodege,0.0,2143114,CAN,BC,Vancouver,24.84.160.12,POLYMYALGIA RHEUMATICA causes PAIN,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/3/2014 16:59:33,,1314124967,7/3/2014 16:59:21,neodev,0.0,18517457,GBR,,,86.29.55.201,POLYMYALGIA RHEUMATICA causes PAIN,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/3/2014 17:52:56,,1314175541,7/3/2014 17:52:26,instagc,0.0,19636746,USA,NY,Canandaigua,192.182.211.200,POLYMYALGIA RHEUMATICA causes PAIN,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/3/2014 18:13:04,,1314193216,7/3/2014 18:12:31,zoombucks,0.0,27687111,USA,CA,Corona,99.44.120.153,POLYMYALGIA RHEUMATICA causes PAIN,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/3/2014 19:08:56,,1314235809,7/3/2014 19:08:51,prodege,0.0,18960400,GBR,A2,Edgware,31.54.207.221,POLYMYALGIA RHEUMATICA causes PAIN,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/3/2014 19:26:08,,1314249705,7/3/2014 19:25:50,clixsense,0.0,6331514,CAN,ON,Sault Sainte Marie,65.95.60.150,POLYMYALGIA RHEUMATICA causes PAIN,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/3/2014 20:22:46,,1314300691,7/3/2014 20:22:33,eup_slw,0.0,20818028,GBR,A7,Birmingham,92.232.139.254,POLYMYALGIA RHEUMATICA causes PAIN,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/3/2014 21:32:12,,1314360551,7/3/2014 21:31:30,bitcoinget,0.0,21490602,USA,NJ,Bound Brook,68.193.36.186,POLYMYALGIA RHEUMATICA causes PAIN,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/3/2014 21:48:35,,1314375973,7/3/2014 21:48:03,instagc,0.0,26801585,USA,WA,Everett,76.28.248.228,no_relation,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/3/2014 22:52:34,,1314414914,7/3/2014 22:52:15,clixsense,0.0,19803139,NLD,6,Veldhoven,212.61.84.196,POLYMYALGIA RHEUMATICA causes PAIN,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/3/2014 23:37:22,,1314438302,7/3/2014 23:36:11,neodev,0.0,25804244,USA,IL,Chicago,216.104.36.236,POLYMYALGIA RHEUMATICA causes PAIN,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/4/2014 00:40:09,,1314471718,7/4/2014 00:39:33,instagc,0.0,19686223,CAN,BC,Surrey,184.65.16.6,no_relation,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/4/2014 01:02:36,,1314483511,7/4/2014 01:02:31,clixsense,0.0,17121874,GBR,U9,Falkirk,80.192.66.214,PAIN causes POLYMYALGIA RHEUMATICA,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/4/2014 02:32:52,,1314539752,7/4/2014 02:32:30,zoombucks,0.0,28232452,USA,NC,Cary,174.97.217.113,POLYMYALGIA RHEUMATICA causes PAIN,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/4/2014 02:46:05,,1314546276,7/4/2014 02:45:36,rewardsspot,0.0,24482174,GBR,H9,London,46.23.68.180,PAIN causes POLYMYALGIA RHEUMATICA,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/4/2014 02:47:28,,1314547068,7/4/2014 02:47:01,rewardsspot,0.0,17763704,USA,IL,Chicago,67.212.175.123,PAIN causes POLYMYALGIA RHEUMATICA,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/4/2014 03:41:22,,1314571703,7/4/2014 03:40:55,clixsense,0.0,17722340,CAN,BC,Mission,50.98.185.25,POLYMYALGIA RHEUMATICA causes PAIN,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/4/2014 04:39:07,,1314596527,7/4/2014 04:38:50,instagc,0.0,13846187,USA,MO,Chesterfield,63.137.150.235,POLYMYALGIA RHEUMATICA causes PAIN,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/4/2014 04:40:59,,1314597807,7/4/2014 04:40:51,gptbanks,0.0,18496428,USA,CA,Newhall,199.244.112.121,PAIN causes POLYMYALGIA RHEUMATICA,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/4/2014 04:50:56,,1314602635,7/4/2014 04:50:47,clixsense,0.0,24429778,AUS,2,Sydney,125.255.54.86,POLYMYALGIA RHEUMATICA causes PAIN,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/4/2014 06:56:42,,1314659388,7/4/2014 06:56:04,clixsense,0.0,27969116,NLD,,,91.213.37.165,no_relation,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/4/2014 07:14:48,,1314670717,7/4/2014 07:14:36,clixsense,0.0,19190439,GBR,H9,London,86.15.32.131,no_relation,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/4/2014 08:08:52,,1314696045,7/4/2014 08:08:23,clixsense,0.0,23138831,NLD,,,77.174.95.58,POLYMYALGIA RHEUMATICA causes PAIN,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/4/2014 08:39:13,,1314710273,7/4/2014 08:38:48,prodege,0.0,15439740,AUS,2,Jannali,27.96.208.89,no_relation,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762771,7/4/2014 09:17:52,,1314729111,7/4/2014 09:16:52,eup_slw,0.0,21338859,GBR,K6,Portsmouth,86.6.113.168,no_relation,248,192,,252,214,causes,0.4886777774,904769-FS1-4,"The clinical features of GCA can be classified into: (1) the systemic manifestations of malaise, weight loss, fever, night sweats and depression; (2) the proximal muscle pain and stiffness of POLYMYALGIA RHEUMATICA; (3) arteritic manifestations of PAIN or tenderness due to local inflammation; and (4) arteritic manifestations of ischaemia due to narrowing or occlusion of vessels",PAIN,POLYMYALGIA RHEUMATICA,RO-has_definitional_manifestation
497762772,7/3/2014 10:26:38,,1313874207,7/3/2014 10:26:33,instagc,0.0,27753923,GBR,,,92.40.75.232,TEMPORAL LOBE EPILEPSY causes SEIZURE,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/3/2014 10:32:48,,1313878461,7/3/2014 10:32:15,clixsense,0.0,15189335,GBR,I9,Dereham,86.157.163.112,TEMPORAL LOBE EPILEPSY causes SEIZURE,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/3/2014 10:49:54,,1313889644,7/3/2014 10:49:10,vivatic,0.0,25451531,GBR,,,83.67.28.193,TEMPORAL LOBE EPILEPSY causes SEIZURE,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/3/2014 14:19:42,,1313996864,7/3/2014 14:19:19,instagc,0.0,21838928,GBR,U1,Alloa,86.155.175.33,TEMPORAL LOBE EPILEPSY causes SEIZURE,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/3/2014 15:05:39,,1314032089,7/3/2014 15:05:13,clixsense,0.0,27871219,NLD,7,Amsterdam,87.210.207.223,TEMPORAL LOBE EPILEPSY causes SEIZURE,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/3/2014 15:10:44,,1314036050,7/3/2014 15:10:28,instagc,0.0,20183814,USA,,,166.182.80.97,TEMPORAL LOBE EPILEPSY causes SEIZURE,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/3/2014 15:23:07,,1314045867,7/3/2014 15:22:51,neodev,0.0,21405167,USA,MD,Pasadena,69.243.35.97,TEMPORAL LOBE EPILEPSY causes SEIZURE,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/3/2014 16:00:02,,1314076697,7/3/2014 15:59:37,superrewards,0.0,22638731,USA,IL,Carterville,50.40.185.175,SEIZURE causes TEMPORAL LOBE EPILEPSY,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/3/2014 16:39:54,,1314110386,7/3/2014 16:39:44,prodege,0.0,2143114,CAN,BC,Vancouver,24.84.160.12,TEMPORAL LOBE EPILEPSY causes SEIZURE,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/3/2014 17:00:01,,1314125369,7/3/2014 16:59:44,clixsense,0.0,17950689,GBR,X5,Cardiff,89.168.38.216,TEMPORAL LOBE EPILEPSY causes SEIZURE,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/3/2014 17:01:03,,1314126143,7/3/2014 17:00:47,neodev,0.0,18517457,GBR,,,86.29.55.201,TEMPORAL LOBE EPILEPSY causes SEIZURE,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/3/2014 17:50:35,,1314172998,7/3/2014 17:50:19,instagc,0.0,19636746,USA,NY,Canandaigua,192.182.211.200,TEMPORAL LOBE EPILEPSY causes SEIZURE,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/3/2014 18:12:30,,1314192679,7/3/2014 18:12:10,zoombucks,0.0,27687111,USA,CA,Corona,99.44.120.153,TEMPORAL LOBE EPILEPSY causes SEIZURE,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/3/2014 19:08:44,,1314235587,7/3/2014 19:08:31,prodege,0.0,18960400,GBR,A2,Edgware,31.54.207.221,TEMPORAL LOBE EPILEPSY causes SEIZURE,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/3/2014 19:23:57,,1314248043,7/3/2014 19:23:37,clixsense,0.0,6331514,CAN,ON,Sault Sainte Marie,65.95.60.150,SEIZURE causes TEMPORAL LOBE EPILEPSY,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/3/2014 20:18:53,,1314296400,7/3/2014 20:18:11,eup_slw,0.0,20818028,GBR,A7,Birmingham,92.232.139.254,TEMPORAL LOBE EPILEPSY causes SEIZURE,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/3/2014 21:26:20,,1314356119,7/3/2014 21:25:33,clixsense,0.0,10428985,GBR,M3,South Petherton,86.186.150.111,TEMPORAL LOBE EPILEPSY causes SEIZURE,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/3/2014 21:33:43,,1314362286,7/3/2014 21:33:02,bitcoinget,0.0,21490602,USA,NJ,Bound Brook,68.193.36.186,TEMPORAL LOBE EPILEPSY causes SEIZURE,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/3/2014 21:47:16,,1314375149,7/3/2014 21:46:52,instagc,0.0,26801585,USA,WA,Everett,76.28.248.228,TEMPORAL LOBE EPILEPSY causes SEIZURE,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/3/2014 21:56:08,,1314380339,7/3/2014 21:55:19,neodev,0.0,28221768,USA,CA,Fremont,64.62.198.233,SEIZURE causes TEMPORAL LOBE EPILEPSY,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/3/2014 22:54:03,,1314415730,7/3/2014 22:53:48,clixsense,0.0,19803139,NLD,6,Veldhoven,212.61.84.196,TEMPORAL LOBE EPILEPSY causes SEIZURE,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/4/2014 01:02:29,,1314483398,7/4/2014 01:02:25,clixsense,0.0,17121874,GBR,U9,Falkirk,80.192.66.214,SEIZURE causes TEMPORAL LOBE EPILEPSY,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/4/2014 01:05:21,,1314484945,7/4/2014 01:04:16,clixsense,0.0,6340562,CAN,SK,Saskatoon,207.47.212.206,TEMPORAL LOBE EPILEPSY causes SEIZURE,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/4/2014 01:58:01,,1314517557,7/4/2014 01:57:40,instagc,0.0,19686223,CAN,BC,Surrey,184.65.16.6,SEIZURE causes TEMPORAL LOBE EPILEPSY,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/4/2014 02:35:10,,1314540823,7/4/2014 02:34:34,zoombucks,0.0,28232452,USA,NC,Cary,174.97.217.113,TEMPORAL LOBE EPILEPSY causes SEIZURE,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/4/2014 02:42:02,,1314544198,7/4/2014 02:41:36,rewardsspot,0.0,24482174,GBR,H9,London,46.23.68.180,SEIZURE causes TEMPORAL LOBE EPILEPSY,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/4/2014 02:44:06,,1314545240,7/4/2014 02:43:41,rewardsspot,0.0,17763704,USA,IL,Chicago,67.212.175.123,TEMPORAL LOBE EPILEPSY causes SEIZURE,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/4/2014 03:40:10,,1314571059,7/4/2014 03:39:47,clixsense,0.0,17722340,CAN,BC,Mission,50.98.185.25,TEMPORAL LOBE EPILEPSY causes SEIZURE,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/4/2014 04:47:38,,1314601004,7/4/2014 04:47:33,gptbanks,0.0,18496428,USA,CA,Newhall,199.244.112.121,SEIZURE causes TEMPORAL LOBE EPILEPSY,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/4/2014 04:52:14,,1314603259,7/4/2014 04:52:02,clixsense,0.0,24429778,AUS,2,Sydney,125.255.54.86,TEMPORAL LOBE EPILEPSY causes SEIZURE,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/4/2014 04:52:40,,1314603411,7/4/2014 04:52:13,instagc,0.0,13846187,USA,MO,Chesterfield,63.137.150.235,TEMPORAL LOBE EPILEPSY causes SEIZURE,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/4/2014 06:58:55,,1314660885,7/4/2014 06:58:16,clixsense,0.0,27969116,NLD,,,91.213.37.165,SEIZURE causes TEMPORAL LOBE EPILEPSY,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/4/2014 07:11:18,,1314669166,7/4/2014 07:11:04,clixsense,0.0,19190439,GBR,H9,London,86.15.32.131,TEMPORAL LOBE EPILEPSY causes SEIZURE,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/4/2014 08:11:59,,1314697415,7/4/2014 08:11:25,clixsense,0.0,23138831,NLD,,,77.174.95.58,TEMPORAL LOBE EPILEPSY causes SEIZURE,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762772,7/4/2014 08:39:41,,1314710546,7/4/2014 08:39:29,prodege,0.0,15439740,AUS,2,Jannali,27.96.208.89,no_relation,131,62,,138,84,causes,0.9649012814,904604-FS1-4,We apply this method to the study of a group of patients with TEMPORAL LOBE EPILEPSY recorded intracranially during transitions to SEIZURE,SEIZURE,TEMPORAL LOBE EPILEPSY,RO-has_definitional_manifestation
497762779,7/3/2014 10:26:08,,1313873946,7/3/2014 10:26:01,instagc,0.0,27753923,GBR,,,92.40.75.232,ZOSTER causes VARICELLA,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/3/2014 10:31:46,,1313877773,7/3/2014 10:31:20,clixsense,0.0,15189335,GBR,I9,Dereham,86.157.163.112,ZOSTER causes VARICELLA,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/3/2014 10:43:09,,1313885308,7/3/2014 10:42:08,vivatic,0.0,25451531,GBR,,,83.67.28.193,no_relation,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/3/2014 14:16:21,,1313995037,7/3/2014 14:15:58,instagc,0.0,21838928,GBR,U1,Alloa,86.155.175.33,no_relation,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/3/2014 15:06:55,,1314033108,7/3/2014 15:06:17,clixsense,0.0,27871219,NLD,7,Amsterdam,87.210.207.223,no_relation,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/3/2014 15:08:30,,1314034199,7/3/2014 15:07:56,instagc,0.0,20183814,USA,,,166.182.80.97,VARICELLA causes ZOSTER,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/3/2014 15:19:39,,1314042926,7/3/2014 15:19:18,neodev,0.0,21405167,USA,MD,Pasadena,69.243.35.97,no_relation,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/3/2014 15:46:18,,1314064999,7/3/2014 15:46:13,clixsense,0.0,17950689,GBR,X5,Cardiff,89.168.38.216,ZOSTER causes VARICELLA,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/3/2014 16:04:40,,1314080832,7/3/2014 16:04:20,superrewards,0.0,22638731,USA,IL,Carterville,50.40.185.175,ZOSTER causes VARICELLA,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/3/2014 16:42:22,,1314112124,7/3/2014 16:42:03,prodege,0.0,2143114,CAN,BC,Vancouver,24.84.160.12,ZOSTER causes VARICELLA,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/3/2014 17:01:55,,1314126933,7/3/2014 17:01:40,neodev,0.0,18517457,GBR,,,86.29.55.201,no_relation,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/3/2014 17:19:07,,1314141485,7/3/2014 17:18:09,bitcoinget,0.0,26217831,GBR,H9,London,82.35.240.150,no_relation,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/3/2014 17:52:56,,1314175540,7/3/2014 17:52:26,instagc,0.0,19636746,USA,NY,Canandaigua,192.182.211.200,no_relation,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/3/2014 18:16:43,,1314196095,7/3/2014 18:16:13,zoombucks,0.0,27687111,USA,CA,Corona,99.44.120.153,no_relation,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/3/2014 19:25:49,,1314249449,7/3/2014 19:25:33,clixsense,0.0,6331514,CAN,ON,Sault Sainte Marie,65.95.60.150,ZOSTER causes VARICELLA,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/3/2014 19:49:30,,1314268269,7/3/2014 19:49:26,prodege,0.0,18960400,GBR,A2,Edgware,31.54.207.221,ZOSTER causes VARICELLA,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/3/2014 20:24:27,,1314302402,7/3/2014 20:23:38,eup_slw,0.0,20818028,GBR,A7,Birmingham,92.232.139.254,no_relation,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/3/2014 21:21:15,,1314352627,7/3/2014 21:20:15,clixsense,0.0,10428985,GBR,M3,South Petherton,86.186.150.111,VARICELLA causes ZOSTER,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/3/2014 21:29:45,,1314358605,7/3/2014 21:28:53,bitcoinget,0.0,21490602,USA,NJ,Bound Brook,68.193.36.186,no_relation,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/3/2014 21:49:52,,1314376711,7/3/2014 21:49:32,instagc,0.0,26801585,USA,WA,Everett,76.28.248.228,no_relation,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/3/2014 21:56:08,,1314380341,7/3/2014 21:55:19,neodev,0.0,28221768,USA,CA,Fremont,64.62.198.233,VARICELLA causes ZOSTER,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/4/2014 01:02:11,,1314483216,7/4/2014 01:02:05,clixsense,0.0,17121874,GBR,U9,Falkirk,80.192.66.214,VARICELLA causes ZOSTER,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/4/2014 01:58:30,,1314517851,7/4/2014 01:58:02,instagc,0.0,19686223,CAN,BC,Surrey,184.65.16.6,no_relation,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/4/2014 02:34:33,,1314540573,7/4/2014 02:33:57,zoombucks,0.0,28232452,USA,NC,Cary,174.97.217.113,no_relation,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/4/2014 02:40:55,,1314543645,7/4/2014 02:40:30,rewardsspot,0.0,24482174,GBR,H9,London,46.23.68.180,ZOSTER causes VARICELLA,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/4/2014 02:44:06,,1314545241,7/4/2014 02:43:41,rewardsspot,0.0,17763704,USA,IL,Chicago,67.212.175.123,ZOSTER causes VARICELLA,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/4/2014 03:40:51,,1314571447,7/4/2014 03:40:12,clixsense,0.0,17722340,CAN,BC,Mission,50.98.185.25,no_relation,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/4/2014 04:40:03,,1314597254,7/4/2014 04:39:59,gptbanks,0.0,18496428,USA,CA,Newhall,199.244.112.121,VARICELLA causes ZOSTER,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/4/2014 04:51:11,,1314602745,7/4/2014 04:50:44,instagc,0.0,13846187,USA,MO,Chesterfield,63.137.150.235,no_relation,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/4/2014 06:55:30,,1314658596,7/4/2014 06:54:57,clixsense,0.0,27969116,NLD,,,91.213.37.165,no_relation,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/4/2014 07:11:41,,1314669338,7/4/2014 07:11:19,clixsense,0.0,19190439,GBR,H9,London,86.15.32.131,no_relation,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/4/2014 08:07:38,,1314695561,7/4/2014 08:07:17,clixsense,0.0,23138831,NLD,,,77.174.95.58,no_relation,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/4/2014 08:36:02,,1314708430,7/4/2014 08:35:43,prodege,0.0,15439740,AUS,2,Jannali,27.96.208.89,no_relation,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762779,7/4/2014 09:14:22,,1314727524,7/4/2014 09:13:31,eup_slw,0.0,21338859,GBR,K6,Portsmouth,86.6.113.168,no_relation,86,158,,95,164,causes,0.5388159061,903686-FS1-4,VZV-specific DNA was demonstrated in 15 lymphocyte preparations of nine patients with VARICELLA and in one with disseminated zoster out of five patients with ZOSTER,VARICELLA,ZOSTER,RO-has_causative_agent
497762782,7/3/2014 10:25:31,,1313873468,7/3/2014 10:25:05,instagc,0.0,27753923,GBR,,,92.40.75.232,PRURITUS causes ITCH,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/3/2014 10:31:18,,1313877465,7/3/2014 10:30:51,clixsense,0.0,15189335,GBR,I9,Dereham,86.157.163.112,PRURITUS causes ITCH,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/3/2014 10:49:09,,1313889117,7/3/2014 10:48:27,vivatic,0.0,25451531,GBR,,,83.67.28.193,PRURITUS causes ITCH,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/3/2014 14:16:21,,1313995041,7/3/2014 14:15:58,instagc,0.0,21838928,GBR,U1,Alloa,86.155.175.33,no_relation,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/3/2014 15:10:54,,1314036224,7/3/2014 15:10:05,clixsense,0.0,27871219,NLD,7,Amsterdam,87.210.207.223,PRURITUS causes ITCH,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/3/2014 15:11:34,,1314036691,7/3/2014 15:11:08,instagc,0.0,20183814,USA,,,166.182.80.97,PRURITUS causes ITCH,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/3/2014 15:23:39,,1314046320,7/3/2014 15:23:31,neodev,0.0,21405167,USA,MD,Pasadena,69.243.35.97,PRURITUS causes ITCH,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/3/2014 16:04:40,,1314080830,7/3/2014 16:04:20,superrewards,0.0,22638731,USA,IL,Carterville,50.40.185.175,PRURITUS causes ITCH,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/3/2014 16:41:45,,1314111647,7/3/2014 16:41:34,prodege,0.0,2143114,CAN,BC,Vancouver,24.84.160.12,PRURITUS causes ITCH,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/3/2014 16:59:23,,1314124809,7/3/2014 16:59:15,clixsense,0.0,17950689,GBR,X5,Cardiff,89.168.38.216,ITCH causes PRURITUS,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/3/2014 17:00:31,,1314125671,7/3/2014 17:00:20,neodev,0.0,18517457,GBR,,,86.29.55.201,PRURITUS causes ITCH,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/3/2014 17:49:53,,1314172197,7/3/2014 17:49:30,instagc,0.0,19636746,USA,NY,Canandaigua,192.182.211.200,PRURITUS causes ITCH,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/3/2014 18:11:35,,1314192034,7/3/2014 18:10:50,zoombucks,0.0,27687111,USA,CA,Corona,99.44.120.153,PRURITUS causes ITCH,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/3/2014 19:09:02,,1314235910,7/3/2014 19:08:57,prodege,0.0,18960400,GBR,A2,Edgware,31.54.207.221,PRURITUS causes ITCH,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/3/2014 19:26:31,,1314249954,7/3/2014 19:26:10,clixsense,0.0,6331514,CAN,ON,Sault Sainte Marie,65.95.60.150,PRURITUS causes ITCH,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/3/2014 20:18:53,,1314296399,7/3/2014 20:18:11,eup_slw,0.0,20818028,GBR,A7,Birmingham,92.232.139.254,no_relation,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/3/2014 21:25:32,,1314355522,7/3/2014 21:24:49,clixsense,0.0,10428985,GBR,M3,South Petherton,86.186.150.111,PRURITUS causes ITCH,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/3/2014 21:37:12,,1314365499,7/3/2014 21:36:49,bitcoinget,0.0,21490602,USA,NJ,Bound Brook,68.193.36.186,no_relation,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/3/2014 21:46:51,,1314374760,7/3/2014 21:46:31,instagc,0.0,26801585,USA,WA,Everett,76.28.248.228,PRURITUS causes ITCH,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/3/2014 22:54:17,,1314415841,7/3/2014 22:54:05,clixsense,0.0,19803139,NLD,6,Veldhoven,212.61.84.196,PRURITUS causes ITCH,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/3/2014 23:38:23,,1314438905,7/3/2014 23:37:25,neodev,0.0,25804244,USA,IL,Chicago,216.104.36.236,PRURITUS causes ITCH,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/4/2014 01:03:13,,1314483807,7/4/2014 01:02:57,clixsense,0.0,17121874,GBR,U9,Falkirk,80.192.66.214,PRURITUS causes ITCH,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/4/2014 01:06:52,,1314485712,7/4/2014 01:06:14,clixsense,0.0,6340562,CAN,SK,Saskatoon,207.47.212.206,no_relation,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/4/2014 02:02:52,,1314520777,7/4/2014 02:02:24,instagc,0.0,19686223,CAN,BC,Surrey,184.65.16.6,no_relation,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/4/2014 02:37:51,,1314542079,7/4/2014 02:37:26,zoombucks,0.0,28232452,USA,NC,Cary,174.97.217.113,PRURITUS causes ITCH,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/4/2014 02:39:10,,1314542727,7/4/2014 02:38:33,rewardsspot,0.0,24482174,GBR,H9,London,46.23.68.180,PRURITUS causes ITCH,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/4/2014 02:45:55,,1314546208,7/4/2014 02:45:39,rewardsspot,0.0,17763704,USA,IL,Chicago,67.212.175.123,PRURITUS causes ITCH,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/4/2014 03:44:07,,1314572884,7/4/2014 03:43:35,clixsense,0.0,17722340,CAN,BC,Mission,50.98.185.25,ITCH causes PRURITUS,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/4/2014 04:47:31,,1314600966,7/4/2014 04:47:27,gptbanks,0.0,18496428,USA,CA,Newhall,199.244.112.121,ITCH causes PRURITUS,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/4/2014 04:52:12,,1314603241,7/4/2014 04:51:57,instagc,0.0,13846187,USA,MO,Chesterfield,63.137.150.235,PRURITUS causes ITCH,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/4/2014 04:52:22,,1314603298,7/4/2014 04:52:17,clixsense,0.0,24429778,AUS,2,Sydney,125.255.54.86,PRURITUS causes ITCH,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/4/2014 06:56:03,,1314658968,7/4/2014 06:55:31,clixsense,0.0,27969116,NLD,,,91.213.37.165,PRURITUS causes ITCH,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/4/2014 07:12:29,,1314669663,7/4/2014 07:11:42,clixsense,0.0,19190439,GBR,H9,London,86.15.32.131,PRURITUS causes ITCH,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/4/2014 07:37:29,,1314681912,7/4/2014 07:36:16,prodege,0.0,12641652,GBR,H2,Oswaldtwistle,31.53.75.91,no_relation,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762782,7/4/2014 08:05:20,,1314694507,7/4/2014 08:04:50,clixsense,0.0,23138831,NLD,,,77.174.95.58,no_relation,77,161,,85,165,causes,0.9918365981,904699-FS1-4,"The aim of the study was to assess the therapeutic efficacy of loratadine on PRURITUS in patients with atopic dermatitis, considering the patients' sensation of ITCH",PRURITUS,ITCH,RO-has_definitional_manifestation
497762783,7/3/2014 10:27:01,,1313874444,7/3/2014 10:26:53,instagc,0.0,27753923,GBR,,,92.40.75.232,PRIMARY DYSMENORRHEA causes PAIN,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/3/2014 10:35:52,,1313880601,7/3/2014 10:35:16,clixsense,0.0,15189335,GBR,I9,Dereham,86.157.163.112,PRIMARY DYSMENORRHEA causes PAIN,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/3/2014 10:48:25,,1313888657,7/3/2014 10:47:55,vivatic,0.0,25451531,GBR,,,83.67.28.193,PRIMARY DYSMENORRHEA causes PAIN,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/3/2014 14:17:10,,1313995471,7/3/2014 14:16:39,instagc,0.0,21838928,GBR,U1,Alloa,86.155.175.33,no_relation,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/3/2014 15:08:59,,1314034569,7/3/2014 15:08:34,clixsense,0.0,27871219,NLD,7,Amsterdam,87.210.207.223,PRIMARY DYSMENORRHEA causes PAIN,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/3/2014 15:11:07,,1314036366,7/3/2014 15:10:45,instagc,0.0,20183814,USA,,,166.182.80.97,PRIMARY DYSMENORRHEA causes PAIN,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/3/2014 15:19:17,,1314042646,7/3/2014 15:18:59,neodev,0.0,21405167,USA,MD,Pasadena,69.243.35.97,PRIMARY DYSMENORRHEA causes PAIN,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/3/2014 15:46:28,,1314065155,7/3/2014 15:46:25,clixsense,0.0,17950689,GBR,X5,Cardiff,89.168.38.216,no_relation,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/3/2014 16:02:24,,1314078733,7/3/2014 16:02:01,superrewards,0.0,22638731,USA,IL,Carterville,50.40.185.175,PRIMARY DYSMENORRHEA causes PAIN,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/3/2014 16:41:15,,1314111308,7/3/2014 16:41:04,prodege,0.0,2143114,CAN,BC,Vancouver,24.84.160.12,PRIMARY DYSMENORRHEA causes PAIN,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/3/2014 16:58:28,,1314124153,7/3/2014 16:58:07,neodev,0.0,18517457,GBR,,,86.29.55.201,PRIMARY DYSMENORRHEA causes PAIN,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/3/2014 17:19:52,,1314142211,7/3/2014 17:19:09,bitcoinget,0.0,26217831,GBR,H9,London,82.35.240.150,PRIMARY DYSMENORRHEA causes PAIN,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/3/2014 17:50:19,,1314172602,7/3/2014 17:49:54,instagc,0.0,19636746,USA,NY,Canandaigua,192.182.211.200,PRIMARY DYSMENORRHEA causes PAIN,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/3/2014 18:12:08,,1314192456,7/3/2014 18:11:36,zoombucks,0.0,27687111,USA,CA,Corona,99.44.120.153,PRIMARY DYSMENORRHEA causes PAIN,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/3/2014 19:23:36,,1314247799,7/3/2014 19:23:18,clixsense,0.0,6331514,CAN,ON,Sault Sainte Marie,65.95.60.150,PRIMARY DYSMENORRHEA causes PAIN,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/3/2014 19:49:06,,1314267947,7/3/2014 19:49:02,prodege,0.0,18960400,GBR,A2,Edgware,31.54.207.221,PRIMARY DYSMENORRHEA causes PAIN,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/3/2014 20:21:40,,1314299580,7/3/2014 20:21:18,eup_slw,0.0,20818028,GBR,A7,Birmingham,92.232.139.254,PRIMARY DYSMENORRHEA causes PAIN,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/3/2014 21:29:13,,1314358137,7/3/2014 21:28:35,clixsense,0.0,10428985,GBR,M3,South Petherton,86.186.150.111,PRIMARY DYSMENORRHEA causes PAIN,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/3/2014 21:29:45,,1314358610,7/3/2014 21:28:53,bitcoinget,0.0,21490602,USA,NJ,Bound Brook,68.193.36.186,PRIMARY DYSMENORRHEA causes PAIN,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/3/2014 21:46:30,,1314374475,7/3/2014 21:46:03,instagc,0.0,26801585,USA,WA,Everett,76.28.248.228,PRIMARY DYSMENORRHEA causes PAIN,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/3/2014 22:52:51,,1314415062,7/3/2014 22:52:36,clixsense,0.0,19803139,NLD,6,Veldhoven,212.61.84.196,PRIMARY DYSMENORRHEA causes PAIN,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/4/2014 01:01:44,,1314482940,7/4/2014 01:01:40,clixsense,0.0,17121874,GBR,U9,Falkirk,80.192.66.214,PRIMARY DYSMENORRHEA causes PAIN,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/4/2014 02:02:01,,1314520199,7/4/2014 02:01:15,instagc,0.0,19686223,CAN,BC,Surrey,184.65.16.6,no_relation,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/4/2014 02:38:30,,1314542398,7/4/2014 02:37:53,zoombucks,0.0,28232452,USA,NC,Cary,174.97.217.113,PRIMARY DYSMENORRHEA causes PAIN,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/4/2014 02:46:05,,1314546289,7/4/2014 02:45:36,rewardsspot,0.0,24482174,GBR,H9,London,46.23.68.180,PAIN causes PRIMARY DYSMENORRHEA,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/4/2014 02:46:14,,1314546402,7/4/2014 02:45:57,rewardsspot,0.0,17763704,USA,IL,Chicago,67.212.175.123,PAIN causes PRIMARY DYSMENORRHEA,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/4/2014 03:40:51,,1314571448,7/4/2014 03:40:12,clixsense,0.0,17722340,CAN,BC,Mission,50.98.185.25,PAIN causes PRIMARY DYSMENORRHEA,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/4/2014 04:39:07,,1314596543,7/4/2014 04:38:50,instagc,0.0,13846187,USA,MO,Chesterfield,63.137.150.235,PRIMARY DYSMENORRHEA causes PAIN,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/4/2014 04:47:24,,1314600913,7/4/2014 04:47:19,gptbanks,0.0,18496428,USA,CA,Newhall,199.244.112.121,PAIN causes PRIMARY DYSMENORRHEA,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/4/2014 06:58:55,,1314660884,7/4/2014 06:58:16,clixsense,0.0,27969116,NLD,,,91.213.37.165,PRIMARY DYSMENORRHEA causes PAIN,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/4/2014 07:13:46,,1314670245,7/4/2014 07:13:23,clixsense,0.0,19190439,GBR,H9,London,86.15.32.131,PRIMARY DYSMENORRHEA causes PAIN,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/4/2014 08:06:23,,1314695017,7/4/2014 08:05:51,clixsense,0.0,23138831,NLD,,,77.174.95.58,PRIMARY DYSMENORRHEA causes PAIN,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/4/2014 08:39:27,,1314710400,7/4/2014 08:39:15,prodege,0.0,15439740,AUS,2,Jannali,27.96.208.89,no_relation,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762783,7/4/2014 09:16:51,,1314728517,7/4/2014 09:16:19,eup_slw,0.0,21338859,GBR,K6,Portsmouth,86.6.113.168,PRIMARY DYSMENORRHEA causes PAIN,172,201,,176,221,causes,0.9931270662999999,904931-FS1-4,"A double-blind crossover study was carried out to evaluate the therapeutic efficacy of nimesulide and its effects on uterine activity, menstrual fluid prostaglandin F, and PAIN in women suffering from PRIMARY DYSMENORRHEA",PAIN,PRIMARY DYSMENORRHEA,RO-has_definitional_manifestation
497762784,7/3/2014 10:27:14,,1313874605,7/3/2014 10:27:09,instagc,0.0,27753923,GBR,,,92.40.75.232,FEVER causes MULTICENTRIC CASTLEMAN'S DISEASE,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/3/2014 10:32:13,,1313878069,7/3/2014 10:31:48,clixsense,0.0,15189335,GBR,I9,Dereham,86.157.163.112,MULTICENTRIC CASTLEMAN'S DISEASE causes FEVER,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/3/2014 10:43:55,,1313885827,7/3/2014 10:43:09,vivatic,0.0,25451531,GBR,,,83.67.28.193,FEVER causes MULTICENTRIC CASTLEMAN'S DISEASE,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/3/2014 14:17:31,,1313995619,7/3/2014 14:17:12,instagc,0.0,21838928,GBR,U1,Alloa,86.155.175.33,no_relation,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/3/2014 15:07:08,,1314033278,7/3/2014 15:06:43,instagc,0.0,20183814,USA,,,166.182.80.97,MULTICENTRIC CASTLEMAN'S DISEASE causes FEVER,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/3/2014 15:11:43,,1314036775,7/3/2014 15:10:55,clixsense,0.0,27871219,NLD,7,Amsterdam,87.210.207.223,MULTICENTRIC CASTLEMAN'S DISEASE causes FEVER,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/3/2014 15:21:10,,1314044201,7/3/2014 15:20:55,neodev,0.0,21405167,USA,MD,Pasadena,69.243.35.97,MULTICENTRIC CASTLEMAN'S DISEASE causes FEVER,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/3/2014 16:01:59,,1314078348,7/3/2014 16:01:42,superrewards,0.0,22638731,USA,IL,Carterville,50.40.185.175,MULTICENTRIC CASTLEMAN'S DISEASE causes FEVER,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/3/2014 16:40:32,,1314110795,7/3/2014 16:40:22,prodege,0.0,2143114,CAN,BC,Vancouver,24.84.160.12,MULTICENTRIC CASTLEMAN'S DISEASE causes FEVER,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/3/2014 17:00:02,,1314125380,7/3/2014 16:59:51,neodev,0.0,18517457,GBR,,,86.29.55.201,MULTICENTRIC CASTLEMAN'S DISEASE causes FEVER,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/3/2014 17:00:09,,1314125454,7/3/2014 17:00:02,clixsense,0.0,17950689,GBR,X5,Cardiff,89.168.38.216,FEVER causes MULTICENTRIC CASTLEMAN'S DISEASE,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/3/2014 17:52:07,,1314174556,7/3/2014 17:51:52,instagc,0.0,19636746,USA,NY,Canandaigua,192.182.211.200,MULTICENTRIC CASTLEMAN'S DISEASE causes FEVER,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/3/2014 18:14:24,,1314194281,7/3/2014 18:13:56,zoombucks,0.0,27687111,USA,CA,Corona,99.44.120.153,MULTICENTRIC CASTLEMAN'S DISEASE causes FEVER,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/3/2014 19:08:50,,1314235695,7/3/2014 19:08:45,prodege,0.0,18960400,GBR,A2,Edgware,31.54.207.221,MULTICENTRIC CASTLEMAN'S DISEASE causes FEVER,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/3/2014 19:27:44,,1314250927,7/3/2014 19:27:32,clixsense,0.0,6331514,CAN,ON,Sault Sainte Marie,65.95.60.150,MULTICENTRIC CASTLEMAN'S DISEASE causes FEVER,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/3/2014 20:19:52,,1314297716,7/3/2014 20:19:27,eup_slw,0.0,20818028,GBR,A7,Birmingham,92.232.139.254,FEVER causes MULTICENTRIC CASTLEMAN'S DISEASE,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/3/2014 21:26:20,,1314356120,7/3/2014 21:25:33,clixsense,0.0,10428985,GBR,M3,South Petherton,86.186.150.111,FEVER causes MULTICENTRIC CASTLEMAN'S DISEASE,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/3/2014 21:37:12,,1314365500,7/3/2014 21:36:49,bitcoinget,0.0,21490602,USA,NJ,Bound Brook,68.193.36.186,MULTICENTRIC CASTLEMAN'S DISEASE causes FEVER,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/3/2014 21:47:30,,1314375309,7/3/2014 21:47:18,instagc,0.0,26801585,USA,WA,Everett,76.28.248.228,MULTICENTRIC CASTLEMAN'S DISEASE causes FEVER,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/3/2014 22:54:17,,1314415843,7/3/2014 22:54:05,clixsense,0.0,19803139,NLD,6,Veldhoven,212.61.84.196,MULTICENTRIC CASTLEMAN'S DISEASE causes FEVER,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/3/2014 23:39:41,,1314439548,7/3/2014 23:39:30,neodev,0.0,25804244,USA,IL,Chicago,216.104.36.236,MULTICENTRIC CASTLEMAN'S DISEASE causes FEVER,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/4/2014 01:02:11,,1314483220,7/4/2014 01:02:05,clixsense,0.0,17121874,GBR,U9,Falkirk,80.192.66.214,FEVER causes MULTICENTRIC CASTLEMAN'S DISEASE,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/4/2014 01:59:10,,1314518290,7/4/2014 01:58:31,instagc,0.0,19686223,CAN,BC,Surrey,184.65.16.6,FEVER causes MULTICENTRIC CASTLEMAN'S DISEASE,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/4/2014 02:36:55,,1314541612,7/4/2014 02:36:36,zoombucks,0.0,28232452,USA,NC,Cary,174.97.217.113,MULTICENTRIC CASTLEMAN'S DISEASE causes FEVER,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/4/2014 02:42:02,,1314544191,7/4/2014 02:41:36,rewardsspot,0.0,24482174,GBR,H9,London,46.23.68.180,FEVER causes MULTICENTRIC CASTLEMAN'S DISEASE,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/4/2014 02:46:37,,1314546586,7/4/2014 02:46:17,rewardsspot,0.0,17763704,USA,IL,Chicago,67.212.175.123,FEVER causes MULTICENTRIC CASTLEMAN'S DISEASE,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/4/2014 03:45:13,,1314573333,7/4/2014 03:44:37,clixsense,0.0,17722340,CAN,BC,Mission,50.98.185.25,MULTICENTRIC CASTLEMAN'S DISEASE causes FEVER,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/4/2014 04:39:55,,1314597188,7/4/2014 04:39:38,instagc,0.0,13846187,USA,MO,Chesterfield,63.137.150.235,MULTICENTRIC CASTLEMAN'S DISEASE causes FEVER,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/4/2014 04:47:38,,1314601013,7/4/2014 04:47:33,gptbanks,0.0,18496428,USA,CA,Newhall,199.244.112.121,FEVER causes MULTICENTRIC CASTLEMAN'S DISEASE,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/4/2014 05:08:38,,1314610516,7/4/2014 05:08:26,clixsense,0.0,24429778,AUS,2,Sydney,125.255.54.86,MULTICENTRIC CASTLEMAN'S DISEASE causes FEVER,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/4/2014 06:57:20,,1314659806,7/4/2014 06:56:43,clixsense,0.0,27969116,NLD,,,91.213.37.165,MULTICENTRIC CASTLEMAN'S DISEASE causes FEVER,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/4/2014 07:14:03,,1314670371,7/4/2014 07:13:48,clixsense,0.0,19190439,GBR,H9,London,86.15.32.131,MULTICENTRIC CASTLEMAN'S DISEASE causes FEVER,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/4/2014 07:38:15,,1314682240,7/4/2014 07:37:30,prodege,0.0,12641652,GBR,H2,Oswaldtwistle,31.53.75.91,MULTICENTRIC CASTLEMAN'S DISEASE causes FEVER,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/4/2014 08:07:16,,1314695415,7/4/2014 08:06:57,clixsense,0.0,23138831,NLD,,,77.174.95.58,no_relation,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762784,7/4/2014 08:36:19,,1314708542,7/4/2014 08:36:03,prodege,0.0,15439740,AUS,2,Jannali,27.96.208.89,no_relation,32,80,,37,112,causes,0.9799578870000001,901863-FS1-4,Generalized lymphadenopathy and FEVER appeared and the patient was diagnosed as MULTICENTRIC CASTLEMAN'S DISEASE (MCD) at 40 years of age,FEVER,MULTICENTRIC CASTLEMAN'S DISEASE,RO-disease_has_finding
497762788,7/3/2014 10:25:52,,1313873747,7/3/2014 10:25:32,instagc,0.0,27753923,GBR,,,92.40.75.232,THROMBOCYTOSIS causes ESSENTIAL THROMBOCYTHEMIA,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/3/2014 10:33:42,,1313879157,7/3/2014 10:33:14,clixsense,0.0,15189335,GBR,I9,Dereham,86.157.163.112,THROMBOCYTOSIS causes ESSENTIAL THROMBOCYTHEMIA,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/3/2014 10:45:08,,1313886587,7/3/2014 10:44:39,vivatic,0.0,25451531,GBR,,,83.67.28.193,THROMBOCYTOSIS causes ESSENTIAL THROMBOCYTHEMIA,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/3/2014 14:17:31,,1313995618,7/3/2014 14:17:12,instagc,0.0,21838928,GBR,U1,Alloa,86.155.175.33,no_relation,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/3/2014 15:06:15,,1314032538,7/3/2014 15:05:41,clixsense,0.0,27871219,NLD,7,Amsterdam,87.210.207.223,ESSENTIAL THROMBOCYTHEMIA causes THROMBOCYTOSIS,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/3/2014 15:07:08,,1314033277,7/3/2014 15:06:43,instagc,0.0,20183814,USA,,,166.182.80.97,ESSENTIAL THROMBOCYTHEMIA causes THROMBOCYTOSIS,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/3/2014 15:20:54,,1314043927,7/3/2014 15:20:33,neodev,0.0,21405167,USA,MD,Pasadena,69.243.35.97,ESSENTIAL THROMBOCYTHEMIA causes THROMBOCYTOSIS,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/3/2014 15:47:24,,1314065971,7/3/2014 15:46:30,clixsense,0.0,17950689,GBR,X5,Cardiff,89.168.38.216,ESSENTIAL THROMBOCYTHEMIA causes THROMBOCYTOSIS,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/3/2014 15:59:35,,1314076276,7/3/2014 15:59:12,superrewards,0.0,22638731,USA,IL,Carterville,50.40.185.175,THROMBOCYTOSIS causes ESSENTIAL THROMBOCYTHEMIA,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/3/2014 16:42:02,,1314111877,7/3/2014 16:41:47,prodege,0.0,2143114,CAN,BC,Vancouver,24.84.160.12,ESSENTIAL THROMBOCYTHEMIA causes THROMBOCYTOSIS,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/3/2014 16:58:06,,1314123869,7/3/2014 16:57:30,neodev,0.0,18517457,GBR,,,86.29.55.201,ESSENTIAL THROMBOCYTHEMIA causes THROMBOCYTOSIS,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/3/2014 17:21:57,,1314144169,7/3/2014 17:21:03,bitcoinget,0.0,26217831,GBR,H9,London,82.35.240.150,ESSENTIAL THROMBOCYTHEMIA causes THROMBOCYTOSIS,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/3/2014 17:48:18,,1314170602,7/3/2014 17:47:30,instagc,0.0,19636746,USA,NY,Canandaigua,192.182.211.200,no_relation,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/3/2014 18:11:35,,1314192032,7/3/2014 18:10:50,zoombucks,0.0,27687111,USA,CA,Corona,99.44.120.153,ESSENTIAL THROMBOCYTHEMIA causes THROMBOCYTOSIS,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/3/2014 19:23:17,,1314247539,7/3/2014 19:22:55,clixsense,0.0,6331514,CAN,ON,Sault Sainte Marie,65.95.60.150,ESSENTIAL THROMBOCYTHEMIA causes THROMBOCYTOSIS,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/3/2014 19:49:25,,1314268201,7/3/2014 19:49:19,prodege,0.0,18960400,GBR,A2,Edgware,31.54.207.221,THROMBOCYTOSIS causes ESSENTIAL THROMBOCYTHEMIA,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/3/2014 20:23:37,,1314301542,7/3/2014 20:23:16,eup_slw,0.0,20818028,GBR,A7,Birmingham,92.232.139.254,ESSENTIAL THROMBOCYTHEMIA causes THROMBOCYTOSIS,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/3/2014 21:28:32,,1314357671,7/3/2014 21:27:47,clixsense,0.0,10428985,GBR,M3,South Petherton,86.186.150.111,THROMBOCYTOSIS causes ESSENTIAL THROMBOCYTHEMIA,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/3/2014 21:32:12,,1314360562,7/3/2014 21:31:30,bitcoinget,0.0,21490602,USA,NJ,Bound Brook,68.193.36.186,ESSENTIAL THROMBOCYTHEMIA causes THROMBOCYTOSIS,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/3/2014 21:50:39,,1314377140,7/3/2014 21:50:29,instagc,0.0,26801585,USA,WA,Everett,76.28.248.228,ESSENTIAL THROMBOCYTHEMIA causes THROMBOCYTOSIS,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/3/2014 22:52:14,,1314414737,7/3/2014 22:51:56,clixsense,0.0,19803139,NLD,6,Veldhoven,212.61.84.196,ESSENTIAL THROMBOCYTHEMIA causes THROMBOCYTOSIS,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/4/2014 01:02:04,,1314483141,7/4/2014 01:01:59,clixsense,0.0,17121874,GBR,U9,Falkirk,80.192.66.214,THROMBOCYTOSIS causes ESSENTIAL THROMBOCYTHEMIA,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/4/2014 02:00:24,,1314519188,7/4/2014 02:00:04,instagc,0.0,19686223,CAN,BC,Surrey,184.65.16.6,THROMBOCYTOSIS causes ESSENTIAL THROMBOCYTHEMIA,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/4/2014 02:36:55,,1314541613,7/4/2014 02:36:36,zoombucks,0.0,28232452,USA,NC,Cary,174.97.217.113,ESSENTIAL THROMBOCYTHEMIA causes THROMBOCYTOSIS,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/4/2014 02:43:31,,1314544950,7/4/2014 02:43:10,rewardsspot,0.0,24482174,GBR,H9,London,46.23.68.180,no_relation,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/4/2014 02:48:23,,1314547442,7/4/2014 02:47:57,rewardsspot,0.0,17763704,USA,IL,Chicago,67.212.175.123,ESSENTIAL THROMBOCYTHEMIA causes THROMBOCYTOSIS,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/4/2014 03:42:04,,1314571986,7/4/2014 03:41:24,clixsense,0.0,17722340,CAN,BC,Mission,50.98.185.25,THROMBOCYTOSIS causes ESSENTIAL THROMBOCYTHEMIA,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/4/2014 04:40:45,,1314597660,7/4/2014 04:40:29,instagc,0.0,13846187,USA,MO,Chesterfield,63.137.150.235,ESSENTIAL THROMBOCYTHEMIA causes THROMBOCYTOSIS,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/4/2014 04:47:31,,1314600968,7/4/2014 04:47:27,gptbanks,0.0,18496428,USA,CA,Newhall,199.244.112.121,THROMBOCYTOSIS causes ESSENTIAL THROMBOCYTHEMIA,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/4/2014 05:10:25,,1314611348,7/4/2014 05:10:03,clixsense,0.0,24429778,AUS,2,Sydney,125.255.54.86,THROMBOCYTOSIS causes ESSENTIAL THROMBOCYTHEMIA,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/4/2014 06:58:14,,1314660458,7/4/2014 06:57:22,clixsense,0.0,27969116,NLD,,,91.213.37.165,no_relation,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/4/2014 07:11:41,,1314669337,7/4/2014 07:11:19,clixsense,0.0,19190439,GBR,H9,London,86.15.32.131,ESSENTIAL THROMBOCYTHEMIA causes THROMBOCYTOSIS,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/4/2014 07:39:52,,1314682940,7/4/2014 07:39:22,prodege,0.0,12641652,GBR,H2,Oswaldtwistle,31.53.75.91,ESSENTIAL THROMBOCYTHEMIA causes THROMBOCYTOSIS,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/4/2014 08:12:13,,1314697501,7/4/2014 08:11:59,clixsense,0.0,23138831,NLD,,,77.174.95.58,no_relation,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
497762788,7/4/2014 08:38:14,,1314709682,7/4/2014 08:37:51,prodege,0.0,15439740,AUS,2,Jannali,27.96.208.89,THROMBOCYTOSIS causes ESSENTIAL THROMBOCYTHEMIA,45,120,,59,145,causes,0.9819805061,901906-FS1-4,A dog with a myeloproliferative disorder and THROMBOCYTOSIS had clinical signs that were consistent with a diagnosis of ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTOSIS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_has_finding
502250144,7/11/2014 13:43:28,,1320737195,7/11/2014 13:43:04,clixsense,0.9583,17950689,GBR,X5,Cardiff,89.168.38.216,DIABETIC NEUROPATHY causes DIABETES MELLITUS,109,47,,128,64,causes,0.9091372900969901,900046-FS1-4,"Diabetic neuropathy is common in patients with DIABETES MELLITUS, and 7.5% of diabetics experience pain from DIABETIC NEUROPATHY",DIABETIC NEUROPATHY,DIABETES MELLITUS,RO-disease_may_have_finding
502250144,7/11/2014 13:45:05,,1320737741,7/11/2014 13:44:36,instagc,0.75,25901556,GBR,C3,Saint Ives,82.9.129.2,DIABETES MELLITUS causes DIABETIC NEUROPATHY,109,47,,128,64,causes,0.9091372900969901,900046-FS1-4,"Diabetic neuropathy is common in patients with DIABETES MELLITUS, and 7.5% of diabetics experience pain from DIABETIC NEUROPATHY",DIABETIC NEUROPATHY,DIABETES MELLITUS,RO-disease_may_have_finding
502250144,7/11/2014 13:49:45,,1320739553,7/11/2014 13:49:30,tremorgames,0.8194,24449707,CAN,QC,Laval,96.21.249.72,DIABETES MELLITUS causes DIABETIC NEUROPATHY,109,47,,128,64,causes,0.9091372900969901,900046-FS1-4,"Diabetic neuropathy is common in patients with DIABETES MELLITUS, and 7.5% of diabetics experience pain from DIABETIC NEUROPATHY",DIABETIC NEUROPATHY,DIABETES MELLITUS,RO-disease_may_have_finding
502250144,7/11/2014 14:19:29,,1320751050,7/11/2014 14:18:41,gifthulk,0.4155,20382530,CAN,ON,Hamilton,216.209.129.7,no_relation,109,47,,128,64,causes,0.9091372900969901,900046-FS1-4,"Diabetic neuropathy is common in patients with DIABETES MELLITUS, and 7.5% of diabetics experience pain from DIABETIC NEUROPATHY",DIABETIC NEUROPATHY,DIABETES MELLITUS,RO-disease_may_have_finding
502250144,7/11/2014 14:23:40,,1320752547,7/11/2014 14:23:12,zoombucks,0.5657,5919735,USA,PA,Doylestown,173.49.91.231,DIABETES MELLITUS causes DIABETIC NEUROPATHY,109,47,,128,64,causes,0.9091372900969901,900046-FS1-4,"Diabetic neuropathy is common in patients with DIABETES MELLITUS, and 7.5% of diabetics experience pain from DIABETIC NEUROPATHY",DIABETIC NEUROPATHY,DIABETES MELLITUS,RO-disease_may_have_finding
502250144,7/11/2014 14:31:36,,1320755499,7/11/2014 14:31:30,neodev,0.4786,25224036,CAN,ON,Sudbury,67.204.218.187,DIABETIC NEUROPATHY causes DIABETES MELLITUS,109,47,,128,64,causes,0.9091372900969901,900046-FS1-4,"Diabetic neuropathy is common in patients with DIABETES MELLITUS, and 7.5% of diabetics experience pain from DIABETIC NEUROPATHY",DIABETIC NEUROPATHY,DIABETES MELLITUS,RO-disease_may_have_finding
502250144,7/11/2014 14:36:11,,1320757477,7/11/2014 14:35:49,clixsense,0.6339,25595227,CAN,SK,North Battleford,24.72.96.119,DIABETES MELLITUS causes DIABETIC NEUROPATHY,109,47,,128,64,causes,0.9091372900969901,900046-FS1-4,"Diabetic neuropathy is common in patients with DIABETES MELLITUS, and 7.5% of diabetics experience pain from DIABETIC NEUROPATHY",DIABETIC NEUROPATHY,DIABETES MELLITUS,RO-disease_may_have_finding
502250146,7/11/2014 13:43:38,,1320737253,7/11/2014 13:43:29,clixsense,0.9583,17950689,GBR,X5,Cardiff,89.168.38.216,DKA causes DIABETES MELLITUS,72,27,,75,44,causes,0.936382183834624,900254-FS1-4,Rationale: ? Patients with DIABETES MELLITUS may present initially with DKA,DKA,DIABETES MELLITUS,RO-disease_may_have_finding
502250146,7/11/2014 13:44:35,,1320737589,7/11/2014 13:44:17,instagc,0.75,25901556,GBR,C3,Saint Ives,82.9.129.2,DIABETES MELLITUS causes DKA,72,27,,75,44,causes,0.936382183834624,900254-FS1-4,Rationale: ? Patients with DIABETES MELLITUS may present initially with DKA,DKA,DIABETES MELLITUS,RO-disease_may_have_finding
502250146,7/11/2014 13:48:51,,1320739244,7/11/2014 13:48:34,tremorgames,0.8194,24449707,CAN,QC,Laval,96.21.249.72,DIABETES MELLITUS causes DKA,72,27,,75,44,causes,0.936382183834624,900254-FS1-4,Rationale: ? Patients with DIABETES MELLITUS may present initially with DKA,DKA,DIABETES MELLITUS,RO-disease_may_have_finding
502250146,7/11/2014 13:51:18,,1320740015,7/11/2014 13:51:03,clixsense,0.5764,19162475,GBR,M3,Frome,82.33.126.30,DKA causes DIABETES MELLITUS,72,27,,75,44,causes,0.936382183834624,900254-FS1-4,Rationale: ? Patients with DIABETES MELLITUS may present initially with DKA,DKA,DIABETES MELLITUS,RO-disease_may_have_finding
502250146,7/11/2014 14:23:23,,1320752473,7/11/2014 14:22:38,prodege,0.5169,19192508,USA,OK,Broken Arrow,70.177.111.89,DIABETES MELLITUS causes DKA,72,27,,75,44,causes,0.936382183834624,900254-FS1-4,Rationale: ? Patients with DIABETES MELLITUS may present initially with DKA,DKA,DIABETES MELLITUS,RO-disease_may_have_finding
502250146,7/11/2014 14:25:09,,1320753044,7/11/2014 14:24:55,zoombucks,0.5657,5919735,USA,PA,Doylestown,173.49.91.231,DKA causes DIABETES MELLITUS,72,27,,75,44,causes,0.936382183834624,900254-FS1-4,Rationale: ? Patients with DIABETES MELLITUS may present initially with DKA,DKA,DIABETES MELLITUS,RO-disease_may_have_finding
502250146,7/11/2014 14:31:07,,1320755326,7/11/2014 14:30:50,clixsense,0.6764,15189335,GBR,I9,Norwich,86.155.45.231,DIABETES MELLITUS causes DKA,72,27,,75,44,causes,0.936382183834624,900254-FS1-4,Rationale: ? Patients with DIABETES MELLITUS may present initially with DKA,DKA,DIABETES MELLITUS,RO-disease_may_have_finding
502250156,7/11/2014 13:42:34,,1320736818,7/11/2014 13:42:24,clixsense,0.9583,17950689,GBR,X5,Cardiff,89.168.38.216,RESPIRATORY ALKALOSIS causes HYPERVENTILATION,67,44,,88,60,causes,0.30151134457776396,900419-FS1-4,Hyperactivity may quickly turn to lethargy; HYPERVENTILATION (with RESPIRATORY ALKALOSIS) changes to hypoventilation (with mixed respiratory and metabolic acidosis) and respiratory failure,RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-disease_may_have_finding
502250156,7/11/2014 13:45:42,,1320737977,7/11/2014 13:45:06,instagc,0.75,25901556,GBR,C3,Saint Ives,82.9.129.2,HYPERVENTILATION causes RESPIRATORY ALKALOSIS,67,44,,88,60,causes,0.30151134457776396,900419-FS1-4,Hyperactivity may quickly turn to lethargy; HYPERVENTILATION (with RESPIRATORY ALKALOSIS) changes to hypoventilation (with mixed respiratory and metabolic acidosis) and respiratory failure,RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-disease_may_have_finding
502250156,7/11/2014 14:20:21,,1320751338,7/11/2014 14:19:37,clixsense,0.4554,6574199,USA,TX,San Antonio,207.230.144.242,no_relation,67,44,,88,60,causes,0.30151134457776396,900419-FS1-4,Hyperactivity may quickly turn to lethargy; HYPERVENTILATION (with RESPIRATORY ALKALOSIS) changes to hypoventilation (with mixed respiratory and metabolic acidosis) and respiratory failure,RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-disease_may_have_finding
502250156,7/11/2014 14:24:54,,1320752974,7/11/2014 14:24:34,zoombucks,0.5657,5919735,USA,PA,Doylestown,173.49.91.231,HYPERVENTILATION causes RESPIRATORY ALKALOSIS,67,44,,88,60,causes,0.30151134457776396,900419-FS1-4,Hyperactivity may quickly turn to lethargy; HYPERVENTILATION (with RESPIRATORY ALKALOSIS) changes to hypoventilation (with mixed respiratory and metabolic acidosis) and respiratory failure,RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-disease_may_have_finding
502250156,7/11/2014 14:42:28,,1320759940,7/11/2014 14:42:05,prodege,0.6349,7664351,USA,NY,Cicero,74.111.0.21,HYPERVENTILATION causes RESPIRATORY ALKALOSIS,67,44,,88,60,causes,0.30151134457776396,900419-FS1-4,Hyperactivity may quickly turn to lethargy; HYPERVENTILATION (with RESPIRATORY ALKALOSIS) changes to hypoventilation (with mixed respiratory and metabolic acidosis) and respiratory failure,RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-disease_may_have_finding
502250156,7/11/2014 14:49:58,,1320762840,7/11/2014 14:49:37,gifthulk,0.5328,22144176,GBR,U8,Edinburgh,129.215.149.97,no_relation,67,44,,88,60,causes,0.30151134457776396,900419-FS1-4,Hyperactivity may quickly turn to lethargy; HYPERVENTILATION (with RESPIRATORY ALKALOSIS) changes to hypoventilation (with mixed respiratory and metabolic acidosis) and respiratory failure,RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-disease_may_have_finding
502250156,7/11/2014 14:53:14,,1320764144,7/11/2014 14:53:07,prodege,0.3571,18960400,GBR,A2,Edgware,31.54.207.221,HYPERVENTILATION causes RESPIRATORY ALKALOSIS,67,44,,88,60,causes,0.30151134457776396,900419-FS1-4,Hyperactivity may quickly turn to lethargy; HYPERVENTILATION (with RESPIRATORY ALKALOSIS) changes to hypoventilation (with mixed respiratory and metabolic acidosis) and respiratory failure,RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-disease_may_have_finding
502250157,7/11/2014 14:21:23,,1320751724,7/11/2014 14:20:44,gifthulk,0.4155,20382530,CAN,ON,Hamilton,216.209.129.7,FAMILIAL ADENOMATOUS POLYPOSIS causes DYSPLASIA,70,25,,79,55,causes,0.768221279597376,901680-FS1-4,"We report a patient with FAMILIAL ADENOMATOUS POLYPOSIS who developed DYSPLASIA in a large exophytic hyperplastic gastric tumor that appeared to arise on a background of diffuse fundic gland polyposis and presented with anemia, hypoalbuminemia, and a protein-losing enteropathy",DYSPLASIA,FAMILIAL ADENOMATOUS POLYPOSIS,RO-disease_may_have_finding
502250157,7/11/2014 14:35:17,,1320757058,7/11/2014 14:34:47,clixsense,0.6339,25595227,CAN,SK,North Battleford,24.72.96.119,FAMILIAL ADENOMATOUS POLYPOSIS causes DYSPLASIA,70,25,,79,55,causes,0.768221279597376,901680-FS1-4,"We report a patient with FAMILIAL ADENOMATOUS POLYPOSIS who developed DYSPLASIA in a large exophytic hyperplastic gastric tumor that appeared to arise on a background of diffuse fundic gland polyposis and presented with anemia, hypoalbuminemia, and a protein-losing enteropathy",DYSPLASIA,FAMILIAL ADENOMATOUS POLYPOSIS,RO-disease_may_have_finding
502250157,7/11/2014 14:42:04,,1320759794,7/11/2014 14:41:44,prodege,0.6349,7664351,USA,NY,Cicero,74.111.0.21,FAMILIAL ADENOMATOUS POLYPOSIS causes DYSPLASIA,70,25,,79,55,causes,0.768221279597376,901680-FS1-4,"We report a patient with FAMILIAL ADENOMATOUS POLYPOSIS who developed DYSPLASIA in a large exophytic hyperplastic gastric tumor that appeared to arise on a background of diffuse fundic gland polyposis and presented with anemia, hypoalbuminemia, and a protein-losing enteropathy",DYSPLASIA,FAMILIAL ADENOMATOUS POLYPOSIS,RO-disease_may_have_finding
502250157,7/11/2014 14:50:44,,1320763201,7/11/2014 14:50:22,gifthulk,0.5328,22144176,GBR,U8,Edinburgh,129.215.149.97,FAMILIAL ADENOMATOUS POLYPOSIS causes DYSPLASIA,70,25,,79,55,causes,0.768221279597376,901680-FS1-4,"We report a patient with FAMILIAL ADENOMATOUS POLYPOSIS who developed DYSPLASIA in a large exophytic hyperplastic gastric tumor that appeared to arise on a background of diffuse fundic gland polyposis and presented with anemia, hypoalbuminemia, and a protein-losing enteropathy",DYSPLASIA,FAMILIAL ADENOMATOUS POLYPOSIS,RO-disease_may_have_finding
502250157,7/11/2014 14:53:14,,1320764134,7/11/2014 14:53:07,prodege,0.3571,18960400,GBR,A2,Edgware,31.54.207.221,no_relation,70,25,,79,55,causes,0.768221279597376,901680-FS1-4,"We report a patient with FAMILIAL ADENOMATOUS POLYPOSIS who developed DYSPLASIA in a large exophytic hyperplastic gastric tumor that appeared to arise on a background of diffuse fundic gland polyposis and presented with anemia, hypoalbuminemia, and a protein-losing enteropathy",DYSPLASIA,FAMILIAL ADENOMATOUS POLYPOSIS,RO-disease_may_have_finding
502250157,7/11/2014 14:58:55,,1320766557,7/11/2014 14:58:34,prodege,0.5833,1852770,USA,TX,Abilene,76.198.102.54,FAMILIAL ADENOMATOUS POLYPOSIS causes DYSPLASIA,70,25,,79,55,causes,0.768221279597376,901680-FS1-4,"We report a patient with FAMILIAL ADENOMATOUS POLYPOSIS who developed DYSPLASIA in a large exophytic hyperplastic gastric tumor that appeared to arise on a background of diffuse fundic gland polyposis and presented with anemia, hypoalbuminemia, and a protein-losing enteropathy",DYSPLASIA,FAMILIAL ADENOMATOUS POLYPOSIS,RO-disease_may_have_finding
502250157,7/11/2014 15:20:03,,1320777034,7/11/2014 15:19:29,clixsense,0.8571,8100278,USA,FL,Orlando,98.70.77.97,FAMILIAL ADENOMATOUS POLYPOSIS causes DYSPLASIA,70,25,,79,55,causes,0.768221279597376,901680-FS1-4,"We report a patient with FAMILIAL ADENOMATOUS POLYPOSIS who developed DYSPLASIA in a large exophytic hyperplastic gastric tumor that appeared to arise on a background of diffuse fundic gland polyposis and presented with anemia, hypoalbuminemia, and a protein-losing enteropathy",DYSPLASIA,FAMILIAL ADENOMATOUS POLYPOSIS,RO-disease_may_have_finding
502250158,7/11/2014 13:49:28,,1320739450,7/11/2014 13:49:16,tremorgames,0.8194,24449707,CAN,QC,Laval,96.21.249.72,ESSENTIAL THROMBOCYTHEMIA causes HIGH PLATELET COUNTS,87,0,,107,25,causes,0.9539980920057242,901905-FS1-4,"ESSENTIAL THROMBOCYTHEMIA (ET) in an 11-year-old dog was characterized by persistently HIGH PLATELET COUNTS (range, 4.19 X 10(6)/microliters to 4.95 X 10(6)/microliters, abnormal platelet morphology, marked megakaryocytic hyperplasia in the bone marrow, absence of circulating megakaryoblasts, and history of splenomegaly and gastrointestinal bleeding",HIGH PLATELET COUNTS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_may_have_finding
502250158,7/11/2014 13:51:01,,1320739923,7/11/2014 13:50:53,clixsense,0.5764,19162475,GBR,M3,Frome,82.33.126.30,HIGH PLATELET COUNTS causes ESSENTIAL THROMBOCYTHEMIA,87,0,,107,25,causes,0.9539980920057242,901905-FS1-4,"ESSENTIAL THROMBOCYTHEMIA (ET) in an 11-year-old dog was characterized by persistently HIGH PLATELET COUNTS (range, 4.19 X 10(6)/microliters to 4.95 X 10(6)/microliters, abnormal platelet morphology, marked megakaryocytic hyperplasia in the bone marrow, absence of circulating megakaryoblasts, and history of splenomegaly and gastrointestinal bleeding",HIGH PLATELET COUNTS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_may_have_finding
502250158,7/11/2014 14:03:07,,1320744336,7/11/2014 14:02:31,vivatic,0.6889,25451531,GBR,,,83.67.28.193,ESSENTIAL THROMBOCYTHEMIA causes HIGH PLATELET COUNTS,87,0,,107,25,causes,0.9539980920057242,901905-FS1-4,"ESSENTIAL THROMBOCYTHEMIA (ET) in an 11-year-old dog was characterized by persistently HIGH PLATELET COUNTS (range, 4.19 X 10(6)/microliters to 4.95 X 10(6)/microliters, abnormal platelet morphology, marked megakaryocytic hyperplasia in the bone marrow, absence of circulating megakaryoblasts, and history of splenomegaly and gastrointestinal bleeding",HIGH PLATELET COUNTS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_may_have_finding
502250158,7/11/2014 14:21:23,,1320751721,7/11/2014 14:20:44,gifthulk,0.4155,20382530,CAN,ON,Hamilton,216.209.129.7,no_relation,87,0,,107,25,causes,0.9539980920057242,901905-FS1-4,"ESSENTIAL THROMBOCYTHEMIA (ET) in an 11-year-old dog was characterized by persistently HIGH PLATELET COUNTS (range, 4.19 X 10(6)/microliters to 4.95 X 10(6)/microliters, abnormal platelet morphology, marked megakaryocytic hyperplasia in the bone marrow, absence of circulating megakaryoblasts, and history of splenomegaly and gastrointestinal bleeding",HIGH PLATELET COUNTS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_may_have_finding
502250158,7/11/2014 14:25:29,,1320753198,7/11/2014 14:25:01,prodege,0.5169,19192508,USA,OK,Broken Arrow,70.177.111.89,ESSENTIAL THROMBOCYTHEMIA causes HIGH PLATELET COUNTS,87,0,,107,25,causes,0.9539980920057242,901905-FS1-4,"ESSENTIAL THROMBOCYTHEMIA (ET) in an 11-year-old dog was characterized by persistently HIGH PLATELET COUNTS (range, 4.19 X 10(6)/microliters to 4.95 X 10(6)/microliters, abnormal platelet morphology, marked megakaryocytic hyperplasia in the bone marrow, absence of circulating megakaryoblasts, and history of splenomegaly and gastrointestinal bleeding",HIGH PLATELET COUNTS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_may_have_finding
502250158,7/11/2014 14:31:58,,1320755636,7/11/2014 14:31:50,neodev,0.4786,25224036,CAN,ON,Sudbury,67.204.218.187,HIGH PLATELET COUNTS causes ESSENTIAL THROMBOCYTHEMIA,87,0,,107,25,causes,0.9539980920057242,901905-FS1-4,"ESSENTIAL THROMBOCYTHEMIA (ET) in an 11-year-old dog was characterized by persistently HIGH PLATELET COUNTS (range, 4.19 X 10(6)/microliters to 4.95 X 10(6)/microliters, abnormal platelet morphology, marked megakaryocytic hyperplasia in the bone marrow, absence of circulating megakaryoblasts, and history of splenomegaly and gastrointestinal bleeding",HIGH PLATELET COUNTS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_may_have_finding
502250158,7/11/2014 14:32:01,,1320755662,7/11/2014 14:31:43,clixsense,0.6764,15189335,GBR,I9,Norwich,86.155.45.231,ESSENTIAL THROMBOCYTHEMIA causes HIGH PLATELET COUNTS,87,0,,107,25,causes,0.9539980920057242,901905-FS1-4,"ESSENTIAL THROMBOCYTHEMIA (ET) in an 11-year-old dog was characterized by persistently HIGH PLATELET COUNTS (range, 4.19 X 10(6)/microliters to 4.95 X 10(6)/microliters, abnormal platelet morphology, marked megakaryocytic hyperplasia in the bone marrow, absence of circulating megakaryoblasts, and history of splenomegaly and gastrointestinal bleeding",HIGH PLATELET COUNTS,ESSENTIAL THROMBOCYTHEMIA,RO-disease_may_have_finding
502250159,7/11/2014 13:42:47,,1320736909,7/11/2014 13:42:35,clixsense,0.9583,17950689,GBR,X5,Cardiff,89.168.38.216,INFECTIOUS MONONUCLEOSIS causes LYMPHADENOPATHY,94,17,,109,41,causes,0.953462589245592,901833-FS1-4,"The elderly with INFECTIOUS MONONUCLEOSIS had significantly fewer occurrences of pharyngitis, LYMPHADENOPATHY, and splenomegaly when compared with young adults",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
502250159,7/11/2014 13:43:28,,1320737194,7/11/2014 13:43:07,instagc,0.75,25901556,GBR,C3,Saint Ives,82.9.129.2,no_relation,94,17,,109,41,causes,0.953462589245592,901833-FS1-4,"The elderly with INFECTIOUS MONONUCLEOSIS had significantly fewer occurrences of pharyngitis, LYMPHADENOPATHY, and splenomegaly when compared with young adults",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
502250159,7/11/2014 13:49:15,,1320739382,7/11/2014 13:48:52,tremorgames,0.8194,24449707,CAN,QC,Laval,96.21.249.72,INFECTIOUS MONONUCLEOSIS causes LYMPHADENOPATHY,94,17,,109,41,causes,0.953462589245592,901833-FS1-4,"The elderly with INFECTIOUS MONONUCLEOSIS had significantly fewer occurrences of pharyngitis, LYMPHADENOPATHY, and splenomegaly when compared with young adults",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
502250159,7/11/2014 13:51:18,,1320740016,7/11/2014 13:51:03,clixsense,0.5764,19162475,GBR,M3,Frome,82.33.126.30,LYMPHADENOPATHY causes INFECTIOUS MONONUCLEOSIS,94,17,,109,41,causes,0.953462589245592,901833-FS1-4,"The elderly with INFECTIOUS MONONUCLEOSIS had significantly fewer occurrences of pharyngitis, LYMPHADENOPATHY, and splenomegaly when compared with young adults",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
502250159,7/11/2014 14:24:33,,1320752870,7/11/2014 14:24:17,zoombucks,0.5657,5919735,USA,PA,Doylestown,173.49.91.231,INFECTIOUS MONONUCLEOSIS causes LYMPHADENOPATHY,94,17,,109,41,causes,0.953462589245592,901833-FS1-4,"The elderly with INFECTIOUS MONONUCLEOSIS had significantly fewer occurrences of pharyngitis, LYMPHADENOPATHY, and splenomegaly when compared with young adults",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
502250159,7/11/2014 14:30:49,,1320755206,7/11/2014 14:30:09,clixsense,0.6764,15189335,GBR,I9,Norwich,86.155.45.231,INFECTIOUS MONONUCLEOSIS causes LYMPHADENOPATHY,94,17,,109,41,causes,0.953462589245592,901833-FS1-4,"The elderly with INFECTIOUS MONONUCLEOSIS had significantly fewer occurrences of pharyngitis, LYMPHADENOPATHY, and splenomegaly when compared with young adults",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
502250159,7/11/2014 14:32:04,,1320755679,7/11/2014 14:31:58,neodev,0.4786,25224036,CAN,ON,Sudbury,67.204.218.187,LYMPHADENOPATHY causes INFECTIOUS MONONUCLEOSIS,94,17,,109,41,causes,0.953462589245592,901833-FS1-4,"The elderly with INFECTIOUS MONONUCLEOSIS had significantly fewer occurrences of pharyngitis, LYMPHADENOPATHY, and splenomegaly when compared with young adults",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,RO-disease_may_have_finding
502250165,7/11/2014 13:43:55,,1320737335,7/11/2014 13:43:29,instagc,0.75,25901556,GBR,C3,Saint Ives,82.9.129.2,WEIGHT LOSS causes PANCREATIC ADENOCARCINOMA,63,164,,74,189,causes,0.975900072948533,902684-FS1-4,"Because duodenal and/or pancreatic cancer was suspected due to WEIGHT LOSS, the pancreatic and bile duct obstruction, and the increased risk of small intestine and PANCREATIC ADENOCARCINOMA in patients with PSJ, a pancreatoduodenectomy was performed",WEIGHT LOSS,PANCREATIC ADENOCARCINOMA,RO-disease_may_have_finding
502250165,7/11/2014 14:25:00,,1320752996,7/11/2014 14:24:20,prodege,0.5169,19192508,USA,OK,Broken Arrow,70.177.111.89,PANCREATIC ADENOCARCINOMA causes WEIGHT LOSS,63,164,,74,189,causes,0.975900072948533,902684-FS1-4,"Because duodenal and/or pancreatic cancer was suspected due to WEIGHT LOSS, the pancreatic and bile duct obstruction, and the increased risk of small intestine and PANCREATIC ADENOCARCINOMA in patients with PSJ, a pancreatoduodenectomy was performed",WEIGHT LOSS,PANCREATIC ADENOCARCINOMA,RO-disease_may_have_finding
502250165,7/11/2014 14:31:49,,1320755558,7/11/2014 14:31:44,neodev,0.4786,25224036,CAN,ON,Sudbury,67.204.218.187,PANCREATIC ADENOCARCINOMA causes WEIGHT LOSS,63,164,,74,189,causes,0.975900072948533,902684-FS1-4,"Because duodenal and/or pancreatic cancer was suspected due to WEIGHT LOSS, the pancreatic and bile duct obstruction, and the increased risk of small intestine and PANCREATIC ADENOCARCINOMA in patients with PSJ, a pancreatoduodenectomy was performed",WEIGHT LOSS,PANCREATIC ADENOCARCINOMA,RO-disease_may_have_finding
502250165,7/11/2014 14:36:51,,1320757769,7/11/2014 14:36:12,clixsense,0.6339,25595227,CAN,SK,North Battleford,24.72.96.119,no_relation,63,164,,74,189,causes,0.975900072948533,902684-FS1-4,"Because duodenal and/or pancreatic cancer was suspected due to WEIGHT LOSS, the pancreatic and bile duct obstruction, and the increased risk of small intestine and PANCREATIC ADENOCARCINOMA in patients with PSJ, a pancreatoduodenectomy was performed",WEIGHT LOSS,PANCREATIC ADENOCARCINOMA,RO-disease_may_have_finding
502250165,7/11/2014 14:41:20,,1320759512,7/11/2014 14:40:45,prodege,0.6349,7664351,USA,NY,Cicero,74.111.0.21,no_relation,63,164,,74,189,causes,0.975900072948533,902684-FS1-4,"Because duodenal and/or pancreatic cancer was suspected due to WEIGHT LOSS, the pancreatic and bile duct obstruction, and the increased risk of small intestine and PANCREATIC ADENOCARCINOMA in patients with PSJ, a pancreatoduodenectomy was performed",WEIGHT LOSS,PANCREATIC ADENOCARCINOMA,RO-disease_may_have_finding
502250165,7/11/2014 14:50:21,,1320762984,7/11/2014 14:49:59,gifthulk,0.5328,22144176,GBR,U8,Edinburgh,129.215.149.97,no_relation,63,164,,74,189,causes,0.975900072948533,902684-FS1-4,"Because duodenal and/or pancreatic cancer was suspected due to WEIGHT LOSS, the pancreatic and bile duct obstruction, and the increased risk of small intestine and PANCREATIC ADENOCARCINOMA in patients with PSJ, a pancreatoduodenectomy was performed",WEIGHT LOSS,PANCREATIC ADENOCARCINOMA,RO-disease_may_have_finding
502250165,7/11/2014 14:53:06,,1320764109,7/11/2014 14:53:00,prodege,0.3571,18960400,GBR,A2,Edgware,31.54.207.221,PANCREATIC ADENOCARCINOMA causes WEIGHT LOSS,63,164,,74,189,causes,0.975900072948533,902684-FS1-4,"Because duodenal and/or pancreatic cancer was suspected due to WEIGHT LOSS, the pancreatic and bile duct obstruction, and the increased risk of small intestine and PANCREATIC ADENOCARCINOMA in patients with PSJ, a pancreatoduodenectomy was performed",WEIGHT LOSS,PANCREATIC ADENOCARCINOMA,RO-disease_may_have_finding
502254076,7/11/2014 16:09:00,,1320797856,7/11/2014 16:08:44,instagc,0.8333,13763729,USA,,,75.182.89.225,no_relation,3,34,,26,41,causes,0.358568582800318,901791-FS1-4,"In COMPLICATED PREGNANCIES (e.g., TOXEMIA, diabetes mellitus) the L/S ratio may result in erroneous clinical interpretation and premature intervention",COMPLICATED PREGNANCIES,TOXEMIA,RO-has_manifestation
502254076,7/11/2014 16:18:15,,1320800851,7/11/2014 16:17:19,clixsense,0.7097,27871219,NLD,7,Amsterdam,87.210.207.223,TOXEMIA causes COMPLICATED PREGNANCIES,3,34,,26,41,causes,0.358568582800318,901791-FS1-4,"In COMPLICATED PREGNANCIES (e.g., TOXEMIA, diabetes mellitus) the L/S ratio may result in erroneous clinical interpretation and premature intervention",COMPLICATED PREGNANCIES,TOXEMIA,RO-has_manifestation
502254076,7/11/2014 16:32:46,,1320804995,7/11/2014 16:32:31,zoombucks,0.6433,5919735,USA,PA,Doylestown,173.49.91.231,no_relation,3,34,,26,41,causes,0.358568582800318,901791-FS1-4,"In COMPLICATED PREGNANCIES (e.g., TOXEMIA, diabetes mellitus) the L/S ratio may result in erroneous clinical interpretation and premature intervention",COMPLICATED PREGNANCIES,TOXEMIA,RO-has_manifestation
502254076,7/11/2014 16:33:03,,1320805058,7/11/2014 16:32:50,clixsense,0.5175,27793793,GBR,C5,Chester,151.230.27.155,TOXEMIA causes COMPLICATED PREGNANCIES,3,34,,26,41,causes,0.358568582800318,901791-FS1-4,"In COMPLICATED PREGNANCIES (e.g., TOXEMIA, diabetes mellitus) the L/S ratio may result in erroneous clinical interpretation and premature intervention",COMPLICATED PREGNANCIES,TOXEMIA,RO-has_manifestation
502254076,7/11/2014 16:33:14,,1320805112,7/11/2014 16:32:51,clixsense,0.6942,6355977,NLD,7,Amsterdam,46.129.42.165,no_relation,3,34,,26,41,causes,0.358568582800318,901791-FS1-4,"In COMPLICATED PREGNANCIES (e.g., TOXEMIA, diabetes mellitus) the L/S ratio may result in erroneous clinical interpretation and premature intervention",COMPLICATED PREGNANCIES,TOXEMIA,RO-has_manifestation
502254076,7/11/2014 16:36:29,,1320806472,7/11/2014 16:36:13,prodege,0.373,2143114,CAN,BC,Vancouver,24.84.160.12,TOXEMIA causes COMPLICATED PREGNANCIES,3,34,,26,41,causes,0.358568582800318,901791-FS1-4,"In COMPLICATED PREGNANCIES (e.g., TOXEMIA, diabetes mellitus) the L/S ratio may result in erroneous clinical interpretation and premature intervention",COMPLICATED PREGNANCIES,TOXEMIA,RO-has_manifestation
502254076,7/11/2014 16:37:38,,1320806786,7/11/2014 16:37:17,instagc,0.7067,28301350,GBR,K4,Plymouth,78.145.138.230,TOXEMIA causes COMPLICATED PREGNANCIES,3,34,,26,41,causes,0.358568582800318,901791-FS1-4,"In COMPLICATED PREGNANCIES (e.g., TOXEMIA, diabetes mellitus) the L/S ratio may result in erroneous clinical interpretation and premature intervention",COMPLICATED PREGNANCIES,TOXEMIA,RO-has_manifestation
502254077,7/11/2014 16:09:44,,1320798224,7/11/2014 16:09:21,instagc,0.8333,13763729,USA,,,75.182.89.225,no_relation,104,27,,128,52,causes,0.9258200997725509,900113-FS1-4,A patient presented with a HYPERSENSITIVITY REACTION to the aromatic anticonvulsants which evolved into STEVENS-JOHNSON SYNDROME and was complicated by the presence of adult respiratory distress syndrome,STEVENS-JOHNSON SYNDROME,HYPERSENSITIVITY REACTION,RO-has_manifestation
502254077,7/11/2014 16:14:21,,1320799607,7/11/2014 16:13:43,prodege,0.7222,9559045,USA,TX,Katy,107.204.186.172,HYPERSENSITIVITY REACTION causes STEVENS-JOHNSON SYNDROME,104,27,,128,52,causes,0.9258200997725509,900113-FS1-4,A patient presented with a HYPERSENSITIVITY REACTION to the aromatic anticonvulsants which evolved into STEVENS-JOHNSON SYNDROME and was complicated by the presence of adult respiratory distress syndrome,STEVENS-JOHNSON SYNDROME,HYPERSENSITIVITY REACTION,RO-has_manifestation
502254077,7/11/2014 16:16:55,,1320800204,7/11/2014 16:16:27,clixsense,0.6375,25419319,GBR,H8,Liverpool,94.4.192.228,STEVENS-JOHNSON SYNDROME causes HYPERSENSITIVITY REACTION,104,27,,128,52,causes,0.9258200997725509,900113-FS1-4,A patient presented with a HYPERSENSITIVITY REACTION to the aromatic anticonvulsants which evolved into STEVENS-JOHNSON SYNDROME and was complicated by the presence of adult respiratory distress syndrome,STEVENS-JOHNSON SYNDROME,HYPERSENSITIVITY REACTION,RO-has_manifestation
502254077,7/11/2014 16:32:31,,1320804910,7/11/2014 16:31:33,clixsense,0.6942,6355977,NLD,7,Amsterdam,46.129.42.165,HYPERSENSITIVITY REACTION causes STEVENS-JOHNSON SYNDROME,104,27,,128,52,causes,0.9258200997725509,900113-FS1-4,A patient presented with a HYPERSENSITIVITY REACTION to the aromatic anticonvulsants which evolved into STEVENS-JOHNSON SYNDROME and was complicated by the presence of adult respiratory distress syndrome,STEVENS-JOHNSON SYNDROME,HYPERSENSITIVITY REACTION,RO-has_manifestation
502254077,7/11/2014 16:32:46,,1320804994,7/11/2014 16:32:31,zoombucks,0.6433,5919735,USA,PA,Doylestown,173.49.91.231,HYPERSENSITIVITY REACTION causes STEVENS-JOHNSON SYNDROME,104,27,,128,52,causes,0.9258200997725509,900113-FS1-4,A patient presented with a HYPERSENSITIVITY REACTION to the aromatic anticonvulsants which evolved into STEVENS-JOHNSON SYNDROME and was complicated by the presence of adult respiratory distress syndrome,STEVENS-JOHNSON SYNDROME,HYPERSENSITIVITY REACTION,RO-has_manifestation
502254077,7/11/2014 16:33:30,,1320805179,7/11/2014 16:33:16,clixsense,0.5175,27793793,GBR,C5,Chester,151.230.27.155,HYPERSENSITIVITY REACTION causes STEVENS-JOHNSON SYNDROME,104,27,,128,52,causes,0.9258200997725509,900113-FS1-4,A patient presented with a HYPERSENSITIVITY REACTION to the aromatic anticonvulsants which evolved into STEVENS-JOHNSON SYNDROME and was complicated by the presence of adult respiratory distress syndrome,STEVENS-JOHNSON SYNDROME,HYPERSENSITIVITY REACTION,RO-has_manifestation
502254077,7/11/2014 16:36:10,,1320806378,7/11/2014 16:35:39,prodege,0.373,2143114,CAN,BC,Vancouver,24.84.160.12,STEVENS-JOHNSON SYNDROME causes HYPERSENSITIVITY REACTION,104,27,,128,52,causes,0.9258200997725509,900113-FS1-4,A patient presented with a HYPERSENSITIVITY REACTION to the aromatic anticonvulsants which evolved into STEVENS-JOHNSON SYNDROME and was complicated by the presence of adult respiratory distress syndrome,STEVENS-JOHNSON SYNDROME,HYPERSENSITIVITY REACTION,RO-has_manifestation
502254082,7/11/2014 16:09:59,,1320798319,7/11/2014 16:09:41,neodev,0.7097,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,52,118,,69,143,causes,0.848528137423857,900132-FS1-4,"Although many foods have been described to cause an ALLERGIC REACTION, only a few are responsible for the majority of HYPERSENSITIVITY SYMPTOMS",ALLERGIC REACTION,HYPERSENSITIVITY SYMPTOMS,RO-has_manifestation
502254082,7/11/2014 16:19:52,,1320801316,7/11/2014 16:19:27,clixsense,0.7097,27871219,NLD,7,Amsterdam,87.210.207.223,no_relation,52,118,,69,143,causes,0.848528137423857,900132-FS1-4,"Although many foods have been described to cause an ALLERGIC REACTION, only a few are responsible for the majority of HYPERSENSITIVITY SYMPTOMS",ALLERGIC REACTION,HYPERSENSITIVITY SYMPTOMS,RO-has_manifestation
502254082,7/11/2014 16:28:24,,1320803646,7/11/2014 16:28:05,clixsense,0.3913,19162475,GBR,M3,Frome,82.33.126.30,HYPERSENSITIVITY SYMPTOMS causes ALLERGIC REACTION,52,118,,69,143,causes,0.848528137423857,900132-FS1-4,"Although many foods have been described to cause an ALLERGIC REACTION, only a few are responsible for the majority of HYPERSENSITIVITY SYMPTOMS",ALLERGIC REACTION,HYPERSENSITIVITY SYMPTOMS,RO-has_manifestation
502254082,7/11/2014 16:33:40,,1320805233,7/11/2014 16:33:20,zoombucks,0.6433,5919735,USA,PA,Doylestown,173.49.91.231,no_relation,52,118,,69,143,causes,0.848528137423857,900132-FS1-4,"Although many foods have been described to cause an ALLERGIC REACTION, only a few are responsible for the majority of HYPERSENSITIVITY SYMPTOMS",ALLERGIC REACTION,HYPERSENSITIVITY SYMPTOMS,RO-has_manifestation
502254082,7/11/2014 16:34:24,,1320805753,7/11/2014 16:34:01,clixsense,0.6942,6355977,NLD,7,Amsterdam,46.129.42.165,no_relation,52,118,,69,143,causes,0.848528137423857,900132-FS1-4,"Although many foods have been described to cause an ALLERGIC REACTION, only a few are responsible for the majority of HYPERSENSITIVITY SYMPTOMS",ALLERGIC REACTION,HYPERSENSITIVITY SYMPTOMS,RO-has_manifestation
502254082,7/11/2014 16:37:02,,1320806638,7/11/2014 16:36:47,prodege,0.373,2143114,CAN,BC,Vancouver,24.84.160.12,HYPERSENSITIVITY SYMPTOMS causes ALLERGIC REACTION,52,118,,69,143,causes,0.848528137423857,900132-FS1-4,"Although many foods have been described to cause an ALLERGIC REACTION, only a few are responsible for the majority of HYPERSENSITIVITY SYMPTOMS",ALLERGIC REACTION,HYPERSENSITIVITY SYMPTOMS,RO-has_manifestation
502254082,7/11/2014 16:37:15,,1320806655,7/11/2014 16:36:32,instagc,0.7067,28301350,GBR,K4,Plymouth,78.145.138.230,no_relation,52,118,,69,143,causes,0.848528137423857,900132-FS1-4,"Although many foods have been described to cause an ALLERGIC REACTION, only a few are responsible for the majority of HYPERSENSITIVITY SYMPTOMS",ALLERGIC REACTION,HYPERSENSITIVITY SYMPTOMS,RO-has_manifestation
502254083,7/11/2014 16:07:48,,1320797294,7/11/2014 16:07:29,neodev,0.7097,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,176,167,,192,174,causes,0.328797974610715,901853-FS1-4,"Of the patients undergoing cryosurgical treatment, 83 had cervical intraepithelial neoplasia (CIN) I (mild dysplasia), 172 had CIN II (moderate dysplasia), and 60 had CIN III (SEVERE DYSPLASIA and carcinoma in situ",SEVERE DYSPLASIA,CIN III,RO-has_manifestation
502254083,7/11/2014 16:12:49,,1320799162,7/11/2014 16:12:20,prodege,0.7222,9559045,USA,TX,Katy,107.204.186.172,no_relation,176,167,,192,174,causes,0.328797974610715,901853-FS1-4,"Of the patients undergoing cryosurgical treatment, 83 had cervical intraepithelial neoplasia (CIN) I (mild dysplasia), 172 had CIN II (moderate dysplasia), and 60 had CIN III (SEVERE DYSPLASIA and carcinoma in situ",SEVERE DYSPLASIA,CIN III,RO-has_manifestation
502254083,7/11/2014 16:17:17,,1320800329,7/11/2014 16:16:29,clixsense,0.7097,27871219,NLD,7,Amsterdam,87.210.207.223,no_relation,176,167,,192,174,causes,0.328797974610715,901853-FS1-4,"Of the patients undergoing cryosurgical treatment, 83 had cervical intraepithelial neoplasia (CIN) I (mild dysplasia), 172 had CIN II (moderate dysplasia), and 60 had CIN III (SEVERE DYSPLASIA and carcinoma in situ",SEVERE DYSPLASIA,CIN III,RO-has_manifestation
502254083,7/11/2014 16:26:42,,1320803131,7/11/2014 16:26:04,elite,0.6389,27788262,USA,,,172.162.25.242,no_relation,176,167,,192,174,causes,0.328797974610715,901853-FS1-4,"Of the patients undergoing cryosurgical treatment, 83 had cervical intraepithelial neoplasia (CIN) I (mild dysplasia), 172 had CIN II (moderate dysplasia), and 60 had CIN III (SEVERE DYSPLASIA and carcinoma in situ",SEVERE DYSPLASIA,CIN III,RO-has_manifestation
502254083,7/11/2014 16:34:00,,1320805327,7/11/2014 16:33:36,clixsense,0.6942,6355977,NLD,7,Amsterdam,46.129.42.165,no_relation,176,167,,192,174,causes,0.328797974610715,901853-FS1-4,"Of the patients undergoing cryosurgical treatment, 83 had cervical intraepithelial neoplasia (CIN) I (mild dysplasia), 172 had CIN II (moderate dysplasia), and 60 had CIN III (SEVERE DYSPLASIA and carcinoma in situ",SEVERE DYSPLASIA,CIN III,RO-has_manifestation
502254083,7/11/2014 16:36:10,,1320806376,7/11/2014 16:35:39,prodege,0.373,2143114,CAN,BC,Vancouver,24.84.160.12,SEVERE DYSPLASIA causes CIN III,176,167,,192,174,causes,0.328797974610715,901853-FS1-4,"Of the patients undergoing cryosurgical treatment, 83 had cervical intraepithelial neoplasia (CIN) I (mild dysplasia), 172 had CIN II (moderate dysplasia), and 60 had CIN III (SEVERE DYSPLASIA and carcinoma in situ",SEVERE DYSPLASIA,CIN III,RO-has_manifestation
502254083,7/11/2014 16:38:32,,1320807036,7/11/2014 16:38:03,instagc,0.7067,28301350,GBR,K4,Plymouth,78.145.138.230,no_relation,176,167,,192,174,causes,0.328797974610715,901853-FS1-4,"Of the patients undergoing cryosurgical treatment, 83 had cervical intraepithelial neoplasia (CIN) I (mild dysplasia), 172 had CIN II (moderate dysplasia), and 60 had CIN III (SEVERE DYSPLASIA and carcinoma in situ",SEVERE DYSPLASIA,CIN III,RO-has_manifestation
502254084,7/11/2014 16:13:42,,1320799410,7/11/2014 16:12:50,prodege,0.7222,9559045,USA,TX,Katy,107.204.186.172,no_relation,186,100,,198,127,causes,0.896258159530272,901687-FS1-4,Prevention of the occurrence of neurological deficits in children with acute glomerulonephritis and HYPERTENSIVE ENCEPHALOPATHY requires careful evaluation and appropriate management of HYPERTENSION,HYPERTENSION,HYPERTENSIVE ENCEPHALOPATHY,RO-has_manifestation
502254084,7/11/2014 16:29:51,,1320804141,7/11/2014 16:29:38,clixsense,0.3913,19162475,GBR,M3,Frome,82.33.126.30,HYPERTENSIVE ENCEPHALOPATHY causes HYPERTENSION,186,100,,198,127,causes,0.896258159530272,901687-FS1-4,Prevention of the occurrence of neurological deficits in children with acute glomerulonephritis and HYPERTENSIVE ENCEPHALOPATHY requires careful evaluation and appropriate management of HYPERTENSION,HYPERTENSION,HYPERTENSIVE ENCEPHALOPATHY,RO-has_manifestation
502254084,7/11/2014 16:32:16,,1320804837,7/11/2014 16:31:54,zoombucks,0.6433,5919735,USA,PA,Doylestown,173.49.91.231,HYPERTENSION causes HYPERTENSIVE ENCEPHALOPATHY,186,100,,198,127,causes,0.896258159530272,901687-FS1-4,Prevention of the occurrence of neurological deficits in children with acute glomerulonephritis and HYPERTENSIVE ENCEPHALOPATHY requires careful evaluation and appropriate management of HYPERTENSION,HYPERTENSION,HYPERTENSIVE ENCEPHALOPATHY,RO-has_manifestation
502254084,7/11/2014 16:32:33,,1320804913,7/11/2014 16:32:22,clixsense,0.5175,27793793,GBR,C5,Chester,151.230.27.155,HYPERTENSION causes HYPERTENSIVE ENCEPHALOPATHY,186,100,,198,127,causes,0.896258159530272,901687-FS1-4,Prevention of the occurrence of neurological deficits in children with acute glomerulonephritis and HYPERTENSIVE ENCEPHALOPATHY requires careful evaluation and appropriate management of HYPERTENSION,HYPERTENSION,HYPERTENSIVE ENCEPHALOPATHY,RO-has_manifestation
502254084,7/11/2014 16:37:15,,1320806659,7/11/2014 16:36:32,instagc,0.7067,28301350,GBR,K4,Plymouth,78.145.138.230,HYPERTENSION causes HYPERTENSIVE ENCEPHALOPATHY,186,100,,198,127,causes,0.896258159530272,901687-FS1-4,Prevention of the occurrence of neurological deficits in children with acute glomerulonephritis and HYPERTENSIVE ENCEPHALOPATHY requires careful evaluation and appropriate management of HYPERTENSION,HYPERTENSION,HYPERTENSIVE ENCEPHALOPATHY,RO-has_manifestation
502254084,7/11/2014 16:37:16,,1320806666,7/11/2014 16:37:05,prodege,0.373,2143114,CAN,BC,Vancouver,24.84.160.12,HYPERTENSION causes HYPERTENSIVE ENCEPHALOPATHY,186,100,,198,127,causes,0.896258159530272,901687-FS1-4,Prevention of the occurrence of neurological deficits in children with acute glomerulonephritis and HYPERTENSIVE ENCEPHALOPATHY requires careful evaluation and appropriate management of HYPERTENSION,HYPERTENSION,HYPERTENSIVE ENCEPHALOPATHY,RO-has_manifestation
502254084,7/11/2014 16:52:30,,1320811315,7/11/2014 16:52:15,prodege,0.4524,12944140,GBR,C8,Croydon,92.21.54.140,no_relation,186,100,,198,127,causes,0.896258159530272,901687-FS1-4,Prevention of the occurrence of neurological deficits in children with acute glomerulonephritis and HYPERTENSIVE ENCEPHALOPATHY requires careful evaluation and appropriate management of HYPERTENSION,HYPERTENSION,HYPERTENSIVE ENCEPHALOPATHY,RO-has_manifestation
502254086,7/11/2014 16:08:43,,1320797559,7/11/2014 16:08:21,instagc,0.8333,13763729,USA,,,75.182.89.225,no_relation,283,303,,298,321,causes,0.549442255794756,900296-FS1-4,"Allergen specific immunotherapy has been shown to be effective in rigorous double-blind placebo-controlled clinical trials in both children and adults A recent WHO position paper stated that immunotherapy is an effective treatment for patients with allergic rhinitis/conjunctivitis, ALLERGIC ASTHMA and ALLERGIC REACTIONS from stinging insects and is thought to be more effective in children than in adults",ALLERGIC ASTHMA,ALLERGIC REACTIONS,RO-has_manifestation
502254086,7/11/2014 16:15:29,,1320799870,7/11/2014 16:14:35,clixsense,0.6375,25419319,GBR,H8,Liverpool,94.4.192.228,ALLERGIC ASTHMA causes ALLERGIC REACTIONS,283,303,,298,321,causes,0.549442255794756,900296-FS1-4,"Allergen specific immunotherapy has been shown to be effective in rigorous double-blind placebo-controlled clinical trials in both children and adults A recent WHO position paper stated that immunotherapy is an effective treatment for patients with allergic rhinitis/conjunctivitis, ALLERGIC ASTHMA and ALLERGIC REACTIONS from stinging insects and is thought to be more effective in children than in adults",ALLERGIC ASTHMA,ALLERGIC REACTIONS,RO-has_manifestation
502254086,7/11/2014 16:21:50,,1320801793,7/11/2014 16:21:34,neodev,0.7097,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,283,303,,298,321,causes,0.549442255794756,900296-FS1-4,"Allergen specific immunotherapy has been shown to be effective in rigorous double-blind placebo-controlled clinical trials in both children and adults A recent WHO position paper stated that immunotherapy is an effective treatment for patients with allergic rhinitis/conjunctivitis, ALLERGIC ASTHMA and ALLERGIC REACTIONS from stinging insects and is thought to be more effective in children than in adults",ALLERGIC ASTHMA,ALLERGIC REACTIONS,RO-has_manifestation
502254086,7/11/2014 16:33:14,,1320805114,7/11/2014 16:33:04,clixsense,0.5175,27793793,GBR,C5,Chester,151.230.27.155,ALLERGIC REACTIONS causes ALLERGIC ASTHMA,283,303,,298,321,causes,0.549442255794756,900296-FS1-4,"Allergen specific immunotherapy has been shown to be effective in rigorous double-blind placebo-controlled clinical trials in both children and adults A recent WHO position paper stated that immunotherapy is an effective treatment for patients with allergic rhinitis/conjunctivitis, ALLERGIC ASTHMA and ALLERGIC REACTIONS from stinging insects and is thought to be more effective in children than in adults",ALLERGIC ASTHMA,ALLERGIC REACTIONS,RO-has_manifestation
502254086,7/11/2014 16:36:29,,1320806471,7/11/2014 16:36:13,prodege,0.373,2143114,CAN,BC,Vancouver,24.84.160.12,ALLERGIC ASTHMA causes ALLERGIC REACTIONS,283,303,,298,321,causes,0.549442255794756,900296-FS1-4,"Allergen specific immunotherapy has been shown to be effective in rigorous double-blind placebo-controlled clinical trials in both children and adults A recent WHO position paper stated that immunotherapy is an effective treatment for patients with allergic rhinitis/conjunctivitis, ALLERGIC ASTHMA and ALLERGIC REACTIONS from stinging insects and is thought to be more effective in children than in adults",ALLERGIC ASTHMA,ALLERGIC REACTIONS,RO-has_manifestation
502254086,7/11/2014 16:38:52,,1320807134,7/11/2014 16:38:33,instagc,0.7067,28301350,GBR,K4,Plymouth,78.145.138.230,no_relation,283,303,,298,321,causes,0.549442255794756,900296-FS1-4,"Allergen specific immunotherapy has been shown to be effective in rigorous double-blind placebo-controlled clinical trials in both children and adults A recent WHO position paper stated that immunotherapy is an effective treatment for patients with allergic rhinitis/conjunctivitis, ALLERGIC ASTHMA and ALLERGIC REACTIONS from stinging insects and is thought to be more effective in children than in adults",ALLERGIC ASTHMA,ALLERGIC REACTIONS,RO-has_manifestation
502254086,7/11/2014 16:52:30,,1320811309,7/11/2014 16:52:15,prodege,0.4524,12944140,GBR,C8,Croydon,92.21.54.140,no_relation,283,303,,298,321,causes,0.549442255794756,900296-FS1-4,"Allergen specific immunotherapy has been shown to be effective in rigorous double-blind placebo-controlled clinical trials in both children and adults A recent WHO position paper stated that immunotherapy is an effective treatment for patients with allergic rhinitis/conjunctivitis, ALLERGIC ASTHMA and ALLERGIC REACTIONS from stinging insects and is thought to be more effective in children than in adults",ALLERGIC ASTHMA,ALLERGIC REACTIONS,RO-has_manifestation
502254087,7/11/2014 16:09:59,,1320798311,7/11/2014 16:09:41,neodev,0.7097,18755947,GBR,H2,Accrington,80.47.185.52,no_relation,39,4,,52,29,causes,0.975900072948533,902666-FS1-4,"The INVASIVE DUCTAL CARCINOMA showed a SOLID PATTERN, high nuclear and structural atypia and frequent mitotic figures, while the tubular adenoma consisted of a proliferation of small ducts lined by single layers of epithelial and myoepithelial cells with bland nuclei and inconspicuous nucleoli",SOLID PATTERN,INVASIVE DUCTAL CARCINOMA,RO-has_manifestation
502254087,7/11/2014 16:14:51,,1320799750,7/11/2014 16:14:23,prodege,0.7222,9559045,USA,TX,Katy,107.204.186.172,INVASIVE DUCTAL CARCINOMA causes SOLID PATTERN,39,4,,52,29,causes,0.975900072948533,902666-FS1-4,"The INVASIVE DUCTAL CARCINOMA showed a SOLID PATTERN, high nuclear and structural atypia and frequent mitotic figures, while the tubular adenoma consisted of a proliferation of small ducts lined by single layers of epithelial and myoepithelial cells with bland nuclei and inconspicuous nucleoli",SOLID PATTERN,INVASIVE DUCTAL CARCINOMA,RO-has_manifestation
502254087,7/11/2014 16:19:26,,1320801169,7/11/2014 16:18:42,clixsense,0.7097,27871219,NLD,7,Amsterdam,87.210.207.223,INVASIVE DUCTAL CARCINOMA causes SOLID PATTERN,39,4,,52,29,causes,0.975900072948533,902666-FS1-4,"The INVASIVE DUCTAL CARCINOMA showed a SOLID PATTERN, high nuclear and structural atypia and frequent mitotic figures, while the tubular adenoma consisted of a proliferation of small ducts lined by single layers of epithelial and myoepithelial cells with bland nuclei and inconspicuous nucleoli",SOLID PATTERN,INVASIVE DUCTAL CARCINOMA,RO-has_manifestation
502254087,7/11/2014 16:29:36,,1320804080,7/11/2014 16:28:25,clixsense,0.3913,19162475,GBR,M3,Frome,82.33.126.30,INVASIVE DUCTAL CARCINOMA causes SOLID PATTERN,39,4,,52,29,causes,0.975900072948533,902666-FS1-4,"The INVASIVE DUCTAL CARCINOMA showed a SOLID PATTERN, high nuclear and structural atypia and frequent mitotic figures, while the tubular adenoma consisted of a proliferation of small ducts lined by single layers of epithelial and myoepithelial cells with bland nuclei and inconspicuous nucleoli",SOLID PATTERN,INVASIVE DUCTAL CARCINOMA,RO-has_manifestation
502254087,7/11/2014 16:34:00,,1320805335,7/11/2014 16:33:36,clixsense,0.6942,6355977,NLD,7,Amsterdam,46.129.42.165,no_relation,39,4,,52,29,causes,0.975900072948533,902666-FS1-4,"The INVASIVE DUCTAL CARCINOMA showed a SOLID PATTERN, high nuclear and structural atypia and frequent mitotic figures, while the tubular adenoma consisted of a proliferation of small ducts lined by single layers of epithelial and myoepithelial cells with bland nuclei and inconspicuous nucleoli",SOLID PATTERN,INVASIVE DUCTAL CARCINOMA,RO-has_manifestation
502254087,7/11/2014 16:36:44,,1320806540,7/11/2014 16:36:32,prodege,0.373,2143114,CAN,BC,Vancouver,24.84.160.12,INVASIVE DUCTAL CARCINOMA causes SOLID PATTERN,39,4,,52,29,causes,0.975900072948533,902666-FS1-4,"The INVASIVE DUCTAL CARCINOMA showed a SOLID PATTERN, high nuclear and structural atypia and frequent mitotic figures, while the tubular adenoma consisted of a proliferation of small ducts lined by single layers of epithelial and myoepithelial cells with bland nuclei and inconspicuous nucleoli",SOLID PATTERN,INVASIVE DUCTAL CARCINOMA,RO-has_manifestation
502254087,7/11/2014 16:52:14,,1320811254,7/11/2014 16:51:57,prodege,0.4524,12944140,GBR,C8,Croydon,92.21.54.140,no_relation,39,4,,52,29,causes,0.975900072948533,902666-FS1-4,"The INVASIVE DUCTAL CARCINOMA showed a SOLID PATTERN, high nuclear and structural atypia and frequent mitotic figures, while the tubular adenoma consisted of a proliferation of small ducts lined by single layers of epithelial and myoepithelial cells with bland nuclei and inconspicuous nucleoli",SOLID PATTERN,INVASIVE DUCTAL CARCINOMA,RO-has_manifestation
497243649,7/2/2014 17:40:04,,1313113585,7/2/2014 17:39:43,prodege,0,14848125,GBR,V2,Glasgow,86.130.194.252,CHRONIC EOSINOPHILIC LEUKAEMIA is diagnosed by BONE MARROW,131,15,,142,45,is diagnosed by,0.538815906080325,902218-FS1-13,"A diagnosis of CHRONIC EOSINOPHILIC LEUKAEMIA was made on the basis of myeloproliferative involvement of both peripheral blood and BONE MARROW, associated with eosinophilic differentiation and a t(5;12)(q33;p13) translocation",BONE MARROW,CHRONIC EOSINOPHILIC LEUKAEMIA,RO-disease_has_primary_anatomic_site
497243649,7/2/2014 18:04:52,,1313140240,7/2/2014 18:04:23,clixsense,0,16008027,NLD,11,Zoetermeer,77.172.67.149,CHRONIC EOSINOPHILIC LEUKAEMIA is diagnosed by BONE MARROW,131,15,,142,45,is diagnosed by,0.538815906080325,902218-FS1-13,"A diagnosis of CHRONIC EOSINOPHILIC LEUKAEMIA was made on the basis of myeloproliferative involvement of both peripheral blood and BONE MARROW, associated with eosinophilic differentiation and a t(5;12)(q33;p13) translocation",BONE MARROW,CHRONIC EOSINOPHILIC LEUKAEMIA,RO-disease_has_primary_anatomic_site
497243649,7/2/2014 18:22:43,,1313155429,7/2/2014 18:22:22,clixsense,0,6518883,GBR,E6,Westbury,217.43.36.187,CHRONIC EOSINOPHILIC LEUKAEMIA is diagnosed by BONE MARROW,131,15,,142,45,is diagnosed by,0.538815906080325,902218-FS1-13,"A diagnosis of CHRONIC EOSINOPHILIC LEUKAEMIA was made on the basis of myeloproliferative involvement of both peripheral blood and BONE MARROW, associated with eosinophilic differentiation and a t(5;12)(q33;p13) translocation",BONE MARROW,CHRONIC EOSINOPHILIC LEUKAEMIA,RO-disease_has_primary_anatomic_site
497243649,7/2/2014 18:26:09,,1313158312,7/2/2014 18:25:46,prodege,0,2143114,CAN,BC,Vancouver,24.84.160.12,CHRONIC EOSINOPHILIC LEUKAEMIA is diagnosed by BONE MARROW,131,15,,142,45,is diagnosed by,0.538815906080325,902218-FS1-13,"A diagnosis of CHRONIC EOSINOPHILIC LEUKAEMIA was made on the basis of myeloproliferative involvement of both peripheral blood and BONE MARROW, associated with eosinophilic differentiation and a t(5;12)(q33;p13) translocation",BONE MARROW,CHRONIC EOSINOPHILIC LEUKAEMIA,RO-disease_has_primary_anatomic_site
497243649,7/2/2014 19:39:02,,1313228537,7/2/2014 19:38:22,instagc,0,13763729,USA,,,75.182.89.225,CHRONIC EOSINOPHILIC LEUKAEMIA is diagnosed by BONE MARROW,131,15,,142,45,is diagnosed by,0.538815906080325,902218-FS1-13,"A diagnosis of CHRONIC EOSINOPHILIC LEUKAEMIA was made on the basis of myeloproliferative involvement of both peripheral blood and BONE MARROW, associated with eosinophilic differentiation and a t(5;12)(q33;p13) translocation",BONE MARROW,CHRONIC EOSINOPHILIC LEUKAEMIA,RO-disease_has_primary_anatomic_site
497243649,7/2/2014 21:23:45,,1313390015,7/2/2014 21:23:10,instagc,0,26801585,USA,WA,Everett,76.28.248.228,CHRONIC EOSINOPHILIC LEUKAEMIA is diagnosed by BONE MARROW,131,15,,142,45,is diagnosed by,0.538815906080325,902218-FS1-13,"A diagnosis of CHRONIC EOSINOPHILIC LEUKAEMIA was made on the basis of myeloproliferative involvement of both peripheral blood and BONE MARROW, associated with eosinophilic differentiation and a t(5;12)(q33;p13) translocation",BONE MARROW,CHRONIC EOSINOPHILIC LEUKAEMIA,RO-disease_has_primary_anatomic_site
497243649,7/2/2014 21:38:44,,1313398883,7/2/2014 21:37:33,instagc,0,26852700,USA,CA,San Francisco,99.112.70.66,CHRONIC EOSINOPHILIC LEUKAEMIA is diagnosed by BONE MARROW,131,15,,142,45,is diagnosed by,0.538815906080325,902218-FS1-13,"A diagnosis of CHRONIC EOSINOPHILIC LEUKAEMIA was made on the basis of myeloproliferative involvement of both peripheral blood and BONE MARROW, associated with eosinophilic differentiation and a t(5;12)(q33;p13) translocation",BONE MARROW,CHRONIC EOSINOPHILIC LEUKAEMIA,RO-disease_has_primary_anatomic_site
497243649,7/3/2014 01:54:18,,1313561804,7/3/2014 01:53:30,prodege,0,1878608,CAN,BC,Vancouver,108.180.143.28,CHRONIC EOSINOPHILIC LEUKAEMIA is diagnosed by BONE MARROW,131,15,,142,45,is diagnosed by,0.538815906080325,902218-FS1-13,"A diagnosis of CHRONIC EOSINOPHILIC LEUKAEMIA was made on the basis of myeloproliferative involvement of both peripheral blood and BONE MARROW, associated with eosinophilic differentiation and a t(5;12)(q33;p13) translocation",BONE MARROW,CHRONIC EOSINOPHILIC LEUKAEMIA,RO-disease_has_primary_anatomic_site
497243649,7/3/2014 02:10:43,,1313571946,7/3/2014 02:10:09,zoombucks,0,27687111,USA,CA,Corona,99.44.120.153,CHRONIC EOSINOPHILIC LEUKAEMIA is diagnosed by BONE MARROW,131,15,,142,45,is diagnosed by,0.538815906080325,902218-FS1-13,"A diagnosis of CHRONIC EOSINOPHILIC LEUKAEMIA was made on the basis of myeloproliferative involvement of both peripheral blood and BONE MARROW, associated with eosinophilic differentiation and a t(5;12)(q33;p13) translocation",BONE MARROW,CHRONIC EOSINOPHILIC LEUKAEMIA,RO-disease_has_primary_anatomic_site
497243649,7/3/2014 03:00:28,,1313600387,7/3/2014 02:59:52,tremorgames,0,25257192,CAN,ON,North York,207.188.64.245,CHRONIC EOSINOPHILIC LEUKAEMIA is diagnosed by BONE MARROW,131,15,,142,45,is diagnosed by,0.538815906080325,902218-FS1-13,"A diagnosis of CHRONIC EOSINOPHILIC LEUKAEMIA was made on the basis of myeloproliferative involvement of both peripheral blood and BONE MARROW, associated with eosinophilic differentiation and a t(5;12)(q33;p13) translocation",BONE MARROW,CHRONIC EOSINOPHILIC LEUKAEMIA,RO-disease_has_primary_anatomic_site
497243649,7/3/2014 03:26:41,,1313615310,7/3/2014 03:26:15,rewardsspot,0,17763704,USA,VA,Manassas,198.7.62.204,CHRONIC EOSINOPHILIC LEUKAEMIA is diagnosed by BONE MARROW,131,15,,142,45,is diagnosed by,0.538815906080325,902218-FS1-13,"A diagnosis of CHRONIC EOSINOPHILIC LEUKAEMIA was made on the basis of myeloproliferative involvement of both peripheral blood and BONE MARROW, associated with eosinophilic differentiation and a t(5;12)(q33;p13) translocation",BONE MARROW,CHRONIC EOSINOPHILIC LEUKAEMIA,RO-disease_has_primary_anatomic_site
497243649,7/3/2014 08:13:15,,1313771884,7/3/2014 08:12:43,paiddailysurveys,0,11786001,USA,NC,Matthews,174.130.2.189,CHRONIC EOSINOPHILIC LEUKAEMIA is diagnosed by BONE MARROW,131,15,,142,45,is diagnosed by,0.538815906080325,902218-FS1-13,"A diagnosis of CHRONIC EOSINOPHILIC LEUKAEMIA was made on the basis of myeloproliferative involvement of both peripheral blood and BONE MARROW, associated with eosinophilic differentiation and a t(5;12)(q33;p13) translocation",BONE MARROW,CHRONIC EOSINOPHILIC LEUKAEMIA,RO-disease_has_primary_anatomic_site
497243649,7/3/2014 09:54:52,,1313854223,7/3/2014 09:54:26,clixsense,0,18408026,USA,WA,Tacoma,131.191.72.163,CHRONIC EOSINOPHILIC LEUKAEMIA is diagnosed by BONE MARROW,131,15,,142,45,is diagnosed by,0.538815906080325,902218-FS1-13,"A diagnosis of CHRONIC EOSINOPHILIC LEUKAEMIA was made on the basis of myeloproliferative involvement of both peripheral blood and BONE MARROW, associated with eosinophilic differentiation and a t(5;12)(q33;p13) translocation",BONE MARROW,CHRONIC EOSINOPHILIC LEUKAEMIA,RO-disease_has_primary_anatomic_site
497243649,7/3/2014 14:27:06,,1314001690,7/3/2014 14:25:53,prodege,0,22496080,CAN,ON,Mississauga,99.235.68.164,CHRONIC EOSINOPHILIC LEUKAEMIA is diagnosed by BONE MARROW,131,15,,142,45,is diagnosed by,0.538815906080325,902218-FS1-13,"A diagnosis of CHRONIC EOSINOPHILIC LEUKAEMIA was made on the basis of myeloproliferative involvement of both peripheral blood and BONE MARROW, associated with eosinophilic differentiation and a t(5;12)(q33;p13) translocation",BONE MARROW,CHRONIC EOSINOPHILIC LEUKAEMIA,RO-disease_has_primary_anatomic_site
497243649,7/3/2014 20:44:44,,1314324684,7/3/2014 20:43:51,bitcoinget,0,21490602,USA,NJ,Bound Brook,68.193.36.186,CHRONIC EOSINOPHILIC LEUKAEMIA is diagnosed by BONE MARROW,131,15,,142,45,is diagnosed by,0.538815906080325,902218-FS1-13,"A diagnosis of CHRONIC EOSINOPHILIC LEUKAEMIA was made on the basis of myeloproliferative involvement of both peripheral blood and BONE MARROW, associated with eosinophilic differentiation and a t(5;12)(q33;p13) translocation",BONE MARROW,CHRONIC EOSINOPHILIC LEUKAEMIA,RO-disease_has_primary_anatomic_site
497243649,7/3/2014 22:00:21,,1314383277,7/3/2014 21:59:21,clixsense,0,19803139,NLD,6,Veldhoven,212.61.84.196,CHRONIC EOSINOPHILIC LEUKAEMIA is diagnosed by BONE MARROW,131,15,,142,45,is diagnosed by,0.538815906080325,902218-FS1-13,"A diagnosis of CHRONIC EOSINOPHILIC LEUKAEMIA was made on the basis of myeloproliferative involvement of both peripheral blood and BONE MARROW, associated with eosinophilic differentiation and a t(5;12)(q33;p13) translocation",BONE MARROW,CHRONIC EOSINOPHILIC LEUKAEMIA,RO-disease_has_primary_anatomic_site
497243649,7/4/2014 00:37:45,,1314470520,7/4/2014 00:37:00,instagc,0,19686223,CAN,BC,Surrey,184.65.16.6,CHRONIC EOSINOPHILIC LEUKAEMIA is diagnosed by BONE MARROW,131,15,,142,45,is diagnosed by,0.538815906080325,902218-FS1-13,"A diagnosis of CHRONIC EOSINOPHILIC LEUKAEMIA was made on the basis of myeloproliferative involvement of both peripheral blood and BONE MARROW, associated with eosinophilic differentiation and a t(5;12)(q33;p13) translocation",BONE MARROW,CHRONIC EOSINOPHILIC LEUKAEMIA,RO-disease_has_primary_anatomic_site
497243649,7/4/2014 00:51:40,,1314477742,7/4/2014 00:51:07,clixsense,0,17121874,GBR,U9,Falkirk,80.192.66.214,CHRONIC EOSINOPHILIC LEUKAEMIA is diagnosed by BONE MARROW,131,15,,142,45,is diagnosed by,0.538815906080325,902218-FS1-13,"A diagnosis of CHRONIC EOSINOPHILIC LEUKAEMIA was made on the basis of myeloproliferative involvement of both peripheral blood and BONE MARROW, associated with eosinophilic differentiation and a t(5;12)(q33;p13) translocation",BONE MARROW,CHRONIC EOSINOPHILIC LEUKAEMIA,RO-disease_has_primary_anatomic_site
497243649,7/4/2014 01:47:27,,1314510310,7/4/2014 01:47:11,elite,0,22155198,USA,IL,Chicago,108.233.0.38,CHRONIC EOSINOPHILIC LEUKAEMIA is diagnosed by BONE MARROW,131,15,,142,45,is diagnosed by,0.538815906080325,902218-FS1-13,"A diagnosis of CHRONIC EOSINOPHILIC LEUKAEMIA was made on the basis of myeloproliferative involvement of both peripheral blood and BONE MARROW, associated with eosinophilic differentiation and a t(5;12)(q33;p13) translocation",BONE MARROW,CHRONIC EOSINOPHILIC LEUKAEMIA,RO-disease_has_primary_anatomic_site
497243649,7/4/2014 03:35:41,,1314568911,7/4/2014 03:35:08,prodege,0,6011370,CAN,BC,Richmond,70.79.45.148,CHRONIC EOSINOPHILIC LEUKAEMIA is diagnosed by BONE MARROW,131,15,,142,45,is diagnosed by,0.538815906080325,902218-FS1-13,"A diagnosis of CHRONIC EOSINOPHILIC LEUKAEMIA was made on the basis of myeloproliferative involvement of both peripheral blood and BONE MARROW, associated with eosinophilic differentiation and a t(5;12)(q33;p13) translocation",BONE MARROW,CHRONIC EOSINOPHILIC LEUKAEMIA,RO-disease_has_primary_anatomic_site
497243649,7/4/2014 04:28:07,,1314590670,7/4/2014 04:27:25,instagc,0,18973775,USA,TX,Garland,108.69.194.105,CHRONIC EOSINOPHILIC LEUKAEMIA is diagnosed by BONE MARROW,131,15,,142,45,is diagnosed by,0.538815906080325,902218-FS1-13,"A diagnosis of CHRONIC EOSINOPHILIC LEUKAEMIA was made on the basis of myeloproliferative involvement of both peripheral blood and BONE MARROW, associated with eosinophilic differentiation and a t(5;12)(q33;p13) translocation",BONE MARROW,CHRONIC EOSINOPHILIC LEUKAEMIA,RO-disease_has_primary_anatomic_site
497243653,7/2/2014 18:28:10,,1313159970,7/2/2014 18:27:52,neodev,0,22098386,GBR,,,213.160.119.242,SPLENOMEGALY causes HAIRY CELL LEUKAEMIA,103,129,,115,149,causes,0.917662935482247,901614-FS1-4,The material investigated consisted of two spleens resected at gastrectomy and one resected because of SPLENOMEGALY in a case of HAIRY CELL LEUKAEMIA,SPLENOMEGALY,HAIRY CELL LEUKAEMIA,RO-disease_has_finding
497243653,7/2/2014 20:29:59,,1313349857,7/2/2014 20:29:27,neodev,0,18755947,GBR,H2,Accrington,80.47.187.155,HAIRY CELL LEUKAEMIA causes SPLENOMEGALY,103,129,,115,149,causes,0.917662935482247,901614-FS1-4,The material investigated consisted of two spleens resected at gastrectomy and one resected because of SPLENOMEGALY in a case of HAIRY CELL LEUKAEMIA,SPLENOMEGALY,HAIRY CELL LEUKAEMIA,RO-disease_has_finding
497243653,7/2/2014 21:24:20,,1313390353,7/2/2014 21:23:46,instagc,0,26801585,USA,WA,Everett,76.28.248.228,HAIRY CELL LEUKAEMIA causes SPLENOMEGALY,103,129,,115,149,causes,0.917662935482247,901614-FS1-4,The material investigated consisted of two spleens resected at gastrectomy and one resected because of SPLENOMEGALY in a case of HAIRY CELL LEUKAEMIA,SPLENOMEGALY,HAIRY CELL LEUKAEMIA,RO-disease_has_finding
497243653,7/2/2014 22:26:55,,1313431043,7/2/2014 22:26:38,clixsense,0,24429778,AUS,,,121.211.46.103,SPLENOMEGALY causes HAIRY CELL LEUKAEMIA,103,129,,115,149,causes,0.917662935482247,901614-FS1-4,The material investigated consisted of two spleens resected at gastrectomy and one resected because of SPLENOMEGALY in a case of HAIRY CELL LEUKAEMIA,SPLENOMEGALY,HAIRY CELL LEUKAEMIA,RO-disease_has_finding
497243653,7/2/2014 22:29:18,,1313432571,7/2/2014 22:28:41,neodev,0,19795508,USA,TX,Irving,199.83.189.175,no_relation,103,129,,115,149,causes,0.917662935482247,901614-FS1-4,The material investigated consisted of two spleens resected at gastrectomy and one resected because of SPLENOMEGALY in a case of HAIRY CELL LEUKAEMIA,SPLENOMEGALY,HAIRY CELL LEUKAEMIA,RO-disease_has_finding
497243653,7/2/2014 22:44:13,,1313442030,7/2/2014 22:43:35,fepcrowdflower,0,17940235,GBR,X5,Cardiff,176.252.22.6,HAIRY CELL LEUKAEMIA causes SPLENOMEGALY,103,129,,115,149,causes,0.917662935482247,901614-FS1-4,The material investigated consisted of two spleens resected at gastrectomy and one resected because of SPLENOMEGALY in a case of HAIRY CELL LEUKAEMIA,SPLENOMEGALY,HAIRY CELL LEUKAEMIA,RO-disease_has_finding
497243653,7/2/2014 23:49:58,,1313492547,7/2/2014 23:49:01,clixsense,0,9289735,USA,IL,Chicago,69.210.253.196,no_relation,103,129,,115,149,causes,0.917662935482247,901614-FS1-4,The material investigated consisted of two spleens resected at gastrectomy and one resected because of SPLENOMEGALY in a case of HAIRY CELL LEUKAEMIA,SPLENOMEGALY,HAIRY CELL LEUKAEMIA,RO-disease_has_finding
497243653,7/3/2014 02:10:08,,1313571571,7/3/2014 02:09:41,zoombucks,0,27687111,USA,CA,Corona,99.44.120.153,SPLENOMEGALY causes HAIRY CELL LEUKAEMIA,103,129,,115,149,causes,0.917662935482247,901614-FS1-4,The material investigated consisted of two spleens resected at gastrectomy and one resected because of SPLENOMEGALY in a case of HAIRY CELL LEUKAEMIA,SPLENOMEGALY,HAIRY CELL LEUKAEMIA,RO-disease_has_finding
497243653,7/3/2014 03:03:42,,1313602483,7/3/2014 03:02:29,instagc,0,23149109,USA,NC,Durham,75.189.206.205,no_relation,103,129,,115,149,causes,0.917662935482247,901614-FS1-4,The material investigated consisted of two spleens resected at gastrectomy and one resected because of SPLENOMEGALY in a case of HAIRY CELL LEUKAEMIA,SPLENOMEGALY,HAIRY CELL LEUKAEMIA,RO-disease_has_finding
497243653,7/3/2014 09:28:16,,1313836949,7/3/2014 09:27:41,clixsense,0,15189335,GBR,I9,Dereham,86.157.163.112,HAIRY CELL LEUKAEMIA causes SPLENOMEGALY,103,129,,115,149,causes,0.917662935482247,901614-FS1-4,The material investigated consisted of two spleens resected at gastrectomy and one resected because of SPLENOMEGALY in a case of HAIRY CELL LEUKAEMIA,SPLENOMEGALY,HAIRY CELL LEUKAEMIA,RO-disease_has_finding
497243653,7/3/2014 15:12:17,,1314037218,7/3/2014 15:11:17,neodev,0,21405167,USA,MD,Pasadena,69.243.35.97,HAIRY CELL LEUKAEMIA causes SPLENOMEGALY,103,129,,115,149,causes,0.917662935482247,901614-FS1-4,The material investigated consisted of two spleens resected at gastrectomy and one resected because of SPLENOMEGALY in a case of HAIRY CELL LEUKAEMIA,SPLENOMEGALY,HAIRY CELL LEUKAEMIA,RO-disease_has_finding
497243653,7/3/2014 15:31:20,,1314052660,7/3/2014 15:31:06,prodege,0,18960400,GBR,H9,London,109.154.7.94,HAIRY CELL LEUKAEMIA causes SPLENOMEGALY,103,129,,115,149,causes,0.917662935482247,901614-FS1-4,The material investigated consisted of two spleens resected at gastrectomy and one resected because of SPLENOMEGALY in a case of HAIRY CELL LEUKAEMIA,SPLENOMEGALY,HAIRY CELL LEUKAEMIA,RO-disease_has_finding
497243653,7/3/2014 16:46:05,,1314114814,7/3/2014 16:45:32,neodev,0,18517457,GBR,,,86.29.55.201,HAIRY CELL LEUKAEMIA causes SPLENOMEGALY,103,129,,115,149,causes,0.917662935482247,901614-FS1-4,The material investigated consisted of two spleens resected at gastrectomy and one resected because of SPLENOMEGALY in a case of HAIRY CELL LEUKAEMIA,SPLENOMEGALY,HAIRY CELL LEUKAEMIA,RO-disease_has_finding
497243653,7/3/2014 18:13:33,,1314193506,7/3/2014 18:13:08,instagc,0,19636746,USA,NY,Canandaigua,192.182.211.200,no_relation,103,129,,115,149,causes,0.917662935482247,901614-FS1-4,The material investigated consisted of two spleens resected at gastrectomy and one resected because of SPLENOMEGALY in a case of HAIRY CELL LEUKAEMIA,SPLENOMEGALY,HAIRY CELL LEUKAEMIA,RO-disease_has_finding
497243653,7/3/2014 20:41:58,,1314322377,7/3/2014 20:41:21,bitcoinget,0,21490602,USA,NJ,Bound Brook,68.193.36.186,HAIRY CELL LEUKAEMIA causes SPLENOMEGALY,103,129,,115,149,causes,0.917662935482247,901614-FS1-4,The material investigated consisted of two spleens resected at gastrectomy and one resected because of SPLENOMEGALY in a case of HAIRY CELL LEUKAEMIA,SPLENOMEGALY,HAIRY CELL LEUKAEMIA,RO-disease_has_finding
497243653,7/4/2014 01:31:08,,1314499660,7/4/2014 01:30:28,bitcoinget,0,27914370,USA,TX,Dallas,99.2.124.119,HAIRY CELL LEUKAEMIA causes SPLENOMEGALY,103,129,,115,149,causes,0.917662935482247,901614-FS1-4,The material investigated consisted of two spleens resected at gastrectomy and one resected because of SPLENOMEGALY in a case of HAIRY CELL LEUKAEMIA,SPLENOMEGALY,HAIRY CELL LEUKAEMIA,RO-disease_has_finding
497243653,7/4/2014 04:42:22,,1314598513,7/4/2014 04:41:52,instagc,0,13846187,USA,MO,Chesterfield,63.137.150.235,HAIRY CELL LEUKAEMIA causes SPLENOMEGALY,103,129,,115,149,causes,0.917662935482247,901614-FS1-4,The material investigated consisted of two spleens resected at gastrectomy and one resected because of SPLENOMEGALY in a case of HAIRY CELL LEUKAEMIA,SPLENOMEGALY,HAIRY CELL LEUKAEMIA,RO-disease_has_finding
497243653,7/4/2014 07:09:07,,1314668061,7/4/2014 07:08:50,clixsense,0,19190439,GBR,H9,London,86.15.32.131,no_relation,103,129,,115,149,causes,0.917662935482247,901614-FS1-4,The material investigated consisted of two spleens resected at gastrectomy and one resected because of SPLENOMEGALY in a case of HAIRY CELL LEUKAEMIA,SPLENOMEGALY,HAIRY CELL LEUKAEMIA,RO-disease_has_finding
497243653,7/4/2014 07:31:51,,1314679348,7/4/2014 07:31:08,clixsense,0,27969116,NLD,,,91.213.37.165,HAIRY CELL LEUKAEMIA causes SPLENOMEGALY,103,129,,115,149,causes,0.917662935482247,901614-FS1-4,The material investigated consisted of two spleens resected at gastrectomy and one resected because of SPLENOMEGALY in a case of HAIRY CELL LEUKAEMIA,SPLENOMEGALY,HAIRY CELL LEUKAEMIA,RO-disease_has_finding
497243653,7/4/2014 08:34:20,,1314707712,7/4/2014 08:33:50,prodege,0,15439740,AUS,2,Jannali,27.96.208.89,no_relation,103,129,,115,149,causes,0.917662935482247,901614-FS1-4,The material investigated consisted of two spleens resected at gastrectomy and one resected because of SPLENOMEGALY in a case of HAIRY CELL LEUKAEMIA,SPLENOMEGALY,HAIRY CELL LEUKAEMIA,RO-disease_has_finding
497243653,7/4/2014 09:18:48,,1314729582,7/4/2014 09:18:15,eup_slw,0,21338859,GBR,K6,Portsmouth,86.6.113.168,HAIRY CELL LEUKAEMIA causes SPLENOMEGALY,103,129,,115,149,causes,0.917662935482247,901614-FS1-4,The material investigated consisted of two spleens resected at gastrectomy and one resected because of SPLENOMEGALY in a case of HAIRY CELL LEUKAEMIA,SPLENOMEGALY,HAIRY CELL LEUKAEMIA,RO-disease_has_finding
497243655,7/2/2014 18:04:21,,1313139778,7/2/2014 18:03:27,clixsense,0,16008027,NLD,11,Zoetermeer,77.172.67.149,no_relation,32,101,,46,125,is diagnosed by,0.45749571099781394,902455-FS1-13,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243655,7/2/2014 18:05:37,,1313140855,7/2/2014 18:05:24,clixsense,0,19162475,GBR,M3,Frome,82.33.126.30,no_relation,32,101,,46,125,is diagnosed by,0.45749571099781394,902455-FS1-13,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243655,7/2/2014 18:26:39,,1313158713,7/2/2014 18:26:29,prodege,0,2143114,CAN,BC,Vancouver,24.84.160.12,BENIGN FOLLICULAR TUMORS is diagnosed by HAIR FOLLICLES,32,101,,46,125,is diagnosed by,0.45749571099781394,902455-FS1-13,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243655,7/2/2014 20:30:32,,1313350386,7/2/2014 20:30:00,neodev,0,18755947,GBR,H2,Accrington,80.47.187.155,no_relation,32,101,,46,125,is diagnosed by,0.45749571099781394,902455-FS1-13,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243655,7/2/2014 20:39:55,,1313357647,7/2/2014 20:38:54,clixsense,0,27871219,NLD,7,Amsterdam,87.210.207.223,BENIGN FOLLICULAR TUMORS is diagnosed by HAIR FOLLICLES,32,101,,46,125,is diagnosed by,0.45749571099781394,902455-FS1-13,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243655,7/2/2014 21:26:09,,1313391329,7/2/2014 21:25:43,instagc,0,26801585,USA,WA,Everett,76.28.248.228,BENIGN FOLLICULAR TUMORS is diagnosed by HAIR FOLLICLES,32,101,,46,125,is diagnosed by,0.45749571099781394,902455-FS1-13,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243655,7/2/2014 21:45:12,,1313403176,7/2/2014 21:45:02,clixsense,0,17950689,GBR,X5,Cardiff,89.168.38.216,HAIR FOLLICLES is diagnosed by BENIGN FOLLICULAR TUMORS,32,101,,46,125,is diagnosed by,0.45749571099781394,902455-FS1-13,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243655,7/3/2014 01:52:59,,1313561167,7/3/2014 01:52:28,prodege,0,1878608,CAN,BC,Vancouver,108.180.143.28,no_relation,32,101,,46,125,is diagnosed by,0.45749571099781394,902455-FS1-13,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243655,7/3/2014 03:11:32,,1313607041,7/3/2014 03:10:47,rewardsspot,0,24482174,GBR,H9,London,46.23.68.180,BENIGN FOLLICULAR TUMORS is diagnosed by HAIR FOLLICLES,32,101,,46,125,is diagnosed by,0.45749571099781394,902455-FS1-13,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243655,7/3/2014 08:08:58,,1313769427,7/3/2014 08:08:21,paiddailysurveys,0,11786001,USA,NC,Matthews,174.130.2.189,BENIGN FOLLICULAR TUMORS is diagnosed by HAIR FOLLICLES,32,101,,46,125,is diagnosed by,0.45749571099781394,902455-FS1-13,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243655,7/3/2014 08:54:08,,1313802693,7/3/2014 08:52:45,prodege,0,21891314,AUS,7,Mornington,203.214.41.115,BENIGN FOLLICULAR TUMORS is diagnosed by HAIR FOLLICLES,32,101,,46,125,is diagnosed by,0.45749571099781394,902455-FS1-13,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243655,7/3/2014 13:56:44,,1313986959,7/3/2014 13:56:38,instagc,0,27753923,GBR,,,92.40.75.232,HAIR FOLLICLES is diagnosed by BENIGN FOLLICULAR TUMORS,32,101,,46,125,is diagnosed by,0.45749571099781394,902455-FS1-13,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243655,7/3/2014 15:12:17,,1314037223,7/3/2014 15:11:17,neodev,0,21405167,USA,MD,Pasadena,69.243.35.97,BENIGN FOLLICULAR TUMORS is diagnosed by HAIR FOLLICLES,32,101,,46,125,is diagnosed by,0.45749571099781394,902455-FS1-13,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243655,7/3/2014 15:57:10,,1314074194,7/3/2014 15:56:27,superrewards,0,22638731,USA,IL,Carterville,50.40.185.175,no_relation,32,101,,46,125,is diagnosed by,0.45749571099781394,902455-FS1-13,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243655,7/3/2014 20:42:53,,1314323230,7/3/2014 20:41:59,bitcoinget,0,21490602,USA,NJ,Bound Brook,68.193.36.186,no_relation,32,101,,46,125,is diagnosed by,0.45749571099781394,902455-FS1-13,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243655,7/4/2014 00:51:06,,1314477334,7/4/2014 00:50:34,clixsense,0,17121874,GBR,U9,Falkirk,80.192.66.214,HAIR FOLLICLES is diagnosed by BENIGN FOLLICULAR TUMORS,32,101,,46,125,is diagnosed by,0.45749571099781394,902455-FS1-13,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243655,7/4/2014 00:57:15,,1314480597,7/4/2014 00:56:25,neodev,0,16871906,CAN,ON,Kanata,99.224.9.12,BENIGN FOLLICULAR TUMORS is diagnosed by HAIR FOLLICLES,32,101,,46,125,is diagnosed by,0.45749571099781394,902455-FS1-13,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243655,7/4/2014 04:39:13,,1314596589,7/4/2014 04:39:08,gptbanks,0,18496428,USA,CA,Newhall,199.244.112.121,BENIGN FOLLICULAR TUMORS is diagnosed by HAIR FOLLICLES,32,101,,46,125,is diagnosed by,0.45749571099781394,902455-FS1-13,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243655,7/4/2014 07:35:44,,1314681062,7/4/2014 07:35:05,clixsense,0,27969116,NLD,,,91.213.37.165,no_relation,32,101,,46,125,is diagnosed by,0.45749571099781394,902455-FS1-13,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243655,7/4/2014 08:35:25,,1314708212,7/4/2014 08:35:10,prodege,0,15439740,AUS,2,Jannali,27.96.208.89,no_relation,32,101,,46,125,is diagnosed by,0.45749571099781394,902455-FS1-13,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243655,7/4/2014 09:20:34,,1314730455,7/4/2014 09:20:16,eup_slw,0,21338859,GBR,K6,Portsmouth,86.6.113.168,BENIGN FOLLICULAR TUMORS is diagnosed by HAIR FOLLICLES,32,101,,46,125,is diagnosed by,0.45749571099781394,902455-FS1-13,"However, the deeper portions of HAIR FOLLICLES were also found to be unlabeled, and further study of BENIGN FOLLICULAR TUMORS which may histologically mimic basal cell carcinomas is suggested",HAIR FOLLICLES,BENIGN FOLLICULAR TUMORS,RO-disease_has_primary_anatomic_site
497243657,7/2/2014 17:28:57,,1313102847,7/2/2014 17:28:40,prodege,0,14890188,GBR,C5,Crewe,151.230.22.222,BONE MARROW FIBROSIS causes ACUTE MYELOFIBROSIS,95,0,,115,19,causes,0.832050294337844,901546-FS1-4,ACUTE MYELOFIBROSIS (AM) or malignant myelosclerosis is a myeloprofilerative syndrome in which BONE MARROW FIBROSIS is associated with a proliferation of immature myeloid cells,BONE MARROW FIBROSIS,ACUTE MYELOFIBROSIS,RO-disease_has_finding
497243657,7/2/2014 18:03:25,,1313139050,7/2/2014 18:02:52,clixsense,0,16008027,NLD,11,Zoetermeer,77.172.67.149,no_relation,95,0,,115,19,causes,0.832050294337844,901546-FS1-4,ACUTE MYELOFIBROSIS (AM) or malignant myelosclerosis is a myeloprofilerative syndrome in which BONE MARROW FIBROSIS is associated with a proliferation of immature myeloid cells,BONE MARROW FIBROSIS,ACUTE MYELOFIBROSIS,RO-disease_has_finding
497243657,7/2/2014 18:21:23,,1313154175,7/2/2014 18:20:51,clixsense,0,6518883,GBR,E6,Westbury,217.43.36.187,no_relation,95,0,,115,19,causes,0.832050294337844,901546-FS1-4,ACUTE MYELOFIBROSIS (AM) or malignant myelosclerosis is a myeloprofilerative syndrome in which BONE MARROW FIBROSIS is associated with a proliferation of immature myeloid cells,BONE MARROW FIBROSIS,ACUTE MYELOFIBROSIS,RO-disease_has_finding
497243657,7/2/2014 18:26:09,,1313158311,7/2/2014 18:25:46,prodege,0,2143114,CAN,BC,Vancouver,24.84.160.12,ACUTE MYELOFIBROSIS causes BONE MARROW FIBROSIS,95,0,,115,19,causes,0.832050294337844,901546-FS1-4,ACUTE MYELOFIBROSIS (AM) or malignant myelosclerosis is a myeloprofilerative syndrome in which BONE MARROW FIBROSIS is associated with a proliferation of immature myeloid cells,BONE MARROW FIBROSIS,ACUTE MYELOFIBROSIS,RO-disease_has_finding
497243657,7/2/2014 18:27:40,,1313159608,7/2/2014 18:27:30,neodev,0,22098386,GBR,,,213.160.119.242,BONE MARROW FIBROSIS causes ACUTE MYELOFIBROSIS,95,0,,115,19,causes,0.832050294337844,901546-FS1-4,ACUTE MYELOFIBROSIS (AM) or malignant myelosclerosis is a myeloprofilerative syndrome in which BONE MARROW FIBROSIS is associated with a proliferation of immature myeloid cells,BONE MARROW FIBROSIS,ACUTE MYELOFIBROSIS,RO-disease_has_finding
497243657,7/2/2014 18:49:47,,1313180519,7/2/2014 18:49:08,instagc,0,14656399,USA,KY,Richmond,69.23.61.189,no_relation,95,0,,115,19,causes,0.832050294337844,901546-FS1-4,ACUTE MYELOFIBROSIS (AM) or malignant myelosclerosis is a myeloprofilerative syndrome in which BONE MARROW FIBROSIS is associated with a proliferation of immature myeloid cells,BONE MARROW FIBROSIS,ACUTE MYELOFIBROSIS,RO-disease_has_finding
497243657,7/2/2014 20:38:52,,1313356791,7/2/2014 20:38:12,clixsense,0,27871219,NLD,7,Amsterdam,87.210.207.223,ACUTE MYELOFIBROSIS causes BONE MARROW FIBROSIS,95,0,,115,19,causes,0.832050294337844,901546-FS1-4,ACUTE MYELOFIBROSIS (AM) or malignant myelosclerosis is a myeloprofilerative syndrome in which BONE MARROW FIBROSIS is associated with a proliferation of immature myeloid cells,BONE MARROW FIBROSIS,ACUTE MYELOFIBROSIS,RO-disease_has_finding
497243657,7/3/2014 05:36:53,,1313681100,7/3/2014 05:36:36,clixsense,0,24429778,AUS,,,121.211.46.103,ACUTE MYELOFIBROSIS causes BONE MARROW FIBROSIS,95,0,,115,19,causes,0.832050294337844,901546-FS1-4,ACUTE MYELOFIBROSIS (AM) or malignant myelosclerosis is a myeloprofilerative syndrome in which BONE MARROW FIBROSIS is associated with a proliferation of immature myeloid cells,BONE MARROW FIBROSIS,ACUTE MYELOFIBROSIS,RO-disease_has_finding
497243657,7/3/2014 08:12:42,,1313771596,7/3/2014 08:12:07,paiddailysurveys,0,11786001,USA,NC,Matthews,174.130.2.189,ACUTE MYELOFIBROSIS causes BONE MARROW FIBROSIS,95,0,,115,19,causes,0.832050294337844,901546-FS1-4,ACUTE MYELOFIBROSIS (AM) or malignant myelosclerosis is a myeloprofilerative syndrome in which BONE MARROW FIBROSIS is associated with a proliferation of immature myeloid cells,BONE MARROW FIBROSIS,ACUTE MYELOFIBROSIS,RO-disease_has_finding
497243657,7/3/2014 08:55:43,,1313804445,7/3/2014 08:54:57,prodege,0,21891314,AUS,7,Mornington,203.214.41.115,ACUTE MYELOFIBROSIS causes BONE MARROW FIBROSIS,95,0,,115,19,causes,0.832050294337844,901546-FS1-4,ACUTE MYELOFIBROSIS (AM) or malignant myelosclerosis is a myeloprofilerative syndrome in which BONE MARROW FIBROSIS is associated with a proliferation of immature myeloid cells,BONE MARROW FIBROSIS,ACUTE MYELOFIBROSIS,RO-disease_has_finding
497243657,7/3/2014 11:04:00,,1313901642,7/3/2014 11:03:11,vivatic,0,25451531,GBR,,,83.67.28.193,no_relation,95,0,,115,19,causes,0.832050294337844,901546-FS1-4,ACUTE MYELOFIBROSIS (AM) or malignant myelosclerosis is a myeloprofilerative syndrome in which BONE MARROW FIBROSIS is associated with a proliferation of immature myeloid cells,BONE MARROW FIBROSIS,ACUTE MYELOFIBROSIS,RO-disease_has_finding
497243657,7/3/2014 13:57:13,,1313987117,7/3/2014 13:56:53,instagc,0,27753923,GBR,,,92.40.75.232,BONE MARROW FIBROSIS causes ACUTE MYELOFIBROSIS,95,0,,115,19,causes,0.832050294337844,901546-FS1-4,ACUTE MYELOFIBROSIS (AM) or malignant myelosclerosis is a myeloprofilerative syndrome in which BONE MARROW FIBROSIS is associated with a proliferation of immature myeloid cells,BONE MARROW FIBROSIS,ACUTE MYELOFIBROSIS,RO-disease_has_finding
497243657,7/3/2014 15:02:34,,1314029813,7/3/2014 15:01:08,instagc,0,20183814,USA,,,166.182.80.97,BONE MARROW FIBROSIS causes ACUTE MYELOFIBROSIS,95,0,,115,19,causes,0.832050294337844,901546-FS1-4,ACUTE MYELOFIBROSIS (AM) or malignant myelosclerosis is a myeloprofilerative syndrome in which BONE MARROW FIBROSIS is associated with a proliferation of immature myeloid cells,BONE MARROW FIBROSIS,ACUTE MYELOFIBROSIS,RO-disease_has_finding
497243657,7/3/2014 15:31:05,,1314052409,7/3/2014 15:30:47,prodege,0,18960400,GBR,H9,London,109.154.7.94,BONE MARROW FIBROSIS causes ACUTE MYELOFIBROSIS,95,0,,115,19,causes,0.832050294337844,901546-FS1-4,ACUTE MYELOFIBROSIS (AM) or malignant myelosclerosis is a myeloprofilerative syndrome in which BONE MARROW FIBROSIS is associated with a proliferation of immature myeloid cells,BONE MARROW FIBROSIS,ACUTE MYELOFIBROSIS,RO-disease_has_finding
497243657,7/3/2014 20:43:49,,1314323980,7/3/2014 20:42:54,bitcoinget,0,21490602,USA,NJ,Bound Brook,68.193.36.186,ACUTE MYELOFIBROSIS causes BONE MARROW FIBROSIS,95,0,,115,19,causes,0.832050294337844,901546-FS1-4,ACUTE MYELOFIBROSIS (AM) or malignant myelosclerosis is a myeloprofilerative syndrome in which BONE MARROW FIBROSIS is associated with a proliferation of immature myeloid cells,BONE MARROW FIBROSIS,ACUTE MYELOFIBROSIS,RO-disease_has_finding
497243657,7/4/2014 00:37:45,,1314470527,7/4/2014 00:37:00,instagc,0,19686223,CAN,BC,Surrey,184.65.16.6,BONE MARROW FIBROSIS causes ACUTE MYELOFIBROSIS,95,0,,115,19,causes,0.832050294337844,901546-FS1-4,ACUTE MYELOFIBROSIS (AM) or malignant myelosclerosis is a myeloprofilerative syndrome in which BONE MARROW FIBROSIS is associated with a proliferation of immature myeloid cells,BONE MARROW FIBROSIS,ACUTE MYELOFIBROSIS,RO-disease_has_finding
497243657,7/4/2014 03:50:37,,1314575527,7/4/2014 03:50:05,clixsense,0,17722340,CAN,BC,Mission,50.98.185.25,ACUTE MYELOFIBROSIS causes BONE MARROW FIBROSIS,95,0,,115,19,causes,0.832050294337844,901546-FS1-4,ACUTE MYELOFIBROSIS (AM) or malignant myelosclerosis is a myeloprofilerative syndrome in which BONE MARROW FIBROSIS is associated with a proliferation of immature myeloid cells,BONE MARROW FIBROSIS,ACUTE MYELOFIBROSIS,RO-disease_has_finding
497243657,7/4/2014 07:08:48,,1314667914,7/4/2014 07:08:12,clixsense,0,19190439,GBR,H9,London,86.15.32.131,no_relation,95,0,,115,19,causes,0.832050294337844,901546-FS1-4,ACUTE MYELOFIBROSIS (AM) or malignant myelosclerosis is a myeloprofilerative syndrome in which BONE MARROW FIBROSIS is associated with a proliferation of immature myeloid cells,BONE MARROW FIBROSIS,ACUTE MYELOFIBROSIS,RO-disease_has_finding
497243657,7/4/2014 07:32:21,,1314679598,7/4/2014 07:31:52,clixsense,0,27969116,NLD,,,91.213.37.165,no_relation,95,0,,115,19,causes,0.832050294337844,901546-FS1-4,ACUTE MYELOFIBROSIS (AM) or malignant myelosclerosis is a myeloprofilerative syndrome in which BONE MARROW FIBROSIS is associated with a proliferation of immature myeloid cells,BONE MARROW FIBROSIS,ACUTE MYELOFIBROSIS,RO-disease_has_finding
497243657,7/4/2014 08:04:04,,1314693944,7/4/2014 08:03:41,clixsense,0,23138831,NLD,,,77.174.95.58,no_relation,95,0,,115,19,causes,0.832050294337844,901546-FS1-4,ACUTE MYELOFIBROSIS (AM) or malignant myelosclerosis is a myeloprofilerative syndrome in which BONE MARROW FIBROSIS is associated with a proliferation of immature myeloid cells,BONE MARROW FIBROSIS,ACUTE MYELOFIBROSIS,RO-disease_has_finding
497243657,7/4/2014 08:34:20,,1314707706,7/4/2014 08:33:50,prodege,0,15439740,AUS,2,Jannali,27.96.208.89,BONE MARROW FIBROSIS causes ACUTE MYELOFIBROSIS,95,0,,115,19,causes,0.832050294337844,901546-FS1-4,ACUTE MYELOFIBROSIS (AM) or malignant myelosclerosis is a myeloprofilerative syndrome in which BONE MARROW FIBROSIS is associated with a proliferation of immature myeloid cells,BONE MARROW FIBROSIS,ACUTE MYELOFIBROSIS,RO-disease_has_finding
497243662,7/2/2014 17:41:25,,1313114989,7/2/2014 17:40:51,prodege,0,14848125,GBR,V2,Glasgow,86.130.194.252,HYPERVENTILATION causes RESPIRATORY ALKALOSIS,67,44,,88,60,causes,0.30151134457776396,900419-FS1-4,Hyperactivity may quickly turn to lethargy; HYPERVENTILATION (with RESPIRATORY ALKALOSIS) changes to hypoventilation (with mixed respiratory and metabolic acidosis) and respiratory failure,RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-cause_of
497243662,7/2/2014 18:02:51,,1313138539,7/2/2014 18:02:10,clixsense,0,16008027,NLD,11,Zoetermeer,77.172.67.149,no_relation,67,44,,88,60,causes,0.30151134457776396,900419-FS1-4,Hyperactivity may quickly turn to lethargy; HYPERVENTILATION (with RESPIRATORY ALKALOSIS) changes to hypoventilation (with mixed respiratory and metabolic acidosis) and respiratory failure,RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-cause_of
497243662,7/2/2014 18:04:41,,1313140080,7/2/2014 18:04:20,clixsense,0,19162475,GBR,M3,Frome,82.33.126.30,HYPERVENTILATION causes RESPIRATORY ALKALOSIS,67,44,,88,60,causes,0.30151134457776396,900419-FS1-4,Hyperactivity may quickly turn to lethargy; HYPERVENTILATION (with RESPIRATORY ALKALOSIS) changes to hypoventilation (with mixed respiratory and metabolic acidosis) and respiratory failure,RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-cause_of
497243662,7/2/2014 18:22:21,,1313155062,7/2/2014 18:21:58,clixsense,0,6518883,GBR,E6,Westbury,217.43.36.187,RESPIRATORY ALKALOSIS causes HYPERVENTILATION,67,44,,88,60,causes,0.30151134457776396,900419-FS1-4,Hyperactivity may quickly turn to lethargy; HYPERVENTILATION (with RESPIRATORY ALKALOSIS) changes to hypoventilation (with mixed respiratory and metabolic acidosis) and respiratory failure,RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-cause_of
497243662,7/2/2014 18:22:30,,1313155248,7/2/2014 18:21:30,instagc,0,14656399,USA,KY,Richmond,69.23.61.189,no_relation,67,44,,88,60,causes,0.30151134457776396,900419-FS1-4,Hyperactivity may quickly turn to lethargy; HYPERVENTILATION (with RESPIRATORY ALKALOSIS) changes to hypoventilation (with mixed respiratory and metabolic acidosis) and respiratory failure,RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-cause_of
497243662,7/2/2014 20:30:32,,1313350391,7/2/2014 20:30:00,neodev,0,18755947,GBR,H2,Accrington,80.47.187.155,HYPERVENTILATION causes RESPIRATORY ALKALOSIS,67,44,,88,60,causes,0.30151134457776396,900419-FS1-4,Hyperactivity may quickly turn to lethargy; HYPERVENTILATION (with RESPIRATORY ALKALOSIS) changes to hypoventilation (with mixed respiratory and metabolic acidosis) and respiratory failure,RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-cause_of
497243662,7/2/2014 20:42:01,,1313359320,7/2/2014 20:41:02,prodege,0,20018366,GBR,K8,Ilford,86.167.106.124,no_relation,67,44,,88,60,causes,0.30151134457776396,900419-FS1-4,Hyperactivity may quickly turn to lethargy; HYPERVENTILATION (with RESPIRATORY ALKALOSIS) changes to hypoventilation (with mixed respiratory and metabolic acidosis) and respiratory failure,RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-cause_of
497243662,7/3/2014 03:06:52,,1313604567,7/3/2014 03:06:12,instagc,0,23149109,USA,NC,Durham,75.189.206.205,RESPIRATORY ALKALOSIS causes HYPERVENTILATION,67,44,,88,60,causes,0.30151134457776396,900419-FS1-4,Hyperactivity may quickly turn to lethargy; HYPERVENTILATION (with RESPIRATORY ALKALOSIS) changes to hypoventilation (with mixed respiratory and metabolic acidosis) and respiratory failure,RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-cause_of
497243662,7/3/2014 03:26:13,,1313615074,7/3/2014 03:25:49,rewardsspot,0,17763704,USA,VA,Manassas,198.7.62.204,HYPERVENTILATION causes RESPIRATORY ALKALOSIS,67,44,,88,60,causes,0.30151134457776396,900419-FS1-4,Hyperactivity may quickly turn to lethargy; HYPERVENTILATION (with RESPIRATORY ALKALOSIS) changes to hypoventilation (with mixed respiratory and metabolic acidosis) and respiratory failure,RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-cause_of
497243662,7/3/2014 15:00:00,,1314027821,7/3/2014 14:59:44,neodev,0,27597779,CAN,AB,Calgary,72.29.251.209,no_relation,67,44,,88,60,causes,0.30151134457776396,900419-FS1-4,Hyperactivity may quickly turn to lethargy; HYPERVENTILATION (with RESPIRATORY ALKALOSIS) changes to hypoventilation (with mixed respiratory and metabolic acidosis) and respiratory failure,RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-cause_of
497243662,7/3/2014 15:03:06,,1314030217,7/3/2014 15:02:35,instagc,0,20183814,USA,,,166.182.80.97,RESPIRATORY ALKALOSIS causes HYPERVENTILATION,67,44,,88,60,causes,0.30151134457776396,900419-FS1-4,Hyperactivity may quickly turn to lethargy; HYPERVENTILATION (with RESPIRATORY ALKALOSIS) changes to hypoventilation (with mixed respiratory and metabolic acidosis) and respiratory failure,RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-cause_of
497243662,7/3/2014 15:13:45,,1314038245,7/3/2014 15:13:24,neodev,0,21405167,USA,MD,Pasadena,69.243.35.97,HYPERVENTILATION causes RESPIRATORY ALKALOSIS,67,44,,88,60,causes,0.30151134457776396,900419-FS1-4,Hyperactivity may quickly turn to lethargy; HYPERVENTILATION (with RESPIRATORY ALKALOSIS) changes to hypoventilation (with mixed respiratory and metabolic acidosis) and respiratory failure,RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-cause_of
497243662,7/3/2014 15:31:51,,1314053067,7/3/2014 15:31:35,prodege,0,18960400,GBR,H9,London,109.154.7.94,RESPIRATORY ALKALOSIS causes HYPERVENTILATION,67,44,,88,60,causes,0.30151134457776396,900419-FS1-4,Hyperactivity may quickly turn to lethargy; HYPERVENTILATION (with RESPIRATORY ALKALOSIS) changes to hypoventilation (with mixed respiratory and metabolic acidosis) and respiratory failure,RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-cause_of
497243662,7/3/2014 15:58:20,,1314075169,7/3/2014 15:57:52,superrewards,0,22638731,USA,IL,Carterville,50.40.185.175,no_relation,67,44,,88,60,causes,0.30151134457776396,900419-FS1-4,Hyperactivity may quickly turn to lethargy; HYPERVENTILATION (with RESPIRATORY ALKALOSIS) changes to hypoventilation (with mixed respiratory and metabolic acidosis) and respiratory failure,RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-cause_of
497243662,7/4/2014 00:51:40,,1314477741,7/4/2014 00:51:07,clixsense,0,17121874,GBR,U9,Falkirk,80.192.66.214,HYPERVENTILATION causes RESPIRATORY ALKALOSIS,67,44,,88,60,causes,0.30151134457776396,900419-FS1-4,Hyperactivity may quickly turn to lethargy; HYPERVENTILATION (with RESPIRATORY ALKALOSIS) changes to hypoventilation (with mixed respiratory and metabolic acidosis) and respiratory failure,RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-cause_of
497243662,7/4/2014 00:56:24,,1314480200,7/4/2014 00:55:40,neodev,0,16871906,CAN,ON,Kanata,99.224.9.12,HYPERVENTILATION causes RESPIRATORY ALKALOSIS,67,44,,88,60,causes,0.30151134457776396,900419-FS1-4,Hyperactivity may quickly turn to lethargy; HYPERVENTILATION (with RESPIRATORY ALKALOSIS) changes to hypoventilation (with mixed respiratory and metabolic acidosis) and respiratory failure,RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-cause_of
497243662,7/4/2014 03:50:03,,1314575284,7/4/2014 03:49:20,clixsense,0,17722340,CAN,BC,Mission,50.98.185.25,RESPIRATORY ALKALOSIS causes HYPERVENTILATION,67,44,,88,60,causes,0.30151134457776396,900419-FS1-4,Hyperactivity may quickly turn to lethargy; HYPERVENTILATION (with RESPIRATORY ALKALOSIS) changes to hypoventilation (with mixed respiratory and metabolic acidosis) and respiratory failure,RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-cause_of
497243662,7/4/2014 04:43:15,,1314599009,7/4/2014 04:42:45,instagc,0,13846187,USA,MO,Chesterfield,63.137.150.235,RESPIRATORY ALKALOSIS causes HYPERVENTILATION,67,44,,88,60,causes,0.30151134457776396,900419-FS1-4,Hyperactivity may quickly turn to lethargy; HYPERVENTILATION (with RESPIRATORY ALKALOSIS) changes to hypoventilation (with mixed respiratory and metabolic acidosis) and respiratory failure,RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-cause_of
497243662,7/4/2014 07:32:21,,1314679597,7/4/2014 07:31:52,clixsense,0,27969116,NLD,,,91.213.37.165,no_relation,67,44,,88,60,causes,0.30151134457776396,900419-FS1-4,Hyperactivity may quickly turn to lethargy; HYPERVENTILATION (with RESPIRATORY ALKALOSIS) changes to hypoventilation (with mixed respiratory and metabolic acidosis) and respiratory failure,RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-cause_of
497243662,7/4/2014 08:34:38,,1314707859,7/4/2014 08:34:22,prodege,0,15439740,AUS,2,Jannali,27.96.208.89,no_relation,67,44,,88,60,causes,0.30151134457776396,900419-FS1-4,Hyperactivity may quickly turn to lethargy; HYPERVENTILATION (with RESPIRATORY ALKALOSIS) changes to hypoventilation (with mixed respiratory and metabolic acidosis) and respiratory failure,RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-cause_of
497243662,7/4/2014 09:18:48,,1314729583,7/4/2014 09:18:15,eup_slw,0,21338859,GBR,K6,Portsmouth,86.6.113.168,HYPERVENTILATION causes RESPIRATORY ALKALOSIS,67,44,,88,60,causes,0.30151134457776396,900419-FS1-4,Hyperactivity may quickly turn to lethargy; HYPERVENTILATION (with RESPIRATORY ALKALOSIS) changes to hypoventilation (with mixed respiratory and metabolic acidosis) and respiratory failure,RESPIRATORY ALKALOSIS,HYPERVENTILATION,RO-cause_of
497984409,7/4/2014 10:30:34,,1314761994,7/4/2014 10:30:30,clixsense,0.8875,19162475,GBR,M3,Frome,82.33.126.30,GAMMA HEAVY CHAIN DISEASE is diagnosed by SPLENOMEGALY,116,15,,128,40,is diagnosed by,0.50709255283711,902622-FS1-13,A patient with GAMMA HEAVY CHAIN DISEASE (Franklin's disease) was discovered during evaluation for pancytopenia and SPLENOMEGALY,SPLENOMEGALY,GAMMA HEAVY CHAIN DISEASE,RO-disease_may_have_finding
497984409,7/4/2014 10:32:59,,1314762960,7/4/2014 10:32:30,clixsense,0.7,15189335,GBR,I9,Dereham,86.157.163.112,GAMMA HEAVY CHAIN DISEASE is diagnosed by SPLENOMEGALY,116,15,,128,40,is diagnosed by,0.50709255283711,902622-FS1-13,A patient with GAMMA HEAVY CHAIN DISEASE (Franklin's disease) was discovered during evaluation for pancytopenia and SPLENOMEGALY,SPLENOMEGALY,GAMMA HEAVY CHAIN DISEASE,RO-disease_may_have_finding
497984409,7/4/2014 10:56:52,,1314774115,7/4/2014 10:56:03,clixsense,0.5958,27969116,NLD,,,91.213.37.165,GAMMA HEAVY CHAIN DISEASE is diagnosed by SPLENOMEGALY,116,15,,128,40,is diagnosed by,0.50709255283711,902622-FS1-13,A patient with GAMMA HEAVY CHAIN DISEASE (Franklin's disease) was discovered during evaluation for pancytopenia and SPLENOMEGALY,SPLENOMEGALY,GAMMA HEAVY CHAIN DISEASE,RO-disease_may_have_finding
498010597,7/4/2014 12:47:36,False,1314841027,7/4/2014 12:47:14,rewardsspot,0.75,17763704,USA,VA,Manassas,198.7.62.204,SEIZURES causes EPILEPSY,96,17,,104,25,causes,0.975900072948533,904946-FS1-4,The treatment of EPILEPSY after the first epileptic seizure decreases effectively the number of SEIZURES within the first three years,SEIZURES,EPILEPSY,RO-has_definitional_manifestation
498010597,7/4/2014 13:06:16,False,1314855590,7/4/2014 13:06:12,prodege,0.5238,18960400,GBR,A2,Edgware,31.54.207.221,EPILEPSY causes SEIZURES,96,17,,104,25,causes,0.975900072948533,904946-FS1-4,The treatment of EPILEPSY after the first epileptic seizure decreases effectively the number of SEIZURES within the first three years,SEIZURES,EPILEPSY,RO-has_definitional_manifestation
498010597,7/4/2014 12:40:16,False,1314836110,7/4/2014 12:40:01,clixsense,0.8809999999999999,26649250,GBR,N7,Epsom,193.117.31.2,EPILEPSY causes SEIZURES,96,17,,104,25,causes,0.975900072948533,904946-FS1-4,The treatment of EPILEPSY after the first epileptic seizure decreases effectively the number of SEIZURES within the first three years,SEIZURES,EPILEPSY,RO-has_definitional_manifestation
497984414,7/4/2014 10:30:18,,1314761878,7/4/2014 10:30:13,clixsense,0.8875,19162475,GBR,M3,Frome,82.33.126.30,NEUROMYELITIS OPTICA is location of SPINAL CORD,65,121,,76,141,is location of,0.753778361444409,905148-FS1-9,"Recognizing that the patient's disease was localized only to the SPINAL CORD led to an eventual serological diagnosis of NEUROMYELITIS OPTICA (Devic's disease), a demyelinating syndrome that is now considered distinct from multiple sclerosis and that primarily affects the spinal cord and optic nerves",SPINAL CORD,NEUROMYELITIS OPTICA,RO-has_finding_site
497984414,7/4/2014 10:31:10,,1314762226,7/4/2014 10:30:40,clixsense,0.7,15189335,GBR,I9,Dereham,86.157.163.112,SPINAL CORD is location of NEUROMYELITIS OPTICA,65,121,,76,141,is location of,0.753778361444409,905148-FS1-9,"Recognizing that the patient's disease was localized only to the SPINAL CORD led to an eventual serological diagnosis of NEUROMYELITIS OPTICA (Devic's disease), a demyelinating syndrome that is now considered distinct from multiple sclerosis and that primarily affects the spinal cord and optic nerves",SPINAL CORD,NEUROMYELITIS OPTICA,RO-has_finding_site
497984414,7/4/2014 10:53:47,,1314772735,7/4/2014 10:53:16,clixsense,0.5958,27969116,NLD,,,91.213.37.165,SPINAL CORD is location of NEUROMYELITIS OPTICA,65,121,,76,141,is location of,0.753778361444409,905148-FS1-9,"Recognizing that the patient's disease was localized only to the SPINAL CORD led to an eventual serological diagnosis of NEUROMYELITIS OPTICA (Devic's disease), a demyelinating syndrome that is now considered distinct from multiple sclerosis and that primarily affects the spinal cord and optic nerves",SPINAL CORD,NEUROMYELITIS OPTICA,RO-has_finding_site
497984415,7/4/2014 10:29:28,,1314761556,7/4/2014 10:29:23,clixsense,0.8875,19162475,GBR,M3,Frome,82.33.126.30,PANCREATITIS causes PANCREAS,98,154,,106,166,causes,0.48666426339228797,905240-FS1-4,"The changes in ductal vascularity correlated with the severity of the histological changes to the PANCREAS and may, thus, in part explain the progress of PANCREATITIS",PANCREAS,PANCREATITIS,RO-has_finding_site
497984415,7/4/2014 10:29:38,,1314761608,7/4/2014 10:29:06,clixsense,0.7,15189335,GBR,I9,Dereham,86.157.163.112,no_relation,98,154,,106,166,causes,0.48666426339228797,905240-FS1-4,"The changes in ductal vascularity correlated with the severity of the histological changes to the PANCREAS and may, thus, in part explain the progress of PANCREATITIS",PANCREAS,PANCREATITIS,RO-has_finding_site
497984415,7/4/2014 11:00:21,,1314775551,7/4/2014 10:59:46,clixsense,0.5958,27969116,NLD,,,91.213.37.165,PANCREAS causes PANCREATITIS,98,154,,106,166,causes,0.48666426339228797,905240-FS1-4,"The changes in ductal vascularity correlated with the severity of the histological changes to the PANCREAS and may, thus, in part explain the progress of PANCREATITIS",PANCREAS,PANCREATITIS,RO-has_finding_site
498010590,7/4/2014 12:23:37,False,1314825523,7/4/2014 12:23:05,clixsense,1.0,15189335,GBR,I9,Dereham,86.157.163.112,no_relation,118,163,,124,178,causes,0.6488856845230501,906227-FS1-4,"We review the role of platelets in inflammation, how they assist in the recruitment of leukocytes into lung tissue in ASTHMA, and evidence of their dysfunction in CYSTIC FIBROSIS (CF",ASTHMA,CYSTIC FIBROSIS,RO-has_manifestation
498010590,7/4/2014 12:35:29,False,1314832987,7/4/2014 12:34:35,rewardsspot,0.6905,24482174,GBR,H9,London,46.23.68.180,CYSTIC FIBROSIS causes ASTHMA,118,163,,124,178,causes,0.6488856845230501,906227-FS1-4,"We review the role of platelets in inflammation, how they assist in the recruitment of leukocytes into lung tissue in ASTHMA, and evidence of their dysfunction in CYSTIC FIBROSIS (CF",ASTHMA,CYSTIC FIBROSIS,RO-has_manifestation
498010590,7/4/2014 13:13:59,False,1314861835,7/4/2014 13:13:24,clixsense,0.7051,27871219,NLD,7,Amsterdam,87.210.207.223,no_relation,118,163,,124,178,causes,0.6488856845230501,906227-FS1-4,"We review the role of platelets in inflammation, how they assist in the recruitment of leukocytes into lung tissue in ASTHMA, and evidence of their dysfunction in CYSTIC FIBROSIS (CF",ASTHMA,CYSTIC FIBROSIS,RO-has_manifestation
497999921,7/4/2014 11:35:38,,1314794176,7/4/2014 11:35:26,neodev,0.9875,18517457,GBR,,,86.29.55.201,HYDROCHLOROTHIAZIDE treats HYPERTENSION,164,79,,176,98,treats,0.911684611677103,907530-FS1-2,"b ,   c  Class:  beta-Adrenergic Blocking Agents 24:24; CV100 (VA)  Synonyms:  HYDROCHLOROTHIAZIDE and Propranolol Hydrochloride  Uses  Hypertension  Management of HYPERTENSION, alone or in combination with other antihypertensive agents",HYPERTENSION,HYDROCHLOROTHIAZIDE,RO-may_treat
497999921,7/4/2014 11:52:38,,1314804051,7/4/2014 11:52:14,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,HYDROCHLOROTHIAZIDE treats HYPERTENSION,164,79,,176,98,treats,0.911684611677103,907530-FS1-2,"b ,   c  Class:  beta-Adrenergic Blocking Agents 24:24; CV100 (VA)  Synonyms:  HYDROCHLOROTHIAZIDE and Propranolol Hydrochloride  Uses  Hypertension  Management of HYPERTENSION, alone or in combination with other antihypertensive agents",HYPERTENSION,HYDROCHLOROTHIAZIDE,RO-may_treat
497999921,7/4/2014 12:21:16,,1314823804,7/4/2014 12:20:45,clixsense,0.775,27969116,NLD,,,91.213.37.165,no_relation,164,79,,176,98,treats,0.911684611677103,907530-FS1-2,"b ,   c  Class:  beta-Adrenergic Blocking Agents 24:24; CV100 (VA)  Synonyms:  HYDROCHLOROTHIAZIDE and Propranolol Hydrochloride  Uses  Hypertension  Management of HYPERTENSION, alone or in combination with other antihypertensive agents",HYPERTENSION,HYDROCHLOROTHIAZIDE,RO-may_treat
497999928,7/4/2014 11:40:06,,1314796503,7/4/2014 11:39:54,neodev,0.9875,18517457,GBR,,,86.29.55.201,ORLISTAT treats OBESITY,97,54,,104,62,treats,1.0,907526-FS1-2,"Evaluation of the safety and efficacy of sibutramine, ORLISTAT and metformin in the treatment of OBESITY",OBESITY,ORLISTAT,RO-may_treat
497999928,7/4/2014 12:18:18,,1314821515,7/4/2014 12:17:45,clixsense,0.775,27969116,NLD,,,91.213.37.165,ORLISTAT treats OBESITY,97,54,,104,62,treats,1.0,907526-FS1-2,"Evaluation of the safety and efficacy of sibutramine, ORLISTAT and metformin in the treatment of OBESITY",OBESITY,ORLISTAT,RO-may_treat
497999928,7/4/2014 12:26:52,,1314827769,7/4/2014 12:26:36,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,ORLISTAT treats OBESITY,97,54,,104,62,treats,1.0,907526-FS1-2,"Evaluation of the safety and efficacy of sibutramine, ORLISTAT and metformin in the treatment of OBESITY",OBESITY,ORLISTAT,RO-may_treat
497999933,7/4/2014 11:34:29,,1314793546,7/4/2014 11:34:04,neodev,0.9875,18517457,GBR,,,86.29.55.201,no_relation,43,14,,61,18,causes,0.762000762001143,902739-FS1-4,Many cases of DCIS are detected because of MICROCALCIFICATION on mammograms; 20% of screen-detected cancers are of this type,MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
497999933,7/4/2014 12:22:37,,1314824848,7/4/2014 12:21:51,clixsense,0.775,27969116,NLD,,,91.213.37.165,no_relation,43,14,,61,18,causes,0.762000762001143,902739-FS1-4,Many cases of DCIS are detected because of MICROCALCIFICATION on mammograms; 20% of screen-detected cancers are of this type,MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
497999933,7/4/2014 12:30:15,,1314829724,7/4/2014 12:29:52,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,MICROCALCIFICATION causes DCIS,43,14,,61,18,causes,0.762000762001143,902739-FS1-4,Many cases of DCIS are detected because of MICROCALCIFICATION on mammograms; 20% of screen-detected cancers are of this type,MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
497999936,7/4/2014 11:35:25,,1314794029,7/4/2014 11:34:56,neodev,0.9875,18517457,GBR,,,86.29.55.201,no_relation,163,120,,174,134,is diagnosed by,0.42426406871192895,907509-FS1-13,"Ayestaran A, Lopez R, Montoro JB et al. Pharmacokinetics of conventional formulation versus fat emulsion formulation of AMPHOTERICIN B in a group of patients with NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,RO-may_treat
497999936,7/4/2014 12:22:37,,1314824843,7/4/2014 12:21:51,clixsense,0.775,27969116,NLD,,,91.213.37.165,AMPHOTERICIN B is diagnosed by NEUTROPENIA,163,120,,174,134,is diagnosed by,0.42426406871192895,907509-FS1-13,"Ayestaran A, Lopez R, Montoro JB et al. Pharmacokinetics of conventional formulation versus fat emulsion formulation of AMPHOTERICIN B in a group of patients with NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,RO-may_treat
497999936,7/4/2014 12:31:13,,1314830288,7/4/2014 12:30:50,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,no_relation,163,120,,174,134,is diagnosed by,0.42426406871192895,907509-FS1-13,"Ayestaran A, Lopez R, Montoro JB et al. Pharmacokinetics of conventional formulation versus fat emulsion formulation of AMPHOTERICIN B in a group of patients with NEUTROPENIA",NEUTROPENIA,AMPHOTERICIN B,RO-may_treat
497999938,7/4/2014 11:40:54,,1314796982,7/4/2014 11:40:36,neodev,0.9875,18517457,GBR,,,86.29.55.201,METHYLPREDNISOLONE treats GVHD,16,51,,20,69,treats,0.577350269189626,907108-FS1-2,Prophylaxis for GVHD consisted of cyclosporine and METHYLPREDNISOLONE,GVHD,METHYLPREDNISOLONE,RO-may_prevent
497999938,7/4/2014 11:52:13,,1314803825,7/4/2014 11:51:17,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,no_relation,16,51,,20,69,treats,0.577350269189626,907108-FS1-2,Prophylaxis for GVHD consisted of cyclosporine and METHYLPREDNISOLONE,GVHD,METHYLPREDNISOLONE,RO-may_prevent
497999938,7/4/2014 12:14:12,,1314818450,7/4/2014 12:13:25,clixsense,0.775,27969116,NLD,,,91.213.37.165,METHYLPREDNISOLONE treats GVHD,16,51,,20,69,treats,0.577350269189626,907108-FS1-2,Prophylaxis for GVHD consisted of cyclosporine and METHYLPREDNISOLONE,GVHD,METHYLPREDNISOLONE,RO-may_prevent
497999951,7/4/2014 11:41:46,,1314797518,7/4/2014 11:41:24,neodev,0.9875,18517457,GBR,,,86.29.55.201,THYROID DISORDERS is diagnosed by TRIIODOTHYRONINE,80,138,,97,154,is diagnosed by,0.940720868383597,906871-FS1-13,"The commonly used laboratory investigations for the diagnosis and management of THYROID DISORDERS are the thyroid hormones, thyroxine and TRIIODOTHYRONINE and the pituitary hormone, thyrotrophin (TSH",THYROID DISORDERS,TRIIODOTHYRONINE,RO-may_diagnose
497999951,7/4/2014 11:50:52,,1314803166,7/4/2014 11:50:29,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,THYROID DISORDERS is diagnosed by TRIIODOTHYRONINE,80,138,,97,154,is diagnosed by,0.940720868383597,906871-FS1-13,"The commonly used laboratory investigations for the diagnosis and management of THYROID DISORDERS are the thyroid hormones, thyroxine and TRIIODOTHYRONINE and the pituitary hormone, thyrotrophin (TSH",THYROID DISORDERS,TRIIODOTHYRONINE,RO-may_diagnose
497999951,7/4/2014 12:14:12,,1314818449,7/4/2014 12:13:25,clixsense,0.775,27969116,NLD,,,91.213.37.165,TRIIODOTHYRONINE is diagnosed by THYROID DISORDERS,80,138,,97,154,is diagnosed by,0.940720868383597,906871-FS1-13,"The commonly used laboratory investigations for the diagnosis and management of THYROID DISORDERS are the thyroid hormones, thyroxine and TRIIODOTHYRONINE and the pituitary hormone, thyrotrophin (TSH",THYROID DISORDERS,TRIIODOTHYRONINE,RO-may_diagnose
497999952,7/4/2014 12:24:53,,1314826382,7/4/2014 12:23:49,clixsense,0.775,27969116,NLD,,,91.213.37.165,no_relation,73,106,,97,114,treats,0.9797958971132711,907345-FS1-2,"In order to evaluate the preventive effect of estrogen and vitamin D3 on POSTMENOPAUSAL BONE LOSS, either ESTROGEN (Premarin 0.625 mg/day) or vitamin D3 (Onealfa 1.0 micrograms/day) was administered to postmenopausal women",POSTMENOPAUSAL BONE LOSS,ESTROGEN,RO-may_prevent
497999952,7/4/2014 12:28:10,,1314828515,7/4/2014 12:27:46,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,ESTROGEN treats POSTMENOPAUSAL BONE LOSS,73,106,,97,114,treats,0.9797958971132711,907345-FS1-2,"In order to evaluate the preventive effect of estrogen and vitamin D3 on POSTMENOPAUSAL BONE LOSS, either ESTROGEN (Premarin 0.625 mg/day) or vitamin D3 (Onealfa 1.0 micrograms/day) was administered to postmenopausal women",POSTMENOPAUSAL BONE LOSS,ESTROGEN,RO-may_prevent
497999952,7/4/2014 12:29:40,,1314829346,7/4/2014 12:29:02,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,ESTROGEN treats POSTMENOPAUSAL BONE LOSS,73,106,,97,114,treats,0.9797958971132711,907345-FS1-2,"In order to evaluate the preventive effect of estrogen and vitamin D3 on POSTMENOPAUSAL BONE LOSS, either ESTROGEN (Premarin 0.625 mg/day) or vitamin D3 (Onealfa 1.0 micrograms/day) was administered to postmenopausal women",POSTMENOPAUSAL BONE LOSS,ESTROGEN,RO-may_prevent
497999953,7/4/2014 12:26:34,,1314827567,7/4/2014 12:26:06,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,DEXAMETHASONE treats HYPERCORTISOLISM,48,104,,64,117,treats,0.78086880944303,906657-FS1-2,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
497999953,7/4/2014 12:32:37,,1314831058,7/4/2014 12:32:25,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,no_relation,48,104,,64,117,treats,0.78086880944303,906657-FS1-2,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
497999953,7/4/2014 12:33:17,,1314831523,7/4/2014 12:32:43,rewardsspot,0.7879,24482174,GBR,H9,London,46.23.68.180,DEXAMETHASONE treats HYPERCORTISOLISM,48,104,,64,117,treats,0.78086880944303,906657-FS1-2,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
497999955,7/4/2014 11:47:07,,1314800821,7/4/2014 11:46:45,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,ISOTRETINOIN treats ACNE,37,61,,41,73,treats,0.9838699100999069,907655-FS1-2,Association of suicide attempts with ACNE and treatment with ISOTRETINOIN: retrospective Swedish cohort study,ACNE,ISOTRETINOIN,RO-may_treat
497999955,7/4/2014 12:31:19,,1314830363,7/4/2014 12:31:05,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,ISOTRETINOIN treats ACNE,37,61,,41,73,treats,0.9838699100999069,907655-FS1-2,Association of suicide attempts with ACNE and treatment with ISOTRETINOIN: retrospective Swedish cohort study,ACNE,ISOTRETINOIN,RO-may_treat
497999955,7/4/2014 12:32:23,,1314830962,7/4/2014 12:31:57,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,ISOTRETINOIN treats ACNE,37,61,,41,73,treats,0.9838699100999069,907655-FS1-2,Association of suicide attempts with ACNE and treatment with ISOTRETINOIN: retrospective Swedish cohort study,ACNE,ISOTRETINOIN,RO-may_treat
497999963,7/4/2014 12:16:03,,1314819812,7/4/2014 12:15:33,clixsense,0.775,27969116,NLD,,,91.213.37.165,ERGONOVINE is diagnosed by VASOSPASTIC ANGINA,156,103,,174,113,is diagnosed by,0.975900072948533,906650-FS1-13,"These results suggest that the two provocative tests for coronary spasm that involve acetylcholine and ERGONOVINE are clinically useful in the diagnosis of VASOSPASTIC ANGINA, but testing with intracoronary ergonovine is needed when a spontaneous focal coronary spasm is relieved by the intracoronary injection of acetylcholine",VASOSPASTIC ANGINA,ERGONOVINE,RO-may_diagnose
497999963,7/4/2014 12:31:56,,1314830758,7/4/2014 12:31:34,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,VASOSPASTIC ANGINA is diagnosed by ERGONOVINE,156,103,,174,113,is diagnosed by,0.975900072948533,906650-FS1-13,"These results suggest that the two provocative tests for coronary spasm that involve acetylcholine and ERGONOVINE are clinically useful in the diagnosis of VASOSPASTIC ANGINA, but testing with intracoronary ergonovine is needed when a spontaneous focal coronary spasm is relieved by the intracoronary injection of acetylcholine",VASOSPASTIC ANGINA,ERGONOVINE,RO-may_diagnose
497999963,7/4/2014 12:33:13,,1314831449,7/4/2014 12:32:39,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,VASOSPASTIC ANGINA is diagnosed by ERGONOVINE,156,103,,174,113,is diagnosed by,0.975900072948533,906650-FS1-13,"These results suggest that the two provocative tests for coronary spasm that involve acetylcholine and ERGONOVINE are clinically useful in the diagnosis of VASOSPASTIC ANGINA, but testing with intracoronary ergonovine is needed when a spontaneous focal coronary spasm is relieved by the intracoronary injection of acetylcholine",VASOSPASTIC ANGINA,ERGONOVINE,RO-may_diagnose
497999967,7/4/2014 11:35:48,,1314794261,7/4/2014 11:35:40,neodev,0.9875,18517457,GBR,,,86.29.55.201,THYROXINE treats THYROID DEFICIENCY,180,126,,198,135,treats,0.635000635000953,907209-FS1-2,"In developing PTU-treated rats, the abnormalities completely disappeared after therapy with increasing physiological doses of THYROXINE; consequently they were directly related to THYROID DEFICIENCY and not to toxic effects of PTU",THYROID DEFICIENCY,THYROXINE,RO-may_prevent
497999967,7/4/2014 12:28:23,,1314828600,7/4/2014 12:27:55,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,THYROXINE treats THYROID DEFICIENCY,180,126,,198,135,treats,0.635000635000953,907209-FS1-2,"In developing PTU-treated rats, the abnormalities completely disappeared after therapy with increasing physiological doses of THYROXINE; consequently they were directly related to THYROID DEFICIENCY and not to toxic effects of PTU",THYROID DEFICIENCY,THYROXINE,RO-may_prevent
497999967,7/4/2014 12:31:24,,1314830432,7/4/2014 12:30:46,rewardsspot,0.7879,24482174,GBR,H9,London,46.23.68.180,THYROXINE treats THYROID DEFICIENCY,180,126,,198,135,treats,0.635000635000953,907209-FS1-2,"In developing PTU-treated rats, the abnormalities completely disappeared after therapy with increasing physiological doses of THYROXINE; consequently they were directly related to THYROID DEFICIENCY and not to toxic effects of PTU",THYROID DEFICIENCY,THYROXINE,RO-may_prevent
497999981,7/4/2014 11:39:50,,1314796373,7/4/2014 11:39:30,clixsense,0.902,27871219,NLD,7,Amsterdam,87.210.207.223,PENTAMIDINE ISETHIONATE treats PNEUMOCYSTIS PNEUMONIA,101,68,,123,91,treats,0.953462589245592,907179-FS1-2,"In 1984, three patients died of severe hypoglycemia after receiving PENTAMIDINE ISETHIONATE to treat PNEUMOCYSTIS PNEUMONIA",PNEUMOCYSTIS PNEUMONIA,PENTAMIDINE ISETHIONATE,RO-may_prevent
497999981,7/4/2014 12:27:45,,1314828187,7/4/2014 12:27:25,neodev,0.8048,11014534,GBR,H9,London,80.254.147.52,PNEUMOCYSTIS PNEUMONIA treats PENTAMIDINE ISETHIONATE,101,68,,123,91,treats,0.953462589245592,907179-FS1-2,"In 1984, three patients died of severe hypoglycemia after receiving PENTAMIDINE ISETHIONATE to treat PNEUMOCYSTIS PNEUMONIA",PNEUMOCYSTIS PNEUMONIA,PENTAMIDINE ISETHIONATE,RO-may_prevent
497999981,7/4/2014 12:33:13,,1314831442,7/4/2014 12:32:39,clixsense,0.8073,15189335,GBR,I9,Dereham,86.157.163.112,PENTAMIDINE ISETHIONATE treats PNEUMOCYSTIS PNEUMONIA,101,68,,123,91,treats,0.953462589245592,907179-FS1-2,"In 1984, three patients died of severe hypoglycemia after receiving PENTAMIDINE ISETHIONATE to treat PNEUMOCYSTIS PNEUMONIA",PNEUMOCYSTIS PNEUMONIA,PENTAMIDINE ISETHIONATE,RO-may_prevent
498023341,7/4/2014 15:04:34,False,1314949832,7/4/2014 15:04:07,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,no_relation,69,11,,97,23,treats,0.956182887467515,907847-FS1-2,Effects of CHLORAMBUCIL and therapeutic decision in initial forms of CHRONIC LYMPHOCYTIC LEUKEMIA (stage A): results of a randomized clinical trial on 612 patients,CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL,RO-may_treat
498023341,7/4/2014 15:19:28,False,1314961329,7/4/2014 15:19:07,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,CHLORAMBUCIL treats CHRONIC LYMPHOCYTIC LEUKEMIA,69,11,,97,23,treats,0.956182887467515,907847-FS1-2,Effects of CHLORAMBUCIL and therapeutic decision in initial forms of CHRONIC LYMPHOCYTIC LEUKEMIA (stage A): results of a randomized clinical trial on 612 patients,CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL,RO-may_treat
498023341,7/4/2014 15:31:15,False,1314971483,7/4/2014 15:31:00,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,CHLORAMBUCIL treats CHRONIC LYMPHOCYTIC LEUKEMIA,69,11,,97,23,treats,0.956182887467515,907847-FS1-2,Effects of CHLORAMBUCIL and therapeutic decision in initial forms of CHRONIC LYMPHOCYTIC LEUKEMIA (stage A): results of a randomized clinical trial on 612 patients,CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL,RO-may_treat
498023341,7/4/2014 15:47:18,False,1314983270,7/4/2014 15:46:47,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,CHLORAMBUCIL treats CHRONIC LYMPHOCYTIC LEUKEMIA,69,11,,97,23,treats,0.956182887467515,907847-FS1-2,Effects of CHLORAMBUCIL and therapeutic decision in initial forms of CHRONIC LYMPHOCYTIC LEUKEMIA (stage A): results of a randomized clinical trial on 612 patients,CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL,RO-may_treat
498023341,7/4/2014 15:48:44,False,1314984514,7/4/2014 15:48:09,rewardsspot,0.6639,24482174,GBR,H9,London,146.185.23.27,CHLORAMBUCIL treats CHRONIC LYMPHOCYTIC LEUKEMIA,69,11,,97,23,treats,0.956182887467515,907847-FS1-2,Effects of CHLORAMBUCIL and therapeutic decision in initial forms of CHRONIC LYMPHOCYTIC LEUKEMIA (stage A): results of a randomized clinical trial on 612 patients,CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL,RO-may_treat
498023361,7/4/2014 14:48:00,False,1314936179,7/4/2014 14:47:49,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,METHYLPREDNISOLONE treats GVHD,16,51,,20,69,treats,0.577350269189626,907108-FS1-2,Prophylaxis for GVHD consisted of cyclosporine and METHYLPREDNISOLONE,GVHD,METHYLPREDNISOLONE,RO-may_prevent
498023361,7/4/2014 15:21:17,False,1314962897,7/4/2014 15:21:05,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,METHYLPREDNISOLONE treats GVHD,16,51,,20,69,treats,0.577350269189626,907108-FS1-2,Prophylaxis for GVHD consisted of cyclosporine and METHYLPREDNISOLONE,GVHD,METHYLPREDNISOLONE,RO-may_prevent
498023361,7/4/2014 15:32:37,False,1314972750,7/4/2014 15:32:24,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,METHYLPREDNISOLONE treats GVHD,16,51,,20,69,treats,0.577350269189626,907108-FS1-2,Prophylaxis for GVHD consisted of cyclosporine and METHYLPREDNISOLONE,GVHD,METHYLPREDNISOLONE,RO-may_prevent
498023361,7/4/2014 15:40:58,False,1314978747,7/4/2014 15:40:14,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,METHYLPREDNISOLONE treats GVHD,16,51,,20,69,treats,0.577350269189626,907108-FS1-2,Prophylaxis for GVHD consisted of cyclosporine and METHYLPREDNISOLONE,GVHD,METHYLPREDNISOLONE,RO-may_prevent
498023361,7/4/2014 15:52:06,False,1314987216,7/4/2014 15:51:58,neodev,0.5875,25804244,USA,IL,Chicago,99.198.108.116,METHYLPREDNISOLONE treats GVHD,16,51,,20,69,treats,0.577350269189626,907108-FS1-2,Prophylaxis for GVHD consisted of cyclosporine and METHYLPREDNISOLONE,GVHD,METHYLPREDNISOLONE,RO-may_prevent
498023364,7/4/2014 14:54:12,False,1314941137,7/4/2014 14:53:35,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,no_relation,5,30,,28,51,contraindicates,0.308606699924184,902767-FS1-10,"With POSTMENOPAUSAL BLEEDING, ENDOMETRIAL CARCINOMA must always be ruled out",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,RO-disease_may_have_finding
498023364,7/4/2014 15:14:04,False,1314957093,7/4/2014 15:13:34,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,5,30,,28,51,contraindicates,0.308606699924184,902767-FS1-10,"With POSTMENOPAUSAL BLEEDING, ENDOMETRIAL CARCINOMA must always be ruled out",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,RO-disease_may_have_finding
498023364,7/4/2014 15:26:55,False,1314967303,7/4/2014 15:26:34,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,ENDOMETRIAL CARCINOMA contraindicates POSTMENOPAUSAL BLEEDING,5,30,,28,51,contraindicates,0.308606699924184,902767-FS1-10,"With POSTMENOPAUSAL BLEEDING, ENDOMETRIAL CARCINOMA must always be ruled out",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,RO-disease_may_have_finding
498023364,7/4/2014 15:30:57,False,1314971229,7/4/2014 15:30:21,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,POSTMENOPAUSAL BLEEDING contraindicates ENDOMETRIAL CARCINOMA,5,30,,28,51,contraindicates,0.308606699924184,902767-FS1-10,"With POSTMENOPAUSAL BLEEDING, ENDOMETRIAL CARCINOMA must always be ruled out",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,RO-disease_may_have_finding
498023364,7/4/2014 15:45:11,False,1314981641,7/4/2014 15:44:40,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,no_relation,5,30,,28,51,contraindicates,0.308606699924184,902767-FS1-10,"With POSTMENOPAUSAL BLEEDING, ENDOMETRIAL CARCINOMA must always be ruled out",POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,RO-disease_may_have_finding
498023367,7/4/2014 14:45:17,False,1314933495,7/4/2014 14:45:02,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,no_relation,105,59,,128,72,treats,0.811107105653813,907865-FS1-2,A clinical comparison between glipizide (Glibenese LIBENCLAMIDEnclamide (Daonil  tMATURITY ONSET DIABETESy onset diabetes: a controlled double-blind cross-over study,MATURITY ONSET DIABETES,GLIBENCLAMIDE,RO-may_treat
498023367,7/4/2014 14:51:45,False,1314939323,7/4/2014 14:51:28,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,no_relation,105,59,,128,72,treats,0.811107105653813,907865-FS1-2,A clinical comparison between glipizide (Glibenese LIBENCLAMIDEnclamide (Daonil  tMATURITY ONSET DIABETESy onset diabetes: a controlled double-blind cross-over study,MATURITY ONSET DIABETES,GLIBENCLAMIDE,RO-may_treat
498023367,7/4/2014 15:02:52,False,1314948428,7/4/2014 15:01:48,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,no_relation,105,59,,128,72,treats,0.811107105653813,907865-FS1-2,A clinical comparison between glipizide (Glibenese LIBENCLAMIDEnclamide (Daonil  tMATURITY ONSET DIABETESy onset diabetes: a controlled double-blind cross-over study,MATURITY ONSET DIABETES,GLIBENCLAMIDE,RO-may_treat
498023367,7/4/2014 15:30:13,False,1314970357,7/4/2014 15:30:01,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,GLIBENCLAMIDE treats MATURITY ONSET DIABETES,105,59,,128,72,treats,0.811107105653813,907865-FS1-2,A clinical comparison between glipizide (Glibenese LIBENCLAMIDEnclamide (Daonil  tMATURITY ONSET DIABETESy onset diabetes: a controlled double-blind cross-over study,MATURITY ONSET DIABETES,GLIBENCLAMIDE,RO-may_treat
498023367,7/4/2014 15:30:19,False,1314970531,7/4/2014 15:30:13,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,GLIBENCLAMIDE treats MATURITY ONSET DIABETES,105,59,,128,72,treats,0.811107105653813,907865-FS1-2,A clinical comparison between glipizide (Glibenese LIBENCLAMIDEnclamide (Daonil  tMATURITY ONSET DIABETESy onset diabetes: a controlled double-blind cross-over study,MATURITY ONSET DIABETES,GLIBENCLAMIDE,RO-may_treat
498023374,7/4/2014 14:49:08,False,1314937082,7/4/2014 14:48:42,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,no_relation,80,138,,97,154,is diagnosed by,0.940720868383597,906871-FS1-13,"The commonly used laboratory investigations for the diagnosis and management of THYROID DISORDERS are the thyroid hormones, thyroxine and TRIIODOTHYRONINE and the pituitary hormone, thyrotrophin (TSH",THYROID DISORDERS,TRIIODOTHYRONINE,RO-may_diagnose
498023374,7/4/2014 15:02:52,False,1314948431,7/4/2014 15:01:48,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,THYROID DISORDERS is diagnosed by TRIIODOTHYRONINE,80,138,,97,154,is diagnosed by,0.940720868383597,906871-FS1-13,"The commonly used laboratory investigations for the diagnosis and management of THYROID DISORDERS are the thyroid hormones, thyroxine and TRIIODOTHYRONINE and the pituitary hormone, thyrotrophin (TSH",THYROID DISORDERS,TRIIODOTHYRONINE,RO-may_diagnose
498023374,7/4/2014 15:10:34,False,1314954771,7/4/2014 15:10:12,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,80,138,,97,154,is diagnosed by,0.940720868383597,906871-FS1-13,"The commonly used laboratory investigations for the diagnosis and management of THYROID DISORDERS are the thyroid hormones, thyroxine and TRIIODOTHYRONINE and the pituitary hormone, thyrotrophin (TSH",THYROID DISORDERS,TRIIODOTHYRONINE,RO-may_diagnose
498023374,7/4/2014 15:30:19,False,1314970532,7/4/2014 15:30:13,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,THYROID DISORDERS is diagnosed by TRIIODOTHYRONINE,80,138,,97,154,is diagnosed by,0.940720868383597,906871-FS1-13,"The commonly used laboratory investigations for the diagnosis and management of THYROID DISORDERS are the thyroid hormones, thyroxine and TRIIODOTHYRONINE and the pituitary hormone, thyrotrophin (TSH",THYROID DISORDERS,TRIIODOTHYRONINE,RO-may_diagnose
498023374,7/4/2014 15:30:42,False,1314970986,7/4/2014 15:30:14,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,no_relation,80,138,,97,154,is diagnosed by,0.940720868383597,906871-FS1-13,"The commonly used laboratory investigations for the diagnosis and management of THYROID DISORDERS are the thyroid hormones, thyroxine and TRIIODOTHYRONINE and the pituitary hormone, thyrotrophin (TSH",THYROID DISORDERS,TRIIODOTHYRONINE,RO-may_diagnose
498023377,7/4/2014 14:49:41,False,1314937649,7/4/2014 14:49:29,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,no_relation,48,104,,64,117,causes,0.312347523777212,906657-FS1-4,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
498023377,7/4/2014 14:52:30,False,1314939760,7/4/2014 14:52:07,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,no_relation,48,104,,64,117,causes,0.312347523777212,906657-FS1-4,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
498023377,7/4/2014 15:23:43,False,1314964710,7/4/2014 15:23:16,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,DEXAMETHASONE causes HYPERCORTISOLISM,48,104,,64,117,causes,0.312347523777212,906657-FS1-4,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
498023377,7/4/2014 15:30:42,False,1314970993,7/4/2014 15:30:14,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,no_relation,48,104,,64,117,causes,0.312347523777212,906657-FS1-4,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
498023377,7/4/2014 15:31:53,False,1314972112,7/4/2014 15:31:42,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,HYPERCORTISOLISM causes DEXAMETHASONE,48,104,,64,117,causes,0.312347523777212,906657-FS1-4,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
498023383,7/4/2014 14:46:48,False,1314934905,7/4/2014 14:46:33,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,INSULIN treats HYPERGLYCEMIA,82,138,,95,145,treats,0.98058067569092,907915-FS1-2,"Beta cells are nonetheless destroyed (by unknown means), and the patient develops HYPERGLYCEMIA or ketoacidosis unless he or she receives INSULIN",HYPERGLYCEMIA,INSULIN,RO-may_treat
498023383,7/4/2014 14:49:33,False,1314937571,7/4/2014 14:49:09,clixsense,0.8625,19803139,NLD,6,Veldhoven,212.61.84.196,INSULIN treats HYPERGLYCEMIA,82,138,,95,145,treats,0.98058067569092,907915-FS1-2,"Beta cells are nonetheless destroyed (by unknown means), and the patient develops HYPERGLYCEMIA or ketoacidosis unless he or she receives INSULIN",HYPERGLYCEMIA,INSULIN,RO-may_treat
498023383,7/4/2014 15:14:24,False,1314957301,7/4/2014 15:14:06,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,82,138,,95,145,treats,0.98058067569092,907915-FS1-2,"Beta cells are nonetheless destroyed (by unknown means), and the patient develops HYPERGLYCEMIA or ketoacidosis unless he or she receives INSULIN",HYPERGLYCEMIA,INSULIN,RO-may_treat
498023383,7/4/2014 15:21:54,False,1314963328,7/4/2014 15:21:39,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,INSULIN treats HYPERGLYCEMIA,82,138,,95,145,treats,0.98058067569092,907915-FS1-2,"Beta cells are nonetheless destroyed (by unknown means), and the patient develops HYPERGLYCEMIA or ketoacidosis unless he or she receives INSULIN",HYPERGLYCEMIA,INSULIN,RO-may_treat
498023383,7/4/2014 15:31:47,False,1314972049,7/4/2014 15:31:32,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,INSULIN treats HYPERGLYCEMIA,82,138,,95,145,treats,0.98058067569092,907915-FS1-2,"Beta cells are nonetheless destroyed (by unknown means), and the patient develops HYPERGLYCEMIA or ketoacidosis unless he or she receives INSULIN",HYPERGLYCEMIA,INSULIN,RO-may_treat
498023397,7/4/2014 14:55:14,False,1314941951,7/4/2014 14:54:13,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,ERGOMETRINE treats VARIANT ANGINA,214,128,,228,139,treats,0.964901281354015,906931-FS1-2,"Studies were performed on isolated canine coronary artery segments to characterize the mechanism of the constrictor response of ERGOMETRINE (ergonovine), an agent used to induce coronary vasospasm in patients with VARIANT ANGINA",VARIANT ANGINA,ERGOMETRINE,RO-may_diagnose
498023397,7/4/2014 15:15:33,False,1314958170,7/4/2014 15:15:15,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,214,128,,228,139,treats,0.964901281354015,906931-FS1-2,"Studies were performed on isolated canine coronary artery segments to characterize the mechanism of the constrictor response of ERGOMETRINE (ergonovine), an agent used to induce coronary vasospasm in patients with VARIANT ANGINA",VARIANT ANGINA,ERGOMETRINE,RO-may_diagnose
498023397,7/4/2014 15:25:02,False,1314965712,7/4/2014 15:24:37,clixsense,0.6246,15189335,GBR,I9,Dereham,86.157.163.112,ERGOMETRINE treats VARIANT ANGINA,214,128,,228,139,treats,0.964901281354015,906931-FS1-2,"Studies were performed on isolated canine coronary artery segments to characterize the mechanism of the constrictor response of ERGOMETRINE (ergonovine), an agent used to induce coronary vasospasm in patients with VARIANT ANGINA",VARIANT ANGINA,ERGOMETRINE,RO-may_diagnose
498023397,7/4/2014 15:31:31,False,1314971797,7/4/2014 15:31:16,prodege,0.6637,14848125,GBR,V2,Glasgow,86.130.194.252,ERGOMETRINE treats VARIANT ANGINA,214,128,,228,139,treats,0.964901281354015,906931-FS1-2,"Studies were performed on isolated canine coronary artery segments to characterize the mechanism of the constrictor response of ERGOMETRINE (ergonovine), an agent used to induce coronary vasospasm in patients with VARIANT ANGINA",VARIANT ANGINA,ERGOMETRINE,RO-may_diagnose
498023397,7/4/2014 15:42:10,False,1314979517,7/4/2014 15:41:20,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,no_relation,214,128,,228,139,treats,0.964901281354015,906931-FS1-2,"Studies were performed on isolated canine coronary artery segments to characterize the mechanism of the constrictor response of ERGOMETRINE (ergonovine), an agent used to induce coronary vasospasm in patients with VARIANT ANGINA",VARIANT ANGINA,ERGOMETRINE,RO-may_diagnose
498023403,7/4/2014 14:49:58,False,1314937825,7/4/2014 14:49:42,prodege,0.8625,14890188,GBR,I2,Manchester,151.230.18.68,DCIS is diagnosed by MICROCALCIFICATION,43,14,,61,18,is diagnosed by,0.635000635000953,902739-FS1-13,Many cases of DCIS are detected because of MICROCALCIFICATION on mammograms; 20% of screen-detected cancers are of this type,MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
498023403,7/4/2014 14:59:43,False,1314945441,7/4/2014 14:59:04,clixsense,0.7667,27969116,NLD,4,Veendam,185.12.216.74,DCIS is diagnosed by MICROCALCIFICATION,43,14,,61,18,is diagnosed by,0.635000635000953,902739-FS1-13,Many cases of DCIS are detected because of MICROCALCIFICATION on mammograms; 20% of screen-detected cancers are of this type,MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
498023403,7/4/2014 15:10:10,False,1314954450,7/4/2014 15:09:50,clixsense,0.6479,6394333,GBR,,,86.29.240.182,no_relation,43,14,,61,18,is diagnosed by,0.635000635000953,902739-FS1-13,Many cases of DCIS are detected because of MICROCALCIFICATION on mammograms; 20% of screen-detected cancers are of this type,MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
498023403,7/4/2014 15:37:00,False,1314975970,7/4/2014 15:36:36,gptbanks,0.4263,18496428,USA,CA,Newhall,199.244.112.44,MICROCALCIFICATION is diagnosed by DCIS,43,14,,61,18,is diagnosed by,0.635000635000953,902739-FS1-13,Many cases of DCIS are detected because of MICROCALCIFICATION on mammograms; 20% of screen-detected cancers are of this type,MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
498023403,7/4/2014 15:44:13,False,1314980861,7/4/2014 15:43:35,bitcoinget,0.6363,21490602,USA,NJ,Dunellen,68.193.37.224,DCIS is diagnosed by MICROCALCIFICATION,43,14,,61,18,is diagnosed by,0.635000635000953,902739-FS1-13,Many cases of DCIS are detected because of MICROCALCIFICATION on mammograms; 20% of screen-detected cancers are of this type,MICROCALCIFICATION,DCIS,RO-disease_may_have_finding
502804122,7/13/2014 10:57:47,,1321825259,7/13/2014 10:57:40,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,DIABETES INSIPIDUS causes WOLFRAM SYNDROME,85,0,,102,15,causes,0.9950371901999999,906382-FS1-4,"WOLFRAM SYNDROME (WFS) is a rare diffuse neurodegenerative disorder characterized by DIABETES INSIPIDUS diabetes mellitus, optic atrophy, deafness, and a wide variety of central nervous system abnormalities.",DIABETES INSIPIDUS,WOLFRAM SYNDROME,RO-has_manifestation
502804122,7/13/2014 11:07:18,,1321828689,7/13/2014 11:07:02,clixsense,0.6806,27793793,GBR,C5,Chester,151.230.27.155,DIABETES INSIPIDUS causes WOLFRAM SYNDROME,85,0,,102,15,causes,0.9950371901999999,906382-FS1-4,"WOLFRAM SYNDROME (WFS) is a rare diffuse neurodegenerative disorder characterized by DIABETES INSIPIDUS diabetes mellitus, optic atrophy, deafness, and a wide variety of central nervous system abnormalities.",DIABETES INSIPIDUS,WOLFRAM SYNDROME,RO-has_manifestation
502804122,7/13/2014 11:50:46,,1321846243,7/13/2014 11:50:34,prodege,0.5986,12944140,GBR,I4,Mitcham,92.21.66.102,WOLFRAM SYNDROME causes DIABETES INSIPIDUS,85,0,,102,15,causes,0.9950371901999999,906382-FS1-4,"WOLFRAM SYNDROME (WFS) is a rare diffuse neurodegenerative disorder characterized by DIABETES INSIPIDUS diabetes mellitus, optic atrophy, deafness, and a wide variety of central nervous system abnormalities.",DIABETES INSIPIDUS,WOLFRAM SYNDROME,RO-has_manifestation
502804122,7/13/2014 12:00:27,,1321850017,7/13/2014 11:59:56,prodege,0.4611,28039757,GBR,L8,Southport,109.155.158.54,no_relation,85,0,,102,15,causes,0.9950371901999999,906382-FS1-4,"WOLFRAM SYNDROME (WFS) is a rare diffuse neurodegenerative disorder characterized by DIABETES INSIPIDUS diabetes mellitus, optic atrophy, deafness, and a wide variety of central nervous system abnormalities.",DIABETES INSIPIDUS,WOLFRAM SYNDROME,RO-has_manifestation
502804122,7/13/2014 12:11:38,,1321853857,7/13/2014 12:11:18,instagc,0.6389,15445601,USA,FL,Jacksonville,24.129.68.254,no_relation,85,0,,102,15,causes,0.9950371901999999,906382-FS1-4,"WOLFRAM SYNDROME (WFS) is a rare diffuse neurodegenerative disorder characterized by DIABETES INSIPIDUS diabetes mellitus, optic atrophy, deafness, and a wide variety of central nervous system abnormalities.",DIABETES INSIPIDUS,WOLFRAM SYNDROME,RO-has_manifestation
502804122,7/13/2014 12:15:08,,1321855011,7/13/2014 12:14:44,clixsense,0.5603,27871219,NLD,07,Amsterdam,87.210.207.223,WOLFRAM SYNDROME causes DIABETES INSIPIDUS,85,0,,102,15,causes,0.9950371901999999,906382-FS1-4,"WOLFRAM SYNDROME (WFS) is a rare diffuse neurodegenerative disorder characterized by DIABETES INSIPIDUS diabetes mellitus, optic atrophy, deafness, and a wide variety of central nervous system abnormalities.",DIABETES INSIPIDUS,WOLFRAM SYNDROME,RO-has_manifestation
502804122,7/13/2014 12:32:06,,1321861831,7/13/2014 12:31:07,prodege,0.4998,28480832,GBR,J1,Northampton,78.151.200.222,DIABETES INSIPIDUS causes WOLFRAM SYNDROME,85,0,,102,15,causes,0.9950371901999999,906382-FS1-4,"WOLFRAM SYNDROME (WFS) is a rare diffuse neurodegenerative disorder characterized by DIABETES INSIPIDUS diabetes mellitus, optic atrophy, deafness, and a wide variety of central nervous system abnormalities.",DIABETES INSIPIDUS,WOLFRAM SYNDROME,RO-has_manifestation
502804128,7/13/2014 10:58:10,,1321825436,7/13/2014 10:58:03,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,MYXEDEMA treats INTRAVENOUS L THYROXINE,79,106,,86,128,treats,0.9525793444,907952-FS1-2,"2]  Ridgway EC, McCammon JA, Benotti J, Maloof F. Acute metabolic responses in MYXEDEMA to large doses of INTRAVENOUS L THYROXINE",MYXEDEMA,INTRAVENOUS L THYROXINE,RO-may_treat
502804128,7/13/2014 11:07:18,,1321828690,7/13/2014 11:07:02,clixsense,0.6806,27793793,GBR,C5,Chester,151.230.27.155,INTRAVENOUS L THYROXINE treats MYXEDEMA,79,106,,86,128,treats,0.9525793444,907952-FS1-2,"2]  Ridgway EC, McCammon JA, Benotti J, Maloof F. Acute metabolic responses in MYXEDEMA to large doses of INTRAVENOUS L THYROXINE",MYXEDEMA,INTRAVENOUS L THYROXINE,RO-may_treat
502804128,7/13/2014 11:17:56,,1321833494,7/13/2014 11:17:20,rewardsspot,0.7222,24482174,GBR,H9,London,46.23.68.180,INTRAVENOUS L THYROXINE treats MYXEDEMA,79,106,,86,128,treats,0.9525793444,907952-FS1-2,"2]  Ridgway EC, McCammon JA, Benotti J, Maloof F. Acute metabolic responses in MYXEDEMA to large doses of INTRAVENOUS L THYROXINE",MYXEDEMA,INTRAVENOUS L THYROXINE,RO-may_treat
502804128,7/13/2014 12:07:17,,1321852399,7/13/2014 12:07:04,instagc,0.6389,15445601,USA,FL,Jacksonville,24.129.68.254,INTRAVENOUS L THYROXINE treats MYXEDEMA,79,106,,86,128,treats,0.9525793444,907952-FS1-2,"2]  Ridgway EC, McCammon JA, Benotti J, Maloof F. Acute metabolic responses in MYXEDEMA to large doses of INTRAVENOUS L THYROXINE",MYXEDEMA,INTRAVENOUS L THYROXINE,RO-may_treat
502804128,7/13/2014 13:05:44,,1321875518,7/13/2014 13:05:20,instagc,0.6448,23149109,USA,NC,Durham,75.189.206.205,INTRAVENOUS L THYROXINE treats MYXEDEMA,79,106,,86,128,treats,0.9525793444,907952-FS1-2,"2]  Ridgway EC, McCammon JA, Benotti J, Maloof F. Acute metabolic responses in MYXEDEMA to large doses of INTRAVENOUS L THYROXINE",MYXEDEMA,INTRAVENOUS L THYROXINE,RO-may_treat
502804128,7/13/2014 13:18:26,,1321880665,7/13/2014 13:17:45,instagc,0.7079,21551272,GBR,Q3,Wolverhampton,2.103.57.104,INTRAVENOUS L THYROXINE treats MYXEDEMA,79,106,,86,128,treats,0.9525793444,907952-FS1-2,"2]  Ridgway EC, McCammon JA, Benotti J, Maloof F. Acute metabolic responses in MYXEDEMA to large doses of INTRAVENOUS L THYROXINE",MYXEDEMA,INTRAVENOUS L THYROXINE,RO-may_treat
502804128,7/13/2014 13:18:58,,1321880914,7/13/2014 13:18:39,neodev,0.6736,14861092,GBR,I2,Manchester,90.194.137.76,INTRAVENOUS L THYROXINE treats MYXEDEMA,79,106,,86,128,treats,0.9525793444,907952-FS1-2,"2]  Ridgway EC, McCammon JA, Benotti J, Maloof F. Acute metabolic responses in MYXEDEMA to large doses of INTRAVENOUS L THYROXINE",MYXEDEMA,INTRAVENOUS L THYROXINE,RO-may_treat
502804129,7/13/2014 11:50:13,,1321845995,7/13/2014 11:49:36,instagc,0.6486,19004168,GBR,H2,Accrington,80.47.185.52,CONTROLLED TRIAL OF NORFLOXACIN AND AMOXYCILLIN IN treats TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTION IN THE ELDERLY,90,35,,154,84,treats,0.8111071056999999,907612-FS1-2,"Hill S, Yeates M, Pathy J et al. A CONTROLLED TRIAL OF NORFLOXACIN AND AMOXYCILLIN IN the TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTION IN THE ELDERLY.",TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTION IN THE ELDERLY,CONTROLLED TRIAL OF NORFLOXACIN AND AMOXYCILLIN IN,RO-may_treat
502804129,7/13/2014 11:50:46,,1321846242,7/13/2014 11:50:34,prodege,0.5986,12944140,GBR,I4,Mitcham,92.21.66.102,no_relation,90,35,,154,84,treats,0.8111071056999999,907612-FS1-2,"Hill S, Yeates M, Pathy J et al. A CONTROLLED TRIAL OF NORFLOXACIN AND AMOXYCILLIN IN the TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTION IN THE ELDERLY.",TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTION IN THE ELDERLY,CONTROLLED TRIAL OF NORFLOXACIN AND AMOXYCILLIN IN,RO-may_treat
502804129,7/13/2014 11:57:27,,1321848774,7/13/2014 11:57:04,prodege,0.4611,28039757,GBR,L8,Southport,109.155.158.54,no_relation,90,35,,154,84,treats,0.8111071056999999,907612-FS1-2,"Hill S, Yeates M, Pathy J et al. A CONTROLLED TRIAL OF NORFLOXACIN AND AMOXYCILLIN IN the TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTION IN THE ELDERLY.",TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTION IN THE ELDERLY,CONTROLLED TRIAL OF NORFLOXACIN AND AMOXYCILLIN IN,RO-may_treat
502804129,7/13/2014 12:14:43,,1321854869,7/13/2014 12:14:06,clixsense,0.5603,27871219,NLD,07,Amsterdam,87.210.207.223,CONTROLLED TRIAL OF NORFLOXACIN AND AMOXYCILLIN IN treats TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTION IN THE ELDERLY,90,35,,154,84,treats,0.8111071056999999,907612-FS1-2,"Hill S, Yeates M, Pathy J et al. A CONTROLLED TRIAL OF NORFLOXACIN AND AMOXYCILLIN IN the TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTION IN THE ELDERLY.",TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTION IN THE ELDERLY,CONTROLLED TRIAL OF NORFLOXACIN AND AMOXYCILLIN IN,RO-may_treat
502804129,7/13/2014 12:32:40,,1321862038,7/13/2014 12:32:35,prodege,0.4998,28480832,GBR,J1,Northampton,78.151.200.222,TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTION IN THE ELDERLY treats CONTROLLED TRIAL OF NORFLOXACIN AND AMOXYCILLIN IN,90,35,,154,84,treats,0.8111071056999999,907612-FS1-2,"Hill S, Yeates M, Pathy J et al. A CONTROLLED TRIAL OF NORFLOXACIN AND AMOXYCILLIN IN the TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTION IN THE ELDERLY.",TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTION IN THE ELDERLY,CONTROLLED TRIAL OF NORFLOXACIN AND AMOXYCILLIN IN,RO-may_treat
502804129,7/13/2014 13:06:44,,1321875944,7/13/2014 13:06:09,instagc,0.6448,23149109,USA,NC,Durham,75.189.206.205,no_relation,90,35,,154,84,treats,0.8111071056999999,907612-FS1-2,"Hill S, Yeates M, Pathy J et al. A CONTROLLED TRIAL OF NORFLOXACIN AND AMOXYCILLIN IN the TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTION IN THE ELDERLY.",TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTION IN THE ELDERLY,CONTROLLED TRIAL OF NORFLOXACIN AND AMOXYCILLIN IN,RO-may_treat
502804129,7/13/2014 13:16:37,,1321880031,7/13/2014 13:15:38,instagc,0.7056,19686223,CAN,BC,Surrey,154.20.155.106,CONTROLLED TRIAL OF NORFLOXACIN AND AMOXYCILLIN IN treats TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTION IN THE ELDERLY,90,35,,154,84,treats,0.8111071056999999,907612-FS1-2,"Hill S, Yeates M, Pathy J et al. A CONTROLLED TRIAL OF NORFLOXACIN AND AMOXYCILLIN IN the TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTION IN THE ELDERLY.",TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTION IN THE ELDERLY,CONTROLLED TRIAL OF NORFLOXACIN AND AMOXYCILLIN IN,RO-may_treat
502804147,7/13/2014 11:17:37,,1321833305,7/13/2014 11:17:15,neodev,0.9167,28336203,USA,PA,Harrisburg,50.149.53.150,METHOTREXATE treats OSTEOSARCOMA,114,142,,125,153,treats,0.9759000729,908313-FS1-2,This paper will present the experience of the Department of Clinical Haematology and Oncology in the treatment of OSTEOSARCOMA with high dose METHOTREXATE and summarize other groups' experiences with various chemotherapy regimes.,OSTEOSARCOMA,METHOTREXATE,RO-may_treat
502804147,7/13/2014 11:45:22,,1321844341,7/13/2014 11:44:44,instagc,0.6583,24252915,GBR,B7,Bristol,77.98.139.82,METHOTREXATE treats OSTEOSARCOMA,114,142,,125,153,treats,0.9759000729,908313-FS1-2,This paper will present the experience of the Department of Clinical Haematology and Oncology in the treatment of OSTEOSARCOMA with high dose METHOTREXATE and summarize other groups' experiences with various chemotherapy regimes.,OSTEOSARCOMA,METHOTREXATE,RO-may_treat
502804147,7/13/2014 11:49:35,,1321845852,7/13/2014 11:49:17,instagc,0.6486,19004168,GBR,H2,Accrington,80.47.185.52,METHOTREXATE treats OSTEOSARCOMA,114,142,,125,153,treats,0.9759000729,908313-FS1-2,This paper will present the experience of the Department of Clinical Haematology and Oncology in the treatment of OSTEOSARCOMA with high dose METHOTREXATE and summarize other groups' experiences with various chemotherapy regimes.,OSTEOSARCOMA,METHOTREXATE,RO-may_treat
502804147,7/13/2014 12:20:15,,1321856963,7/13/2014 12:19:55,instagc,0.6246,13763729,USA,,,75.182.89.225,METHOTREXATE treats OSTEOSARCOMA,114,142,,125,153,treats,0.9759000729,908313-FS1-2,This paper will present the experience of the Department of Clinical Haematology and Oncology in the treatment of OSTEOSARCOMA with high dose METHOTREXATE and summarize other groups' experiences with various chemotherapy regimes.,OSTEOSARCOMA,METHOTREXATE,RO-may_treat
502804147,7/13/2014 13:06:08,,1321875726,7/13/2014 13:05:45,instagc,0.6448,23149109,USA,NC,Durham,75.189.206.205,METHOTREXATE treats OSTEOSARCOMA,114,142,,125,153,treats,0.9759000729,908313-FS1-2,This paper will present the experience of the Department of Clinical Haematology and Oncology in the treatment of OSTEOSARCOMA with high dose METHOTREXATE and summarize other groups' experiences with various chemotherapy regimes.,OSTEOSARCOMA,METHOTREXATE,RO-may_treat
502804147,7/13/2014 13:15:36,,1321879469,7/13/2014 13:14:59,instagc,0.7056,19686223,CAN,BC,Surrey,154.20.155.106,METHOTREXATE treats OSTEOSARCOMA,114,142,,125,153,treats,0.9759000729,908313-FS1-2,This paper will present the experience of the Department of Clinical Haematology and Oncology in the treatment of OSTEOSARCOMA with high dose METHOTREXATE and summarize other groups' experiences with various chemotherapy regimes.,OSTEOSARCOMA,METHOTREXATE,RO-may_treat
502804147,7/13/2014 13:21:13,,1321881839,7/13/2014 13:20:41,instagc,0.7079,21551272,GBR,Q3,Wolverhampton,2.103.57.104,METHOTREXATE treats OSTEOSARCOMA,114,142,,125,153,treats,0.9759000729,908313-FS1-2,This paper will present the experience of the Department of Clinical Haematology and Oncology in the treatment of OSTEOSARCOMA with high dose METHOTREXATE and summarize other groups' experiences with various chemotherapy regimes.,OSTEOSARCOMA,METHOTREXATE,RO-may_treat
502804151,7/13/2014 10:59:47,,1321825858,7/13/2014 10:59:22,clixsense,0.9167,15189335,GBR,I9,Norwich,86.155.45.231,VARIOLA MAJOR VIRUS causes SMALLPOX,0,43,,18,50,causes,1.0,903785-FS1-4,VARIOLA MAJOR VIRUS the causative agent of SMALLPOX encodes the dual specificity H1 phosphatase.,VARIOLA MAJOR VIRUS,SMALLPOX,RO-has_causative_agent
502804151,7/13/2014 11:50:13,,1321845994,7/13/2014 11:49:36,instagc,0.6486,19004168,GBR,H2,Accrington,80.47.185.52,VARIOLA MAJOR VIRUS causes SMALLPOX,0,43,,18,50,causes,1.0,903785-FS1-4,VARIOLA MAJOR VIRUS the causative agent of SMALLPOX encodes the dual specificity H1 phosphatase.,VARIOLA MAJOR VIRUS,SMALLPOX,RO-has_causative_agent
502804151,7/13/2014 12:04:40,,1321851463,7/13/2014 12:04:05,vivatic,0.5236,25451531,GBR,,,83.67.28.193,VARIOLA MAJOR VIRUS causes SMALLPOX,0,43,,18,50,causes,1.0,903785-FS1-4,VARIOLA MAJOR VIRUS the causative agent of SMALLPOX encodes the dual specificity H1 phosphatase.,VARIOLA MAJOR VIRUS,SMALLPOX,RO-has_causative_agent
502804151,7/13/2014 12:08:03,,1321852718,7/13/2014 12:07:50,instagc,0.6389,15445601,USA,FL,Jacksonville,24.129.68.254,VARIOLA MAJOR VIRUS causes SMALLPOX,0,43,,18,50,causes,1.0,903785-FS1-4,VARIOLA MAJOR VIRUS the causative agent of SMALLPOX encodes the dual specificity H1 phosphatase.,VARIOLA MAJOR VIRUS,SMALLPOX,RO-has_causative_agent
502804151,7/13/2014 12:43:33,,1321866575,7/13/2014 12:43:09,neodev,0.6177,18517457,GBR,,,86.29.147.112,VARIOLA MAJOR VIRUS causes SMALLPOX,0,43,,18,50,causes,1.0,903785-FS1-4,VARIOLA MAJOR VIRUS the causative agent of SMALLPOX encodes the dual specificity H1 phosphatase.,VARIOLA MAJOR VIRUS,SMALLPOX,RO-has_causative_agent
502804151,7/13/2014 13:05:44,,1321875517,7/13/2014 13:05:20,instagc,0.6448,23149109,USA,NC,Durham,75.189.206.205,VARIOLA MAJOR VIRUS causes SMALLPOX,0,43,,18,50,causes,1.0,903785-FS1-4,VARIOLA MAJOR VIRUS the causative agent of SMALLPOX encodes the dual specificity H1 phosphatase.,VARIOLA MAJOR VIRUS,SMALLPOX,RO-has_causative_agent
502804151,7/13/2014 13:14:58,,1321879265,7/13/2014 13:14:16,instagc,0.7056,19686223,CAN,BC,Surrey,154.20.155.106,VARIOLA MAJOR VIRUS causes SMALLPOX,0,43,,18,50,causes,1.0,903785-FS1-4,VARIOLA MAJOR VIRUS the causative agent of SMALLPOX encodes the dual specificity H1 phosphatase.,VARIOLA MAJOR VIRUS,SMALLPOX,RO-has_causative_agent
502804152,7/13/2014 11:02:47,,1321827061,7/13/2014 11:01:45,clixsense,0.9167,15189335,GBR,I9,Norwich,86.155.45.231,no_relation,89,48,,123,72,causes,0.8980265101,900111-FS1-4,The Basenji greyhound (BG) has been proposed as A MODEL OF ATOPIC DISEASE because of its CHRONIC RELAPSING ATOPIC DERMATITIS as well as airway hyperresponsiveness.,CHRONIC RELAPSING ATOPIC DERMATITIS,A MODEL OF ATOPIC DISEASE,RO-cause_of
502804152,7/13/2014 12:05:30,,1321851811,7/13/2014 12:04:42,vivatic,0.5236,25451531,GBR,,,83.67.28.193,CHRONIC RELAPSING ATOPIC DERMATITIS causes A MODEL OF ATOPIC DISEASE,89,48,,123,72,causes,0.8980265101,900111-FS1-4,The Basenji greyhound (BG) has been proposed as A MODEL OF ATOPIC DISEASE because of its CHRONIC RELAPSING ATOPIC DERMATITIS as well as airway hyperresponsiveness.,CHRONIC RELAPSING ATOPIC DERMATITIS,A MODEL OF ATOPIC DISEASE,RO-cause_of
502804152,7/13/2014 12:07:03,,1321852326,7/13/2014 12:06:32,instagc,0.6389,15445601,USA,FL,Jacksonville,24.129.68.254,CHRONIC RELAPSING ATOPIC DERMATITIS causes A MODEL OF ATOPIC DISEASE,89,48,,123,72,causes,0.8980265101,900111-FS1-4,The Basenji greyhound (BG) has been proposed as A MODEL OF ATOPIC DISEASE because of its CHRONIC RELAPSING ATOPIC DERMATITIS as well as airway hyperresponsiveness.,CHRONIC RELAPSING ATOPIC DERMATITIS,A MODEL OF ATOPIC DISEASE,RO-cause_of
502804152,7/13/2014 12:18:49,,1321856431,7/13/2014 12:18:25,instagc,0.6246,13763729,USA,,,75.182.89.225,no_relation,89,48,,123,72,causes,0.8980265101,900111-FS1-4,The Basenji greyhound (BG) has been proposed as A MODEL OF ATOPIC DISEASE because of its CHRONIC RELAPSING ATOPIC DERMATITIS as well as airway hyperresponsiveness.,CHRONIC RELAPSING ATOPIC DERMATITIS,A MODEL OF ATOPIC DISEASE,RO-cause_of
502804152,7/13/2014 12:32:13,,1321861869,7/13/2014 12:31:39,clixsense,0.4819,27969116,NLD,04,Veendam,185.12.216.74,A MODEL OF ATOPIC DISEASE causes CHRONIC RELAPSING ATOPIC DERMATITIS,89,48,,123,72,causes,0.8980265101,900111-FS1-4,The Basenji greyhound (BG) has been proposed as A MODEL OF ATOPIC DISEASE because of its CHRONIC RELAPSING ATOPIC DERMATITIS as well as airway hyperresponsiveness.,CHRONIC RELAPSING ATOPIC DERMATITIS,A MODEL OF ATOPIC DISEASE,RO-cause_of
502804152,7/13/2014 12:32:34,,1321862008,7/13/2014 12:32:27,prodege,0.4998,28480832,GBR,J1,Northampton,78.151.200.222,A MODEL OF ATOPIC DISEASE causes CHRONIC RELAPSING ATOPIC DERMATITIS,89,48,,123,72,causes,0.8980265101,900111-FS1-4,The Basenji greyhound (BG) has been proposed as A MODEL OF ATOPIC DISEASE because of its CHRONIC RELAPSING ATOPIC DERMATITIS as well as airway hyperresponsiveness.,CHRONIC RELAPSING ATOPIC DERMATITIS,A MODEL OF ATOPIC DISEASE,RO-cause_of
502804152,7/13/2014 12:43:08,,1321866356,7/13/2014 12:42:46,neodev,0.6177,18517457,GBR,,,86.29.147.112,no_relation,89,48,,123,72,causes,0.8980265101,900111-FS1-4,The Basenji greyhound (BG) has been proposed as A MODEL OF ATOPIC DISEASE because of its CHRONIC RELAPSING ATOPIC DERMATITIS as well as airway hyperresponsiveness.,CHRONIC RELAPSING ATOPIC DERMATITIS,A MODEL OF ATOPIC DISEASE,RO-cause_of
502804153,7/13/2014 10:57:47,,1321825250,7/13/2014 10:57:40,neodev,1.0,17610000,GBR,I2,Manchester,90.200.140.201,TETRACYCLINE contraindicates PREGNANCY,399,370,,410,378,contraindicates,0.8219949365000001,901288-FS1-10,"B]  Specific Recommendation: ? Review the list of medications that should be discontinued before conception: ? Isotretinoin ? Methotrexate ? Thalidomide ? DES ? Misoprostol ? Penicillamine ? Gold ? Etretinate or acitretin ? Review the list of medications that should be discontinued immediately with diagnosis of pregnancy and substituted with alternatives preferred in PREGNANCY ? ACE inhibitors ? TETRACYCLINE ? Coumadin ? Methimazole ? Trimethadione  Rationale: ? These are all medications with known teratogenic effects used for nonessential indications (e.g., acne) or for which there are safer alternatives in pregnancy.",TETRACYCLINE,PREGNANCY,RO-contraindicated_drug
502804153,7/13/2014 11:20:13,,1321834502,7/13/2014 11:19:35,rewardsspot,0.7222,24482174,GBR,H9,London,46.23.68.180,no_relation,399,370,,410,378,contraindicates,0.8219949365000001,901288-FS1-10,"B]  Specific Recommendation: ? Review the list of medications that should be discontinued before conception: ? Isotretinoin ? Methotrexate ? Thalidomide ? DES ? Misoprostol ? Penicillamine ? Gold ? Etretinate or acitretin ? Review the list of medications that should be discontinued immediately with diagnosis of pregnancy and substituted with alternatives preferred in PREGNANCY ? ACE inhibitors ? TETRACYCLINE ? Coumadin ? Methimazole ? Trimethadione  Rationale: ? These are all medications with known teratogenic effects used for nonessential indications (e.g., acne) or for which there are safer alternatives in pregnancy.",TETRACYCLINE,PREGNANCY,RO-contraindicated_drug
502804153,7/13/2014 11:44:43,,1321844009,7/13/2014 11:44:08,instagc,0.6583,24252915,GBR,B7,Bristol,77.98.139.82,no_relation,399,370,,410,378,contraindicates,0.8219949365000001,901288-FS1-10,"B]  Specific Recommendation: ? Review the list of medications that should be discontinued before conception: ? Isotretinoin ? Methotrexate ? Thalidomide ? DES ? Misoprostol ? Penicillamine ? Gold ? Etretinate or acitretin ? Review the list of medications that should be discontinued immediately with diagnosis of pregnancy and substituted with alternatives preferred in PREGNANCY ? ACE inhibitors ? TETRACYCLINE ? Coumadin ? Methimazole ? Trimethadione  Rationale: ? These are all medications with known teratogenic effects used for nonessential indications (e.g., acne) or for which there are safer alternatives in pregnancy.",TETRACYCLINE,PREGNANCY,RO-contraindicated_drug
502804153,7/13/2014 11:51:09,,1321846364,7/13/2014 11:50:34,instagc,0.6486,19004168,GBR,H2,Accrington,80.47.185.52,PREGNANCY contraindicates TETRACYCLINE,399,370,,410,378,contraindicates,0.8219949365000001,901288-FS1-10,"B]  Specific Recommendation: ? Review the list of medications that should be discontinued before conception: ? Isotretinoin ? Methotrexate ? Thalidomide ? DES ? Misoprostol ? Penicillamine ? Gold ? Etretinate or acitretin ? Review the list of medications that should be discontinued immediately with diagnosis of pregnancy and substituted with alternatives preferred in PREGNANCY ? ACE inhibitors ? TETRACYCLINE ? Coumadin ? Methimazole ? Trimethadione  Rationale: ? These are all medications with known teratogenic effects used for nonessential indications (e.g., acne) or for which there are safer alternatives in pregnancy.",TETRACYCLINE,PREGNANCY,RO-contraindicated_drug
502804153,7/13/2014 11:58:42,,1321849302,7/13/2014 11:57:59,prodege,0.4611,28039757,GBR,L8,Southport,109.155.158.54,no_relation,399,370,,410,378,contraindicates,0.8219949365000001,901288-FS1-10,"B]  Specific Recommendation: ? Review the list of medications that should be discontinued before conception: ? Isotretinoin ? Methotrexate ? Thalidomide ? DES ? Misoprostol ? Penicillamine ? Gold ? Etretinate or acitretin ? Review the list of medications that should be discontinued immediately with diagnosis of pregnancy and substituted with alternatives preferred in PREGNANCY ? ACE inhibitors ? TETRACYCLINE ? Coumadin ? Methimazole ? Trimethadione  Rationale: ? These are all medications with known teratogenic effects used for nonessential indications (e.g., acne) or for which there are safer alternatives in pregnancy.",TETRACYCLINE,PREGNANCY,RO-contraindicated_drug
502804153,7/13/2014 12:04:40,,1321851464,7/13/2014 12:04:05,vivatic,0.5236,25451531,GBR,,,83.67.28.193,PREGNANCY contraindicates TETRACYCLINE,399,370,,410,378,contraindicates,0.8219949365000001,901288-FS1-10,"B]  Specific Recommendation: ? Review the list of medications that should be discontinued before conception: ? Isotretinoin ? Methotrexate ? Thalidomide ? DES ? Misoprostol ? Penicillamine ? Gold ? Etretinate or acitretin ? Review the list of medications that should be discontinued immediately with diagnosis of pregnancy and substituted with alternatives preferred in PREGNANCY ? ACE inhibitors ? TETRACYCLINE ? Coumadin ? Methimazole ? Trimethadione  Rationale: ? These are all medications with known teratogenic effects used for nonessential indications (e.g., acne) or for which there are safer alternatives in pregnancy.",TETRACYCLINE,PREGNANCY,RO-contraindicated_drug
502804153,7/13/2014 12:31:38,,1321861566,7/13/2014 12:30:48,clixsense,0.4819,27969116,NLD,04,Veendam,185.12.216.74,no_relation,399,370,,410,378,contraindicates,0.8219949365000001,901288-FS1-10,"B]  Specific Recommendation: ? Review the list of medications that should be discontinued before conception: ? Isotretinoin ? Methotrexate ? Thalidomide ? DES ? Misoprostol ? Penicillamine ? Gold ? Etretinate or acitretin ? Review the list of medications that should be discontinued immediately with diagnosis of pregnancy and substituted with alternatives preferred in PREGNANCY ? ACE inhibitors ? TETRACYCLINE ? Coumadin ? Methimazole ? Trimethadione  Rationale: ? These are all medications with known teratogenic effects used for nonessential indications (e.g., acne) or for which there are safer alternatives in pregnancy.",TETRACYCLINE,PREGNANCY,RO-contraindicated_drug
502804156,7/13/2014 11:05:06,,1321827912,7/13/2014 11:04:03,clixsense,0.9167,15189335,GBR,I9,Norwich,86.155.45.231,SYSTEMIC HYPERTENSION treats SUBLINGUAL NIFEDIPINE,95,47,,115,67,treats,0.9878783399,907907-FS1-2,"Beer N, Gallegos I, Cohen A et al. Efficacy of SUBLINGUAL NIFEDIPINE in the acute treatment of SYSTEMIC HYPERTENSION",SYSTEMIC HYPERTENSION,SUBLINGUAL NIFEDIPINE,RO-may_treat
502804156,7/13/2014 12:07:49,,1321852586,7/13/2014 12:07:33,instagc,0.6389,15445601,USA,FL,Jacksonville,24.129.68.254,SUBLINGUAL NIFEDIPINE treats SYSTEMIC HYPERTENSION,95,47,,115,67,treats,0.9878783399,907907-FS1-2,"Beer N, Gallegos I, Cohen A et al. Efficacy of SUBLINGUAL NIFEDIPINE in the acute treatment of SYSTEMIC HYPERTENSION",SYSTEMIC HYPERTENSION,SUBLINGUAL NIFEDIPINE,RO-may_treat
502804156,7/13/2014 12:19:12,,1321856566,7/13/2014 12:18:49,instagc,0.6246,13763729,USA,,,75.182.89.225,SUBLINGUAL NIFEDIPINE treats SYSTEMIC HYPERTENSION,95,47,,115,67,treats,0.9878783399,907907-FS1-2,"Beer N, Gallegos I, Cohen A et al. Efficacy of SUBLINGUAL NIFEDIPINE in the acute treatment of SYSTEMIC HYPERTENSION",SYSTEMIC HYPERTENSION,SUBLINGUAL NIFEDIPINE,RO-may_treat
502804156,7/13/2014 12:32:47,,1321862062,7/13/2014 12:32:41,prodege,0.4998,28480832,GBR,J1,Northampton,78.151.200.222,SUBLINGUAL NIFEDIPINE treats SYSTEMIC HYPERTENSION,95,47,,115,67,treats,0.9878783399,907907-FS1-2,"Beer N, Gallegos I, Cohen A et al. Efficacy of SUBLINGUAL NIFEDIPINE in the acute treatment of SYSTEMIC HYPERTENSION",SYSTEMIC HYPERTENSION,SUBLINGUAL NIFEDIPINE,RO-may_treat
502804156,7/13/2014 12:43:08,,1321866349,7/13/2014 12:42:46,neodev,0.6177,18517457,GBR,,,86.29.147.112,SUBLINGUAL NIFEDIPINE treats SYSTEMIC HYPERTENSION,95,47,,115,67,treats,0.9878783399,907907-FS1-2,"Beer N, Gallegos I, Cohen A et al. Efficacy of SUBLINGUAL NIFEDIPINE in the acute treatment of SYSTEMIC HYPERTENSION",SYSTEMIC HYPERTENSION,SUBLINGUAL NIFEDIPINE,RO-may_treat
502804156,7/13/2014 13:14:14,,1321879003,7/13/2014 13:13:35,instagc,0.7056,19686223,CAN,BC,Surrey,154.20.155.106,SUBLINGUAL NIFEDIPINE treats SYSTEMIC HYPERTENSION,95,47,,115,67,treats,0.9878783399,907907-FS1-2,"Beer N, Gallegos I, Cohen A et al. Efficacy of SUBLINGUAL NIFEDIPINE in the acute treatment of SYSTEMIC HYPERTENSION",SYSTEMIC HYPERTENSION,SUBLINGUAL NIFEDIPINE,RO-may_treat
502804156,7/13/2014 13:23:53,,1321882923,7/13/2014 13:23:46,neodev,0.302,25224036,CAN,ON,Sudbury,67.204.218.187,no_relation,95,47,,115,67,treats,0.9878783399,907907-FS1-2,"Beer N, Gallegos I, Cohen A et al. Efficacy of SUBLINGUAL NIFEDIPINE in the acute treatment of SYSTEMIC HYPERTENSION",SYSTEMIC HYPERTENSION,SUBLINGUAL NIFEDIPINE,RO-may_treat
718228457,5/10/2015 13:33:03,1633642267,5/10/2015 13:32:42,False,elite,0.8690000000000001,31883685,GBR,H2,Accrington,80.47.186.28,NOCARDIA causes NOCARDIOSIS,89,119,,1,99,causes,0.9958932064677041,810907-FS1-4,"c ,   116  Nocardiosis  Tetracyclines are alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA",NOCARDIOSIS,NOCARDIA,TWrex-cause
718228457,5/10/2015 13:59:34,1633649008,5/10/2015 13:58:54,False,sharecashgpt,0.75,28627999,CAN,ON,Sudbury,66.103.55.12,NOCARDIA causes NOCARDIOSIS,89,119,,1,99,causes,0.9958932064677041,810907-FS1-4,"c ,   116  Nocardiosis  Tetracyclines are alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA",NOCARDIOSIS,NOCARDIA,TWrex-cause
718228457,5/10/2015 14:14:57,1633653003,5/10/2015 14:14:47,False,instagc,0.625,31184650,USA,IA,Mason City,173.26.27.82,NOCARDIA causes NOCARDIOSIS,89,119,,1,99,causes,0.9958932064677041,810907-FS1-4,"c ,   116  Nocardiosis  Tetracyclines are alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA",NOCARDIOSIS,NOCARDIA,TWrex-cause
718228457,5/10/2015 14:26:10,1633656072,5/10/2015 14:25:34,False,clixsense,0.5327,10798016,GBR,C7,Coventry,86.24.245.191,NOCARDIOSIS causes NOCARDIA,89,119,,1,99,causes,0.9958932064677041,810907-FS1-4,"c ,   116  Nocardiosis  Tetracyclines are alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA",NOCARDIOSIS,NOCARDIA,TWrex-cause
718228457,5/10/2015 14:37:41,1633659050,5/10/2015 14:37:36,False,neodev,0.3542,32103286,CAN,AB,Edmonton,208.123.223.44,NOCARDIA causes NOCARDIOSIS,89,119,,1,99,causes,0.9958932064677041,810907-FS1-4,"c ,   116  Nocardiosis  Tetracyclines are alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA",NOCARDIOSIS,NOCARDIA,TWrex-cause
718228457,5/10/2015 14:58:54,1633664550,5/10/2015 14:58:18,False,neodev,0.6022,24564999,GBR,H9,London,86.145.227.9,no_relation,89,119,,1,99,causes,0.9958932064677041,810907-FS1-4,"c ,   116  Nocardiosis  Tetracyclines are alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA",NOCARDIOSIS,NOCARDIA,TWrex-cause
718228457,5/10/2015 15:04:16,1633665890,5/10/2015 15:03:33,False,neodev,0.7119,14096345,NLD,03,Eibergen,77.174.124.109,NOCARDIA causes NOCARDIOSIS,89,119,,1,99,causes,0.9958932064677041,810907-FS1-4,"c ,   116  Nocardiosis  Tetracyclines are alternative to co trimoxazole for treatment of NOCARDIOSIS   +    caused by  NOCARDIA",NOCARDIOSIS,NOCARDIA,TWrex-cause
718228460,5/10/2015 15:27:09,1633672020,5/10/2015 15:26:41,False,clixsense,0.7052,9343409,NLD,03,Hattem,77.171.50.249,no_relation,122,58,,1,141,causes,0.870388279778489,814230-FS1-4,"134 ,   e  Warnings/Precautions  Warnings  Systemic Lupus ERYTHEMATOSUS (SLE  May cause SLE (e.g., glomerulonephritis) or RHEUMATOID ARTHRITIS  134 ,   d ,   e   particularly in patients receiving >200 mg daily dosage for prolonged periods, in slow acetylators of hydralazine, or in those with decreased renal function.",RHEUMATOID ARTHRITIS,ERYTHEMATOSUS (SLE,TWrex-cause
718228460,5/10/2015 15:46:07,1633677088,5/10/2015 15:45:40,False,prodege,0.7608,13300986,CAN,AB,Edmonton,68.150.40.134,no_relation,122,58,,1,141,causes,0.870388279778489,814230-FS1-4,"134 ,   e  Warnings/Precautions  Warnings  Systemic Lupus ERYTHEMATOSUS (SLE  May cause SLE (e.g., glomerulonephritis) or RHEUMATOID ARTHRITIS  134 ,   d ,   e   particularly in patients receiving >200 mg daily dosage for prolonged periods, in slow acetylators of hydralazine, or in those with decreased renal function.",RHEUMATOID ARTHRITIS,ERYTHEMATOSUS (SLE,TWrex-cause
718228460,5/10/2015 15:50:44,1633678139,5/10/2015 15:50:12,False,gifthulk,0.6799,18666417,USA,PA,Meadville,24.101.97.237,ERYTHEMATOSUS (SLE causes RHEUMATOID ARTHRITIS,122,58,,1,141,causes,0.870388279778489,814230-FS1-4,"134 ,   e  Warnings/Precautions  Warnings  Systemic Lupus ERYTHEMATOSUS (SLE  May cause SLE (e.g., glomerulonephritis) or RHEUMATOID ARTHRITIS  134 ,   d ,   e   particularly in patients receiving >200 mg daily dosage for prolonged periods, in slow acetylators of hydralazine, or in those with decreased renal function.",RHEUMATOID ARTHRITIS,ERYTHEMATOSUS (SLE,TWrex-cause
718228460,5/10/2015 15:59:23,1633680341,5/10/2015 15:58:39,False,prodege,0.8214,24403612,CAN,ON,Ajax,99.239.181.149,no_relation,122,58,,1,141,causes,0.870388279778489,814230-FS1-4,"134 ,   e  Warnings/Precautions  Warnings  Systemic Lupus ERYTHEMATOSUS (SLE  May cause SLE (e.g., glomerulonephritis) or RHEUMATOID ARTHRITIS  134 ,   d ,   e   particularly in patients receiving >200 mg daily dosage for prolonged periods, in slow acetylators of hydralazine, or in those with decreased renal function.",RHEUMATOID ARTHRITIS,ERYTHEMATOSUS (SLE,TWrex-cause
718228460,5/10/2015 16:04:49,1633681756,5/10/2015 16:04:28,False,prodege,0.91,29849805,GBR,Z1,Swansea,82.1.37.235,no_relation,122,58,,1,141,causes,0.870388279778489,814230-FS1-4,"134 ,   e  Warnings/Precautions  Warnings  Systemic Lupus ERYTHEMATOSUS (SLE  May cause SLE (e.g., glomerulonephritis) or RHEUMATOID ARTHRITIS  134 ,   d ,   e   particularly in patients receiving >200 mg daily dosage for prolonged periods, in slow acetylators of hydralazine, or in those with decreased renal function.",RHEUMATOID ARTHRITIS,ERYTHEMATOSUS (SLE,TWrex-cause
718228460,5/10/2015 16:12:02,1633683481,5/10/2015 16:11:31,False,clixsense,0.3171,17950689,GBR,Y9,Porth,217.43.32.119,ERYTHEMATOSUS (SLE causes RHEUMATOID ARTHRITIS,122,58,,1,141,causes,0.870388279778489,814230-FS1-4,"134 ,   e  Warnings/Precautions  Warnings  Systemic Lupus ERYTHEMATOSUS (SLE  May cause SLE (e.g., glomerulonephritis) or RHEUMATOID ARTHRITIS  134 ,   d ,   e   particularly in patients receiving >200 mg daily dosage for prolonged periods, in slow acetylators of hydralazine, or in those with decreased renal function.",RHEUMATOID ARTHRITIS,ERYTHEMATOSUS (SLE,TWrex-cause
718228460,5/10/2015 16:12:27,1633683615,5/10/2015 16:11:50,False,memolink,0.4841,6587538,CAN,ON,Toronto,65.95.204.180,ERYTHEMATOSUS (SLE causes RHEUMATOID ARTHRITIS,122,58,,1,141,causes,0.870388279778489,814230-FS1-4,"134 ,   e  Warnings/Precautions  Warnings  Systemic Lupus ERYTHEMATOSUS (SLE  May cause SLE (e.g., glomerulonephritis) or RHEUMATOID ARTHRITIS  134 ,   d ,   e   particularly in patients receiving >200 mg daily dosage for prolonged periods, in slow acetylators of hydralazine, or in those with decreased renal function.",RHEUMATOID ARTHRITIS,ERYTHEMATOSUS (SLE,TWrex-cause
718228480,5/10/2015 11:57:42,1633619205,5/10/2015 11:57:19,False,prodege,1.0,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,8,8,,-1,37,causes,0.6154574548966639,802831-FS1-4,"And for GLAUCOMATOUS PAINFUL BLIND EYE and some cases of GLAUCOMA Cyclocryotherapy for ciliary body ablation could be considered to be performed.[28] [edit] Veterinary implant  TR BioSurgical has commercialized a new implant specifically for veterinary medicine, called TR ClarifEYE.",GLAUCOMATOUS PAINFUL BLIND EYE,GLAUCOMA,TWrex-cause
718228480,5/10/2015 12:05:14,1633620826,5/10/2015 12:05:00,False,gifthunterclub,0.55,31241093,GBR,L9,Sheffield,90.217.213.219,GLAUCOMATOUS PAINFUL BLIND EYE causes GLAUCOMA,8,8,,-1,37,causes,0.6154574548966639,802831-FS1-4,"And for GLAUCOMATOUS PAINFUL BLIND EYE and some cases of GLAUCOMA Cyclocryotherapy for ciliary body ablation could be considered to be performed.[28] [edit] Veterinary implant  TR BioSurgical has commercialized a new implant specifically for veterinary medicine, called TR ClarifEYE.",GLAUCOMATOUS PAINFUL BLIND EYE,GLAUCOMA,TWrex-cause
718228480,5/10/2015 12:11:57,1633622193,5/10/2015 12:11:41,False,meprizescf,0.6014,28483210,USA,WI,Minocqua,75.143.134.247,no_relation,8,8,,-1,37,causes,0.6154574548966639,802831-FS1-4,"And for GLAUCOMATOUS PAINFUL BLIND EYE and some cases of GLAUCOMA Cyclocryotherapy for ciliary body ablation could be considered to be performed.[28] [edit] Veterinary implant  TR BioSurgical has commercialized a new implant specifically for veterinary medicine, called TR ClarifEYE.",GLAUCOMATOUS PAINFUL BLIND EYE,GLAUCOMA,TWrex-cause
718228480,5/10/2015 12:13:10,1633622446,5/10/2015 12:12:54,False,clixsense,0.5639,28457001,CAN,ON,North Bay,24.204.202.220,no_relation,8,8,,-1,37,causes,0.6154574548966639,802831-FS1-4,"And for GLAUCOMATOUS PAINFUL BLIND EYE and some cases of GLAUCOMA Cyclocryotherapy for ciliary body ablation could be considered to be performed.[28] [edit] Veterinary implant  TR BioSurgical has commercialized a new implant specifically for veterinary medicine, called TR ClarifEYE.",GLAUCOMATOUS PAINFUL BLIND EYE,GLAUCOMA,TWrex-cause
718228480,5/10/2015 12:14:30,1633622694,5/10/2015 12:13:48,False,instagc,0.6708,18531561,CAN,ON,Mississauga,99.229.92.227,no_relation,8,8,,-1,37,causes,0.6154574548966639,802831-FS1-4,"And for GLAUCOMATOUS PAINFUL BLIND EYE and some cases of GLAUCOMA Cyclocryotherapy for ciliary body ablation could be considered to be performed.[28] [edit] Veterinary implant  TR BioSurgical has commercialized a new implant specifically for veterinary medicine, called TR ClarifEYE.",GLAUCOMATOUS PAINFUL BLIND EYE,GLAUCOMA,TWrex-cause
718228480,5/10/2015 12:16:03,1633623003,5/10/2015 12:15:37,False,clixsense,0.5944,19638651,USA,SC,Summerville,174.107.73.211,no_relation,8,8,,-1,37,causes,0.6154574548966639,802831-FS1-4,"And for GLAUCOMATOUS PAINFUL BLIND EYE and some cases of GLAUCOMA Cyclocryotherapy for ciliary body ablation could be considered to be performed.[28] [edit] Veterinary implant  TR BioSurgical has commercialized a new implant specifically for veterinary medicine, called TR ClarifEYE.",GLAUCOMATOUS PAINFUL BLIND EYE,GLAUCOMA,TWrex-cause
718228480,5/10/2015 12:27:34,1633625797,5/10/2015 12:27:08,False,points4rewards,0.6171,20113482,USA,OR,Portland,67.213.218.72,no_relation,8,8,,-1,37,causes,0.6154574548966639,802831-FS1-4,"And for GLAUCOMATOUS PAINFUL BLIND EYE and some cases of GLAUCOMA Cyclocryotherapy for ciliary body ablation could be considered to be performed.[28] [edit] Veterinary implant  TR BioSurgical has commercialized a new implant specifically for veterinary medicine, called TR ClarifEYE.",GLAUCOMATOUS PAINFUL BLIND EYE,GLAUCOMA,TWrex-cause
718228484,5/10/2015 11:52:00,1633618063,5/10/2015 11:51:44,False,prodege,1.0,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,78,22,,1,103,causes,0.312347523777212,813805-FS1-4,March Hemoglobinuria  MARCH HEMOGLOBINURIA a disorder that somewhat resembles MICROANGIOPATHIC HEMOLYSIS usually occurs in young persons after prolonged marching or running or playing on bongo drums.,MICROANGIOPATHIC HEMOLYSIS,MARCH HEMOGLOBINURIA,TWrex-cause
718228484,5/10/2015 12:04:45,1633620713,5/10/2015 12:04:30,False,gifthunterclub,0.55,31241093,GBR,L9,Sheffield,90.217.213.219,MARCH HEMOGLOBINURIA causes MICROANGIOPATHIC HEMOLYSIS,78,22,,1,103,causes,0.312347523777212,813805-FS1-4,March Hemoglobinuria  MARCH HEMOGLOBINURIA a disorder that somewhat resembles MICROANGIOPATHIC HEMOLYSIS usually occurs in young persons after prolonged marching or running or playing on bongo drums.,MICROANGIOPATHIC HEMOLYSIS,MARCH HEMOGLOBINURIA,TWrex-cause
718228484,5/10/2015 12:11:21,1633622107,5/10/2015 12:10:24,False,meprizescf,0.6014,28483210,USA,WI,Minocqua,75.143.134.247,no_relation,78,22,,1,103,causes,0.312347523777212,813805-FS1-4,March Hemoglobinuria  MARCH HEMOGLOBINURIA a disorder that somewhat resembles MICROANGIOPATHIC HEMOLYSIS usually occurs in young persons after prolonged marching or running or playing on bongo drums.,MICROANGIOPATHIC HEMOLYSIS,MARCH HEMOGLOBINURIA,TWrex-cause
718228484,5/10/2015 12:12:39,1633622336,5/10/2015 12:11:48,False,clixsense,0.5639,28457001,CAN,ON,North Bay,24.204.202.220,MARCH HEMOGLOBINURIA causes MICROANGIOPATHIC HEMOLYSIS,78,22,,1,103,causes,0.312347523777212,813805-FS1-4,March Hemoglobinuria  MARCH HEMOGLOBINURIA a disorder that somewhat resembles MICROANGIOPATHIC HEMOLYSIS usually occurs in young persons after prolonged marching or running or playing on bongo drums.,MICROANGIOPATHIC HEMOLYSIS,MARCH HEMOGLOBINURIA,TWrex-cause
718228484,5/10/2015 12:12:58,1633622366,5/10/2015 12:12:23,False,instagc,0.6708,18531561,CAN,ON,Mississauga,99.229.92.227,no_relation,78,22,,1,103,causes,0.312347523777212,813805-FS1-4,March Hemoglobinuria  MARCH HEMOGLOBINURIA a disorder that somewhat resembles MICROANGIOPATHIC HEMOLYSIS usually occurs in young persons after prolonged marching or running or playing on bongo drums.,MICROANGIOPATHIC HEMOLYSIS,MARCH HEMOGLOBINURIA,TWrex-cause
718228484,5/10/2015 12:14:52,1633622772,5/10/2015 12:14:11,False,clixsense,0.5944,19638651,USA,SC,Summerville,174.107.73.211,no_relation,78,22,,1,103,causes,0.312347523777212,813805-FS1-4,March Hemoglobinuria  MARCH HEMOGLOBINURIA a disorder that somewhat resembles MICROANGIOPATHIC HEMOLYSIS usually occurs in young persons after prolonged marching or running or playing on bongo drums.,MICROANGIOPATHIC HEMOLYSIS,MARCH HEMOGLOBINURIA,TWrex-cause
718228484,5/10/2015 12:24:49,1633625127,5/10/2015 12:24:34,False,points4rewards,0.6171,20113482,USA,OR,Portland,67.213.218.72,no_relation,78,22,,1,103,causes,0.312347523777212,813805-FS1-4,March Hemoglobinuria  MARCH HEMOGLOBINURIA a disorder that somewhat resembles MICROANGIOPATHIC HEMOLYSIS usually occurs in young persons after prolonged marching or running or playing on bongo drums.,MICROANGIOPATHIC HEMOLYSIS,MARCH HEMOGLOBINURIA,TWrex-cause
718228487,5/10/2015 11:52:00,1633618077,5/10/2015 11:51:44,False,prodege,1.0,21417560,GBR,C3,Cambridge,151.225.116.143,LEWY BODY DEMENTIA causes WELL FORMED VISUAL HALLUCINATIONS,50,139,,1,82,causes,0.975900072948533,813253-FS1-4,"Fluctuations in cognition, parkinsonian symptoms, WELL FORMED VISUAL HALLUCINATIONS and relative preservation of short term memory suggest LEWY BODY DEMENTIA rather than Alzheimer's disease (see  Table 213 5.",WELL FORMED VISUAL HALLUCINATIONS,LEWY BODY DEMENTIA,TWrex-cause
718228487,5/10/2015 12:04:45,1633620714,5/10/2015 12:04:30,False,gifthunterclub,0.55,31241093,GBR,L9,Sheffield,90.217.213.219,WELL FORMED VISUAL HALLUCINATIONS causes LEWY BODY DEMENTIA,50,139,,1,82,causes,0.975900072948533,813253-FS1-4,"Fluctuations in cognition, parkinsonian symptoms, WELL FORMED VISUAL HALLUCINATIONS and relative preservation of short term memory suggest LEWY BODY DEMENTIA rather than Alzheimer's disease (see  Table 213 5.",WELL FORMED VISUAL HALLUCINATIONS,LEWY BODY DEMENTIA,TWrex-cause
718228487,5/10/2015 12:11:21,1633622095,5/10/2015 12:10:24,False,meprizescf,0.6014,28483210,USA,WI,Minocqua,75.143.134.247,no_relation,50,139,,1,82,causes,0.975900072948533,813253-FS1-4,"Fluctuations in cognition, parkinsonian symptoms, WELL FORMED VISUAL HALLUCINATIONS and relative preservation of short term memory suggest LEWY BODY DEMENTIA rather than Alzheimer's disease (see  Table 213 5.",WELL FORMED VISUAL HALLUCINATIONS,LEWY BODY DEMENTIA,TWrex-cause
718228487,5/10/2015 12:12:39,1633622337,5/10/2015 12:11:48,False,clixsense,0.5639,28457001,CAN,ON,North Bay,24.204.202.220,LEWY BODY DEMENTIA causes WELL FORMED VISUAL HALLUCINATIONS,50,139,,1,82,causes,0.975900072948533,813253-FS1-4,"Fluctuations in cognition, parkinsonian symptoms, WELL FORMED VISUAL HALLUCINATIONS and relative preservation of short term memory suggest LEWY BODY DEMENTIA rather than Alzheimer's disease (see  Table 213 5.",WELL FORMED VISUAL HALLUCINATIONS,LEWY BODY DEMENTIA,TWrex-cause
718228487,5/10/2015 12:12:58,1633622367,5/10/2015 12:12:23,False,instagc,0.6708,18531561,CAN,ON,Mississauga,99.229.92.227,LEWY BODY DEMENTIA causes WELL FORMED VISUAL HALLUCINATIONS,50,139,,1,82,causes,0.975900072948533,813253-FS1-4,"Fluctuations in cognition, parkinsonian symptoms, WELL FORMED VISUAL HALLUCINATIONS and relative preservation of short term memory suggest LEWY BODY DEMENTIA rather than Alzheimer's disease (see  Table 213 5.",WELL FORMED VISUAL HALLUCINATIONS,LEWY BODY DEMENTIA,TWrex-cause
718228487,5/10/2015 12:14:52,1633622770,5/10/2015 12:14:11,False,clixsense,0.5944,19638651,USA,SC,Summerville,174.107.73.211,LEWY BODY DEMENTIA causes WELL FORMED VISUAL HALLUCINATIONS,50,139,,1,82,causes,0.975900072948533,813253-FS1-4,"Fluctuations in cognition, parkinsonian symptoms, WELL FORMED VISUAL HALLUCINATIONS and relative preservation of short term memory suggest LEWY BODY DEMENTIA rather than Alzheimer's disease (see  Table 213 5.",WELL FORMED VISUAL HALLUCINATIONS,LEWY BODY DEMENTIA,TWrex-cause
718228487,5/10/2015 12:24:49,1633625126,5/10/2015 12:24:34,False,points4rewards,0.6171,20113482,USA,OR,Portland,67.213.218.72,no_relation,50,139,,1,82,causes,0.975900072948533,813253-FS1-4,"Fluctuations in cognition, parkinsonian symptoms, WELL FORMED VISUAL HALLUCINATIONS and relative preservation of short term memory suggest LEWY BODY DEMENTIA rather than Alzheimer's disease (see  Table 213 5.",WELL FORMED VISUAL HALLUCINATIONS,LEWY BODY DEMENTIA,TWrex-cause
718228491,5/10/2015 13:32:41,1633642124,5/10/2015 13:32:30,False,elite,0.8690000000000001,31883685,GBR,H2,Accrington,80.47.186.28,no_relation,156,11,,1,184,causes,0.327326835353989,813298-FS1-4,"Irregular, NARROW QRS COMPLEX TACHYARRHYTHMIAS include atrial fibrillation (AF), atrial flutter or true atrial tachycardia with variable AV conduction, and MULTIFOCAL ATRIAL TACHYCARDIA",MULTIFOCAL ATRIAL TACHYCARDIA,NARROW QRS COMPLEX TACHYARRHYTHMIAS,TWrex-cause
718228491,5/10/2015 13:58:53,1633648825,5/10/2015 13:58:23,False,sharecashgpt,0.75,28627999,CAN,ON,Sudbury,66.103.55.12,MULTIFOCAL ATRIAL TACHYCARDIA causes NARROW QRS COMPLEX TACHYARRHYTHMIAS,156,11,,1,184,causes,0.327326835353989,813298-FS1-4,"Irregular, NARROW QRS COMPLEX TACHYARRHYTHMIAS include atrial fibrillation (AF), atrial flutter or true atrial tachycardia with variable AV conduction, and MULTIFOCAL ATRIAL TACHYCARDIA",MULTIFOCAL ATRIAL TACHYCARDIA,NARROW QRS COMPLEX TACHYARRHYTHMIAS,TWrex-cause
718228491,5/10/2015 14:14:46,1633652978,5/10/2015 14:13:57,False,instagc,0.625,31184650,USA,IA,Mason City,173.26.27.82,no_relation,156,11,,1,184,causes,0.327326835353989,813298-FS1-4,"Irregular, NARROW QRS COMPLEX TACHYARRHYTHMIAS include atrial fibrillation (AF), atrial flutter or true atrial tachycardia with variable AV conduction, and MULTIFOCAL ATRIAL TACHYCARDIA",MULTIFOCAL ATRIAL TACHYCARDIA,NARROW QRS COMPLEX TACHYARRHYTHMIAS,TWrex-cause
718228491,5/10/2015 14:15:26,1633653173,5/10/2015 14:14:59,False,prodege,0.5,4853734,CAN,ON,Milton,108.170.128.226,no_relation,156,11,,1,184,causes,0.327326835353989,813298-FS1-4,"Irregular, NARROW QRS COMPLEX TACHYARRHYTHMIAS include atrial fibrillation (AF), atrial flutter or true atrial tachycardia with variable AV conduction, and MULTIFOCAL ATRIAL TACHYCARDIA",MULTIFOCAL ATRIAL TACHYCARDIA,NARROW QRS COMPLEX TACHYARRHYTHMIAS,TWrex-cause
718228491,5/10/2015 14:25:33,1633655903,5/10/2015 14:24:46,False,clixsense,0.5327,10798016,GBR,C7,Coventry,86.24.245.191,MULTIFOCAL ATRIAL TACHYCARDIA causes NARROW QRS COMPLEX TACHYARRHYTHMIAS,156,11,,1,184,causes,0.327326835353989,813298-FS1-4,"Irregular, NARROW QRS COMPLEX TACHYARRHYTHMIAS include atrial fibrillation (AF), atrial flutter or true atrial tachycardia with variable AV conduction, and MULTIFOCAL ATRIAL TACHYCARDIA",MULTIFOCAL ATRIAL TACHYCARDIA,NARROW QRS COMPLEX TACHYARRHYTHMIAS,TWrex-cause
718228491,5/10/2015 14:37:35,1633659022,5/10/2015 14:37:13,False,neodev,0.3542,32103286,CAN,AB,Edmonton,208.123.223.44,NARROW QRS COMPLEX TACHYARRHYTHMIAS causes MULTIFOCAL ATRIAL TACHYCARDIA,156,11,,1,184,causes,0.327326835353989,813298-FS1-4,"Irregular, NARROW QRS COMPLEX TACHYARRHYTHMIAS include atrial fibrillation (AF), atrial flutter or true atrial tachycardia with variable AV conduction, and MULTIFOCAL ATRIAL TACHYCARDIA",MULTIFOCAL ATRIAL TACHYCARDIA,NARROW QRS COMPLEX TACHYARRHYTHMIAS,TWrex-cause
718228491,5/10/2015 14:58:17,1633664381,5/10/2015 14:57:29,False,neodev,0.6022,24564999,GBR,H9,London,86.145.227.9,no_relation,156,11,,1,184,causes,0.327326835353989,813298-FS1-4,"Irregular, NARROW QRS COMPLEX TACHYARRHYTHMIAS include atrial fibrillation (AF), atrial flutter or true atrial tachycardia with variable AV conduction, and MULTIFOCAL ATRIAL TACHYCARDIA",MULTIFOCAL ATRIAL TACHYCARDIA,NARROW QRS COMPLEX TACHYARRHYTHMIAS,TWrex-cause
718228494,5/10/2015 11:59:26,1633619561,5/10/2015 11:58:52,False,prodege,1.0,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,56,130,,1,71,causes,0.650944554904119,814666-FS1-4,"Nerve injury and reduced sensory input more often cause NEUROPATHIC PAIN than cure it, and augmenting sensory input often lessens NEURALGIA",NEUROPATHIC PAIN,NEURALGIA,TWrex-cause
718228494,5/10/2015 12:13:03,1633622435,5/10/2015 12:12:38,False,meprizescf,0.6014,28483210,USA,WI,Minocqua,75.143.134.247,NEURALGIA causes NEUROPATHIC PAIN,56,130,,1,71,causes,0.650944554904119,814666-FS1-4,"Nerve injury and reduced sensory input more often cause NEUROPATHIC PAIN than cure it, and augmenting sensory input often lessens NEURALGIA",NEUROPATHIC PAIN,NEURALGIA,TWrex-cause
718228494,5/10/2015 12:13:58,1633622562,5/10/2015 12:13:46,False,clixsense,0.5639,28457001,CAN,ON,North Bay,24.204.202.220,no_relation,56,130,,1,71,causes,0.650944554904119,814666-FS1-4,"Nerve injury and reduced sensory input more often cause NEUROPATHIC PAIN than cure it, and augmenting sensory input often lessens NEURALGIA",NEUROPATHIC PAIN,NEURALGIA,TWrex-cause
718228494,5/10/2015 12:16:14,1633623015,5/10/2015 12:15:32,False,instagc,0.6708,18531561,CAN,ON,Mississauga,99.229.92.227,no_relation,56,130,,1,71,causes,0.650944554904119,814666-FS1-4,"Nerve injury and reduced sensory input more often cause NEUROPATHIC PAIN than cure it, and augmenting sensory input often lessens NEURALGIA",NEUROPATHIC PAIN,NEURALGIA,TWrex-cause
718228494,5/10/2015 12:17:14,1633623281,5/10/2015 12:16:47,False,clixsense,0.5944,19638651,USA,SC,Summerville,174.107.73.211,no_relation,56,130,,1,71,causes,0.650944554904119,814666-FS1-4,"Nerve injury and reduced sensory input more often cause NEUROPATHIC PAIN than cure it, and augmenting sensory input often lessens NEURALGIA",NEUROPATHIC PAIN,NEURALGIA,TWrex-cause
718228494,5/10/2015 12:29:50,1633626248,5/10/2015 12:29:19,False,points4rewards,0.6171,20113482,USA,OR,Portland,67.213.218.72,no_relation,56,130,,1,71,causes,0.650944554904119,814666-FS1-4,"Nerve injury and reduced sensory input more often cause NEUROPATHIC PAIN than cure it, and augmenting sensory input often lessens NEURALGIA",NEUROPATHIC PAIN,NEURALGIA,TWrex-cause
718228494,5/10/2015 12:31:10,1633626589,5/10/2015 12:30:55,False,inboxpounds,0.9,30211697,GBR,B7,Bristol,90.222.102.171,no_relation,56,130,,1,71,causes,0.650944554904119,814666-FS1-4,"Nerve injury and reduced sensory input more often cause NEUROPATHIC PAIN than cure it, and augmenting sensory input often lessens NEURALGIA",NEUROPATHIC PAIN,NEURALGIA,TWrex-cause
718228495,5/10/2015 11:58:16,1633619303,5/10/2015 11:57:44,False,prodege,1.0,21417560,GBR,C3,Cambridge,151.225.116.143,PHEOCHROMOCYTOMA RESECTION causes POSTOPERATIVE HYPERTENSION,33,98,,1,58,causes,0.8660254037844392,813536-FS1-4," According to an expert review, POSTOPERATIVE HYPERTENSION occurs in up to 50% of patients after PHEOCHROMOCYTOMA RESECTION ( 29.",POSTOPERATIVE HYPERTENSION,PHEOCHROMOCYTOMA RESECTION,TWrex-cause
718228495,5/10/2015 12:05:28,1633620873,5/10/2015 12:05:15,False,gifthunterclub,0.55,31241093,GBR,L9,Sheffield,90.217.213.219,POSTOPERATIVE HYPERTENSION causes PHEOCHROMOCYTOMA RESECTION,33,98,,1,58,causes,0.8660254037844392,813536-FS1-4," According to an expert review, POSTOPERATIVE HYPERTENSION occurs in up to 50% of patients after PHEOCHROMOCYTOMA RESECTION ( 29.",POSTOPERATIVE HYPERTENSION,PHEOCHROMOCYTOMA RESECTION,TWrex-cause
718228495,5/10/2015 12:12:20,1633622275,5/10/2015 12:11:58,False,meprizescf,0.6014,28483210,USA,WI,Minocqua,75.143.134.247,POSTOPERATIVE HYPERTENSION causes PHEOCHROMOCYTOMA RESECTION,33,98,,1,58,causes,0.8660254037844392,813536-FS1-4," According to an expert review, POSTOPERATIVE HYPERTENSION occurs in up to 50% of patients after PHEOCHROMOCYTOMA RESECTION ( 29.",POSTOPERATIVE HYPERTENSION,PHEOCHROMOCYTOMA RESECTION,TWrex-cause
718228495,5/10/2015 12:13:31,1633622506,5/10/2015 12:13:11,False,clixsense,0.5639,28457001,CAN,ON,North Bay,24.204.202.220,PHEOCHROMOCYTOMA RESECTION causes POSTOPERATIVE HYPERTENSION,33,98,,1,58,causes,0.8660254037844392,813536-FS1-4," According to an expert review, POSTOPERATIVE HYPERTENSION occurs in up to 50% of patients after PHEOCHROMOCYTOMA RESECTION ( 29.",POSTOPERATIVE HYPERTENSION,PHEOCHROMOCYTOMA RESECTION,TWrex-cause
718228495,5/10/2015 12:14:49,1633622769,5/10/2015 12:14:32,False,instagc,0.6708,18531561,CAN,ON,Mississauga,99.229.92.227,PHEOCHROMOCYTOMA RESECTION causes POSTOPERATIVE HYPERTENSION,33,98,,1,58,causes,0.8660254037844392,813536-FS1-4," According to an expert review, POSTOPERATIVE HYPERTENSION occurs in up to 50% of patients after PHEOCHROMOCYTOMA RESECTION ( 29.",POSTOPERATIVE HYPERTENSION,PHEOCHROMOCYTOMA RESECTION,TWrex-cause
718228495,5/10/2015 12:16:26,1633623036,5/10/2015 12:16:03,False,clixsense,0.5944,19638651,USA,SC,Summerville,174.107.73.211,PHEOCHROMOCYTOMA RESECTION causes POSTOPERATIVE HYPERTENSION,33,98,,1,58,causes,0.8660254037844392,813536-FS1-4," According to an expert review, POSTOPERATIVE HYPERTENSION occurs in up to 50% of patients after PHEOCHROMOCYTOMA RESECTION ( 29.",POSTOPERATIVE HYPERTENSION,PHEOCHROMOCYTOMA RESECTION,TWrex-cause
718228495,5/10/2015 12:28:17,1633626004,5/10/2015 12:27:39,False,points4rewards,0.6171,20113482,USA,OR,Portland,67.213.218.72,PHEOCHROMOCYTOMA RESECTION causes POSTOPERATIVE HYPERTENSION,33,98,,1,58,causes,0.8660254037844392,813536-FS1-4," According to an expert review, POSTOPERATIVE HYPERTENSION occurs in up to 50% of patients after PHEOCHROMOCYTOMA RESECTION ( 29.",POSTOPERATIVE HYPERTENSION,PHEOCHROMOCYTOMA RESECTION,TWrex-cause
718434602,5/11/2015 11:48:21,1634028622,5/11/2015 11:47:48,False,neodev,0.7619,20961587,NLD,05,Maastricht,84.26.48.136,LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE causes GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY,0,150,,-1,50,causes,0.847998304005088,803342-FS1-4,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE acetate therapy in four cases.,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY,LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE,TWrex-cause
718434602,5/11/2015 12:01:56,1634032135,5/11/2015 12:01:37,False,prodege,1.0,29686407,GBR,E4,Billericay,109.153.202.28,LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE causes GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY,0,150,,-1,50,causes,0.847998304005088,803342-FS1-4,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE acetate therapy in four cases.,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY,LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE,TWrex-cause
718434602,5/11/2015 12:20:23,1634037629,5/11/2015 12:19:56,False,points4rewards,0.8125,28755767,USA,VA,Chester,68.57.118.32,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY causes LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE,0,150,,-1,50,causes,0.847998304005088,803342-FS1-4,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE acetate therapy in four cases.,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY,LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE,TWrex-cause
718434602,5/11/2015 12:20:33,1634037671,5/11/2015 12:19:57,False,instagc,0.8542,18960682,GBR,C9,Carlisle,92.18.171.231,no_relation,0,150,,-1,50,causes,0.847998304005088,803342-FS1-4,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE acetate therapy in four cases.,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY,LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE,TWrex-cause
718434602,5/11/2015 12:24:10,1634038782,5/11/2015 12:23:42,False,clixsense,0.7556,21933552,CAN,ON,Ottawa,70.49.14.161,no_relation,0,150,,-1,50,causes,0.847998304005088,803342-FS1-4,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE acetate therapy in four cases.,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY,LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE,TWrex-cause
718434602,5/11/2015 12:31:35,1634041056,5/11/2015 12:31:24,False,clixsense,0.7768,8888883,USA,,,73.21.180.112,LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE causes GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY,0,150,,-1,50,causes,0.847998304005088,803342-FS1-4,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE acetate therapy in four cases.,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY,LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE,TWrex-cause
718434602,5/11/2015 12:33:45,1634042001,5/11/2015 12:33:17,False,neodev,0.4971,32124234,USA,DE,,108.59.8.218,LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE causes GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY,0,150,,-1,50,causes,0.847998304005088,803342-FS1-4,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE acetate therapy in four cases.,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY,LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE,TWrex-cause
718434606,5/11/2015 11:09:15,1634019301,5/11/2015 11:08:49,False,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,32,88,,-1,40,causes,0.452267016866645,803225-FS1-4,"b ,    e  Specific Populations  PREGNANCY  Category C.  b ,   c ,   d ,   e  Lactation  CALCITRIOL may be distributed into human milk.",PREGNANCY,CALCITRIOL,TWrex-cause
718434606,5/11/2015 11:14:53,1634020528,5/11/2015 11:14:28,False,neodev,0.875,14096345,NLD,03,Eibergen,77.174.124.109,no_relation,32,88,,-1,40,causes,0.452267016866645,803225-FS1-4,"b ,    e  Specific Populations  PREGNANCY  Category C.  b ,   c ,   d ,   e  Lactation  CALCITRIOL may be distributed into human milk.",PREGNANCY,CALCITRIOL,TWrex-cause
718434606,5/11/2015 11:19:55,1634021616,5/11/2015 11:19:39,False,gifthunterclub,0.6667,31241093,GBR,Y1,Flint,2.127.1.248,no_relation,32,88,,-1,40,causes,0.452267016866645,803225-FS1-4,"b ,    e  Specific Populations  PREGNANCY  Category C.  b ,   c ,   d ,   e  Lactation  CALCITRIOL may be distributed into human milk.",PREGNANCY,CALCITRIOL,TWrex-cause
718434606,5/11/2015 11:29:56,1634024157,5/11/2015 11:29:29,False,fusioncash,0.6875,31757234,USA,KY,London,76.177.136.50,PREGNANCY causes CALCITRIOL,32,88,,-1,40,causes,0.452267016866645,803225-FS1-4,"b ,    e  Specific Populations  PREGNANCY  Category C.  b ,   c ,   d ,   e  Lactation  CALCITRIOL may be distributed into human milk.",PREGNANCY,CALCITRIOL,TWrex-cause
718434606,5/11/2015 11:46:28,1634028145,5/11/2015 11:46:01,False,prodege,0.6619,29849805,GBR,Z1,Swansea,82.1.37.235,no_relation,32,88,,-1,40,causes,0.452267016866645,803225-FS1-4,"b ,    e  Specific Populations  PREGNANCY  Category C.  b ,   c ,   d ,   e  Lactation  CALCITRIOL may be distributed into human milk.",PREGNANCY,CALCITRIOL,TWrex-cause
718434606,5/11/2015 11:47:16,1634028324,5/11/2015 11:46:35,False,neodev,0.5595,12115558,USA,OH,Twinsburg,98.27.164.131,no_relation,32,88,,-1,40,causes,0.452267016866645,803225-FS1-4,"b ,    e  Specific Populations  PREGNANCY  Category C.  b ,   c ,   d ,   e  Lactation  CALCITRIOL may be distributed into human milk.",PREGNANCY,CALCITRIOL,TWrex-cause
718434606,5/11/2015 11:47:46,1634028431,5/11/2015 11:47:20,False,neodev,0.7619,20961587,NLD,05,Maastricht,84.26.48.136,no_relation,32,88,,-1,40,causes,0.452267016866645,803225-FS1-4,"b ,    e  Specific Populations  PREGNANCY  Category C.  b ,   c ,   d ,   e  Lactation  CALCITRIOL may be distributed into human milk.",PREGNANCY,CALCITRIOL,TWrex-cause
718434617,5/11/2015 10:15:16,1634004879,5/11/2015 10:14:55,False,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,L MONOCYTOGENES causes LISTERIA INFECTIONS,0,56,,1,18,causes,0.9878291611472622,811897-FS1-4,"LISTERIA INFECTIONS  Treatment of infections caused by  L MONOCYTOGENES  (e.g., infections during pregnancy, granulomatosis infantiseptica, sepsis, meningitis, endocarditis, foodborne infections.",LISTERIA INFECTIONS,L MONOCYTOGENES,TWrex-cause
718434617,5/11/2015 10:17:57,1634005614,5/11/2015 10:17:06,False,points4rewards,0.625,20113482,USA,OR,Portland,67.213.218.72,L MONOCYTOGENES causes LISTERIA INFECTIONS,0,56,,1,18,causes,0.9878291611472622,811897-FS1-4,"LISTERIA INFECTIONS  Treatment of infections caused by  L MONOCYTOGENES  (e.g., infections during pregnancy, granulomatosis infantiseptica, sepsis, meningitis, endocarditis, foodborne infections.",LISTERIA INFECTIONS,L MONOCYTOGENES,TWrex-cause
718434617,5/11/2015 10:23:43,1634007190,5/11/2015 10:23:13,False,instagc,0.7222,18531561,CAN,ON,Mississauga,99.229.92.227,L MONOCYTOGENES causes LISTERIA INFECTIONS,0,56,,1,18,causes,0.9878291611472622,811897-FS1-4,"LISTERIA INFECTIONS  Treatment of infections caused by  L MONOCYTOGENES  (e.g., infections during pregnancy, granulomatosis infantiseptica, sepsis, meningitis, endocarditis, foodborne infections.",LISTERIA INFECTIONS,L MONOCYTOGENES,TWrex-cause
718434617,5/11/2015 10:37:37,1634011227,5/11/2015 10:37:22,False,meprizescf,0.4792,28483210,USA,WI,Minocqua,75.143.134.247,LISTERIA INFECTIONS causes L MONOCYTOGENES,0,56,,1,18,causes,0.9878291611472622,811897-FS1-4,"LISTERIA INFECTIONS  Treatment of infections caused by  L MONOCYTOGENES  (e.g., infections during pregnancy, granulomatosis infantiseptica, sepsis, meningitis, endocarditis, foodborne infections.",LISTERIA INFECTIONS,L MONOCYTOGENES,TWrex-cause
718434617,5/11/2015 10:40:51,1634011970,5/11/2015 10:40:03,False,superrewards,0.6167,31767535,GBR,V2,Glasgow,94.9.182.127,no_relation,0,56,,1,18,causes,0.9878291611472622,811897-FS1-4,"LISTERIA INFECTIONS  Treatment of infections caused by  L MONOCYTOGENES  (e.g., infections during pregnancy, granulomatosis infantiseptica, sepsis, meningitis, endocarditis, foodborne infections.",LISTERIA INFECTIONS,L MONOCYTOGENES,TWrex-cause
718434617,5/11/2015 10:51:16,1634014587,5/11/2015 10:50:28,False,clixsense,0.6389,6338946,CAN,QC,Montral,209.197.170.96,no_relation,0,56,,1,18,causes,0.9878291611472622,811897-FS1-4,"LISTERIA INFECTIONS  Treatment of infections caused by  L MONOCYTOGENES  (e.g., infections during pregnancy, granulomatosis infantiseptica, sepsis, meningitis, endocarditis, foodborne infections.",LISTERIA INFECTIONS,L MONOCYTOGENES,TWrex-cause
718434617,5/11/2015 11:01:07,1634017130,5/11/2015 11:00:47,False,elite,0.6071,31883685,GBR,H2,Accrington,80.47.186.28,L MONOCYTOGENES causes LISTERIA INFECTIONS,0,56,,1,18,causes,0.9878291611472622,811897-FS1-4,"LISTERIA INFECTIONS  Treatment of infections caused by  L MONOCYTOGENES  (e.g., infections during pregnancy, granulomatosis infantiseptica, sepsis, meningitis, endocarditis, foodborne infections.",LISTERIA INFECTIONS,L MONOCYTOGENES,TWrex-cause
718434622,5/11/2015 11:07:05,1634018755,5/11/2015 11:06:25,False,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,22,42,,1,32,causes,0.4472135954999579,812152-FS1-4,"Drugs associated with GI BLEEDING include ANTICOAGULANTS (HEPARIN WARFARIN those affecting platelet function (eg, aspirin and certain other NSAIDs, clopidogrel, SSRIs), and those affecting mucosal defenses (eg, NSAIDs.",GI BLEEDING,ANTICOAGULANTS (HEPARIN WARFARIN,TWrex-cause
718434622,5/11/2015 11:13:38,1634020217,5/11/2015 11:13:03,False,neodev,0.875,14096345,NLD,03,Eibergen,77.174.124.109,no_relation,22,42,,1,32,causes,0.4472135954999579,812152-FS1-4,"Drugs associated with GI BLEEDING include ANTICOAGULANTS (HEPARIN WARFARIN those affecting platelet function (eg, aspirin and certain other NSAIDs, clopidogrel, SSRIs), and those affecting mucosal defenses (eg, NSAIDs.",GI BLEEDING,ANTICOAGULANTS (HEPARIN WARFARIN,TWrex-cause
718434622,5/11/2015 11:18:59,1634021414,5/11/2015 11:18:29,False,gifthunterclub,0.6667,31241093,GBR,Y1,Flint,2.127.1.248,ANTICOAGULANTS (HEPARIN WARFARIN causes GI BLEEDING,22,42,,1,32,causes,0.4472135954999579,812152-FS1-4,"Drugs associated with GI BLEEDING include ANTICOAGULANTS (HEPARIN WARFARIN those affecting platelet function (eg, aspirin and certain other NSAIDs, clopidogrel, SSRIs), and those affecting mucosal defenses (eg, NSAIDs.",GI BLEEDING,ANTICOAGULANTS (HEPARIN WARFARIN,TWrex-cause
718434622,5/11/2015 11:27:21,1634023418,5/11/2015 11:26:56,False,fusioncash,0.6875,31757234,USA,KY,London,76.177.136.50,ANTICOAGULANTS (HEPARIN WARFARIN causes GI BLEEDING,22,42,,1,32,causes,0.4472135954999579,812152-FS1-4,"Drugs associated with GI BLEEDING include ANTICOAGULANTS (HEPARIN WARFARIN those affecting platelet function (eg, aspirin and certain other NSAIDs, clopidogrel, SSRIs), and those affecting mucosal defenses (eg, NSAIDs.",GI BLEEDING,ANTICOAGULANTS (HEPARIN WARFARIN,TWrex-cause
718434622,5/11/2015 11:45:04,1634027833,5/11/2015 11:44:31,False,prodege,0.6619,29849805,GBR,Z1,Swansea,82.1.37.235,ANTICOAGULANTS (HEPARIN WARFARIN causes GI BLEEDING,22,42,,1,32,causes,0.4472135954999579,812152-FS1-4,"Drugs associated with GI BLEEDING include ANTICOAGULANTS (HEPARIN WARFARIN those affecting platelet function (eg, aspirin and certain other NSAIDs, clopidogrel, SSRIs), and those affecting mucosal defenses (eg, NSAIDs.",GI BLEEDING,ANTICOAGULANTS (HEPARIN WARFARIN,TWrex-cause
718434622,5/11/2015 11:45:33,1634027889,5/11/2015 11:44:41,False,neodev,0.5595,12115558,USA,OH,Twinsburg,98.27.164.131,GI BLEEDING causes ANTICOAGULANTS (HEPARIN WARFARIN,22,42,,1,32,causes,0.4472135954999579,812152-FS1-4,"Drugs associated with GI BLEEDING include ANTICOAGULANTS (HEPARIN WARFARIN those affecting platelet function (eg, aspirin and certain other NSAIDs, clopidogrel, SSRIs), and those affecting mucosal defenses (eg, NSAIDs.",GI BLEEDING,ANTICOAGULANTS (HEPARIN WARFARIN,TWrex-cause
718434622,5/11/2015 11:46:32,1634028170,5/11/2015 11:45:50,False,neodev,0.7619,20961587,NLD,05,Maastricht,84.26.48.136,no_relation,22,42,,1,32,causes,0.4472135954999579,812152-FS1-4,"Drugs associated with GI BLEEDING include ANTICOAGULANTS (HEPARIN WARFARIN those affecting platelet function (eg, aspirin and certain other NSAIDs, clopidogrel, SSRIs), and those affecting mucosal defenses (eg, NSAIDs.",GI BLEEDING,ANTICOAGULANTS (HEPARIN WARFARIN,TWrex-cause
718434624,5/11/2015 10:16:27,1634005293,5/11/2015 10:16:15,False,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,TRIGEMINAL NEURALGIA causes PAIN,76,13,,1,79,causes,0.9761870601839531,812797-FS1-4,"Rationale:  TRIGEMINAL NEURALGIA is unpredictable, and expected attacks of PAIN are possible at any time.",PAIN,TRIGEMINAL NEURALGIA,TWrex-cause
718434624,5/11/2015 10:20:24,1634006260,5/11/2015 10:19:47,False,points4rewards,0.625,20113482,USA,OR,Portland,67.213.218.72,TRIGEMINAL NEURALGIA causes PAIN,76,13,,1,79,causes,0.9761870601839531,812797-FS1-4,"Rationale:  TRIGEMINAL NEURALGIA is unpredictable, and expected attacks of PAIN are possible at any time.",PAIN,TRIGEMINAL NEURALGIA,TWrex-cause
718434624,5/11/2015 10:25:23,1634007652,5/11/2015 10:25:07,False,instagc,0.7222,18531561,CAN,ON,Mississauga,99.229.92.227,TRIGEMINAL NEURALGIA causes PAIN,76,13,,1,79,causes,0.9761870601839531,812797-FS1-4,"Rationale:  TRIGEMINAL NEURALGIA is unpredictable, and expected attacks of PAIN are possible at any time.",PAIN,TRIGEMINAL NEURALGIA,TWrex-cause
718434624,5/11/2015 10:39:11,1634011642,5/11/2015 10:38:58,False,meprizescf,0.4792,28483210,USA,WI,Minocqua,75.143.134.247,no_relation,76,13,,1,79,causes,0.9761870601839531,812797-FS1-4,"Rationale:  TRIGEMINAL NEURALGIA is unpredictable, and expected attacks of PAIN are possible at any time.",PAIN,TRIGEMINAL NEURALGIA,TWrex-cause
718434624,5/11/2015 10:42:11,1634012323,5/11/2015 10:41:53,False,superrewards,0.6167,31767535,GBR,V2,Glasgow,94.9.182.127,TRIGEMINAL NEURALGIA causes PAIN,76,13,,1,79,causes,0.9761870601839531,812797-FS1-4,"Rationale:  TRIGEMINAL NEURALGIA is unpredictable, and expected attacks of PAIN are possible at any time.",PAIN,TRIGEMINAL NEURALGIA,TWrex-cause
718434624,5/11/2015 10:54:35,1634015431,5/11/2015 10:53:36,False,clixsense,0.6389,6338946,CAN,QC,Montral,209.197.170.96,TRIGEMINAL NEURALGIA causes PAIN,76,13,,1,79,causes,0.9761870601839531,812797-FS1-4,"Rationale:  TRIGEMINAL NEURALGIA is unpredictable, and expected attacks of PAIN are possible at any time.",PAIN,TRIGEMINAL NEURALGIA,TWrex-cause
718434624,5/11/2015 11:02:29,1634017523,5/11/2015 11:02:15,False,elite,0.6071,31883685,GBR,H2,Accrington,80.47.186.28,TRIGEMINAL NEURALGIA causes PAIN,76,13,,1,79,causes,0.9761870601839531,812797-FS1-4,"Rationale:  TRIGEMINAL NEURALGIA is unpredictable, and expected attacks of PAIN are possible at any time.",PAIN,TRIGEMINAL NEURALGIA,TWrex-cause
718434630,5/11/2015 12:43:15,1634045170,5/11/2015 12:42:51,False,onestopgpt,0.6806,21275875,CAN,ON,Hamilton,24.36.121.10,PMR causes PAIN,127,0,,1,130,causes,0.9958932064677041,814468-FS1-4,"PMR is differentiated from polymyositis by normal muscle enzymes, electromyography, and muscle biopsy and by the prominence of PAIN over weakness.",PAIN,PMR,TWrex-cause
718434630,5/11/2015 12:45:59,1634046061,5/11/2015 12:45:35,False,prodege,0.7646,22031444,GBR,K6,Portsmouth,89.240.160.95,PMR causes PAIN,127,0,,1,130,causes,0.9958932064677041,814468-FS1-4,"PMR is differentiated from polymyositis by normal muscle enzymes, electromyography, and muscle biopsy and by the prominence of PAIN over weakness.",PAIN,PMR,TWrex-cause
718434630,5/11/2015 12:46:25,1634046157,5/11/2015 12:46:05,False,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,PMR causes PAIN,127,0,,1,130,causes,0.9958932064677041,814468-FS1-4,"PMR is differentiated from polymyositis by normal muscle enzymes, electromyography, and muscle biopsy and by the prominence of PAIN over weakness.",PAIN,PMR,TWrex-cause
718434630,5/11/2015 12:47:30,1634046485,5/11/2015 12:46:43,False,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,PMR causes PAIN,127,0,,1,130,causes,0.9958932064677041,814468-FS1-4,"PMR is differentiated from polymyositis by normal muscle enzymes, electromyography, and muscle biopsy and by the prominence of PAIN over weakness.",PAIN,PMR,TWrex-cause
718434630,5/11/2015 12:47:55,1634046628,5/11/2015 12:47:26,False,clixsense,0.6971,28351359,GBR,F6,Upminster,80.43.233.94,no_relation,127,0,,1,130,causes,0.9958932064677041,814468-FS1-4,"PMR is differentiated from polymyositis by normal muscle enzymes, electromyography, and muscle biopsy and by the prominence of PAIN over weakness.",PAIN,PMR,TWrex-cause
718434630,5/11/2015 12:49:53,1634047254,5/11/2015 12:49:32,False,elite,0.7809999999999999,29768955,GBR,,,213.152.52.145,no_relation,127,0,,1,130,causes,0.9958932064677041,814468-FS1-4,"PMR is differentiated from polymyositis by normal muscle enzymes, electromyography, and muscle biopsy and by the prominence of PAIN over weakness.",PAIN,PMR,TWrex-cause
718434630,5/11/2015 12:52:56,1634048055,5/11/2015 12:52:22,False,elite,0.4286,31913360,USA,DE,Wilmington,199.115.115.214,PAIN causes PMR,127,0,,1,130,causes,0.9958932064677041,814468-FS1-4,"PMR is differentiated from polymyositis by normal muscle enzymes, electromyography, and muscle biopsy and by the prominence of PAIN over weakness.",PAIN,PMR,TWrex-cause
718434633,5/11/2015 10:16:14,1634005226,5/11/2015 10:15:54,False,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,MYOCLONUS causes CJD,0,137,,1,8,causes,0.848528137423857,813336-FS1-4,"MYOCLONUS (a jerky reaction, particularly prominent after a startle) is an important physical finding, but its absence does not rule out CJD",MYOCLONUS,CJD,TWrex-cause
718434633,5/11/2015 10:19:44,1634006083,5/11/2015 10:19:10,False,points4rewards,0.625,20113482,USA,OR,Portland,67.213.218.72,no_relation,0,137,,1,8,causes,0.848528137423857,813336-FS1-4,"MYOCLONUS (a jerky reaction, particularly prominent after a startle) is an important physical finding, but its absence does not rule out CJD",MYOCLONUS,CJD,TWrex-cause
718434633,5/11/2015 10:25:07,1634007601,5/11/2015 10:24:37,False,instagc,0.7222,18531561,CAN,ON,Mississauga,99.229.92.227,CJD causes MYOCLONUS,0,137,,1,8,causes,0.848528137423857,813336-FS1-4,"MYOCLONUS (a jerky reaction, particularly prominent after a startle) is an important physical finding, but its absence does not rule out CJD",MYOCLONUS,CJD,TWrex-cause
718434633,5/11/2015 10:38:58,1634011607,5/11/2015 10:38:33,False,meprizescf,0.4792,28483210,USA,WI,Minocqua,75.143.134.247,no_relation,0,137,,1,8,causes,0.848528137423857,813336-FS1-4,"MYOCLONUS (a jerky reaction, particularly prominent after a startle) is an important physical finding, but its absence does not rule out CJD",MYOCLONUS,CJD,TWrex-cause
718434633,5/11/2015 10:41:52,1634012212,5/11/2015 10:41:35,False,superrewards,0.6167,31767535,GBR,V2,Glasgow,94.9.182.127,no_relation,0,137,,1,8,causes,0.848528137423857,813336-FS1-4,"MYOCLONUS (a jerky reaction, particularly prominent after a startle) is an important physical finding, but its absence does not rule out CJD",MYOCLONUS,CJD,TWrex-cause
718434633,5/11/2015 10:53:35,1634015118,5/11/2015 10:52:51,False,clixsense,0.6389,6338946,CAN,QC,Montral,209.197.170.96,no_relation,0,137,,1,8,causes,0.848528137423857,813336-FS1-4,"MYOCLONUS (a jerky reaction, particularly prominent after a startle) is an important physical finding, but its absence does not rule out CJD",MYOCLONUS,CJD,TWrex-cause
718434633,5/11/2015 11:02:14,1634017482,5/11/2015 11:01:52,False,elite,0.6071,31883685,GBR,H2,Accrington,80.47.186.28,CJD causes MYOCLONUS,0,137,,1,8,causes,0.848528137423857,813336-FS1-4,"MYOCLONUS (a jerky reaction, particularly prominent after a startle) is an important physical finding, but its absence does not rule out CJD",MYOCLONUS,CJD,TWrex-cause
718434636,5/11/2015 10:15:53,1634005133,5/11/2015 10:15:38,False,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,DKC causes CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE,45,17,,1,101,causes,0.9901475429766742,813814-FS1-4,"Characteristics  DKC can be characterized by CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE nails, leukoplakia of the oral mucosa, continuous lacrimation due to atresia of the lacrimal ducts, often thrombocytopenia, anemia, testicular atrophy in the male carriers, and predisposition to cancer.",CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE,DKC,TWrex-cause
718434636,5/11/2015 10:19:05,1634005874,5/11/2015 10:18:33,False,points4rewards,0.625,20113482,USA,OR,Portland,67.213.218.72,no_relation,45,17,,1,101,causes,0.9901475429766742,813814-FS1-4,"Characteristics  DKC can be characterized by CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE nails, leukoplakia of the oral mucosa, continuous lacrimation due to atresia of the lacrimal ducts, often thrombocytopenia, anemia, testicular atrophy in the male carriers, and predisposition to cancer.",CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE,DKC,TWrex-cause
718434636,5/11/2015 10:24:36,1634007482,5/11/2015 10:24:07,False,instagc,0.7222,18531561,CAN,ON,Mississauga,99.229.92.227,DKC causes CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE,45,17,,1,101,causes,0.9901475429766742,813814-FS1-4,"Characteristics  DKC can be characterized by CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE nails, leukoplakia of the oral mucosa, continuous lacrimation due to atresia of the lacrimal ducts, often thrombocytopenia, anemia, testicular atrophy in the male carriers, and predisposition to cancer.",CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE,DKC,TWrex-cause
718434636,5/11/2015 10:38:32,1634011436,5/11/2015 10:38:11,False,meprizescf,0.4792,28483210,USA,WI,Minocqua,75.143.134.247,CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE causes DKC,45,17,,1,101,causes,0.9901475429766742,813814-FS1-4,"Characteristics  DKC can be characterized by CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE nails, leukoplakia of the oral mucosa, continuous lacrimation due to atresia of the lacrimal ducts, often thrombocytopenia, anemia, testicular atrophy in the male carriers, and predisposition to cancer.",CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE,DKC,TWrex-cause
718434636,5/11/2015 10:41:34,1634012168,5/11/2015 10:41:13,False,superrewards,0.6167,31767535,GBR,V2,Glasgow,94.9.182.127,no_relation,45,17,,1,101,causes,0.9901475429766742,813814-FS1-4,"Characteristics  DKC can be characterized by CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE nails, leukoplakia of the oral mucosa, continuous lacrimation due to atresia of the lacrimal ducts, often thrombocytopenia, anemia, testicular atrophy in the male carriers, and predisposition to cancer.",CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE,DKC,TWrex-cause
718434636,5/11/2015 10:52:50,1634014980,5/11/2015 10:52:10,False,clixsense,0.6389,6338946,CAN,QC,Montral,209.197.170.96,no_relation,45,17,,1,101,causes,0.9901475429766742,813814-FS1-4,"Characteristics  DKC can be characterized by CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE nails, leukoplakia of the oral mucosa, continuous lacrimation due to atresia of the lacrimal ducts, often thrombocytopenia, anemia, testicular atrophy in the male carriers, and predisposition to cancer.",CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE,DKC,TWrex-cause
718434636,5/11/2015 11:01:51,1634017351,5/11/2015 11:01:35,False,elite,0.6071,31883685,GBR,H2,Accrington,80.47.186.28,DKC causes CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE,45,17,,1,101,causes,0.9901475429766742,813814-FS1-4,"Characteristics  DKC can be characterized by CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE nails, leukoplakia of the oral mucosa, continuous lacrimation due to atresia of the lacrimal ducts, often thrombocytopenia, anemia, testicular atrophy in the male carriers, and predisposition to cancer.",CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE,DKC,TWrex-cause
720316448,5/11/2015 22:16:46,1634400881,5/11/2015 22:16:30,False,instagc,0.9583,13581319,USA,IL,Mount Vernon,66.232.166.86,LAURENCE MOON SYNDROME causes MENTAL RETARDATION,53,0,,1,70,causes,0.939793423488437,812898-FS1-4,"LAURENCE MOON SYNDROME  is characterized by obesity, MENTAL RETARDATION retinitis pigmentosa, and polydactyly.",MENTAL RETARDATION,LAURENCE MOON SYNDROME,TWrex-cause
720316448,5/11/2015 22:19:09,1634401991,5/11/2015 22:18:28,False,clixsense,0.7083,17950689,GBR,Y9,Tonypandy,92.2.44.79,LAURENCE MOON SYNDROME causes MENTAL RETARDATION,53,0,,1,70,causes,0.939793423488437,812898-FS1-4,"LAURENCE MOON SYNDROME  is characterized by obesity, MENTAL RETARDATION retinitis pigmentosa, and polydactyly.",MENTAL RETARDATION,LAURENCE MOON SYNDROME,TWrex-cause
720316448,5/11/2015 22:22:17,1634403554,5/11/2015 22:21:45,False,clixsense,0.6361,17201951,GBR,L9,Sheffield,109.145.116.218,LAURENCE MOON SYNDROME causes MENTAL RETARDATION,53,0,,1,70,causes,0.939793423488437,812898-FS1-4,"LAURENCE MOON SYNDROME  is characterized by obesity, MENTAL RETARDATION retinitis pigmentosa, and polydactyly.",MENTAL RETARDATION,LAURENCE MOON SYNDROME,TWrex-cause
720316448,5/11/2015 22:23:17,1634404076,5/11/2015 22:22:38,False,points4rewards,0.5778,20113482,USA,OR,Portland,67.213.218.72,LAURENCE MOON SYNDROME causes MENTAL RETARDATION,53,0,,1,70,causes,0.939793423488437,812898-FS1-4,"LAURENCE MOON SYNDROME  is characterized by obesity, MENTAL RETARDATION retinitis pigmentosa, and polydactyly.",MENTAL RETARDATION,LAURENCE MOON SYNDROME,TWrex-cause
720316448,5/11/2015 22:28:57,1634406419,5/11/2015 22:28:18,False,elite,0.7397,31883685,GBR,H2,Accrington,80.47.186.28,LAURENCE MOON SYNDROME causes MENTAL RETARDATION,53,0,,1,70,causes,0.939793423488437,812898-FS1-4,"LAURENCE MOON SYNDROME  is characterized by obesity, MENTAL RETARDATION retinitis pigmentosa, and polydactyly.",MENTAL RETARDATION,LAURENCE MOON SYNDROME,TWrex-cause
720316448,5/11/2015 22:31:31,1634407340,5/11/2015 22:30:47,False,neodev,0.8651,18881135,CAN,ON,Ajax,99.243.87.224,no_relation,53,0,,1,70,causes,0.939793423488437,812898-FS1-4,"LAURENCE MOON SYNDROME  is characterized by obesity, MENTAL RETARDATION retinitis pigmentosa, and polydactyly.",MENTAL RETARDATION,LAURENCE MOON SYNDROME,TWrex-cause
720316448,5/11/2015 22:31:33,1634407373,5/11/2015 22:31:02,False,cotter,0.6964,13805544,USA,MI,Battle Creek,107.140.176.37,no_relation,53,0,,1,70,causes,0.939793423488437,812898-FS1-4,"LAURENCE MOON SYNDROME  is characterized by obesity, MENTAL RETARDATION retinitis pigmentosa, and polydactyly.",MENTAL RETARDATION,LAURENCE MOON SYNDROME,TWrex-cause
720316449,5/11/2015 22:51:12,1634416656,5/11/2015 22:50:44,False,prodege,0.8417,1924522,USA,NY,New York,96.224.13.217,NEISSERIA MENINGITIDIS causes MENINGOCOCCAL INFECTION,25,98,,1,47,causes,1.0,811176-FS1-4,"1 ,   4 ,   106 ,   108  MENINGOCOCCAL INFECTION is an acute, life threatening illness caused by  NEISSERIA MENINGITIDIS  and is transmitted person to person by the respiratory route.",MENINGOCOCCAL INFECTION,NEISSERIA MENINGITIDIS,TWrex-cause
720316449,5/11/2015 22:52:23,1634417052,5/11/2015 22:52:05,False,instagc,0.7667,18531561,CAN,ON,Mississauga,99.229.92.227,NEISSERIA MENINGITIDIS causes MENINGOCOCCAL INFECTION,25,98,,1,47,causes,1.0,811176-FS1-4,"1 ,   4 ,   106 ,   108  MENINGOCOCCAL INFECTION is an acute, life threatening illness caused by  NEISSERIA MENINGITIDIS  and is transmitted person to person by the respiratory route.",MENINGOCOCCAL INFECTION,NEISSERIA MENINGITIDIS,TWrex-cause
720316449,5/11/2015 23:04:36,1634421043,5/11/2015 23:04:10,False,instagc,0.6925,30506788,USA,MO,Springfield,50.81.216.165,NEISSERIA MENINGITIDIS causes MENINGOCOCCAL INFECTION,25,98,,1,47,causes,1.0,811176-FS1-4,"1 ,   4 ,   106 ,   108  MENINGOCOCCAL INFECTION is an acute, life threatening illness caused by  NEISSERIA MENINGITIDIS  and is transmitted person to person by the respiratory route.",MENINGOCOCCAL INFECTION,NEISSERIA MENINGITIDIS,TWrex-cause
720316449,5/11/2015 23:07:23,1634422154,5/11/2015 23:07:04,False,neodev,0.6327,15848372,AUS,02,Jannali,14.200.59.55,NEISSERIA MENINGITIDIS causes MENINGOCOCCAL INFECTION,25,98,,1,47,causes,1.0,811176-FS1-4,"1 ,   4 ,   106 ,   108  MENINGOCOCCAL INFECTION is an acute, life threatening illness caused by  NEISSERIA MENINGITIDIS  and is transmitted person to person by the respiratory route.",MENINGOCOCCAL INFECTION,NEISSERIA MENINGITIDIS,TWrex-cause
720316449,5/11/2015 23:14:28,1634426680,5/11/2015 23:14:10,False,instagc,0.7619,24252915,GBR,K6,Portsmouth,89.240.160.95,NEISSERIA MENINGITIDIS causes MENINGOCOCCAL INFECTION,25,98,,1,47,causes,1.0,811176-FS1-4,"1 ,   4 ,   106 ,   108  MENINGOCOCCAL INFECTION is an acute, life threatening illness caused by  NEISSERIA MENINGITIDIS  and is transmitted person to person by the respiratory route.",MENINGOCOCCAL INFECTION,NEISSERIA MENINGITIDIS,TWrex-cause
720316449,5/11/2015 23:15:10,1634427072,5/11/2015 23:14:55,False,prodege,0.5143,29197974,USA,CA,Carmichael,73.41.174.119,MENINGOCOCCAL INFECTION causes NEISSERIA MENINGITIDIS,25,98,,1,47,causes,1.0,811176-FS1-4,"1 ,   4 ,   106 ,   108  MENINGOCOCCAL INFECTION is an acute, life threatening illness caused by  NEISSERIA MENINGITIDIS  and is transmitted person to person by the respiratory route.",MENINGOCOCCAL INFECTION,NEISSERIA MENINGITIDIS,TWrex-cause
720316449,5/11/2015 23:15:33,1634427241,5/11/2015 23:15:08,False,elite,0.7619,32173500,GBR,,,90.194.126.118,MENINGOCOCCAL INFECTION causes NEISSERIA MENINGITIDIS,25,98,,1,47,causes,1.0,811176-FS1-4,"1 ,   4 ,   106 ,   108  MENINGOCOCCAL INFECTION is an acute, life threatening illness caused by  NEISSERIA MENINGITIDIS  and is transmitted person to person by the respiratory route.",MENINGOCOCCAL INFECTION,NEISSERIA MENINGITIDIS,TWrex-cause
720316452,5/11/2015 23:18:42,1634428535,5/11/2015 23:18:03,False,elite,0.7619,32173500,GBR,,,90.194.126.118,INFECTIOUS MONONUCLEOSIS causes LYMPHADENOPATHY,9,46,,1,23,causes,1.0,814049-FS1-4,"Painless LYMPHADENOPATHY can also result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,TWrex-cause
720316452,5/11/2015 23:41:39,1634440672,5/11/2015 23:41:24,False,instagc,0.7576,22396848,USA,MA,Waltham,146.115.168.153,INFECTIOUS MONONUCLEOSIS causes LYMPHADENOPATHY,9,46,,1,23,causes,1.0,814049-FS1-4,"Painless LYMPHADENOPATHY can also result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,TWrex-cause
720316452,5/11/2015 23:45:19,1634442361,5/11/2015 23:45:00,False,neodev,0.816,11382239,AUS,02,Strathfield,60.241.129.81,INFECTIOUS MONONUCLEOSIS causes LYMPHADENOPATHY,9,46,,1,23,causes,1.0,814049-FS1-4,"Painless LYMPHADENOPATHY can also result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,TWrex-cause
720316452,5/11/2015 23:48:41,1634443661,5/11/2015 23:48:21,False,instagc,0.8111,20342442,USA,NJ,Westfield,108.53.92.41,INFECTIOUS MONONUCLEOSIS causes LYMPHADENOPATHY,9,46,,1,23,causes,1.0,814049-FS1-4,"Painless LYMPHADENOPATHY can also result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,TWrex-cause
720316452,5/12/2015 00:02:29,1634448700,5/12/2015 00:02:00,False,clixsense,0.4286,10798016,GBR,C7,Coventry,86.24.245.191,LYMPHADENOPATHY causes INFECTIOUS MONONUCLEOSIS,9,46,,1,23,causes,1.0,814049-FS1-4,"Painless LYMPHADENOPATHY can also result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,TWrex-cause
720316452,5/12/2015 00:09:28,1634451299,5/12/2015 00:09:07,False,zoombucks,0.5646,4711962,CAN,ON,Markham,174.88.29.12,INFECTIOUS MONONUCLEOSIS causes LYMPHADENOPATHY,9,46,,1,23,causes,1.0,814049-FS1-4,"Painless LYMPHADENOPATHY can also result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,TWrex-cause
720316452,5/12/2015 00:15:08,1634453325,5/12/2015 00:14:52,False,onestopgpt,0.8286,21275875,CAN,ON,Hamilton,24.36.121.10,INFECTIOUS MONONUCLEOSIS causes LYMPHADENOPATHY,9,46,,1,23,causes,1.0,814049-FS1-4,"Painless LYMPHADENOPATHY can also result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,TWrex-cause
720316453,5/11/2015 22:16:13,1634400635,5/11/2015 22:15:58,False,instagc,0.9583,13581319,USA,IL,Mount Vernon,66.232.166.86,ENDOMETRIOSIS causes PAIN,35,56,,1,38,causes,0.34188172937891403,812862-FS1-4,7.4 Consider the LNG IUS to reduce PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS,TWrex-cause
720316453,5/11/2015 22:17:59,1634401432,5/11/2015 22:17:24,False,clixsense,0.7083,17950689,GBR,Y9,Tonypandy,92.2.44.79,PAIN causes ENDOMETRIOSIS,35,56,,1,38,causes,0.34188172937891403,812862-FS1-4,7.4 Consider the LNG IUS to reduce PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS,TWrex-cause
720316453,5/11/2015 22:21:25,1634403191,5/11/2015 22:21:08,False,clixsense,0.6361,17201951,GBR,L9,Sheffield,109.145.116.218,ENDOMETRIOSIS causes PAIN,35,56,,1,38,causes,0.34188172937891403,812862-FS1-4,7.4 Consider the LNG IUS to reduce PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS,TWrex-cause
720316453,5/11/2015 22:21:36,1634403294,5/11/2015 22:21:06,False,points4rewards,0.5778,20113482,USA,OR,Portland,67.213.218.72,no_relation,35,56,,1,38,causes,0.34188172937891403,812862-FS1-4,7.4 Consider the LNG IUS to reduce PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS,TWrex-cause
720316453,5/11/2015 22:25:46,1634405064,5/11/2015 22:25:18,False,clixsense,0.5874,23197581,NLD,11,Den Haag,82.217.5.55,ENDOMETRIOSIS causes PAIN,35,56,,1,38,causes,0.34188172937891403,812862-FS1-4,7.4 Consider the LNG IUS to reduce PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS,TWrex-cause
720316453,5/11/2015 22:27:35,1634405896,5/11/2015 22:26:53,False,elite,0.7397,31883685,GBR,H2,Accrington,80.47.186.28,ENDOMETRIOSIS causes PAIN,35,56,,1,38,causes,0.34188172937891403,812862-FS1-4,7.4 Consider the LNG IUS to reduce PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS,TWrex-cause
720316453,5/11/2015 22:30:28,1634406889,5/11/2015 22:29:56,False,cotter,0.6964,13805544,USA,MI,Battle Creek,107.140.176.37,ENDOMETRIOSIS causes PAIN,35,56,,1,38,causes,0.34188172937891403,812862-FS1-4,7.4 Consider the LNG IUS to reduce PAIN associated with ENDOMETRIOSIS,PAIN,ENDOMETRIOSIS,TWrex-cause
720316459,5/11/2015 22:29:39,1634406632,5/11/2015 22:29:00,False,elite,0.7397,31883685,GBR,H2,Accrington,80.47.186.28,PLASMODIUM FALCIPARUM causes MALARIA,0,19,,1,6,causes,0.99654575824488,810964-FS1-4,MALARIA caused by  PLASMODIUM FALCIPARUM.,MALARIA,PLASMODIUM FALCIPARUM,TWrex-cause
720316459,5/11/2015 22:31:54,1634407474,5/11/2015 22:31:34,False,cotter,0.6964,13805544,USA,MI,Battle Creek,107.140.176.37,PLASMODIUM FALCIPARUM causes MALARIA,0,19,,1,6,causes,0.99654575824488,810964-FS1-4,MALARIA caused by  PLASMODIUM FALCIPARUM.,MALARIA,PLASMODIUM FALCIPARUM,TWrex-cause
720316459,5/11/2015 22:32:28,1634407615,5/11/2015 22:31:40,False,neodev,0.8651,18881135,CAN,ON,Ajax,99.243.87.224,PLASMODIUM FALCIPARUM causes MALARIA,0,19,,1,6,causes,0.99654575824488,810964-FS1-4,MALARIA caused by  PLASMODIUM FALCIPARUM.,MALARIA,PLASMODIUM FALCIPARUM,TWrex-cause
720316459,5/11/2015 22:48:05,1634415270,5/11/2015 22:47:36,False,prodege,0.8417,1924522,USA,NY,New York,96.224.13.217,PLASMODIUM FALCIPARUM causes MALARIA,0,19,,1,6,causes,0.99654575824488,810964-FS1-4,MALARIA caused by  PLASMODIUM FALCIPARUM.,MALARIA,PLASMODIUM FALCIPARUM,TWrex-cause
720316459,5/11/2015 22:49:53,1634416033,5/11/2015 22:49:20,False,instagc,0.7667,18531561,CAN,ON,Mississauga,99.229.92.227,PLASMODIUM FALCIPARUM causes MALARIA,0,19,,1,6,causes,0.99654575824488,810964-FS1-4,MALARIA caused by  PLASMODIUM FALCIPARUM.,MALARIA,PLASMODIUM FALCIPARUM,TWrex-cause
720316459,5/11/2015 22:51:41,1634416846,5/11/2015 22:51:24,False,neodev,0.4167,31977841,USA,IL,Chicago,69.175.85.2,PLASMODIUM FALCIPARUM causes MALARIA,0,19,,1,6,causes,0.99654575824488,810964-FS1-4,MALARIA caused by  PLASMODIUM FALCIPARUM.,MALARIA,PLASMODIUM FALCIPARUM,TWrex-cause
720316459,5/11/2015 23:00:57,1634419779,5/11/2015 23:00:04,False,instagc,0.6925,30506788,USA,MO,Springfield,50.81.216.165,PLASMODIUM FALCIPARUM causes MALARIA,0,19,,1,6,causes,0.99654575824488,810964-FS1-4,MALARIA caused by  PLASMODIUM FALCIPARUM.,MALARIA,PLASMODIUM FALCIPARUM,TWrex-cause
720316463,5/11/2015 23:18:02,1634428199,5/11/2015 23:17:30,False,elite,0.7619,32173500,GBR,,,90.194.126.118,DRUG causes OVERDOSE,0,69,,1,7,causes,0.975900072948533,810495-FS1-4,"OVERDOSE can result from inhalation, injection, or absorption of the DRUG from the gastrointestinal tract ('body packing')",OVERDOSE,DRUG,TWrex-cause
720316463,5/11/2015 23:41:23,1634440553,5/11/2015 23:41:12,False,instagc,0.7576,22396848,USA,MA,Waltham,146.115.168.153,DRUG causes OVERDOSE,0,69,,1,7,causes,0.975900072948533,810495-FS1-4,"OVERDOSE can result from inhalation, injection, or absorption of the DRUG from the gastrointestinal tract ('body packing')",OVERDOSE,DRUG,TWrex-cause
720316463,5/11/2015 23:44:58,1634442226,5/11/2015 23:44:22,False,neodev,0.816,11382239,AUS,02,Strathfield,60.241.129.81,DRUG causes OVERDOSE,0,69,,1,7,causes,0.975900072948533,810495-FS1-4,"OVERDOSE can result from inhalation, injection, or absorption of the DRUG from the gastrointestinal tract ('body packing')",OVERDOSE,DRUG,TWrex-cause
720316463,5/11/2015 23:48:20,1634443540,5/11/2015 23:47:44,False,instagc,0.8111,20342442,USA,NJ,Westfield,108.53.92.41,DRUG causes OVERDOSE,0,69,,1,7,causes,0.975900072948533,810495-FS1-4,"OVERDOSE can result from inhalation, injection, or absorption of the DRUG from the gastrointestinal tract ('body packing')",OVERDOSE,DRUG,TWrex-cause
720316463,5/12/2015 00:01:59,1634448421,5/12/2015 00:01:20,False,clixsense,0.4286,10798016,GBR,C7,Coventry,86.24.245.191,OVERDOSE causes DRUG,0,69,,1,7,causes,0.975900072948533,810495-FS1-4,"OVERDOSE can result from inhalation, injection, or absorption of the DRUG from the gastrointestinal tract ('body packing')",OVERDOSE,DRUG,TWrex-cause
720316463,5/12/2015 00:09:06,1634451213,5/12/2015 00:08:50,False,zoombucks,0.5646,4711962,CAN,ON,Markham,174.88.29.12,DRUG causes OVERDOSE,0,69,,1,7,causes,0.975900072948533,810495-FS1-4,"OVERDOSE can result from inhalation, injection, or absorption of the DRUG from the gastrointestinal tract ('body packing')",OVERDOSE,DRUG,TWrex-cause
720316463,5/12/2015 00:14:52,1634453267,5/12/2015 00:14:23,False,onestopgpt,0.8286,21275875,CAN,ON,Hamilton,24.36.121.10,DRUG causes OVERDOSE,0,69,,1,7,causes,0.975900072948533,810495-FS1-4,"OVERDOSE can result from inhalation, injection, or absorption of the DRUG from the gastrointestinal tract ('body packing')",OVERDOSE,DRUG,TWrex-cause
720316467,5/11/2015 22:16:29,1634400768,5/11/2015 22:16:13,False,instagc,0.9583,13581319,USA,IL,Mount Vernon,66.232.166.86,FM causes PAIN,126,67,,1,129,causes,0.9237604307034009,812634-FS1-4,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self reported PAIN life interference, and affective distress than patients with idiopathic onset.",PAIN,FM,TWrex-cause
720316467,5/11/2015 22:18:27,1634401673,5/11/2015 22:18:00,False,clixsense,0.7083,17950689,GBR,Y9,Tonypandy,92.2.44.79,FM causes PAIN,126,67,,1,129,causes,0.9237604307034009,812634-FS1-4,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self reported PAIN life interference, and affective distress than patients with idiopathic onset.",PAIN,FM,TWrex-cause
720316467,5/11/2015 22:21:44,1634403339,5/11/2015 22:21:26,False,clixsense,0.6361,17201951,GBR,L9,Sheffield,109.145.116.218,FM causes PAIN,126,67,,1,129,causes,0.9237604307034009,812634-FS1-4,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self reported PAIN life interference, and affective distress than patients with idiopathic onset.",PAIN,FM,TWrex-cause
720316467,5/11/2015 22:22:32,1634403668,5/11/2015 22:21:43,False,points4rewards,0.5778,20113482,USA,OR,Portland,67.213.218.72,FM causes PAIN,126,67,,1,129,causes,0.9237604307034009,812634-FS1-4,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self reported PAIN life interference, and affective distress than patients with idiopathic onset.",PAIN,FM,TWrex-cause
720316467,5/11/2015 22:26:15,1634405305,5/11/2015 22:25:46,False,clixsense,0.5874,23197581,NLD,11,Den Haag,82.217.5.55,no_relation,126,67,,1,129,causes,0.9237604307034009,812634-FS1-4,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self reported PAIN life interference, and affective distress than patients with idiopathic onset.",PAIN,FM,TWrex-cause
720316467,5/11/2015 22:28:17,1634406131,5/11/2015 22:27:36,False,elite,0.7397,31883685,GBR,H2,Accrington,80.47.186.28,FM causes PAIN,126,67,,1,129,causes,0.9237604307034009,812634-FS1-4,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self reported PAIN life interference, and affective distress than patients with idiopathic onset.",PAIN,FM,TWrex-cause
720316467,5/11/2015 22:31:00,1634407121,5/11/2015 22:30:29,False,cotter,0.6964,13805544,USA,MI,Battle Creek,107.140.176.37,FM causes PAIN,126,67,,1,129,causes,0.9237604307034009,812634-FS1-4,"25   At a clinical level, however, individuals who attribute their FM to trauma have more perceived disability, self reported PAIN life interference, and affective distress than patients with idiopathic onset.",PAIN,FM,TWrex-cause
721149594,5/13/2015 11:02:09,1635694858,5/13/2015 11:01:46,False,neodev,0.8631,11014534,GBR,B8,Bromley,86.18.149.6,INCREASED INTRACRANIAL PRESSURE causes PAPILLEDEMA,0,22,,10,53,causes,0.9918365981341758,813185-FS1-4,"PAPILLEDEMA indicates INCREASED INTRACRANIAL PRESSURE which may be due to idiopathic intracranial hypertension, accelerated hypertension, a mass lesion, or sagittal sinus thrombosis.",PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE,TWrex-cause
721149594,5/13/2015 11:26:45,1635701062,5/13/2015 11:26:09,False,neodev,0.7,18881135,CAN,ON,Ajax,99.243.87.224,no_relation,0,22,,10,53,causes,0.9918365981341758,813185-FS1-4,"PAPILLEDEMA indicates INCREASED INTRACRANIAL PRESSURE which may be due to idiopathic intracranial hypertension, accelerated hypertension, a mass lesion, or sagittal sinus thrombosis.",PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE,TWrex-cause
721149594,5/13/2015 11:27:39,1635701312,5/13/2015 11:26:59,False,clixsense,0.65,29594612,NLD,11,Rotterdam,82.156.132.195,PAPILLEDEMA causes INCREASED INTRACRANIAL PRESSURE,0,22,,10,53,causes,0.9918365981341758,813185-FS1-4,"PAPILLEDEMA indicates INCREASED INTRACRANIAL PRESSURE which may be due to idiopathic intracranial hypertension, accelerated hypertension, a mass lesion, or sagittal sinus thrombosis.",PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE,TWrex-cause
721149594,5/13/2015 11:39:47,1635704791,5/13/2015 11:39:07,False,prodege,0.7381,27934334,GBR,D3,Swadlincote,109.150.228.127,no_relation,0,22,,10,53,causes,0.9918365981341758,813185-FS1-4,"PAPILLEDEMA indicates INCREASED INTRACRANIAL PRESSURE which may be due to idiopathic intracranial hypertension, accelerated hypertension, a mass lesion, or sagittal sinus thrombosis.",PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE,TWrex-cause
721149594,5/13/2015 11:41:25,1635705123,5/13/2015 11:40:59,False,clixsense,0.5,21933552,CAN,ON,Ottawa,70.49.14.161,no_relation,0,22,,10,53,causes,0.9918365981341758,813185-FS1-4,"PAPILLEDEMA indicates INCREASED INTRACRANIAL PRESSURE which may be due to idiopathic intracranial hypertension, accelerated hypertension, a mass lesion, or sagittal sinus thrombosis.",PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE,TWrex-cause
721149594,5/13/2015 11:41:29,1635705138,5/13/2015 11:41:00,False,clixsense,0.7694,6338946,CAN,QC,Montral,209.197.141.151,PAPILLEDEMA causes INCREASED INTRACRANIAL PRESSURE,0,22,,10,53,causes,0.9918365981341758,813185-FS1-4,"PAPILLEDEMA indicates INCREASED INTRACRANIAL PRESSURE which may be due to idiopathic intracranial hypertension, accelerated hypertension, a mass lesion, or sagittal sinus thrombosis.",PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE,TWrex-cause
721149594,5/13/2015 12:29:31,1635721013,5/13/2015 12:29:16,False,bitcoinget,0.622,21614812,USA,PA,Erie,174.100.250.115,no_relation,0,22,,10,53,causes,0.9918365981341758,813185-FS1-4,"PAPILLEDEMA indicates INCREASED INTRACRANIAL PRESSURE which may be due to idiopathic intracranial hypertension, accelerated hypertension, a mass lesion, or sagittal sinus thrombosis.",PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE,TWrex-cause
721149599,5/13/2015 11:00:16,1635694219,5/13/2015 11:00:05,False,elite,0.7817,31856422,GBR,C9,Workington,92.18.169.149,IOSCA causes ATAXIA,33,14,,38,19,causes,0.9237604307034009,813622-FS1-4,"Children with IOSCA present with ATAXIA peripheral neuropathy, areflexia, athetosis, and Babinski signs early in the first decade of life.",ATAXIA,IOSCA,TWrex-cause
721149599,5/13/2015 11:00:26,1635694291,5/13/2015 11:00:01,False,neodev,0.6667,12115558,USA,OH,Twinsburg,98.27.164.131,no_relation,33,14,,38,19,causes,0.9237604307034009,813622-FS1-4,"Children with IOSCA present with ATAXIA peripheral neuropathy, areflexia, athetosis, and Babinski signs early in the first decade of life.",ATAXIA,IOSCA,TWrex-cause
721149599,5/13/2015 11:00:28,1635694299,5/13/2015 11:00:14,False,neodev,0.8631,11014534,GBR,B8,Bromley,86.18.149.6,IOSCA causes ATAXIA,33,14,,38,19,causes,0.9237604307034009,813622-FS1-4,"Children with IOSCA present with ATAXIA peripheral neuropathy, areflexia, athetosis, and Babinski signs early in the first decade of life.",ATAXIA,IOSCA,TWrex-cause
721149599,5/13/2015 11:23:59,1635700186,5/13/2015 11:23:18,False,neodev,0.7,18881135,CAN,ON,Ajax,99.243.87.224,no_relation,33,14,,38,19,causes,0.9237604307034009,813622-FS1-4,"Children with IOSCA present with ATAXIA peripheral neuropathy, areflexia, athetosis, and Babinski signs early in the first decade of life.",ATAXIA,IOSCA,TWrex-cause
721149599,5/13/2015 11:25:32,1635700701,5/13/2015 11:25:21,False,clixsense,0.65,29594612,NLD,11,Rotterdam,82.156.132.195,ATAXIA causes IOSCA,33,14,,38,19,causes,0.9237604307034009,813622-FS1-4,"Children with IOSCA present with ATAXIA peripheral neuropathy, areflexia, athetosis, and Babinski signs early in the first decade of life.",ATAXIA,IOSCA,TWrex-cause
721149599,5/13/2015 11:31:50,1635702037,5/13/2015 11:30:58,False,clixsense,0.7292,6599120,GBR,B7,Bristol,185.14.137.237,IOSCA causes ATAXIA,33,14,,38,19,causes,0.9237604307034009,813622-FS1-4,"Children with IOSCA present with ATAXIA peripheral neuropathy, areflexia, athetosis, and Babinski signs early in the first decade of life.",ATAXIA,IOSCA,TWrex-cause
721149599,5/13/2015 11:33:29,1635702365,5/13/2015 11:32:46,False,prodege,0.75,29686407,GBR,E4,Billericay,109.153.202.59,IOSCA causes ATAXIA,33,14,,38,19,causes,0.9237604307034009,813622-FS1-4,"Children with IOSCA present with ATAXIA peripheral neuropathy, areflexia, athetosis, and Babinski signs early in the first decade of life.",ATAXIA,IOSCA,TWrex-cause
721149602,5/13/2015 10:41:40,1635688636,5/13/2015 10:41:14,False,prodege,1.0,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,0,91,,13,110,causes,0.95257934441568,812182-FS1-4,ONCHOCERCIASIS  (River Blindness)  ONCHOCERCIASIS is infection with the filarial nematode  ONCHOCERCA VOLVULUS,ONCHOCERCIASIS,ONCHOCERCA VOLVULUS,TWrex-cause
721149602,5/13/2015 10:50:11,1635691288,5/13/2015 10:49:37,False,clixsense,0.5639,17950689,GBR,Y9,Tonypandy,92.2.44.79,ONCHOCERCIASIS causes ONCHOCERCA VOLVULUS,0,91,,13,110,causes,0.95257934441568,812182-FS1-4,ONCHOCERCIASIS  (River Blindness)  ONCHOCERCIASIS is infection with the filarial nematode  ONCHOCERCA VOLVULUS,ONCHOCERCIASIS,ONCHOCERCA VOLVULUS,TWrex-cause
721149602,5/13/2015 10:50:34,1635691376,5/13/2015 10:49:59,False,neodev,0.4972,29579905,GBR,,,5.152.206.71,ONCHOCERCIASIS causes ONCHOCERCA VOLVULUS,0,91,,13,110,causes,0.95257934441568,812182-FS1-4,ONCHOCERCIASIS  (River Blindness)  ONCHOCERCIASIS is infection with the filarial nematode  ONCHOCERCA VOLVULUS,ONCHOCERCIASIS,ONCHOCERCA VOLVULUS,TWrex-cause
721149602,5/13/2015 10:50:59,1635691556,5/13/2015 10:50:11,False,clixsense,0.5972,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,0,91,,13,110,causes,0.95257934441568,812182-FS1-4,ONCHOCERCIASIS  (River Blindness)  ONCHOCERCIASIS is infection with the filarial nematode  ONCHOCERCA VOLVULUS,ONCHOCERCIASIS,ONCHOCERCA VOLVULUS,TWrex-cause
721149602,5/13/2015 10:51:12,1635691693,5/13/2015 10:50:47,False,neodev,0.6389,14096345,NLD,03,Eibergen,77.174.124.109,no_relation,0,91,,13,110,causes,0.95257934441568,812182-FS1-4,ONCHOCERCIASIS  (River Blindness)  ONCHOCERCIASIS is infection with the filarial nematode  ONCHOCERCA VOLVULUS,ONCHOCERCIASIS,ONCHOCERCA VOLVULUS,TWrex-cause
721149602,5/13/2015 10:51:28,1635691746,5/13/2015 10:51:07,False,instagc,0.6458,13581319,USA,IL,Mount Vernon,66.232.166.86,ONCHOCERCIASIS causes ONCHOCERCA VOLVULUS,0,91,,13,110,causes,0.95257934441568,812182-FS1-4,ONCHOCERCIASIS  (River Blindness)  ONCHOCERCIASIS is infection with the filarial nematode  ONCHOCERCA VOLVULUS,ONCHOCERCIASIS,ONCHOCERCA VOLVULUS,TWrex-cause
721149602,5/13/2015 10:59:13,1635693954,5/13/2015 10:58:36,False,neodev,0.6667,12115558,USA,OH,Twinsburg,98.27.164.131,no_relation,0,91,,13,110,causes,0.95257934441568,812182-FS1-4,ONCHOCERCIASIS  (River Blindness)  ONCHOCERCIASIS is infection with the filarial nematode  ONCHOCERCA VOLVULUS,ONCHOCERCIASIS,ONCHOCERCA VOLVULUS,TWrex-cause
721149606,5/13/2015 11:00:44,1635694368,5/13/2015 11:00:31,False,elite,0.7817,31856422,GBR,C9,Workington,92.18.169.149,DRUGS causes OVERDOSE,60,26,,67,31,causes,0.971285862357264,811695-FS1-4,"Although effective, these DRUGS are now rarely used because OVERDOSE causes toxicity and they have more adverse effects.",OVERDOSE,DRUGS,TWrex-cause
721149606,5/13/2015 11:01:28,1635694695,5/13/2015 11:00:58,False,neodev,0.8631,11014534,GBR,B8,Bromley,86.18.149.6,DRUGS causes OVERDOSE,60,26,,67,31,causes,0.971285862357264,811695-FS1-4,"Although effective, these DRUGS are now rarely used because OVERDOSE causes toxicity and they have more adverse effects.",OVERDOSE,DRUGS,TWrex-cause
721149606,5/13/2015 11:02:37,1635695142,5/13/2015 11:02:02,False,neodev,0.6667,12115558,USA,OH,Twinsburg,98.27.164.131,no_relation,60,26,,67,31,causes,0.971285862357264,811695-FS1-4,"Although effective, these DRUGS are now rarely used because OVERDOSE causes toxicity and they have more adverse effects.",OVERDOSE,DRUGS,TWrex-cause
721149606,5/13/2015 11:25:17,1635700588,5/13/2015 11:24:42,False,neodev,0.7,18881135,CAN,ON,Ajax,99.243.87.224,DRUGS causes OVERDOSE,60,26,,67,31,causes,0.971285862357264,811695-FS1-4,"Although effective, these DRUGS are now rarely used because OVERDOSE causes toxicity and they have more adverse effects.",OVERDOSE,DRUGS,TWrex-cause
721149606,5/13/2015 11:26:35,1635701032,5/13/2015 11:26:06,False,clixsense,0.65,29594612,NLD,11,Rotterdam,82.156.132.195,DRUGS causes OVERDOSE,60,26,,67,31,causes,0.971285862357264,811695-FS1-4,"Although effective, these DRUGS are now rarely used because OVERDOSE causes toxicity and they have more adverse effects.",OVERDOSE,DRUGS,TWrex-cause
721149606,5/13/2015 11:32:43,1635702177,5/13/2015 11:32:15,False,clixsense,0.7292,6599120,GBR,B7,Bristol,185.14.137.237,DRUGS causes OVERDOSE,60,26,,67,31,causes,0.971285862357264,811695-FS1-4,"Although effective, these DRUGS are now rarely used because OVERDOSE causes toxicity and they have more adverse effects.",OVERDOSE,DRUGS,TWrex-cause
721149606,5/13/2015 11:38:38,1635704470,5/13/2015 11:38:10,False,prodege,0.7381,27934334,GBR,D3,Swadlincote,109.150.228.127,DRUGS causes OVERDOSE,60,26,,67,31,causes,0.971285862357264,811695-FS1-4,"Although effective, these DRUGS are now rarely used because OVERDOSE causes toxicity and they have more adverse effects.",OVERDOSE,DRUGS,TWrex-cause
721149611,5/13/2015 10:42:14,1635688801,5/13/2015 10:41:41,False,prodege,1.0,21417560,GBR,C3,Cambridge,151.225.116.143,SEVERE HYPERTENSION causes PHEOCHROMOCYTOMA,86,200,,104,216,causes,0.99124070716193,812868-FS1-4,"HYPERTENSION  Although mild or moderate hypertension does not usually cause headache, SEVERE HYPERTENSION from the following conditions can cause headache: acute pressor response to exogenous agents, PHEOCHROMOCYTOMA malignant hypertension, and preeclampsia and eclampsia.",SEVERE HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
721149611,5/13/2015 10:50:53,1635691501,5/13/2015 10:50:37,False,neodev,0.4972,29579905,GBR,,,5.152.206.71,PHEOCHROMOCYTOMA causes SEVERE HYPERTENSION,86,200,,104,216,causes,0.99124070716193,812868-FS1-4,"HYPERTENSION  Although mild or moderate hypertension does not usually cause headache, SEVERE HYPERTENSION from the following conditions can cause headache: acute pressor response to exogenous agents, PHEOCHROMOCYTOMA malignant hypertension, and preeclampsia and eclampsia.",SEVERE HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
721149611,5/13/2015 10:50:51,1635691502,5/13/2015 10:50:12,False,clixsense,0.5639,17950689,GBR,Y9,Tonypandy,92.2.44.79,SEVERE HYPERTENSION causes PHEOCHROMOCYTOMA,86,200,,104,216,causes,0.99124070716193,812868-FS1-4,"HYPERTENSION  Although mild or moderate hypertension does not usually cause headache, SEVERE HYPERTENSION from the following conditions can cause headache: acute pressor response to exogenous agents, PHEOCHROMOCYTOMA malignant hypertension, and preeclampsia and eclampsia.",SEVERE HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
721149611,5/13/2015 10:51:46,1635691814,5/13/2015 10:51:14,False,neodev,0.6389,14096345,NLD,03,Eibergen,77.174.124.109,SEVERE HYPERTENSION causes PHEOCHROMOCYTOMA,86,200,,104,216,causes,0.99124070716193,812868-FS1-4,"HYPERTENSION  Although mild or moderate hypertension does not usually cause headache, SEVERE HYPERTENSION from the following conditions can cause headache: acute pressor response to exogenous agents, PHEOCHROMOCYTOMA malignant hypertension, and preeclampsia and eclampsia.",SEVERE HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
721149611,5/13/2015 10:51:46,1635691820,5/13/2015 10:51:00,False,clixsense,0.5972,10798016,GBR,C7,Coventry,86.24.245.191,SEVERE HYPERTENSION causes PHEOCHROMOCYTOMA,86,200,,104,216,causes,0.99124070716193,812868-FS1-4,"HYPERTENSION  Although mild or moderate hypertension does not usually cause headache, SEVERE HYPERTENSION from the following conditions can cause headache: acute pressor response to exogenous agents, PHEOCHROMOCYTOMA malignant hypertension, and preeclampsia and eclampsia.",SEVERE HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
721149611,5/13/2015 10:51:48,1635691842,5/13/2015 10:51:29,False,instagc,0.6458,13581319,USA,IL,Mount Vernon,66.232.166.86,SEVERE HYPERTENSION causes PHEOCHROMOCYTOMA,86,200,,104,216,causes,0.99124070716193,812868-FS1-4,"HYPERTENSION  Although mild or moderate hypertension does not usually cause headache, SEVERE HYPERTENSION from the following conditions can cause headache: acute pressor response to exogenous agents, PHEOCHROMOCYTOMA malignant hypertension, and preeclampsia and eclampsia.",SEVERE HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
721149611,5/13/2015 11:00:00,1635694145,5/13/2015 10:59:15,False,neodev,0.6667,12115558,USA,OH,Twinsburg,98.27.164.131,PHEOCHROMOCYTOMA causes SEVERE HYPERTENSION,86,200,,104,216,causes,0.99124070716193,812868-FS1-4,"HYPERTENSION  Although mild or moderate hypertension does not usually cause headache, SEVERE HYPERTENSION from the following conditions can cause headache: acute pressor response to exogenous agents, PHEOCHROMOCYTOMA malignant hypertension, and preeclampsia and eclampsia.",SEVERE HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
721149617,5/13/2015 10:41:40,1635688632,5/13/2015 10:41:14,False,prodege,1.0,21417560,GBR,C3,Cambridge,151.225.116.143,BACTERIUM causes BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS,35,105,,75,114,causes,1.0,810095-FS1-4,"Among young children, up to 50% of BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS cases may be caused by this BACTERIUM",BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS,BACTERIUM,TWrex-cause
721149617,5/13/2015 10:50:11,1635691276,5/13/2015 10:49:37,False,clixsense,0.5639,17950689,GBR,Y9,Tonypandy,92.2.44.79,BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS causes BACTERIUM,35,105,,75,114,causes,1.0,810095-FS1-4,"Among young children, up to 50% of BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS cases may be caused by this BACTERIUM",BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS,BACTERIUM,TWrex-cause
721149617,5/13/2015 10:50:34,1635691375,5/13/2015 10:49:59,False,neodev,0.4972,29579905,GBR,,,5.152.206.71,BACTERIUM causes BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS,35,105,,75,114,causes,1.0,810095-FS1-4,"Among young children, up to 50% of BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS cases may be caused by this BACTERIUM",BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS,BACTERIUM,TWrex-cause
721149617,5/13/2015 10:50:59,1635691560,5/13/2015 10:50:11,False,clixsense,0.5972,10798016,GBR,C7,Coventry,86.24.245.191,BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS causes BACTERIUM,35,105,,75,114,causes,1.0,810095-FS1-4,"Among young children, up to 50% of BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS cases may be caused by this BACTERIUM",BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS,BACTERIUM,TWrex-cause
721149617,5/13/2015 10:51:12,1635691700,5/13/2015 10:50:47,False,neodev,0.6389,14096345,NLD,03,Eibergen,77.174.124.109,BACTERIUM causes BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS,35,105,,75,114,causes,1.0,810095-FS1-4,"Among young children, up to 50% of BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS cases may be caused by this BACTERIUM",BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS,BACTERIUM,TWrex-cause
721149617,5/13/2015 10:51:28,1635691741,5/13/2015 10:51:07,False,instagc,0.6458,13581319,USA,IL,Mount Vernon,66.232.166.86,BACTERIUM causes BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS,35,105,,75,114,causes,1.0,810095-FS1-4,"Among young children, up to 50% of BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS cases may be caused by this BACTERIUM",BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS,BACTERIUM,TWrex-cause
721149617,5/13/2015 10:59:13,1635693956,5/13/2015 10:58:36,False,neodev,0.6667,12115558,USA,OH,Twinsburg,98.27.164.131,BACTERIUM causes BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS,35,105,,75,114,causes,1.0,810095-FS1-4,"Among young children, up to 50% of BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS cases may be caused by this BACTERIUM",BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS,BACTERIUM,TWrex-cause
721149620,5/13/2015 11:27:41,1635701343,5/13/2015 11:26:47,False,neodev,0.7,18881135,CAN,ON,Ajax,99.243.87.224,MEDICATION causes TOLERANCE,80,20,,88,30,causes,0.9494253265550829,811066-FS1-4,He usually took the MEDICATION within the prescribed limits but developed rapid TOLERANCE and found himself taking 'a few more here and there',TOLERANCE,MEDICATION,TWrex-cause
721149620,5/13/2015 11:28:10,1635701395,5/13/2015 11:27:40,False,clixsense,0.65,29594612,NLD,11,Rotterdam,82.156.132.195,no_relation,80,20,,88,30,causes,0.9494253265550829,811066-FS1-4,He usually took the MEDICATION within the prescribed limits but developed rapid TOLERANCE and found himself taking 'a few more here and there',TOLERANCE,MEDICATION,TWrex-cause
721149620,5/13/2015 11:40:19,1635704890,5/13/2015 11:39:48,False,prodege,0.7381,27934334,GBR,D3,Swadlincote,109.150.228.127,MEDICATION causes TOLERANCE,80,20,,88,30,causes,0.9494253265550829,811066-FS1-4,He usually took the MEDICATION within the prescribed limits but developed rapid TOLERANCE and found himself taking 'a few more here and there',TOLERANCE,MEDICATION,TWrex-cause
721149620,5/13/2015 11:41:52,1635705217,5/13/2015 11:41:25,False,clixsense,0.5,21933552,CAN,ON,Ottawa,70.49.14.161,MEDICATION causes TOLERANCE,80,20,,88,30,causes,0.9494253265550829,811066-FS1-4,He usually took the MEDICATION within the prescribed limits but developed rapid TOLERANCE and found himself taking 'a few more here and there',TOLERANCE,MEDICATION,TWrex-cause
721149620,5/13/2015 11:42:15,1635705301,5/13/2015 11:41:32,False,clixsense,0.7694,6338946,CAN,QC,Montral,209.197.141.151,MEDICATION causes TOLERANCE,80,20,,88,30,causes,0.9494253265550829,811066-FS1-4,He usually took the MEDICATION within the prescribed limits but developed rapid TOLERANCE and found himself taking 'a few more here and there',TOLERANCE,MEDICATION,TWrex-cause
721149620,5/13/2015 12:29:45,1635721063,5/13/2015 12:29:32,False,bitcoinget,0.622,21614812,USA,PA,Erie,174.100.250.115,MEDICATION causes TOLERANCE,80,20,,88,30,causes,0.9494253265550829,811066-FS1-4,He usually took the MEDICATION within the prescribed limits but developed rapid TOLERANCE and found himself taking 'a few more here and there',TOLERANCE,MEDICATION,TWrex-cause
721149620,5/13/2015 12:32:27,1635721789,5/13/2015 12:32:16,False,neodev,0.7209,32216655,NLD,07,Amsterdam,145.100.72.168,MEDICATION causes TOLERANCE,80,20,,88,30,causes,0.9494253265550829,811066-FS1-4,He usually took the MEDICATION within the prescribed limits but developed rapid TOLERANCE and found himself taking 'a few more here and there',TOLERANCE,MEDICATION,TWrex-cause
721149623,5/13/2015 09:55:38,1635676194,5/13/2015 09:54:58,False,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,no_relation,92,125,,95,137,causes,0.9113223768657671,812711-FS1-4,"MAIN RESULTS  Pregabalin,  300 mg/d, reduced pain in patients with postherpetic neuralgia, PAINful diabetic neuropathy, and FIBROMYALGIA; 600 mg/d reduced pain in patients with central neuropathic pain (Table.",PAIN,FIBROMYALGIA,TWrex-cause
721149623,5/13/2015 10:02:08,1635677885,5/13/2015 10:01:21,False,instagc,0.7083,18531561,CAN,ON,Mississauga,99.229.92.227,FIBROMYALGIA causes PAIN,92,125,,95,137,causes,0.9113223768657671,812711-FS1-4,"MAIN RESULTS  Pregabalin,  300 mg/d, reduced pain in patients with postherpetic neuralgia, PAINful diabetic neuropathy, and FIBROMYALGIA; 600 mg/d reduced pain in patients with central neuropathic pain (Table.",PAIN,FIBROMYALGIA,TWrex-cause
721149623,5/13/2015 10:03:15,1635678145,5/13/2015 10:02:57,False,neodev,0.8056,30627835,GBR,H9,London,5.81.27.94,no_relation,92,125,,95,137,causes,0.9113223768657671,812711-FS1-4,"MAIN RESULTS  Pregabalin,  300 mg/d, reduced pain in patients with postherpetic neuralgia, PAINful diabetic neuropathy, and FIBROMYALGIA; 600 mg/d reduced pain in patients with central neuropathic pain (Table.",PAIN,FIBROMYALGIA,TWrex-cause
721149623,5/13/2015 10:04:09,1635678399,5/13/2015 10:03:39,False,neodev,0.7708,11001780,AUS,07,Elwood,14.201.215.31,FIBROMYALGIA causes PAIN,92,125,,95,137,causes,0.9113223768657671,812711-FS1-4,"MAIN RESULTS  Pregabalin,  300 mg/d, reduced pain in patients with postherpetic neuralgia, PAINful diabetic neuropathy, and FIBROMYALGIA; 600 mg/d reduced pain in patients with central neuropathic pain (Table.",PAIN,FIBROMYALGIA,TWrex-cause
721149623,5/13/2015 10:10:57,1635680205,5/13/2015 10:10:32,False,gifthunterclub,0.75,30901412,GBR,H9,London,77.89.149.62,no_relation,92,125,,95,137,causes,0.9113223768657671,812711-FS1-4,"MAIN RESULTS  Pregabalin,  300 mg/d, reduced pain in patients with postherpetic neuralgia, PAINful diabetic neuropathy, and FIBROMYALGIA; 600 mg/d reduced pain in patients with central neuropathic pain (Table.",PAIN,FIBROMYALGIA,TWrex-cause
721149623,5/13/2015 10:13:11,1635680754,5/13/2015 10:12:45,False,neodev,0.4444,31326282,NLD,,,82.169.243.65,no_relation,92,125,,95,137,causes,0.9113223768657671,812711-FS1-4,"MAIN RESULTS  Pregabalin,  300 mg/d, reduced pain in patients with postherpetic neuralgia, PAINful diabetic neuropathy, and FIBROMYALGIA; 600 mg/d reduced pain in patients with central neuropathic pain (Table.",PAIN,FIBROMYALGIA,TWrex-cause
721149623,5/13/2015 10:18:40,1635682003,5/13/2015 10:18:23,False,pocketmoneygpt,0.7024,28884030,USA,WI,Minocqua,75.143.134.247,FIBROMYALGIA causes PAIN,92,125,,95,137,causes,0.9113223768657671,812711-FS1-4,"MAIN RESULTS  Pregabalin,  300 mg/d, reduced pain in patients with postherpetic neuralgia, PAINful diabetic neuropathy, and FIBROMYALGIA; 600 mg/d reduced pain in patients with central neuropathic pain (Table.",PAIN,FIBROMYALGIA,TWrex-cause
721149627,5/13/2015 09:55:38,1635676197,5/13/2015 09:54:58,False,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,no_relation,126,0,,151,16,causes,0.375,812640-FS1-4,"GILBERT SYNDROME is differentiated from hepatitis by fractionation that shows predominantly unconjugated bilirubin, otherwise NORMAL LIVER FUNCTION TEST results, and absence of urinary bilirubin.",NORMAL LIVER FUNCTION TEST,GILBERT SYNDROME,TWrex-cause
721149627,5/13/2015 10:02:08,1635677902,5/13/2015 10:01:21,False,instagc,0.7083,18531561,CAN,ON,Mississauga,99.229.92.227,GILBERT SYNDROME causes NORMAL LIVER FUNCTION TEST,126,0,,151,16,causes,0.375,812640-FS1-4,"GILBERT SYNDROME is differentiated from hepatitis by fractionation that shows predominantly unconjugated bilirubin, otherwise NORMAL LIVER FUNCTION TEST results, and absence of urinary bilirubin.",NORMAL LIVER FUNCTION TEST,GILBERT SYNDROME,TWrex-cause
721149627,5/13/2015 10:03:15,1635678134,5/13/2015 10:02:57,False,neodev,0.8056,30627835,GBR,H9,London,5.81.27.94,no_relation,126,0,,151,16,causes,0.375,812640-FS1-4,"GILBERT SYNDROME is differentiated from hepatitis by fractionation that shows predominantly unconjugated bilirubin, otherwise NORMAL LIVER FUNCTION TEST results, and absence of urinary bilirubin.",NORMAL LIVER FUNCTION TEST,GILBERT SYNDROME,TWrex-cause
721149627,5/13/2015 10:04:09,1635678402,5/13/2015 10:03:39,False,neodev,0.7708,11001780,AUS,07,Elwood,14.201.215.31,GILBERT SYNDROME causes NORMAL LIVER FUNCTION TEST,126,0,,151,16,causes,0.375,812640-FS1-4,"GILBERT SYNDROME is differentiated from hepatitis by fractionation that shows predominantly unconjugated bilirubin, otherwise NORMAL LIVER FUNCTION TEST results, and absence of urinary bilirubin.",NORMAL LIVER FUNCTION TEST,GILBERT SYNDROME,TWrex-cause
721149627,5/13/2015 10:10:57,1635680207,5/13/2015 10:10:32,False,gifthunterclub,0.75,30901412,GBR,H9,London,77.89.149.62,no_relation,126,0,,151,16,causes,0.375,812640-FS1-4,"GILBERT SYNDROME is differentiated from hepatitis by fractionation that shows predominantly unconjugated bilirubin, otherwise NORMAL LIVER FUNCTION TEST results, and absence of urinary bilirubin.",NORMAL LIVER FUNCTION TEST,GILBERT SYNDROME,TWrex-cause
721149627,5/13/2015 10:13:11,1635680752,5/13/2015 10:12:45,False,neodev,0.4444,31326282,NLD,,,82.169.243.65,GILBERT SYNDROME causes NORMAL LIVER FUNCTION TEST,126,0,,151,16,causes,0.375,812640-FS1-4,"GILBERT SYNDROME is differentiated from hepatitis by fractionation that shows predominantly unconjugated bilirubin, otherwise NORMAL LIVER FUNCTION TEST results, and absence of urinary bilirubin.",NORMAL LIVER FUNCTION TEST,GILBERT SYNDROME,TWrex-cause
721149627,5/13/2015 10:18:40,1635682004,5/13/2015 10:18:23,False,pocketmoneygpt,0.7024,28884030,USA,WI,Minocqua,75.143.134.247,no_relation,126,0,,151,16,causes,0.375,812640-FS1-4,"GILBERT SYNDROME is differentiated from hepatitis by fractionation that shows predominantly unconjugated bilirubin, otherwise NORMAL LIVER FUNCTION TEST results, and absence of urinary bilirubin.",NORMAL LIVER FUNCTION TEST,GILBERT SYNDROME,TWrex-cause
721149629,5/13/2015 11:27:41,1635701342,5/13/2015 11:26:47,False,neodev,0.7,18881135,CAN,ON,Ajax,99.243.87.224,no_relation,105,33,,113,49,causes,0.312347523777212,813259-FS1-4,"In all of these pathway defects, HEMOLYTIC ANEMIA occurs only in homozygotes, and the exact mechanism of HEMOLYSIS is unknown.",HEMOLYSIS,HEMOLYTIC ANEMIA,TWrex-cause
721149629,5/13/2015 11:28:10,1635701394,5/13/2015 11:27:40,False,clixsense,0.65,29594612,NLD,11,Rotterdam,82.156.132.195,HEMOLYSIS causes HEMOLYTIC ANEMIA,105,33,,113,49,causes,0.312347523777212,813259-FS1-4,"In all of these pathway defects, HEMOLYTIC ANEMIA occurs only in homozygotes, and the exact mechanism of HEMOLYSIS is unknown.",HEMOLYSIS,HEMOLYTIC ANEMIA,TWrex-cause
721149629,5/13/2015 11:40:19,1635704889,5/13/2015 11:39:48,False,prodege,0.7381,27934334,GBR,D3,Swadlincote,109.150.228.127,HEMOLYTIC ANEMIA causes HEMOLYSIS,105,33,,113,49,causes,0.312347523777212,813259-FS1-4,"In all of these pathway defects, HEMOLYTIC ANEMIA occurs only in homozygotes, and the exact mechanism of HEMOLYSIS is unknown.",HEMOLYSIS,HEMOLYTIC ANEMIA,TWrex-cause
721149629,5/13/2015 11:41:52,1635705220,5/13/2015 11:41:25,False,clixsense,0.5,21933552,CAN,ON,Ottawa,70.49.14.161,no_relation,105,33,,113,49,causes,0.312347523777212,813259-FS1-4,"In all of these pathway defects, HEMOLYTIC ANEMIA occurs only in homozygotes, and the exact mechanism of HEMOLYSIS is unknown.",HEMOLYSIS,HEMOLYTIC ANEMIA,TWrex-cause
721149629,5/13/2015 11:42:15,1635705307,5/13/2015 11:41:32,False,clixsense,0.7694,6338946,CAN,QC,Montral,209.197.141.151,no_relation,105,33,,113,49,causes,0.312347523777212,813259-FS1-4,"In all of these pathway defects, HEMOLYTIC ANEMIA occurs only in homozygotes, and the exact mechanism of HEMOLYSIS is unknown.",HEMOLYSIS,HEMOLYTIC ANEMIA,TWrex-cause
721149629,5/13/2015 12:29:45,1635721055,5/13/2015 12:29:32,False,bitcoinget,0.622,21614812,USA,PA,Erie,174.100.250.115,no_relation,105,33,,113,49,causes,0.312347523777212,813259-FS1-4,"In all of these pathway defects, HEMOLYTIC ANEMIA occurs only in homozygotes, and the exact mechanism of HEMOLYSIS is unknown.",HEMOLYSIS,HEMOLYTIC ANEMIA,TWrex-cause
721149629,5/13/2015 12:32:27,1635721790,5/13/2015 12:32:16,False,neodev,0.7209,32216655,NLD,07,Amsterdam,145.100.72.168,no_relation,105,33,,113,49,causes,0.312347523777212,813259-FS1-4,"In all of these pathway defects, HEMOLYTIC ANEMIA occurs only in homozygotes, and the exact mechanism of HEMOLYSIS is unknown.",HEMOLYSIS,HEMOLYTIC ANEMIA,TWrex-cause
721149633,5/13/2015 09:54:04,1635675875,5/13/2015 09:53:11,False,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,no_relation,56,86,,67,102,causes,0.9647638212377321,812968-FS1-4,"In elderly patients, severe weight loss with persistent HYPERTENSION is suggestive of PHEOCHROMOCYTOMA",HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
721149633,5/13/2015 10:00:33,1635677543,5/13/2015 10:00:02,False,instagc,0.7083,18531561,CAN,ON,Mississauga,99.229.92.227,PHEOCHROMOCYTOMA causes HYPERTENSION,56,86,,67,102,causes,0.9647638212377321,812968-FS1-4,"In elderly patients, severe weight loss with persistent HYPERTENSION is suggestive of PHEOCHROMOCYTOMA",HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
721149633,5/13/2015 10:02:32,1635677971,5/13/2015 10:02:11,False,neodev,0.8056,30627835,GBR,H9,London,5.81.27.94,no_relation,56,86,,67,102,causes,0.9647638212377321,812968-FS1-4,"In elderly patients, severe weight loss with persistent HYPERTENSION is suggestive of PHEOCHROMOCYTOMA",HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
721149633,5/13/2015 10:02:48,1635677988,5/13/2015 10:02:24,False,neodev,0.7708,11001780,AUS,07,Elwood,14.201.215.31,PHEOCHROMOCYTOMA causes HYPERTENSION,56,86,,67,102,causes,0.9647638212377321,812968-FS1-4,"In elderly patients, severe weight loss with persistent HYPERTENSION is suggestive of PHEOCHROMOCYTOMA",HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
721149633,5/13/2015 10:10:00,1635679939,5/13/2015 10:09:32,False,gifthunterclub,0.75,30901412,GBR,H9,London,77.89.149.62,HYPERTENSION causes PHEOCHROMOCYTOMA,56,86,,67,102,causes,0.9647638212377321,812968-FS1-4,"In elderly patients, severe weight loss with persistent HYPERTENSION is suggestive of PHEOCHROMOCYTOMA",HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
721149633,5/13/2015 10:12:05,1635680493,5/13/2015 10:11:36,False,neodev,0.4444,31326282,NLD,,,82.169.243.65,PHEOCHROMOCYTOMA causes HYPERTENSION,56,86,,67,102,causes,0.9647638212377321,812968-FS1-4,"In elderly patients, severe weight loss with persistent HYPERTENSION is suggestive of PHEOCHROMOCYTOMA",HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
721149633,5/13/2015 10:18:01,1635681871,5/13/2015 10:17:20,False,pocketmoneygpt,0.7024,28884030,USA,WI,Minocqua,75.143.134.247,HYPERTENSION causes PHEOCHROMOCYTOMA,56,86,,67,102,causes,0.9647638212377321,812968-FS1-4,"In elderly patients, severe weight loss with persistent HYPERTENSION is suggestive of PHEOCHROMOCYTOMA",HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
721149719,5/13/2015 09:59:54,1635677396,5/13/2015 09:59:43,False,neodev,1.0,30627835,GBR,H9,London,5.81.27.94,no_relation,68,99,,79,126,causes,0.986393923832143,814273-FS1-4,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing marked HEPATOMEGALY in a patient with AL AMYLOIDOSIS OF THE LIVER and spleen.,HEPATOMEGALY,AL AMYLOIDOSIS OF THE LIVER,TWrex-cause
721149719,5/13/2015 10:04:39,1635678491,5/13/2015 10:03:42,False,instagc,0.75,18531561,CAN,ON,Mississauga,99.229.92.227,AL AMYLOIDOSIS OF THE LIVER causes HEPATOMEGALY,68,99,,79,126,causes,0.986393923832143,814273-FS1-4,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing marked HEPATOMEGALY in a patient with AL AMYLOIDOSIS OF THE LIVER and spleen.,HEPATOMEGALY,AL AMYLOIDOSIS OF THE LIVER,TWrex-cause
721149719,5/13/2015 10:07:11,1635679114,5/13/2015 10:06:53,False,gifthunterclub,0.5278,30901412,GBR,H9,London,77.89.149.62,HEPATOMEGALY causes AL AMYLOIDOSIS OF THE LIVER,68,99,,79,126,causes,0.986393923832143,814273-FS1-4,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing marked HEPATOMEGALY in a patient with AL AMYLOIDOSIS OF THE LIVER and spleen.,HEPATOMEGALY,AL AMYLOIDOSIS OF THE LIVER,TWrex-cause
721149719,5/13/2015 10:14:29,1635681031,5/13/2015 10:14:12,False,neodev,0.5292,31326282,NLD,,,82.169.243.65,HEPATOMEGALY causes AL AMYLOIDOSIS OF THE LIVER,68,99,,79,126,causes,0.986393923832143,814273-FS1-4,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing marked HEPATOMEGALY in a patient with AL AMYLOIDOSIS OF THE LIVER and spleen.,HEPATOMEGALY,AL AMYLOIDOSIS OF THE LIVER,TWrex-cause
721149719,5/13/2015 10:14:46,1635681089,5/13/2015 10:14:10,False,prodege,0.6333,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,68,99,,79,126,causes,0.986393923832143,814273-FS1-4,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing marked HEPATOMEGALY in a patient with AL AMYLOIDOSIS OF THE LIVER and spleen.,HEPATOMEGALY,AL AMYLOIDOSIS OF THE LIVER,TWrex-cause
721149719,5/13/2015 10:19:12,1635682193,5/13/2015 10:18:16,False,points4rewards,0.5833,20113482,USA,OR,Portland,67.213.218.72,no_relation,68,99,,79,126,causes,0.986393923832143,814273-FS1-4,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing marked HEPATOMEGALY in a patient with AL AMYLOIDOSIS OF THE LIVER and spleen.,HEPATOMEGALY,AL AMYLOIDOSIS OF THE LIVER,TWrex-cause
721149719,5/13/2015 10:19:50,1635682454,5/13/2015 10:19:33,False,pocketmoneygpt,0.6349,28884030,USA,WI,Minocqua,75.143.134.247,no_relation,68,99,,79,126,causes,0.986393923832143,814273-FS1-4,Nuclear Liver Spleen Scan  Nuclear liver spleen scan showing marked HEPATOMEGALY in a patient with AL AMYLOIDOSIS OF THE LIVER and spleen.,HEPATOMEGALY,AL AMYLOIDOSIS OF THE LIVER,TWrex-cause
721149721,5/13/2015 10:58:37,1635693795,5/13/2015 10:58:17,False,neodev,0.7440000000000001,11014534,GBR,B8,Bromley,86.18.149.6,no_relation,101,15,,114,38,causes,0.606339062590832,812890-FS1-4,"Thus, the term IMMOTILE CILIA SYNDROME was coined to include all patients with chronic sinusitis and BRONCHIECTASIS resulting from ultrastructural abnormalities of cilia.",BRONCHIECTASIS,IMMOTILE CILIA SYNDROME,TWrex-cause
721149721,5/13/2015 10:59:30,1635693994,5/13/2015 10:58:49,False,clixsense,0.6964,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,101,15,,114,38,causes,0.606339062590832,812890-FS1-4,"Thus, the term IMMOTILE CILIA SYNDROME was coined to include all patients with chronic sinusitis and BRONCHIECTASIS resulting from ultrastructural abnormalities of cilia.",BRONCHIECTASIS,IMMOTILE CILIA SYNDROME,TWrex-cause
721149721,5/13/2015 11:01:13,1635694525,5/13/2015 11:00:51,False,elite,0.875,31856422,GBR,C9,Workington,92.18.169.149,no_relation,101,15,,114,38,causes,0.606339062590832,812890-FS1-4,"Thus, the term IMMOTILE CILIA SYNDROME was coined to include all patients with chronic sinusitis and BRONCHIECTASIS resulting from ultrastructural abnormalities of cilia.",BRONCHIECTASIS,IMMOTILE CILIA SYNDROME,TWrex-cause
721149721,5/13/2015 11:31:09,1635701877,5/13/2015 11:30:39,False,prodege,0.3611,29686407,GBR,E4,Billericay,109.153.202.59,IMMOTILE CILIA SYNDROME causes BRONCHIECTASIS,101,15,,114,38,causes,0.606339062590832,812890-FS1-4,"Thus, the term IMMOTILE CILIA SYNDROME was coined to include all patients with chronic sinusitis and BRONCHIECTASIS resulting from ultrastructural abnormalities of cilia.",BRONCHIECTASIS,IMMOTILE CILIA SYNDROME,TWrex-cause
721149721,5/13/2015 11:41:40,1635705185,5/13/2015 11:41:09,False,prodege,0.7472,27934334,GBR,D3,Swadlincote,109.150.228.127,no_relation,101,15,,114,38,causes,0.606339062590832,812890-FS1-4,"Thus, the term IMMOTILE CILIA SYNDROME was coined to include all patients with chronic sinusitis and BRONCHIECTASIS resulting from ultrastructural abnormalities of cilia.",BRONCHIECTASIS,IMMOTILE CILIA SYNDROME,TWrex-cause
721149721,5/13/2015 11:46:46,1635706342,5/13/2015 11:46:08,False,clixsense,0.6319,6338946,CAN,QC,Montral,209.197.141.151,no_relation,101,15,,114,38,causes,0.606339062590832,812890-FS1-4,"Thus, the term IMMOTILE CILIA SYNDROME was coined to include all patients with chronic sinusitis and BRONCHIECTASIS resulting from ultrastructural abnormalities of cilia.",BRONCHIECTASIS,IMMOTILE CILIA SYNDROME,TWrex-cause
721149721,5/13/2015 11:55:29,1635708623,5/13/2015 11:55:06,False,neodev,0.7083,18881135,CAN,ON,Ajax,99.243.87.224,no_relation,101,15,,114,38,causes,0.606339062590832,812890-FS1-4,"Thus, the term IMMOTILE CILIA SYNDROME was coined to include all patients with chronic sinusitis and BRONCHIECTASIS resulting from ultrastructural abnormalities of cilia.",BRONCHIECTASIS,IMMOTILE CILIA SYNDROME,TWrex-cause
721149723,5/13/2015 11:01:07,1635694479,5/13/2015 11:00:45,False,clixsense,0.6964,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,0,47,,30,62,causes,0.9383148632568359,814113-FS1-4,METASTATIC BASAL CELL CARCINOMA to the bone in GORLIN SYNDROME,METASTATIC BASAL CELL CARCINOMA,GORLIN SYNDROME,TWrex-cause
721149723,5/13/2015 11:02:04,1635694840,5/13/2015 11:01:53,False,elite,0.875,31856422,GBR,C9,Workington,92.18.169.149,GORLIN SYNDROME causes METASTATIC BASAL CELL CARCINOMA,0,47,,30,62,causes,0.9383148632568359,814113-FS1-4,METASTATIC BASAL CELL CARCINOMA to the bone in GORLIN SYNDROME,METASTATIC BASAL CELL CARCINOMA,GORLIN SYNDROME,TWrex-cause
721149723,5/13/2015 11:43:17,1635705472,5/13/2015 11:42:59,False,prodege,0.7472,27934334,GBR,D3,Swadlincote,109.150.228.127,GORLIN SYNDROME causes METASTATIC BASAL CELL CARCINOMA,0,47,,30,62,causes,0.9383148632568359,814113-FS1-4,METASTATIC BASAL CELL CARCINOMA to the bone in GORLIN SYNDROME,METASTATIC BASAL CELL CARCINOMA,GORLIN SYNDROME,TWrex-cause
721149723,5/13/2015 11:49:35,1635707052,5/13/2015 11:49:00,False,clixsense,0.6319,6338946,CAN,QC,Montral,209.197.141.151,no_relation,0,47,,30,62,causes,0.9383148632568359,814113-FS1-4,METASTATIC BASAL CELL CARCINOMA to the bone in GORLIN SYNDROME,METASTATIC BASAL CELL CARCINOMA,GORLIN SYNDROME,TWrex-cause
721149723,5/13/2015 11:56:47,1635709027,5/13/2015 11:56:27,False,neodev,0.7083,18881135,CAN,ON,Ajax,99.243.87.224,GORLIN SYNDROME causes METASTATIC BASAL CELL CARCINOMA,0,47,,30,62,causes,0.9383148632568359,814113-FS1-4,METASTATIC BASAL CELL CARCINOMA to the bone in GORLIN SYNDROME,METASTATIC BASAL CELL CARCINOMA,GORLIN SYNDROME,TWrex-cause
721149723,5/13/2015 12:31:05,1635721381,5/13/2015 12:30:51,False,bitcoinget,0.5625,21614812,USA,PA,Erie,174.100.250.115,no_relation,0,47,,30,62,causes,0.9383148632568359,814113-FS1-4,METASTATIC BASAL CELL CARCINOMA to the bone in GORLIN SYNDROME,METASTATIC BASAL CELL CARCINOMA,GORLIN SYNDROME,TWrex-cause
721149723,5/13/2015 12:35:06,1635722733,5/13/2015 12:34:55,False,prodege,0.8786,23482077,USA,TX,Garland,71.164.238.226,no_relation,0,47,,30,62,causes,0.9383148632568359,814113-FS1-4,METASTATIC BASAL CELL CARCINOMA to the bone in GORLIN SYNDROME,METASTATIC BASAL CELL CARCINOMA,GORLIN SYNDROME,TWrex-cause
721149736,5/13/2015 10:59:05,1635693875,5/13/2015 10:58:38,False,neodev,0.7440000000000001,11014534,GBR,B8,Bromley,86.18.149.6,TRICHURIS TRICHIURA causes TRICHURIASIS,0,87,,11,106,causes,0.9383148632568359,812426-FS1-4,TRICHURIASIS  (Whipworm Infection; Trichocephaliasis)  TRICHURIASIS is infection with  TRICHURIS TRICHIURA,TRICHURIASIS,TRICHURIS TRICHIURA,TWrex-cause
721149736,5/13/2015 11:00:12,1635694194,5/13/2015 10:59:31,False,clixsense,0.6964,10798016,GBR,C7,Coventry,86.24.245.191,TRICHURIS TRICHIURA causes TRICHURIASIS,0,87,,11,106,causes,0.9383148632568359,812426-FS1-4,TRICHURIASIS  (Whipworm Infection; Trichocephaliasis)  TRICHURIASIS is infection with  TRICHURIS TRICHIURA,TRICHURIASIS,TRICHURIS TRICHIURA,TWrex-cause
721149736,5/13/2015 11:01:28,1635694684,5/13/2015 11:01:15,False,elite,0.875,31856422,GBR,C9,Workington,92.18.169.149,TRICHURIS TRICHIURA causes TRICHURIASIS,0,87,,11,106,causes,0.9383148632568359,812426-FS1-4,TRICHURIASIS  (Whipworm Infection; Trichocephaliasis)  TRICHURIASIS is infection with  TRICHURIS TRICHIURA,TRICHURIASIS,TRICHURIS TRICHIURA,TWrex-cause
721149736,5/13/2015 11:31:45,1635701982,5/13/2015 11:31:11,False,prodege,0.3611,29686407,GBR,E4,Billericay,109.153.202.59,no_relation,0,87,,11,106,causes,0.9383148632568359,812426-FS1-4,TRICHURIASIS  (Whipworm Infection; Trichocephaliasis)  TRICHURIASIS is infection with  TRICHURIS TRICHIURA,TRICHURIASIS,TRICHURIS TRICHIURA,TWrex-cause
721149736,5/13/2015 11:42:08,1635705276,5/13/2015 11:41:41,False,prodege,0.7472,27934334,GBR,D3,Swadlincote,109.150.228.127,TRICHURIS TRICHIURA causes TRICHURIASIS,0,87,,11,106,causes,0.9383148632568359,812426-FS1-4,TRICHURIASIS  (Whipworm Infection; Trichocephaliasis)  TRICHURIASIS is infection with  TRICHURIS TRICHIURA,TRICHURIASIS,TRICHURIS TRICHIURA,TWrex-cause
721149736,5/13/2015 11:47:12,1635706484,5/13/2015 11:46:47,False,clixsense,0.6319,6338946,CAN,QC,Montral,209.197.141.151,no_relation,0,87,,11,106,causes,0.9383148632568359,812426-FS1-4,TRICHURIASIS  (Whipworm Infection; Trichocephaliasis)  TRICHURIASIS is infection with  TRICHURIS TRICHIURA,TRICHURIASIS,TRICHURIS TRICHIURA,TWrex-cause
721149736,5/13/2015 11:55:57,1635708747,5/13/2015 11:55:30,False,neodev,0.7083,18881135,CAN,ON,Ajax,99.243.87.224,no_relation,0,87,,11,106,causes,0.9383148632568359,812426-FS1-4,TRICHURIASIS  (Whipworm Infection; Trichocephaliasis)  TRICHURIASIS is infection with  TRICHURIS TRICHIURA,TRICHURIASIS,TRICHURIS TRICHIURA,TWrex-cause
721149738,5/13/2015 10:46:24,1635690180,5/13/2015 10:45:56,False,prodege,0.875,3056891,CAN,ON,Niagara Falls,173.238.144.19,HYPOPHOSPHATEMIA causes FANCONI SYNDROME,124,12,,139,28,causes,0.787838597158335,814097-FS1-4,"In acquired FANCONI SYNDROME adults present with the laboratory abnormalities of renal tubular acidosis (proximal type II), HYPOPHOSPHATEMIA and hypokalemia.",HYPOPHOSPHATEMIA,FANCONI SYNDROME,TWrex-cause
721149738,5/13/2015 10:51:25,1635691704,5/13/2015 10:51:04,False,clixsense,0.5972,17950689,GBR,Y9,Tonypandy,92.2.44.79,no_relation,124,12,,139,28,causes,0.787838597158335,814097-FS1-4,"In acquired FANCONI SYNDROME adults present with the laboratory abnormalities of renal tubular acidosis (proximal type II), HYPOPHOSPHATEMIA and hypokalemia.",HYPOPHOSPHATEMIA,FANCONI SYNDROME,TWrex-cause
721149738,5/13/2015 10:51:35,1635691782,5/13/2015 10:51:15,False,neodev,0.6127,29579905,GBR,,,5.152.206.71,no_relation,124,12,,139,28,causes,0.787838597158335,814097-FS1-4,"In acquired FANCONI SYNDROME adults present with the laboratory abnormalities of renal tubular acidosis (proximal type II), HYPOPHOSPHATEMIA and hypokalemia.",HYPOPHOSPHATEMIA,FANCONI SYNDROME,TWrex-cause
721149738,5/13/2015 10:54:26,1635692594,5/13/2015 10:54:08,False,instagc,0.5,13581319,USA,IL,Mount Vernon,66.232.166.86,FANCONI SYNDROME causes HYPOPHOSPHATEMIA,124,12,,139,28,causes,0.787838597158335,814097-FS1-4,"In acquired FANCONI SYNDROME adults present with the laboratory abnormalities of renal tubular acidosis (proximal type II), HYPOPHOSPHATEMIA and hypokalemia.",HYPOPHOSPHATEMIA,FANCONI SYNDROME,TWrex-cause
721149738,5/13/2015 10:55:23,1635692733,5/13/2015 10:54:46,False,neodev,0.5083,14096345,NLD,03,Eibergen,77.174.124.109,no_relation,124,12,,139,28,causes,0.787838597158335,814097-FS1-4,"In acquired FANCONI SYNDROME adults present with the laboratory abnormalities of renal tubular acidosis (proximal type II), HYPOPHOSPHATEMIA and hypokalemia.",HYPOPHOSPHATEMIA,FANCONI SYNDROME,TWrex-cause
721149738,5/13/2015 10:55:49,1635692889,5/13/2015 10:54:57,False,pocketmoneygpt,0.4732,21432964,GBR,T5,Aberdeen,88.104.216.210,FANCONI SYNDROME causes HYPOPHOSPHATEMIA,124,12,,139,28,causes,0.787838597158335,814097-FS1-4,"In acquired FANCONI SYNDROME adults present with the laboratory abnormalities of renal tubular acidosis (proximal type II), HYPOPHOSPHATEMIA and hypokalemia.",HYPOPHOSPHATEMIA,FANCONI SYNDROME,TWrex-cause
721149738,5/13/2015 10:57:59,1635693670,5/13/2015 10:57:10,False,neodev,0.7440000000000001,11014534,GBR,B8,Bromley,86.18.149.6,FANCONI SYNDROME causes HYPOPHOSPHATEMIA,124,12,,139,28,causes,0.787838597158335,814097-FS1-4,"In acquired FANCONI SYNDROME adults present with the laboratory abnormalities of renal tubular acidosis (proximal type II), HYPOPHOSPHATEMIA and hypokalemia.",HYPOPHOSPHATEMIA,FANCONI SYNDROME,TWrex-cause
721149740,5/13/2015 10:01:19,1635677758,5/13/2015 10:00:58,False,neodev,1.0,30627835,GBR,H9,London,5.81.27.94,no_relation,23,78,,31,85,causes,0.768221279597376,803089-FS1-4,"Aortic valve stenosis, PREGNANCY obesity, and the use of certain drugs (e.g., COCAINE amphetamines, steroids, or erythropoietin) also may lead to hypertension.",PREGNANCY,COCAINE,TWrex-cause
721149740,5/13/2015 10:06:34,1635678994,5/13/2015 10:06:01,False,instagc,0.75,18531561,CAN,ON,Mississauga,99.229.92.227,no_relation,23,78,,31,85,causes,0.768221279597376,803089-FS1-4,"Aortic valve stenosis, PREGNANCY obesity, and the use of certain drugs (e.g., COCAINE amphetamines, steroids, or erythropoietin) also may lead to hypertension.",PREGNANCY,COCAINE,TWrex-cause
721149740,5/13/2015 10:08:33,1635679485,5/13/2015 10:08:09,False,gifthunterclub,0.5278,30901412,GBR,H9,London,77.89.149.62,no_relation,23,78,,31,85,causes,0.768221279597376,803089-FS1-4,"Aortic valve stenosis, PREGNANCY obesity, and the use of certain drugs (e.g., COCAINE amphetamines, steroids, or erythropoietin) also may lead to hypertension.",PREGNANCY,COCAINE,TWrex-cause
721149740,5/13/2015 10:15:25,1635681255,5/13/2015 10:15:10,False,neodev,0.5292,31326282,NLD,,,82.169.243.65,no_relation,23,78,,31,85,causes,0.768221279597376,803089-FS1-4,"Aortic valve stenosis, PREGNANCY obesity, and the use of certain drugs (e.g., COCAINE amphetamines, steroids, or erythropoietin) also may lead to hypertension.",PREGNANCY,COCAINE,TWrex-cause
721149740,5/13/2015 10:16:37,1635681557,5/13/2015 10:16:06,False,prodege,0.6333,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,23,78,,31,85,causes,0.768221279597376,803089-FS1-4,"Aortic valve stenosis, PREGNANCY obesity, and the use of certain drugs (e.g., COCAINE amphetamines, steroids, or erythropoietin) also may lead to hypertension.",PREGNANCY,COCAINE,TWrex-cause
721149740,5/13/2015 10:20:38,1635682750,5/13/2015 10:20:20,False,pocketmoneygpt,0.6349,28884030,USA,WI,Minocqua,75.143.134.247,no_relation,23,78,,31,85,causes,0.768221279597376,803089-FS1-4,"Aortic valve stenosis, PREGNANCY obesity, and the use of certain drugs (e.g., COCAINE amphetamines, steroids, or erythropoietin) also may lead to hypertension.",PREGNANCY,COCAINE,TWrex-cause
721149740,5/13/2015 10:21:12,1635683009,5/13/2015 10:20:52,False,points4rewards,0.5833,20113482,USA,OR,Portland,67.213.218.72,no_relation,23,78,,31,85,causes,0.768221279597376,803089-FS1-4,"Aortic valve stenosis, PREGNANCY obesity, and the use of certain drugs (e.g., COCAINE amphetamines, steroids, or erythropoietin) also may lead to hypertension.",PREGNANCY,COCAINE,TWrex-cause
721149743,5/13/2015 09:59:54,1635677397,5/13/2015 09:59:43,False,neodev,1.0,30627835,GBR,H9,London,5.81.27.94,no_relation,230,4,,241,27,causes,0.9760921603577251,813003-FS1-4,"14  BIRT HOGG DUBE SYNDROME  BIRT HOGG DUBE SYNDROME (BHDS) is an autosomal dominant multisystem disorder characterized by the cutaneous triad of fibrofolliculomas, trichodiscomas, and acrochordons; the development of spontaneous PNEUMOTHORAX in association with lung cysts; and a predisposition to renal neoplasms.",PNEUMOTHORAX,BIRT HOGG DUBE SYNDROME,TWrex-cause
721149743,5/13/2015 10:04:39,1635678492,5/13/2015 10:03:42,False,instagc,0.75,18531561,CAN,ON,Mississauga,99.229.92.227,BIRT HOGG DUBE SYNDROME causes PNEUMOTHORAX,230,4,,241,27,causes,0.9760921603577251,813003-FS1-4,"14  BIRT HOGG DUBE SYNDROME  BIRT HOGG DUBE SYNDROME (BHDS) is an autosomal dominant multisystem disorder characterized by the cutaneous triad of fibrofolliculomas, trichodiscomas, and acrochordons; the development of spontaneous PNEUMOTHORAX in association with lung cysts; and a predisposition to renal neoplasms.",PNEUMOTHORAX,BIRT HOGG DUBE SYNDROME,TWrex-cause
721149743,5/13/2015 10:07:11,1635679125,5/13/2015 10:06:53,False,gifthunterclub,0.5278,30901412,GBR,H9,London,77.89.149.62,PNEUMOTHORAX causes BIRT HOGG DUBE SYNDROME,230,4,,241,27,causes,0.9760921603577251,813003-FS1-4,"14  BIRT HOGG DUBE SYNDROME  BIRT HOGG DUBE SYNDROME (BHDS) is an autosomal dominant multisystem disorder characterized by the cutaneous triad of fibrofolliculomas, trichodiscomas, and acrochordons; the development of spontaneous PNEUMOTHORAX in association with lung cysts; and a predisposition to renal neoplasms.",PNEUMOTHORAX,BIRT HOGG DUBE SYNDROME,TWrex-cause
721149743,5/13/2015 10:14:29,1635681032,5/13/2015 10:14:12,False,neodev,0.5292,31326282,NLD,,,82.169.243.65,BIRT HOGG DUBE SYNDROME causes PNEUMOTHORAX,230,4,,241,27,causes,0.9760921603577251,813003-FS1-4,"14  BIRT HOGG DUBE SYNDROME  BIRT HOGG DUBE SYNDROME (BHDS) is an autosomal dominant multisystem disorder characterized by the cutaneous triad of fibrofolliculomas, trichodiscomas, and acrochordons; the development of spontaneous PNEUMOTHORAX in association with lung cysts; and a predisposition to renal neoplasms.",PNEUMOTHORAX,BIRT HOGG DUBE SYNDROME,TWrex-cause
721149743,5/13/2015 10:14:46,1635681090,5/13/2015 10:14:10,False,prodege,0.6333,21417560,GBR,C3,Cambridge,151.225.116.143,BIRT HOGG DUBE SYNDROME causes PNEUMOTHORAX,230,4,,241,27,causes,0.9760921603577251,813003-FS1-4,"14  BIRT HOGG DUBE SYNDROME  BIRT HOGG DUBE SYNDROME (BHDS) is an autosomal dominant multisystem disorder characterized by the cutaneous triad of fibrofolliculomas, trichodiscomas, and acrochordons; the development of spontaneous PNEUMOTHORAX in association with lung cysts; and a predisposition to renal neoplasms.",PNEUMOTHORAX,BIRT HOGG DUBE SYNDROME,TWrex-cause
721149743,5/13/2015 10:19:12,1635682192,5/13/2015 10:18:16,False,points4rewards,0.5833,20113482,USA,OR,Portland,67.213.218.72,BIRT HOGG DUBE SYNDROME causes PNEUMOTHORAX,230,4,,241,27,causes,0.9760921603577251,813003-FS1-4,"14  BIRT HOGG DUBE SYNDROME  BIRT HOGG DUBE SYNDROME (BHDS) is an autosomal dominant multisystem disorder characterized by the cutaneous triad of fibrofolliculomas, trichodiscomas, and acrochordons; the development of spontaneous PNEUMOTHORAX in association with lung cysts; and a predisposition to renal neoplasms.",PNEUMOTHORAX,BIRT HOGG DUBE SYNDROME,TWrex-cause
721149743,5/13/2015 10:19:50,1635682453,5/13/2015 10:19:33,False,pocketmoneygpt,0.6349,28884030,USA,WI,Minocqua,75.143.134.247,PNEUMOTHORAX causes BIRT HOGG DUBE SYNDROME,230,4,,241,27,causes,0.9760921603577251,813003-FS1-4,"14  BIRT HOGG DUBE SYNDROME  BIRT HOGG DUBE SYNDROME (BHDS) is an autosomal dominant multisystem disorder characterized by the cutaneous triad of fibrofolliculomas, trichodiscomas, and acrochordons; the development of spontaneous PNEUMOTHORAX in association with lung cysts; and a predisposition to renal neoplasms.",PNEUMOTHORAX,BIRT HOGG DUBE SYNDROME,TWrex-cause
721149745,5/13/2015 10:58:37,1635693794,5/13/2015 10:58:17,False,neodev,0.7440000000000001,11014534,GBR,B8,Bromley,86.18.149.6,DUBIN JOHNSON SYNDROME causes CONJUGATED HYPERBILIRUBINEMIA,0,72,,28,94,causes,0.9958932064677041,813049-FS1-4,CONJUGATED HYPERBILIRUBINEMIA due to impaired excretion can result from DUBIN JOHNSON SYNDROME,CONJUGATED HYPERBILIRUBINEMIA,DUBIN JOHNSON SYNDROME,TWrex-cause
721149745,5/13/2015 10:59:30,1635693991,5/13/2015 10:58:49,False,clixsense,0.6964,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,0,72,,28,94,causes,0.9958932064677041,813049-FS1-4,CONJUGATED HYPERBILIRUBINEMIA due to impaired excretion can result from DUBIN JOHNSON SYNDROME,CONJUGATED HYPERBILIRUBINEMIA,DUBIN JOHNSON SYNDROME,TWrex-cause
721149745,5/13/2015 11:01:13,1635694529,5/13/2015 11:00:51,False,elite,0.875,31856422,GBR,C9,Workington,92.18.169.149,DUBIN JOHNSON SYNDROME causes CONJUGATED HYPERBILIRUBINEMIA,0,72,,28,94,causes,0.9958932064677041,813049-FS1-4,CONJUGATED HYPERBILIRUBINEMIA due to impaired excretion can result from DUBIN JOHNSON SYNDROME,CONJUGATED HYPERBILIRUBINEMIA,DUBIN JOHNSON SYNDROME,TWrex-cause
721149745,5/13/2015 11:31:09,1635701876,5/13/2015 11:30:39,False,prodege,0.3611,29686407,GBR,E4,Billericay,109.153.202.59,DUBIN JOHNSON SYNDROME causes CONJUGATED HYPERBILIRUBINEMIA,0,72,,28,94,causes,0.9958932064677041,813049-FS1-4,CONJUGATED HYPERBILIRUBINEMIA due to impaired excretion can result from DUBIN JOHNSON SYNDROME,CONJUGATED HYPERBILIRUBINEMIA,DUBIN JOHNSON SYNDROME,TWrex-cause
721149745,5/13/2015 11:41:40,1635705184,5/13/2015 11:41:09,False,prodege,0.7472,27934334,GBR,D3,Swadlincote,109.150.228.127,DUBIN JOHNSON SYNDROME causes CONJUGATED HYPERBILIRUBINEMIA,0,72,,28,94,causes,0.9958932064677041,813049-FS1-4,CONJUGATED HYPERBILIRUBINEMIA due to impaired excretion can result from DUBIN JOHNSON SYNDROME,CONJUGATED HYPERBILIRUBINEMIA,DUBIN JOHNSON SYNDROME,TWrex-cause
721149745,5/13/2015 11:46:46,1635706338,5/13/2015 11:46:08,False,clixsense,0.6319,6338946,CAN,QC,Montral,209.197.141.151,DUBIN JOHNSON SYNDROME causes CONJUGATED HYPERBILIRUBINEMIA,0,72,,28,94,causes,0.9958932064677041,813049-FS1-4,CONJUGATED HYPERBILIRUBINEMIA due to impaired excretion can result from DUBIN JOHNSON SYNDROME,CONJUGATED HYPERBILIRUBINEMIA,DUBIN JOHNSON SYNDROME,TWrex-cause
721149745,5/13/2015 11:55:29,1635708628,5/13/2015 11:55:06,False,neodev,0.7083,18881135,CAN,ON,Ajax,99.243.87.224,DUBIN JOHNSON SYNDROME causes CONJUGATED HYPERBILIRUBINEMIA,0,72,,28,94,causes,0.9958932064677041,813049-FS1-4,CONJUGATED HYPERBILIRUBINEMIA due to impaired excretion can result from DUBIN JOHNSON SYNDROME,CONJUGATED HYPERBILIRUBINEMIA,DUBIN JOHNSON SYNDROME,TWrex-cause
721149746,5/13/2015 10:00:19,1635677521,5/13/2015 09:59:54,False,neodev,1.0,30627835,GBR,H9,London,5.81.27.94,no_relation,254,79,,283,102,causes,0.8908708063747479,813889-FS1-4,"Thiamine (vitamin B 1 ) deficiency is responsible for the hallmark features of WERNICKE ENCEPHALOPATHY which include ophthalmoplegia (i.e., nystagmus, extraocular palsies, gaze palsies, and, in rare cases, internuclear ophthalmoplegia), gait ataxia, and FLUCTUATING CONFUSIONAL STATES",FLUCTUATING CONFUSIONAL STATES,WERNICKE ENCEPHALOPATHY,TWrex-cause
721149746,5/13/2015 10:05:05,1635678556,5/13/2015 10:04:40,False,instagc,0.75,18531561,CAN,ON,Mississauga,99.229.92.227,WERNICKE ENCEPHALOPATHY causes FLUCTUATING CONFUSIONAL STATES,254,79,,283,102,causes,0.8908708063747479,813889-FS1-4,"Thiamine (vitamin B 1 ) deficiency is responsible for the hallmark features of WERNICKE ENCEPHALOPATHY which include ophthalmoplegia (i.e., nystagmus, extraocular palsies, gaze palsies, and, in rare cases, internuclear ophthalmoplegia), gait ataxia, and FLUCTUATING CONFUSIONAL STATES",FLUCTUATING CONFUSIONAL STATES,WERNICKE ENCEPHALOPATHY,TWrex-cause
721149746,5/13/2015 10:07:41,1635679203,5/13/2015 10:07:13,False,gifthunterclub,0.5278,30901412,GBR,H9,London,77.89.149.62,WERNICKE ENCEPHALOPATHY causes FLUCTUATING CONFUSIONAL STATES,254,79,,283,102,causes,0.8908708063747479,813889-FS1-4,"Thiamine (vitamin B 1 ) deficiency is responsible for the hallmark features of WERNICKE ENCEPHALOPATHY which include ophthalmoplegia (i.e., nystagmus, extraocular palsies, gaze palsies, and, in rare cases, internuclear ophthalmoplegia), gait ataxia, and FLUCTUATING CONFUSIONAL STATES",FLUCTUATING CONFUSIONAL STATES,WERNICKE ENCEPHALOPATHY,TWrex-cause
721149746,5/13/2015 10:14:48,1635681112,5/13/2015 10:14:31,False,neodev,0.5292,31326282,NLD,,,82.169.243.65,FLUCTUATING CONFUSIONAL STATES causes WERNICKE ENCEPHALOPATHY,254,79,,283,102,causes,0.8908708063747479,813889-FS1-4,"Thiamine (vitamin B 1 ) deficiency is responsible for the hallmark features of WERNICKE ENCEPHALOPATHY which include ophthalmoplegia (i.e., nystagmus, extraocular palsies, gaze palsies, and, in rare cases, internuclear ophthalmoplegia), gait ataxia, and FLUCTUATING CONFUSIONAL STATES",FLUCTUATING CONFUSIONAL STATES,WERNICKE ENCEPHALOPATHY,TWrex-cause
721149746,5/13/2015 10:15:26,1635681257,5/13/2015 10:14:47,False,prodege,0.6333,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,254,79,,283,102,causes,0.8908708063747479,813889-FS1-4,"Thiamine (vitamin B 1 ) deficiency is responsible for the hallmark features of WERNICKE ENCEPHALOPATHY which include ophthalmoplegia (i.e., nystagmus, extraocular palsies, gaze palsies, and, in rare cases, internuclear ophthalmoplegia), gait ataxia, and FLUCTUATING CONFUSIONAL STATES",FLUCTUATING CONFUSIONAL STATES,WERNICKE ENCEPHALOPATHY,TWrex-cause
721149746,5/13/2015 10:20:03,1635682489,5/13/2015 10:19:51,False,pocketmoneygpt,0.6349,28884030,USA,WI,Minocqua,75.143.134.247,no_relation,254,79,,283,102,causes,0.8908708063747479,813889-FS1-4,"Thiamine (vitamin B 1 ) deficiency is responsible for the hallmark features of WERNICKE ENCEPHALOPATHY which include ophthalmoplegia (i.e., nystagmus, extraocular palsies, gaze palsies, and, in rare cases, internuclear ophthalmoplegia), gait ataxia, and FLUCTUATING CONFUSIONAL STATES",FLUCTUATING CONFUSIONAL STATES,WERNICKE ENCEPHALOPATHY,TWrex-cause
721149746,5/13/2015 10:20:10,1635682549,5/13/2015 10:19:16,False,points4rewards,0.5833,20113482,USA,OR,Portland,67.213.218.72,no_relation,254,79,,283,102,causes,0.8908708063747479,813889-FS1-4,"Thiamine (vitamin B 1 ) deficiency is responsible for the hallmark features of WERNICKE ENCEPHALOPATHY which include ophthalmoplegia (i.e., nystagmus, extraocular palsies, gaze palsies, and, in rare cases, internuclear ophthalmoplegia), gait ataxia, and FLUCTUATING CONFUSIONAL STATES",FLUCTUATING CONFUSIONAL STATES,WERNICKE ENCEPHALOPATHY,TWrex-cause
721149749,5/13/2015 10:28:52,1635684988,5/13/2015 10:28:42,False,elite,1.0,28406437,GBR,Q5,York,2.217.42.241,no_relation,2,71,,25,101,causes,0.44172610429938597,813608-FS1-4," PAPILLARY THYROID CANCER occurs in approximately 2% of patients with FAMILIAL ADENOMATOUS POLYPOSIS most often in female carriers, who manifest the disease at about age 28.",PAPILLARY THYROID CANCER,FAMILIAL ADENOMATOUS POLYPOSIS,TWrex-cause
721149749,5/13/2015 10:45:10,1635689836,5/13/2015 10:44:54,False,prodege,0.875,3056891,CAN,ON,Niagara Falls,173.238.144.19,FAMILIAL ADENOMATOUS POLYPOSIS causes PAPILLARY THYROID CANCER,2,71,,25,101,causes,0.44172610429938597,813608-FS1-4," PAPILLARY THYROID CANCER occurs in approximately 2% of patients with FAMILIAL ADENOMATOUS POLYPOSIS most often in female carriers, who manifest the disease at about age 28.",PAPILLARY THYROID CANCER,FAMILIAL ADENOMATOUS POLYPOSIS,TWrex-cause
721149749,5/13/2015 10:49:56,1635691197,5/13/2015 10:49:41,False,clixsense,0.5972,17950689,GBR,Y9,Tonypandy,92.2.44.79,FAMILIAL ADENOMATOUS POLYPOSIS causes PAPILLARY THYROID CANCER,2,71,,25,101,causes,0.44172610429938597,813608-FS1-4," PAPILLARY THYROID CANCER occurs in approximately 2% of patients with FAMILIAL ADENOMATOUS POLYPOSIS most often in female carriers, who manifest the disease at about age 28.",PAPILLARY THYROID CANCER,FAMILIAL ADENOMATOUS POLYPOSIS,TWrex-cause
721149749,5/13/2015 10:50:27,1635691370,5/13/2015 10:49:45,False,neodev,0.6127,29579905,GBR,,,5.152.206.71,FAMILIAL ADENOMATOUS POLYPOSIS causes PAPILLARY THYROID CANCER,2,71,,25,101,causes,0.44172610429938597,813608-FS1-4," PAPILLARY THYROID CANCER occurs in approximately 2% of patients with FAMILIAL ADENOMATOUS POLYPOSIS most often in female carriers, who manifest the disease at about age 28.",PAPILLARY THYROID CANCER,FAMILIAL ADENOMATOUS POLYPOSIS,TWrex-cause
721149749,5/13/2015 10:53:36,1635692415,5/13/2015 10:53:12,False,instagc,0.5,13581319,USA,IL,Mount Vernon,66.232.166.86,FAMILIAL ADENOMATOUS POLYPOSIS causes PAPILLARY THYROID CANCER,2,71,,25,101,causes,0.44172610429938597,813608-FS1-4," PAPILLARY THYROID CANCER occurs in approximately 2% of patients with FAMILIAL ADENOMATOUS POLYPOSIS most often in female carriers, who manifest the disease at about age 28.",PAPILLARY THYROID CANCER,FAMILIAL ADENOMATOUS POLYPOSIS,TWrex-cause
721149749,5/13/2015 10:53:55,1635692478,5/13/2015 10:53:18,False,pocketmoneygpt,0.4732,21432964,GBR,T5,Aberdeen,88.104.216.210,PAPILLARY THYROID CANCER causes FAMILIAL ADENOMATOUS POLYPOSIS,2,71,,25,101,causes,0.44172610429938597,813608-FS1-4," PAPILLARY THYROID CANCER occurs in approximately 2% of patients with FAMILIAL ADENOMATOUS POLYPOSIS most often in female carriers, who manifest the disease at about age 28.",PAPILLARY THYROID CANCER,FAMILIAL ADENOMATOUS POLYPOSIS,TWrex-cause
721149749,5/13/2015 10:53:56,1635692486,5/13/2015 10:53:37,False,neodev,0.5083,14096345,NLD,03,Eibergen,77.174.124.109,no_relation,2,71,,25,101,causes,0.44172610429938597,813608-FS1-4," PAPILLARY THYROID CANCER occurs in approximately 2% of patients with FAMILIAL ADENOMATOUS POLYPOSIS most often in female carriers, who manifest the disease at about age 28.",PAPILLARY THYROID CANCER,FAMILIAL ADENOMATOUS POLYPOSIS,TWrex-cause
721149753,5/13/2015 10:47:28,1635690466,5/13/2015 10:46:57,False,prodege,0.875,3056891,CAN,ON,Niagara Falls,173.238.144.19,ACUTE PORPHYRIA causes FLACCID PARALYSIS,129,47,,145,62,causes,0.975900072948533,812686-FS1-4,porphyric p.     Polyneuropathy resulting from ACUTE PORPHYRIA characterized by pains and paresthesias in the extremities and by FLACCID PARALYSIS,FLACCID PARALYSIS,ACUTE PORPHYRIA,TWrex-cause
721149753,5/13/2015 10:52:30,1635692079,5/13/2015 10:51:58,False,clixsense,0.5972,17950689,GBR,Y9,Tonypandy,92.2.44.79,FLACCID PARALYSIS causes ACUTE PORPHYRIA,129,47,,145,62,causes,0.975900072948533,812686-FS1-4,porphyric p.     Polyneuropathy resulting from ACUTE PORPHYRIA characterized by pains and paresthesias in the extremities and by FLACCID PARALYSIS,FLACCID PARALYSIS,ACUTE PORPHYRIA,TWrex-cause
721149753,5/13/2015 10:54:09,1635692509,5/13/2015 10:53:38,False,neodev,0.6127,29579905,GBR,,,5.152.206.71,ACUTE PORPHYRIA causes FLACCID PARALYSIS,129,47,,145,62,causes,0.975900072948533,812686-FS1-4,porphyric p.     Polyneuropathy resulting from ACUTE PORPHYRIA characterized by pains and paresthesias in the extremities and by FLACCID PARALYSIS,FLACCID PARALYSIS,ACUTE PORPHYRIA,TWrex-cause
721149753,5/13/2015 10:56:19,1635693023,5/13/2015 10:55:55,False,neodev,0.5083,14096345,NLD,03,Eibergen,77.174.124.109,FLACCID PARALYSIS causes ACUTE PORPHYRIA,129,47,,145,62,causes,0.975900072948533,812686-FS1-4,porphyric p.     Polyneuropathy resulting from ACUTE PORPHYRIA characterized by pains and paresthesias in the extremities and by FLACCID PARALYSIS,FLACCID PARALYSIS,ACUTE PORPHYRIA,TWrex-cause
721149753,5/13/2015 10:58:16,1635693718,5/13/2015 10:58:00,False,neodev,0.7440000000000001,11014534,GBR,B8,Bromley,86.18.149.6,no_relation,129,47,,145,62,causes,0.975900072948533,812686-FS1-4,porphyric p.     Polyneuropathy resulting from ACUTE PORPHYRIA characterized by pains and paresthesias in the extremities and by FLACCID PARALYSIS,FLACCID PARALYSIS,ACUTE PORPHYRIA,TWrex-cause
721149753,5/13/2015 10:58:19,1635693740,5/13/2015 10:57:21,False,pocketmoneygpt,0.4732,21432964,GBR,T5,Aberdeen,88.104.216.210,no_relation,129,47,,145,62,causes,0.975900072948533,812686-FS1-4,porphyric p.     Polyneuropathy resulting from ACUTE PORPHYRIA characterized by pains and paresthesias in the extremities and by FLACCID PARALYSIS,FLACCID PARALYSIS,ACUTE PORPHYRIA,TWrex-cause
721149753,5/13/2015 10:58:48,1635693818,5/13/2015 10:57:59,False,clixsense,0.6964,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,129,47,,145,62,causes,0.975900072948533,812686-FS1-4,porphyric p.     Polyneuropathy resulting from ACUTE PORPHYRIA characterized by pains and paresthesias in the extremities and by FLACCID PARALYSIS,FLACCID PARALYSIS,ACUTE PORPHYRIA,TWrex-cause
721149756,5/13/2015 10:00:57,1635677650,5/13/2015 10:00:20,False,neodev,1.0,30627835,GBR,H9,London,5.81.27.94,BACTERIA causes BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS,89,169,,132,177,causes,0.855186110494136,810102-FS1-4,Causes [edit] Infectious parotitis  Acute bacterial parotitis: is most often caused by a BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS but may be caused by any commensal BACTERIA[1]  Parotitis as Extrapulmonary Tuberculosis: The mycobacterium that cause tuberculosis can also cause parotid infection.,BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS,BACTERIA,TWrex-cause
721149756,5/13/2015 10:06:01,1635678790,5/13/2015 10:05:06,False,instagc,0.75,18531561,CAN,ON,Mississauga,99.229.92.227,BACTERIA causes BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS,89,169,,132,177,causes,0.855186110494136,810102-FS1-4,Causes [edit] Infectious parotitis  Acute bacterial parotitis: is most often caused by a BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS but may be caused by any commensal BACTERIA[1]  Parotitis as Extrapulmonary Tuberculosis: The mycobacterium that cause tuberculosis can also cause parotid infection.,BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS,BACTERIA,TWrex-cause
721149756,5/13/2015 10:08:07,1635679305,5/13/2015 10:07:42,False,gifthunterclub,0.5278,30901412,GBR,H9,London,77.89.149.62,BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS causes BACTERIA,89,169,,132,177,causes,0.855186110494136,810102-FS1-4,Causes [edit] Infectious parotitis  Acute bacterial parotitis: is most often caused by a BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS but may be caused by any commensal BACTERIA[1]  Parotitis as Extrapulmonary Tuberculosis: The mycobacterium that cause tuberculosis can also cause parotid infection.,BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS,BACTERIA,TWrex-cause
721149756,5/13/2015 10:15:08,1635681191,5/13/2015 10:14:50,False,neodev,0.5292,31326282,NLD,,,82.169.243.65,BACTERIA causes BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS,89,169,,132,177,causes,0.855186110494136,810102-FS1-4,Causes [edit] Infectious parotitis  Acute bacterial parotitis: is most often caused by a BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS but may be caused by any commensal BACTERIA[1]  Parotitis as Extrapulmonary Tuberculosis: The mycobacterium that cause tuberculosis can also cause parotid infection.,BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS,BACTERIA,TWrex-cause
721149756,5/13/2015 10:16:05,1635681394,5/13/2015 10:15:27,False,prodege,0.6333,21417560,GBR,C3,Cambridge,151.225.116.143,BACTERIA causes BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS,89,169,,132,177,causes,0.855186110494136,810102-FS1-4,Causes [edit] Infectious parotitis  Acute bacterial parotitis: is most often caused by a BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS but may be caused by any commensal BACTERIA[1]  Parotitis as Extrapulmonary Tuberculosis: The mycobacterium that cause tuberculosis can also cause parotid infection.,BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS,BACTERIA,TWrex-cause
721149756,5/13/2015 10:20:19,1635682632,5/13/2015 10:20:03,False,pocketmoneygpt,0.6349,28884030,USA,WI,Minocqua,75.143.134.247,BACTERIA causes BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS,89,169,,132,177,causes,0.855186110494136,810102-FS1-4,Causes [edit] Infectious parotitis  Acute bacterial parotitis: is most often caused by a BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS but may be caused by any commensal BACTERIA[1]  Parotitis as Extrapulmonary Tuberculosis: The mycobacterium that cause tuberculosis can also cause parotid infection.,BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS,BACTERIA,TWrex-cause
721149756,5/13/2015 10:20:48,1635682768,5/13/2015 10:20:14,False,points4rewards,0.5833,20113482,USA,OR,Portland,67.213.218.72,BACTERIA causes BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS,89,169,,132,177,causes,0.855186110494136,810102-FS1-4,Causes [edit] Infectious parotitis  Acute bacterial parotitis: is most often caused by a BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS but may be caused by any commensal BACTERIA[1]  Parotitis as Extrapulmonary Tuberculosis: The mycobacterium that cause tuberculosis can also cause parotid infection.,BACTERIAL INFECTION OF STAPHYLOCOCCUS AUREUS,BACTERIA,TWrex-cause
721149757,5/13/2015 10:47:28,1635690465,5/13/2015 10:46:57,False,prodege,0.875,3056891,CAN,ON,Niagara Falls,173.238.144.19,no_relation,249,146,,252,155,causes,0.471404520791032,802767-FS1-4, Other causes of lung abscess do not result from aspiration of oral anaerobic bacteria and are not preventable except by decreasing the risk for PNEUMONIA by immunizations or by quickly treating extrapulmonary sites of infections that can seed the LUNG,LUNG,PNEUMONIA,TWrex-cause
721149757,5/13/2015 10:52:30,1635692077,5/13/2015 10:51:58,False,clixsense,0.5972,17950689,GBR,Y9,Tonypandy,92.2.44.79,PNEUMONIA causes LUNG,249,146,,252,155,causes,0.471404520791032,802767-FS1-4, Other causes of lung abscess do not result from aspiration of oral anaerobic bacteria and are not preventable except by decreasing the risk for PNEUMONIA by immunizations or by quickly treating extrapulmonary sites of infections that can seed the LUNG,LUNG,PNEUMONIA,TWrex-cause
721149757,5/13/2015 10:54:09,1635692514,5/13/2015 10:53:38,False,neodev,0.6127,29579905,GBR,,,5.152.206.71,LUNG causes PNEUMONIA,249,146,,252,155,causes,0.471404520791032,802767-FS1-4, Other causes of lung abscess do not result from aspiration of oral anaerobic bacteria and are not preventable except by decreasing the risk for PNEUMONIA by immunizations or by quickly treating extrapulmonary sites of infections that can seed the LUNG,LUNG,PNEUMONIA,TWrex-cause
721149757,5/13/2015 10:56:19,1635693024,5/13/2015 10:55:55,False,neodev,0.5083,14096345,NLD,03,Eibergen,77.174.124.109,no_relation,249,146,,252,155,causes,0.471404520791032,802767-FS1-4, Other causes of lung abscess do not result from aspiration of oral anaerobic bacteria and are not preventable except by decreasing the risk for PNEUMONIA by immunizations or by quickly treating extrapulmonary sites of infections that can seed the LUNG,LUNG,PNEUMONIA,TWrex-cause
721149757,5/13/2015 10:58:16,1635693722,5/13/2015 10:58:00,False,neodev,0.7440000000000001,11014534,GBR,B8,Bromley,86.18.149.6,no_relation,249,146,,252,155,causes,0.471404520791032,802767-FS1-4, Other causes of lung abscess do not result from aspiration of oral anaerobic bacteria and are not preventable except by decreasing the risk for PNEUMONIA by immunizations or by quickly treating extrapulmonary sites of infections that can seed the LUNG,LUNG,PNEUMONIA,TWrex-cause
721149757,5/13/2015 10:58:19,1635693749,5/13/2015 10:57:21,False,pocketmoneygpt,0.4732,21432964,GBR,T5,Aberdeen,88.104.216.210,LUNG causes PNEUMONIA,249,146,,252,155,causes,0.471404520791032,802767-FS1-4, Other causes of lung abscess do not result from aspiration of oral anaerobic bacteria and are not preventable except by decreasing the risk for PNEUMONIA by immunizations or by quickly treating extrapulmonary sites of infections that can seed the LUNG,LUNG,PNEUMONIA,TWrex-cause
721149757,5/13/2015 10:58:48,1635693816,5/13/2015 10:57:59,False,clixsense,0.6964,10798016,GBR,C7,Coventry,86.24.245.191,LUNG causes PNEUMONIA,249,146,,252,155,causes,0.471404520791032,802767-FS1-4, Other causes of lung abscess do not result from aspiration of oral anaerobic bacteria and are not preventable except by decreasing the risk for PNEUMONIA by immunizations or by quickly treating extrapulmonary sites of infections that can seed the LUNG,LUNG,PNEUMONIA,TWrex-cause
721149758,5/13/2015 10:46:56,1635690315,5/13/2015 10:46:24,False,prodege,0.875,3056891,CAN,ON,Niagara Falls,173.238.144.19,no_relation,231,113,,267,133,causes,0.48154341234307707,812801-FS1-4,"Other parkinsonian syndromes include progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), multiple SYSTEM ATROPHY (MSA) vascular parkinsonism, normal pressure hydrocephalus (NPH), drug induced parkinsonism (DIP), and DEMENTIA ASSOCIATED WITH PARKINSONISM",DEMENTIA ASSOCIATED WITH PARKINSONISM,SYSTEM ATROPHY (MSA),TWrex-cause
721149758,5/13/2015 10:51:57,1635691860,5/13/2015 10:51:26,False,clixsense,0.5972,17950689,GBR,Y9,Tonypandy,92.2.44.79,SYSTEM ATROPHY (MSA) causes DEMENTIA ASSOCIATED WITH PARKINSONISM,231,113,,267,133,causes,0.48154341234307707,812801-FS1-4,"Other parkinsonian syndromes include progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), multiple SYSTEM ATROPHY (MSA) vascular parkinsonism, normal pressure hydrocephalus (NPH), drug induced parkinsonism (DIP), and DEMENTIA ASSOCIATED WITH PARKINSONISM",DEMENTIA ASSOCIATED WITH PARKINSONISM,SYSTEM ATROPHY (MSA),TWrex-cause
721149758,5/13/2015 10:53:33,1635692401,5/13/2015 10:52:53,False,neodev,0.6127,29579905,GBR,,,5.152.206.71,DEMENTIA ASSOCIATED WITH PARKINSONISM causes SYSTEM ATROPHY (MSA),231,113,,267,133,causes,0.48154341234307707,812801-FS1-4,"Other parkinsonian syndromes include progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), multiple SYSTEM ATROPHY (MSA) vascular parkinsonism, normal pressure hydrocephalus (NPH), drug induced parkinsonism (DIP), and DEMENTIA ASSOCIATED WITH PARKINSONISM",DEMENTIA ASSOCIATED WITH PARKINSONISM,SYSTEM ATROPHY (MSA),TWrex-cause
721149758,5/13/2015 10:54:36,1635692638,5/13/2015 10:54:27,False,instagc,0.5,13581319,USA,IL,Mount Vernon,66.232.166.86,DEMENTIA ASSOCIATED WITH PARKINSONISM causes SYSTEM ATROPHY (MSA),231,113,,267,133,causes,0.48154341234307707,812801-FS1-4,"Other parkinsonian syndromes include progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), multiple SYSTEM ATROPHY (MSA) vascular parkinsonism, normal pressure hydrocephalus (NPH), drug induced parkinsonism (DIP), and DEMENTIA ASSOCIATED WITH PARKINSONISM",DEMENTIA ASSOCIATED WITH PARKINSONISM,SYSTEM ATROPHY (MSA),TWrex-cause
721149758,5/13/2015 10:55:54,1635692903,5/13/2015 10:55:23,False,neodev,0.5083,14096345,NLD,03,Eibergen,77.174.124.109,no_relation,231,113,,267,133,causes,0.48154341234307707,812801-FS1-4,"Other parkinsonian syndromes include progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), multiple SYSTEM ATROPHY (MSA) vascular parkinsonism, normal pressure hydrocephalus (NPH), drug induced parkinsonism (DIP), and DEMENTIA ASSOCIATED WITH PARKINSONISM",DEMENTIA ASSOCIATED WITH PARKINSONISM,SYSTEM ATROPHY (MSA),TWrex-cause
721149758,5/13/2015 10:57:20,1635693439,5/13/2015 10:57:08,False,pocketmoneygpt,0.4732,21432964,GBR,T5,Aberdeen,88.104.216.210,no_relation,231,113,,267,133,causes,0.48154341234307707,812801-FS1-4,"Other parkinsonian syndromes include progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), multiple SYSTEM ATROPHY (MSA) vascular parkinsonism, normal pressure hydrocephalus (NPH), drug induced parkinsonism (DIP), and DEMENTIA ASSOCIATED WITH PARKINSONISM",DEMENTIA ASSOCIATED WITH PARKINSONISM,SYSTEM ATROPHY (MSA),TWrex-cause
721149758,5/13/2015 10:57:58,1635693658,5/13/2015 10:57:25,False,clixsense,0.6964,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,231,113,,267,133,causes,0.48154341234307707,812801-FS1-4,"Other parkinsonian syndromes include progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), multiple SYSTEM ATROPHY (MSA) vascular parkinsonism, normal pressure hydrocephalus (NPH), drug induced parkinsonism (DIP), and DEMENTIA ASSOCIATED WITH PARKINSONISM",DEMENTIA ASSOCIATED WITH PARKINSONISM,SYSTEM ATROPHY (MSA),TWrex-cause
721702140,5/14/2015 19:01:44,1636466114,5/14/2015 19:01:14,False,clixsense,0.7083,28351359,GBR,F6,Romford,80.43.183.92,SECRETION (PHEOCHROMOCYTOMAS) causes HYPERTENSION,0,69,,11,98,causes,0.9931270663228409,813064-FS1-4,HYPERTENSION may result from abnormal epinephrine and norepinephrine SECRETION (PHEOCHROMOCYTOMAS) or from cortisol excess (ACTH secreting tumors.,HYPERTENSION,SECRETION (PHEOCHROMOCYTOMAS),TWrex-cause
721702140,5/14/2015 19:30:31,1636494274,5/14/2015 19:29:52,False,clixsense,0.6607,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,0,69,,11,98,causes,0.9931270663228409,813064-FS1-4,HYPERTENSION may result from abnormal epinephrine and norepinephrine SECRETION (PHEOCHROMOCYTOMAS) or from cortisol excess (ACTH secreting tumors.,HYPERTENSION,SECRETION (PHEOCHROMOCYTOMAS),TWrex-cause
721702140,5/14/2015 19:37:37,1636499703,5/14/2015 19:37:23,False,instagc,0.7986,22535866,GBR,M2,Solihull,80.195.193.86,SECRETION (PHEOCHROMOCYTOMAS) causes HYPERTENSION,0,69,,11,98,causes,0.9931270663228409,813064-FS1-4,HYPERTENSION may result from abnormal epinephrine and norepinephrine SECRETION (PHEOCHROMOCYTOMAS) or from cortisol excess (ACTH secreting tumors.,HYPERTENSION,SECRETION (PHEOCHROMOCYTOMAS),TWrex-cause
721702140,5/14/2015 19:56:03,1636507137,5/14/2015 19:55:54,False,clixsense,0.7875,32549163,CAN,MB,Winnipeg,206.45.167.246,SECRETION (PHEOCHROMOCYTOMAS) causes HYPERTENSION,0,69,,11,98,causes,0.9931270663228409,813064-FS1-4,HYPERTENSION may result from abnormal epinephrine and norepinephrine SECRETION (PHEOCHROMOCYTOMAS) or from cortisol excess (ACTH secreting tumors.,HYPERTENSION,SECRETION (PHEOCHROMOCYTOMAS),TWrex-cause
721702140,5/14/2015 20:02:38,1636509618,5/14/2015 20:02:18,False,instagc,0.6667,32352104,USA,ME,Bangor,74.75.63.81,HYPERTENSION causes SECRETION (PHEOCHROMOCYTOMAS),0,69,,11,98,causes,0.9931270663228409,813064-FS1-4,HYPERTENSION may result from abnormal epinephrine and norepinephrine SECRETION (PHEOCHROMOCYTOMAS) or from cortisol excess (ACTH secreting tumors.,HYPERTENSION,SECRETION (PHEOCHROMOCYTOMAS),TWrex-cause
721702140,5/14/2015 20:04:12,1636510413,5/14/2015 20:03:57,False,clixsense,0.7579,11106820,USA,MA,Taunton,173.48.52.95,SECRETION (PHEOCHROMOCYTOMAS) causes HYPERTENSION,0,69,,11,98,causes,0.9931270663228409,813064-FS1-4,HYPERTENSION may result from abnormal epinephrine and norepinephrine SECRETION (PHEOCHROMOCYTOMAS) or from cortisol excess (ACTH secreting tumors.,HYPERTENSION,SECRETION (PHEOCHROMOCYTOMAS),TWrex-cause
721702140,5/14/2015 20:14:41,1636518383,5/14/2015 20:14:05,False,clixsense,0.8373,30313955,GBR,K5,Poole,2.30.145.202,SECRETION (PHEOCHROMOCYTOMAS) causes HYPERTENSION,0,69,,11,98,causes,0.9931270663228409,813064-FS1-4,HYPERTENSION may result from abnormal epinephrine and norepinephrine SECRETION (PHEOCHROMOCYTOMAS) or from cortisol excess (ACTH secreting tumors.,HYPERTENSION,SECRETION (PHEOCHROMOCYTOMAS),TWrex-cause
721702146,5/14/2015 18:54:57,1636463395,5/14/2015 18:54:38,False,instagc,0.6881,30326470,USA,CA,Santee,99.44.37.73,DIABETES MELLITUS causes DIABETIC KETOACIDOSIS,172,53,,192,70,causes,0.9494253265550829,811962-FS1-4,"185  Hyperglycemic Effects  Hyperglycemia, new onset DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of HIV protease inhibitors (PIs); DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,DIABETES MELLITUS,TWrex-cause
721702146,5/14/2015 19:01:13,1636465892,5/14/2015 19:00:41,False,clixsense,0.7083,28351359,GBR,F6,Romford,80.43.183.92,no_relation,172,53,,192,70,causes,0.9494253265550829,811962-FS1-4,"185  Hyperglycemic Effects  Hyperglycemia, new onset DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of HIV protease inhibitors (PIs); DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,DIABETES MELLITUS,TWrex-cause
721702146,5/14/2015 19:29:51,1636493677,5/14/2015 19:29:18,False,clixsense,0.6607,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,172,53,,192,70,causes,0.9494253265550829,811962-FS1-4,"185  Hyperglycemic Effects  Hyperglycemia, new onset DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of HIV protease inhibitors (PIs); DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,DIABETES MELLITUS,TWrex-cause
721702146,5/14/2015 19:37:22,1636499551,5/14/2015 19:36:28,False,instagc,0.7986,22535866,GBR,M2,Solihull,80.195.193.86,DIABETES MELLITUS causes DIABETIC KETOACIDOSIS,172,53,,192,70,causes,0.9494253265550829,811962-FS1-4,"185  Hyperglycemic Effects  Hyperglycemia, new onset DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of HIV protease inhibitors (PIs); DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,DIABETES MELLITUS,TWrex-cause
721702146,5/14/2015 19:55:54,1636507118,5/14/2015 19:55:16,False,clixsense,0.7875,32549163,CAN,MB,Winnipeg,206.45.167.246,no_relation,172,53,,192,70,causes,0.9494253265550829,811962-FS1-4,"185  Hyperglycemic Effects  Hyperglycemia, new onset DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of HIV protease inhibitors (PIs); DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,DIABETES MELLITUS,TWrex-cause
721702146,5/14/2015 19:58:23,1636508048,5/14/2015 19:57:37,False,clixsense,0.7579,11106820,USA,MA,Taunton,173.48.52.95,DIABETES MELLITUS causes DIABETIC KETOACIDOSIS,172,53,,192,70,causes,0.9494253265550829,811962-FS1-4,"185  Hyperglycemic Effects  Hyperglycemia, new onset DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of HIV protease inhibitors (PIs); DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,DIABETES MELLITUS,TWrex-cause
721702146,5/14/2015 20:02:17,1636509504,5/14/2015 20:01:38,False,instagc,0.6667,32352104,USA,ME,Bangor,74.75.63.81,DIABETES MELLITUS causes DIABETIC KETOACIDOSIS,172,53,,192,70,causes,0.9494253265550829,811962-FS1-4,"185  Hyperglycemic Effects  Hyperglycemia, new onset DIABETES MELLITUS or exacerbation of preexisting diabetes mellitus reported with use of HIV protease inhibitors (PIs); DIABETIC KETOACIDOSIS has occurred.",DIABETIC KETOACIDOSIS,DIABETES MELLITUS,TWrex-cause
721702154,5/14/2015 18:41:44,1636457797,5/14/2015 18:41:25,False,clixsense,0.5111,6362702,GBR,B7,Bristol,90.222.95.91,HERPES ZOSTER causes CYTOMEGALOVIRUS [CMV] INFECTIONS,28,77,,59,90,causes,0.40824829046386296,811454-FS1-4,"1   Viral infections (e.g., CYTOMEGALOVIRUS [CMV] INFECTIONS herpes simplex, HERPES ZOSTER reported more frequently in cardiac transplant recipients receiving mycophenolate than in those receiving azathioprine.",CYTOMEGALOVIRUS [CMV] INFECTIONS,HERPES ZOSTER,TWrex-cause
721702154,5/14/2015 18:42:16,1636457975,5/14/2015 18:41:35,False,prodege,0.5833,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,28,77,,59,90,causes,0.40824829046386296,811454-FS1-4,"1   Viral infections (e.g., CYTOMEGALOVIRUS [CMV] INFECTIONS herpes simplex, HERPES ZOSTER reported more frequently in cardiac transplant recipients receiving mycophenolate than in those receiving azathioprine.",CYTOMEGALOVIRUS [CMV] INFECTIONS,HERPES ZOSTER,TWrex-cause
721702154,5/14/2015 18:42:46,1636458184,5/14/2015 18:42:17,False,neodev,0.5972,18881135,CAN,ON,Ajax,99.243.87.224,no_relation,28,77,,59,90,causes,0.40824829046386296,811454-FS1-4,"1   Viral infections (e.g., CYTOMEGALOVIRUS [CMV] INFECTIONS herpes simplex, HERPES ZOSTER reported more frequently in cardiac transplant recipients receiving mycophenolate than in those receiving azathioprine.",CYTOMEGALOVIRUS [CMV] INFECTIONS,HERPES ZOSTER,TWrex-cause
721702154,5/14/2015 18:48:51,1636460598,5/14/2015 18:48:44,False,neodev,0.6478,31706957,NLD,07,Amsterdam,145.100.72.165,no_relation,28,77,,59,90,causes,0.40824829046386296,811454-FS1-4,"1   Viral infections (e.g., CYTOMEGALOVIRUS [CMV] INFECTIONS herpes simplex, HERPES ZOSTER reported more frequently in cardiac transplant recipients receiving mycophenolate than in those receiving azathioprine.",CYTOMEGALOVIRUS [CMV] INFECTIONS,HERPES ZOSTER,TWrex-cause
721702154,5/14/2015 18:54:36,1636463200,5/14/2015 18:54:09,False,instagc,0.6881,30326470,USA,CA,Santee,99.44.37.73,no_relation,28,77,,59,90,causes,0.40824829046386296,811454-FS1-4,"1   Viral infections (e.g., CYTOMEGALOVIRUS [CMV] INFECTIONS herpes simplex, HERPES ZOSTER reported more frequently in cardiac transplant recipients receiving mycophenolate than in those receiving azathioprine.",CYTOMEGALOVIRUS [CMV] INFECTIONS,HERPES ZOSTER,TWrex-cause
721702154,5/14/2015 19:00:40,1636465664,5/14/2015 19:00:10,False,clixsense,0.7083,28351359,GBR,F6,Romford,80.43.183.92,no_relation,28,77,,59,90,causes,0.40824829046386296,811454-FS1-4,"1   Viral infections (e.g., CYTOMEGALOVIRUS [CMV] INFECTIONS herpes simplex, HERPES ZOSTER reported more frequently in cardiac transplant recipients receiving mycophenolate than in those receiving azathioprine.",CYTOMEGALOVIRUS [CMV] INFECTIONS,HERPES ZOSTER,TWrex-cause
721702154,5/14/2015 19:29:17,1636493198,5/14/2015 19:28:41,False,clixsense,0.6607,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,28,77,,59,90,causes,0.40824829046386296,811454-FS1-4,"1   Viral infections (e.g., CYTOMEGALOVIRUS [CMV] INFECTIONS herpes simplex, HERPES ZOSTER reported more frequently in cardiac transplant recipients receiving mycophenolate than in those receiving azathioprine.",CYTOMEGALOVIRUS [CMV] INFECTIONS,HERPES ZOSTER,TWrex-cause
721702158,5/14/2015 18:23:11,1636447795,5/14/2015 18:22:36,False,neodev,1.0,31743852,GBR,G5,Margate,85.210.120.188,FEBRILE SEIZURES causes EPILEPSY,56,14,,71,22,causes,0.889000889001333,815023-FS1-4,Predictors of EPILEPSY in children who have experienced FEBRILE SEIZURES,FEBRILE SEIZURES,EPILEPSY,TWrex-cause
721702158,5/14/2015 18:32:13,1636453378,5/14/2015 18:31:47,False,clixsense,0.6639,22751911,NLD,04,Groningen,195.241.153.97,FEBRILE SEIZURES causes EPILEPSY,56,14,,71,22,causes,0.889000889001333,815023-FS1-4,Predictors of EPILEPSY in children who have experienced FEBRILE SEIZURES,FEBRILE SEIZURES,EPILEPSY,TWrex-cause
721702158,5/14/2015 18:33:31,1636454097,5/14/2015 18:32:58,False,prodege,0.5306,1878608,CAN,BC,Vancouver,216.251.132.22,EPILEPSY causes FEBRILE SEIZURES,56,14,,71,22,causes,0.889000889001333,815023-FS1-4,Predictors of EPILEPSY in children who have experienced FEBRILE SEIZURES,FEBRILE SEIZURES,EPILEPSY,TWrex-cause
721702158,5/14/2015 18:33:55,1636454247,5/14/2015 18:33:42,False,elite,0.6153,31883685,GBR,H2,Accrington,80.47.186.28,no_relation,56,14,,71,22,causes,0.889000889001333,815023-FS1-4,Predictors of EPILEPSY in children who have experienced FEBRILE SEIZURES,FEBRILE SEIZURES,EPILEPSY,TWrex-cause
721702158,5/14/2015 18:34:56,1636454662,5/14/2015 18:34:26,False,points4rewards,0.6131,20113482,USA,OR,Portland,67.213.218.72,no_relation,56,14,,71,22,causes,0.889000889001333,815023-FS1-4,Predictors of EPILEPSY in children who have experienced FEBRILE SEIZURES,FEBRILE SEIZURES,EPILEPSY,TWrex-cause
721702158,5/14/2015 18:36:30,1636455291,5/14/2015 18:36:04,False,instagc,0.5179,13581319,USA,IL,Mount Vernon,66.232.166.86,no_relation,56,14,,71,22,causes,0.889000889001333,815023-FS1-4,Predictors of EPILEPSY in children who have experienced FEBRILE SEIZURES,FEBRILE SEIZURES,EPILEPSY,TWrex-cause
721702158,5/14/2015 18:37:57,1636456047,5/14/2015 18:37:14,False,prodege,0.5613,3587109,CAN,NS,Sydney,142.177.43.253,FEBRILE SEIZURES causes EPILEPSY,56,14,,71,22,causes,0.889000889001333,815023-FS1-4,Predictors of EPILEPSY in children who have experienced FEBRILE SEIZURES,FEBRILE SEIZURES,EPILEPSY,TWrex-cause
721702161,5/14/2015 18:24:02,1636448127,5/14/2015 18:23:39,False,neodev,1.0,31743852,GBR,G5,Margate,85.210.120.188,TRICHOSTRONGYLIASIS causes TRICHOSTRONGYLUS,38,76,,56,92,causes,0.8944271909999159,812597-FS1-4,13  Trichostrongyliasis  Treatment of TRICHOSTRONGYLIASIS   +    caused by  TRICHOSTRONGYLUS,TRICHOSTRONGYLIASIS,TRICHOSTRONGYLUS,TWrex-cause
721702161,5/14/2015 18:33:04,1636453852,5/14/2015 18:32:40,False,clixsense,0.6639,22751911,NLD,04,Groningen,195.241.153.97,TRICHOSTRONGYLIASIS causes TRICHOSTRONGYLUS,38,76,,56,92,causes,0.8944271909999159,812597-FS1-4,13  Trichostrongyliasis  Treatment of TRICHOSTRONGYLIASIS   +    caused by  TRICHOSTRONGYLUS,TRICHOSTRONGYLIASIS,TRICHOSTRONGYLUS,TWrex-cause
721702161,5/14/2015 18:34:41,1636454572,5/14/2015 18:34:05,False,prodege,0.5306,1878608,CAN,BC,Vancouver,216.251.132.22,no_relation,38,76,,56,92,causes,0.8944271909999159,812597-FS1-4,13  Trichostrongyliasis  Treatment of TRICHOSTRONGYLIASIS   +    caused by  TRICHOSTRONGYLUS,TRICHOSTRONGYLIASIS,TRICHOSTRONGYLUS,TWrex-cause
721702161,5/14/2015 18:35:21,1636454813,5/14/2015 18:34:43,False,elite,0.6153,31883685,GBR,H2,Accrington,80.47.186.28,TRICHOSTRONGYLUS causes TRICHOSTRONGYLIASIS,38,76,,56,92,causes,0.8944271909999159,812597-FS1-4,13  Trichostrongyliasis  Treatment of TRICHOSTRONGYLIASIS   +    caused by  TRICHOSTRONGYLUS,TRICHOSTRONGYLIASIS,TRICHOSTRONGYLUS,TWrex-cause
721702161,5/14/2015 18:36:32,1636455327,5/14/2015 18:35:59,False,points4rewards,0.6131,20113482,USA,OR,Portland,67.213.218.72,TRICHOSTRONGYLUS causes TRICHOSTRONGYLIASIS,38,76,,56,92,causes,0.8944271909999159,812597-FS1-4,13  Trichostrongyliasis  Treatment of TRICHOSTRONGYLIASIS   +    caused by  TRICHOSTRONGYLUS,TRICHOSTRONGYLIASIS,TRICHOSTRONGYLUS,TWrex-cause
721702161,5/14/2015 18:37:03,1636455523,5/14/2015 18:36:47,False,instagc,0.5179,13581319,USA,IL,Mount Vernon,66.232.166.86,TRICHOSTRONGYLUS causes TRICHOSTRONGYLIASIS,38,76,,56,92,causes,0.8944271909999159,812597-FS1-4,13  Trichostrongyliasis  Treatment of TRICHOSTRONGYLIASIS   +    caused by  TRICHOSTRONGYLUS,TRICHOSTRONGYLIASIS,TRICHOSTRONGYLUS,TWrex-cause
721702161,5/14/2015 18:37:43,1636455895,5/14/2015 18:37:22,False,pocketmoneygpt,0.6183,28884030,USA,WI,Minocqua,75.143.134.247,TRICHOSTRONGYLUS causes TRICHOSTRONGYLIASIS,38,76,,56,92,causes,0.8944271909999159,812597-FS1-4,13  Trichostrongyliasis  Treatment of TRICHOSTRONGYLIASIS   +    caused by  TRICHOSTRONGYLUS,TRICHOSTRONGYLIASIS,TRICHOSTRONGYLUS,TWrex-cause
721702163,5/14/2015 18:23:37,1636447959,5/14/2015 18:23:12,False,neodev,1.0,31743852,GBR,G5,Margate,85.210.120.188,HIT WITH THROMBOSIS causes THROMBOCYTOPENIA,36,110,,51,129,causes,0.9045340337332909,814930-FS1-4,471   Evaluate patients who develop THROMBOCYTOPENIA or thrombosis after treatment discontinuance for HIT and HIT WITH THROMBOSIS.,THROMBOCYTOPENIA,HIT WITH THROMBOSIS,TWrex-cause
721702163,5/14/2015 18:32:38,1636453556,5/14/2015 18:32:14,False,clixsense,0.6639,22751911,NLD,04,Groningen,195.241.153.97,THROMBOCYTOPENIA causes HIT WITH THROMBOSIS,36,110,,51,129,causes,0.9045340337332909,814930-FS1-4,471   Evaluate patients who develop THROMBOCYTOPENIA or thrombosis after treatment discontinuance for HIT and HIT WITH THROMBOSIS.,THROMBOCYTOPENIA,HIT WITH THROMBOSIS,TWrex-cause
721702163,5/14/2015 18:34:03,1636454268,5/14/2015 18:33:32,False,prodege,0.5306,1878608,CAN,BC,Vancouver,216.251.132.22,no_relation,36,110,,51,129,causes,0.9045340337332909,814930-FS1-4,471   Evaluate patients who develop THROMBOCYTOPENIA or thrombosis after treatment discontinuance for HIT and HIT WITH THROMBOSIS.,THROMBOCYTOPENIA,HIT WITH THROMBOSIS,TWrex-cause
721702163,5/14/2015 18:34:42,1636454584,5/14/2015 18:33:56,False,elite,0.6153,31883685,GBR,H2,Accrington,80.47.186.28,no_relation,36,110,,51,129,causes,0.9045340337332909,814930-FS1-4,471   Evaluate patients who develop THROMBOCYTOPENIA or thrombosis after treatment discontinuance for HIT and HIT WITH THROMBOSIS.,THROMBOCYTOPENIA,HIT WITH THROMBOSIS,TWrex-cause
721702163,5/14/2015 18:35:53,1636455027,5/14/2015 18:35:02,False,points4rewards,0.6131,20113482,USA,OR,Portland,67.213.218.72,HIT WITH THROMBOSIS causes THROMBOCYTOPENIA,36,110,,51,129,causes,0.9045340337332909,814930-FS1-4,471   Evaluate patients who develop THROMBOCYTOPENIA or thrombosis after treatment discontinuance for HIT and HIT WITH THROMBOSIS.,THROMBOCYTOPENIA,HIT WITH THROMBOSIS,TWrex-cause
721702163,5/14/2015 18:36:45,1636455394,5/14/2015 18:36:31,False,instagc,0.5179,13581319,USA,IL,Mount Vernon,66.232.166.86,HIT WITH THROMBOSIS causes THROMBOCYTOPENIA,36,110,,51,129,causes,0.9045340337332909,814930-FS1-4,471   Evaluate patients who develop THROMBOCYTOPENIA or thrombosis after treatment discontinuance for HIT and HIT WITH THROMBOSIS.,THROMBOCYTOPENIA,HIT WITH THROMBOSIS,TWrex-cause
721702163,5/14/2015 18:38:08,1636456175,5/14/2015 18:37:44,False,pocketmoneygpt,0.6183,28884030,USA,WI,Minocqua,75.143.134.247,no_relation,36,110,,51,129,causes,0.9045340337332909,814930-FS1-4,471   Evaluate patients who develop THROMBOCYTOPENIA or thrombosis after treatment discontinuance for HIT and HIT WITH THROMBOSIS.,THROMBOCYTOPENIA,HIT WITH THROMBOSIS,TWrex-cause
721702164,5/14/2015 19:38:23,1636500120,5/14/2015 19:38:10,False,instagc,0.7986,22535866,GBR,M2,Solihull,80.195.193.86,ENDOMETRIOSIS causes PAIN,113,79,,116,92,causes,0.975900072948533,813600-FS1-4,C]  Specific recommendation:  Encourage patients to differentiate the pain of ENDOMETRIOSIS from other types of PAIN and its relation to their menstrual cycle and intercourse and to keep a diary of their symptoms.,PAIN,ENDOMETRIOSIS,TWrex-cause
721702164,5/14/2015 20:05:24,1636511233,5/14/2015 20:04:52,False,clixsense,0.7579,11106820,USA,MA,Taunton,173.48.52.95,ENDOMETRIOSIS causes PAIN,113,79,,116,92,causes,0.975900072948533,813600-FS1-4,C]  Specific recommendation:  Encourage patients to differentiate the pain of ENDOMETRIOSIS from other types of PAIN and its relation to their menstrual cycle and intercourse and to keep a diary of their symptoms.,PAIN,ENDOMETRIOSIS,TWrex-cause
721702164,5/14/2015 20:15:29,1636519254,5/14/2015 20:15:07,False,clixsense,0.8373,30313955,GBR,K5,Poole,2.30.145.202,ENDOMETRIOSIS causes PAIN,113,79,,116,92,causes,0.975900072948533,813600-FS1-4,C]  Specific recommendation:  Encourage patients to differentiate the pain of ENDOMETRIOSIS from other types of PAIN and its relation to their menstrual cycle and intercourse and to keep a diary of their symptoms.,PAIN,ENDOMETRIOSIS,TWrex-cause
721702164,5/14/2015 20:15:30,1636519320,5/14/2015 20:15:10,False,neodev,0.7333,31091664,USA,CA,Sunnyvale,199.168.148.136,no_relation,113,79,,116,92,causes,0.975900072948533,813600-FS1-4,C]  Specific recommendation:  Encourage patients to differentiate the pain of ENDOMETRIOSIS from other types of PAIN and its relation to their menstrual cycle and intercourse and to keep a diary of their symptoms.,PAIN,ENDOMETRIOSIS,TWrex-cause
721702164,5/14/2015 20:26:19,1636530140,5/14/2015 20:26:08,False,elite,0.5524,30064988,GBR,H3,Leeds,92.22.198.222,no_relation,113,79,,116,92,causes,0.975900072948533,813600-FS1-4,C]  Specific recommendation:  Encourage patients to differentiate the pain of ENDOMETRIOSIS from other types of PAIN and its relation to their menstrual cycle and intercourse and to keep a diary of their symptoms.,PAIN,ENDOMETRIOSIS,TWrex-cause
721702164,5/14/2015 20:32:39,1636536827,5/14/2015 20:32:18,False,fusioncash,0.7286,5620345,USA,HI,Honolulu,132.160.235.13,no_relation,113,79,,116,92,causes,0.975900072948533,813600-FS1-4,C]  Specific recommendation:  Encourage patients to differentiate the pain of ENDOMETRIOSIS from other types of PAIN and its relation to their menstrual cycle and intercourse and to keep a diary of their symptoms.,PAIN,ENDOMETRIOSIS,TWrex-cause
721702164,5/14/2015 20:34:24,1636538688,5/14/2015 20:34:09,False,instagc,0.6339,20845955,GBR,I2,Manchester,90.214.24.62,ENDOMETRIOSIS causes PAIN,113,79,,116,92,causes,0.975900072948533,813600-FS1-4,C]  Specific recommendation:  Encourage patients to differentiate the pain of ENDOMETRIOSIS from other types of PAIN and its relation to their menstrual cycle and intercourse and to keep a diary of their symptoms.,PAIN,ENDOMETRIOSIS,TWrex-cause
721702166,5/14/2015 18:25:04,1636448609,5/14/2015 18:24:46,False,neodev,1.0,31743852,GBR,G5,Margate,85.210.120.188,JC VIRUS causes PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,0,73,,41,81,causes,0.997054485501582,810459-FS1-4,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY and other disorders caused by JC VIRUS: clinical features and pathogenesis.,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,JC VIRUS,TWrex-cause
721702166,5/14/2015 18:35:49,1636455006,5/14/2015 18:35:21,False,prodege,0.5306,1878608,CAN,BC,Vancouver,216.251.132.22,JC VIRUS causes PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,0,73,,41,81,causes,0.997054485501582,810459-FS1-4,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY and other disorders caused by JC VIRUS: clinical features and pathogenesis.,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,JC VIRUS,TWrex-cause
721702166,5/14/2015 18:36:11,1636455202,5/14/2015 18:35:59,False,elite,0.6153,31883685,GBR,H2,Accrington,80.47.186.28,JC VIRUS causes PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,0,73,,41,81,causes,0.997054485501582,810459-FS1-4,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY and other disorders caused by JC VIRUS: clinical features and pathogenesis.,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,JC VIRUS,TWrex-cause
721702166,5/14/2015 18:36:34,1636455335,5/14/2015 18:36:18,False,clixsense,0.6639,22751911,NLD,04,Groningen,195.241.153.97,JC VIRUS causes PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,0,73,,41,81,causes,0.997054485501582,810459-FS1-4,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY and other disorders caused by JC VIRUS: clinical features and pathogenesis.,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,JC VIRUS,TWrex-cause
721702166,5/14/2015 18:37:53,1636456020,5/14/2015 18:37:38,False,points4rewards,0.6131,20113482,USA,OR,Portland,67.213.218.72,JC VIRUS causes PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,0,73,,41,81,causes,0.997054485501582,810459-FS1-4,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY and other disorders caused by JC VIRUS: clinical features and pathogenesis.,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,JC VIRUS,TWrex-cause
721702166,5/14/2015 18:38:05,1636456120,5/14/2015 18:37:49,False,instagc,0.5179,13581319,USA,IL,Mount Vernon,66.232.166.86,JC VIRUS causes PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,0,73,,41,81,causes,0.997054485501582,810459-FS1-4,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY and other disorders caused by JC VIRUS: clinical features and pathogenesis.,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,JC VIRUS,TWrex-cause
721702166,5/14/2015 18:38:24,1636456339,5/14/2015 18:38:10,False,pocketmoneygpt,0.6183,28884030,USA,WI,Minocqua,75.143.134.247,JC VIRUS causes PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,0,73,,41,81,causes,0.997054485501582,810459-FS1-4,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY and other disorders caused by JC VIRUS: clinical features and pathogenesis.,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,JC VIRUS,TWrex-cause
721702167,5/14/2015 19:02:13,1636466251,5/14/2015 19:01:45,False,clixsense,0.7083,28351359,GBR,F6,Romford,80.43.183.92,no_relation,3,50,,24,67,causes,0.7548294124240691,812483-FS1-4,"If MALIGNANT HYPERTHERMIA occurs, discontinue all ANESTHETIC AGENTS and initiate IV dantrolene therapy  a   in conjunction with supportive measures (e.g., administering oxygen, treating metabolic acidosis, instituting cooling procedures); maintain urinary output and monitor serum electrolytes.",MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS,TWrex-cause
721702167,5/14/2015 19:31:05,1636494641,5/14/2015 19:30:32,False,clixsense,0.6607,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,3,50,,24,67,causes,0.7548294124240691,812483-FS1-4,"If MALIGNANT HYPERTHERMIA occurs, discontinue all ANESTHETIC AGENTS and initiate IV dantrolene therapy  a   in conjunction with supportive measures (e.g., administering oxygen, treating metabolic acidosis, instituting cooling procedures); maintain urinary output and monitor serum electrolytes.",MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS,TWrex-cause
721702167,5/14/2015 19:38:09,1636500002,5/14/2015 19:37:38,False,instagc,0.7986,22535866,GBR,M2,Solihull,80.195.193.86,ANESTHETIC AGENTS causes MALIGNANT HYPERTHERMIA,3,50,,24,67,causes,0.7548294124240691,812483-FS1-4,"If MALIGNANT HYPERTHERMIA occurs, discontinue all ANESTHETIC AGENTS and initiate IV dantrolene therapy  a   in conjunction with supportive measures (e.g., administering oxygen, treating metabolic acidosis, instituting cooling procedures); maintain urinary output and monitor serum electrolytes.",MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS,TWrex-cause
721702167,5/14/2015 20:04:50,1636510777,5/14/2015 20:04:13,False,clixsense,0.7579,11106820,USA,MA,Taunton,173.48.52.95,ANESTHETIC AGENTS causes MALIGNANT HYPERTHERMIA,3,50,,24,67,causes,0.7548294124240691,812483-FS1-4,"If MALIGNANT HYPERTHERMIA occurs, discontinue all ANESTHETIC AGENTS and initiate IV dantrolene therapy  a   in conjunction with supportive measures (e.g., administering oxygen, treating metabolic acidosis, instituting cooling procedures); maintain urinary output and monitor serum electrolytes.",MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS,TWrex-cause
721702167,5/14/2015 20:15:07,1636518842,5/14/2015 20:14:42,False,clixsense,0.8373,30313955,GBR,K5,Poole,2.30.145.202,ANESTHETIC AGENTS causes MALIGNANT HYPERTHERMIA,3,50,,24,67,causes,0.7548294124240691,812483-FS1-4,"If MALIGNANT HYPERTHERMIA occurs, discontinue all ANESTHETIC AGENTS and initiate IV dantrolene therapy  a   in conjunction with supportive measures (e.g., administering oxygen, treating metabolic acidosis, instituting cooling procedures); maintain urinary output and monitor serum electrolytes.",MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS,TWrex-cause
721702167,5/14/2015 20:15:09,1636518859,5/14/2015 20:14:25,False,neodev,0.7333,31091664,USA,CA,Sunnyvale,199.168.148.136,ANESTHETIC AGENTS causes MALIGNANT HYPERTHERMIA,3,50,,24,67,causes,0.7548294124240691,812483-FS1-4,"If MALIGNANT HYPERTHERMIA occurs, discontinue all ANESTHETIC AGENTS and initiate IV dantrolene therapy  a   in conjunction with supportive measures (e.g., administering oxygen, treating metabolic acidosis, instituting cooling procedures); maintain urinary output and monitor serum electrolytes.",MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS,TWrex-cause
721702167,5/14/2015 20:26:06,1636529790,5/14/2015 20:25:40,False,elite,0.5524,30064988,GBR,H3,Leeds,92.22.198.222,no_relation,3,50,,24,67,causes,0.7548294124240691,812483-FS1-4,"If MALIGNANT HYPERTHERMIA occurs, discontinue all ANESTHETIC AGENTS and initiate IV dantrolene therapy  a   in conjunction with supportive measures (e.g., administering oxygen, treating metabolic acidosis, instituting cooling procedures); maintain urinary output and monitor serum electrolytes.",MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS,TWrex-cause
721702168,5/14/2015 19:38:23,1636500123,5/14/2015 19:38:10,False,instagc,0.7986,22535866,GBR,M2,Solihull,80.195.193.86,INFECTIOUS MONONUCLEOSIS causes LYMPHADENOPATHY,8,40,,22,64,causes,0.9941348467724341,813256-FS1-4,"Similar LYMPHADENOPATHY can result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, non Hodgkin lymphoma, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,TWrex-cause
721702168,5/14/2015 20:05:24,1636511234,5/14/2015 20:04:52,False,clixsense,0.7579,11106820,USA,MA,Taunton,173.48.52.95,INFECTIOUS MONONUCLEOSIS causes LYMPHADENOPATHY,8,40,,22,64,causes,0.9941348467724341,813256-FS1-4,"Similar LYMPHADENOPATHY can result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, non Hodgkin lymphoma, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,TWrex-cause
721702168,5/14/2015 20:15:29,1636519249,5/14/2015 20:15:07,False,clixsense,0.8373,30313955,GBR,K5,Poole,2.30.145.202,INFECTIOUS MONONUCLEOSIS causes LYMPHADENOPATHY,8,40,,22,64,causes,0.9941348467724341,813256-FS1-4,"Similar LYMPHADENOPATHY can result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, non Hodgkin lymphoma, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,TWrex-cause
721702168,5/14/2015 20:15:30,1636519293,5/14/2015 20:15:10,False,neodev,0.7333,31091664,USA,CA,Sunnyvale,199.168.148.136,INFECTIOUS MONONUCLEOSIS causes LYMPHADENOPATHY,8,40,,22,64,causes,0.9941348467724341,813256-FS1-4,"Similar LYMPHADENOPATHY can result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, non Hodgkin lymphoma, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,TWrex-cause
721702168,5/14/2015 20:26:19,1636530129,5/14/2015 20:26:08,False,elite,0.5524,30064988,GBR,H3,Leeds,92.22.198.222,INFECTIOUS MONONUCLEOSIS causes LYMPHADENOPATHY,8,40,,22,64,causes,0.9941348467724341,813256-FS1-4,"Similar LYMPHADENOPATHY can result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, non Hodgkin lymphoma, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,TWrex-cause
721702168,5/14/2015 20:32:39,1636536828,5/14/2015 20:32:18,False,fusioncash,0.7286,5620345,USA,HI,Honolulu,132.160.235.13,INFECTIOUS MONONUCLEOSIS causes LYMPHADENOPATHY,8,40,,22,64,causes,0.9941348467724341,813256-FS1-4,"Similar LYMPHADENOPATHY can result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, non Hodgkin lymphoma, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,TWrex-cause
721702168,5/14/2015 20:34:24,1636538687,5/14/2015 20:34:09,False,instagc,0.6339,20845955,GBR,I2,Manchester,90.214.24.62,INFECTIOUS MONONUCLEOSIS causes LYMPHADENOPATHY,8,40,,22,64,causes,0.9941348467724341,813256-FS1-4,"Similar LYMPHADENOPATHY can result from INFECTIOUS MONONUCLEOSIS toxoplasmosis, cytomegalovirus, non Hodgkin lymphoma, or leukemia.",LYMPHADENOPATHY,INFECTIOUS MONONUCLEOSIS,TWrex-cause
721702176,5/14/2015 18:39:10,1636456584,5/14/2015 18:38:54,False,pocketmoneygpt,0.6183,28884030,USA,WI,Minocqua,75.143.134.247,ENTEROTOXIGENIC  ESCHERICHIA COLI causes TRAVELERS' DIARRHEA,144,186,,162,219,causes,0.936382183834624,810943-FS1-4,"302 ,   321  Data are limited regarding safety of repeated use of co trimoxazole in pediatric patients   186 ,   a  GI Infections  Treatment of TRAVELERS' DIARRHEA caused by susceptible ENTEROTOXIGENIC  ESCHERICHIA COLI",TRAVELERS' DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI,TWrex-cause
721702176,5/14/2015 18:39:52,1636456903,5/14/2015 18:39:34,False,clixsense,0.5111,6362702,GBR,B7,Bristol,90.222.95.91,TRAVELERS' DIARRHEA causes ENTEROTOXIGENIC  ESCHERICHIA COLI,144,186,,162,219,causes,0.936382183834624,810943-FS1-4,"302 ,   321  Data are limited regarding safety of repeated use of co trimoxazole in pediatric patients   186 ,   a  GI Infections  Treatment of TRAVELERS' DIARRHEA caused by susceptible ENTEROTOXIGENIC  ESCHERICHIA COLI",TRAVELERS' DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI,TWrex-cause
721702176,5/14/2015 18:40:04,1636456993,5/14/2015 18:39:22,False,prodege,0.5833,21417560,GBR,C3,Cambridge,151.225.116.143,ENTEROTOXIGENIC  ESCHERICHIA COLI causes TRAVELERS' DIARRHEA,144,186,,162,219,causes,0.936382183834624,810943-FS1-4,"302 ,   321  Data are limited regarding safety of repeated use of co trimoxazole in pediatric patients   186 ,   a  GI Infections  Treatment of TRAVELERS' DIARRHEA caused by susceptible ENTEROTOXIGENIC  ESCHERICHIA COLI",TRAVELERS' DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI,TWrex-cause
721702176,5/14/2015 18:40:07,1636457005,5/14/2015 18:39:48,False,prodege,0.5613,3587109,CAN,NS,Sydney,142.177.43.253,ENTEROTOXIGENIC  ESCHERICHIA COLI causes TRAVELERS' DIARRHEA,144,186,,162,219,causes,0.936382183834624,810943-FS1-4,"302 ,   321  Data are limited regarding safety of repeated use of co trimoxazole in pediatric patients   186 ,   a  GI Infections  Treatment of TRAVELERS' DIARRHEA caused by susceptible ENTEROTOXIGENIC  ESCHERICHIA COLI",TRAVELERS' DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI,TWrex-cause
721702176,5/14/2015 18:40:30,1636457267,5/14/2015 18:40:02,False,neodev,0.5972,18881135,CAN,ON,Ajax,99.243.87.224,ENTEROTOXIGENIC  ESCHERICHIA COLI causes TRAVELERS' DIARRHEA,144,186,,162,219,causes,0.936382183834624,810943-FS1-4,"302 ,   321  Data are limited regarding safety of repeated use of co trimoxazole in pediatric patients   186 ,   a  GI Infections  Treatment of TRAVELERS' DIARRHEA caused by susceptible ENTEROTOXIGENIC  ESCHERICHIA COLI",TRAVELERS' DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI,TWrex-cause
721702176,5/14/2015 18:45:20,1636459138,5/14/2015 18:44:45,False,neodev,0.6478,31706957,NLD,07,Amsterdam,145.100.72.165,ENTEROTOXIGENIC  ESCHERICHIA COLI causes TRAVELERS' DIARRHEA,144,186,,162,219,causes,0.936382183834624,810943-FS1-4,"302 ,   321  Data are limited regarding safety of repeated use of co trimoxazole in pediatric patients   186 ,   a  GI Infections  Treatment of TRAVELERS' DIARRHEA caused by susceptible ENTEROTOXIGENIC  ESCHERICHIA COLI",TRAVELERS' DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI,TWrex-cause
721702176,5/14/2015 18:52:59,1636462417,5/14/2015 18:52:40,False,instagc,0.6881,30326470,USA,CA,Santee,99.44.37.73,ENTEROTOXIGENIC  ESCHERICHIA COLI causes TRAVELERS' DIARRHEA,144,186,,162,219,causes,0.936382183834624,810943-FS1-4,"302 ,   321  Data are limited regarding safety of repeated use of co trimoxazole in pediatric patients   186 ,   a  GI Infections  Treatment of TRAVELERS' DIARRHEA caused by susceptible ENTEROTOXIGENIC  ESCHERICHIA COLI",TRAVELERS' DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI,TWrex-cause
723907890,5/20/2015 12:09:21,1639642517,5/20/2015 12:08:32,False,prodege,0.6048,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,60,145,,75,147,causes,0.9918365981341758,813061-FS1-4,"In inflammatory pain attributable to synovitis or bursitis, NEUROPATHIC PAIN caused by direct nerve injury, and the central pain augmentation of FM and other CSSs, pain amplification is associated with lower pain threshold.",NEUROPATHIC PAIN,FM,TWrex-cause
723907890,5/20/2015 12:13:09,1639643971,5/20/2015 12:12:54,False,clixsense,0.6167,6352682,GBR,H9,London,2.122.19.138,NEUROPATHIC PAIN causes FM,60,145,,75,147,causes,0.9918365981341758,813061-FS1-4,"In inflammatory pain attributable to synovitis or bursitis, NEUROPATHIC PAIN caused by direct nerve injury, and the central pain augmentation of FM and other CSSs, pain amplification is associated with lower pain threshold.",NEUROPATHIC PAIN,FM,TWrex-cause
723907890,5/20/2015 12:20:22,1639646613,5/20/2015 12:20:05,False,instagc,0.7014,13581319,USA,IL,Mount Vernon,66.232.166.86,FM causes NEUROPATHIC PAIN,60,145,,75,147,causes,0.9918365981341758,813061-FS1-4,"In inflammatory pain attributable to synovitis or bursitis, NEUROPATHIC PAIN caused by direct nerve injury, and the central pain augmentation of FM and other CSSs, pain amplification is associated with lower pain threshold.",NEUROPATHIC PAIN,FM,TWrex-cause
723907890,5/20/2015 12:30:02,1639650229,5/20/2015 12:29:34,False,prodege,0.6238,27934334,GBR,D2,Derby,86.162.35.12,no_relation,60,145,,75,147,causes,0.9918365981341758,813061-FS1-4,"In inflammatory pain attributable to synovitis or bursitis, NEUROPATHIC PAIN caused by direct nerve injury, and the central pain augmentation of FM and other CSSs, pain amplification is associated with lower pain threshold.",NEUROPATHIC PAIN,FM,TWrex-cause
723907890,5/20/2015 12:30:26,1639650323,5/20/2015 12:29:45,False,neodev,0.6827,14096345,NLD,03,Eibergen,77.174.124.109,FM causes NEUROPATHIC PAIN,60,145,,75,147,causes,0.9918365981341758,813061-FS1-4,"In inflammatory pain attributable to synovitis or bursitis, NEUROPATHIC PAIN caused by direct nerve injury, and the central pain augmentation of FM and other CSSs, pain amplification is associated with lower pain threshold.",NEUROPATHIC PAIN,FM,TWrex-cause
723907890,5/20/2015 12:31:46,1639650827,5/20/2015 12:31:17,False,neodev,0.7972,12115558,USA,OH,Twinsburg,98.27.164.131,no_relation,60,145,,75,147,causes,0.9918365981341758,813061-FS1-4,"In inflammatory pain attributable to synovitis or bursitis, NEUROPATHIC PAIN caused by direct nerve injury, and the central pain augmentation of FM and other CSSs, pain amplification is associated with lower pain threshold.",NEUROPATHIC PAIN,FM,TWrex-cause
723907890,5/20/2015 12:34:38,1639651891,5/20/2015 12:34:12,False,neodev,0.7587,31326282,NLD,,,82.169.243.65,no_relation,60,145,,75,147,causes,0.9918365981341758,813061-FS1-4,"In inflammatory pain attributable to synovitis or bursitis, NEUROPATHIC PAIN caused by direct nerve injury, and the central pain augmentation of FM and other CSSs, pain amplification is associated with lower pain threshold.",NEUROPATHIC PAIN,FM,TWrex-cause
723907891,5/20/2015 12:52:53,1639658445,5/20/2015 12:52:38,False,instagc,0.9333,31184650,USA,IA,Mason City,173.26.27.82,no_relation,27,51,,30,60,causes,0.363803437554499,802650-FS1-4,"Conditions that affect the LUNG diffusely, such as EMPHYSEMA and pulmonary fibrosis, decrease both DLCO and alveolar ventilation (V A.",LUNG,EMPHYSEMA,TWrex-cause
723907891,5/20/2015 13:11:35,1639665579,5/20/2015 13:10:58,False,clixsense,0.8105,11106820,USA,MA,Taunton,173.48.52.95,EMPHYSEMA causes LUNG,27,51,,30,60,causes,0.363803437554499,802650-FS1-4,"Conditions that affect the LUNG diffusely, such as EMPHYSEMA and pulmonary fibrosis, decrease both DLCO and alveolar ventilation (V A.",LUNG,EMPHYSEMA,TWrex-cause
723907891,5/20/2015 13:12:04,1639665729,5/20/2015 13:11:57,False,elite,0.5848,31913360,USA,DE,,108.59.8.217,EMPHYSEMA causes LUNG,27,51,,30,60,causes,0.363803437554499,802650-FS1-4,"Conditions that affect the LUNG diffusely, such as EMPHYSEMA and pulmonary fibrosis, decrease both DLCO and alveolar ventilation (V A.",LUNG,EMPHYSEMA,TWrex-cause
723907891,5/20/2015 13:38:02,1639670345,5/20/2015 13:37:44,False,clixsense,0.5794,22751911,NLD,04,Groningen,195.241.153.97,no_relation,27,51,,30,60,causes,0.363803437554499,802650-FS1-4,"Conditions that affect the LUNG diffusely, such as EMPHYSEMA and pulmonary fibrosis, decrease both DLCO and alveolar ventilation (V A.",LUNG,EMPHYSEMA,TWrex-cause
723907891,5/20/2015 13:41:51,1639672244,5/20/2015 13:41:21,False,gifthunterclub,0.6786,30901412,GBR,G5,Margate,85.210.124.18,no_relation,27,51,,30,60,causes,0.363803437554499,802650-FS1-4,"Conditions that affect the LUNG diffusely, such as EMPHYSEMA and pulmonary fibrosis, decrease both DLCO and alveolar ventilation (V A.",LUNG,EMPHYSEMA,TWrex-cause
723907891,5/20/2015 13:44:22,1639673026,5/20/2015 13:43:49,False,neodev,0.6476,18881135,CAN,ON,Ajax,99.243.87.224,no_relation,27,51,,30,60,causes,0.363803437554499,802650-FS1-4,"Conditions that affect the LUNG diffusely, such as EMPHYSEMA and pulmonary fibrosis, decrease both DLCO and alveolar ventilation (V A.",LUNG,EMPHYSEMA,TWrex-cause
723907891,5/20/2015 13:53:02,1639675716,5/20/2015 13:52:14,False,sharecashgpt,0.4429,28627999,CAN,ON,Sudbury,66.103.55.12,no_relation,27,51,,30,60,causes,0.363803437554499,802650-FS1-4,"Conditions that affect the LUNG diffusely, such as EMPHYSEMA and pulmonary fibrosis, decrease both DLCO and alveolar ventilation (V A.",LUNG,EMPHYSEMA,TWrex-cause
723907896,5/20/2015 12:45:08,1639655508,5/20/2015 12:44:40,False,points4rewards,0.7821,28755767,USA,VA,Chester,68.57.118.32,TRIGEMINAL NEURALGIA causes PAIN,43,60,,46,80,causes,0.801783725737273,814679-FS1-4,"Intermittent unilateral facial numbness or PAIN (resembling TRIGEMINAL NEURALGIA palsy, or spasm may occur.",PAIN,TRIGEMINAL NEURALGIA,TWrex-cause
723907896,5/20/2015 12:52:37,1639658331,5/20/2015 12:52:04,False,instagc,0.9333,31184650,USA,IA,Mason City,173.26.27.82,TRIGEMINAL NEURALGIA causes PAIN,43,60,,46,80,causes,0.801783725737273,814679-FS1-4,"Intermittent unilateral facial numbness or PAIN (resembling TRIGEMINAL NEURALGIA palsy, or spasm may occur.",PAIN,TRIGEMINAL NEURALGIA,TWrex-cause
723907896,5/20/2015 13:10:58,1639665451,5/20/2015 13:10:40,False,clixsense,0.8105,11106820,USA,MA,Taunton,173.48.52.95,TRIGEMINAL NEURALGIA causes PAIN,43,60,,46,80,causes,0.801783725737273,814679-FS1-4,"Intermittent unilateral facial numbness or PAIN (resembling TRIGEMINAL NEURALGIA palsy, or spasm may occur.",PAIN,TRIGEMINAL NEURALGIA,TWrex-cause
723907896,5/20/2015 13:11:55,1639665680,5/20/2015 13:11:39,False,elite,0.5848,31913360,USA,DE,,108.59.8.217,TRIGEMINAL NEURALGIA causes PAIN,43,60,,46,80,causes,0.801783725737273,814679-FS1-4,"Intermittent unilateral facial numbness or PAIN (resembling TRIGEMINAL NEURALGIA palsy, or spasm may occur.",PAIN,TRIGEMINAL NEURALGIA,TWrex-cause
723907896,5/20/2015 13:37:43,1639670188,5/20/2015 13:37:25,False,clixsense,0.5794,22751911,NLD,04,Groningen,195.241.153.97,no_relation,43,60,,46,80,causes,0.801783725737273,814679-FS1-4,"Intermittent unilateral facial numbness or PAIN (resembling TRIGEMINAL NEURALGIA palsy, or spasm may occur.",PAIN,TRIGEMINAL NEURALGIA,TWrex-cause
723907896,5/20/2015 13:41:20,1639672021,5/20/2015 13:40:59,False,gifthunterclub,0.6786,30901412,GBR,G5,Margate,85.210.124.18,no_relation,43,60,,46,80,causes,0.801783725737273,814679-FS1-4,"Intermittent unilateral facial numbness or PAIN (resembling TRIGEMINAL NEURALGIA palsy, or spasm may occur.",PAIN,TRIGEMINAL NEURALGIA,TWrex-cause
723907896,5/20/2015 13:43:47,1639672907,5/20/2015 13:42:57,False,neodev,0.6476,18881135,CAN,ON,Ajax,99.243.87.224,no_relation,43,60,,46,80,causes,0.801783725737273,814679-FS1-4,"Intermittent unilateral facial numbness or PAIN (resembling TRIGEMINAL NEURALGIA palsy, or spasm may occur.",PAIN,TRIGEMINAL NEURALGIA,TWrex-cause
723907898,5/20/2015 12:45:08,1639655507,5/20/2015 12:44:40,False,points4rewards,0.7821,28755767,USA,VA,Chester,68.57.118.32,ECLAMPSIA causes GENERALIZED SEIZURES,23,2,,42,11,causes,0.964901281354015,814519-FS1-4, ECLAMPSIA defined by GENERALIZED SEIZURES may first occur following delivery simulating TTP ( 71.,GENERALIZED SEIZURES,ECLAMPSIA,TWrex-cause
723907898,5/20/2015 12:52:37,1639658339,5/20/2015 12:52:04,False,instagc,0.9333,31184650,USA,IA,Mason City,173.26.27.82,ECLAMPSIA causes GENERALIZED SEIZURES,23,2,,42,11,causes,0.964901281354015,814519-FS1-4, ECLAMPSIA defined by GENERALIZED SEIZURES may first occur following delivery simulating TTP ( 71.,GENERALIZED SEIZURES,ECLAMPSIA,TWrex-cause
723907898,5/20/2015 13:10:58,1639665452,5/20/2015 13:10:40,False,clixsense,0.8105,11106820,USA,MA,Taunton,173.48.52.95,ECLAMPSIA causes GENERALIZED SEIZURES,23,2,,42,11,causes,0.964901281354015,814519-FS1-4, ECLAMPSIA defined by GENERALIZED SEIZURES may first occur following delivery simulating TTP ( 71.,GENERALIZED SEIZURES,ECLAMPSIA,TWrex-cause
723907898,5/20/2015 13:11:55,1639665681,5/20/2015 13:11:39,False,elite,0.5848,31913360,USA,DE,,108.59.8.217,GENERALIZED SEIZURES causes ECLAMPSIA,23,2,,42,11,causes,0.964901281354015,814519-FS1-4, ECLAMPSIA defined by GENERALIZED SEIZURES may first occur following delivery simulating TTP ( 71.,GENERALIZED SEIZURES,ECLAMPSIA,TWrex-cause
723907898,5/20/2015 13:37:43,1639670199,5/20/2015 13:37:25,False,clixsense,0.5794,22751911,NLD,04,Groningen,195.241.153.97,no_relation,23,2,,42,11,causes,0.964901281354015,814519-FS1-4, ECLAMPSIA defined by GENERALIZED SEIZURES may first occur following delivery simulating TTP ( 71.,GENERALIZED SEIZURES,ECLAMPSIA,TWrex-cause
723907898,5/20/2015 13:41:20,1639672018,5/20/2015 13:40:59,False,gifthunterclub,0.6786,30901412,GBR,G5,Margate,85.210.124.18,no_relation,23,2,,42,11,causes,0.964901281354015,814519-FS1-4, ECLAMPSIA defined by GENERALIZED SEIZURES may first occur following delivery simulating TTP ( 71.,GENERALIZED SEIZURES,ECLAMPSIA,TWrex-cause
723907898,5/20/2015 13:43:47,1639672905,5/20/2015 13:42:57,False,neodev,0.6476,18881135,CAN,ON,Ajax,99.243.87.224,ECLAMPSIA causes GENERALIZED SEIZURES,23,2,,42,11,causes,0.964901281354015,814519-FS1-4, ECLAMPSIA defined by GENERALIZED SEIZURES may first occur following delivery simulating TTP ( 71.,GENERALIZED SEIZURES,ECLAMPSIA,TWrex-cause
723907905,5/20/2015 12:38:26,1639653098,5/20/2015 12:38:11,False,meprizescf,0.8204,28483210,USA,WI,Minocqua,75.143.134.247,BWS[ causes NEONATAL HYPOGLYCEMIA,0,106,,20,110,causes,0.847998304005088,814920-FS1-4,"NEONATAL HYPOGLYCEMIA low blood glucose in the first month of life, occurs in about half of children with BWS[9] Most of these hypoglycemic newborns are asymptomatic and have a normal blood glucose level within days.",NEONATAL HYPOGLYCEMIA,BWS[,TWrex-cause
723907905,5/20/2015 12:44:39,1639655382,5/20/2015 12:44:15,False,points4rewards,0.7821,28755767,USA,VA,Chester,68.57.118.32,BWS[ causes NEONATAL HYPOGLYCEMIA,0,106,,20,110,causes,0.847998304005088,814920-FS1-4,"NEONATAL HYPOGLYCEMIA low blood glucose in the first month of life, occurs in about half of children with BWS[9] Most of these hypoglycemic newborns are asymptomatic and have a normal blood glucose level within days.",NEONATAL HYPOGLYCEMIA,BWS[,TWrex-cause
723907905,5/20/2015 12:52:03,1639658101,5/20/2015 12:51:51,False,instagc,0.9333,31184650,USA,IA,Mason City,173.26.27.82,BWS[ causes NEONATAL HYPOGLYCEMIA,0,106,,20,110,causes,0.847998304005088,814920-FS1-4,"NEONATAL HYPOGLYCEMIA low blood glucose in the first month of life, occurs in about half of children with BWS[9] Most of these hypoglycemic newborns are asymptomatic and have a normal blood glucose level within days.",NEONATAL HYPOGLYCEMIA,BWS[,TWrex-cause
723907905,5/20/2015 13:10:39,1639665376,5/20/2015 13:10:13,False,clixsense,0.8105,11106820,USA,MA,Taunton,173.48.52.95,BWS[ causes NEONATAL HYPOGLYCEMIA,0,106,,20,110,causes,0.847998304005088,814920-FS1-4,"NEONATAL HYPOGLYCEMIA low blood glucose in the first month of life, occurs in about half of children with BWS[9] Most of these hypoglycemic newborns are asymptomatic and have a normal blood glucose level within days.",NEONATAL HYPOGLYCEMIA,BWS[,TWrex-cause
723907905,5/20/2015 13:11:37,1639665596,5/20/2015 13:11:27,False,elite,0.5848,31913360,USA,DE,,108.59.8.217,BWS[ causes NEONATAL HYPOGLYCEMIA,0,106,,20,110,causes,0.847998304005088,814920-FS1-4,"NEONATAL HYPOGLYCEMIA low blood glucose in the first month of life, occurs in about half of children with BWS[9] Most of these hypoglycemic newborns are asymptomatic and have a normal blood glucose level within days.",NEONATAL HYPOGLYCEMIA,BWS[,TWrex-cause
723907905,5/20/2015 13:37:23,1639670091,5/20/2015 13:37:08,False,clixsense,0.5794,22751911,NLD,04,Groningen,195.241.153.97,no_relation,0,106,,20,110,causes,0.847998304005088,814920-FS1-4,"NEONATAL HYPOGLYCEMIA low blood glucose in the first month of life, occurs in about half of children with BWS[9] Most of these hypoglycemic newborns are asymptomatic and have a normal blood glucose level within days.",NEONATAL HYPOGLYCEMIA,BWS[,TWrex-cause
723907905,5/20/2015 13:40:57,1639671893,5/20/2015 13:40:34,False,gifthunterclub,0.6786,30901412,GBR,G5,Margate,85.210.124.18,BWS[ causes NEONATAL HYPOGLYCEMIA,0,106,,20,110,causes,0.847998304005088,814920-FS1-4,"NEONATAL HYPOGLYCEMIA low blood glucose in the first month of life, occurs in about half of children with BWS[9] Most of these hypoglycemic newborns are asymptomatic and have a normal blood glucose level within days.",NEONATAL HYPOGLYCEMIA,BWS[,TWrex-cause
723907908,5/20/2015 12:08:31,1639642234,5/20/2015 12:07:40,False,prodege,0.6048,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,0,48,,20,61,causes,0.913811548620257,811615-FS1-4,"CONGENITAL INFECTIONS that can cause MR include RUBELLA VIRUS cytomegalovirus,  Toxoplasma gondii ,  Treponema pallidum , and HIV.",CONGENITAL INFECTIONS,RUBELLA VIRUS,TWrex-cause
723907908,5/20/2015 12:12:53,1639643905,5/20/2015 12:12:41,False,clixsense,0.6167,6352682,GBR,H9,London,2.122.19.138,RUBELLA VIRUS causes CONGENITAL INFECTIONS,0,48,,20,61,causes,0.913811548620257,811615-FS1-4,"CONGENITAL INFECTIONS that can cause MR include RUBELLA VIRUS cytomegalovirus,  Toxoplasma gondii ,  Treponema pallidum , and HIV.",CONGENITAL INFECTIONS,RUBELLA VIRUS,TWrex-cause
723907908,5/20/2015 12:20:04,1639646465,5/20/2015 12:19:40,False,instagc,0.7014,13581319,USA,IL,Mount Vernon,66.232.166.86,RUBELLA VIRUS causes CONGENITAL INFECTIONS,0,48,,20,61,causes,0.913811548620257,811615-FS1-4,"CONGENITAL INFECTIONS that can cause MR include RUBELLA VIRUS cytomegalovirus,  Toxoplasma gondii ,  Treponema pallidum , and HIV.",CONGENITAL INFECTIONS,RUBELLA VIRUS,TWrex-cause
723907908,5/20/2015 12:29:33,1639650040,5/20/2015 12:29:23,False,prodege,0.6238,27934334,GBR,D2,Derby,86.162.35.12,RUBELLA VIRUS causes CONGENITAL INFECTIONS,0,48,,20,61,causes,0.913811548620257,811615-FS1-4,"CONGENITAL INFECTIONS that can cause MR include RUBELLA VIRUS cytomegalovirus,  Toxoplasma gondii ,  Treponema pallidum , and HIV.",CONGENITAL INFECTIONS,RUBELLA VIRUS,TWrex-cause
723907908,5/20/2015 12:29:44,1639650135,5/20/2015 12:29:21,False,neodev,0.6827,14096345,NLD,03,Eibergen,77.174.124.109,CONGENITAL INFECTIONS causes RUBELLA VIRUS,0,48,,20,61,causes,0.913811548620257,811615-FS1-4,"CONGENITAL INFECTIONS that can cause MR include RUBELLA VIRUS cytomegalovirus,  Toxoplasma gondii ,  Treponema pallidum , and HIV.",CONGENITAL INFECTIONS,RUBELLA VIRUS,TWrex-cause
723907908,5/20/2015 12:31:17,1639650695,5/20/2015 12:30:28,False,neodev,0.7972,12115558,USA,OH,Twinsburg,98.27.164.131,no_relation,0,48,,20,61,causes,0.913811548620257,811615-FS1-4,"CONGENITAL INFECTIONS that can cause MR include RUBELLA VIRUS cytomegalovirus,  Toxoplasma gondii ,  Treponema pallidum , and HIV.",CONGENITAL INFECTIONS,RUBELLA VIRUS,TWrex-cause
723907908,5/20/2015 12:34:11,1639651708,5/20/2015 12:33:43,False,neodev,0.7587,31326282,NLD,,,82.169.243.65,RUBELLA VIRUS causes CONGENITAL INFECTIONS,0,48,,20,61,causes,0.913811548620257,811615-FS1-4,"CONGENITAL INFECTIONS that can cause MR include RUBELLA VIRUS cytomegalovirus,  Toxoplasma gondii ,  Treponema pallidum , and HIV.",CONGENITAL INFECTIONS,RUBELLA VIRUS,TWrex-cause
723907915,5/20/2015 13:55:29,1639676459,5/20/2015 13:55:07,False,sharecashgpt,0.4429,28627999,CAN,ON,Sudbury,66.103.55.12,PROCAINAMIDE causes SYSTEMIC LUPUS ERYTHEMATOSUS,226,276,,253,288,causes,0.50709255283711,803248-FS1-4,"ETIOLOGY: Many diseases and conditions can inflame the membranous covering of the heart, including infections (bacterial, tubercular, viral, fungal); collagen vascular diseases (e.g., rheumatic fever, rheumatoid arthritis, or SYSTEMIC LUPUS ERYTHEMATOSUS; drugs (hydralazine, PROCAINAMIDE isoniazid, minoxidil); myocardial infarction; cancer; renal failure; cardiac surgery; or trauma.",SYSTEMIC LUPUS ERYTHEMATOSUS,PROCAINAMIDE,TWrex-cause
723907915,5/20/2015 13:58:07,1639677369,5/20/2015 13:57:53,False,clixsense,0.7448,27754226,GBR,O3,South Ockendon,92.232.236.243,no_relation,226,276,,253,288,causes,0.50709255283711,803248-FS1-4,"ETIOLOGY: Many diseases and conditions can inflame the membranous covering of the heart, including infections (bacterial, tubercular, viral, fungal); collagen vascular diseases (e.g., rheumatic fever, rheumatoid arthritis, or SYSTEMIC LUPUS ERYTHEMATOSUS; drugs (hydralazine, PROCAINAMIDE isoniazid, minoxidil); myocardial infarction; cancer; renal failure; cardiac surgery; or trauma.",SYSTEMIC LUPUS ERYTHEMATOSUS,PROCAINAMIDE,TWrex-cause
723907915,5/20/2015 14:06:17,1639679303,5/20/2015 14:05:35,False,onestopgpt,0.7151,21275875,CAN,ON,Hamilton,24.36.121.10,no_relation,226,276,,253,288,causes,0.50709255283711,803248-FS1-4,"ETIOLOGY: Many diseases and conditions can inflame the membranous covering of the heart, including infections (bacterial, tubercular, viral, fungal); collagen vascular diseases (e.g., rheumatic fever, rheumatoid arthritis, or SYSTEMIC LUPUS ERYTHEMATOSUS; drugs (hydralazine, PROCAINAMIDE isoniazid, minoxidil); myocardial infarction; cancer; renal failure; cardiac surgery; or trauma.",SYSTEMIC LUPUS ERYTHEMATOSUS,PROCAINAMIDE,TWrex-cause
723907915,5/20/2015 14:06:47,1639679409,5/20/2015 14:06:14,False,prodege,0.6212,29849805,GBR,Z1,Swansea,82.1.37.235,no_relation,226,276,,253,288,causes,0.50709255283711,803248-FS1-4,"ETIOLOGY: Many diseases and conditions can inflame the membranous covering of the heart, including infections (bacterial, tubercular, viral, fungal); collagen vascular diseases (e.g., rheumatic fever, rheumatoid arthritis, or SYSTEMIC LUPUS ERYTHEMATOSUS; drugs (hydralazine, PROCAINAMIDE isoniazid, minoxidil); myocardial infarction; cancer; renal failure; cardiac surgery; or trauma.",SYSTEMIC LUPUS ERYTHEMATOSUS,PROCAINAMIDE,TWrex-cause
723907915,5/20/2015 14:12:21,1639681173,5/20/2015 14:12:06,False,neodev,0.3024,32456300,USA,IL,Chicago,69.175.85.2,PROCAINAMIDE causes SYSTEMIC LUPUS ERYTHEMATOSUS,226,276,,253,288,causes,0.50709255283711,803248-FS1-4,"ETIOLOGY: Many diseases and conditions can inflame the membranous covering of the heart, including infections (bacterial, tubercular, viral, fungal); collagen vascular diseases (e.g., rheumatic fever, rheumatoid arthritis, or SYSTEMIC LUPUS ERYTHEMATOSUS; drugs (hydralazine, PROCAINAMIDE isoniazid, minoxidil); myocardial infarction; cancer; renal failure; cardiac surgery; or trauma.",SYSTEMIC LUPUS ERYTHEMATOSUS,PROCAINAMIDE,TWrex-cause
723907915,5/20/2015 14:22:10,1639684391,5/20/2015 14:21:27,False,bitcoinget,0.637,30546513,GBR,G6,Hull,194.42.67.50,no_relation,226,276,,253,288,causes,0.50709255283711,803248-FS1-4,"ETIOLOGY: Many diseases and conditions can inflame the membranous covering of the heart, including infections (bacterial, tubercular, viral, fungal); collagen vascular diseases (e.g., rheumatic fever, rheumatoid arthritis, or SYSTEMIC LUPUS ERYTHEMATOSUS; drugs (hydralazine, PROCAINAMIDE isoniazid, minoxidil); myocardial infarction; cancer; renal failure; cardiac surgery; or trauma.",SYSTEMIC LUPUS ERYTHEMATOSUS,PROCAINAMIDE,TWrex-cause
723907915,5/20/2015 14:29:31,1639686672,5/20/2015 14:29:02,False,prodege,0.6048,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,226,276,,253,288,causes,0.50709255283711,803248-FS1-4,"ETIOLOGY: Many diseases and conditions can inflame the membranous covering of the heart, including infections (bacterial, tubercular, viral, fungal); collagen vascular diseases (e.g., rheumatic fever, rheumatoid arthritis, or SYSTEMIC LUPUS ERYTHEMATOSUS; drugs (hydralazine, PROCAINAMIDE isoniazid, minoxidil); myocardial infarction; cancer; renal failure; cardiac surgery; or trauma.",SYSTEMIC LUPUS ERYTHEMATOSUS,PROCAINAMIDE,TWrex-cause
723907926,5/20/2015 12:53:35,1639658762,5/20/2015 12:53:18,False,instagc,0.9333,31184650,USA,IA,Mason City,173.26.27.82,no_relation,108,123,,118,156,causes,0.8090398349558909,810069-FS1-4,"Although specific pathogens commonly produce characteristic clinical manifestations (eg, rhinovirus and the COMMON COLD or RESPIRATORY SYNCYTIAL VIRUS [RSV] and bronchiolitis), each is capable of causing any of the viral respiratory syndromes.",COMMON COLD,RESPIRATORY SYNCYTIAL VIRUS [RSV],TWrex-cause
723907926,5/20/2015 13:13:18,1639666115,5/20/2015 13:12:34,False,clixsense,0.8105,11106820,USA,MA,Taunton,173.48.52.95,COMMON COLD causes RESPIRATORY SYNCYTIAL VIRUS [RSV],108,123,,118,156,causes,0.8090398349558909,810069-FS1-4,"Although specific pathogens commonly produce characteristic clinical manifestations (eg, rhinovirus and the COMMON COLD or RESPIRATORY SYNCYTIAL VIRUS [RSV] and bronchiolitis), each is capable of causing any of the viral respiratory syndromes.",COMMON COLD,RESPIRATORY SYNCYTIAL VIRUS [RSV],TWrex-cause
723907926,5/20/2015 13:38:40,1639670621,5/20/2015 13:38:22,False,clixsense,0.5794,22751911,NLD,04,Groningen,195.241.153.97,no_relation,108,123,,118,156,causes,0.8090398349558909,810069-FS1-4,"Although specific pathogens commonly produce characteristic clinical manifestations (eg, rhinovirus and the COMMON COLD or RESPIRATORY SYNCYTIAL VIRUS [RSV] and bronchiolitis), each is capable of causing any of the viral respiratory syndromes.",COMMON COLD,RESPIRATORY SYNCYTIAL VIRUS [RSV],TWrex-cause
723907926,5/20/2015 13:42:49,1639672601,5/20/2015 13:42:35,False,gifthunterclub,0.6786,30901412,GBR,G5,Margate,85.210.124.18,COMMON COLD causes RESPIRATORY SYNCYTIAL VIRUS [RSV],108,123,,118,156,causes,0.8090398349558909,810069-FS1-4,"Although specific pathogens commonly produce characteristic clinical manifestations (eg, rhinovirus and the COMMON COLD or RESPIRATORY SYNCYTIAL VIRUS [RSV] and bronchiolitis), each is capable of causing any of the viral respiratory syndromes.",COMMON COLD,RESPIRATORY SYNCYTIAL VIRUS [RSV],TWrex-cause
723907926,5/20/2015 13:45:32,1639673424,5/20/2015 13:45:06,False,neodev,0.6476,18881135,CAN,ON,Ajax,99.243.87.224,no_relation,108,123,,118,156,causes,0.8090398349558909,810069-FS1-4,"Although specific pathogens commonly produce characteristic clinical manifestations (eg, rhinovirus and the COMMON COLD or RESPIRATORY SYNCYTIAL VIRUS [RSV] and bronchiolitis), each is capable of causing any of the viral respiratory syndromes.",COMMON COLD,RESPIRATORY SYNCYTIAL VIRUS [RSV],TWrex-cause
723907926,5/20/2015 13:54:06,1639675978,5/20/2015 13:53:46,False,sharecashgpt,0.4429,28627999,CAN,ON,Sudbury,66.103.55.12,RESPIRATORY SYNCYTIAL VIRUS [RSV] causes COMMON COLD,108,123,,118,156,causes,0.8090398349558909,810069-FS1-4,"Although specific pathogens commonly produce characteristic clinical manifestations (eg, rhinovirus and the COMMON COLD or RESPIRATORY SYNCYTIAL VIRUS [RSV] and bronchiolitis), each is capable of causing any of the viral respiratory syndromes.",COMMON COLD,RESPIRATORY SYNCYTIAL VIRUS [RSV],TWrex-cause
723907926,5/20/2015 13:57:26,1639677157,5/20/2015 13:57:13,False,clixsense,0.7448,27754226,GBR,O3,South Ockendon,92.232.236.243,no_relation,108,123,,118,156,causes,0.8090398349558909,810069-FS1-4,"Although specific pathogens commonly produce characteristic clinical manifestations (eg, rhinovirus and the COMMON COLD or RESPIRATORY SYNCYTIAL VIRUS [RSV] and bronchiolitis), each is capable of causing any of the viral respiratory syndromes.",COMMON COLD,RESPIRATORY SYNCYTIAL VIRUS [RSV],TWrex-cause
723907928,5/20/2015 12:53:16,1639658647,5/20/2015 12:52:54,False,instagc,0.9333,31184650,USA,IA,Mason City,173.26.27.82,URINARY TRACT FIBROSIS causes URINARY TRACT INFECTIONS,240,373,,261,397,causes,0.964901281354015,801998-FS1-4," Reproductive assistance for infertility in women  Dialysis for renal failure  Rationale:  Immune mediated inflammatory granulomas leading to widespread fibrosis of affected organs can cause complications such as portal hypertension and URINARY TRACT FIBROSIS which, in turn, can progress to varix formation, ascites, pedal edema, splenomegaly, hydronephrosis, repeated URINARY TRACT INFECTIONS and liver and renal failure.",URINARY TRACT FIBROSIS,URINARY TRACT INFECTIONS,TWrex-cause
723907928,5/20/2015 13:12:33,1639665909,5/20/2015 13:11:35,False,clixsense,0.8105,11106820,USA,MA,Taunton,173.48.52.95,URINARY TRACT FIBROSIS causes URINARY TRACT INFECTIONS,240,373,,261,397,causes,0.964901281354015,801998-FS1-4," Reproductive assistance for infertility in women  Dialysis for renal failure  Rationale:  Immune mediated inflammatory granulomas leading to widespread fibrosis of affected organs can cause complications such as portal hypertension and URINARY TRACT FIBROSIS which, in turn, can progress to varix formation, ascites, pedal edema, splenomegaly, hydronephrosis, repeated URINARY TRACT INFECTIONS and liver and renal failure.",URINARY TRACT FIBROSIS,URINARY TRACT INFECTIONS,TWrex-cause
723907928,5/20/2015 13:38:20,1639670480,5/20/2015 13:38:03,False,clixsense,0.5794,22751911,NLD,04,Groningen,195.241.153.97,no_relation,240,373,,261,397,causes,0.964901281354015,801998-FS1-4," Reproductive assistance for infertility in women  Dialysis for renal failure  Rationale:  Immune mediated inflammatory granulomas leading to widespread fibrosis of affected organs can cause complications such as portal hypertension and URINARY TRACT FIBROSIS which, in turn, can progress to varix formation, ascites, pedal edema, splenomegaly, hydronephrosis, repeated URINARY TRACT INFECTIONS and liver and renal failure.",URINARY TRACT FIBROSIS,URINARY TRACT INFECTIONS,TWrex-cause
723907928,5/20/2015 13:42:34,1639672495,5/20/2015 13:41:52,False,gifthunterclub,0.6786,30901412,GBR,G5,Margate,85.210.124.18,URINARY TRACT FIBROSIS causes URINARY TRACT INFECTIONS,240,373,,261,397,causes,0.964901281354015,801998-FS1-4," Reproductive assistance for infertility in women  Dialysis for renal failure  Rationale:  Immune mediated inflammatory granulomas leading to widespread fibrosis of affected organs can cause complications such as portal hypertension and URINARY TRACT FIBROSIS which, in turn, can progress to varix formation, ascites, pedal edema, splenomegaly, hydronephrosis, repeated URINARY TRACT INFECTIONS and liver and renal failure.",URINARY TRACT FIBROSIS,URINARY TRACT INFECTIONS,TWrex-cause
723907928,5/20/2015 13:45:04,1639673246,5/20/2015 13:44:23,False,neodev,0.6476,18881135,CAN,ON,Ajax,99.243.87.224,URINARY TRACT FIBROSIS causes URINARY TRACT INFECTIONS,240,373,,261,397,causes,0.964901281354015,801998-FS1-4," Reproductive assistance for infertility in women  Dialysis for renal failure  Rationale:  Immune mediated inflammatory granulomas leading to widespread fibrosis of affected organs can cause complications such as portal hypertension and URINARY TRACT FIBROSIS which, in turn, can progress to varix formation, ascites, pedal edema, splenomegaly, hydronephrosis, repeated URINARY TRACT INFECTIONS and liver and renal failure.",URINARY TRACT FIBROSIS,URINARY TRACT INFECTIONS,TWrex-cause
723907928,5/20/2015 13:53:46,1639675872,5/20/2015 13:53:04,False,sharecashgpt,0.4429,28627999,CAN,ON,Sudbury,66.103.55.12,no_relation,240,373,,261,397,causes,0.964901281354015,801998-FS1-4," Reproductive assistance for infertility in women  Dialysis for renal failure  Rationale:  Immune mediated inflammatory granulomas leading to widespread fibrosis of affected organs can cause complications such as portal hypertension and URINARY TRACT FIBROSIS which, in turn, can progress to varix formation, ascites, pedal edema, splenomegaly, hydronephrosis, repeated URINARY TRACT INFECTIONS and liver and renal failure.",URINARY TRACT FIBROSIS,URINARY TRACT INFECTIONS,TWrex-cause
723907928,5/20/2015 13:57:12,1639677091,5/20/2015 13:56:45,False,clixsense,0.7448,27754226,GBR,O3,South Ockendon,92.232.236.243,URINARY TRACT FIBROSIS causes URINARY TRACT INFECTIONS,240,373,,261,397,causes,0.964901281354015,801998-FS1-4," Reproductive assistance for infertility in women  Dialysis for renal failure  Rationale:  Immune mediated inflammatory granulomas leading to widespread fibrosis of affected organs can cause complications such as portal hypertension and URINARY TRACT FIBROSIS which, in turn, can progress to varix formation, ascites, pedal edema, splenomegaly, hydronephrosis, repeated URINARY TRACT INFECTIONS and liver and renal failure.",URINARY TRACT FIBROSIS,URINARY TRACT INFECTIONS,TWrex-cause
723907930,5/20/2015 12:07:08,1639641769,5/20/2015 12:06:24,False,prodege,0.6048,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,67,121,,72,153,causes,0.493196961916072,802807-FS1-4,"retinotomy    (                  audio )  Surgical incision of the RETINA e.g., to remove proliferating blood vessels in AGE RELATED MACULAR DEGENERATION",RETINA,AGE RELATED MACULAR DEGENERATION,TWrex-cause
723907930,5/20/2015 12:09:23,1639642525,5/20/2015 12:09:03,False,clixsense,0.375,28457001,CAN,ON,North Bay,24.204.202.220,no_relation,67,121,,72,153,causes,0.493196961916072,802807-FS1-4,"retinotomy    (                  audio )  Surgical incision of the RETINA e.g., to remove proliferating blood vessels in AGE RELATED MACULAR DEGENERATION",RETINA,AGE RELATED MACULAR DEGENERATION,TWrex-cause
723907930,5/20/2015 12:12:20,1639643704,5/20/2015 12:11:54,False,clixsense,0.6167,6352682,GBR,H9,London,2.122.19.138,AGE RELATED MACULAR DEGENERATION causes RETINA,67,121,,72,153,causes,0.493196961916072,802807-FS1-4,"retinotomy    (                  audio )  Surgical incision of the RETINA e.g., to remove proliferating blood vessels in AGE RELATED MACULAR DEGENERATION",RETINA,AGE RELATED MACULAR DEGENERATION,TWrex-cause
723907930,5/20/2015 12:13:47,1639644254,5/20/2015 12:13:38,False,clixsense,0.5,19638651,USA,SC,Summerville,174.107.73.211,no_relation,67,121,,72,153,causes,0.493196961916072,802807-FS1-4,"retinotomy    (                  audio )  Surgical incision of the RETINA e.g., to remove proliferating blood vessels in AGE RELATED MACULAR DEGENERATION",RETINA,AGE RELATED MACULAR DEGENERATION,TWrex-cause
723907930,5/20/2015 12:19:22,1639646263,5/20/2015 12:19:00,False,instagc,0.7014,13581319,USA,IL,Mount Vernon,66.232.166.86,no_relation,67,121,,72,153,causes,0.493196961916072,802807-FS1-4,"retinotomy    (                  audio )  Surgical incision of the RETINA e.g., to remove proliferating blood vessels in AGE RELATED MACULAR DEGENERATION",RETINA,AGE RELATED MACULAR DEGENERATION,TWrex-cause
723907930,5/20/2015 12:19:52,1639646409,5/20/2015 12:19:38,False,clixsense,0.5071,6488338,USA,HI,Honolulu,72.130.214.250,AGE RELATED MACULAR DEGENERATION causes RETINA,67,121,,72,153,causes,0.493196961916072,802807-FS1-4,"retinotomy    (                  audio )  Surgical incision of the RETINA e.g., to remove proliferating blood vessels in AGE RELATED MACULAR DEGENERATION",RETINA,AGE RELATED MACULAR DEGENERATION,TWrex-cause
723907930,5/20/2015 12:27:43,1639649424,5/20/2015 12:26:48,False,prodege,0.6238,27934334,GBR,D2,Derby,86.162.35.12,no_relation,67,121,,72,153,causes,0.493196961916072,802807-FS1-4,"retinotomy    (                  audio )  Surgical incision of the RETINA e.g., to remove proliferating blood vessels in AGE RELATED MACULAR DEGENERATION",RETINA,AGE RELATED MACULAR DEGENERATION,TWrex-cause
724124098,5/20/2015 22:27:15,1639889884,5/20/2015 22:26:46,False,elite,0.7361,32173500,GBR,E4,Rayleigh,176.24.16.182,no_relation,329,357,,347,323,causes,0.412081691846067,813789-FS1-4,"These disorders include inflammatory arteriopathies such as collagen vascular diseases, Takayasu disease, and neurovascular syphilis, as well as noninflammatory arteriopathies such as arterial dissection, fibromuscular dysplasia, moyamoya disease, CADASIL (CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS) and LEUKOENCEPHALOPATHY radiation vasculopathy, and vasospasm after SAH.",LEUKOENCEPHALOPATHY,CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS,TWrex-cause
724124098,5/20/2015 22:28:35,1639890325,5/20/2015 22:28:06,False,clixsense,0.8381,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,329,357,,347,323,causes,0.412081691846067,813789-FS1-4,"These disorders include inflammatory arteriopathies such as collagen vascular diseases, Takayasu disease, and neurovascular syphilis, as well as noninflammatory arteriopathies such as arterial dissection, fibromuscular dysplasia, moyamoya disease, CADASIL (CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS) and LEUKOENCEPHALOPATHY radiation vasculopathy, and vasospasm after SAH.",LEUKOENCEPHALOPATHY,CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS,TWrex-cause
724124098,5/20/2015 22:30:01,1639890744,5/20/2015 22:29:34,False,elite,0.875,31883685,GBR,H2,Accrington,80.47.186.28,no_relation,329,357,,347,323,causes,0.412081691846067,813789-FS1-4,"These disorders include inflammatory arteriopathies such as collagen vascular diseases, Takayasu disease, and neurovascular syphilis, as well as noninflammatory arteriopathies such as arterial dissection, fibromuscular dysplasia, moyamoya disease, CADASIL (CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS) and LEUKOENCEPHALOPATHY radiation vasculopathy, and vasospasm after SAH.",LEUKOENCEPHALOPATHY,CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS,TWrex-cause
724124098,5/20/2015 22:35:02,1639892611,5/20/2015 22:34:38,False,superrewards,0.8304,32390657,CAN,BC,Vancouver,108.180.109.12,no_relation,329,357,,347,323,causes,0.412081691846067,813789-FS1-4,"These disorders include inflammatory arteriopathies such as collagen vascular diseases, Takayasu disease, and neurovascular syphilis, as well as noninflammatory arteriopathies such as arterial dissection, fibromuscular dysplasia, moyamoya disease, CADASIL (CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS) and LEUKOENCEPHALOPATHY radiation vasculopathy, and vasospasm after SAH.",LEUKOENCEPHALOPATHY,CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS,TWrex-cause
724124098,5/20/2015 22:55:37,1639899904,5/20/2015 22:54:59,False,instagc,0.7833,32352104,USA,ME,Bangor,74.75.63.81,CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS causes LEUKOENCEPHALOPATHY,329,357,,347,323,causes,0.412081691846067,813789-FS1-4,"These disorders include inflammatory arteriopathies such as collagen vascular diseases, Takayasu disease, and neurovascular syphilis, as well as noninflammatory arteriopathies such as arterial dissection, fibromuscular dysplasia, moyamoya disease, CADASIL (CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS) and LEUKOENCEPHALOPATHY radiation vasculopathy, and vasospasm after SAH.",LEUKOENCEPHALOPATHY,CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS,TWrex-cause
724124098,5/20/2015 23:05:21,1639903891,5/20/2015 23:05:11,False,instagc,0.7252,15864091,USA,OK,Oklahoma City,104.0.113.133,no_relation,329,357,,347,323,causes,0.412081691846067,813789-FS1-4,"These disorders include inflammatory arteriopathies such as collagen vascular diseases, Takayasu disease, and neurovascular syphilis, as well as noninflammatory arteriopathies such as arterial dissection, fibromuscular dysplasia, moyamoya disease, CADASIL (CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS) and LEUKOENCEPHALOPATHY radiation vasculopathy, and vasospasm after SAH.",LEUKOENCEPHALOPATHY,CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS,TWrex-cause
724124098,5/20/2015 23:05:50,1639903997,5/20/2015 23:05:04,False,instagc,0.62,14723284,USA,NY,New York,96.224.13.217,no_relation,329,357,,347,323,causes,0.412081691846067,813789-FS1-4,"These disorders include inflammatory arteriopathies such as collagen vascular diseases, Takayasu disease, and neurovascular syphilis, as well as noninflammatory arteriopathies such as arterial dissection, fibromuscular dysplasia, moyamoya disease, CADASIL (CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS) and LEUKOENCEPHALOPATHY radiation vasculopathy, and vasospasm after SAH.",LEUKOENCEPHALOPATHY,CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS,TWrex-cause
724124106,5/20/2015 20:43:23,1639861048,5/20/2015 20:42:53,False,prodege,1.0,21417560,GBR,C3,Cambridge,151.225.116.143,AVIRULENT BACTERIA causes SBE,0,36,,2,54,causes,0.99654575824488,811054-FS1-4,SBE is usually caused by relatively AVIRULENT BACTERIA the most common species being streptococci from the normal oral or gastrointestinal (GI) flora.,SBE,AVIRULENT BACTERIA,TWrex-cause
724124106,5/20/2015 20:48:15,1639863022,5/20/2015 20:47:48,False,neodev,0.875,32216655,NLD,07,Amsterdam,145.100.72.168,AVIRULENT BACTERIA causes SBE,0,36,,2,54,causes,0.99654575824488,811054-FS1-4,SBE is usually caused by relatively AVIRULENT BACTERIA the most common species being streptococci from the normal oral or gastrointestinal (GI) flora.,SBE,AVIRULENT BACTERIA,TWrex-cause
724124106,5/20/2015 20:54:25,1639865707,5/20/2015 20:53:50,False,prodege,1.0,26159434,CAN,ON,Thornhill,99.238.74.196,AVIRULENT BACTERIA causes SBE,0,36,,2,54,causes,0.99654575824488,811054-FS1-4,SBE is usually caused by relatively AVIRULENT BACTERIA the most common species being streptococci from the normal oral or gastrointestinal (GI) flora.,SBE,AVIRULENT BACTERIA,TWrex-cause
724124106,5/20/2015 20:55:18,1639865929,5/20/2015 20:55:03,False,sharecashgpt,0.4917,28627999,CAN,ON,Sudbury,66.103.55.12,AVIRULENT BACTERIA causes SBE,0,36,,2,54,causes,0.99654575824488,811054-FS1-4,SBE is usually caused by relatively AVIRULENT BACTERIA the most common species being streptococci from the normal oral or gastrointestinal (GI) flora.,SBE,AVIRULENT BACTERIA,TWrex-cause
724124106,5/20/2015 20:56:28,1639866401,5/20/2015 20:55:57,False,clixsense,0.7167,30130805,USA,MI,Wyandotte,63.141.31.35,AVIRULENT BACTERIA causes SBE,0,36,,2,54,causes,0.99654575824488,811054-FS1-4,SBE is usually caused by relatively AVIRULENT BACTERIA the most common species being streptococci from the normal oral or gastrointestinal (GI) flora.,SBE,AVIRULENT BACTERIA,TWrex-cause
724124106,5/20/2015 20:57:24,1639866752,5/20/2015 20:56:53,False,instagc,0.7333,23032978,USA,PA,Philadelphia,76.98.187.59,AVIRULENT BACTERIA causes SBE,0,36,,2,54,causes,0.99654575824488,811054-FS1-4,SBE is usually caused by relatively AVIRULENT BACTERIA the most common species being streptococci from the normal oral or gastrointestinal (GI) flora.,SBE,AVIRULENT BACTERIA,TWrex-cause
724124106,5/20/2015 20:58:36,1639867171,5/20/2015 20:57:42,False,quickrewards,0.8512,8672587,USA,TX,El Paso,209.194.208.150,AVIRULENT BACTERIA causes SBE,0,36,,2,54,causes,0.99654575824488,811054-FS1-4,SBE is usually caused by relatively AVIRULENT BACTERIA the most common species being streptococci from the normal oral or gastrointestinal (GI) flora.,SBE,AVIRULENT BACTERIA,TWrex-cause
724124112,5/21/2015 00:15:48,1639933510,5/21/2015 00:15:18,False,gifthulk,0.5149,18666417,USA,PA,Meadville,24.101.97.237,no_relation,170,38,,175,59,causes,0.964901281354015,813238-FS1-4,"Rationale:  It is characteristic for tRIGEMINAL NEURALGIA To have periods of weeks, months, or even years during which there is no pain and then varying intervals where pAIN IS frequent.",AIN IS,RIGEMINAL NEURALGIA T,TWrex-cause
724124112,5/21/2015 00:25:22,1639938109,5/21/2015 00:24:33,False,clixsense,0.4952,17950689,GBR,Y9,Tonypandy,92.2.44.79,AIN IS causes RIGEMINAL NEURALGIA T,170,38,,175,59,causes,0.964901281354015,813238-FS1-4,"Rationale:  It is characteristic for tRIGEMINAL NEURALGIA To have periods of weeks, months, or even years during which there is no pain and then varying intervals where pAIN IS frequent.",AIN IS,RIGEMINAL NEURALGIA T,TWrex-cause
724124112,5/21/2015 00:34:49,1639942934,5/21/2015 00:34:37,False,elite,0.6556,32306791,GBR,,,109.200.26.4,AIN IS causes RIGEMINAL NEURALGIA T,170,38,,175,59,causes,0.964901281354015,813238-FS1-4,"Rationale:  It is characteristic for tRIGEMINAL NEURALGIA To have periods of weeks, months, or even years during which there is no pain and then varying intervals where pAIN IS frequent.",AIN IS,RIGEMINAL NEURALGIA T,TWrex-cause
724124112,5/21/2015 00:58:37,1639957454,5/21/2015 00:57:59,False,instagc,0.5556,23287154,USA,CA,San Jose,130.65.251.20,RIGEMINAL NEURALGIA T causes AIN IS,170,38,,175,59,causes,0.964901281354015,813238-FS1-4,"Rationale:  It is characteristic for tRIGEMINAL NEURALGIA To have periods of weeks, months, or even years during which there is no pain and then varying intervals where pAIN IS frequent.",AIN IS,RIGEMINAL NEURALGIA T,TWrex-cause
724124112,5/21/2015 01:14:40,1639966928,5/21/2015 01:13:09,False,neodev,0.65,24564999,GBR,H9,London,86.148.196.204,no_relation,170,38,,175,59,causes,0.964901281354015,813238-FS1-4,"Rationale:  It is characteristic for tRIGEMINAL NEURALGIA To have periods of weeks, months, or even years during which there is no pain and then varying intervals where pAIN IS frequent.",AIN IS,RIGEMINAL NEURALGIA T,TWrex-cause
724124112,5/21/2015 01:25:05,1639972794,5/21/2015 01:22:54,False,neodev,0.5,31670127,USA,FL,Key West,162.233.108.112,RIGEMINAL NEURALGIA T causes AIN IS,170,38,,175,59,causes,0.964901281354015,813238-FS1-4,"Rationale:  It is characteristic for tRIGEMINAL NEURALGIA To have periods of weeks, months, or even years during which there is no pain and then varying intervals where pAIN IS frequent.",AIN IS,RIGEMINAL NEURALGIA T,TWrex-cause
724124112,5/21/2015 01:27:59,1639974284,5/21/2015 01:23:08,False,clixsense,0.2857,24170547,USA,NJ,Moorestown,71.168.207.190,RIGEMINAL NEURALGIA T causes AIN IS,170,38,,175,59,causes,0.964901281354015,813238-FS1-4,"Rationale:  It is characteristic for tRIGEMINAL NEURALGIA To have periods of weeks, months, or even years during which there is no pain and then varying intervals where pAIN IS frequent.",AIN IS,RIGEMINAL NEURALGIA T,TWrex-cause
724124115,5/20/2015 22:27:15,1639889883,5/20/2015 22:26:46,False,elite,0.7361,32173500,GBR,E4,Rayleigh,176.24.16.182,SALMONELLA TYPHI causes TYPHOID FEVER,76,136,,88,152,causes,0.98058067569092,810842-FS1-4,Typhoid Fever and other Salmonella Infections  Alternative for treatment of TYPHOID FEVER   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER,SALMONELLA TYPHI,TWrex-cause
724124115,5/20/2015 22:28:35,1639890323,5/20/2015 22:28:06,False,clixsense,0.8381,10798016,GBR,C7,Coventry,86.24.245.191,SALMONELLA TYPHI causes TYPHOID FEVER,76,136,,88,152,causes,0.98058067569092,810842-FS1-4,Typhoid Fever and other Salmonella Infections  Alternative for treatment of TYPHOID FEVER   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER,SALMONELLA TYPHI,TWrex-cause
724124115,5/20/2015 22:30:01,1639890749,5/20/2015 22:29:34,False,elite,0.875,31883685,GBR,H2,Accrington,80.47.186.28,SALMONELLA TYPHI causes TYPHOID FEVER,76,136,,88,152,causes,0.98058067569092,810842-FS1-4,Typhoid Fever and other Salmonella Infections  Alternative for treatment of TYPHOID FEVER   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER,SALMONELLA TYPHI,TWrex-cause
724124115,5/20/2015 22:35:02,1639892635,5/20/2015 22:34:38,False,superrewards,0.8304,32390657,CAN,BC,Vancouver,108.180.109.12,SALMONELLA TYPHI causes TYPHOID FEVER,76,136,,88,152,causes,0.98058067569092,810842-FS1-4,Typhoid Fever and other Salmonella Infections  Alternative for treatment of TYPHOID FEVER   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER,SALMONELLA TYPHI,TWrex-cause
724124115,5/20/2015 22:55:37,1639899909,5/20/2015 22:54:59,False,instagc,0.7833,32352104,USA,ME,Bangor,74.75.63.81,no_relation,76,136,,88,152,causes,0.98058067569092,810842-FS1-4,Typhoid Fever and other Salmonella Infections  Alternative for treatment of TYPHOID FEVER   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER,SALMONELLA TYPHI,TWrex-cause
724124115,5/20/2015 23:05:21,1639903894,5/20/2015 23:05:11,False,instagc,0.7252,15864091,USA,OK,Oklahoma City,104.0.113.133,SALMONELLA TYPHI causes TYPHOID FEVER,76,136,,88,152,causes,0.98058067569092,810842-FS1-4,Typhoid Fever and other Salmonella Infections  Alternative for treatment of TYPHOID FEVER   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER,SALMONELLA TYPHI,TWrex-cause
724124115,5/20/2015 23:05:50,1639903995,5/20/2015 23:05:04,False,instagc,0.62,14723284,USA,NY,New York,96.224.13.217,SALMONELLA TYPHI causes TYPHOID FEVER,76,136,,88,152,causes,0.98058067569092,810842-FS1-4,Typhoid Fever and other Salmonella Infections  Alternative for treatment of TYPHOID FEVER   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER,SALMONELLA TYPHI,TWrex-cause
724124117,5/20/2015 21:30:34,1639879088,5/20/2015 21:30:10,False,neodev,0.8278,11014534,GBR,,,213.205.194.72,B RECURRENTIS causes LOUSE BORNE RELAPSING FEVER,14,78,,40,91,causes,0.997054485501582,810207-FS1-4,EPIDEMIOLOGY  LOUSE BORNE RELAPSING FEVER (LBRF) is caused by infection with  B RECURRENTIS,LOUSE BORNE RELAPSING FEVER,B RECURRENTIS,TWrex-cause
724124117,5/20/2015 21:34:31,1639880447,5/20/2015 21:34:11,False,instagc,0.772,18531561,CAN,ON,Mississauga,99.229.92.227,B RECURRENTIS causes LOUSE BORNE RELAPSING FEVER,14,78,,40,91,causes,0.997054485501582,810207-FS1-4,EPIDEMIOLOGY  LOUSE BORNE RELAPSING FEVER (LBRF) is caused by infection with  B RECURRENTIS,LOUSE BORNE RELAPSING FEVER,B RECURRENTIS,TWrex-cause
724124117,5/20/2015 21:37:21,1639881404,5/20/2015 21:36:48,False,points4rewards,0.754,20113482,USA,OR,Portland,67.213.218.72,B RECURRENTIS causes LOUSE BORNE RELAPSING FEVER,14,78,,40,91,causes,0.997054485501582,810207-FS1-4,EPIDEMIOLOGY  LOUSE BORNE RELAPSING FEVER (LBRF) is caused by infection with  B RECURRENTIS,LOUSE BORNE RELAPSING FEVER,B RECURRENTIS,TWrex-cause
724124117,5/20/2015 22:26:45,1639889726,5/20/2015 22:26:13,False,elite,0.7361,32173500,GBR,E4,Rayleigh,176.24.16.182,B RECURRENTIS causes LOUSE BORNE RELAPSING FEVER,14,78,,40,91,causes,0.997054485501582,810207-FS1-4,EPIDEMIOLOGY  LOUSE BORNE RELAPSING FEVER (LBRF) is caused by infection with  B RECURRENTIS,LOUSE BORNE RELAPSING FEVER,B RECURRENTIS,TWrex-cause
724124117,5/20/2015 22:27:44,1639890026,5/20/2015 22:27:20,False,clixsense,0.8381,10798016,GBR,C7,Coventry,86.24.245.191,B RECURRENTIS causes LOUSE BORNE RELAPSING FEVER,14,78,,40,91,causes,0.997054485501582,810207-FS1-4,EPIDEMIOLOGY  LOUSE BORNE RELAPSING FEVER (LBRF) is caused by infection with  B RECURRENTIS,LOUSE BORNE RELAPSING FEVER,B RECURRENTIS,TWrex-cause
724124117,5/20/2015 22:29:33,1639890576,5/20/2015 22:29:18,False,elite,0.875,31883685,GBR,H2,Accrington,80.47.186.28,B RECURRENTIS causes LOUSE BORNE RELAPSING FEVER,14,78,,40,91,causes,0.997054485501582,810207-FS1-4,EPIDEMIOLOGY  LOUSE BORNE RELAPSING FEVER (LBRF) is caused by infection with  B RECURRENTIS,LOUSE BORNE RELAPSING FEVER,B RECURRENTIS,TWrex-cause
724124117,5/20/2015 22:34:37,1639892406,5/20/2015 22:34:02,False,superrewards,0.8304,32390657,CAN,BC,Vancouver,108.180.109.12,B RECURRENTIS causes LOUSE BORNE RELAPSING FEVER,14,78,,40,91,causes,0.997054485501582,810207-FS1-4,EPIDEMIOLOGY  LOUSE BORNE RELAPSING FEVER (LBRF) is caused by infection with  B RECURRENTIS,LOUSE BORNE RELAPSING FEVER,B RECURRENTIS,TWrex-cause
724124120,5/20/2015 22:56:59,1639900450,5/20/2015 22:56:49,False,instagc,0.7833,32352104,USA,ME,Bangor,74.75.63.81,DIPHENHYDRAMINE causes MOTION SICKNESS,319,355,,333,370,causes,0.42008402520840293,805266-FS1-4,"Infants are at risk for toxicity from drugs used by adults; toxicity can occur prenatally when they are exposed via placental transfer or postnatally through breast milk (numerous agentssee  Drugs  and  Table 266 4 ) or skin contact with caregivers who have recently applied certain topical drugs (eg, scopolamine for MOTION SICKNESS malathion for lice, DIPHENHYDRAMINE for poison ivy.",MOTION SICKNESS,DIPHENHYDRAMINE,TWrex-cause
724124120,5/20/2015 23:07:12,1639904543,5/20/2015 23:06:50,False,instagc,0.7252,15864091,USA,OK,Oklahoma City,104.0.113.133,no_relation,319,355,,333,370,causes,0.42008402520840293,805266-FS1-4,"Infants are at risk for toxicity from drugs used by adults; toxicity can occur prenatally when they are exposed via placental transfer or postnatally through breast milk (numerous agentssee  Drugs  and  Table 266 4 ) or skin contact with caregivers who have recently applied certain topical drugs (eg, scopolamine for MOTION SICKNESS malathion for lice, DIPHENHYDRAMINE for poison ivy.",MOTION SICKNESS,DIPHENHYDRAMINE,TWrex-cause
724124120,5/20/2015 23:07:35,1639904672,5/20/2015 23:07:04,False,instagc,0.62,14723284,USA,NY,New York,96.224.13.217,no_relation,319,355,,333,370,causes,0.42008402520840293,805266-FS1-4,"Infants are at risk for toxicity from drugs used by adults; toxicity can occur prenatally when they are exposed via placental transfer or postnatally through breast milk (numerous agentssee  Drugs  and  Table 266 4 ) or skin contact with caregivers who have recently applied certain topical drugs (eg, scopolamine for MOTION SICKNESS malathion for lice, DIPHENHYDRAMINE for poison ivy.",MOTION SICKNESS,DIPHENHYDRAMINE,TWrex-cause
724124120,5/20/2015 23:09:27,1639905478,5/20/2015 23:09:20,False,instagc,0.4278,31861996,USA,FL,Homestead,73.46.199.178,DIPHENHYDRAMINE causes MOTION SICKNESS,319,355,,333,370,causes,0.42008402520840293,805266-FS1-4,"Infants are at risk for toxicity from drugs used by adults; toxicity can occur prenatally when they are exposed via placental transfer or postnatally through breast milk (numerous agentssee  Drugs  and  Table 266 4 ) or skin contact with caregivers who have recently applied certain topical drugs (eg, scopolamine for MOTION SICKNESS malathion for lice, DIPHENHYDRAMINE for poison ivy.",MOTION SICKNESS,DIPHENHYDRAMINE,TWrex-cause
724124120,5/20/2015 23:21:37,1639909284,5/20/2015 23:21:11,False,instagc,0.7833,20312760,GBR,I2,Manchester,90.244.152.57,no_relation,319,355,,333,370,causes,0.42008402520840293,805266-FS1-4,"Infants are at risk for toxicity from drugs used by adults; toxicity can occur prenatally when they are exposed via placental transfer or postnatally through breast milk (numerous agentssee  Drugs  and  Table 266 4 ) or skin contact with caregivers who have recently applied certain topical drugs (eg, scopolamine for MOTION SICKNESS malathion for lice, DIPHENHYDRAMINE for poison ivy.",MOTION SICKNESS,DIPHENHYDRAMINE,TWrex-cause
724124120,5/20/2015 23:42:19,1639918761,5/20/2015 23:41:36,False,prodege,0.875,15439740,AUS,02,Jannali,14.200.59.55,no_relation,319,355,,333,370,causes,0.42008402520840293,805266-FS1-4,"Infants are at risk for toxicity from drugs used by adults; toxicity can occur prenatally when they are exposed via placental transfer or postnatally through breast milk (numerous agentssee  Drugs  and  Table 266 4 ) or skin contact with caregivers who have recently applied certain topical drugs (eg, scopolamine for MOTION SICKNESS malathion for lice, DIPHENHYDRAMINE for poison ivy.",MOTION SICKNESS,DIPHENHYDRAMINE,TWrex-cause
724124120,5/20/2015 23:45:00,1639919958,5/20/2015 23:44:51,False,clixsense,0.75,16498372,CAN,ON,Toronto,206.248.183.181,no_relation,319,355,,333,370,causes,0.42008402520840293,805266-FS1-4,"Infants are at risk for toxicity from drugs used by adults; toxicity can occur prenatally when they are exposed via placental transfer or postnatally through breast milk (numerous agentssee  Drugs  and  Table 266 4 ) or skin contact with caregivers who have recently applied certain topical drugs (eg, scopolamine for MOTION SICKNESS malathion for lice, DIPHENHYDRAMINE for poison ivy.",MOTION SICKNESS,DIPHENHYDRAMINE,TWrex-cause
724124126,5/20/2015 23:44:51,1639919882,5/20/2015 23:44:38,False,prodege,0.875,15439740,AUS,02,Jannali,14.200.59.55,no_relation,127,14,,149,24,causes,0.37210420376762504,800496-FS1-4,"2]  Proye CA, MULLIEZ EA Carnaille BM, Lecomte Houcke M, Decoulx M, Wemeau JL, et al. Essential hypertension: first reason for PERSISTENT HYPERTENSION after unilateral adrenalectomy for primary aldosteronism.",PERSISTENT HYPERTENSION,MULLIEZ EA,TWrex-cause
724124126,5/20/2015 23:45:28,1639920174,5/20/2015 23:44:34,False,neodev,0.7559999999999999,11382239,AUS,02,Strathfield,60.241.129.81,no_relation,127,14,,149,24,causes,0.37210420376762504,800496-FS1-4,"2]  Proye CA, MULLIEZ EA Carnaille BM, Lecomte Houcke M, Decoulx M, Wemeau JL, et al. Essential hypertension: first reason for PERSISTENT HYPERTENSION after unilateral adrenalectomy for primary aldosteronism.",PERSISTENT HYPERTENSION,MULLIEZ EA,TWrex-cause
724124126,5/20/2015 23:48:40,1639921554,5/20/2015 23:48:16,False,pocketmoneygpt,0.5764,28884030,USA,WI,Minocqua,75.143.134.247,MULLIEZ EA causes PERSISTENT HYPERTENSION,127,14,,149,24,causes,0.37210420376762504,800496-FS1-4,"2]  Proye CA, MULLIEZ EA Carnaille BM, Lecomte Houcke M, Decoulx M, Wemeau JL, et al. Essential hypertension: first reason for PERSISTENT HYPERTENSION after unilateral adrenalectomy for primary aldosteronism.",PERSISTENT HYPERTENSION,MULLIEZ EA,TWrex-cause
724124126,5/21/2015 00:06:36,1639929059,5/21/2015 00:05:51,False,onestopgpt,0.7284,21275875,CAN,ON,Hamilton,24.36.121.10,no_relation,127,14,,149,24,causes,0.37210420376762504,800496-FS1-4,"2]  Proye CA, MULLIEZ EA Carnaille BM, Lecomte Houcke M, Decoulx M, Wemeau JL, et al. Essential hypertension: first reason for PERSISTENT HYPERTENSION after unilateral adrenalectomy for primary aldosteronism.",PERSISTENT HYPERTENSION,MULLIEZ EA,TWrex-cause
724124126,5/21/2015 00:14:35,1639932744,5/21/2015 00:13:38,False,gifthulk,0.5149,18666417,USA,PA,Meadville,24.101.97.237,MULLIEZ EA causes PERSISTENT HYPERTENSION,127,14,,149,24,causes,0.37210420376762504,800496-FS1-4,"2]  Proye CA, MULLIEZ EA Carnaille BM, Lecomte Houcke M, Decoulx M, Wemeau JL, et al. Essential hypertension: first reason for PERSISTENT HYPERTENSION after unilateral adrenalectomy for primary aldosteronism.",PERSISTENT HYPERTENSION,MULLIEZ EA,TWrex-cause
724124126,5/21/2015 00:23:46,1639937226,5/21/2015 00:23:21,False,clixsense,0.4952,17950689,GBR,Y9,Tonypandy,92.2.44.79,PERSISTENT HYPERTENSION causes MULLIEZ EA,127,14,,149,24,causes,0.37210420376762504,800496-FS1-4,"2]  Proye CA, MULLIEZ EA Carnaille BM, Lecomte Houcke M, Decoulx M, Wemeau JL, et al. Essential hypertension: first reason for PERSISTENT HYPERTENSION after unilateral adrenalectomy for primary aldosteronism.",PERSISTENT HYPERTENSION,MULLIEZ EA,TWrex-cause
724124126,5/21/2015 00:29:34,1639940253,5/21/2015 00:29:29,False,neodev,0.25,31789301,USA,,,178.62.40.84,PERSISTENT HYPERTENSION causes MULLIEZ EA,127,14,,149,24,causes,0.37210420376762504,800496-FS1-4,"2]  Proye CA, MULLIEZ EA Carnaille BM, Lecomte Houcke M, Decoulx M, Wemeau JL, et al. Essential hypertension: first reason for PERSISTENT HYPERTENSION after unilateral adrenalectomy for primary aldosteronism.",PERSISTENT HYPERTENSION,MULLIEZ EA,TWrex-cause
724124133,5/20/2015 23:22:40,1639909605,5/20/2015 23:22:23,False,instagc,0.7833,20312760,GBR,I2,Manchester,90.244.152.57,no_relation,123,27,,143,47,causes,0.7293249574894731,812481-FS1-4,"Liver infections caused by NONHEPATITIS VIRUSES (eg, Epstein Barr, yellow fever, cytomegalovirus) generally are not termed ACUTE VIRAL HEPATITIS",ACUTE VIRAL HEPATITIS,NONHEPATITIS VIRUSES,TWrex-cause
724124133,5/20/2015 23:43:21,1639919257,5/20/2015 23:43:00,False,prodege,0.875,15439740,AUS,02,Jannali,14.200.59.55,no_relation,123,27,,143,47,causes,0.7293249574894731,812481-FS1-4,"Liver infections caused by NONHEPATITIS VIRUSES (eg, Epstein Barr, yellow fever, cytomegalovirus) generally are not termed ACUTE VIRAL HEPATITIS",ACUTE VIRAL HEPATITIS,NONHEPATITIS VIRUSES,TWrex-cause
724124133,5/20/2015 23:43:40,1639919406,5/20/2015 23:43:10,False,neodev,0.7559999999999999,11382239,AUS,02,Strathfield,60.241.129.81,no_relation,123,27,,143,47,causes,0.7293249574894731,812481-FS1-4,"Liver infections caused by NONHEPATITIS VIRUSES (eg, Epstein Barr, yellow fever, cytomegalovirus) generally are not termed ACUTE VIRAL HEPATITIS",ACUTE VIRAL HEPATITIS,NONHEPATITIS VIRUSES,TWrex-cause
724124133,5/20/2015 23:47:42,1639921153,5/20/2015 23:47:29,False,pocketmoneygpt,0.5764,28884030,USA,WI,Minocqua,75.143.134.247,NONHEPATITIS VIRUSES causes ACUTE VIRAL HEPATITIS,123,27,,143,47,causes,0.7293249574894731,812481-FS1-4,"Liver infections caused by NONHEPATITIS VIRUSES (eg, Epstein Barr, yellow fever, cytomegalovirus) generally are not termed ACUTE VIRAL HEPATITIS",ACUTE VIRAL HEPATITIS,NONHEPATITIS VIRUSES,TWrex-cause
724124133,5/20/2015 23:57:16,1639924965,5/20/2015 23:57:07,False,neodev,0.9,31066862,USA,CA,San Jose,128.107.241.174,no_relation,123,27,,143,47,causes,0.7293249574894731,812481-FS1-4,"Liver infections caused by NONHEPATITIS VIRUSES (eg, Epstein Barr, yellow fever, cytomegalovirus) generally are not termed ACUTE VIRAL HEPATITIS",ACUTE VIRAL HEPATITIS,NONHEPATITIS VIRUSES,TWrex-cause
724124133,5/21/2015 00:04:49,1639928175,5/21/2015 00:04:27,False,onestopgpt,0.7284,21275875,CAN,ON,Hamilton,24.36.121.10,no_relation,123,27,,143,47,causes,0.7293249574894731,812481-FS1-4,"Liver infections caused by NONHEPATITIS VIRUSES (eg, Epstein Barr, yellow fever, cytomegalovirus) generally are not termed ACUTE VIRAL HEPATITIS",ACUTE VIRAL HEPATITIS,NONHEPATITIS VIRUSES,TWrex-cause
724124133,5/21/2015 00:08:05,1639929663,5/21/2015 00:07:57,False,instagc,0.9286,31130954,USA,IL,Schaumburg,99.141.252.213,no_relation,123,27,,143,47,causes,0.7293249574894731,812481-FS1-4,"Liver infections caused by NONHEPATITIS VIRUSES (eg, Epstein Barr, yellow fever, cytomegalovirus) generally are not termed ACUTE VIRAL HEPATITIS",ACUTE VIRAL HEPATITIS,NONHEPATITIS VIRUSES,TWrex-cause
724124136,5/20/2015 21:06:58,1639870267,5/20/2015 21:06:45,False,instagc,0.5675,13581319,USA,IL,Mount Vernon,66.232.166.86,VIRAL INFECTIONS causes EPSTEIN BARR VIRUS,18,126,,33,144,causes,0.988371697650617,810263-FS1-4,"compromise  Treat VIRAL INFECTIONS that may cause vasculitis (HIV, hepatitis, cytomegalovirus, parvovirus B19, herpes zoster, EPSTEIN BARR VIRUS with antiviral agents, if possible.",VIRAL INFECTIONS,EPSTEIN BARR VIRUS,TWrex-cause
724124136,5/20/2015 21:11:16,1639871636,5/20/2015 21:10:43,False,instagc,0.7401,30326470,USA,CA,Santee,99.44.37.73,VIRAL INFECTIONS causes EPSTEIN BARR VIRUS,18,126,,33,144,causes,0.988371697650617,810263-FS1-4,"compromise  Treat VIRAL INFECTIONS that may cause vasculitis (HIV, hepatitis, cytomegalovirus, parvovirus B19, herpes zoster, EPSTEIN BARR VIRUS with antiviral agents, if possible.",VIRAL INFECTIONS,EPSTEIN BARR VIRUS,TWrex-cause
724124136,5/20/2015 21:11:18,1639871645,5/20/2015 21:10:48,False,neodev,0.748,18881135,CAN,ON,Ajax,99.243.87.224,no_relation,18,126,,33,144,causes,0.988371697650617,810263-FS1-4,"compromise  Treat VIRAL INFECTIONS that may cause vasculitis (HIV, hepatitis, cytomegalovirus, parvovirus B19, herpes zoster, EPSTEIN BARR VIRUS with antiviral agents, if possible.",VIRAL INFECTIONS,EPSTEIN BARR VIRUS,TWrex-cause
724124136,5/20/2015 21:26:50,1639877988,5/20/2015 21:26:31,False,neodev,0.8278,11014534,GBR,,,213.205.194.72,VIRAL INFECTIONS causes EPSTEIN BARR VIRUS,18,126,,33,144,causes,0.988371697650617,810263-FS1-4,"compromise  Treat VIRAL INFECTIONS that may cause vasculitis (HIV, hepatitis, cytomegalovirus, parvovirus B19, herpes zoster, EPSTEIN BARR VIRUS with antiviral agents, if possible.",VIRAL INFECTIONS,EPSTEIN BARR VIRUS,TWrex-cause
724124136,5/20/2015 21:28:49,1639878618,5/20/2015 21:28:18,False,instagc,0.6,24252915,GBR,B7,Bristol,92.236.71.128,EPSTEIN BARR VIRUS causes VIRAL INFECTIONS,18,126,,33,144,causes,0.988371697650617,810263-FS1-4,"compromise  Treat VIRAL INFECTIONS that may cause vasculitis (HIV, hepatitis, cytomegalovirus, parvovirus B19, herpes zoster, EPSTEIN BARR VIRUS with antiviral agents, if possible.",VIRAL INFECTIONS,EPSTEIN BARR VIRUS,TWrex-cause
724124136,5/20/2015 21:31:21,1639879391,5/20/2015 21:30:56,False,instagc,0.772,18531561,CAN,ON,Mississauga,99.229.92.227,VIRAL INFECTIONS causes EPSTEIN BARR VIRUS,18,126,,33,144,causes,0.988371697650617,810263-FS1-4,"compromise  Treat VIRAL INFECTIONS that may cause vasculitis (HIV, hepatitis, cytomegalovirus, parvovirus B19, herpes zoster, EPSTEIN BARR VIRUS with antiviral agents, if possible.",VIRAL INFECTIONS,EPSTEIN BARR VIRUS,TWrex-cause
724124136,5/20/2015 21:34:18,1639880363,5/20/2015 21:33:47,False,points4rewards,0.754,20113482,USA,OR,Portland,67.213.218.72,VIRAL INFECTIONS causes EPSTEIN BARR VIRUS,18,126,,33,144,causes,0.988371697650617,810263-FS1-4,"compromise  Treat VIRAL INFECTIONS that may cause vasculitis (HIV, hepatitis, cytomegalovirus, parvovirus B19, herpes zoster, EPSTEIN BARR VIRUS with antiviral agents, if possible.",VIRAL INFECTIONS,EPSTEIN BARR VIRUS,TWrex-cause
724398393,5/21/2015 12:05:59,1640275878,5/21/2015 12:05:24,False,cotter,0.8294,13805544,USA,MI,Battle Creek,107.140.176.37,no_relation,135,42,,149,65,causes,0.34874291623145803,805281-FS1-4,Three  versus four week administration of BENZATHINE PENICILLIN G: effects on incidence of streptococcal infections and recurrences of RHEUMATIC FEVER,RHEUMATIC FEVER,BENZATHINE PENICILLIN G,TWrex-cause
724398393,5/21/2015 12:08:11,1640276933,5/21/2015 12:07:39,False,neodev,0.7917,12115558,USA,OH,Twinsburg,98.27.164.131,BENZATHINE PENICILLIN G causes RHEUMATIC FEVER,135,42,,149,65,causes,0.34874291623145803,805281-FS1-4,Three  versus four week administration of BENZATHINE PENICILLIN G: effects on incidence of streptococcal infections and recurrences of RHEUMATIC FEVER,RHEUMATIC FEVER,BENZATHINE PENICILLIN G,TWrex-cause
724398393,5/21/2015 12:29:46,1640286584,5/21/2015 12:28:54,False,neodev,0.6944,30588889,NLD,07,Amsterdam,77.248.175.222,no_relation,135,42,,149,65,causes,0.34874291623145803,805281-FS1-4,Three  versus four week administration of BENZATHINE PENICILLIN G: effects on incidence of streptococcal infections and recurrences of RHEUMATIC FEVER,RHEUMATIC FEVER,BENZATHINE PENICILLIN G,TWrex-cause
724398393,5/21/2015 12:37:28,1640289776,5/21/2015 12:36:20,False,clixsense,0.6062,22947672,GBR,,,88.144.127.68,no_relation,135,42,,149,65,causes,0.34874291623145803,805281-FS1-4,Three  versus four week administration of BENZATHINE PENICILLIN G: effects on incidence of streptococcal infections and recurrences of RHEUMATIC FEVER,RHEUMATIC FEVER,BENZATHINE PENICILLIN G,TWrex-cause
724398393,5/21/2015 12:47:34,1640294223,5/21/2015 12:47:13,False,pocketmoneygpt,0.675,28884030,USA,WI,Minocqua,75.143.134.247,BENZATHINE PENICILLIN G causes RHEUMATIC FEVER,135,42,,149,65,causes,0.34874291623145803,805281-FS1-4,Three  versus four week administration of BENZATHINE PENICILLIN G: effects on incidence of streptococcal infections and recurrences of RHEUMATIC FEVER,RHEUMATIC FEVER,BENZATHINE PENICILLIN G,TWrex-cause
724398393,5/21/2015 12:49:21,1640294943,5/21/2015 12:49:04,False,instagc,0.6417,13581319,USA,IL,Mount Vernon,66.232.166.86,no_relation,135,42,,149,65,causes,0.34874291623145803,805281-FS1-4,Three  versus four week administration of BENZATHINE PENICILLIN G: effects on incidence of streptococcal infections and recurrences of RHEUMATIC FEVER,RHEUMATIC FEVER,BENZATHINE PENICILLIN G,TWrex-cause
724398393,5/21/2015 12:56:08,1640297789,5/21/2015 12:55:42,False,prodege,0.6825,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,135,42,,149,65,causes,0.34874291623145803,805281-FS1-4,Three  versus four week administration of BENZATHINE PENICILLIN G: effects on incidence of streptococcal infections and recurrences of RHEUMATIC FEVER,RHEUMATIC FEVER,BENZATHINE PENICILLIN G,TWrex-cause
724398394,5/21/2015 12:04:39,1640275275,5/21/2015 12:04:03,False,cotter,0.8294,13805544,USA,MI,Battle Creek,107.140.176.37,PSEUDOHYPOPARATHYROIDISM causes HYPOCALCEMIA,81,0,,92,24,causes,1.0,812050-FS1-4,"PSEUDOHYPOPARATHYROIDISM is caused by inherited PTH resistance, which results in HYPOCALCEMIA and secondary marked elevations of PTH levels.",HYPOCALCEMIA,PSEUDOHYPOPARATHYROIDISM,TWrex-cause
724398394,5/21/2015 12:06:48,1640276239,5/21/2015 12:06:10,False,neodev,0.7917,12115558,USA,OH,Twinsburg,98.27.164.131,no_relation,81,0,,92,24,causes,1.0,812050-FS1-4,"PSEUDOHYPOPARATHYROIDISM is caused by inherited PTH resistance, which results in HYPOCALCEMIA and secondary marked elevations of PTH levels.",HYPOCALCEMIA,PSEUDOHYPOPARATHYROIDISM,TWrex-cause
724398394,5/21/2015 12:26:22,1640285002,5/21/2015 12:25:44,False,neodev,0.6944,30588889,NLD,07,Amsterdam,77.248.175.222,PSEUDOHYPOPARATHYROIDISM causes HYPOCALCEMIA,81,0,,92,24,causes,1.0,812050-FS1-4,"PSEUDOHYPOPARATHYROIDISM is caused by inherited PTH resistance, which results in HYPOCALCEMIA and secondary marked elevations of PTH levels.",HYPOCALCEMIA,PSEUDOHYPOPARATHYROIDISM,TWrex-cause
724398394,5/21/2015 12:35:13,1640288869,5/21/2015 12:31:09,False,clixsense,0.6062,22947672,GBR,,,88.144.127.68,no_relation,81,0,,92,24,causes,1.0,812050-FS1-4,"PSEUDOHYPOPARATHYROIDISM is caused by inherited PTH resistance, which results in HYPOCALCEMIA and secondary marked elevations of PTH levels.",HYPOCALCEMIA,PSEUDOHYPOPARATHYROIDISM,TWrex-cause
724398394,5/21/2015 12:46:43,1640293916,5/21/2015 12:46:20,False,pocketmoneygpt,0.675,28884030,USA,WI,Minocqua,75.143.134.247,PSEUDOHYPOPARATHYROIDISM causes HYPOCALCEMIA,81,0,,92,24,causes,1.0,812050-FS1-4,"PSEUDOHYPOPARATHYROIDISM is caused by inherited PTH resistance, which results in HYPOCALCEMIA and secondary marked elevations of PTH levels.",HYPOCALCEMIA,PSEUDOHYPOPARATHYROIDISM,TWrex-cause
724398394,5/21/2015 12:48:31,1640294608,5/21/2015 12:48:16,False,instagc,0.6417,13581319,USA,IL,Mount Vernon,66.232.166.86,HYPOCALCEMIA causes PSEUDOHYPOPARATHYROIDISM,81,0,,92,24,causes,1.0,812050-FS1-4,"PSEUDOHYPOPARATHYROIDISM is caused by inherited PTH resistance, which results in HYPOCALCEMIA and secondary marked elevations of PTH levels.",HYPOCALCEMIA,PSEUDOHYPOPARATHYROIDISM,TWrex-cause
724398394,5/21/2015 12:54:45,1640297241,5/21/2015 12:54:16,False,prodege,0.6825,21417560,GBR,C3,Cambridge,151.225.116.143,PSEUDOHYPOPARATHYROIDISM causes HYPOCALCEMIA,81,0,,92,24,causes,1.0,812050-FS1-4,"PSEUDOHYPOPARATHYROIDISM is caused by inherited PTH resistance, which results in HYPOCALCEMIA and secondary marked elevations of PTH levels.",HYPOCALCEMIA,PSEUDOHYPOPARATHYROIDISM,TWrex-cause
724398398,5/21/2015 10:33:03,1640232920,5/21/2015 10:32:16,False,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,no_relation,2,79,,17,90,causes,0.923380516876639,810591-FS1-4," TOLERANCE TO H 2 RAs may develop relatively quickly in patients taking these MEDICATIONS on a regular basis, limiting their efficacy.",TOLERANCE TO H 2,MEDICATIONS,TWrex-cause
724398398,5/21/2015 10:55:53,1640244747,5/21/2015 10:55:35,False,instagc,0.9167,20845955,GBR,I2,Manchester,90.214.24.62,MEDICATIONS causes TOLERANCE TO H 2,2,79,,17,90,causes,0.923380516876639,810591-FS1-4," TOLERANCE TO H 2 RAs may develop relatively quickly in patients taking these MEDICATIONS on a regular basis, limiting their efficacy.",TOLERANCE TO H 2,MEDICATIONS,TWrex-cause
724398398,5/21/2015 11:20:17,1640255445,5/21/2015 11:19:57,False,bitcoinget,0.75,30546513,GBR,G6,Hull,194.42.67.50,MEDICATIONS causes TOLERANCE TO H 2,2,79,,17,90,causes,0.923380516876639,810591-FS1-4," TOLERANCE TO H 2 RAs may develop relatively quickly in patients taking these MEDICATIONS on a regular basis, limiting their efficacy.",TOLERANCE TO H 2,MEDICATIONS,TWrex-cause
724398398,5/21/2015 11:27:29,1640258385,5/21/2015 11:26:45,False,prodege,0.9028,2850251,USA,IL,Plainfield,71.201.50.48,MEDICATIONS causes TOLERANCE TO H 2,2,79,,17,90,causes,0.923380516876639,810591-FS1-4," TOLERANCE TO H 2 RAs may develop relatively quickly in patients taking these MEDICATIONS on a regular basis, limiting their efficacy.",TOLERANCE TO H 2,MEDICATIONS,TWrex-cause
724398398,5/21/2015 11:36:46,1640262580,5/21/2015 11:35:40,False,clixsense,0.9056,31579138,AUS,02,Hurstville,14.200.129.68,MEDICATIONS causes TOLERANCE TO H 2,2,79,,17,90,causes,0.923380516876639,810591-FS1-4," TOLERANCE TO H 2 RAs may develop relatively quickly in patients taking these MEDICATIONS on a regular basis, limiting their efficacy.",TOLERANCE TO H 2,MEDICATIONS,TWrex-cause
724398398,5/21/2015 11:37:59,1640263146,5/21/2015 11:37:32,False,prodege,0.8847,27934334,GBR,D2,Derby,86.162.35.12,MEDICATIONS causes TOLERANCE TO H 2,2,79,,17,90,causes,0.923380516876639,810591-FS1-4," TOLERANCE TO H 2 RAs may develop relatively quickly in patients taking these MEDICATIONS on a regular basis, limiting their efficacy.",TOLERANCE TO H 2,MEDICATIONS,TWrex-cause
724398398,5/21/2015 12:00:27,1640273443,5/21/2015 12:00:08,False,elite,0.4821,31913360,USA,DE,,108.59.8.218,MEDICATIONS causes TOLERANCE TO H 2,2,79,,17,90,causes,0.923380516876639,810591-FS1-4," TOLERANCE TO H 2 RAs may develop relatively quickly in patients taking these MEDICATIONS on a regular basis, limiting their efficacy.",TOLERANCE TO H 2,MEDICATIONS,TWrex-cause
724398402,5/21/2015 13:30:26,1640313811,5/21/2015 13:29:32,False,clixsense,0.8958,17950689,GBR,Y9,Tonypandy,92.2.44.79,CENTRAL NERVOUS SYSTEM (CNS causes COMA,49,133,,75,137,causes,0.964901281354015,802413-FS1-4,"47  During a later phase, in up to 80% of cases, CENTRAL NERVOUS SYSTEM (CNS manifestations such as delirium that interrupts stupor, COMA and seizures, as well as hearing loss, can occur.",CENTRAL NERVOUS SYSTEM (CNS,COMA,TWrex-cause
724398402,5/21/2015 13:45:36,1640321399,5/21/2015 13:45:14,False,prodege,0.6032,16101132,GBR,G1,Hounslow,90.207.88.197,no_relation,49,133,,75,137,causes,0.964901281354015,802413-FS1-4,"47  During a later phase, in up to 80% of cases, CENTRAL NERVOUS SYSTEM (CNS manifestations such as delirium that interrupts stupor, COMA and seizures, as well as hearing loss, can occur.",CENTRAL NERVOUS SYSTEM (CNS,COMA,TWrex-cause
724398402,5/21/2015 13:45:45,1640321469,5/21/2015 13:45:07,False,points4rewards,0.6548,28755767,USA,VA,Chester,68.57.118.32,CENTRAL NERVOUS SYSTEM (CNS causes COMA,49,133,,75,137,causes,0.964901281354015,802413-FS1-4,"47  During a later phase, in up to 80% of cases, CENTRAL NERVOUS SYSTEM (CNS manifestations such as delirium that interrupts stupor, COMA and seizures, as well as hearing loss, can occur.",CENTRAL NERVOUS SYSTEM (CNS,COMA,TWrex-cause
724398402,5/21/2015 13:47:08,1640322098,5/21/2015 13:46:11,False,instagc,0.6964,15285653,USA,,,172.162.76.35,CENTRAL NERVOUS SYSTEM (CNS causes COMA,49,133,,75,137,causes,0.964901281354015,802413-FS1-4,"47  During a later phase, in up to 80% of cases, CENTRAL NERVOUS SYSTEM (CNS manifestations such as delirium that interrupts stupor, COMA and seizures, as well as hearing loss, can occur.",CENTRAL NERVOUS SYSTEM (CNS,COMA,TWrex-cause
724398402,5/21/2015 13:51:17,1640324371,5/21/2015 13:50:47,False,sharecashgpt,0.55,28627999,CAN,ON,Sudbury,66.103.55.12,COMA causes CENTRAL NERVOUS SYSTEM (CNS,49,133,,75,137,causes,0.964901281354015,802413-FS1-4,"47  During a later phase, in up to 80% of cases, CENTRAL NERVOUS SYSTEM (CNS manifestations such as delirium that interrupts stupor, COMA and seizures, as well as hearing loss, can occur.",CENTRAL NERVOUS SYSTEM (CNS,COMA,TWrex-cause
724398402,5/21/2015 14:02:43,1640331095,5/21/2015 14:02:18,False,clixsense,0.5833,22751911,NLD,04,Groningen,195.241.153.97,CENTRAL NERVOUS SYSTEM (CNS causes COMA,49,133,,75,137,causes,0.964901281354015,802413-FS1-4,"47  During a later phase, in up to 80% of cases, CENTRAL NERVOUS SYSTEM (CNS manifestations such as delirium that interrupts stupor, COMA and seizures, as well as hearing loss, can occur.",CENTRAL NERVOUS SYSTEM (CNS,COMA,TWrex-cause
724398402,5/21/2015 14:07:08,1640333937,5/21/2015 14:04:39,False,prodege,0.6488,14571439,CAN,ON,Toronto,142.20.20.193,no_relation,49,133,,75,137,causes,0.964901281354015,802413-FS1-4,"47  During a later phase, in up to 80% of cases, CENTRAL NERVOUS SYSTEM (CNS manifestations such as delirium that interrupts stupor, COMA and seizures, as well as hearing loss, can occur.",CENTRAL NERVOUS SYSTEM (CNS,COMA,TWrex-cause
724398403,5/21/2015 12:48:03,1640294410,5/21/2015 12:47:48,False,pocketmoneygpt,0.675,28884030,USA,WI,Minocqua,75.143.134.247,PERNICIOUS ANEMIA causes FOOD COBALAMIN MALABSORPTION,174,8,,190,36,causes,0.824957911384306,804713-FS1-4,"Whereas FOOD COBALAMIN MALABSORPTION is common among patients with subclinical deficiency, those with clinical manifestations of cobalamin deficiency are more likely to have PERNICIOUS ANEMIA",PERNICIOUS ANEMIA,FOOD COBALAMIN MALABSORPTION,TWrex-cause
724398403,5/21/2015 12:49:53,1640295240,5/21/2015 12:49:38,False,instagc,0.6417,13581319,USA,IL,Mount Vernon,66.232.166.86,FOOD COBALAMIN MALABSORPTION causes PERNICIOUS ANEMIA,174,8,,190,36,causes,0.824957911384306,804713-FS1-4,"Whereas FOOD COBALAMIN MALABSORPTION is common among patients with subclinical deficiency, those with clinical manifestations of cobalamin deficiency are more likely to have PERNICIOUS ANEMIA",PERNICIOUS ANEMIA,FOOD COBALAMIN MALABSORPTION,TWrex-cause
724398403,5/21/2015 12:57:08,1640298243,5/21/2015 12:56:39,False,prodege,0.6825,21417560,GBR,C3,Cambridge,151.225.116.143,FOOD COBALAMIN MALABSORPTION causes PERNICIOUS ANEMIA,174,8,,190,36,causes,0.824957911384306,804713-FS1-4,"Whereas FOOD COBALAMIN MALABSORPTION is common among patients with subclinical deficiency, those with clinical manifestations of cobalamin deficiency are more likely to have PERNICIOUS ANEMIA",PERNICIOUS ANEMIA,FOOD COBALAMIN MALABSORPTION,TWrex-cause
724398403,5/21/2015 13:26:00,1640311681,5/21/2015 13:25:14,False,clixsense,0.8958,17950689,GBR,Y9,Tonypandy,92.2.44.79,PERNICIOUS ANEMIA causes FOOD COBALAMIN MALABSORPTION,174,8,,190,36,causes,0.824957911384306,804713-FS1-4,"Whereas FOOD COBALAMIN MALABSORPTION is common among patients with subclinical deficiency, those with clinical manifestations of cobalamin deficiency are more likely to have PERNICIOUS ANEMIA",PERNICIOUS ANEMIA,FOOD COBALAMIN MALABSORPTION,TWrex-cause
724398403,5/21/2015 13:41:25,1640319205,5/21/2015 13:39:25,False,instagc,0.6964,15285653,USA,,,172.162.76.35,PERNICIOUS ANEMIA causes FOOD COBALAMIN MALABSORPTION,174,8,,190,36,causes,0.824957911384306,804713-FS1-4,"Whereas FOOD COBALAMIN MALABSORPTION is common among patients with subclinical deficiency, those with clinical manifestations of cobalamin deficiency are more likely to have PERNICIOUS ANEMIA",PERNICIOUS ANEMIA,FOOD COBALAMIN MALABSORPTION,TWrex-cause
724398403,5/21/2015 13:43:02,1640319973,5/21/2015 13:40:42,False,points4rewards,0.6548,28755767,USA,VA,Chester,68.57.118.32,FOOD COBALAMIN MALABSORPTION causes PERNICIOUS ANEMIA,174,8,,190,36,causes,0.824957911384306,804713-FS1-4,"Whereas FOOD COBALAMIN MALABSORPTION is common among patients with subclinical deficiency, those with clinical manifestations of cobalamin deficiency are more likely to have PERNICIOUS ANEMIA",PERNICIOUS ANEMIA,FOOD COBALAMIN MALABSORPTION,TWrex-cause
724398403,5/21/2015 13:44:03,1640320551,5/21/2015 13:42:52,False,prodege,0.6032,16101132,GBR,G1,Hounslow,90.207.88.197,no_relation,174,8,,190,36,causes,0.824957911384306,804713-FS1-4,"Whereas FOOD COBALAMIN MALABSORPTION is common among patients with subclinical deficiency, those with clinical manifestations of cobalamin deficiency are more likely to have PERNICIOUS ANEMIA",PERNICIOUS ANEMIA,FOOD COBALAMIN MALABSORPTION,TWrex-cause
724398407,5/21/2015 10:33:25,1640233089,5/21/2015 10:33:04,False,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,CLOSTRIDIUM causes CLOSTRIDIUM INFECTIONS,5,5,,26,16,causes,0.913811548620257,810875-FS1-4,100  CLOSTRIDIUM INFECTIONS  Treatment of infections caused by  CLOSTRIDIUM,CLOSTRIDIUM INFECTIONS,CLOSTRIDIUM,TWrex-cause
724398407,5/21/2015 10:56:39,1640245112,5/21/2015 10:55:54,False,instagc,0.9167,20845955,GBR,I2,Manchester,90.214.24.62,CLOSTRIDIUM causes CLOSTRIDIUM INFECTIONS,5,5,,26,16,causes,0.913811548620257,810875-FS1-4,100  CLOSTRIDIUM INFECTIONS  Treatment of infections caused by  CLOSTRIDIUM,CLOSTRIDIUM INFECTIONS,CLOSTRIDIUM,TWrex-cause
724398407,5/21/2015 11:20:45,1640255644,5/21/2015 11:20:18,False,bitcoinget,0.75,30546513,GBR,G6,Hull,194.42.67.50,no_relation,5,5,,26,16,causes,0.913811548620257,810875-FS1-4,100  CLOSTRIDIUM INFECTIONS  Treatment of infections caused by  CLOSTRIDIUM,CLOSTRIDIUM INFECTIONS,CLOSTRIDIUM,TWrex-cause
724398407,5/21/2015 11:38:07,1640263229,5/21/2015 11:36:48,False,clixsense,0.9056,31579138,AUS,02,Hurstville,14.200.129.68,CLOSTRIDIUM causes CLOSTRIDIUM INFECTIONS,5,5,,26,16,causes,0.913811548620257,810875-FS1-4,100  CLOSTRIDIUM INFECTIONS  Treatment of infections caused by  CLOSTRIDIUM,CLOSTRIDIUM INFECTIONS,CLOSTRIDIUM,TWrex-cause
724398407,5/21/2015 11:38:20,1640263425,5/21/2015 11:38:01,False,prodege,0.8847,27934334,GBR,D2,Derby,86.162.35.12,CLOSTRIDIUM causes CLOSTRIDIUM INFECTIONS,5,5,,26,16,causes,0.913811548620257,810875-FS1-4,100  CLOSTRIDIUM INFECTIONS  Treatment of infections caused by  CLOSTRIDIUM,CLOSTRIDIUM INFECTIONS,CLOSTRIDIUM,TWrex-cause
724398407,5/21/2015 12:00:39,1640273514,5/21/2015 12:00:29,False,elite,0.4821,31913360,USA,DE,,108.59.8.218,CLOSTRIDIUM INFECTIONS causes CLOSTRIDIUM,5,5,,26,16,causes,0.913811548620257,810875-FS1-4,100  CLOSTRIDIUM INFECTIONS  Treatment of infections caused by  CLOSTRIDIUM,CLOSTRIDIUM INFECTIONS,CLOSTRIDIUM,TWrex-cause
724398407,5/21/2015 12:01:05,1640273714,5/21/2015 12:00:10,False,instagc,0.6786,15176395,USA,IN,Greenwood,50.195.163.121,CLOSTRIDIUM causes CLOSTRIDIUM INFECTIONS,5,5,,26,16,causes,0.913811548620257,810875-FS1-4,100  CLOSTRIDIUM INFECTIONS  Treatment of infections caused by  CLOSTRIDIUM,CLOSTRIDIUM INFECTIONS,CLOSTRIDIUM,TWrex-cause
724398412,5/21/2015 12:05:23,1640275639,5/21/2015 12:04:56,False,cotter,0.8294,13805544,USA,MI,Battle Creek,107.140.176.37,TAPEWORM LARVAE causes COENUROSIS,0,21,,9,36,causes,1.0,810913-FS1-4,COENUROSIS caused by TAPEWORM LARVAE usually produces grapelike cysts that may obstruct CSF outflow in the 4th ventricle.,COENUROSIS,TAPEWORM LARVAE,TWrex-cause
724398412,5/21/2015 12:07:38,1640276710,5/21/2015 12:07:24,False,neodev,0.7917,12115558,USA,OH,Twinsburg,98.27.164.131,TAPEWORM LARVAE causes COENUROSIS,0,21,,9,36,causes,1.0,810913-FS1-4,COENUROSIS caused by TAPEWORM LARVAE usually produces grapelike cysts that may obstruct CSF outflow in the 4th ventricle.,COENUROSIS,TAPEWORM LARVAE,TWrex-cause
724398412,5/21/2015 12:28:52,1640286225,5/21/2015 12:27:05,False,neodev,0.6944,30588889,NLD,07,Amsterdam,77.248.175.222,TAPEWORM LARVAE causes COENUROSIS,0,21,,9,36,causes,1.0,810913-FS1-4,COENUROSIS caused by TAPEWORM LARVAE usually produces grapelike cysts that may obstruct CSF outflow in the 4th ventricle.,COENUROSIS,TAPEWORM LARVAE,TWrex-cause
724398412,5/21/2015 12:36:16,1640289223,5/21/2015 12:35:39,False,clixsense,0.6062,22947672,GBR,,,88.144.127.68,TAPEWORM LARVAE causes COENUROSIS,0,21,,9,36,causes,1.0,810913-FS1-4,COENUROSIS caused by TAPEWORM LARVAE usually produces grapelike cysts that may obstruct CSF outflow in the 4th ventricle.,COENUROSIS,TAPEWORM LARVAE,TWrex-cause
724398412,5/21/2015 12:47:12,1640294102,5/21/2015 12:47:02,False,pocketmoneygpt,0.675,28884030,USA,WI,Minocqua,75.143.134.247,TAPEWORM LARVAE causes COENUROSIS,0,21,,9,36,causes,1.0,810913-FS1-4,COENUROSIS caused by TAPEWORM LARVAE usually produces grapelike cysts that may obstruct CSF outflow in the 4th ventricle.,COENUROSIS,TAPEWORM LARVAE,TWrex-cause
724398412,5/21/2015 12:49:03,1640294858,5/21/2015 12:48:51,False,instagc,0.6417,13581319,USA,IL,Mount Vernon,66.232.166.86,TAPEWORM LARVAE causes COENUROSIS,0,21,,9,36,causes,1.0,810913-FS1-4,COENUROSIS caused by TAPEWORM LARVAE usually produces grapelike cysts that may obstruct CSF outflow in the 4th ventricle.,COENUROSIS,TAPEWORM LARVAE,TWrex-cause
724398412,5/21/2015 12:55:41,1640297636,5/21/2015 12:55:17,False,prodege,0.6825,21417560,GBR,C3,Cambridge,151.225.116.143,TAPEWORM LARVAE causes COENUROSIS,0,21,,9,36,causes,1.0,810913-FS1-4,COENUROSIS caused by TAPEWORM LARVAE usually produces grapelike cysts that may obstruct CSF outflow in the 4th ventricle.,COENUROSIS,TAPEWORM LARVAE,TWrex-cause
724398418,5/21/2015 10:30:26,1640231621,5/21/2015 10:30:10,False,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,no_relation,63,38,,66,42,causes,0.488677777425221,802787-FS1-4,"exanthema , eruption] Any eruption or RASH that appears on the SKIN as opposed to one that appears on the mucous membranes (enanthem.",SKIN,RASH,TWrex-cause
724398418,5/21/2015 10:55:13,1640244470,5/21/2015 10:54:52,False,instagc,0.9167,20845955,GBR,I2,Manchester,90.214.24.62,no_relation,63,38,,66,42,causes,0.488677777425221,802787-FS1-4,"exanthema , eruption] Any eruption or RASH that appears on the SKIN as opposed to one that appears on the mucous membranes (enanthem.",SKIN,RASH,TWrex-cause
724398418,5/21/2015 11:05:36,1640249175,5/21/2015 11:05:16,False,bitcoinget,0.75,30546513,GBR,G6,Hull,194.42.67.50,no_relation,63,38,,66,42,causes,0.488677777425221,802787-FS1-4,"exanthema , eruption] Any eruption or RASH that appears on the SKIN as opposed to one that appears on the mucous membranes (enanthem.",SKIN,RASH,TWrex-cause
724398418,5/21/2015 11:26:00,1640257812,5/21/2015 11:25:23,False,prodege,0.9028,2850251,USA,IL,Plainfield,71.201.50.48,no_relation,63,38,,66,42,causes,0.488677777425221,802787-FS1-4,"exanthema , eruption] Any eruption or RASH that appears on the SKIN as opposed to one that appears on the mucous membranes (enanthem.",SKIN,RASH,TWrex-cause
724398418,5/21/2015 11:31:26,1640260286,5/21/2015 11:29:10,False,clixsense,0.9056,31579138,AUS,02,Hurstville,14.200.129.68,no_relation,63,38,,66,42,causes,0.488677777425221,802787-FS1-4,"exanthema , eruption] Any eruption or RASH that appears on the SKIN as opposed to one that appears on the mucous membranes (enanthem.",SKIN,RASH,TWrex-cause
724398418,5/21/2015 11:37:05,1640262681,5/21/2015 11:36:35,False,prodege,0.8847,27934334,GBR,D2,Derby,86.162.35.12,no_relation,63,38,,66,42,causes,0.488677777425221,802787-FS1-4,"exanthema , eruption] Any eruption or RASH that appears on the SKIN as opposed to one that appears on the mucous membranes (enanthem.",SKIN,RASH,TWrex-cause
724398418,5/21/2015 11:59:14,1640272898,5/21/2015 11:58:06,False,instagc,0.6786,15176395,USA,IN,Greenwood,50.195.163.121,no_relation,63,38,,66,42,causes,0.488677777425221,802787-FS1-4,"exanthema , eruption] Any eruption or RASH that appears on the SKIN as opposed to one that appears on the mucous membranes (enanthem.",SKIN,RASH,TWrex-cause
724398420,5/21/2015 13:52:12,1640324825,5/21/2015 13:51:45,False,sharecashgpt,0.55,28627999,CAN,ON,Sudbury,66.103.55.12,no_relation,0,83,,13,98,causes,0.640512615220348,812989-FS1-4,"OSTEOARTHRITIS other degenerative changes, trauma or fractures, osteomyelitis, and PAGET'S DISEASE can all result in increased uptake on bone scans.",OSTEOARTHRITIS,PAGET'S DISEASE,TWrex-cause
724398420,5/21/2015 14:03:29,1640331529,5/21/2015 14:03:14,False,clixsense,0.5833,22751911,NLD,04,Groningen,195.241.153.97,no_relation,0,83,,13,98,causes,0.640512615220348,812989-FS1-4,"OSTEOARTHRITIS other degenerative changes, trauma or fractures, osteomyelitis, and PAGET'S DISEASE can all result in increased uptake on bone scans.",OSTEOARTHRITIS,PAGET'S DISEASE,TWrex-cause
724398420,5/21/2015 14:12:27,1640337257,5/21/2015 14:12:05,False,prodege,0.6071,22031444,GBR,F2,Gosport,92.24.208.136,no_relation,0,83,,13,98,causes,0.640512615220348,812989-FS1-4,"OSTEOARTHRITIS other degenerative changes, trauma or fractures, osteomyelitis, and PAGET'S DISEASE can all result in increased uptake on bone scans.",OSTEOARTHRITIS,PAGET'S DISEASE,TWrex-cause
724398420,5/21/2015 14:12:59,1640337531,5/21/2015 14:08:41,False,prodege,0.6488,14571439,CAN,ON,Toronto,142.20.20.193,no_relation,0,83,,13,98,causes,0.640512615220348,812989-FS1-4,"OSTEOARTHRITIS other degenerative changes, trauma or fractures, osteomyelitis, and PAGET'S DISEASE can all result in increased uptake on bone scans.",OSTEOARTHRITIS,PAGET'S DISEASE,TWrex-cause
724398420,5/21/2015 14:14:22,1640338241,5/21/2015 14:13:22,False,onestopgpt,0.75,21275875,CAN,ON,Hamilton,24.36.121.10,no_relation,0,83,,13,98,causes,0.640512615220348,812989-FS1-4,"OSTEOARTHRITIS other degenerative changes, trauma or fractures, osteomyelitis, and PAGET'S DISEASE can all result in increased uptake on bone scans.",OSTEOARTHRITIS,PAGET'S DISEASE,TWrex-cause
724398420,5/21/2015 14:15:36,1640339058,5/21/2015 14:14:32,False,clixsense,0.5833,30681826,GBR,I3,Rochester,86.163.150.232,no_relation,0,83,,13,98,causes,0.640512615220348,812989-FS1-4,"OSTEOARTHRITIS other degenerative changes, trauma or fractures, osteomyelitis, and PAGET'S DISEASE can all result in increased uptake on bone scans.",OSTEOARTHRITIS,PAGET'S DISEASE,TWrex-cause
724398420,5/21/2015 14:20:58,1640342587,5/21/2015 14:19:39,False,vivatic,0.7857,32338429,GBR,G1,Feltham,92.24.40.208,no_relation,0,83,,13,98,causes,0.640512615220348,812989-FS1-4,"OSTEOARTHRITIS other degenerative changes, trauma or fractures, osteomyelitis, and PAGET'S DISEASE can all result in increased uptake on bone scans.",OSTEOARTHRITIS,PAGET'S DISEASE,TWrex-cause
724398426,5/21/2015 13:30:47,1640313981,5/21/2015 13:30:28,False,clixsense,0.8958,17950689,GBR,Y9,Tonypandy,92.2.44.79,CLOSTRIDIA causes EMPHYSEMATOUS CHOLECYSTITIS GAS GANGRENE OF THE UTERUS,43,0,,96,10,causes,0.929981109950554,810051-FS1-4,"CLOSTRIDIA are often the primary agents in EMPHYSEMATOUS CHOLECYSTITIS GAS GANGRENE OF THE UTERUS (previously common with septic abortion), certain other female genital tract infections (tubo ovarian, pelvic, and uterine abscesses), and infection after perforation of colon carcinoma.",EMPHYSEMATOUS CHOLECYSTITIS GAS GANGRENE OF THE UTERUS,CLOSTRIDIA,TWrex-cause
724398426,5/21/2015 13:45:59,1640321583,5/21/2015 13:45:37,False,prodege,0.6032,16101132,GBR,G1,Hounslow,90.207.88.197,CLOSTRIDIA causes EMPHYSEMATOUS CHOLECYSTITIS GAS GANGRENE OF THE UTERUS,43,0,,96,10,causes,0.929981109950554,810051-FS1-4,"CLOSTRIDIA are often the primary agents in EMPHYSEMATOUS CHOLECYSTITIS GAS GANGRENE OF THE UTERUS (previously common with septic abortion), certain other female genital tract infections (tubo ovarian, pelvic, and uterine abscesses), and infection after perforation of colon carcinoma.",EMPHYSEMATOUS CHOLECYSTITIS GAS GANGRENE OF THE UTERUS,CLOSTRIDIA,TWrex-cause
724398426,5/21/2015 13:46:23,1640321796,5/21/2015 13:45:47,False,points4rewards,0.6548,28755767,USA,VA,Chester,68.57.118.32,CLOSTRIDIA causes EMPHYSEMATOUS CHOLECYSTITIS GAS GANGRENE OF THE UTERUS,43,0,,96,10,causes,0.929981109950554,810051-FS1-4,"CLOSTRIDIA are often the primary agents in EMPHYSEMATOUS CHOLECYSTITIS GAS GANGRENE OF THE UTERUS (previously common with septic abortion), certain other female genital tract infections (tubo ovarian, pelvic, and uterine abscesses), and infection after perforation of colon carcinoma.",EMPHYSEMATOUS CHOLECYSTITIS GAS GANGRENE OF THE UTERUS,CLOSTRIDIA,TWrex-cause
724398426,5/21/2015 13:48:03,1640322571,5/21/2015 13:47:09,False,instagc,0.6964,15285653,USA,,,172.162.76.35,CLOSTRIDIA causes EMPHYSEMATOUS CHOLECYSTITIS GAS GANGRENE OF THE UTERUS,43,0,,96,10,causes,0.929981109950554,810051-FS1-4,"CLOSTRIDIA are often the primary agents in EMPHYSEMATOUS CHOLECYSTITIS GAS GANGRENE OF THE UTERUS (previously common with septic abortion), certain other female genital tract infections (tubo ovarian, pelvic, and uterine abscesses), and infection after perforation of colon carcinoma.",EMPHYSEMATOUS CHOLECYSTITIS GAS GANGRENE OF THE UTERUS,CLOSTRIDIA,TWrex-cause
724398426,5/21/2015 13:51:44,1640324650,5/21/2015 13:51:19,False,sharecashgpt,0.55,28627999,CAN,ON,Sudbury,66.103.55.12,CLOSTRIDIA causes EMPHYSEMATOUS CHOLECYSTITIS GAS GANGRENE OF THE UTERUS,43,0,,96,10,causes,0.929981109950554,810051-FS1-4,"CLOSTRIDIA are often the primary agents in EMPHYSEMATOUS CHOLECYSTITIS GAS GANGRENE OF THE UTERUS (previously common with septic abortion), certain other female genital tract infections (tubo ovarian, pelvic, and uterine abscesses), and infection after perforation of colon carcinoma.",EMPHYSEMATOUS CHOLECYSTITIS GAS GANGRENE OF THE UTERUS,CLOSTRIDIA,TWrex-cause
724398426,5/21/2015 14:03:13,1640331387,5/21/2015 14:02:44,False,clixsense,0.5833,22751911,NLD,04,Groningen,195.241.153.97,no_relation,43,0,,96,10,causes,0.929981109950554,810051-FS1-4,"CLOSTRIDIA are often the primary agents in EMPHYSEMATOUS CHOLECYSTITIS GAS GANGRENE OF THE UTERUS (previously common with septic abortion), certain other female genital tract infections (tubo ovarian, pelvic, and uterine abscesses), and infection after perforation of colon carcinoma.",EMPHYSEMATOUS CHOLECYSTITIS GAS GANGRENE OF THE UTERUS,CLOSTRIDIA,TWrex-cause
724398426,5/21/2015 14:08:40,1640334894,5/21/2015 14:07:08,False,prodege,0.6488,14571439,CAN,ON,Toronto,142.20.20.193,CLOSTRIDIA causes EMPHYSEMATOUS CHOLECYSTITIS GAS GANGRENE OF THE UTERUS,43,0,,96,10,causes,0.929981109950554,810051-FS1-4,"CLOSTRIDIA are often the primary agents in EMPHYSEMATOUS CHOLECYSTITIS GAS GANGRENE OF THE UTERUS (previously common with septic abortion), certain other female genital tract infections (tubo ovarian, pelvic, and uterine abscesses), and infection after perforation of colon carcinoma.",EMPHYSEMATOUS CHOLECYSTITIS GAS GANGRENE OF THE UTERUS,CLOSTRIDIA,TWrex-cause
724534003,5/21/2015 17:13:45,1640448077,5/21/2015 17:13:27,False,clixsense,0.96,32549163,CAN,MB,Winnipeg,206.45.167.246,no_relation,26,76,,43,117,causes,0.464990554975277,803065-FS1-4," In evaluating women for CUSHING'S SYNDROME vs. polycystic ovary syndrome, 1 MG DEXAMETHASONE SUPPRESSION or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",CUSHING'S SYNDROME,1 MG DEXAMETHASONE SUPPRESSION,TWrex-cause
724534003,5/21/2015 17:14:28,1640448439,5/21/2015 17:14:12,False,clixsense,0.95,6417722,USA,MI,Taylor,99.170.106.105,no_relation,26,76,,43,117,causes,0.464990554975277,803065-FS1-4," In evaluating women for CUSHING'S SYNDROME vs. polycystic ovary syndrome, 1 MG DEXAMETHASONE SUPPRESSION or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",CUSHING'S SYNDROME,1 MG DEXAMETHASONE SUPPRESSION,TWrex-cause
724534003,5/21/2015 17:17:05,1640450144,5/21/2015 17:16:33,False,gifthunterclub,0.8611,29582088,GBR,I2,Manchester,89.240.68.44,no_relation,26,76,,43,117,causes,0.464990554975277,803065-FS1-4," In evaluating women for CUSHING'S SYNDROME vs. polycystic ovary syndrome, 1 MG DEXAMETHASONE SUPPRESSION or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",CUSHING'S SYNDROME,1 MG DEXAMETHASONE SUPPRESSION,TWrex-cause
724534003,5/21/2015 17:28:35,1640457859,5/21/2015 17:28:01,False,vivatic,0.8809999999999999,32338429,GBR,G1,Feltham,92.24.40.208,no_relation,26,76,,43,117,causes,0.464990554975277,803065-FS1-4," In evaluating women for CUSHING'S SYNDROME vs. polycystic ovary syndrome, 1 MG DEXAMETHASONE SUPPRESSION or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",CUSHING'S SYNDROME,1 MG DEXAMETHASONE SUPPRESSION,TWrex-cause
724534003,5/21/2015 17:30:48,1640459239,5/21/2015 17:30:13,False,instagc,0.7264,32352104,USA,ME,Bangor,74.75.63.81,no_relation,26,76,,43,117,causes,0.464990554975277,803065-FS1-4," In evaluating women for CUSHING'S SYNDROME vs. polycystic ovary syndrome, 1 MG DEXAMETHASONE SUPPRESSION or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",CUSHING'S SYNDROME,1 MG DEXAMETHASONE SUPPRESSION,TWrex-cause
724534003,5/21/2015 17:36:30,1640462600,5/21/2015 17:34:28,False,clixsense,0.7083,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,26,76,,43,117,causes,0.464990554975277,803065-FS1-4," In evaluating women for CUSHING'S SYNDROME vs. polycystic ovary syndrome, 1 MG DEXAMETHASONE SUPPRESSION or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",CUSHING'S SYNDROME,1 MG DEXAMETHASONE SUPPRESSION,TWrex-cause
724534003,5/21/2015 17:40:16,1640465242,5/21/2015 17:39:32,False,neodev,0.7798,20961587,NLD,05,Maastricht,84.26.48.136,no_relation,26,76,,43,117,causes,0.464990554975277,803065-FS1-4," In evaluating women for CUSHING'S SYNDROME vs. polycystic ovary syndrome, 1 MG DEXAMETHASONE SUPPRESSION or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",CUSHING'S SYNDROME,1 MG DEXAMETHASONE SUPPRESSION,TWrex-cause
724534007,5/21/2015 17:40:55,1640465668,5/21/2015 17:40:37,False,instagc,0.6607,13581319,USA,IL,Mount Vernon,66.232.166.86,PV causes THROMBOSIS,96,16,,105,18,causes,0.696310623822791,812730-FS1-4," Management in PV should be individualized by age, the presence or absence of risk factors for THROMBOSIS and childbearing potential.",THROMBOSIS,PV,TWrex-cause
724534007,5/21/2015 17:41:36,1640466189,5/21/2015 17:41:13,False,neodev,0.7798,20961587,NLD,05,Maastricht,84.26.48.136,no_relation,96,16,,105,18,causes,0.696310623822791,812730-FS1-4," Management in PV should be individualized by age, the presence or absence of risk factors for THROMBOSIS and childbearing potential.",THROMBOSIS,PV,TWrex-cause
724534007,5/21/2015 17:46:01,1640468995,5/21/2015 17:45:56,False,neodev,0.4167,31977841,USA,IL,Chicago,69.175.85.2,THROMBOSIS causes PV,96,16,,105,18,causes,0.696310623822791,812730-FS1-4," Management in PV should be individualized by age, the presence or absence of risk factors for THROMBOSIS and childbearing potential.",THROMBOSIS,PV,TWrex-cause
724534007,5/21/2015 17:54:12,1640474061,5/21/2015 17:53:09,False,points4rewards,0.7576,20113482,USA,OR,Portland,67.213.218.72,no_relation,96,16,,105,18,causes,0.696310623822791,812730-FS1-4," Management in PV should be individualized by age, the presence or absence of risk factors for THROMBOSIS and childbearing potential.",THROMBOSIS,PV,TWrex-cause
724534007,5/21/2015 18:16:05,1640489326,5/21/2015 18:15:23,False,instagc,0.6134,15864091,USA,OK,Oklahoma City,104.0.113.133,PV causes THROMBOSIS,96,16,,105,18,causes,0.696310623822791,812730-FS1-4," Management in PV should be individualized by age, the presence or absence of risk factors for THROMBOSIS and childbearing potential.",THROMBOSIS,PV,TWrex-cause
724534007,5/21/2015 18:31:46,1640493347,5/21/2015 18:30:58,False,neodev,0.6778,32216655,NLD,07,Amsterdam,145.100.72.168,no_relation,96,16,,105,18,causes,0.696310623822791,812730-FS1-4," Management in PV should be individualized by age, the presence or absence of risk factors for THROMBOSIS and childbearing potential.",THROMBOSIS,PV,TWrex-cause
724534007,5/21/2015 18:37:17,1640498482,5/21/2015 18:35:57,False,neodev,0.7011,31448050,GBR,,,92.24.68.74,no_relation,96,16,,105,18,causes,0.696310623822791,812730-FS1-4," Management in PV should be individualized by age, the presence or absence of risk factors for THROMBOSIS and childbearing potential.",THROMBOSIS,PV,TWrex-cause
724534008,5/21/2015 16:37:42,1640424999,5/21/2015 16:37:27,False,instagc,0.8333,23287154,USA,CA,San Jose,130.65.251.20,BOTULINUM TOXIN causes BOTULISM,0,33,,7,48,causes,1.0,810555-FS1-4,BOTULISM caused by production of BOTULINUM TOXIN in the colon following ingestion of spores of  Clostridium botulinum.,BOTULISM,BOTULINUM TOXIN,TWrex-cause
724534008,5/21/2015 16:40:22,1640426771,5/21/2015 16:40:05,False,neodev,0.8472,14096345,NLD,03,Eibergen,77.174.124.109,BOTULINUM TOXIN causes BOTULISM,0,33,,7,48,causes,1.0,810555-FS1-4,BOTULISM caused by production of BOTULINUM TOXIN in the colon following ingestion of spores of  Clostridium botulinum.,BOTULISM,BOTULINUM TOXIN,TWrex-cause
724534008,5/21/2015 17:05:57,1640443091,5/21/2015 17:05:49,False,neodev,0.2202,31789301,USA,CA,Torrance,66.171.228.87,BOTULISM causes BOTULINUM TOXIN,0,33,,7,48,causes,1.0,810555-FS1-4,BOTULISM caused by production of BOTULINUM TOXIN in the colon following ingestion of spores of  Clostridium botulinum.,BOTULISM,BOTULINUM TOXIN,TWrex-cause
724534008,5/21/2015 17:12:51,1640447419,5/21/2015 17:12:21,False,clixsense,0.96,32549163,CAN,MB,Winnipeg,206.45.167.246,BOTULINUM TOXIN causes BOTULISM,0,33,,7,48,causes,1.0,810555-FS1-4,BOTULISM caused by production of BOTULINUM TOXIN in the colon following ingestion of spores of  Clostridium botulinum.,BOTULISM,BOTULINUM TOXIN,TWrex-cause
724534008,5/21/2015 17:13:30,1640447874,5/21/2015 17:12:53,False,clixsense,0.95,6417722,USA,MI,Taylor,99.170.106.105,BOTULINUM TOXIN causes BOTULISM,0,33,,7,48,causes,1.0,810555-FS1-4,BOTULISM caused by production of BOTULINUM TOXIN in the colon following ingestion of spores of  Clostridium botulinum.,BOTULISM,BOTULINUM TOXIN,TWrex-cause
724534008,5/21/2015 17:15:20,1640448847,5/21/2015 17:14:24,False,gifthunterclub,0.8611,29582088,GBR,I2,Manchester,89.240.68.44,BOTULINUM TOXIN causes BOTULISM,0,33,,7,48,causes,1.0,810555-FS1-4,BOTULISM caused by production of BOTULINUM TOXIN in the colon following ingestion of spores of  Clostridium botulinum.,BOTULISM,BOTULINUM TOXIN,TWrex-cause
724534008,5/21/2015 17:26:43,1640456700,5/21/2015 17:25:59,False,vivatic,0.8809999999999999,32338429,GBR,G1,Feltham,92.24.40.208,BOTULINUM TOXIN causes BOTULISM,0,33,,7,48,causes,1.0,810555-FS1-4,BOTULISM caused by production of BOTULINUM TOXIN in the colon following ingestion of spores of  Clostridium botulinum.,BOTULISM,BOTULINUM TOXIN,TWrex-cause
724534017,5/21/2015 16:16:58,1640411233,5/21/2015 16:16:26,False,pocketmoneygpt,0.9722,28884030,USA,WI,Minocqua,75.143.134.247,RABIES VIRUS causes PARALYTIC RABIES,174,124,,189,136,causes,0.9878291611472622,815099-FS1-4,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La Ongpant M, et al. Sequence analysis of RABIES VIRUS in humans exhibiting encephalitic or PARALYTIC RABIES",PARALYTIC RABIES,RABIES VIRUS,TWrex-cause
724534017,5/21/2015 16:19:19,1640412692,5/21/2015 16:19:02,False,neodev,0.6667,31066862,USA,CA,San Jose,128.107.241.176,no_relation,174,124,,189,136,causes,0.9878291611472622,815099-FS1-4,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La Ongpant M, et al. Sequence analysis of RABIES VIRUS in humans exhibiting encephalitic or PARALYTIC RABIES",PARALYTIC RABIES,RABIES VIRUS,TWrex-cause
724534017,5/21/2015 16:22:31,1640414950,5/21/2015 16:18:58,False,clixsense,0.7569,30681826,GBR,I3,Rochester,86.163.150.232,RABIES VIRUS causes PARALYTIC RABIES,174,124,,189,136,causes,0.9878291611472622,815099-FS1-4,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La Ongpant M, et al. Sequence analysis of RABIES VIRUS in humans exhibiting encephalitic or PARALYTIC RABIES",PARALYTIC RABIES,RABIES VIRUS,TWrex-cause
724534017,5/21/2015 16:23:58,1640415886,5/21/2015 16:23:38,False,onestopgpt,0.6458,21275875,CAN,ON,Hamilton,24.36.121.10,RABIES VIRUS causes PARALYTIC RABIES,174,124,,189,136,causes,0.9878291611472622,815099-FS1-4,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La Ongpant M, et al. Sequence analysis of RABIES VIRUS in humans exhibiting encephalitic or PARALYTIC RABIES",PARALYTIC RABIES,RABIES VIRUS,TWrex-cause
724534017,5/21/2015 16:30:12,1640420162,5/21/2015 16:29:50,False,sharecashgpt,0.4208,28627999,CAN,ON,Sudbury,66.103.55.12,PARALYTIC RABIES causes RABIES VIRUS,174,124,,189,136,causes,0.9878291611472622,815099-FS1-4,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La Ongpant M, et al. Sequence analysis of RABIES VIRUS in humans exhibiting encephalitic or PARALYTIC RABIES",PARALYTIC RABIES,RABIES VIRUS,TWrex-cause
724534017,5/21/2015 16:31:44,1640421271,5/21/2015 16:31:02,False,prodege,0.7321,14848125,GBR,U8,Edinburgh,86.149.215.103,no_relation,174,124,,189,136,causes,0.9878291611472622,815099-FS1-4,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La Ongpant M, et al. Sequence analysis of RABIES VIRUS in humans exhibiting encephalitic or PARALYTIC RABIES",PARALYTIC RABIES,RABIES VIRUS,TWrex-cause
724534017,5/21/2015 16:33:27,1640422337,5/21/2015 16:33:12,False,instagc,0.8571,31184650,USA,IA,West Des Moines,63.153.203.116,RABIES VIRUS causes PARALYTIC RABIES,174,124,,189,136,causes,0.9878291611472622,815099-FS1-4,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La Ongpant M, et al. Sequence analysis of RABIES VIRUS in humans exhibiting encephalitic or PARALYTIC RABIES",PARALYTIC RABIES,RABIES VIRUS,TWrex-cause
724534019,5/21/2015 16:15:05,1640410052,5/21/2015 16:14:49,False,pocketmoneygpt,0.9722,28884030,USA,WI,Minocqua,75.143.134.247,ESSENTIAL THROMBOCYTHEMIA causes HEMORRHAGE,75,18,,84,43,causes,0.668153104781061,813035-FS1-4,"In a patient with ESSENTIAL THROMBOCYTHEMIA who has clinically significant HEMORRHAGE or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,TWrex-cause
724534019,5/21/2015 16:16:01,1640410736,5/21/2015 16:15:11,False,clixsense,0.7569,30681826,GBR,I3,Rochester,86.163.150.232,ESSENTIAL THROMBOCYTHEMIA causes HEMORRHAGE,75,18,,84,43,causes,0.668153104781061,813035-FS1-4,"In a patient with ESSENTIAL THROMBOCYTHEMIA who has clinically significant HEMORRHAGE or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,TWrex-cause
724534019,5/21/2015 16:16:59,1640411245,5/21/2015 16:16:11,False,neodev,0.6667,31066862,USA,CA,San Jose,128.107.241.176,no_relation,75,18,,84,43,causes,0.668153104781061,813035-FS1-4,"In a patient with ESSENTIAL THROMBOCYTHEMIA who has clinically significant HEMORRHAGE or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,TWrex-cause
724534019,5/21/2015 16:20:22,1640413417,5/21/2015 16:19:49,False,onestopgpt,0.6458,21275875,CAN,ON,Hamilton,24.36.121.10,no_relation,75,18,,84,43,causes,0.668153104781061,813035-FS1-4,"In a patient with ESSENTIAL THROMBOCYTHEMIA who has clinically significant HEMORRHAGE or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,TWrex-cause
724534019,5/21/2015 16:27:54,1640418694,5/21/2015 16:27:29,False,sharecashgpt,0.4208,28627999,CAN,ON,Sudbury,66.103.55.12,ESSENTIAL THROMBOCYTHEMIA causes HEMORRHAGE,75,18,,84,43,causes,0.668153104781061,813035-FS1-4,"In a patient with ESSENTIAL THROMBOCYTHEMIA who has clinically significant HEMORRHAGE or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,TWrex-cause
724534019,5/21/2015 16:28:48,1640419174,5/21/2015 16:28:15,False,prodege,0.7321,14848125,GBR,U8,Edinburgh,86.149.215.103,ESSENTIAL THROMBOCYTHEMIA causes HEMORRHAGE,75,18,,84,43,causes,0.668153104781061,813035-FS1-4,"In a patient with ESSENTIAL THROMBOCYTHEMIA who has clinically significant HEMORRHAGE or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,TWrex-cause
724534019,5/21/2015 16:32:14,1640421706,5/21/2015 16:31:29,False,neodev,0.7857,19004420,GBR,P8,Devizes,31.54.209.43,no_relation,75,18,,84,43,causes,0.668153104781061,813035-FS1-4,"In a patient with ESSENTIAL THROMBOCYTHEMIA who has clinically significant HEMORRHAGE or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,TWrex-cause
724534038,5/21/2015 17:32:50,1640460324,5/21/2015 17:32:16,False,instagc,0.7264,32352104,USA,ME,Bangor,74.75.63.81,no_relation,93,115,,96,128,causes,0.948683298050514,811229-FS1-4,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, PUUMALA VIRUS and Dobrava/Belgrade virus.",HFRS,PUUMALA VIRUS,TWrex-cause
724534038,5/21/2015 17:40:36,1640465458,5/21/2015 17:40:12,False,instagc,0.6607,13581319,USA,IL,Mount Vernon,66.232.166.86,PUUMALA VIRUS causes HFRS,93,115,,96,128,causes,0.948683298050514,811229-FS1-4,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, PUUMALA VIRUS and Dobrava/Belgrade virus.",HFRS,PUUMALA VIRUS,TWrex-cause
724534038,5/21/2015 17:41:12,1640465897,5/21/2015 17:40:48,False,neodev,0.7798,20961587,NLD,05,Maastricht,84.26.48.136,PUUMALA VIRUS causes HFRS,93,115,,96,128,causes,0.948683298050514,811229-FS1-4,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, PUUMALA VIRUS and Dobrava/Belgrade virus.",HFRS,PUUMALA VIRUS,TWrex-cause
724534038,5/21/2015 17:45:54,1640468865,5/21/2015 17:45:32,False,neodev,0.4167,31977841,USA,IL,Chicago,69.175.85.2,PUUMALA VIRUS causes HFRS,93,115,,96,128,causes,0.948683298050514,811229-FS1-4,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, PUUMALA VIRUS and Dobrava/Belgrade virus.",HFRS,PUUMALA VIRUS,TWrex-cause
724534038,5/21/2015 17:46:30,1640469485,5/21/2015 17:44:57,False,clixsense,0.475,6330997,USA,PA,Greencastle,98.237.7.75,no_relation,93,115,,96,128,causes,0.948683298050514,811229-FS1-4,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, PUUMALA VIRUS and Dobrava/Belgrade virus.",HFRS,PUUMALA VIRUS,TWrex-cause
724534038,5/21/2015 17:53:04,1640473353,5/21/2015 17:51:16,False,points4rewards,0.7576,20113482,USA,OR,Portland,67.213.218.72,PUUMALA VIRUS causes HFRS,93,115,,96,128,causes,0.948683298050514,811229-FS1-4,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, PUUMALA VIRUS and Dobrava/Belgrade virus.",HFRS,PUUMALA VIRUS,TWrex-cause
724534038,5/21/2015 18:15:21,1640488713,5/21/2015 18:14:24,False,instagc,0.6134,15864091,USA,OK,Oklahoma City,104.0.113.133,HFRS causes PUUMALA VIRUS,93,115,,96,128,causes,0.948683298050514,811229-FS1-4,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, PUUMALA VIRUS and Dobrava/Belgrade virus.",HFRS,PUUMALA VIRUS,TWrex-cause
724919790,5/22/2015 08:48:31,1641131615,5/22/2015 08:47:48,False,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,no_relation,90,23,,113,49,causes,0.9045340337332909,815002-FS1-4,"Sensitivity Reactions  HYPERSENSITIVITY REACTIONS  Serious cutaneous reactions, including STEVENS JOHNSON SYNDROME  1 ,   2 ,   93 ,   99   erythema multiforme.",STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTIONS,TWrex-cause
724919790,5/22/2015 08:55:56,1641135209,5/22/2015 08:55:38,False,neodev,0.7361,14096345,NLD,03,Eibergen,77.174.124.109,no_relation,90,23,,113,49,causes,0.9045340337332909,815002-FS1-4,"Sensitivity Reactions  HYPERSENSITIVITY REACTIONS  Serious cutaneous reactions, including STEVENS JOHNSON SYNDROME  1 ,   2 ,   93 ,   99   erythema multiforme.",STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTIONS,TWrex-cause
724919790,5/22/2015 09:00:36,1641137663,5/22/2015 08:59:47,False,prodege,0.5625,19854505,GBR,H8,Liverpool,92.28.85.177,HYPERSENSITIVITY REACTIONS causes STEVENS JOHNSON SYNDROME,90,23,,113,49,causes,0.9045340337332909,815002-FS1-4,"Sensitivity Reactions  HYPERSENSITIVITY REACTIONS  Serious cutaneous reactions, including STEVENS JOHNSON SYNDROME  1 ,   2 ,   93 ,   99   erythema multiforme.",STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTIONS,TWrex-cause
724919790,5/22/2015 09:07:18,1641141090,5/22/2015 09:07:00,False,instagc,0.6917,13581319,USA,IL,Mount Vernon,66.232.166.86,no_relation,90,23,,113,49,causes,0.9045340337332909,815002-FS1-4,"Sensitivity Reactions  HYPERSENSITIVITY REACTIONS  Serious cutaneous reactions, including STEVENS JOHNSON SYNDROME  1 ,   2 ,   93 ,   99   erythema multiforme.",STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTIONS,TWrex-cause
724919790,5/22/2015 09:13:21,1641144037,5/22/2015 09:12:35,False,vivatic,0.7359,32338429,GBR,G1,Feltham,92.24.40.208,no_relation,90,23,,113,49,causes,0.9045340337332909,815002-FS1-4,"Sensitivity Reactions  HYPERSENSITIVITY REACTIONS  Serious cutaneous reactions, including STEVENS JOHNSON SYNDROME  1 ,   2 ,   93 ,   99   erythema multiforme.",STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTIONS,TWrex-cause
724919790,5/22/2015 09:14:49,1641144862,5/22/2015 09:14:30,False,neodev,0.696,30627835,GBR,H9,London,5.81.27.94,no_relation,90,23,,113,49,causes,0.9045340337332909,815002-FS1-4,"Sensitivity Reactions  HYPERSENSITIVITY REACTIONS  Serious cutaneous reactions, including STEVENS JOHNSON SYNDROME  1 ,   2 ,   93 ,   99   erythema multiforme.",STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTIONS,TWrex-cause
724919790,5/22/2015 09:24:23,1641149764,5/22/2015 09:23:56,False,prodege,0.8095,27934334,GBR,D2,Derby,86.162.35.12,no_relation,90,23,,113,49,causes,0.9045340337332909,815002-FS1-4,"Sensitivity Reactions  HYPERSENSITIVITY REACTIONS  Serious cutaneous reactions, including STEVENS JOHNSON SYNDROME  1 ,   2 ,   93 ,   99   erythema multiforme.",STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTIONS,TWrex-cause
724919796,5/22/2015 08:49:58,1641132240,5/22/2015 08:49:35,False,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,no_relation,88,0,,93,13,causes,0.538815906080325,802539-FS1-4,"KERATOUVEITIS    Inflammation of both the cornea and the uveal tract (i.e., of both the CORNEA and the iris, ciliary body, and choroid.",CORNEA,KERATOUVEITIS,TWrex-cause
724919796,5/22/2015 08:56:47,1641135669,5/22/2015 08:56:30,False,neodev,0.7361,14096345,NLD,03,Eibergen,77.174.124.109,no_relation,88,0,,93,13,causes,0.538815906080325,802539-FS1-4,"KERATOUVEITIS    Inflammation of both the cornea and the uveal tract (i.e., of both the CORNEA and the iris, ciliary body, and choroid.",CORNEA,KERATOUVEITIS,TWrex-cause
724919796,5/22/2015 09:08:11,1641141531,5/22/2015 09:07:56,False,instagc,0.6917,13581319,USA,IL,Mount Vernon,66.232.166.86,KERATOUVEITIS causes CORNEA,88,0,,93,13,causes,0.538815906080325,802539-FS1-4,"KERATOUVEITIS    Inflammation of both the cornea and the uveal tract (i.e., of both the CORNEA and the iris, ciliary body, and choroid.",CORNEA,KERATOUVEITIS,TWrex-cause
724919796,5/22/2015 09:14:59,1641144960,5/22/2015 09:14:28,False,vivatic,0.7359,32338429,GBR,G1,Feltham,92.24.40.208,no_relation,88,0,,93,13,causes,0.538815906080325,802539-FS1-4,"KERATOUVEITIS    Inflammation of both the cornea and the uveal tract (i.e., of both the CORNEA and the iris, ciliary body, and choroid.",CORNEA,KERATOUVEITIS,TWrex-cause
724919796,5/22/2015 09:16:00,1641145379,5/22/2015 09:15:41,False,neodev,0.696,30627835,GBR,H9,London,5.81.27.94,no_relation,88,0,,93,13,causes,0.538815906080325,802539-FS1-4,"KERATOUVEITIS    Inflammation of both the cornea and the uveal tract (i.e., of both the CORNEA and the iris, ciliary body, and choroid.",CORNEA,KERATOUVEITIS,TWrex-cause
724919796,5/22/2015 09:25:33,1641150291,5/22/2015 09:25:08,False,prodege,0.8095,27934334,GBR,D2,Derby,86.162.35.12,no_relation,88,0,,93,13,causes,0.538815906080325,802539-FS1-4,"KERATOUVEITIS    Inflammation of both the cornea and the uveal tract (i.e., of both the CORNEA and the iris, ciliary body, and choroid.",CORNEA,KERATOUVEITIS,TWrex-cause
724919796,5/22/2015 09:29:51,1641152586,5/22/2015 09:29:31,False,clixsense,0.4881,6352682,GBR,H9,London,2.122.19.138,no_relation,88,0,,93,13,causes,0.538815906080325,802539-FS1-4,"KERATOUVEITIS    Inflammation of both the cornea and the uveal tract (i.e., of both the CORNEA and the iris, ciliary body, and choroid.",CORNEA,KERATOUVEITIS,TWrex-cause
724919805,5/22/2015 10:35:15,1641188176,5/22/2015 10:34:32,False,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,75,18,,84,43,causes,0.717137165600636,813035-FS1-4,"In a patient with ESSENTIAL THROMBOCYTHEMIA who has clinically significant HEMORRHAGE or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,TWrex-cause
724919805,5/22/2015 10:43:08,1641193249,5/22/2015 10:42:47,False,gifthunterclub,0.7778,30901412,GBR,G5,Margate,85.210.124.44,no_relation,75,18,,84,43,causes,0.717137165600636,813035-FS1-4,"In a patient with ESSENTIAL THROMBOCYTHEMIA who has clinically significant HEMORRHAGE or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,TWrex-cause
724919805,5/22/2015 10:48:52,1641196716,5/22/2015 10:48:33,False,instagc,0.7222,20845955,GBR,I2,Manchester,90.214.24.62,no_relation,75,18,,84,43,causes,0.717137165600636,813035-FS1-4,"In a patient with ESSENTIAL THROMBOCYTHEMIA who has clinically significant HEMORRHAGE or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,TWrex-cause
724919805,5/22/2015 11:23:16,1641217411,5/22/2015 11:22:49,False,instagc,0.5375,32352104,USA,ME,Bangor,74.75.63.81,no_relation,75,18,,84,43,causes,0.717137165600636,813035-FS1-4,"In a patient with ESSENTIAL THROMBOCYTHEMIA who has clinically significant HEMORRHAGE or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,TWrex-cause
724919805,5/22/2015 11:39:45,1641227353,5/22/2015 11:38:23,False,prodege,0.6433,3056891,CAN,ON,Niagara Falls,173.238.144.19,no_relation,75,18,,84,43,causes,0.717137165600636,813035-FS1-4,"In a patient with ESSENTIAL THROMBOCYTHEMIA who has clinically significant HEMORRHAGE or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,TWrex-cause
724919805,5/22/2015 11:50:11,1641233554,5/22/2015 11:49:47,False,prodege,0.7103,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,75,18,,84,43,causes,0.717137165600636,813035-FS1-4,"In a patient with ESSENTIAL THROMBOCYTHEMIA who has clinically significant HEMORRHAGE or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,TWrex-cause
724919805,5/22/2015 11:54:00,1641235596,5/22/2015 11:51:51,False,fusioncash,0.1667,31757234,USA,KY,London,76.177.136.50,ESSENTIAL THROMBOCYTHEMIA causes HEMORRHAGE,75,18,,84,43,causes,0.717137165600636,813035-FS1-4,"In a patient with ESSENTIAL THROMBOCYTHEMIA who has clinically significant HEMORRHAGE or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,TWrex-cause
724919810,5/22/2015 10:35:15,1641188174,5/22/2015 10:34:32,False,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,14,35,,33,74,causes,0.929981109950554,810489-FS1-4,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS,TWrex-cause
724919810,5/22/2015 10:43:08,1641193260,5/22/2015 10:42:47,False,gifthunterclub,0.7778,30901412,GBR,G5,Margate,85.210.124.44,TOXIC SHOCK SYNDROME causes TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS,14,35,,33,74,causes,0.929981109950554,810489-FS1-4,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS,TWrex-cause
724919810,5/22/2015 10:48:52,1641196718,5/22/2015 10:48:33,False,instagc,0.7222,20845955,GBR,I2,Manchester,90.214.24.62,no_relation,14,35,,33,74,causes,0.929981109950554,810489-FS1-4,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS,TWrex-cause
724919810,5/22/2015 11:23:16,1641217413,5/22/2015 11:22:49,False,instagc,0.5375,32352104,USA,ME,Bangor,74.75.63.81,TOXIC SHOCK SYNDROME causes TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS,14,35,,33,74,causes,0.929981109950554,810489-FS1-4,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS,TWrex-cause
724919810,5/22/2015 11:39:45,1641227349,5/22/2015 11:38:23,False,prodege,0.6433,3056891,CAN,ON,Niagara Falls,173.238.144.19,no_relation,14,35,,33,74,causes,0.929981109950554,810489-FS1-4,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS,TWrex-cause
724919810,5/22/2015 11:50:11,1641233552,5/22/2015 11:49:47,False,prodege,0.7103,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,14,35,,33,74,causes,0.929981109950554,810489-FS1-4,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS,TWrex-cause
724919810,5/22/2015 11:54:00,1641235597,5/22/2015 11:51:51,False,fusioncash,0.1667,31757234,USA,KY,London,76.177.136.50,TOXIC SHOCK SYNDROME causes TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS,14,35,,33,74,causes,0.929981109950554,810489-FS1-4,Prevalence of TOXIC SHOCK SYNDROME TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS and the presence of antibodies to this superantigen in menstruating women.,TOXIC SHOCK SYNDROME,TOXIN 1 PRODUCING STAPHYLOCOCCUS AUREUS,TWrex-cause
724919816,5/22/2015 08:49:34,1641132094,5/22/2015 08:48:53,False,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,VULVODYNIA causes NEUROPATHIC PAIN,2,71,,17,81,causes,0.48507125007266605,813761-FS1-4, NEUROPATHIC PAIN can be generalized to the entire vulva (generalized VULVODYNIA and is coupled with a normal physical exam.,NEUROPATHIC PAIN,VULVODYNIA,TWrex-cause
724919816,5/22/2015 08:56:29,1641135533,5/22/2015 08:56:13,False,neodev,0.7361,14096345,NLD,03,Eibergen,77.174.124.109,no_relation,2,71,,17,81,causes,0.48507125007266605,813761-FS1-4, NEUROPATHIC PAIN can be generalized to the entire vulva (generalized VULVODYNIA and is coupled with a normal physical exam.,NEUROPATHIC PAIN,VULVODYNIA,TWrex-cause
724919816,5/22/2015 09:07:56,1641141402,5/22/2015 09:07:37,False,instagc,0.6917,13581319,USA,IL,Mount Vernon,66.232.166.86,no_relation,2,71,,17,81,causes,0.48507125007266605,813761-FS1-4, NEUROPATHIC PAIN can be generalized to the entire vulva (generalized VULVODYNIA and is coupled with a normal physical exam.,NEUROPATHIC PAIN,VULVODYNIA,TWrex-cause
724919816,5/22/2015 09:14:27,1641144639,5/22/2015 09:13:48,False,vivatic,0.7359,32338429,GBR,G1,Feltham,92.24.40.208,no_relation,2,71,,17,81,causes,0.48507125007266605,813761-FS1-4, NEUROPATHIC PAIN can be generalized to the entire vulva (generalized VULVODYNIA and is coupled with a normal physical exam.,NEUROPATHIC PAIN,VULVODYNIA,TWrex-cause
724919816,5/22/2015 09:15:39,1641145249,5/22/2015 09:15:11,False,neodev,0.696,30627835,GBR,H9,London,5.81.27.94,no_relation,2,71,,17,81,causes,0.48507125007266605,813761-FS1-4, NEUROPATHIC PAIN can be generalized to the entire vulva (generalized VULVODYNIA and is coupled with a normal physical exam.,NEUROPATHIC PAIN,VULVODYNIA,TWrex-cause
724919816,5/22/2015 09:25:07,1641150100,5/22/2015 09:24:44,False,prodege,0.8095,27934334,GBR,D2,Derby,86.162.35.12,no_relation,2,71,,17,81,causes,0.48507125007266605,813761-FS1-4, NEUROPATHIC PAIN can be generalized to the entire vulva (generalized VULVODYNIA and is coupled with a normal physical exam.,NEUROPATHIC PAIN,VULVODYNIA,TWrex-cause
724919816,5/22/2015 09:29:30,1641152472,5/22/2015 09:29:16,False,clixsense,0.4881,6352682,GBR,H9,London,2.122.19.138,VULVODYNIA causes NEUROPATHIC PAIN,2,71,,17,81,causes,0.48507125007266605,813761-FS1-4, NEUROPATHIC PAIN can be generalized to the entire vulva (generalized VULVODYNIA and is coupled with a normal physical exam.,NEUROPATHIC PAIN,VULVODYNIA,TWrex-cause
724919818,5/22/2015 09:31:15,1641153077,5/22/2015 09:30:50,False,cointasker,0.9167,21783324,NLD,11,Schiedam,194.13.104.198,no_relation,36,0,,44,28,causes,0.320256307610174,803249-FS1-4,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY,TWrex-cause
724919818,5/22/2015 09:39:56,1641157270,5/22/2015 09:39:26,False,coinworker,0.7778,20231698,USA,,,172.56.32.164,no_relation,36,0,,44,28,causes,0.320256307610174,803249-FS1-4,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY,TWrex-cause
724919818,5/22/2015 10:05:25,1641171077,5/22/2015 10:03:06,False,points4rewards,0.7986,20113482,USA,OR,Portland,67.213.218.72,no_relation,36,0,,44,28,causes,0.320256307610174,803249-FS1-4,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY,TWrex-cause
724919818,5/22/2015 10:17:44,1641177690,5/22/2015 10:17:20,False,instagc,0.8042,18531561,CAN,ON,Mississauga,99.229.92.227,no_relation,36,0,,44,28,causes,0.320256307610174,803249-FS1-4,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY,TWrex-cause
724919818,5/22/2015 10:23:31,1641181056,5/22/2015 10:22:35,False,clixsense,0.7857,22947672,GBR,,,88.144.127.68,PREGNANCY causes NICOTINE REPLACEMENT THERAPY,36,0,,44,28,causes,0.320256307610174,803249-FS1-4,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY,TWrex-cause
724919818,5/22/2015 10:23:53,1641181287,5/22/2015 10:23:26,False,cotter,0.877,13805544,USA,MI,Battle Creek,107.140.176.37,no_relation,36,0,,44,28,causes,0.320256307610174,803249-FS1-4,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY,TWrex-cause
724919818,5/22/2015 10:23:55,1641181314,5/22/2015 10:23:10,False,clixsense,0.8175,26648627,GBR,,,87.115.101.39,no_relation,36,0,,44,28,causes,0.320256307610174,803249-FS1-4,NICOTINE REPLACEMENT THERAPY during PREGNANCY,PREGNANCY,NICOTINE REPLACEMENT THERAPY,TWrex-cause
724992208,5/22/2015 17:31:42,1641445827,5/22/2015 17:30:59,False,instagc,0.7599,30326470,USA,CA,Santee,99.44.37.73,no_relation,232,190,,240,201,causes,0.474712663277541,803077-FS1-4,"a ,   b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, MEPROBAMATE during the first trimester of PREGNANCY",PREGNANCY,MEPROBAMATE,TWrex-cause
724992208,5/22/2015 17:34:24,1641447456,5/22/2015 17:33:57,False,prodege,0.8393,21417560,GBR,C3,Cambridge,151.225.116.143,PREGNANCY causes MEPROBAMATE,232,190,,240,201,causes,0.474712663277541,803077-FS1-4,"a ,   b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, MEPROBAMATE during the first trimester of PREGNANCY",PREGNANCY,MEPROBAMATE,TWrex-cause
724992208,5/22/2015 17:43:07,1641453334,5/22/2015 17:42:49,False,instagc,0.9375,24252915,GBR,K6,Southsea,80.44.194.25,no_relation,232,190,,240,201,causes,0.474712663277541,803077-FS1-4,"a ,   b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, MEPROBAMATE during the first trimester of PREGNANCY",PREGNANCY,MEPROBAMATE,TWrex-cause
724992208,5/22/2015 17:44:14,1641453996,5/22/2015 17:43:44,False,clixsense,0.9583,23197581,NLD,11,Den Haag,82.217.5.55,no_relation,232,190,,240,201,causes,0.474712663277541,803077-FS1-4,"a ,   b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, MEPROBAMATE during the first trimester of PREGNANCY",PREGNANCY,MEPROBAMATE,TWrex-cause
724992208,5/22/2015 17:47:06,1641455593,5/22/2015 17:46:17,False,clixsense,0.7958,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,232,190,,240,201,causes,0.474712663277541,803077-FS1-4,"a ,   b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, MEPROBAMATE during the first trimester of PREGNANCY",PREGNANCY,MEPROBAMATE,TWrex-cause
724992208,5/22/2015 18:06:30,1641472150,5/22/2015 18:04:44,False,clixsense,0.6312,11106820,USA,MA,Taunton,173.48.52.95,no_relation,232,190,,240,201,causes,0.474712663277541,803077-FS1-4,"a ,   b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, MEPROBAMATE during the first trimester of PREGNANCY",PREGNANCY,MEPROBAMATE,TWrex-cause
724992208,5/22/2015 18:09:24,1641475056,5/22/2015 18:08:51,False,instagc,0.7337,20312760,GBR,I2,Manchester,90.244.158.78,no_relation,232,190,,240,201,causes,0.474712663277541,803077-FS1-4,"a ,   b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, MEPROBAMATE during the first trimester of PREGNANCY",PREGNANCY,MEPROBAMATE,TWrex-cause
724992222,5/22/2015 17:35:11,1641448033,5/22/2015 17:34:47,False,prodege,0.8393,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,359,192,,391,204,causes,0.368229847159329,804373-FS1-4,"upper gastrointestinal symptoms: a randomized placebo controlled trial  Meta analysis: the relationship between Helicobacter pylori infection and gastro oesophageal reflux disease  Once daily PANTOPRAZOLE 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD related symptoms  Is there any association between myocardial infarction, GASTRO OESOPHAGEAL REFLUX DISEASE and acid suppressing drugs.",GASTRO OESOPHAGEAL REFLUX DISEASE,PANTOPRAZOLE,TWrex-cause
724992222,5/22/2015 17:43:54,1641453861,5/22/2015 17:43:26,False,instagc,0.9375,24252915,GBR,K6,Southsea,80.44.194.25,no_relation,359,192,,391,204,causes,0.368229847159329,804373-FS1-4,"upper gastrointestinal symptoms: a randomized placebo controlled trial  Meta analysis: the relationship between Helicobacter pylori infection and gastro oesophageal reflux disease  Once daily PANTOPRAZOLE 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD related symptoms  Is there any association between myocardial infarction, GASTRO OESOPHAGEAL REFLUX DISEASE and acid suppressing drugs.",GASTRO OESOPHAGEAL REFLUX DISEASE,PANTOPRAZOLE,TWrex-cause
724992222,5/22/2015 17:45:30,1641454734,5/22/2015 17:45:00,False,clixsense,0.9583,23197581,NLD,11,Den Haag,82.217.5.55,no_relation,359,192,,391,204,causes,0.368229847159329,804373-FS1-4,"upper gastrointestinal symptoms: a randomized placebo controlled trial  Meta analysis: the relationship between Helicobacter pylori infection and gastro oesophageal reflux disease  Once daily PANTOPRAZOLE 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD related symptoms  Is there any association between myocardial infarction, GASTRO OESOPHAGEAL REFLUX DISEASE and acid suppressing drugs.",GASTRO OESOPHAGEAL REFLUX DISEASE,PANTOPRAZOLE,TWrex-cause
724992222,5/22/2015 17:48:57,1641456708,5/22/2015 17:48:13,False,clixsense,0.7958,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,359,192,,391,204,causes,0.368229847159329,804373-FS1-4,"upper gastrointestinal symptoms: a randomized placebo controlled trial  Meta analysis: the relationship between Helicobacter pylori infection and gastro oesophageal reflux disease  Once daily PANTOPRAZOLE 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD related symptoms  Is there any association between myocardial infarction, GASTRO OESOPHAGEAL REFLUX DISEASE and acid suppressing drugs.",GASTRO OESOPHAGEAL REFLUX DISEASE,PANTOPRAZOLE,TWrex-cause
724992222,5/22/2015 18:08:19,1641473949,5/22/2015 18:07:26,False,clixsense,0.6312,11106820,USA,MA,Taunton,173.48.52.95,no_relation,359,192,,391,204,causes,0.368229847159329,804373-FS1-4,"upper gastrointestinal symptoms: a randomized placebo controlled trial  Meta analysis: the relationship between Helicobacter pylori infection and gastro oesophageal reflux disease  Once daily PANTOPRAZOLE 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD related symptoms  Is there any association between myocardial infarction, GASTRO OESOPHAGEAL REFLUX DISEASE and acid suppressing drugs.",GASTRO OESOPHAGEAL REFLUX DISEASE,PANTOPRAZOLE,TWrex-cause
724992222,5/22/2015 18:10:01,1641475702,5/22/2015 18:09:43,False,instagc,0.7337,20312760,GBR,I2,Manchester,90.244.158.78,no_relation,359,192,,391,204,causes,0.368229847159329,804373-FS1-4,"upper gastrointestinal symptoms: a randomized placebo controlled trial  Meta analysis: the relationship between Helicobacter pylori infection and gastro oesophageal reflux disease  Once daily PANTOPRAZOLE 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD related symptoms  Is there any association between myocardial infarction, GASTRO OESOPHAGEAL REFLUX DISEASE and acid suppressing drugs.",GASTRO OESOPHAGEAL REFLUX DISEASE,PANTOPRAZOLE,TWrex-cause
724992222,5/22/2015 18:12:02,1641477979,5/22/2015 18:11:38,False,instagc,0.6905,32352104,USA,ME,Bangor,74.75.63.81,PANTOPRAZOLE causes GASTRO OESOPHAGEAL REFLUX DISEASE,359,192,,391,204,causes,0.368229847159329,804373-FS1-4,"upper gastrointestinal symptoms: a randomized placebo controlled trial  Meta analysis: the relationship between Helicobacter pylori infection and gastro oesophageal reflux disease  Once daily PANTOPRAZOLE 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD related symptoms  Is there any association between myocardial infarction, GASTRO OESOPHAGEAL REFLUX DISEASE and acid suppressing drugs.",GASTRO OESOPHAGEAL REFLUX DISEASE,PANTOPRAZOLE,TWrex-cause
724992223,5/22/2015 16:52:02,1641420997,5/22/2015 16:51:42,False,neodev,0.875,14096345,NLD,03,Eibergen,77.174.124.109,no_relation,79,164,,102,172,causes,0.606091526731326,803086-FS1-4,"1  Fixed combination Vaccine Containing DTaP and IPV (DTaP IPV; Kinrix  ,    SEVERE ALLERGIC REACTION (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., NEOMYCIN polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, or poliovirus antigens.",SEVERE ALLERGIC REACTION,NEOMYCIN,TWrex-cause
724992223,5/22/2015 16:59:51,1641426409,5/22/2015 16:58:08,False,clixsense,0.8889,22947672,GBR,,,88.144.127.68,NEOMYCIN causes SEVERE ALLERGIC REACTION,79,164,,102,172,causes,0.606091526731326,803086-FS1-4,"1  Fixed combination Vaccine Containing DTaP and IPV (DTaP IPV; Kinrix  ,    SEVERE ALLERGIC REACTION (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., NEOMYCIN polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, or poliovirus antigens.",SEVERE ALLERGIC REACTION,NEOMYCIN,TWrex-cause
724992223,5/22/2015 17:05:37,1641429777,5/22/2015 17:05:25,False,instagc,0.6806,13581319,USA,IL,Mount Vernon,66.232.166.86,SEVERE ALLERGIC REACTION causes NEOMYCIN,79,164,,102,172,causes,0.606091526731326,803086-FS1-4,"1  Fixed combination Vaccine Containing DTaP and IPV (DTaP IPV; Kinrix  ,    SEVERE ALLERGIC REACTION (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., NEOMYCIN polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, or poliovirus antigens.",SEVERE ALLERGIC REACTION,NEOMYCIN,TWrex-cause
724992223,5/22/2015 17:09:47,1641432656,5/22/2015 17:08:02,False,points4rewards,0.7069,20113482,USA,OR,Portland,67.213.218.72,NEOMYCIN causes SEVERE ALLERGIC REACTION,79,164,,102,172,causes,0.606091526731326,803086-FS1-4,"1  Fixed combination Vaccine Containing DTaP and IPV (DTaP IPV; Kinrix  ,    SEVERE ALLERGIC REACTION (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., NEOMYCIN polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, or poliovirus antigens.",SEVERE ALLERGIC REACTION,NEOMYCIN,TWrex-cause
724992223,5/22/2015 17:15:49,1641436792,5/22/2015 17:15:11,False,gifthunterclub,0.7183,29582088,GBR,I2,Manchester,89.240.68.44,no_relation,79,164,,102,172,causes,0.606091526731326,803086-FS1-4,"1  Fixed combination Vaccine Containing DTaP and IPV (DTaP IPV; Kinrix  ,    SEVERE ALLERGIC REACTION (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., NEOMYCIN polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, or poliovirus antigens.",SEVERE ALLERGIC REACTION,NEOMYCIN,TWrex-cause
724992223,5/22/2015 17:17:07,1641437685,5/22/2015 17:16:34,False,sharecashgpt,0.6067,28627999,CAN,ON,Sudbury,66.103.55.12,NEOMYCIN causes SEVERE ALLERGIC REACTION,79,164,,102,172,causes,0.606091526731326,803086-FS1-4,"1  Fixed combination Vaccine Containing DTaP and IPV (DTaP IPV; Kinrix  ,    SEVERE ALLERGIC REACTION (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., NEOMYCIN polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, or poliovirus antigens.",SEVERE ALLERGIC REACTION,NEOMYCIN,TWrex-cause
724992223,5/22/2015 17:24:45,1641442455,5/22/2015 17:23:57,False,instagc,0.7599,30326470,USA,CA,Santee,99.44.37.73,no_relation,79,164,,102,172,causes,0.606091526731326,803086-FS1-4,"1  Fixed combination Vaccine Containing DTaP and IPV (DTaP IPV; Kinrix  ,    SEVERE ALLERGIC REACTION (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., NEOMYCIN polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, or poliovirus antigens.",SEVERE ALLERGIC REACTION,NEOMYCIN,TWrex-cause
724992228,5/22/2015 17:35:46,1641448509,5/22/2015 17:35:13,False,prodege,0.8393,21417560,GBR,C3,Cambridge,151.225.116.143,MITES causes NORMAL SCABIES,87,116,,100,121,causes,0.589767824619588,811101-FS1-4," Investigations of the prevalence of mites in the personal environment of 37 cases of NORMAL SCABIES revealed live MITES from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",NORMAL SCABIES,MITES,TWrex-cause
724992228,5/22/2015 17:44:28,1641454207,5/22/2015 17:43:56,False,instagc,0.9375,24252915,GBR,K6,Southsea,80.44.194.25,no_relation,87,116,,100,121,causes,0.589767824619588,811101-FS1-4," Investigations of the prevalence of mites in the personal environment of 37 cases of NORMAL SCABIES revealed live MITES from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",NORMAL SCABIES,MITES,TWrex-cause
724992228,5/22/2015 17:49:49,1641457310,5/22/2015 17:48:58,False,clixsense,0.7958,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,87,116,,100,121,causes,0.589767824619588,811101-FS1-4," Investigations of the prevalence of mites in the personal environment of 37 cases of NORMAL SCABIES revealed live MITES from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",NORMAL SCABIES,MITES,TWrex-cause
724992228,5/22/2015 18:08:59,1641474645,5/22/2015 18:08:20,False,clixsense,0.6312,11106820,USA,MA,Taunton,173.48.52.95,MITES causes NORMAL SCABIES,87,116,,100,121,causes,0.589767824619588,811101-FS1-4," Investigations of the prevalence of mites in the personal environment of 37 cases of NORMAL SCABIES revealed live MITES from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",NORMAL SCABIES,MITES,TWrex-cause
724992228,5/22/2015 18:10:30,1641476191,5/22/2015 18:10:03,False,instagc,0.7337,20312760,GBR,I2,Manchester,90.244.158.78,MITES causes NORMAL SCABIES,87,116,,100,121,causes,0.589767824619588,811101-FS1-4," Investigations of the prevalence of mites in the personal environment of 37 cases of NORMAL SCABIES revealed live MITES from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",NORMAL SCABIES,MITES,TWrex-cause
724992228,5/22/2015 18:12:27,1641478507,5/22/2015 18:12:03,False,instagc,0.6905,32352104,USA,ME,Bangor,74.75.63.81,MITES causes NORMAL SCABIES,87,116,,100,121,causes,0.589767824619588,811101-FS1-4," Investigations of the prevalence of mites in the personal environment of 37 cases of NORMAL SCABIES revealed live MITES from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",NORMAL SCABIES,MITES,TWrex-cause
724992228,5/22/2015 18:20:16,1641486643,5/22/2015 18:19:14,False,neodev,0.7798,18703384,GBR,T5,Aberdeen,151.229.113.63,no_relation,87,116,,100,121,causes,0.589767824619588,811101-FS1-4," Investigations of the prevalence of mites in the personal environment of 37 cases of NORMAL SCABIES revealed live MITES from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",NORMAL SCABIES,MITES,TWrex-cause
724992231,5/22/2015 16:27:08,1641401948,5/22/2015 16:26:51,False,neodev,0.9583,31743852,GBR,G5,Maidstone,85.210.127.64,EPILEPSY causes SEIZURES,47,72,,54,80,causes,0.341743063086704,813403-FS1-4,">     Other Seizure Etiologies  IM or IV:  For SEIZURES associated with EPILEPSY glomerulonephritis, or hypothyroidism: Usually, 1 g.",SEIZURES,EPILEPSY,TWrex-cause
724992231,5/22/2015 16:29:53,1641404067,5/22/2015 16:27:55,False,neodev,0.7389,18881135,CAN,ON,Ajax,99.243.87.224,EPILEPSY causes SEIZURES,47,72,,54,80,causes,0.341743063086704,813403-FS1-4,">     Other Seizure Etiologies  IM or IV:  For SEIZURES associated with EPILEPSY glomerulonephritis, or hypothyroidism: Usually, 1 g.",SEIZURES,EPILEPSY,TWrex-cause
724992231,5/22/2015 16:33:56,1641407046,5/22/2015 16:33:27,False,pocketmoneygpt,0.675,21432964,GBR,K5,Poole,109.155.122.13,EPILEPSY causes SEIZURES,47,72,,54,80,causes,0.341743063086704,813403-FS1-4,">     Other Seizure Etiologies  IM or IV:  For SEIZURES associated with EPILEPSY glomerulonephritis, or hypothyroidism: Usually, 1 g.",SEIZURES,EPILEPSY,TWrex-cause
724992231,5/22/2015 16:34:40,1641407567,5/22/2015 16:34:22,False,prodege,0.8167,27934334,GBR,D2,Derby,86.162.35.12,EPILEPSY causes SEIZURES,47,72,,54,80,causes,0.341743063086704,813403-FS1-4,">     Other Seizure Etiologies  IM or IV:  For SEIZURES associated with EPILEPSY glomerulonephritis, or hypothyroidism: Usually, 1 g.",SEIZURES,EPILEPSY,TWrex-cause
724992231,5/22/2015 16:36:03,1641408686,5/22/2015 16:35:31,False,clixsense,0.7214,30681826,GBR,I3,Rochester,86.163.150.232,no_relation,47,72,,54,80,causes,0.341743063086704,813403-FS1-4,">     Other Seizure Etiologies  IM or IV:  For SEIZURES associated with EPILEPSY glomerulonephritis, or hypothyroidism: Usually, 1 g.",SEIZURES,EPILEPSY,TWrex-cause
724992231,5/22/2015 16:36:42,1641409277,5/22/2015 16:36:32,False,elite,0.8333,31883685,GBR,H2,Accrington,80.47.186.28,EPILEPSY causes SEIZURES,47,72,,54,80,causes,0.341743063086704,813403-FS1-4,">     Other Seizure Etiologies  IM or IV:  For SEIZURES associated with EPILEPSY glomerulonephritis, or hypothyroidism: Usually, 1 g.",SEIZURES,EPILEPSY,TWrex-cause
724992231,5/22/2015 16:42:02,1641413411,5/22/2015 16:40:49,False,onestopgpt,0.7976,21275875,CAN,ON,Hamilton,24.36.121.10,EPILEPSY causes SEIZURES,47,72,,54,80,causes,0.341743063086704,813403-FS1-4,">     Other Seizure Etiologies  IM or IV:  For SEIZURES associated with EPILEPSY glomerulonephritis, or hypothyroidism: Usually, 1 g.",SEIZURES,EPILEPSY,TWrex-cause
724992236,5/22/2015 18:22:38,1641489144,5/22/2015 18:22:17,False,neodev,0.7798,18703384,GBR,T5,Aberdeen,151.229.113.63,no_relation,12,29,,15,44,causes,0.818181818181818,802286-FS1-4,"Evidence:  BONE affected by PAGET'S DISEASE can enlarge, and this enlargement of deformity is a presenting symptom in 20% of patients.",BONE,PAGET'S DISEASE,TWrex-cause
724992236,5/22/2015 18:40:19,1641508682,5/22/2015 18:39:49,False,prodege,0.8,1924522,USA,NY,New York,96.224.13.217,no_relation,12,29,,15,44,causes,0.818181818181818,802286-FS1-4,"Evidence:  BONE affected by PAGET'S DISEASE can enlarge, and this enlargement of deformity is a presenting symptom in 20% of patients.",BONE,PAGET'S DISEASE,TWrex-cause
724992236,5/22/2015 19:07:36,1641537327,5/22/2015 19:06:50,False,fusioncash,0.8542,5656294,USA,TN,Cookeville,75.136.162.83,no_relation,12,29,,15,44,causes,0.818181818181818,802286-FS1-4,"Evidence:  BONE affected by PAGET'S DISEASE can enlarge, and this enlargement of deformity is a presenting symptom in 20% of patients.",BONE,PAGET'S DISEASE,TWrex-cause
724992236,5/22/2015 19:43:39,1641592260,5/22/2015 19:42:46,False,neodev,0.8839,30940715,USA,IL,Lisle,50.247.189.225,no_relation,12,29,,15,44,causes,0.818181818181818,802286-FS1-4,"Evidence:  BONE affected by PAGET'S DISEASE can enlarge, and this enlargement of deformity is a presenting symptom in 20% of patients.",BONE,PAGET'S DISEASE,TWrex-cause
724992236,5/22/2015 20:11:37,1641631135,5/22/2015 20:11:25,False,neodev,0.475,31789301,GBR,H9,London,193.109.196.182,BONE causes PAGET'S DISEASE,12,29,,15,44,causes,0.818181818181818,802286-FS1-4,"Evidence:  BONE affected by PAGET'S DISEASE can enlarge, and this enlargement of deformity is a presenting symptom in 20% of patients.",BONE,PAGET'S DISEASE,TWrex-cause
724992236,5/22/2015 20:13:10,1641633043,5/22/2015 20:12:01,False,clixsense,0.5992,21139796,USA,NC,Rocky Mount,184.3.161.91,PAGET'S DISEASE causes BONE,12,29,,15,44,causes,0.818181818181818,802286-FS1-4,"Evidence:  BONE affected by PAGET'S DISEASE can enlarge, and this enlargement of deformity is a presenting symptom in 20% of patients.",BONE,PAGET'S DISEASE,TWrex-cause
724992236,5/22/2015 20:14:30,1641635111,5/22/2015 20:13:15,False,elite,0.7063,32732290,GBR,A7,Birmingham,86.147.79.250,no_relation,12,29,,15,44,causes,0.818181818181818,802286-FS1-4,"Evidence:  BONE affected by PAGET'S DISEASE can enlarge, and this enlargement of deformity is a presenting symptom in 20% of patients.",BONE,PAGET'S DISEASE,TWrex-cause
725204821,5/23/2015 14:33:26,1642197553,5/23/2015 14:32:52,False,prodege,0.7361,21417560,GBR,C3,Cambridge,151.225.116.143,HTLV 1 causes TROPICAL SPASTIC PARAPARESIS,139,0,,166,6,causes,0.9701425001453321,811684-FS1-4,"HTLV 1 causes adult T lymphocyte (ATL)leukemia/lymphoma, T cell non Hodgkin lymphoma, and an unusual neurodegenerative syndrome designated TROPICAL SPASTIC PARAPARESIS or HTLV 1 associated myelopathy (TSP/HAM.",TROPICAL SPASTIC PARAPARESIS,HTLV 1,TWrex-cause
725204821,5/23/2015 14:33:48,1642197629,5/23/2015 14:33:28,False,neodev,0.8889,14096345,NLD,03,Eibergen,77.174.124.109,HTLV 1 causes TROPICAL SPASTIC PARAPARESIS,139,0,,166,6,causes,0.9701425001453321,811684-FS1-4,"HTLV 1 causes adult T lymphocyte (ATL)leukemia/lymphoma, T cell non Hodgkin lymphoma, and an unusual neurodegenerative syndrome designated TROPICAL SPASTIC PARAPARESIS or HTLV 1 associated myelopathy (TSP/HAM.",TROPICAL SPASTIC PARAPARESIS,HTLV 1,TWrex-cause
725204821,5/23/2015 14:36:40,1642198475,5/23/2015 14:36:21,False,onestopgpt,0.7133,21275875,CAN,ON,Hamilton,24.36.121.10,HTLV 1 causes TROPICAL SPASTIC PARAPARESIS,139,0,,166,6,causes,0.9701425001453321,811684-FS1-4,"HTLV 1 causes adult T lymphocyte (ATL)leukemia/lymphoma, T cell non Hodgkin lymphoma, and an unusual neurodegenerative syndrome designated TROPICAL SPASTIC PARAPARESIS or HTLV 1 associated myelopathy (TSP/HAM.",TROPICAL SPASTIC PARAPARESIS,HTLV 1,TWrex-cause
725204821,5/23/2015 14:44:59,1642200635,5/23/2015 14:44:46,False,elite,0.6597,31883685,GBR,H2,Accrington,80.47.186.28,HTLV 1 causes TROPICAL SPASTIC PARAPARESIS,139,0,,166,6,causes,0.9701425001453321,811684-FS1-4,"HTLV 1 causes adult T lymphocyte (ATL)leukemia/lymphoma, T cell non Hodgkin lymphoma, and an unusual neurodegenerative syndrome designated TROPICAL SPASTIC PARAPARESIS or HTLV 1 associated myelopathy (TSP/HAM.",TROPICAL SPASTIC PARAPARESIS,HTLV 1,TWrex-cause
725204821,5/23/2015 14:46:01,1642200868,5/23/2015 14:45:36,False,clixsense,0.6194,31482589,NLD,,,31.201.11.16,no_relation,139,0,,166,6,causes,0.9701425001453321,811684-FS1-4,"HTLV 1 causes adult T lymphocyte (ATL)leukemia/lymphoma, T cell non Hodgkin lymphoma, and an unusual neurodegenerative syndrome designated TROPICAL SPASTIC PARAPARESIS or HTLV 1 associated myelopathy (TSP/HAM.",TROPICAL SPASTIC PARAPARESIS,HTLV 1,TWrex-cause
725204821,5/23/2015 14:52:02,1642202473,5/23/2015 14:51:11,False,instagc,0.5683,18531561,CAN,ON,Mississauga,99.229.92.227,no_relation,139,0,,166,6,causes,0.9701425001453321,811684-FS1-4,"HTLV 1 causes adult T lymphocyte (ATL)leukemia/lymphoma, T cell non Hodgkin lymphoma, and an unusual neurodegenerative syndrome designated TROPICAL SPASTIC PARAPARESIS or HTLV 1 associated myelopathy (TSP/HAM.",TROPICAL SPASTIC PARAPARESIS,HTLV 1,TWrex-cause
725204821,5/23/2015 15:07:40,1642206416,5/23/2015 15:00:05,False,clixsense,0.4576,17950689,GBR,Y9,Porth,217.43.32.119,TROPICAL SPASTIC PARAPARESIS causes HTLV 1,139,0,,166,6,causes,0.9701425001453321,811684-FS1-4,"HTLV 1 causes adult T lymphocyte (ATL)leukemia/lymphoma, T cell non Hodgkin lymphoma, and an unusual neurodegenerative syndrome designated TROPICAL SPASTIC PARAPARESIS or HTLV 1 associated myelopathy (TSP/HAM.",TROPICAL SPASTIC PARAPARESIS,HTLV 1,TWrex-cause
725204823,5/23/2015 14:35:15,1642198045,5/23/2015 14:34:56,False,neodev,0.8889,14096345,NLD,03,Eibergen,77.174.124.109,no_relation,56,2,,67,19,causes,0.997054485501582,812777-FS1-4," PHEOCHROMOCYTOMAS pose a risk to health and life, and HYPERTENSION may be the initial clue to their presence.",HYPERTENSION,PHEOCHROMOCYTOMAS,TWrex-cause
725204823,5/23/2015 14:46:00,1642200869,5/23/2015 14:45:49,False,elite,0.6597,31883685,GBR,H2,Accrington,80.47.186.28,PHEOCHROMOCYTOMAS causes HYPERTENSION,56,2,,67,19,causes,0.997054485501582,812777-FS1-4," PHEOCHROMOCYTOMAS pose a risk to health and life, and HYPERTENSION may be the initial clue to their presence.",HYPERTENSION,PHEOCHROMOCYTOMAS,TWrex-cause
725204823,5/23/2015 14:47:59,1642201495,5/23/2015 14:47:37,False,clixsense,0.6194,31482589,NLD,,,31.201.11.16,PHEOCHROMOCYTOMAS causes HYPERTENSION,56,2,,67,19,causes,0.997054485501582,812777-FS1-4," PHEOCHROMOCYTOMAS pose a risk to health and life, and HYPERTENSION may be the initial clue to their presence.",HYPERTENSION,PHEOCHROMOCYTOMAS,TWrex-cause
725204823,5/23/2015 14:55:51,1642203599,5/23/2015 14:55:32,False,instagc,0.6667,20312760,GBR,I2,Manchester,90.244.149.130,HYPERTENSION causes PHEOCHROMOCYTOMAS,56,2,,67,19,causes,0.997054485501582,812777-FS1-4," PHEOCHROMOCYTOMAS pose a risk to health and life, and HYPERTENSION may be the initial clue to their presence.",HYPERTENSION,PHEOCHROMOCYTOMAS,TWrex-cause
725204823,5/23/2015 14:56:13,1642203690,5/23/2015 14:54:55,False,instagc,0.5683,18531561,CAN,ON,Mississauga,99.229.92.227,PHEOCHROMOCYTOMAS causes HYPERTENSION,56,2,,67,19,causes,0.997054485501582,812777-FS1-4," PHEOCHROMOCYTOMAS pose a risk to health and life, and HYPERTENSION may be the initial clue to their presence.",HYPERTENSION,PHEOCHROMOCYTOMAS,TWrex-cause
725204823,5/23/2015 14:59:12,1642204480,5/23/2015 14:58:56,False,elite,0.7667,31856422,GBR,C9,Carlisle,92.19.36.179,PHEOCHROMOCYTOMAS causes HYPERTENSION,56,2,,67,19,causes,0.997054485501582,812777-FS1-4," PHEOCHROMOCYTOMAS pose a risk to health and life, and HYPERTENSION may be the initial clue to their presence.",HYPERTENSION,PHEOCHROMOCYTOMAS,TWrex-cause
725204823,5/23/2015 15:00:52,1642204819,5/23/2015 15:00:42,False,instagc,0.3988,18805669,CAN,ON,Toronto,76.10.153.80,HYPERTENSION causes PHEOCHROMOCYTOMAS,56,2,,67,19,causes,0.997054485501582,812777-FS1-4," PHEOCHROMOCYTOMAS pose a risk to health and life, and HYPERTENSION may be the initial clue to their presence.",HYPERTENSION,PHEOCHROMOCYTOMAS,TWrex-cause
725204831,5/23/2015 14:34:55,1642197993,5/23/2015 14:34:39,False,neodev,0.8889,14096345,NLD,03,Eibergen,77.174.124.109,no_relation,291,99,,306,123,causes,0.8728715609439692,812620-FS1-4,"Evidence:  A unilateral mass (adenoma or carcinoma) with contralateral atrophy, bilateral masses (MCCUNE ALBRIGHT SYNDROME massive macronodular adrenal disease), or small and/or nodular glands (exogenous glucocorticoids, primary pigmented nodular adrenal disease) are seen in patients with HYPERCORTISOLISM of adrenal origin ( 95 ;  96.",HYPERCORTISOLISM,MCCUNE ALBRIGHT SYNDROME,TWrex-cause
725204831,5/23/2015 14:45:47,1642200834,5/23/2015 14:45:31,False,elite,0.6597,31883685,GBR,H2,Accrington,80.47.186.28,HYPERCORTISOLISM causes MCCUNE ALBRIGHT SYNDROME,291,99,,306,123,causes,0.8728715609439692,812620-FS1-4,"Evidence:  A unilateral mass (adenoma or carcinoma) with contralateral atrophy, bilateral masses (MCCUNE ALBRIGHT SYNDROME massive macronodular adrenal disease), or small and/or nodular glands (exogenous glucocorticoids, primary pigmented nodular adrenal disease) are seen in patients with HYPERCORTISOLISM of adrenal origin ( 95 ;  96.",HYPERCORTISOLISM,MCCUNE ALBRIGHT SYNDROME,TWrex-cause
725204831,5/23/2015 14:47:35,1642201356,5/23/2015 14:47:17,False,clixsense,0.6194,31482589,NLD,,,31.201.11.16,MCCUNE ALBRIGHT SYNDROME causes HYPERCORTISOLISM,291,99,,306,123,causes,0.8728715609439692,812620-FS1-4,"Evidence:  A unilateral mass (adenoma or carcinoma) with contralateral atrophy, bilateral masses (MCCUNE ALBRIGHT SYNDROME massive macronodular adrenal disease), or small and/or nodular glands (exogenous glucocorticoids, primary pigmented nodular adrenal disease) are seen in patients with HYPERCORTISOLISM of adrenal origin ( 95 ;  96.",HYPERCORTISOLISM,MCCUNE ALBRIGHT SYNDROME,TWrex-cause
725204831,5/23/2015 14:54:55,1642203265,5/23/2015 14:53:59,False,instagc,0.5683,18531561,CAN,ON,Mississauga,99.229.92.227,HYPERCORTISOLISM causes MCCUNE ALBRIGHT SYNDROME,291,99,,306,123,causes,0.8728715609439692,812620-FS1-4,"Evidence:  A unilateral mass (adenoma or carcinoma) with contralateral atrophy, bilateral masses (MCCUNE ALBRIGHT SYNDROME massive macronodular adrenal disease), or small and/or nodular glands (exogenous glucocorticoids, primary pigmented nodular adrenal disease) are seen in patients with HYPERCORTISOLISM of adrenal origin ( 95 ;  96.",HYPERCORTISOLISM,MCCUNE ALBRIGHT SYNDROME,TWrex-cause
725204831,5/23/2015 14:55:31,1642203418,5/23/2015 14:54:58,False,instagc,0.6667,20312760,GBR,I2,Manchester,90.244.149.130,no_relation,291,99,,306,123,causes,0.8728715609439692,812620-FS1-4,"Evidence:  A unilateral mass (adenoma or carcinoma) with contralateral atrophy, bilateral masses (MCCUNE ALBRIGHT SYNDROME massive macronodular adrenal disease), or small and/or nodular glands (exogenous glucocorticoids, primary pigmented nodular adrenal disease) are seen in patients with HYPERCORTISOLISM of adrenal origin ( 95 ;  96.",HYPERCORTISOLISM,MCCUNE ALBRIGHT SYNDROME,TWrex-cause
725204831,5/23/2015 15:00:04,1642204702,5/23/2015 14:58:46,False,clixsense,0.4576,17950689,GBR,Y9,Porth,217.43.32.119,HYPERCORTISOLISM causes MCCUNE ALBRIGHT SYNDROME,291,99,,306,123,causes,0.8728715609439692,812620-FS1-4,"Evidence:  A unilateral mass (adenoma or carcinoma) with contralateral atrophy, bilateral masses (MCCUNE ALBRIGHT SYNDROME massive macronodular adrenal disease), or small and/or nodular glands (exogenous glucocorticoids, primary pigmented nodular adrenal disease) are seen in patients with HYPERCORTISOLISM of adrenal origin ( 95 ;  96.",HYPERCORTISOLISM,MCCUNE ALBRIGHT SYNDROME,TWrex-cause
725204831,5/23/2015 15:00:41,1642204797,5/23/2015 14:58:15,False,instagc,0.3988,18805669,CAN,ON,Toronto,76.10.153.80,HYPERCORTISOLISM causes MCCUNE ALBRIGHT SYNDROME,291,99,,306,123,causes,0.8728715609439692,812620-FS1-4,"Evidence:  A unilateral mass (adenoma or carcinoma) with contralateral atrophy, bilateral masses (MCCUNE ALBRIGHT SYNDROME massive macronodular adrenal disease), or small and/or nodular glands (exogenous glucocorticoids, primary pigmented nodular adrenal disease) are seen in patients with HYPERCORTISOLISM of adrenal origin ( 95 ;  96.",HYPERCORTISOLISM,MCCUNE ALBRIGHT SYNDROME,TWrex-cause
725204834,5/23/2015 13:30:01,1642180669,5/23/2015 13:29:49,False,instagc,0.7917,13581319,USA,IL,Mount Vernon,66.232.166.86,no_relation,170,64,,184,78,causes,0.9918365981341758,812825-FS1-4,"Trigeminal Neuralgia (Tic Douloureux)  Trigeminal neuralgia, or TIC DOULOUREUX is a distinctive facial pain syndrome of middle aged and elderly persons in which intense, PAROXYSMAL PAIN occurs several times to dozens of times daily.",PAROXYSMAL PAIN,TIC DOULOUREUX,TWrex-cause
725204834,5/23/2015 13:30:06,1642180719,5/23/2015 13:29:17,False,points4rewards,0.6806,20113482,USA,OR,Portland,67.213.218.72,TIC DOULOUREUX causes PAROXYSMAL PAIN,170,64,,184,78,causes,0.9918365981341758,812825-FS1-4,"Trigeminal Neuralgia (Tic Douloureux)  Trigeminal neuralgia, or TIC DOULOUREUX is a distinctive facial pain syndrome of middle aged and elderly persons in which intense, PAROXYSMAL PAIN occurs several times to dozens of times daily.",PAROXYSMAL PAIN,TIC DOULOUREUX,TWrex-cause
725204834,5/23/2015 13:32:04,1642181298,5/23/2015 13:31:42,False,clixsense,0.7222,30681350,GBR,Q3,Wolverhampton,92.26.249.197,TIC DOULOUREUX causes PAROXYSMAL PAIN,170,64,,184,78,causes,0.9918365981341758,812825-FS1-4,"Trigeminal Neuralgia (Tic Douloureux)  Trigeminal neuralgia, or TIC DOULOUREUX is a distinctive facial pain syndrome of middle aged and elderly persons in which intense, PAROXYSMAL PAIN occurs several times to dozens of times daily.",PAROXYSMAL PAIN,TIC DOULOUREUX,TWrex-cause
725204834,5/23/2015 13:41:44,1642183983,5/23/2015 13:40:18,False,neodev,0.7083,18881135,CAN,ON,Ajax,99.243.87.224,TIC DOULOUREUX causes PAROXYSMAL PAIN,170,64,,184,78,causes,0.9918365981341758,812825-FS1-4,"Trigeminal Neuralgia (Tic Douloureux)  Trigeminal neuralgia, or TIC DOULOUREUX is a distinctive facial pain syndrome of middle aged and elderly persons in which intense, PAROXYSMAL PAIN occurs several times to dozens of times daily.",PAROXYSMAL PAIN,TIC DOULOUREUX,TWrex-cause
725204834,5/23/2015 13:42:29,1642184186,5/23/2015 13:42:16,False,instagc,0.6875,31184650,USA,IA,Mason City,173.26.27.82,TIC DOULOUREUX causes PAROXYSMAL PAIN,170,64,,184,78,causes,0.9918365981341758,812825-FS1-4,"Trigeminal Neuralgia (Tic Douloureux)  Trigeminal neuralgia, or TIC DOULOUREUX is a distinctive facial pain syndrome of middle aged and elderly persons in which intense, PAROXYSMAL PAIN occurs several times to dozens of times daily.",PAROXYSMAL PAIN,TIC DOULOUREUX,TWrex-cause
725204834,5/23/2015 13:48:58,1642185947,5/23/2015 13:48:17,False,elite,0.6817,29768955,GBR,H9,London,213.205.231.165,TIC DOULOUREUX causes PAROXYSMAL PAIN,170,64,,184,78,causes,0.9918365981341758,812825-FS1-4,"Trigeminal Neuralgia (Tic Douloureux)  Trigeminal neuralgia, or TIC DOULOUREUX is a distinctive facial pain syndrome of middle aged and elderly persons in which intense, PAROXYSMAL PAIN occurs several times to dozens of times daily.",PAROXYSMAL PAIN,TIC DOULOUREUX,TWrex-cause
725204834,5/23/2015 14:01:53,1642188986,5/23/2015 14:01:15,False,points4rewards,0.75,28755767,USA,VA,Chester,68.57.118.32,TIC DOULOUREUX causes PAROXYSMAL PAIN,170,64,,184,78,causes,0.9918365981341758,812825-FS1-4,"Trigeminal Neuralgia (Tic Douloureux)  Trigeminal neuralgia, or TIC DOULOUREUX is a distinctive facial pain syndrome of middle aged and elderly persons in which intense, PAROXYSMAL PAIN occurs several times to dozens of times daily.",PAROXYSMAL PAIN,TIC DOULOUREUX,TWrex-cause
725204837,5/23/2015 14:08:42,1642190644,5/23/2015 14:07:42,False,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,GRAVES' DISEASE causes THYROTOXICOSIS,51,126,,65,140,causes,0.985329278164293,812907-FS1-4,"Hyperthyroidism during childhood and adolescence:  GRAVES' DISEASE is the usual cause; it is characterized by diffuse goiter, THYROTOXICOSIS and, rarely, infiltrative ophthalmopathy.",GRAVES' DISEASE,THYROTOXICOSIS,TWrex-cause
725204837,5/23/2015 14:15:38,1642192546,5/23/2015 14:15:21,False,neodev,0.75,18087394,GBR,H9,London,86.3.191.235,GRAVES' DISEASE causes THYROTOXICOSIS,51,126,,65,140,causes,0.985329278164293,812907-FS1-4,"Hyperthyroidism during childhood and adolescence:  GRAVES' DISEASE is the usual cause; it is characterized by diffuse goiter, THYROTOXICOSIS and, rarely, infiltrative ophthalmopathy.",GRAVES' DISEASE,THYROTOXICOSIS,TWrex-cause
725204837,5/23/2015 14:16:17,1642192696,5/23/2015 14:15:59,False,clixsense,0.8194,22518719,GBR,J8,Nottingham,86.10.69.152,GRAVES' DISEASE causes THYROTOXICOSIS,51,126,,65,140,causes,0.985329278164293,812907-FS1-4,"Hyperthyroidism during childhood and adolescence:  GRAVES' DISEASE is the usual cause; it is characterized by diffuse goiter, THYROTOXICOSIS and, rarely, infiltrative ophthalmopathy.",GRAVES' DISEASE,THYROTOXICOSIS,TWrex-cause
725204837,5/23/2015 14:20:05,1642193736,5/23/2015 14:19:41,False,neodev,0.6708,31448050,GBR,Q3,Wolverhampton,80.43.86.150,no_relation,51,126,,65,140,causes,0.985329278164293,812907-FS1-4,"Hyperthyroidism during childhood and adolescence:  GRAVES' DISEASE is the usual cause; it is characterized by diffuse goiter, THYROTOXICOSIS and, rarely, infiltrative ophthalmopathy.",GRAVES' DISEASE,THYROTOXICOSIS,TWrex-cause
725204837,5/23/2015 14:24:58,1642195157,5/23/2015 14:24:33,False,gifthunterclub,0.6359,30901412,GBR,I3,Gillingham,85.210.125.10,GRAVES' DISEASE causes THYROTOXICOSIS,51,126,,65,140,causes,0.985329278164293,812907-FS1-4,"Hyperthyroidism during childhood and adolescence:  GRAVES' DISEASE is the usual cause; it is characterized by diffuse goiter, THYROTOXICOSIS and, rarely, infiltrative ophthalmopathy.",GRAVES' DISEASE,THYROTOXICOSIS,TWrex-cause
725204837,5/23/2015 14:25:26,1642195337,5/23/2015 14:24:58,False,sharecashgpt,0.5786,28627999,CAN,ON,Sudbury,66.103.55.12,no_relation,51,126,,65,140,causes,0.985329278164293,812907-FS1-4,"Hyperthyroidism during childhood and adolescence:  GRAVES' DISEASE is the usual cause; it is characterized by diffuse goiter, THYROTOXICOSIS and, rarely, infiltrative ophthalmopathy.",GRAVES' DISEASE,THYROTOXICOSIS,TWrex-cause
725204837,5/23/2015 14:31:14,1642197067,5/23/2015 14:30:32,False,prodege,0.7361,21417560,GBR,C3,Cambridge,151.225.116.143,GRAVES' DISEASE causes THYROTOXICOSIS,51,126,,65,140,causes,0.985329278164293,812907-FS1-4,"Hyperthyroidism during childhood and adolescence:  GRAVES' DISEASE is the usual cause; it is characterized by diffuse goiter, THYROTOXICOSIS and, rarely, infiltrative ophthalmopathy.",GRAVES' DISEASE,THYROTOXICOSIS,TWrex-cause
725204838,5/23/2015 14:06:25,1642189951,5/23/2015 14:05:35,False,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,WHOOPING COUGH causes BORDETELLA PERTUSSIS,60,86,,73,106,causes,1.0,810171-FS1-4,"2]  He Q, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. WHOOPING COUGH caused by  BORDETELLA PERTUSSIS  and  Bordetella parapertussis  in an immunized population.",WHOOPING COUGH,BORDETELLA PERTUSSIS,TWrex-cause
725204838,5/23/2015 14:14:50,1642192277,5/23/2015 14:14:28,False,neodev,0.75,18087394,GBR,H9,London,86.3.191.235,BORDETELLA PERTUSSIS causes WHOOPING COUGH,60,86,,73,106,causes,1.0,810171-FS1-4,"2]  He Q, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. WHOOPING COUGH caused by  BORDETELLA PERTUSSIS  and  Bordetella parapertussis  in an immunized population.",WHOOPING COUGH,BORDETELLA PERTUSSIS,TWrex-cause
725204838,5/23/2015 14:14:56,1642192314,5/23/2015 14:14:42,False,clixsense,0.8194,22518719,GBR,J8,Nottingham,86.10.69.152,BORDETELLA PERTUSSIS causes WHOOPING COUGH,60,86,,73,106,causes,1.0,810171-FS1-4,"2]  He Q, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. WHOOPING COUGH caused by  BORDETELLA PERTUSSIS  and  Bordetella parapertussis  in an immunized population.",WHOOPING COUGH,BORDETELLA PERTUSSIS,TWrex-cause
725204838,5/23/2015 14:18:45,1642193358,5/23/2015 14:18:37,False,clixsense,0.9167,28457001,CAN,ON,North Bay,24.204.202.220,BORDETELLA PERTUSSIS causes WHOOPING COUGH,60,86,,73,106,causes,1.0,810171-FS1-4,"2]  He Q, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. WHOOPING COUGH caused by  BORDETELLA PERTUSSIS  and  Bordetella parapertussis  in an immunized population.",WHOOPING COUGH,BORDETELLA PERTUSSIS,TWrex-cause
725204838,5/23/2015 14:18:55,1642193386,5/23/2015 14:18:41,False,neodev,0.6708,31448050,GBR,Q3,Wolverhampton,80.43.86.150,BORDETELLA PERTUSSIS causes WHOOPING COUGH,60,86,,73,106,causes,1.0,810171-FS1-4,"2]  He Q, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. WHOOPING COUGH caused by  BORDETELLA PERTUSSIS  and  Bordetella parapertussis  in an immunized population.",WHOOPING COUGH,BORDETELLA PERTUSSIS,TWrex-cause
725204838,5/23/2015 14:23:45,1642194895,5/23/2015 14:23:27,False,gifthunterclub,0.6359,30901412,GBR,I3,Gillingham,85.210.125.10,BORDETELLA PERTUSSIS causes WHOOPING COUGH,60,86,,73,106,causes,1.0,810171-FS1-4,"2]  He Q, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. WHOOPING COUGH caused by  BORDETELLA PERTUSSIS  and  Bordetella parapertussis  in an immunized population.",WHOOPING COUGH,BORDETELLA PERTUSSIS,TWrex-cause
725204838,5/23/2015 14:24:05,1642194943,5/23/2015 14:23:35,False,sharecashgpt,0.5786,28627999,CAN,ON,Sudbury,66.103.55.12,no_relation,60,86,,73,106,causes,1.0,810171-FS1-4,"2]  He Q, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. WHOOPING COUGH caused by  BORDETELLA PERTUSSIS  and  Bordetella parapertussis  in an immunized population.",WHOOPING COUGH,BORDETELLA PERTUSSIS,TWrex-cause
725204840,5/23/2015 14:04:10,1642189464,5/23/2015 14:03:45,False,points4rewards,0.75,28755767,USA,VA,Chester,68.57.118.32,TTP causes FEVER,2,47,,6,50,causes,0.9166984970282109,813289-FS1-4," FEVER and neurologic impairment are found in TTP which is characterized by thrombocytopenia, microangiopathic hemolytic anemia, and renal failure.",FEVER,TTP,TWrex-cause
725204840,5/23/2015 14:05:34,1642189801,5/23/2015 14:04:30,False,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,TTP causes FEVER,2,47,,6,50,causes,0.9166984970282109,813289-FS1-4," FEVER and neurologic impairment are found in TTP which is characterized by thrombocytopenia, microangiopathic hemolytic anemia, and renal failure.",FEVER,TTP,TWrex-cause
725204840,5/23/2015 14:14:27,1642192147,5/23/2015 14:14:06,False,neodev,0.75,18087394,GBR,H9,London,86.3.191.235,TTP causes FEVER,2,47,,6,50,causes,0.9166984970282109,813289-FS1-4," FEVER and neurologic impairment are found in TTP which is characterized by thrombocytopenia, microangiopathic hemolytic anemia, and renal failure.",FEVER,TTP,TWrex-cause
725204840,5/23/2015 14:14:41,1642192184,5/23/2015 14:12:01,False,clixsense,0.8194,22518719,GBR,J8,Nottingham,86.10.69.152,TTP causes FEVER,2,47,,6,50,causes,0.9166984970282109,813289-FS1-4," FEVER and neurologic impairment are found in TTP which is characterized by thrombocytopenia, microangiopathic hemolytic anemia, and renal failure.",FEVER,TTP,TWrex-cause
725204840,5/23/2015 14:18:36,1642193318,5/23/2015 14:18:19,False,clixsense,0.9167,28457001,CAN,ON,North Bay,24.204.202.220,TTP causes FEVER,2,47,,6,50,causes,0.9166984970282109,813289-FS1-4," FEVER and neurologic impairment are found in TTP which is characterized by thrombocytopenia, microangiopathic hemolytic anemia, and renal failure.",FEVER,TTP,TWrex-cause
725204840,5/23/2015 14:18:40,1642193354,5/23/2015 14:17:59,False,neodev,0.6708,31448050,GBR,Q3,Wolverhampton,80.43.86.150,TTP causes FEVER,2,47,,6,50,causes,0.9166984970282109,813289-FS1-4," FEVER and neurologic impairment are found in TTP which is characterized by thrombocytopenia, microangiopathic hemolytic anemia, and renal failure.",FEVER,TTP,TWrex-cause
725204840,5/23/2015 14:22:29,1642194629,5/23/2015 14:22:05,False,gifthunterclub,0.6359,30901412,GBR,I3,Gillingham,85.210.125.10,TTP causes FEVER,2,47,,6,50,causes,0.9166984970282109,813289-FS1-4," FEVER and neurologic impairment are found in TTP which is characterized by thrombocytopenia, microangiopathic hemolytic anemia, and renal failure.",FEVER,TTP,TWrex-cause
725204841,5/23/2015 14:07:00,1642190120,5/23/2015 14:06:26,False,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,SEIZURE causes SE,3,3,,9,5,causes,0.95257934441568,813520-FS1-4,"Do SEIZURE type, cause, and duration of SE affect long term mortality.",SEIZURE,SE,TWrex-cause
725204841,5/23/2015 14:15:03,1642192359,5/23/2015 14:14:51,False,neodev,0.75,18087394,GBR,H9,London,86.3.191.235,no_relation,3,3,,9,5,causes,0.95257934441568,813520-FS1-4,"Do SEIZURE type, cause, and duration of SE affect long term mortality.",SEIZURE,SE,TWrex-cause
725204841,5/23/2015 14:15:23,1642192447,5/23/2015 14:14:57,False,clixsense,0.8194,22518719,GBR,J8,Nottingham,86.10.69.152,SE causes SEIZURE,3,3,,9,5,causes,0.95257934441568,813520-FS1-4,"Do SEIZURE type, cause, and duration of SE affect long term mortality.",SEIZURE,SE,TWrex-cause
725204841,5/23/2015 14:19:22,1642193515,5/23/2015 14:18:56,False,neodev,0.6708,31448050,GBR,Q3,Wolverhampton,80.43.86.150,SE causes SEIZURE,3,3,,9,5,causes,0.95257934441568,813520-FS1-4,"Do SEIZURE type, cause, and duration of SE affect long term mortality.",SEIZURE,SE,TWrex-cause
725204841,5/23/2015 14:24:09,1642194961,5/23/2015 14:23:46,False,gifthunterclub,0.6359,30901412,GBR,I3,Gillingham,85.210.125.10,no_relation,3,3,,9,5,causes,0.95257934441568,813520-FS1-4,"Do SEIZURE type, cause, and duration of SE affect long term mortality.",SEIZURE,SE,TWrex-cause
725204841,5/23/2015 14:24:31,1642195047,5/23/2015 14:24:07,False,sharecashgpt,0.5786,28627999,CAN,ON,Sudbury,66.103.55.12,no_relation,3,3,,9,5,causes,0.95257934441568,813520-FS1-4,"Do SEIZURE type, cause, and duration of SE affect long term mortality.",SEIZURE,SE,TWrex-cause
725204841,5/23/2015 14:30:07,1642196743,5/23/2015 14:27:56,False,onestopgpt,0.7133,21275875,CAN,ON,Hamilton,24.36.121.10,no_relation,3,3,,9,5,causes,0.95257934441568,813520-FS1-4,"Do SEIZURE type, cause, and duration of SE affect long term mortality.",SEIZURE,SE,TWrex-cause
725204853,5/23/2015 14:04:10,1642189465,5/23/2015 14:03:45,False,points4rewards,0.75,28755767,USA,VA,Chester,68.57.118.32,no_relation,87,51,,94,69,causes,0.398014876083996,804829-FS1-4,"As hypomagnesia is a common cause of VT, stat dose MAGNESIUM SULPHATE can be given for TORSADES or if hypomagnesemia is found/suspected.",TORSADES,MAGNESIUM SULPHATE,TWrex-cause
725204853,5/23/2015 14:05:34,1642189800,5/23/2015 14:04:30,False,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,no_relation,87,51,,94,69,causes,0.398014876083996,804829-FS1-4,"As hypomagnesia is a common cause of VT, stat dose MAGNESIUM SULPHATE can be given for TORSADES or if hypomagnesemia is found/suspected.",TORSADES,MAGNESIUM SULPHATE,TWrex-cause
725204853,5/23/2015 14:14:27,1642192146,5/23/2015 14:14:06,False,neodev,0.75,18087394,GBR,H9,London,86.3.191.235,no_relation,87,51,,94,69,causes,0.398014876083996,804829-FS1-4,"As hypomagnesia is a common cause of VT, stat dose MAGNESIUM SULPHATE can be given for TORSADES or if hypomagnesemia is found/suspected.",TORSADES,MAGNESIUM SULPHATE,TWrex-cause
725204853,5/23/2015 14:14:41,1642192186,5/23/2015 14:12:01,False,clixsense,0.8194,22518719,GBR,J8,Nottingham,86.10.69.152,no_relation,87,51,,94,69,causes,0.398014876083996,804829-FS1-4,"As hypomagnesia is a common cause of VT, stat dose MAGNESIUM SULPHATE can be given for TORSADES or if hypomagnesemia is found/suspected.",TORSADES,MAGNESIUM SULPHATE,TWrex-cause
725204853,5/23/2015 14:18:36,1642193320,5/23/2015 14:18:19,False,clixsense,0.9167,28457001,CAN,ON,North Bay,24.204.202.220,no_relation,87,51,,94,69,causes,0.398014876083996,804829-FS1-4,"As hypomagnesia is a common cause of VT, stat dose MAGNESIUM SULPHATE can be given for TORSADES or if hypomagnesemia is found/suspected.",TORSADES,MAGNESIUM SULPHATE,TWrex-cause
725204853,5/23/2015 14:18:40,1642193355,5/23/2015 14:17:59,False,neodev,0.6708,31448050,GBR,Q3,Wolverhampton,80.43.86.150,no_relation,87,51,,94,69,causes,0.398014876083996,804829-FS1-4,"As hypomagnesia is a common cause of VT, stat dose MAGNESIUM SULPHATE can be given for TORSADES or if hypomagnesemia is found/suspected.",TORSADES,MAGNESIUM SULPHATE,TWrex-cause
725204853,5/23/2015 14:22:29,1642194620,5/23/2015 14:22:05,False,gifthunterclub,0.6359,30901412,GBR,I3,Gillingham,85.210.125.10,no_relation,87,51,,94,69,causes,0.398014876083996,804829-FS1-4,"As hypomagnesia is a common cause of VT, stat dose MAGNESIUM SULPHATE can be given for TORSADES or if hypomagnesemia is found/suspected.",TORSADES,MAGNESIUM SULPHATE,TWrex-cause
725258432,5/23/2015 20:37:42,1642361432,5/23/2015 20:37:29,False,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,LUNG DISEASES causes INTERSTITIUM OF THE LUNG,67,109,,90,122,causes,0.480384461415261,802334-FS1-4,"Because airway disease and other lung diseases also may affect the INTERSTITIUM OF THE LUNG and interstitial LUNG DISEASES can affect the airways, the term  diffuse parenchymal lung disease  (DPLD) is often preferred.",INTERSTITIUM OF THE LUNG,LUNG DISEASES,TWrex-cause
725258432,5/23/2015 20:40:26,1642363098,5/23/2015 20:39:36,False,prodege,0.5944,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,67,109,,90,122,causes,0.480384461415261,802334-FS1-4,"Because airway disease and other lung diseases also may affect the INTERSTITIUM OF THE LUNG and interstitial LUNG DISEASES can affect the airways, the term  diffuse parenchymal lung disease  (DPLD) is often preferred.",INTERSTITIUM OF THE LUNG,LUNG DISEASES,TWrex-cause
725258432,5/23/2015 20:42:32,1642364167,5/23/2015 20:42:16,False,pocketmoneygpt,0.6181,28884030,USA,WI,Minocqua,75.143.134.247,LUNG DISEASES causes INTERSTITIUM OF THE LUNG,67,109,,90,122,causes,0.480384461415261,802334-FS1-4,"Because airway disease and other lung diseases also may affect the INTERSTITIUM OF THE LUNG and interstitial LUNG DISEASES can affect the airways, the term  diffuse parenchymal lung disease  (DPLD) is often preferred.",INTERSTITIUM OF THE LUNG,LUNG DISEASES,TWrex-cause
725258432,5/23/2015 20:43:14,1642364554,5/23/2015 20:39:01,False,points4rewards,0.6806,20113482,USA,OR,Portland,67.213.218.72,no_relation,67,109,,90,122,causes,0.480384461415261,802334-FS1-4,"Because airway disease and other lung diseases also may affect the INTERSTITIUM OF THE LUNG and interstitial LUNG DISEASES can affect the airways, the term  diffuse parenchymal lung disease  (DPLD) is often preferred.",INTERSTITIUM OF THE LUNG,LUNG DISEASES,TWrex-cause
725258432,5/23/2015 20:45:27,1642365946,5/23/2015 20:42:53,False,neodev,0.6643,18881135,CAN,ON,Ajax,99.243.87.224,LUNG DISEASES causes INTERSTITIUM OF THE LUNG,67,109,,90,122,causes,0.480384461415261,802334-FS1-4,"Because airway disease and other lung diseases also may affect the INTERSTITIUM OF THE LUNG and interstitial LUNG DISEASES can affect the airways, the term  diffuse parenchymal lung disease  (DPLD) is often preferred.",INTERSTITIUM OF THE LUNG,LUNG DISEASES,TWrex-cause
725258432,5/23/2015 20:50:28,1642368879,5/23/2015 20:50:10,False,instagc,0.6754,18531561,CAN,ON,Mississauga,99.229.92.227,no_relation,67,109,,90,122,causes,0.480384461415261,802334-FS1-4,"Because airway disease and other lung diseases also may affect the INTERSTITIUM OF THE LUNG and interstitial LUNG DISEASES can affect the airways, the term  diffuse parenchymal lung disease  (DPLD) is often preferred.",INTERSTITIUM OF THE LUNG,LUNG DISEASES,TWrex-cause
725258432,5/23/2015 20:51:51,1642369681,5/23/2015 20:51:31,False,cointasker,0.7190000000000001,21783324,NLD,,,31.151.239.133,no_relation,67,109,,90,122,causes,0.480384461415261,802334-FS1-4,"Because airway disease and other lung diseases also may affect the INTERSTITIUM OF THE LUNG and interstitial LUNG DISEASES can affect the airways, the term  diffuse parenchymal lung disease  (DPLD) is often preferred.",INTERSTITIUM OF THE LUNG,LUNG DISEASES,TWrex-cause
725258440,5/23/2015 21:05:29,1642375965,5/23/2015 21:04:03,False,elite,0.9028,31883685,GBR,H2,Accrington,80.47.186.28,BRUCELLA MELITENSIS causes BRUCELLOSIS,79,109,,89,128,causes,0.9941348467724341,811413-FS1-4,"538 ,   667 ,   729 ,   730 ,   731 ,   732 ,   733  Brucellosis  Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.",BRUCELLOSIS,BRUCELLA MELITENSIS,TWrex-cause
725258440,5/23/2015 21:14:55,1642380519,5/23/2015 21:10:51,False,neodev,0.6208,22052203,USA,KS,Manhattan,70.179.128.5,BRUCELLA MELITENSIS causes BRUCELLOSIS,79,109,,89,128,causes,0.9941348467724341,811413-FS1-4,"538 ,   667 ,   729 ,   730 ,   731 ,   732 ,   733  Brucellosis  Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.",BRUCELLOSIS,BRUCELLA MELITENSIS,TWrex-cause
725258440,5/23/2015 21:26:09,1642385997,5/23/2015 21:25:52,False,clixsense,0.7153,30313955,GBR,K5,Poole,2.30.145.202,BRUCELLA MELITENSIS causes BRUCELLOSIS,79,109,,89,128,causes,0.9941348467724341,811413-FS1-4,"538 ,   667 ,   729 ,   730 ,   731 ,   732 ,   733  Brucellosis  Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.",BRUCELLOSIS,BRUCELLA MELITENSIS,TWrex-cause
725258440,5/23/2015 21:27:47,1642386835,5/23/2015 21:27:24,False,neodev,0.7905,30627835,GBR,H9,London,5.81.27.94,no_relation,79,109,,89,128,causes,0.9941348467724341,811413-FS1-4,"538 ,   667 ,   729 ,   730 ,   731 ,   732 ,   733  Brucellosis  Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.",BRUCELLOSIS,BRUCELLA MELITENSIS,TWrex-cause
725258440,5/23/2015 21:37:02,1642391605,5/23/2015 21:36:31,False,neodev,0.8194,11460728,CAN,BC,Burnaby,70.79.16.165,BRUCELLA MELITENSIS causes BRUCELLOSIS,79,109,,89,128,causes,0.9941348467724341,811413-FS1-4,"538 ,   667 ,   729 ,   730 ,   731 ,   732 ,   733  Brucellosis  Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.",BRUCELLOSIS,BRUCELLA MELITENSIS,TWrex-cause
725258440,5/23/2015 22:10:43,1642406911,5/23/2015 22:10:12,False,instagc,0.6389,15864091,USA,OK,Oklahoma City,104.0.113.133,BRUCELLOSIS causes BRUCELLA MELITENSIS,79,109,,89,128,causes,0.9941348467724341,811413-FS1-4,"538 ,   667 ,   729 ,   730 ,   731 ,   732 ,   733  Brucellosis  Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.",BRUCELLOSIS,BRUCELLA MELITENSIS,TWrex-cause
725258440,5/23/2015 22:18:47,1642410940,5/23/2015 22:17:09,False,clixsense,0.6194,10798016,GBR,C7,Coventry,86.24.245.191,BRUCELLA MELITENSIS causes BRUCELLOSIS,79,109,,89,128,causes,0.9941348467724341,811413-FS1-4,"538 ,   667 ,   729 ,   730 ,   731 ,   732 ,   733  Brucellosis  Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.",BRUCELLOSIS,BRUCELLA MELITENSIS,TWrex-cause
725258441,5/23/2015 20:38:52,1642362135,5/23/2015 20:38:43,False,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,RICKETTSIA AKARI causes SELF LIMITED DISEASE,69,101,,88,117,causes,1.0,810845-FS1-4,"rickettsialpox    (                      audio )  An acute, febrile, SELF LIMITED DISEASE caused by  RICKETTSIA AKARI.",SELF LIMITED DISEASE,RICKETTSIA AKARI,TWrex-cause
725258441,5/23/2015 20:43:03,1642364428,5/23/2015 20:42:34,False,prodege,0.5944,21417560,GBR,C3,Cambridge,151.225.116.143,RICKETTSIA AKARI causes SELF LIMITED DISEASE,69,101,,88,117,causes,1.0,810845-FS1-4,"rickettsialpox    (                      audio )  An acute, febrile, SELF LIMITED DISEASE caused by  RICKETTSIA AKARI.",SELF LIMITED DISEASE,RICKETTSIA AKARI,TWrex-cause
725258441,5/23/2015 20:43:50,1642364922,5/23/2015 20:43:35,False,pocketmoneygpt,0.6181,28884030,USA,WI,Minocqua,75.143.134.247,RICKETTSIA AKARI causes SELF LIMITED DISEASE,69,101,,88,117,causes,1.0,810845-FS1-4,"rickettsialpox    (                      audio )  An acute, febrile, SELF LIMITED DISEASE caused by  RICKETTSIA AKARI.",SELF LIMITED DISEASE,RICKETTSIA AKARI,TWrex-cause
725258441,5/23/2015 20:50:36,1642368983,5/23/2015 20:49:32,False,points4rewards,0.6806,20113482,USA,OR,Portland,67.213.218.72,RICKETTSIA AKARI causes SELF LIMITED DISEASE,69,101,,88,117,causes,1.0,810845-FS1-4,"rickettsialpox    (                      audio )  An acute, febrile, SELF LIMITED DISEASE caused by  RICKETTSIA AKARI.",SELF LIMITED DISEASE,RICKETTSIA AKARI,TWrex-cause
725258441,5/23/2015 20:52:25,1642370037,5/23/2015 20:51:59,False,instagc,0.6754,18531561,CAN,ON,Mississauga,99.229.92.227,SELF LIMITED DISEASE causes RICKETTSIA AKARI,69,101,,88,117,causes,1.0,810845-FS1-4,"rickettsialpox    (                      audio )  An acute, febrile, SELF LIMITED DISEASE caused by  RICKETTSIA AKARI.",SELF LIMITED DISEASE,RICKETTSIA AKARI,TWrex-cause
725258441,5/23/2015 20:53:03,1642370389,5/23/2015 20:52:45,False,cointasker,0.7190000000000001,21783324,NLD,,,31.151.239.133,RICKETTSIA AKARI causes SELF LIMITED DISEASE,69,101,,88,117,causes,1.0,810845-FS1-4,"rickettsialpox    (                      audio )  An acute, febrile, SELF LIMITED DISEASE caused by  RICKETTSIA AKARI.",SELF LIMITED DISEASE,RICKETTSIA AKARI,TWrex-cause
725258441,5/23/2015 20:58:39,1642373079,5/23/2015 20:54:20,False,neodev,0.6643,18881135,CAN,ON,Ajax,99.243.87.224,RICKETTSIA AKARI causes SELF LIMITED DISEASE,69,101,,88,117,causes,1.0,810845-FS1-4,"rickettsialpox    (                      audio )  An acute, febrile, SELF LIMITED DISEASE caused by  RICKETTSIA AKARI.",SELF LIMITED DISEASE,RICKETTSIA AKARI,TWrex-cause
725258444,5/23/2015 21:05:29,1642375964,5/23/2015 21:04:03,False,elite,0.9028,31883685,GBR,H2,Accrington,80.47.186.28,SWEET SYNDROME causes NEUTROPHILIA,137,42,,148,56,causes,0.6154574548966639,813001-FS1-4,One such uncommon idiopathic condition is SWEET SYNDROME which is an acute febrile illness with painful cutaneous plaques and associated NEUTROPHILIA of any cause.,NEUTROPHILIA,SWEET SYNDROME,TWrex-cause
725258444,5/23/2015 21:14:55,1642380512,5/23/2015 21:10:51,False,neodev,0.6208,22052203,USA,KS,Manhattan,70.179.128.5,NEUTROPHILIA causes SWEET SYNDROME,137,42,,148,56,causes,0.6154574548966639,813001-FS1-4,One such uncommon idiopathic condition is SWEET SYNDROME which is an acute febrile illness with painful cutaneous plaques and associated NEUTROPHILIA of any cause.,NEUTROPHILIA,SWEET SYNDROME,TWrex-cause
725258444,5/23/2015 21:26:09,1642385998,5/23/2015 21:25:52,False,clixsense,0.7153,30313955,GBR,K5,Poole,2.30.145.202,SWEET SYNDROME causes NEUTROPHILIA,137,42,,148,56,causes,0.6154574548966639,813001-FS1-4,One such uncommon idiopathic condition is SWEET SYNDROME which is an acute febrile illness with painful cutaneous plaques and associated NEUTROPHILIA of any cause.,NEUTROPHILIA,SWEET SYNDROME,TWrex-cause
725258444,5/23/2015 21:27:47,1642386830,5/23/2015 21:27:24,False,neodev,0.7905,30627835,GBR,H9,London,5.81.27.94,SWEET SYNDROME causes NEUTROPHILIA,137,42,,148,56,causes,0.6154574548966639,813001-FS1-4,One such uncommon idiopathic condition is SWEET SYNDROME which is an acute febrile illness with painful cutaneous plaques and associated NEUTROPHILIA of any cause.,NEUTROPHILIA,SWEET SYNDROME,TWrex-cause
725258444,5/23/2015 21:37:02,1642391606,5/23/2015 21:36:31,False,neodev,0.8194,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,137,42,,148,56,causes,0.6154574548966639,813001-FS1-4,One such uncommon idiopathic condition is SWEET SYNDROME which is an acute febrile illness with painful cutaneous plaques and associated NEUTROPHILIA of any cause.,NEUTROPHILIA,SWEET SYNDROME,TWrex-cause
725258444,5/23/2015 22:10:43,1642406915,5/23/2015 22:10:12,False,instagc,0.6389,15864091,USA,OK,Oklahoma City,104.0.113.133,no_relation,137,42,,148,56,causes,0.6154574548966639,813001-FS1-4,One such uncommon idiopathic condition is SWEET SYNDROME which is an acute febrile illness with painful cutaneous plaques and associated NEUTROPHILIA of any cause.,NEUTROPHILIA,SWEET SYNDROME,TWrex-cause
725258444,5/23/2015 22:18:47,1642410961,5/23/2015 22:17:09,False,clixsense,0.6194,10798016,GBR,C7,Coventry,86.24.245.191,NEUTROPHILIA causes SWEET SYNDROME,137,42,,148,56,causes,0.6154574548966639,813001-FS1-4,One such uncommon idiopathic condition is SWEET SYNDROME which is an acute febrile illness with painful cutaneous plaques and associated NEUTROPHILIA of any cause.,NEUTROPHILIA,SWEET SYNDROME,TWrex-cause
725258446,5/23/2015 20:57:36,1642372599,5/23/2015 20:56:25,False,instagc,0.9524,30326470,USA,CA,Santee,99.44.37.73,FRUCTOSE INTOLERANCE causes POSTPRANDIAL HYPOGLYCEMIA,39,0,,63,20,causes,0.993883734673619,811861-FS1-4,FRUCTOSE INTOLERANCE most often causes POSTPRANDIAL HYPOGLYCEMIA that usually manifests in infancy and occasionally later in life ( 23.,POSTPRANDIAL HYPOGLYCEMIA,FRUCTOSE INTOLERANCE,TWrex-cause
725258446,5/23/2015 21:03:35,1642375218,5/23/2015 21:03:22,False,elite,0.9028,31883685,GBR,H2,Accrington,80.47.186.28,FRUCTOSE INTOLERANCE causes POSTPRANDIAL HYPOGLYCEMIA,39,0,,63,20,causes,0.993883734673619,811861-FS1-4,FRUCTOSE INTOLERANCE most often causes POSTPRANDIAL HYPOGLYCEMIA that usually manifests in infancy and occasionally later in life ( 23.,POSTPRANDIAL HYPOGLYCEMIA,FRUCTOSE INTOLERANCE,TWrex-cause
725258446,5/23/2015 21:09:57,1642378266,5/23/2015 21:09:26,False,neodev,0.6208,22052203,USA,KS,Manhattan,70.179.128.5,FRUCTOSE INTOLERANCE causes POSTPRANDIAL HYPOGLYCEMIA,39,0,,63,20,causes,0.993883734673619,811861-FS1-4,FRUCTOSE INTOLERANCE most often causes POSTPRANDIAL HYPOGLYCEMIA that usually manifests in infancy and occasionally later in life ( 23.,POSTPRANDIAL HYPOGLYCEMIA,FRUCTOSE INTOLERANCE,TWrex-cause
725258446,5/23/2015 21:25:31,1642385606,5/23/2015 21:25:05,False,clixsense,0.7153,30313955,GBR,K5,Poole,2.30.145.202,FRUCTOSE INTOLERANCE causes POSTPRANDIAL HYPOGLYCEMIA,39,0,,63,20,causes,0.993883734673619,811861-FS1-4,FRUCTOSE INTOLERANCE most often causes POSTPRANDIAL HYPOGLYCEMIA that usually manifests in infancy and occasionally later in life ( 23.,POSTPRANDIAL HYPOGLYCEMIA,FRUCTOSE INTOLERANCE,TWrex-cause
725258446,5/23/2015 21:26:55,1642386340,5/23/2015 21:26:41,False,neodev,0.7905,30627835,GBR,H9,London,5.81.27.94,FRUCTOSE INTOLERANCE causes POSTPRANDIAL HYPOGLYCEMIA,39,0,,63,20,causes,0.993883734673619,811861-FS1-4,FRUCTOSE INTOLERANCE most often causes POSTPRANDIAL HYPOGLYCEMIA that usually manifests in infancy and occasionally later in life ( 23.,POSTPRANDIAL HYPOGLYCEMIA,FRUCTOSE INTOLERANCE,TWrex-cause
725258446,5/23/2015 21:35:43,1642390885,5/23/2015 21:34:54,False,neodev,0.8194,11460728,CAN,BC,Burnaby,70.79.16.165,FRUCTOSE INTOLERANCE causes POSTPRANDIAL HYPOGLYCEMIA,39,0,,63,20,causes,0.993883734673619,811861-FS1-4,FRUCTOSE INTOLERANCE most often causes POSTPRANDIAL HYPOGLYCEMIA that usually manifests in infancy and occasionally later in life ( 23.,POSTPRANDIAL HYPOGLYCEMIA,FRUCTOSE INTOLERANCE,TWrex-cause
725258446,5/23/2015 22:09:39,1642406396,5/23/2015 22:09:21,False,instagc,0.6389,15864091,USA,OK,Oklahoma City,104.0.113.133,FRUCTOSE INTOLERANCE causes POSTPRANDIAL HYPOGLYCEMIA,39,0,,63,20,causes,0.993883734673619,811861-FS1-4,FRUCTOSE INTOLERANCE most often causes POSTPRANDIAL HYPOGLYCEMIA that usually manifests in infancy and occasionally later in life ( 23.,POSTPRANDIAL HYPOGLYCEMIA,FRUCTOSE INTOLERANCE,TWrex-cause
725258447,5/23/2015 20:38:13,1642361716,5/23/2015 20:37:59,False,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,no_relation,244,194,,247,204,causes,0.33968311024337894,802357-FS1-4,"Asymmetrical pulmonary edema can occur as a result of the patient's lying on the involved side as the edema develops, or it may result from vascular obstruction (thromboembolism) or attenuation (EMPHYSEMA) in the more radiolucent regions of the LUNG",LUNG,EMPHYSEMA,TWrex-cause
725258447,5/23/2015 20:42:02,1642363922,5/23/2015 20:41:22,False,prodege,0.5944,21417560,GBR,C3,Cambridge,151.225.116.143,EMPHYSEMA causes LUNG,244,194,,247,204,causes,0.33968311024337894,802357-FS1-4,"Asymmetrical pulmonary edema can occur as a result of the patient's lying on the involved side as the edema develops, or it may result from vascular obstruction (thromboembolism) or attenuation (EMPHYSEMA) in the more radiolucent regions of the LUNG",LUNG,EMPHYSEMA,TWrex-cause
725258447,5/23/2015 20:43:17,1642364575,5/23/2015 20:42:57,False,pocketmoneygpt,0.6181,28884030,USA,WI,Minocqua,75.143.134.247,no_relation,244,194,,247,204,causes,0.33968311024337894,802357-FS1-4,"Asymmetrical pulmonary edema can occur as a result of the patient's lying on the involved side as the edema develops, or it may result from vascular obstruction (thromboembolism) or attenuation (EMPHYSEMA) in the more radiolucent regions of the LUNG",LUNG,EMPHYSEMA,TWrex-cause
725258447,5/23/2015 20:46:56,1642366925,5/23/2015 20:44:16,False,points4rewards,0.6806,20113482,USA,OR,Portland,67.213.218.72,no_relation,244,194,,247,204,causes,0.33968311024337894,802357-FS1-4,"Asymmetrical pulmonary edema can occur as a result of the patient's lying on the involved side as the edema develops, or it may result from vascular obstruction (thromboembolism) or attenuation (EMPHYSEMA) in the more radiolucent regions of the LUNG",LUNG,EMPHYSEMA,TWrex-cause
725258447,5/23/2015 20:51:31,1642369494,5/23/2015 20:51:16,False,instagc,0.6754,18531561,CAN,ON,Mississauga,99.229.92.227,no_relation,244,194,,247,204,causes,0.33968311024337894,802357-FS1-4,"Asymmetrical pulmonary edema can occur as a result of the patient's lying on the involved side as the edema develops, or it may result from vascular obstruction (thromboembolism) or attenuation (EMPHYSEMA) in the more radiolucent regions of the LUNG",LUNG,EMPHYSEMA,TWrex-cause
725258447,5/23/2015 20:52:21,1642369968,5/23/2015 20:52:04,False,cointasker,0.7190000000000001,21783324,NLD,,,31.151.239.133,no_relation,244,194,,247,204,causes,0.33968311024337894,802357-FS1-4,"Asymmetrical pulmonary edema can occur as a result of the patient's lying on the involved side as the edema develops, or it may result from vascular obstruction (thromboembolism) or attenuation (EMPHYSEMA) in the more radiolucent regions of the LUNG",LUNG,EMPHYSEMA,TWrex-cause
725258447,5/23/2015 20:54:17,1642370976,5/23/2015 20:53:43,False,instagc,0.9524,30326470,USA,CA,Santee,99.44.37.73,no_relation,244,194,,247,204,causes,0.33968311024337894,802357-FS1-4,"Asymmetrical pulmonary edema can occur as a result of the patient's lying on the involved side as the edema develops, or it may result from vascular obstruction (thromboembolism) or attenuation (EMPHYSEMA) in the more radiolucent regions of the LUNG",LUNG,EMPHYSEMA,TWrex-cause
725258454,5/23/2015 20:56:23,1642371994,5/23/2015 20:55:41,False,instagc,0.9524,30326470,USA,CA,Santee,99.44.37.73,no_relation,24,3,,47,9,causes,0.8576900278702358,814347-FS1-4,"If MEN II is suspected, MEDULLARY THYROID CANCER should be considered, and pheochromocytoma must be excluded before the patient goes to surgery.",MEDULLARY THYROID CANCER,MEN II,TWrex-cause
725258454,5/23/2015 21:03:21,1642375114,5/23/2015 21:03:06,False,elite,0.9028,31883685,GBR,H2,Accrington,80.47.186.28,no_relation,24,3,,47,9,causes,0.8576900278702358,814347-FS1-4,"If MEN II is suspected, MEDULLARY THYROID CANCER should be considered, and pheochromocytoma must be excluded before the patient goes to surgery.",MEDULLARY THYROID CANCER,MEN II,TWrex-cause
725258454,5/23/2015 21:09:24,1642377993,5/23/2015 21:08:56,False,neodev,0.6208,22052203,USA,KS,Manhattan,70.179.128.5,MEN II causes MEDULLARY THYROID CANCER,24,3,,47,9,causes,0.8576900278702358,814347-FS1-4,"If MEN II is suspected, MEDULLARY THYROID CANCER should be considered, and pheochromocytoma must be excluded before the patient goes to surgery.",MEDULLARY THYROID CANCER,MEN II,TWrex-cause
725258454,5/23/2015 21:25:00,1642385323,5/23/2015 21:24:38,False,clixsense,0.7153,30313955,GBR,K5,Poole,2.30.145.202,no_relation,24,3,,47,9,causes,0.8576900278702358,814347-FS1-4,"If MEN II is suspected, MEDULLARY THYROID CANCER should be considered, and pheochromocytoma must be excluded before the patient goes to surgery.",MEDULLARY THYROID CANCER,MEN II,TWrex-cause
725258454,5/23/2015 21:26:40,1642386231,5/23/2015 21:26:25,False,neodev,0.7905,30627835,GBR,H9,London,5.81.27.94,no_relation,24,3,,47,9,causes,0.8576900278702358,814347-FS1-4,"If MEN II is suspected, MEDULLARY THYROID CANCER should be considered, and pheochromocytoma must be excluded before the patient goes to surgery.",MEDULLARY THYROID CANCER,MEN II,TWrex-cause
725258454,5/23/2015 21:34:52,1642390465,5/23/2015 21:33:48,False,neodev,0.8194,11460728,CAN,BC,Burnaby,70.79.16.165,MEN II causes MEDULLARY THYROID CANCER,24,3,,47,9,causes,0.8576900278702358,814347-FS1-4,"If MEN II is suspected, MEDULLARY THYROID CANCER should be considered, and pheochromocytoma must be excluded before the patient goes to surgery.",MEDULLARY THYROID CANCER,MEN II,TWrex-cause
725258454,5/23/2015 22:09:20,1642406224,5/23/2015 22:08:38,False,instagc,0.6389,15864091,USA,OK,Oklahoma City,104.0.113.133,MEN II causes MEDULLARY THYROID CANCER,24,3,,47,9,causes,0.8576900278702358,814347-FS1-4,"If MEN II is suspected, MEDULLARY THYROID CANCER should be considered, and pheochromocytoma must be excluded before the patient goes to surgery.",MEDULLARY THYROID CANCER,MEN II,TWrex-cause
725258457,5/23/2015 22:22:05,1642412623,5/23/2015 22:21:33,False,clixsense,0.6194,10798016,GBR,C7,Coventry,86.24.245.191,PHEOCHROMOCYTOMA causes HYPERTENSION,136,159,,147,175,causes,0.997054485501582,812849-FS1-4,"a ,   b  Considered drug of choice for medical management of pheochromocytoma until surgery is performed and for prolonged treatment of HYPERTENSION caused by PHEOCHROMOCYTOMA  not  amenable to surgery.",HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
725258457,5/23/2015 22:25:11,1642414153,5/23/2015 22:22:05,False,clixsense,0.6296,17950689,GBR,Y9,Tonypandy,92.2.44.79,PHEOCHROMOCYTOMA causes HYPERTENSION,136,159,,147,175,causes,0.997054485501582,812849-FS1-4,"a ,   b  Considered drug of choice for medical management of pheochromocytoma until surgery is performed and for prolonged treatment of HYPERTENSION caused by PHEOCHROMOCYTOMA  not  amenable to surgery.",HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
725258457,5/23/2015 22:27:06,1642414978,5/23/2015 22:26:53,False,instagc,0.6508,31184650,USA,IA,Mason City,173.26.27.82,PHEOCHROMOCYTOMA causes HYPERTENSION,136,159,,147,175,causes,0.997054485501582,812849-FS1-4,"a ,   b  Considered drug of choice for medical management of pheochromocytoma until surgery is performed and for prolonged treatment of HYPERTENSION caused by PHEOCHROMOCYTOMA  not  amenable to surgery.",HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
725258457,5/23/2015 22:37:16,1642420189,5/23/2015 22:36:48,False,clixsense,0.6833,11106820,USA,MA,Taunton,173.48.52.95,PHEOCHROMOCYTOMA causes HYPERTENSION,136,159,,147,175,causes,0.997054485501582,812849-FS1-4,"a ,   b  Considered drug of choice for medical management of pheochromocytoma until surgery is performed and for prolonged treatment of HYPERTENSION caused by PHEOCHROMOCYTOMA  not  amenable to surgery.",HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
725258457,5/23/2015 22:49:36,1642426593,5/23/2015 22:48:21,False,instagc,0.7,26024737,GBR,H2,Preston,92.23.190.167,PHEOCHROMOCYTOMA causes HYPERTENSION,136,159,,147,175,causes,0.997054485501582,812849-FS1-4,"a ,   b  Considered drug of choice for medical management of pheochromocytoma until surgery is performed and for prolonged treatment of HYPERTENSION caused by PHEOCHROMOCYTOMA  not  amenable to surgery.",HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
725258457,5/23/2015 23:04:52,1642434164,5/23/2015 23:04:17,False,neodev,0.6679999999999999,30588889,NLD,07,Amsterdam,77.248.175.222,PHEOCHROMOCYTOMA causes HYPERTENSION,136,159,,147,175,causes,0.997054485501582,812849-FS1-4,"a ,   b  Considered drug of choice for medical management of pheochromocytoma until surgery is performed and for prolonged treatment of HYPERTENSION caused by PHEOCHROMOCYTOMA  not  amenable to surgery.",HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
725258457,5/23/2015 23:18:16,1642439640,5/23/2015 23:17:35,False,neodev,0.6429,24628757,CAN,,,107.179.231.99,PHEOCHROMOCYTOMA causes HYPERTENSION,136,159,,147,175,causes,0.997054485501582,812849-FS1-4,"a ,   b  Considered drug of choice for medical management of pheochromocytoma until surgery is performed and for prolonged treatment of HYPERTENSION caused by PHEOCHROMOCYTOMA  not  amenable to surgery.",HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
725343166,5/24/2015 11:32:09,1642604598,5/24/2015 11:31:41,False,prodege,1.0,21417560,GBR,C3,Cambridge,151.225.116.143,FAMILIAL ADENOMATOUS POLYPOSIS causes COLON CARCINOMA,137,0,,151,30,causes,1.0,814087-FS1-4,FAMILIAL ADENOMATOUS POLYPOSIS  FAMILIAL ADENOMATOUS POLYPOSIS is a hereditary disorder causing numerous colonic polyps and resulting in COLON CARCINOMA by age 40.,COLON CARCINOMA,FAMILIAL ADENOMATOUS POLYPOSIS,TWrex-cause
725343166,5/24/2015 11:38:56,1642605595,5/24/2015 11:36:28,False,points4rewards,0.8333,20113482,USA,OR,Portland,67.213.218.72,FAMILIAL ADENOMATOUS POLYPOSIS causes COLON CARCINOMA,137,0,,151,30,causes,1.0,814087-FS1-4,FAMILIAL ADENOMATOUS POLYPOSIS  FAMILIAL ADENOMATOUS POLYPOSIS is a hereditary disorder causing numerous colonic polyps and resulting in COLON CARCINOMA by age 40.,COLON CARCINOMA,FAMILIAL ADENOMATOUS POLYPOSIS,TWrex-cause
725343166,5/24/2015 11:50:20,1642607396,5/24/2015 11:49:09,False,clixsense,0.7847,32173073,GBR,L9,Sheffield,146.200.132.135,FAMILIAL ADENOMATOUS POLYPOSIS causes COLON CARCINOMA,137,0,,151,30,causes,1.0,814087-FS1-4,FAMILIAL ADENOMATOUS POLYPOSIS  FAMILIAL ADENOMATOUS POLYPOSIS is a hereditary disorder causing numerous colonic polyps and resulting in COLON CARCINOMA by age 40.,COLON CARCINOMA,FAMILIAL ADENOMATOUS POLYPOSIS,TWrex-cause
725343166,5/24/2015 11:51:40,1642607591,5/24/2015 11:51:23,False,pocketmoneygpt,0.625,28884030,USA,WI,Minocqua,75.143.134.247,FAMILIAL ADENOMATOUS POLYPOSIS causes COLON CARCINOMA,137,0,,151,30,causes,1.0,814087-FS1-4,FAMILIAL ADENOMATOUS POLYPOSIS  FAMILIAL ADENOMATOUS POLYPOSIS is a hereditary disorder causing numerous colonic polyps and resulting in COLON CARCINOMA by age 40.,COLON CARCINOMA,FAMILIAL ADENOMATOUS POLYPOSIS,TWrex-cause
725343166,5/24/2015 11:55:11,1642608333,5/24/2015 11:54:54,False,neodev,0.65,14096345,NLD,03,Eibergen,77.174.124.109,FAMILIAL ADENOMATOUS POLYPOSIS causes COLON CARCINOMA,137,0,,151,30,causes,1.0,814087-FS1-4,FAMILIAL ADENOMATOUS POLYPOSIS  FAMILIAL ADENOMATOUS POLYPOSIS is a hereditary disorder causing numerous colonic polyps and resulting in COLON CARCINOMA by age 40.,COLON CARCINOMA,FAMILIAL ADENOMATOUS POLYPOSIS,TWrex-cause
725343166,5/24/2015 11:59:16,1642608860,5/24/2015 11:56:54,False,clixsense,0.6131,10798016,GBR,C7,Coventry,86.24.245.191,FAMILIAL ADENOMATOUS POLYPOSIS causes COLON CARCINOMA,137,0,,151,30,causes,1.0,814087-FS1-4,FAMILIAL ADENOMATOUS POLYPOSIS  FAMILIAL ADENOMATOUS POLYPOSIS is a hereditary disorder causing numerous colonic polyps and resulting in COLON CARCINOMA by age 40.,COLON CARCINOMA,FAMILIAL ADENOMATOUS POLYPOSIS,TWrex-cause
725343166,5/24/2015 12:10:44,1642610883,5/24/2015 12:10:24,False,instagc,0.7976,13581319,USA,IL,Mount Vernon,66.232.166.86,COLON CARCINOMA causes FAMILIAL ADENOMATOUS POLYPOSIS,137,0,,151,30,causes,1.0,814087-FS1-4,FAMILIAL ADENOMATOUS POLYPOSIS  FAMILIAL ADENOMATOUS POLYPOSIS is a hereditary disorder causing numerous colonic polyps and resulting in COLON CARCINOMA by age 40.,COLON CARCINOMA,FAMILIAL ADENOMATOUS POLYPOSIS,TWrex-cause
725343172,5/24/2015 12:06:30,1642610091,5/24/2015 12:06:09,False,prodege,0.7976,27934334,GBR,D2,Derby,86.162.35.12,DRUGS causes DRUG INDUCED PHOTOSENSITIVITY,0,57,,28,62,causes,0.953462589245592,811333-FS1-4,DRUG INDUCED PHOTOSENSITIVITY: Individuals using certain DRUGS or other chemicals may develop dermatitis or sunburn after exposure to light of an intensity or duration that normally would not have affected them.,DRUG INDUCED PHOTOSENSITIVITY,DRUGS,TWrex-cause
725343172,5/24/2015 12:07:02,1642610187,5/24/2015 12:06:54,False,neodev,0.0,31789301,CAN,QC,Montral,192.99.8.206,DRUG INDUCED PHOTOSENSITIVITY causes DRUGS,0,57,,28,62,causes,0.953462589245592,811333-FS1-4,DRUG INDUCED PHOTOSENSITIVITY: Individuals using certain DRUGS or other chemicals may develop dermatitis or sunburn after exposure to light of an intensity or duration that normally would not have affected them.,DRUG INDUCED PHOTOSENSITIVITY,DRUGS,TWrex-cause
725343172,5/24/2015 12:10:59,1642610893,5/24/2015 12:10:44,False,instagc,0.7976,13581319,USA,IL,Mount Vernon,66.232.166.86,DRUGS causes DRUG INDUCED PHOTOSENSITIVITY,0,57,,28,62,causes,0.953462589245592,811333-FS1-4,DRUG INDUCED PHOTOSENSITIVITY: Individuals using certain DRUGS or other chemicals may develop dermatitis or sunburn after exposure to light of an intensity or duration that normally would not have affected them.,DRUG INDUCED PHOTOSENSITIVITY,DRUGS,TWrex-cause
725343172,5/24/2015 12:16:23,1642611740,5/24/2015 12:12:40,False,instagc,0.7569,18531561,CAN,ON,Mississauga,99.229.92.227,DRUGS causes DRUG INDUCED PHOTOSENSITIVITY,0,57,,28,62,causes,0.953462589245592,811333-FS1-4,DRUG INDUCED PHOTOSENSITIVITY: Individuals using certain DRUGS or other chemicals may develop dermatitis or sunburn after exposure to light of an intensity or duration that normally would not have affected them.,DRUG INDUCED PHOTOSENSITIVITY,DRUGS,TWrex-cause
725343172,5/24/2015 12:27:03,1642613490,5/24/2015 12:26:40,False,neodev,0.6944,31743852,GBR,G5,Maidstone,85.210.127.98,DRUGS causes DRUG INDUCED PHOTOSENSITIVITY,0,57,,28,62,causes,0.953462589245592,811333-FS1-4,DRUG INDUCED PHOTOSENSITIVITY: Individuals using certain DRUGS or other chemicals may develop dermatitis or sunburn after exposure to light of an intensity or duration that normally would not have affected them.,DRUG INDUCED PHOTOSENSITIVITY,DRUGS,TWrex-cause
725343172,5/24/2015 12:27:29,1642613594,5/24/2015 12:26:57,False,neodev,0.626,12115558,USA,OH,Twinsburg,98.27.164.131,DRUGS causes DRUG INDUCED PHOTOSENSITIVITY,0,57,,28,62,causes,0.953462589245592,811333-FS1-4,DRUG INDUCED PHOTOSENSITIVITY: Individuals using certain DRUGS or other chemicals may develop dermatitis or sunburn after exposure to light of an intensity or duration that normally would not have affected them.,DRUG INDUCED PHOTOSENSITIVITY,DRUGS,TWrex-cause
725343172,5/24/2015 12:28:24,1642613745,5/24/2015 12:27:39,False,vivatic,0.7778,32338429,GBR,G1,Feltham,92.24.40.208,DRUGS causes DRUG INDUCED PHOTOSENSITIVITY,0,57,,28,62,causes,0.953462589245592,811333-FS1-4,DRUG INDUCED PHOTOSENSITIVITY: Individuals using certain DRUGS or other chemicals may develop dermatitis or sunburn after exposure to light of an intensity or duration that normally would not have affected them.,DRUG INDUCED PHOTOSENSITIVITY,DRUGS,TWrex-cause
725343178,5/24/2015 13:17:43,1642622865,5/24/2015 13:17:28,False,instagc,0.9167,31184650,USA,IA,Mason City,173.26.27.82,no_relation,181,170,,188,189,causes,0.824957911384306,812992-FS1-4,"C]  Specific recommendation:  Obtain consultation with a gastroenterologist for colonoscopy and biopsies in patients with:  Diarrhea, tenesmus, and bloody stools after INFECTIOUS DIARRHEA has been excluded with appropriate stool cultures  Persistent DIARRHEA or tenesmus without a clear cause  Extraintestinal rheumatologic or dermatologic manifestations.",DIARRHEA,INFECTIOUS DIARRHEA,TWrex-cause
725343178,5/24/2015 13:27:24,1642624709,5/24/2015 13:27:07,False,bitcoinget,0.6607,21614812,USA,NJ,Blackwood,50.153.127.35,INFECTIOUS DIARRHEA causes DIARRHEA,181,170,,188,189,causes,0.824957911384306,812992-FS1-4,"C]  Specific recommendation:  Obtain consultation with a gastroenterologist for colonoscopy and biopsies in patients with:  Diarrhea, tenesmus, and bloody stools after INFECTIOUS DIARRHEA has been excluded with appropriate stool cultures  Persistent DIARRHEA or tenesmus without a clear cause  Extraintestinal rheumatologic or dermatologic manifestations.",DIARRHEA,INFECTIOUS DIARRHEA,TWrex-cause
725343178,5/24/2015 13:33:10,1642625794,5/24/2015 13:32:54,False,clixsense,0.7528,17609394,CAN,ON,Mississauga,99.229.57.218,INFECTIOUS DIARRHEA causes DIARRHEA,181,170,,188,189,causes,0.824957911384306,812992-FS1-4,"C]  Specific recommendation:  Obtain consultation with a gastroenterologist for colonoscopy and biopsies in patients with:  Diarrhea, tenesmus, and bloody stools after INFECTIOUS DIARRHEA has been excluded with appropriate stool cultures  Persistent DIARRHEA or tenesmus without a clear cause  Extraintestinal rheumatologic or dermatologic manifestations.",DIARRHEA,INFECTIOUS DIARRHEA,TWrex-cause
725343178,5/24/2015 13:36:40,1642626541,5/24/2015 13:36:03,False,neodev,0.7669,19004420,GBR,P8,Devizes,86.167.180.107,no_relation,181,170,,188,189,causes,0.824957911384306,812992-FS1-4,"C]  Specific recommendation:  Obtain consultation with a gastroenterologist for colonoscopy and biopsies in patients with:  Diarrhea, tenesmus, and bloody stools after INFECTIOUS DIARRHEA has been excluded with appropriate stool cultures  Persistent DIARRHEA or tenesmus without a clear cause  Extraintestinal rheumatologic or dermatologic manifestations.",DIARRHEA,INFECTIOUS DIARRHEA,TWrex-cause
725343178,5/24/2015 13:37:51,1642626753,5/24/2015 13:36:28,False,fusioncash,0.6601,5656294,USA,TN,Cookeville,75.136.162.83,no_relation,181,170,,188,189,causes,0.824957911384306,812992-FS1-4,"C]  Specific recommendation:  Obtain consultation with a gastroenterologist for colonoscopy and biopsies in patients with:  Diarrhea, tenesmus, and bloody stools after INFECTIOUS DIARRHEA has been excluded with appropriate stool cultures  Persistent DIARRHEA or tenesmus without a clear cause  Extraintestinal rheumatologic or dermatologic manifestations.",DIARRHEA,INFECTIOUS DIARRHEA,TWrex-cause
725343178,5/24/2015 13:54:59,1642629800,5/24/2015 13:52:37,False,neodev,0.7917,18881135,CAN,ON,Ajax,99.243.87.224,no_relation,181,170,,188,189,causes,0.824957911384306,812992-FS1-4,"C]  Specific recommendation:  Obtain consultation with a gastroenterologist for colonoscopy and biopsies in patients with:  Diarrhea, tenesmus, and bloody stools after INFECTIOUS DIARRHEA has been excluded with appropriate stool cultures  Persistent DIARRHEA or tenesmus without a clear cause  Extraintestinal rheumatologic or dermatologic manifestations.",DIARRHEA,INFECTIOUS DIARRHEA,TWrex-cause
725343178,5/24/2015 13:58:11,1642630330,5/24/2015 13:55:46,False,fusioncash,0.7506,7012325,USA,NY,Pelham,74.88.63.28,INFECTIOUS DIARRHEA causes DIARRHEA,181,170,,188,189,causes,0.824957911384306,812992-FS1-4,"C]  Specific recommendation:  Obtain consultation with a gastroenterologist for colonoscopy and biopsies in patients with:  Diarrhea, tenesmus, and bloody stools after INFECTIOUS DIARRHEA has been excluded with appropriate stool cultures  Persistent DIARRHEA or tenesmus without a clear cause  Extraintestinal rheumatologic or dermatologic manifestations.",DIARRHEA,INFECTIOUS DIARRHEA,TWrex-cause
725343184,5/24/2015 12:36:24,1642615145,5/24/2015 12:34:42,False,fusioncash,0.6497,31757234,USA,KY,London,76.177.136.50,BRONCHOGENIC CARCINOMA causes CHRONIC COUGH,53,5,,65,27,causes,0.963863194682999,813647-FS1-4,"62   BRONCHOGENIC CARCINOMA is not a common cause of CHRONIC COUGH but should be included in the differential diagnosis when the chest roentgenogram is abnormal, especially when the film shows centrally located lesions.",CHRONIC COUGH,BRONCHOGENIC CARCINOMA,TWrex-cause
725343184,5/24/2015 12:38:41,1642615578,5/24/2015 12:38:32,False,elite,0.775,31913360,GBR,,,5.152.201.148,BRONCHOGENIC CARCINOMA causes CHRONIC COUGH,53,5,,65,27,causes,0.963863194682999,813647-FS1-4,"62   BRONCHOGENIC CARCINOMA is not a common cause of CHRONIC COUGH but should be included in the differential diagnosis when the chest roentgenogram is abnormal, especially when the film shows centrally located lesions.",CHRONIC COUGH,BRONCHOGENIC CARCINOMA,TWrex-cause
725343184,5/24/2015 13:16:40,1642622718,5/24/2015 13:16:30,False,instagc,0.9167,31184650,USA,IA,Mason City,173.26.27.82,no_relation,53,5,,65,27,causes,0.963863194682999,813647-FS1-4,"62   BRONCHOGENIC CARCINOMA is not a common cause of CHRONIC COUGH but should be included in the differential diagnosis when the chest roentgenogram is abnormal, especially when the film shows centrally located lesions.",CHRONIC COUGH,BRONCHOGENIC CARCINOMA,TWrex-cause
725343184,5/24/2015 13:26:48,1642624626,5/24/2015 13:26:28,False,bitcoinget,0.6607,21614812,USA,NJ,Blackwood,50.153.127.35,BRONCHOGENIC CARCINOMA causes CHRONIC COUGH,53,5,,65,27,causes,0.963863194682999,813647-FS1-4,"62   BRONCHOGENIC CARCINOMA is not a common cause of CHRONIC COUGH but should be included in the differential diagnosis when the chest roentgenogram is abnormal, especially when the film shows centrally located lesions.",CHRONIC COUGH,BRONCHOGENIC CARCINOMA,TWrex-cause
725343184,5/24/2015 13:32:31,1642625631,5/24/2015 13:32:07,False,clixsense,0.7528,17609394,CAN,ON,Mississauga,99.229.57.218,no_relation,53,5,,65,27,causes,0.963863194682999,813647-FS1-4,"62   BRONCHOGENIC CARCINOMA is not a common cause of CHRONIC COUGH but should be included in the differential diagnosis when the chest roentgenogram is abnormal, especially when the film shows centrally located lesions.",CHRONIC COUGH,BRONCHOGENIC CARCINOMA,TWrex-cause
725343184,5/24/2015 13:34:57,1642626129,5/24/2015 13:32:41,False,fusioncash,0.6601,5656294,USA,TN,Cookeville,75.136.162.83,no_relation,53,5,,65,27,causes,0.963863194682999,813647-FS1-4,"62   BRONCHOGENIC CARCINOMA is not a common cause of CHRONIC COUGH but should be included in the differential diagnosis when the chest roentgenogram is abnormal, especially when the film shows centrally located lesions.",CHRONIC COUGH,BRONCHOGENIC CARCINOMA,TWrex-cause
725343184,5/24/2015 13:35:27,1642626274,5/24/2015 13:34:53,False,neodev,0.7669,19004420,GBR,P8,Devizes,86.167.180.107,BRONCHOGENIC CARCINOMA causes CHRONIC COUGH,53,5,,65,27,causes,0.963863194682999,813647-FS1-4,"62   BRONCHOGENIC CARCINOMA is not a common cause of CHRONIC COUGH but should be included in the differential diagnosis when the chest roentgenogram is abnormal, especially when the film shows centrally located lesions.",CHRONIC COUGH,BRONCHOGENIC CARCINOMA,TWrex-cause
725343186,5/24/2015 14:04:53,1642631464,5/24/2015 14:04:32,False,fusioncash,0.7506,7012325,USA,NY,Pelham,74.88.63.28,INGESTED SUBSTANCES causes ALLERGIC REACTIONS,46,12,,63,31,causes,0.9897433186107869,810538-FS1-4,The list of INGESTED SUBSTANCES said to cause ALLERGIC REACTIONS is seemingly endless.,ALLERGIC REACTIONS,INGESTED SUBSTANCES,TWrex-cause
725343186,5/24/2015 14:06:49,1642631796,5/24/2015 14:06:39,False,clixsense,0.8333,22947672,GBR,,,88.144.127.68,INGESTED SUBSTANCES causes ALLERGIC REACTIONS,46,12,,63,31,causes,0.9897433186107869,810538-FS1-4,The list of INGESTED SUBSTANCES said to cause ALLERGIC REACTIONS is seemingly endless.,ALLERGIC REACTIONS,INGESTED SUBSTANCES,TWrex-cause
725343186,5/24/2015 14:10:41,1642632409,5/24/2015 14:09:28,False,clixsense,0.8929,24170547,USA,NJ,Clementon,71.168.199.135,INGESTED SUBSTANCES causes ALLERGIC REACTIONS,46,12,,63,31,causes,0.9897433186107869,810538-FS1-4,The list of INGESTED SUBSTANCES said to cause ALLERGIC REACTIONS is seemingly endless.,ALLERGIC REACTIONS,INGESTED SUBSTANCES,TWrex-cause
725343186,5/24/2015 14:21:55,1642634644,5/24/2015 14:20:15,False,clixsense,0.4167,17950689,GBR,Y9,Tonypandy,92.2.44.79,ALLERGIC REACTIONS causes INGESTED SUBSTANCES,46,12,,63,31,causes,0.9897433186107869,810538-FS1-4,The list of INGESTED SUBSTANCES said to cause ALLERGIC REACTIONS is seemingly endless.,ALLERGIC REACTIONS,INGESTED SUBSTANCES,TWrex-cause
725343186,5/24/2015 14:24:38,1642635210,5/24/2015 14:24:15,False,gifthunterclub,0.6,24043308,GBR,,,94.102.147.250,INGESTED SUBSTANCES causes ALLERGIC REACTIONS,46,12,,63,31,causes,0.9897433186107869,810538-FS1-4,The list of INGESTED SUBSTANCES said to cause ALLERGIC REACTIONS is seemingly endless.,ALLERGIC REACTIONS,INGESTED SUBSTANCES,TWrex-cause
725343186,5/24/2015 14:26:39,1642635618,5/24/2015 14:26:24,False,fusioncash,0.6497,31757234,USA,KY,London,76.177.136.50,INGESTED SUBSTANCES causes ALLERGIC REACTIONS,46,12,,63,31,causes,0.9897433186107869,810538-FS1-4,The list of INGESTED SUBSTANCES said to cause ALLERGIC REACTIONS is seemingly endless.,ALLERGIC REACTIONS,INGESTED SUBSTANCES,TWrex-cause
725343186,5/24/2015 14:29:12,1642636101,5/24/2015 14:28:58,False,sharecashgpt,0.1429,28627999,CAN,ON,Sudbury,66.103.55.12,no_relation,46,12,,63,31,causes,0.9897433186107869,810538-FS1-4,The list of INGESTED SUBSTANCES said to cause ALLERGIC REACTIONS is seemingly endless.,ALLERGIC REACTIONS,INGESTED SUBSTANCES,TWrex-cause
725343187,5/24/2015 12:11:28,1642610956,5/24/2015 12:11:14,False,instagc,0.7976,13581319,USA,IL,Mount Vernon,66.232.166.86,CORYNEBACTERIUM DIPHTHERIAE causes NASOPHARYNX (RESPIRATORY DIPHTHERIA),49,0,,84,27,causes,0.911684611677103,810937-FS1-4,CORYNEBACTERIUM DIPHTHERIAE  usually infects the NASOPHARYNX (RESPIRATORY DIPHTHERIA) or skin.,NASOPHARYNX (RESPIRATORY DIPHTHERIA),CORYNEBACTERIUM DIPHTHERIAE,TWrex-cause
725343187,5/24/2015 12:17:18,1642611911,5/24/2015 12:16:59,False,instagc,0.7569,18531561,CAN,ON,Mississauga,99.229.92.227,no_relation,49,0,,84,27,causes,0.911684611677103,810937-FS1-4,CORYNEBACTERIUM DIPHTHERIAE  usually infects the NASOPHARYNX (RESPIRATORY DIPHTHERIA) or skin.,NASOPHARYNX (RESPIRATORY DIPHTHERIA),CORYNEBACTERIUM DIPHTHERIAE,TWrex-cause
725343187,5/24/2015 12:27:41,1642613605,5/24/2015 12:27:24,False,neodev,0.6944,31743852,GBR,G5,Maidstone,85.210.127.98,CORYNEBACTERIUM DIPHTHERIAE causes NASOPHARYNX (RESPIRATORY DIPHTHERIA),49,0,,84,27,causes,0.911684611677103,810937-FS1-4,CORYNEBACTERIUM DIPHTHERIAE  usually infects the NASOPHARYNX (RESPIRATORY DIPHTHERIA) or skin.,NASOPHARYNX (RESPIRATORY DIPHTHERIA),CORYNEBACTERIUM DIPHTHERIAE,TWrex-cause
725343187,5/24/2015 12:28:36,1642613767,5/24/2015 12:28:16,False,neodev,0.626,12115558,USA,OH,Twinsburg,98.27.164.131,no_relation,49,0,,84,27,causes,0.911684611677103,810937-FS1-4,CORYNEBACTERIUM DIPHTHERIAE  usually infects the NASOPHARYNX (RESPIRATORY DIPHTHERIA) or skin.,NASOPHARYNX (RESPIRATORY DIPHTHERIA),CORYNEBACTERIUM DIPHTHERIAE,TWrex-cause
725343187,5/24/2015 12:29:03,1642613833,5/24/2015 12:28:30,False,points4rewards,0.7292,28755767,USA,VA,Chester,68.57.118.32,CORYNEBACTERIUM DIPHTHERIAE causes NASOPHARYNX (RESPIRATORY DIPHTHERIA),49,0,,84,27,causes,0.911684611677103,810937-FS1-4,CORYNEBACTERIUM DIPHTHERIAE  usually infects the NASOPHARYNX (RESPIRATORY DIPHTHERIA) or skin.,NASOPHARYNX (RESPIRATORY DIPHTHERIA),CORYNEBACTERIUM DIPHTHERIAE,TWrex-cause
725343187,5/24/2015 12:29:10,1642613842,5/24/2015 12:28:25,False,vivatic,0.7778,32338429,GBR,G1,Feltham,92.24.40.208,CORYNEBACTERIUM DIPHTHERIAE causes NASOPHARYNX (RESPIRATORY DIPHTHERIA),49,0,,84,27,causes,0.911684611677103,810937-FS1-4,CORYNEBACTERIUM DIPHTHERIAE  usually infects the NASOPHARYNX (RESPIRATORY DIPHTHERIA) or skin.,NASOPHARYNX (RESPIRATORY DIPHTHERIA),CORYNEBACTERIUM DIPHTHERIAE,TWrex-cause
725343187,5/24/2015 12:29:26,1642613907,5/24/2015 12:28:54,False,clixsense,0.6409,31482589,NLD,,,31.201.11.16,CORYNEBACTERIUM DIPHTHERIAE causes NASOPHARYNX (RESPIRATORY DIPHTHERIA),49,0,,84,27,causes,0.911684611677103,810937-FS1-4,CORYNEBACTERIUM DIPHTHERIAE  usually infects the NASOPHARYNX (RESPIRATORY DIPHTHERIA) or skin.,NASOPHARYNX (RESPIRATORY DIPHTHERIA),CORYNEBACTERIUM DIPHTHERIAE,TWrex-cause
725343191,5/24/2015 11:37:42,1642605420,5/24/2015 11:36:46,False,prodege,1.0,21417560,GBR,C3,Cambridge,151.225.116.143,INTRAARTICULAR HYALURONATE INJECTION causes PAIN,8,16,,11,52,causes,0.721687836487032,805278-FS1-4,Reduced PAIN of INTRAARTICULAR HYALURONATE INJECTION with the reciprocating procedure device.,PAIN,INTRAARTICULAR HYALURONATE INJECTION,TWrex-cause
725343191,5/24/2015 11:43:22,1642606315,5/24/2015 11:42:40,False,points4rewards,0.8333,20113482,USA,OR,Portland,67.213.218.72,no_relation,8,16,,11,52,causes,0.721687836487032,805278-FS1-4,Reduced PAIN of INTRAARTICULAR HYALURONATE INJECTION with the reciprocating procedure device.,PAIN,INTRAARTICULAR HYALURONATE INJECTION,TWrex-cause
725343191,5/24/2015 11:53:02,1642607924,5/24/2015 11:52:42,False,clixsense,0.7847,32173073,GBR,L9,Sheffield,146.200.132.135,no_relation,8,16,,11,52,causes,0.721687836487032,805278-FS1-4,Reduced PAIN of INTRAARTICULAR HYALURONATE INJECTION with the reciprocating procedure device.,PAIN,INTRAARTICULAR HYALURONATE INJECTION,TWrex-cause
725343191,5/24/2015 11:53:27,1642607985,5/24/2015 11:53:13,False,pocketmoneygpt,0.625,28884030,USA,WI,Minocqua,75.143.134.247,INTRAARTICULAR HYALURONATE INJECTION causes PAIN,8,16,,11,52,causes,0.721687836487032,805278-FS1-4,Reduced PAIN of INTRAARTICULAR HYALURONATE INJECTION with the reciprocating procedure device.,PAIN,INTRAARTICULAR HYALURONATE INJECTION,TWrex-cause
725343191,5/24/2015 11:56:35,1642608481,5/24/2015 11:56:18,False,neodev,0.65,14096345,NLD,03,Eibergen,77.174.124.109,no_relation,8,16,,11,52,causes,0.721687836487032,805278-FS1-4,Reduced PAIN of INTRAARTICULAR HYALURONATE INJECTION with the reciprocating procedure device.,PAIN,INTRAARTICULAR HYALURONATE INJECTION,TWrex-cause
725343191,5/24/2015 12:05:17,1642609925,5/24/2015 12:04:26,False,clixsense,0.6131,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,8,16,,11,52,causes,0.721687836487032,805278-FS1-4,Reduced PAIN of INTRAARTICULAR HYALURONATE INJECTION with the reciprocating procedure device.,PAIN,INTRAARTICULAR HYALURONATE INJECTION,TWrex-cause
725343191,5/24/2015 12:06:08,1642610005,5/24/2015 12:05:53,False,prodege,0.7976,27934334,GBR,D2,Derby,86.162.35.12,no_relation,8,16,,11,52,causes,0.721687836487032,805278-FS1-4,Reduced PAIN of INTRAARTICULAR HYALURONATE INJECTION with the reciprocating procedure device.,PAIN,INTRAARTICULAR HYALURONATE INJECTION,TWrex-cause
725343192,5/24/2015 12:06:49,1642610148,5/24/2015 12:06:31,False,prodege,0.7976,27934334,GBR,D2,Derby,86.162.35.12,LESCH NYHAN SYNDROME causes HYPERURICEMIA,32,90,,44,110,causes,0.9918365981341758,814189-FS1-4,"Athetosis, self mutilation, and HYPERURICEMIA in boys indicate Lesch Nyhan syndrome (see  LESCH NYHAN SYNDROME.",HYPERURICEMIA,LESCH NYHAN SYNDROME,TWrex-cause
725343192,5/24/2015 12:11:13,1642610919,5/24/2015 12:11:00,False,instagc,0.7976,13581319,USA,IL,Mount Vernon,66.232.166.86,LESCH NYHAN SYNDROME causes HYPERURICEMIA,32,90,,44,110,causes,0.9918365981341758,814189-FS1-4,"Athetosis, self mutilation, and HYPERURICEMIA in boys indicate Lesch Nyhan syndrome (see  LESCH NYHAN SYNDROME.",HYPERURICEMIA,LESCH NYHAN SYNDROME,TWrex-cause
725343192,5/24/2015 12:16:58,1642611856,5/24/2015 12:16:24,False,instagc,0.7569,18531561,CAN,ON,Mississauga,99.229.92.227,no_relation,32,90,,44,110,causes,0.9918365981341758,814189-FS1-4,"Athetosis, self mutilation, and HYPERURICEMIA in boys indicate Lesch Nyhan syndrome (see  LESCH NYHAN SYNDROME.",HYPERURICEMIA,LESCH NYHAN SYNDROME,TWrex-cause
725343192,5/24/2015 12:27:23,1642613565,5/24/2015 12:27:05,False,neodev,0.6944,31743852,GBR,G5,Maidstone,85.210.127.98,HYPERURICEMIA causes LESCH NYHAN SYNDROME,32,90,,44,110,causes,0.9918365981341758,814189-FS1-4,"Athetosis, self mutilation, and HYPERURICEMIA in boys indicate Lesch Nyhan syndrome (see  LESCH NYHAN SYNDROME.",HYPERURICEMIA,LESCH NYHAN SYNDROME,TWrex-cause
725343192,5/24/2015 12:28:15,1642613709,5/24/2015 12:27:31,False,neodev,0.626,12115558,USA,OH,Twinsburg,98.27.164.131,no_relation,32,90,,44,110,causes,0.9918365981341758,814189-FS1-4,"Athetosis, self mutilation, and HYPERURICEMIA in boys indicate Lesch Nyhan syndrome (see  LESCH NYHAN SYNDROME.",HYPERURICEMIA,LESCH NYHAN SYNDROME,TWrex-cause
725343192,5/24/2015 12:28:30,1642613762,5/24/2015 12:27:59,False,points4rewards,0.7292,28755767,USA,VA,Chester,68.57.118.32,LESCH NYHAN SYNDROME causes HYPERURICEMIA,32,90,,44,110,causes,0.9918365981341758,814189-FS1-4,"Athetosis, self mutilation, and HYPERURICEMIA in boys indicate Lesch Nyhan syndrome (see  LESCH NYHAN SYNDROME.",HYPERURICEMIA,LESCH NYHAN SYNDROME,TWrex-cause
725343192,5/24/2015 12:28:53,1642613776,5/24/2015 12:28:16,False,clixsense,0.6409,31482589,NLD,,,31.201.11.16,no_relation,32,90,,44,110,causes,0.9918365981341758,814189-FS1-4,"Athetosis, self mutilation, and HYPERURICEMIA in boys indicate Lesch Nyhan syndrome (see  LESCH NYHAN SYNDROME.",HYPERURICEMIA,LESCH NYHAN SYNDROME,TWrex-cause
725343199,5/24/2015 11:33:04,1642604787,5/24/2015 11:32:11,False,prodege,1.0,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,15,108,,29,121,causes,0.790569415042095,803932-FS1-4,"In adults with TYPE 2 DIABETES children, and women with gestational diabetes, insulin analogues and regular HUMAN INSULIN do not differ in effect.",TYPE 2 DIABETES,HUMAN INSULIN,TWrex-cause
725343199,5/24/2015 11:39:56,1642605777,5/24/2015 11:39:00,False,points4rewards,0.8333,20113482,USA,OR,Portland,67.213.218.72,no_relation,15,108,,29,121,causes,0.790569415042095,803932-FS1-4,"In adults with TYPE 2 DIABETES children, and women with gestational diabetes, insulin analogues and regular HUMAN INSULIN do not differ in effect.",TYPE 2 DIABETES,HUMAN INSULIN,TWrex-cause
725343199,5/24/2015 11:50:59,1642607513,5/24/2015 11:50:21,False,clixsense,0.7847,32173073,GBR,L9,Sheffield,146.200.132.135,no_relation,15,108,,29,121,causes,0.790569415042095,803932-FS1-4,"In adults with TYPE 2 DIABETES children, and women with gestational diabetes, insulin analogues and regular HUMAN INSULIN do not differ in effect.",TYPE 2 DIABETES,HUMAN INSULIN,TWrex-cause
725343199,5/24/2015 11:52:00,1642607660,5/24/2015 11:51:41,False,pocketmoneygpt,0.625,28884030,USA,WI,Minocqua,75.143.134.247,no_relation,15,108,,29,121,causes,0.790569415042095,803932-FS1-4,"In adults with TYPE 2 DIABETES children, and women with gestational diabetes, insulin analogues and regular HUMAN INSULIN do not differ in effect.",TYPE 2 DIABETES,HUMAN INSULIN,TWrex-cause
725343199,5/24/2015 11:55:26,1642608348,5/24/2015 11:55:12,False,neodev,0.65,14096345,NLD,03,Eibergen,77.174.124.109,no_relation,15,108,,29,121,causes,0.790569415042095,803932-FS1-4,"In adults with TYPE 2 DIABETES children, and women with gestational diabetes, insulin analogues and regular HUMAN INSULIN do not differ in effect.",TYPE 2 DIABETES,HUMAN INSULIN,TWrex-cause
725343199,5/24/2015 12:00:07,1642608993,5/24/2015 11:59:17,False,clixsense,0.6131,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,15,108,,29,121,causes,0.790569415042095,803932-FS1-4,"In adults with TYPE 2 DIABETES children, and women with gestational diabetes, insulin analogues and regular HUMAN INSULIN do not differ in effect.",TYPE 2 DIABETES,HUMAN INSULIN,TWrex-cause
725343199,5/24/2015 12:04:40,1642609771,5/24/2015 12:04:20,False,prodege,0.7976,27934334,GBR,D2,Derby,86.162.35.12,no_relation,15,108,,29,121,causes,0.790569415042095,803932-FS1-4,"In adults with TYPE 2 DIABETES children, and women with gestational diabetes, insulin analogues and regular HUMAN INSULIN do not differ in effect.",TYPE 2 DIABETES,HUMAN INSULIN,TWrex-cause
725373414,5/24/2015 19:08:00,1642727187,5/24/2015 19:07:43,False,bitcoinget,0.7458,21614812,USA,NJ,Burlington,50.153.125.0,M LEPRAE causes LEPROSY,22,103,,28,111,causes,0.950255268139496,811086-FS1-4,"The manifestations of LEPROSY depend on the infected person's immune response to the causative agent,  M LEPRAE",LEPROSY,M LEPRAE,TWrex-cause
725373414,5/24/2015 19:09:40,1642727940,5/24/2015 19:09:15,False,neodev,0.8611,31448050,GBR,,,92.24.65.218,M LEPRAE causes LEPROSY,22,103,,28,111,causes,0.950255268139496,811086-FS1-4,"The manifestations of LEPROSY depend on the infected person's immune response to the causative agent,  M LEPRAE",LEPROSY,M LEPRAE,TWrex-cause
725373414,5/24/2015 19:11:02,1642728554,5/24/2015 19:10:19,False,prodege,0.6764,21417560,GBR,C3,Cambridge,151.225.116.143,M LEPRAE causes LEPROSY,22,103,,28,111,causes,0.950255268139496,811086-FS1-4,"The manifestations of LEPROSY depend on the infected person's immune response to the causative agent,  M LEPRAE",LEPROSY,M LEPRAE,TWrex-cause
725373414,5/24/2015 19:11:09,1642728617,5/24/2015 19:10:54,False,sharecashgpt,0.5431,28627999,CAN,ON,Sudbury,66.103.55.12,no_relation,22,103,,28,111,causes,0.950255268139496,811086-FS1-4,"The manifestations of LEPROSY depend on the infected person's immune response to the causative agent,  M LEPRAE",LEPROSY,M LEPRAE,TWrex-cause
725373414,5/24/2015 19:13:49,1642729615,5/24/2015 19:13:19,False,neodev,0.6167,30627835,GBR,H9,London,5.81.27.94,no_relation,22,103,,28,111,causes,0.950255268139496,811086-FS1-4,"The manifestations of LEPROSY depend on the infected person's immune response to the causative agent,  M LEPRAE",LEPROSY,M LEPRAE,TWrex-cause
725373414,5/24/2015 19:14:56,1642730142,5/24/2015 19:13:59,False,neodev,0.7123,18881135,CAN,ON,Ajax,99.243.87.224,M LEPRAE causes LEPROSY,22,103,,28,111,causes,0.950255268139496,811086-FS1-4,"The manifestations of LEPROSY depend on the infected person's immune response to the causative agent,  M LEPRAE",LEPROSY,M LEPRAE,TWrex-cause
725373414,5/24/2015 19:19:24,1642733926,5/24/2015 19:18:24,False,clixsense,0.7857,10798016,GBR,C7,Coventry,86.24.245.191,M LEPRAE causes LEPROSY,22,103,,28,111,causes,0.950255268139496,811086-FS1-4,"The manifestations of LEPROSY depend on the infected person's immune response to the causative agent,  M LEPRAE",LEPROSY,M LEPRAE,TWrex-cause
725373420,5/24/2015 19:28:33,1642742230,5/24/2015 19:27:55,False,neodev,0.8556,27667288,CAN,MB,Brandon,216.36.187.168,HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION causes WAGR SYNDROME,138,0,,186,13,causes,0.622171016838255,813427-FS1-4,"WAGR SYNDROME is the combination of Wilms' tumor (with  WT1  deletion), aniridia, GU malformations (eg, renal hypoplasia, cystic disease, HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION",HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION,WAGR SYNDROME,TWrex-cause
725373420,5/24/2015 19:31:05,1642743524,5/24/2015 19:30:42,False,instagc,0.7014,30326470,USA,CA,Santee,99.44.37.73,no_relation,138,0,,186,13,causes,0.622171016838255,813427-FS1-4,"WAGR SYNDROME is the combination of Wilms' tumor (with  WT1  deletion), aniridia, GU malformations (eg, renal hypoplasia, cystic disease, HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION",HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION,WAGR SYNDROME,TWrex-cause
725373420,5/24/2015 19:35:20,1642745572,5/24/2015 19:34:56,False,instagc,0.6875,20312760,GBR,I2,Manchester,90.244.149.130,no_relation,138,0,,186,13,causes,0.622171016838255,813427-FS1-4,"WAGR SYNDROME is the combination of Wilms' tumor (with  WT1  deletion), aniridia, GU malformations (eg, renal hypoplasia, cystic disease, HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION",HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION,WAGR SYNDROME,TWrex-cause
725373420,5/24/2015 19:35:43,1642745757,5/24/2015 19:34:20,False,clixsense,0.4202,17950689,GBR,Y9,Tonypandy,92.2.44.79,HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION causes WAGR SYNDROME,138,0,,186,13,causes,0.622171016838255,813427-FS1-4,"WAGR SYNDROME is the combination of Wilms' tumor (with  WT1  deletion), aniridia, GU malformations (eg, renal hypoplasia, cystic disease, HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION",HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION,WAGR SYNDROME,TWrex-cause
725373420,5/24/2015 19:40:15,1642747643,5/24/2015 19:39:55,False,instagc,0.7905,18531561,CAN,ON,Mississauga,99.229.92.227,no_relation,138,0,,186,13,causes,0.622171016838255,813427-FS1-4,"WAGR SYNDROME is the combination of Wilms' tumor (with  WT1  deletion), aniridia, GU malformations (eg, renal hypoplasia, cystic disease, HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION",HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION,WAGR SYNDROME,TWrex-cause
725373420,5/24/2015 19:41:05,1642747961,5/24/2015 19:41:01,False,neodev,0.4333,30749660,USA,NC,Durham,24.211.188.217,HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION causes WAGR SYNDROME,138,0,,186,13,causes,0.622171016838255,813427-FS1-4,"WAGR SYNDROME is the combination of Wilms' tumor (with  WT1  deletion), aniridia, GU malformations (eg, renal hypoplasia, cystic disease, HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION",HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION,WAGR SYNDROME,TWrex-cause
725373420,5/24/2015 19:41:21,1642748026,5/24/2015 19:40:59,False,clixsense,0.8671,31482589,NLD,,,31.201.11.16,no_relation,138,0,,186,13,causes,0.622171016838255,813427-FS1-4,"WAGR SYNDROME is the combination of Wilms' tumor (with  WT1  deletion), aniridia, GU malformations (eg, renal hypoplasia, cystic disease, HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION",HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION,WAGR SYNDROME,TWrex-cause
725373424,5/24/2015 19:41:51,1642748235,5/24/2015 19:41:31,False,instagc,0.7905,18531561,CAN,ON,Mississauga,99.229.92.227,SODIUM BICARBONATE causes METABOLIC ALKALOSIS,33,3,,51,21,causes,1.0,815016-FS1-4,b  SODIUM BICARBONATE: May cause METABOLIC ALKALOSIS in patients with renal insufficiency.,METABOLIC ALKALOSIS,SODIUM BICARBONATE,TWrex-cause
725373424,5/24/2015 19:43:21,1642748771,5/24/2015 19:42:58,False,clixsense,0.8671,31482589,NLD,,,31.201.11.16,SODIUM BICARBONATE causes METABOLIC ALKALOSIS,33,3,,51,21,causes,1.0,815016-FS1-4,b  SODIUM BICARBONATE: May cause METABOLIC ALKALOSIS in patients with renal insufficiency.,METABOLIC ALKALOSIS,SODIUM BICARBONATE,TWrex-cause
725373424,5/24/2015 19:53:04,1642751732,5/24/2015 19:52:25,False,clixsense,0.8194,28351359,GBR,H9,London,80.43.180.102,SODIUM BICARBONATE causes METABOLIC ALKALOSIS,33,3,,51,21,causes,1.0,815016-FS1-4,b  SODIUM BICARBONATE: May cause METABOLIC ALKALOSIS in patients with renal insufficiency.,METABOLIC ALKALOSIS,SODIUM BICARBONATE,TWrex-cause
725373424,5/24/2015 19:56:33,1642752969,5/24/2015 19:56:24,False,neodev,0.3833,32562748,CAN,BC,Vancouver,108.180.140.140,SODIUM BICARBONATE causes METABOLIC ALKALOSIS,33,3,,51,21,causes,1.0,815016-FS1-4,b  SODIUM BICARBONATE: May cause METABOLIC ALKALOSIS in patients with renal insufficiency.,METABOLIC ALKALOSIS,SODIUM BICARBONATE,TWrex-cause
725373424,5/24/2015 20:02:23,1642754484,5/24/2015 20:02:07,False,clixsense,0.7093,23585686,GBR,H9,London,86.148.196.204,SODIUM BICARBONATE causes METABOLIC ALKALOSIS,33,3,,51,21,causes,1.0,815016-FS1-4,b  SODIUM BICARBONATE: May cause METABOLIC ALKALOSIS in patients with renal insufficiency.,METABOLIC ALKALOSIS,SODIUM BICARBONATE,TWrex-cause
725373424,5/24/2015 20:03:08,1642754705,5/24/2015 20:02:01,False,clixsense,0.8145,32549163,CAN,MB,Winnipeg,206.45.167.246,SODIUM BICARBONATE causes METABOLIC ALKALOSIS,33,3,,51,21,causes,1.0,815016-FS1-4,b  SODIUM BICARBONATE: May cause METABOLIC ALKALOSIS in patients with renal insufficiency.,METABOLIC ALKALOSIS,SODIUM BICARBONATE,TWrex-cause
725373424,5/24/2015 20:24:49,1642760195,5/24/2015 20:24:08,False,instagc,0.8838,19602039,USA,WA,Bellevue,50.135.214.140,SODIUM BICARBONATE causes METABOLIC ALKALOSIS,33,3,,51,21,causes,1.0,815016-FS1-4,b  SODIUM BICARBONATE: May cause METABOLIC ALKALOSIS in patients with renal insufficiency.,METABOLIC ALKALOSIS,SODIUM BICARBONATE,TWrex-cause
725373430,5/24/2015 19:43:34,1642748828,5/24/2015 19:43:22,False,clixsense,0.8671,31482589,NLD,,,31.201.11.16,no_relation,0,30,,10,61,causes,0.979911869877732,813956-FS1-4,PAPILLEDEMA is a late sign of INCREASED INTRACRANIAL PRESSURE; initial absence is not reassuring.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE,TWrex-cause
725373430,5/24/2015 19:53:30,1642751929,5/24/2015 19:53:05,False,clixsense,0.8194,28351359,GBR,H9,London,80.43.180.102,no_relation,0,30,,10,61,causes,0.979911869877732,813956-FS1-4,PAPILLEDEMA is a late sign of INCREASED INTRACRANIAL PRESSURE; initial absence is not reassuring.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE,TWrex-cause
725373430,5/24/2015 20:02:49,1642754624,5/24/2015 20:02:25,False,clixsense,0.7093,23585686,GBR,H9,London,86.148.196.204,INCREASED INTRACRANIAL PRESSURE causes PAPILLEDEMA,0,30,,10,61,causes,0.979911869877732,813956-FS1-4,PAPILLEDEMA is a late sign of INCREASED INTRACRANIAL PRESSURE; initial absence is not reassuring.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE,TWrex-cause
725373430,5/24/2015 20:03:36,1642754820,5/24/2015 20:03:12,False,clixsense,0.8145,32549163,CAN,MB,Winnipeg,206.45.167.246,no_relation,0,30,,10,61,causes,0.979911869877732,813956-FS1-4,PAPILLEDEMA is a late sign of INCREASED INTRACRANIAL PRESSURE; initial absence is not reassuring.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE,TWrex-cause
725373430,5/24/2015 20:25:26,1642760313,5/24/2015 20:24:54,False,instagc,0.8838,19602039,USA,WA,Bellevue,50.135.214.140,INCREASED INTRACRANIAL PRESSURE causes PAPILLEDEMA,0,30,,10,61,causes,0.979911869877732,813956-FS1-4,PAPILLEDEMA is a late sign of INCREASED INTRACRANIAL PRESSURE; initial absence is not reassuring.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE,TWrex-cause
725373430,5/24/2015 20:29:29,1642761544,5/24/2015 20:29:13,False,clixsense,0.727,30313955,GBR,K5,Poole,2.30.145.202,INCREASED INTRACRANIAL PRESSURE causes PAPILLEDEMA,0,30,,10,61,causes,0.979911869877732,813956-FS1-4,PAPILLEDEMA is a late sign of INCREASED INTRACRANIAL PRESSURE; initial absence is not reassuring.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE,TWrex-cause
725373430,5/24/2015 20:30:06,1642761733,5/24/2015 20:28:46,False,prodege,0.7943,22496080,CAN,ON,Toronto,173.33.212.234,INCREASED INTRACRANIAL PRESSURE causes PAPILLEDEMA,0,30,,10,61,causes,0.979911869877732,813956-FS1-4,PAPILLEDEMA is a late sign of INCREASED INTRACRANIAL PRESSURE; initial absence is not reassuring.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE,TWrex-cause
725373432,5/24/2015 19:24:12,1642740024,5/24/2015 19:23:29,False,points4rewards,0.8333,20113482,USA,OR,Portland,67.213.218.72,ENDOMETRIOSIS causes PELVIC PAIN,114,176,,124,189,causes,0.99124070716193,814294-FS1-4,"menorrhalgia    (                  audio )  [&dblprime; +  rhoia , flow, +  algia , pain] Painful menstruation or PELVIC PAIN accompanying menstruation, sometimes a symptom of ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS,TWrex-cause
725373432,5/24/2015 19:25:35,1642740686,5/24/2015 19:24:28,False,clixsense,0.7857,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,114,176,,124,189,causes,0.99124070716193,814294-FS1-4,"menorrhalgia    (                  audio )  [&dblprime; +  rhoia , flow, +  algia , pain] Painful menstruation or PELVIC PAIN accompanying menstruation, sometimes a symptom of ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS,TWrex-cause
725373432,5/24/2015 19:27:08,1642741480,5/24/2015 19:26:11,False,neodev,0.8556,27667288,CAN,MB,Brandon,216.36.187.168,ENDOMETRIOSIS causes PELVIC PAIN,114,176,,124,189,causes,0.99124070716193,814294-FS1-4,"menorrhalgia    (                  audio )  [&dblprime; +  rhoia , flow, +  algia , pain] Painful menstruation or PELVIC PAIN accompanying menstruation, sometimes a symptom of ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS,TWrex-cause
725373432,5/24/2015 19:30:20,1642743174,5/24/2015 19:29:53,False,instagc,0.7014,30326470,USA,CA,Santee,99.44.37.73,ENDOMETRIOSIS causes PELVIC PAIN,114,176,,124,189,causes,0.99124070716193,814294-FS1-4,"menorrhalgia    (                  audio )  [&dblprime; +  rhoia , flow, +  algia , pain] Painful menstruation or PELVIC PAIN accompanying menstruation, sometimes a symptom of ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS,TWrex-cause
725373432,5/24/2015 19:33:29,1642744786,5/24/2015 19:31:05,False,clixsense,0.4202,17950689,GBR,Y9,Tonypandy,92.2.44.79,PELVIC PAIN causes ENDOMETRIOSIS,114,176,,124,189,causes,0.99124070716193,814294-FS1-4,"menorrhalgia    (                  audio )  [&dblprime; +  rhoia , flow, +  algia , pain] Painful menstruation or PELVIC PAIN accompanying menstruation, sometimes a symptom of ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS,TWrex-cause
725373432,5/24/2015 19:34:36,1642745239,5/24/2015 19:34:24,False,instagc,0.6875,20312760,GBR,I2,Manchester,90.244.149.130,ENDOMETRIOSIS causes PELVIC PAIN,114,176,,124,189,causes,0.99124070716193,814294-FS1-4,"menorrhalgia    (                  audio )  [&dblprime; +  rhoia , flow, +  algia , pain] Painful menstruation or PELVIC PAIN accompanying menstruation, sometimes a symptom of ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS,TWrex-cause
725373432,5/24/2015 19:36:19,1642746046,5/24/2015 19:35:54,False,clixsense,0.4375,6417722,USA,MI,Taylor,99.170.106.105,no_relation,114,176,,124,189,causes,0.99124070716193,814294-FS1-4,"menorrhalgia    (                  audio )  [&dblprime; +  rhoia , flow, +  algia , pain] Painful menstruation or PELVIC PAIN accompanying menstruation, sometimes a symptom of ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS,TWrex-cause
725373438,5/24/2015 19:27:53,1642741930,5/24/2015 19:27:09,False,neodev,0.8556,27667288,CAN,MB,Brandon,216.36.187.168,no_relation,76,4,,90,9,causes,0.8626621856275071,811028-FS1-4,"The VIRUS then spreads to the regional lymph nodes, enters the bloodstream ('MINOR' VIREMIA) and reaches the reticuloendothelial system (i.e., deep lymph nodes, bone marrow, spleen, and liver)",'MINOR' VIREMIA,VIRUS,TWrex-cause
725373438,5/24/2015 19:30:41,1642743327,5/24/2015 19:30:21,False,instagc,0.7014,30326470,USA,CA,Santee,99.44.37.73,VIRUS causes 'MINOR' VIREMIA,76,4,,90,9,causes,0.8626621856275071,811028-FS1-4,"The VIRUS then spreads to the regional lymph nodes, enters the bloodstream ('MINOR' VIREMIA) and reaches the reticuloendothelial system (i.e., deep lymph nodes, bone marrow, spleen, and liver)",'MINOR' VIREMIA,VIRUS,TWrex-cause
725373438,5/24/2015 19:34:19,1642745113,5/24/2015 19:33:30,False,clixsense,0.4202,17950689,GBR,Y9,Tonypandy,92.2.44.79,'MINOR' VIREMIA causes VIRUS,76,4,,90,9,causes,0.8626621856275071,811028-FS1-4,"The VIRUS then spreads to the regional lymph nodes, enters the bloodstream ('MINOR' VIREMIA) and reaches the reticuloendothelial system (i.e., deep lymph nodes, bone marrow, spleen, and liver)",'MINOR' VIREMIA,VIRUS,TWrex-cause
725373438,5/24/2015 19:34:55,1642745409,5/24/2015 19:34:38,False,instagc,0.6875,20312760,GBR,I2,Manchester,90.244.149.130,no_relation,76,4,,90,9,causes,0.8626621856275071,811028-FS1-4,"The VIRUS then spreads to the regional lymph nodes, enters the bloodstream ('MINOR' VIREMIA) and reaches the reticuloendothelial system (i.e., deep lymph nodes, bone marrow, spleen, and liver)",'MINOR' VIREMIA,VIRUS,TWrex-cause
725373438,5/24/2015 19:36:26,1642746079,5/24/2015 19:36:20,False,clixsense,0.4375,6417722,USA,MI,Taylor,99.170.106.105,no_relation,76,4,,90,9,causes,0.8626621856275071,811028-FS1-4,"The VIRUS then spreads to the regional lymph nodes, enters the bloodstream ('MINOR' VIREMIA) and reaches the reticuloendothelial system (i.e., deep lymph nodes, bone marrow, spleen, and liver)",'MINOR' VIREMIA,VIRUS,TWrex-cause
725373438,5/24/2015 19:39:54,1642747531,5/24/2015 19:39:24,False,instagc,0.7905,18531561,CAN,ON,Mississauga,99.229.92.227,VIRUS causes 'MINOR' VIREMIA,76,4,,90,9,causes,0.8626621856275071,811028-FS1-4,"The VIRUS then spreads to the regional lymph nodes, enters the bloodstream ('MINOR' VIREMIA) and reaches the reticuloendothelial system (i.e., deep lymph nodes, bone marrow, spleen, and liver)",'MINOR' VIREMIA,VIRUS,TWrex-cause
725373438,5/24/2015 19:41:00,1642747928,5/24/2015 19:40:43,False,neodev,0.4333,30749660,USA,NC,Durham,24.211.188.217,'MINOR' VIREMIA causes VIRUS,76,4,,90,9,causes,0.8626621856275071,811028-FS1-4,"The VIRUS then spreads to the regional lymph nodes, enters the bloodstream ('MINOR' VIREMIA) and reaches the reticuloendothelial system (i.e., deep lymph nodes, bone marrow, spleen, and liver)",'MINOR' VIREMIA,VIRUS,TWrex-cause
725480737,5/25/2015 10:29:06,1642962529,5/25/2015 10:28:14,False,vivatic,0.9333,13889585,GBR,A1,Dagenham,2.28.66.9,ENCAINIDE causes VENTRICULAR ARRHYTHMIA SUPPRESSION,20,58,,53,67,causes,0.45749571099781394,804674-FS1-4,"Mortality following VENTRICULAR ARRHYTHMIA SUPPRESSION by ENCAINIDE flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",VENTRICULAR ARRHYTHMIA SUPPRESSION,ENCAINIDE,TWrex-cause
725480737,5/25/2015 10:33:21,1642965052,5/25/2015 10:31:56,False,instagc,0.8306,18531561,CAN,ON,Mississauga,99.229.92.227,no_relation,20,58,,53,67,causes,0.45749571099781394,804674-FS1-4,"Mortality following VENTRICULAR ARRHYTHMIA SUPPRESSION by ENCAINIDE flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",VENTRICULAR ARRHYTHMIA SUPPRESSION,ENCAINIDE,TWrex-cause
725480737,5/25/2015 10:36:11,1642967366,5/25/2015 10:34:46,False,points4rewards,0.8083,20113482,USA,OR,Portland,67.213.218.72,no_relation,20,58,,53,67,causes,0.45749571099781394,804674-FS1-4,"Mortality following VENTRICULAR ARRHYTHMIA SUPPRESSION by ENCAINIDE flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",VENTRICULAR ARRHYTHMIA SUPPRESSION,ENCAINIDE,TWrex-cause
725480737,5/25/2015 10:41:50,1642972542,5/25/2015 10:41:35,False,clixsense,0.7062,22751911,NLD,04,Groningen,195.241.153.97,no_relation,20,58,,53,67,causes,0.45749571099781394,804674-FS1-4,"Mortality following VENTRICULAR ARRHYTHMIA SUPPRESSION by ENCAINIDE flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",VENTRICULAR ARRHYTHMIA SUPPRESSION,ENCAINIDE,TWrex-cause
725480737,5/25/2015 10:48:19,1642975144,5/25/2015 10:47:53,False,clixsense,0.7545,30313955,GBR,K5,Poole,2.30.145.202,VENTRICULAR ARRHYTHMIA SUPPRESSION causes ENCAINIDE,20,58,,53,67,causes,0.45749571099781394,804674-FS1-4,"Mortality following VENTRICULAR ARRHYTHMIA SUPPRESSION by ENCAINIDE flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",VENTRICULAR ARRHYTHMIA SUPPRESSION,ENCAINIDE,TWrex-cause
725480737,5/25/2015 11:06:49,1642978232,5/25/2015 11:05:41,False,fusioncash,0.5847,31757234,USA,KY,London,76.177.136.50,ENCAINIDE causes VENTRICULAR ARRHYTHMIA SUPPRESSION,20,58,,53,67,causes,0.45749571099781394,804674-FS1-4,"Mortality following VENTRICULAR ARRHYTHMIA SUPPRESSION by ENCAINIDE flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",VENTRICULAR ARRHYTHMIA SUPPRESSION,ENCAINIDE,TWrex-cause
725480737,5/25/2015 11:07:16,1642978335,5/25/2015 11:06:30,False,prodege,0.7056,29849805,GBR,Z1,Swansea,82.1.37.235,no_relation,20,58,,53,67,causes,0.45749571099781394,804674-FS1-4,"Mortality following VENTRICULAR ARRHYTHMIA SUPPRESSION by ENCAINIDE flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",VENTRICULAR ARRHYTHMIA SUPPRESSION,ENCAINIDE,TWrex-cause
725480746,5/25/2015 08:23:25,1642940338,5/25/2015 08:23:06,False,gifthunterclub,1.0,30901412,GBR,G5,Margate,85.210.116.56,PASTEURELLA causes PASTEURELLOSIS,0,106,,13,117,causes,0.9950371902099889,810361-FS1-4,PASTEURELLOSIS    (                    audio )  A disease caused by infection with bacteria of the genus  PASTEURELLA,PASTEURELLOSIS,PASTEURELLA,TWrex-cause
725480746,5/25/2015 08:32:08,1642941602,5/25/2015 08:31:22,False,instagc,0.8333,30326470,USA,CA,Santee,99.44.37.73,PASTEURELLA causes PASTEURELLOSIS,0,106,,13,117,causes,0.9950371902099889,810361-FS1-4,PASTEURELLOSIS    (                    audio )  A disease caused by infection with bacteria of the genus  PASTEURELLA,PASTEURELLOSIS,PASTEURELLA,TWrex-cause
725480746,5/25/2015 08:39:00,1642942944,5/25/2015 08:38:29,False,bitcoinget,0.6667,30546513,GBR,G6,Hull,194.42.67.50,PASTEURELLA causes PASTEURELLOSIS,0,106,,13,117,causes,0.9950371902099889,810361-FS1-4,PASTEURELLOSIS    (                    audio )  A disease caused by infection with bacteria of the genus  PASTEURELLA,PASTEURELLOSIS,PASTEURELLA,TWrex-cause
725480746,5/25/2015 08:44:34,1642943855,5/25/2015 08:43:49,False,prodege,0.8125,21417560,GBR,C3,Cambridge,151.225.116.143,PASTEURELLA causes PASTEURELLOSIS,0,106,,13,117,causes,0.9950371902099889,810361-FS1-4,PASTEURELLOSIS    (                    audio )  A disease caused by infection with bacteria of the genus  PASTEURELLA,PASTEURELLOSIS,PASTEURELLA,TWrex-cause
725480746,5/25/2015 09:02:12,1642946709,5/25/2015 09:01:18,False,clixsense,0.7595,19587102,NLD,11,Den Haag,84.87.89.153,PASTEURELLA causes PASTEURELLOSIS,0,106,,13,117,causes,0.9950371902099889,810361-FS1-4,PASTEURELLOSIS    (                    audio )  A disease caused by infection with bacteria of the genus  PASTEURELLA,PASTEURELLOSIS,PASTEURELLA,TWrex-cause
725480746,5/25/2015 09:04:54,1642947058,5/25/2015 09:04:28,False,prodege,0.7837,27934334,GBR,D2,Derby,86.162.35.12,PASTEURELLA causes PASTEURELLOSIS,0,106,,13,117,causes,0.9950371902099889,810361-FS1-4,PASTEURELLOSIS    (                    audio )  A disease caused by infection with bacteria of the genus  PASTEURELLA,PASTEURELLOSIS,PASTEURELLA,TWrex-cause
725480746,5/25/2015 09:11:03,1642948003,5/25/2015 09:10:28,False,pocketmoneygpt,0.7857,21432964,GBR,K5,Poole,109.155.122.13,PASTEURELLA causes PASTEURELLOSIS,0,106,,13,117,causes,0.9950371902099889,810361-FS1-4,PASTEURELLOSIS    (                    audio )  A disease caused by infection with bacteria of the genus  PASTEURELLA,PASTEURELLOSIS,PASTEURELLA,TWrex-cause
725480752,5/25/2015 10:49:43,1642975383,5/25/2015 10:49:32,False,clixsense,0.7545,30313955,GBR,K5,Poole,2.30.145.202,CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS causes LEISHMANIA PARASITES,161,230,,217,250,causes,1.0,810929-FS1-4,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS  Caused by LEISHMANIA PARASITES transmitted by sand fly bites.",CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS,LEISHMANIA PARASITES,TWrex-cause
725480752,5/25/2015 11:10:24,1642978930,5/25/2015 11:10:04,False,fusioncash,0.5847,31757234,USA,KY,London,76.177.136.50,LEISHMANIA PARASITES causes CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS,161,230,,217,250,causes,1.0,810929-FS1-4,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS  Caused by LEISHMANIA PARASITES transmitted by sand fly bites.",CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS,LEISHMANIA PARASITES,TWrex-cause
725480752,5/25/2015 11:10:33,1642978971,5/25/2015 11:10:03,False,prodege,0.7056,29849805,GBR,Z1,Swansea,82.1.37.235,LEISHMANIA PARASITES causes CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS,161,230,,217,250,causes,1.0,810929-FS1-4,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS  Caused by LEISHMANIA PARASITES transmitted by sand fly bites.",CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS,LEISHMANIA PARASITES,TWrex-cause
725480752,5/25/2015 11:15:53,1642980060,5/25/2015 11:15:39,False,cotter,0.6429,13805544,USA,MI,Battle Creek,107.140.176.37,LEISHMANIA PARASITES causes CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS,161,230,,217,250,causes,1.0,810929-FS1-4,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS  Caused by LEISHMANIA PARASITES transmitted by sand fly bites.",CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS,LEISHMANIA PARASITES,TWrex-cause
725480752,5/25/2015 11:19:10,1642980689,5/25/2015 11:18:49,False,neodev,0.6857,11382239,AUS,02,Strathfield,60.241.129.81,LEISHMANIA PARASITES causes CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS,161,230,,217,250,causes,1.0,810929-FS1-4,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS  Caused by LEISHMANIA PARASITES transmitted by sand fly bites.",CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS,LEISHMANIA PARASITES,TWrex-cause
725480752,5/25/2015 11:22:29,1642981363,5/25/2015 11:22:09,False,prodege,0.6667,4316379,CAN,ON,Windsor,206.47.90.133,LEISHMANIA PARASITES causes CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS,161,230,,217,250,causes,1.0,810929-FS1-4,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS  Caused by LEISHMANIA PARASITES transmitted by sand fly bites.",CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS,LEISHMANIA PARASITES,TWrex-cause
725480752,5/25/2015 11:39:36,1642984553,5/25/2015 11:39:24,False,neodev,0.8571,14096345,NLD,03,Eibergen,77.174.124.109,LEISHMANIA PARASITES causes CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS,161,230,,217,250,causes,1.0,810929-FS1-4,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS  Caused by LEISHMANIA PARASITES transmitted by sand fly bites.",CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS,LEISHMANIA PARASITES,TWrex-cause
725480753,5/25/2015 09:13:25,1642948315,5/25/2015 09:12:34,False,pocketmoneygpt,0.7857,21432964,GBR,K5,Poole,109.155.122.13,OBSTRUCTIVE JAUNDICE causes HEPATOCELLULAR CARCINOMA,198,40,,217,64,causes,0.369274472937998,814090-FS1-4,"They may also occur as complications of HEPATOCELLULAR CARCINOMA  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and OBSTRUCTIVE JAUNDICE",OBSTRUCTIVE JAUNDICE,HEPATOCELLULAR CARCINOMA,TWrex-cause
725480753,5/25/2015 09:26:41,1642950338,5/25/2015 09:26:16,False,instagc,0.8333,13581319,USA,IL,Mount Vernon,66.232.166.86,no_relation,198,40,,217,64,causes,0.369274472937998,814090-FS1-4,"They may also occur as complications of HEPATOCELLULAR CARCINOMA  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and OBSTRUCTIVE JAUNDICE",OBSTRUCTIVE JAUNDICE,HEPATOCELLULAR CARCINOMA,TWrex-cause
725480753,5/25/2015 09:32:03,1642951232,5/25/2015 09:31:43,False,elite,0.7153,31856422,GBR,C9,Carlisle,92.19.36.179,HEPATOCELLULAR CARCINOMA causes OBSTRUCTIVE JAUNDICE,198,40,,217,64,causes,0.369274472937998,814090-FS1-4,"They may also occur as complications of HEPATOCELLULAR CARCINOMA  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and OBSTRUCTIVE JAUNDICE",OBSTRUCTIVE JAUNDICE,HEPATOCELLULAR CARCINOMA,TWrex-cause
725480753,5/25/2015 09:36:17,1642952138,5/25/2015 09:35:13,False,clixsense,0.7556,31345986,GBR,,,86.165.143.234,HEPATOCELLULAR CARCINOMA causes OBSTRUCTIVE JAUNDICE,198,40,,217,64,causes,0.369274472937998,814090-FS1-4,"They may also occur as complications of HEPATOCELLULAR CARCINOMA  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and OBSTRUCTIVE JAUNDICE",OBSTRUCTIVE JAUNDICE,HEPATOCELLULAR CARCINOMA,TWrex-cause
725480753,5/25/2015 09:45:34,1642953474,5/25/2015 09:45:22,False,cointasker,0.6236,21783324,NLD,,,31.151.239.133,no_relation,198,40,,217,64,causes,0.369274472937998,814090-FS1-4,"They may also occur as complications of HEPATOCELLULAR CARCINOMA  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and OBSTRUCTIVE JAUNDICE",OBSTRUCTIVE JAUNDICE,HEPATOCELLULAR CARCINOMA,TWrex-cause
725480753,5/25/2015 10:10:09,1642957356,5/25/2015 10:09:40,False,neodev,0.7143,11014534,GBR,B8,Bromley,86.18.149.6,no_relation,198,40,,217,64,causes,0.369274472937998,814090-FS1-4,"They may also occur as complications of HEPATOCELLULAR CARCINOMA  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and OBSTRUCTIVE JAUNDICE",OBSTRUCTIVE JAUNDICE,HEPATOCELLULAR CARCINOMA,TWrex-cause
725480753,5/25/2015 10:15:35,1642958368,5/25/2015 10:14:59,False,points4rewards,0.6786,28755767,USA,VA,Chester,68.57.118.32,OBSTRUCTIVE JAUNDICE causes HEPATOCELLULAR CARCINOMA,198,40,,217,64,causes,0.369274472937998,814090-FS1-4,"They may also occur as complications of HEPATOCELLULAR CARCINOMA  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and OBSTRUCTIVE JAUNDICE",OBSTRUCTIVE JAUNDICE,HEPATOCELLULAR CARCINOMA,TWrex-cause
725480760,5/25/2015 08:22:20,1642940070,5/25/2015 08:21:52,False,gifthunterclub,1.0,30901412,GBR,G5,Margate,85.210.116.56,MEN1 causes MULTIPLE FACIAL ANGIOFIBROMAS,69,58,,97,62,causes,0.9630868246861541,813841-FS1-4, A survey study of a consecutive sample of patients with MEN1 found MULTIPLE FACIAL ANGIOFIBROMAS and collagenomas to be cutaneous manifestations of the disease ( 22.,MULTIPLE FACIAL ANGIOFIBROMAS,MEN1,TWrex-cause
725480760,5/25/2015 08:28:22,1642941105,5/25/2015 08:26:40,False,instagc,0.8333,30326470,USA,CA,Santee,99.44.37.73,no_relation,69,58,,97,62,causes,0.9630868246861541,813841-FS1-4, A survey study of a consecutive sample of patients with MEN1 found MULTIPLE FACIAL ANGIOFIBROMAS and collagenomas to be cutaneous manifestations of the disease ( 22.,MULTIPLE FACIAL ANGIOFIBROMAS,MEN1,TWrex-cause
725480760,5/25/2015 08:36:52,1642942573,5/25/2015 08:35:57,False,bitcoinget,0.6667,30546513,GBR,G6,Hull,194.42.67.50,MEN1 causes MULTIPLE FACIAL ANGIOFIBROMAS,69,58,,97,62,causes,0.9630868246861541,813841-FS1-4, A survey study of a consecutive sample of patients with MEN1 found MULTIPLE FACIAL ANGIOFIBROMAS and collagenomas to be cutaneous manifestations of the disease ( 22.,MULTIPLE FACIAL ANGIOFIBROMAS,MEN1,TWrex-cause
725480760,5/25/2015 08:42:01,1642943399,5/25/2015 08:40:53,False,prodege,0.8125,21417560,GBR,C3,Cambridge,151.225.116.143,MEN1 causes MULTIPLE FACIAL ANGIOFIBROMAS,69,58,,97,62,causes,0.9630868246861541,813841-FS1-4, A survey study of a consecutive sample of patients with MEN1 found MULTIPLE FACIAL ANGIOFIBROMAS and collagenomas to be cutaneous manifestations of the disease ( 22.,MULTIPLE FACIAL ANGIOFIBROMAS,MEN1,TWrex-cause
725480760,5/25/2015 08:47:59,1642944336,5/25/2015 08:47:20,False,neodev,0.7976,30588889,NLD,07,Amsterdam,77.248.175.222,no_relation,69,58,,97,62,causes,0.9630868246861541,813841-FS1-4, A survey study of a consecutive sample of patients with MEN1 found MULTIPLE FACIAL ANGIOFIBROMAS and collagenomas to be cutaneous manifestations of the disease ( 22.,MULTIPLE FACIAL ANGIOFIBROMAS,MEN1,TWrex-cause
725480760,5/25/2015 08:57:45,1642946080,5/25/2015 08:57:05,False,clixsense,0.7595,19587102,NLD,11,Den Haag,84.87.89.153,MEN1 causes MULTIPLE FACIAL ANGIOFIBROMAS,69,58,,97,62,causes,0.9630868246861541,813841-FS1-4, A survey study of a consecutive sample of patients with MEN1 found MULTIPLE FACIAL ANGIOFIBROMAS and collagenomas to be cutaneous manifestations of the disease ( 22.,MULTIPLE FACIAL ANGIOFIBROMAS,MEN1,TWrex-cause
725480760,5/25/2015 09:03:12,1642946803,5/25/2015 09:02:54,False,prodege,0.7837,27934334,GBR,D2,Derby,86.162.35.12,MEN1 causes MULTIPLE FACIAL ANGIOFIBROMAS,69,58,,97,62,causes,0.9630868246861541,813841-FS1-4, A survey study of a consecutive sample of patients with MEN1 found MULTIPLE FACIAL ANGIOFIBROMAS and collagenomas to be cutaneous manifestations of the disease ( 22.,MULTIPLE FACIAL ANGIOFIBROMAS,MEN1,TWrex-cause
725480761,5/25/2015 10:19:13,1642959027,5/25/2015 10:18:52,False,clixsense,0.8095,31482589,NLD,,,31.201.11.16,no_relation,148,76,,169,105,causes,0.416025147168922,813962-FS1-4,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on POSTTRAUMATIC STRESS DISORDER from the international consensus group on DEPRESSION AND ANXIETY",DEPRESSION AND ANXIETY,POSTTRAUMATIC STRESS DISORDER,TWrex-cause
725480761,5/25/2015 10:22:20,1642959895,5/25/2015 10:21:05,False,clixsense,0.877,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,148,76,,169,105,causes,0.416025147168922,813962-FS1-4,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on POSTTRAUMATIC STRESS DISORDER from the international consensus group on DEPRESSION AND ANXIETY",DEPRESSION AND ANXIETY,POSTTRAUMATIC STRESS DISORDER,TWrex-cause
725480761,5/25/2015 10:27:08,1642961590,5/25/2015 10:26:05,False,vivatic,0.9333,13889585,GBR,A1,Dagenham,2.28.66.9,no_relation,148,76,,169,105,causes,0.416025147168922,813962-FS1-4,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on POSTTRAUMATIC STRESS DISORDER from the international consensus group on DEPRESSION AND ANXIETY",DEPRESSION AND ANXIETY,POSTTRAUMATIC STRESS DISORDER,TWrex-cause
725480761,5/25/2015 10:30:48,1642963374,5/25/2015 10:30:10,False,instagc,0.8306,18531561,CAN,ON,Mississauga,99.229.92.227,no_relation,148,76,,169,105,causes,0.416025147168922,813962-FS1-4,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on POSTTRAUMATIC STRESS DISORDER from the international consensus group on DEPRESSION AND ANXIETY",DEPRESSION AND ANXIETY,POSTTRAUMATIC STRESS DISORDER,TWrex-cause
725480761,5/25/2015 10:33:47,1642965366,5/25/2015 10:31:45,False,points4rewards,0.8083,20113482,USA,OR,Portland,67.213.218.72,no_relation,148,76,,169,105,causes,0.416025147168922,813962-FS1-4,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on POSTTRAUMATIC STRESS DISORDER from the international consensus group on DEPRESSION AND ANXIETY",DEPRESSION AND ANXIETY,POSTTRAUMATIC STRESS DISORDER,TWrex-cause
725480761,5/25/2015 10:41:16,1642972106,5/25/2015 10:41:00,False,clixsense,0.7062,22751911,NLD,04,Groningen,195.241.153.97,no_relation,148,76,,169,105,causes,0.416025147168922,813962-FS1-4,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on POSTTRAUMATIC STRESS DISORDER from the international consensus group on DEPRESSION AND ANXIETY",DEPRESSION AND ANXIETY,POSTTRAUMATIC STRESS DISORDER,TWrex-cause
725480761,5/25/2015 10:43:26,1642973714,5/25/2015 10:43:08,False,neodev,0.7976,30588889,NLD,07,Amsterdam,77.248.175.222,no_relation,148,76,,169,105,causes,0.416025147168922,813962-FS1-4,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on POSTTRAUMATIC STRESS DISORDER from the international consensus group on DEPRESSION AND ANXIETY",DEPRESSION AND ANXIETY,POSTTRAUMATIC STRESS DISORDER,TWrex-cause
725480764,5/25/2015 09:27:21,1642950505,5/25/2015 09:27:07,False,instagc,0.8333,13581319,USA,IL,Mount Vernon,66.232.166.86,CHRONIC PAIN SYNDROME causes CHRONIC PAIN,73,73,,84,94,causes,0.606339062590832,812911-FS1-4,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of CHRONIC PAIN SYNDROME (see  CHRONIC PAIN ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons.",CHRONIC PAIN,CHRONIC PAIN SYNDROME,TWrex-cause
725480764,5/25/2015 09:32:56,1642951495,5/25/2015 09:32:46,False,elite,0.7153,31856422,GBR,C9,Carlisle,92.19.36.179,no_relation,73,73,,84,94,causes,0.606339062590832,812911-FS1-4,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of CHRONIC PAIN SYNDROME (see  CHRONIC PAIN ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons.",CHRONIC PAIN,CHRONIC PAIN SYNDROME,TWrex-cause
725480764,5/25/2015 09:39:54,1642952718,5/25/2015 09:39:07,False,clixsense,0.7556,31345986,GBR,,,86.165.143.234,no_relation,73,73,,84,94,causes,0.606339062590832,812911-FS1-4,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of CHRONIC PAIN SYNDROME (see  CHRONIC PAIN ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons.",CHRONIC PAIN,CHRONIC PAIN SYNDROME,TWrex-cause
725480764,5/25/2015 09:46:26,1642953548,5/25/2015 09:46:08,False,cointasker,0.6236,21783324,NLD,,,31.151.239.133,no_relation,73,73,,84,94,causes,0.606339062590832,812911-FS1-4,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of CHRONIC PAIN SYNDROME (see  CHRONIC PAIN ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons.",CHRONIC PAIN,CHRONIC PAIN SYNDROME,TWrex-cause
725480764,5/25/2015 10:12:02,1642957672,5/25/2015 10:11:27,False,neodev,0.7143,11014534,GBR,B8,Bromley,86.18.149.6,no_relation,73,73,,84,94,causes,0.606339062590832,812911-FS1-4,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of CHRONIC PAIN SYNDROME (see  CHRONIC PAIN ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons.",CHRONIC PAIN,CHRONIC PAIN SYNDROME,TWrex-cause
725480764,5/25/2015 10:17:18,1642958638,5/25/2015 10:16:50,False,points4rewards,0.6786,28755767,USA,VA,Chester,68.57.118.32,no_relation,73,73,,84,94,causes,0.606339062590832,812911-FS1-4,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of CHRONIC PAIN SYNDROME (see  CHRONIC PAIN ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons.",CHRONIC PAIN,CHRONIC PAIN SYNDROME,TWrex-cause
725480764,5/25/2015 10:18:27,1642958863,5/25/2015 10:17:01,False,clixsense,0.877,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,73,73,,84,94,causes,0.606339062590832,812911-FS1-4,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of CHRONIC PAIN SYNDROME (see  CHRONIC PAIN ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons.",CHRONIC PAIN,CHRONIC PAIN SYNDROME,TWrex-cause
725480775,5/25/2015 09:13:25,1642948314,5/25/2015 09:12:34,False,pocketmoneygpt,0.7857,21432964,GBR,K5,Poole,109.155.122.13,no_relation,20,16,,44,46,causes,0.474712663277541,810309-FS1-4,"Mumps and other PARAINFLUENZA VIRUS INFECTIONS as well as INFLUENZA VIRUS INFECTION most often present in the winter, although they may occur at any time of year.",INFLUENZA VIRUS INFECTION,PARAINFLUENZA VIRUS INFECTIONS,TWrex-cause
725480775,5/25/2015 09:26:41,1642950345,5/25/2015 09:26:16,False,instagc,0.8333,13581319,USA,IL,Mount Vernon,66.232.166.86,no_relation,20,16,,44,46,causes,0.474712663277541,810309-FS1-4,"Mumps and other PARAINFLUENZA VIRUS INFECTIONS as well as INFLUENZA VIRUS INFECTION most often present in the winter, although they may occur at any time of year.",INFLUENZA VIRUS INFECTION,PARAINFLUENZA VIRUS INFECTIONS,TWrex-cause
725480775,5/25/2015 09:32:03,1642951228,5/25/2015 09:31:43,False,elite,0.7153,31856422,GBR,C9,Carlisle,92.19.36.179,no_relation,20,16,,44,46,causes,0.474712663277541,810309-FS1-4,"Mumps and other PARAINFLUENZA VIRUS INFECTIONS as well as INFLUENZA VIRUS INFECTION most often present in the winter, although they may occur at any time of year.",INFLUENZA VIRUS INFECTION,PARAINFLUENZA VIRUS INFECTIONS,TWrex-cause
725480775,5/25/2015 09:36:17,1642952143,5/25/2015 09:35:13,False,clixsense,0.7556,31345986,GBR,,,86.165.143.234,no_relation,20,16,,44,46,causes,0.474712663277541,810309-FS1-4,"Mumps and other PARAINFLUENZA VIRUS INFECTIONS as well as INFLUENZA VIRUS INFECTION most often present in the winter, although they may occur at any time of year.",INFLUENZA VIRUS INFECTION,PARAINFLUENZA VIRUS INFECTIONS,TWrex-cause
725480775,5/25/2015 09:45:34,1642953472,5/25/2015 09:45:22,False,cointasker,0.6236,21783324,NLD,,,31.151.239.133,no_relation,20,16,,44,46,causes,0.474712663277541,810309-FS1-4,"Mumps and other PARAINFLUENZA VIRUS INFECTIONS as well as INFLUENZA VIRUS INFECTION most often present in the winter, although they may occur at any time of year.",INFLUENZA VIRUS INFECTION,PARAINFLUENZA VIRUS INFECTIONS,TWrex-cause
725480775,5/25/2015 10:10:09,1642957355,5/25/2015 10:09:40,False,neodev,0.7143,11014534,GBR,B8,Bromley,86.18.149.6,no_relation,20,16,,44,46,causes,0.474712663277541,810309-FS1-4,"Mumps and other PARAINFLUENZA VIRUS INFECTIONS as well as INFLUENZA VIRUS INFECTION most often present in the winter, although they may occur at any time of year.",INFLUENZA VIRUS INFECTION,PARAINFLUENZA VIRUS INFECTIONS,TWrex-cause
725480775,5/25/2015 10:15:35,1642958363,5/25/2015 10:14:59,False,points4rewards,0.6786,28755767,USA,VA,Chester,68.57.118.32,no_relation,20,16,,44,46,causes,0.474712663277541,810309-FS1-4,"Mumps and other PARAINFLUENZA VIRUS INFECTIONS as well as INFLUENZA VIRUS INFECTION most often present in the winter, although they may occur at any time of year.",INFLUENZA VIRUS INFECTION,PARAINFLUENZA VIRUS INFECTIONS,TWrex-cause
725540683,5/25/2015 16:12:06,1643045975,5/25/2015 16:10:48,False,onestopgpt,0.6905,21275875,CAN,ON,Hamilton,24.36.121.10,VARICELLA ZOSTER VIRUS causes SHINGLES,51,125,,58,147,causes,0.9958932064677041,811528-FS1-4,46  Focal and Regional Neuropathic Pain Syndromes  SHINGLES and postherpetic neuralgia (PHN)   are caused by reactivation of VARICELLA ZOSTER VIRUS (VZV) in a sensory ganglion.,SHINGLES,VARICELLA ZOSTER VIRUS,TWrex-cause
725540683,5/25/2015 16:13:05,1643046287,5/25/2015 16:12:31,False,clixsense,0.9333,28351359,GBR,H9,London,80.43.180.102,VARICELLA ZOSTER VIRUS causes SHINGLES,51,125,,58,147,causes,0.9958932064677041,811528-FS1-4,46  Focal and Regional Neuropathic Pain Syndromes  SHINGLES and postherpetic neuralgia (PHN)   are caused by reactivation of VARICELLA ZOSTER VIRUS (VZV) in a sensory ganglion.,SHINGLES,VARICELLA ZOSTER VIRUS,TWrex-cause
725540683,5/25/2015 16:15:50,1643047016,5/25/2015 16:15:27,False,instagc,0.9444,15864091,USA,OK,Oklahoma City,104.0.113.133,VARICELLA ZOSTER VIRUS causes SHINGLES,51,125,,58,147,causes,0.9958932064677041,811528-FS1-4,46  Focal and Regional Neuropathic Pain Syndromes  SHINGLES and postherpetic neuralgia (PHN)   are caused by reactivation of VARICELLA ZOSTER VIRUS (VZV) in a sensory ganglion.,SHINGLES,VARICELLA ZOSTER VIRUS,TWrex-cause
725540683,5/25/2015 16:17:52,1643047687,5/25/2015 16:13:08,False,neodev,0.873,27667288,CAN,MB,Brandon,216.36.187.168,VARICELLA ZOSTER VIRUS causes SHINGLES,51,125,,58,147,causes,0.9958932064677041,811528-FS1-4,46  Focal and Regional Neuropathic Pain Syndromes  SHINGLES and postherpetic neuralgia (PHN)   are caused by reactivation of VARICELLA ZOSTER VIRUS (VZV) in a sensory ganglion.,SHINGLES,VARICELLA ZOSTER VIRUS,TWrex-cause
725540683,5/25/2015 16:39:02,1643052243,5/25/2015 16:38:40,False,neodev,0.9792,31743852,GBR,G5,Margate,85.210.126.147,VARICELLA ZOSTER VIRUS causes SHINGLES,51,125,,58,147,causes,0.9958932064677041,811528-FS1-4,46  Focal and Regional Neuropathic Pain Syndromes  SHINGLES and postherpetic neuralgia (PHN)   are caused by reactivation of VARICELLA ZOSTER VIRUS (VZV) in a sensory ganglion.,SHINGLES,VARICELLA ZOSTER VIRUS,TWrex-cause
725540683,5/25/2015 16:48:35,1643054506,5/25/2015 16:48:15,False,superrewards,0.8194,32390657,CAN,BC,Vancouver,108.180.109.12,VARICELLA ZOSTER VIRUS causes SHINGLES,51,125,,58,147,causes,0.9958932064677041,811528-FS1-4,46  Focal and Regional Neuropathic Pain Syndromes  SHINGLES and postherpetic neuralgia (PHN)   are caused by reactivation of VARICELLA ZOSTER VIRUS (VZV) in a sensory ganglion.,SHINGLES,VARICELLA ZOSTER VIRUS,TWrex-cause
725540683,5/25/2015 16:49:39,1643054788,5/25/2015 16:45:18,False,neodev,0.8889,18881135,CAN,ON,Ajax,99.243.87.224,VARICELLA ZOSTER VIRUS causes SHINGLES,51,125,,58,147,causes,0.9958932064677041,811528-FS1-4,46  Focal and Regional Neuropathic Pain Syndromes  SHINGLES and postherpetic neuralgia (PHN)   are caused by reactivation of VARICELLA ZOSTER VIRUS (VZV) in a sensory ganglion.,SHINGLES,VARICELLA ZOSTER VIRUS,TWrex-cause
725540691,5/25/2015 16:12:06,1643045976,5/25/2015 16:10:48,False,onestopgpt,0.6905,21275875,CAN,ON,Hamilton,24.36.121.10,CANDIDA causes VULVOVAGINAL CANDIDIASIS,149,201,,172,208,causes,0.9838699100999069,812304-FS1-4,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7 14 days of an intravaginal azole for VULVOVAGINAL CANDIDIASIS that is severe, caused by  CANDIDA  other than  C. albicans , or occurring in women with underlying medical conditions.",VULVOVAGINAL CANDIDIASIS,CANDIDA,TWrex-cause
725540691,5/25/2015 16:13:05,1643046286,5/25/2015 16:12:31,False,clixsense,0.9333,28351359,GBR,H9,London,80.43.180.102,CANDIDA causes VULVOVAGINAL CANDIDIASIS,149,201,,172,208,causes,0.9838699100999069,812304-FS1-4,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7 14 days of an intravaginal azole for VULVOVAGINAL CANDIDIASIS that is severe, caused by  CANDIDA  other than  C. albicans , or occurring in women with underlying medical conditions.",VULVOVAGINAL CANDIDIASIS,CANDIDA,TWrex-cause
725540691,5/25/2015 16:15:50,1643047017,5/25/2015 16:15:27,False,instagc,0.9444,15864091,USA,OK,Oklahoma City,104.0.113.133,CANDIDA causes VULVOVAGINAL CANDIDIASIS,149,201,,172,208,causes,0.9838699100999069,812304-FS1-4,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7 14 days of an intravaginal azole for VULVOVAGINAL CANDIDIASIS that is severe, caused by  CANDIDA  other than  C. albicans , or occurring in women with underlying medical conditions.",VULVOVAGINAL CANDIDIASIS,CANDIDA,TWrex-cause
725540691,5/25/2015 16:17:52,1643047688,5/25/2015 16:13:08,False,neodev,0.873,27667288,CAN,MB,Brandon,216.36.187.168,CANDIDA causes VULVOVAGINAL CANDIDIASIS,149,201,,172,208,causes,0.9838699100999069,812304-FS1-4,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7 14 days of an intravaginal azole for VULVOVAGINAL CANDIDIASIS that is severe, caused by  CANDIDA  other than  C. albicans , or occurring in women with underlying medical conditions.",VULVOVAGINAL CANDIDIASIS,CANDIDA,TWrex-cause
725540691,5/25/2015 16:39:02,1643052242,5/25/2015 16:38:40,False,neodev,0.9792,31743852,GBR,G5,Margate,85.210.126.147,CANDIDA causes VULVOVAGINAL CANDIDIASIS,149,201,,172,208,causes,0.9838699100999069,812304-FS1-4,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7 14 days of an intravaginal azole for VULVOVAGINAL CANDIDIASIS that is severe, caused by  CANDIDA  other than  C. albicans , or occurring in women with underlying medical conditions.",VULVOVAGINAL CANDIDIASIS,CANDIDA,TWrex-cause
725540691,5/25/2015 16:48:35,1643054505,5/25/2015 16:48:15,False,superrewards,0.8194,32390657,CAN,BC,Vancouver,108.180.109.12,CANDIDA causes VULVOVAGINAL CANDIDIASIS,149,201,,172,208,causes,0.9838699100999069,812304-FS1-4,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7 14 days of an intravaginal azole for VULVOVAGINAL CANDIDIASIS that is severe, caused by  CANDIDA  other than  C. albicans , or occurring in women with underlying medical conditions.",VULVOVAGINAL CANDIDIASIS,CANDIDA,TWrex-cause
725540691,5/25/2015 16:49:39,1643054794,5/25/2015 16:45:18,False,neodev,0.8889,18881135,CAN,ON,Ajax,99.243.87.224,CANDIDA causes VULVOVAGINAL CANDIDIASIS,149,201,,172,208,causes,0.9838699100999069,812304-FS1-4,"108 ,   127 ,   128  >     Other Complicated Vulvovaginal Infections  Intravaginal:  CDC and others recommend 7 14 days of an intravaginal azole for VULVOVAGINAL CANDIDIASIS that is severe, caused by  CANDIDA  other than  C. albicans , or occurring in women with underlying medical conditions.",VULVOVAGINAL CANDIDIASIS,CANDIDA,TWrex-cause
725540698,5/25/2015 15:24:26,1643033049,5/25/2015 15:23:52,False,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,no_relation,0,74,,15,77,causes,0.762000762001143,813561-FS1-4,KERATOACANTHOMAS and sebaceous hyperplasia are also seen in patients with MTS,KERATOACANTHOMAS,MTS,TWrex-cause
725540698,5/25/2015 15:27:03,1643033806,5/25/2015 15:26:46,False,bitcoinget,0.8333,30546513,GBR,G6,Hull,194.42.67.50,MTS causes KERATOACANTHOMAS,0,74,,15,77,causes,0.762000762001143,813561-FS1-4,KERATOACANTHOMAS and sebaceous hyperplasia are also seen in patients with MTS,KERATOACANTHOMAS,MTS,TWrex-cause
725540698,5/25/2015 15:29:54,1643034634,5/25/2015 15:29:12,False,neodev,0.5417,31977841,USA,IL,Chicago,69.175.85.2,KERATOACANTHOMAS causes MTS,0,74,,15,77,causes,0.762000762001143,813561-FS1-4,KERATOACANTHOMAS and sebaceous hyperplasia are also seen in patients with MTS,KERATOACANTHOMAS,MTS,TWrex-cause
725540698,5/25/2015 15:31:14,1643035107,5/25/2015 15:31:00,False,meprizescf,0.5625,28483210,USA,WI,Minocqua,75.143.134.247,MTS causes KERATOACANTHOMAS,0,74,,15,77,causes,0.762000762001143,813561-FS1-4,KERATOACANTHOMAS and sebaceous hyperplasia are also seen in patients with MTS,KERATOACANTHOMAS,MTS,TWrex-cause
725540698,5/25/2015 15:32:57,1643035610,5/25/2015 15:32:38,False,instagc,0.5833,13581319,USA,IL,Mount Vernon,66.232.166.86,no_relation,0,74,,15,77,causes,0.762000762001143,813561-FS1-4,KERATOACANTHOMAS and sebaceous hyperplasia are also seen in patients with MTS,KERATOACANTHOMAS,MTS,TWrex-cause
725540698,5/25/2015 15:36:57,1643036813,5/25/2015 15:36:40,False,elite,0.3532,32306791,USA,DE,Wilmington,199.58.86.213,KERATOACANTHOMAS causes MTS,0,74,,15,77,causes,0.762000762001143,813561-FS1-4,KERATOACANTHOMAS and sebaceous hyperplasia are also seen in patients with MTS,KERATOACANTHOMAS,MTS,TWrex-cause
725540698,5/25/2015 15:43:51,1643039166,5/25/2015 15:40:43,False,neodev,0.5661,31086320,NLD,05,Brunssum,84.28.176.117,MTS causes KERATOACANTHOMAS,0,74,,15,77,causes,0.762000762001143,813561-FS1-4,KERATOACANTHOMAS and sebaceous hyperplasia are also seen in patients with MTS,KERATOACANTHOMAS,MTS,TWrex-cause
725540703,5/25/2015 16:13:27,1643046410,5/25/2015 16:13:06,False,clixsense,0.9333,28351359,GBR,H9,London,80.43.180.102,no_relation,75,46,,95,70,causes,0.458831467741123,810496-FS1-4,"Michielsen P, Heinemann L, Mihatsch M, et al. NONPHENACETIN ANALGESICS and ANALGESIC NEPHROPATHY: clinical assessment of high users from a case control study.",ANALGESIC NEPHROPATHY,NONPHENACETIN ANALGESICS,TWrex-cause
725540703,5/25/2015 16:16:42,1643047262,5/25/2015 16:15:51,False,instagc,0.9444,15864091,USA,OK,Oklahoma City,104.0.113.133,no_relation,75,46,,95,70,causes,0.458831467741123,810496-FS1-4,"Michielsen P, Heinemann L, Mihatsch M, et al. NONPHENACETIN ANALGESICS and ANALGESIC NEPHROPATHY: clinical assessment of high users from a case control study.",ANALGESIC NEPHROPATHY,NONPHENACETIN ANALGESICS,TWrex-cause
725540703,5/25/2015 16:18:25,1643047855,5/25/2015 16:17:55,False,neodev,0.873,27667288,CAN,MB,Brandon,216.36.187.168,no_relation,75,46,,95,70,causes,0.458831467741123,810496-FS1-4,"Michielsen P, Heinemann L, Mihatsch M, et al. NONPHENACETIN ANALGESICS and ANALGESIC NEPHROPATHY: clinical assessment of high users from a case control study.",ANALGESIC NEPHROPATHY,NONPHENACETIN ANALGESICS,TWrex-cause
725540703,5/25/2015 16:39:16,1643052289,5/25/2015 16:39:04,False,neodev,0.9792,31743852,GBR,G5,Margate,85.210.126.147,no_relation,75,46,,95,70,causes,0.458831467741123,810496-FS1-4,"Michielsen P, Heinemann L, Mihatsch M, et al. NONPHENACETIN ANALGESICS and ANALGESIC NEPHROPATHY: clinical assessment of high users from a case control study.",ANALGESIC NEPHROPATHY,NONPHENACETIN ANALGESICS,TWrex-cause
725540703,5/25/2015 16:49:01,1643054655,5/25/2015 16:48:37,False,superrewards,0.8194,32390657,CAN,BC,Vancouver,108.180.109.12,no_relation,75,46,,95,70,causes,0.458831467741123,810496-FS1-4,"Michielsen P, Heinemann L, Mihatsch M, et al. NONPHENACETIN ANALGESICS and ANALGESIC NEPHROPATHY: clinical assessment of high users from a case control study.",ANALGESIC NEPHROPATHY,NONPHENACETIN ANALGESICS,TWrex-cause
725540703,5/25/2015 16:49:58,1643054912,5/25/2015 16:49:42,False,neodev,0.8889,18881135,CAN,ON,Ajax,99.243.87.224,no_relation,75,46,,95,70,causes,0.458831467741123,810496-FS1-4,"Michielsen P, Heinemann L, Mihatsch M, et al. NONPHENACETIN ANALGESICS and ANALGESIC NEPHROPATHY: clinical assessment of high users from a case control study.",ANALGESIC NEPHROPATHY,NONPHENACETIN ANALGESICS,TWrex-cause
725540703,5/25/2015 16:54:23,1643056225,5/25/2015 16:53:24,False,gifthunterclub,0.8734,29582088,GBR,I2,Manchester,89.240.68.44,no_relation,75,46,,95,70,causes,0.458831467741123,810496-FS1-4,"Michielsen P, Heinemann L, Mihatsch M, et al. NONPHENACETIN ANALGESICS and ANALGESIC NEPHROPATHY: clinical assessment of high users from a case control study.",ANALGESIC NEPHROPATHY,NONPHENACETIN ANALGESICS,TWrex-cause
725540704,5/25/2015 16:56:53,1643056990,5/25/2015 16:56:38,False,gifthunterclub,0.8734,29582088,GBR,I2,Manchester,89.240.68.44,no_relation,72,0,,83,31,causes,0.6974858324629161,813445-FS1-4,TYPE I PSEUDOHYPOPARATHYROIDISM can be distinguished by the presence of HYPOCALCEMIA despite normal to elevated levels of circulating PTH.,HYPOCALCEMIA,TYPE I PSEUDOHYPOPARATHYROIDISM,TWrex-cause
725540704,5/25/2015 17:03:40,1643059614,5/25/2015 17:03:18,False,instagc,0.96,18985376,GBR,D2,Derby,86.27.159.112,no_relation,72,0,,83,31,causes,0.6974858324629161,813445-FS1-4,TYPE I PSEUDOHYPOPARATHYROIDISM can be distinguished by the presence of HYPOCALCEMIA despite normal to elevated levels of circulating PTH.,HYPOCALCEMIA,TYPE I PSEUDOHYPOPARATHYROIDISM,TWrex-cause
725540704,5/25/2015 17:22:01,1643068390,5/25/2015 17:21:12,False,instagc,0.7,31861996,USA,FL,Homestead,73.46.199.178,HYPOCALCEMIA causes TYPE I PSEUDOHYPOPARATHYROIDISM,72,0,,83,31,causes,0.6974858324629161,813445-FS1-4,TYPE I PSEUDOHYPOPARATHYROIDISM can be distinguished by the presence of HYPOCALCEMIA despite normal to elevated levels of circulating PTH.,HYPOCALCEMIA,TYPE I PSEUDOHYPOPARATHYROIDISM,TWrex-cause
725540704,5/25/2015 17:24:51,1643069842,5/25/2015 17:24:40,False,bitcoinget,0.8381,21614812,USA,NJ,Blackwood,50.153.127.136,no_relation,72,0,,83,31,causes,0.6974858324629161,813445-FS1-4,TYPE I PSEUDOHYPOPARATHYROIDISM can be distinguished by the presence of HYPOCALCEMIA despite normal to elevated levels of circulating PTH.,HYPOCALCEMIA,TYPE I PSEUDOHYPOPARATHYROIDISM,TWrex-cause
725540704,5/25/2015 17:28:32,1643071584,5/25/2015 17:28:13,False,clixsense,0.4667,22518719,GBR,J8,Nottingham,86.10.69.152,TYPE I PSEUDOHYPOPARATHYROIDISM causes HYPOCALCEMIA,72,0,,83,31,causes,0.6974858324629161,813445-FS1-4,TYPE I PSEUDOHYPOPARATHYROIDISM can be distinguished by the presence of HYPOCALCEMIA despite normal to elevated levels of circulating PTH.,HYPOCALCEMIA,TYPE I PSEUDOHYPOPARATHYROIDISM,TWrex-cause
725540704,5/25/2015 17:35:23,1643074727,5/25/2015 17:33:21,False,clixsense,0.7778,29275930,GBR,H3,Leeds,86.147.196.127,no_relation,72,0,,83,31,causes,0.6974858324629161,813445-FS1-4,TYPE I PSEUDOHYPOPARATHYROIDISM can be distinguished by the presence of HYPOCALCEMIA despite normal to elevated levels of circulating PTH.,HYPOCALCEMIA,TYPE I PSEUDOHYPOPARATHYROIDISM,TWrex-cause
725540704,5/25/2015 17:36:02,1643075038,5/25/2015 17:34:59,False,clixsense,0.6667,10032240,USA,FL,Naples,76.101.211.223,no_relation,72,0,,83,31,causes,0.6974858324629161,813445-FS1-4,TYPE I PSEUDOHYPOPARATHYROIDISM can be distinguished by the presence of HYPOCALCEMIA despite normal to elevated levels of circulating PTH.,HYPOCALCEMIA,TYPE I PSEUDOHYPOPARATHYROIDISM,TWrex-cause
725540707,5/25/2015 15:44:55,1643039405,5/25/2015 15:44:34,False,neodev,0.8571,30504276,CAN,ON,Sudbury,66.103.55.12,no_relation,56,0,,68,15,causes,0.7453559924999301,813251-FS1-4,"PYKNODYSOSTOSIS:  In this autosomal recessive disorder, SHORT STATURE becomes evident in early childhood; adult height is  150 cm (5 ft.",SHORT STATURE,PYKNODYSOSTOSIS,TWrex-cause
725540707,5/25/2015 15:46:53,1643039998,5/25/2015 15:46:23,False,points4rewards,0.7708,28755767,USA,VA,Chester,68.57.118.32,PYKNODYSOSTOSIS causes SHORT STATURE,56,0,,68,15,causes,0.7453559924999301,813251-FS1-4,"PYKNODYSOSTOSIS:  In this autosomal recessive disorder, SHORT STATURE becomes evident in early childhood; adult height is  150 cm (5 ft.",SHORT STATURE,PYKNODYSOSTOSIS,TWrex-cause
725540707,5/25/2015 15:48:26,1643040514,5/25/2015 15:47:04,False,clixsense,0.4931,17950689,GBR,Y9,Tonypandy,92.2.44.79,PYKNODYSOSTOSIS causes SHORT STATURE,56,0,,68,15,causes,0.7453559924999301,813251-FS1-4,"PYKNODYSOSTOSIS:  In this autosomal recessive disorder, SHORT STATURE becomes evident in early childhood; adult height is  150 cm (5 ft.",SHORT STATURE,PYKNODYSOSTOSIS,TWrex-cause
725540707,5/25/2015 15:49:59,1643040945,5/25/2015 15:47:42,False,neodev,0.5661,31086320,NLD,05,Brunssum,84.28.176.117,no_relation,56,0,,68,15,causes,0.7453559924999301,813251-FS1-4,"PYKNODYSOSTOSIS:  In this autosomal recessive disorder, SHORT STATURE becomes evident in early childhood; adult height is  150 cm (5 ft.",SHORT STATURE,PYKNODYSOSTOSIS,TWrex-cause
725540707,5/25/2015 15:56:39,1643042450,5/25/2015 15:55:56,False,clixsense,0.5,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,56,0,,68,15,causes,0.7453559924999301,813251-FS1-4,"PYKNODYSOSTOSIS:  In this autosomal recessive disorder, SHORT STATURE becomes evident in early childhood; adult height is  150 cm (5 ft.",SHORT STATURE,PYKNODYSOSTOSIS,TWrex-cause
725540707,5/25/2015 15:59:55,1643043258,5/25/2015 15:59:42,False,neodev,0.5722,14096345,NLD,03,Eibergen,77.174.124.109,no_relation,56,0,,68,15,causes,0.7453559924999301,813251-FS1-4,"PYKNODYSOSTOSIS:  In this autosomal recessive disorder, SHORT STATURE becomes evident in early childhood; adult height is  150 cm (5 ft.",SHORT STATURE,PYKNODYSOSTOSIS,TWrex-cause
725540707,5/25/2015 16:05:09,1643044214,5/25/2015 16:04:15,False,prodege,0.5893,21417560,GBR,C3,Cambridge,151.225.116.143,PYKNODYSOSTOSIS causes SHORT STATURE,56,0,,68,15,causes,0.7453559924999301,813251-FS1-4,"PYKNODYSOSTOSIS:  In this autosomal recessive disorder, SHORT STATURE becomes evident in early childhood; adult height is  150 cm (5 ft.",SHORT STATURE,PYKNODYSOSTOSIS,TWrex-cause
725540708,5/25/2015 16:07:21,1643044655,5/25/2015 16:07:14,False,prodege,0.7,2143114,CAN,BC,Vancouver,24.85.153.181,POLYCYSTIC DISEASE OF THE KIDNEYS causes KIDNEYS,32,6,,38,39,causes,0.8677218312746251,802042-FS1-4,edit] POLYCYSTIC DISEASE OF THE KIDNEYS Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the KIDNEYS,KIDNEYS,POLYCYSTIC DISEASE OF THE KIDNEYS,TWrex-cause
725540708,5/25/2015 16:08:08,1643044824,5/25/2015 16:07:36,False,prodege,0.5893,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,32,6,,38,39,causes,0.8677218312746251,802042-FS1-4,edit] POLYCYSTIC DISEASE OF THE KIDNEYS Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the KIDNEYS,KIDNEYS,POLYCYSTIC DISEASE OF THE KIDNEYS,TWrex-cause
725540708,5/25/2015 16:09:39,1643045237,5/25/2015 16:08:38,False,onestopgpt,0.6905,21275875,CAN,ON,Hamilton,24.36.121.10,no_relation,32,6,,38,39,causes,0.8677218312746251,802042-FS1-4,edit] POLYCYSTIC DISEASE OF THE KIDNEYS Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the KIDNEYS,KIDNEYS,POLYCYSTIC DISEASE OF THE KIDNEYS,TWrex-cause
725540708,5/25/2015 16:10:59,1643045556,5/25/2015 16:07:55,False,neodev,0.873,27667288,CAN,MB,Brandon,216.36.187.168,no_relation,32,6,,38,39,causes,0.8677218312746251,802042-FS1-4,edit] POLYCYSTIC DISEASE OF THE KIDNEYS Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the KIDNEYS,KIDNEYS,POLYCYSTIC DISEASE OF THE KIDNEYS,TWrex-cause
725540708,5/25/2015 16:11:53,1643045926,5/25/2015 16:11:16,False,clixsense,0.9333,28351359,GBR,H9,London,80.43.180.102,no_relation,32,6,,38,39,causes,0.8677218312746251,802042-FS1-4,edit] POLYCYSTIC DISEASE OF THE KIDNEYS Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the KIDNEYS,KIDNEYS,POLYCYSTIC DISEASE OF THE KIDNEYS,TWrex-cause
725540708,5/25/2015 16:15:07,1643046905,5/25/2015 16:14:43,False,instagc,0.9444,15864091,USA,OK,Oklahoma City,104.0.113.133,no_relation,32,6,,38,39,causes,0.8677218312746251,802042-FS1-4,edit] POLYCYSTIC DISEASE OF THE KIDNEYS Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the KIDNEYS,KIDNEYS,POLYCYSTIC DISEASE OF THE KIDNEYS,TWrex-cause
725540708,5/25/2015 16:19:04,1643047956,5/25/2015 16:18:55,False,clixsense,0.6667,28457001,CAN,ON,North Bay,24.204.202.220,no_relation,32,6,,38,39,causes,0.8677218312746251,802042-FS1-4,edit] POLYCYSTIC DISEASE OF THE KIDNEYS Main article: Polycystic Disease of the Kidneys  Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the KIDNEYS,KIDNEYS,POLYCYSTIC DISEASE OF THE KIDNEYS,TWrex-cause
725540712,5/25/2015 15:20:47,1643031951,5/25/2015 15:20:13,False,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,LOWER CERVICAL SPINAL CORD causes CERVICAL MYELOPATHY,253,37,,278,56,causes,0.8834522085987719,802405-FS1-4,CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes CERVICAL MYELOPATHY from encroachment of bony osteoarthritic growths (osteophytes) on the LOWER CERVICAL SPINAL CORD sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.,LOWER CERVICAL SPINAL CORD,CERVICAL MYELOPATHY,TWrex-cause
725540712,5/25/2015 15:26:10,1643033531,5/25/2015 15:25:33,False,bitcoinget,0.8333,30546513,GBR,G6,Hull,194.42.67.50,LOWER CERVICAL SPINAL CORD causes CERVICAL MYELOPATHY,253,37,,278,56,causes,0.8834522085987719,802405-FS1-4,CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes CERVICAL MYELOPATHY from encroachment of bony osteoarthritic growths (osteophytes) on the LOWER CERVICAL SPINAL CORD sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.,LOWER CERVICAL SPINAL CORD,CERVICAL MYELOPATHY,TWrex-cause
725540712,5/25/2015 15:28:58,1643034291,5/25/2015 15:28:20,False,neodev,0.5417,31977841,USA,IL,Chicago,69.175.85.2,LOWER CERVICAL SPINAL CORD causes CERVICAL MYELOPATHY,253,37,,278,56,causes,0.8834522085987719,802405-FS1-4,CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes CERVICAL MYELOPATHY from encroachment of bony osteoarthritic growths (osteophytes) on the LOWER CERVICAL SPINAL CORD sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.,LOWER CERVICAL SPINAL CORD,CERVICAL MYELOPATHY,TWrex-cause
725540712,5/25/2015 15:30:43,1643034932,5/25/2015 15:30:20,False,meprizescf,0.5625,28483210,USA,WI,Minocqua,75.143.134.247,CERVICAL MYELOPATHY causes LOWER CERVICAL SPINAL CORD,253,37,,278,56,causes,0.8834522085987719,802405-FS1-4,CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes CERVICAL MYELOPATHY from encroachment of bony osteoarthritic growths (osteophytes) on the LOWER CERVICAL SPINAL CORD sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.,LOWER CERVICAL SPINAL CORD,CERVICAL MYELOPATHY,TWrex-cause
725540712,5/25/2015 15:32:25,1643035455,5/25/2015 15:32:10,False,instagc,0.5833,13581319,USA,IL,Mount Vernon,66.232.166.86,no_relation,253,37,,278,56,causes,0.8834522085987719,802405-FS1-4,CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes CERVICAL MYELOPATHY from encroachment of bony osteoarthritic growths (osteophytes) on the LOWER CERVICAL SPINAL CORD sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.,LOWER CERVICAL SPINAL CORD,CERVICAL MYELOPATHY,TWrex-cause
725540712,5/25/2015 15:35:54,1643036501,5/25/2015 15:35:07,False,elite,0.3532,32306791,USA,DE,Wilmington,199.58.86.213,LOWER CERVICAL SPINAL CORD causes CERVICAL MYELOPATHY,253,37,,278,56,causes,0.8834522085987719,802405-FS1-4,CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes CERVICAL MYELOPATHY from encroachment of bony osteoarthritic growths (osteophytes) on the LOWER CERVICAL SPINAL CORD sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.,LOWER CERVICAL SPINAL CORD,CERVICAL MYELOPATHY,TWrex-cause
725540712,5/25/2015 15:36:27,1643036686,5/25/2015 15:36:10,False,cointasker,0.2619,21783324,NLD,,,31.151.239.133,no_relation,253,37,,278,56,causes,0.8834522085987719,802405-FS1-4,CERVICAL SPONDYLOSIS AND SPONDYLOTIC CERVICAL MYELOPATHY  Cervical spondylosis is osteoarthritis of the cervical spine causing stenosis of the canal and sometimes CERVICAL MYELOPATHY from encroachment of bony osteoarthritic growths (osteophytes) on the LOWER CERVICAL SPINAL CORD sometimes with involvement of lower cervical nerve roots (radiculomyelopathy.,LOWER CERVICAL SPINAL CORD,CERVICAL MYELOPATHY,TWrex-cause
725540713,5/25/2015 15:48:49,1643040610,5/25/2015 15:48:20,False,points4rewards,0.7708,28755767,USA,VA,Chester,68.57.118.32,SUSCEPTIBLE PLASMODIA causes MALARIA,225,243,,231,264,causes,0.956182887467515,810506-FS1-4,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of MALARIA caused by SUSCEPTIBLE PLASMODIA",MALARIA,SUSCEPTIBLE PLASMODIA,TWrex-cause
725540713,5/25/2015 15:51:46,1643041418,5/25/2015 15:51:15,False,clixsense,0.4931,17950689,GBR,Y9,Tonypandy,92.2.44.79,MALARIA causes SUSCEPTIBLE PLASMODIA,225,243,,231,264,causes,0.956182887467515,810506-FS1-4,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of MALARIA caused by SUSCEPTIBLE PLASMODIA",MALARIA,SUSCEPTIBLE PLASMODIA,TWrex-cause
725540713,5/25/2015 15:59:52,1643043236,5/25/2015 15:58:55,False,clixsense,0.5,10798016,GBR,C7,Coventry,86.24.245.191,no_relation,225,243,,231,264,causes,0.956182887467515,810506-FS1-4,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of MALARIA caused by SUSCEPTIBLE PLASMODIA",MALARIA,SUSCEPTIBLE PLASMODIA,TWrex-cause
725540713,5/25/2015 16:01:41,1643043524,5/25/2015 16:01:19,False,neodev,0.5722,14096345,NLD,03,Eibergen,77.174.124.109,SUSCEPTIBLE PLASMODIA causes MALARIA,225,243,,231,264,causes,0.956182887467515,810506-FS1-4,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of MALARIA caused by SUSCEPTIBLE PLASMODIA",MALARIA,SUSCEPTIBLE PLASMODIA,TWrex-cause
725540713,5/25/2015 16:07:13,1643044604,5/25/2015 16:07:02,False,prodege,0.7,2143114,CAN,BC,Vancouver,24.85.153.181,MALARIA causes SUSCEPTIBLE PLASMODIA,225,243,,231,264,causes,0.956182887467515,810506-FS1-4,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of MALARIA caused by SUSCEPTIBLE PLASMODIA",MALARIA,SUSCEPTIBLE PLASMODIA,TWrex-cause
725540713,5/25/2015 16:07:35,1643044728,5/25/2015 16:06:45,False,prodege,0.5893,21417560,GBR,C3,Cambridge,151.225.116.143,SUSCEPTIBLE PLASMODIA causes MALARIA,225,243,,231,264,causes,0.956182887467515,810506-FS1-4,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of MALARIA caused by SUSCEPTIBLE PLASMODIA",MALARIA,SUSCEPTIBLE PLASMODIA,TWrex-cause
725540713,5/25/2015 16:08:37,1643044953,5/25/2015 16:07:46,False,onestopgpt,0.6905,21275875,CAN,ON,Hamilton,24.36.121.10,SUSCEPTIBLE PLASMODIA causes MALARIA,225,243,,231,264,causes,0.956182887467515,810506-FS1-4,"164  The CDC and other clinicians recommend use of other antimalarial agents (e.g., chloroquine [or hydroxychloroquine], mefloquine, doxycycline, fixed combination of atovaquone and proguanil hydrochloride) for prevention of MALARIA caused by SUSCEPTIBLE PLASMODIA",MALARIA,SUSCEPTIBLE PLASMODIA,TWrex-cause
725582627,5/25/2015 21:34:40,1643166177,5/25/2015 21:33:53,False,prodege,1.0,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,69,113,,93,128,causes,0.811107105653813,813266-FS1-4,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME,TWrex-cause
725582627,5/25/2015 21:37:59,1643166988,5/25/2015 21:37:13,False,clixsense,0.7597,32254355,CAN,ON,London,50.101.209.220,no_relation,69,113,,93,128,causes,0.811107105653813,813266-FS1-4,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME,TWrex-cause
725582627,5/25/2015 21:38:27,1643167166,5/25/2015 21:37:42,False,bitcoinget,0.6889,21678835,USA,OH,Ironton,76.177.160.209,no_relation,69,113,,93,128,causes,0.811107105653813,813266-FS1-4,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME,TWrex-cause
725582627,5/25/2015 21:40:28,1643167870,5/25/2015 21:40:13,False,meprizescf,0.6042,28483210,USA,WI,Minocqua,75.143.134.247,MARFAN SYNDROME causes ASCENDING AORTIC ANEURYSM,69,113,,93,128,causes,0.811107105653813,813266-FS1-4,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME,TWrex-cause
725582627,5/25/2015 21:40:42,1643168043,5/25/2015 21:40:00,False,neodev,0.627,27667288,CAN,MB,Brandon,216.36.187.168,no_relation,69,113,,93,128,causes,0.811107105653813,813266-FS1-4,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME,TWrex-cause
725582627,5/25/2015 21:42:44,1643168649,5/25/2015 21:42:08,False,onestopgpt,0.6008,21275875,CAN,ON,Hamilton,24.36.121.10,no_relation,69,113,,93,128,causes,0.811107105653813,813266-FS1-4,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME,TWrex-cause
725582627,5/25/2015 21:44:28,1643169087,5/25/2015 21:43:28,False,points4rewards,0.6865,20113482,USA,OR,Portland,67.213.218.72,no_relation,69,113,,93,128,causes,0.811107105653813,813266-FS1-4,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME,TWrex-cause
725582636,5/25/2015 21:35:16,1643166387,5/25/2015 21:34:42,False,prodege,1.0,21417560,GBR,C3,Cambridge,151.225.116.143,ZOSTER causes VARICELLA VIRUS,0,27,,5,42,causes,0.857142857142857,814960-FS1-4,ZOSTER     Reactivation of VARICELLA VIRUS years after the initial infection with chickenpox.,ZOSTER,VARICELLA VIRUS,TWrex-cause
725582636,5/25/2015 21:38:50,1643167324,5/25/2015 21:38:01,False,clixsense,0.7597,32254355,CAN,ON,London,50.101.209.220,no_relation,0,27,,5,42,causes,0.857142857142857,814960-FS1-4,ZOSTER     Reactivation of VARICELLA VIRUS years after the initial infection with chickenpox.,ZOSTER,VARICELLA VIRUS,TWrex-cause
725582636,5/25/2015 21:39:07,1643167441,5/25/2015 21:38:28,False,bitcoinget,0.6889,21678835,USA,OH,Ironton,76.177.160.209,no_relation,0,27,,5,42,causes,0.857142857142857,814960-FS1-4,ZOSTER     Reactivation of VARICELLA VIRUS years after the initial infection with chickenpox.,ZOSTER,VARICELLA VIRUS,TWrex-cause
725582636,5/25/2015 21:40:42,1643168047,5/25/2015 21:40:28,False,meprizescf,0.6042,28483210,USA,WI,Minocqua,75.143.134.247,VARICELLA VIRUS causes ZOSTER,0,27,,5,42,causes,0.857142857142857,814960-FS1-4,ZOSTER     Reactivation of VARICELLA VIRUS years after the initial infection with chickenpox.,ZOSTER,VARICELLA VIRUS,TWrex-cause
725582636,5/25/2015 21:43:08,1643168787,5/25/2015 21:40:52,False,neodev,0.627,27667288,CAN,MB,Brandon,216.36.187.168,no_relation,0,27,,5,42,causes,0.857142857142857,814960-FS1-4,ZOSTER     Reactivation of VARICELLA VIRUS years after the initial infection with chickenpox.,ZOSTER,VARICELLA VIRUS,TWrex-cause
725582636,5/25/2015 21:43:31,1643168870,5/25/2015 21:42:45,False,onestopgpt,0.6008,21275875,CAN,ON,Hamilton,24.36.121.10,ZOSTER causes VARICELLA VIRUS,0,27,,5,42,causes,0.857142857142857,814960-FS1-4,ZOSTER     Reactivation of VARICELLA VIRUS years after the initial infection with chickenpox.,ZOSTER,VARICELLA VIRUS,TWrex-cause
725582636,5/25/2015 21:45:15,1643169376,5/25/2015 21:44:33,False,points4rewards,0.6865,20113482,USA,OR,Portland,67.213.218.72,no_relation,0,27,,5,42,causes,0.857142857142857,814960-FS1-4,ZOSTER     Reactivation of VARICELLA VIRUS years after the initial infection with chickenpox.,ZOSTER,VARICELLA VIRUS,TWrex-cause
725582637,5/25/2015 22:35:19,1643184160,5/25/2015 22:35:03,False,superrewards,0.7119,24796792,USA,NY,New York,72.80.63.240,POSTOPERATIVE NAUSEA AND VOMITING causes METOCLOPRAMIDE,128,192,,160,206,causes,0.444444444444444,804325-FS1-4,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent POSTOPERATIVE NAUSEA AND VOMITING consider the possibility that METOCLOPRAMIDE theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE,TWrex-cause
725582637,5/25/2015 22:35:23,1643184196,5/25/2015 22:35:09,False,neodev,0.875,11014811,GBR,G6,Hull,87.102.82.212,no_relation,128,192,,160,206,causes,0.444444444444444,804325-FS1-4,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent POSTOPERATIVE NAUSEA AND VOMITING consider the possibility that METOCLOPRAMIDE theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE,TWrex-cause
725582637,5/25/2015 22:36:27,1643184534,5/25/2015 22:36:14,False,instagc,0.8190000000000001,26024737,GBR,A9,Blackpool,2.97.97.40,METOCLOPRAMIDE causes POSTOPERATIVE NAUSEA AND VOMITING,128,192,,160,206,causes,0.444444444444444,804325-FS1-4,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent POSTOPERATIVE NAUSEA AND VOMITING consider the possibility that METOCLOPRAMIDE theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE,TWrex-cause
725582637,5/25/2015 22:37:20,1643184822,5/25/2015 22:36:32,False,elite,0.8185,30064988,GBR,H3,Leeds,92.22.210.218,no_relation,128,192,,160,206,causes,0.444444444444444,804325-FS1-4,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent POSTOPERATIVE NAUSEA AND VOMITING consider the possibility that METOCLOPRAMIDE theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE,TWrex-cause
725582637,5/25/2015 22:37:33,1643184894,5/25/2015 22:36:58,False,prodege,0.6256,28103910,GBR,C3,Wisbech,2.222.58.164,METOCLOPRAMIDE causes POSTOPERATIVE NAUSEA AND VOMITING,128,192,,160,206,causes,0.444444444444444,804325-FS1-4,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent POSTOPERATIVE NAUSEA AND VOMITING consider the possibility that METOCLOPRAMIDE theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE,TWrex-cause
725582637,5/25/2015 22:40:36,1643186011,5/25/2015 22:39:37,False,clixsense,0.7052,22947672,GBR,,,88.144.128.65,no_relation,128,192,,160,206,causes,0.444444444444444,804325-FS1-4,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent POSTOPERATIVE NAUSEA AND VOMITING consider the possibility that METOCLOPRAMIDE theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE,TWrex-cause
725582637,5/25/2015 22:43:59,1643187085,5/25/2015 22:43:02,False,neodev,0.8383,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,128,192,,160,206,causes,0.444444444444444,804325-FS1-4,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent POSTOPERATIVE NAUSEA AND VOMITING consider the possibility that METOCLOPRAMIDE theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE,TWrex-cause
725582649,5/25/2015 21:47:26,1643169991,5/25/2015 21:46:56,False,prodege,0.9206,26159434,CAN,ON,Thornhill,99.238.74.196,no_relation,0,7,,19,11,causes,0.9494253265550829,812433-FS1-4,"DIRECT DRUG TOXICITY  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to DRUG.",DIRECT DRUG TOXICITY,DRUG,TWrex-cause
725582649,5/25/2015 21:47:28,1643169995,5/25/2015 21:47:16,False,instagc,0.9048,15864091,USA,OK,Oklahoma City,104.0.113.133,no_relation,0,7,,19,11,causes,0.9494253265550829,812433-FS1-4,"DIRECT DRUG TOXICITY  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to DRUG.",DIRECT DRUG TOXICITY,DRUG,TWrex-cause
725582649,5/25/2015 21:47:41,1643170034,5/25/2015 21:47:15,False,points4rewards,0.6865,20113482,USA,OR,Portland,67.213.218.72,DRUG causes DIRECT DRUG TOXICITY,0,7,,19,11,causes,0.9494253265550829,812433-FS1-4,"DIRECT DRUG TOXICITY  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to DRUG.",DIRECT DRUG TOXICITY,DRUG,TWrex-cause
725582649,5/25/2015 21:51:02,1643171276,5/25/2015 21:50:55,False,bitcoinget,0.6833,21614812,USA,NJ,Blackwood,50.153.127.136,DRUG causes DIRECT DRUG TOXICITY,0,7,,19,11,causes,0.9494253265550829,812433-FS1-4,"DIRECT DRUG TOXICITY  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to DRUG.",DIRECT DRUG TOXICITY,DRUG,TWrex-cause
725582649,5/25/2015 21:58:16,1643173004,5/25/2015 21:57:43,False,pocketmoneygpt,0.9389,21432964,GBR,K5,Poole,109.155.122.13,no_relation,0,7,,19,11,causes,0.9494253265550829,812433-FS1-4,"DIRECT DRUG TOXICITY  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to DRUG.",DIRECT DRUG TOXICITY,DRUG,TWrex-cause
725582649,5/25/2015 22:04:09,1643174510,5/25/2015 22:03:39,False,prodege,0.7679,18793920,USA,CA,Salinas,73.162.0.87,DRUG causes DIRECT DRUG TOXICITY,0,7,,19,11,causes,0.9494253265550829,812433-FS1-4,"DIRECT DRUG TOXICITY  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to DRUG.",DIRECT DRUG TOXICITY,DRUG,TWrex-cause
725582649,5/25/2015 22:15:03,1643178024,5/25/2015 22:14:35,False,neodev,0.5387,11257883,CAN,BC,Surrey,76.77.82.83,DRUG causes DIRECT DRUG TOXICITY,0,7,,19,11,causes,0.9494253265550829,812433-FS1-4,"DIRECT DRUG TOXICITY  Although antimicrobials can damage virtually all human organ systems, the potential for toxicity varies widely from drug to DRUG.",DIRECT DRUG TOXICITY,DRUG,TWrex-cause
725582650,5/25/2015 22:35:36,1643184244,5/25/2015 22:35:25,False,neodev,0.875,11014811,GBR,G6,Hull,87.102.82.212,no_relation,146,78,,157,91,causes,0.668153104781061,813567-FS1-4,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and MONONUCLEOSIS (see information on immune hemolytic anemias)  Fever, SPLENOMEGALY and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area.",SPLENOMEGALY,MONONUCLEOSIS,TWrex-cause
725582650,5/25/2015 22:37:17,1643184812,5/25/2015 22:36:28,False,instagc,0.8190000000000001,26024737,GBR,A9,Blackpool,2.97.97.40,no_relation,146,78,,157,91,causes,0.668153104781061,813567-FS1-4,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and MONONUCLEOSIS (see information on immune hemolytic anemias)  Fever, SPLENOMEGALY and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area.",SPLENOMEGALY,MONONUCLEOSIS,TWrex-cause
725582650,5/25/2015 22:37:54,1643185042,5/25/2015 22:37:33,False,prodege,0.6256,28103910,GBR,C3,Wisbech,2.222.58.164,MONONUCLEOSIS causes SPLENOMEGALY,146,78,,157,91,causes,0.668153104781061,813567-FS1-4,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and MONONUCLEOSIS (see information on immune hemolytic anemias)  Fever, SPLENOMEGALY and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area.",SPLENOMEGALY,MONONUCLEOSIS,TWrex-cause
725582650,5/25/2015 22:38:12,1643185090,5/25/2015 22:37:24,False,elite,0.8185,30064988,GBR,H3,Leeds,92.22.210.218,no_relation,146,78,,157,91,causes,0.668153104781061,813567-FS1-4,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and MONONUCLEOSIS (see information on immune hemolytic anemias)  Fever, SPLENOMEGALY and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area.",SPLENOMEGALY,MONONUCLEOSIS,TWrex-cause
725582650,5/25/2015 22:41:23,1643186239,5/25/2015 22:40:38,False,clixsense,0.7052,22947672,GBR,,,88.144.128.65,no_relation,146,78,,157,91,causes,0.668153104781061,813567-FS1-4,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and MONONUCLEOSIS (see information on immune hemolytic anemias)  Fever, SPLENOMEGALY and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area.",SPLENOMEGALY,MONONUCLEOSIS,TWrex-cause
725582650,5/25/2015 22:44:57,1643187404,5/25/2015 22:43:59,False,neodev,0.8383,11460728,CAN,BC,Burnaby,70.79.16.165,no_relation,146,78,,157,91,causes,0.668153104781061,813567-FS1-4,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and MONONUCLEOSIS (see information on immune hemolytic anemias)  Fever, SPLENOMEGALY and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area.",SPLENOMEGALY,MONONUCLEOSIS,TWrex-cause
725582650,5/25/2015 22:54:40,1643190156,5/25/2015 22:54:08,False,instagc,0.7440000000000001,31184650,USA,IA,Mason City,173.26.27.82,no_relation,146,78,,157,91,causes,0.668153104781061,813567-FS1-4,"Some infections can induce erythrocyte autoantibodies, such as mycoplasma and MONONUCLEOSIS (see information on immune hemolytic anemias)  Fever, SPLENOMEGALY and hemolysis suggest malaria in a patient with appropriate travel history or babesiosis in an endemic area.",SPLENOMEGALY,MONONUCLEOSIS,TWrex-cause
725582653,5/25/2015 21:36:08,1643166575,5/25/2015 21:35:17,False,prodege,1.0,21417560,GBR,C3,Cambridge,151.225.116.143,IPF causes NONPRODUCTIVE COUGH,77,123,,95,126,causes,0.927172649945531,812914-FS1-4,Clinical Features  History and physical examination   The insidious onset of NONPRODUCTIVE COUGH and dyspnea characterizes IPF,NONPRODUCTIVE COUGH,IPF,TWrex-cause
725582653,5/25/2015 21:39:29,1643167567,5/25/2015 21:39:08,False,bitcoinget,0.6889,21678835,USA,OH,Ironton,76.177.160.209,no_relation,77,123,,95,126,causes,0.927172649945531,812914-FS1-4,Clinical Features  History and physical examination   The insidious onset of NONPRODUCTIVE COUGH and dyspnea characterizes IPF,NONPRODUCTIVE COUGH,IPF,TWrex-cause
725582653,5/25/2015 21:39:33,1643167589,5/25/2015 21:38:51,False,clixsense,0.7597,32254355,CAN,ON,London,50.101.209.220,NONPRODUCTIVE COUGH causes IPF,77,123,,95,126,causes,0.927172649945531,812914-FS1-4,Clinical Features  History and physical examination   The insidious onset of NONPRODUCTIVE COUGH and dyspnea characterizes IPF,NONPRODUCTIVE COUGH,IPF,TWrex-cause
725582653,5/25/2015 21:41:01,1643168168,5/25/2015 21:40:43,False,meprizescf,0.6042,28483210,USA,WI,Minocqua,75.143.134.247,IPF causes NONPRODUCTIVE COUGH,77,123,,95,126,causes,0.927172649945531,812914-FS1-4,Clinical Features  History and physical examination   The insidious onset of NONPRODUCTIVE COUGH and dyspnea characterizes IPF,NONPRODUCTIVE COUGH,IPF,TWrex-cause
725582653,5/25/2015 21:44:14,1643169015,5/25/2015 21:43:32,False,onestopgpt,0.6008,21275875,CAN,ON,Hamilton,24.36.121.10,no_relation,77,123,,95,126,causes,0.927172649945531,812914-FS1-4,Clinical Features  History and physical examination   The insidious onset of NONPRODUCTIVE COUGH and dyspnea characterizes IPF,NONPRODUCTIVE COUGH,IPF,TWrex-cause
725582653,5/25/2015 21:45:51,1643169508,5/25/2015 21:43:09,False,neodev,0.627,27667288,CAN,MB,Brandon,216.36.187.168,no_relation,77,123,,95,126,causes,0.927172649945531,812914-FS1-4,Clinical Features  History and physical examination   The insidious onset of NONPRODUCTIVE COUGH and dyspnea characterizes IPF,NONPRODUCTIVE COUGH,IPF,TWrex-cause
725582653,5/25/2015 21:46:34,1643169748,5/25/2015 21:45:20,False,points4rewards,0.6865,20113482,USA,OR,Portland,67.213.218.72,no_relation,77,123,,95,126,causes,0.927172649945531,812914-FS1-4,Clinical Features  History and physical examination   The insidious onset of NONPRODUCTIVE COUGH and dyspnea characterizes IPF,NONPRODUCTIVE COUGH,IPF,TWrex-cause
725582654,5/25/2015 21:33:52,1643165861,5/25/2015 21:33:07,False,prodege,1.0,21417560,GBR,C3,Cambridge,151.225.116.143,no_relation,190,103,,196,132,causes,0.40824829046386296,814420-FS1-4,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on POSTTRAUMATIC STRESS DISORDER from the International Consensus Group on Depression and ANXIETY",ANXIETY,POSTTRAUMATIC STRESS DISORDER,TWrex-cause
725582654,5/25/2015 21:37:12,1643166834,5/25/2015 21:36:16,False,clixsense,0.7597,32254355,CAN,ON,London,50.101.209.220,no_relation,190,103,,196,132,causes,0.40824829046386296,814420-FS1-4,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on POSTTRAUMATIC STRESS DISORDER from the International Consensus Group on Depression and ANXIETY",ANXIETY,POSTTRAUMATIC STRESS DISORDER,TWrex-cause
725582654,5/25/2015 21:37:41,1643166936,5/25/2015 21:36:49,False,bitcoinget,0.6889,21678835,USA,OH,Ironton,76.177.160.209,no_relation,190,103,,196,132,causes,0.40824829046386296,814420-FS1-4,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on POSTTRAUMATIC STRESS DISORDER from the International Consensus Group on Depression and ANXIETY",ANXIETY,POSTTRAUMATIC STRESS DISORDER,TWrex-cause
725582654,5/25/2015 21:38:24,1643167144,5/25/2015 21:36:56,False,neodev,0.627,27667288,CAN,MB,Brandon,216.36.187.168,no_relation,190,103,,196,132,causes,0.40824829046386296,814420-FS1-4,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on POSTTRAUMATIC STRESS DISORDER from the International Consensus Group on Depression and ANXIETY",ANXIETY,POSTTRAUMATIC STRESS DISORDER,TWrex-cause
725582654,5/25/2015 21:40:12,1643167800,5/25/2015 21:39:58,False,meprizescf,0.6042,28483210,USA,WI,Minocqua,75.143.134.247,POSTTRAUMATIC STRESS DISORDER causes ANXIETY,190,103,,196,132,causes,0.40824829046386296,814420-FS1-4,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on POSTTRAUMATIC STRESS DISORDER from the International Consensus Group on Depression and ANXIETY",ANXIETY,POSTTRAUMATIC STRESS DISORDER,TWrex-cause
725582654,5/25/2015 21:42:07,1643168448,5/25/2015 21:41:36,False,onestopgpt,0.6008,21275875,CAN,ON,Hamilton,24.36.121.10,ANXIETY causes POSTTRAUMATIC STRESS DISORDER,190,103,,196,132,causes,0.40824829046386296,814420-FS1-4,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on POSTTRAUMATIC STRESS DISORDER from the International Consensus Group on Depression and ANXIETY",ANXIETY,POSTTRAUMATIC STRESS DISORDER,TWrex-cause
725582654,5/25/2015 21:43:23,1643168842,5/25/2015 21:42:27,False,points4rewards,0.6865,20113482,USA,OR,Portland,67.213.218.72,no_relation,190,103,,196,132,causes,0.40824829046386296,814420-FS1-4,"3]  Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al. Consensus statement on POSTTRAUMATIC STRESS DISORDER from the International Consensus Group on Depression and ANXIETY",ANXIETY,POSTTRAUMATIC STRESS DISORDER,TWrex-cause
725582655,5/25/2015 21:48:10,1643170161,5/25/2015 21:47:59,False,instagc,0.9048,15864091,USA,OK,Oklahoma City,104.0.113.133,LARVAL TAPEWORMS causes SPARGANOSIS,0,36,,10,52,causes,0.9918365981341758,812045-FS1-4,"SPARGANOSIS represents infection by LARVAL TAPEWORMS of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium.",SPARGANOSIS,LARVAL TAPEWORMS,TWrex-cause
725582655,5/25/2015 21:59:27,1643173338,5/25/2015 21:58:57,False,pocketmoneygpt,0.9389,21432964,GBR,K5,Poole,109.155.122.13,LARVAL TAPEWORMS causes SPARGANOSIS,0,36,,10,52,causes,0.9918365981341758,812045-FS1-4,"SPARGANOSIS represents infection by LARVAL TAPEWORMS of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium.",SPARGANOSIS,LARVAL TAPEWORMS,TWrex-cause
725582655,5/25/2015 22:05:14,1643174792,5/25/2015 22:04:49,False,prodege,0.7679,18793920,USA,CA,Salinas,73.162.0.87,SPARGANOSIS causes LARVAL TAPEWORMS,0,36,,10,52,causes,0.9918365981341758,812045-FS1-4,"SPARGANOSIS represents infection by LARVAL TAPEWORMS of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium.",SPARGANOSIS,LARVAL TAPEWORMS,TWrex-cause
725582655,5/25/2015 22:15:38,1643178211,5/25/2015 22:15:23,False,neodev,0.8444,31326282,NLD,,,82.169.243.65,SPARGANOSIS causes LARVAL TAPEWORMS,0,36,,10,52,causes,0.9918365981341758,812045-FS1-4,"SPARGANOSIS represents infection by LARVAL TAPEWORMS of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium.",SPARGANOSIS,LARVAL TAPEWORMS,TWrex-cause
725582655,5/25/2015 22:18:17,1643179062,5/25/2015 22:15:54,False,neodev,0.5387,11257883,CAN,BC,Surrey,76.77.82.83,LARVAL TAPEWORMS causes SPARGANOSIS,0,36,,10,52,causes,0.9918365981341758,812045-FS1-4,"SPARGANOSIS represents infection by LARVAL TAPEWORMS of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium.",SPARGANOSIS,LARVAL TAPEWORMS,TWrex-cause
725582655,5/25/2015 22:25:35,1643181107,5/25/2015 22:25:15,False,clixsense,0.7556,28351359,GBR,H9,London,80.43.180.102,LARVAL TAPEWORMS causes SPARGANOSIS,0,36,,10,52,causes,0.9918365981341758,812045-FS1-4,"SPARGANOSIS represents infection by LARVAL TAPEWORMS of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium.",SPARGANOSIS,LARVAL TAPEWORMS,TWrex-cause
725582655,5/25/2015 22:32:10,1643183230,5/25/2015 22:31:32,False,superrewards,0.7119,24796792,USA,NY,New York,72.80.63.240,LARVAL TAPEWORMS causes SPARGANOSIS,0,36,,10,52,causes,0.9918365981341758,812045-FS1-4,"SPARGANOSIS represents infection by LARVAL TAPEWORMS of the genus  Spirometra , which are closely related to tapeworms of the genus  Diphyllobothrium.",SPARGANOSIS,LARVAL TAPEWORMS,TWrex-cause
725582657,5/25/2015 21:47:58,1643170130,5/25/2015 21:47:29,False,instagc,0.9048,15864091,USA,OK,Oklahoma City,104.0.113.133,no_relation,76,154,,114,165,causes,0.30151134457776396,804941-FS1-4,"A randomized, placebo controlled trial of propafenone in the prophylaxis of PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA and paroxysmal atrial fibrillation.UK PROPAFENONE PSVT Study Group:  Circulation 92:2550, 1995  17.",PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,PROPAFENONE,TWrex-cause
725582657,5/25/2015 21:58:55,1643173169,5/25/2015 21:58:16,False,pocketmoneygpt,0.9389,21432964,GBR,K5,Poole,109.155.122.13,no_relation,76,154,,114,165,causes,0.30151134457776396,804941-FS1-4,"A randomized, placebo controlled trial of propafenone in the prophylaxis of PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA and paroxysmal atrial fibrillation.UK PROPAFENONE PSVT Study Group:  Circulation 92:2550, 1995  17.",PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,PROPAFENONE,TWrex-cause
725582657,5/25/2015 22:04:47,1643174644,5/25/2015 22:04:11,False,prodege,0.7679,18793920,USA,CA,Salinas,73.162.0.87,no_relation,76,154,,114,165,causes,0.30151134457776396,804941-FS1-4,"A randomized, placebo controlled trial of propafenone in the prophylaxis of PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA and paroxysmal atrial fibrillation.UK PROPAFENONE PSVT Study Group:  Circulation 92:2550, 1995  17.",PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,PROPAFENONE,TWrex-cause
725582657,5/25/2015 22:15:22,1643178122,5/25/2015 22:14:57,False,neodev,0.8444,31326282,NLD,,,82.169.243.65,no_relation,76,154,,114,165,causes,0.30151134457776396,804941-FS1-4,"A randomized, placebo controlled trial of propafenone in the prophylaxis of PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA and paroxysmal atrial fibrillation.UK PROPAFENONE PSVT Study Group:  Circulation 92:2550, 1995  17.",PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,PROPAFENONE,TWrex-cause
725582657,5/25/2015 22:15:53,1643178233,5/25/2015 22:15:04,False,neodev,0.5387,11257883,CAN,BC,Surrey,76.77.82.83,no_relation,76,154,,114,165,causes,0.30151134457776396,804941-FS1-4,"A randomized, placebo controlled trial of propafenone in the prophylaxis of PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA and paroxysmal atrial fibrillation.UK PROPAFENONE PSVT Study Group:  Circulation 92:2550, 1995  17.",PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,PROPAFENONE,TWrex-cause
725582657,5/25/2015 22:25:13,1643180994,5/25/2015 22:24:46,False,clixsense,0.7556,28351359,GBR,H9,London,80.43.180.102,no_relation,76,154,,114,165,causes,0.30151134457776396,804941-FS1-4,"A randomized, placebo controlled trial of propafenone in the prophylaxis of PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA and paroxysmal atrial fibrillation.UK PROPAFENONE PSVT Study Group:  Circulation 92:2550, 1995  17.",PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,PROPAFENONE,TWrex-cause
725582657,5/25/2015 22:39:36,1643185607,5/25/2015 22:38:38,False,clixsense,0.7052,22947672,GBR,,,88.144.128.65,no_relation,76,154,,114,165,causes,0.30151134457776396,804941-FS1-4,"A randomized, placebo controlled trial of propafenone in the prophylaxis of PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA and paroxysmal atrial fibrillation.UK PROPAFENONE PSVT Study Group:  Circulation 92:2550, 1995  17.",PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,PROPAFENONE,TWrex-cause
725582658,5/25/2015 22:41:18,1643186216,5/25/2015 22:40:12,False,elite,0.8185,30064988,GBR,H3,Leeds,92.22.210.218,ENTEROVIRUSES causes EPIDEMIC PLEURODYNIA,0,113,,19,126,causes,0.99654575824488,810784-FS1-4,"EPIDEMIC PLEURODYNIA hand foot and mouth disease, herpangina, and poliomyelitis are caused almost exclusively by ENTEROVIRUSES",EPIDEMIC PLEURODYNIA,ENTEROVIRUSES,TWrex-cause
725582658,5/25/2015 22:44:17,1643187219,5/25/2015 22:42:56,False,clixsense,0.7052,22947672,GBR,,,88.144.128.65,ENTEROVIRUSES causes EPIDEMIC PLEURODYNIA,0,113,,19,126,causes,0.99654575824488,810784-FS1-4,"EPIDEMIC PLEURODYNIA hand foot and mouth disease, herpangina, and poliomyelitis are caused almost exclusively by ENTEROVIRUSES",EPIDEMIC PLEURODYNIA,ENTEROVIRUSES,TWrex-cause
725582658,5/25/2015 22:46:25,1643187819,5/25/2015 22:45:41,False,neodev,0.8383,11460728,CAN,BC,Burnaby,70.79.16.165,ENTEROVIRUSES causes EPIDEMIC PLEURODYNIA,0,113,,19,126,causes,0.99654575824488,810784-FS1-4,"EPIDEMIC PLEURODYNIA hand foot and mouth disease, herpangina, and poliomyelitis are caused almost exclusively by ENTEROVIRUSES",EPIDEMIC PLEURODYNIA,ENTEROVIRUSES,TWrex-cause
725582658,5/25/2015 22:46:41,1643187895,5/25/2015 22:46:32,False,neodev,0.2875,31789301,USA,NY,New York,162.243.173.22,EPIDEMIC PLEURODYNIA causes ENTEROVIRUSES,0,113,,19,126,causes,0.99654575824488,810784-FS1-4,"EPIDEMIC PLEURODYNIA hand foot and mouth disease, herpangina, and poliomyelitis are caused almost exclusively by ENTEROVIRUSES",EPIDEMIC PLEURODYNIA,ENTEROVIRUSES,TWrex-cause
725582658,5/25/2015 22:48:00,1643188336,5/25/2015 22:46:49,False,zoombucks,0.8429,6744840,CAN,BC,Kelowna,174.4.58.160,ENTEROVIRUSES causes EPIDEMIC PLEURODYNIA,0,113,,19,126,causes,0.99654575824488,810784-FS1-4,"EPIDEMIC PLEURODYNIA hand foot and mouth disease, herpangina, and poliomyelitis are caused almost exclusively by ENTEROVIRUSES",EPIDEMIC PLEURODYNIA,ENTEROVIRUSES,TWrex-cause
725582658,5/25/2015 22:49:53,1643188831,5/25/2015 22:49:40,False,neodev,0.4444,30504276,CAN,ON,Sudbury,66.103.55.12,ENTEROVIRUSES causes EPIDEMIC PLEURODYNIA,0,113,,19,126,causes,0.99654575824488,810784-FS1-4,"EPIDEMIC PLEURODYNIA hand foot and mouth disease, herpangina, and poliomyelitis are caused almost exclusively by ENTEROVIRUSES",EPIDEMIC PLEURODYNIA,ENTEROVIRUSES,TWrex-cause
725582658,5/25/2015 22:52:39,1643189600,5/25/2015 22:51:48,False,bitcoinget,0.7057,28503763,USA,CA,San Francisco,107.217.186.64,ENTEROVIRUSES causes EPIDEMIC PLEURODYNIA,0,113,,19,126,causes,0.99654575824488,810784-FS1-4,"EPIDEMIC PLEURODYNIA hand foot and mouth disease, herpangina, and poliomyelitis are caused almost exclusively by ENTEROVIRUSES",EPIDEMIC PLEURODYNIA,ENTEROVIRUSES,TWrex-cause
725582661,5/25/2015 22:16:46,1643178541,5/25/2015 22:16:34,False,neodev,0.8444,31326282,NLD,,,82.169.243.65,AIP causes SEIZURES,43,17,,50,20,causes,0.4472135954999579,814789-FS1-4,"Acute attacks of AIP may be accompanied by SEIZURES especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH.",SEIZURES,AIP,TWrex-cause
725582661,5/25/2015 22:27:16,1643181715,5/25/2015 22:26:49,False,clixsense,0.7556,28351359,GBR,H9,London,80.43.180.102,AIP causes SEIZURES,43,17,,50,20,causes,0.4472135954999579,814789-FS1-4,"Acute attacks of AIP may be accompanied by SEIZURES especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH.",SEIZURES,AIP,TWrex-cause
725582661,5/25/2015 22:35:02,1643184128,5/25/2015 22:34:47,False,superrewards,0.7119,24796792,USA,NY,New York,72.80.63.240,AIP causes SEIZURES,43,17,,50,20,causes,0.4472135954999579,814789-FS1-4,"Acute attacks of AIP may be accompanied by SEIZURES especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH.",SEIZURES,AIP,TWrex-cause
725582661,5/25/2015 22:35:08,1643184141,5/25/2015 22:34:36,False,neodev,0.875,11014811,GBR,G6,Hull,87.102.82.212,AIP causes SEIZURES,43,17,,50,20,causes,0.4472135954999579,814789-FS1-4,"Acute attacks of AIP may be accompanied by SEIZURES especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH.",SEIZURES,AIP,TWrex-cause
725582661,5/25/2015 22:36:13,1643184477,5/25/2015 22:36:01,False,instagc,0.8190000000000001,26024737,GBR,A9,Blackpool,2.97.97.40,AIP causes SEIZURES,43,17,,50,20,causes,0.4472135954999579,814789-FS1-4,"Acute attacks of AIP may be accompanied by SEIZURES especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH.",SEIZURES,AIP,TWrex-cause
725582661,5/25/2015 22:36:28,1643184561,5/25/2015 22:35:41,False,elite,0.8185,30064988,GBR,H3,Leeds,92.22.210.218,no_relation,43,17,,50,20,causes,0.4472135954999579,814789-FS1-4,"Acute attacks of AIP may be accompanied by SEIZURES especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH.",SEIZURES,AIP,TWrex-cause
725582661,5/25/2015 22:36:57,1643184761,5/25/2015 22:36:31,False,prodege,0.6256,28103910,GBR,C3,Wisbech,2.222.58.164,AIP causes SEIZURES,43,17,,50,20,causes,0.4472135954999579,814789-FS1-4,"Acute attacks of AIP may be accompanied by SEIZURES especially in patients with hyponatremia caused by vomiting, inappropriate fluid therapy, or the syndrome of inappropriate antidiuretic hormone (SIADH.",SEIZURES,AIP,TWrex-cause
788211721,9/14/2015 17:19:34,1737993569,9/14/2015 17:19:27,False,instagc,0.9267,16469970,USA,OK,Broken Arrow,72.192.89.181,PYRAZINOIC ACID AMIDE treats TUBERCULOSIS (TB),162,69,,178,90,treats,0.9704949588309459,803518,124  Class:  Antituberculosis Agents 8:16.04; AM500 (VA)  Synonyms:  PYRAZINOIC ACID AMIDE; Rifater; Tebrazid  Uses  Tuberculosis  Treatment of active (clinical) TUBERCULOSIS (TB) in conjunction with other antituberculosis agents.,TUBERCULOSIS (TB),PYRAZINOIC ACID AMIDE,TWrex-cause
788211721,9/14/2015 17:23:23,1737995633,9/14/2015 17:22:35,False,clixsense,0.9226,6338159,CAN,ON,Ottawa,108.168.124.170,PYRAZINOIC ACID AMIDE treats TUBERCULOSIS (TB),162,69,,178,90,treats,0.9704949588309459,803518,124  Class:  Antituberculosis Agents 8:16.04; AM500 (VA)  Synonyms:  PYRAZINOIC ACID AMIDE; Rifater; Tebrazid  Uses  Tuberculosis  Treatment of active (clinical) TUBERCULOSIS (TB) in conjunction with other antituberculosis agents.,TUBERCULOSIS (TB),PYRAZINOIC ACID AMIDE,TWrex-cause
788211721,9/14/2015 17:28:58,1737997939,9/14/2015 17:28:34,False,neodev,0.9246,11014811,GBR,G6,Hull,87.102.82.212,PYRAZINOIC ACID AMIDE treats TUBERCULOSIS (TB),162,69,,178,90,treats,0.9704949588309459,803518,124  Class:  Antituberculosis Agents 8:16.04; AM500 (VA)  Synonyms:  PYRAZINOIC ACID AMIDE; Rifater; Tebrazid  Uses  Tuberculosis  Treatment of active (clinical) TUBERCULOSIS (TB) in conjunction with other antituberculosis agents.,TUBERCULOSIS (TB),PYRAZINOIC ACID AMIDE,TWrex-cause
788211721,9/14/2015 17:34:44,1738000806,9/14/2015 17:34:16,False,neodev,0.9583,12115558,USA,OH,Twinsburg,98.27.164.131,PYRAZINOIC ACID AMIDE treats TUBERCULOSIS (TB),162,69,,178,90,treats,0.9704949588309459,803518,124  Class:  Antituberculosis Agents 8:16.04; AM500 (VA)  Synonyms:  PYRAZINOIC ACID AMIDE; Rifater; Tebrazid  Uses  Tuberculosis  Treatment of active (clinical) TUBERCULOSIS (TB) in conjunction with other antituberculosis agents.,TUBERCULOSIS (TB),PYRAZINOIC ACID AMIDE,TWrex-cause
788211721,9/14/2015 17:35:15,1738001046,9/14/2015 17:35:07,False,instagc,0.95,15577915,USA,IL,Trenton,208.70.36.12,PYRAZINOIC ACID AMIDE treats TUBERCULOSIS (TB),162,69,,178,90,treats,0.9704949588309459,803518,124  Class:  Antituberculosis Agents 8:16.04; AM500 (VA)  Synonyms:  PYRAZINOIC ACID AMIDE; Rifater; Tebrazid  Uses  Tuberculosis  Treatment of active (clinical) TUBERCULOSIS (TB) in conjunction with other antituberculosis agents.,TUBERCULOSIS (TB),PYRAZINOIC ACID AMIDE,TWrex-cause
788211721,9/14/2015 17:39:09,1738003384,9/14/2015 17:38:48,False,inboxpounds,0.7917,34449186,GBR,H9,London,82.23.2.74,TUBERCULOSIS (TB) treats PYRAZINOIC ACID AMIDE,162,69,,178,90,treats,0.9704949588309459,803518,124  Class:  Antituberculosis Agents 8:16.04; AM500 (VA)  Synonyms:  PYRAZINOIC ACID AMIDE; Rifater; Tebrazid  Uses  Tuberculosis  Treatment of active (clinical) TUBERCULOSIS (TB) in conjunction with other antituberculosis agents.,TUBERCULOSIS (TB),PYRAZINOIC ACID AMIDE,TWrex-cause
788211721,9/14/2015 17:50:54,1738009077,9/14/2015 17:50:00,False,neodev,0.6577,34281269,USA,VA,Mclean,63.141.204.170,PYRAZINOIC ACID AMIDE treats TUBERCULOSIS (TB),162,69,,178,90,treats,0.9704949588309459,803518,124  Class:  Antituberculosis Agents 8:16.04; AM500 (VA)  Synonyms:  PYRAZINOIC ACID AMIDE; Rifater; Tebrazid  Uses  Tuberculosis  Treatment of active (clinical) TUBERCULOSIS (TB) in conjunction with other antituberculosis agents.,TUBERCULOSIS (TB),PYRAZINOIC ACID AMIDE,TWrex-cause
788211727,9/14/2015 18:37:07,1738034775,9/14/2015 18:36:37,False,instagc,0.748,33058612,USA,IL,Glenview,162.229.106.229,no_relation,82,0,,90,16,treats,0.9113223768657671,803224,PROPYLTHIOURACIL may be preferred if antithyroid drug therapy must be used during PREGNANCY or breastfeeding because it is less likely to cross the placenta or enter breast milk.,PREGNANCY,PROPYLTHIOURACIL,TWrex-cause
788211727,9/14/2015 19:24:58,1738103262,9/14/2015 19:24:42,False,clixsense,0.7806,19638651,USA,SC,Summerville,174.107.73.211,no_relation,82,0,,90,16,treats,0.9113223768657671,803224,PROPYLTHIOURACIL may be preferred if antithyroid drug therapy must be used during PREGNANCY or breastfeeding because it is less likely to cross the placenta or enter breast milk.,PREGNANCY,PROPYLTHIOURACIL,TWrex-cause
788211727,9/14/2015 19:29:19,1738109432,9/14/2015 19:29:09,False,instagc,0.7604,32352104,USA,ME,Bangor,74.75.63.81,no_relation,82,0,,90,16,treats,0.9113223768657671,803224,PROPYLTHIOURACIL may be preferred if antithyroid drug therapy must be used during PREGNANCY or breastfeeding because it is less likely to cross the placenta or enter breast milk.,PREGNANCY,PROPYLTHIOURACIL,TWrex-cause
788211727,9/14/2015 19:36:38,1738119712,9/14/2015 19:36:13,False,clixsense,0.8881,11106820,USA,MA,Taunton,173.48.52.95,no_relation,82,0,,90,16,treats,0.9113223768657671,803224,PROPYLTHIOURACIL may be preferred if antithyroid drug therapy must be used during PREGNANCY or breastfeeding because it is less likely to cross the placenta or enter breast milk.,PREGNANCY,PROPYLTHIOURACIL,TWrex-cause
788211727,9/14/2015 19:46:37,1738133101,9/14/2015 19:46:18,False,clixsense,0.8333,21665495,CAN,,,24.105.69.70,no_relation,82,0,,90,16,treats,0.9113223768657671,803224,PROPYLTHIOURACIL may be preferred if antithyroid drug therapy must be used during PREGNANCY or breastfeeding because it is less likely to cross the placenta or enter breast milk.,PREGNANCY,PROPYLTHIOURACIL,TWrex-cause
788211727,9/14/2015 19:51:20,1738138927,9/14/2015 19:50:33,False,instagc,1.0,21467491,USA,PA,Erie,24.165.145.54,no_relation,82,0,,90,16,treats,0.9113223768657671,803224,PROPYLTHIOURACIL may be preferred if antithyroid drug therapy must be used during PREGNANCY or breastfeeding because it is less likely to cross the placenta or enter breast milk.,PREGNANCY,PROPYLTHIOURACIL,TWrex-cause
788211727,9/14/2015 19:53:00,1738140947,9/14/2015 19:52:41,False,zoombucks,0.7321,4688131,CAN,BC,Vancouver,216.251.132.22,no_relation,82,0,,90,16,treats,0.9113223768657671,803224,PROPYLTHIOURACIL may be preferred if antithyroid drug therapy must be used during PREGNANCY or breastfeeding because it is less likely to cross the placenta or enter breast milk.,PREGNANCY,PROPYLTHIOURACIL,TWrex-cause
788211729,9/14/2015 15:04:27,1737926715,9/14/2015 15:04:07,False,prodege,0.8889,24403612,CAN,ON,Ajax,99.239.181.149,IRON treats IRON DEFICIENCY ANEMIA,0,0,,21,4,treats,0.9918365981341751,804747,IRON DEFICIENCY ANEMIA may require supplemental IRON,IRON DEFICIENCY ANEMIA,IRON,TWrex-cause
788211729,9/14/2015 15:09:22,1737928836,9/14/2015 15:08:39,False,neodev,0.7986,33758777,USA,,,38.95.108.251,no_relation,0,0,,21,4,treats,0.9918365981341751,804747,IRON DEFICIENCY ANEMIA may require supplemental IRON,IRON DEFICIENCY ANEMIA,IRON,TWrex-cause
788211729,9/14/2015 15:09:31,1737928905,9/14/2015 15:07:26,False,points4rewards,0.8165,20113482,USA,PA,Philadelphia,162.208.49.45,IRON treats IRON DEFICIENCY ANEMIA,0,0,,21,4,treats,0.9918365981341751,804747,IRON DEFICIENCY ANEMIA may require supplemental IRON,IRON DEFICIENCY ANEMIA,IRON,TWrex-cause
788211729,9/14/2015 15:13:13,1737930496,9/14/2015 15:13:01,False,meprizescf,0.8115,28483210,USA,WI,Minocqua,75.143.134.247,no_relation,0,0,,21,4,treats,0.9918365981341751,804747,IRON DEFICIENCY ANEMIA may require supplemental IRON,IRON DEFICIENCY ANEMIA,IRON,TWrex-cause
788211729,9/14/2015 15:14:22,1737930954,9/14/2015 15:13:35,False,prodege,0.7778,21417560,GBR,C3,Cambridge,151.224.120.191,IRON treats IRON DEFICIENCY ANEMIA,0,0,,21,4,treats,0.9918365981341751,804747,IRON DEFICIENCY ANEMIA may require supplemental IRON,IRON DEFICIENCY ANEMIA,IRON,TWrex-cause
788211729,9/14/2015 15:15:25,1737931461,9/14/2015 15:15:05,False,dailyrewardsca,0.7867,32219778,CAN,ON,Ottawa,99.241.19.27,IRON treats IRON DEFICIENCY ANEMIA,0,0,,21,4,treats,0.9918365981341751,804747,IRON DEFICIENCY ANEMIA may require supplemental IRON,IRON DEFICIENCY ANEMIA,IRON,TWrex-cause
788211729,9/14/2015 15:19:05,1737933472,9/14/2015 15:17:54,False,clixsense,0.7252,21875134,GBR,,,80.189.12.98,IRON treats IRON DEFICIENCY ANEMIA,0,0,,21,4,treats,0.9918365981341751,804747,IRON DEFICIENCY ANEMIA may require supplemental IRON,IRON DEFICIENCY ANEMIA,IRON,TWrex-cause
788211730,9/14/2015 15:01:07,1737925233,9/14/2015 14:59:20,False,neodev,0.8036,33238512,GBR,C5,Runcorn,109.147.217.212,THERAPY WITH WARFARIN T treats ENOUS THROMBOSIS I,111,49,,128,72,treats,0.997785157856609,800003, A randomized controlled trial comparing heparin THERAPY WITH WARFARIN Therapy for the long term treatment of vENOUS THROMBOSIS In 106 nonpregnant patients found that adjusted dose subcutaneous heparin therapy provides an effective alternative to warfarin and is associated with a lower risk of bleeding ( 109.,ENOUS THROMBOSIS I,THERAPY WITH WARFARIN T,TWrex-cause
788211730,9/14/2015 15:04:06,1737926564,9/14/2015 15:03:21,False,prodege,0.8889,24403612,CAN,ON,Ajax,99.239.181.149,THERAPY WITH WARFARIN T treats ENOUS THROMBOSIS I,111,49,,128,72,treats,0.997785157856609,800003, A randomized controlled trial comparing heparin THERAPY WITH WARFARIN Therapy for the long term treatment of vENOUS THROMBOSIS In 106 nonpregnant patients found that adjusted dose subcutaneous heparin therapy provides an effective alternative to warfarin and is associated with a lower risk of bleeding ( 109.,ENOUS THROMBOSIS I,THERAPY WITH WARFARIN T,TWrex-cause
788211730,9/14/2015 15:07:02,1737927840,9/14/2015 15:06:02,False,neodev,0.7986,33758777,USA,,,38.95.108.251,THERAPY WITH WARFARIN T treats ENOUS THROMBOSIS I,111,49,,128,72,treats,0.997785157856609,800003, A randomized controlled trial comparing heparin THERAPY WITH WARFARIN Therapy for the long term treatment of vENOUS THROMBOSIS In 106 nonpregnant patients found that adjusted dose subcutaneous heparin therapy provides an effective alternative to warfarin and is associated with a lower risk of bleeding ( 109.,ENOUS THROMBOSIS I,THERAPY WITH WARFARIN T,TWrex-cause
788211730,9/14/2015 15:07:23,1737927974,9/14/2015 15:05:20,False,points4rewards,0.8165,20113482,USA,PA,Philadelphia,162.208.49.45,THERAPY WITH WARFARIN T treats ENOUS THROMBOSIS I,111,49,,128,72,treats,0.997785157856609,800003, A randomized controlled trial comparing heparin THERAPY WITH WARFARIN Therapy for the long term treatment of vENOUS THROMBOSIS In 106 nonpregnant patients found that adjusted dose subcutaneous heparin therapy provides an effective alternative to warfarin and is associated with a lower risk of bleeding ( 109.,ENOUS THROMBOSIS I,THERAPY WITH WARFARIN T,TWrex-cause
788211730,9/14/2015 15:13:00,1737930420,9/14/2015 15:12:38,False,meprizescf,0.8115,28483210,USA,WI,Minocqua,75.143.134.247,THERAPY WITH WARFARIN T treats ENOUS THROMBOSIS I,111,49,,128,72,treats,0.997785157856609,800003, A randomized controlled trial comparing heparin THERAPY WITH WARFARIN Therapy for the long term treatment of vENOUS THROMBOSIS In 106 nonpregnant patients found that adjusted dose subcutaneous heparin therapy provides an effective alternative to warfarin and is associated with a lower risk of bleeding ( 109.,ENOUS THROMBOSIS I,THERAPY WITH WARFARIN T,TWrex-cause
788211730,9/14/2015 15:13:34,1737930657,9/14/2015 15:12:10,False,prodege,0.7778,21417560,GBR,C3,Cambridge,151.224.120.191,THERAPY WITH WARFARIN T treats ENOUS THROMBOSIS I,111,49,,128,72,treats,0.997785157856609,800003, A randomized controlled trial comparing heparin THERAPY WITH WARFARIN Therapy for the long term treatment of vENOUS THROMBOSIS In 106 nonpregnant patients found that adjusted dose subcutaneous heparin therapy provides an effective alternative to warfarin and is associated with a lower risk of bleeding ( 109.,ENOUS THROMBOSIS I,THERAPY WITH WARFARIN T,TWrex-cause
788211730,9/14/2015 15:15:05,1737931327,9/14/2015 15:14:43,False,dailyrewardsca,0.7867,32219778,CAN,ON,Ottawa,99.241.19.27,THERAPY WITH WARFARIN T treats ENOUS THROMBOSIS I,111,49,,128,72,treats,0.997785157856609,800003, A randomized controlled trial comparing heparin THERAPY WITH WARFARIN Therapy for the long term treatment of vENOUS THROMBOSIS In 106 nonpregnant patients found that adjusted dose subcutaneous heparin therapy provides an effective alternative to warfarin and is associated with a lower risk of bleeding ( 109.,ENOUS THROMBOSIS I,THERAPY WITH WARFARIN T,TWrex-cause
788211748,9/14/2015 15:45:11,1737945470,9/14/2015 15:44:50,False,instagc,0.8583,30398579,USA,MA,Winchendon,73.38.174.116,no_relation,4,63,,25,86,treats,0.39823398695998297,811236,24  CLOSTRIDIUM INFECTIONS  Treatment of infections caused by  CLOSTRIDIUM PERFRINGENS    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections.,CLOSTRIDIUM INFECTIONS,CLOSTRIDIUM PERFRINGENS,TWrex-cause
788211748,9/14/2015 15:52:28,1737949609,9/14/2015 15:52:12,False,clixsense,0.7341,10390268,USA,NY,New Paltz,100.40.136.250,no_relation,4,63,,25,86,treats,0.39823398695998297,811236,24  CLOSTRIDIUM INFECTIONS  Treatment of infections caused by  CLOSTRIDIUM PERFRINGENS    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections.,CLOSTRIDIUM INFECTIONS,CLOSTRIDIUM PERFRINGENS,TWrex-cause
788211748,9/14/2015 15:55:33,1737951195,9/14/2015 15:54:51,False,bitcoinget,0.8714,21743413,USA,WA,Port Angeles,24.113.29.97,no_relation,4,63,,25,86,treats,0.39823398695998297,811236,24  CLOSTRIDIUM INFECTIONS  Treatment of infections caused by  CLOSTRIDIUM PERFRINGENS    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections.,CLOSTRIDIUM INFECTIONS,CLOSTRIDIUM PERFRINGENS,TWrex-cause
788211748,9/14/2015 16:08:19,1737957373,9/14/2015 16:07:15,False,neodev,0.8464,13253916,GBR,K4,Plymouth,92.17.245.86,no_relation,4,63,,25,86,treats,0.39823398695998297,811236,24  CLOSTRIDIUM INFECTIONS  Treatment of infections caused by  CLOSTRIDIUM PERFRINGENS    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections.,CLOSTRIDIUM INFECTIONS,CLOSTRIDIUM PERFRINGENS,TWrex-cause
788211748,9/14/2015 16:08:25,1737957446,9/14/2015 16:07:49,False,instagc,0.8659,31888345,USA,CA,Hayward,24.7.3.180,CLOSTRIDIUM PERFRINGENS treats CLOSTRIDIUM INFECTIONS,4,63,,25,86,treats,0.39823398695998297,811236,24  CLOSTRIDIUM INFECTIONS  Treatment of infections caused by  CLOSTRIDIUM PERFRINGENS    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections.,CLOSTRIDIUM INFECTIONS,CLOSTRIDIUM PERFRINGENS,TWrex-cause
788211748,9/14/2015 16:15:07,1737960494,9/14/2015 16:14:18,False,clixsense,0.8958,9001027,CAN,QC,Dollard-des-ormeaux,96.21.122.219,no_relation,4,63,,25,86,treats,0.39823398695998297,811236,24  CLOSTRIDIUM INFECTIONS  Treatment of infections caused by  CLOSTRIDIUM PERFRINGENS    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections.,CLOSTRIDIUM INFECTIONS,CLOSTRIDIUM PERFRINGENS,TWrex-cause
788211748,9/14/2015 16:20:28,1737963490,9/14/2015 16:20:02,False,prodege,0.904,22031444,GBR,M4,Southampton,80.44.195.214,no_relation,4,63,,25,86,treats,0.39823398695998297,811236,24  CLOSTRIDIUM INFECTIONS  Treatment of infections caused by  CLOSTRIDIUM PERFRINGENS    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections.,CLOSTRIDIUM INFECTIONS,CLOSTRIDIUM PERFRINGENS,TWrex-cause
788211750,9/14/2015 16:09:17,1737957934,9/14/2015 16:09:01,False,instagc,0.8659,31888345,USA,CA,Hayward,24.7.3.180,AMPHOTERICIN B treats COCCIDIOIDOMYCOSIS,114,18,,131,32,treats,0.9434563530497271,803451,441  Conventional AMPHOTERICIN B in HIV infected adolescents with diffuse pulmonary or extrathoracic disseminated COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.,COCCIDIOIDOMYCOSIS,AMPHOTERICIN B,TWrex-cause
788211750,9/14/2015 16:10:27,1737958456,9/14/2015 16:09:42,False,neodev,0.8464,13253916,GBR,K4,Plymouth,92.17.245.86,no_relation,114,18,,131,32,treats,0.9434563530497271,803451,441  Conventional AMPHOTERICIN B in HIV infected adolescents with diffuse pulmonary or extrathoracic disseminated COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.,COCCIDIOIDOMYCOSIS,AMPHOTERICIN B,TWrex-cause
788211750,9/14/2015 16:21:42,1737963987,9/14/2015 16:21:12,False,prodege,0.904,22031444,GBR,M4,Southampton,80.44.195.214,no_relation,114,18,,131,32,treats,0.9434563530497271,803451,441  Conventional AMPHOTERICIN B in HIV infected adolescents with diffuse pulmonary or extrathoracic disseminated COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.,COCCIDIOIDOMYCOSIS,AMPHOTERICIN B,TWrex-cause
788211750,9/14/2015 16:35:10,1737970462,9/14/2015 16:35:02,False,elite,0.25,33798502,USA,DE,,108.59.8.218,COCCIDIOIDOMYCOSIS treats AMPHOTERICIN B,114,18,,131,32,treats,0.9434563530497271,803451,441  Conventional AMPHOTERICIN B in HIV infected adolescents with diffuse pulmonary or extrathoracic disseminated COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.,COCCIDIOIDOMYCOSIS,AMPHOTERICIN B,TWrex-cause
788211750,9/14/2015 16:45:27,1737975440,9/14/2015 16:44:42,False,clixsense,0.8889,31813170,GBR,I7,Newcastle Upon Tyne,151.227.167.232,AMPHOTERICIN B treats COCCIDIOIDOMYCOSIS,114,18,,131,32,treats,0.9434563530497271,803451,441  Conventional AMPHOTERICIN B in HIV infected adolescents with diffuse pulmonary or extrathoracic disseminated COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.,COCCIDIOIDOMYCOSIS,AMPHOTERICIN B,TWrex-cause
788211750,9/14/2015 16:45:34,1737975495,9/14/2015 16:45:11,False,prodege,0.9167,27934334,GBR,C8,Croydon,81.159.60.206,AMPHOTERICIN B treats COCCIDIOIDOMYCOSIS,114,18,,131,32,treats,0.9434563530497271,803451,441  Conventional AMPHOTERICIN B in HIV infected adolescents with diffuse pulmonary or extrathoracic disseminated COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.,COCCIDIOIDOMYCOSIS,AMPHOTERICIN B,TWrex-cause
788211750,9/14/2015 16:46:16,1737975824,9/14/2015 16:44:41,False,instagc,0.8373,18672993,CAN,BC,Surrey,76.77.82.83,AMPHOTERICIN B treats COCCIDIOIDOMYCOSIS,114,18,,131,32,treats,0.9434563530497271,803451,441  Conventional AMPHOTERICIN B in HIV infected adolescents with diffuse pulmonary or extrathoracic disseminated COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.,COCCIDIOIDOMYCOSIS,AMPHOTERICIN B,TWrex-cause
788211756,9/14/2015 15:42:19,1737944267,9/14/2015 15:41:43,False,neodev,0.7944,14096345,NLD,03,Eibergen,178.85.94.186,no_relation,191,102,,212,112,treats,0.993883734673619,907235,Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with RANITIDINE indicating the importance of overnight gastric acidity in the pathogenesis of DUODENAL ULCER DISEASE,DUODENAL ULCER DISEASE,RANITIDINE,RO-may_prevent
788211756,9/14/2015 15:44:01,1737945015,9/14/2015 15:43:35,False,instagc,0.8583,30398579,USA,MA,Winchendon,73.38.174.116,RANITIDINE treats DUODENAL ULCER DISEASE,191,102,,212,112,treats,0.993883734673619,907235,Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with RANITIDINE indicating the importance of overnight gastric acidity in the pathogenesis of DUODENAL ULCER DISEASE,DUODENAL ULCER DISEASE,RANITIDINE,RO-may_prevent
788211756,9/14/2015 15:51:52,1737949281,9/14/2015 15:51:29,False,clixsense,0.7341,10390268,USA,NY,New Paltz,100.40.136.250,RANITIDINE treats DUODENAL ULCER DISEASE,191,102,,212,112,treats,0.993883734673619,907235,Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with RANITIDINE indicating the importance of overnight gastric acidity in the pathogenesis of DUODENAL ULCER DISEASE,DUODENAL ULCER DISEASE,RANITIDINE,RO-may_prevent
788211756,9/14/2015 15:52:43,1737949719,9/14/2015 15:52:12,False,neodev,0.5595,33761260,USA,DE,,108.59.8.210,RANITIDINE treats DUODENAL ULCER DISEASE,191,102,,212,112,treats,0.993883734673619,907235,Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with RANITIDINE indicating the importance of overnight gastric acidity in the pathogenesis of DUODENAL ULCER DISEASE,DUODENAL ULCER DISEASE,RANITIDINE,RO-may_prevent
788211756,9/14/2015 15:54:23,1737950637,9/14/2015 15:53:47,False,bitcoinget,0.8714,21743413,USA,WA,Port Angeles,24.113.29.97,RANITIDINE treats DUODENAL ULCER DISEASE,191,102,,212,112,treats,0.993883734673619,907235,Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with RANITIDINE indicating the importance of overnight gastric acidity in the pathogenesis of DUODENAL ULCER DISEASE,DUODENAL ULCER DISEASE,RANITIDINE,RO-may_prevent
788211756,9/14/2015 16:06:08,1737956362,9/14/2015 16:05:05,False,neodev,0.8464,13253916,GBR,K4,Plymouth,92.17.245.86,RANITIDINE treats DUODENAL ULCER DISEASE,191,102,,212,112,treats,0.993883734673619,907235,Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with RANITIDINE indicating the importance of overnight gastric acidity in the pathogenesis of DUODENAL ULCER DISEASE,DUODENAL ULCER DISEASE,RANITIDINE,RO-may_prevent
788211756,9/14/2015 16:07:48,1737957124,9/14/2015 16:07:17,False,instagc,0.8659,31888345,USA,CA,Hayward,24.7.3.180,RANITIDINE treats DUODENAL ULCER DISEASE,191,102,,212,112,treats,0.993883734673619,907235,Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with RANITIDINE indicating the importance of overnight gastric acidity in the pathogenesis of DUODENAL ULCER DISEASE,DUODENAL ULCER DISEASE,RANITIDINE,RO-may_prevent
788211765,9/14/2015 15:21:10,1737934387,9/14/2015 15:20:55,False,zoombucks,0.9333,4711962,CAN,ON,Markham,174.88.29.138,TUBERCULIN SKIN TEST treats TUBERCULOSIS,13,78,,24,98,treats,0.42857142857142894,803036,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  TUBERCULIN SKIN TEST ;  vaccine, BCG;   Nursing Diagnoses Appendix.",TUBERCULOSIS,TUBERCULIN SKIN TEST,TWrex-cause
788211765,9/14/2015 15:23:22,1737935406,9/14/2015 15:21:55,False,clixsense,0.7857,24170547,USA,NJ,Clementon,71.168.241.145,no_relation,13,78,,24,98,treats,0.42857142857142894,803036,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  TUBERCULIN SKIN TEST ;  vaccine, BCG;   Nursing Diagnoses Appendix.",TUBERCULOSIS,TUBERCULIN SKIN TEST,TWrex-cause
788211765,9/14/2015 15:26:57,1737936883,9/14/2015 15:26:27,False,elite,0.8472,30064988,GBR,H3,Leeds,92.22.124.130,no_relation,13,78,,24,98,treats,0.42857142857142894,803036,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  TUBERCULIN SKIN TEST ;  vaccine, BCG;   Nursing Diagnoses Appendix.",TUBERCULOSIS,TUBERCULIN SKIN TEST,TWrex-cause
788211765,9/14/2015 15:27:36,1737937140,9/14/2015 15:25:50,False,neodev,0.6111,33644825,USA,IL,Chicago,65.60.20.67,TUBERCULIN SKIN TEST treats TUBERCULOSIS,13,78,,24,98,treats,0.42857142857142894,803036,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  TUBERCULIN SKIN TEST ;  vaccine, BCG;   Nursing Diagnoses Appendix.",TUBERCULOSIS,TUBERCULIN SKIN TEST,TWrex-cause
788211765,9/14/2015 15:28:49,1737937689,9/14/2015 15:22:58,False,clixsense,0.7252,21875134,GBR,,,80.189.12.98,no_relation,13,78,,24,98,treats,0.42857142857142894,803036,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  TUBERCULIN SKIN TEST ;  vaccine, BCG;   Nursing Diagnoses Appendix.",TUBERCULOSIS,TUBERCULIN SKIN TEST,TWrex-cause
788211765,9/14/2015 15:29:24,1737937953,9/14/2015 15:28:28,False,prodege,0.8452,13300986,CAN,AB,Edmonton,68.150.40.134,no_relation,13,78,,24,98,treats,0.42857142857142894,803036,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  TUBERCULIN SKIN TEST ;  vaccine, BCG;   Nursing Diagnoses Appendix.",TUBERCULOSIS,TUBERCULIN SKIN TEST,TWrex-cause
788211765,9/14/2015 15:29:42,1737938070,9/14/2015 15:29:29,False,neodev,0.623,33228343,USA,VA,Manassas,198.7.59.107,TUBERCULOSIS treats TUBERCULIN SKIN TEST,13,78,,24,98,treats,0.42857142857142894,803036,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  TUBERCULIN SKIN TEST ;  vaccine, BCG;   Nursing Diagnoses Appendix.",TUBERCULOSIS,TUBERCULIN SKIN TEST,TWrex-cause
788211769,9/14/2015 16:46:09,1737975773,9/14/2015 16:45:55,False,prodege,0.9167,27934334,GBR,C8,Croydon,81.159.60.206,ACTING INSULIN ANALOG LISPRO treats TYPE 1 DIABETES,75,106,,89,134,treats,1.0,800069,"Lalli C, Ciofetta M, Del Sindaco P et al. Long term intensive treatment of TYPE 1 DIABETES with the short ACTING INSULIN ANALOG LISPRO in variable combination with NPH insulin at mealtime.",TYPE 1 DIABETES,ACTING INSULIN ANALOG LISPRO,TWrex-cause
788211769,9/14/2015 16:46:31,1737975904,9/14/2015 16:46:05,False,clixsense,0.8889,31813170,GBR,I7,Newcastle Upon Tyne,151.227.167.232,ACTING INSULIN ANALOG LISPRO treats TYPE 1 DIABETES,75,106,,89,134,treats,1.0,800069,"Lalli C, Ciofetta M, Del Sindaco P et al. Long term intensive treatment of TYPE 1 DIABETES with the short ACTING INSULIN ANALOG LISPRO in variable combination with NPH insulin at mealtime.",TYPE 1 DIABETES,ACTING INSULIN ANALOG LISPRO,TWrex-cause
788211769,9/14/2015 16:49:28,1737977659,9/14/2015 16:48:52,False,instagc,0.8373,18672993,CAN,BC,Surrey,76.77.82.83,ACTING INSULIN ANALOG LISPRO treats TYPE 1 DIABETES,75,106,,89,134,treats,1.0,800069,"Lalli C, Ciofetta M, Del Sindaco P et al. Long term intensive treatment of TYPE 1 DIABETES with the short ACTING INSULIN ANALOG LISPRO in variable combination with NPH insulin at mealtime.",TYPE 1 DIABETES,ACTING INSULIN ANALOG LISPRO,TWrex-cause
788211769,9/14/2015 16:55:11,1737980606,9/14/2015 16:55:06,False,prodege,0.8125,2143114,CAN,BC,Vancouver,24.85.153.181,TYPE 1 DIABETES treats ACTING INSULIN ANALOG LISPRO,75,106,,89,134,treats,1.0,800069,"Lalli C, Ciofetta M, Del Sindaco P et al. Long term intensive treatment of TYPE 1 DIABETES with the short ACTING INSULIN ANALOG LISPRO in variable combination with NPH insulin at mealtime.",TYPE 1 DIABETES,ACTING INSULIN ANALOG LISPRO,TWrex-cause
788211769,9/14/2015 17:05:59,1737986714,9/14/2015 17:05:47,False,clixsense,0.8292,19162475,GBR,P8,Trowbridge,82.33.126.30,ACTING INSULIN ANALOG LISPRO treats TYPE 1 DIABETES,75,106,,89,134,treats,1.0,800069,"Lalli C, Ciofetta M, Del Sindaco P et al. Long term intensive treatment of TYPE 1 DIABETES with the short ACTING INSULIN ANALOG LISPRO in variable combination with NPH insulin at mealtime.",TYPE 1 DIABETES,ACTING INSULIN ANALOG LISPRO,TWrex-cause
788211769,9/14/2015 17:12:53,1737990139,9/14/2015 17:12:09,False,superrewards,0.8583,33199643,USA,WI,La Crosse,138.49.1.27,ACTING INSULIN ANALOG LISPRO treats TYPE 1 DIABETES,75,106,,89,134,treats,1.0,800069,"Lalli C, Ciofetta M, Del Sindaco P et al. Long term intensive treatment of TYPE 1 DIABETES with the short ACTING INSULIN ANALOG LISPRO in variable combination with NPH insulin at mealtime.",TYPE 1 DIABETES,ACTING INSULIN ANALOG LISPRO,TWrex-cause
788211769,9/14/2015 17:21:20,1737994696,9/14/2015 17:20:40,False,clixsense,0.9226,6338159,CAN,ON,Ottawa,108.168.124.170,ACTING INSULIN ANALOG LISPRO treats TYPE 1 DIABETES,75,106,,89,134,treats,1.0,800069,"Lalli C, Ciofetta M, Del Sindaco P et al. Long term intensive treatment of TYPE 1 DIABETES with the short ACTING INSULIN ANALOG LISPRO in variable combination with NPH insulin at mealtime.",TYPE 1 DIABETES,ACTING INSULIN ANALOG LISPRO,TWrex-cause
788211777,9/14/2015 17:19:26,1737993505,9/14/2015 17:19:02,False,instagc,0.9267,16469970,USA,OK,Broken Arrow,72.192.89.181,SOTALOL treats SUSTAINED VENTRICULAR TACHYCARDIA,134,232,,166,239,treats,0.9941348467724341,800319,"Evidence:  The AVID trial randomly assigned patients with primary ventricular fibrillation, syncope with ventricular tachycardia, or SUSTAINED VENTRICULAR TACHYCARDIA in patients with LVEF less than 40% to ICD or drug therapy with SOTALOL guided by EPS or amiodarone therapy.",SUSTAINED VENTRICULAR TACHYCARDIA,SOTALOL,TWrex-cause
788211777,9/14/2015 17:22:34,1737995294,9/14/2015 17:21:21,False,clixsense,0.9226,6338159,CAN,ON,Ottawa,108.168.124.170,SUSTAINED VENTRICULAR TACHYCARDIA treats SOTALOL,134,232,,166,239,treats,0.9941348467724341,800319,"Evidence:  The AVID trial randomly assigned patients with primary ventricular fibrillation, syncope with ventricular tachycardia, or SUSTAINED VENTRICULAR TACHYCARDIA in patients with LVEF less than 40% to ICD or drug therapy with SOTALOL guided by EPS or amiodarone therapy.",SUSTAINED VENTRICULAR TACHYCARDIA,SOTALOL,TWrex-cause
788211777,9/14/2015 17:28:33,1737997747,9/14/2015 17:28:22,False,neodev,0.9246,11014811,GBR,G6,Hull,87.102.82.212,SOTALOL treats SUSTAINED VENTRICULAR TACHYCARDIA,134,232,,166,239,treats,0.9941348467724341,800319,"Evidence:  The AVID trial randomly assigned patients with primary ventricular fibrillation, syncope with ventricular tachycardia, or SUSTAINED VENTRICULAR TACHYCARDIA in patients with LVEF less than 40% to ICD or drug therapy with SOTALOL guided by EPS or amiodarone therapy.",SUSTAINED VENTRICULAR TACHYCARDIA,SOTALOL,TWrex-cause
788211777,9/14/2015 17:34:16,1738000540,9/14/2015 17:33:59,False,neodev,0.9583,12115558,USA,OH,Twinsburg,98.27.164.131,SOTALOL treats SUSTAINED VENTRICULAR TACHYCARDIA,134,232,,166,239,treats,0.9941348467724341,800319,"Evidence:  The AVID trial randomly assigned patients with primary ventricular fibrillation, syncope with ventricular tachycardia, or SUSTAINED VENTRICULAR TACHYCARDIA in patients with LVEF less than 40% to ICD or drug therapy with SOTALOL guided by EPS or amiodarone therapy.",SUSTAINED VENTRICULAR TACHYCARDIA,SOTALOL,TWrex-cause
788211777,9/14/2015 17:35:06,1738000952,9/14/2015 17:34:50,False,instagc,0.95,15577915,USA,IL,Trenton,208.70.36.12,SOTALOL treats SUSTAINED VENTRICULAR TACHYCARDIA,134,232,,166,239,treats,0.9941348467724341,800319,"Evidence:  The AVID trial randomly assigned patients with primary ventricular fibrillation, syncope with ventricular tachycardia, or SUSTAINED VENTRICULAR TACHYCARDIA in patients with LVEF less than 40% to ICD or drug therapy with SOTALOL guided by EPS or amiodarone therapy.",SUSTAINED VENTRICULAR TACHYCARDIA,SOTALOL,TWrex-cause
788211777,9/14/2015 17:38:47,1738003192,9/14/2015 17:38:11,False,inboxpounds,0.7917,34449186,GBR,H9,London,82.23.2.74,SOTALOL treats SUSTAINED VENTRICULAR TACHYCARDIA,134,232,,166,239,treats,0.9941348467724341,800319,"Evidence:  The AVID trial randomly assigned patients with primary ventricular fibrillation, syncope with ventricular tachycardia, or SUSTAINED VENTRICULAR TACHYCARDIA in patients with LVEF less than 40% to ICD or drug therapy with SOTALOL guided by EPS or amiodarone therapy.",SUSTAINED VENTRICULAR TACHYCARDIA,SOTALOL,TWrex-cause
788211777,9/14/2015 17:49:28,1738008218,9/14/2015 17:48:34,False,neodev,0.75,20306047,GBR,,,80.41.0.252,SOTALOL treats SUSTAINED VENTRICULAR TACHYCARDIA,134,232,,166,239,treats,0.9941348467724341,800319,"Evidence:  The AVID trial randomly assigned patients with primary ventricular fibrillation, syncope with ventricular tachycardia, or SUSTAINED VENTRICULAR TACHYCARDIA in patients with LVEF less than 40% to ICD or drug therapy with SOTALOL guided by EPS or amiodarone therapy.",SUSTAINED VENTRICULAR TACHYCARDIA,SOTALOL,TWrex-cause
788211784,9/14/2015 17:24:23,1737996027,9/14/2015 17:23:24,False,clixsense,0.9226,6338159,CAN,ON,Ottawa,108.168.124.170,HIGH DOSE FLUCONAZOLE treats CRYPTOCOCCAL MENINGITIS,151,70,,173,91,treats,0.9838699100999069,800099,"Nussbaum JC, Jackson A, Namarika D et al. Combination flucytosine and HIGH DOSE FLUCONAZOLE compared with fluconazole monotherapy for the treatment of CRYPTOCOCCAL MENINGITIS: a randomized trial in Malawi.",CRYPTOCOCCAL MENINGITIS,HIGH DOSE FLUCONAZOLE,TWrex-cause
788211784,9/14/2015 17:29:12,1737998016,9/14/2015 17:28:59,False,neodev,0.9246,11014811,GBR,G6,Hull,87.102.82.212,HIGH DOSE FLUCONAZOLE treats CRYPTOCOCCAL MENINGITIS,151,70,,173,91,treats,0.9838699100999069,800099,"Nussbaum JC, Jackson A, Namarika D et al. Combination flucytosine and HIGH DOSE FLUCONAZOLE compared with fluconazole monotherapy for the treatment of CRYPTOCOCCAL MENINGITIS: a randomized trial in Malawi.",CRYPTOCOCCAL MENINGITIS,HIGH DOSE FLUCONAZOLE,TWrex-cause
788211784,9/14/2015 17:35:14,1738001026,9/14/2015 17:34:45,False,neodev,0.9583,12115558,USA,OH,Twinsburg,98.27.164.131,HIGH DOSE FLUCONAZOLE treats CRYPTOCOCCAL MENINGITIS,151,70,,173,91,treats,0.9838699100999069,800099,"Nussbaum JC, Jackson A, Namarika D et al. Combination flucytosine and HIGH DOSE FLUCONAZOLE compared with fluconazole monotherapy for the treatment of CRYPTOCOCCAL MENINGITIS: a randomized trial in Malawi.",CRYPTOCOCCAL MENINGITIS,HIGH DOSE FLUCONAZOLE,TWrex-cause
788211784,9/14/2015 17:40:11,1738003890,9/14/2015 17:39:29,False,inboxpounds,0.7917,34449186,GBR,H9,London,82.23.2.74,HIGH DOSE FLUCONAZOLE treats CRYPTOCOCCAL MENINGITIS,151,70,,173,91,treats,0.9838699100999069,800099,"Nussbaum JC, Jackson A, Namarika D et al. Combination flucytosine and HIGH DOSE FLUCONAZOLE compared with fluconazole monotherapy for the treatment of CRYPTOCOCCAL MENINGITIS: a randomized trial in Malawi.",CRYPTOCOCCAL MENINGITIS,HIGH DOSE FLUCONAZOLE,TWrex-cause
788211784,9/14/2015 17:41:03,1738004258,9/14/2015 17:40:22,False,clixsense,0.7381,23144069,GBR,G6,Hull,83.100.235.226,HIGH DOSE FLUCONAZOLE treats CRYPTOCOCCAL MENINGITIS,151,70,,173,91,treats,0.9838699100999069,800099,"Nussbaum JC, Jackson A, Namarika D et al. Combination flucytosine and HIGH DOSE FLUCONAZOLE compared with fluconazole monotherapy for the treatment of CRYPTOCOCCAL MENINGITIS: a randomized trial in Malawi.",CRYPTOCOCCAL MENINGITIS,HIGH DOSE FLUCONAZOLE,TWrex-cause
788211784,9/14/2015 17:43:53,1738005442,9/14/2015 17:41:19,False,clixsense,0.7738,33878524,CAN,BC,Princeton,75.156.83.71,HIGH DOSE FLUCONAZOLE treats CRYPTOCOCCAL MENINGITIS,151,70,,173,91,treats,0.9838699100999069,800099,"Nussbaum JC, Jackson A, Namarika D et al. Combination flucytosine and HIGH DOSE FLUCONAZOLE compared with fluconazole monotherapy for the treatment of CRYPTOCOCCAL MENINGITIS: a randomized trial in Malawi.",CRYPTOCOCCAL MENINGITIS,HIGH DOSE FLUCONAZOLE,TWrex-cause
788211784,9/14/2015 17:44:47,1738005920,9/14/2015 17:44:11,False,instagc,0.7589,26024737,GBR,H2,Preston,92.23.186.130,HIGH DOSE FLUCONAZOLE treats CRYPTOCOCCAL MENINGITIS,151,70,,173,91,treats,0.9838699100999069,800099,"Nussbaum JC, Jackson A, Namarika D et al. Combination flucytosine and HIGH DOSE FLUCONAZOLE compared with fluconazole monotherapy for the treatment of CRYPTOCOCCAL MENINGITIS: a randomized trial in Malawi.",CRYPTOCOCCAL MENINGITIS,HIGH DOSE FLUCONAZOLE,TWrex-cause
788211787,9/14/2015 17:45:55,1738006454,9/14/2015 17:45:38,False,neodev,0.6994,31984900,CAN,AB,Edmonton,208.123.223.100,[ALTEPLASE] treats [ISCHEMIC STROKE],51,21,,65,29,treats,0.990586012095595,217962,A recent study using [ALTEPLASE] for thrombolysis in [ISCHEMIC STROKE] suggests clinical benefit with administration 3 to 4.5 hours after stroke onset.,[ISCHEMIC STROKE],[ALTEPLASE],TWrex-treat
788211787,9/14/2015 17:46:01,1738006488,9/14/2015 17:45:52,False,instagc,0.7589,26024737,GBR,H2,Preston,92.23.186.130,[ALTEPLASE] treats [ISCHEMIC STROKE],51,21,,65,29,treats,0.990586012095595,217962,A recent study using [ALTEPLASE] for thrombolysis in [ISCHEMIC STROKE] suggests clinical benefit with administration 3 to 4.5 hours after stroke onset.,[ISCHEMIC STROKE],[ALTEPLASE],TWrex-treat
788211787,9/14/2015 17:51:09,1738009196,9/14/2015 17:50:44,False,neodev,0.75,20306047,GBR,,,80.41.0.252,[ALTEPLASE] treats [ISCHEMIC STROKE],51,21,,65,29,treats,0.990586012095595,217962,A recent study using [ALTEPLASE] for thrombolysis in [ISCHEMIC STROKE] suggests clinical benefit with administration 3 to 4.5 hours after stroke onset.,[ISCHEMIC STROKE],[ALTEPLASE],TWrex-treat
788211787,9/14/2015 17:53:18,1738010576,9/14/2015 17:51:55,False,neodev,0.6577,34281269,USA,VA,Mclean,63.141.204.170,[ALTEPLASE] treats [ISCHEMIC STROKE],51,21,,65,29,treats,0.990586012095595,217962,A recent study using [ALTEPLASE] for thrombolysis in [ISCHEMIC STROKE] suggests clinical benefit with administration 3 to 4.5 hours after stroke onset.,[ISCHEMIC STROKE],[ALTEPLASE],TWrex-treat
788211787,9/14/2015 17:54:27,1738011074,9/14/2015 17:52:54,False,clixsense,0.8601,30777913,GBR,U8,Edinburgh,92.239.140.40,[ALTEPLASE] treats [ISCHEMIC STROKE],51,21,,65,29,treats,0.990586012095595,217962,A recent study using [ALTEPLASE] for thrombolysis in [ISCHEMIC STROKE] suggests clinical benefit with administration 3 to 4.5 hours after stroke onset.,[ISCHEMIC STROKE],[ALTEPLASE],TWrex-treat
788211787,9/14/2015 17:54:54,1738011297,9/14/2015 17:53:02,False,clixsense,0.7738,33878524,CAN,BC,Princeton,75.156.83.71,[ALTEPLASE] treats [ISCHEMIC STROKE],51,21,,65,29,treats,0.990586012095595,217962,A recent study using [ALTEPLASE] for thrombolysis in [ISCHEMIC STROKE] suggests clinical benefit with administration 3 to 4.5 hours after stroke onset.,[ISCHEMIC STROKE],[ALTEPLASE],TWrex-treat
788211787,9/14/2015 17:55:12,1738011455,9/14/2015 17:53:55,False,instagc,0.8155,22192177,CAN,AB,Calgary,108.181.28.71,[ALTEPLASE] treats [ISCHEMIC STROKE],51,21,,65,29,treats,0.990586012095595,217962,A recent study using [ALTEPLASE] for thrombolysis in [ISCHEMIC STROKE] suggests clinical benefit with administration 3 to 4.5 hours after stroke onset.,[ISCHEMIC STROKE],[ALTEPLASE],TWrex-treat
788211790,9/14/2015 14:50:27,1737920600,9/14/2015 14:50:09,False,tremorgames,0.8167,24449707,CAN,QC,Laval,96.20.14.148,no_relation,88,14,,121,25,treats,0.9282791216329142,803645,"compared with CLOPIDOGREL in patients undergoing percutaneous coronary intervention for ST ELEVATION MYOCARDIAL INFARCTION (TRITON TIMI 38): double blind, randomised controlled trial.",ST ELEVATION MYOCARDIAL INFARCTION,CLOPIDOGREL,TWrex-cause
788211790,9/14/2015 14:50:56,1737920768,9/14/2015 14:50:02,False,clixsense,0.8792,30681826,GBR,E4,Clacton-on-sea,109.157.135.57,CLOPIDOGREL treats ST ELEVATION MYOCARDIAL INFARCTION,88,14,,121,25,treats,0.9282791216329142,803645,"compared with CLOPIDOGREL in patients undergoing percutaneous coronary intervention for ST ELEVATION MYOCARDIAL INFARCTION (TRITON TIMI 38): double blind, randomised controlled trial.",ST ELEVATION MYOCARDIAL INFARCTION,CLOPIDOGREL,TWrex-cause
788211790,9/14/2015 14:51:58,1737921192,9/14/2015 14:51:39,False,elite,0.8333,31883685,GBR,,,79.66.254.237,CLOPIDOGREL treats ST ELEVATION MYOCARDIAL INFARCTION,88,14,,121,25,treats,0.9282791216329142,803645,"compared with CLOPIDOGREL in patients undergoing percutaneous coronary intervention for ST ELEVATION MYOCARDIAL INFARCTION (TRITON TIMI 38): double blind, randomised controlled trial.",ST ELEVATION MYOCARDIAL INFARCTION,CLOPIDOGREL,TWrex-cause
788211790,9/14/2015 14:52:04,1737921240,9/14/2015 14:51:45,False,clixsense,0.8458,22751911,NLD,04,Groningen,195.241.153.97,CLOPIDOGREL treats ST ELEVATION MYOCARDIAL INFARCTION,88,14,,121,25,treats,0.9282791216329142,803645,"compared with CLOPIDOGREL in patients undergoing percutaneous coronary intervention for ST ELEVATION MYOCARDIAL INFARCTION (TRITON TIMI 38): double blind, randomised controlled trial.",ST ELEVATION MYOCARDIAL INFARCTION,CLOPIDOGREL,TWrex-cause
788211790,9/14/2015 14:52:06,1737921263,9/14/2015 14:51:26,False,onestopgpt,0.775,21275875,CAN,ON,Hamilton,24.36.124.79,CLOPIDOGREL treats ST ELEVATION MYOCARDIAL INFARCTION,88,14,,121,25,treats,0.9282791216329142,803645,"compared with CLOPIDOGREL in patients undergoing percutaneous coronary intervention for ST ELEVATION MYOCARDIAL INFARCTION (TRITON TIMI 38): double blind, randomised controlled trial.",ST ELEVATION MYOCARDIAL INFARCTION,CLOPIDOGREL,TWrex-cause
788211790,9/14/2015 14:54:35,1737922388,9/14/2015 14:53:56,False,elite,0.6468,34356654,USA,DE,Wilmington,108.59.2.230,CLOPIDOGREL treats ST ELEVATION MYOCARDIAL INFARCTION,88,14,,121,25,treats,0.9282791216329142,803645,"compared with CLOPIDOGREL in patients undergoing percutaneous coronary intervention for ST ELEVATION MYOCARDIAL INFARCTION (TRITON TIMI 38): double blind, randomised controlled trial.",ST ELEVATION MYOCARDIAL INFARCTION,CLOPIDOGREL,TWrex-cause
788211790,9/14/2015 14:56:23,1737923238,9/14/2015 14:53:20,False,neodev,0.6012,32053642,GBR,I7,Newcastle Upon Tyne,92.23.136.205,no_relation,88,14,,121,25,treats,0.9282791216329142,803645,"compared with CLOPIDOGREL in patients undergoing percutaneous coronary intervention for ST ELEVATION MYOCARDIAL INFARCTION (TRITON TIMI 38): double blind, randomised controlled trial.",ST ELEVATION MYOCARDIAL INFARCTION,CLOPIDOGREL,TWrex-cause
788211800,9/14/2015 16:46:57,1737976082,9/14/2015 16:46:41,False,prodege,0.9167,27934334,GBR,C8,Croydon,81.159.60.206,[NON NSAID ANALGESIC AGENT] treats [SEVERE AND CHRONIC PAIN],86,31,,109,55,treats,1.0,222120,Ziconotide is a non opioid and [NON NSAID ANALGESIC AGENT] used for the amelioration of [SEVERE AND CHRONIC PAIN],[SEVERE AND CHRONIC PAIN],[NON NSAID ANALGESIC AGENT],TWrex-treat
788211800,9/14/2015 16:48:57,1737977279,9/14/2015 16:47:43,False,clixsense,0.8889,31813170,GBR,I7,Newcastle Upon Tyne,151.227.167.232,[NON NSAID ANALGESIC AGENT] treats [SEVERE AND CHRONIC PAIN],86,31,,109,55,treats,1.0,222120,Ziconotide is a non opioid and [NON NSAID ANALGESIC AGENT] used for the amelioration of [SEVERE AND CHRONIC PAIN],[SEVERE AND CHRONIC PAIN],[NON NSAID ANALGESIC AGENT],TWrex-treat
788211800,9/14/2015 17:06:21,1737986884,9/14/2015 17:06:14,False,clixsense,0.8292,19162475,GBR,P8,Trowbridge,82.33.126.30,[NON NSAID ANALGESIC AGENT] treats [SEVERE AND CHRONIC PAIN],86,31,,109,55,treats,1.0,222120,Ziconotide is a non opioid and [NON NSAID ANALGESIC AGENT] used for the amelioration of [SEVERE AND CHRONIC PAIN],[SEVERE AND CHRONIC PAIN],[NON NSAID ANALGESIC AGENT],TWrex-treat
788211800,9/14/2015 17:18:43,1737992993,9/14/2015 17:18:29,False,instagc,0.9267,16469970,USA,OK,Broken Arrow,72.192.89.181,[NON NSAID ANALGESIC AGENT] treats [SEVERE AND CHRONIC PAIN],86,31,,109,55,treats,1.0,222120,Ziconotide is a non opioid and [NON NSAID ANALGESIC AGENT] used for the amelioration of [SEVERE AND CHRONIC PAIN],[SEVERE AND CHRONIC PAIN],[NON NSAID ANALGESIC AGENT],TWrex-treat
788211800,9/14/2015 17:20:02,1737993876,9/14/2015 17:18:59,False,clixsense,0.9226,6338159,CAN,ON,Ottawa,108.168.124.170,[NON NSAID ANALGESIC AGENT] treats [SEVERE AND CHRONIC PAIN],86,31,,109,55,treats,1.0,222120,Ziconotide is a non opioid and [NON NSAID ANALGESIC AGENT] used for the amelioration of [SEVERE AND CHRONIC PAIN],[SEVERE AND CHRONIC PAIN],[NON NSAID ANALGESIC AGENT],TWrex-treat
788211800,9/14/2015 17:24:13,1737995962,9/14/2015 17:23:22,False,clixsense,0.9286,21490235,GBR,N7,Woking,86.30.254.232,[NON NSAID ANALGESIC AGENT] treats [SEVERE AND CHRONIC PAIN],86,31,,109,55,treats,1.0,222120,Ziconotide is a non opioid and [NON NSAID ANALGESIC AGENT] used for the amelioration of [SEVERE AND CHRONIC PAIN],[SEVERE AND CHRONIC PAIN],[NON NSAID ANALGESIC AGENT],TWrex-treat
788211800,9/14/2015 17:25:01,1737996289,9/14/2015 17:24:43,False,instagc,0.9286,13581319,USA,IL,Trenton,208.70.36.12,[NON NSAID ANALGESIC AGENT] treats [SEVERE AND CHRONIC PAIN],86,31,,109,55,treats,1.0,222120,Ziconotide is a non opioid and [NON NSAID ANALGESIC AGENT] used for the amelioration of [SEVERE AND CHRONIC PAIN],[SEVERE AND CHRONIC PAIN],[NON NSAID ANALGESIC AGENT],TWrex-treat
788211803,9/14/2015 17:55:40,1738011731,9/14/2015 17:55:29,False,clixsense,0.8601,30777913,GBR,U8,Edinburgh,92.239.140.40,VALSARTAN treats ALZHEIMER DISEASE,109,8,,126,17,treats,0.9761870602,224963,title = [VALSARTAN] lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of [ALZHEIMER DISEASE].,ALZHEIMER DISEASE,VALSARTAN,TWrex-treat
788211803,9/14/2015 18:02:35,1738015117,9/14/2015 18:02:23,False,neodev,0.8,33895262,USA,CA,San Jose,50.118.172.54,ALZHEIMER DISEASE treats VALSARTAN,109,8,,126,17,treats,0.9761870602,224963,title = [VALSARTAN] lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of [ALZHEIMER DISEASE].,ALZHEIMER DISEASE,VALSARTAN,TWrex-treat
788211803,9/14/2015 18:14:27,1738021694,9/14/2015 18:12:58,False,clixsense,0.7381,23144069,GBR,G6,Hull,83.100.235.226,VALSARTAN treats ALZHEIMER DISEASE,109,8,,126,17,treats,0.9761870602,224963,title = [VALSARTAN] lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of [ALZHEIMER DISEASE].,ALZHEIMER DISEASE,VALSARTAN,TWrex-treat
788211803,9/14/2015 18:22:21,1738025693,9/14/2015 18:21:36,False,neodev,0.6401,33011398,USA,DE,,108.59.8.208,VALSARTAN treats ALZHEIMER DISEASE,109,8,,126,17,treats,0.9761870602,224963,title = [VALSARTAN] lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of [ALZHEIMER DISEASE].,ALZHEIMER DISEASE,VALSARTAN,TWrex-treat
788211803,9/14/2015 18:24:47,1738027196,9/14/2015 18:23:31,False,clixsense,0.5694,32916182,GBR,L9,Sheffield,5.81.109.21,no_relation,109,8,,126,17,treats,0.9761870602,224963,title = [VALSARTAN] lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of [ALZHEIMER DISEASE].,ALZHEIMER DISEASE,VALSARTAN,TWrex-treat
788211803,9/14/2015 18:25:53,1738027874,9/14/2015 18:25:42,False,neodev,0.4222,33701549,USA,CA,San Jose,23.27.248.77,no_relation,109,8,,126,17,treats,0.9761870602,224963,title = [VALSARTAN] lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of [ALZHEIMER DISEASE].,ALZHEIMER DISEASE,VALSARTAN,TWrex-treat
788211803,9/14/2015 19:23:07,1738100646,9/14/2015 19:22:29,False,clixsense,0.7806,19638651,USA,SC,Summerville,174.107.73.211,VALSARTAN treats ALZHEIMER DISEASE,109,8,,126,17,treats,0.9761870602,224963,title = [VALSARTAN] lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of [ALZHEIMER DISEASE].,ALZHEIMER DISEASE,VALSARTAN,TWrex-treat
788211806,9/14/2015 15:10:53,1737929393,9/14/2015 15:10:12,False,neodev,0.7986,33758777,USA,,,38.95.108.251,CEFACLOR treats PHARYNGITIS,144,181,,155,189,treats,0.976546150525391,908192,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with PHARYNGITIS received 20 mg/kg/day of CEFACLOR or penicillin V potassium for ten days.,PHARYNGITIS,CEFACLOR,RO-may_treat
788211806,9/14/2015 15:14:04,1737930861,9/14/2015 15:13:49,False,meprizescf,0.8115,28483210,USA,WI,Minocqua,75.143.134.247,CEFACLOR treats PHARYNGITIS,144,181,,155,189,treats,0.976546150525391,908192,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with PHARYNGITIS received 20 mg/kg/day of CEFACLOR or penicillin V potassium for ten days.,PHARYNGITIS,CEFACLOR,RO-may_treat
788211806,9/14/2015 15:15:36,1737931560,9/14/2015 15:15:01,False,prodege,0.7778,21417560,GBR,C3,Cambridge,151.224.120.191,CEFACLOR treats PHARYNGITIS,144,181,,155,189,treats,0.976546150525391,908192,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with PHARYNGITIS received 20 mg/kg/day of CEFACLOR or penicillin V potassium for ten days.,PHARYNGITIS,CEFACLOR,RO-may_treat
788211806,9/14/2015 15:16:42,1737932208,9/14/2015 15:16:18,False,dailyrewardsca,0.7867,32219778,CAN,ON,Ottawa,99.241.19.27,no_relation,144,181,,155,189,treats,0.976546150525391,908192,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with PHARYNGITIS received 20 mg/kg/day of CEFACLOR or penicillin V potassium for ten days.,PHARYNGITIS,CEFACLOR,RO-may_treat
788211806,9/14/2015 15:17:16,1737932554,9/14/2015 15:15:24,False,points4rewards,0.8165,20113482,USA,PA,Philadelphia,162.208.49.45,CEFACLOR treats PHARYNGITIS,144,181,,155,189,treats,0.976546150525391,908192,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with PHARYNGITIS received 20 mg/kg/day of CEFACLOR or penicillin V potassium for ten days.,PHARYNGITIS,CEFACLOR,RO-may_treat
788211806,9/14/2015 15:20:39,1737934097,9/14/2015 15:19:42,False,zoombucks,0.9333,4711962,CAN,ON,Markham,174.88.29.138,CEFACLOR treats PHARYNGITIS,144,181,,155,189,treats,0.976546150525391,908192,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with PHARYNGITIS received 20 mg/kg/day of CEFACLOR or penicillin V potassium for ten days.,PHARYNGITIS,CEFACLOR,RO-may_treat
788211806,9/14/2015 15:21:52,1737934837,9/14/2015 15:19:06,False,clixsense,0.7252,21875134,GBR,,,80.189.12.98,CEFACLOR treats PHARYNGITIS,144,181,,155,189,treats,0.976546150525391,908192,Patients with otitis media received approximately 40 mg/kg/day of cefaclor or amoxicillin trihydrate for ten days to three weeks; patients with PHARYNGITIS received 20 mg/kg/day of CEFACLOR or penicillin V potassium for ten days.,PHARYNGITIS,CEFACLOR,RO-may_treat
788211810,9/14/2015 14:50:58,1737920781,9/14/2015 14:50:28,False,tremorgames,0.8167,24449707,CAN,QC,Laval,96.20.14.148,ANTIARRHYTHMIC DRUGS treats REENTRANT ARRHYTHMIAS,54,130,,74,150,treats,0.4313310928137539,907439,Our results suggest that the heart rate dependence of REENTRANT ARRHYTHMIAS might be of prognostic value in the administration of ANTIARRHYTHMIC DRUGS,REENTRANT ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,RO-may_prevent
788211810,9/14/2015 14:51:38,1737921094,9/14/2015 14:50:57,False,clixsense,0.8792,30681826,GBR,E4,Clacton-on-sea,109.157.135.57,ANTIARRHYTHMIC DRUGS treats REENTRANT ARRHYTHMIAS,54,130,,74,150,treats,0.4313310928137539,907439,Our results suggest that the heart rate dependence of REENTRANT ARRHYTHMIAS might be of prognostic value in the administration of ANTIARRHYTHMIC DRUGS,REENTRANT ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,RO-may_prevent
788211810,9/14/2015 14:52:20,1737921360,9/14/2015 14:51:59,False,elite,0.8333,31883685,GBR,,,79.66.254.237,no_relation,54,130,,74,150,treats,0.4313310928137539,907439,Our results suggest that the heart rate dependence of REENTRANT ARRHYTHMIAS might be of prognostic value in the administration of ANTIARRHYTHMIC DRUGS,REENTRANT ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,RO-may_prevent
788211810,9/14/2015 14:52:26,1737921389,9/14/2015 14:52:05,False,clixsense,0.8458,22751911,NLD,04,Groningen,195.241.153.97,ANTIARRHYTHMIC DRUGS treats REENTRANT ARRHYTHMIAS,54,130,,74,150,treats,0.4313310928137539,907439,Our results suggest that the heart rate dependence of REENTRANT ARRHYTHMIAS might be of prognostic value in the administration of ANTIARRHYTHMIC DRUGS,REENTRANT ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,RO-may_prevent
788211810,9/14/2015 14:53:17,1737921729,9/14/2015 14:52:07,False,onestopgpt,0.775,21275875,CAN,ON,Hamilton,24.36.124.79,ANTIARRHYTHMIC DRUGS treats REENTRANT ARRHYTHMIAS,54,130,,74,150,treats,0.4313310928137539,907439,Our results suggest that the heart rate dependence of REENTRANT ARRHYTHMIAS might be of prognostic value in the administration of ANTIARRHYTHMIC DRUGS,REENTRANT ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,RO-may_prevent
788211810,9/14/2015 14:55:17,1737922708,9/14/2015 14:54:36,False,elite,0.6468,34356654,USA,DE,Wilmington,108.59.2.230,ANTIARRHYTHMIC DRUGS treats REENTRANT ARRHYTHMIAS,54,130,,74,150,treats,0.4313310928137539,907439,Our results suggest that the heart rate dependence of REENTRANT ARRHYTHMIAS might be of prognostic value in the administration of ANTIARRHYTHMIC DRUGS,REENTRANT ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,RO-may_prevent
788211810,9/14/2015 15:05:58,1737927349,9/14/2015 15:05:10,False,prodege,0.8889,24403612,CAN,ON,Ajax,99.239.181.149,ANTIARRHYTHMIC DRUGS treats REENTRANT ARRHYTHMIAS,54,130,,74,150,treats,0.4313310928137539,907439,Our results suggest that the heart rate dependence of REENTRANT ARRHYTHMIAS might be of prognostic value in the administration of ANTIARRHYTHMIC DRUGS,REENTRANT ARRHYTHMIAS,ANTIARRHYTHMIC DRUGS,RO-may_prevent
788211812,9/14/2015 15:28:15,1737937448,9/14/2015 15:27:53,False,elite,0.8472,30064988,GBR,H3,Leeds,92.22.124.130,no_relation,31,103,,39,118,treats,0.871857290578645,216777,"In severe cases, a person with [PARURESIS] can urinate only when alone at home or through the process of [CATHETERIZATION]",[PARURESIS],[CATHETERIZATION],TWrex-treat
788211812,9/14/2015 15:31:21,1737939040,9/14/2015 15:30:57,False,prodege,0.8452,13300986,CAN,AB,Edmonton,68.150.40.134,[CATHETERIZATION] treats [PARURESIS],31,103,,39,118,treats,0.871857290578645,216777,"In severe cases, a person with [PARURESIS] can urinate only when alone at home or through the process of [CATHETERIZATION]",[PARURESIS],[CATHETERIZATION],TWrex-treat
788211812,9/14/2015 15:32:38,1737939691,9/14/2015 15:32:12,False,prodege,0.7917,4316379,CAN,ON,Windsor,206.47.90.133,no_relation,31,103,,39,118,treats,0.871857290578645,216777,"In severe cases, a person with [PARURESIS] can urinate only when alone at home or through the process of [CATHETERIZATION]",[PARURESIS],[CATHETERIZATION],TWrex-treat
788211812,9/14/2015 15:33:17,1737940083,9/14/2015 15:32:16,False,neodev,0.6111,33644825,USA,IL,Chicago,65.60.20.67,[CATHETERIZATION] treats [PARURESIS],31,103,,39,118,treats,0.871857290578645,216777,"In severe cases, a person with [PARURESIS] can urinate only when alone at home or through the process of [CATHETERIZATION]",[PARURESIS],[CATHETERIZATION],TWrex-treat
788211812,9/14/2015 15:37:54,1737942331,9/14/2015 15:37:19,False,fusioncash,0.6762,5861591,USA,OK,Muskogee,74.197.206.241,[CATHETERIZATION] treats [PARURESIS],31,103,,39,118,treats,0.871857290578645,216777,"In severe cases, a person with [PARURESIS] can urinate only when alone at home or through the process of [CATHETERIZATION]",[PARURESIS],[CATHETERIZATION],TWrex-treat
788211812,9/14/2015 15:40:35,1737943421,9/14/2015 15:39:59,False,neodev,0.7944,14096345,NLD,03,Eibergen,178.85.94.186,[CATHETERIZATION] treats [PARURESIS],31,103,,39,118,treats,0.871857290578645,216777,"In severe cases, a person with [PARURESIS] can urinate only when alone at home or through the process of [CATHETERIZATION]",[PARURESIS],[CATHETERIZATION],TWrex-treat
788211812,9/14/2015 15:49:31,1737947927,9/14/2015 15:41:15,False,neodev,0.5595,33761260,USA,DE,,108.59.8.210,[PARURESIS] treats [CATHETERIZATION],31,103,,39,118,treats,0.871857290578645,216777,"In severe cases, a person with [PARURESIS] can urinate only when alone at home or through the process of [CATHETERIZATION]",[PARURESIS],[CATHETERIZATION],TWrex-treat
788211816,9/14/2015 18:28:29,1738029263,9/14/2015 18:28:08,False,clixsense,0.5694,32916182,GBR,L9,Sheffield,5.81.109.21,no_relation,65,51,,79,60,treats,0.981980506061966,210527,Biogen Idec has recently announced that a trial of [MEFLOQUINE] in [HIV RELATED PML] is beginning.,[HIV RELATED PML],[MEFLOQUINE],TWrex-treat
788211816,9/14/2015 18:35:54,1738033845,9/14/2015 18:35:24,False,instagc,0.748,33058612,USA,IL,Glenview,162.229.106.229,[MEFLOQUINE] treats [HIV RELATED PML],65,51,,79,60,treats,0.981980506061966,210527,Biogen Idec has recently announced that a trial of [MEFLOQUINE] in [HIV RELATED PML] is beginning.,[HIV RELATED PML],[MEFLOQUINE],TWrex-treat
788211816,9/14/2015 18:38:46,1738036494,9/14/2015 18:38:31,False,clixsense,0.7123,33115750,GBR,I3,Rochester,90.222.106.192,[MEFLOQUINE] treats [HIV RELATED PML],65,51,,79,60,treats,0.981980506061966,210527,Biogen Idec has recently announced that a trial of [MEFLOQUINE] in [HIV RELATED PML] is beginning.,[HIV RELATED PML],[MEFLOQUINE],TWrex-treat
788211816,9/14/2015 19:24:11,1738102023,9/14/2015 19:23:54,False,clixsense,0.7806,19638651,USA,SC,Summerville,174.107.73.211,[MEFLOQUINE] treats [HIV RELATED PML],65,51,,79,60,treats,0.981980506061966,210527,Biogen Idec has recently announced that a trial of [MEFLOQUINE] in [HIV RELATED PML] is beginning.,[HIV RELATED PML],[MEFLOQUINE],TWrex-treat
788211816,9/14/2015 19:28:14,1738108031,9/14/2015 19:27:41,False,elite,0.7857,33238902,NLD,06,Budel,77.248.148.5,[MEFLOQUINE] treats [HIV RELATED PML],65,51,,79,60,treats,0.981980506061966,210527,Biogen Idec has recently announced that a trial of [MEFLOQUINE] in [HIV RELATED PML] is beginning.,[HIV RELATED PML],[MEFLOQUINE],TWrex-treat
788211816,9/14/2015 19:28:57,1738108940,9/14/2015 19:28:44,False,instagc,0.7604,32352104,USA,ME,Bangor,74.75.63.81,[HIV RELATED PML] treats [MEFLOQUINE],65,51,,79,60,treats,0.981980506061966,210527,Biogen Idec has recently announced that a trial of [MEFLOQUINE] in [HIV RELATED PML] is beginning.,[HIV RELATED PML],[MEFLOQUINE],TWrex-treat
788211816,9/14/2015 19:35:16,1738117585,9/14/2015 19:34:53,False,clixsense,0.8881,11106820,USA,MA,Taunton,173.48.52.95,[MEFLOQUINE] treats [HIV RELATED PML],65,51,,79,60,treats,0.981980506061966,210527,Biogen Idec has recently announced that a trial of [MEFLOQUINE] in [HIV RELATED PML] is beginning.,[HIV RELATED PML],[MEFLOQUINE],TWrex-treat
788659614,9/15/2015 12:36:18,1738702027,9/15/2015 12:36:04,False,neodev,0.9208,12115558,USA,OH,Twinsburg,98.27.164.131,LATENT TB treats TUBERCULOSIS,131,76,,142,85,treats,0.371390676354104,803039,This finding could have serious implications for using the test to diagnose LATENT TB in populations where empirical treatment for TUBERCULOSIS is widespread.,TUBERCULOSIS,LATENT TB,TWrex-cause
788659614,9/15/2015 12:36:54,1738702238,9/15/2015 12:34:25,False,neodev,0.7528,33758777,USA,,,38.95.108.251,no_relation,131,76,,142,85,treats,0.371390676354104,803039,This finding could have serious implications for using the test to diagnose LATENT TB in populations where empirical treatment for TUBERCULOSIS is widespread.,TUBERCULOSIS,LATENT TB,TWrex-cause
788659614,9/15/2015 12:38:41,1738702875,9/15/2015 12:38:00,False,vivatic,0.7972,32338429,GBR,N7,Guildford,92.21.219.178,no_relation,131,76,,142,85,treats,0.371390676354104,803039,This finding could have serious implications for using the test to diagnose LATENT TB in populations where empirical treatment for TUBERCULOSIS is widespread.,TUBERCULOSIS,LATENT TB,TWrex-cause
788659614,9/15/2015 12:44:27,1738704572,9/15/2015 12:44:01,False,prodege,0.8024,3587109,CAN,NS,Sydney,142.177.43.123,no_relation,131,76,,142,85,treats,0.371390676354104,803039,This finding could have serious implications for using the test to diagnose LATENT TB in populations where empirical treatment for TUBERCULOSIS is widespread.,TUBERCULOSIS,LATENT TB,TWrex-cause
788659614,9/15/2015 12:44:47,1738704716,9/15/2015 12:43:50,False,prodege,0.6643,24945126,GBR,K8,Ilford,82.12.220.44,no_relation,131,76,,142,85,treats,0.371390676354104,803039,This finding could have serious implications for using the test to diagnose LATENT TB in populations where empirical treatment for TUBERCULOSIS is widespread.,TUBERCULOSIS,LATENT TB,TWrex-cause
788659614,9/15/2015 12:55:30,1738707410,9/15/2015 12:55:07,False,zoombucks,0.45,4711962,CAN,ON,Markham,174.88.29.138,LATENT TB treats TUBERCULOSIS,131,76,,142,85,treats,0.371390676354104,803039,This finding could have serious implications for using the test to diagnose LATENT TB in populations where empirical treatment for TUBERCULOSIS is widespread.,TUBERCULOSIS,LATENT TB,TWrex-cause
788659614,9/15/2015 13:05:21,1738709919,9/15/2015 13:05:14,False,neodev,0.5,33701549,USA,CA,San Jose,23.27.248.252,LATENT TB treats TUBERCULOSIS,131,76,,142,85,treats,0.371390676354104,803039,This finding could have serious implications for using the test to diagnose LATENT TB in populations where empirical treatment for TUBERCULOSIS is widespread.,TUBERCULOSIS,LATENT TB,TWrex-cause
788659616,9/15/2015 14:26:59,1738734230,9/15/2015 14:26:46,False,elite,0.9643,30064988,GBR,G8,Huddersfield,92.29.158.223,METHOTREXATE treats OSTEOSARCOMA,114,142,,125,153,treats,0.9647638212377321,908313,This paper will present the experience of the Department of Clinical Haematology and Oncology in the treatment of OSTEOSARCOMA with high dose METHOTREXATE and summarize other groups' experiences with various chemotherapy regimes.,OSTEOSARCOMA,METHOTREXATE,RO-may_treat
788659616,9/15/2015 14:41:55,1738738179,9/15/2015 14:41:17,False,clixsense,0.9583,30258829,NLD,05,Velden,84.104.254.214,METHOTREXATE treats OSTEOSARCOMA,114,142,,125,153,treats,0.9647638212377321,908313,This paper will present the experience of the Department of Clinical Haematology and Oncology in the treatment of OSTEOSARCOMA with high dose METHOTREXATE and summarize other groups' experiences with various chemotherapy regimes.,OSTEOSARCOMA,METHOTREXATE,RO-may_treat
788659616,9/15/2015 14:45:42,1738739365,9/15/2015 14:44:32,False,gifthulk,0.9097,18666417,USA,PA,Meadville,24.101.32.13,METHOTREXATE treats OSTEOSARCOMA,114,142,,125,153,treats,0.9647638212377321,908313,This paper will present the experience of the Department of Clinical Haematology and Oncology in the treatment of OSTEOSARCOMA with high dose METHOTREXATE and summarize other groups' experiences with various chemotherapy regimes.,OSTEOSARCOMA,METHOTREXATE,RO-may_treat
788659616,9/15/2015 14:51:49,1738741130,9/15/2015 14:51:23,False,elite,0.7861,30312592,CAN,ON,Sudbury,66.103.55.12,METHOTREXATE treats OSTEOSARCOMA,114,142,,125,153,treats,0.9647638212377321,908313,This paper will present the experience of the Department of Clinical Haematology and Oncology in the treatment of OSTEOSARCOMA with high dose METHOTREXATE and summarize other groups' experiences with various chemotherapy regimes.,OSTEOSARCOMA,METHOTREXATE,RO-may_treat
788659616,9/15/2015 15:12:50,1738748793,9/15/2015 15:11:31,False,coinworker,0.9,20231698,USA,OR,,172.56.33.130,METHOTREXATE treats OSTEOSARCOMA,114,142,,125,153,treats,0.9647638212377321,908313,This paper will present the experience of the Department of Clinical Haematology and Oncology in the treatment of OSTEOSARCOMA with high dose METHOTREXATE and summarize other groups' experiences with various chemotherapy regimes.,OSTEOSARCOMA,METHOTREXATE,RO-may_treat
788659616,9/15/2015 15:36:42,1738757381,9/15/2015 15:36:00,False,clixsense,0.7083,22984878,CAN,ON,Kingston,67.193.186.57,METHOTREXATE treats OSTEOSARCOMA,114,142,,125,153,treats,0.9647638212377321,908313,This paper will present the experience of the Department of Clinical Haematology and Oncology in the treatment of OSTEOSARCOMA with high dose METHOTREXATE and summarize other groups' experiences with various chemotherapy regimes.,OSTEOSARCOMA,METHOTREXATE,RO-may_treat
788659616,9/15/2015 15:40:04,1738758381,9/15/2015 15:39:15,False,neodev,0.3857,33155316,GBR,I9,Dereham,31.50.244.140,OSTEOSARCOMA treats METHOTREXATE,114,142,,125,153,treats,0.9647638212377321,908313,This paper will present the experience of the Department of Clinical Haematology and Oncology in the treatment of OSTEOSARCOMA with high dose METHOTREXATE and summarize other groups' experiences with various chemotherapy regimes.,OSTEOSARCOMA,METHOTREXATE,RO-may_treat
788659617,9/15/2015 10:01:38,1738649631,9/15/2015 10:00:07,False,neodev,0.8889,33644825,USA,IL,Chicago,65.60.20.67,PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS treats SEIZURES,11,40,,18,87,treats,0.31622776601683805,813607,Persistent SEIZURES after lorazepam and PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,SEIZURES,PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,TWrex-cause
788659617,9/15/2015 10:03:23,1738650153,9/15/2015 10:03:03,False,gifthulk,0.8056,33936811,AUS,04,Brisbane,121.208.7.253,no_relation,11,40,,18,87,treats,0.31622776601683805,813607,Persistent SEIZURES after lorazepam and PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,SEIZURES,PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,TWrex-cause
788659617,9/15/2015 10:05:33,1738650718,9/15/2015 10:05:12,False,meprizescf,0.8611,28483210,USA,WI,Minocqua,75.143.134.247,no_relation,11,40,,18,87,treats,0.31622776601683805,813607,Persistent SEIZURES after lorazepam and PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,SEIZURES,PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,TWrex-cause
788659617,9/15/2015 10:18:23,1738654328,9/15/2015 10:17:48,False,prodege,0.8764,21417560,GBR,C3,Cambridge,151.224.120.191,no_relation,11,40,,18,87,treats,0.31622776601683805,813607,Persistent SEIZURES after lorazepam and PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,SEIZURES,PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,TWrex-cause
788659617,9/15/2015 10:20:23,1738654793,9/15/2015 10:20:04,False,prodege,0.7056,4316379,CAN,ON,Windsor,198.91.219.55,no_relation,11,40,,18,87,treats,0.31622776601683805,813607,Persistent SEIZURES after lorazepam and PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,SEIZURES,PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,TWrex-cause
788659617,9/15/2015 10:21:08,1738654985,9/15/2015 10:20:49,False,gifthunterclub,0.8036,30901412,GBR,H9,London,77.89.149.62,no_relation,11,40,,18,87,treats,0.31622776601683805,813607,Persistent SEIZURES after lorazepam and PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,SEIZURES,PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,TWrex-cause
788659617,9/15/2015 10:22:32,1738655365,9/15/2015 10:21:32,False,keeprewarding,0.8556,29139615,CAN,ON,Perth,192.186.81.178,no_relation,11,40,,18,87,treats,0.31622776601683805,813607,Persistent SEIZURES after lorazepam and PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,SEIZURES,PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,TWrex-cause
788659619,9/15/2015 10:24:15,1738655871,9/15/2015 10:23:36,False,keeprewarding,0.8556,29139615,CAN,ON,Perth,192.186.81.178,no_relation,94,32,,116,58,treats,0.635000635000952,908168,"In spite of the large number of ANTIEPILEPTIC DRUGS (AEDS) actually available, the problem of DRUG RESISTANT EPILEPSY has not been solved.",DRUG RESISTANT EPILEPSY,ANTIEPILEPTIC DRUGS (AEDS),RO-may_treat
788659619,9/15/2015 10:25:02,1738656112,9/15/2015 10:24:35,False,prodege,0.8151,9169061,CAN,ON,Kitchener,99.235.192.130,no_relation,94,32,,116,58,treats,0.635000635000952,908168,"In spite of the large number of ANTIEPILEPTIC DRUGS (AEDS) actually available, the problem of DRUG RESISTANT EPILEPSY has not been solved.",DRUG RESISTANT EPILEPSY,ANTIEPILEPTIC DRUGS (AEDS),RO-may_treat
788659619,9/15/2015 10:30:58,1738657462,9/15/2015 10:27:45,False,gifthunterclub,0.85,24043308,GBR,,,94.102.147.250,no_relation,94,32,,116,58,treats,0.635000635000952,908168,"In spite of the large number of ANTIEPILEPTIC DRUGS (AEDS) actually available, the problem of DRUG RESISTANT EPILEPSY has not been solved.",DRUG RESISTANT EPILEPSY,ANTIEPILEPTIC DRUGS (AEDS),RO-may_treat
788659619,9/15/2015 10:35:44,1738658568,9/15/2015 10:35:16,False,clixsense,0.7167,6344072,CAN,BC,Burnaby,172.218.166.58,ANTIEPILEPTIC DRUGS (AEDS) treats DRUG RESISTANT EPILEPSY,94,32,,116,58,treats,0.635000635000952,908168,"In spite of the large number of ANTIEPILEPTIC DRUGS (AEDS) actually available, the problem of DRUG RESISTANT EPILEPSY has not been solved.",DRUG RESISTANT EPILEPSY,ANTIEPILEPTIC DRUGS (AEDS),RO-may_treat
788659619,9/15/2015 10:36:31,1738658755,9/15/2015 10:35:25,False,neodev,0.7063,33238512,CAN,AB,Calgary,136.159.234.238,ANTIEPILEPTIC DRUGS (AEDS) treats DRUG RESISTANT EPILEPSY,94,32,,116,58,treats,0.635000635000952,908168,"In spite of the large number of ANTIEPILEPTIC DRUGS (AEDS) actually available, the problem of DRUG RESISTANT EPILEPSY has not been solved.",DRUG RESISTANT EPILEPSY,ANTIEPILEPTIC DRUGS (AEDS),RO-may_treat
788659619,9/15/2015 10:45:55,1738661246,9/15/2015 10:45:13,False,clixsense,0.8958,21490235,GBR,N7,Woking,86.30.254.232,no_relation,94,32,,116,58,treats,0.635000635000952,908168,"In spite of the large number of ANTIEPILEPTIC DRUGS (AEDS) actually available, the problem of DRUG RESISTANT EPILEPSY has not been solved.",DRUG RESISTANT EPILEPSY,ANTIEPILEPTIC DRUGS (AEDS),RO-may_treat
788659619,9/15/2015 10:58:13,1738663993,9/15/2015 10:56:26,False,points4rewards,0.5893,20113482,USA,PA,Philadelphia,162.208.49.45,no_relation,94,32,,116,58,treats,0.635000635000952,908168,"In spite of the large number of ANTIEPILEPTIC DRUGS (AEDS) actually available, the problem of DRUG RESISTANT EPILEPSY has not been solved.",DRUG RESISTANT EPILEPSY,ANTIEPILEPTIC DRUGS (AEDS),RO-may_treat
788659624,9/15/2015 14:43:51,1738738813,9/15/2015 14:43:11,False,clixsense,0.9583,30258829,NLD,05,Velden,84.104.254.214,BETULIN treats TUMOR,135,62,,140,69,treats,0.9805806757,207613,"Recent clinical studies have verified that red alder contains [BETULIN] and lupeol, compounds shown to be effective against a variety of [TUMOR]s.",TUMOR,BETULIN,TWrex-treat
788659624,9/15/2015 14:48:09,1738740186,9/15/2015 14:47:38,False,gifthulk,0.9097,18666417,USA,PA,Meadville,24.101.32.13,BETULIN treats TUMOR,135,62,,140,69,treats,0.9805806757,207613,"Recent clinical studies have verified that red alder contains [BETULIN] and lupeol, compounds shown to be effective against a variety of [TUMOR]s.",TUMOR,BETULIN,TWrex-treat
788659624,9/15/2015 14:53:12,1738741429,9/15/2015 14:52:30,False,elite,0.7861,30312592,CAN,ON,Sudbury,66.103.55.12,BETULIN treats TUMOR,135,62,,140,69,treats,0.9805806757,207613,"Recent clinical studies have verified that red alder contains [BETULIN] and lupeol, compounds shown to be effective against a variety of [TUMOR]s.",TUMOR,BETULIN,TWrex-treat
788659624,9/15/2015 15:38:11,1738757840,9/15/2015 15:37:31,False,clixsense,0.7083,22984878,CAN,ON,Kingston,67.193.186.57,no_relation,135,62,,140,69,treats,0.9805806757,207613,"Recent clinical studies have verified that red alder contains [BETULIN] and lupeol, compounds shown to be effective against a variety of [TUMOR]s.",TUMOR,BETULIN,TWrex-treat
788659624,9/15/2015 15:40:31,1738758527,9/15/2015 15:40:19,False,neodev,0.3857,33155316,GBR,I9,Dereham,31.50.244.140,BETULIN treats TUMOR,135,62,,140,69,treats,0.9805806757,207613,"Recent clinical studies have verified that red alder contains [BETULIN] and lupeol, compounds shown to be effective against a variety of [TUMOR]s.",TUMOR,BETULIN,TWrex-treat
788659624,9/15/2015 15:44:44,1738759777,9/15/2015 15:44:11,False,clixsense,0.6111,32053717,GBR,,,51.174.76.80,BETULIN treats TUMOR,135,62,,140,69,treats,0.9805806757,207613,"Recent clinical studies have verified that red alder contains [BETULIN] and lupeol, compounds shown to be effective against a variety of [TUMOR]s.",TUMOR,BETULIN,TWrex-treat
788659624,9/15/2015 15:47:57,1738760721,9/15/2015 15:47:48,False,bitcoinget,0.75,21743413,USA,WA,Port Angeles,24.113.29.97,BETULIN treats TUMOR,135,62,,140,69,treats,0.9805806757,207613,"Recent clinical studies have verified that red alder contains [BETULIN] and lupeol, compounds shown to be effective against a variety of [TUMOR]s.",TUMOR,BETULIN,TWrex-treat
788659626,9/15/2015 11:47:04,1738684556,9/15/2015 11:46:52,False,elite,0.9048,31883685,GBR,,,79.66.254.237,FLUOXETINE treats ANXIETY,124,0,,131,10,treats,0.9773555548999999,208517,"[FLUOXETINE] was shown to be effective for depression in 6-week long double-blind controlled trials, where it also alleviated [ANXIETY] and improved sleep.",ANXIETY,FLUOXETINE,TWrex-treat
788659626,9/15/2015 11:53:13,1738687288,9/15/2015 11:52:52,False,fusioncash,0.9389,31742806,USA,OH,Kent,66.61.82.242,FLUOXETINE treats ANXIETY,124,0,,131,10,treats,0.9773555548999999,208517,"[FLUOXETINE] was shown to be effective for depression in 6-week long double-blind controlled trials, where it also alleviated [ANXIETY] and improved sleep.",ANXIETY,FLUOXETINE,TWrex-treat
788659626,9/15/2015 12:00:22,1738689708,9/15/2015 12:00:07,False,prodege,0.9167,27934334,GBR,C8,Croydon,81.159.60.206,FLUOXETINE treats ANXIETY,124,0,,131,10,treats,0.9773555548999999,208517,"[FLUOXETINE] was shown to be effective for depression in 6-week long double-blind controlled trials, where it also alleviated [ANXIETY] and improved sleep.",ANXIETY,FLUOXETINE,TWrex-treat
788659626,9/15/2015 12:14:18,1738694268,9/15/2015 12:12:51,False,clixsense,0.6972,17950689,GBR,L9,Sheffield,146.200.192.103,FLUOXETINE treats ANXIETY,124,0,,131,10,treats,0.9773555548999999,208517,"[FLUOXETINE] was shown to be effective for depression in 6-week long double-blind controlled trials, where it also alleviated [ANXIETY] and improved sleep.",ANXIETY,FLUOXETINE,TWrex-treat
788659626,9/15/2015 12:15:04,1738694607,9/15/2015 12:14:26,False,prodege,0.8754,3056891,CAN,ON,Niagara Falls,173.238.144.19,FLUOXETINE treats ANXIETY,124,0,,131,10,treats,0.9773555548999999,208517,"[FLUOXETINE] was shown to be effective for depression in 6-week long double-blind controlled trials, where it also alleviated [ANXIETY] and improved sleep.",ANXIETY,FLUOXETINE,TWrex-treat
788659626,9/15/2015 12:19:40,1738696425,9/15/2015 12:19:15,False,pocketmoneygpt,0.877,21432964,GBR,F8,Borehamwood,81.159.185.70,FLUOXETINE treats ANXIETY,124,0,,131,10,treats,0.9773555548999999,208517,"[FLUOXETINE] was shown to be effective for depression in 6-week long double-blind controlled trials, where it also alleviated [ANXIETY] and improved sleep.",ANXIETY,FLUOXETINE,TWrex-treat
788659626,9/15/2015 12:24:47,1738698062,9/15/2015 12:22:37,False,neodev,0.7897,34429821,USA,CA,Torrance,66.171.228.249,ANXIETY treats FLUOXETINE,124,0,,131,10,treats,0.9773555548999999,208517,"[FLUOXETINE] was shown to be effective for depression in 6-week long double-blind controlled trials, where it also alleviated [ANXIETY] and improved sleep.",ANXIETY,FLUOXETINE,TWrex-treat
788659637,9/15/2015 10:01:38,1738649629,9/15/2015 10:00:07,False,neodev,0.8889,33644825,USA,IL,Chicago,65.60.20.67,FAMOTIDINE treats DUODENAL ULCER,95,34,,108,44,treats,0.9950371902099889,803533,"Simon B, Dammann HG, Jakob G et alFAMOTIDINE versus ranitidine for the short term treatment of DUODENAL ULCER",DUODENAL ULCER,FAMOTIDINE,TWrex-cause
788659637,9/15/2015 10:03:23,1738650151,9/15/2015 10:03:03,False,gifthulk,0.8056,33936811,AUS,04,Brisbane,121.208.7.253,FAMOTIDINE treats DUODENAL ULCER,95,34,,108,44,treats,0.9950371902099889,803533,"Simon B, Dammann HG, Jakob G et alFAMOTIDINE versus ranitidine for the short term treatment of DUODENAL ULCER",DUODENAL ULCER,FAMOTIDINE,TWrex-cause
788659637,9/15/2015 10:05:33,1738650716,9/15/2015 10:05:12,False,meprizescf,0.8611,28483210,USA,WI,Minocqua,75.143.134.247,FAMOTIDINE treats DUODENAL ULCER,95,34,,108,44,treats,0.9950371902099889,803533,"Simon B, Dammann HG, Jakob G et alFAMOTIDINE versus ranitidine for the short term treatment of DUODENAL ULCER",DUODENAL ULCER,FAMOTIDINE,TWrex-cause
788659637,9/15/2015 10:18:23,1738654327,9/15/2015 10:17:48,False,prodege,0.8764,21417560,GBR,C3,Cambridge,151.224.120.191,FAMOTIDINE treats DUODENAL ULCER,95,34,,108,44,treats,0.9950371902099889,803533,"Simon B, Dammann HG, Jakob G et alFAMOTIDINE versus ranitidine for the short term treatment of DUODENAL ULCER",DUODENAL ULCER,FAMOTIDINE,TWrex-cause
788659637,9/15/2015 10:20:23,1738654790,9/15/2015 10:20:04,False,prodege,0.7056,4316379,CAN,ON,Windsor,198.91.219.55,no_relation,95,34,,108,44,treats,0.9950371902099889,803533,"Simon B, Dammann HG, Jakob G et alFAMOTIDINE versus ranitidine for the short term treatment of DUODENAL ULCER",DUODENAL ULCER,FAMOTIDINE,TWrex-cause
788659637,9/15/2015 10:21:08,1738654986,9/15/2015 10:20:49,False,gifthunterclub,0.8036,30901412,GBR,H9,London,77.89.149.62,FAMOTIDINE treats DUODENAL ULCER,95,34,,108,44,treats,0.9950371902099889,803533,"Simon B, Dammann HG, Jakob G et alFAMOTIDINE versus ranitidine for the short term treatment of DUODENAL ULCER",DUODENAL ULCER,FAMOTIDINE,TWrex-cause
788659637,9/15/2015 10:22:32,1738655366,9/15/2015 10:21:32,False,keeprewarding,0.8556,29139615,CAN,ON,Perth,192.186.81.178,FAMOTIDINE treats DUODENAL ULCER,95,34,,108,44,treats,0.9950371902099889,803533,"Simon B, Dammann HG, Jakob G et alFAMOTIDINE versus ranitidine for the short term treatment of DUODENAL ULCER",DUODENAL ULCER,FAMOTIDINE,TWrex-cause
788659647,9/15/2015 11:47:04,1738684555,9/15/2015 11:46:52,False,elite,0.9048,31883685,GBR,,,79.66.254.237,RILUZOLE treats AMYOTROPHIC LATERAL SCLEROSIS,13,0,,41,8,treats,0.938314863256837,907922,RILUZOLE for AMYOTROPHIC LATERAL SCLEROSIS (ALS)/motor neuron disease (MND.,AMYOTROPHIC LATERAL SCLEROSIS,RILUZOLE,RO-may_treat
788659647,9/15/2015 11:53:13,1738687284,9/15/2015 11:52:52,False,fusioncash,0.9389,31742806,USA,OH,Kent,66.61.82.242,RILUZOLE treats AMYOTROPHIC LATERAL SCLEROSIS,13,0,,41,8,treats,0.938314863256837,907922,RILUZOLE for AMYOTROPHIC LATERAL SCLEROSIS (ALS)/motor neuron disease (MND.,AMYOTROPHIC LATERAL SCLEROSIS,RILUZOLE,RO-may_treat
788659647,9/15/2015 12:00:22,1738689706,9/15/2015 12:00:07,False,prodege,0.9167,27934334,GBR,C8,Croydon,81.159.60.206,RILUZOLE treats AMYOTROPHIC LATERAL SCLEROSIS,13,0,,41,8,treats,0.938314863256837,907922,RILUZOLE for AMYOTROPHIC LATERAL SCLEROSIS (ALS)/motor neuron disease (MND.,AMYOTROPHIC LATERAL SCLEROSIS,RILUZOLE,RO-may_treat
788659647,9/15/2015 12:14:18,1738694267,9/15/2015 12:12:51,False,clixsense,0.6972,17950689,GBR,L9,Sheffield,146.200.192.103,AMYOTROPHIC LATERAL SCLEROSIS treats RILUZOLE,13,0,,41,8,treats,0.938314863256837,907922,RILUZOLE for AMYOTROPHIC LATERAL SCLEROSIS (ALS)/motor neuron disease (MND.,AMYOTROPHIC LATERAL SCLEROSIS,RILUZOLE,RO-may_treat
788659647,9/15/2015 12:15:04,1738694604,9/15/2015 12:14:26,False,prodege,0.8754,3056891,CAN,ON,Niagara Falls,173.238.144.19,RILUZOLE treats AMYOTROPHIC LATERAL SCLEROSIS,13,0,,41,8,treats,0.938314863256837,907922,RILUZOLE for AMYOTROPHIC LATERAL SCLEROSIS (ALS)/motor neuron disease (MND.,AMYOTROPHIC LATERAL SCLEROSIS,RILUZOLE,RO-may_treat
788659647,9/15/2015 12:19:40,1738696424,9/15/2015 12:19:15,False,pocketmoneygpt,0.877,21432964,GBR,F8,Borehamwood,81.159.185.70,RILUZOLE treats AMYOTROPHIC LATERAL SCLEROSIS,13,0,,41,8,treats,0.938314863256837,907922,RILUZOLE for AMYOTROPHIC LATERAL SCLEROSIS (ALS)/motor neuron disease (MND.,AMYOTROPHIC LATERAL SCLEROSIS,RILUZOLE,RO-may_treat
788659647,9/15/2015 12:24:47,1738698063,9/15/2015 12:22:37,False,neodev,0.7897,34429821,USA,CA,Torrance,66.171.228.249,RILUZOLE treats AMYOTROPHIC LATERAL SCLEROSIS,13,0,,41,8,treats,0.938314863256837,907922,RILUZOLE for AMYOTROPHIC LATERAL SCLEROSIS (ALS)/motor neuron disease (MND.,AMYOTROPHIC LATERAL SCLEROSIS,RILUZOLE,RO-may_treat
788659653,9/15/2015 09:14:42,1738637351,9/15/2015 09:13:32,False,clixsense,0.9028,30681826,GBR,I9,Diss,31.49.71.254,no_relation,39,51,,42,78,treats,0.870062840141097,803399,There was a significant alleviation of PAIN in the CHONDROITIN SULFATE TREATED groups compared to placebo.,PAIN,CHONDROITIN SULFATE TREATED,TWrex-cause
788659653,9/15/2015 09:16:07,1738637633,9/15/2015 09:15:55,False,neodev,0.7083,32053642,GBR,I7,Newcastle Upon Tyne,92.23.136.205,no_relation,39,51,,42,78,treats,0.870062840141097,803399,There was a significant alleviation of PAIN in the CHONDROITIN SULFATE TREATED groups compared to placebo.,PAIN,CHONDROITIN SULFATE TREATED,TWrex-cause
788659653,9/15/2015 09:17:39,1738637824,9/15/2015 09:16:49,False,neodev,0.7778,20306047,GBR,,,80.41.0.252,CHONDROITIN SULFATE TREATED treats PAIN,39,51,,42,78,treats,0.870062840141097,803399,There was a significant alleviation of PAIN in the CHONDROITIN SULFATE TREATED groups compared to placebo.,PAIN,CHONDROITIN SULFATE TREATED,TWrex-cause
788659653,9/15/2015 09:27:04,1738639793,9/15/2015 09:26:28,False,tremorgames,0.8333,32655637,CAN,ON,Markham,135.23.223.26,CHONDROITIN SULFATE TREATED treats PAIN,39,51,,42,78,treats,0.870062840141097,803399,There was a significant alleviation of PAIN in the CHONDROITIN SULFATE TREATED groups compared to placebo.,PAIN,CHONDROITIN SULFATE TREATED,TWrex-cause
788659653,9/15/2015 09:36:05,1738642450,9/15/2015 09:35:43,False,clixsense,0.775,22751911,NLD,04,Groningen,195.241.153.97,CHONDROITIN SULFATE TREATED treats PAIN,39,51,,42,78,treats,0.870062840141097,803399,There was a significant alleviation of PAIN in the CHONDROITIN SULFATE TREATED groups compared to placebo.,PAIN,CHONDROITIN SULFATE TREATED,TWrex-cause
788659653,9/15/2015 09:38:11,1738643181,9/15/2015 09:37:27,False,treasuretrooper,0.625,17956656,AUS,02,Jannali,14.200.59.55,no_relation,39,51,,42,78,treats,0.870062840141097,803399,There was a significant alleviation of PAIN in the CHONDROITIN SULFATE TREATED groups compared to placebo.,PAIN,CHONDROITIN SULFATE TREATED,TWrex-cause
788659653,9/15/2015 09:41:21,1738644216,9/15/2015 09:41:09,False,instagc,0.7857,18960682,GBR,U2,Annan,92.18.213.181,CHONDROITIN SULFATE TREATED treats PAIN,39,51,,42,78,treats,0.870062840141097,803399,There was a significant alleviation of PAIN in the CHONDROITIN SULFATE TREATED groups compared to placebo.,PAIN,CHONDROITIN SULFATE TREATED,TWrex-cause
788659662,9/15/2015 15:38:50,1738758030,9/15/2015 15:38:12,False,clixsense,0.7083,22984878,CAN,ON,Kingston,67.193.186.57,no_relation,128,192,,160,206,treats,0.8888888888888891,804325,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent POSTOPERATIVE NAUSEA AND VOMITING consider the possibility that METOCLOPRAMIDE theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE,TWrex-cause
788659662,9/15/2015 15:40:45,1738758583,9/15/2015 15:40:32,False,neodev,0.3857,33155316,GBR,I9,Dereham,31.50.244.140,POSTOPERATIVE NAUSEA AND VOMITING treats METOCLOPRAMIDE,128,192,,160,206,treats,0.8888888888888891,804325,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent POSTOPERATIVE NAUSEA AND VOMITING consider the possibility that METOCLOPRAMIDE theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE,TWrex-cause
788659662,9/15/2015 15:45:06,1738759859,9/15/2015 15:44:45,False,clixsense,0.6111,32053717,GBR,,,51.174.76.80,METOCLOPRAMIDE treats POSTOPERATIVE NAUSEA AND VOMITING,128,192,,160,206,treats,0.8888888888888891,804325,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent POSTOPERATIVE NAUSEA AND VOMITING consider the possibility that METOCLOPRAMIDE theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE,TWrex-cause
788659662,9/15/2015 15:48:21,1738760827,9/15/2015 15:48:07,False,neodev,0.625,33895262,USA,VA,Mclean,63.141.204.167,no_relation,128,192,,160,206,treats,0.8888888888888891,804325,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent POSTOPERATIVE NAUSEA AND VOMITING consider the possibility that METOCLOPRAMIDE theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE,TWrex-cause
788659662,9/15/2015 15:55:38,1738763481,9/15/2015 15:54:41,False,onestopgpt,0.6571,21275875,CAN,ON,Hamilton,24.36.124.79,METOCLOPRAMIDE treats POSTOPERATIVE NAUSEA AND VOMITING,128,192,,160,206,treats,0.8888888888888891,804325,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent POSTOPERATIVE NAUSEA AND VOMITING consider the possibility that METOCLOPRAMIDE theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE,TWrex-cause
788659662,9/15/2015 16:06:42,1738768291,9/15/2015 16:05:43,False,instagc,0.6667,33058612,USA,IL,Glenview,162.229.106.229,METOCLOPRAMIDE treats POSTOPERATIVE NAUSEA AND VOMITING,128,192,,160,206,treats,0.8888888888888891,804325,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent POSTOPERATIVE NAUSEA AND VOMITING consider the possibility that METOCLOPRAMIDE theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE,TWrex-cause
788659662,9/15/2015 16:09:28,1738769427,9/15/2015 16:08:43,False,neodev,1.0,31326282,NLD,,,82.169.243.65,no_relation,128,192,,160,206,treats,0.8888888888888891,804325,"11 ,   12  General Precautions  GI Anastomosis or Closure  When deciding whether to use metoclopramide or NG suction to prevent POSTOPERATIVE NAUSEA AND VOMITING consider the possibility that METOCLOPRAMIDE theoretically could produce increased pressure on suture lines following GI anastomosis or closure.",POSTOPERATIVE NAUSEA AND VOMITING,METOCLOPRAMIDE,TWrex-cause
788659672,9/15/2015 09:15:37,1738637544,9/15/2015 09:15:11,False,clixsense,0.9028,30681826,GBR,I9,Diss,31.49.71.254,TOPICAL STEROID treats ITCHING,64,23,,71,38,treats,1.0,221085,Oral antihistamines or [TOPICAL STEROID]s may be used to decrease [ITCHING].,ITCHING,TOPICAL STEROID,TWrex-treat
788659672,9/15/2015 09:16:45,1738637723,9/15/2015 09:16:30,False,neodev,0.7083,32053642,GBR,I7,Newcastle Upon Tyne,92.23.136.205,TOPICAL STEROID treats ITCHING,64,23,,71,38,treats,1.0,221085,Oral antihistamines or [TOPICAL STEROID]s may be used to decrease [ITCHING].,ITCHING,TOPICAL STEROID,TWrex-treat
788659672,9/15/2015 09:18:06,1738637900,9/15/2015 09:17:56,False,neodev,0.7778,20306047,GBR,,,80.41.0.252,TOPICAL STEROID treats ITCHING,64,23,,71,38,treats,1.0,221085,Oral antihistamines or [TOPICAL STEROID]s may be used to decrease [ITCHING].,ITCHING,TOPICAL STEROID,TWrex-treat
788659672,9/15/2015 09:28:09,1738640063,9/15/2015 09:27:38,False,tremorgames,0.8333,32655637,CAN,ON,Markham,135.23.223.26,TOPICAL STEROID treats ITCHING,64,23,,71,38,treats,1.0,221085,Oral antihistamines or [TOPICAL STEROID]s may be used to decrease [ITCHING].,ITCHING,TOPICAL STEROID,TWrex-treat
788659672,9/15/2015 09:36:44,1738642690,9/15/2015 09:36:26,False,clixsense,0.775,22751911,NLD,04,Groningen,195.241.153.97,TOPICAL STEROID treats ITCHING,64,23,,71,38,treats,1.0,221085,Oral antihistamines or [TOPICAL STEROID]s may be used to decrease [ITCHING].,ITCHING,TOPICAL STEROID,TWrex-treat
788659672,9/15/2015 09:38:59,1738643541,9/15/2015 09:38:42,False,treasuretrooper,0.625,17956656,AUS,02,Jannali,14.200.59.55,TOPICAL STEROID treats ITCHING,64,23,,71,38,treats,1.0,221085,Oral antihistamines or [TOPICAL STEROID]s may be used to decrease [ITCHING].,ITCHING,TOPICAL STEROID,TWrex-treat
788659672,9/15/2015 09:41:48,1738644371,9/15/2015 09:41:39,False,instagc,0.7857,18960682,GBR,U2,Annan,92.18.213.181,TOPICAL STEROID treats ITCHING,64,23,,71,38,treats,1.0,221085,Oral antihistamines or [TOPICAL STEROID]s may be used to decrease [ITCHING].,ITCHING,TOPICAL STEROID,TWrex-treat
788659673,9/15/2015 11:11:52,1738667232,9/15/2015 11:11:32,False,elite,0.7333,34356654,USA,CA,San Jose,50.118.198.254,RAVUCONAZOLE treats ZYGOMYCETES,89,9,,100,21,treats,0.5601120336,213851,"However, [RAVUCONAZOLE] has limited activity against species of fusarium, scedosporium and [ZYGOMYCETES].",ZYGOMYCETES,RAVUCONAZOLE,TWrex-treat
788659673,9/15/2015 11:16:30,1738669275,9/15/2015 11:15:23,False,neodev,0.6468,11001780,AUS,07,Elwood,14.201.215.31,RAVUCONAZOLE treats ZYGOMYCETES,89,9,,100,21,treats,0.5601120336,213851,"However, [RAVUCONAZOLE] has limited activity against species of fusarium, scedosporium and [ZYGOMYCETES].",ZYGOMYCETES,RAVUCONAZOLE,TWrex-treat
788659673,9/15/2015 11:18:20,1738670101,9/15/2015 11:18:08,False,clixsense,0.8097,19638651,USA,SC,Summerville,174.107.73.211,RAVUCONAZOLE treats ZYGOMYCETES,89,9,,100,21,treats,0.5601120336,213851,"However, [RAVUCONAZOLE] has limited activity against species of fusarium, scedosporium and [ZYGOMYCETES].",ZYGOMYCETES,RAVUCONAZOLE,TWrex-treat
788659673,9/15/2015 11:19:30,1738670768,9/15/2015 11:19:15,False,clixsense,0.6431,10390268,USA,NY,New Paltz,100.40.136.250,no_relation,89,9,,100,21,treats,0.5601120336,213851,"However, [RAVUCONAZOLE] has limited activity against species of fusarium, scedosporium and [ZYGOMYCETES].",ZYGOMYCETES,RAVUCONAZOLE,TWrex-treat
788659673,9/15/2015 11:22:01,1738672246,9/15/2015 11:21:16,False,clixsense,0.7357,21875134,GBR,,,80.189.12.98,RAVUCONAZOLE treats ZYGOMYCETES,89,9,,100,21,treats,0.5601120336,213851,"However, [RAVUCONAZOLE] has limited activity against species of fusarium, scedosporium and [ZYGOMYCETES].",ZYGOMYCETES,RAVUCONAZOLE,TWrex-treat
788659673,9/15/2015 11:32:00,1738677901,9/15/2015 11:31:36,False,clixsense,0.7559999999999999,24104564,AUS,02,Surry Hills,60.241.132.132,RAVUCONAZOLE treats ZYGOMYCETES,89,9,,100,21,treats,0.5601120336,213851,"However, [RAVUCONAZOLE] has limited activity against species of fusarium, scedosporium and [ZYGOMYCETES].",ZYGOMYCETES,RAVUCONAZOLE,TWrex-treat
788659673,9/15/2015 11:36:31,1738679724,9/15/2015 11:36:01,False,prodege,0.9365,14848125,GBR,V8,Airdrie,86.151.77.161,RAVUCONAZOLE treats ZYGOMYCETES,89,9,,100,21,treats,0.5601120336,213851,"However, [RAVUCONAZOLE] has limited activity against species of fusarium, scedosporium and [ZYGOMYCETES].",ZYGOMYCETES,RAVUCONAZOLE,TWrex-treat
788659679,9/15/2015 12:25:41,1738698284,9/15/2015 12:25:20,False,clixsense,0.9762,30777913,GBR,U8,Edinburgh,92.239.140.40,SINGLE DOSE CEFUROXIME AXETIL treats UNCOMPLICATED GONORRHEA,92,42,,114,71,treats,1.0,803565,"Reichman RC, Nolte FS, Wolinsky SM et al. SINGLE DOSE CEFUROXIME AXETIL in the treatment of UNCOMPLICATED GONORRHEA: a controlled trial.",UNCOMPLICATED GONORRHEA,SINGLE DOSE CEFUROXIME AXETIL,TWrex-cause
788659679,9/15/2015 12:26:50,1738698675,9/15/2015 12:26:36,False,neodev,0.7897,34429821,USA,CA,Torrance,66.171.228.249,SINGLE DOSE CEFUROXIME AXETIL treats UNCOMPLICATED GONORRHEA,92,42,,114,71,treats,1.0,803565,"Reichman RC, Nolte FS, Wolinsky SM et al. SINGLE DOSE CEFUROXIME AXETIL in the treatment of UNCOMPLICATED GONORRHEA: a controlled trial.",UNCOMPLICATED GONORRHEA,SINGLE DOSE CEFUROXIME AXETIL,TWrex-cause
788659679,9/15/2015 12:33:05,1738700762,9/15/2015 12:32:39,False,neodev,0.7528,33758777,USA,,,38.95.108.251,SINGLE DOSE CEFUROXIME AXETIL treats UNCOMPLICATED GONORRHEA,92,42,,114,71,treats,1.0,803565,"Reichman RC, Nolte FS, Wolinsky SM et al. SINGLE DOSE CEFUROXIME AXETIL in the treatment of UNCOMPLICATED GONORRHEA: a controlled trial.",UNCOMPLICATED GONORRHEA,SINGLE DOSE CEFUROXIME AXETIL,TWrex-cause
788659679,9/15/2015 12:35:36,1738701789,9/15/2015 12:35:19,False,neodev,0.9208,12115558,USA,OH,Twinsburg,98.27.164.131,SINGLE DOSE CEFUROXIME AXETIL treats UNCOMPLICATED GONORRHEA,92,42,,114,71,treats,1.0,803565,"Reichman RC, Nolte FS, Wolinsky SM et al. SINGLE DOSE CEFUROXIME AXETIL in the treatment of UNCOMPLICATED GONORRHEA: a controlled trial.",UNCOMPLICATED GONORRHEA,SINGLE DOSE CEFUROXIME AXETIL,TWrex-cause
788659679,9/15/2015 12:37:04,1738702309,9/15/2015 12:36:38,False,vivatic,0.7972,32338429,GBR,N7,Guildford,92.21.219.178,SINGLE DOSE CEFUROXIME AXETIL treats UNCOMPLICATED GONORRHEA,92,42,,114,71,treats,1.0,803565,"Reichman RC, Nolte FS, Wolinsky SM et al. SINGLE DOSE CEFUROXIME AXETIL in the treatment of UNCOMPLICATED GONORRHEA: a controlled trial.",UNCOMPLICATED GONORRHEA,SINGLE DOSE CEFUROXIME AXETIL,TWrex-cause
788659679,9/15/2015 12:42:29,1738704027,9/15/2015 12:42:18,False,instagc,1.0,13581319,USA,IL,Trenton,208.70.36.12,SINGLE DOSE CEFUROXIME AXETIL treats UNCOMPLICATED GONORRHEA,92,42,,114,71,treats,1.0,803565,"Reichman RC, Nolte FS, Wolinsky SM et al. SINGLE DOSE CEFUROXIME AXETIL in the treatment of UNCOMPLICATED GONORRHEA: a controlled trial.",UNCOMPLICATED GONORRHEA,SINGLE DOSE CEFUROXIME AXETIL,TWrex-cause
788659679,9/15/2015 12:42:48,1738704081,9/15/2015 12:42:22,False,prodege,0.6643,24945126,GBR,K8,Ilford,82.12.220.44,SINGLE DOSE CEFUROXIME AXETIL treats UNCOMPLICATED GONORRHEA,92,42,,114,71,treats,1.0,803565,"Reichman RC, Nolte FS, Wolinsky SM et al. SINGLE DOSE CEFUROXIME AXETIL in the treatment of UNCOMPLICATED GONORRHEA: a controlled trial.",UNCOMPLICATED GONORRHEA,SINGLE DOSE CEFUROXIME AXETIL,TWrex-cause
788659682,9/15/2015 12:26:01,1738698420,9/15/2015 12:25:42,False,clixsense,0.9762,30777913,GBR,U8,Edinburgh,92.239.140.40,[IMATINIB] treats [TUMORS],121,142,,126,149,treats,0.9494253265550829,206509,The same group in Italy found that the combination of imatinib and sirolimus caused a response in several patients whose [TUMORS] progressed on [IMATINIB] alone.,[TUMORS],[IMATINIB],TWrex-treat
788659682,9/15/2015 12:27:06,1738698737,9/15/2015 12:26:52,False,neodev,0.7897,34429821,USA,CA,Torrance,66.171.228.249,[IMATINIB] treats [TUMORS],121,142,,126,149,treats,0.9494253265550829,206509,The same group in Italy found that the combination of imatinib and sirolimus caused a response in several patients whose [TUMORS] progressed on [IMATINIB] alone.,[TUMORS],[IMATINIB],TWrex-treat
788659682,9/15/2015 12:33:39,1738701040,9/15/2015 12:33:07,False,neodev,0.7528,33758777,USA,,,38.95.108.251,[IMATINIB] treats [TUMORS],121,142,,126,149,treats,0.9494253265550829,206509,The same group in Italy found that the combination of imatinib and sirolimus caused a response in several patients whose [TUMORS] progressed on [IMATINIB] alone.,[TUMORS],[IMATINIB],TWrex-treat
788659682,9/15/2015 12:35:50,1738701862,9/15/2015 12:35:37,False,neodev,0.9208,12115558,USA,OH,Twinsburg,98.27.164.131,[IMATINIB] treats [TUMORS],121,142,,126,149,treats,0.9494253265550829,206509,The same group in Italy found that the combination of imatinib and sirolimus caused a response in several patients whose [TUMORS] progressed on [IMATINIB] alone.,[TUMORS],[IMATINIB],TWrex-treat
788659682,9/15/2015 12:37:34,1738702533,9/15/2015 12:37:05,False,vivatic,0.7972,32338429,GBR,N7,Guildford,92.21.219.178,[IMATINIB] treats [TUMORS],121,142,,126,149,treats,0.9494253265550829,206509,The same group in Italy found that the combination of imatinib and sirolimus caused a response in several patients whose [TUMORS] progressed on [IMATINIB] alone.,[TUMORS],[IMATINIB],TWrex-treat
788659682,9/15/2015 12:42:39,1738704073,9/15/2015 12:42:30,False,instagc,1.0,13581319,USA,IL,Trenton,208.70.36.12,[IMATINIB] treats [TUMORS],121,142,,126,149,treats,0.9494253265550829,206509,The same group in Italy found that the combination of imatinib and sirolimus caused a response in several patients whose [TUMORS] progressed on [IMATINIB] alone.,[TUMORS],[IMATINIB],TWrex-treat
788659682,9/15/2015 12:43:20,1738704188,9/15/2015 12:42:49,False,prodege,0.6643,24945126,GBR,K8,Ilford,82.12.220.44,no_relation,121,142,,126,149,treats,0.9494253265550829,206509,The same group in Italy found that the combination of imatinib and sirolimus caused a response in several patients whose [TUMORS] progressed on [IMATINIB] alone.,[TUMORS],[IMATINIB],TWrex-treat
788659683,9/15/2015 09:57:09,1738648471,9/15/2015 09:57:00,False,neodev,1.0,14096345,NLD,03,Eibergen,178.85.94.186,no_relation,16,29,,24,51,treats,0.956182887467515,804799,The response of PSORIASIS to BETAMETHASONE VALERATE and clobetasol propionate: a 6 month controlled study.,PSORIASIS,BETAMETHASONE VALERATE,TWrex-cause
788659683,9/15/2015 09:58:35,1738648832,9/15/2015 09:57:25,False,neodev,0.8889,33644825,USA,IL,Chicago,65.60.20.67,BETAMETHASONE VALERATE treats PSORIASIS,16,29,,24,51,treats,0.956182887467515,804799,The response of PSORIASIS to BETAMETHASONE VALERATE and clobetasol propionate: a 6 month controlled study.,PSORIASIS,BETAMETHASONE VALERATE,TWrex-cause
788659683,9/15/2015 09:59:11,1738648934,9/15/2015 09:58:49,False,gifthulk,0.8056,33936811,AUS,04,Brisbane,121.208.7.253,BETAMETHASONE VALERATE treats PSORIASIS,16,29,,24,51,treats,0.956182887467515,804799,The response of PSORIASIS to BETAMETHASONE VALERATE and clobetasol propionate: a 6 month controlled study.,PSORIASIS,BETAMETHASONE VALERATE,TWrex-cause
788659683,9/15/2015 10:04:22,1738650429,9/15/2015 10:04:09,False,meprizescf,0.8611,28483210,USA,WI,Minocqua,75.143.134.247,BETAMETHASONE VALERATE treats PSORIASIS,16,29,,24,51,treats,0.956182887467515,804799,The response of PSORIASIS to BETAMETHASONE VALERATE and clobetasol propionate: a 6 month controlled study.,PSORIASIS,BETAMETHASONE VALERATE,TWrex-cause
788659683,9/15/2015 10:16:05,1738653772,9/15/2015 10:15:39,False,prodege,0.8764,21417560,GBR,C3,Cambridge,151.224.120.191,BETAMETHASONE VALERATE treats PSORIASIS,16,29,,24,51,treats,0.956182887467515,804799,The response of PSORIASIS to BETAMETHASONE VALERATE and clobetasol propionate: a 6 month controlled study.,PSORIASIS,BETAMETHASONE VALERATE,TWrex-cause
788659683,9/15/2015 10:18:55,1738654439,9/15/2015 10:18:30,False,prodege,0.7056,4316379,CAN,ON,Windsor,198.91.219.55,no_relation,16,29,,24,51,treats,0.956182887467515,804799,The response of PSORIASIS to BETAMETHASONE VALERATE and clobetasol propionate: a 6 month controlled study.,PSORIASIS,BETAMETHASONE VALERATE,TWrex-cause
788659683,9/15/2015 10:21:32,1738655097,9/15/2015 10:19:40,False,keeprewarding,0.8556,29139615,CAN,ON,Perth,192.186.81.178,no_relation,16,29,,24,51,treats,0.956182887467515,804799,The response of PSORIASIS to BETAMETHASONE VALERATE and clobetasol propionate: a 6 month controlled study.,PSORIASIS,BETAMETHASONE VALERATE,TWrex-cause
788659698,9/15/2015 10:25:10,1738656133,9/15/2015 10:24:16,False,keeprewarding,0.8556,29139615,CAN,ON,Perth,192.186.81.178,NIT treats LICE,120,99,,123,102,treats,0.857492925712544,815154,"Parents were to wash the hair, apply lots of conditioner, comb the hair straight, and then use the NIT comb to comb out LICE until none were found.",LICE,NIT,TWrex-cause
788659698,9/15/2015 10:25:18,1738656172,9/15/2015 10:25:02,False,prodege,0.8151,9169061,CAN,ON,Kitchener,99.235.192.130,NIT treats LICE,120,99,,123,102,treats,0.857492925712544,815154,"Parents were to wash the hair, apply lots of conditioner, comb the hair straight, and then use the NIT comb to comb out LICE until none were found.",LICE,NIT,TWrex-cause
788659698,9/15/2015 10:32:02,1738657646,9/15/2015 10:31:00,False,gifthunterclub,0.85,24043308,GBR,,,94.102.147.250,no_relation,120,99,,123,102,treats,0.857492925712544,815154,"Parents were to wash the hair, apply lots of conditioner, comb the hair straight, and then use the NIT comb to comb out LICE until none were found.",LICE,NIT,TWrex-cause
788659698,9/15/2015 10:36:45,1738658819,9/15/2015 10:35:46,False,clixsense,0.7167,6344072,CAN,BC,Burnaby,172.218.166.58,NIT treats LICE,120,99,,123,102,treats,0.857492925712544,815154,"Parents were to wash the hair, apply lots of conditioner, comb the hair straight, and then use the NIT comb to comb out LICE until none were found.",LICE,NIT,TWrex-cause
788659698,9/15/2015 10:37:25,1738659045,9/15/2015 10:36:32,False,neodev,0.7063,33238512,CAN,AB,Calgary,136.159.234.238,no_relation,120,99,,123,102,treats,0.857492925712544,815154,"Parents were to wash the hair, apply lots of conditioner, comb the hair straight, and then use the NIT comb to comb out LICE until none were found.",LICE,NIT,TWrex-cause
788659698,9/15/2015 10:46:25,1738661422,9/15/2015 10:45:56,False,clixsense,0.8958,21490235,GBR,N7,Woking,86.30.254.232,no_relation,120,99,,123,102,treats,0.857492925712544,815154,"Parents were to wash the hair, apply lots of conditioner, comb the hair straight, and then use the NIT comb to comb out LICE until none were found.",LICE,NIT,TWrex-cause
788659698,9/15/2015 10:59:25,1738664271,9/15/2015 10:58:18,False,points4rewards,0.5893,20113482,USA,PA,Philadelphia,162.208.49.45,NIT treats LICE,120,99,,123,102,treats,0.857492925712544,815154,"Parents were to wash the hair, apply lots of conditioner, comb the hair straight, and then use the NIT comb to comb out LICE until none were found.",LICE,NIT,TWrex-cause
788659700,9/15/2015 12:36:30,1738702093,9/15/2015 12:36:19,False,neodev,0.9208,12115558,USA,OH,Twinsburg,98.27.164.131,CEFTRIAXONE treats BACTERIAL MENINGITIS,53,14,,73,25,treats,0.875,907846,Comparison of CEFTRIAXONE and traditional therapy of BACTERIAL MENINGITIS,BACTERIAL MENINGITIS,CEFTRIAXONE,RO-may_treat
788659700,9/15/2015 12:38:44,1738702876,9/15/2015 12:36:55,False,neodev,0.7528,33758777,USA,,,38.95.108.251,no_relation,53,14,,73,25,treats,0.875,907846,Comparison of CEFTRIAXONE and traditional therapy of BACTERIAL MENINGITIS,BACTERIAL MENINGITIS,CEFTRIAXONE,RO-may_treat
788659700,9/15/2015 12:39:09,1738703050,9/15/2015 12:38:43,False,vivatic,0.7972,32338429,GBR,N7,Guildford,92.21.219.178,CEFTRIAXONE treats BACTERIAL MENINGITIS,53,14,,73,25,treats,0.875,907846,Comparison of CEFTRIAXONE and traditional therapy of BACTERIAL MENINGITIS,BACTERIAL MENINGITIS,CEFTRIAXONE,RO-may_treat
788659700,9/15/2015 12:44:48,1738704717,9/15/2015 12:44:28,False,prodege,0.8024,3587109,CAN,NS,Sydney,142.177.43.123,no_relation,53,14,,73,25,treats,0.875,907846,Comparison of CEFTRIAXONE and traditional therapy of BACTERIAL MENINGITIS,BACTERIAL MENINGITIS,CEFTRIAXONE,RO-may_treat
788659700,9/15/2015 12:46:52,1738705369,9/15/2015 12:45:03,False,prodege,0.6643,24945126,GBR,K8,Ilford,82.12.220.44,CEFTRIAXONE treats BACTERIAL MENINGITIS,53,14,,73,25,treats,0.875,907846,Comparison of CEFTRIAXONE and traditional therapy of BACTERIAL MENINGITIS,BACTERIAL MENINGITIS,CEFTRIAXONE,RO-may_treat
788659700,9/15/2015 12:55:40,1738707436,9/15/2015 12:55:31,False,zoombucks,0.45,4711962,CAN,ON,Markham,174.88.29.138,CEFTRIAXONE treats BACTERIAL MENINGITIS,53,14,,73,25,treats,0.875,907846,Comparison of CEFTRIAXONE and traditional therapy of BACTERIAL MENINGITIS,BACTERIAL MENINGITIS,CEFTRIAXONE,RO-may_treat
788659700,9/15/2015 13:21:00,1738714359,9/15/2015 13:20:52,False,clixsense,0.5714,19162475,GBR,P8,Trowbridge,82.33.126.30,CEFTRIAXONE treats BACTERIAL MENINGITIS,53,14,,73,25,treats,0.875,907846,Comparison of CEFTRIAXONE and traditional therapy of BACTERIAL MENINGITIS,BACTERIAL MENINGITIS,CEFTRIAXONE,RO-may_treat
788659702,9/15/2015 10:33:05,1738657952,9/15/2015 10:32:43,False,gifthunterclub,0.85,24043308,GBR,,,94.102.147.250,TOTAL THYROXINE treats THYROID DISEASE,154,203,,168,218,treats,0.629940788348712,906870,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
788659702,9/15/2015 10:36:48,1738658835,9/15/2015 10:27:13,False,prodege,0.8151,9169061,CAN,ON,Kitchener,99.235.192.130,TOTAL THYROXINE treats THYROID DISEASE,154,203,,168,218,treats,0.629940788348712,906870,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
788659702,9/15/2015 10:39:01,1738659464,9/15/2015 10:38:20,False,neodev,0.7063,33238512,CAN,AB,Calgary,136.159.234.238,TOTAL THYROXINE treats THYROID DISEASE,154,203,,168,218,treats,0.629940788348712,906870,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
788659702,9/15/2015 10:47:36,1738661663,9/15/2015 10:47:18,False,clixsense,0.8958,21490235,GBR,N7,Woking,86.30.254.232,TOTAL THYROXINE treats THYROID DISEASE,154,203,,168,218,treats,0.629940788348712,906870,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
788659702,9/15/2015 11:01:22,1738664741,9/15/2015 11:00:13,False,prodege,0.7103,6309240,USA,CA,San Diego,76.167.68.73,TOTAL THYROXINE treats THYROID DISEASE,154,203,,168,218,treats,0.629940788348712,906870,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
788659702,9/15/2015 11:03:07,1738665112,9/15/2015 11:02:43,False,clixsense,0.6488,28351359,GBR,K8,Ilford,80.44.178.106,no_relation,154,203,,168,218,treats,0.629940788348712,906870,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
788659702,9/15/2015 11:07:21,1738666064,9/15/2015 11:02:05,False,points4rewards,0.5893,20113482,USA,PA,Philadelphia,162.208.49.45,no_relation,154,203,,168,218,treats,0.629940788348712,906870,"Each patient had a physical examination performed by his or her primary care provider, was given a standardized questionnaire that focused on symptoms of THYROID DISEASE and underwent a venipuncture for TOTAL THYROXINE triiodothyronine resin uptake and thyrotropin (TSH) concentration.",THYROID DISEASE,TOTAL THYROXINE,RO-may_diagnose
788659704,9/15/2015 11:47:17,1738684636,9/15/2015 11:47:05,False,elite,0.9048,31883685,GBR,,,79.66.254.237,THALIDOMIDE treats ACTINIC PRURIGO,85,15,,100,26,treats,0.9684959969581859,212552,"In some cases, [THALIDOMIDE] has proven to be effective in controlling the symptoms of [ACTINIC PRURIGO].",ACTINIC PRURIGO,THALIDOMIDE,TWrex-treat
788659704,9/15/2015 11:53:35,1738687420,9/15/2015 11:53:13,False,fusioncash,0.9389,31742806,USA,OH,Kent,66.61.82.242,THALIDOMIDE treats ACTINIC PRURIGO,85,15,,100,26,treats,0.9684959969581859,212552,"In some cases, [THALIDOMIDE] has proven to be effective in controlling the symptoms of [ACTINIC PRURIGO].",ACTINIC PRURIGO,THALIDOMIDE,TWrex-treat
788659704,9/15/2015 12:00:46,1738689810,9/15/2015 12:00:23,False,prodege,0.9167,27934334,GBR,C8,Croydon,81.159.60.206,THALIDOMIDE treats ACTINIC PRURIGO,85,15,,100,26,treats,0.9684959969581859,212552,"In some cases, [THALIDOMIDE] has proven to be effective in controlling the symptoms of [ACTINIC PRURIGO].",ACTINIC PRURIGO,THALIDOMIDE,TWrex-treat
788659704,9/15/2015 12:15:21,1738694676,9/15/2015 12:14:19,False,clixsense,0.6972,17950689,GBR,L9,Sheffield,146.200.192.103,THALIDOMIDE treats ACTINIC PRURIGO,85,15,,100,26,treats,0.9684959969581859,212552,"In some cases, [THALIDOMIDE] has proven to be effective in controlling the symptoms of [ACTINIC PRURIGO].",ACTINIC PRURIGO,THALIDOMIDE,TWrex-treat
788659704,9/15/2015 12:15:26,1738694697,9/15/2015 12:15:05,False,prodege,0.8754,3056891,CAN,ON,Niagara Falls,173.238.144.19,THALIDOMIDE treats ACTINIC PRURIGO,85,15,,100,26,treats,0.9684959969581859,212552,"In some cases, [THALIDOMIDE] has proven to be effective in controlling the symptoms of [ACTINIC PRURIGO].",ACTINIC PRURIGO,THALIDOMIDE,TWrex-treat
788659704,9/15/2015 12:20:04,1738696569,9/15/2015 12:19:41,False,pocketmoneygpt,0.877,21432964,GBR,F8,Borehamwood,81.159.185.70,THALIDOMIDE treats ACTINIC PRURIGO,85,15,,100,26,treats,0.9684959969581859,212552,"In some cases, [THALIDOMIDE] has proven to be effective in controlling the symptoms of [ACTINIC PRURIGO].",ACTINIC PRURIGO,THALIDOMIDE,TWrex-treat
788659704,9/15/2015 12:24:11,1738697930,9/15/2015 12:23:35,False,clixsense,0.9762,30777913,GBR,U8,Edinburgh,92.239.140.40,THALIDOMIDE treats ACTINIC PRURIGO,85,15,,100,26,treats,0.9684959969581859,212552,"In some cases, [THALIDOMIDE] has proven to be effective in controlling the symptoms of [ACTINIC PRURIGO].",ACTINIC PRURIGO,THALIDOMIDE,TWrex-treat
788659709,9/15/2015 11:38:07,1738680379,9/15/2015 11:37:56,False,prodege,0.9365,14848125,GBR,V8,Airdrie,86.151.77.161,no_relation,75,128,,81,136,treats,0.30618621784789696,904836,Serial addition to 3 or more antiepileptic drugs is less likely to lead to SEIZURE freedom for patients with difficult to treat EPILEPSY,SEIZURE,EPILEPSY,RO-has_definitional_manifestation
788659709,9/15/2015 11:46:51,1738684502,9/15/2015 11:46:35,False,elite,0.9048,31883685,GBR,,,79.66.254.237,no_relation,75,128,,81,136,treats,0.30618621784789696,904836,Serial addition to 3 or more antiepileptic drugs is less likely to lead to SEIZURE freedom for patients with difficult to treat EPILEPSY,SEIZURE,EPILEPSY,RO-has_definitional_manifestation
788659709,9/15/2015 11:52:50,1738687144,9/15/2015 11:52:18,False,fusioncash,0.9389,31742806,USA,OH,Kent,66.61.82.242,no_relation,75,128,,81,136,treats,0.30618621784789696,904836,Serial addition to 3 or more antiepileptic drugs is less likely to lead to SEIZURE freedom for patients with difficult to treat EPILEPSY,SEIZURE,EPILEPSY,RO-has_definitional_manifestation
788659709,9/15/2015 12:00:05,1738689630,9/15/2015 11:59:46,False,prodege,0.9167,27934334,GBR,C8,Croydon,81.159.60.206,no_relation,75,128,,81,136,treats,0.30618621784789696,904836,Serial addition to 3 or more antiepileptic drugs is less likely to lead to SEIZURE freedom for patients with difficult to treat EPILEPSY,SEIZURE,EPILEPSY,RO-has_definitional_manifestation
788659709,9/15/2015 12:12:50,1738693784,9/15/2015 12:11:57,False,clixsense,0.6972,17950689,GBR,L9,Sheffield,146.200.192.103,SEIZURE treats EPILEPSY,75,128,,81,136,treats,0.30618621784789696,904836,Serial addition to 3 or more antiepileptic drugs is less likely to lead to SEIZURE freedom for patients with difficult to treat EPILEPSY,SEIZURE,EPILEPSY,RO-has_definitional_manifestation
788659709,9/15/2015 12:14:25,1738694322,9/15/2015 12:13:34,False,prodege,0.8754,3056891,CAN,ON,Niagara Falls,173.238.144.19,no_relation,75,128,,81,136,treats,0.30618621784789696,904836,Serial addition to 3 or more antiepileptic drugs is less likely to lead to SEIZURE freedom for patients with difficult to treat EPILEPSY,SEIZURE,EPILEPSY,RO-has_definitional_manifestation
788659709,9/15/2015 12:19:14,1738696244,9/15/2015 12:18:34,False,pocketmoneygpt,0.877,21432964,GBR,F8,Borehamwood,81.159.185.70,no_relation,75,128,,81,136,treats,0.30618621784789696,904836,Serial addition to 3 or more antiepileptic drugs is less likely to lead to SEIZURE freedom for patients with difficult to treat EPILEPSY,SEIZURE,EPILEPSY,RO-has_definitional_manifestation
788748019,9/15/2015 18:33:31,1738896982,9/15/2015 18:33:00,False,instagc,0.8861,31184650,USA,IA,Mason City,173.26.179.94,no_relation,41,87,,63,117,treats,0.625,803279, Avoid hospitalization of patients with UNCOMPLICATED VARICELLA to reduce the risk of NOSOCOMIAL TRANSMISSION OF VZV,UNCOMPLICATED VARICELLA,NOSOCOMIAL TRANSMISSION OF VZV,TWrex-cause
788748019,9/15/2015 18:34:39,1738897803,9/15/2015 18:33:58,False,instagc,0.7607,20312760,GBR,O1,Dukinfield,2.96.59.31,no_relation,41,87,,63,117,treats,0.625,803279, Avoid hospitalization of patients with UNCOMPLICATED VARICELLA to reduce the risk of NOSOCOMIAL TRANSMISSION OF VZV,UNCOMPLICATED VARICELLA,NOSOCOMIAL TRANSMISSION OF VZV,TWrex-cause
788748019,9/15/2015 18:35:16,1738898190,9/15/2015 18:35:02,False,prodege,0.8167,6309240,USA,CA,San Diego,108.178.173.218,no_relation,41,87,,63,117,treats,0.625,803279, Avoid hospitalization of patients with UNCOMPLICATED VARICELLA to reduce the risk of NOSOCOMIAL TRANSMISSION OF VZV,UNCOMPLICATED VARICELLA,NOSOCOMIAL TRANSMISSION OF VZV,TWrex-cause
788748019,9/15/2015 18:36:10,1738898758,9/15/2015 18:35:34,False,bitcoinget,0.6607,29516942,USA,CA,Saratoga,107.178.35.226,no_relation,41,87,,63,117,treats,0.625,803279, Avoid hospitalization of patients with UNCOMPLICATED VARICELLA to reduce the risk of NOSOCOMIAL TRANSMISSION OF VZV,UNCOMPLICATED VARICELLA,NOSOCOMIAL TRANSMISSION OF VZV,TWrex-cause
788748019,9/15/2015 18:41:03,1738901717,9/15/2015 18:40:35,False,clixsense,0.7532,32916182,GBR,L9,Sheffield,5.81.109.21,no_relation,41,87,,63,117,treats,0.625,803279, Avoid hospitalization of patients with UNCOMPLICATED VARICELLA to reduce the risk of NOSOCOMIAL TRANSMISSION OF VZV,UNCOMPLICATED VARICELLA,NOSOCOMIAL TRANSMISSION OF VZV,TWrex-cause
788748019,9/15/2015 18:50:39,1738906875,9/15/2015 18:50:17,False,elite,0.8065,30507455,CAN,BC,Richmond,174.6.137.222,no_relation,41,87,,63,117,treats,0.625,803279, Avoid hospitalization of patients with UNCOMPLICATED VARICELLA to reduce the risk of NOSOCOMIAL TRANSMISSION OF VZV,UNCOMPLICATED VARICELLA,NOSOCOMIAL TRANSMISSION OF VZV,TWrex-cause
788748019,9/15/2015 18:55:16,1738909130,9/15/2015 18:54:34,False,neodev,0.6052,34281269,USA,CA,Torrance,66.171.228.88,UNCOMPLICATED VARICELLA treats NOSOCOMIAL TRANSMISSION OF VZV,41,87,,63,117,treats,0.625,803279, Avoid hospitalization of patients with UNCOMPLICATED VARICELLA to reduce the risk of NOSOCOMIAL TRANSMISSION OF VZV,UNCOMPLICATED VARICELLA,NOSOCOMIAL TRANSMISSION OF VZV,TWrex-cause
788748028,9/15/2015 17:53:52,1738860686,9/15/2015 17:53:29,False,prodege,0.8532,27753453,USA,NY,Liverpool,71.176.126.145,no_relation,42,165,,45,182,treats,0.40824829046386296,813736," Alendronate has been shown to alleviate PAIN and improve joint mobility and pressure tolerance in a randomized, controlled, double blind study in 40 patients with POSTTRAUMATIC RSD ( 50.",PAIN,POSTTRAUMATIC RSD,TWrex-cause
788748028,9/15/2015 18:01:00,1738870972,9/15/2015 18:00:04,False,neodev,0.6198,33238512,NLD,11,Delft,94.210.42.212,POSTTRAUMATIC RSD treats PAIN,42,165,,45,182,treats,0.40824829046386296,813736," Alendronate has been shown to alleviate PAIN and improve joint mobility and pressure tolerance in a randomized, controlled, double blind study in 40 patients with POSTTRAUMATIC RSD ( 50.",PAIN,POSTTRAUMATIC RSD,TWrex-cause
788748028,9/15/2015 18:02:47,1738872175,9/15/2015 18:02:05,False,neodev,0.7889,20306047,GBR,,,80.41.0.252,no_relation,42,165,,45,182,treats,0.40824829046386296,813736," Alendronate has been shown to alleviate PAIN and improve joint mobility and pressure tolerance in a randomized, controlled, double blind study in 40 patients with POSTTRAUMATIC RSD ( 50.",PAIN,POSTTRAUMATIC RSD,TWrex-cause
788748028,9/15/2015 18:11:53,1738882095,9/15/2015 18:09:39,False,clixsense,0.6484,17950689,GBR,L9,Sheffield,146.200.192.103,PAIN treats POSTTRAUMATIC RSD,42,165,,45,182,treats,0.40824829046386296,813736," Alendronate has been shown to alleviate PAIN and improve joint mobility and pressure tolerance in a randomized, controlled, double blind study in 40 patients with POSTTRAUMATIC RSD ( 50.",PAIN,POSTTRAUMATIC RSD,TWrex-cause
788748028,9/15/2015 18:13:47,1738884094,9/15/2015 18:13:31,False,instagc,0.85,18985376,GBR,D2,Derby,86.27.159.112,no_relation,42,165,,45,182,treats,0.40824829046386296,813736," Alendronate has been shown to alleviate PAIN and improve joint mobility and pressure tolerance in a randomized, controlled, double blind study in 40 patients with POSTTRAUMATIC RSD ( 50.",PAIN,POSTTRAUMATIC RSD,TWrex-cause
788748028,9/15/2015 18:17:10,1738886909,9/15/2015 18:15:53,False,zoombucks,0.8357,6744840,CAN,BC,Kelowna,174.4.58.160,no_relation,42,165,,45,182,treats,0.40824829046386296,813736," Alendronate has been shown to alleviate PAIN and improve joint mobility and pressure tolerance in a randomized, controlled, double blind study in 40 patients with POSTTRAUMATIC RSD ( 50.",PAIN,POSTTRAUMATIC RSD,TWrex-cause
788748028,9/15/2015 18:20:19,1738889109,9/15/2015 18:19:56,False,clixsense,0.8357,19638651,USA,SC,Summerville,174.107.73.211,no_relation,42,165,,45,182,treats,0.40824829046386296,813736," Alendronate has been shown to alleviate PAIN and improve joint mobility and pressure tolerance in a randomized, controlled, double blind study in 40 patients with POSTTRAUMATIC RSD ( 50.",PAIN,POSTTRAUMATIC RSD,TWrex-cause
788748030,9/15/2015 18:37:05,1738899318,9/15/2015 18:36:38,False,prodege,0.8167,6309240,USA,CA,San Diego,108.178.173.218,RIBAVIRIN treats CHRONIC HEPATITIS C,153,118,,171,127,treats,1.0,800639,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomized trial.",CHRONIC HEPATITIS C,RIBAVIRIN,TWrex-cause
788748030,9/15/2015 18:51:39,1738907336,9/15/2015 18:51:19,False,elite,0.8065,30507455,CAN,BC,Richmond,174.6.137.222,RIBAVIRIN treats CHRONIC HEPATITIS C,153,118,,171,127,treats,1.0,800639,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomized trial.",CHRONIC HEPATITIS C,RIBAVIRIN,TWrex-cause
788748030,9/15/2015 18:56:44,1738909887,9/15/2015 18:56:19,False,neodev,0.6052,34281269,USA,CA,Torrance,66.171.228.88,RIBAVIRIN treats CHRONIC HEPATITIS C,153,118,,171,127,treats,1.0,800639,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomized trial.",CHRONIC HEPATITIS C,RIBAVIRIN,TWrex-cause
788748030,9/15/2015 19:05:36,1738914002,9/15/2015 19:04:55,False,prodege,0.9028,3587109,CAN,NS,Sydney,142.177.43.123,RIBAVIRIN treats CHRONIC HEPATITIS C,153,118,,171,127,treats,1.0,800639,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomized trial.",CHRONIC HEPATITIS C,RIBAVIRIN,TWrex-cause
788748030,9/15/2015 19:14:57,1738918192,9/15/2015 19:14:37,False,instagc,0.6857,19602039,USA,WA,Bellevue,50.135.225.35,RIBAVIRIN treats CHRONIC HEPATITIS C,153,118,,171,127,treats,1.0,800639,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomized trial.",CHRONIC HEPATITIS C,RIBAVIRIN,TWrex-cause
788748030,9/15/2015 19:17:45,1738919391,9/15/2015 19:17:21,False,zoombucks,0.8333,4688131,CAN,BC,Vancouver,216.251.132.22,RIBAVIRIN treats CHRONIC HEPATITIS C,153,118,,171,127,treats,1.0,800639,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomized trial.",CHRONIC HEPATITIS C,RIBAVIRIN,TWrex-cause
788748030,9/15/2015 19:24:46,1738922684,9/15/2015 19:24:30,False,clixsense,0.6548,11106820,USA,MA,Taunton,173.48.52.95,RIBAVIRIN treats CHRONIC HEPATITIS C,153,118,,171,127,treats,1.0,800639,"Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus RIBAVIRIN for initial treatment of CHRONIC HEPATITIS C: a randomized trial.",CHRONIC HEPATITIS C,RIBAVIRIN,TWrex-cause
788748035,9/15/2015 19:35:35,1738926193,9/15/2015 19:35:17,False,prodege,0.773,34247194,CAN,ON,Toronto,99.244.108.95,no_relation,109,69,,133,83,treats,0.98058067569092,907821,"Martin DF, Sierra Madero J, Walmsley S, et al: A controlled trial of VALGANCICLOVIR as induction therapy for CYTOMEGALOVIRUS RETINITIS",CYTOMEGALOVIRUS RETINITIS,VALGANCICLOVIR,RO-may_treat
788748035,9/15/2015 19:36:49,1738926538,9/15/2015 19:36:12,False,instagc,0.8393,31157999,USA,KS,Topeka,68.102.220.35,no_relation,109,69,,133,83,treats,0.98058067569092,907821,"Martin DF, Sierra Madero J, Walmsley S, et al: A controlled trial of VALGANCICLOVIR as induction therapy for CYTOMEGALOVIRUS RETINITIS",CYTOMEGALOVIRUS RETINITIS,VALGANCICLOVIR,RO-may_treat
788748035,9/15/2015 19:39:05,1738927355,9/15/2015 19:38:48,False,elite,0.6639,29768955,GBR,C3,Gamlingay,31.50.187.165,VALGANCICLOVIR treats CYTOMEGALOVIRUS RETINITIS,109,69,,133,83,treats,0.98058067569092,907821,"Martin DF, Sierra Madero J, Walmsley S, et al: A controlled trial of VALGANCICLOVIR as induction therapy for CYTOMEGALOVIRUS RETINITIS",CYTOMEGALOVIRUS RETINITIS,VALGANCICLOVIR,RO-may_treat
788748035,9/15/2015 19:42:45,1738928617,9/15/2015 19:42:14,False,clixsense,0.6786,32053717,GBR,,,51.174.76.80,VALGANCICLOVIR treats CYTOMEGALOVIRUS RETINITIS,109,69,,133,83,treats,0.98058067569092,907821,"Martin DF, Sierra Madero J, Walmsley S, et al: A controlled trial of VALGANCICLOVIR as induction therapy for CYTOMEGALOVIRUS RETINITIS",CYTOMEGALOVIRUS RETINITIS,VALGANCICLOVIR,RO-may_treat
788748035,9/15/2015 19:43:40,1738928943,9/15/2015 19:43:21,False,prodege,0.7111,16101132,GBR,F9,Hayes,2.216.28.167,VALGANCICLOVIR treats CYTOMEGALOVIRUS RETINITIS,109,69,,133,83,treats,0.98058067569092,907821,"Martin DF, Sierra Madero J, Walmsley S, et al: A controlled trial of VALGANCICLOVIR as induction therapy for CYTOMEGALOVIRUS RETINITIS",CYTOMEGALOVIRUS RETINITIS,VALGANCICLOVIR,RO-may_treat
788748035,9/15/2015 19:48:51,1738931166,9/15/2015 19:48:26,False,pocketmoneygpt,0.7604,34458129,USA,CA,Lake Forest,158.69.137.23,VALGANCICLOVIR treats CYTOMEGALOVIRUS RETINITIS,109,69,,133,83,treats,0.98058067569092,907821,"Martin DF, Sierra Madero J, Walmsley S, et al: A controlled trial of VALGANCICLOVIR as induction therapy for CYTOMEGALOVIRUS RETINITIS",CYTOMEGALOVIRUS RETINITIS,VALGANCICLOVIR,RO-may_treat
788748035,9/15/2015 19:58:35,1738936852,9/15/2015 19:58:01,False,neodev,0.8433,33758777,USA,,,38.95.108.251,VALGANCICLOVIR treats CYTOMEGALOVIRUS RETINITIS,109,69,,133,83,treats,0.98058067569092,907821,"Martin DF, Sierra Madero J, Walmsley S, et al: A controlled trial of VALGANCICLOVIR as induction therapy for CYTOMEGALOVIRUS RETINITIS",CYTOMEGALOVIRUS RETINITIS,VALGANCICLOVIR,RO-may_treat
788748052,9/15/2015 19:19:17,1738920253,9/15/2015 19:19:04,False,zoombucks,0.8333,4688131,CAN,BC,Vancouver,216.251.132.22,LIDOCAINE treats MYOFASCIAL PAIN,52,18,,66,27,treats,0.9897433186107869,800546,Diclofenac versus LIDOCAINE as injection therapy in MYOFASCIAL PAIN,MYOFASCIAL PAIN,LIDOCAINE,TWrex-cause
788748052,9/15/2015 19:28:29,1738924031,9/15/2015 19:27:57,False,elite,0.6,30312592,CAN,ON,Sudbury,66.103.55.12,LIDOCAINE treats MYOFASCIAL PAIN,52,18,,66,27,treats,0.9897433186107869,800546,Diclofenac versus LIDOCAINE as injection therapy in MYOFASCIAL PAIN,MYOFASCIAL PAIN,LIDOCAINE,TWrex-cause
788748052,9/15/2015 19:34:51,1738925838,9/15/2015 19:34:31,False,prodege,0.773,34247194,CAN,ON,Toronto,99.244.108.95,no_relation,52,18,,66,27,treats,0.9897433186107869,800546,Diclofenac versus LIDOCAINE as injection therapy in MYOFASCIAL PAIN,MYOFASCIAL PAIN,LIDOCAINE,TWrex-cause
788748052,9/15/2015 19:35:28,1738926129,9/15/2015 19:35:03,False,instagc,0.8393,31157999,USA,KS,Topeka,68.102.220.35,no_relation,52,18,,66,27,treats,0.9897433186107869,800546,Diclofenac versus LIDOCAINE as injection therapy in MYOFASCIAL PAIN,MYOFASCIAL PAIN,LIDOCAINE,TWrex-cause
788748052,9/15/2015 19:38:27,1738927153,9/15/2015 19:37:45,False,elite,0.6639,29768955,GBR,C3,Gamlingay,31.50.187.165,LIDOCAINE treats MYOFASCIAL PAIN,52,18,,66,27,treats,0.9897433186107869,800546,Diclofenac versus LIDOCAINE as injection therapy in MYOFASCIAL PAIN,MYOFASCIAL PAIN,LIDOCAINE,TWrex-cause
788748052,9/15/2015 19:41:42,1738928203,9/15/2015 19:41:25,False,clixsense,0.6786,32053717,GBR,,,51.174.76.80,LIDOCAINE treats MYOFASCIAL PAIN,52,18,,66,27,treats,0.9897433186107869,800546,Diclofenac versus LIDOCAINE as injection therapy in MYOFASCIAL PAIN,MYOFASCIAL PAIN,LIDOCAINE,TWrex-cause
788748052,9/15/2015 19:42:23,1738928455,9/15/2015 19:41:53,False,prodege,0.7111,16101132,GBR,F9,Hayes,2.216.28.167,LIDOCAINE treats MYOFASCIAL PAIN,52,18,,66,27,treats,0.9897433186107869,800546,Diclofenac versus LIDOCAINE as injection therapy in MYOFASCIAL PAIN,MYOFASCIAL PAIN,LIDOCAINE,TWrex-cause
788748053,9/15/2015 16:38:25,1738779906,9/15/2015 16:38:10,False,instagc,0.9306,18960682,GBR,U2,Annan,92.18.213.181,INHALED BECLOMETHASONE DIPROPIONATE treats STEROID DEPENDENT ASTHMA,124,85,,147,120,treats,0.997785157856609,803669,"Broder I, Tarlo SM, Davies GM et al. Safety and efficacy of long term treatment with INHALED BECLOMETHASONE DIPROPIONATE in STEROID DEPENDENT ASTHMA",STEROID DEPENDENT ASTHMA,INHALED BECLOMETHASONE DIPROPIONATE,TWrex-cause
788748053,9/15/2015 16:43:08,1738782306,9/15/2015 16:42:45,False,elite,0.6895,34356654,USA,DE,,108.59.11.227,INHALED BECLOMETHASONE DIPROPIONATE treats STEROID DEPENDENT ASTHMA,124,85,,147,120,treats,0.997785157856609,803669,"Broder I, Tarlo SM, Davies GM et al. Safety and efficacy of long term treatment with INHALED BECLOMETHASONE DIPROPIONATE in STEROID DEPENDENT ASTHMA",STEROID DEPENDENT ASTHMA,INHALED BECLOMETHASONE DIPROPIONATE,TWrex-cause
788748053,9/15/2015 16:49:00,1738786764,9/15/2015 16:48:23,False,prodege,0.9139,21417560,GBR,C3,Cambridge,151.224.120.191,INHALED BECLOMETHASONE DIPROPIONATE treats STEROID DEPENDENT ASTHMA,124,85,,147,120,treats,0.997785157856609,803669,"Broder I, Tarlo SM, Davies GM et al. Safety and efficacy of long term treatment with INHALED BECLOMETHASONE DIPROPIONATE in STEROID DEPENDENT ASTHMA",STEROID DEPENDENT ASTHMA,INHALED BECLOMETHASONE DIPROPIONATE,TWrex-cause
788748053,9/15/2015 16:56:31,1738793462,9/15/2015 16:56:16,False,neodev,0.904,31743852,GBR,G5,Margate,85.210.124.152,INHALED BECLOMETHASONE DIPROPIONATE treats STEROID DEPENDENT ASTHMA,124,85,,147,120,treats,0.997785157856609,803669,"Broder I, Tarlo SM, Davies GM et al. Safety and efficacy of long term treatment with INHALED BECLOMETHASONE DIPROPIONATE in STEROID DEPENDENT ASTHMA",STEROID DEPENDENT ASTHMA,INHALED BECLOMETHASONE DIPROPIONATE,TWrex-cause
788748053,9/15/2015 16:57:35,1738794435,9/15/2015 16:57:20,False,neodev,0.9159,18881135,CAN,ON,Ajax,99.243.87.224,INHALED BECLOMETHASONE DIPROPIONATE treats STEROID DEPENDENT ASTHMA,124,85,,147,120,treats,0.997785157856609,803669,"Broder I, Tarlo SM, Davies GM et al. Safety and efficacy of long term treatment with INHALED BECLOMETHASONE DIPROPIONATE in STEROID DEPENDENT ASTHMA",STEROID DEPENDENT ASTHMA,INHALED BECLOMETHASONE DIPROPIONATE,TWrex-cause
788748053,9/15/2015 17:04:15,1738800580,9/15/2015 17:03:48,False,instagc,0.8214,33058612,USA,IL,Glenview,162.229.106.229,INHALED BECLOMETHASONE DIPROPIONATE treats STEROID DEPENDENT ASTHMA,124,85,,147,120,treats,0.997785157856609,803669,"Broder I, Tarlo SM, Davies GM et al. Safety and efficacy of long term treatment with INHALED BECLOMETHASONE DIPROPIONATE in STEROID DEPENDENT ASTHMA",STEROID DEPENDENT ASTHMA,INHALED BECLOMETHASONE DIPROPIONATE,TWrex-cause
788748053,9/15/2015 17:04:50,1738801210,9/15/2015 17:04:42,False,instagc,0.9286,26024737,GBR,H2,Preston,78.144.133.234,INHALED BECLOMETHASONE DIPROPIONATE treats STEROID DEPENDENT ASTHMA,124,85,,147,120,treats,0.997785157856609,803669,"Broder I, Tarlo SM, Davies GM et al. Safety and efficacy of long term treatment with INHALED BECLOMETHASONE DIPROPIONATE in STEROID DEPENDENT ASTHMA",STEROID DEPENDENT ASTHMA,INHALED BECLOMETHASONE DIPROPIONATE,TWrex-cause
788748055,9/15/2015 19:35:17,1738926062,9/15/2015 19:34:52,False,prodege,0.773,34247194,CAN,ON,Toronto,99.244.108.95,EPOETIN ALFA THERAPY treats IRON DEFICIENCY ANEMIA,210,268,,231,288,treats,0.8616404368553291,907636,Class:  Iron Preparations 20:04.04  Synonyms:  Iron Saccharate; Iron Sucron Complex; Saccharated Ferric Oxide  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of IRON DEFICIENCY ANEMIA in hemodialysis patients receiving EPOETIN ALFA THERAPY.,IRON DEFICIENCY ANEMIA,EPOETIN ALFA THERAPY,RO-may_treat
788748055,9/15/2015 19:36:10,1738926337,9/15/2015 19:35:29,False,instagc,0.8393,31157999,USA,KS,Topeka,68.102.220.35,EPOETIN ALFA THERAPY treats IRON DEFICIENCY ANEMIA,210,268,,231,288,treats,0.8616404368553291,907636,Class:  Iron Preparations 20:04.04  Synonyms:  Iron Saccharate; Iron Sucron Complex; Saccharated Ferric Oxide  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of IRON DEFICIENCY ANEMIA in hemodialysis patients receiving EPOETIN ALFA THERAPY.,IRON DEFICIENCY ANEMIA,EPOETIN ALFA THERAPY,RO-may_treat
788748055,9/15/2015 19:38:47,1738927235,9/15/2015 19:38:29,False,elite,0.6639,29768955,GBR,C3,Gamlingay,31.50.187.165,EPOETIN ALFA THERAPY treats IRON DEFICIENCY ANEMIA,210,268,,231,288,treats,0.8616404368553291,907636,Class:  Iron Preparations 20:04.04  Synonyms:  Iron Saccharate; Iron Sucron Complex; Saccharated Ferric Oxide  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of IRON DEFICIENCY ANEMIA in hemodialysis patients receiving EPOETIN ALFA THERAPY.,IRON DEFICIENCY ANEMIA,EPOETIN ALFA THERAPY,RO-may_treat
788748055,9/15/2015 19:42:13,1738928405,9/15/2015 19:41:43,False,clixsense,0.6786,32053717,GBR,,,51.174.76.80,EPOETIN ALFA THERAPY treats IRON DEFICIENCY ANEMIA,210,268,,231,288,treats,0.8616404368553291,907636,Class:  Iron Preparations 20:04.04  Synonyms:  Iron Saccharate; Iron Sucron Complex; Saccharated Ferric Oxide  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of IRON DEFICIENCY ANEMIA in hemodialysis patients receiving EPOETIN ALFA THERAPY.,IRON DEFICIENCY ANEMIA,EPOETIN ALFA THERAPY,RO-may_treat
788748055,9/15/2015 19:43:20,1738928847,9/15/2015 19:42:24,False,prodege,0.7111,16101132,GBR,F9,Hayes,2.216.28.167,EPOETIN ALFA THERAPY treats IRON DEFICIENCY ANEMIA,210,268,,231,288,treats,0.8616404368553291,907636,Class:  Iron Preparations 20:04.04  Synonyms:  Iron Saccharate; Iron Sucron Complex; Saccharated Ferric Oxide  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of IRON DEFICIENCY ANEMIA in hemodialysis patients receiving EPOETIN ALFA THERAPY.,IRON DEFICIENCY ANEMIA,EPOETIN ALFA THERAPY,RO-may_treat
788748055,9/15/2015 19:48:25,1738930990,9/15/2015 19:48:03,False,pocketmoneygpt,0.7604,34458129,USA,CA,Lake Forest,158.69.137.23,EPOETIN ALFA THERAPY treats IRON DEFICIENCY ANEMIA,210,268,,231,288,treats,0.8616404368553291,907636,Class:  Iron Preparations 20:04.04  Synonyms:  Iron Saccharate; Iron Sucron Complex; Saccharated Ferric Oxide  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of IRON DEFICIENCY ANEMIA in hemodialysis patients receiving EPOETIN ALFA THERAPY.,IRON DEFICIENCY ANEMIA,EPOETIN ALFA THERAPY,RO-may_treat
788748055,9/15/2015 19:57:59,1738936396,9/15/2015 19:57:14,False,neodev,0.8433,33758777,USA,,,38.95.108.251,EPOETIN ALFA THERAPY treats IRON DEFICIENCY ANEMIA,210,268,,231,288,treats,0.8616404368553291,907636,Class:  Iron Preparations 20:04.04  Synonyms:  Iron Saccharate; Iron Sucron Complex; Saccharated Ferric Oxide  Uses  Iron Deficiency Anemia in Hemodialysis Patients Receiving Epoetin Alfa Therapy  Treatment of IRON DEFICIENCY ANEMIA in hemodialysis patients receiving EPOETIN ALFA THERAPY.,IRON DEFICIENCY ANEMIA,EPOETIN ALFA THERAPY,RO-may_treat
788748058,9/15/2015 18:51:56,1738907462,9/15/2015 18:51:40,False,elite,0.8065,30507455,CAN,BC,Richmond,174.6.137.222,INTERFERON ALFA treats METASTATIC RENAL CARCINOMA,64,144,,89,159,treats,0.9761870601839531,803792,"Negrier S, Caty A, Lesimple T et al. Treatment of patients with METASTATIC RENAL CARCINOMA with a combination of subcutaneous interleukin 2 and INTERFERON ALFA with or without fluorouracil.",METASTATIC RENAL CARCINOMA,INTERFERON ALFA,TWrex-cause
788748058,9/15/2015 18:57:09,1738910103,9/15/2015 18:56:45,False,neodev,0.6052,34281269,USA,CA,Torrance,66.171.228.88,INTERFERON ALFA treats METASTATIC RENAL CARCINOMA,64,144,,89,159,treats,0.9761870601839531,803792,"Negrier S, Caty A, Lesimple T et al. Treatment of patients with METASTATIC RENAL CARCINOMA with a combination of subcutaneous interleukin 2 and INTERFERON ALFA with or without fluorouracil.",METASTATIC RENAL CARCINOMA,INTERFERON ALFA,TWrex-cause
788748058,9/15/2015 19:05:55,1738914152,9/15/2015 19:05:37,False,prodege,0.9028,3587109,CAN,NS,Sydney,142.177.43.123,INTERFERON ALFA treats METASTATIC RENAL CARCINOMA,64,144,,89,159,treats,0.9761870601839531,803792,"Negrier S, Caty A, Lesimple T et al. Treatment of patients with METASTATIC RENAL CARCINOMA with a combination of subcutaneous interleukin 2 and INTERFERON ALFA with or without fluorouracil.",METASTATIC RENAL CARCINOMA,INTERFERON ALFA,TWrex-cause
788748058,9/15/2015 19:18:17,1738919773,9/15/2015 19:17:46,False,zoombucks,0.8333,4688131,CAN,BC,Vancouver,216.251.132.22,INTERFERON ALFA treats METASTATIC RENAL CARCINOMA,64,144,,89,159,treats,0.9761870601839531,803792,"Negrier S, Caty A, Lesimple T et al. Treatment of patients with METASTATIC RENAL CARCINOMA with a combination of subcutaneous interleukin 2 and INTERFERON ALFA with or without fluorouracil.",METASTATIC RENAL CARCINOMA,INTERFERON ALFA,TWrex-cause
788748058,9/15/2015 19:24:57,1738922773,9/15/2015 19:24:46,False,clixsense,0.6548,11106820,USA,MA,Taunton,173.48.52.95,INTERFERON ALFA treats METASTATIC RENAL CARCINOMA,64,144,,89,159,treats,0.9761870601839531,803792,"Negrier S, Caty A, Lesimple T et al. Treatment of patients with METASTATIC RENAL CARCINOMA with a combination of subcutaneous interleukin 2 and INTERFERON ALFA with or without fluorouracil.",METASTATIC RENAL CARCINOMA,INTERFERON ALFA,TWrex-cause
788748058,9/15/2015 19:26:23,1738923309,9/15/2015 19:25:59,False,elite,0.6,30312592,CAN,ON,Sudbury,66.103.55.12,no_relation,64,144,,89,159,treats,0.9761870601839531,803792,"Negrier S, Caty A, Lesimple T et al. Treatment of patients with METASTATIC RENAL CARCINOMA with a combination of subcutaneous interleukin 2 and INTERFERON ALFA with or without fluorouracil.",METASTATIC RENAL CARCINOMA,INTERFERON ALFA,TWrex-cause
788748058,9/15/2015 19:29:08,1738924197,9/15/2015 19:28:56,False,neodev,0.7321,11014811,GBR,G6,Hull,87.102.82.212,INTERFERON ALFA treats METASTATIC RENAL CARCINOMA,64,144,,89,159,treats,0.9761870601839531,803792,"Negrier S, Caty A, Lesimple T et al. Treatment of patients with METASTATIC RENAL CARCINOMA with a combination of subcutaneous interleukin 2 and INTERFERON ALFA with or without fluorouracil.",METASTATIC RENAL CARCINOMA,INTERFERON ALFA,TWrex-cause
788748060,9/15/2015 17:06:12,1738802767,9/15/2015 17:05:40,False,instagc,0.8214,33058612,USA,IL,Glenview,162.229.106.229,TISSUE PLASMINOGEN ACTIVATOR treats ACUTE PULMONARY EMBOLISM,98,147,,121,175,treats,0.9958932064677041,800484,"Come PC, Kim D, Parker JA et al. Early reversal of right ventricular dysfunction in patients with ACUTE PULMONARY EMBOLISM after treatment with IV TISSUE PLASMINOGEN ACTIVATOR",ACUTE PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR,TWrex-cause
788748060,9/15/2015 17:07:45,1738804473,9/15/2015 17:07:22,False,neodev,0.5337,33701549,CAN,AB,Edmonton,208.123.223.189,ACUTE PULMONARY EMBOLISM treats TISSUE PLASMINOGEN ACTIVATOR,98,147,,121,175,treats,0.9958932064677041,800484,"Come PC, Kim D, Parker JA et al. Early reversal of right ventricular dysfunction in patients with ACUTE PULMONARY EMBOLISM after treatment with IV TISSUE PLASMINOGEN ACTIVATOR",ACUTE PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR,TWrex-cause
788748060,9/15/2015 17:10:57,1738807778,9/15/2015 17:10:38,False,clixsense,0.7361,33115750,GBR,I3,Rochester,90.222.106.192,TISSUE PLASMINOGEN ACTIVATOR treats ACUTE PULMONARY EMBOLISM,98,147,,121,175,treats,0.9958932064677041,800484,"Come PC, Kim D, Parker JA et al. Early reversal of right ventricular dysfunction in patients with ACUTE PULMONARY EMBOLISM after treatment with IV TISSUE PLASMINOGEN ACTIVATOR",ACUTE PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR,TWrex-cause
788748060,9/15/2015 17:16:20,1738811297,9/15/2015 17:15:51,False,clixsense,0.7893,33980820,USA,IL,Chicago,69.47.104.214,TISSUE PLASMINOGEN ACTIVATOR treats ACUTE PULMONARY EMBOLISM,98,147,,121,175,treats,0.9958932064677041,800484,"Come PC, Kim D, Parker JA et al. Early reversal of right ventricular dysfunction in patients with ACUTE PULMONARY EMBOLISM after treatment with IV TISSUE PLASMINOGEN ACTIVATOR",ACUTE PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR,TWrex-cause
788748060,9/15/2015 17:17:09,1738811740,9/15/2015 17:16:43,False,zoombucks,0.7258,4711962,CAN,ON,Markham,174.88.29.138,TISSUE PLASMINOGEN ACTIVATOR treats ACUTE PULMONARY EMBOLISM,98,147,,121,175,treats,0.9958932064677041,800484,"Come PC, Kim D, Parker JA et al. Early reversal of right ventricular dysfunction in patients with ACUTE PULMONARY EMBOLISM after treatment with IV TISSUE PLASMINOGEN ACTIVATOR",ACUTE PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR,TWrex-cause
788748060,9/15/2015 17:21:58,1738814065,9/15/2015 17:21:50,False,elite,0.2143,33798502,USA,VA,Manassas,207.244.77.3,ACUTE PULMONARY EMBOLISM treats TISSUE PLASMINOGEN ACTIVATOR,98,147,,121,175,treats,0.9958932064677041,800484,"Come PC, Kim D, Parker JA et al. Early reversal of right ventricular dysfunction in patients with ACUTE PULMONARY EMBOLISM after treatment with IV TISSUE PLASMINOGEN ACTIVATOR",ACUTE PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR,TWrex-cause
788748060,9/15/2015 17:24:18,1738815264,9/15/2015 17:20:22,False,clixsense,0.7214,21875134,GBR,,,80.189.12.98,TISSUE PLASMINOGEN ACTIVATOR treats ACUTE PULMONARY EMBOLISM,98,147,,121,175,treats,0.9958932064677041,800484,"Come PC, Kim D, Parker JA et al. Early reversal of right ventricular dysfunction in patients with ACUTE PULMONARY EMBOLISM after treatment with IV TISSUE PLASMINOGEN ACTIVATOR",ACUTE PULMONARY EMBOLISM,TISSUE PLASMINOGEN ACTIVATOR,TWrex-cause
788748062,9/15/2015 19:35:35,1738926192,9/15/2015 19:35:17,False,prodege,0.773,34247194,CAN,ON,Toronto,99.244.108.95,no_relation,67,15,,73,44,treats,0.7293249574894731,209425,"A trial with 2 [HOMOCYSTEINE LOWERING VITAMINS] in people with prior [STROKE] there was an 80% reduction in fractures, mainly hip, after 2 years.",[STROKE],[HOMOCYSTEINE LOWERING VITAMINS],TWrex-treat
788748062,9/15/2015 19:36:49,1738926545,9/15/2015 19:36:12,False,instagc,0.8393,31157999,USA,KS,Topeka,68.102.220.35,no_relation,67,15,,73,44,treats,0.7293249574894731,209425,"A trial with 2 [HOMOCYSTEINE LOWERING VITAMINS] in people with prior [STROKE] there was an 80% reduction in fractures, mainly hip, after 2 years.",[STROKE],[HOMOCYSTEINE LOWERING VITAMINS],TWrex-treat
788748062,9/15/2015 19:39:05,1738927356,9/15/2015 19:38:48,False,elite,0.6639,29768955,GBR,C3,Gamlingay,31.50.187.165,[HOMOCYSTEINE LOWERING VITAMINS] treats [STROKE],67,15,,73,44,treats,0.7293249574894731,209425,"A trial with 2 [HOMOCYSTEINE LOWERING VITAMINS] in people with prior [STROKE] there was an 80% reduction in fractures, mainly hip, after 2 years.",[STROKE],[HOMOCYSTEINE LOWERING VITAMINS],TWrex-treat
788748062,9/15/2015 19:42:45,1738928622,9/15/2015 19:42:14,False,clixsense,0.6786,32053717,GBR,,,51.174.76.80,[HOMOCYSTEINE LOWERING VITAMINS] treats [STROKE],67,15,,73,44,treats,0.7293249574894731,209425,"A trial with 2 [HOMOCYSTEINE LOWERING VITAMINS] in people with prior [STROKE] there was an 80% reduction in fractures, mainly hip, after 2 years.",[STROKE],[HOMOCYSTEINE LOWERING VITAMINS],TWrex-treat
788748062,9/15/2015 19:43:40,1738928944,9/15/2015 19:43:21,False,prodege,0.7111,16101132,GBR,F9,Hayes,2.216.28.167,no_relation,67,15,,73,44,treats,0.7293249574894731,209425,"A trial with 2 [HOMOCYSTEINE LOWERING VITAMINS] in people with prior [STROKE] there was an 80% reduction in fractures, mainly hip, after 2 years.",[STROKE],[HOMOCYSTEINE LOWERING VITAMINS],TWrex-treat
788748062,9/15/2015 19:48:51,1738931165,9/15/2015 19:48:26,False,pocketmoneygpt,0.7604,34458129,USA,CA,Lake Forest,158.69.137.23,[HOMOCYSTEINE LOWERING VITAMINS] treats [STROKE],67,15,,73,44,treats,0.7293249574894731,209425,"A trial with 2 [HOMOCYSTEINE LOWERING VITAMINS] in people with prior [STROKE] there was an 80% reduction in fractures, mainly hip, after 2 years.",[STROKE],[HOMOCYSTEINE LOWERING VITAMINS],TWrex-treat
788748062,9/15/2015 19:58:35,1738936867,9/15/2015 19:58:01,False,neodev,0.8433,33758777,USA,,,38.95.108.251,[HOMOCYSTEINE LOWERING VITAMINS] treats [STROKE],67,15,,73,44,treats,0.7293249574894731,209425,"A trial with 2 [HOMOCYSTEINE LOWERING VITAMINS] in people with prior [STROKE] there was an 80% reduction in fractures, mainly hip, after 2 years.",[STROKE],[HOMOCYSTEINE LOWERING VITAMINS],TWrex-treat
788748094,9/15/2015 17:12:22,1738809052,9/15/2015 17:11:57,False,clixsense,0.7361,33115750,GBR,I3,Rochester,90.222.106.192,THALIDOMIDE treats APHTHOUS ULCERS,16,0,,30,11,treats,0.9704949588309459,804857,THALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE,TWrex-cause
788748094,9/15/2015 17:17:54,1738812030,9/15/2015 17:17:30,False,clixsense,0.7893,33980820,USA,IL,Chicago,69.47.104.214,THALIDOMIDE treats APHTHOUS ULCERS,16,0,,30,11,treats,0.9704949588309459,804857,THALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE,TWrex-cause
788748094,9/15/2015 17:18:28,1738812272,9/15/2015 17:17:58,False,zoombucks,0.7258,4711962,CAN,ON,Markham,174.88.29.138,THALIDOMIDE treats APHTHOUS ULCERS,16,0,,30,11,treats,0.9704949588309459,804857,THALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE,TWrex-cause
788748094,9/15/2015 17:26:16,1738816158,9/15/2015 17:25:42,False,gifthunterclub,0.8413,29582088,GBR,I2,Manchester,2.99.153.19,THALIDOMIDE treats APHTHOUS ULCERS,16,0,,30,11,treats,0.9704949588309459,804857,THALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE,TWrex-cause
788748094,9/15/2015 17:32:50,1738821347,9/15/2015 17:31:52,False,clixsense,0.7214,21875134,GBR,,,80.189.12.98,THALIDOMIDE treats APHTHOUS ULCERS,16,0,,30,11,treats,0.9704949588309459,804857,THALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE,TWrex-cause
788748094,9/15/2015 17:39:36,1738830315,9/15/2015 17:38:36,False,prodege,0.4306,1859229,USA,LA,Zachary,72.219.10.101,APHTHOUS ULCERS treats THALIDOMIDE,16,0,,30,11,treats,0.9704949588309459,804857,THALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE,TWrex-cause
788748094,9/15/2015 17:45:17,1738840701,9/15/2015 17:45:07,False,prodege,0.3786,2143114,CAN,BC,Vancouver,24.85.153.181,APHTHOUS ULCERS treats THALIDOMIDE,16,0,,30,11,treats,0.9704949588309459,804857,THALIDOMIDE for APHTHOUS ULCERS in HIV infection.,APHTHOUS ULCERS,THALIDOMIDE,TWrex-cause
788748099,9/15/2015 17:53:00,1738858560,9/15/2015 17:52:38,False,prodege,0.8532,27753453,USA,NY,Liverpool,71.176.126.145,no_relation,116,65,,135,88,treats,1.0,804366,"Khalil SN, Roth AG, Cohen IT et al. A double blind comparison of INTRAVENOUS ONDANSETRON and placebo for preventing POSTOPERATIVE EMESIS in 1  to 24 month old pediatric patients after surgery under general anesthesia.",POSTOPERATIVE EMESIS,INTRAVENOUS ONDANSETRON,TWrex-cause
788748099,9/15/2015 17:59:26,1738869865,9/15/2015 17:58:40,False,neodev,0.6198,33238512,NLD,11,Delft,94.210.42.212,INTRAVENOUS ONDANSETRON treats POSTOPERATIVE EMESIS,116,65,,135,88,treats,1.0,804366,"Khalil SN, Roth AG, Cohen IT et al. A double blind comparison of INTRAVENOUS ONDANSETRON and placebo for preventing POSTOPERATIVE EMESIS in 1  to 24 month old pediatric patients after surgery under general anesthesia.",POSTOPERATIVE EMESIS,INTRAVENOUS ONDANSETRON,TWrex-cause
788748099,9/15/2015 18:01:50,1738871536,9/15/2015 17:59:06,False,neodev,0.7889,20306047,GBR,,,80.41.0.252,INTRAVENOUS ONDANSETRON treats POSTOPERATIVE EMESIS,116,65,,135,88,treats,1.0,804366,"Khalil SN, Roth AG, Cohen IT et al. A double blind comparison of INTRAVENOUS ONDANSETRON and placebo for preventing POSTOPERATIVE EMESIS in 1  to 24 month old pediatric patients after surgery under general anesthesia.",POSTOPERATIVE EMESIS,INTRAVENOUS ONDANSETRON,TWrex-cause
788748099,9/15/2015 18:09:06,1738878882,9/15/2015 18:08:32,False,clixsense,0.6484,17950689,GBR,L9,Sheffield,146.200.192.103,INTRAVENOUS ONDANSETRON treats POSTOPERATIVE EMESIS,116,65,,135,88,treats,1.0,804366,"Khalil SN, Roth AG, Cohen IT et al. A double blind comparison of INTRAVENOUS ONDANSETRON and placebo for preventing POSTOPERATIVE EMESIS in 1  to 24 month old pediatric patients after surgery under general anesthesia.",POSTOPERATIVE EMESIS,INTRAVENOUS ONDANSETRON,TWrex-cause
788748099,9/15/2015 18:13:12,1738883505,9/15/2015 18:12:44,False,instagc,0.85,18985376,GBR,D2,Derby,86.27.159.112,INTRAVENOUS ONDANSETRON treats POSTOPERATIVE EMESIS,116,65,,135,88,treats,1.0,804366,"Khalil SN, Roth AG, Cohen IT et al. A double blind comparison of INTRAVENOUS ONDANSETRON and placebo for preventing POSTOPERATIVE EMESIS in 1  to 24 month old pediatric patients after surgery under general anesthesia.",POSTOPERATIVE EMESIS,INTRAVENOUS ONDANSETRON,TWrex-cause
788748099,9/15/2015 18:14:14,1738884523,9/15/2015 18:11:36,False,zoombucks,0.8357,6744840,CAN,BC,Kelowna,174.4.58.160,INTRAVENOUS ONDANSETRON treats POSTOPERATIVE EMESIS,116,65,,135,88,treats,1.0,804366,"Khalil SN, Roth AG, Cohen IT et al. A double blind comparison of INTRAVENOUS ONDANSETRON and placebo for preventing POSTOPERATIVE EMESIS in 1  to 24 month old pediatric patients after surgery under general anesthesia.",POSTOPERATIVE EMESIS,INTRAVENOUS ONDANSETRON,TWrex-cause
788748099,9/15/2015 18:19:41,1738888650,9/15/2015 18:19:27,False,clixsense,0.8357,19638651,USA,SC,Summerville,174.107.73.211,INTRAVENOUS ONDANSETRON treats POSTOPERATIVE EMESIS,116,65,,135,88,treats,1.0,804366,"Khalil SN, Roth AG, Cohen IT et al. A double blind comparison of INTRAVENOUS ONDANSETRON and placebo for preventing POSTOPERATIVE EMESIS in 1  to 24 month old pediatric patients after surgery under general anesthesia.",POSTOPERATIVE EMESIS,INTRAVENOUS ONDANSETRON,TWrex-cause
788748100,9/15/2015 17:06:33,1738803206,9/15/2015 17:06:14,False,instagc,0.8214,33058612,USA,IL,Glenview,162.229.106.229,MESALAMINE treats ULCERATIVE COLITIS,175,136,,192,146,treats,0.9116846116771039,800903,"Levine DS, Pruitt R, Riff D et al. A multi center double blind dose response trial of Colazide   (balsalazide disodium) and Asacol   (MESALAMINE) for mild moderately active ULCERATIVE COLITIS",ULCERATIVE COLITIS,MESALAMINE,TWrex-cause
788748100,9/15/2015 17:08:25,1738805196,9/15/2015 17:07:47,False,neodev,0.5337,33701549,CAN,AB,Edmonton,208.123.223.189,MESALAMINE treats ULCERATIVE COLITIS,175,136,,192,146,treats,0.9116846116771039,800903,"Levine DS, Pruitt R, Riff D et al. A multi center double blind dose response trial of Colazide   (balsalazide disodium) and Asacol   (MESALAMINE) for mild moderately active ULCERATIVE COLITIS",ULCERATIVE COLITIS,MESALAMINE,TWrex-cause
788748100,9/15/2015 17:11:21,1738808137,9/15/2015 17:10:58,False,clixsense,0.7361,33115750,GBR,I3,Rochester,90.222.106.192,MESALAMINE treats ULCERATIVE COLITIS,175,136,,192,146,treats,0.9116846116771039,800903,"Levine DS, Pruitt R, Riff D et al. A multi center double blind dose response trial of Colazide   (balsalazide disodium) and Asacol   (MESALAMINE) for mild moderately active ULCERATIVE COLITIS",ULCERATIVE COLITIS,MESALAMINE,TWrex-cause
788748100,9/15/2015 17:16:48,1738811545,9/15/2015 17:16:21,False,clixsense,0.7893,33980820,USA,IL,Chicago,69.47.104.214,MESALAMINE treats ULCERATIVE COLITIS,175,136,,192,146,treats,0.9116846116771039,800903,"Levine DS, Pruitt R, Riff D et al. A multi center double blind dose response trial of Colazide   (balsalazide disodium) and Asacol   (MESALAMINE) for mild moderately active ULCERATIVE COLITIS",ULCERATIVE COLITIS,MESALAMINE,TWrex-cause
788748100,9/15/2015 17:17:27,1738811849,9/15/2015 17:17:11,False,zoombucks,0.7258,4711962,CAN,ON,Markham,174.88.29.138,MESALAMINE treats ULCERATIVE COLITIS,175,136,,192,146,treats,0.9116846116771039,800903,"Levine DS, Pruitt R, Riff D et al. A multi center double blind dose response trial of Colazide   (balsalazide disodium) and Asacol   (MESALAMINE) for mild moderately active ULCERATIVE COLITIS",ULCERATIVE COLITIS,MESALAMINE,TWrex-cause
788748100,9/15/2015 17:25:11,1738815680,9/15/2015 17:24:19,False,clixsense,0.7214,21875134,GBR,,,80.189.12.98,MESALAMINE treats ULCERATIVE COLITIS,175,136,,192,146,treats,0.9116846116771039,800903,"Levine DS, Pruitt R, Riff D et al. A multi center double blind dose response trial of Colazide   (balsalazide disodium) and Asacol   (MESALAMINE) for mild moderately active ULCERATIVE COLITIS",ULCERATIVE COLITIS,MESALAMINE,TWrex-cause
788748100,9/15/2015 17:25:16,1738815733,9/15/2015 17:24:38,False,gifthunterclub,0.8413,29582088,GBR,I2,Manchester,2.99.153.19,MESALAMINE treats ULCERATIVE COLITIS,175,136,,192,146,treats,0.9116846116771039,800903,"Levine DS, Pruitt R, Riff D et al. A multi center double blind dose response trial of Colazide   (balsalazide disodium) and Asacol   (MESALAMINE) for mild moderately active ULCERATIVE COLITIS",ULCERATIVE COLITIS,MESALAMINE,TWrex-cause
788748101,9/15/2015 18:34:01,1738897284,9/15/2015 18:33:46,False,instagc,0.8861,31184650,USA,IA,Mason City,173.26.179.94,OCTREOTIDE treats REFRACTORY DIARRHOEA,13,62,,33,72,treats,0.986393923832144,907795,Treatment of REFRACTORY DIARRHOEA in AIDS with acetorphan and OCTREOTIDE: a randomized crossover study.,REFRACTORY DIARRHOEA,OCTREOTIDE,RO-may_treat
788748101,9/15/2015 18:36:37,1738899060,9/15/2015 18:36:16,False,prodege,0.8167,6309240,USA,CA,San Diego,108.178.173.218,no_relation,13,62,,33,72,treats,0.986393923832144,907795,Treatment of REFRACTORY DIARRHOEA in AIDS with acetorphan and OCTREOTIDE: a randomized crossover study.,REFRACTORY DIARRHOEA,OCTREOTIDE,RO-may_treat
788748101,9/15/2015 18:42:33,1738902486,9/15/2015 18:41:41,False,clixsense,0.7532,32916182,GBR,L9,Sheffield,5.81.109.21,OCTREOTIDE treats REFRACTORY DIARRHOEA,13,62,,33,72,treats,0.986393923832144,907795,Treatment of REFRACTORY DIARRHOEA in AIDS with acetorphan and OCTREOTIDE: a randomized crossover study.,REFRACTORY DIARRHOEA,OCTREOTIDE,RO-may_treat
788748101,9/15/2015 18:51:18,1738907145,9/15/2015 18:51:00,False,elite,0.8065,30507455,CAN,BC,Richmond,174.6.137.222,OCTREOTIDE treats REFRACTORY DIARRHOEA,13,62,,33,72,treats,0.986393923832144,907795,Treatment of REFRACTORY DIARRHOEA in AIDS with acetorphan and OCTREOTIDE: a randomized crossover study.,REFRACTORY DIARRHOEA,OCTREOTIDE,RO-may_treat
788748101,9/15/2015 18:56:18,1738909702,9/15/2015 18:55:49,False,neodev,0.6052,34281269,USA,CA,Torrance,66.171.228.88,OCTREOTIDE treats REFRACTORY DIARRHOEA,13,62,,33,72,treats,0.986393923832144,907795,Treatment of REFRACTORY DIARRHOEA in AIDS with acetorphan and OCTREOTIDE: a randomized crossover study.,REFRACTORY DIARRHOEA,OCTREOTIDE,RO-may_treat
788748101,9/15/2015 19:04:55,1738913621,9/15/2015 19:04:32,False,prodege,0.9028,3587109,CAN,NS,Sydney,142.177.43.123,OCTREOTIDE treats REFRACTORY DIARRHOEA,13,62,,33,72,treats,0.986393923832144,907795,Treatment of REFRACTORY DIARRHOEA in AIDS with acetorphan and OCTREOTIDE: a randomized crossover study.,REFRACTORY DIARRHOEA,OCTREOTIDE,RO-may_treat
788748101,9/15/2015 19:14:36,1738918072,9/15/2015 19:14:02,False,instagc,0.6857,19602039,USA,WA,Bellevue,50.135.225.35,OCTREOTIDE treats REFRACTORY DIARRHOEA,13,62,,33,72,treats,0.986393923832144,907795,Treatment of REFRACTORY DIARRHOEA in AIDS with acetorphan and OCTREOTIDE: a randomized crossover study.,REFRACTORY DIARRHOEA,OCTREOTIDE,RO-may_treat
788748102,9/15/2015 19:19:17,1738920226,9/15/2015 19:19:04,False,zoombucks,0.8333,4688131,CAN,BC,Vancouver,216.251.132.22,no_relation,67,25,,78,33,treats,0.625,907545,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
788748102,9/15/2015 19:28:29,1738924030,9/15/2015 19:27:57,False,elite,0.6,30312592,CAN,ON,Sudbury,66.103.55.12,no_relation,67,25,,78,33,treats,0.625,907545,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
788748102,9/15/2015 19:34:51,1738925834,9/15/2015 19:34:31,False,prodege,0.773,34247194,CAN,ON,Toronto,99.244.108.95,no_relation,67,25,,78,33,treats,0.625,907545,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
788748102,9/15/2015 19:35:28,1738926133,9/15/2015 19:35:03,False,instagc,0.8393,31157999,USA,KS,Topeka,68.102.220.35,no_relation,67,25,,78,33,treats,0.625,907545,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
788748102,9/15/2015 19:38:27,1738927155,9/15/2015 19:37:45,False,elite,0.6639,29768955,GBR,C3,Gamlingay,31.50.187.165,DEXTROSE treats HYPOGLYCEMIA,67,25,,78,33,treats,0.625,907545,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
788748102,9/15/2015 19:41:42,1738928202,9/15/2015 19:41:25,False,clixsense,0.6786,32053717,GBR,,,51.174.76.80,DEXTROSE treats HYPOGLYCEMIA,67,25,,78,33,treats,0.625,907545,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
788748102,9/15/2015 19:42:23,1738928452,9/15/2015 19:41:53,False,prodege,0.7111,16101132,GBR,F9,Hayes,2.216.28.167,no_relation,67,25,,78,33,treats,0.625,907545,Do not substitute for IV DEXTROSE in emergency situations in which HYPOGLYCEMIA is suspected but not established.,HYPOGLYCEMIA,DEXTROSE,RO-may_treat
788748111,9/15/2015 18:34:01,1738897287,9/15/2015 18:33:46,False,instagc,0.8861,31184650,USA,IA,Mason City,173.26.179.94,no_relation,124,22,,143,35,treats,0.480384461415261,216954,"Its first metabolite, [OXCARBAZEPINE], is both safe and effective in other neuropathic disorders, but has not been studied in [DIABETIC NEUROPATHY].",DIABETIC NEUROPATHY,OXCARBAZEPINE,TWrex-treat
788748111,9/15/2015 18:36:37,1738899049,9/15/2015 18:36:16,False,prodege,0.8167,6309240,USA,CA,San Diego,108.178.173.218,no_relation,124,22,,143,35,treats,0.480384461415261,216954,"Its first metabolite, [OXCARBAZEPINE], is both safe and effective in other neuropathic disorders, but has not been studied in [DIABETIC NEUROPATHY].",DIABETIC NEUROPATHY,OXCARBAZEPINE,TWrex-treat
788748111,9/15/2015 18:42:33,1738902487,9/15/2015 18:41:41,False,clixsense,0.7532,32916182,GBR,L9,Sheffield,5.81.109.21,no_relation,124,22,,143,35,treats,0.480384461415261,216954,"Its first metabolite, [OXCARBAZEPINE], is both safe and effective in other neuropathic disorders, but has not been studied in [DIABETIC NEUROPATHY].",DIABETIC NEUROPATHY,OXCARBAZEPINE,TWrex-treat
788748111,9/15/2015 18:51:18,1738907146,9/15/2015 18:51:00,False,elite,0.8065,30507455,CAN,BC,Richmond,174.6.137.222,no_relation,124,22,,143,35,treats,0.480384461415261,216954,"Its first metabolite, [OXCARBAZEPINE], is both safe and effective in other neuropathic disorders, but has not been studied in [DIABETIC NEUROPATHY].",DIABETIC NEUROPATHY,OXCARBAZEPINE,TWrex-treat
788748111,9/15/2015 18:56:18,1738909699,9/15/2015 18:55:49,False,neodev,0.6052,34281269,USA,CA,Torrance,66.171.228.88,OXCARBAZEPINE treats DIABETIC NEUROPATHY,124,22,,143,35,treats,0.480384461415261,216954,"Its first metabolite, [OXCARBAZEPINE], is both safe and effective in other neuropathic disorders, but has not been studied in [DIABETIC NEUROPATHY].",DIABETIC NEUROPATHY,OXCARBAZEPINE,TWrex-treat
788748111,9/15/2015 19:04:55,1738913623,9/15/2015 19:04:32,False,prodege,0.9028,3587109,CAN,NS,Sydney,142.177.43.123,no_relation,124,22,,143,35,treats,0.480384461415261,216954,"Its first metabolite, [OXCARBAZEPINE], is both safe and effective in other neuropathic disorders, but has not been studied in [DIABETIC NEUROPATHY].",DIABETIC NEUROPATHY,OXCARBAZEPINE,TWrex-treat
788748111,9/15/2015 19:14:36,1738918070,9/15/2015 19:14:02,False,instagc,0.6857,19602039,USA,WA,Bellevue,50.135.225.35,OXCARBAZEPINE treats DIABETIC NEUROPATHY,124,22,,143,35,treats,0.480384461415261,216954,"Its first metabolite, [OXCARBAZEPINE], is both safe and effective in other neuropathic disorders, but has not been studied in [DIABETIC NEUROPATHY].",DIABETIC NEUROPATHY,OXCARBAZEPINE,TWrex-treat
788748112,9/15/2015 18:14:18,1738884576,9/15/2015 18:14:03,False,instagc,0.85,18985376,GBR,D2,Derby,86.27.159.112,no_relation,124,67,,145,84,treats,0.5656854249492379,811489,109  Malignant Hyperthermia Crisis    Immediately discontinue all ANESTHETIC AGENTS and institute IV dantrolene as soon as MALIGNANT HYPERTHERMIA crisis is recognized.,MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS,TWrex-cause
788748112,9/15/2015 18:21:05,1738889570,9/15/2015 18:19:16,False,zoombucks,0.8357,6744840,CAN,BC,Kelowna,174.4.58.160,no_relation,124,67,,145,84,treats,0.5656854249492379,811489,109  Malignant Hyperthermia Crisis    Immediately discontinue all ANESTHETIC AGENTS and institute IV dantrolene as soon as MALIGNANT HYPERTHERMIA crisis is recognized.,MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS,TWrex-cause
788748112,9/15/2015 18:21:09,1738889647,9/15/2015 18:20:44,False,clixsense,0.8357,19638651,USA,SC,Summerville,174.107.73.211,no_relation,124,67,,145,84,treats,0.5656854249492379,811489,109  Malignant Hyperthermia Crisis    Immediately discontinue all ANESTHETIC AGENTS and institute IV dantrolene as soon as MALIGNANT HYPERTHERMIA crisis is recognized.,MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS,TWrex-cause
788748112,9/15/2015 18:32:19,1738896252,9/15/2015 18:31:54,False,instagc,0.8861,31184650,USA,IA,Mason City,173.26.179.94,no_relation,124,67,,145,84,treats,0.5656854249492379,811489,109  Malignant Hyperthermia Crisis    Immediately discontinue all ANESTHETIC AGENTS and institute IV dantrolene as soon as MALIGNANT HYPERTHERMIA crisis is recognized.,MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS,TWrex-cause
788748112,9/15/2015 18:32:44,1738896469,9/15/2015 18:32:12,False,instagc,0.7607,20312760,GBR,O1,Dukinfield,2.96.59.31,no_relation,124,67,,145,84,treats,0.5656854249492379,811489,109  Malignant Hyperthermia Crisis    Immediately discontinue all ANESTHETIC AGENTS and institute IV dantrolene as soon as MALIGNANT HYPERTHERMIA crisis is recognized.,MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS,TWrex-cause
788748112,9/15/2015 18:33:18,1738896841,9/15/2015 18:32:20,False,bitcoinget,0.6607,29516942,USA,CA,Saratoga,107.178.35.226,no_relation,124,67,,145,84,treats,0.5656854249492379,811489,109  Malignant Hyperthermia Crisis    Immediately discontinue all ANESTHETIC AGENTS and institute IV dantrolene as soon as MALIGNANT HYPERTHERMIA crisis is recognized.,MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS,TWrex-cause
788748112,9/15/2015 18:44:21,1738903366,9/15/2015 18:42:38,False,clixsense,0.7532,32916182,GBR,L9,Sheffield,5.81.109.21,no_relation,124,67,,145,84,treats,0.5656854249492379,811489,109  Malignant Hyperthermia Crisis    Immediately discontinue all ANESTHETIC AGENTS and institute IV dantrolene as soon as MALIGNANT HYPERTHERMIA crisis is recognized.,MALIGNANT HYPERTHERMIA,ANESTHETIC AGENTS,TWrex-cause
788748116,9/15/2015 16:12:29,1738770425,9/15/2015 16:11:56,False,gifthunterclub,0.8036,24043308,GBR,,,94.102.147.250,DOPAMINE treats HYPERDYNAMIC SEPTIC SHOCK,101,71,,125,79,treats,1.0,800477,"2]  Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or DOPAMINE for the treatment of HYPERDYNAMIC SEPTIC SHOCK",HYPERDYNAMIC SEPTIC SHOCK,DOPAMINE,TWrex-cause
788748116,9/15/2015 16:12:49,1738770507,9/15/2015 16:12:27,False,neodev,0.9167,14096345,NLD,03,Eibergen,178.85.94.186,DOPAMINE treats HYPERDYNAMIC SEPTIC SHOCK,101,71,,125,79,treats,1.0,800477,"2]  Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or DOPAMINE for the treatment of HYPERDYNAMIC SEPTIC SHOCK",HYPERDYNAMIC SEPTIC SHOCK,DOPAMINE,TWrex-cause
788748116,9/15/2015 16:12:53,1738770531,9/15/2015 16:10:22,False,elite,0.8889,31883685,GBR,,,79.66.244.188,DOPAMINE treats HYPERDYNAMIC SEPTIC SHOCK,101,71,,125,79,treats,1.0,800477,"2]  Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or DOPAMINE for the treatment of HYPERDYNAMIC SEPTIC SHOCK",HYPERDYNAMIC SEPTIC SHOCK,DOPAMINE,TWrex-cause
788748116,9/15/2015 16:15:31,1738771587,9/15/2015 16:15:24,False,instagc,1.0,15577915,USA,IL,Trenton,208.70.36.12,DOPAMINE treats HYPERDYNAMIC SEPTIC SHOCK,101,71,,125,79,treats,1.0,800477,"2]  Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or DOPAMINE for the treatment of HYPERDYNAMIC SEPTIC SHOCK",HYPERDYNAMIC SEPTIC SHOCK,DOPAMINE,TWrex-cause
788748116,9/15/2015 16:17:00,1738772094,9/15/2015 16:16:46,False,prodege,0.8611,22031444,GBR,F2,Gosport,92.24.223.243,DOPAMINE treats HYPERDYNAMIC SEPTIC SHOCK,101,71,,125,79,treats,1.0,800477,"2]  Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or DOPAMINE for the treatment of HYPERDYNAMIC SEPTIC SHOCK",HYPERDYNAMIC SEPTIC SHOCK,DOPAMINE,TWrex-cause
788748116,9/15/2015 16:17:28,1738772236,9/15/2015 16:16:33,False,clixsense,0.8407,33878524,CAN,BC,Princeton,75.156.83.71,DOPAMINE treats HYPERDYNAMIC SEPTIC SHOCK,101,71,,125,79,treats,1.0,800477,"2]  Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or DOPAMINE for the treatment of HYPERDYNAMIC SEPTIC SHOCK",HYPERDYNAMIC SEPTIC SHOCK,DOPAMINE,TWrex-cause
788748116,9/15/2015 16:18:22,1738772587,9/15/2015 16:15:16,False,points4rewards,0.7282,20113482,USA,PA,Philadelphia,162.208.49.45,DOPAMINE treats HYPERDYNAMIC SEPTIC SHOCK,101,71,,125,79,treats,1.0,800477,"2]  Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or DOPAMINE for the treatment of HYPERDYNAMIC SEPTIC SHOCK",HYPERDYNAMIC SEPTIC SHOCK,DOPAMINE,TWrex-cause
788865469,9/15/2015 22:47:04,1739064996,9/15/2015 22:46:19,False,clixsense,0.8917,20587495,CAN,NB,Saint John,142.162.106.74,FLUCONAZOLE treats HISTOPLASMOSIS,44,141,,57,152,treats,0.9918365981341751,800386,"Sharkey Mathis PK, Velez J, Fetchick R et alHISTOPLASMOSIS in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and FLUCONAZOLE",HISTOPLASMOSIS,FLUCONAZOLE,TWrex-cause
788865469,9/15/2015 22:56:16,1739068248,9/15/2015 22:55:57,False,clixsense,0.85,21963184,GBR,L9,Sheffield,146.199.61.136,FLUCONAZOLE treats HISTOPLASMOSIS,44,141,,57,152,treats,0.9918365981341751,800386,"Sharkey Mathis PK, Velez J, Fetchick R et alHISTOPLASMOSIS in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and FLUCONAZOLE",HISTOPLASMOSIS,FLUCONAZOLE,TWrex-cause
788865469,9/15/2015 22:57:15,1739068557,9/15/2015 22:56:15,False,instagc,0.6222,20392280,USA,CA,Los Angeles,172.56.17.103,FLUCONAZOLE treats HISTOPLASMOSIS,44,141,,57,152,treats,0.9918365981341751,800386,"Sharkey Mathis PK, Velez J, Fetchick R et alHISTOPLASMOSIS in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and FLUCONAZOLE",HISTOPLASMOSIS,FLUCONAZOLE,TWrex-cause
788865469,9/15/2015 22:57:51,1739068730,9/15/2015 22:57:18,False,clixsense,0.8349,6344072,CAN,BC,Burnaby,172.218.166.58,FLUCONAZOLE treats HISTOPLASMOSIS,44,141,,57,152,treats,0.9918365981341751,800386,"Sharkey Mathis PK, Velez J, Fetchick R et alHISTOPLASMOSIS in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and FLUCONAZOLE",HISTOPLASMOSIS,FLUCONAZOLE,TWrex-cause
788865469,9/15/2015 23:08:17,1739072413,9/15/2015 23:07:59,False,clixsense,0.9315,11106820,USA,MA,Taunton,173.48.52.95,FLUCONAZOLE treats HISTOPLASMOSIS,44,141,,57,152,treats,0.9918365981341751,800386,"Sharkey Mathis PK, Velez J, Fetchick R et alHISTOPLASMOSIS in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and FLUCONAZOLE",HISTOPLASMOSIS,FLUCONAZOLE,TWrex-cause
788865469,9/15/2015 23:43:09,1739082881,9/15/2015 23:42:38,False,neodev,0.9417,22074628,GBR,,,92.4.207.4,FLUCONAZOLE treats HISTOPLASMOSIS,44,141,,57,152,treats,0.9918365981341751,800386,"Sharkey Mathis PK, Velez J, Fetchick R et alHISTOPLASMOSIS in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and FLUCONAZOLE",HISTOPLASMOSIS,FLUCONAZOLE,TWrex-cause
788865469,9/15/2015 23:55:13,1739086147,9/15/2015 23:54:35,False,clixsense,0.9583,33980820,USA,IL,Chicago,69.47.104.214,FLUCONAZOLE treats HISTOPLASMOSIS,44,141,,57,152,treats,0.9918365981341751,800386,"Sharkey Mathis PK, Velez J, Fetchick R et alHISTOPLASMOSIS in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and FLUCONAZOLE",HISTOPLASMOSIS,FLUCONAZOLE,TWrex-cause
788865471,9/16/2015 01:29:44,1739120582,9/16/2015 01:29:22,False,cotter,0.8968,34377132,USA,OH,Athens,107.10.138.13,MALATHION LOTION treats HEAD LICE,105,65,,113,81,treats,1.0,804486,New Reference of Interest  2010 03 11     Oral ivermectin versus MALATHION LOTION for difficult to treat HEAD LICE,HEAD LICE,MALATHION LOTION,TWrex-cause
788865471,9/16/2015 01:48:01,1739136951,9/16/2015 01:47:04,False,prodege,0.7440000000000001,24403612,USA,MI,Royal Oak,198.208.251.21,MALATHION LOTION treats HEAD LICE,105,65,,113,81,treats,1.0,804486,New Reference of Interest  2010 03 11     Oral ivermectin versus MALATHION LOTION for difficult to treat HEAD LICE,HEAD LICE,MALATHION LOTION,TWrex-cause
788865471,9/16/2015 02:38:01,1739179005,9/16/2015 02:37:13,False,elite,0.7847,30312592,CAN,ON,Sudbury,66.103.55.12,MALATHION LOTION treats HEAD LICE,105,65,,113,81,treats,1.0,804486,New Reference of Interest  2010 03 11     Oral ivermectin versus MALATHION LOTION for difficult to treat HEAD LICE,HEAD LICE,MALATHION LOTION,TWrex-cause
788865471,9/16/2015 02:51:16,1739191963,9/16/2015 02:51:05,False,zoombucks,0.7242,4688131,CAN,BC,Vancouver,75.157.35.92,MALATHION LOTION treats HEAD LICE,105,65,,113,81,treats,1.0,804486,New Reference of Interest  2010 03 11     Oral ivermectin versus MALATHION LOTION for difficult to treat HEAD LICE,HEAD LICE,MALATHION LOTION,TWrex-cause
788865471,9/16/2015 02:54:21,1739194628,9/16/2015 02:53:49,False,prodege,0.5833,7348582,CAN,MB,Winnipeg,207.161.108.104,MALATHION LOTION treats HEAD LICE,105,65,,113,81,treats,1.0,804486,New Reference of Interest  2010 03 11     Oral ivermectin versus MALATHION LOTION for difficult to treat HEAD LICE,HEAD LICE,MALATHION LOTION,TWrex-cause
788865471,9/16/2015 03:17:02,1739214914,9/16/2015 03:16:48,False,elite,0.648,34356654,USA,DE,,108.59.11.227,MALATHION LOTION treats HEAD LICE,105,65,,113,81,treats,1.0,804486,New Reference of Interest  2010 03 11     Oral ivermectin versus MALATHION LOTION for difficult to treat HEAD LICE,HEAD LICE,MALATHION LOTION,TWrex-cause
788865471,9/16/2015 03:28:23,1739225468,9/16/2015 03:27:58,False,instagc,0.8145,33058612,USA,IL,Glenview,162.229.106.229,MALATHION LOTION treats HEAD LICE,105,65,,113,81,treats,1.0,804486,New Reference of Interest  2010 03 11     Oral ivermectin versus MALATHION LOTION for difficult to treat HEAD LICE,HEAD LICE,MALATHION LOTION,TWrex-cause
788865472,9/16/2015 05:24:50,1739339158,9/16/2015 05:22:51,False,gifthunterclub,0.7778,24043308,GBR,,,94.102.147.250,TRANSDERMAL NICOTINE treats ULCERATIVE COLITIS,302,251,,319,271,treats,0.975900072948533,804658,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6 mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  TRANSDERMAL NICOTINE for induction of remission in ULCERATIVE COLITIS (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis   a meta analysis.,ULCERATIVE COLITIS,TRANSDERMAL NICOTINE,TWrex-cause
788865472,9/16/2015 05:36:16,1739351683,9/16/2015 05:35:46,False,clixsense,0.8399,31304413,CAN,BC,Kelowna,66.183.36.177,TRANSDERMAL NICOTINE treats ULCERATIVE COLITIS,302,251,,319,271,treats,0.975900072948533,804658,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6 mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  TRANSDERMAL NICOTINE for induction of remission in ULCERATIVE COLITIS (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis   a meta analysis.,ULCERATIVE COLITIS,TRANSDERMAL NICOTINE,TWrex-cause
788865472,9/16/2015 05:50:03,1739368051,9/16/2015 05:49:32,False,instagc,0.7163,21613169,GBR,A7,Birmingham,109.156.129.221,no_relation,302,251,,319,271,treats,0.975900072948533,804658,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6 mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  TRANSDERMAL NICOTINE for induction of remission in ULCERATIVE COLITIS (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis   a meta analysis.,ULCERATIVE COLITIS,TRANSDERMAL NICOTINE,TWrex-cause
788865472,9/16/2015 06:06:36,1739384432,9/16/2015 06:06:04,False,points4rewards,0.8065,20306700,USA,WA,Bothell,50.106.46.70,TRANSDERMAL NICOTINE treats ULCERATIVE COLITIS,302,251,,319,271,treats,0.975900072948533,804658,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6 mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  TRANSDERMAL NICOTINE for induction of remission in ULCERATIVE COLITIS (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis   a meta analysis.,ULCERATIVE COLITIS,TRANSDERMAL NICOTINE,TWrex-cause
788865472,9/16/2015 06:18:03,1739392542,9/16/2015 06:17:34,False,prodege,0.825,27934334,GBR,C8,Croydon,81.159.60.206,no_relation,302,251,,319,271,treats,0.975900072948533,804658,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6 mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  TRANSDERMAL NICOTINE for induction of remission in ULCERATIVE COLITIS (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis   a meta analysis.,ULCERATIVE COLITIS,TRANSDERMAL NICOTINE,TWrex-cause
788865472,9/16/2015 06:24:58,1739396818,9/16/2015 06:23:19,False,points4rewards,0.8859,28703583,USA,,,184.53.32.197,TRANSDERMAL NICOTINE treats ULCERATIVE COLITIS,302,251,,319,271,treats,0.975900072948533,804658,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6 mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  TRANSDERMAL NICOTINE for induction of remission in ULCERATIVE COLITIS (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis   a meta analysis.,ULCERATIVE COLITIS,TRANSDERMAL NICOTINE,TWrex-cause
788865472,9/16/2015 06:28:47,1739398901,9/16/2015 06:26:43,False,clixsense,0.8762,28570371,NLD,,,91.213.37.165,TRANSDERMAL NICOTINE treats ULCERATIVE COLITIS,302,251,,319,271,treats,0.975900072948533,804658,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6 mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  TRANSDERMAL NICOTINE for induction of remission in ULCERATIVE COLITIS (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis   a meta analysis.,ULCERATIVE COLITIS,TRANSDERMAL NICOTINE,TWrex-cause
788865477,9/15/2015 21:43:11,1739041097,9/15/2015 21:42:43,False,neodev,0.8611,33644825,USA,FL,Fort Lauderdale,65.111.173.161,DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE treats CENTRAL PRECOCIOUS PUBERTY,146,66,,171,111,treats,1.0,803542,"Clemons RD, Kappy MS, Stuart TE et al. Long term effectiveness of DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE in the treatment of children with CENTRAL PRECOCIOUS PUBERTY",CENTRAL PRECOCIOUS PUBERTY,DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE,TWrex-cause
788865477,9/15/2015 21:49:18,1739044292,9/15/2015 21:48:55,False,prodege,0.9667,21417560,GBR,C3,Cambridge,151.224.120.191,DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE treats CENTRAL PRECOCIOUS PUBERTY,146,66,,171,111,treats,1.0,803542,"Clemons RD, Kappy MS, Stuart TE et al. Long term effectiveness of DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE in the treatment of children with CENTRAL PRECOCIOUS PUBERTY",CENTRAL PRECOCIOUS PUBERTY,DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE,TWrex-cause
788865477,9/15/2015 21:52:17,1739045678,9/15/2015 21:51:51,False,pocketmoneygpt,0.7877,21432964,GBR,F8,Borehamwood,81.159.185.70,DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE treats CENTRAL PRECOCIOUS PUBERTY,146,66,,171,111,treats,1.0,803542,"Clemons RD, Kappy MS, Stuart TE et al. Long term effectiveness of DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE in the treatment of children with CENTRAL PRECOCIOUS PUBERTY",CENTRAL PRECOCIOUS PUBERTY,DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE,TWrex-cause
788865477,9/15/2015 21:56:07,1739047244,9/15/2015 21:55:38,False,neodev,0.6843,33701549,NLD,,,85.203.17.204,CENTRAL PRECOCIOUS PUBERTY treats DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE,146,66,,171,111,treats,1.0,803542,"Clemons RD, Kappy MS, Stuart TE et al. Long term effectiveness of DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE in the treatment of children with CENTRAL PRECOCIOUS PUBERTY",CENTRAL PRECOCIOUS PUBERTY,DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE,TWrex-cause
788865477,9/15/2015 21:56:13,1739047260,9/15/2015 21:55:51,False,clixsense,0.7919,32053717,GBR,,,51.174.76.80,DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE treats CENTRAL PRECOCIOUS PUBERTY,146,66,,171,111,treats,1.0,803542,"Clemons RD, Kappy MS, Stuart TE et al. Long term effectiveness of DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE in the treatment of children with CENTRAL PRECOCIOUS PUBERTY",CENTRAL PRECOCIOUS PUBERTY,DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE,TWrex-cause
788865477,9/15/2015 22:02:31,1739050224,9/15/2015 22:01:12,False,clixsense,0.8375,31182465,GBR,A4,Bath,86.144.102.125,DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE treats CENTRAL PRECOCIOUS PUBERTY,146,66,,171,111,treats,1.0,803542,"Clemons RD, Kappy MS, Stuart TE et al. Long term effectiveness of DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE in the treatment of children with CENTRAL PRECOCIOUS PUBERTY",CENTRAL PRECOCIOUS PUBERTY,DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE,TWrex-cause
788865477,9/15/2015 22:06:46,1739051700,9/15/2015 22:03:29,False,onestopgpt,0.8546,21275875,CAN,ON,Hamilton,24.36.124.79,DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE treats CENTRAL PRECOCIOUS PUBERTY,146,66,,171,111,treats,1.0,803542,"Clemons RD, Kappy MS, Stuart TE et al. Long term effectiveness of DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE in the treatment of children with CENTRAL PRECOCIOUS PUBERTY",CENTRAL PRECOCIOUS PUBERTY,DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE,TWrex-cause
788865478,9/15/2015 22:19:04,1739055850,9/15/2015 22:18:25,False,neodev,0.8889,33758777,USA,,,38.95.108.251,ESOPHAGUS treats ESOPHAGEAL CANCER,122,32,,130,49,treats,0.477334370505438,902460,"Since 1982, three patients with ESOPHAGEAL CANCER complicated with pulmonary bullae have been treated by operation on the ESOPHAGUS and lung in one performance: In all the patients, the bullae were on the same side of the operation.",ESOPHAGUS,ESOPHAGEAL CANCER,RO-disease_has_primary_anatomic_site
788865478,9/15/2015 22:28:53,1739058993,9/15/2015 22:27:51,False,points4rewards,0.7798,20113482,USA,PA,Philadelphia,162.208.49.45,no_relation,122,32,,130,49,treats,0.477334370505438,902460,"Since 1982, three patients with ESOPHAGEAL CANCER complicated with pulmonary bullae have been treated by operation on the ESOPHAGUS and lung in one performance: In all the patients, the bullae were on the same side of the operation.",ESOPHAGUS,ESOPHAGEAL CANCER,RO-disease_has_primary_anatomic_site
788865478,9/15/2015 22:30:04,1739059407,9/15/2015 22:29:06,False,fusioncash,0.8313,31742806,USA,OH,Kent,66.61.82.242,no_relation,122,32,,130,49,treats,0.477334370505438,902460,"Since 1982, three patients with ESOPHAGEAL CANCER complicated with pulmonary bullae have been treated by operation on the ESOPHAGUS and lung in one performance: In all the patients, the bullae were on the same side of the operation.",ESOPHAGUS,ESOPHAGEAL CANCER,RO-disease_has_primary_anatomic_site
788865478,9/15/2015 22:42:56,1739063671,9/15/2015 22:42:26,False,instagc,0.9048,23287154,USA,CA,San Jose,50.184.60.102,no_relation,122,32,,130,49,treats,0.477334370505438,902460,"Since 1982, three patients with ESOPHAGEAL CANCER complicated with pulmonary bullae have been treated by operation on the ESOPHAGUS and lung in one performance: In all the patients, the bullae were on the same side of the operation.",ESOPHAGUS,ESOPHAGEAL CANCER,RO-disease_has_primary_anatomic_site
788865478,9/15/2015 22:43:28,1739063806,9/15/2015 22:42:37,False,clixsense,0.8917,20587495,CAN,NB,Saint John,142.162.106.74,no_relation,122,32,,130,49,treats,0.477334370505438,902460,"Since 1982, three patients with ESOPHAGEAL CANCER complicated with pulmonary bullae have been treated by operation on the ESOPHAGUS and lung in one performance: In all the patients, the bullae were on the same side of the operation.",ESOPHAGUS,ESOPHAGEAL CANCER,RO-disease_has_primary_anatomic_site
788865478,9/15/2015 22:52:49,1739066994,9/15/2015 22:49:27,False,instagc,0.6222,20392280,USA,CA,Los Angeles,172.56.17.103,no_relation,122,32,,130,49,treats,0.477334370505438,902460,"Since 1982, three patients with ESOPHAGEAL CANCER complicated with pulmonary bullae have been treated by operation on the ESOPHAGUS and lung in one performance: In all the patients, the bullae were on the same side of the operation.",ESOPHAGUS,ESOPHAGEAL CANCER,RO-disease_has_primary_anatomic_site
788865478,9/15/2015 22:53:15,1739067165,9/15/2015 22:51:44,False,clixsense,0.8349,6344072,CAN,BC,Burnaby,172.218.166.58,no_relation,122,32,,130,49,treats,0.477334370505438,902460,"Since 1982, three patients with ESOPHAGEAL CANCER complicated with pulmonary bullae have been treated by operation on the ESOPHAGUS and lung in one performance: In all the patients, the bullae were on the same side of the operation.",ESOPHAGUS,ESOPHAGEAL CANCER,RO-disease_has_primary_anatomic_site
788865479,9/16/2015 05:51:35,1739369632,9/16/2015 05:51:24,False,instagc,0.7163,21613169,GBR,A7,Birmingham,109.156.129.221,no_relation,76,0,,85,8,treats,0.9958932064677041,223683,[DIAZEPAM] that can be inserted rectally is often prescribed to caregivers of [EPILEPTIC]s.,EPILEPTIC,DIAZEPAM,TWrex-treat
788865479,9/16/2015 06:07:27,1739384927,9/16/2015 06:07:07,False,points4rewards,0.8065,20306700,USA,WA,Bothell,50.106.46.70,DIAZEPAM treats EPILEPTIC,76,0,,85,8,treats,0.9958932064677041,223683,[DIAZEPAM] that can be inserted rectally is often prescribed to caregivers of [EPILEPTIC]s.,EPILEPTIC,DIAZEPAM,TWrex-treat
788865479,9/16/2015 06:19:09,1739393496,9/16/2015 06:18:30,False,prodege,0.825,27934334,GBR,C8,Croydon,81.159.60.206,no_relation,76,0,,85,8,treats,0.9958932064677041,223683,[DIAZEPAM] that can be inserted rectally is often prescribed to caregivers of [EPILEPTIC]s.,EPILEPTIC,DIAZEPAM,TWrex-treat
788865479,9/16/2015 06:26:35,1739397813,9/16/2015 06:25:57,False,points4rewards,0.8859,28703583,USA,,,184.53.32.197,DIAZEPAM treats EPILEPTIC,76,0,,85,8,treats,0.9958932064677041,223683,[DIAZEPAM] that can be inserted rectally is often prescribed to caregivers of [EPILEPTIC]s.,EPILEPTIC,DIAZEPAM,TWrex-treat
788865479,9/16/2015 06:30:30,1739400110,9/16/2015 06:30:01,False,clixsense,0.8762,28570371,NLD,,,91.213.37.165,DIAZEPAM treats EPILEPTIC,76,0,,85,8,treats,0.9958932064677041,223683,[DIAZEPAM] that can be inserted rectally is often prescribed to caregivers of [EPILEPTIC]s.,EPILEPTIC,DIAZEPAM,TWrex-treat
788865479,9/16/2015 06:31:01,1739400372,9/16/2015 06:30:10,False,clixsense,0.8155,31482589,NLD,11,Gouda,77.167.232.121,no_relation,76,0,,85,8,treats,0.9958932064677041,223683,[DIAZEPAM] that can be inserted rectally is often prescribed to caregivers of [EPILEPTIC]s.,EPILEPTIC,DIAZEPAM,TWrex-treat
788865479,9/16/2015 06:41:50,1739406481,9/16/2015 06:41:35,False,gifthunterclub,0.7639,33931170,AUS,04,Brisbane,121.208.7.253,DIAZEPAM treats EPILEPTIC,76,0,,85,8,treats,0.9958932064677041,223683,[DIAZEPAM] that can be inserted rectally is often prescribed to caregivers of [EPILEPTIC]s.,EPILEPTIC,DIAZEPAM,TWrex-treat
788865480,9/15/2015 22:56:49,1739068413,9/15/2015 22:56:35,False,clixsense,0.85,21963184,GBR,L9,Sheffield,146.199.61.136,EZETIMIBE treats HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,52,109,,91,118,treats,0.962250448649376,907719,"In other studies by the same team, in patients with HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA the addition of EZETIMIBE to 40 mg/d of either simvastatin or atorvastatin increased effectiveness almost 4 times more than increasing the statin dosage to 80 mg/d  (2).",HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,EZETIMIBE,RO-may_treat
788865480,9/15/2015 23:09:26,1739072969,9/15/2015 23:08:53,False,clixsense,0.9315,11106820,USA,MA,Taunton,173.48.52.95,EZETIMIBE treats HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,52,109,,91,118,treats,0.962250448649376,907719,"In other studies by the same team, in patients with HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA the addition of EZETIMIBE to 40 mg/d of either simvastatin or atorvastatin increased effectiveness almost 4 times more than increasing the statin dosage to 80 mg/d  (2).",HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,EZETIMIBE,RO-may_treat
788865480,9/15/2015 23:44:03,1739083068,9/15/2015 23:43:36,False,neodev,0.9417,22074628,GBR,,,92.4.207.4,EZETIMIBE treats HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,52,109,,91,118,treats,0.962250448649376,907719,"In other studies by the same team, in patients with HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA the addition of EZETIMIBE to 40 mg/d of either simvastatin or atorvastatin increased effectiveness almost 4 times more than increasing the statin dosage to 80 mg/d  (2).",HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,EZETIMIBE,RO-may_treat
788865480,9/15/2015 23:56:03,1739086451,9/15/2015 23:55:32,False,clixsense,0.9583,33980820,USA,IL,Chicago,69.47.104.214,EZETIMIBE treats HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,52,109,,91,118,treats,0.962250448649376,907719,"In other studies by the same team, in patients with HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA the addition of EZETIMIBE to 40 mg/d of either simvastatin or atorvastatin increased effectiveness almost 4 times more than increasing the statin dosage to 80 mg/d  (2).",HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,EZETIMIBE,RO-may_treat
788865480,9/16/2015 00:03:36,1739088142,9/16/2015 00:03:25,False,clixsense,0.8333,28457001,CAN,ON,North Bay,24.204.202.220,EZETIMIBE treats HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,52,109,,91,118,treats,0.962250448649376,907719,"In other studies by the same team, in patients with HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA the addition of EZETIMIBE to 40 mg/d of either simvastatin or atorvastatin increased effectiveness almost 4 times more than increasing the statin dosage to 80 mg/d  (2).",HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,EZETIMIBE,RO-may_treat
788865480,9/16/2015 00:12:25,1739090465,9/16/2015 00:12:10,False,instagc,0.9028,31888345,USA,CA,Hayward,24.7.3.180,EZETIMIBE treats HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,52,109,,91,118,treats,0.962250448649376,907719,"In other studies by the same team, in patients with HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA the addition of EZETIMIBE to 40 mg/d of either simvastatin or atorvastatin increased effectiveness almost 4 times more than increasing the statin dosage to 80 mg/d  (2).",HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,EZETIMIBE,RO-may_treat
788865480,9/16/2015 01:03:06,1739104350,9/16/2015 01:02:53,False,prodege,0.8917,3587109,CAN,NS,Sydney,142.177.43.123,EZETIMIBE treats HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,52,109,,91,118,treats,0.962250448649376,907719,"In other studies by the same team, in patients with HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA the addition of EZETIMIBE to 40 mg/d of either simvastatin or atorvastatin increased effectiveness almost 4 times more than increasing the statin dosage to 80 mg/d  (2).",HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA,EZETIMIBE,RO-may_treat
788865489,9/16/2015 04:02:29,1739257214,9/16/2015 04:02:08,False,clixsense,0.8194,21665495,CAN,,,24.105.69.70,no_relation,45,86,,65,95,treats,0.9970544855015809,211716,"Oral combination chemotherapy with Pep-C for [MANTLE CELL LYMPHOMA] : Daily prednisone, [ETOPOSIDE], procarbazine and cyclophosphamide.",MANTLE CELL LYMPHOMA,ETOPOSIDE,TWrex-treat
788865489,9/16/2015 04:47:09,1739301354,9/16/2015 04:46:45,False,gifthunterclub,0.894,30901412,GBR,G5,Margate,85.210.116.48,ETOPOSIDE treats MANTLE CELL LYMPHOMA,45,86,,65,95,treats,0.9970544855015809,211716,"Oral combination chemotherapy with Pep-C for [MANTLE CELL LYMPHOMA] : Daily prednisone, [ETOPOSIDE], procarbazine and cyclophosphamide.",MANTLE CELL LYMPHOMA,ETOPOSIDE,TWrex-treat
788865489,9/16/2015 05:13:10,1739328049,9/16/2015 05:12:53,False,elite,0.8839,31883685,GBR,,,79.66.244.188,ETOPOSIDE treats MANTLE CELL LYMPHOMA,45,86,,65,95,treats,0.9970544855015809,211716,"Oral combination chemotherapy with Pep-C for [MANTLE CELL LYMPHOMA] : Daily prednisone, [ETOPOSIDE], procarbazine and cyclophosphamide.",MANTLE CELL LYMPHOMA,ETOPOSIDE,TWrex-treat
788865489,9/16/2015 05:13:53,1739328938,9/16/2015 05:12:28,False,prodege,0.7524,5007431,USA,MI,Saginaw,68.188.255.98,no_relation,45,86,,65,95,treats,0.9970544855015809,211716,"Oral combination chemotherapy with Pep-C for [MANTLE CELL LYMPHOMA] : Daily prednisone, [ETOPOSIDE], procarbazine and cyclophosphamide.",MANTLE CELL LYMPHOMA,ETOPOSIDE,TWrex-treat
788865489,9/16/2015 05:14:35,1739329492,9/16/2015 05:13:45,False,gifthunterclub,0.7778,24043308,GBR,,,94.102.147.250,MANTLE CELL LYMPHOMA treats ETOPOSIDE,45,86,,65,95,treats,0.9970544855015809,211716,"Oral combination chemotherapy with Pep-C for [MANTLE CELL LYMPHOMA] : Daily prednisone, [ETOPOSIDE], procarbazine and cyclophosphamide.",MANTLE CELL LYMPHOMA,ETOPOSIDE,TWrex-treat
788865489,9/16/2015 05:31:56,1739346589,9/16/2015 05:30:40,False,neodev,0.7679,16854635,USA,OH,Lakewood,70.187.67.225,ETOPOSIDE treats MANTLE CELL LYMPHOMA,45,86,,65,95,treats,0.9970544855015809,211716,"Oral combination chemotherapy with Pep-C for [MANTLE CELL LYMPHOMA] : Daily prednisone, [ETOPOSIDE], procarbazine and cyclophosphamide.",MANTLE CELL LYMPHOMA,ETOPOSIDE,TWrex-treat
788865489,9/16/2015 05:33:15,1739348213,9/16/2015 05:31:54,False,clixsense,0.8399,31304413,CAN,BC,Kelowna,66.183.36.177,ETOPOSIDE treats MANTLE CELL LYMPHOMA,45,86,,65,95,treats,0.9970544855015809,211716,"Oral combination chemotherapy with Pep-C for [MANTLE CELL LYMPHOMA] : Daily prednisone, [ETOPOSIDE], procarbazine and cyclophosphamide.",MANTLE CELL LYMPHOMA,ETOPOSIDE,TWrex-treat
788865494,9/16/2015 05:51:23,1739369487,9/16/2015 05:50:04,False,instagc,0.7163,21613169,GBR,A7,Birmingham,109.156.129.221,PROMETHAZINE treats VOMITING,289,369,,297,381,treats,0.9761870601839531,907548,"b  Class:  Antihistamines 56:22.08; First Generation Antihistamines 4:04; A04AD (ATC)  Synonyms:  dimenhy DRINATE ; Anti-nauseant; Anti-nausee; Dimenhydrinate; Dinate; Gravergol; Gravol; Nauseatol; Travel  Uses  Motion Sickness  Used principally in the prevention and treatment of nausea, VOMITING, and/or vertigo associated with motion sickness, although scopolamine, PROMETHAZINE, or meclizine may be more effective",VOMITING,PROMETHAZINE,RO-may_treat
788865494,9/16/2015 06:07:06,1739384686,9/16/2015 06:06:37,False,points4rewards,0.8065,20306700,USA,WA,Bothell,50.106.46.70,PROMETHAZINE treats VOMITING,289,369,,297,381,treats,0.9761870601839531,907548,"b  Class:  Antihistamines 56:22.08; First Generation Antihistamines 4:04; A04AD (ATC)  Synonyms:  dimenhy DRINATE ; Anti-nauseant; Anti-nausee; Dimenhydrinate; Dinate; Gravergol; Gravol; Nauseatol; Travel  Uses  Motion Sickness  Used principally in the prevention and treatment of nausea, VOMITING, and/or vertigo associated with motion sickness, although scopolamine, PROMETHAZINE, or meclizine may be more effective",VOMITING,PROMETHAZINE,RO-may_treat
788865494,9/16/2015 06:18:29,1739392941,9/16/2015 06:18:04,False,prodege,0.825,27934334,GBR,C8,Croydon,81.159.60.206,PROMETHAZINE treats VOMITING,289,369,,297,381,treats,0.9761870601839531,907548,"b  Class:  Antihistamines 56:22.08; First Generation Antihistamines 4:04; A04AD (ATC)  Synonyms:  dimenhy DRINATE ; Anti-nauseant; Anti-nausee; Dimenhydrinate; Dinate; Gravergol; Gravol; Nauseatol; Travel  Uses  Motion Sickness  Used principally in the prevention and treatment of nausea, VOMITING, and/or vertigo associated with motion sickness, although scopolamine, PROMETHAZINE, or meclizine may be more effective",VOMITING,PROMETHAZINE,RO-may_treat
788865494,9/16/2015 06:25:55,1739397392,9/16/2015 06:25:04,False,points4rewards,0.8859,28703583,USA,,,184.53.32.197,PROMETHAZINE treats VOMITING,289,369,,297,381,treats,0.9761870601839531,907548,"b  Class:  Antihistamines 56:22.08; First Generation Antihistamines 4:04; A04AD (ATC)  Synonyms:  dimenhy DRINATE ; Anti-nauseant; Anti-nausee; Dimenhydrinate; Dinate; Gravergol; Gravol; Nauseatol; Travel  Uses  Motion Sickness  Used principally in the prevention and treatment of nausea, VOMITING, and/or vertigo associated with motion sickness, although scopolamine, PROMETHAZINE, or meclizine may be more effective",VOMITING,PROMETHAZINE,RO-may_treat
788865494,9/16/2015 06:29:58,1739399795,9/16/2015 06:28:50,False,clixsense,0.8762,28570371,NLD,,,91.213.37.165,PROMETHAZINE treats VOMITING,289,369,,297,381,treats,0.9761870601839531,907548,"b  Class:  Antihistamines 56:22.08; First Generation Antihistamines 4:04; A04AD (ATC)  Synonyms:  dimenhy DRINATE ; Anti-nauseant; Anti-nausee; Dimenhydrinate; Dinate; Gravergol; Gravol; Nauseatol; Travel  Uses  Motion Sickness  Used principally in the prevention and treatment of nausea, VOMITING, and/or vertigo associated with motion sickness, although scopolamine, PROMETHAZINE, or meclizine may be more effective",VOMITING,PROMETHAZINE,RO-may_treat
788865494,9/16/2015 06:30:09,1739399883,9/16/2015 06:28:25,False,clixsense,0.8155,31482589,NLD,11,Gouda,77.167.232.121,no_relation,289,369,,297,381,treats,0.9761870601839531,907548,"b  Class:  Antihistamines 56:22.08; First Generation Antihistamines 4:04; A04AD (ATC)  Synonyms:  dimenhy DRINATE ; Anti-nauseant; Anti-nausee; Dimenhydrinate; Dinate; Gravergol; Gravol; Nauseatol; Travel  Uses  Motion Sickness  Used principally in the prevention and treatment of nausea, VOMITING, and/or vertigo associated with motion sickness, although scopolamine, PROMETHAZINE, or meclizine may be more effective",VOMITING,PROMETHAZINE,RO-may_treat
788865494,9/16/2015 06:32:52,1739401460,9/16/2015 06:30:26,False,neodev,0.6019,21515166,NLD,11,Nieuwkoop,83.84.200.25,no_relation,289,369,,297,381,treats,0.9761870601839531,907548,"b  Class:  Antihistamines 56:22.08; First Generation Antihistamines 4:04; A04AD (ATC)  Synonyms:  dimenhy DRINATE ; Anti-nauseant; Anti-nausee; Dimenhydrinate; Dinate; Gravergol; Gravol; Nauseatol; Travel  Uses  Motion Sickness  Used principally in the prevention and treatment of nausea, VOMITING, and/or vertigo associated with motion sickness, although scopolamine, PROMETHAZINE, or meclizine may be more effective",VOMITING,PROMETHAZINE,RO-may_treat
788865495,9/16/2015 06:08:07,1739385240,9/16/2015 06:07:29,False,points4rewards,0.8065,20306700,USA,WA,Bothell,50.106.46.70,no_relation,22,110,,44,125,treats,0.338061701891407,805299,131  Individuals with ACUTE TYPHOID INFECTION and those who are chronic typhoid carriers should  not  receive TYPHOID VACCINE,ACUTE TYPHOID INFECTION,TYPHOID VACCINE,TWrex-cause
788865495,9/16/2015 06:19:34,1739393678,9/16/2015 06:19:09,False,prodege,0.825,27934334,GBR,C8,Croydon,81.159.60.206,no_relation,22,110,,44,125,treats,0.338061701891407,805299,131  Individuals with ACUTE TYPHOID INFECTION and those who are chronic typhoid carriers should  not  receive TYPHOID VACCINE,ACUTE TYPHOID INFECTION,TYPHOID VACCINE,TWrex-cause
788865495,9/16/2015 06:27:36,1739398336,9/16/2015 06:26:40,False,points4rewards,0.8859,28703583,USA,,,184.53.32.197,no_relation,22,110,,44,125,treats,0.338061701891407,805299,131  Individuals with ACUTE TYPHOID INFECTION and those who are chronic typhoid carriers should  not  receive TYPHOID VACCINE,ACUTE TYPHOID INFECTION,TYPHOID VACCINE,TWrex-cause
788865495,9/16/2015 06:31:20,1739400611,9/16/2015 06:30:32,False,clixsense,0.8762,28570371,NLD,,,91.213.37.165,no_relation,22,110,,44,125,treats,0.338061701891407,805299,131  Individuals with ACUTE TYPHOID INFECTION and those who are chronic typhoid carriers should  not  receive TYPHOID VACCINE,ACUTE TYPHOID INFECTION,TYPHOID VACCINE,TWrex-cause
788865495,9/16/2015 06:31:42,1739400841,9/16/2015 06:31:02,False,clixsense,0.8155,31482589,NLD,11,Gouda,77.167.232.121,no_relation,22,110,,44,125,treats,0.338061701891407,805299,131  Individuals with ACUTE TYPHOID INFECTION and those who are chronic typhoid carriers should  not  receive TYPHOID VACCINE,ACUTE TYPHOID INFECTION,TYPHOID VACCINE,TWrex-cause
788865495,9/16/2015 06:33:27,1739401808,9/16/2015 06:32:53,False,neodev,0.6019,21515166,NLD,11,Nieuwkoop,83.84.200.25,no_relation,22,110,,44,125,treats,0.338061701891407,805299,131  Individuals with ACUTE TYPHOID INFECTION and those who are chronic typhoid carriers should  not  receive TYPHOID VACCINE,ACUTE TYPHOID INFECTION,TYPHOID VACCINE,TWrex-cause
788865495,9/16/2015 06:41:16,1739406203,9/16/2015 06:40:53,False,gifthunterclub,0.7639,33931170,AUS,04,Brisbane,121.208.7.253,no_relation,22,110,,44,125,treats,0.338061701891407,805299,131  Individuals with ACUTE TYPHOID INFECTION and those who are chronic typhoid carriers should  not  receive TYPHOID VACCINE,ACUTE TYPHOID INFECTION,TYPHOID VACCINE,TWrex-cause
788865500,9/16/2015 06:08:07,1739385241,9/16/2015 06:07:29,False,points4rewards,0.8065,20306700,USA,WA,Bothell,50.106.46.70,no_relation,55,27,,66,47,treats,0.9938586931957759,206219,title=Guidelines for using [ANTIRETROVIRAL AGENTS] among [HIV INFECTED] adults and adolescents.,[HIV INFECTED],[ANTIRETROVIRAL AGENTS],TWrex-treat
788865500,9/16/2015 06:19:34,1739393679,9/16/2015 06:19:09,False,prodege,0.825,27934334,GBR,C8,Croydon,81.159.60.206,[ANTIRETROVIRAL AGENTS] treats [HIV INFECTED],55,27,,66,47,treats,0.9938586931957759,206219,title=Guidelines for using [ANTIRETROVIRAL AGENTS] among [HIV INFECTED] adults and adolescents.,[HIV INFECTED],[ANTIRETROVIRAL AGENTS],TWrex-treat
788865500,9/16/2015 06:27:36,1739398334,9/16/2015 06:26:40,False,points4rewards,0.8859,28703583,USA,,,184.53.32.197,[ANTIRETROVIRAL AGENTS] treats [HIV INFECTED],55,27,,66,47,treats,0.9938586931957759,206219,title=Guidelines for using [ANTIRETROVIRAL AGENTS] among [HIV INFECTED] adults and adolescents.,[HIV INFECTED],[ANTIRETROVIRAL AGENTS],TWrex-treat
788865500,9/16/2015 06:31:20,1739400633,9/16/2015 06:30:32,False,clixsense,0.8762,28570371,NLD,,,91.213.37.165,[ANTIRETROVIRAL AGENTS] treats [HIV INFECTED],55,27,,66,47,treats,0.9938586931957759,206219,title=Guidelines for using [ANTIRETROVIRAL AGENTS] among [HIV INFECTED] adults and adolescents.,[HIV INFECTED],[ANTIRETROVIRAL AGENTS],TWrex-treat
788865500,9/16/2015 06:31:42,1739400840,9/16/2015 06:31:02,False,clixsense,0.8155,31482589,NLD,11,Gouda,77.167.232.121,[ANTIRETROVIRAL AGENTS] treats [HIV INFECTED],55,27,,66,47,treats,0.9938586931957759,206219,title=Guidelines for using [ANTIRETROVIRAL AGENTS] among [HIV INFECTED] adults and adolescents.,[HIV INFECTED],[ANTIRETROVIRAL AGENTS],TWrex-treat
788865500,9/16/2015 06:33:27,1739401811,9/16/2015 06:32:53,False,neodev,0.6019,21515166,NLD,11,Nieuwkoop,83.84.200.25,no_relation,55,27,,66,47,treats,0.9938586931957759,206219,title=Guidelines for using [ANTIRETROVIRAL AGENTS] among [HIV INFECTED] adults and adolescents.,[HIV INFECTED],[ANTIRETROVIRAL AGENTS],TWrex-treat
788865500,9/16/2015 06:41:16,1739406212,9/16/2015 06:40:53,False,gifthunterclub,0.7639,33931170,AUS,04,Brisbane,121.208.7.253,[ANTIRETROVIRAL AGENTS] treats [HIV INFECTED],55,27,,66,47,treats,0.9938586931957759,206219,title=Guidelines for using [ANTIRETROVIRAL AGENTS] among [HIV INFECTED] adults and adolescents.,[HIV INFECTED],[ANTIRETROVIRAL AGENTS],TWrex-treat
788865503,9/15/2015 22:56:34,1739068334,9/15/2015 22:56:17,False,clixsense,0.85,21963184,GBR,L9,Sheffield,146.199.61.136,FROVA treats MENSTRUAL MIGRAINE,114,25,,132,30,treats,1.0,218578,"If the sNDA is approved, [FROVA] will be the only medication indicated in the U.S. for the short-term prevention of [MENSTRUAL MIGRAINE] .",MENSTRUAL MIGRAINE,FROVA,TWrex-treat
788865503,9/15/2015 22:58:10,1739068773,9/15/2015 22:57:16,False,instagc,0.6222,20392280,USA,CA,Los Angeles,172.56.17.103,no_relation,114,25,,132,30,treats,1.0,218578,"If the sNDA is approved, [FROVA] will be the only medication indicated in the U.S. for the short-term prevention of [MENSTRUAL MIGRAINE] .",MENSTRUAL MIGRAINE,FROVA,TWrex-treat
788865503,9/15/2015 22:58:20,1739068902,9/15/2015 22:57:52,False,clixsense,0.8349,6344072,CAN,BC,Burnaby,172.218.166.58,FROVA treats MENSTRUAL MIGRAINE,114,25,,132,30,treats,1.0,218578,"If the sNDA is approved, [FROVA] will be the only medication indicated in the U.S. for the short-term prevention of [MENSTRUAL MIGRAINE] .",MENSTRUAL MIGRAINE,FROVA,TWrex-treat
788865503,9/15/2015 23:08:52,1739072735,9/15/2015 23:08:18,False,clixsense,0.9315,11106820,USA,MA,Taunton,173.48.52.95,FROVA treats MENSTRUAL MIGRAINE,114,25,,132,30,treats,1.0,218578,"If the sNDA is approved, [FROVA] will be the only medication indicated in the U.S. for the short-term prevention of [MENSTRUAL MIGRAINE] .",MENSTRUAL MIGRAINE,FROVA,TWrex-treat
788865503,9/15/2015 23:43:33,1739083009,9/15/2015 23:43:10,False,neodev,0.9417,22074628,GBR,,,92.4.207.4,FROVA treats MENSTRUAL MIGRAINE,114,25,,132,30,treats,1.0,218578,"If the sNDA is approved, [FROVA] will be the only medication indicated in the U.S. for the short-term prevention of [MENSTRUAL MIGRAINE] .",MENSTRUAL MIGRAINE,FROVA,TWrex-treat
788865503,9/15/2015 23:55:32,1739086251,9/15/2015 23:55:14,False,clixsense,0.9583,33980820,USA,IL,Chicago,69.47.104.214,FROVA treats MENSTRUAL MIGRAINE,114,25,,132,30,treats,1.0,218578,"If the sNDA is approved, [FROVA] will be the only medication indicated in the U.S. for the short-term prevention of [MENSTRUAL MIGRAINE] .",MENSTRUAL MIGRAINE,FROVA,TWrex-treat
788865503,9/16/2015 00:03:25,1739088120,9/16/2015 00:03:12,False,clixsense,0.8333,28457001,CAN,ON,North Bay,24.204.202.220,FROVA treats MENSTRUAL MIGRAINE,114,25,,132,30,treats,1.0,218578,"If the sNDA is approved, [FROVA] will be the only medication indicated in the U.S. for the short-term prevention of [MENSTRUAL MIGRAINE] .",MENSTRUAL MIGRAINE,FROVA,TWrex-treat
788865508,9/16/2015 06:20:14,1739394067,9/16/2015 06:19:36,False,prodege,0.825,27934334,GBR,C8,Croydon,81.159.60.206,ERYTHROMYCIN treats ACNE VULGARIS,85,24,,97,36,treats,0.99654575824488,804127,Topical clindamycin and ERYTHROMYCIN are used as primary or adjunctive treatment for ACNE VULGARIS in patients who do not warrant or tolerate oral antibiotics.,ACNE VULGARIS,ERYTHROMYCIN,TWrex-cause
788865508,9/16/2015 06:28:30,1739398771,9/16/2015 06:27:40,False,points4rewards,0.8859,28703583,USA,,,184.53.32.197,ERYTHROMYCIN treats ACNE VULGARIS,85,24,,97,36,treats,0.99654575824488,804127,Topical clindamycin and ERYTHROMYCIN are used as primary or adjunctive treatment for ACNE VULGARIS in patients who do not warrant or tolerate oral antibiotics.,ACNE VULGARIS,ERYTHROMYCIN,TWrex-cause
788865508,9/16/2015 06:31:58,1739400994,9/16/2015 06:31:22,False,clixsense,0.8762,28570371,NLD,,,91.213.37.165,ERYTHROMYCIN treats ACNE VULGARIS,85,24,,97,36,treats,0.99654575824488,804127,Topical clindamycin and ERYTHROMYCIN are used as primary or adjunctive treatment for ACNE VULGARIS in patients who do not warrant or tolerate oral antibiotics.,ACNE VULGARIS,ERYTHROMYCIN,TWrex-cause
788865508,9/16/2015 06:32:36,1739401335,9/16/2015 06:31:42,False,clixsense,0.8155,31482589,NLD,11,Gouda,77.167.232.121,ERYTHROMYCIN treats ACNE VULGARIS,85,24,,97,36,treats,0.99654575824488,804127,Topical clindamycin and ERYTHROMYCIN are used as primary or adjunctive treatment for ACNE VULGARIS in patients who do not warrant or tolerate oral antibiotics.,ACNE VULGARIS,ERYTHROMYCIN,TWrex-cause
788865508,9/16/2015 06:33:57,1739402074,9/16/2015 06:33:28,False,neodev,0.6019,21515166,NLD,11,Nieuwkoop,83.84.200.25,ERYTHROMYCIN treats ACNE VULGARIS,85,24,,97,36,treats,0.99654575824488,804127,Topical clindamycin and ERYTHROMYCIN are used as primary or adjunctive treatment for ACNE VULGARIS in patients who do not warrant or tolerate oral antibiotics.,ACNE VULGARIS,ERYTHROMYCIN,TWrex-cause
788865508,9/16/2015 06:41:34,1739406325,9/16/2015 06:41:18,False,gifthunterclub,0.7639,33931170,AUS,04,Brisbane,121.208.7.253,ERYTHROMYCIN treats ACNE VULGARIS,85,24,,97,36,treats,0.99654575824488,804127,Topical clindamycin and ERYTHROMYCIN are used as primary or adjunctive treatment for ACNE VULGARIS in patients who do not warrant or tolerate oral antibiotics.,ACNE VULGARIS,ERYTHROMYCIN,TWrex-cause
788865508,9/16/2015 06:45:05,1739408392,9/16/2015 06:44:10,False,prodege,0.9018,30501999,CAN,ON,Ottawa,137.122.64.22,ERYTHROMYCIN treats ACNE VULGARIS,85,24,,97,36,treats,0.99654575824488,804127,Topical clindamycin and ERYTHROMYCIN are used as primary or adjunctive treatment for ACNE VULGARIS in patients who do not warrant or tolerate oral antibiotics.,ACNE VULGARIS,ERYTHROMYCIN,TWrex-cause
788865516,9/15/2015 21:18:31,1739027462,9/15/2015 21:18:17,False,neodev,1.0,20306047,GBR,,,80.41.0.252,METHOTREXATE treats RHEUMATOID ARTHRITIS,102,56,,122,68,treats,0.997458699830735,205149,However some studies have shown that the combination of [METHOTREXATE] and leflunomide in patients with [RHEUMATOID ARTHRITIS] gave better results than either drug alone.,RHEUMATOID ARTHRITIS,METHOTREXATE,TWrex-treat
788865516,9/15/2015 21:28:43,1739033232,9/15/2015 21:28:36,False,zoombucks,1.0,4711962,CAN,ON,Markham,174.88.29.138,METHOTREXATE treats RHEUMATOID ARTHRITIS,102,56,,122,68,treats,0.997458699830735,205149,However some studies have shown that the combination of [METHOTREXATE] and leflunomide in patients with [RHEUMATOID ARTHRITIS] gave better results than either drug alone.,RHEUMATOID ARTHRITIS,METHOTREXATE,TWrex-treat
788865516,9/15/2015 21:36:55,1739037749,9/15/2015 21:35:49,False,clixsense,0.9167,30681826,GBR,I9,Diss,31.49.71.254,METHOTREXATE treats RHEUMATOID ARTHRITIS,102,56,,122,68,treats,0.997458699830735,205149,However some studies have shown that the combination of [METHOTREXATE] and leflunomide in patients with [RHEUMATOID ARTHRITIS] gave better results than either drug alone.,RHEUMATOID ARTHRITIS,METHOTREXATE,TWrex-treat
788865516,9/15/2015 21:40:20,1739039599,9/15/2015 21:40:03,False,neodev,0.8611,33644825,USA,FL,Fort Lauderdale,65.111.173.161,METHOTREXATE treats RHEUMATOID ARTHRITIS,102,56,,122,68,treats,0.997458699830735,205149,However some studies have shown that the combination of [METHOTREXATE] and leflunomide in patients with [RHEUMATOID ARTHRITIS] gave better results than either drug alone.,RHEUMATOID ARTHRITIS,METHOTREXATE,TWrex-treat
788865516,9/15/2015 21:43:41,1739041404,9/15/2015 21:37:09,False,clixsense,0.919,21875134,GBR,,,80.189.12.98,METHOTREXATE treats RHEUMATOID ARTHRITIS,102,56,,122,68,treats,0.997458699830735,205149,However some studies have shown that the combination of [METHOTREXATE] and leflunomide in patients with [RHEUMATOID ARTHRITIS] gave better results than either drug alone.,RHEUMATOID ARTHRITIS,METHOTREXATE,TWrex-treat
788865516,9/15/2015 21:46:44,1739043027,9/15/2015 21:46:36,False,instagc,1.0,26024737,GBR,H2,Preston,78.144.133.234,METHOTREXATE treats RHEUMATOID ARTHRITIS,102,56,,122,68,treats,0.997458699830735,205149,However some studies have shown that the combination of [METHOTREXATE] and leflunomide in patients with [RHEUMATOID ARTHRITIS] gave better results than either drug alone.,RHEUMATOID ARTHRITIS,METHOTREXATE,TWrex-treat
788865516,9/15/2015 21:47:04,1739043275,9/15/2015 21:46:15,False,prodege,0.9667,21417560,GBR,C3,Cambridge,151.224.120.191,METHOTREXATE treats RHEUMATOID ARTHRITIS,102,56,,122,68,treats,0.997458699830735,205149,However some studies have shown that the combination of [METHOTREXATE] and leflunomide in patients with [RHEUMATOID ARTHRITIS] gave better results than either drug alone.,RHEUMATOID ARTHRITIS,METHOTREXATE,TWrex-treat
788865533,9/15/2015 22:12:51,1739053549,9/15/2015 22:12:35,False,prodege,0.6984,15439740,AUS,02,Jannali,14.200.59.55,no_relation,15,0,,36,10,treats,1.0,804161,GABAPENTIN for ACUTE AND CHRONIC PAIN,ACUTE AND CHRONIC PAIN,GABAPENTIN,TWrex-cause
788865533,9/15/2015 22:14:35,1739054212,9/15/2015 22:14:04,False,neodev,0.5536,33238512,CAN,NB,Miramichi,174.118.173.203,GABAPENTIN treats ACUTE AND CHRONIC PAIN,15,0,,36,10,treats,1.0,804161,GABAPENTIN for ACUTE AND CHRONIC PAIN,ACUTE AND CHRONIC PAIN,GABAPENTIN,TWrex-cause
788865533,9/15/2015 22:18:24,1739055638,9/15/2015 22:17:56,False,neodev,0.8889,33758777,USA,,,38.95.108.251,GABAPENTIN treats ACUTE AND CHRONIC PAIN,15,0,,36,10,treats,1.0,804161,GABAPENTIN for ACUTE AND CHRONIC PAIN,ACUTE AND CHRONIC PAIN,GABAPENTIN,TWrex-cause
788865533,9/15/2015 22:25:52,1739057957,9/15/2015 22:21:40,False,neodev,0.7452,18881135,CAN,ON,Ajax,99.243.87.224,GABAPENTIN treats ACUTE AND CHRONIC PAIN,15,0,,36,10,treats,1.0,804161,GABAPENTIN for ACUTE AND CHRONIC PAIN,ACUTE AND CHRONIC PAIN,GABAPENTIN,TWrex-cause
788865533,9/15/2015 22:27:46,1739058551,9/15/2015 22:26:24,False,points4rewards,0.7798,20113482,USA,PA,Philadelphia,162.208.49.45,GABAPENTIN treats ACUTE AND CHRONIC PAIN,15,0,,36,10,treats,1.0,804161,GABAPENTIN for ACUTE AND CHRONIC PAIN,ACUTE AND CHRONIC PAIN,GABAPENTIN,TWrex-cause
788865533,9/15/2015 22:29:05,1739059063,9/15/2015 22:28:04,False,fusioncash,0.8313,31742806,USA,OH,Kent,66.61.82.242,GABAPENTIN treats ACUTE AND CHRONIC PAIN,15,0,,36,10,treats,1.0,804161,GABAPENTIN for ACUTE AND CHRONIC PAIN,ACUTE AND CHRONIC PAIN,GABAPENTIN,TWrex-cause
788865533,9/15/2015 22:42:25,1739063522,9/15/2015 22:41:31,False,instagc,0.9048,23287154,USA,CA,San Jose,50.184.60.102,GABAPENTIN treats ACUTE AND CHRONIC PAIN,15,0,,36,10,treats,1.0,804161,GABAPENTIN for ACUTE AND CHRONIC PAIN,ACUTE AND CHRONIC PAIN,GABAPENTIN,TWrex-cause
788865534,9/15/2015 22:32:12,1739060142,9/15/2015 22:31:32,False,fusioncash,0.8313,31742806,USA,OH,Kent,66.61.82.242,PROSTAGLANDIN treats CIRRHOSIS,137,14,,146,27,treats,0.936329177569045,224526,"Nitric oxide, [PROSTAGLANDIN]s, and other vasoactive substances have been hypothesized as powerful mediators of splanchnic vasodilation in [CIRRHOSIS].",CIRRHOSIS,PROSTAGLANDIN,TWrex-treat
788865534,9/15/2015 22:44:15,1739064067,9/15/2015 22:43:53,False,instagc,0.9048,23287154,USA,CA,San Jose,50.184.60.102,PROSTAGLANDIN treats CIRRHOSIS,137,14,,146,27,treats,0.936329177569045,224526,"Nitric oxide, [PROSTAGLANDIN]s, and other vasoactive substances have been hypothesized as powerful mediators of splanchnic vasodilation in [CIRRHOSIS].",CIRRHOSIS,PROSTAGLANDIN,TWrex-treat
788865534,9/15/2015 22:45:25,1739064466,9/15/2015 22:44:55,False,clixsense,0.8917,20587495,CAN,NB,Saint John,142.162.106.74,PROSTAGLANDIN treats CIRRHOSIS,137,14,,146,27,treats,0.936329177569045,224526,"Nitric oxide, [PROSTAGLANDIN]s, and other vasoactive substances have been hypothesized as powerful mediators of splanchnic vasodilation in [CIRRHOSIS].",CIRRHOSIS,PROSTAGLANDIN,TWrex-treat
788865534,9/15/2015 22:55:10,1739067984,9/15/2015 22:54:01,False,instagc,0.6222,20392280,USA,CA,Los Angeles,172.56.17.103,no_relation,137,14,,146,27,treats,0.936329177569045,224526,"Nitric oxide, [PROSTAGLANDIN]s, and other vasoactive substances have been hypothesized as powerful mediators of splanchnic vasodilation in [CIRRHOSIS].",CIRRHOSIS,PROSTAGLANDIN,TWrex-treat
788865534,9/15/2015 22:55:31,1739068069,9/15/2015 22:54:34,False,clixsense,0.85,21963184,GBR,L9,Sheffield,146.199.61.136,no_relation,137,14,,146,27,treats,0.936329177569045,224526,"Nitric oxide, [PROSTAGLANDIN]s, and other vasoactive substances have been hypothesized as powerful mediators of splanchnic vasodilation in [CIRRHOSIS].",CIRRHOSIS,PROSTAGLANDIN,TWrex-treat
788865534,9/15/2015 22:56:52,1739068426,9/15/2015 22:56:30,False,clixsense,0.8349,6344072,CAN,BC,Burnaby,172.218.166.58,PROSTAGLANDIN treats CIRRHOSIS,137,14,,146,27,treats,0.936329177569045,224526,"Nitric oxide, [PROSTAGLANDIN]s, and other vasoactive substances have been hypothesized as powerful mediators of splanchnic vasodilation in [CIRRHOSIS].",CIRRHOSIS,PROSTAGLANDIN,TWrex-treat
788865534,9/15/2015 22:59:19,1739069150,9/15/2015 22:59:08,False,instagc,0.7619,15577915,USA,IL,Trenton,208.70.36.12,PROSTAGLANDIN treats CIRRHOSIS,137,14,,146,27,treats,0.936329177569045,224526,"Nitric oxide, [PROSTAGLANDIN]s, and other vasoactive substances have been hypothesized as powerful mediators of splanchnic vasodilation in [CIRRHOSIS].",CIRRHOSIS,PROSTAGLANDIN,TWrex-treat
788865542,9/16/2015 06:20:31,1739394208,9/16/2015 06:20:15,False,prodege,0.825,27934334,GBR,C8,Croydon,81.159.60.206,LEVODOPA treats PARKINSON'S DISEASE,66,54,,84,62,treats,0.6488856845230501,907899,Lieberman A. Long term experience with selegiline and LEVODOPA in PARKINSON'S DISEASE,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
788865542,9/16/2015 06:29:05,1739399097,9/16/2015 06:28:35,False,points4rewards,0.8859,28703583,USA,,,184.53.32.197,LEVODOPA treats PARKINSON'S DISEASE,66,54,,84,62,treats,0.6488856845230501,907899,Lieberman A. Long term experience with selegiline and LEVODOPA in PARKINSON'S DISEASE,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
788865542,9/16/2015 06:32:31,1739401271,9/16/2015 06:32:00,False,clixsense,0.8762,28570371,NLD,,,91.213.37.165,LEVODOPA treats PARKINSON'S DISEASE,66,54,,84,62,treats,0.6488856845230501,907899,Lieberman A. Long term experience with selegiline and LEVODOPA in PARKINSON'S DISEASE,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
788865542,9/16/2015 06:33:14,1739401707,9/16/2015 06:32:36,False,clixsense,0.8155,31482589,NLD,11,Gouda,77.167.232.121,LEVODOPA treats PARKINSON'S DISEASE,66,54,,84,62,treats,0.6488856845230501,907899,Lieberman A. Long term experience with selegiline and LEVODOPA in PARKINSON'S DISEASE,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
788865542,9/16/2015 06:34:34,1739402392,9/16/2015 06:33:59,False,neodev,0.6019,21515166,NLD,11,Nieuwkoop,83.84.200.25,no_relation,66,54,,84,62,treats,0.6488856845230501,907899,Lieberman A. Long term experience with selegiline and LEVODOPA in PARKINSON'S DISEASE,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
788865542,9/16/2015 06:42:02,1739406660,9/16/2015 06:41:51,False,gifthunterclub,0.7639,33931170,AUS,04,Brisbane,121.208.7.253,LEVODOPA treats PARKINSON'S DISEASE,66,54,,84,62,treats,0.6488856845230501,907899,Lieberman A. Long term experience with selegiline and LEVODOPA in PARKINSON'S DISEASE,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
788865542,9/16/2015 06:45:54,1739408866,9/16/2015 06:45:06,False,prodege,0.9018,30501999,CAN,ON,Ottawa,137.122.64.22,LEVODOPA treats PARKINSON'S DISEASE,66,54,,84,62,treats,0.6488856845230501,907899,Lieberman A. Long term experience with selegiline and LEVODOPA in PARKINSON'S DISEASE,PARKINSON'S DISEASE,LEVODOPA,RO-may_treat
788865547,9/16/2015 06:47:25,1739409550,9/16/2015 06:47:15,False,prodege,0.9018,30501999,CAN,ON,Ottawa,137.122.64.22,INH treats TB,83,42,,84,45,treats,1.0,803948,The reason for maintaining the patient on INH is that INH is so potent in treating TB that it is foolish to omit it until there is microbiological proof that it is ineffective (even though isoniazid resistance so commonly occurs with rifampicin resistance.,TB,INH,TWrex-cause
788865547,9/16/2015 06:52:52,1739410628,9/16/2015 06:52:37,False,bitcoinget,0.85,30546513,GBR,G6,Hull,194.42.67.50,INH treats TB,83,42,,84,45,treats,1.0,803948,The reason for maintaining the patient on INH is that INH is so potent in treating TB that it is foolish to omit it until there is microbiological proof that it is ineffective (even though isoniazid resistance so commonly occurs with rifampicin resistance.,TB,INH,TWrex-cause
788865547,9/16/2015 06:59:38,1739411614,9/16/2015 06:59:05,False,neodev,0.7813,11460728,CAN,BC,Burnaby,70.79.16.165,INH treats TB,83,42,,84,45,treats,1.0,803948,The reason for maintaining the patient on INH is that INH is so potent in treating TB that it is foolish to omit it until there is microbiological proof that it is ineffective (even though isoniazid resistance so commonly occurs with rifampicin resistance.,TB,INH,TWrex-cause
788865547,9/16/2015 07:02:05,1739411940,9/16/2015 07:01:03,False,fusioncash,0.9583,5626024,USA,AR,Clarksville,75.121.20.252,INH treats TB,83,42,,84,45,treats,1.0,803948,The reason for maintaining the patient on INH is that INH is so potent in treating TB that it is foolish to omit it until there is microbiological proof that it is ineffective (even though isoniazid resistance so commonly occurs with rifampicin resistance.,TB,INH,TWrex-cause
788865547,9/16/2015 07:26:07,1739416030,9/16/2015 07:25:47,False,instagc,0.8333,18960682,GBR,U2,Annan,92.18.213.181,INH treats TB,83,42,,84,45,treats,1.0,803948,The reason for maintaining the patient on INH is that INH is so potent in treating TB that it is foolish to omit it until there is microbiological proof that it is ineffective (even though isoniazid resistance so commonly occurs with rifampicin resistance.,TB,INH,TWrex-cause
788865547,9/16/2015 07:29:14,1739416710,9/16/2015 07:28:27,False,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,INH treats TB,83,42,,84,45,treats,1.0,803948,The reason for maintaining the patient on INH is that INH is so potent in treating TB that it is foolish to omit it until there is microbiological proof that it is ineffective (even though isoniazid resistance so commonly occurs with rifampicin resistance.,TB,INH,TWrex-cause
788865547,9/16/2015 07:35:25,1739418078,9/16/2015 07:34:57,False,prodege,1.0,22031444,GBR,F2,Gosport,92.24.223.243,INH treats TB,83,42,,84,45,treats,1.0,803948,The reason for maintaining the patient on INH is that INH is so potent in treating TB that it is foolish to omit it until there is microbiological proof that it is ineffective (even though isoniazid resistance so commonly occurs with rifampicin resistance.,TB,INH,TWrex-cause
788865552,9/16/2015 06:33:39,1739401919,9/16/2015 06:33:15,False,clixsense,0.8155,31482589,NLD,11,Gouda,77.167.232.121,PHEOCHROMOCYTOMA treats HYPERTENSION,42,11,,53,27,treats,0.9918365981341751,813350,Removal of PHEOCHROMOCYTOMA may also cure HYPERTENSION ( 77.,HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
788865552,9/16/2015 06:35:32,1739402859,9/16/2015 06:34:35,False,neodev,0.6019,21515166,NLD,11,Nieuwkoop,83.84.200.25,no_relation,42,11,,53,27,treats,0.9918365981341751,813350,Removal of PHEOCHROMOCYTOMA may also cure HYPERTENSION ( 77.,HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
788865552,9/16/2015 06:42:16,1739406778,9/16/2015 06:42:03,False,gifthunterclub,0.7639,33931170,AUS,04,Brisbane,121.208.7.253,no_relation,42,11,,53,27,treats,0.9918365981341751,813350,Removal of PHEOCHROMOCYTOMA may also cure HYPERTENSION ( 77.,HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
788865552,9/16/2015 06:46:29,1739409145,9/16/2015 06:45:55,False,prodege,0.9018,30501999,CAN,ON,Ottawa,137.122.64.22,no_relation,42,11,,53,27,treats,0.9918365981341751,813350,Removal of PHEOCHROMOCYTOMA may also cure HYPERTENSION ( 77.,HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
788865552,9/16/2015 06:52:12,1739410521,9/16/2015 06:51:34,False,bitcoinget,0.85,30546513,GBR,G6,Hull,194.42.67.50,PHEOCHROMOCYTOMA treats HYPERTENSION,42,11,,53,27,treats,0.9918365981341751,813350,Removal of PHEOCHROMOCYTOMA may also cure HYPERTENSION ( 77.,HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
788865552,9/16/2015 06:58:25,1739411415,9/16/2015 06:57:34,False,neodev,0.7813,11460728,CAN,BC,Burnaby,70.79.16.165,PHEOCHROMOCYTOMA treats HYPERTENSION,42,11,,53,27,treats,0.9918365981341751,813350,Removal of PHEOCHROMOCYTOMA may also cure HYPERTENSION ( 77.,HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
788865552,9/16/2015 07:00:31,1739411754,9/16/2015 06:58:00,False,neodev,0.7440000000000001,17963941,GBR,V2,Glasgow,2.24.248.140,no_relation,42,11,,53,27,treats,0.9918365981341751,813350,Removal of PHEOCHROMOCYTOMA may also cure HYPERTENSION ( 77.,HYPERTENSION,PHEOCHROMOCYTOMA,TWrex-cause
788865555,9/16/2015 05:14:14,1739329211,9/16/2015 05:13:50,False,elite,0.8839,31883685,GBR,,,79.66.244.188,no_relation,126,39,,171,83,treats,0.7293249574894731,907304,"Therefore, vaccination of all children AT BIRTH WITH HEPATITIS B VACCINE COULD BE AN effective vaccine strategy despite a low INCIDENCE OF VERTICAL HEPATITIS B TRANSMISSION.",INCIDENCE OF VERTICAL HEPATITIS B TRANSMISSION,AT BIRTH WITH HEPATITIS B VACCINE COULD BE AN,RO-may_prevent
788865555,9/16/2015 05:22:50,1739337194,9/16/2015 05:20:13,False,gifthunterclub,0.7778,24043308,GBR,,,94.102.147.250,AT BIRTH WITH HEPATITIS B VACCINE COULD BE AN treats INCIDENCE OF VERTICAL HEPATITIS B TRANSMISSION,126,39,,171,83,treats,0.7293249574894731,907304,"Therefore, vaccination of all children AT BIRTH WITH HEPATITIS B VACCINE COULD BE AN effective vaccine strategy despite a low INCIDENCE OF VERTICAL HEPATITIS B TRANSMISSION.",INCIDENCE OF VERTICAL HEPATITIS B TRANSMISSION,AT BIRTH WITH HEPATITIS B VACCINE COULD BE AN,RO-may_prevent
788865555,9/16/2015 05:34:26,1739349571,9/16/2015 05:33:59,False,neodev,0.7679,16854635,USA,OH,Lakewood,70.187.67.225,AT BIRTH WITH HEPATITIS B VACCINE COULD BE AN treats INCIDENCE OF VERTICAL HEPATITIS B TRANSMISSION,126,39,,171,83,treats,0.7293249574894731,907304,"Therefore, vaccination of all children AT BIRTH WITH HEPATITIS B VACCINE COULD BE AN effective vaccine strategy despite a low INCIDENCE OF VERTICAL HEPATITIS B TRANSMISSION.",INCIDENCE OF VERTICAL HEPATITIS B TRANSMISSION,AT BIRTH WITH HEPATITIS B VACCINE COULD BE AN,RO-may_prevent
788865555,9/16/2015 05:35:46,1739351016,9/16/2015 05:35:11,False,clixsense,0.8399,31304413,CAN,BC,Kelowna,66.183.36.177,no_relation,126,39,,171,83,treats,0.7293249574894731,907304,"Therefore, vaccination of all children AT BIRTH WITH HEPATITIS B VACCINE COULD BE AN effective vaccine strategy despite a low INCIDENCE OF VERTICAL HEPATITIS B TRANSMISSION.",INCIDENCE OF VERTICAL HEPATITIS B TRANSMISSION,AT BIRTH WITH HEPATITIS B VACCINE COULD BE AN,RO-may_prevent
788865555,9/16/2015 05:49:31,1739367393,9/16/2015 05:49:04,False,instagc,0.7163,21613169,GBR,A7,Birmingham,109.156.129.221,no_relation,126,39,,171,83,treats,0.7293249574894731,907304,"Therefore, vaccination of all children AT BIRTH WITH HEPATITIS B VACCINE COULD BE AN effective vaccine strategy despite a low INCIDENCE OF VERTICAL HEPATITIS B TRANSMISSION.",INCIDENCE OF VERTICAL HEPATITIS B TRANSMISSION,AT BIRTH WITH HEPATITIS B VACCINE COULD BE AN,RO-may_prevent
788865555,9/16/2015 05:51:13,1739369283,9/16/2015 05:51:06,False,neodev,0.5476,34429821,USA,CA,San Jose,50.118.172.120,AT BIRTH WITH HEPATITIS B VACCINE COULD BE AN treats INCIDENCE OF VERTICAL HEPATITIS B TRANSMISSION,126,39,,171,83,treats,0.7293249574894731,907304,"Therefore, vaccination of all children AT BIRTH WITH HEPATITIS B VACCINE COULD BE AN effective vaccine strategy despite a low INCIDENCE OF VERTICAL HEPATITIS B TRANSMISSION.",INCIDENCE OF VERTICAL HEPATITIS B TRANSMISSION,AT BIRTH WITH HEPATITIS B VACCINE COULD BE AN,RO-may_prevent
788865555,9/16/2015 06:06:03,1739384199,9/16/2015 06:04:37,False,points4rewards,0.8065,20306700,USA,WA,Bothell,50.106.46.70,no_relation,126,39,,171,83,treats,0.7293249574894731,907304,"Therefore, vaccination of all children AT BIRTH WITH HEPATITIS B VACCINE COULD BE AN effective vaccine strategy despite a low INCIDENCE OF VERTICAL HEPATITIS B TRANSMISSION.",INCIDENCE OF VERTICAL HEPATITIS B TRANSMISSION,AT BIRTH WITH HEPATITIS B VACCINE COULD BE AN,RO-may_prevent
788865561,9/16/2015 04:47:46,1739301953,9/16/2015 04:47:29,False,gifthunterclub,0.894,30901412,GBR,G5,Margate,85.210.116.48,no_relation,34,124,,76,133,treats,0.707106781186547,906978,"The antigen, which was named MTSA 10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10) is a prime candidate for a component of a new TUBERCULIN that will allow discrimination by a skin test of latent M. tuberculosis infection from vaccination with BCG or from sensitization with environmental, nontuberculous mycobacteria.",10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10),TUBERCULIN,RO-may_diagnose
788865561,9/16/2015 05:13:38,1739328530,9/16/2015 05:13:24,False,elite,0.8839,31883685,GBR,,,79.66.244.188,10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10) treats TUBERCULIN,34,124,,76,133,treats,0.707106781186547,906978,"The antigen, which was named MTSA 10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10) is a prime candidate for a component of a new TUBERCULIN that will allow discrimination by a skin test of latent M. tuberculosis infection from vaccination with BCG or from sensitization with environmental, nontuberculous mycobacteria.",10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10),TUBERCULIN,RO-may_diagnose
788865561,9/16/2015 05:18:30,1739333417,9/16/2015 05:16:51,False,gifthunterclub,0.7778,24043308,GBR,,,94.102.147.250,TUBERCULIN treats 10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10),34,124,,76,133,treats,0.707106781186547,906978,"The antigen, which was named MTSA 10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10) is a prime candidate for a component of a new TUBERCULIN that will allow discrimination by a skin test of latent M. tuberculosis infection from vaccination with BCG or from sensitization with environmental, nontuberculous mycobacteria.",10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10),TUBERCULIN,RO-may_diagnose
788865561,9/16/2015 05:33:24,1739348427,9/16/2015 05:33:00,False,neodev,0.7679,16854635,USA,OH,Lakewood,70.187.67.225,TUBERCULIN treats 10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10),34,124,,76,133,treats,0.707106781186547,906978,"The antigen, which was named MTSA 10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10) is a prime candidate for a component of a new TUBERCULIN that will allow discrimination by a skin test of latent M. tuberculosis infection from vaccination with BCG or from sensitization with environmental, nontuberculous mycobacteria.",10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10),TUBERCULIN,RO-may_diagnose
788865561,9/16/2015 05:34:45,1739349925,9/16/2015 05:33:55,False,clixsense,0.8399,31304413,CAN,BC,Kelowna,66.183.36.177,no_relation,34,124,,76,133,treats,0.707106781186547,906978,"The antigen, which was named MTSA 10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10) is a prime candidate for a component of a new TUBERCULIN that will allow discrimination by a skin test of latent M. tuberculosis infection from vaccination with BCG or from sensitization with environmental, nontuberculous mycobacteria.",10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10),TUBERCULIN,RO-may_diagnose
788865561,9/16/2015 05:48:33,1739366212,9/16/2015 05:47:57,False,instagc,0.7163,21613169,GBR,A7,Birmingham,109.156.129.221,no_relation,34,124,,76,133,treats,0.707106781186547,906978,"The antigen, which was named MTSA 10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10) is a prime candidate for a component of a new TUBERCULIN that will allow discrimination by a skin test of latent M. tuberculosis infection from vaccination with BCG or from sensitization with environmental, nontuberculous mycobacteria.",10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10),TUBERCULIN,RO-may_diagnose
788865561,9/16/2015 05:50:48,1739368893,9/16/2015 05:50:34,False,neodev,0.5476,34429821,USA,CA,San Jose,50.118.172.120,10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10) treats TUBERCULIN,34,124,,76,133,treats,0.707106781186547,906978,"The antigen, which was named MTSA 10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10) is a prime candidate for a component of a new TUBERCULIN that will allow discrimination by a skin test of latent M. tuberculosis infection from vaccination with BCG or from sensitization with environmental, nontuberculous mycobacteria.",10 (FOR M TUBERCULOSIS SPECIFIC ANTIGEN 10),TUBERCULIN,RO-may_diagnose
789214457,9/16/2015 12:47:33,1739495084,9/16/2015 12:47:15,False,bitcoinget,0.9375,30546513,GBR,G6,Hull,194.42.67.50,HTLV III/LAV treats AIDS,147,104,,150,116,treats,0.6,812467,"Yarchoan R, Klecker RE, Weinhold KJ et al Administration of 3 azido 3 deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS related complex.",AIDS,HTLV III/LAV,TWrex-cause
789214457,9/16/2015 13:33:22,1739509739,9/16/2015 13:29:27,False,clixsense,0.6944,21875134,GBR,,,80.189.12.98,no_relation,147,104,,150,116,treats,0.6,812467,"Yarchoan R, Klecker RE, Weinhold KJ et al Administration of 3 azido 3 deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS related complex.",AIDS,HTLV III/LAV,TWrex-cause
789214457,9/16/2015 14:01:36,1739520806,9/16/2015 14:01:15,False,clixsense,0.8393,6340330,USA,NY,Canajoharie,67.248.115.74,HTLV III/LAV treats AIDS,147,104,,150,116,treats,0.6,812467,"Yarchoan R, Klecker RE, Weinhold KJ et al Administration of 3 azido 3 deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS related complex.",AIDS,HTLV III/LAV,TWrex-cause
789214457,9/16/2015 14:16:23,1739525974,9/16/2015 14:15:05,False,gifthulk,0.8833,18666417,USA,PA,Meadville,24.101.32.13,no_relation,147,104,,150,116,treats,0.6,812467,"Yarchoan R, Klecker RE, Weinhold KJ et al Administration of 3 azido 3 deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS related complex.",AIDS,HTLV III/LAV,TWrex-cause
789214457,9/16/2015 14:20:40,1739527496,9/16/2015 14:20:18,False,points4rewards,0.7119,20306700,USA,WA,Bothell,50.106.46.70,HTLV III/LAV treats AIDS,147,104,,150,116,treats,0.6,812467,"Yarchoan R, Klecker RE, Weinhold KJ et al Administration of 3 azido 3 deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS related complex.",AIDS,HTLV III/LAV,TWrex-cause
789214457,9/16/2015 14:29:44,1739530604,9/16/2015 14:29:20,False,onestopgpt,0.8333,21275875,CAN,ON,Hamilton,24.36.124.79,no_relation,147,104,,150,116,treats,0.6,812467,"Yarchoan R, Klecker RE, Weinhold KJ et al Administration of 3 azido 3 deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS related complex.",AIDS,HTLV III/LAV,TWrex-cause
789214457,9/16/2015 14:34:49,1739532521,9/16/2015 14:33:55,False,points4rewards,0.7123,28755767,USA,VA,Chester,68.57.118.32,HTLV III/LAV treats AIDS,147,104,,150,116,treats,0.6,812467,"Yarchoan R, Klecker RE, Weinhold KJ et al Administration of 3 azido 3 deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS related complex.",AIDS,HTLV III/LAV,TWrex-cause
789214459,9/16/2015 15:55:39,1739574784,9/16/2015 15:55:13,False,prodege,0.9181,24945126,GBR,K8,Ilford,82.12.220.44,DOXAZOSIN treats HYPERTENSION,50,25,,61,34,treats,0.99654575824488,908046,He took a 1 mg tablet of DOXAZOSIN daily for mild HYPERTENSION,HYPERTENSION,DOXAZOSIN,RO-may_treat
789214459,9/16/2015 16:16:15,1739584227,9/16/2015 16:15:52,False,points4rewards,0.9083,28703583,USA,,,184.53.32.62,DOXAZOSIN treats HYPERTENSION,50,25,,61,34,treats,0.99654575824488,908046,He took a 1 mg tablet of DOXAZOSIN daily for mild HYPERTENSION,HYPERTENSION,DOXAZOSIN,RO-may_treat
789214459,9/16/2015 16:39:15,1739594332,9/16/2015 16:39:03,False,elite,0.8889,30064988,GBR,B4,Bradford,92.22.135.111,DOXAZOSIN treats HYPERTENSION,50,25,,61,34,treats,0.99654575824488,908046,He took a 1 mg tablet of DOXAZOSIN daily for mild HYPERTENSION,HYPERTENSION,DOXAZOSIN,RO-may_treat
789214459,9/16/2015 16:52:18,1739600722,9/16/2015 16:52:07,False,instagc,0.8619,26024737,GBR,A9,Blackpool,92.23.159.7,DOXAZOSIN treats HYPERTENSION,50,25,,61,34,treats,0.99654575824488,908046,He took a 1 mg tablet of DOXAZOSIN daily for mild HYPERTENSION,HYPERTENSION,DOXAZOSIN,RO-may_treat
789214459,9/16/2015 16:52:20,1739600731,9/16/2015 16:52:13,False,prodege,0.2,2143114,CAN,BC,Vancouver,24.85.153.181,HYPERTENSION treats DOXAZOSIN,50,25,,61,34,treats,0.99654575824488,908046,He took a 1 mg tablet of DOXAZOSIN daily for mild HYPERTENSION,HYPERTENSION,DOXAZOSIN,RO-may_treat
789214459,9/16/2015 17:12:53,1739610907,9/16/2015 17:12:45,False,superrewards,0.8333,33199643,USA,WI,La Crosse,138.49.2.136,DOXAZOSIN treats HYPERTENSION,50,25,,61,34,treats,0.99654575824488,908046,He took a 1 mg tablet of DOXAZOSIN daily for mild HYPERTENSION,HYPERTENSION,DOXAZOSIN,RO-may_treat
789214459,9/16/2015 17:24:23,1739615930,9/16/2015 17:23:54,False,clixsense,0.9276,20587495,CAN,NL,St. John's,142.162.227.3,DOXAZOSIN treats HYPERTENSION,50,25,,61,34,treats,0.99654575824488,908046,He took a 1 mg tablet of DOXAZOSIN daily for mild HYPERTENSION,HYPERTENSION,DOXAZOSIN,RO-may_treat
789214462,9/16/2015 12:45:20,1739494278,9/16/2015 12:45:06,False,clixsense,0.9603,10390268,USA,NY,New Paltz,100.40.133.216,DISOPYRAMIDE treats VENTRICULAR TACHYCARDIA,233,257,,255,269,treats,0.609994281330419,907380,"In 75% of supraventricular parossistic tachycardia and in 75% of parossistic atrial fibrillation, arrhythmia was interrupted within few minutes from drug injection; in 90% with premature ventricular contractions (PVC) and in 100% of VENTRICULAR TACHYCARDIA DISOPYRAMIDE was capable to interrupt the arrhythmias.",VENTRICULAR TACHYCARDIA,DISOPYRAMIDE,RO-may_prevent
789214462,9/16/2015 12:47:14,1739495018,9/16/2015 12:46:49,False,bitcoinget,0.9375,30546513,GBR,G6,Hull,194.42.67.50,no_relation,233,257,,255,269,treats,0.609994281330419,907380,"In 75% of supraventricular parossistic tachycardia and in 75% of parossistic atrial fibrillation, arrhythmia was interrupted within few minutes from drug injection; in 90% with premature ventricular contractions (PVC) and in 100% of VENTRICULAR TACHYCARDIA DISOPYRAMIDE was capable to interrupt the arrhythmias.",VENTRICULAR TACHYCARDIA,DISOPYRAMIDE,RO-may_prevent
789214462,9/16/2015 13:29:25,1739508510,9/16/2015 13:28:11,False,clixsense,0.6944,21875134,GBR,,,80.189.12.98,DISOPYRAMIDE treats VENTRICULAR TACHYCARDIA,233,257,,255,269,treats,0.609994281330419,907380,"In 75% of supraventricular parossistic tachycardia and in 75% of parossistic atrial fibrillation, arrhythmia was interrupted within few minutes from drug injection; in 90% with premature ventricular contractions (PVC) and in 100% of VENTRICULAR TACHYCARDIA DISOPYRAMIDE was capable to interrupt the arrhythmias.",VENTRICULAR TACHYCARDIA,DISOPYRAMIDE,RO-may_prevent
789214462,9/16/2015 13:41:49,1739514436,9/16/2015 13:40:59,False,neodev,0.7657,30588889,NLD,07,Amsterdam,77.248.175.222,DISOPYRAMIDE treats VENTRICULAR TACHYCARDIA,233,257,,255,269,treats,0.609994281330419,907380,"In 75% of supraventricular parossistic tachycardia and in 75% of parossistic atrial fibrillation, arrhythmia was interrupted within few minutes from drug injection; in 90% with premature ventricular contractions (PVC) and in 100% of VENTRICULAR TACHYCARDIA DISOPYRAMIDE was capable to interrupt the arrhythmias.",VENTRICULAR TACHYCARDIA,DISOPYRAMIDE,RO-may_prevent
789214462,9/16/2015 13:53:49,1739518214,9/16/2015 13:53:24,False,clixsense,0.8809999999999999,9001027,CAN,QC,Dollard-des-ormeaux,96.21.122.219,DISOPYRAMIDE treats VENTRICULAR TACHYCARDIA,233,257,,255,269,treats,0.609994281330419,907380,"In 75% of supraventricular parossistic tachycardia and in 75% of parossistic atrial fibrillation, arrhythmia was interrupted within few minutes from drug injection; in 90% with premature ventricular contractions (PVC) and in 100% of VENTRICULAR TACHYCARDIA DISOPYRAMIDE was capable to interrupt the arrhythmias.",VENTRICULAR TACHYCARDIA,DISOPYRAMIDE,RO-may_prevent
789214462,9/16/2015 14:01:12,1739520658,9/16/2015 14:00:13,False,clixsense,0.8393,6340330,USA,NY,Canajoharie,67.248.115.74,DISOPYRAMIDE treats VENTRICULAR TACHYCARDIA,233,257,,255,269,treats,0.609994281330419,907380,"In 75% of supraventricular parossistic tachycardia and in 75% of parossistic atrial fibrillation, arrhythmia was interrupted within few minutes from drug injection; in 90% with premature ventricular contractions (PVC) and in 100% of VENTRICULAR TACHYCARDIA DISOPYRAMIDE was capable to interrupt the arrhythmias.",VENTRICULAR TACHYCARDIA,DISOPYRAMIDE,RO-may_prevent
789214462,9/16/2015 14:20:16,1739527363,9/16/2015 14:11:17,False,points4rewards,0.7119,20306700,USA,WA,Bothell,50.106.46.70,DISOPYRAMIDE treats VENTRICULAR TACHYCARDIA,233,257,,255,269,treats,0.609994281330419,907380,"In 75% of supraventricular parossistic tachycardia and in 75% of parossistic atrial fibrillation, arrhythmia was interrupted within few minutes from drug injection; in 90% with premature ventricular contractions (PVC) and in 100% of VENTRICULAR TACHYCARDIA DISOPYRAMIDE was capable to interrupt the arrhythmias.",VENTRICULAR TACHYCARDIA,DISOPYRAMIDE,RO-may_prevent
789214466,9/16/2015 14:01:53,1739520847,9/16/2015 14:01:36,False,clixsense,0.8393,6340330,USA,NY,Canajoharie,67.248.115.74,INSULIN ASPART treats TYPE 1 DIABETES,157,68,,171,82,treats,0.99654575824488,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of INSULIN ASPART used in continuous subcutaneous insulin infusion therapy in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN ASPART,TWrex-cause
789214466,9/16/2015 14:17:18,1739526265,9/16/2015 14:16:24,False,gifthulk,0.8833,18666417,USA,PA,Meadville,24.101.32.13,INSULIN ASPART treats TYPE 1 DIABETES,157,68,,171,82,treats,0.99654575824488,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of INSULIN ASPART used in continuous subcutaneous insulin infusion therapy in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN ASPART,TWrex-cause
789214466,9/16/2015 14:20:53,1739527572,9/16/2015 14:20:40,False,points4rewards,0.7119,20306700,USA,WA,Bothell,50.106.46.70,INSULIN ASPART treats TYPE 1 DIABETES,157,68,,171,82,treats,0.99654575824488,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of INSULIN ASPART used in continuous subcutaneous insulin infusion therapy in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN ASPART,TWrex-cause
789214466,9/16/2015 14:29:54,1739530698,9/16/2015 14:29:45,False,onestopgpt,0.8333,21275875,CAN,ON,Hamilton,24.36.124.79,INSULIN ASPART treats TYPE 1 DIABETES,157,68,,171,82,treats,0.99654575824488,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of INSULIN ASPART used in continuous subcutaneous insulin infusion therapy in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN ASPART,TWrex-cause
789214466,9/16/2015 14:35:18,1739532680,9/16/2015 14:34:49,False,points4rewards,0.7123,28755767,USA,VA,Chester,68.57.118.32,INSULIN ASPART treats TYPE 1 DIABETES,157,68,,171,82,treats,0.99654575824488,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of INSULIN ASPART used in continuous subcutaneous insulin infusion therapy in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN ASPART,TWrex-cause
789214466,9/16/2015 14:38:53,1739534038,9/16/2015 14:37:53,False,neodev,0.8095,18881135,CAN,ON,Ajax,99.243.87.224,INSULIN ASPART treats TYPE 1 DIABETES,157,68,,171,82,treats,0.99654575824488,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of INSULIN ASPART used in continuous subcutaneous insulin infusion therapy in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN ASPART,TWrex-cause
789214466,9/16/2015 14:43:10,1739535717,9/16/2015 14:43:02,False,neodev,0.1429,11291592,USA,MI,Taylor,99.170.106.105,no_relation,157,68,,171,82,treats,0.99654575824488,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of INSULIN ASPART used in continuous subcutaneous insulin infusion therapy in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN ASPART,TWrex-cause
789214475,9/16/2015 15:56:03,1739574983,9/16/2015 15:55:40,False,prodege,0.9181,24945126,GBR,K8,Ilford,82.12.220.44,ERGONOVINE treats VARIANT ANGINA,26,58,,40,68,treats,0.957427107756338,500145,"However, in patients with VARIANT ANGINA, a small dose of ERGONOVINE produced a percentage of change in diameter of 39.8 +/- 15.3% at the site of spastic occlusion included by a larger dose of ergonovine, compared with that of 7.0 +/- 11.9% in the remaining non-spastic coronary arteries (p less than 0.05",VARIANT ANGINA,ERGONOVINE,TWrex-diagnose
789214475,9/16/2015 16:16:36,1739584331,9/16/2015 16:16:19,False,points4rewards,0.9083,28703583,USA,,,184.53.32.62,ERGONOVINE treats VARIANT ANGINA,26,58,,40,68,treats,0.957427107756338,500145,"However, in patients with VARIANT ANGINA, a small dose of ERGONOVINE produced a percentage of change in diameter of 39.8 +/- 15.3% at the site of spastic occlusion included by a larger dose of ergonovine, compared with that of 7.0 +/- 11.9% in the remaining non-spastic coronary arteries (p less than 0.05",VARIANT ANGINA,ERGONOVINE,TWrex-diagnose
789214475,9/16/2015 16:39:27,1739594400,9/16/2015 16:39:17,False,elite,0.8889,30064988,GBR,B4,Bradford,92.22.135.111,ERGONOVINE treats VARIANT ANGINA,26,58,,40,68,treats,0.957427107756338,500145,"However, in patients with VARIANT ANGINA, a small dose of ERGONOVINE produced a percentage of change in diameter of 39.8 +/- 15.3% at the site of spastic occlusion included by a larger dose of ergonovine, compared with that of 7.0 +/- 11.9% in the remaining non-spastic coronary arteries (p less than 0.05",VARIANT ANGINA,ERGONOVINE,TWrex-diagnose
789214475,9/16/2015 16:52:25,1739600738,9/16/2015 16:52:19,False,instagc,0.8619,26024737,GBR,A9,Blackpool,92.23.159.7,ERGONOVINE treats VARIANT ANGINA,26,58,,40,68,treats,0.957427107756338,500145,"However, in patients with VARIANT ANGINA, a small dose of ERGONOVINE produced a percentage of change in diameter of 39.8 +/- 15.3% at the site of spastic occlusion included by a larger dose of ergonovine, compared with that of 7.0 +/- 11.9% in the remaining non-spastic coronary arteries (p less than 0.05",VARIANT ANGINA,ERGONOVINE,TWrex-diagnose
789214475,9/16/2015 17:25:13,1739616345,9/16/2015 17:24:24,False,clixsense,0.9276,20587495,CAN,NL,St. John's,142.162.227.3,ERGONOVINE treats VARIANT ANGINA,26,58,,40,68,treats,0.957427107756338,500145,"However, in patients with VARIANT ANGINA, a small dose of ERGONOVINE produced a percentage of change in diameter of 39.8 +/- 15.3% at the site of spastic occlusion included by a larger dose of ergonovine, compared with that of 7.0 +/- 11.9% in the remaining non-spastic coronary arteries (p less than 0.05",VARIANT ANGINA,ERGONOVINE,TWrex-diagnose
789214475,9/16/2015 17:28:45,1739618763,9/16/2015 17:27:35,False,neodev,1.0,23017572,USA,CA,Santa Ana,67.215.241.18,ERGONOVINE treats VARIANT ANGINA,26,58,,40,68,treats,0.957427107756338,500145,"However, in patients with VARIANT ANGINA, a small dose of ERGONOVINE produced a percentage of change in diameter of 39.8 +/- 15.3% at the site of spastic occlusion included by a larger dose of ergonovine, compared with that of 7.0 +/- 11.9% in the remaining non-spastic coronary arteries (p less than 0.05",VARIANT ANGINA,ERGONOVINE,TWrex-diagnose
789214475,9/16/2015 17:37:06,1739623949,9/16/2015 17:36:42,False,gifthunterclub,0.8792,29582088,GBR,I2,Manchester,92.19.111.82,ERGONOVINE treats VARIANT ANGINA,26,58,,40,68,treats,0.957427107756338,500145,"However, in patients with VARIANT ANGINA, a small dose of ERGONOVINE produced a percentage of change in diameter of 39.8 +/- 15.3% at the site of spastic occlusion included by a larger dose of ergonovine, compared with that of 7.0 +/- 11.9% in the remaining non-spastic coronary arteries (p less than 0.05",VARIANT ANGINA,ERGONOVINE,TWrex-diagnose
789214490,9/16/2015 15:56:03,1739574982,9/16/2015 15:55:40,False,prodege,0.9181,24945126,GBR,K8,Ilford,82.12.220.44,ALPROX treats ERECTILE DYSFUNCTION,70,48,,90,54,treats,0.9704949587999999,207310,NexMed is developing transdermal formulations - [ALPROX]-TDfor men with [ERECTILE DYSFUNCTION] and Femproxfor female sexual arousal disorder.,ERECTILE DYSFUNCTION,ALPROX,TWrex-treat
789214490,9/16/2015 16:16:36,1739584330,9/16/2015 16:16:19,False,points4rewards,0.9083,28703583,USA,,,184.53.32.62,ALPROX treats ERECTILE DYSFUNCTION,70,48,,90,54,treats,0.9704949587999999,207310,NexMed is developing transdermal formulations - [ALPROX]-TDfor men with [ERECTILE DYSFUNCTION] and Femproxfor female sexual arousal disorder.,ERECTILE DYSFUNCTION,ALPROX,TWrex-treat
789214490,9/16/2015 16:39:27,1739594441,9/16/2015 16:39:17,False,elite,0.8889,30064988,GBR,B4,Bradford,92.22.135.111,ALPROX treats ERECTILE DYSFUNCTION,70,48,,90,54,treats,0.9704949587999999,207310,NexMed is developing transdermal formulations - [ALPROX]-TDfor men with [ERECTILE DYSFUNCTION] and Femproxfor female sexual arousal disorder.,ERECTILE DYSFUNCTION,ALPROX,TWrex-treat
789214490,9/16/2015 16:52:25,1739600737,9/16/2015 16:52:19,False,instagc,0.8619,26024737,GBR,A9,Blackpool,92.23.159.7,ALPROX treats ERECTILE DYSFUNCTION,70,48,,90,54,treats,0.9704949587999999,207310,NexMed is developing transdermal formulations - [ALPROX]-TDfor men with [ERECTILE DYSFUNCTION] and Femproxfor female sexual arousal disorder.,ERECTILE DYSFUNCTION,ALPROX,TWrex-treat
789214490,9/16/2015 17:25:13,1739616361,9/16/2015 17:24:24,False,clixsense,0.9276,20587495,CAN,NL,St. John's,142.162.227.3,ALPROX treats ERECTILE DYSFUNCTION,70,48,,90,54,treats,0.9704949587999999,207310,NexMed is developing transdermal formulations - [ALPROX]-TDfor men with [ERECTILE DYSFUNCTION] and Femproxfor female sexual arousal disorder.,ERECTILE DYSFUNCTION,ALPROX,TWrex-treat
789214490,9/16/2015 17:28:45,1739618771,9/16/2015 17:27:35,False,neodev,1.0,23017572,USA,CA,Santa Ana,67.215.241.18,ALPROX treats ERECTILE DYSFUNCTION,70,48,,90,54,treats,0.9704949587999999,207310,NexMed is developing transdermal formulations - [ALPROX]-TDfor men with [ERECTILE DYSFUNCTION] and Femproxfor female sexual arousal disorder.,ERECTILE DYSFUNCTION,ALPROX,TWrex-treat
789214490,9/16/2015 17:37:06,1739623941,9/16/2015 17:36:42,False,gifthunterclub,0.8792,29582088,GBR,I2,Manchester,92.19.111.82,ALPROX treats ERECTILE DYSFUNCTION,70,48,,90,54,treats,0.9704949587999999,207310,NexMed is developing transdermal formulations - [ALPROX]-TDfor men with [ERECTILE DYSFUNCTION] and Femproxfor female sexual arousal disorder.,ERECTILE DYSFUNCTION,ALPROX,TWrex-treat
789214495,9/16/2015 14:48:23,1739537725,9/16/2015 14:48:06,False,neodev,0.8095,18881135,CAN,ON,Ajax,99.243.87.224,LORAZEPAM treats EMESIS,170,139,,175,148,treats,0.99654575824488,804523,A randomized double blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and LORAZEPAM in the prevention of EMESIS due to cisplatin based chemotherapy.,EMESIS,LORAZEPAM,TWrex-cause
789214495,9/16/2015 14:59:41,1739542391,9/16/2015 14:59:25,False,clixsense,0.8319,33115750,GBR,I3,Rochester,90.222.106.192,LORAZEPAM treats EMESIS,170,139,,175,148,treats,0.99654575824488,804523,A randomized double blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and LORAZEPAM in the prevention of EMESIS due to cisplatin based chemotherapy.,EMESIS,LORAZEPAM,TWrex-cause
789214495,9/16/2015 15:06:52,1739545288,9/16/2015 15:05:18,False,clixsense,0.675,32049531,USA,VA,Manassas,198.7.59.110,LORAZEPAM treats EMESIS,170,139,,175,148,treats,0.99654575824488,804523,A randomized double blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and LORAZEPAM in the prevention of EMESIS due to cisplatin based chemotherapy.,EMESIS,LORAZEPAM,TWrex-cause
789214495,9/16/2015 15:12:56,1739547781,9/16/2015 15:11:52,False,neodev,0.6468,33238512,CAN,BC,Langley,205.250.50.224,no_relation,170,139,,175,148,treats,0.99654575824488,804523,A randomized double blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and LORAZEPAM in the prevention of EMESIS due to cisplatin based chemotherapy.,EMESIS,LORAZEPAM,TWrex-cause
789214495,9/16/2015 15:13:28,1739547997,9/16/2015 15:13:02,False,neodev,0.6677,33701549,AUS,02,Sydney,103.238.131.137,LORAZEPAM treats EMESIS,170,139,,175,148,treats,0.99654575824488,804523,A randomized double blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and LORAZEPAM in the prevention of EMESIS due to cisplatin based chemotherapy.,EMESIS,LORAZEPAM,TWrex-cause
789214495,9/16/2015 15:14:42,1739548538,9/16/2015 15:13:50,False,clixsense,0.3143,6336109,CAN,BC,Prince George,198.254.211.52,no_relation,170,139,,175,148,treats,0.99654575824488,804523,A randomized double blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and LORAZEPAM in the prevention of EMESIS due to cisplatin based chemotherapy.,EMESIS,LORAZEPAM,TWrex-cause
789214495,9/16/2015 15:30:35,1739562609,9/16/2015 15:30:14,False,tremorgames,0.5357,24449707,CAN,QC,Laval,96.20.14.148,LORAZEPAM treats EMESIS,170,139,,175,148,treats,0.99654575824488,804523,A randomized double blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and LORAZEPAM in the prevention of EMESIS due to cisplatin based chemotherapy.,EMESIS,LORAZEPAM,TWrex-cause
789214506,9/16/2015 12:04:59,1739483811,9/16/2015 12:04:31,False,prodege,0.8139,27934334,GBR,C8,Croydon,81.159.60.206,no_relation,126,63,,147,96,treats,0.986393923832144,804378,"1]  Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Postoperative FONDAPARINUX VERSUS POSTOPERATIVE enoxaparin for prevention of VENOUS THROMBOEMBOLISM after elective hip replacement surgery: a randomised double blind trial.",VENOUS THROMBOEMBOLISM,FONDAPARINUX VERSUS POSTOPERATIVE,TWrex-cause
789214506,9/16/2015 12:18:37,1739487109,9/16/2015 12:18:02,False,instagc,0.7488,16573689,USA,MI,Hanover,74.45.203.252,FONDAPARINUX VERSUS POSTOPERATIVE treats VENOUS THROMBOEMBOLISM,126,63,,147,96,treats,0.986393923832144,804378,"1]  Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Postoperative FONDAPARINUX VERSUS POSTOPERATIVE enoxaparin for prevention of VENOUS THROMBOEMBOLISM after elective hip replacement surgery: a randomised double blind trial.",VENOUS THROMBOEMBOLISM,FONDAPARINUX VERSUS POSTOPERATIVE,TWrex-cause
789214506,9/16/2015 12:43:52,1739493800,9/16/2015 12:43:25,False,clixsense,0.9603,10390268,USA,NY,New Paltz,100.40.133.216,FONDAPARINUX VERSUS POSTOPERATIVE treats VENOUS THROMBOEMBOLISM,126,63,,147,96,treats,0.986393923832144,804378,"1]  Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Postoperative FONDAPARINUX VERSUS POSTOPERATIVE enoxaparin for prevention of VENOUS THROMBOEMBOLISM after elective hip replacement surgery: a randomised double blind trial.",VENOUS THROMBOEMBOLISM,FONDAPARINUX VERSUS POSTOPERATIVE,TWrex-cause
789214506,9/16/2015 12:45:46,1739494383,9/16/2015 12:45:26,False,bitcoinget,0.9375,30546513,GBR,G6,Hull,194.42.67.50,FONDAPARINUX VERSUS POSTOPERATIVE treats VENOUS THROMBOEMBOLISM,126,63,,147,96,treats,0.986393923832144,804378,"1]  Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Postoperative FONDAPARINUX VERSUS POSTOPERATIVE enoxaparin for prevention of VENOUS THROMBOEMBOLISM after elective hip replacement surgery: a randomised double blind trial.",VENOUS THROMBOEMBOLISM,FONDAPARINUX VERSUS POSTOPERATIVE,TWrex-cause
789214506,9/16/2015 12:53:47,1739497030,9/16/2015 12:53:38,False,instagc,0.8661,15577915,USA,IL,Trenton,208.70.36.12,FONDAPARINUX VERSUS POSTOPERATIVE treats VENOUS THROMBOEMBOLISM,126,63,,147,96,treats,0.986393923832144,804378,"1]  Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Postoperative FONDAPARINUX VERSUS POSTOPERATIVE enoxaparin for prevention of VENOUS THROMBOEMBOLISM after elective hip replacement surgery: a randomised double blind trial.",VENOUS THROMBOEMBOLISM,FONDAPARINUX VERSUS POSTOPERATIVE,TWrex-cause
789214506,9/16/2015 13:22:17,1739506456,9/16/2015 13:20:43,False,clixsense,0.6944,21875134,GBR,,,80.189.12.98,no_relation,126,63,,147,96,treats,0.986393923832144,804378,"1]  Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Postoperative FONDAPARINUX VERSUS POSTOPERATIVE enoxaparin for prevention of VENOUS THROMBOEMBOLISM after elective hip replacement surgery: a randomised double blind trial.",VENOUS THROMBOEMBOLISM,FONDAPARINUX VERSUS POSTOPERATIVE,TWrex-cause
789214506,9/16/2015 13:38:00,1739513090,9/16/2015 13:37:22,False,neodev,0.7657,30588889,NLD,07,Amsterdam,77.248.175.222,no_relation,126,63,,147,96,treats,0.986393923832144,804378,"1]  Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Postoperative FONDAPARINUX VERSUS POSTOPERATIVE enoxaparin for prevention of VENOUS THROMBOEMBOLISM after elective hip replacement surgery: a randomised double blind trial.",VENOUS THROMBOEMBOLISM,FONDAPARINUX VERSUS POSTOPERATIVE,TWrex-cause
789214512,9/16/2015 11:05:00,1739469246,9/16/2015 11:04:45,False,clixsense,0.9048,24104564,AUS,02,Surry Hills,60.241.245.92,CONVENTIONAL AMPHOTERICIN B treats EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,114,37,,158,64,treats,0.8741572761215379,800971,"211 ,   245 ,   293 ,   426 ,   436  CONVENTIONAL AMPHOTERICIN B in HIV infected adults with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.",EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,CONVENTIONAL AMPHOTERICIN B,TWrex-cause
789214512,9/16/2015 11:09:24,1739470291,9/16/2015 11:08:52,False,clixsense,0.875,32053717,GBR,,,51.174.76.80,CONVENTIONAL AMPHOTERICIN B treats EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,114,37,,158,64,treats,0.8741572761215379,800971,"211 ,   245 ,   293 ,   426 ,   436  CONVENTIONAL AMPHOTERICIN B in HIV infected adults with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.",EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,CONVENTIONAL AMPHOTERICIN B,TWrex-cause
789214512,9/16/2015 11:19:21,1739472990,9/16/2015 11:19:04,False,bitcoinget,0.9083,31256687,USA,NY,Brooklyn,24.146.181.193,CONVENTIONAL AMPHOTERICIN B treats EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,114,37,,158,64,treats,0.8741572761215379,800971,"211 ,   245 ,   293 ,   426 ,   436  CONVENTIONAL AMPHOTERICIN B in HIV infected adults with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.",EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,CONVENTIONAL AMPHOTERICIN B,TWrex-cause
789214512,9/16/2015 11:20:11,1739473195,9/16/2015 11:19:53,False,neodev,0.8264,31326282,NLD,,,82.169.243.65,no_relation,114,37,,158,64,treats,0.8741572761215379,800971,"211 ,   245 ,   293 ,   426 ,   436  CONVENTIONAL AMPHOTERICIN B in HIV infected adults with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.",EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,CONVENTIONAL AMPHOTERICIN B,TWrex-cause
789214512,9/16/2015 11:26:26,1739474424,9/16/2015 11:25:41,False,keeprewarding,0.8204,29139615,CAN,ON,Perth,192.186.81.178,no_relation,114,37,,158,64,treats,0.8741572761215379,800971,"211 ,   245 ,   293 ,   426 ,   436  CONVENTIONAL AMPHOTERICIN B in HIV infected adults with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.",EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,CONVENTIONAL AMPHOTERICIN B,TWrex-cause
789214512,9/16/2015 11:26:52,1739474471,9/16/2015 11:26:27,False,gifthunterclub,0.8694,24043308,GBR,,,94.102.147.250,no_relation,114,37,,158,64,treats,0.8741572761215379,800971,"211 ,   245 ,   293 ,   426 ,   436  CONVENTIONAL AMPHOTERICIN B in HIV infected adults with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.",EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,CONVENTIONAL AMPHOTERICIN B,TWrex-cause
789214512,9/16/2015 11:29:47,1739475211,9/16/2015 11:26:12,False,points4rewards,0.7956,20113482,USA,PA,Philadelphia,162.208.49.45,no_relation,114,37,,158,64,treats,0.8741572761215379,800971,"211 ,   245 ,   293 ,   426 ,   436  CONVENTIONAL AMPHOTERICIN B in HIV infected adults with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.",EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,CONVENTIONAL AMPHOTERICIN B,TWrex-cause
789214519,9/16/2015 10:14:42,1739454072,9/16/2015 10:14:19,False,neodev,1.0,20306047,GBR,,,80.41.0.252,ABCIXIMAB treats REFRACTORY UNSTABLE ANGINA,92,39,,117,48,treats,0.889000889001333,800959,Randomised placebo controlled trial of ABCIXIMAB before and during coronary intervention in REFRACTORY UNSTABLE ANGINA: the CAPTURE study.,REFRACTORY UNSTABLE ANGINA,ABCIXIMAB,TWrex-cause
789214519,9/16/2015 10:15:57,1739454589,9/16/2015 10:15:20,False,neodev,0.9167,30627835,GBR,D8,Bishop Auckland,217.44.84.223,ABCIXIMAB treats REFRACTORY UNSTABLE ANGINA,92,39,,117,48,treats,0.889000889001333,800959,Randomised placebo controlled trial of ABCIXIMAB before and during coronary intervention in REFRACTORY UNSTABLE ANGINA: the CAPTURE study.,REFRACTORY UNSTABLE ANGINA,ABCIXIMAB,TWrex-cause
789214519,9/16/2015 10:18:07,1739455390,9/16/2015 10:17:30,False,pocketmoneygpt,0.9643,21432964,GBR,F8,Borehamwood,81.159.185.70,ABCIXIMAB treats REFRACTORY UNSTABLE ANGINA,92,39,,117,48,treats,0.889000889001333,800959,Randomised placebo controlled trial of ABCIXIMAB before and during coronary intervention in REFRACTORY UNSTABLE ANGINA: the CAPTURE study.,REFRACTORY UNSTABLE ANGINA,ABCIXIMAB,TWrex-cause
789214519,9/16/2015 10:43:44,1739462676,9/16/2015 10:42:48,False,neodev,0.8806,33758777,USA,,,38.95.108.251,ABCIXIMAB treats REFRACTORY UNSTABLE ANGINA,92,39,,117,48,treats,0.889000889001333,800959,Randomised placebo controlled trial of ABCIXIMAB before and during coronary intervention in REFRACTORY UNSTABLE ANGINA: the CAPTURE study.,REFRACTORY UNSTABLE ANGINA,ABCIXIMAB,TWrex-cause
789214519,9/16/2015 10:45:02,1739463087,9/16/2015 10:44:26,False,neodev,0.9083,33644825,USA,FL,Fort Lauderdale,65.111.173.161,ABCIXIMAB treats REFRACTORY UNSTABLE ANGINA,92,39,,117,48,treats,0.889000889001333,800959,Randomised placebo controlled trial of ABCIXIMAB before and during coronary intervention in REFRACTORY UNSTABLE ANGINA: the CAPTURE study.,REFRACTORY UNSTABLE ANGINA,ABCIXIMAB,TWrex-cause
789214519,9/16/2015 10:50:15,1739464694,9/16/2015 10:46:57,False,neodev,0.5167,30581619,USA,CA,Laguna Niguel,216.177.129.147,REFRACTORY UNSTABLE ANGINA treats ABCIXIMAB,92,39,,117,48,treats,0.889000889001333,800959,Randomised placebo controlled trial of ABCIXIMAB before and during coronary intervention in REFRACTORY UNSTABLE ANGINA: the CAPTURE study.,REFRACTORY UNSTABLE ANGINA,ABCIXIMAB,TWrex-cause
789214519,9/16/2015 11:01:04,1739468046,9/16/2015 11:00:52,False,elite,0.4385,34356654,USA,DE,,108.59.11.227,no_relation,92,39,,117,48,treats,0.889000889001333,800959,Randomised placebo controlled trial of ABCIXIMAB before and during coronary intervention in REFRACTORY UNSTABLE ANGINA: the CAPTURE study.,REFRACTORY UNSTABLE ANGINA,ABCIXIMAB,TWrex-cause
789214526,9/16/2015 17:28:04,1739618266,9/16/2015 17:27:27,False,clixsense,0.9276,20587495,CAN,NL,St. John's,142.162.227.3,THALIDOMIDE treats ERYTHEMA NODOSUM LEPROSUM,25,0,,49,11,treats,0.979957887012223,804706,THALIDOMIDE approved for ERYTHEMA NODOSUM LEPROSUM.,ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE,TWrex-cause
789214526,9/16/2015 17:38:24,1739624490,9/16/2015 17:38:10,False,gifthunterclub,0.8792,29582088,GBR,I2,Manchester,92.19.111.82,THALIDOMIDE treats ERYTHEMA NODOSUM LEPROSUM,25,0,,49,11,treats,0.979957887012223,804706,THALIDOMIDE approved for ERYTHEMA NODOSUM LEPROSUM.,ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE,TWrex-cause
789214526,9/16/2015 17:53:25,1739631271,9/16/2015 17:53:04,False,prodege,0.8853,6309240,USA,CA,San Diego,205.241.40.254,THALIDOMIDE treats ERYTHEMA NODOSUM LEPROSUM,25,0,,49,11,treats,0.979957887012223,804706,THALIDOMIDE approved for ERYTHEMA NODOSUM LEPROSUM.,ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE,TWrex-cause
789214526,9/16/2015 17:58:52,1739637297,9/16/2015 17:58:31,False,prodege,0.8929,13300986,CAN,AB,Edmonton,68.150.40.134,THALIDOMIDE treats ERYTHEMA NODOSUM LEPROSUM,25,0,,49,11,treats,0.979957887012223,804706,THALIDOMIDE approved for ERYTHEMA NODOSUM LEPROSUM.,ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE,TWrex-cause
789214526,9/16/2015 18:13:39,1739658755,9/16/2015 18:13:26,False,clixsense,0.8809999999999999,9001027,CAN,QC,Dollard-des-ormeaux,96.21.122.219,THALIDOMIDE treats ERYTHEMA NODOSUM LEPROSUM,25,0,,49,11,treats,0.979957887012223,804706,THALIDOMIDE approved for ERYTHEMA NODOSUM LEPROSUM.,ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE,TWrex-cause
789214526,9/16/2015 18:15:15,1739661755,9/16/2015 18:13:32,False,elite,0.875,31883685,GBR,,,79.66.244.188,THALIDOMIDE treats ERYTHEMA NODOSUM LEPROSUM,25,0,,49,11,treats,0.979957887012223,804706,THALIDOMIDE approved for ERYTHEMA NODOSUM LEPROSUM.,ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE,TWrex-cause
789214526,9/16/2015 18:23:04,1739677100,9/16/2015 18:22:32,False,prodege,0.8383,21417560,GBR,C3,Cambridge,151.224.120.191,THALIDOMIDE treats ERYTHEMA NODOSUM LEPROSUM,25,0,,49,11,treats,0.979957887012223,804706,THALIDOMIDE approved for ERYTHEMA NODOSUM LEPROSUM.,ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE,TWrex-cause
789214527,9/16/2015 09:37:28,1739443459,9/16/2015 09:36:15,False,clixsense,1.0,30681826,GBR,I9,Diss,31.49.71.254,no_relation,69,113,,93,128,treats,0.48666426339228797,813266,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME,TWrex-cause
789214527,9/16/2015 09:44:26,1739445188,9/16/2015 09:44:11,False,instagc,0.9583,18960682,GBR,U2,Annan,92.18.213.181,no_relation,69,113,,93,128,treats,0.48666426339228797,813266,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME,TWrex-cause
789214527,9/16/2015 09:50:50,1739446710,9/16/2015 09:50:24,False,gifthulk,0.9722,24928180,GBR,M1,Slough,90.206.237.191,no_relation,69,113,,93,128,treats,0.48666426339228797,813266,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME,TWrex-cause
789214527,9/16/2015 09:53:45,1739447570,9/16/2015 09:53:17,False,meprizescf,0.8167,28483210,USA,WI,Minocqua,75.143.134.247,no_relation,69,113,,93,128,treats,0.48666426339228797,813266,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME,TWrex-cause
789214527,9/16/2015 09:53:51,1739447598,9/16/2015 09:53:35,False,neodev,0.6667,14096345,NLD,03,Eibergen,178.85.94.186,no_relation,69,113,,93,128,treats,0.48666426339228797,813266,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME,TWrex-cause
789214527,9/16/2015 10:04:16,1739450861,9/16/2015 10:04:10,False,clixsense,0.4905,19162475,GBR,P8,Trowbridge,82.33.126.30,MARFAN SYNDROME treats ASCENDING AORTIC ANEURYSM,69,113,,93,128,treats,0.48666426339228797,813266,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME,TWrex-cause
789214527,9/16/2015 10:04:56,1739451167,9/16/2015 10:03:58,False,neodev,0.6746,31988911,USA,CA,Saratoga,107.178.37.2,no_relation,69,113,,93,128,treats,0.48666426339228797,813266,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME,TWrex-cause
789214534,9/16/2015 10:14:18,1739453976,9/16/2015 10:13:41,False,neodev,1.0,20306047,GBR,,,80.41.0.252,ESTROGEN treats POSTMENOPAUSAL BONE LOSS,73,106,,97,114,treats,0.9701425001453321,907345,"In order to evaluate the preventive effect of estrogen and vitamin D3 on POSTMENOPAUSAL BONE LOSS, either ESTROGEN (Premarin 0.625 mg/day) or vitamin D3 (Onealfa 1.0 micrograms/day) was administered to postmenopausal women",POSTMENOPAUSAL BONE LOSS,ESTROGEN,RO-may_prevent
789214534,9/16/2015 10:15:18,1739454327,9/16/2015 10:14:27,False,neodev,0.9167,30627835,GBR,D8,Bishop Auckland,217.44.84.223,ESTROGEN treats POSTMENOPAUSAL BONE LOSS,73,106,,97,114,treats,0.9701425001453321,907345,"In order to evaluate the preventive effect of estrogen and vitamin D3 on POSTMENOPAUSAL BONE LOSS, either ESTROGEN (Premarin 0.625 mg/day) or vitamin D3 (Onealfa 1.0 micrograms/day) was administered to postmenopausal women",POSTMENOPAUSAL BONE LOSS,ESTROGEN,RO-may_prevent
789214534,9/16/2015 10:17:29,1739455151,9/16/2015 10:15:19,False,pocketmoneygpt,0.9643,21432964,GBR,F8,Borehamwood,81.159.185.70,ESTROGEN treats POSTMENOPAUSAL BONE LOSS,73,106,,97,114,treats,0.9701425001453321,907345,"In order to evaluate the preventive effect of estrogen and vitamin D3 on POSTMENOPAUSAL BONE LOSS, either ESTROGEN (Premarin 0.625 mg/day) or vitamin D3 (Onealfa 1.0 micrograms/day) was administered to postmenopausal women",POSTMENOPAUSAL BONE LOSS,ESTROGEN,RO-may_prevent
789214534,9/16/2015 10:42:45,1739462429,9/16/2015 10:42:09,False,neodev,0.8806,33758777,USA,,,38.95.108.251,ESTROGEN treats POSTMENOPAUSAL BONE LOSS,73,106,,97,114,treats,0.9701425001453321,907345,"In order to evaluate the preventive effect of estrogen and vitamin D3 on POSTMENOPAUSAL BONE LOSS, either ESTROGEN (Premarin 0.625 mg/day) or vitamin D3 (Onealfa 1.0 micrograms/day) was administered to postmenopausal women",POSTMENOPAUSAL BONE LOSS,ESTROGEN,RO-may_prevent
789214534,9/16/2015 10:44:24,1739462921,9/16/2015 10:43:43,False,neodev,0.9083,33644825,USA,FL,Fort Lauderdale,65.111.173.161,ESTROGEN treats POSTMENOPAUSAL BONE LOSS,73,106,,97,114,treats,0.9701425001453321,907345,"In order to evaluate the preventive effect of estrogen and vitamin D3 on POSTMENOPAUSAL BONE LOSS, either ESTROGEN (Premarin 0.625 mg/day) or vitamin D3 (Onealfa 1.0 micrograms/day) was administered to postmenopausal women",POSTMENOPAUSAL BONE LOSS,ESTROGEN,RO-may_prevent
789214534,9/16/2015 10:46:55,1739463683,9/16/2015 10:45:54,False,neodev,0.5167,30581619,USA,CA,Laguna Niguel,216.177.129.147,POSTMENOPAUSAL BONE LOSS treats ESTROGEN,73,106,,97,114,treats,0.9701425001453321,907345,"In order to evaluate the preventive effect of estrogen and vitamin D3 on POSTMENOPAUSAL BONE LOSS, either ESTROGEN (Premarin 0.625 mg/day) or vitamin D3 (Onealfa 1.0 micrograms/day) was administered to postmenopausal women",POSTMENOPAUSAL BONE LOSS,ESTROGEN,RO-may_prevent
789214534,9/16/2015 11:00:51,1739467971,9/16/2015 11:00:30,False,elite,0.4385,34356654,USA,DE,,108.59.11.227,no_relation,73,106,,97,114,treats,0.9701425001453321,907345,"In order to evaluate the preventive effect of estrogen and vitamin D3 on POSTMENOPAUSAL BONE LOSS, either ESTROGEN (Premarin 0.625 mg/day) or vitamin D3 (Onealfa 1.0 micrograms/day) was administered to postmenopausal women",POSTMENOPAUSAL BONE LOSS,ESTROGEN,RO-may_prevent
789214538,9/16/2015 10:14:59,1739454193,9/16/2015 10:14:43,False,neodev,1.0,20306047,GBR,,,80.41.0.252,LEVOTHYROXINE treats HYPOTHYROIDISM,84,41,,97,54,treats,0.9958932064677041,800221,Bioequivalence of generic and brand name LEVOTHYROXINE products in the treatment of HYPOTHYROIDISM,HYPOTHYROIDISM,LEVOTHYROXINE,TWrex-cause
789214538,9/16/2015 10:16:18,1739454688,9/16/2015 10:15:58,False,neodev,0.9167,30627835,GBR,D8,Bishop Auckland,217.44.84.223,LEVOTHYROXINE treats HYPOTHYROIDISM,84,41,,97,54,treats,0.9958932064677041,800221,Bioequivalence of generic and brand name LEVOTHYROXINE products in the treatment of HYPOTHYROIDISM,HYPOTHYROIDISM,LEVOTHYROXINE,TWrex-cause
789214538,9/16/2015 10:44:15,1739462872,9/16/2015 10:43:47,False,neodev,0.8806,33758777,USA,,,38.95.108.251,LEVOTHYROXINE treats HYPOTHYROIDISM,84,41,,97,54,treats,0.9958932064677041,800221,Bioequivalence of generic and brand name LEVOTHYROXINE products in the treatment of HYPOTHYROIDISM,HYPOTHYROIDISM,LEVOTHYROXINE,TWrex-cause
789214538,9/16/2015 10:45:41,1739463251,9/16/2015 10:45:04,False,neodev,0.9083,33644825,USA,FL,Fort Lauderdale,65.111.173.161,LEVOTHYROXINE treats HYPOTHYROIDISM,84,41,,97,54,treats,0.9958932064677041,800221,Bioequivalence of generic and brand name LEVOTHYROXINE products in the treatment of HYPOTHYROIDISM,HYPOTHYROIDISM,LEVOTHYROXINE,TWrex-cause
789214538,9/16/2015 10:51:03,1739464996,9/16/2015 10:50:16,False,neodev,0.5167,30581619,USA,CA,Laguna Niguel,216.177.129.147,HYPOTHYROIDISM treats LEVOTHYROXINE,84,41,,97,54,treats,0.9958932064677041,800221,Bioequivalence of generic and brand name LEVOTHYROXINE products in the treatment of HYPOTHYROIDISM,HYPOTHYROIDISM,LEVOTHYROXINE,TWrex-cause
789214538,9/16/2015 11:01:23,1739468176,9/16/2015 11:01:05,False,elite,0.4385,34356654,USA,DE,,108.59.11.227,LEVOTHYROXINE treats HYPOTHYROIDISM,84,41,,97,54,treats,0.9958932064677041,800221,Bioequivalence of generic and brand name LEVOTHYROXINE products in the treatment of HYPOTHYROIDISM,HYPOTHYROIDISM,LEVOTHYROXINE,TWrex-cause
789214538,9/16/2015 11:03:56,1739468893,9/16/2015 11:03:22,False,clixsense,0.9048,24104564,AUS,02,Surry Hills,60.241.245.92,LEVOTHYROXINE treats HYPOTHYROIDISM,84,41,,97,54,treats,0.9958932064677041,800221,Bioequivalence of generic and brand name LEVOTHYROXINE products in the treatment of HYPOTHYROIDISM,HYPOTHYROIDISM,LEVOTHYROXINE,TWrex-cause
789214544,9/16/2015 18:17:45,1739666390,9/16/2015 18:17:31,False,elite,0.875,31883685,GBR,,,79.66.244.188,GLUTEN FREE DIET treats COELIAC DISEASE,262,231,,277,246,treats,0.9958932064677041,903747,The 5 HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten free diet for less than a year (p less than 0.01) but also compared with the patients with COELIAC DISEASE treated with a GLUTEN FREE DIET for more than a year (p less than 0.01.,GLUTEN FREE DIET,COELIAC DISEASE,RO-has_causative_agent
789214544,9/16/2015 18:25:34,1739682323,9/16/2015 18:24:54,False,prodege,0.8383,21417560,GBR,C3,Cambridge,151.224.120.191,no_relation,262,231,,277,246,treats,0.9958932064677041,903747,The 5 HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten free diet for less than a year (p less than 0.01) but also compared with the patients with COELIAC DISEASE treated with a GLUTEN FREE DIET for more than a year (p less than 0.01.,GLUTEN FREE DIET,COELIAC DISEASE,RO-has_causative_agent
789214544,9/16/2015 18:29:02,1739690131,9/16/2015 18:28:53,False,prodege,0.7438,1924522,USA,NY,New York,96.224.4.120,GLUTEN FREE DIET treats COELIAC DISEASE,262,231,,277,246,treats,0.9958932064677041,903747,The 5 HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten free diet for less than a year (p less than 0.01) but also compared with the patients with COELIAC DISEASE treated with a GLUTEN FREE DIET for more than a year (p less than 0.01.,GLUTEN FREE DIET,COELIAC DISEASE,RO-has_causative_agent
789214544,9/16/2015 18:56:12,1739757633,9/16/2015 18:54:39,False,clixsense,0.769,33878524,CAN,BC,Princeton,75.156.83.71,GLUTEN FREE DIET treats COELIAC DISEASE,262,231,,277,246,treats,0.9958932064677041,903747,The 5 HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten free diet for less than a year (p less than 0.01) but also compared with the patients with COELIAC DISEASE treated with a GLUTEN FREE DIET for more than a year (p less than 0.01.,GLUTEN FREE DIET,COELIAC DISEASE,RO-has_causative_agent
789214544,9/16/2015 19:08:38,1739773950,9/16/2015 19:07:41,False,neodev,0.7040000000000001,11026968,CAN,ON,Ottawa,108.168.124.170,GLUTEN FREE DIET treats COELIAC DISEASE,262,231,,277,246,treats,0.9958932064677041,903747,The 5 HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten free diet for less than a year (p less than 0.01) but also compared with the patients with COELIAC DISEASE treated with a GLUTEN FREE DIET for more than a year (p less than 0.01.,GLUTEN FREE DIET,COELIAC DISEASE,RO-has_causative_agent
789214544,9/16/2015 19:28:02,1739783564,9/16/2015 19:27:44,False,clixsense,0.8036,23197581,NLD,11,Den Haag,82.217.6.160,GLUTEN FREE DIET treats COELIAC DISEASE,262,231,,277,246,treats,0.9958932064677041,903747,The 5 HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten free diet for less than a year (p less than 0.01) but also compared with the patients with COELIAC DISEASE treated with a GLUTEN FREE DIET for more than a year (p less than 0.01.,GLUTEN FREE DIET,COELIAC DISEASE,RO-has_causative_agent
789214544,9/16/2015 19:29:47,1739784333,9/16/2015 19:29:39,False,instagc,0.75,16469970,USA,OK,Broken Arrow,72.192.89.181,GLUTEN FREE DIET treats COELIAC DISEASE,262,231,,277,246,treats,0.9958932064677041,903747,The 5 HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten free diet for less than a year (p less than 0.01) but also compared with the patients with COELIAC DISEASE treated with a GLUTEN FREE DIET for more than a year (p less than 0.01.,GLUTEN FREE DIET,COELIAC DISEASE,RO-has_causative_agent
789214545,9/16/2015 15:15:15,1739548831,9/16/2015 15:14:59,False,neodev,0.6677,33701549,AUS,02,Sydney,103.238.131.137,RIFAMPICIN treats DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,145,90,,183,100,treats,0.9830783046228491,800095,"Benator D, Bhattacharya M, Bozeman L, et al: Rifapentine and isoniazid once a week versus RIFAMPICIN and isoniazid twice a week for treatment of DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS in HIV negative patients: a randomised clinical trial.",DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,RIFAMPICIN,TWrex-cause
789214545,9/16/2015 15:43:25,1739569028,9/16/2015 15:43:16,False,prodege,0.7024,14848125,GBR,V8,Airdrie,86.151.77.161,RIFAMPICIN treats DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,145,90,,183,100,treats,0.9830783046228491,800095,"Benator D, Bhattacharya M, Bozeman L, et al: Rifapentine and isoniazid once a week versus RIFAMPICIN and isoniazid twice a week for treatment of DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS in HIV negative patients: a randomised clinical trial.",DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,RIFAMPICIN,TWrex-cause
789214545,9/16/2015 15:55:12,1739574610,9/16/2015 15:53:49,False,prodege,0.9181,24945126,GBR,K8,Ilford,82.12.220.44,RIFAMPICIN treats DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,145,90,,183,100,treats,0.9830783046228491,800095,"Benator D, Bhattacharya M, Bozeman L, et al: Rifapentine and isoniazid once a week versus RIFAMPICIN and isoniazid twice a week for treatment of DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS in HIV negative patients: a randomised clinical trial.",DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,RIFAMPICIN,TWrex-cause
789214545,9/16/2015 16:15:48,1739584107,9/16/2015 16:14:59,False,points4rewards,0.9083,28703583,USA,,,184.53.32.62,RIFAMPICIN treats DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,145,90,,183,100,treats,0.9830783046228491,800095,"Benator D, Bhattacharya M, Bozeman L, et al: Rifapentine and isoniazid once a week versus RIFAMPICIN and isoniazid twice a week for treatment of DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS in HIV negative patients: a randomised clinical trial.",DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,RIFAMPICIN,TWrex-cause
789214545,9/16/2015 16:17:49,1739584881,9/16/2015 16:17:42,False,neodev,0.3,33373894,USA,TX,Sandy,99.126.198.148,DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS treats RIFAMPICIN,145,90,,183,100,treats,0.9830783046228491,800095,"Benator D, Bhattacharya M, Bozeman L, et al: Rifapentine and isoniazid once a week versus RIFAMPICIN and isoniazid twice a week for treatment of DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS in HIV negative patients: a randomised clinical trial.",DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,RIFAMPICIN,TWrex-cause
789214545,9/16/2015 16:39:03,1739594277,9/16/2015 16:38:50,False,elite,0.8889,30064988,GBR,B4,Bradford,92.22.135.111,RIFAMPICIN treats DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,145,90,,183,100,treats,0.9830783046228491,800095,"Benator D, Bhattacharya M, Bozeman L, et al: Rifapentine and isoniazid once a week versus RIFAMPICIN and isoniazid twice a week for treatment of DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS in HIV negative patients: a randomised clinical trial.",DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,RIFAMPICIN,TWrex-cause
789214545,9/16/2015 16:52:06,1739600659,9/16/2015 16:51:37,False,instagc,0.8619,26024737,GBR,A9,Blackpool,92.23.159.7,RIFAMPICIN treats DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,145,90,,183,100,treats,0.9830783046228491,800095,"Benator D, Bhattacharya M, Bozeman L, et al: Rifapentine and isoniazid once a week versus RIFAMPICIN and isoniazid twice a week for treatment of DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS in HIV negative patients: a randomised clinical trial.",DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,RIFAMPICIN,TWrex-cause
789779023,9/16/2015 23:20:22,1739953447,9/16/2015 23:19:49,False,elite,1.0,33238902,NLD,06,Budel,77.248.148.5,AMPHOTERICIN B treats CYSTITIS,162,97,,169,111,treats,0.997785157856609,803516,"440  >     Treatment of Symptomatic Cystitis, Pyelonephritis, or Fungus Balls  IV:  Conventional AMPHOTERICIN B: 0.3 0.6 mg/kg daily for 1 7 days for symptomatic CYSTITIS",CYSTITIS,AMPHOTERICIN B,TWrex-cause
789779023,9/16/2015 23:23:45,1739954656,9/16/2015 23:23:09,False,neodev,0.9056,11460728,CAN,BC,Burnaby,70.79.16.165,AMPHOTERICIN B treats CYSTITIS,162,97,,169,111,treats,0.997785157856609,803516,"440  >     Treatment of Symptomatic Cystitis, Pyelonephritis, or Fungus Balls  IV:  Conventional AMPHOTERICIN B: 0.3 0.6 mg/kg daily for 1 7 days for symptomatic CYSTITIS",CYSTITIS,AMPHOTERICIN B,TWrex-cause
789779023,9/16/2015 23:24:15,1739954883,9/16/2015 23:23:50,False,instagc,0.9556,32654723,USA,MO,Columbia,150.199.20.174,AMPHOTERICIN B treats CYSTITIS,162,97,,169,111,treats,0.997785157856609,803516,"440  >     Treatment of Symptomatic Cystitis, Pyelonephritis, or Fungus Balls  IV:  Conventional AMPHOTERICIN B: 0.3 0.6 mg/kg daily for 1 7 days for symptomatic CYSTITIS",CYSTITIS,AMPHOTERICIN B,TWrex-cause
789779023,9/16/2015 23:58:17,1739965245,9/16/2015 23:57:40,False,clixsense,0.8798,33115750,GBR,I3,Rochester,90.222.106.192,AMPHOTERICIN B treats CYSTITIS,162,97,,169,111,treats,0.997785157856609,803516,"440  >     Treatment of Symptomatic Cystitis, Pyelonephritis, or Fungus Balls  IV:  Conventional AMPHOTERICIN B: 0.3 0.6 mg/kg daily for 1 7 days for symptomatic CYSTITIS",CYSTITIS,AMPHOTERICIN B,TWrex-cause
789779023,9/17/2015 00:16:10,1739969913,9/17/2015 00:15:49,False,neodev,0.8972,33716139,USA,VA,Manassas,207.244.79.146,AMPHOTERICIN B treats CYSTITIS,162,97,,169,111,treats,0.997785157856609,803516,"440  >     Treatment of Symptomatic Cystitis, Pyelonephritis, or Fungus Balls  IV:  Conventional AMPHOTERICIN B: 0.3 0.6 mg/kg daily for 1 7 days for symptomatic CYSTITIS",CYSTITIS,AMPHOTERICIN B,TWrex-cause
789779023,9/17/2015 00:30:05,1739974758,9/17/2015 00:28:20,False,meprizescf,0.9167,20102110,USA,,,64.134.11.53,AMPHOTERICIN B treats CYSTITIS,162,97,,169,111,treats,0.997785157856609,803516,"440  >     Treatment of Symptomatic Cystitis, Pyelonephritis, or Fungus Balls  IV:  Conventional AMPHOTERICIN B: 0.3 0.6 mg/kg daily for 1 7 days for symptomatic CYSTITIS",CYSTITIS,AMPHOTERICIN B,TWrex-cause
789779023,9/17/2015 00:35:08,1739975621,9/17/2015 00:34:54,False,instagc,0.9365,33058612,USA,IL,Glenview,162.229.106.229,AMPHOTERICIN B treats CYSTITIS,162,97,,169,111,treats,0.997785157856609,803516,"440  >     Treatment of Symptomatic Cystitis, Pyelonephritis, or Fungus Balls  IV:  Conventional AMPHOTERICIN B: 0.3 0.6 mg/kg daily for 1 7 days for symptomatic CYSTITIS",CYSTITIS,AMPHOTERICIN B,TWrex-cause
789779024,9/16/2015 20:40:16,1739862212,9/16/2015 20:39:33,False,cotter,0.9504,34377132,USA,OH,Athens,107.10.138.13,PILOCARPINE treats RADIATION INDUCED XEROSTOMIA,339,306,,366,317,treats,0.9918365981341751,908334,"Two hundred sixty five patients with head and neck cancer who had previously participated in either a fixed dose, dose titration, or dose ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36 month multicenter maintenance study to evaluate the long term safety and efficacy of oral PILOCARPINE for the treatment of RADIATION INDUCED XEROSTOMIA",RADIATION INDUCED XEROSTOMIA,PILOCARPINE,RO-may_treat
789779024,9/16/2015 20:55:46,1739879200,9/16/2015 20:54:13,False,neodev,0.6022,33701549,USA,CA,Torrance,66.171.228.172,PILOCARPINE treats RADIATION INDUCED XEROSTOMIA,339,306,,366,317,treats,0.9918365981341751,908334,"Two hundred sixty five patients with head and neck cancer who had previously participated in either a fixed dose, dose titration, or dose ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36 month multicenter maintenance study to evaluate the long term safety and efficacy of oral PILOCARPINE for the treatment of RADIATION INDUCED XEROSTOMIA",RADIATION INDUCED XEROSTOMIA,PILOCARPINE,RO-may_treat
789779024,9/16/2015 20:55:48,1739879221,9/16/2015 20:55:29,False,prodege,0.8395,3587109,CAN,NS,Havre Boucher,142.166.204.244,PILOCARPINE treats RADIATION INDUCED XEROSTOMIA,339,306,,366,317,treats,0.9918365981341751,908334,"Two hundred sixty five patients with head and neck cancer who had previously participated in either a fixed dose, dose titration, or dose ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36 month multicenter maintenance study to evaluate the long term safety and efficacy of oral PILOCARPINE for the treatment of RADIATION INDUCED XEROSTOMIA",RADIATION INDUCED XEROSTOMIA,PILOCARPINE,RO-may_treat
789779024,9/16/2015 20:56:58,1739880357,9/16/2015 20:55:21,False,points4rewards,0.6937,20113482,USA,PA,Philadelphia,162.208.49.45,PILOCARPINE treats RADIATION INDUCED XEROSTOMIA,339,306,,366,317,treats,0.9918365981341751,908334,"Two hundred sixty five patients with head and neck cancer who had previously participated in either a fixed dose, dose titration, or dose ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36 month multicenter maintenance study to evaluate the long term safety and efficacy of oral PILOCARPINE for the treatment of RADIATION INDUCED XEROSTOMIA",RADIATION INDUCED XEROSTOMIA,PILOCARPINE,RO-may_treat
789779024,9/16/2015 20:57:35,1739880881,9/16/2015 20:57:15,False,bitcoinget,0.8659,21743413,USA,WA,Port Angeles,24.113.29.97,PILOCARPINE treats RADIATION INDUCED XEROSTOMIA,339,306,,366,317,treats,0.9918365981341751,908334,"Two hundred sixty five patients with head and neck cancer who had previously participated in either a fixed dose, dose titration, or dose ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36 month multicenter maintenance study to evaluate the long term safety and efficacy of oral PILOCARPINE for the treatment of RADIATION INDUCED XEROSTOMIA",RADIATION INDUCED XEROSTOMIA,PILOCARPINE,RO-may_treat
789779024,9/16/2015 21:09:29,1739893243,9/16/2015 21:07:58,False,onestopgpt,0.823,21275875,CAN,ON,Hamilton,24.36.124.79,PILOCARPINE treats RADIATION INDUCED XEROSTOMIA,339,306,,366,317,treats,0.9918365981341751,908334,"Two hundred sixty five patients with head and neck cancer who had previously participated in either a fixed dose, dose titration, or dose ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36 month multicenter maintenance study to evaluate the long term safety and efficacy of oral PILOCARPINE for the treatment of RADIATION INDUCED XEROSTOMIA",RADIATION INDUCED XEROSTOMIA,PILOCARPINE,RO-may_treat
789779024,9/16/2015 21:09:45,1739893644,9/16/2015 21:09:24,False,neodev,0.6377,18881135,CAN,ON,Ajax,99.243.87.224,PILOCARPINE treats RADIATION INDUCED XEROSTOMIA,339,306,,366,317,treats,0.9918365981341751,908334,"Two hundred sixty five patients with head and neck cancer who had previously participated in either a fixed dose, dose titration, or dose ranging trial of oral pilocarpine hydrochloride tablets were enrolled in a 36 month multicenter maintenance study to evaluate the long term safety and efficacy of oral PILOCARPINE for the treatment of RADIATION INDUCED XEROSTOMIA",RADIATION INDUCED XEROSTOMIA,PILOCARPINE,RO-may_treat
789779027,9/17/2015 01:27:15,1739996043,9/17/2015 01:26:50,False,prodege,0.9742,10959404,USA,CA,Studio City,108.217.110.104,no_relation,248,224,,264,240,treats,0.666666666666667,907823,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
789779027,9/17/2015 01:30:37,1739998494,9/17/2015 01:30:21,False,instagc,0.9722,31184650,USA,IA,Mason City,173.26.179.94,no_relation,248,224,,264,240,treats,0.666666666666667,907823,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
789779027,9/17/2015 01:31:51,1739999428,9/17/2015 01:30:02,False,instagc,0.8016,31861996,USA,FL,Homestead,73.46.199.178,AGENTS (ATROPINE treats ARREST ARRHYTHMIA,248,224,,264,240,treats,0.666666666666667,907823,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
789779027,9/17/2015 01:34:03,1740001313,9/17/2015 01:33:20,False,instagc,0.9083,30184706,USA,IA,Council Bluffs,67.3.207.60,no_relation,248,224,,264,240,treats,0.666666666666667,907823,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
789779027,9/17/2015 01:37:26,1740005246,9/17/2015 01:33:17,False,neodev,0.8389,33801943,USA,CA,San Jose,23.27.220.252,ARREST ARRHYTHMIA treats AGENTS (ATROPINE,248,224,,264,240,treats,0.666666666666667,907823,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
789779027,9/17/2015 01:56:45,1740022632,9/17/2015 01:56:30,False,bitcoinget,0.6667,31256687,USA,NY,Brooklyn,24.146.181.193,AGENTS (ATROPINE treats ARREST ARRHYTHMIA,248,224,,264,240,treats,0.666666666666667,907823,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
789779027,9/17/2015 02:03:32,1740028723,9/17/2015 02:00:03,False,instagc,0.8286,19480545,USA,MA,Brookline,209.6.138.58,AGENTS (ATROPINE treats ARREST ARRHYTHMIA,248,224,,264,240,treats,0.666666666666667,907823,"The commonly used medications in cardiac resuscitation may be grouped into the following general categories: vasopressors (epinephrine or vasopressin), antiarrhythmics (amiodarone, lidocaine, and magnesium), anticholinergic AGENTS (ATROPINE if the ARREST ARRHYTHMIA is asystole or PEA is slow), and miscellaneous drugs used to treat specific problems contributing to the arrest state, such as sodium bicarbonate (for severe metabolic acidosis, hyperkalemia, and certain drug overdoses) and calcium chloride (for hyperkalemia, calcium channel blocker drug overdose, or severe hypocalcemia) [ see.",ARREST ARRHYTHMIA,AGENTS (ATROPINE,RO-may_treat
789779031,9/16/2015 21:21:50,1739901880,9/16/2015 21:21:30,False,prodege,0.9583,22031444,GBR,F2,Gosport,89.240.162.20,GABAPENTIN treats CHRONIC PAIN,47,14,,58,24,treats,0.997458699830735,804182,Tiagabine and GABAPENTIN for the management of CHRONIC PAIN,CHRONIC PAIN,GABAPENTIN,TWrex-cause
789779031,9/16/2015 21:37:58,1739907823,9/16/2015 21:37:28,False,pocketmoneygpt,0.7321,21432964,GBR,F8,Borehamwood,81.159.185.70,GABAPENTIN treats CHRONIC PAIN,47,14,,58,24,treats,0.997458699830735,804182,Tiagabine and GABAPENTIN for the management of CHRONIC PAIN,CHRONIC PAIN,GABAPENTIN,TWrex-cause
789779031,9/16/2015 21:43:37,1739910001,9/16/2015 21:42:15,False,treasuretrooper,0.85,17956656,AUS,02,Jannali,14.200.59.55,GABAPENTIN treats CHRONIC PAIN,47,14,,58,24,treats,0.997458699830735,804182,Tiagabine and GABAPENTIN for the management of CHRONIC PAIN,CHRONIC PAIN,GABAPENTIN,TWrex-cause
789779031,9/16/2015 21:47:12,1739911270,9/16/2015 21:45:47,False,clixsense,0.6161,20587495,CAN,NL,St. John's,142.162.227.3,GABAPENTIN treats CHRONIC PAIN,47,14,,58,24,treats,0.997458699830735,804182,Tiagabine and GABAPENTIN for the management of CHRONIC PAIN,CHRONIC PAIN,GABAPENTIN,TWrex-cause
789779031,9/16/2015 21:51:24,1739912749,9/16/2015 21:50:19,False,clixsense,0.6548,6363498,USA,GA,Fort Valley,23.125.3.6,GABAPENTIN treats CHRONIC PAIN,47,14,,58,24,treats,0.997458699830735,804182,Tiagabine and GABAPENTIN for the management of CHRONIC PAIN,CHRONIC PAIN,GABAPENTIN,TWrex-cause
789779031,9/16/2015 21:53:28,1739913587,9/16/2015 21:52:58,False,clixsense,0.7222,6340330,USA,NY,Canajoharie,67.248.115.74,GABAPENTIN treats CHRONIC PAIN,47,14,,58,24,treats,0.997458699830735,804182,Tiagabine and GABAPENTIN for the management of CHRONIC PAIN,CHRONIC PAIN,GABAPENTIN,TWrex-cause
789779031,9/16/2015 22:06:58,1739918448,9/16/2015 22:05:48,False,neodev,0.7679,33761260,USA,UT,Providence,206.190.151.208,GABAPENTIN treats CHRONIC PAIN,47,14,,58,24,treats,0.997458699830735,804182,Tiagabine and GABAPENTIN for the management of CHRONIC PAIN,CHRONIC PAIN,GABAPENTIN,TWrex-cause
789779036,9/16/2015 22:12:13,1739920934,9/16/2015 22:10:29,False,neodev,0.7679,33761260,USA,UT,Providence,206.190.151.208,ANTIARRHYTHMIC AGENTS treats DYSRHYTHMIA,0,45,,11,66,treats,0.9958932064677041,907097,"DYSRHYTHMIA should be treated with atropine, ANTIARRHYTHMIC AGENTS, and a temporary pacemaker, in order to avoid lethal results",DYSRHYTHMIA,ANTIARRHYTHMIC AGENTS,RO-may_prevent
789779036,9/16/2015 22:17:23,1739922672,9/16/2015 22:16:36,False,prodege,0.9444,25111984,USA,CO,Denver,75.166.201.119,ANTIARRHYTHMIC AGENTS treats DYSRHYTHMIA,0,45,,11,66,treats,0.9958932064677041,907097,"DYSRHYTHMIA should be treated with atropine, ANTIARRHYTHMIC AGENTS, and a temporary pacemaker, in order to avoid lethal results",DYSRHYTHMIA,ANTIARRHYTHMIC AGENTS,RO-may_prevent
789779036,9/16/2015 22:35:25,1739929642,9/16/2015 22:35:02,False,fusioncash,0.925,31742806,USA,OH,Kent,66.61.82.242,ANTIARRHYTHMIC AGENTS treats DYSRHYTHMIA,0,45,,11,66,treats,0.9958932064677041,907097,"DYSRHYTHMIA should be treated with atropine, ANTIARRHYTHMIC AGENTS, and a temporary pacemaker, in order to avoid lethal results",DYSRHYTHMIA,ANTIARRHYTHMIC AGENTS,RO-may_prevent
789779036,9/16/2015 22:39:47,1739931851,9/16/2015 22:39:15,False,elite,0.9389,32173500,GBR,E4,Rayleigh,90.219.100.52,ANTIARRHYTHMIC AGENTS treats DYSRHYTHMIA,0,45,,11,66,treats,0.9958932064677041,907097,"DYSRHYTHMIA should be treated with atropine, ANTIARRHYTHMIC AGENTS, and a temporary pacemaker, in order to avoid lethal results",DYSRHYTHMIA,ANTIARRHYTHMIC AGENTS,RO-may_prevent
789779036,9/16/2015 22:44:28,1739934360,9/16/2015 22:43:51,False,clixsense,0.7599,6330007,AUS,,,101.178.25.217,ANTIARRHYTHMIC AGENTS treats DYSRHYTHMIA,0,45,,11,66,treats,0.9958932064677041,907097,"DYSRHYTHMIA should be treated with atropine, ANTIARRHYTHMIC AGENTS, and a temporary pacemaker, in order to avoid lethal results",DYSRHYTHMIA,ANTIARRHYTHMIC AGENTS,RO-may_prevent
789779036,9/16/2015 22:44:41,1739934451,9/16/2015 22:43:53,False,clixsense,0.7527,17950689,GBR,L9,Sheffield,146.200.192.103,ANTIARRHYTHMIC AGENTS treats DYSRHYTHMIA,0,45,,11,66,treats,0.9958932064677041,907097,"DYSRHYTHMIA should be treated with atropine, ANTIARRHYTHMIC AGENTS, and a temporary pacemaker, in order to avoid lethal results",DYSRHYTHMIA,ANTIARRHYTHMIC AGENTS,RO-may_prevent
789779036,9/16/2015 22:46:09,1739935303,9/16/2015 22:45:42,False,clixsense,0.9583,6344072,CAN,BC,Burnaby,172.218.166.58,ANTIARRHYTHMIC AGENTS treats DYSRHYTHMIA,0,45,,11,66,treats,0.9958932064677041,907097,"DYSRHYTHMIA should be treated with atropine, ANTIARRHYTHMIC AGENTS, and a temporary pacemaker, in order to avoid lethal results",DYSRHYTHMIA,ANTIARRHYTHMIC AGENTS,RO-may_prevent
789779037,9/17/2015 01:27:29,1739996227,9/17/2015 01:27:17,False,prodege,0.9742,10959404,USA,CA,Studio City,108.217.110.104,AMPHOTERICIN B treats INVASIVE ASPERGILLOSIS,106,76,,127,90,treats,0.9958932064677041,800220,"White MH, Anaissie EJ, Kusne S et al. Amphotericin B colloidal dispersion vsAMPHOTERICIN B as therapy for INVASIVE ASPERGILLOSIS",INVASIVE ASPERGILLOSIS,AMPHOTERICIN B,TWrex-cause
789779037,9/17/2015 01:30:59,1739998765,9/17/2015 01:30:37,False,instagc,0.9722,31184650,USA,IA,Mason City,173.26.179.94,AMPHOTERICIN B treats INVASIVE ASPERGILLOSIS,106,76,,127,90,treats,0.9958932064677041,800220,"White MH, Anaissie EJ, Kusne S et al. Amphotericin B colloidal dispersion vsAMPHOTERICIN B as therapy for INVASIVE ASPERGILLOSIS",INVASIVE ASPERGILLOSIS,AMPHOTERICIN B,TWrex-cause
789779037,9/17/2015 01:32:17,1739999918,9/17/2015 01:31:51,False,instagc,0.8016,31861996,USA,FL,Homestead,73.46.199.178,AMPHOTERICIN B treats INVASIVE ASPERGILLOSIS,106,76,,127,90,treats,0.9958932064677041,800220,"White MH, Anaissie EJ, Kusne S et al. Amphotericin B colloidal dispersion vsAMPHOTERICIN B as therapy for INVASIVE ASPERGILLOSIS",INVASIVE ASPERGILLOSIS,AMPHOTERICIN B,TWrex-cause
789779037,9/17/2015 01:34:41,1740001803,9/17/2015 01:34:06,False,instagc,0.9083,30184706,USA,IA,Council Bluffs,67.3.207.60,AMPHOTERICIN B treats INVASIVE ASPERGILLOSIS,106,76,,127,90,treats,0.9958932064677041,800220,"White MH, Anaissie EJ, Kusne S et al. Amphotericin B colloidal dispersion vsAMPHOTERICIN B as therapy for INVASIVE ASPERGILLOSIS",INVASIVE ASPERGILLOSIS,AMPHOTERICIN B,TWrex-cause
789779037,9/17/2015 01:38:27,1740006356,9/17/2015 01:37:28,False,neodev,0.8389,33801943,USA,CA,San Jose,23.27.220.252,INVASIVE ASPERGILLOSIS treats AMPHOTERICIN B,106,76,,127,90,treats,0.9958932064677041,800220,"White MH, Anaissie EJ, Kusne S et al. Amphotericin B colloidal dispersion vsAMPHOTERICIN B as therapy for INVASIVE ASPERGILLOSIS",INVASIVE ASPERGILLOSIS,AMPHOTERICIN B,TWrex-cause
789779037,9/17/2015 01:57:00,1740022780,9/17/2015 01:56:46,False,bitcoinget,0.6667,31256687,USA,NY,Brooklyn,24.146.181.193,AMPHOTERICIN B treats INVASIVE ASPERGILLOSIS,106,76,,127,90,treats,0.9958932064677041,800220,"White MH, Anaissie EJ, Kusne S et al. Amphotericin B colloidal dispersion vsAMPHOTERICIN B as therapy for INVASIVE ASPERGILLOSIS",INVASIVE ASPERGILLOSIS,AMPHOTERICIN B,TWrex-cause
789779037,9/17/2015 02:04:55,1740029947,9/17/2015 02:03:32,False,instagc,0.8286,19480545,USA,MA,Brookline,209.6.138.58,AMPHOTERICIN B treats INVASIVE ASPERGILLOSIS,106,76,,127,90,treats,0.9958932064677041,800220,"White MH, Anaissie EJ, Kusne S et al. Amphotericin B colloidal dispersion vsAMPHOTERICIN B as therapy for INVASIVE ASPERGILLOSIS",INVASIVE ASPERGILLOSIS,AMPHOTERICIN B,TWrex-cause
789779043,9/16/2015 21:22:07,1739901965,9/16/2015 21:21:51,False,prodege,0.9583,22031444,GBR,F2,Gosport,89.240.162.20,AMPHOTERICIN treats BLASTOMYCOSIS,39,72,,51,84,treats,1.0,803836,423  Blastomycosis  >     Treatment of BLASTOMYCOSIS  IV:  Conventional AMPHOTERICIN B: 0.5 1 mg/kg daily.,BLASTOMYCOSIS,AMPHOTERICIN,TWrex-cause
789779043,9/16/2015 21:38:21,1739907971,9/16/2015 21:38:00,False,pocketmoneygpt,0.7321,21432964,GBR,F8,Borehamwood,81.159.185.70,no_relation,39,72,,51,84,treats,1.0,803836,423  Blastomycosis  >     Treatment of BLASTOMYCOSIS  IV:  Conventional AMPHOTERICIN B: 0.5 1 mg/kg daily.,BLASTOMYCOSIS,AMPHOTERICIN,TWrex-cause
789779043,9/16/2015 21:44:24,1739910340,9/16/2015 21:43:39,False,treasuretrooper,0.85,17956656,AUS,02,Jannali,14.200.59.55,AMPHOTERICIN treats BLASTOMYCOSIS,39,72,,51,84,treats,1.0,803836,423  Blastomycosis  >     Treatment of BLASTOMYCOSIS  IV:  Conventional AMPHOTERICIN B: 0.5 1 mg/kg daily.,BLASTOMYCOSIS,AMPHOTERICIN,TWrex-cause
789779043,9/16/2015 21:47:46,1739911436,9/16/2015 21:47:13,False,clixsense,0.6161,20587495,CAN,NL,St. John's,142.162.227.3,AMPHOTERICIN treats BLASTOMYCOSIS,39,72,,51,84,treats,1.0,803836,423  Blastomycosis  >     Treatment of BLASTOMYCOSIS  IV:  Conventional AMPHOTERICIN B: 0.5 1 mg/kg daily.,BLASTOMYCOSIS,AMPHOTERICIN,TWrex-cause
789779043,9/16/2015 21:52:10,1739912988,9/16/2015 21:51:25,False,clixsense,0.6548,6363498,USA,GA,Fort Valley,23.125.3.6,AMPHOTERICIN treats BLASTOMYCOSIS,39,72,,51,84,treats,1.0,803836,423  Blastomycosis  >     Treatment of BLASTOMYCOSIS  IV:  Conventional AMPHOTERICIN B: 0.5 1 mg/kg daily.,BLASTOMYCOSIS,AMPHOTERICIN,TWrex-cause
789779043,9/16/2015 21:53:44,1739913697,9/16/2015 21:53:29,False,clixsense,0.7222,6340330,USA,NY,Canajoharie,67.248.115.74,AMPHOTERICIN treats BLASTOMYCOSIS,39,72,,51,84,treats,1.0,803836,423  Blastomycosis  >     Treatment of BLASTOMYCOSIS  IV:  Conventional AMPHOTERICIN B: 0.5 1 mg/kg daily.,BLASTOMYCOSIS,AMPHOTERICIN,TWrex-cause
789779043,9/16/2015 22:07:42,1739918849,9/16/2015 22:07:01,False,neodev,0.7679,33761260,USA,UT,Providence,206.190.151.208,AMPHOTERICIN treats BLASTOMYCOSIS,39,72,,51,84,treats,1.0,803836,423  Blastomycosis  >     Treatment of BLASTOMYCOSIS  IV:  Conventional AMPHOTERICIN B: 0.5 1 mg/kg daily.,BLASTOMYCOSIS,AMPHOTERICIN,TWrex-cause
789779046,9/16/2015 23:58:52,1739965416,9/16/2015 23:58:35,False,clixsense,0.8798,33115750,GBR,I3,Rochester,90.222.106.192,[ELECTROCONVULSIVE THERAPY] treats [PSYCHOTIC SYMPTOMS],58,0,,75,24,treats,0.9970544855015809,208303,"[ELECTROCONVULSIVE THERAPY] or ECT has been shown to reduce [PSYCHOTIC SYMPTOMS] associated with schizophrenia, mania, and depression, and is often used in psychiatric hospitals.",[PSYCHOTIC SYMPTOMS],[ELECTROCONVULSIVE THERAPY],TWrex-treat
789779046,9/17/2015 00:17:40,1739970577,9/17/2015 00:17:03,False,neodev,0.8972,33716139,USA,VA,Manassas,207.244.79.146,[ELECTROCONVULSIVE THERAPY] treats [PSYCHOTIC SYMPTOMS],58,0,,75,24,treats,0.9970544855015809,208303,"[ELECTROCONVULSIVE THERAPY] or ECT has been shown to reduce [PSYCHOTIC SYMPTOMS] associated with schizophrenia, mania, and depression, and is often used in psychiatric hospitals.",[PSYCHOTIC SYMPTOMS],[ELECTROCONVULSIVE THERAPY],TWrex-treat
789779046,9/17/2015 00:35:38,1739975702,9/17/2015 00:35:25,False,instagc,0.9365,33058612,USA,IL,Glenview,162.229.106.229,[ELECTROCONVULSIVE THERAPY] treats [PSYCHOTIC SYMPTOMS],58,0,,75,24,treats,0.9970544855015809,208303,"[ELECTROCONVULSIVE THERAPY] or ECT has been shown to reduce [PSYCHOTIC SYMPTOMS] associated with schizophrenia, mania, and depression, and is often used in psychiatric hospitals.",[PSYCHOTIC SYMPTOMS],[ELECTROCONVULSIVE THERAPY],TWrex-treat
789779046,9/17/2015 00:36:32,1739975873,9/17/2015 00:36:08,False,cotter,0.9722,30870494,USA,TX,Houston,99.45.150.123,[ELECTROCONVULSIVE THERAPY] treats [PSYCHOTIC SYMPTOMS],58,0,,75,24,treats,0.9970544855015809,208303,"[ELECTROCONVULSIVE THERAPY] or ECT has been shown to reduce [PSYCHOTIC SYMPTOMS] associated with schizophrenia, mania, and depression, and is often used in psychiatric hospitals.",[PSYCHOTIC SYMPTOMS],[ELECTROCONVULSIVE THERAPY],TWrex-treat
789779046,9/17/2015 00:51:08,1739979048,9/17/2015 00:49:43,False,zoombucks,0.9375,6744840,CAN,BC,Kelowna,174.4.58.160,[ELECTROCONVULSIVE THERAPY] treats [PSYCHOTIC SYMPTOMS],58,0,,75,24,treats,0.9970544855015809,208303,"[ELECTROCONVULSIVE THERAPY] or ECT has been shown to reduce [PSYCHOTIC SYMPTOMS] associated with schizophrenia, mania, and depression, and is often used in psychiatric hospitals.",[PSYCHOTIC SYMPTOMS],[ELECTROCONVULSIVE THERAPY],TWrex-treat
789779046,9/17/2015 00:59:58,1739981347,9/17/2015 00:59:22,False,clixsense,0.8361,26531841,CAN,ON,Toronto,64.231.8.24,[ELECTROCONVULSIVE THERAPY] treats [PSYCHOTIC SYMPTOMS],58,0,,75,24,treats,0.9970544855015809,208303,"[ELECTROCONVULSIVE THERAPY] or ECT has been shown to reduce [PSYCHOTIC SYMPTOMS] associated with schizophrenia, mania, and depression, and is often used in psychiatric hospitals.",[PSYCHOTIC SYMPTOMS],[ELECTROCONVULSIVE THERAPY],TWrex-treat
789779046,9/17/2015 01:14:00,1739987499,9/17/2015 01:13:36,False,prodege,0.9306,13300986,CAN,AB,Edmonton,68.150.40.134,[ELECTROCONVULSIVE THERAPY] treats [PSYCHOTIC SYMPTOMS],58,0,,75,24,treats,0.9970544855015809,208303,"[ELECTROCONVULSIVE THERAPY] or ECT has been shown to reduce [PSYCHOTIC SYMPTOMS] associated with schizophrenia, mania, and depression, and is often used in psychiatric hospitals.",[PSYCHOTIC SYMPTOMS],[ELECTROCONVULSIVE THERAPY],TWrex-treat
789779049,9/16/2015 19:43:36,1739790770,9/16/2015 19:43:14,False,clixsense,0.9722,30681826,GBR,I9,Diss,31.49.71.254,CLOMIPRAMINE treats OBSESSIVE COMPULSIVE DISORDER,95,62,,123,74,treats,1.0,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus CLOMIPRAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER: a multicenter, randomized, double blind, parallel group comparison.",OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE,TWrex-cause
789779049,9/16/2015 19:45:27,1739791771,9/16/2015 19:45:21,False,instagc,0.875,26024737,GBR,A9,Blackpool,92.23.159.7,CLOMIPRAMINE treats OBSESSIVE COMPULSIVE DISORDER,95,62,,123,74,treats,1.0,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus CLOMIPRAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER: a multicenter, randomized, double blind, parallel group comparison.",OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE,TWrex-cause
789779049,9/16/2015 19:46:28,1739792310,9/16/2015 19:45:56,False,clixsense,0.8944,33878524,CAN,BC,Princeton,75.156.83.71,CLOMIPRAMINE treats OBSESSIVE COMPULSIVE DISORDER,95,62,,123,74,treats,1.0,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus CLOMIPRAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER: a multicenter, randomized, double blind, parallel group comparison.",OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE,TWrex-cause
789779049,9/16/2015 19:51:42,1739794865,9/16/2015 19:51:27,False,points4rewards,0.9,20306700,USA,WA,Bothell,50.106.46.70,CLOMIPRAMINE treats OBSESSIVE COMPULSIVE DISORDER,95,62,,123,74,treats,1.0,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus CLOMIPRAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER: a multicenter, randomized, double blind, parallel group comparison.",OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE,TWrex-cause
789779049,9/16/2015 19:52:05,1739795059,9/16/2015 19:51:37,False,neodev,0.8806,30627835,GBR,D8,Bishop Auckland,217.44.84.223,CLOMIPRAMINE treats OBSESSIVE COMPULSIVE DISORDER,95,62,,123,74,treats,1.0,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus CLOMIPRAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER: a multicenter, randomized, double blind, parallel group comparison.",OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE,TWrex-cause
789779049,9/16/2015 19:59:23,1739798626,9/16/2015 19:58:39,False,clixsense,0.8323,21875134,GBR,,,80.189.12.98,CLOMIPRAMINE treats OBSESSIVE COMPULSIVE DISORDER,95,62,,123,74,treats,1.0,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus CLOMIPRAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER: a multicenter, randomized, double blind, parallel group comparison.",OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE,TWrex-cause
789779049,9/16/2015 20:09:11,1739806073,9/16/2015 20:08:39,False,clixsense,0.7877,32053717,GBR,,,51.174.76.80,CLOMIPRAMINE treats OBSESSIVE COMPULSIVE DISORDER,95,62,,123,74,treats,1.0,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus CLOMIPRAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER: a multicenter, randomized, double blind, parallel group comparison.",OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE,TWrex-cause
789779050,9/17/2015 00:36:06,1739975773,9/17/2015 00:35:53,False,instagc,0.9365,33058612,USA,IL,Glenview,162.229.106.229,HUMAN INSULIN treats TYPE 1 DIABETES,132,101,,146,114,treats,0.940720868383597,800279,Glycated hemoglobin (HbA 1c ) was reduced more with short acting insulin analogues than with regular HUMAN INSULIN in patients with TYPE 1 DIABETES; no difference was seen in patients with type 2 diabetes (Table.,TYPE 1 DIABETES,HUMAN INSULIN,TWrex-cause
789779050,9/17/2015 00:37:25,1739976042,9/17/2015 00:37:07,False,cotter,0.9722,30870494,USA,TX,Houston,99.45.150.123,HUMAN INSULIN treats TYPE 1 DIABETES,132,101,,146,114,treats,0.940720868383597,800279,Glycated hemoglobin (HbA 1c ) was reduced more with short acting insulin analogues than with regular HUMAN INSULIN in patients with TYPE 1 DIABETES; no difference was seen in patients with type 2 diabetes (Table.,TYPE 1 DIABETES,HUMAN INSULIN,TWrex-cause
789779050,9/17/2015 00:53:34,1739979604,9/17/2015 00:52:28,False,zoombucks,0.9375,6744840,CAN,BC,Kelowna,174.4.58.160,HUMAN INSULIN treats TYPE 1 DIABETES,132,101,,146,114,treats,0.940720868383597,800279,Glycated hemoglobin (HbA 1c ) was reduced more with short acting insulin analogues than with regular HUMAN INSULIN in patients with TYPE 1 DIABETES; no difference was seen in patients with type 2 diabetes (Table.,TYPE 1 DIABETES,HUMAN INSULIN,TWrex-cause
789779050,9/17/2015 01:01:22,1739981812,9/17/2015 01:00:53,False,clixsense,0.8361,26531841,CAN,ON,Toronto,64.231.8.24,HUMAN INSULIN treats TYPE 1 DIABETES,132,101,,146,114,treats,0.940720868383597,800279,Glycated hemoglobin (HbA 1c ) was reduced more with short acting insulin analogues than with regular HUMAN INSULIN in patients with TYPE 1 DIABETES; no difference was seen in patients with type 2 diabetes (Table.,TYPE 1 DIABETES,HUMAN INSULIN,TWrex-cause
789779050,9/17/2015 01:15:02,1739987987,9/17/2015 01:14:36,False,prodege,0.9306,13300986,CAN,AB,Edmonton,68.150.40.134,HUMAN INSULIN treats TYPE 1 DIABETES,132,101,,146,114,treats,0.940720868383597,800279,Glycated hemoglobin (HbA 1c ) was reduced more with short acting insulin analogues than with regular HUMAN INSULIN in patients with TYPE 1 DIABETES; no difference was seen in patients with type 2 diabetes (Table.,TYPE 1 DIABETES,HUMAN INSULIN,TWrex-cause
789779050,9/17/2015 01:20:33,1739991369,9/17/2015 01:19:42,False,elite,0.9071,33251186,USA,MA,Swampscott,207.244.83.216,HUMAN INSULIN treats TYPE 1 DIABETES,132,101,,146,114,treats,0.940720868383597,800279,Glycated hemoglobin (HbA 1c ) was reduced more with short acting insulin analogues than with regular HUMAN INSULIN in patients with TYPE 1 DIABETES; no difference was seen in patients with type 2 diabetes (Table.,TYPE 1 DIABETES,HUMAN INSULIN,TWrex-cause
789779050,9/17/2015 01:26:44,1739995748,9/17/2015 01:25:08,False,instagc,0.8016,31861996,USA,FL,Homestead,73.46.199.178,no_relation,132,101,,146,114,treats,0.940720868383597,800279,Glycated hemoglobin (HbA 1c ) was reduced more with short acting insulin analogues than with regular HUMAN INSULIN in patients with TYPE 1 DIABETES; no difference was seen in patients with type 2 diabetes (Table.,TYPE 1 DIABETES,HUMAN INSULIN,TWrex-cause
789779054,9/17/2015 00:36:18,1739975836,9/17/2015 00:36:07,False,instagc,0.9365,33058612,USA,IL,Glenview,162.229.106.229,ASPIRIN treats MYOCARDIAL INFARCTION,79,42,,99,49,treats,0.971285862357264,804205,2005 03 24     Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.,MYOCARDIAL INFARCTION,ASPIRIN,TWrex-cause
789779054,9/17/2015 00:37:43,1739976102,9/17/2015 00:37:26,False,cotter,0.9722,30870494,USA,TX,Houston,99.45.150.123,ASPIRIN treats MYOCARDIAL INFARCTION,79,42,,99,49,treats,0.971285862357264,804205,2005 03 24     Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.,MYOCARDIAL INFARCTION,ASPIRIN,TWrex-cause
789779054,9/17/2015 00:54:43,1739979894,9/17/2015 00:53:36,False,zoombucks,0.9375,6744840,CAN,BC,Kelowna,174.4.58.160,ASPIRIN treats MYOCARDIAL INFARCTION,79,42,,99,49,treats,0.971285862357264,804205,2005 03 24     Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.,MYOCARDIAL INFARCTION,ASPIRIN,TWrex-cause
789779054,9/17/2015 01:01:38,1739981923,9/17/2015 01:01:22,False,clixsense,0.8361,26531841,CAN,ON,Toronto,64.231.8.24,ASPIRIN treats MYOCARDIAL INFARCTION,79,42,,99,49,treats,0.971285862357264,804205,2005 03 24     Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.,MYOCARDIAL INFARCTION,ASPIRIN,TWrex-cause
789779054,9/17/2015 01:15:22,1739988131,9/17/2015 01:15:03,False,prodege,0.9306,13300986,CAN,AB,Edmonton,68.150.40.134,ASPIRIN treats MYOCARDIAL INFARCTION,79,42,,99,49,treats,0.971285862357264,804205,2005 03 24     Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.,MYOCARDIAL INFARCTION,ASPIRIN,TWrex-cause
789779054,9/17/2015 01:21:09,1739991734,9/17/2015 01:20:35,False,elite,0.9071,33251186,USA,DE,Wilmington,199.115.114.229,ASPIRIN treats MYOCARDIAL INFARCTION,79,42,,99,49,treats,0.971285862357264,804205,2005 03 24     Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.,MYOCARDIAL INFARCTION,ASPIRIN,TWrex-cause
789779054,9/17/2015 01:25:56,1739995183,9/17/2015 01:25:35,False,prodege,0.9742,10959404,USA,CA,Studio City,108.217.110.104,ASPIRIN treats MYOCARDIAL INFARCTION,79,42,,99,49,treats,0.971285862357264,804205,2005 03 24     Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.,MYOCARDIAL INFARCTION,ASPIRIN,TWrex-cause
789779055,9/16/2015 20:32:36,1739848645,9/16/2015 20:32:28,False,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,BLEOMYCIN treats HODGKIN'S DISEASE,136,106,,152,115,treats,0.99654575824488,800855,"Wiernik PH, Longo D, Duffey PL et al. MOPP vs. MOPP alternating with streptozotocin, CCNU, adriamycin and BLEOMYCIN (SCAB) for advanced HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN,TWrex-cause
789779055,9/16/2015 20:32:56,1739849198,9/16/2015 20:32:23,False,prodege,0.8809999999999999,21417560,GBR,C3,Cambridge,151.224.120.191,BLEOMYCIN treats HODGKIN'S DISEASE,136,106,,152,115,treats,0.99654575824488,800855,"Wiernik PH, Longo D, Duffey PL et al. MOPP vs. MOPP alternating with streptozotocin, CCNU, adriamycin and BLEOMYCIN (SCAB) for advanced HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN,TWrex-cause
789779055,9/16/2015 20:35:06,1739852366,9/16/2015 20:34:53,False,instagc,1.0,16469970,USA,OK,Broken Arrow,72.192.89.181,BLEOMYCIN treats HODGKIN'S DISEASE,136,106,,152,115,treats,0.99654575824488,800855,"Wiernik PH, Longo D, Duffey PL et al. MOPP vs. MOPP alternating with streptozotocin, CCNU, adriamycin and BLEOMYCIN (SCAB) for advanced HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN,TWrex-cause
789779055,9/16/2015 20:36:15,1739854412,9/16/2015 20:35:51,False,cotter,0.9504,34377132,USA,OH,Athens,107.10.138.13,BLEOMYCIN treats HODGKIN'S DISEASE,136,106,,152,115,treats,0.99654575824488,800855,"Wiernik PH, Longo D, Duffey PL et al. MOPP vs. MOPP alternating with streptozotocin, CCNU, adriamycin and BLEOMYCIN (SCAB) for advanced HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN,TWrex-cause
789779055,9/16/2015 20:39:47,1739861201,9/16/2015 20:31:41,False,prodege,0.7857,20693658,USA,WI,Chippewa Falls,75.105.241.192,BLEOMYCIN treats HODGKIN'S DISEASE,136,106,,152,115,treats,0.99654575824488,800855,"Wiernik PH, Longo D, Duffey PL et al. MOPP vs. MOPP alternating with streptozotocin, CCNU, adriamycin and BLEOMYCIN (SCAB) for advanced HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN,TWrex-cause
789779055,9/16/2015 20:42:35,1739864910,9/16/2015 20:41:57,False,neodev,0.6377,18881135,CAN,ON,Ajax,99.243.87.224,BLEOMYCIN treats HODGKIN'S DISEASE,136,106,,152,115,treats,0.99654575824488,800855,"Wiernik PH, Longo D, Duffey PL et al. MOPP vs. MOPP alternating with streptozotocin, CCNU, adriamycin and BLEOMYCIN (SCAB) for advanced HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN,TWrex-cause
789779055,9/16/2015 20:51:51,1739875469,9/16/2015 20:51:04,False,neodev,0.6022,33701549,USA,CA,Torrance,66.171.228.172,BLEOMYCIN treats HODGKIN'S DISEASE,136,106,,152,115,treats,0.99654575824488,800855,"Wiernik PH, Longo D, Duffey PL et al. MOPP vs. MOPP alternating with streptozotocin, CCNU, adriamycin and BLEOMYCIN (SCAB) for advanced HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN,TWrex-cause
789779056,9/16/2015 21:22:40,1739902133,9/16/2015 21:22:09,False,prodege,0.9583,22031444,GBR,F2,Gosport,89.240.162.20,ISONIAZID treats TUBERCULOSIS,112,128,,123,137,treats,0.9036961141150641,907365,"After an outbreak of hepatitis in Washington, D.C. in 1970 among a group of persons taking isoniazid to prevent TUBERCULOSIS an ISONIAZID surveillance study was conducted among 13,838 persons in 21 participating health departments.",TUBERCULOSIS,ISONIAZID,RO-may_prevent
789779056,9/16/2015 21:44:46,1739910505,9/16/2015 21:44:26,False,treasuretrooper,0.85,17956656,AUS,02,Jannali,14.200.59.55,ISONIAZID treats TUBERCULOSIS,112,128,,123,137,treats,0.9036961141150641,907365,"After an outbreak of hepatitis in Washington, D.C. in 1970 among a group of persons taking isoniazid to prevent TUBERCULOSIS an ISONIAZID surveillance study was conducted among 13,838 persons in 21 participating health departments.",TUBERCULOSIS,ISONIAZID,RO-may_prevent
789779056,9/16/2015 21:48:14,1739911661,9/16/2015 21:47:53,False,clixsense,0.6161,20587495,CAN,NL,St. John's,142.162.227.3,ISONIAZID treats TUBERCULOSIS,112,128,,123,137,treats,0.9036961141150641,907365,"After an outbreak of hepatitis in Washington, D.C. in 1970 among a group of persons taking isoniazid to prevent TUBERCULOSIS an ISONIAZID surveillance study was conducted among 13,838 persons in 21 participating health departments.",TUBERCULOSIS,ISONIAZID,RO-may_prevent
789779056,9/16/2015 21:53:56,1739913756,9/16/2015 21:53:45,False,clixsense,0.7222,6340330,USA,NY,Canajoharie,67.248.115.74,ISONIAZID treats TUBERCULOSIS,112,128,,123,137,treats,0.9036961141150641,907365,"After an outbreak of hepatitis in Washington, D.C. in 1970 among a group of persons taking isoniazid to prevent TUBERCULOSIS an ISONIAZID surveillance study was conducted among 13,838 persons in 21 participating health departments.",TUBERCULOSIS,ISONIAZID,RO-may_prevent
789779056,9/16/2015 21:54:46,1739914032,9/16/2015 21:52:11,False,clixsense,0.6548,6363498,USA,GA,Fort Valley,23.125.3.6,no_relation,112,128,,123,137,treats,0.9036961141150641,907365,"After an outbreak of hepatitis in Washington, D.C. in 1970 among a group of persons taking isoniazid to prevent TUBERCULOSIS an ISONIAZID surveillance study was conducted among 13,838 persons in 21 participating health departments.",TUBERCULOSIS,ISONIAZID,RO-may_prevent
789779056,9/16/2015 22:08:34,1739919320,9/16/2015 22:07:44,False,neodev,0.7679,33761260,USA,UT,Providence,206.190.151.208,TUBERCULOSIS treats ISONIAZID,112,128,,123,137,treats,0.9036961141150641,907365,"After an outbreak of hepatitis in Washington, D.C. in 1970 among a group of persons taking isoniazid to prevent TUBERCULOSIS an ISONIAZID surveillance study was conducted among 13,838 persons in 21 participating health departments.",TUBERCULOSIS,ISONIAZID,RO-may_prevent
789779056,9/16/2015 22:08:35,1739919344,9/16/2015 22:07:43,False,neodev,0.7119,32424428,USA,VA,Manassas,207.244.76.210,ISONIAZID treats TUBERCULOSIS,112,128,,123,137,treats,0.9036961141150641,907365,"After an outbreak of hepatitis in Washington, D.C. in 1970 among a group of persons taking isoniazid to prevent TUBERCULOSIS an ISONIAZID surveillance study was conducted among 13,838 persons in 21 participating health departments.",TUBERCULOSIS,ISONIAZID,RO-may_prevent
789779066,9/16/2015 19:43:14,1739790611,9/16/2015 19:42:28,False,clixsense,0.9722,30681826,GBR,I9,Diss,31.49.71.254,COTRIMOXAZOLE treats MELIOIDOSIS,43,25,,54,38,treats,0.9918365981341751,216644,title=Dosing regimens of [COTRIMOXAZOLE] for [MELIOIDOSIS].,MELIOIDOSIS,COTRIMOXAZOLE,TWrex-treat
789779066,9/16/2015 19:45:20,1739791711,9/16/2015 19:45:01,False,instagc,0.875,26024737,GBR,A9,Blackpool,92.23.159.7,COTRIMOXAZOLE treats MELIOIDOSIS,43,25,,54,38,treats,0.9918365981341751,216644,title=Dosing regimens of [COTRIMOXAZOLE] for [MELIOIDOSIS].,MELIOIDOSIS,COTRIMOXAZOLE,TWrex-treat
789779066,9/16/2015 19:45:55,1739791969,9/16/2015 19:42:58,False,clixsense,0.8944,33878524,CAN,BC,Princeton,75.156.83.71,COTRIMOXAZOLE treats MELIOIDOSIS,43,25,,54,38,treats,0.9918365981341751,216644,title=Dosing regimens of [COTRIMOXAZOLE] for [MELIOIDOSIS].,MELIOIDOSIS,COTRIMOXAZOLE,TWrex-treat
789779066,9/16/2015 19:51:25,1739794698,9/16/2015 19:50:59,False,points4rewards,0.9,20306700,USA,WA,Bothell,50.106.46.70,COTRIMOXAZOLE treats MELIOIDOSIS,43,25,,54,38,treats,0.9918365981341751,216644,title=Dosing regimens of [COTRIMOXAZOLE] for [MELIOIDOSIS].,MELIOIDOSIS,COTRIMOXAZOLE,TWrex-treat
789779066,9/16/2015 19:51:35,1739794786,9/16/2015 19:51:09,False,neodev,0.8806,30627835,GBR,D8,Bishop Auckland,217.44.84.223,COTRIMOXAZOLE treats MELIOIDOSIS,43,25,,54,38,treats,0.9918365981341751,216644,title=Dosing regimens of [COTRIMOXAZOLE] for [MELIOIDOSIS].,MELIOIDOSIS,COTRIMOXAZOLE,TWrex-treat
789779066,9/16/2015 19:57:17,1739797742,9/16/2015 19:56:39,False,neodev,0.7,30588889,NLD,07,Amsterdam,77.248.175.222,COTRIMOXAZOLE treats MELIOIDOSIS,43,25,,54,38,treats,0.9918365981341751,216644,title=Dosing regimens of [COTRIMOXAZOLE] for [MELIOIDOSIS].,MELIOIDOSIS,COTRIMOXAZOLE,TWrex-treat
789779066,9/16/2015 19:58:37,1739798304,9/16/2015 19:56:06,False,clixsense,0.8323,21875134,GBR,,,80.189.12.98,COTRIMOXAZOLE treats MELIOIDOSIS,43,25,,54,38,treats,0.9918365981341751,216644,title=Dosing regimens of [COTRIMOXAZOLE] for [MELIOIDOSIS].,MELIOIDOSIS,COTRIMOXAZOLE,TWrex-treat
789779076,9/16/2015 20:33:44,1739850143,9/16/2015 20:32:59,False,prodege,0.8809999999999999,21417560,GBR,C3,Cambridge,151.224.120.191,FLUTAMIDE treats HIRSUTISM,167,65,,176,74,treats,0.9897433186107869,907497,17of 18 women with hirsutism treated with combination therapy of FLUTAMIDE 250 mg twice daily and an oral contraceptive pill had a rapid and marked reduction in their HIRSUTISM score.,HIRSUTISM,FLUTAMIDE,RO-may_treat
789779076,9/16/2015 20:36:00,1739853927,9/16/2015 20:35:21,False,instagc,1.0,16469970,USA,OK,Broken Arrow,72.192.89.181,FLUTAMIDE treats HIRSUTISM,167,65,,176,74,treats,0.9897433186107869,907497,17of 18 women with hirsutism treated with combination therapy of FLUTAMIDE 250 mg twice daily and an oral contraceptive pill had a rapid and marked reduction in their HIRSUTISM score.,HIRSUTISM,FLUTAMIDE,RO-may_treat
789779076,9/16/2015 20:37:42,1739857019,9/16/2015 20:36:25,False,cotter,0.9504,34377132,USA,OH,Athens,107.10.138.13,FLUTAMIDE treats HIRSUTISM,167,65,,176,74,treats,0.9897433186107869,907497,17of 18 women with hirsutism treated with combination therapy of FLUTAMIDE 250 mg twice daily and an oral contraceptive pill had a rapid and marked reduction in their HIRSUTISM score.,HIRSUTISM,FLUTAMIDE,RO-may_treat
789779076,9/16/2015 20:51:45,1739875386,9/16/2015 20:51:07,False,points4rewards,0.6937,20113482,USA,PA,Philadelphia,162.208.49.45,FLUTAMIDE treats HIRSUTISM,167,65,,176,74,treats,0.9897433186107869,907497,17of 18 women with hirsutism treated with combination therapy of FLUTAMIDE 250 mg twice daily and an oral contraceptive pill had a rapid and marked reduction in their HIRSUTISM score.,HIRSUTISM,FLUTAMIDE,RO-may_treat
789779076,9/16/2015 20:52:51,1739876403,9/16/2015 20:51:53,False,neodev,0.6022,33701549,USA,CA,Torrance,66.171.228.172,FLUTAMIDE treats HIRSUTISM,167,65,,176,74,treats,0.9897433186107869,907497,17of 18 women with hirsutism treated with combination therapy of FLUTAMIDE 250 mg twice daily and an oral contraceptive pill had a rapid and marked reduction in their HIRSUTISM score.,HIRSUTISM,FLUTAMIDE,RO-may_treat
789779076,9/16/2015 20:55:14,1739878732,9/16/2015 20:54:57,False,prodege,0.8395,3587109,CAN,NS,Havre Boucher,142.166.204.244,FLUTAMIDE treats HIRSUTISM,167,65,,176,74,treats,0.9897433186107869,907497,17of 18 women with hirsutism treated with combination therapy of FLUTAMIDE 250 mg twice daily and an oral contraceptive pill had a rapid and marked reduction in their HIRSUTISM score.,HIRSUTISM,FLUTAMIDE,RO-may_treat
789779076,9/16/2015 20:56:59,1739880379,9/16/2015 20:56:40,False,bitcoinget,0.8659,21743413,USA,WA,Port Angeles,24.113.29.97,FLUTAMIDE treats HIRSUTISM,167,65,,176,74,treats,0.9897433186107869,907497,17of 18 women with hirsutism treated with combination therapy of FLUTAMIDE 250 mg twice daily and an oral contraceptive pill had a rapid and marked reduction in their HIRSUTISM score.,HIRSUTISM,FLUTAMIDE,RO-may_treat
789779077,9/17/2015 01:31:29,1739999214,9/17/2015 01:31:19,False,instagc,0.9722,31184650,USA,IA,Mason City,173.26.179.94,FLUCONAZOLE treats RECURRENT VULVOVAGINAL CANDIDIASIS,114,90,,147,101,treats,0.99654575824488,803460,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance FLUCONAZOLE therapy for RECURRENT VULVOVAGINAL CANDIDIASIS",RECURRENT VULVOVAGINAL CANDIDIASIS,FLUCONAZOLE,TWrex-cause
789779077,9/17/2015 01:35:40,1740002633,9/17/2015 01:35:15,False,instagc,0.9083,30184706,USA,IA,Council Bluffs,67.3.207.60,FLUCONAZOLE treats RECURRENT VULVOVAGINAL CANDIDIASIS,114,90,,147,101,treats,0.99654575824488,803460,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance FLUCONAZOLE therapy for RECURRENT VULVOVAGINAL CANDIDIASIS",RECURRENT VULVOVAGINAL CANDIDIASIS,FLUCONAZOLE,TWrex-cause
789779077,9/17/2015 01:40:16,1740007993,9/17/2015 01:39:48,False,neodev,0.8389,33801943,USA,CA,San Jose,23.27.220.252,FLUCONAZOLE treats RECURRENT VULVOVAGINAL CANDIDIASIS,114,90,,147,101,treats,0.99654575824488,803460,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance FLUCONAZOLE therapy for RECURRENT VULVOVAGINAL CANDIDIASIS",RECURRENT VULVOVAGINAL CANDIDIASIS,FLUCONAZOLE,TWrex-cause
789779077,9/17/2015 02:06:58,1740031834,9/17/2015 02:06:35,False,instagc,0.8646,27914150,USA,AZ,Prescott,67.61.150.50,FLUCONAZOLE treats RECURRENT VULVOVAGINAL CANDIDIASIS,114,90,,147,101,treats,0.99654575824488,803460,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance FLUCONAZOLE therapy for RECURRENT VULVOVAGINAL CANDIDIASIS",RECURRENT VULVOVAGINAL CANDIDIASIS,FLUCONAZOLE,TWrex-cause
789779077,9/17/2015 02:15:21,1740039784,9/17/2015 02:15:07,False,zoombucks,0.8857,4688131,CAN,BC,Vancouver,75.157.35.92,FLUCONAZOLE treats RECURRENT VULVOVAGINAL CANDIDIASIS,114,90,,147,101,treats,0.99654575824488,803460,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance FLUCONAZOLE therapy for RECURRENT VULVOVAGINAL CANDIDIASIS",RECURRENT VULVOVAGINAL CANDIDIASIS,FLUCONAZOLE,TWrex-cause
789779077,9/17/2015 02:17:11,1740041611,9/17/2015 02:15:56,False,clixsense,0.9722,33797413,USA,MS,Carthage,162.228.154.80,FLUCONAZOLE treats RECURRENT VULVOVAGINAL CANDIDIASIS,114,90,,147,101,treats,0.99654575824488,803460,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance FLUCONAZOLE therapy for RECURRENT VULVOVAGINAL CANDIDIASIS",RECURRENT VULVOVAGINAL CANDIDIASIS,FLUCONAZOLE,TWrex-cause
789779077,9/17/2015 02:21:43,1740046951,9/17/2015 02:21:18,False,prodege,1.0,9559045,USA,TX,Katy,107.204.185.88,FLUCONAZOLE treats RECURRENT VULVOVAGINAL CANDIDIASIS,114,90,,147,101,treats,0.99654575824488,803460,"1]  Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance FLUCONAZOLE therapy for RECURRENT VULVOVAGINAL CANDIDIASIS",RECURRENT VULVOVAGINAL CANDIDIASIS,FLUCONAZOLE,TWrex-cause
789779078,9/16/2015 21:21:26,1739901697,9/16/2015 21:21:01,False,prodege,0.9583,22031444,GBR,F2,Gosport,89.240.162.20,no_relation,86,0,,105,6,treats,0.99124070716193,207681,[ZOLINZA] was recently shown to have both in vitro and in vivo effects against latently [HIV INFECTED T CELLS].,[HIV INFECTED T CELLS],[ZOLINZA],TWrex-treat
789779078,9/16/2015 21:37:27,1739907630,9/16/2015 21:36:55,False,pocketmoneygpt,0.7321,21432964,GBR,F8,Borehamwood,81.159.185.70,[ZOLINZA] treats [HIV INFECTED T CELLS],86,0,,105,6,treats,0.99124070716193,207681,[ZOLINZA] was recently shown to have both in vitro and in vivo effects against latently [HIV INFECTED T CELLS].,[HIV INFECTED T CELLS],[ZOLINZA],TWrex-treat
789779078,9/16/2015 21:42:12,1739909421,9/16/2015 21:41:38,False,treasuretrooper,0.85,17956656,AUS,02,Jannali,14.200.59.55,no_relation,86,0,,105,6,treats,0.99124070716193,207681,[ZOLINZA] was recently shown to have both in vitro and in vivo effects against latently [HIV INFECTED T CELLS].,[HIV INFECTED T CELLS],[ZOLINZA],TWrex-treat
789779078,9/16/2015 21:45:45,1739910807,9/16/2015 21:45:21,False,clixsense,0.6161,20587495,CAN,NL,St. John's,142.162.227.3,[ZOLINZA] treats [HIV INFECTED T CELLS],86,0,,105,6,treats,0.99124070716193,207681,[ZOLINZA] was recently shown to have both in vitro and in vivo effects against latently [HIV INFECTED T CELLS].,[HIV INFECTED T CELLS],[ZOLINZA],TWrex-treat
789779078,9/16/2015 21:50:18,1739912385,9/16/2015 21:49:03,False,clixsense,0.6548,6363498,USA,GA,Fort Valley,23.125.3.6,[ZOLINZA] treats [HIV INFECTED T CELLS],86,0,,105,6,treats,0.99124070716193,207681,[ZOLINZA] was recently shown to have both in vitro and in vivo effects against latently [HIV INFECTED T CELLS].,[HIV INFECTED T CELLS],[ZOLINZA],TWrex-treat
789779078,9/16/2015 21:52:57,1739913390,9/16/2015 21:52:39,False,clixsense,0.7222,6340330,USA,NY,Canajoharie,67.248.115.74,[ZOLINZA] treats [HIV INFECTED T CELLS],86,0,,105,6,treats,0.99124070716193,207681,[ZOLINZA] was recently shown to have both in vitro and in vivo effects against latently [HIV INFECTED T CELLS].,[HIV INFECTED T CELLS],[ZOLINZA],TWrex-treat
789779078,9/16/2015 22:07:42,1739918842,9/16/2015 22:04:56,False,neodev,0.7119,32424428,USA,VA,Manassas,207.244.76.210,[ZOLINZA] treats [HIV INFECTED T CELLS],86,0,,105,6,treats,0.99124070716193,207681,[ZOLINZA] was recently shown to have both in vitro and in vivo effects against latently [HIV INFECTED T CELLS].,[HIV INFECTED T CELLS],[ZOLINZA],TWrex-treat
789779089,9/16/2015 20:14:04,1739811060,9/16/2015 20:13:51,False,neodev,0.8809999999999999,20306047,GBR,,,80.41.0.252,IRBESARTAN treats TYPE II DIABETES,86,0,,102,10,treats,0.9931270663228421,219147,"[IRBESARTAN] and losartan have trial data showing benefit in hypertensive patients with [TYPE II DIABETES], and may delay the progression of diabetic nephropathy.",TYPE II DIABETES,IRBESARTAN,TWrex-treat
789779089,9/16/2015 20:19:07,1739819844,9/16/2015 20:18:42,False,clixsense,0.9583,31304413,CAN,BC,Kelowna,66.183.36.177,IRBESARTAN treats TYPE II DIABETES,86,0,,102,10,treats,0.9931270663228421,219147,"[IRBESARTAN] and losartan have trial data showing benefit in hypertensive patients with [TYPE II DIABETES], and may delay the progression of diabetic nephropathy.",TYPE II DIABETES,IRBESARTAN,TWrex-treat
789779089,9/16/2015 20:21:14,1739824667,9/16/2015 20:20:57,False,elite,0.8889,31883685,GBR,,,79.66.244.188,IRBESARTAN treats TYPE II DIABETES,86,0,,102,10,treats,0.9931270663228421,219147,"[IRBESARTAN] and losartan have trial data showing benefit in hypertensive patients with [TYPE II DIABETES], and may delay the progression of diabetic nephropathy.",TYPE II DIABETES,IRBESARTAN,TWrex-treat
789779089,9/16/2015 20:27:35,1739837451,9/16/2015 20:27:25,False,instagc,0.8290000000000001,15577915,USA,IL,Trenton,208.70.36.12,IRBESARTAN treats TYPE II DIABETES,86,0,,102,10,treats,0.9931270663228421,219147,"[IRBESARTAN] and losartan have trial data showing benefit in hypertensive patients with [TYPE II DIABETES], and may delay the progression of diabetic nephropathy.",TYPE II DIABETES,IRBESARTAN,TWrex-treat
789779089,9/16/2015 20:28:05,1739838467,9/16/2015 20:27:40,False,neodev,0.6956,33644825,USA,FL,Fort Lauderdale,65.111.173.161,IRBESARTAN treats TYPE II DIABETES,86,0,,102,10,treats,0.9931270663228421,219147,"[IRBESARTAN] and losartan have trial data showing benefit in hypertensive patients with [TYPE II DIABETES], and may delay the progression of diabetic nephropathy.",TYPE II DIABETES,IRBESARTAN,TWrex-treat
789779089,9/16/2015 20:28:59,1739840649,9/16/2015 20:27:14,False,clixsense,0.5306,32916182,GBR,L9,Sheffield,5.81.109.21,no_relation,86,0,,102,10,treats,0.9931270663228421,219147,"[IRBESARTAN] and losartan have trial data showing benefit in hypertensive patients with [TYPE II DIABETES], and may delay the progression of diabetic nephropathy.",TYPE II DIABETES,IRBESARTAN,TWrex-treat
789779089,9/16/2015 20:30:20,1739844100,9/16/2015 20:29:51,False,prodege,0.8809999999999999,21417560,GBR,C3,Cambridge,151.224.120.191,IRBESARTAN treats TYPE II DIABETES,86,0,,102,10,treats,0.9931270663228421,219147,"[IRBESARTAN] and losartan have trial data showing benefit in hypertensive patients with [TYPE II DIABETES], and may delay the progression of diabetic nephropathy.",TYPE II DIABETES,IRBESARTAN,TWrex-treat
789779091,9/16/2015 19:46:01,1739792008,9/16/2015 19:45:08,False,clixsense,0.9722,30681826,GBR,I9,Diss,31.49.71.254,no_relation,5,5,,26,16,treats,0.406138466053448,810875,100  CLOSTRIDIUM INFECTIONS  Treatment of infections caused by  CLOSTRIDIUM,CLOSTRIDIUM INFECTIONS,CLOSTRIDIUM,TWrex-cause
789779091,9/16/2015 19:53:21,1739795607,9/16/2015 19:52:50,False,neodev,0.8806,30627835,GBR,D8,Bishop Auckland,217.44.84.223,CLOSTRIDIUM treats CLOSTRIDIUM INFECTIONS,5,5,,26,16,treats,0.406138466053448,810875,100  CLOSTRIDIUM INFECTIONS  Treatment of infections caused by  CLOSTRIDIUM,CLOSTRIDIUM INFECTIONS,CLOSTRIDIUM,TWrex-cause
789779091,9/16/2015 19:56:09,1739797045,9/16/2015 19:51:26,False,clixsense,0.8944,33878524,CAN,BC,Princeton,75.156.83.71,no_relation,5,5,,26,16,treats,0.406138466053448,810875,100  CLOSTRIDIUM INFECTIONS  Treatment of infections caused by  CLOSTRIDIUM,CLOSTRIDIUM INFECTIONS,CLOSTRIDIUM,TWrex-cause
789779091,9/16/2015 20:05:39,1739802399,9/16/2015 20:04:41,False,clixsense,0.8323,21875134,GBR,,,80.189.12.98,no_relation,5,5,,26,16,treats,0.406138466053448,810875,100  CLOSTRIDIUM INFECTIONS  Treatment of infections caused by  CLOSTRIDIUM,CLOSTRIDIUM INFECTIONS,CLOSTRIDIUM,TWrex-cause
789779091,9/16/2015 20:10:04,1739807103,9/16/2015 20:09:54,False,tremorgames,0.4583,24449707,CAN,QC,Laval,96.20.14.148,no_relation,5,5,,26,16,treats,0.406138466053448,810875,100  CLOSTRIDIUM INFECTIONS  Treatment of infections caused by  CLOSTRIDIUM,CLOSTRIDIUM INFECTIONS,CLOSTRIDIUM,TWrex-cause
789779091,9/16/2015 20:10:56,1739807939,9/16/2015 20:10:16,False,clixsense,0.7877,32053717,GBR,,,51.174.76.80,CLOSTRIDIUM treats CLOSTRIDIUM INFECTIONS,5,5,,26,16,treats,0.406138466053448,810875,100  CLOSTRIDIUM INFECTIONS  Treatment of infections caused by  CLOSTRIDIUM,CLOSTRIDIUM INFECTIONS,CLOSTRIDIUM,TWrex-cause
789779091,9/16/2015 20:12:58,1739809857,9/16/2015 20:12:29,False,neodev,0.8809999999999999,20306047,GBR,,,80.41.0.252,no_relation,5,5,,26,16,treats,0.406138466053448,810875,100  CLOSTRIDIUM INFECTIONS  Treatment of infections caused by  CLOSTRIDIUM,CLOSTRIDIUM INFECTIONS,CLOSTRIDIUM,TWrex-cause
789779095,9/16/2015 21:20:50,1739901482,9/16/2015 21:20:28,False,prodege,0.9583,22031444,GBR,F2,Gosport,89.240.162.20,no_relation,46,80,,54,96,treats,0.7624928516630229,803215, Methimazole and carbimazole are used during PREGNANCY in many countries where PROPYLTHIOURACIL is not commercially available ( 25.,PREGNANCY,PROPYLTHIOURACIL,TWrex-cause
789779095,9/16/2015 21:36:54,1739907423,9/16/2015 21:36:01,False,pocketmoneygpt,0.7321,21432964,GBR,F8,Borehamwood,81.159.185.70,no_relation,46,80,,54,96,treats,0.7624928516630229,803215, Methimazole and carbimazole are used during PREGNANCY in many countries where PROPYLTHIOURACIL is not commercially available ( 25.,PREGNANCY,PROPYLTHIOURACIL,TWrex-cause
789779095,9/16/2015 21:41:35,1739909182,9/16/2015 21:41:09,False,treasuretrooper,0.85,17956656,AUS,02,Jannali,14.200.59.55,no_relation,46,80,,54,96,treats,0.7624928516630229,803215, Methimazole and carbimazole are used during PREGNANCY in many countries where PROPYLTHIOURACIL is not commercially available ( 25.,PREGNANCY,PROPYLTHIOURACIL,TWrex-cause
789779095,9/16/2015 21:45:19,1739910662,9/16/2015 21:44:43,False,clixsense,0.6161,20587495,CAN,NL,St. John's,142.162.227.3,PROPYLTHIOURACIL treats PREGNANCY,46,80,,54,96,treats,0.7624928516630229,803215, Methimazole and carbimazole are used during PREGNANCY in many countries where PROPYLTHIOURACIL is not commercially available ( 25.,PREGNANCY,PROPYLTHIOURACIL,TWrex-cause
789779095,9/16/2015 21:49:02,1739911958,9/16/2015 21:47:55,False,clixsense,0.6548,6363498,USA,GA,Fort Valley,23.125.3.6,no_relation,46,80,,54,96,treats,0.7624928516630229,803215, Methimazole and carbimazole are used during PREGNANCY in many countries where PROPYLTHIOURACIL is not commercially available ( 25.,PREGNANCY,PROPYLTHIOURACIL,TWrex-cause
789779095,9/16/2015 21:52:38,1739913258,9/16/2015 21:52:13,False,clixsense,0.7222,6340330,USA,NY,Canajoharie,67.248.115.74,PROPYLTHIOURACIL treats PREGNANCY,46,80,,54,96,treats,0.7624928516630229,803215, Methimazole and carbimazole are used during PREGNANCY in many countries where PROPYLTHIOURACIL is not commercially available ( 25.,PREGNANCY,PROPYLTHIOURACIL,TWrex-cause
789779095,9/16/2015 22:04:54,1739917529,9/16/2015 22:02:48,False,neodev,0.7119,32424428,USA,VA,Manassas,207.244.76.210,PROPYLTHIOURACIL treats PREGNANCY,46,80,,54,96,treats,0.7624928516630229,803215, Methimazole and carbimazole are used during PREGNANCY in many countries where PROPYLTHIOURACIL is not commercially available ( 25.,PREGNANCY,PROPYLTHIOURACIL,TWrex-cause
789779106,9/16/2015 22:20:13,1739923668,9/16/2015 22:18:58,False,prodege,0.9444,25111984,USA,CO,Denver,75.166.201.119,VINCRISTINE treats HODGKIN'S DISEASE,56,128,,72,139,treats,1.0,908106,"Seventy six patients with previously untreated advanced HODGKIN'S DISEASE have been treated with the MOPP/ABV (mechlorethamine, VINCRISTINE procarbazine, prednisone/doxorubicin, bleomycin, vincristine) hybrid program.",HODGKIN'S DISEASE,VINCRISTINE,RO-may_treat
789779106,9/16/2015 22:36:31,1739930201,9/16/2015 22:36:21,False,fusioncash,0.925,31742806,USA,OH,Kent,66.61.82.242,VINCRISTINE treats HODGKIN'S DISEASE,56,128,,72,139,treats,1.0,908106,"Seventy six patients with previously untreated advanced HODGKIN'S DISEASE have been treated with the MOPP/ABV (mechlorethamine, VINCRISTINE procarbazine, prednisone/doxorubicin, bleomycin, vincristine) hybrid program.",HODGKIN'S DISEASE,VINCRISTINE,RO-may_treat
789779106,9/16/2015 22:40:58,1739932471,9/16/2015 22:40:33,False,elite,0.9389,32173500,GBR,E4,Rayleigh,90.219.100.52,VINCRISTINE treats HODGKIN'S DISEASE,56,128,,72,139,treats,1.0,908106,"Seventy six patients with previously untreated advanced HODGKIN'S DISEASE have been treated with the MOPP/ABV (mechlorethamine, VINCRISTINE procarbazine, prednisone/doxorubicin, bleomycin, vincristine) hybrid program.",HODGKIN'S DISEASE,VINCRISTINE,RO-may_treat
789779106,9/16/2015 22:46:38,1739935501,9/16/2015 22:45:53,False,clixsense,0.7599,6330007,AUS,,,101.178.25.217,VINCRISTINE treats HODGKIN'S DISEASE,56,128,,72,139,treats,1.0,908106,"Seventy six patients with previously untreated advanced HODGKIN'S DISEASE have been treated with the MOPP/ABV (mechlorethamine, VINCRISTINE procarbazine, prednisone/doxorubicin, bleomycin, vincristine) hybrid program.",HODGKIN'S DISEASE,VINCRISTINE,RO-may_treat
789779106,9/16/2015 22:47:36,1739936114,9/16/2015 22:47:12,False,clixsense,0.9583,6344072,CAN,BC,Burnaby,172.218.166.58,VINCRISTINE treats HODGKIN'S DISEASE,56,128,,72,139,treats,1.0,908106,"Seventy six patients with previously untreated advanced HODGKIN'S DISEASE have been treated with the MOPP/ABV (mechlorethamine, VINCRISTINE procarbazine, prednisone/doxorubicin, bleomycin, vincristine) hybrid program.",HODGKIN'S DISEASE,VINCRISTINE,RO-may_treat
789779106,9/16/2015 23:16:34,1739952091,9/16/2015 23:16:02,False,points4rewards,0.9286,28703583,USA,,,184.53.32.49,VINCRISTINE treats HODGKIN'S DISEASE,56,128,,72,139,treats,1.0,908106,"Seventy six patients with previously untreated advanced HODGKIN'S DISEASE have been treated with the MOPP/ABV (mechlorethamine, VINCRISTINE procarbazine, prednisone/doxorubicin, bleomycin, vincristine) hybrid program.",HODGKIN'S DISEASE,VINCRISTINE,RO-may_treat
789779106,9/16/2015 23:18:23,1739952827,9/16/2015 23:17:16,False,meprizescf,0.9167,20102110,USA,TX,Carrollton,72.190.93.154,VINCRISTINE treats HODGKIN'S DISEASE,56,128,,72,139,treats,1.0,908106,"Seventy six patients with previously untreated advanced HODGKIN'S DISEASE have been treated with the MOPP/ABV (mechlorethamine, VINCRISTINE procarbazine, prednisone/doxorubicin, bleomycin, vincristine) hybrid program.",HODGKIN'S DISEASE,VINCRISTINE,RO-may_treat
790084696,9/17/2015 12:45:53,1740407853,9/17/2015 12:45:20,False,neodev,0.9028,18881135,CAN,ON,Ajax,99.243.87.224,HYDROCHLOROTHIAZIDE treats HYPERTENSION,57,106,,68,125,treats,0.99654575824488,804120,"In addition, her past medical history is significant for HYPERTENSION for which she is being treated with HYDROCHLOROTHIAZIDE; hyperlipidemia, for which she is taking a HMG CoA reductase inhibitor; and gestational diabetes when she was pregnant with her second child 6 years ago, for which she required insulin therapy.",HYPERTENSION,HYDROCHLOROTHIAZIDE,TWrex-cause
790084696,9/17/2015 12:56:05,1740410565,9/17/2015 12:55:51,False,clixsense,0.9292,10390268,USA,NY,New Paltz,100.40.130.164,HYDROCHLOROTHIAZIDE treats HYPERTENSION,57,106,,68,125,treats,0.99654575824488,804120,"In addition, her past medical history is significant for HYPERTENSION for which she is being treated with HYDROCHLOROTHIAZIDE; hyperlipidemia, for which she is taking a HMG CoA reductase inhibitor; and gestational diabetes when she was pregnant with her second child 6 years ago, for which she required insulin therapy.",HYPERTENSION,HYDROCHLOROTHIAZIDE,TWrex-cause
790084696,9/17/2015 12:56:52,1740410729,9/17/2015 12:56:02,False,clixsense,0.8792,21875134,GBR,,,80.189.12.98,HYDROCHLOROTHIAZIDE treats HYPERTENSION,57,106,,68,125,treats,0.99654575824488,804120,"In addition, her past medical history is significant for HYPERTENSION for which she is being treated with HYDROCHLOROTHIAZIDE; hyperlipidemia, for which she is taking a HMG CoA reductase inhibitor; and gestational diabetes when she was pregnant with her second child 6 years ago, for which she required insulin therapy.",HYPERTENSION,HYDROCHLOROTHIAZIDE,TWrex-cause
790084696,9/17/2015 13:09:01,1740414146,9/17/2015 13:04:32,False,clixsense,0.6516,17950689,GBR,L9,Sheffield,146.200.192.103,HYPERTENSION treats HYDROCHLOROTHIAZIDE,57,106,,68,125,treats,0.99654575824488,804120,"In addition, her past medical history is significant for HYPERTENSION for which she is being treated with HYDROCHLOROTHIAZIDE; hyperlipidemia, for which she is taking a HMG CoA reductase inhibitor; and gestational diabetes when she was pregnant with her second child 6 years ago, for which she required insulin therapy.",HYPERTENSION,HYDROCHLOROTHIAZIDE,TWrex-cause
790084696,9/17/2015 13:16:34,1740416410,9/17/2015 13:16:14,False,instagc,0.8643,13581319,USA,IL,Trenton,208.70.36.12,HYDROCHLOROTHIAZIDE treats HYPERTENSION,57,106,,68,125,treats,0.99654575824488,804120,"In addition, her past medical history is significant for HYPERTENSION for which she is being treated with HYDROCHLOROTHIAZIDE; hyperlipidemia, for which she is taking a HMG CoA reductase inhibitor; and gestational diabetes when she was pregnant with her second child 6 years ago, for which she required insulin therapy.",HYPERTENSION,HYDROCHLOROTHIAZIDE,TWrex-cause
790084696,9/17/2015 13:17:27,1740416592,9/17/2015 13:17:00,False,clixsense,0.9464,22751911,NLD,04,Groningen,195.241.153.97,HYDROCHLOROTHIAZIDE treats HYPERTENSION,57,106,,68,125,treats,0.99654575824488,804120,"In addition, her past medical history is significant for HYPERTENSION for which she is being treated with HYDROCHLOROTHIAZIDE; hyperlipidemia, for which she is taking a HMG CoA reductase inhibitor; and gestational diabetes when she was pregnant with her second child 6 years ago, for which she required insulin therapy.",HYPERTENSION,HYDROCHLOROTHIAZIDE,TWrex-cause
790084696,9/17/2015 13:17:50,1740416693,9/17/2015 13:17:04,False,prodege,0.8631,34236350,USA,IA,Des Moines,63.153.219.233,HYDROCHLOROTHIAZIDE treats HYPERTENSION,57,106,,68,125,treats,0.99654575824488,804120,"In addition, her past medical history is significant for HYPERTENSION for which she is being treated with HYDROCHLOROTHIAZIDE; hyperlipidemia, for which she is taking a HMG CoA reductase inhibitor; and gestational diabetes when she was pregnant with her second child 6 years ago, for which she required insulin therapy.",HYPERTENSION,HYDROCHLOROTHIAZIDE,TWrex-cause
790084698,9/17/2015 13:18:36,1740416947,9/17/2015 13:18:20,False,clixsense,0.9464,22751911,NLD,04,Groningen,195.241.153.97,AMPHOTERICIN B treats CRYPTOCOCCAL MENINGITIS,136,102,,158,116,treats,0.964901281354015,803456,A note to physicians: important information on results of a control clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B,TWrex-cause
790084698,9/17/2015 13:20:29,1740417643,9/17/2015 13:20:14,False,prodege,0.925,2145087,USA,NY,New York,107.107.57.52,AMPHOTERICIN B treats CRYPTOCOCCAL MENINGITIS,136,102,,158,116,treats,0.964901281354015,803456,A note to physicians: important information on results of a control clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B,TWrex-cause
790084698,9/17/2015 13:24:37,1740418892,9/17/2015 13:24:26,False,elite,0.7131,31883685,GBR,,,79.66.244.188,CRYPTOCOCCAL MENINGITIS treats AMPHOTERICIN B,136,102,,158,116,treats,0.964901281354015,803456,A note to physicians: important information on results of a control clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B,TWrex-cause
790084698,9/17/2015 13:33:16,1740421545,9/17/2015 13:33:04,False,elite,0.8165,30782237,GBR,H9,London,164.143.240.34,AMPHOTERICIN B treats CRYPTOCOCCAL MENINGITIS,136,102,,158,116,treats,0.964901281354015,803456,A note to physicians: important information on results of a control clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B,TWrex-cause
790084698,9/17/2015 13:41:45,1740426447,9/17/2015 13:41:08,False,elite,0.8452,33238902,NLD,06,Budel,77.248.148.5,AMPHOTERICIN B treats CRYPTOCOCCAL MENINGITIS,136,102,,158,116,treats,0.964901281354015,803456,A note to physicians: important information on results of a control clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B,TWrex-cause
790084698,9/17/2015 13:48:49,1740428669,9/17/2015 13:45:19,False,meprizescf,0.8809999999999999,20102110,USA,TX,Dallas,71.21.217.183,AMPHOTERICIN B treats CRYPTOCOCCAL MENINGITIS,136,102,,158,116,treats,0.964901281354015,803456,A note to physicians: important information on results of a control clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B,TWrex-cause
790084698,9/17/2015 13:50:16,1740429025,9/17/2015 13:49:23,False,tremorgames,0.894,32916723,USA,NY,Attica,70.209.139.92,AMPHOTERICIN B treats CRYPTOCOCCAL MENINGITIS,136,102,,158,116,treats,0.964901281354015,803456,A note to physicians: important information on results of a control clinical trial of fluconazole vs. AMPHOTERICIN B for suppression of CRYPTOCOCCAL MENINGITIS,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN B,TWrex-cause
790084700,9/17/2015 13:21:02,1740417823,9/17/2015 13:20:50,False,prodege,0.925,2145087,USA,NY,New York,107.107.57.52,DEXTROSE treats HYPOGLYCEMIA,92,30,,103,38,treats,0.9701425001453321,800750, Administer either 5% or 10% DEXTROSE during quinidine infusion to reduce the incidence of HYPOGLYCEMIA,HYPOGLYCEMIA,DEXTROSE,TWrex-cause
790084700,9/17/2015 13:34:29,1740421921,9/17/2015 13:33:42,False,elite,0.8165,30782237,GBR,H9,London,164.143.240.34,DEXTROSE treats HYPOGLYCEMIA,92,30,,103,38,treats,0.9701425001453321,800750, Administer either 5% or 10% DEXTROSE during quinidine infusion to reduce the incidence of HYPOGLYCEMIA,HYPOGLYCEMIA,DEXTROSE,TWrex-cause
790084700,9/17/2015 13:50:35,1740429142,9/17/2015 13:50:16,False,tremorgames,0.894,32916723,USA,NY,Attica,70.209.139.92,DEXTROSE treats HYPOGLYCEMIA,92,30,,103,38,treats,0.9701425001453321,800750, Administer either 5% or 10% DEXTROSE during quinidine infusion to reduce the incidence of HYPOGLYCEMIA,HYPOGLYCEMIA,DEXTROSE,TWrex-cause
790084700,9/17/2015 13:50:36,1740429146,9/17/2015 13:50:22,False,clixsense,0.875,9001027,CAN,QC,Dollard-des-ormeaux,96.21.122.219,DEXTROSE treats HYPOGLYCEMIA,92,30,,103,38,treats,0.9701425001453321,800750, Administer either 5% or 10% DEXTROSE during quinidine infusion to reduce the incidence of HYPOGLYCEMIA,HYPOGLYCEMIA,DEXTROSE,TWrex-cause
790084700,9/17/2015 13:52:55,1740429908,9/17/2015 13:52:02,False,clixsense,0.7508,6336109,CAN,BC,Prince George,198.254.211.52,no_relation,92,30,,103,38,treats,0.9701425001453321,800750, Administer either 5% or 10% DEXTROSE during quinidine infusion to reduce the incidence of HYPOGLYCEMIA,HYPOGLYCEMIA,DEXTROSE,TWrex-cause
790084700,9/17/2015 13:55:26,1740430727,9/17/2015 13:54:40,False,meprizescf,0.8809999999999999,20102110,USA,TX,Dallas,71.21.217.183,DEXTROSE treats HYPOGLYCEMIA,92,30,,103,38,treats,0.9701425001453321,800750, Administer either 5% or 10% DEXTROSE during quinidine infusion to reduce the incidence of HYPOGLYCEMIA,HYPOGLYCEMIA,DEXTROSE,TWrex-cause
790084700,9/17/2015 13:55:42,1740430800,9/17/2015 13:55:17,False,clixsense,0.7631,30258829,NLD,05,Velden,84.104.254.214,DEXTROSE treats HYPOGLYCEMIA,92,30,,103,38,treats,0.9701425001453321,800750, Administer either 5% or 10% DEXTROSE during quinidine infusion to reduce the incidence of HYPOGLYCEMIA,HYPOGLYCEMIA,DEXTROSE,TWrex-cause
790084713,9/17/2015 13:50:50,1740429279,9/17/2015 13:50:36,False,tremorgames,0.894,32916723,USA,NY,Attica,70.209.139.92,ATENOLOL treats MYOCARDIAL INFARCTION,72,46,,92,54,treats,0.986393923832144,805248,"Telford AM, Wilson C. Trial of heparin versus ATENOLOL in prevention of MYOCARDIAL INFARCTION in intermediate coronary syndrome.",MYOCARDIAL INFARCTION,ATENOLOL,TWrex-cause
790084713,9/17/2015 13:50:53,1740429285,9/17/2015 13:50:37,False,clixsense,0.875,9001027,CAN,QC,Dollard-des-ormeaux,96.21.122.219,ATENOLOL treats MYOCARDIAL INFARCTION,72,46,,92,54,treats,0.986393923832144,805248,"Telford AM, Wilson C. Trial of heparin versus ATENOLOL in prevention of MYOCARDIAL INFARCTION in intermediate coronary syndrome.",MYOCARDIAL INFARCTION,ATENOLOL,TWrex-cause
790084713,9/17/2015 13:54:54,1740430523,9/17/2015 13:53:01,False,clixsense,0.7508,6336109,CAN,BC,Prince George,198.254.211.52,no_relation,72,46,,92,54,treats,0.986393923832144,805248,"Telford AM, Wilson C. Trial of heparin versus ATENOLOL in prevention of MYOCARDIAL INFARCTION in intermediate coronary syndrome.",MYOCARDIAL INFARCTION,ATENOLOL,TWrex-cause
790084713,9/17/2015 13:56:10,1740430990,9/17/2015 13:55:43,False,clixsense,0.7631,30258829,NLD,05,Velden,84.104.254.214,ATENOLOL treats MYOCARDIAL INFARCTION,72,46,,92,54,treats,0.986393923832144,805248,"Telford AM, Wilson C. Trial of heparin versus ATENOLOL in prevention of MYOCARDIAL INFARCTION in intermediate coronary syndrome.",MYOCARDIAL INFARCTION,ATENOLOL,TWrex-cause
790084713,9/17/2015 13:56:40,1740431148,9/17/2015 13:55:27,False,meprizescf,0.8809999999999999,20102110,USA,TX,Dallas,71.21.217.183,ATENOLOL treats MYOCARDIAL INFARCTION,72,46,,92,54,treats,0.986393923832144,805248,"Telford AM, Wilson C. Trial of heparin versus ATENOLOL in prevention of MYOCARDIAL INFARCTION in intermediate coronary syndrome.",MYOCARDIAL INFARCTION,ATENOLOL,TWrex-cause
790084713,9/17/2015 13:59:30,1740432106,9/17/2015 13:58:56,False,neodev,0.7518,33758777,USA,,,38.95.108.251,ATENOLOL treats MYOCARDIAL INFARCTION,72,46,,92,54,treats,0.986393923832144,805248,"Telford AM, Wilson C. Trial of heparin versus ATENOLOL in prevention of MYOCARDIAL INFARCTION in intermediate coronary syndrome.",MYOCARDIAL INFARCTION,ATENOLOL,TWrex-cause
790084713,9/17/2015 14:00:30,1740432476,9/17/2015 13:59:59,False,points4rewards,0.7685,28755767,USA,VA,Chester,68.57.118.32,ATENOLOL treats MYOCARDIAL INFARCTION,72,46,,92,54,treats,0.986393923832144,805248,"Telford AM, Wilson C. Trial of heparin versus ATENOLOL in prevention of MYOCARDIAL INFARCTION in intermediate coronary syndrome.",MYOCARDIAL INFARCTION,ATENOLOL,TWrex-cause
790084714,9/17/2015 14:26:03,1740441678,9/17/2015 14:25:49,False,neodev,0.7083,33155316,GBR,I9,Dereham,31.50.244.140,MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS treats DHPG,37,146,,85,150,treats,0.9941348467724341,800352,"Shabtai M, Luft B, Waltzer WC et al. MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS in a renal transplant recipient: successful treatment with DHPG",MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS,DHPG,TWrex-cause
790084714,9/17/2015 14:33:23,1740444500,9/17/2015 14:32:49,False,clixsense,0.7798,20587495,CAN,NL,St. John's,142.162.225.210,DHPG treats MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS,37,146,,85,150,treats,0.9941348467724341,800352,"Shabtai M, Luft B, Waltzer WC et al. MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS in a renal transplant recipient: successful treatment with DHPG",MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS,DHPG,TWrex-cause
790084714,9/17/2015 14:38:39,1740446540,9/17/2015 14:38:20,False,tremorgames,0.7167,31906954,USA,NY,Goshen,184.9.83.232,DHPG treats MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS,37,146,,85,150,treats,0.9941348467724341,800352,"Shabtai M, Luft B, Waltzer WC et al. MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS in a renal transplant recipient: successful treatment with DHPG",MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS,DHPG,TWrex-cause
790084714,9/17/2015 14:40:41,1740447465,9/17/2015 14:40:33,False,tremorgames,0.7063,24449707,CAN,QC,Laval,96.20.14.148,DHPG treats MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS,37,146,,85,150,treats,0.9941348467724341,800352,"Shabtai M, Luft B, Waltzer WC et al. MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS in a renal transplant recipient: successful treatment with DHPG",MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS,DHPG,TWrex-cause
790084714,9/17/2015 14:41:30,1740447775,9/17/2015 14:40:52,False,prodege,0.7421,27934334,GBR,C8,Croydon,81.159.60.206,DHPG treats MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS,37,146,,85,150,treats,0.9941348467724341,800352,"Shabtai M, Luft B, Waltzer WC et al. MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS in a renal transplant recipient: successful treatment with DHPG",MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS,DHPG,TWrex-cause
790084714,9/17/2015 14:42:30,1740448166,9/17/2015 14:41:20,False,zoombucks,0.8806,6744840,CAN,BC,Kelowna,174.4.58.160,DHPG treats MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS,37,146,,85,150,treats,0.9941348467724341,800352,"Shabtai M, Luft B, Waltzer WC et al. MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS in a renal transplant recipient: successful treatment with DHPG",MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS,DHPG,TWrex-cause
790084714,9/17/2015 15:00:52,1740455200,9/17/2015 14:59:36,False,instagc,0.6935,22981457,CAN,ON,Ottawa,67.69.8.122,DHPG treats MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS,37,146,,85,150,treats,0.9941348467724341,800352,"Shabtai M, Luft B, Waltzer WC et al. MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS in a renal transplant recipient: successful treatment with DHPG",MASSIVE CYTOMEGALOVIRUS PNEUMONIA AND MYOCARDITIS,DHPG,TWrex-cause
790084715,9/17/2015 14:50:26,1740451495,9/17/2015 14:48:37,False,zoombucks,0.8806,6744840,CAN,BC,Kelowna,174.4.58.160,PHYTONADIONE treats HYPOPROTHROMBINEMIA,48,98,,66,110,treats,0.99124070716193,804858,"Unless severe hepatocellular damage is present, HYPOPROTHROMBINEMIA usually subsides after use of PHYTONADIONE (vitamin K 1 ) 5 to 10 mg sc once/day for 2 to 3 days.",HYPOPROTHROMBINEMIA,PHYTONADIONE,TWrex-cause
790084715,9/17/2015 15:18:58,1740461343,9/17/2015 15:18:46,False,prodege,0.8849,14848125,GBR,V8,Airdrie,86.151.77.161,PHYTONADIONE treats HYPOPROTHROMBINEMIA,48,98,,66,110,treats,0.99124070716193,804858,"Unless severe hepatocellular damage is present, HYPOPROTHROMBINEMIA usually subsides after use of PHYTONADIONE (vitamin K 1 ) 5 to 10 mg sc once/day for 2 to 3 days.",HYPOPROTHROMBINEMIA,PHYTONADIONE,TWrex-cause
790084715,9/17/2015 15:24:15,1740463328,9/17/2015 15:23:52,False,instagc,0.6935,22981457,CAN,ON,Ottawa,67.69.8.122,PHYTONADIONE treats HYPOPROTHROMBINEMIA,48,98,,66,110,treats,0.99124070716193,804858,"Unless severe hepatocellular damage is present, HYPOPROTHROMBINEMIA usually subsides after use of PHYTONADIONE (vitamin K 1 ) 5 to 10 mg sc once/day for 2 to 3 days.",HYPOPROTHROMBINEMIA,PHYTONADIONE,TWrex-cause
790084715,9/17/2015 15:24:30,1740463383,9/17/2015 15:23:35,False,clixsense,0.9375,33878524,CAN,BC,Princeton,75.156.83.71,PHYTONADIONE treats HYPOPROTHROMBINEMIA,48,98,,66,110,treats,0.99124070716193,804858,"Unless severe hepatocellular damage is present, HYPOPROTHROMBINEMIA usually subsides after use of PHYTONADIONE (vitamin K 1 ) 5 to 10 mg sc once/day for 2 to 3 days.",HYPOPROTHROMBINEMIA,PHYTONADIONE,TWrex-cause
790084715,9/17/2015 15:37:30,1740468457,9/17/2015 15:37:02,False,instagc,0.823,31130954,USA,IL,Arlington Heights,99.135.174.103,PHYTONADIONE treats HYPOPROTHROMBINEMIA,48,98,,66,110,treats,0.99124070716193,804858,"Unless severe hepatocellular damage is present, HYPOPROTHROMBINEMIA usually subsides after use of PHYTONADIONE (vitamin K 1 ) 5 to 10 mg sc once/day for 2 to 3 days.",HYPOPROTHROMBINEMIA,PHYTONADIONE,TWrex-cause
790084715,9/17/2015 15:39:48,1740469672,9/17/2015 15:39:10,False,instagc,0.8681,19480545,USA,MA,Brookline,209.6.138.58,PHYTONADIONE treats HYPOPROTHROMBINEMIA,48,98,,66,110,treats,0.99124070716193,804858,"Unless severe hepatocellular damage is present, HYPOPROTHROMBINEMIA usually subsides after use of PHYTONADIONE (vitamin K 1 ) 5 to 10 mg sc once/day for 2 to 3 days.",HYPOPROTHROMBINEMIA,PHYTONADIONE,TWrex-cause
790084715,9/17/2015 15:46:59,1740472504,9/17/2015 15:46:45,False,clixsense,0.8673,24104564,AUS,02,Surry Hills,60.241.132.132,PHYTONADIONE treats HYPOPROTHROMBINEMIA,48,98,,66,110,treats,0.99124070716193,804858,"Unless severe hepatocellular damage is present, HYPOPROTHROMBINEMIA usually subsides after use of PHYTONADIONE (vitamin K 1 ) 5 to 10 mg sc once/day for 2 to 3 days.",HYPOPROTHROMBINEMIA,PHYTONADIONE,TWrex-cause
790084717,9/17/2015 08:56:03,1740358712,9/17/2015 08:55:29,False,neodev,1.0,30627835,GBR,D8,Bishop Auckland,217.44.84.223,IMIQUIMOD THERAPY treats PENILE CONDYLOMA WITH EROSION,0,144,,28,161,treats,0.46816458878452205,803996,PENILE CONDYLOMA WITH EROSION after Imiquimod Therapy  Characteristic condyloma over the penile shaft and foreskin with adjacent erosions after IMIQUIMOD THERAPY.,PENILE CONDYLOMA WITH EROSION,IMIQUIMOD THERAPY,TWrex-cause
790084717,9/17/2015 09:09:15,1740361616,9/17/2015 09:08:34,False,neodev,0.8194,33644825,USA,FL,Fort Lauderdale,65.111.173.161,IMIQUIMOD THERAPY treats PENILE CONDYLOMA WITH EROSION,0,144,,28,161,treats,0.46816458878452205,803996,PENILE CONDYLOMA WITH EROSION after Imiquimod Therapy  Characteristic condyloma over the penile shaft and foreskin with adjacent erosions after IMIQUIMOD THERAPY.,PENILE CONDYLOMA WITH EROSION,IMIQUIMOD THERAPY,TWrex-cause
790084717,9/17/2015 09:10:12,1740361763,9/17/2015 09:03:38,False,clixsense,0.8528,30681826,GBR,I9,Diss,31.49.71.254,IMIQUIMOD THERAPY treats PENILE CONDYLOMA WITH EROSION,0,144,,28,161,treats,0.46816458878452205,803996,PENILE CONDYLOMA WITH EROSION after Imiquimod Therapy  Characteristic condyloma over the penile shaft and foreskin with adjacent erosions after IMIQUIMOD THERAPY.,PENILE CONDYLOMA WITH EROSION,IMIQUIMOD THERAPY,TWrex-cause
790084717,9/17/2015 09:12:33,1740362358,9/17/2015 09:12:28,False,clixsense,0.6667,19162475,GBR,P8,Trowbridge,82.33.126.30,IMIQUIMOD THERAPY treats PENILE CONDYLOMA WITH EROSION,0,144,,28,161,treats,0.46816458878452205,803996,PENILE CONDYLOMA WITH EROSION after Imiquimod Therapy  Characteristic condyloma over the penile shaft and foreskin with adjacent erosions after IMIQUIMOD THERAPY.,PENILE CONDYLOMA WITH EROSION,IMIQUIMOD THERAPY,TWrex-cause
790084717,9/17/2015 09:14:37,1740362877,9/17/2015 09:14:25,False,instagc,0.8222,18960682,GBR,U2,Annan,92.18.213.181,IMIQUIMOD THERAPY treats PENILE CONDYLOMA WITH EROSION,0,144,,28,161,treats,0.46816458878452205,803996,PENILE CONDYLOMA WITH EROSION after Imiquimod Therapy  Characteristic condyloma over the penile shaft and foreskin with adjacent erosions after IMIQUIMOD THERAPY.,PENILE CONDYLOMA WITH EROSION,IMIQUIMOD THERAPY,TWrex-cause
790084717,9/17/2015 09:17:33,1740363492,9/17/2015 09:16:54,False,neodev,0.8059999999999999,20306047,GBR,,,80.41.0.252,IMIQUIMOD THERAPY treats PENILE CONDYLOMA WITH EROSION,0,144,,28,161,treats,0.46816458878452205,803996,PENILE CONDYLOMA WITH EROSION after Imiquimod Therapy  Characteristic condyloma over the penile shaft and foreskin with adjacent erosions after IMIQUIMOD THERAPY.,PENILE CONDYLOMA WITH EROSION,IMIQUIMOD THERAPY,TWrex-cause
790084717,9/17/2015 09:18:22,1740363661,9/17/2015 09:17:43,False,prodege,0.7559999999999999,21417560,GBR,C3,Cambridge,151.224.120.191,IMIQUIMOD THERAPY treats PENILE CONDYLOMA WITH EROSION,0,144,,28,161,treats,0.46816458878452205,803996,PENILE CONDYLOMA WITH EROSION after Imiquimod Therapy  Characteristic condyloma over the penile shaft and foreskin with adjacent erosions after IMIQUIMOD THERAPY.,PENILE CONDYLOMA WITH EROSION,IMIQUIMOD THERAPY,TWrex-cause
790084720,9/17/2015 15:25:47,1740463879,9/17/2015 15:25:09,False,clixsense,0.9375,33878524,CAN,BC,Princeton,75.156.83.71,CITALOPRAM treats OBSESSIVE COMPULSIVE DISORDER,68,37,,96,47,treats,0.9970544855015809,800351,"Kopenen H, Lepola U, Leinonen E et alCITALOPRAM in the treatment of OBSESSIVE COMPULSIVE DISORDER: an open pilot study.",OBSESSIVE COMPULSIVE DISORDER,CITALOPRAM,TWrex-cause
790084720,9/17/2015 15:38:10,1740468765,9/17/2015 15:37:52,False,instagc,0.823,31130954,USA,IL,Arlington Heights,99.135.174.103,CITALOPRAM treats OBSESSIVE COMPULSIVE DISORDER,68,37,,96,47,treats,0.9970544855015809,800351,"Kopenen H, Lepola U, Leinonen E et alCITALOPRAM in the treatment of OBSESSIVE COMPULSIVE DISORDER: an open pilot study.",OBSESSIVE COMPULSIVE DISORDER,CITALOPRAM,TWrex-cause
790084720,9/17/2015 15:42:11,1740470620,9/17/2015 15:41:26,False,instagc,0.8681,19480545,USA,MA,Brookline,209.6.138.58,CITALOPRAM treats OBSESSIVE COMPULSIVE DISORDER,68,37,,96,47,treats,0.9970544855015809,800351,"Kopenen H, Lepola U, Leinonen E et alCITALOPRAM in the treatment of OBSESSIVE COMPULSIVE DISORDER: an open pilot study.",OBSESSIVE COMPULSIVE DISORDER,CITALOPRAM,TWrex-cause
790084720,9/17/2015 15:47:31,1740472723,9/17/2015 15:47:15,False,clixsense,0.8673,24104564,AUS,02,Surry Hills,60.241.132.132,CITALOPRAM treats OBSESSIVE COMPULSIVE DISORDER,68,37,,96,47,treats,0.9970544855015809,800351,"Kopenen H, Lepola U, Leinonen E et alCITALOPRAM in the treatment of OBSESSIVE COMPULSIVE DISORDER: an open pilot study.",OBSESSIVE COMPULSIVE DISORDER,CITALOPRAM,TWrex-cause
790084720,9/17/2015 15:51:32,1740474448,9/17/2015 15:51:03,False,prodege,0.9694,13300986,CAN,AB,Edmonton,68.150.40.134,CITALOPRAM treats OBSESSIVE COMPULSIVE DISORDER,68,37,,96,47,treats,0.9970544855015809,800351,"Kopenen H, Lepola U, Leinonen E et alCITALOPRAM in the treatment of OBSESSIVE COMPULSIVE DISORDER: an open pilot study.",OBSESSIVE COMPULSIVE DISORDER,CITALOPRAM,TWrex-cause
790084720,9/17/2015 15:56:29,1740477013,9/17/2015 15:56:14,False,bitcoinget,0.878,21743413,USA,WA,Port Angeles,24.113.29.97,CITALOPRAM treats OBSESSIVE COMPULSIVE DISORDER,68,37,,96,47,treats,0.9970544855015809,800351,"Kopenen H, Lepola U, Leinonen E et alCITALOPRAM in the treatment of OBSESSIVE COMPULSIVE DISORDER: an open pilot study.",OBSESSIVE COMPULSIVE DISORDER,CITALOPRAM,TWrex-cause
790084720,9/17/2015 16:03:08,1740479852,9/17/2015 16:02:54,False,dailyrewardsca,0.9214,32219778,CAN,ON,Ottawa,99.241.19.27,CITALOPRAM treats OBSESSIVE COMPULSIVE DISORDER,68,37,,96,47,treats,0.9970544855015809,800351,"Kopenen H, Lepola U, Leinonen E et alCITALOPRAM in the treatment of OBSESSIVE COMPULSIVE DISORDER: an open pilot study.",OBSESSIVE COMPULSIVE DISORDER,CITALOPRAM,TWrex-cause
790084724,9/17/2015 09:40:54,1740368717,9/17/2015 09:39:59,False,gifthunterclub,0.8155,24043308,GBR,,,94.102.147.250,[GRD] treats [GREASE],2,16,,4,21,treats,0.9992611746313141,208616,A [GRD] stops the [GREASE] at the source. (,[GRD],[GREASE],TWrex-treat
790084724,9/17/2015 09:48:32,1740370445,9/17/2015 09:48:17,False,vivatic,0.9722,32338429,GBR,N7,Guildford,92.21.219.178,[GRD] treats [GREASE],2,16,,4,21,treats,0.9992611746313141,208616,A [GRD] stops the [GREASE] at the source. (,[GRD],[GREASE],TWrex-treat
790084724,9/17/2015 10:16:42,1740377278,9/17/2015 10:16:03,False,pocketmoneygpt,0.8115,21432964,GBR,F8,Borehamwood,81.159.185.70,no_relation,2,16,,4,21,treats,0.9992611746313141,208616,A [GRD] stops the [GREASE] at the source. (,[GRD],[GREASE],TWrex-treat
790084724,9/17/2015 10:17:28,1740377458,9/17/2015 10:16:14,False,eup_slw,0.8671,32718504,AUS,,,1.128.96.45,[GRD] treats [GREASE],2,16,,4,21,treats,0.9992611746313141,208616,A [GRD] stops the [GREASE] at the source. (,[GRD],[GREASE],TWrex-treat
790084724,9/17/2015 10:41:46,1740382281,9/17/2015 10:41:31,False,clixsense,0.8667,6340330,USA,NY,Canajoharie,67.248.115.74,[GRD] treats [GREASE],2,16,,4,21,treats,0.9992611746313141,208616,A [GRD] stops the [GREASE] at the source. (,[GRD],[GREASE],TWrex-treat
790084724,9/17/2015 10:53:32,1740384326,9/17/2015 10:45:47,False,points4rewards,0.7611,20113482,USA,PA,Philadelphia,162.208.49.45,[GRD] treats [GREASE],2,16,,4,21,treats,0.9992611746313141,208616,A [GRD] stops the [GREASE] at the source. (,[GRD],[GREASE],TWrex-treat
790084724,9/17/2015 11:34:21,1740391983,9/17/2015 11:34:02,False,neodev,0.9127,30588889,NLD,07,Amsterdam,77.248.175.222,[GRD] treats [GREASE],2,16,,4,21,treats,0.9992611746313141,208616,A [GRD] stops the [GREASE] at the source. (,[GRD],[GREASE],TWrex-treat
790084725,9/17/2015 12:16:10,1740400638,9/17/2015 12:15:04,False,prodege,0.9337,3056891,CAN,ON,Niagara Falls,173.238.144.19,no_relation,128,10,,141,33,treats,0.44543540318737396,811170,"91   93   LONG TERM LEAD EXPOSURE can result in chronic tubulointerstitial nephritis and renal insufficiency, hypertension, and SATURNINE GOUT from reduced renal excretion of uric acid.",SATURNINE GOUT,LONG TERM LEAD EXPOSURE,TWrex-cause
790084725,9/17/2015 12:22:44,1740401940,9/17/2015 12:22:12,False,gifthulk,0.9742,24928180,GBR,M1,Slough,90.208.18.156,no_relation,128,10,,141,33,treats,0.44543540318737396,811170,"91   93   LONG TERM LEAD EXPOSURE can result in chronic tubulointerstitial nephritis and renal insufficiency, hypertension, and SATURNINE GOUT from reduced renal excretion of uric acid.",SATURNINE GOUT,LONG TERM LEAD EXPOSURE,TWrex-cause
790084725,9/17/2015 12:27:57,1740403109,9/17/2015 12:26:59,False,clixsense,0.9881,21490235,GBR,N7,Woking,86.30.254.232,no_relation,128,10,,141,33,treats,0.44543540318737396,811170,"91   93   LONG TERM LEAD EXPOSURE can result in chronic tubulointerstitial nephritis and renal insufficiency, hypertension, and SATURNINE GOUT from reduced renal excretion of uric acid.",SATURNINE GOUT,LONG TERM LEAD EXPOSURE,TWrex-cause
790084725,9/17/2015 12:37:05,1740405391,9/17/2015 12:33:35,False,neodev,0.9028,18881135,CAN,ON,Ajax,99.243.87.224,no_relation,128,10,,141,33,treats,0.44543540318737396,811170,"91   93   LONG TERM LEAD EXPOSURE can result in chronic tubulointerstitial nephritis and renal insufficiency, hypertension, and SATURNINE GOUT from reduced renal excretion of uric acid.",SATURNINE GOUT,LONG TERM LEAD EXPOSURE,TWrex-cause
790084725,9/17/2015 12:51:26,1740409385,9/17/2015 12:49:53,False,clixsense,0.8792,21875134,GBR,,,80.189.12.98,no_relation,128,10,,141,33,treats,0.44543540318737396,811170,"91   93   LONG TERM LEAD EXPOSURE can result in chronic tubulointerstitial nephritis and renal insufficiency, hypertension, and SATURNINE GOUT from reduced renal excretion of uric acid.",SATURNINE GOUT,LONG TERM LEAD EXPOSURE,TWrex-cause
790084725,9/17/2015 12:54:29,1740410157,9/17/2015 12:54:02,False,clixsense,0.9292,10390268,USA,NY,New Paltz,100.40.130.164,no_relation,128,10,,141,33,treats,0.44543540318737396,811170,"91   93   LONG TERM LEAD EXPOSURE can result in chronic tubulointerstitial nephritis and renal insufficiency, hypertension, and SATURNINE GOUT from reduced renal excretion of uric acid.",SATURNINE GOUT,LONG TERM LEAD EXPOSURE,TWrex-cause
790084725,9/17/2015 13:00:53,1740411765,9/17/2015 13:00:36,False,clixsense,0.6516,17950689,GBR,L9,Sheffield,146.200.192.103,LONG TERM LEAD EXPOSURE treats SATURNINE GOUT,128,10,,141,33,treats,0.44543540318737396,811170,"91   93   LONG TERM LEAD EXPOSURE can result in chronic tubulointerstitial nephritis and renal insufficiency, hypertension, and SATURNINE GOUT from reduced renal excretion of uric acid.",SATURNINE GOUT,LONG TERM LEAD EXPOSURE,TWrex-cause
790084730,9/17/2015 15:44:22,1740471418,9/17/2015 15:43:13,False,instagc,0.8681,19480545,USA,MA,Brookline,209.6.138.58,PROPRANOLOL treats HYPERTENSION,222,197,,233,208,treats,0.977355554850442,804202,"Semplicini A, Rossi GP, Bongiovi S et al. Time course changes in blood pressure, aldosterone and body fluids during enalapril treatment: a double blind randomized study vs hydrochlorothiazide plus PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL,TWrex-cause
790084730,9/17/2015 15:48:10,1740472938,9/17/2015 15:47:50,False,clixsense,0.8673,24104564,AUS,02,Surry Hills,60.241.132.132,PROPRANOLOL treats HYPERTENSION,222,197,,233,208,treats,0.977355554850442,804202,"Semplicini A, Rossi GP, Bongiovi S et al. Time course changes in blood pressure, aldosterone and body fluids during enalapril treatment: a double blind randomized study vs hydrochlorothiazide plus PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL,TWrex-cause
790084730,9/17/2015 15:52:19,1740474847,9/17/2015 15:51:54,False,prodege,0.9694,13300986,CAN,AB,Edmonton,68.150.40.134,PROPRANOLOL treats HYPERTENSION,222,197,,233,208,treats,0.977355554850442,804202,"Semplicini A, Rossi GP, Bongiovi S et al. Time course changes in blood pressure, aldosterone and body fluids during enalapril treatment: a double blind randomized study vs hydrochlorothiazide plus PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL,TWrex-cause
790084730,9/17/2015 15:56:57,1740477211,9/17/2015 15:56:48,False,bitcoinget,0.878,21743413,USA,WA,Port Angeles,24.113.29.97,PROPRANOLOL treats HYPERTENSION,222,197,,233,208,treats,0.977355554850442,804202,"Semplicini A, Rossi GP, Bongiovi S et al. Time course changes in blood pressure, aldosterone and body fluids during enalapril treatment: a double blind randomized study vs hydrochlorothiazide plus PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL,TWrex-cause
790084730,9/17/2015 16:03:49,1740480023,9/17/2015 16:03:24,False,dailyrewardsca,0.9214,32219778,CAN,ON,Ottawa,99.241.19.27,PROPRANOLOL treats HYPERTENSION,222,197,,233,208,treats,0.977355554850442,804202,"Semplicini A, Rossi GP, Bongiovi S et al. Time course changes in blood pressure, aldosterone and body fluids during enalapril treatment: a double blind randomized study vs hydrochlorothiazide plus PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL,TWrex-cause
790084730,9/17/2015 16:25:32,1740489313,9/17/2015 16:25:07,False,prodege,0.8056,22031444,GBR,K6,Portsmouth,78.146.10.68,PROPRANOLOL treats HYPERTENSION,222,197,,233,208,treats,0.977355554850442,804202,"Semplicini A, Rossi GP, Bongiovi S et al. Time course changes in blood pressure, aldosterone and body fluids during enalapril treatment: a double blind randomized study vs hydrochlorothiazide plus PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL,TWrex-cause
790084730,9/17/2015 16:35:37,1740493326,9/17/2015 16:34:45,False,cotter,0.7679,33673171,USA,MO,Saint Louis,24.207.217.12,PROPRANOLOL treats HYPERTENSION,222,197,,233,208,treats,0.977355554850442,804202,"Semplicini A, Rossi GP, Bongiovi S et al. Time course changes in blood pressure, aldosterone and body fluids during enalapril treatment: a double blind randomized study vs hydrochlorothiazide plus PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL,TWrex-cause
790084733,9/17/2015 15:26:32,1740464139,9/17/2015 15:25:48,False,clixsense,0.9375,33878524,CAN,BC,Princeton,75.156.83.71,ROLAIDS treats ACID REFLUX,58,36,,69,43,treats,0.997458699830735,213435,"antacids - nexium, tums, Pepcid AC, [ROLAIDS], etc. reduces [ACID REFLUX] in the case of hiatal hernia or other.",ACID REFLUX,ROLAIDS,TWrex-treat
790084733,9/17/2015 15:38:46,1740469154,9/17/2015 15:38:12,False,instagc,0.823,31130954,USA,IL,Arlington Heights,99.135.174.103,ROLAIDS treats ACID REFLUX,58,36,,69,43,treats,0.997458699830735,213435,"antacids - nexium, tums, Pepcid AC, [ROLAIDS], etc. reduces [ACID REFLUX] in the case of hiatal hernia or other.",ACID REFLUX,ROLAIDS,TWrex-treat
790084733,9/17/2015 15:43:05,1740470941,9/17/2015 15:42:23,False,instagc,0.8681,19480545,USA,MA,Brookline,209.6.138.58,ROLAIDS treats ACID REFLUX,58,36,,69,43,treats,0.997458699830735,213435,"antacids - nexium, tums, Pepcid AC, [ROLAIDS], etc. reduces [ACID REFLUX] in the case of hiatal hernia or other.",ACID REFLUX,ROLAIDS,TWrex-treat
790084733,9/17/2015 15:47:48,1740472817,9/17/2015 15:47:33,False,clixsense,0.8673,24104564,AUS,02,Surry Hills,60.241.132.132,ROLAIDS treats ACID REFLUX,58,36,,69,43,treats,0.997458699830735,213435,"antacids - nexium, tums, Pepcid AC, [ROLAIDS], etc. reduces [ACID REFLUX] in the case of hiatal hernia or other.",ACID REFLUX,ROLAIDS,TWrex-treat
790084733,9/17/2015 15:51:53,1740474622,9/17/2015 15:51:33,False,prodege,0.9694,13300986,CAN,AB,Edmonton,68.150.40.134,ROLAIDS treats ACID REFLUX,58,36,,69,43,treats,0.997458699830735,213435,"antacids - nexium, tums, Pepcid AC, [ROLAIDS], etc. reduces [ACID REFLUX] in the case of hiatal hernia or other.",ACID REFLUX,ROLAIDS,TWrex-treat
790084733,9/17/2015 15:56:47,1740477140,9/17/2015 15:56:30,False,bitcoinget,0.878,21743413,USA,WA,Port Angeles,24.113.29.97,ROLAIDS treats ACID REFLUX,58,36,,69,43,treats,0.997458699830735,213435,"antacids - nexium, tums, Pepcid AC, [ROLAIDS], etc. reduces [ACID REFLUX] in the case of hiatal hernia or other.",ACID REFLUX,ROLAIDS,TWrex-treat
790084733,9/17/2015 16:03:24,1740479925,9/17/2015 16:03:09,False,dailyrewardsca,0.9214,32219778,CAN,ON,Ottawa,99.241.19.27,ROLAIDS treats ACID REFLUX,58,36,,69,43,treats,0.997458699830735,213435,"antacids - nexium, tums, Pepcid AC, [ROLAIDS], etc. reduces [ACID REFLUX] in the case of hiatal hernia or other.",ACID REFLUX,ROLAIDS,TWrex-treat
790084735,9/17/2015 11:38:47,1740392915,9/17/2015 11:38:18,False,neodev,0.9127,30588889,NLD,07,Amsterdam,77.248.175.222,TRAZODONE treats NUTCRACKER ESOPHAGUS,141,9,,161,18,treats,0.9878783399,207550,"Finally, [TRAZODONE], an anti-depressant that reduces visceral sensitivity, has also been shown to reduce chest pain symptoms in patients with [NUTCRACKER ESOPHAGUS].",NUTCRACKER ESOPHAGUS,TRAZODONE,TWrex-treat
790084735,9/17/2015 11:51:23,1740395348,9/17/2015 11:50:50,False,neodev,0.9464,12115558,USA,OH,Twinsburg,98.27.164.131,TRAZODONE treats NUTCRACKER ESOPHAGUS,141,9,,161,18,treats,0.9878783399,207550,"Finally, [TRAZODONE], an anti-depressant that reduces visceral sensitivity, has also been shown to reduce chest pain symptoms in patients with [NUTCRACKER ESOPHAGUS].",NUTCRACKER ESOPHAGUS,TRAZODONE,TWrex-treat
790084735,9/17/2015 11:53:35,1740395735,9/17/2015 11:53:07,False,elite,0.9722,29768955,GBR,C3,Gamlingay,31.50.187.165,TRAZODONE treats NUTCRACKER ESOPHAGUS,141,9,,161,18,treats,0.9878783399,207550,"Finally, [TRAZODONE], an anti-depressant that reduces visceral sensitivity, has also been shown to reduce chest pain symptoms in patients with [NUTCRACKER ESOPHAGUS].",NUTCRACKER ESOPHAGUS,TRAZODONE,TWrex-treat
790084735,9/17/2015 11:56:41,1740396393,9/17/2015 11:56:08,False,bitcoinget,0.7528,32306192,USA,TX,Austin,172.11.109.161,TRAZODONE treats NUTCRACKER ESOPHAGUS,141,9,,161,18,treats,0.9878783399,207550,"Finally, [TRAZODONE], an anti-depressant that reduces visceral sensitivity, has also been shown to reduce chest pain symptoms in patients with [NUTCRACKER ESOPHAGUS].",NUTCRACKER ESOPHAGUS,TRAZODONE,TWrex-treat
790084735,9/17/2015 12:02:05,1740397462,9/17/2015 12:01:25,False,gifthulk,0.9042,18666417,USA,PA,Meadville,24.101.32.13,TRAZODONE treats NUTCRACKER ESOPHAGUS,141,9,,161,18,treats,0.9878783399,207550,"Finally, [TRAZODONE], an anti-depressant that reduces visceral sensitivity, has also been shown to reduce chest pain symptoms in patients with [NUTCRACKER ESOPHAGUS].",NUTCRACKER ESOPHAGUS,TRAZODONE,TWrex-treat
790084735,9/17/2015 12:05:47,1740398243,9/17/2015 12:05:18,False,prodege,0.8929,3587109,CAN,NS,Eskasoni,142.134.240.160,TRAZODONE treats NUTCRACKER ESOPHAGUS,141,9,,161,18,treats,0.9878783399,207550,"Finally, [TRAZODONE], an anti-depressant that reduces visceral sensitivity, has also been shown to reduce chest pain symptoms in patients with [NUTCRACKER ESOPHAGUS].",NUTCRACKER ESOPHAGUS,TRAZODONE,TWrex-treat
790084735,9/17/2015 12:12:01,1740399651,9/17/2015 12:09:41,False,prodege,0.9337,3056891,CAN,ON,Niagara Falls,173.238.144.19,TRAZODONE treats NUTCRACKER ESOPHAGUS,141,9,,161,18,treats,0.9878783399,207550,"Finally, [TRAZODONE], an anti-depressant that reduces visceral sensitivity, has also been shown to reduce chest pain symptoms in patients with [NUTCRACKER ESOPHAGUS].",NUTCRACKER ESOPHAGUS,TRAZODONE,TWrex-treat
790084764,9/17/2015 11:51:50,1740395419,9/17/2015 11:51:25,False,neodev,0.9464,12115558,USA,OH,Twinsburg,98.27.164.131,DOXYCYCLINE treats EARLY SYPHILIS,69,0,,82,11,treats,0.9594032236002471,803882,DOXYCYCLINE compared with benzathine penicillin for the treatment of EARLY SYPHILIS,EARLY SYPHILIS,DOXYCYCLINE,TWrex-cause
790084764,9/17/2015 11:54:00,1740395804,9/17/2015 11:53:35,False,elite,0.9722,29768955,GBR,C3,Gamlingay,31.50.187.165,DOXYCYCLINE treats EARLY SYPHILIS,69,0,,82,11,treats,0.9594032236002471,803882,DOXYCYCLINE compared with benzathine penicillin for the treatment of EARLY SYPHILIS,EARLY SYPHILIS,DOXYCYCLINE,TWrex-cause
790084764,9/17/2015 11:57:03,1740396453,9/17/2015 11:56:44,False,bitcoinget,0.7528,32306192,USA,TX,Austin,172.11.109.161,DOXYCYCLINE treats EARLY SYPHILIS,69,0,,82,11,treats,0.9594032236002471,803882,DOXYCYCLINE compared with benzathine penicillin for the treatment of EARLY SYPHILIS,EARLY SYPHILIS,DOXYCYCLINE,TWrex-cause
790084764,9/17/2015 12:03:14,1740397704,9/17/2015 12:02:06,False,gifthulk,0.9042,18666417,USA,PA,Meadville,24.101.32.13,DOXYCYCLINE treats EARLY SYPHILIS,69,0,,82,11,treats,0.9594032236002471,803882,DOXYCYCLINE compared with benzathine penicillin for the treatment of EARLY SYPHILIS,EARLY SYPHILIS,DOXYCYCLINE,TWrex-cause
790084764,9/17/2015 12:05:53,1740398269,9/17/2015 12:05:47,False,prodege,0.8929,3587109,CAN,NS,Eskasoni,142.134.240.160,DOXYCYCLINE treats EARLY SYPHILIS,69,0,,82,11,treats,0.9594032236002471,803882,DOXYCYCLINE compared with benzathine penicillin for the treatment of EARLY SYPHILIS,EARLY SYPHILIS,DOXYCYCLINE,TWrex-cause
790084764,9/17/2015 12:10:55,1740399448,9/17/2015 12:10:28,False,prodege,0.9438,9169061,CAN,ON,Kitchener,99.235.192.130,DOXYCYCLINE treats EARLY SYPHILIS,69,0,,82,11,treats,0.9594032236002471,803882,DOXYCYCLINE compared with benzathine penicillin for the treatment of EARLY SYPHILIS,EARLY SYPHILIS,DOXYCYCLINE,TWrex-cause
790084764,9/17/2015 12:12:36,1740399837,9/17/2015 12:12:02,False,prodege,0.9337,3056891,CAN,ON,Niagara Falls,173.238.144.19,DOXYCYCLINE treats EARLY SYPHILIS,69,0,,82,11,treats,0.9594032236002471,803882,DOXYCYCLINE compared with benzathine penicillin for the treatment of EARLY SYPHILIS,EARLY SYPHILIS,DOXYCYCLINE,TWrex-cause
790084766,9/17/2015 09:48:44,1740370520,9/17/2015 09:48:33,False,vivatic,0.9722,32338429,GBR,N7,Guildford,92.21.219.178,CARVEDILOL treats CONGESTIVE HEART FAILURE,68,40,,91,50,treats,0.948683298050514,803316,"Randomised, placebo controlled trial of CARVEDILOL in patients with CONGESTIVE HEART FAILURE due to ischaemic heart disease.",CONGESTIVE HEART FAILURE,CARVEDILOL,TWrex-cause
790084766,9/17/2015 10:17:17,1740377433,9/17/2015 10:16:43,False,pocketmoneygpt,0.8115,21432964,GBR,F8,Borehamwood,81.159.185.70,CARVEDILOL treats CONGESTIVE HEART FAILURE,68,40,,91,50,treats,0.948683298050514,803316,"Randomised, placebo controlled trial of CARVEDILOL in patients with CONGESTIVE HEART FAILURE due to ischaemic heart disease.",CONGESTIVE HEART FAILURE,CARVEDILOL,TWrex-cause
790084766,9/17/2015 10:18:27,1740377595,9/17/2015 10:17:29,False,eup_slw,0.8671,32718504,AUS,,,1.128.96.45,CARVEDILOL treats CONGESTIVE HEART FAILURE,68,40,,91,50,treats,0.948683298050514,803316,"Randomised, placebo controlled trial of CARVEDILOL in patients with CONGESTIVE HEART FAILURE due to ischaemic heart disease.",CONGESTIVE HEART FAILURE,CARVEDILOL,TWrex-cause
790084766,9/17/2015 10:42:00,1740382312,9/17/2015 10:41:47,False,clixsense,0.8667,6340330,USA,NY,Canajoharie,67.248.115.74,CARVEDILOL treats CONGESTIVE HEART FAILURE,68,40,,91,50,treats,0.948683298050514,803316,"Randomised, placebo controlled trial of CARVEDILOL in patients with CONGESTIVE HEART FAILURE due to ischaemic heart disease.",CONGESTIVE HEART FAILURE,CARVEDILOL,TWrex-cause
790084766,9/17/2015 11:00:10,1740385589,9/17/2015 10:53:36,False,points4rewards,0.7611,20113482,USA,PA,Philadelphia,162.208.49.45,no_relation,68,40,,91,50,treats,0.948683298050514,803316,"Randomised, placebo controlled trial of CARVEDILOL in patients with CONGESTIVE HEART FAILURE due to ischaemic heart disease.",CONGESTIVE HEART FAILURE,CARVEDILOL,TWrex-cause
790084766,9/17/2015 11:34:57,1740392065,9/17/2015 11:34:22,False,neodev,0.9127,30588889,NLD,07,Amsterdam,77.248.175.222,CARVEDILOL treats CONGESTIVE HEART FAILURE,68,40,,91,50,treats,0.948683298050514,803316,"Randomised, placebo controlled trial of CARVEDILOL in patients with CONGESTIVE HEART FAILURE due to ischaemic heart disease.",CONGESTIVE HEART FAILURE,CARVEDILOL,TWrex-cause
790084766,9/17/2015 11:37:05,1740392525,9/17/2015 11:36:59,False,elite,0.0,33798502,USA,VA,Manassas,207.244.86.212,CONGESTIVE HEART FAILURE treats CARVEDILOL,68,40,,91,50,treats,0.948683298050514,803316,"Randomised, placebo controlled trial of CARVEDILOL in patients with CONGESTIVE HEART FAILURE due to ischaemic heart disease.",CONGESTIVE HEART FAILURE,CARVEDILOL,TWrex-cause
790084768,9/17/2015 14:26:15,1740441756,9/17/2015 14:26:04,False,neodev,0.7083,33155316,GBR,I9,Dereham,31.50.244.140,EZETIMIBE treats FAMILIAL HYPERCHOLESTEROLEMIA,125,112,,153,121,treats,0.312347523777212,907942,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without EZETIMIBE in FAMILIAL HYPERCHOLESTEROLEMIA",FAMILIAL HYPERCHOLESTEROLEMIA,EZETIMIBE,RO-may_treat
790084768,9/17/2015 14:34:02,1740444780,9/17/2015 14:33:24,False,clixsense,0.7798,20587495,CAN,NL,St. John's,142.162.225.210,EZETIMIBE treats FAMILIAL HYPERCHOLESTEROLEMIA,125,112,,153,121,treats,0.312347523777212,907942,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without EZETIMIBE in FAMILIAL HYPERCHOLESTEROLEMIA",FAMILIAL HYPERCHOLESTEROLEMIA,EZETIMIBE,RO-may_treat
790084768,9/17/2015 14:38:59,1740446681,9/17/2015 14:38:40,False,tremorgames,0.7167,31906954,USA,NY,Goshen,184.9.83.232,no_relation,125,112,,153,121,treats,0.312347523777212,907942,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without EZETIMIBE in FAMILIAL HYPERCHOLESTEROLEMIA",FAMILIAL HYPERCHOLESTEROLEMIA,EZETIMIBE,RO-may_treat
790084768,9/17/2015 14:41:57,1740447988,9/17/2015 14:41:31,False,prodege,0.7421,27934334,GBR,C8,Croydon,81.159.60.206,EZETIMIBE treats FAMILIAL HYPERCHOLESTEROLEMIA,125,112,,153,121,treats,0.312347523777212,907942,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without EZETIMIBE in FAMILIAL HYPERCHOLESTEROLEMIA",FAMILIAL HYPERCHOLESTEROLEMIA,EZETIMIBE,RO-may_treat
790084768,9/17/2015 14:43:43,1740448689,9/17/2015 14:42:31,False,zoombucks,0.8806,6744840,CAN,BC,Kelowna,174.4.58.160,EZETIMIBE treats FAMILIAL HYPERCHOLESTEROLEMIA,125,112,,153,121,treats,0.312347523777212,907942,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without EZETIMIBE in FAMILIAL HYPERCHOLESTEROLEMIA",FAMILIAL HYPERCHOLESTEROLEMIA,EZETIMIBE,RO-may_treat
790084768,9/17/2015 15:01:25,1740455403,9/17/2015 15:00:53,False,instagc,0.6935,22981457,CAN,ON,Ottawa,67.69.8.122,no_relation,125,112,,153,121,treats,0.312347523777212,907942,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without EZETIMIBE in FAMILIAL HYPERCHOLESTEROLEMIA",FAMILIAL HYPERCHOLESTEROLEMIA,EZETIMIBE,RO-may_treat
790084768,9/17/2015 15:18:03,1740460940,9/17/2015 15:17:45,False,prodege,0.8849,14848125,GBR,V8,Airdrie,86.151.77.161,EZETIMIBE treats FAMILIAL HYPERCHOLESTEROLEMIA,125,112,,153,121,treats,0.312347523777212,907942,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without EZETIMIBE in FAMILIAL HYPERCHOLESTEROLEMIA",FAMILIAL HYPERCHOLESTEROLEMIA,EZETIMIBE,RO-may_treat
790084769,9/17/2015 14:48:36,1740450731,9/17/2015 14:47:04,False,zoombucks,0.8806,6744840,CAN,BC,Kelowna,174.4.58.160,INTERFERON ALFA THERAPY treats HCV ASSOCIATED CRYOGLOBULINEMIA,54,115,,84,138,treats,0.992277876713668,803707,"Evidence:  In one controlled study, 20 patients with HCV ASSOCIATED CRYOGLOBULINEMIA who had failed to respond to INTERFERON ALFA THERAPY were treated with rituximab; 16 had rapid and complete remission, which was sustained in 12 subjects ( 70.",HCV ASSOCIATED CRYOGLOBULINEMIA,INTERFERON ALFA THERAPY,TWrex-cause
790084769,9/17/2015 15:04:29,1740456618,9/17/2015 15:03:42,False,instagc,0.6935,22981457,CAN,ON,Ottawa,67.69.8.122,no_relation,54,115,,84,138,treats,0.992277876713668,803707,"Evidence:  In one controlled study, 20 patients with HCV ASSOCIATED CRYOGLOBULINEMIA who had failed to respond to INTERFERON ALFA THERAPY were treated with rituximab; 16 had rapid and complete remission, which was sustained in 12 subjects ( 70.",HCV ASSOCIATED CRYOGLOBULINEMIA,INTERFERON ALFA THERAPY,TWrex-cause
790084769,9/17/2015 15:18:45,1740461258,9/17/2015 15:18:34,False,prodege,0.8849,14848125,GBR,V8,Airdrie,86.151.77.161,INTERFERON ALFA THERAPY treats HCV ASSOCIATED CRYOGLOBULINEMIA,54,115,,84,138,treats,0.992277876713668,803707,"Evidence:  In one controlled study, 20 patients with HCV ASSOCIATED CRYOGLOBULINEMIA who had failed to respond to INTERFERON ALFA THERAPY were treated with rituximab; 16 had rapid and complete remission, which was sustained in 12 subjects ( 70.",HCV ASSOCIATED CRYOGLOBULINEMIA,INTERFERON ALFA THERAPY,TWrex-cause
790084769,9/17/2015 15:23:34,1740463075,9/17/2015 15:22:09,False,clixsense,0.9375,33878524,CAN,BC,Princeton,75.156.83.71,INTERFERON ALFA THERAPY treats HCV ASSOCIATED CRYOGLOBULINEMIA,54,115,,84,138,treats,0.992277876713668,803707,"Evidence:  In one controlled study, 20 patients with HCV ASSOCIATED CRYOGLOBULINEMIA who had failed to respond to INTERFERON ALFA THERAPY were treated with rituximab; 16 had rapid and complete remission, which was sustained in 12 subjects ( 70.",HCV ASSOCIATED CRYOGLOBULINEMIA,INTERFERON ALFA THERAPY,TWrex-cause
790084769,9/17/2015 15:37:00,1740468249,9/17/2015 15:36:32,False,instagc,0.823,31130954,USA,IL,Arlington Heights,99.135.174.103,INTERFERON ALFA THERAPY treats HCV ASSOCIATED CRYOGLOBULINEMIA,54,115,,84,138,treats,0.992277876713668,803707,"Evidence:  In one controlled study, 20 patients with HCV ASSOCIATED CRYOGLOBULINEMIA who had failed to respond to INTERFERON ALFA THERAPY were treated with rituximab; 16 had rapid and complete remission, which was sustained in 12 subjects ( 70.",HCV ASSOCIATED CRYOGLOBULINEMIA,INTERFERON ALFA THERAPY,TWrex-cause
790084769,9/17/2015 15:39:09,1740469287,9/17/2015 15:38:14,False,instagc,0.8681,19480545,USA,MA,Brookline,209.6.138.58,INTERFERON ALFA THERAPY treats HCV ASSOCIATED CRYOGLOBULINEMIA,54,115,,84,138,treats,0.992277876713668,803707,"Evidence:  In one controlled study, 20 patients with HCV ASSOCIATED CRYOGLOBULINEMIA who had failed to respond to INTERFERON ALFA THERAPY were treated with rituximab; 16 had rapid and complete remission, which was sustained in 12 subjects ( 70.",HCV ASSOCIATED CRYOGLOBULINEMIA,INTERFERON ALFA THERAPY,TWrex-cause
790084769,9/17/2015 15:46:43,1740472392,9/17/2015 15:46:17,False,clixsense,0.8673,24104564,AUS,02,Surry Hills,60.241.132.132,no_relation,54,115,,84,138,treats,0.992277876713668,803707,"Evidence:  In one controlled study, 20 patients with HCV ASSOCIATED CRYOGLOBULINEMIA who had failed to respond to INTERFERON ALFA THERAPY were treated with rituximab; 16 had rapid and complete remission, which was sustained in 12 subjects ( 70.",HCV ASSOCIATED CRYOGLOBULINEMIA,INTERFERON ALFA THERAPY,TWrex-cause
790084770,9/17/2015 12:16:10,1740400635,9/17/2015 12:15:04,False,prodege,0.9337,3056891,CAN,ON,Niagara Falls,173.238.144.19,[CORTICOSTEROIDS AND ORAL ANTIHISTAMINES] treats [ITCHING],66,8,,72,46,treats,0.9897433186107869,207687,Topical [CORTICOSTEROIDS AND ORAL ANTIHISTAMINES] can alleviate the [ITCHING] and decrease the size and number of lesions.,[ITCHING],[CORTICOSTEROIDS AND ORAL ANTIHISTAMINES],TWrex-treat
790084770,9/17/2015 12:22:44,1740401947,9/17/2015 12:22:12,False,gifthulk,0.9742,24928180,GBR,M1,Slough,90.208.18.156,[CORTICOSTEROIDS AND ORAL ANTIHISTAMINES] treats [ITCHING],66,8,,72,46,treats,0.9897433186107869,207687,Topical [CORTICOSTEROIDS AND ORAL ANTIHISTAMINES] can alleviate the [ITCHING] and decrease the size and number of lesions.,[ITCHING],[CORTICOSTEROIDS AND ORAL ANTIHISTAMINES],TWrex-treat
790084770,9/17/2015 12:27:57,1740403107,9/17/2015 12:26:59,False,clixsense,0.9881,21490235,GBR,N7,Woking,86.30.254.232,[CORTICOSTEROIDS AND ORAL ANTIHISTAMINES] treats [ITCHING],66,8,,72,46,treats,0.9897433186107869,207687,Topical [CORTICOSTEROIDS AND ORAL ANTIHISTAMINES] can alleviate the [ITCHING] and decrease the size and number of lesions.,[ITCHING],[CORTICOSTEROIDS AND ORAL ANTIHISTAMINES],TWrex-treat
790084770,9/17/2015 12:37:05,1740405388,9/17/2015 12:33:35,False,neodev,0.9028,18881135,CAN,ON,Ajax,99.243.87.224,[CORTICOSTEROIDS AND ORAL ANTIHISTAMINES] treats [ITCHING],66,8,,72,46,treats,0.9897433186107869,207687,Topical [CORTICOSTEROIDS AND ORAL ANTIHISTAMINES] can alleviate the [ITCHING] and decrease the size and number of lesions.,[ITCHING],[CORTICOSTEROIDS AND ORAL ANTIHISTAMINES],TWrex-treat
790084770,9/17/2015 12:51:26,1740409377,9/17/2015 12:49:53,False,clixsense,0.8792,21875134,GBR,,,80.189.12.98,[CORTICOSTEROIDS AND ORAL ANTIHISTAMINES] treats [ITCHING],66,8,,72,46,treats,0.9897433186107869,207687,Topical [CORTICOSTEROIDS AND ORAL ANTIHISTAMINES] can alleviate the [ITCHING] and decrease the size and number of lesions.,[ITCHING],[CORTICOSTEROIDS AND ORAL ANTIHISTAMINES],TWrex-treat
790084770,9/17/2015 12:54:29,1740410158,9/17/2015 12:54:02,False,clixsense,0.9292,10390268,USA,NY,New Paltz,100.40.130.164,[CORTICOSTEROIDS AND ORAL ANTIHISTAMINES] treats [ITCHING],66,8,,72,46,treats,0.9897433186107869,207687,Topical [CORTICOSTEROIDS AND ORAL ANTIHISTAMINES] can alleviate the [ITCHING] and decrease the size and number of lesions.,[ITCHING],[CORTICOSTEROIDS AND ORAL ANTIHISTAMINES],TWrex-treat
790084770,9/17/2015 13:00:53,1740411762,9/17/2015 13:00:36,False,clixsense,0.6516,17950689,GBR,L9,Sheffield,146.200.192.103,[ITCHING] treats [CORTICOSTEROIDS AND ORAL ANTIHISTAMINES],66,8,,72,46,treats,0.9897433186107869,207687,Topical [CORTICOSTEROIDS AND ORAL ANTIHISTAMINES] can alleviate the [ITCHING] and decrease the size and number of lesions.,[ITCHING],[CORTICOSTEROIDS AND ORAL ANTIHISTAMINES],TWrex-treat
790084781,9/17/2015 11:52:34,1740395543,9/17/2015 11:52:13,False,neodev,0.9464,12115558,USA,OH,Twinsburg,98.27.164.131,RIBAVIRIN treats CHRONIC HEPATITIS C,117,103,,135,112,treats,0.9897433186107869,800135,"Carrat F, Bani Sadr F, Pol S, et al: Pegylated interferon alfa 2b vs standard interferon alfa 2b, plus RIBAVIRIN for CHRONIC HEPATITIS C in HIV infected patients: a randomized controlled trial.",CHRONIC HEPATITIS C,RIBAVIRIN,TWrex-cause
790084781,9/17/2015 11:54:32,1740395934,9/17/2015 11:54:18,False,elite,0.9722,29768955,GBR,C3,Gamlingay,31.50.187.165,RIBAVIRIN treats CHRONIC HEPATITIS C,117,103,,135,112,treats,0.9897433186107869,800135,"Carrat F, Bani Sadr F, Pol S, et al: Pegylated interferon alfa 2b vs standard interferon alfa 2b, plus RIBAVIRIN for CHRONIC HEPATITIS C in HIV infected patients: a randomized controlled trial.",CHRONIC HEPATITIS C,RIBAVIRIN,TWrex-cause
790084781,9/17/2015 11:58:01,1740396682,9/17/2015 11:57:35,False,bitcoinget,0.7528,32306192,USA,TX,Austin,172.11.109.161,RIBAVIRIN treats CHRONIC HEPATITIS C,117,103,,135,112,treats,0.9897433186107869,800135,"Carrat F, Bani Sadr F, Pol S, et al: Pegylated interferon alfa 2b vs standard interferon alfa 2b, plus RIBAVIRIN for CHRONIC HEPATITIS C in HIV infected patients: a randomized controlled trial.",CHRONIC HEPATITIS C,RIBAVIRIN,TWrex-cause
790084781,9/17/2015 12:04:16,1740397944,9/17/2015 12:03:54,False,gifthulk,0.9042,18666417,USA,PA,Meadville,24.101.32.13,RIBAVIRIN treats CHRONIC HEPATITIS C,117,103,,135,112,treats,0.9897433186107869,800135,"Carrat F, Bani Sadr F, Pol S, et al: Pegylated interferon alfa 2b vs standard interferon alfa 2b, plus RIBAVIRIN for CHRONIC HEPATITIS C in HIV infected patients: a randomized controlled trial.",CHRONIC HEPATITIS C,RIBAVIRIN,TWrex-cause
790084781,9/17/2015 12:11:33,1740399550,9/17/2015 12:11:12,False,prodege,0.9438,9169061,CAN,ON,Kitchener,99.235.192.130,RIBAVIRIN treats CHRONIC HEPATITIS C,117,103,,135,112,treats,0.9897433186107869,800135,"Carrat F, Bani Sadr F, Pol S, et al: Pegylated interferon alfa 2b vs standard interferon alfa 2b, plus RIBAVIRIN for CHRONIC HEPATITIS C in HIV infected patients: a randomized controlled trial.",CHRONIC HEPATITIS C,RIBAVIRIN,TWrex-cause
790084781,9/17/2015 12:14:17,1740400246,9/17/2015 12:13:26,False,prodege,0.9337,3056891,CAN,ON,Niagara Falls,173.238.144.19,RIBAVIRIN treats CHRONIC HEPATITIS C,117,103,,135,112,treats,0.9897433186107869,800135,"Carrat F, Bani Sadr F, Pol S, et al: Pegylated interferon alfa 2b vs standard interferon alfa 2b, plus RIBAVIRIN for CHRONIC HEPATITIS C in HIV infected patients: a randomized controlled trial.",CHRONIC HEPATITIS C,RIBAVIRIN,TWrex-cause
790084781,9/17/2015 12:21:45,1740401685,9/17/2015 12:20:01,False,gifthulk,0.9742,24928180,GBR,M1,Slough,90.208.18.156,RIBAVIRIN treats CHRONIC HEPATITIS C,117,103,,135,112,treats,0.9897433186107869,800135,"Carrat F, Bani Sadr F, Pol S, et al: Pegylated interferon alfa 2b vs standard interferon alfa 2b, plus RIBAVIRIN for CHRONIC HEPATITIS C in HIV infected patients: a randomized controlled trial.",CHRONIC HEPATITIS C,RIBAVIRIN,TWrex-cause
791857666,9/21/2015 12:58:02,1743054023,9/21/2015 12:57:33,False,neodev,0.5476,31988911,USA,CA,Saratoga,107.178.43.21,no_relation,92,69,,120,87,treats,0.9667364890456641,907579,"Abdi EA, Nguyen GK, Ludwig RN et al. Pulmonary sarcoidosis following INTERFERON THERAPY for ADVANCED RENAL CELL CARCINOMA",ADVANCED RENAL CELL CARCINOMA,INTERFERON THERAPY,RO-may_treat
791857666,9/21/2015 13:02:33,1743055970,9/21/2015 13:00:30,False,neodev,0.7437,32216655,NLD,07,Amsterdam,145.100.72.166,INTERFERON THERAPY treats ADVANCED RENAL CELL CARCINOMA,92,69,,120,87,treats,0.9667364890456641,907579,"Abdi EA, Nguyen GK, Ludwig RN et al. Pulmonary sarcoidosis following INTERFERON THERAPY for ADVANCED RENAL CELL CARCINOMA",ADVANCED RENAL CELL CARCINOMA,INTERFERON THERAPY,RO-may_treat
791857666,9/21/2015 13:03:55,1743056599,9/21/2015 13:03:17,False,elite,0.8514,33238902,NLD,06,Budel,77.248.148.5,INTERFERON THERAPY treats ADVANCED RENAL CELL CARCINOMA,92,69,,120,87,treats,0.9667364890456641,907579,"Abdi EA, Nguyen GK, Ludwig RN et al. Pulmonary sarcoidosis following INTERFERON THERAPY for ADVANCED RENAL CELL CARCINOMA",ADVANCED RENAL CELL CARCINOMA,INTERFERON THERAPY,RO-may_treat
791857666,9/21/2015 13:21:33,1743065676,9/21/2015 13:21:07,False,neodev,0.899,18881135,CAN,ON,Ajax,99.243.87.224,INTERFERON THERAPY treats ADVANCED RENAL CELL CARCINOMA,92,69,,120,87,treats,0.9667364890456641,907579,"Abdi EA, Nguyen GK, Ludwig RN et al. Pulmonary sarcoidosis following INTERFERON THERAPY for ADVANCED RENAL CELL CARCINOMA",ADVANCED RENAL CELL CARCINOMA,INTERFERON THERAPY,RO-may_treat
791857666,9/21/2015 13:36:38,1743073169,9/21/2015 13:35:37,False,clixsense,0.9603,21875134,GBR,,,80.189.12.98,INTERFERON THERAPY treats ADVANCED RENAL CELL CARCINOMA,92,69,,120,87,treats,0.9667364890456641,907579,"Abdi EA, Nguyen GK, Ludwig RN et al. Pulmonary sarcoidosis following INTERFERON THERAPY for ADVANCED RENAL CELL CARCINOMA",ADVANCED RENAL CELL CARCINOMA,INTERFERON THERAPY,RO-may_treat
791857666,9/21/2015 13:38:04,1743075106,9/21/2015 13:37:48,False,prodege,0.7798,22031444,GBR,M4,Southampton,78.147.179.241,INTERFERON THERAPY treats ADVANCED RENAL CELL CARCINOMA,92,69,,120,87,treats,0.9667364890456641,907579,"Abdi EA, Nguyen GK, Ludwig RN et al. Pulmonary sarcoidosis following INTERFERON THERAPY for ADVANCED RENAL CELL CARCINOMA",ADVANCED RENAL CELL CARCINOMA,INTERFERON THERAPY,RO-may_treat
791857666,9/21/2015 13:41:58,1743077558,9/21/2015 13:41:47,False,instagc,0.9167,21017840,USA,DE,Newark,128.4.123.224,INTERFERON THERAPY treats ADVANCED RENAL CELL CARCINOMA,92,69,,120,87,treats,0.9667364890456641,907579,"Abdi EA, Nguyen GK, Ludwig RN et al. Pulmonary sarcoidosis following INTERFERON THERAPY for ADVANCED RENAL CELL CARCINOMA",ADVANCED RENAL CELL CARCINOMA,INTERFERON THERAPY,RO-may_treat
791857673,9/21/2015 11:12:13,1743020674,9/21/2015 11:11:49,False,prodege,0.8155,4316379,CAN,ON,Windsor,198.91.219.55,no_relation,137,99,,161,111,treats,0.8955334711889901,906549,We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with METHACHOLINE and the mechanism of the BRONCHIAL HYPERREACTIVITY in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors.,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,RO-may_diagnose
791857673,9/21/2015 11:12:56,1743020845,9/21/2015 11:12:15,False,instagc,0.7361,33467170,USA,WV,Martinsburg,76.106.109.7,no_relation,137,99,,161,111,treats,0.8955334711889901,906549,We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with METHACHOLINE and the mechanism of the BRONCHIAL HYPERREACTIVITY in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors.,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,RO-may_diagnose
791857673,9/21/2015 11:14:11,1743021186,9/21/2015 11:13:51,False,zoombucks,0.5417,4711962,CAN,ON,Markham,174.88.29.138,METHACHOLINE treats BRONCHIAL HYPERREACTIVITY,137,99,,161,111,treats,0.8955334711889901,906549,We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with METHACHOLINE and the mechanism of the BRONCHIAL HYPERREACTIVITY in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors.,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,RO-may_diagnose
791857673,9/21/2015 11:21:43,1743022986,9/21/2015 11:21:35,False,elite,0.0,33798502,USA,VA,Manassas,207.244.83.106,BRONCHIAL HYPERREACTIVITY treats METHACHOLINE,137,99,,161,111,treats,0.8955334711889901,906549,We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with METHACHOLINE and the mechanism of the BRONCHIAL HYPERREACTIVITY in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors.,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,RO-may_diagnose
791857673,9/21/2015 11:22:28,1743023220,9/21/2015 11:21:35,False,bitcoinget,0.7083,26471938,USA,TX,Missouri City,98.198.169.91,METHACHOLINE treats BRONCHIAL HYPERREACTIVITY,137,99,,161,111,treats,0.8955334711889901,906549,We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with METHACHOLINE and the mechanism of the BRONCHIAL HYPERREACTIVITY in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors.,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,RO-may_diagnose
791857673,9/21/2015 11:32:10,1743026273,9/21/2015 11:31:04,False,fusioncash,0.7514,31742806,USA,OH,Kent,66.61.82.242,METHACHOLINE treats BRONCHIAL HYPERREACTIVITY,137,99,,161,111,treats,0.8955334711889901,906549,We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with METHACHOLINE and the mechanism of the BRONCHIAL HYPERREACTIVITY in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors.,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,RO-may_diagnose
791857673,9/21/2015 11:40:23,1743028589,9/21/2015 11:39:45,False,prodege,0.6286,6309240,USA,CA,San Diego,76.167.68.73,no_relation,137,99,,161,111,treats,0.8955334711889901,906549,We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with METHACHOLINE and the mechanism of the BRONCHIAL HYPERREACTIVITY in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors.,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,RO-may_diagnose
791857680,9/21/2015 12:43:12,1743048039,9/21/2015 12:42:44,False,clixsense,0.8881,32053717,GBR,,,51.174.76.80,[GUAIFENESIN KETAMINE XYLAZINE ANESTHESIA] treats [EQUINE DYSTOCIA],81,36,,96,75,treats,0.99124070716193,220014,title = A case report on the use of [GUAIFENESIN KETAMINE XYLAZINE ANESTHESIA] for [EQUINE DYSTOCIA],[EQUINE DYSTOCIA],[GUAIFENESIN KETAMINE XYLAZINE ANESTHESIA],TWrex-treat
791857680,9/21/2015 12:52:23,1743052034,9/21/2015 12:52:00,False,neodev,0.8448,33011398,USA,VA,Manassas,207.244.86.212,[GUAIFENESIN KETAMINE XYLAZINE ANESTHESIA] treats [EQUINE DYSTOCIA],81,36,,96,75,treats,0.99124070716193,220014,title = A case report on the use of [GUAIFENESIN KETAMINE XYLAZINE ANESTHESIA] for [EQUINE DYSTOCIA],[EQUINE DYSTOCIA],[GUAIFENESIN KETAMINE XYLAZINE ANESTHESIA],TWrex-treat
791857680,9/21/2015 12:56:46,1743053593,9/21/2015 12:56:31,False,neodev,0.5476,31988911,USA,CA,Saratoga,107.178.43.21,no_relation,81,36,,96,75,treats,0.99124070716193,220014,title = A case report on the use of [GUAIFENESIN KETAMINE XYLAZINE ANESTHESIA] for [EQUINE DYSTOCIA],[EQUINE DYSTOCIA],[GUAIFENESIN KETAMINE XYLAZINE ANESTHESIA],TWrex-treat
791857680,9/21/2015 12:57:32,1743053845,9/21/2015 12:56:23,False,neodev,0.7437,32216655,NLD,07,Amsterdam,145.100.72.166,[GUAIFENESIN KETAMINE XYLAZINE ANESTHESIA] treats [EQUINE DYSTOCIA],81,36,,96,75,treats,0.99124070716193,220014,title = A case report on the use of [GUAIFENESIN KETAMINE XYLAZINE ANESTHESIA] for [EQUINE DYSTOCIA],[EQUINE DYSTOCIA],[GUAIFENESIN KETAMINE XYLAZINE ANESTHESIA],TWrex-treat
791857680,9/21/2015 13:02:19,1743055839,9/21/2015 13:01:29,False,elite,0.8514,33238902,NLD,06,Budel,77.248.148.5,[GUAIFENESIN KETAMINE XYLAZINE ANESTHESIA] treats [EQUINE DYSTOCIA],81,36,,96,75,treats,0.99124070716193,220014,title = A case report on the use of [GUAIFENESIN KETAMINE XYLAZINE ANESTHESIA] for [EQUINE DYSTOCIA],[EQUINE DYSTOCIA],[GUAIFENESIN KETAMINE XYLAZINE ANESTHESIA],TWrex-treat
791857680,9/21/2015 13:14:23,1743062100,9/21/2015 13:14:17,False,clixsense,0.7,19162475,GBR,P8,Trowbridge,82.33.126.30,[GUAIFENESIN KETAMINE XYLAZINE ANESTHESIA] treats [EQUINE DYSTOCIA],81,36,,96,75,treats,0.99124070716193,220014,title = A case report on the use of [GUAIFENESIN KETAMINE XYLAZINE ANESTHESIA] for [EQUINE DYSTOCIA],[EQUINE DYSTOCIA],[GUAIFENESIN KETAMINE XYLAZINE ANESTHESIA],TWrex-treat
791857680,9/21/2015 13:20:32,1743065148,9/21/2015 13:19:43,False,neodev,0.899,18881135,CAN,ON,Ajax,99.243.87.224,[GUAIFENESIN KETAMINE XYLAZINE ANESTHESIA] treats [EQUINE DYSTOCIA],81,36,,96,75,treats,0.99124070716193,220014,title = A case report on the use of [GUAIFENESIN KETAMINE XYLAZINE ANESTHESIA] for [EQUINE DYSTOCIA],[EQUINE DYSTOCIA],[GUAIFENESIN KETAMINE XYLAZINE ANESTHESIA],TWrex-treat
791857683,9/21/2015 12:44:03,1743048365,9/21/2015 12:43:31,False,clixsense,0.8881,32053717,GBR,,,51.174.76.80,CLONIDINE treats TAMOXIFEN ASSOCIATED HOT FLASHES,37,0,,68,9,treats,0.986393923832144,907723,CLONIDINE was effective for reducing TAMOXIFEN ASSOCIATED HOT FLASHES in postmenopausal women with breast cancer  Keywords: Breast neoplasms Hot flashes Tamoxifen  ACP Journal Club.,TAMOXIFEN ASSOCIATED HOT FLASHES,CLONIDINE,RO-may_treat
791857683,9/21/2015 12:53:03,1743052248,9/21/2015 12:52:24,False,neodev,0.8448,33011398,USA,VA,Manassas,207.244.86.212,CLONIDINE treats TAMOXIFEN ASSOCIATED HOT FLASHES,37,0,,68,9,treats,0.986393923832144,907723,CLONIDINE was effective for reducing TAMOXIFEN ASSOCIATED HOT FLASHES in postmenopausal women with breast cancer  Keywords: Breast neoplasms Hot flashes Tamoxifen  ACP Journal Club.,TAMOXIFEN ASSOCIATED HOT FLASHES,CLONIDINE,RO-may_treat
791857683,9/21/2015 12:57:08,1743053716,9/21/2015 12:56:46,False,neodev,0.5476,31988911,USA,CA,Saratoga,107.178.43.21,no_relation,37,0,,68,9,treats,0.986393923832144,907723,CLONIDINE was effective for reducing TAMOXIFEN ASSOCIATED HOT FLASHES in postmenopausal women with breast cancer  Keywords: Breast neoplasms Hot flashes Tamoxifen  ACP Journal Club.,TAMOXIFEN ASSOCIATED HOT FLASHES,CLONIDINE,RO-may_treat
791857683,9/21/2015 12:59:24,1743054552,9/21/2015 12:57:33,False,neodev,0.7437,32216655,NLD,07,Amsterdam,145.100.72.166,CLONIDINE treats TAMOXIFEN ASSOCIATED HOT FLASHES,37,0,,68,9,treats,0.986393923832144,907723,CLONIDINE was effective for reducing TAMOXIFEN ASSOCIATED HOT FLASHES in postmenopausal women with breast cancer  Keywords: Breast neoplasms Hot flashes Tamoxifen  ACP Journal Club.,TAMOXIFEN ASSOCIATED HOT FLASHES,CLONIDINE,RO-may_treat
791857683,9/21/2015 13:02:48,1743056084,9/21/2015 13:02:21,False,elite,0.8514,33238902,NLD,06,Budel,77.248.148.5,CLONIDINE treats TAMOXIFEN ASSOCIATED HOT FLASHES,37,0,,68,9,treats,0.986393923832144,907723,CLONIDINE was effective for reducing TAMOXIFEN ASSOCIATED HOT FLASHES in postmenopausal women with breast cancer  Keywords: Breast neoplasms Hot flashes Tamoxifen  ACP Journal Club.,TAMOXIFEN ASSOCIATED HOT FLASHES,CLONIDINE,RO-may_treat
791857683,9/21/2015 13:20:52,1743065351,9/21/2015 13:20:38,False,neodev,0.899,18881135,CAN,ON,Ajax,99.243.87.224,CLONIDINE treats TAMOXIFEN ASSOCIATED HOT FLASHES,37,0,,68,9,treats,0.986393923832144,907723,CLONIDINE was effective for reducing TAMOXIFEN ASSOCIATED HOT FLASHES in postmenopausal women with breast cancer  Keywords: Breast neoplasms Hot flashes Tamoxifen  ACP Journal Club.,TAMOXIFEN ASSOCIATED HOT FLASHES,CLONIDINE,RO-may_treat
791857683,9/21/2015 13:44:43,1743079048,9/21/2015 13:44:34,False,clixsense,0.8333,14353703,USA,IA,Cedar Rapids,173.18.40.82,CLONIDINE treats TAMOXIFEN ASSOCIATED HOT FLASHES,37,0,,68,9,treats,0.986393923832144,907723,CLONIDINE was effective for reducing TAMOXIFEN ASSOCIATED HOT FLASHES in postmenopausal women with breast cancer  Keywords: Breast neoplasms Hot flashes Tamoxifen  ACP Journal Club.,TAMOXIFEN ASSOCIATED HOT FLASHES,CLONIDINE,RO-may_treat
791857684,9/21/2015 11:13:12,1743020893,9/21/2015 11:12:42,False,prodege,0.8155,4316379,CAN,ON,Windsor,198.91.219.55,PARACETAMOL treats MINOR PAIN,74,0,,83,11,treats,0.9284766908852591,908294,PARACETAMOL (acetaminophen) was the most common alternative analgesic for MINOR PAIN,MINOR PAIN,PARACETAMOL,RO-may_treat
791857684,9/21/2015 11:14:40,1743021302,9/21/2015 11:13:26,False,instagc,0.7361,33467170,USA,WV,Martinsburg,76.106.109.7,PARACETAMOL treats MINOR PAIN,74,0,,83,11,treats,0.9284766908852591,908294,PARACETAMOL (acetaminophen) was the most common alternative analgesic for MINOR PAIN,MINOR PAIN,PARACETAMOL,RO-may_treat
791857684,9/21/2015 11:24:50,1743024088,9/21/2015 11:24:03,False,bitcoinget,0.7083,26471938,USA,TX,Missouri City,98.198.169.91,no_relation,74,0,,83,11,treats,0.9284766908852591,908294,PARACETAMOL (acetaminophen) was the most common alternative analgesic for MINOR PAIN,MINOR PAIN,PARACETAMOL,RO-may_treat
791857684,9/21/2015 11:33:21,1743026623,9/21/2015 11:32:31,False,fusioncash,0.7514,31742806,USA,OH,Kent,66.61.82.242,PARACETAMOL treats MINOR PAIN,74,0,,83,11,treats,0.9284766908852591,908294,PARACETAMOL (acetaminophen) was the most common alternative analgesic for MINOR PAIN,MINOR PAIN,PARACETAMOL,RO-may_treat
791857684,9/21/2015 11:41:40,1743029030,9/21/2015 11:41:13,False,prodege,0.6286,6309240,USA,CA,San Diego,76.167.68.73,PARACETAMOL treats MINOR PAIN,74,0,,83,11,treats,0.9284766908852591,908294,PARACETAMOL (acetaminophen) was the most common alternative analgesic for MINOR PAIN,MINOR PAIN,PARACETAMOL,RO-may_treat
791857684,9/21/2015 11:57:51,1743034291,9/21/2015 11:50:36,False,neodev,0.6125,32987272,USA,NY,Albany,74.76.228.48,PARACETAMOL treats MINOR PAIN,74,0,,83,11,treats,0.9284766908852591,908294,PARACETAMOL (acetaminophen) was the most common alternative analgesic for MINOR PAIN,MINOR PAIN,PARACETAMOL,RO-may_treat
791857684,9/21/2015 11:59:33,1743034902,9/21/2015 11:51:41,False,points4rewards,0.5595,20113482,USA,PA,Philadelphia,162.208.49.45,PARACETAMOL treats MINOR PAIN,74,0,,83,11,treats,0.9284766908852591,908294,PARACETAMOL (acetaminophen) was the most common alternative analgesic for MINOR PAIN,MINOR PAIN,PARACETAMOL,RO-may_treat
791857690,9/21/2015 15:37:17,1743150674,9/21/2015 15:37:05,False,instagc,0.9833,21551272,GBR,Q3,Wolverhampton,80.43.83.1,ACEBUTOLOL treats ESSENTIAL HYPERTENSION,138,71,,159,81,treats,0.707106781186548,803478,"Thibonnier M, Lardoux MD, Corvol P. Comparative trial of labetalol and ACEBUTOLOL alone or associated with dihydralazine, in treatment of ESSENTIAL HYPERTENSION",ESSENTIAL HYPERTENSION,ACEBUTOLOL,TWrex-cause
791857690,9/21/2015 15:45:29,1743156152,9/21/2015 15:44:34,False,clixsense,0.8492,33878524,CAN,BC,Princeton,75.156.83.71,ACEBUTOLOL treats ESSENTIAL HYPERTENSION,138,71,,159,81,treats,0.707106781186548,803478,"Thibonnier M, Lardoux MD, Corvol P. Comparative trial of labetalol and ACEBUTOLOL alone or associated with dihydralazine, in treatment of ESSENTIAL HYPERTENSION",ESSENTIAL HYPERTENSION,ACEBUTOLOL,TWrex-cause
791857690,9/21/2015 15:56:54,1743163576,9/21/2015 15:54:57,False,tremorgames,0.6349,33691253,USA,CA,San Jose,50.118.172.10,ESSENTIAL HYPERTENSION treats ACEBUTOLOL,138,71,,159,81,treats,0.707106781186548,803478,"Thibonnier M, Lardoux MD, Corvol P. Comparative trial of labetalol and ACEBUTOLOL alone or associated with dihydralazine, in treatment of ESSENTIAL HYPERTENSION",ESSENTIAL HYPERTENSION,ACEBUTOLOL,TWrex-cause
791857690,9/21/2015 16:04:12,1743168297,9/21/2015 16:03:59,False,bitcoinget,0.7242,32306192,USA,TX,El Paso,99.47.138.44,ACEBUTOLOL treats ESSENTIAL HYPERTENSION,138,71,,159,81,treats,0.707106781186548,803478,"Thibonnier M, Lardoux MD, Corvol P. Comparative trial of labetalol and ACEBUTOLOL alone or associated with dihydralazine, in treatment of ESSENTIAL HYPERTENSION",ESSENTIAL HYPERTENSION,ACEBUTOLOL,TWrex-cause
791857690,9/21/2015 16:05:34,1743169262,9/21/2015 16:04:57,False,gifthulk,0.8083,18666417,USA,PA,Meadville,24.101.32.13,ACEBUTOLOL treats ESSENTIAL HYPERTENSION,138,71,,159,81,treats,0.707106781186548,803478,"Thibonnier M, Lardoux MD, Corvol P. Comparative trial of labetalol and ACEBUTOLOL alone or associated with dihydralazine, in treatment of ESSENTIAL HYPERTENSION",ESSENTIAL HYPERTENSION,ACEBUTOLOL,TWrex-cause
791857690,9/21/2015 16:05:41,1743169313,9/21/2015 16:05:31,False,neodev,0.5833,33155316,GBR,I9,Dereham,31.50.245.178,ACEBUTOLOL treats ESSENTIAL HYPERTENSION,138,71,,159,81,treats,0.707106781186548,803478,"Thibonnier M, Lardoux MD, Corvol P. Comparative trial of labetalol and ACEBUTOLOL alone or associated with dihydralazine, in treatment of ESSENTIAL HYPERTENSION",ESSENTIAL HYPERTENSION,ACEBUTOLOL,TWrex-cause
791857690,9/21/2015 16:31:33,1743184977,9/21/2015 16:31:25,False,prodege,0.0833,2143114,CAN,BC,Vancouver,24.85.153.181,ESSENTIAL HYPERTENSION treats ACEBUTOLOL,138,71,,159,81,treats,0.707106781186548,803478,"Thibonnier M, Lardoux MD, Corvol P. Comparative trial of labetalol and ACEBUTOLOL alone or associated with dihydralazine, in treatment of ESSENTIAL HYPERTENSION",ESSENTIAL HYPERTENSION,ACEBUTOLOL,TWrex-cause
791857699,9/21/2015 16:08:48,1743171195,9/21/2015 16:07:59,False,gifthulk,0.8083,18666417,USA,PA,Meadville,24.101.32.13,L DOPA WITH PERIPHERAL DECARBOXYLASE treats PARKINSON'S SYNDROME,20,71,,39,107,treats,0.979957887012223,908179,In 38 patients with PARKINSON'S SYNDROME Madopar preparation was used (L DOPA WITH PERIPHERAL DECARBOXYLASE inhibitor) in 33 cases as the main drug and in 5 cases as an addition to L dopa.,PARKINSON'S SYNDROME,L DOPA WITH PERIPHERAL DECARBOXYLASE,RO-may_treat
791857699,9/21/2015 16:39:01,1743189388,9/21/2015 16:38:19,False,clixsense,0.8518,32254355,CAN,ON,London,65.93.118.3,L DOPA WITH PERIPHERAL DECARBOXYLASE treats PARKINSON'S SYNDROME,20,71,,39,107,treats,0.979957887012223,908179,In 38 patients with PARKINSON'S SYNDROME Madopar preparation was used (L DOPA WITH PERIPHERAL DECARBOXYLASE inhibitor) in 33 cases as the main drug and in 5 cases as an addition to L dopa.,PARKINSON'S SYNDROME,L DOPA WITH PERIPHERAL DECARBOXYLASE,RO-may_treat
791857699,9/21/2015 16:51:21,1743195635,9/21/2015 16:42:42,False,clixsense,0.75,6344072,CAN,BC,Burnaby,172.218.166.58,L DOPA WITH PERIPHERAL DECARBOXYLASE treats PARKINSON'S SYNDROME,20,71,,39,107,treats,0.979957887012223,908179,In 38 patients with PARKINSON'S SYNDROME Madopar preparation was used (L DOPA WITH PERIPHERAL DECARBOXYLASE inhibitor) in 33 cases as the main drug and in 5 cases as an addition to L dopa.,PARKINSON'S SYNDROME,L DOPA WITH PERIPHERAL DECARBOXYLASE,RO-may_treat
791857699,9/21/2015 17:00:34,1743200618,9/21/2015 16:59:29,False,prodege,0.7976,13642047,GBR,H9,London,94.174.85.56,L DOPA WITH PERIPHERAL DECARBOXYLASE treats PARKINSON'S SYNDROME,20,71,,39,107,treats,0.979957887012223,908179,In 38 patients with PARKINSON'S SYNDROME Madopar preparation was used (L DOPA WITH PERIPHERAL DECARBOXYLASE inhibitor) in 33 cases as the main drug and in 5 cases as an addition to L dopa.,PARKINSON'S SYNDROME,L DOPA WITH PERIPHERAL DECARBOXYLASE,RO-may_treat
791857699,9/21/2015 17:17:14,1743209525,9/21/2015 17:17:03,False,instagc,0.8125,26024737,GBR,H2,Preston,92.22.253.214,L DOPA WITH PERIPHERAL DECARBOXYLASE treats PARKINSON'S SYNDROME,20,71,,39,107,treats,0.979957887012223,908179,In 38 patients with PARKINSON'S SYNDROME Madopar preparation was used (L DOPA WITH PERIPHERAL DECARBOXYLASE inhibitor) in 33 cases as the main drug and in 5 cases as an addition to L dopa.,PARKINSON'S SYNDROME,L DOPA WITH PERIPHERAL DECARBOXYLASE,RO-may_treat
791857699,9/21/2015 17:21:15,1743211625,9/21/2015 17:20:47,False,instagc,0.75,30398579,USA,MA,Winchendon,73.38.174.116,L DOPA WITH PERIPHERAL DECARBOXYLASE treats PARKINSON'S SYNDROME,20,71,,39,107,treats,0.979957887012223,908179,In 38 patients with PARKINSON'S SYNDROME Madopar preparation was used (L DOPA WITH PERIPHERAL DECARBOXYLASE inhibitor) in 33 cases as the main drug and in 5 cases as an addition to L dopa.,PARKINSON'S SYNDROME,L DOPA WITH PERIPHERAL DECARBOXYLASE,RO-may_treat
791857699,9/21/2015 17:30:57,1743216964,9/21/2015 17:30:37,False,prodege,0.7857,13300986,CAN,AB,Edmonton,68.150.40.134,L DOPA WITH PERIPHERAL DECARBOXYLASE treats PARKINSON'S SYNDROME,20,71,,39,107,treats,0.979957887012223,908179,In 38 patients with PARKINSON'S SYNDROME Madopar preparation was used (L DOPA WITH PERIPHERAL DECARBOXYLASE inhibitor) in 33 cases as the main drug and in 5 cases as an addition to L dopa.,PARKINSON'S SYNDROME,L DOPA WITH PERIPHERAL DECARBOXYLASE,RO-may_treat
791857706,9/21/2015 15:59:16,1743165006,9/21/2015 15:58:43,False,tremorgames,0.6349,33691253,USA,CA,San Jose,50.118.172.10,no_relation,154,5,,169,16,treats,0.41931393468876704,210995,"When [HYOSCYAMINE] is used along with opioids or other anti-peristaltic agents, measures to prevent constipation are especially important given the risk of [PARALYTIC ILEUS].",PARALYTIC ILEUS,HYOSCYAMINE,TWrex-treat
791857706,9/21/2015 16:04:59,1743168858,9/21/2015 16:04:49,False,bitcoinget,0.7242,32306192,USA,TX,El Paso,99.47.138.44,HYOSCYAMINE treats PARALYTIC ILEUS,154,5,,169,16,treats,0.41931393468876704,210995,"When [HYOSCYAMINE] is used along with opioids or other anti-peristaltic agents, measures to prevent constipation are especially important given the risk of [PARALYTIC ILEUS].",PARALYTIC ILEUS,HYOSCYAMINE,TWrex-treat
791857706,9/21/2015 16:07:35,1743170522,9/21/2015 16:07:04,False,gifthulk,0.8083,18666417,USA,PA,Meadville,24.101.32.13,HYOSCYAMINE treats PARALYTIC ILEUS,154,5,,169,16,treats,0.41931393468876704,210995,"When [HYOSCYAMINE] is used along with opioids or other anti-peristaltic agents, measures to prevent constipation are especially important given the risk of [PARALYTIC ILEUS].",PARALYTIC ILEUS,HYOSCYAMINE,TWrex-treat
791857706,9/21/2015 16:12:07,1743172989,9/21/2015 16:11:54,False,instagc,0.7833,13581319,USA,IL,Trenton,208.70.36.12,HYOSCYAMINE treats PARALYTIC ILEUS,154,5,,169,16,treats,0.41931393468876704,210995,"When [HYOSCYAMINE] is used along with opioids or other anti-peristaltic agents, measures to prevent constipation are especially important given the risk of [PARALYTIC ILEUS].",PARALYTIC ILEUS,HYOSCYAMINE,TWrex-treat
791857706,9/21/2015 16:37:51,1743188827,9/21/2015 16:37:16,False,clixsense,0.8518,32254355,CAN,ON,London,65.93.118.3,HYOSCYAMINE treats PARALYTIC ILEUS,154,5,,169,16,treats,0.41931393468876704,210995,"When [HYOSCYAMINE] is used along with opioids or other anti-peristaltic agents, measures to prevent constipation are especially important given the risk of [PARALYTIC ILEUS].",PARALYTIC ILEUS,HYOSCYAMINE,TWrex-treat
791857706,9/21/2015 16:42:26,1743191132,9/21/2015 16:41:14,False,clixsense,0.75,6344072,CAN,BC,Burnaby,172.218.166.58,no_relation,154,5,,169,16,treats,0.41931393468876704,210995,"When [HYOSCYAMINE] is used along with opioids or other anti-peristaltic agents, measures to prevent constipation are especially important given the risk of [PARALYTIC ILEUS].",PARALYTIC ILEUS,HYOSCYAMINE,TWrex-treat
791857706,9/21/2015 16:59:09,1743199885,9/21/2015 16:58:19,False,prodege,0.7976,13642047,GBR,H9,London,94.174.85.56,no_relation,154,5,,169,16,treats,0.41931393468876704,210995,"When [HYOSCYAMINE] is used along with opioids or other anti-peristaltic agents, measures to prevent constipation are especially important given the risk of [PARALYTIC ILEUS].",PARALYTIC ILEUS,HYOSCYAMINE,TWrex-treat
791857707,9/21/2015 12:53:28,1743052410,9/21/2015 12:53:04,False,neodev,0.8448,33011398,USA,VA,Manassas,207.244.86.212,AMOXYCILLIN treats URINARY INFECTION,92,40,,108,51,treats,1.0,800684,"Al Roomi LG, Sutton AM, Cockburn F et alAMOXYCILLIN and clavulanic acid in the treatment of URINARY INFECTION",URINARY INFECTION,AMOXYCILLIN,TWrex-cause
791857707,9/21/2015 12:57:33,1743053847,9/21/2015 12:57:08,False,neodev,0.5476,31988911,USA,CA,Saratoga,107.178.43.21,AMOXYCILLIN treats URINARY INFECTION,92,40,,108,51,treats,1.0,800684,"Al Roomi LG, Sutton AM, Cockburn F et alAMOXYCILLIN and clavulanic acid in the treatment of URINARY INFECTION",URINARY INFECTION,AMOXYCILLIN,TWrex-cause
791857707,9/21/2015 13:00:29,1743055122,9/21/2015 12:59:25,False,neodev,0.7437,32216655,NLD,07,Amsterdam,145.100.72.166,AMOXYCILLIN treats URINARY INFECTION,92,40,,108,51,treats,1.0,800684,"Al Roomi LG, Sutton AM, Cockburn F et alAMOXYCILLIN and clavulanic acid in the treatment of URINARY INFECTION",URINARY INFECTION,AMOXYCILLIN,TWrex-cause
791857707,9/21/2015 13:03:16,1743056312,9/21/2015 13:02:49,False,elite,0.8514,33238902,NLD,06,Budel,77.248.148.5,AMOXYCILLIN treats URINARY INFECTION,92,40,,108,51,treats,1.0,800684,"Al Roomi LG, Sutton AM, Cockburn F et alAMOXYCILLIN and clavulanic acid in the treatment of URINARY INFECTION",URINARY INFECTION,AMOXYCILLIN,TWrex-cause
791857707,9/21/2015 13:21:06,1743065476,9/21/2015 13:20:53,False,neodev,0.899,18881135,CAN,ON,Ajax,99.243.87.224,AMOXYCILLIN treats URINARY INFECTION,92,40,,108,51,treats,1.0,800684,"Al Roomi LG, Sutton AM, Cockburn F et alAMOXYCILLIN and clavulanic acid in the treatment of URINARY INFECTION",URINARY INFECTION,AMOXYCILLIN,TWrex-cause
791857707,9/21/2015 13:35:37,1743072762,9/21/2015 13:34:52,False,clixsense,0.9603,21875134,GBR,,,80.189.12.98,AMOXYCILLIN treats URINARY INFECTION,92,40,,108,51,treats,1.0,800684,"Al Roomi LG, Sutton AM, Cockburn F et alAMOXYCILLIN and clavulanic acid in the treatment of URINARY INFECTION",URINARY INFECTION,AMOXYCILLIN,TWrex-cause
791857707,9/21/2015 13:37:47,1743074598,9/21/2015 13:37:32,False,prodege,0.7798,22031444,GBR,M4,Southampton,78.147.179.241,AMOXYCILLIN treats URINARY INFECTION,92,40,,108,51,treats,1.0,800684,"Al Roomi LG, Sutton AM, Cockburn F et alAMOXYCILLIN and clavulanic acid in the treatment of URINARY INFECTION",URINARY INFECTION,AMOXYCILLIN,TWrex-cause
791857710,9/21/2015 08:32:36,1742978932,9/21/2015 08:32:17,False,clixsense,1.0,22751911,NLD,04,Groningen,195.241.153.97,ALTEPLASE treats MYOCARDIAL INFARCTION,153,126,,173,135,treats,0.9931270663228421,908164,"An initial heparin bolus of 60 U/kg (maximum, 4000 U) followed by a 12 U/kg/h infusion (maximum 1000 U/h) is recommended with ALTEPLASE for ST elevation MYOCARDIAL INFARCTION",MYOCARDIAL INFARCTION,ALTEPLASE,RO-may_treat
791857710,9/21/2015 08:39:05,1742981060,9/21/2015 08:38:25,False,clixsense,0.9306,30681826,GBR,I9,Diss,31.49.71.254,ALTEPLASE treats MYOCARDIAL INFARCTION,153,126,,173,135,treats,0.9931270663228421,908164,"An initial heparin bolus of 60 U/kg (maximum, 4000 U) followed by a 12 U/kg/h infusion (maximum 1000 U/h) is recommended with ALTEPLASE for ST elevation MYOCARDIAL INFARCTION",MYOCARDIAL INFARCTION,ALTEPLASE,RO-may_treat
791857710,9/21/2015 08:43:09,1742982269,9/21/2015 08:42:55,False,neodev,0.9167,30627835,GBR,D8,Bishop Auckland,217.44.84.223,ALTEPLASE treats MYOCARDIAL INFARCTION,153,126,,173,135,treats,0.9931270663228421,908164,"An initial heparin bolus of 60 U/kg (maximum, 4000 U) followed by a 12 U/kg/h infusion (maximum 1000 U/h) is recommended with ALTEPLASE for ST elevation MYOCARDIAL INFARCTION",MYOCARDIAL INFARCTION,ALTEPLASE,RO-may_treat
791857710,9/21/2015 08:46:36,1742983402,9/21/2015 08:46:05,False,pocketmoneygpt,0.8833,21432964,GBR,F8,Borehamwood,81.159.185.70,ALTEPLASE treats MYOCARDIAL INFARCTION,153,126,,173,135,treats,0.9931270663228421,908164,"An initial heparin bolus of 60 U/kg (maximum, 4000 U) followed by a 12 U/kg/h infusion (maximum 1000 U/h) is recommended with ALTEPLASE for ST elevation MYOCARDIAL INFARCTION",MYOCARDIAL INFARCTION,ALTEPLASE,RO-may_treat
791857710,9/21/2015 08:48:22,1742983910,9/21/2015 08:48:14,False,elite,0.75,32799278,GBR,,,81.136.60.168,ALTEPLASE treats MYOCARDIAL INFARCTION,153,126,,173,135,treats,0.9931270663228421,908164,"An initial heparin bolus of 60 U/kg (maximum, 4000 U) followed by a 12 U/kg/h infusion (maximum 1000 U/h) is recommended with ALTEPLASE for ST elevation MYOCARDIAL INFARCTION",MYOCARDIAL INFARCTION,ALTEPLASE,RO-may_treat
791857710,9/21/2015 09:04:46,1742988637,9/21/2015 09:04:20,False,prodege,0.85,32850083,GBR,L9,Sheffield,92.239.198.197,ALTEPLASE treats MYOCARDIAL INFARCTION,153,126,,173,135,treats,0.9931270663228421,908164,"An initial heparin bolus of 60 U/kg (maximum, 4000 U) followed by a 12 U/kg/h infusion (maximum 1000 U/h) is recommended with ALTEPLASE for ST elevation MYOCARDIAL INFARCTION",MYOCARDIAL INFARCTION,ALTEPLASE,RO-may_treat
791857710,9/21/2015 09:05:49,1742988900,9/21/2015 09:05:03,False,neodev,0.7798,33644825,USA,FL,Fort Lauderdale,65.111.173.161,ALTEPLASE treats MYOCARDIAL INFARCTION,153,126,,173,135,treats,0.9931270663228421,908164,"An initial heparin bolus of 60 U/kg (maximum, 4000 U) followed by a 12 U/kg/h infusion (maximum 1000 U/h) is recommended with ALTEPLASE for ST elevation MYOCARDIAL INFARCTION",MYOCARDIAL INFARCTION,ALTEPLASE,RO-may_treat
791857712,9/21/2015 11:59:41,1743034934,9/21/2015 11:59:32,False,prodege,0.9278,14848125,GBR,V8,Airdrie,86.151.77.161,ZIDOVUDINE treats ACQUIRED IMMUNODEFICIENCY SYNDROME,137,19,,170,29,treats,0.529812942826018,800417,"Interferon   with ZIDOVUDINE: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS.",ACQUIRED IMMUNODEFICIENCY SYNDROME,ZIDOVUDINE,TWrex-cause
791857712,9/21/2015 12:01:49,1743035565,9/21/2015 12:01:00,False,prodege,0.9694,3056891,CAN,ON,Niagara Falls,173.238.144.19,ZIDOVUDINE treats ACQUIRED IMMUNODEFICIENCY SYNDROME,137,19,,170,29,treats,0.529812942826018,800417,"Interferon   with ZIDOVUDINE: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS.",ACQUIRED IMMUNODEFICIENCY SYNDROME,ZIDOVUDINE,TWrex-cause
791857712,9/21/2015 12:35:55,1743045591,9/21/2015 12:34:53,False,clixsense,0.8611,17950689,GBR,Q4,Bewdley,217.39.99.38,ZIDOVUDINE treats ACQUIRED IMMUNODEFICIENCY SYNDROME,137,19,,170,29,treats,0.529812942826018,800417,"Interferon   with ZIDOVUDINE: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS.",ACQUIRED IMMUNODEFICIENCY SYNDROME,ZIDOVUDINE,TWrex-cause
791857712,9/21/2015 12:38:53,1743046440,9/21/2015 12:38:21,False,instagc,0.7292,16469970,USA,OK,Broken Arrow,72.192.89.181,ZIDOVUDINE treats ACQUIRED IMMUNODEFICIENCY SYNDROME,137,19,,170,29,treats,0.529812942826018,800417,"Interferon   with ZIDOVUDINE: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS.",ACQUIRED IMMUNODEFICIENCY SYNDROME,ZIDOVUDINE,TWrex-cause
791857712,9/21/2015 12:41:46,1743047520,9/21/2015 12:41:22,False,clixsense,0.8881,32053717,GBR,,,51.174.76.80,ZIDOVUDINE treats ACQUIRED IMMUNODEFICIENCY SYNDROME,137,19,,170,29,treats,0.529812942826018,800417,"Interferon   with ZIDOVUDINE: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS.",ACQUIRED IMMUNODEFICIENCY SYNDROME,ZIDOVUDINE,TWrex-cause
791857712,9/21/2015 12:48:12,1743050306,9/21/2015 12:41:29,False,points4rewards,0.5595,20113482,USA,PA,Philadelphia,162.208.49.45,no_relation,137,19,,170,29,treats,0.529812942826018,800417,"Interferon   with ZIDOVUDINE: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS.",ACQUIRED IMMUNODEFICIENCY SYNDROME,ZIDOVUDINE,TWrex-cause
791857712,9/21/2015 12:50:48,1743051346,9/21/2015 12:50:02,False,neodev,0.8448,33011398,USA,VA,Manassas,207.244.86.212,ZIDOVUDINE treats ACQUIRED IMMUNODEFICIENCY SYNDROME,137,19,,170,29,treats,0.529812942826018,800417,"Interferon   with ZIDOVUDINE: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS.",ACQUIRED IMMUNODEFICIENCY SYNDROME,ZIDOVUDINE,TWrex-cause
791857715,9/21/2015 11:12:41,1743020786,9/21/2015 11:12:13,False,prodege,0.8155,4316379,CAN,ON,Windsor,198.91.219.55,INSULIN LISPRO treats TYPE 2 DIABETES MELLITUS,89,40,,112,54,treats,1.0,800060,"Bastyr EJ, Johnson ME, Trautman ME et alINSULIN LISPRO in the treatment of patients with TYPE 2 DIABETES MELLITUS after oral agent failure.",TYPE 2 DIABETES MELLITUS,INSULIN LISPRO,TWrex-cause
791857715,9/21/2015 11:13:25,1743020928,9/21/2015 11:12:57,False,instagc,0.7361,33467170,USA,WV,Martinsburg,76.106.109.7,no_relation,89,40,,112,54,treats,1.0,800060,"Bastyr EJ, Johnson ME, Trautman ME et alINSULIN LISPRO in the treatment of patients with TYPE 2 DIABETES MELLITUS after oral agent failure.",TYPE 2 DIABETES MELLITUS,INSULIN LISPRO,TWrex-cause
791857715,9/21/2015 11:14:17,1743021232,9/21/2015 11:14:12,False,zoombucks,0.5417,4711962,CAN,ON,Markham,174.88.29.138,INSULIN LISPRO treats TYPE 2 DIABETES MELLITUS,89,40,,112,54,treats,1.0,800060,"Bastyr EJ, Johnson ME, Trautman ME et alINSULIN LISPRO in the treatment of patients with TYPE 2 DIABETES MELLITUS after oral agent failure.",TYPE 2 DIABETES MELLITUS,INSULIN LISPRO,TWrex-cause
791857715,9/21/2015 11:24:03,1743023754,9/21/2015 11:22:29,False,bitcoinget,0.7083,26471938,USA,TX,Missouri City,98.198.169.91,INSULIN LISPRO treats TYPE 2 DIABETES MELLITUS,89,40,,112,54,treats,1.0,800060,"Bastyr EJ, Johnson ME, Trautman ME et alINSULIN LISPRO in the treatment of patients with TYPE 2 DIABETES MELLITUS after oral agent failure.",TYPE 2 DIABETES MELLITUS,INSULIN LISPRO,TWrex-cause
791857715,9/21/2015 11:32:31,1743026372,9/21/2015 11:32:12,False,fusioncash,0.7514,31742806,USA,OH,Kent,66.61.82.242,INSULIN LISPRO treats TYPE 2 DIABETES MELLITUS,89,40,,112,54,treats,1.0,800060,"Bastyr EJ, Johnson ME, Trautman ME et alINSULIN LISPRO in the treatment of patients with TYPE 2 DIABETES MELLITUS after oral agent failure.",TYPE 2 DIABETES MELLITUS,INSULIN LISPRO,TWrex-cause
791857715,9/21/2015 11:41:13,1743028899,9/21/2015 11:40:24,False,prodege,0.6286,6309240,USA,CA,San Diego,76.167.68.73,INSULIN LISPRO treats TYPE 2 DIABETES MELLITUS,89,40,,112,54,treats,1.0,800060,"Bastyr EJ, Johnson ME, Trautman ME et alINSULIN LISPRO in the treatment of patients with TYPE 2 DIABETES MELLITUS after oral agent failure.",TYPE 2 DIABETES MELLITUS,INSULIN LISPRO,TWrex-cause
791857715,9/21/2015 11:49:07,1743031634,9/21/2015 11:48:57,False,instagc,0.75,15577915,USA,IL,Trenton,208.70.36.12,INSULIN LISPRO treats TYPE 2 DIABETES MELLITUS,89,40,,112,54,treats,1.0,800060,"Bastyr EJ, Johnson ME, Trautman ME et alINSULIN LISPRO in the treatment of patients with TYPE 2 DIABETES MELLITUS after oral agent failure.",TYPE 2 DIABETES MELLITUS,INSULIN LISPRO,TWrex-cause
791857717,9/21/2015 13:39:10,1743076078,9/21/2015 13:38:27,False,clixsense,0.9603,21875134,GBR,,,80.189.12.98,GLUTEN FREE DIET treats CELIAC DISEASE,17,51,,33,65,treats,0.9901475429766742,903642,"? Adherence to a GLUTEN FREE DIET in patients with CELIAC DISEASE can lead to the correction of iron deficiency anemia and the replacement of iron stores, and it can prevent the recurrence of iron deficiency.",GLUTEN FREE DIET,CELIAC DISEASE,RO-has_causative_agent
791857717,9/21/2015 13:41:06,1743077111,9/21/2015 13:38:51,False,prodege,0.7798,22031444,GBR,M4,Southampton,78.147.179.241,no_relation,17,51,,33,65,treats,0.9901475429766742,903642,"? Adherence to a GLUTEN FREE DIET in patients with CELIAC DISEASE can lead to the correction of iron deficiency anemia and the replacement of iron stores, and it can prevent the recurrence of iron deficiency.",GLUTEN FREE DIET,CELIAC DISEASE,RO-has_causative_agent
791857717,9/21/2015 14:17:16,1743096803,9/21/2015 14:16:43,False,clixsense,0.9444,26531841,CAN,ON,Ottawa,76.69.154.187,GLUTEN FREE DIET treats CELIAC DISEASE,17,51,,33,65,treats,0.9901475429766742,903642,"? Adherence to a GLUTEN FREE DIET in patients with CELIAC DISEASE can lead to the correction of iron deficiency anemia and the replacement of iron stores, and it can prevent the recurrence of iron deficiency.",GLUTEN FREE DIET,CELIAC DISEASE,RO-has_causative_agent
791857717,9/21/2015 14:27:43,1743102182,9/21/2015 14:24:55,False,dollarrewardz,0.8353,15995477,GBR,W5,East Kilbride,5.64.46.24,GLUTEN FREE DIET treats CELIAC DISEASE,17,51,,33,65,treats,0.9901475429766742,903642,"? Adherence to a GLUTEN FREE DIET in patients with CELIAC DISEASE can lead to the correction of iron deficiency anemia and the replacement of iron stores, and it can prevent the recurrence of iron deficiency.",GLUTEN FREE DIET,CELIAC DISEASE,RO-has_causative_agent
791857717,9/21/2015 14:27:59,1743102258,9/21/2015 14:26:12,False,neodev,0.9,33110177,USA,DE,,108.59.8.208,GLUTEN FREE DIET treats CELIAC DISEASE,17,51,,33,65,treats,0.9901475429766742,903642,"? Adherence to a GLUTEN FREE DIET in patients with CELIAC DISEASE can lead to the correction of iron deficiency anemia and the replacement of iron stores, and it can prevent the recurrence of iron deficiency.",GLUTEN FREE DIET,CELIAC DISEASE,RO-has_causative_agent
791857717,9/21/2015 14:28:55,1743102736,9/21/2015 14:28:44,False,bitcoinget,0.875,21743413,USA,WA,Port Angeles,24.113.29.97,GLUTEN FREE DIET treats CELIAC DISEASE,17,51,,33,65,treats,0.9901475429766742,903642,"? Adherence to a GLUTEN FREE DIET in patients with CELIAC DISEASE can lead to the correction of iron deficiency anemia and the replacement of iron stores, and it can prevent the recurrence of iron deficiency.",GLUTEN FREE DIET,CELIAC DISEASE,RO-has_causative_agent
791857717,9/21/2015 14:30:29,1743103452,9/21/2015 14:29:41,False,clixsense,0.9018,33115750,GBR,I3,Rochester,90.222.106.192,GLUTEN FREE DIET treats CELIAC DISEASE,17,51,,33,65,treats,0.9901475429766742,903642,"? Adherence to a GLUTEN FREE DIET in patients with CELIAC DISEASE can lead to the correction of iron deficiency anemia and the replacement of iron stores, and it can prevent the recurrence of iron deficiency.",GLUTEN FREE DIET,CELIAC DISEASE,RO-has_causative_agent
791857719,9/21/2015 11:58:56,1743034674,9/21/2015 11:58:39,False,prodege,0.9278,14848125,GBR,V8,Airdrie,86.151.77.161,[BOTOX INJECTIONS ARE USED] treats [MINOR FOCAL DYSTONIA],30,0,,49,24,treats,0.9984038297885899,215355,[BOTOX INJECTIONS ARE USED] for [MINOR FOCAL DYSTONIA] though not of use on for more advanced tardive dyskinesia.,[MINOR FOCAL DYSTONIA],[BOTOX INJECTIONS ARE USED],TWrex-treat
791857719,9/21/2015 11:59:15,1743034772,9/21/2015 11:58:38,False,prodege,0.9694,3056891,CAN,ON,Niagara Falls,173.238.144.19,[BOTOX INJECTIONS ARE USED] treats [MINOR FOCAL DYSTONIA],30,0,,49,24,treats,0.9984038297885899,215355,[BOTOX INJECTIONS ARE USED] for [MINOR FOCAL DYSTONIA] though not of use on for more advanced tardive dyskinesia.,[MINOR FOCAL DYSTONIA],[BOTOX INJECTIONS ARE USED],TWrex-treat
791857719,9/21/2015 12:06:07,1743036726,9/21/2015 12:05:49,False,dailyrewardsca,0.8829,32219778,CAN,ON,Ottawa,99.241.19.27,[BOTOX INJECTIONS ARE USED] treats [MINOR FOCAL DYSTONIA],30,0,,49,24,treats,0.9984038297885899,215355,[BOTOX INJECTIONS ARE USED] for [MINOR FOCAL DYSTONIA] though not of use on for more advanced tardive dyskinesia.,[MINOR FOCAL DYSTONIA],[BOTOX INJECTIONS ARE USED],TWrex-treat
791857719,9/21/2015 12:18:34,1743040404,9/21/2015 12:18:13,False,prodege,0.9571,3587109,CAN,NS,Antigonish,142.177.108.85,[BOTOX INJECTIONS ARE USED] treats [MINOR FOCAL DYSTONIA],30,0,,49,24,treats,0.9984038297885899,215355,[BOTOX INJECTIONS ARE USED] for [MINOR FOCAL DYSTONIA] though not of use on for more advanced tardive dyskinesia.,[MINOR FOCAL DYSTONIA],[BOTOX INJECTIONS ARE USED],TWrex-treat
791857719,9/21/2015 12:32:22,1743044636,9/21/2015 12:29:27,False,points4rewards,0.5595,20113482,USA,PA,Philadelphia,162.208.49.45,[BOTOX INJECTIONS ARE USED] treats [MINOR FOCAL DYSTONIA],30,0,,49,24,treats,0.9984038297885899,215355,[BOTOX INJECTIONS ARE USED] for [MINOR FOCAL DYSTONIA] though not of use on for more advanced tardive dyskinesia.,[MINOR FOCAL DYSTONIA],[BOTOX INJECTIONS ARE USED],TWrex-treat
791857719,9/21/2015 12:33:14,1743044878,9/21/2015 12:32:59,False,clixsense,0.8611,17950689,GBR,Q4,Bewdley,217.39.99.38,[BOTOX INJECTIONS ARE USED] treats [MINOR FOCAL DYSTONIA],30,0,,49,24,treats,0.9984038297885899,215355,[BOTOX INJECTIONS ARE USED] for [MINOR FOCAL DYSTONIA] though not of use on for more advanced tardive dyskinesia.,[MINOR FOCAL DYSTONIA],[BOTOX INJECTIONS ARE USED],TWrex-treat
791857719,9/21/2015 12:37:24,1743045994,9/21/2015 12:37:11,False,instagc,0.7292,16469970,USA,OK,Broken Arrow,72.192.89.181,[BOTOX INJECTIONS ARE USED] treats [MINOR FOCAL DYSTONIA],30,0,,49,24,treats,0.9984038297885899,215355,[BOTOX INJECTIONS ARE USED] for [MINOR FOCAL DYSTONIA] though not of use on for more advanced tardive dyskinesia.,[MINOR FOCAL DYSTONIA],[BOTOX INJECTIONS ARE USED],TWrex-treat
791857726,9/21/2015 09:33:41,1742997131,9/21/2015 09:33:18,False,neodev,1.0,14096345,NLD,03,Eibergen,178.85.94.186,OBSESSIVE COMPULSIVE DISORDER treats COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN,132,44,,160,107,treats,0.9931270663228421,800045,"Fiqueroa Y, Rosenberg DR, Birmaher B et al. COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN reuptake inhibitors for OBSESSIVE COMPULSIVE DISORDER in children and adolescents.",OBSESSIVE COMPULSIVE DISORDER,COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN,TWrex-cause
791857726,9/21/2015 09:54:23,1743002756,9/21/2015 09:54:05,False,elite,0.725,29768955,GBR,C3,Gamlingay,31.50.187.165,COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN treats OBSESSIVE COMPULSIVE DISORDER,132,44,,160,107,treats,0.9931270663228421,800045,"Fiqueroa Y, Rosenberg DR, Birmaher B et al. COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN reuptake inhibitors for OBSESSIVE COMPULSIVE DISORDER in children and adolescents.",OBSESSIVE COMPULSIVE DISORDER,COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN,TWrex-cause
791857726,9/21/2015 09:55:59,1743003203,9/21/2015 09:55:25,False,gifthunterclub,0.8222,24043308,GBR,,,94.102.147.250,COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN treats OBSESSIVE COMPULSIVE DISORDER,132,44,,160,107,treats,0.9931270663228421,800045,"Fiqueroa Y, Rosenberg DR, Birmaher B et al. COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN reuptake inhibitors for OBSESSIVE COMPULSIVE DISORDER in children and adolescents.",OBSESSIVE COMPULSIVE DISORDER,COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN,TWrex-cause
791857726,9/21/2015 09:56:08,1743003266,9/21/2015 09:55:42,False,neodev,0.7778,20306047,GBR,,,80.41.0.252,COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN treats OBSESSIVE COMPULSIVE DISORDER,132,44,,160,107,treats,0.9931270663228421,800045,"Fiqueroa Y, Rosenberg DR, Birmaher B et al. COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN reuptake inhibitors for OBSESSIVE COMPULSIVE DISORDER in children and adolescents.",OBSESSIVE COMPULSIVE DISORDER,COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN,TWrex-cause
791857726,9/21/2015 09:56:20,1743003339,9/21/2015 09:55:50,False,neodev,0.8222,33758777,USA,,,38.95.108.251,COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN treats OBSESSIVE COMPULSIVE DISORDER,132,44,,160,107,treats,0.9931270663228421,800045,"Fiqueroa Y, Rosenberg DR, Birmaher B et al. COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN reuptake inhibitors for OBSESSIVE COMPULSIVE DISORDER in children and adolescents.",OBSESSIVE COMPULSIVE DISORDER,COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN,TWrex-cause
791857726,9/21/2015 09:58:52,1743003956,9/21/2015 09:58:37,False,meprizescf,0.8512,28483210,USA,WI,Minocqua,75.143.134.247,COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN treats OBSESSIVE COMPULSIVE DISORDER,132,44,,160,107,treats,0.9931270663228421,800045,"Fiqueroa Y, Rosenberg DR, Birmaher B et al. COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN reuptake inhibitors for OBSESSIVE COMPULSIVE DISORDER in children and adolescents.",OBSESSIVE COMPULSIVE DISORDER,COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN,TWrex-cause
791857726,9/21/2015 10:06:03,1743005518,9/21/2015 10:05:39,False,treasuretrooper,0.7381,17956656,AUS,02,Jannali,14.200.59.55,no_relation,132,44,,160,107,treats,0.9931270663228421,800045,"Fiqueroa Y, Rosenberg DR, Birmaher B et al. COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN reuptake inhibitors for OBSESSIVE COMPULSIVE DISORDER in children and adolescents.",OBSESSIVE COMPULSIVE DISORDER,COMBINATION TREATMENT WITH CLOMIPRAMINE AND SELECTIVE SEROTONIN,TWrex-cause
791857729,9/21/2015 09:33:16,1742997014,9/21/2015 09:33:05,False,neodev,1.0,14096345,NLD,03,Eibergen,178.85.94.186,no_relation,84,44,,85,51,treats,0.9684959969581859,907404,"Rationale: ? The combination of heparin and ASPIRIN in ACS reduces the incidence of MI during the in hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures.",MI,ASPIRIN,RO-may_prevent
791857729,9/21/2015 09:54:05,1743002662,9/21/2015 09:53:41,False,elite,0.725,29768955,GBR,C3,Gamlingay,31.50.187.165,ASPIRIN treats MI,84,44,,85,51,treats,0.9684959969581859,907404,"Rationale: ? The combination of heparin and ASPIRIN in ACS reduces the incidence of MI during the in hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures.",MI,ASPIRIN,RO-may_prevent
791857729,9/21/2015 09:55:23,1743003049,9/21/2015 09:54:35,False,gifthunterclub,0.8222,24043308,GBR,,,94.102.147.250,ASPIRIN treats MI,84,44,,85,51,treats,0.9684959969581859,907404,"Rationale: ? The combination of heparin and ASPIRIN in ACS reduces the incidence of MI during the in hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures.",MI,ASPIRIN,RO-may_prevent
791857729,9/21/2015 09:55:41,1743003153,9/21/2015 09:55:22,False,neodev,0.7778,20306047,GBR,,,80.41.0.252,ASPIRIN treats MI,84,44,,85,51,treats,0.9684959969581859,907404,"Rationale: ? The combination of heparin and ASPIRIN in ACS reduces the incidence of MI during the in hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures.",MI,ASPIRIN,RO-may_prevent
791857729,9/21/2015 09:55:49,1743003169,9/21/2015 09:54:55,False,neodev,0.8222,33758777,USA,,,38.95.108.251,ASPIRIN treats MI,84,44,,85,51,treats,0.9684959969581859,907404,"Rationale: ? The combination of heparin and ASPIRIN in ACS reduces the incidence of MI during the in hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures.",MI,ASPIRIN,RO-may_prevent
791857729,9/21/2015 09:58:36,1743003919,9/21/2015 09:58:16,False,meprizescf,0.8512,28483210,USA,WI,Minocqua,75.143.134.247,ASPIRIN treats MI,84,44,,85,51,treats,0.9684959969581859,907404,"Rationale: ? The combination of heparin and ASPIRIN in ACS reduces the incidence of MI during the in hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures.",MI,ASPIRIN,RO-may_prevent
791857729,9/21/2015 10:05:37,1743005427,9/21/2015 10:05:20,False,treasuretrooper,0.7381,17956656,AUS,02,Jannali,14.200.59.55,ASPIRIN treats MI,84,44,,85,51,treats,0.9684959969581859,907404,"Rationale: ? The combination of heparin and ASPIRIN in ACS reduces the incidence of MI during the in hospital period, and LMWHs reduce cardiac events and the need for revascularization procedures.",MI,ASPIRIN,RO-may_prevent
791857731,9/21/2015 11:59:31,1743034860,9/21/2015 11:59:18,False,prodege,0.9278,14848125,GBR,V8,Airdrie,86.151.77.161,HYOSCYAMINE treats CYSTITIS,187,0,,195,11,treats,1.0,210992,"[HYOSCYAMINE] is used to provide symptomatic relief to various gastrointestinal disorders including spasms, peptic ulcers, irritable bowel syndrome, diverticulitis, pancreatitis, colic and [CYSTITIS].",CYSTITIS,HYOSCYAMINE,TWrex-treat
791857731,9/21/2015 12:01:00,1743035306,9/21/2015 12:00:23,False,prodege,0.9694,3056891,CAN,ON,Niagara Falls,173.238.144.19,HYOSCYAMINE treats CYSTITIS,187,0,,195,11,treats,1.0,210992,"[HYOSCYAMINE] is used to provide symptomatic relief to various gastrointestinal disorders including spasms, peptic ulcers, irritable bowel syndrome, diverticulitis, pancreatitis, colic and [CYSTITIS].",CYSTITIS,HYOSCYAMINE,TWrex-treat
791857731,9/21/2015 12:06:48,1743036915,9/21/2015 12:06:32,False,dailyrewardsca,0.8829,32219778,CAN,ON,Ottawa,99.241.19.27,HYOSCYAMINE treats CYSTITIS,187,0,,195,11,treats,1.0,210992,"[HYOSCYAMINE] is used to provide symptomatic relief to various gastrointestinal disorders including spasms, peptic ulcers, irritable bowel syndrome, diverticulitis, pancreatitis, colic and [CYSTITIS].",CYSTITIS,HYOSCYAMINE,TWrex-treat
791857731,9/21/2015 12:19:01,1743040574,9/21/2015 12:18:53,False,prodege,0.9571,3587109,CAN,NS,Antigonish,142.177.108.85,HYOSCYAMINE treats CYSTITIS,187,0,,195,11,treats,1.0,210992,"[HYOSCYAMINE] is used to provide symptomatic relief to various gastrointestinal disorders including spasms, peptic ulcers, irritable bowel syndrome, diverticulitis, pancreatitis, colic and [CYSTITIS].",CYSTITIS,HYOSCYAMINE,TWrex-treat
791857731,9/21/2015 12:34:51,1743045325,9/21/2015 12:34:16,False,clixsense,0.8611,17950689,GBR,Q4,Bewdley,217.39.99.38,HYOSCYAMINE treats CYSTITIS,187,0,,195,11,treats,1.0,210992,"[HYOSCYAMINE] is used to provide symptomatic relief to various gastrointestinal disorders including spasms, peptic ulcers, irritable bowel syndrome, diverticulitis, pancreatitis, colic and [CYSTITIS].",CYSTITIS,HYOSCYAMINE,TWrex-treat
791857731,9/21/2015 12:38:20,1743046315,9/21/2015 12:37:47,False,instagc,0.7292,16469970,USA,OK,Broken Arrow,72.192.89.181,HYOSCYAMINE treats CYSTITIS,187,0,,195,11,treats,1.0,210992,"[HYOSCYAMINE] is used to provide symptomatic relief to various gastrointestinal disorders including spasms, peptic ulcers, irritable bowel syndrome, diverticulitis, pancreatitis, colic and [CYSTITIS].",CYSTITIS,HYOSCYAMINE,TWrex-treat
791857731,9/21/2015 12:41:21,1743047363,9/21/2015 12:39:28,False,clixsense,0.8881,32053717,GBR,,,51.174.76.80,HYOSCYAMINE treats CYSTITIS,187,0,,195,11,treats,1.0,210992,"[HYOSCYAMINE] is used to provide symptomatic relief to various gastrointestinal disorders including spasms, peptic ulcers, irritable bowel syndrome, diverticulitis, pancreatitis, colic and [CYSTITIS].",CYSTITIS,HYOSCYAMINE,TWrex-treat
791857737,9/21/2015 15:37:56,1743151190,9/21/2015 15:37:37,False,instagc,0.9833,21551272,GBR,Q3,Wolverhampton,80.43.83.1,ANTIARRHYTHMIC THERAPY treats ARRHYTHMIA,35,78,,44,100,treats,0.979957887012223,907383,All patients have remained free of ARRHYTHMIA recurrence and have required no ANTIARRHYTHMIC THERAPY after a follow up of 5 to 28 months (mean 14.,ARRHYTHMIA,ANTIARRHYTHMIC THERAPY,RO-may_prevent
791857737,9/21/2015 15:58:41,1743164708,9/21/2015 15:57:58,False,tremorgames,0.6349,33691253,USA,CA,San Jose,50.118.172.10,no_relation,35,78,,44,100,treats,0.979957887012223,907383,All patients have remained free of ARRHYTHMIA recurrence and have required no ANTIARRHYTHMIC THERAPY after a follow up of 5 to 28 months (mean 14.,ARRHYTHMIA,ANTIARRHYTHMIC THERAPY,RO-may_prevent
791857737,9/21/2015 16:04:45,1743168704,9/21/2015 16:04:32,False,bitcoinget,0.7242,32306192,USA,TX,El Paso,99.47.138.44,ANTIARRHYTHMIC THERAPY treats ARRHYTHMIA,35,78,,44,100,treats,0.979957887012223,907383,All patients have remained free of ARRHYTHMIA recurrence and have required no ANTIARRHYTHMIC THERAPY after a follow up of 5 to 28 months (mean 14.,ARRHYTHMIA,ANTIARRHYTHMIC THERAPY,RO-may_prevent
791857737,9/21/2015 16:07:04,1743170191,9/21/2015 16:06:26,False,gifthulk,0.8083,18666417,USA,PA,Meadville,24.101.32.13,ANTIARRHYTHMIC THERAPY treats ARRHYTHMIA,35,78,,44,100,treats,0.979957887012223,907383,All patients have remained free of ARRHYTHMIA recurrence and have required no ANTIARRHYTHMIC THERAPY after a follow up of 5 to 28 months (mean 14.,ARRHYTHMIA,ANTIARRHYTHMIC THERAPY,RO-may_prevent
791857737,9/21/2015 16:11:53,1743172930,9/21/2015 16:11:43,False,instagc,0.7833,13581319,USA,IL,Trenton,208.70.36.12,ANTIARRHYTHMIC THERAPY treats ARRHYTHMIA,35,78,,44,100,treats,0.979957887012223,907383,All patients have remained free of ARRHYTHMIA recurrence and have required no ANTIARRHYTHMIC THERAPY after a follow up of 5 to 28 months (mean 14.,ARRHYTHMIA,ANTIARRHYTHMIC THERAPY,RO-may_prevent
791857737,9/21/2015 16:22:09,1743179083,9/21/2015 16:21:20,False,clixsense,0.8492,33878524,CAN,BC,Princeton,75.156.83.71,ANTIARRHYTHMIC THERAPY treats ARRHYTHMIA,35,78,,44,100,treats,0.979957887012223,907383,All patients have remained free of ARRHYTHMIA recurrence and have required no ANTIARRHYTHMIC THERAPY after a follow up of 5 to 28 months (mean 14.,ARRHYTHMIA,ANTIARRHYTHMIC THERAPY,RO-may_prevent
791857737,9/21/2015 16:37:15,1743188504,9/21/2015 16:36:37,False,clixsense,0.8518,32254355,CAN,ON,London,65.93.118.3,ANTIARRHYTHMIC THERAPY treats ARRHYTHMIA,35,78,,44,100,treats,0.979957887012223,907383,All patients have remained free of ARRHYTHMIA recurrence and have required no ANTIARRHYTHMIC THERAPY after a follow up of 5 to 28 months (mean 14.,ARRHYTHMIA,ANTIARRHYTHMIC THERAPY,RO-may_prevent
791857739,9/21/2015 14:18:02,1743097253,9/21/2015 14:17:46,False,clixsense,0.9444,26531841,CAN,ON,Ottawa,76.69.154.187,[ANTIVIRAL DRUGS] treats [INFLUENZA],48,19,,56,33,treats,1.0,212752,The two classes of [ANTIVIRAL DRUGS] used against [INFLUENZA] are neuraminidase inhibitors and M2 protein inhibitors .,[INFLUENZA],[ANTIVIRAL DRUGS],TWrex-treat
791857739,9/21/2015 14:30:28,1743103439,9/21/2015 14:29:04,False,neodev,0.9,33110177,USA,DE,,108.59.8.208,[ANTIVIRAL DRUGS] treats [INFLUENZA],48,19,,56,33,treats,1.0,212752,The two classes of [ANTIVIRAL DRUGS] used against [INFLUENZA] are neuraminidase inhibitors and M2 protein inhibitors .,[INFLUENZA],[ANTIVIRAL DRUGS],TWrex-treat
791857739,9/21/2015 14:32:23,1743104371,9/21/2015 14:31:08,False,clixsense,0.9018,33115750,GBR,I3,Rochester,90.222.106.192,[ANTIVIRAL DRUGS] treats [INFLUENZA],48,19,,56,33,treats,1.0,212752,The two classes of [ANTIVIRAL DRUGS] used against [INFLUENZA] are neuraminidase inhibitors and M2 protein inhibitors .,[INFLUENZA],[ANTIVIRAL DRUGS],TWrex-treat
791857739,9/21/2015 14:33:46,1743105073,9/21/2015 14:33:11,False,neodev,0.9792,12115558,USA,OH,Twinsburg,98.27.164.131,[ANTIVIRAL DRUGS] treats [INFLUENZA],48,19,,56,33,treats,1.0,212752,The two classes of [ANTIVIRAL DRUGS] used against [INFLUENZA] are neuraminidase inhibitors and M2 protein inhibitors .,[INFLUENZA],[ANTIVIRAL DRUGS],TWrex-treat
791857739,9/21/2015 14:39:51,1743108064,9/21/2015 14:39:03,False,onestopgpt,0.9333,21275875,CAN,ON,Hamilton,24.36.124.79,[ANTIVIRAL DRUGS] treats [INFLUENZA],48,19,,56,33,treats,1.0,212752,The two classes of [ANTIVIRAL DRUGS] used against [INFLUENZA] are neuraminidase inhibitors and M2 protein inhibitors .,[INFLUENZA],[ANTIVIRAL DRUGS],TWrex-treat
791857739,9/21/2015 14:40:23,1743108329,9/21/2015 14:33:18,False,dollarrewardz,0.8353,15995477,GBR,W5,East Kilbride,5.64.46.24,[ANTIVIRAL DRUGS] treats [INFLUENZA],48,19,,56,33,treats,1.0,212752,The two classes of [ANTIVIRAL DRUGS] used against [INFLUENZA] are neuraminidase inhibitors and M2 protein inhibitors .,[INFLUENZA],[ANTIVIRAL DRUGS],TWrex-treat
791857739,9/21/2015 14:43:32,1743109837,9/21/2015 14:42:52,False,elite,0.8849,30312592,CAN,ON,Sudbury,66.103.55.12,[ANTIVIRAL DRUGS] treats [INFLUENZA],48,19,,56,33,treats,1.0,212752,The two classes of [ANTIVIRAL DRUGS] used against [INFLUENZA] are neuraminidase inhibitors and M2 protein inhibitors .,[INFLUENZA],[ANTIVIRAL DRUGS],TWrex-treat
791857746,9/21/2015 14:35:01,1743105665,9/21/2015 14:34:48,False,neodev,0.9792,12115558,USA,OH,Twinsburg,98.27.164.131,LOW MOLECULAR WEIGHT HEPARIN treats RECURRENT VENOUS THROMBOEMBOLISM,69,0,,100,28,treats,0.9950371902099889,907025,LOW MOLECULAR WEIGHT HEPARIN versus a coumarin for the prevention of RECURRENT VENOUS THROMBOEMBOLISM in patients with cancer.,RECURRENT VENOUS THROMBOEMBOLISM,LOW MOLECULAR WEIGHT HEPARIN,RO-may_prevent
791857746,9/21/2015 14:41:04,1743108761,9/21/2015 14:40:55,False,onestopgpt,0.9333,21275875,CAN,ON,Hamilton,24.36.124.79,LOW MOLECULAR WEIGHT HEPARIN treats RECURRENT VENOUS THROMBOEMBOLISM,69,0,,100,28,treats,0.9950371902099889,907025,LOW MOLECULAR WEIGHT HEPARIN versus a coumarin for the prevention of RECURRENT VENOUS THROMBOEMBOLISM in patients with cancer.,RECURRENT VENOUS THROMBOEMBOLISM,LOW MOLECULAR WEIGHT HEPARIN,RO-may_prevent
791857746,9/21/2015 14:50:32,1743114191,9/21/2015 14:50:05,False,elite,0.8849,30312592,CAN,ON,Sudbury,66.103.55.12,no_relation,69,0,,100,28,treats,0.9950371902099889,907025,LOW MOLECULAR WEIGHT HEPARIN versus a coumarin for the prevention of RECURRENT VENOUS THROMBOEMBOLISM in patients with cancer.,RECURRENT VENOUS THROMBOEMBOLISM,LOW MOLECULAR WEIGHT HEPARIN,RO-may_prevent
791857746,9/21/2015 15:28:19,1743144325,9/21/2015 15:28:05,False,clixsense,0.8616,21490235,GBR,N7,Woking,86.30.254.232,LOW MOLECULAR WEIGHT HEPARIN treats RECURRENT VENOUS THROMBOEMBOLISM,69,0,,100,28,treats,0.9950371902099889,907025,LOW MOLECULAR WEIGHT HEPARIN versus a coumarin for the prevention of RECURRENT VENOUS THROMBOEMBOLISM in patients with cancer.,RECURRENT VENOUS THROMBOEMBOLISM,LOW MOLECULAR WEIGHT HEPARIN,RO-may_prevent
791857746,9/21/2015 15:36:47,1743150371,9/21/2015 15:36:30,False,instagc,0.9833,21551272,GBR,Q3,Wolverhampton,80.43.83.1,LOW MOLECULAR WEIGHT HEPARIN treats RECURRENT VENOUS THROMBOEMBOLISM,69,0,,100,28,treats,0.9950371902099889,907025,LOW MOLECULAR WEIGHT HEPARIN versus a coumarin for the prevention of RECURRENT VENOUS THROMBOEMBOLISM in patients with cancer.,RECURRENT VENOUS THROMBOEMBOLISM,LOW MOLECULAR WEIGHT HEPARIN,RO-may_prevent
791857746,9/21/2015 15:42:51,1743154405,9/21/2015 15:41:52,False,clixsense,0.8492,33878524,CAN,BC,Princeton,75.156.83.71,LOW MOLECULAR WEIGHT HEPARIN treats RECURRENT VENOUS THROMBOEMBOLISM,69,0,,100,28,treats,0.9950371902099889,907025,LOW MOLECULAR WEIGHT HEPARIN versus a coumarin for the prevention of RECURRENT VENOUS THROMBOEMBOLISM in patients with cancer.,RECURRENT VENOUS THROMBOEMBOLISM,LOW MOLECULAR WEIGHT HEPARIN,RO-may_prevent
791857746,9/21/2015 15:53:14,1743161332,9/21/2015 15:49:37,False,tremorgames,0.6349,33691253,USA,CA,San Jose,50.118.172.10,no_relation,69,0,,100,28,treats,0.9950371902099889,907025,LOW MOLECULAR WEIGHT HEPARIN versus a coumarin for the prevention of RECURRENT VENOUS THROMBOEMBOLISM in patients with cancer.,RECURRENT VENOUS THROMBOEMBOLISM,LOW MOLECULAR WEIGHT HEPARIN,RO-may_prevent
791857748,9/21/2015 08:33:48,1742979307,9/21/2015 08:33:35,False,clixsense,1.0,22751911,NLD,04,Groningen,195.241.153.97,FOLIC ACID treats NEURAL TUBE DEFECTS,60,33,,78,43,treats,0.994936676326182,804409,Annotation: how do we get enough FOLIC ACID to prevent some NEURAL TUBE DEFECTS,NEURAL TUBE DEFECTS,FOLIC ACID,TWrex-cause
791857748,9/21/2015 08:44:04,1742982555,9/21/2015 08:43:05,False,clixsense,0.9306,30681826,GBR,I9,Diss,31.49.71.254,FOLIC ACID treats NEURAL TUBE DEFECTS,60,33,,78,43,treats,0.994936676326182,804409,Annotation: how do we get enough FOLIC ACID to prevent some NEURAL TUBE DEFECTS,NEURAL TUBE DEFECTS,FOLIC ACID,TWrex-cause
791857748,9/21/2015 08:44:25,1742982626,9/21/2015 08:44:12,False,neodev,0.9167,30627835,GBR,D8,Bishop Auckland,217.44.84.223,FOLIC ACID treats NEURAL TUBE DEFECTS,60,33,,78,43,treats,0.994936676326182,804409,Annotation: how do we get enough FOLIC ACID to prevent some NEURAL TUBE DEFECTS,NEURAL TUBE DEFECTS,FOLIC ACID,TWrex-cause
791857748,9/21/2015 08:54:58,1742985704,9/21/2015 08:54:21,False,pocketmoneygpt,0.8833,21432964,GBR,F8,Borehamwood,81.159.185.70,FOLIC ACID treats NEURAL TUBE DEFECTS,60,33,,78,43,treats,0.994936676326182,804409,Annotation: how do we get enough FOLIC ACID to prevent some NEURAL TUBE DEFECTS,NEURAL TUBE DEFECTS,FOLIC ACID,TWrex-cause
791857748,9/21/2015 09:06:01,1742988924,9/21/2015 09:05:41,False,prodege,0.85,32850083,GBR,L9,Sheffield,92.239.198.197,FOLIC ACID treats NEURAL TUBE DEFECTS,60,33,,78,43,treats,0.994936676326182,804409,Annotation: how do we get enough FOLIC ACID to prevent some NEURAL TUBE DEFECTS,NEURAL TUBE DEFECTS,FOLIC ACID,TWrex-cause
791857748,9/21/2015 09:07:21,1742989296,9/21/2015 09:07:00,False,neodev,0.7798,33644825,USA,FL,Fort Lauderdale,65.111.173.161,FOLIC ACID treats NEURAL TUBE DEFECTS,60,33,,78,43,treats,0.994936676326182,804409,Annotation: how do we get enough FOLIC ACID to prevent some NEURAL TUBE DEFECTS,NEURAL TUBE DEFECTS,FOLIC ACID,TWrex-cause
791857748,9/21/2015 09:17:51,1742992015,9/21/2015 09:17:35,False,instagc,0.8809999999999999,18960682,GBR,U2,Annan,92.18.213.181,FOLIC ACID treats NEURAL TUBE DEFECTS,60,33,,78,43,treats,0.994936676326182,804409,Annotation: how do we get enough FOLIC ACID to prevent some NEURAL TUBE DEFECTS,NEURAL TUBE DEFECTS,FOLIC ACID,TWrex-cause
791857756,9/21/2015 12:53:28,1743052394,9/21/2015 12:53:04,False,neodev,0.8448,33011398,USA,VA,Manassas,207.244.86.212,[ANTIHISTAMINES] treats [ROSACEA],70,33,,77,46,treats,0.412081691846067,219431,There is no evidence at all that [ANTIHISTAMINES] are of any benefit in [ROSACEA],[ROSACEA],[ANTIHISTAMINES],TWrex-treat
791857756,9/21/2015 12:57:33,1743053848,9/21/2015 12:57:08,False,neodev,0.5476,31988911,USA,CA,Saratoga,107.178.43.21,no_relation,70,33,,77,46,treats,0.412081691846067,219431,There is no evidence at all that [ANTIHISTAMINES] are of any benefit in [ROSACEA],[ROSACEA],[ANTIHISTAMINES],TWrex-treat
791857756,9/21/2015 13:00:29,1743055106,9/21/2015 12:59:25,False,neodev,0.7437,32216655,NLD,07,Amsterdam,145.100.72.166,no_relation,70,33,,77,46,treats,0.412081691846067,219431,There is no evidence at all that [ANTIHISTAMINES] are of any benefit in [ROSACEA],[ROSACEA],[ANTIHISTAMINES],TWrex-treat
791857756,9/21/2015 13:03:16,1743056313,9/21/2015 13:02:49,False,elite,0.8514,33238902,NLD,06,Budel,77.248.148.5,no_relation,70,33,,77,46,treats,0.412081691846067,219431,There is no evidence at all that [ANTIHISTAMINES] are of any benefit in [ROSACEA],[ROSACEA],[ANTIHISTAMINES],TWrex-treat
791857756,9/21/2015 13:21:06,1743065467,9/21/2015 13:20:53,False,neodev,0.899,18881135,CAN,ON,Ajax,99.243.87.224,no_relation,70,33,,77,46,treats,0.412081691846067,219431,There is no evidence at all that [ANTIHISTAMINES] are of any benefit in [ROSACEA],[ROSACEA],[ANTIHISTAMINES],TWrex-treat
791857756,9/21/2015 13:35:37,1743072761,9/21/2015 13:34:52,False,clixsense,0.9603,21875134,GBR,,,80.189.12.98,no_relation,70,33,,77,46,treats,0.412081691846067,219431,There is no evidence at all that [ANTIHISTAMINES] are of any benefit in [ROSACEA],[ROSACEA],[ANTIHISTAMINES],TWrex-treat
791857756,9/21/2015 13:37:47,1743074596,9/21/2015 13:37:32,False,prodege,0.7798,22031444,GBR,M4,Southampton,78.147.179.241,no_relation,70,33,,77,46,treats,0.412081691846067,219431,There is no evidence at all that [ANTIHISTAMINES] are of any benefit in [ROSACEA],[ROSACEA],[ANTIHISTAMINES],TWrex-treat
791857761,9/21/2015 13:06:56,1743058089,9/21/2015 13:06:17,False,elite,0.8514,33238902,NLD,06,Budel,77.248.148.5,BOTULINUM A TOXIN treats CRANIAL CERVICAL DYSTONIA,22,0,,46,17,treats,0.99124070716193,804947,"BOTULINUM A TOXIN for CRANIAL CERVICAL DYSTONIA: double blind, placebo controlled study.",CRANIAL CERVICAL DYSTONIA,BOTULINUM A TOXIN,TWrex-cause
791857761,9/21/2015 13:22:13,1743066017,9/21/2015 13:21:57,False,neodev,0.899,18881135,CAN,ON,Ajax,99.243.87.224,BOTULINUM A TOXIN treats CRANIAL CERVICAL DYSTONIA,22,0,,46,17,treats,0.99124070716193,804947,"BOTULINUM A TOXIN for CRANIAL CERVICAL DYSTONIA: double blind, placebo controlled study.",CRANIAL CERVICAL DYSTONIA,BOTULINUM A TOXIN,TWrex-cause
791857761,9/21/2015 13:38:26,1743075547,9/21/2015 13:37:36,False,clixsense,0.9603,21875134,GBR,,,80.189.12.98,BOTULINUM A TOXIN treats CRANIAL CERVICAL DYSTONIA,22,0,,46,17,treats,0.99124070716193,804947,"BOTULINUM A TOXIN for CRANIAL CERVICAL DYSTONIA: double blind, placebo controlled study.",CRANIAL CERVICAL DYSTONIA,BOTULINUM A TOXIN,TWrex-cause
791857761,9/21/2015 13:38:50,1743075853,9/21/2015 13:38:31,False,prodege,0.7798,22031444,GBR,M4,Southampton,78.147.179.241,BOTULINUM A TOXIN treats CRANIAL CERVICAL DYSTONIA,22,0,,46,17,treats,0.99124070716193,804947,"BOTULINUM A TOXIN for CRANIAL CERVICAL DYSTONIA: double blind, placebo controlled study.",CRANIAL CERVICAL DYSTONIA,BOTULINUM A TOXIN,TWrex-cause
791857761,9/21/2015 14:16:42,1743096618,9/21/2015 14:16:13,False,clixsense,0.9444,26531841,CAN,ON,Ottawa,76.69.154.187,BOTULINUM A TOXIN treats CRANIAL CERVICAL DYSTONIA,22,0,,46,17,treats,0.99124070716193,804947,"BOTULINUM A TOXIN for CRANIAL CERVICAL DYSTONIA: double blind, placebo controlled study.",CRANIAL CERVICAL DYSTONIA,BOTULINUM A TOXIN,TWrex-cause
791857761,9/21/2015 14:24:54,1743100906,9/21/2015 14:23:02,False,dollarrewardz,0.8353,15995477,GBR,W5,East Kilbride,5.64.46.24,BOTULINUM A TOXIN treats CRANIAL CERVICAL DYSTONIA,22,0,,46,17,treats,0.99124070716193,804947,"BOTULINUM A TOXIN for CRANIAL CERVICAL DYSTONIA: double blind, placebo controlled study.",CRANIAL CERVICAL DYSTONIA,BOTULINUM A TOXIN,TWrex-cause
791857761,9/21/2015 14:26:11,1743101536,9/21/2015 14:24:25,False,neodev,0.9,33110177,USA,DE,,108.59.8.208,BOTULINUM A TOXIN treats CRANIAL CERVICAL DYSTONIA,22,0,,46,17,treats,0.99124070716193,804947,"BOTULINUM A TOXIN for CRANIAL CERVICAL DYSTONIA: double blind, placebo controlled study.",CRANIAL CERVICAL DYSTONIA,BOTULINUM A TOXIN,TWrex-cause
791857762,9/21/2015 08:33:18,1742979167,9/21/2015 08:32:55,False,clixsense,1.0,22751911,NLD,04,Groningen,195.241.153.97,AZATHIOPRINE treats ULCERATIVE COLITIS,163,87,,181,99,treats,0.9838699100999069,907572,"1 ,   14 ,   15 ,   17 ,   18 ,   41  Administered concomitantly with corticosteroids, AZATHIOPRINE or mercaptopurine, and/or 5-aminosalicyclates in patients with ULCERATIVE COLITIS",ULCERATIVE COLITIS,AZATHIOPRINE,RO-may_treat
791857762,9/21/2015 08:42:41,1742982101,9/21/2015 08:39:47,False,clixsense,0.9306,30681826,GBR,I9,Diss,31.49.71.254,AZATHIOPRINE treats ULCERATIVE COLITIS,163,87,,181,99,treats,0.9838699100999069,907572,"1 ,   14 ,   15 ,   17 ,   18 ,   41  Administered concomitantly with corticosteroids, AZATHIOPRINE or mercaptopurine, and/or 5-aminosalicyclates in patients with ULCERATIVE COLITIS",ULCERATIVE COLITIS,AZATHIOPRINE,RO-may_treat
791857762,9/21/2015 08:43:56,1742982496,9/21/2015 08:43:33,False,neodev,0.9167,30627835,GBR,D8,Bishop Auckland,217.44.84.223,AZATHIOPRINE treats ULCERATIVE COLITIS,163,87,,181,99,treats,0.9838699100999069,907572,"1 ,   14 ,   15 ,   17 ,   18 ,   41  Administered concomitantly with corticosteroids, AZATHIOPRINE or mercaptopurine, and/or 5-aminosalicyclates in patients with ULCERATIVE COLITIS",ULCERATIVE COLITIS,AZATHIOPRINE,RO-may_treat
791857762,9/21/2015 08:53:19,1742985283,9/21/2015 08:52:16,False,pocketmoneygpt,0.8833,21432964,GBR,F8,Borehamwood,81.159.185.70,AZATHIOPRINE treats ULCERATIVE COLITIS,163,87,,181,99,treats,0.9838699100999069,907572,"1 ,   14 ,   15 ,   17 ,   18 ,   41  Administered concomitantly with corticosteroids, AZATHIOPRINE or mercaptopurine, and/or 5-aminosalicyclates in patients with ULCERATIVE COLITIS",ULCERATIVE COLITIS,AZATHIOPRINE,RO-may_treat
791857762,9/21/2015 09:05:24,1742988789,9/21/2015 09:05:07,False,prodege,0.85,32850083,GBR,L9,Sheffield,92.239.198.197,AZATHIOPRINE treats ULCERATIVE COLITIS,163,87,,181,99,treats,0.9838699100999069,907572,"1 ,   14 ,   15 ,   17 ,   18 ,   41  Administered concomitantly with corticosteroids, AZATHIOPRINE or mercaptopurine, and/or 5-aminosalicyclates in patients with ULCERATIVE COLITIS",ULCERATIVE COLITIS,AZATHIOPRINE,RO-may_treat
791857762,9/21/2015 09:06:36,1742989090,9/21/2015 09:06:16,False,neodev,0.7798,33644825,USA,FL,Fort Lauderdale,65.111.173.161,AZATHIOPRINE treats ULCERATIVE COLITIS,163,87,,181,99,treats,0.9838699100999069,907572,"1 ,   14 ,   15 ,   17 ,   18 ,   41  Administered concomitantly with corticosteroids, AZATHIOPRINE or mercaptopurine, and/or 5-aminosalicyclates in patients with ULCERATIVE COLITIS",ULCERATIVE COLITIS,AZATHIOPRINE,RO-may_treat
791857762,9/21/2015 09:17:19,1742991858,9/21/2015 09:16:52,False,instagc,0.8809999999999999,18960682,GBR,U2,Annan,92.18.213.181,AZATHIOPRINE treats ULCERATIVE COLITIS,163,87,,181,99,treats,0.9838699100999069,907572,"1 ,   14 ,   15 ,   17 ,   18 ,   41  Administered concomitantly with corticosteroids, AZATHIOPRINE or mercaptopurine, and/or 5-aminosalicyclates in patients with ULCERATIVE COLITIS",ULCERATIVE COLITIS,AZATHIOPRINE,RO-may_treat
791857764,9/21/2015 08:32:15,1742978845,9/21/2015 08:31:43,False,clixsense,1.0,22751911,NLD,04,Groningen,195.241.153.97,STREPTOCOCCAL INFECTIONS treats STREPTOCOCCI,25,158,,48,170,treats,0.7181848464596079,810339,"Uses  Staphylococcal and STREPTOCOCCAL INFECTIONS  Treatment of serious infections caused by susceptible staphylococci,  Streptococcus pneumoniae , and other STREPTOCOCCI",STREPTOCOCCAL INFECTIONS,STREPTOCOCCI,TWrex-cause
791857764,9/21/2015 08:38:24,1742980860,9/21/2015 08:37:08,False,clixsense,0.9306,30681826,GBR,I9,Diss,31.49.71.254,STREPTOCOCCAL INFECTIONS treats STREPTOCOCCI,25,158,,48,170,treats,0.7181848464596079,810339,"Uses  Staphylococcal and STREPTOCOCCAL INFECTIONS  Treatment of serious infections caused by susceptible staphylococci,  Streptococcus pneumoniae , and other STREPTOCOCCI",STREPTOCOCCAL INFECTIONS,STREPTOCOCCI,TWrex-cause
791857764,9/21/2015 08:42:53,1742982202,9/21/2015 08:42:22,False,neodev,0.9167,30627835,GBR,D8,Bishop Auckland,217.44.84.223,no_relation,25,158,,48,170,treats,0.7181848464596079,810339,"Uses  Staphylococcal and STREPTOCOCCAL INFECTIONS  Treatment of serious infections caused by susceptible staphylococci,  Streptococcus pneumoniae , and other STREPTOCOCCI",STREPTOCOCCAL INFECTIONS,STREPTOCOCCI,TWrex-cause
791857764,9/21/2015 08:46:04,1742983235,9/21/2015 08:45:18,False,pocketmoneygpt,0.8833,21432964,GBR,F8,Borehamwood,81.159.185.70,STREPTOCOCCAL INFECTIONS treats STREPTOCOCCI,25,158,,48,170,treats,0.7181848464596079,810339,"Uses  Staphylococcal and STREPTOCOCCAL INFECTIONS  Treatment of serious infections caused by susceptible staphylococci,  Streptococcus pneumoniae , and other STREPTOCOCCI",STREPTOCOCCAL INFECTIONS,STREPTOCOCCI,TWrex-cause
791857764,9/21/2015 08:48:13,1742983853,9/21/2015 08:47:40,False,elite,0.75,32799278,GBR,,,81.136.60.168,STREPTOCOCCAL INFECTIONS treats STREPTOCOCCI,25,158,,48,170,treats,0.7181848464596079,810339,"Uses  Staphylococcal and STREPTOCOCCAL INFECTIONS  Treatment of serious infections caused by susceptible staphylococci,  Streptococcus pneumoniae , and other STREPTOCOCCI",STREPTOCOCCAL INFECTIONS,STREPTOCOCCI,TWrex-cause
791857764,9/21/2015 09:04:18,1742988527,9/21/2015 09:03:06,False,prodege,0.85,32850083,GBR,L9,Sheffield,92.239.198.197,STREPTOCOCCAL INFECTIONS treats STREPTOCOCCI,25,158,,48,170,treats,0.7181848464596079,810339,"Uses  Staphylococcal and STREPTOCOCCAL INFECTIONS  Treatment of serious infections caused by susceptible staphylococci,  Streptococcus pneumoniae , and other STREPTOCOCCI",STREPTOCOCCAL INFECTIONS,STREPTOCOCCI,TWrex-cause
791857764,9/21/2015 09:05:00,1742988710,9/21/2015 09:04:16,False,neodev,0.7798,33644825,USA,FL,Fort Lauderdale,65.111.173.161,STREPTOCOCCI treats STREPTOCOCCAL INFECTIONS,25,158,,48,170,treats,0.7181848464596079,810339,"Uses  Staphylococcal and STREPTOCOCCAL INFECTIONS  Treatment of serious infections caused by susceptible staphylococci,  Streptococcus pneumoniae , and other STREPTOCOCCI",STREPTOCOCCAL INFECTIONS,STREPTOCOCCI,TWrex-cause
862932342,1/18/2016 18:37:54,1862013949,1/18/2016 18:37:34,False,prodege,0.8532,1924522,USA,NY,New York,96.224.13.135,GLUCAGON treats HYPOGLYCEMIA,179,38,,190,46,treats,0.3396831102,820092, Progressive loss of epinephrine and GLUCAGON response to hypoglycemia with prolonged duration of diabetes contributes to the diminished perception of the adrenergic symptoms of HYPOGLYCEMIA and increases the risk of severe events.,HYPOGLYCEMIA,GLUCAGON,RO-may_treat
862932342,1/18/2016 18:39:42,1862014847,1/18/2016 18:38:56,False,elite,0.8294,29768955,GBR,,,213.205.195.9,GLUCAGON treats HYPOGLYCEMIA,179,38,,190,46,treats,0.3396831102,820092, Progressive loss of epinephrine and GLUCAGON response to hypoglycemia with prolonged duration of diabetes contributes to the diminished perception of the adrenergic symptoms of HYPOGLYCEMIA and increases the risk of severe events.,HYPOGLYCEMIA,GLUCAGON,RO-may_treat
862932342,1/18/2016 18:48:17,1862018032,1/18/2016 18:47:19,False,neodev,0.6563,13253916,GBR,C6,Saint Austell,92.17.245.86,no_relation,179,38,,190,46,treats,0.3396831102,820092, Progressive loss of epinephrine and GLUCAGON response to hypoglycemia with prolonged duration of diabetes contributes to the diminished perception of the adrenergic symptoms of HYPOGLYCEMIA and increases the risk of severe events.,HYPOGLYCEMIA,GLUCAGON,RO-may_treat
862932342,1/18/2016 19:00:29,1862022644,1/18/2016 18:59:26,False,instagc,0.7020000000000001,18672993,CAN,BC,Vancouver,76.77.82.83,no_relation,179,38,,190,46,treats,0.3396831102,820092, Progressive loss of epinephrine and GLUCAGON response to hypoglycemia with prolonged duration of diabetes contributes to the diminished perception of the adrenergic symptoms of HYPOGLYCEMIA and increases the risk of severe events.,HYPOGLYCEMIA,GLUCAGON,RO-may_treat
862932342,1/18/2016 19:04:23,1862023981,1/18/2016 19:04:11,False,neodev,0.622,33155316,GBR,M3,Bridgwater,86.138.4.186,GLUCAGON treats HYPOGLYCEMIA,179,38,,190,46,treats,0.3396831102,820092, Progressive loss of epinephrine and GLUCAGON response to hypoglycemia with prolonged duration of diabetes contributes to the diminished perception of the adrenergic symptoms of HYPOGLYCEMIA and increases the risk of severe events.,HYPOGLYCEMIA,GLUCAGON,RO-may_treat
862932342,1/18/2016 19:06:27,1862024798,1/18/2016 19:05:17,False,zoombucks,0.6528,6744840,CAN,BC,Kelowna,174.4.58.160,GLUCAGON treats HYPOGLYCEMIA,179,38,,190,46,treats,0.3396831102,820092, Progressive loss of epinephrine and GLUCAGON response to hypoglycemia with prolonged duration of diabetes contributes to the diminished perception of the adrenergic symptoms of HYPOGLYCEMIA and increases the risk of severe events.,HYPOGLYCEMIA,GLUCAGON,RO-may_treat
862932342,1/18/2016 19:08:13,1862025509,1/18/2016 19:06:35,False,points4rewards,0.6806,20306700,USA,WA,Kirkland,73.225.187.97,GLUCAGON treats HYPOGLYCEMIA,179,38,,190,46,treats,0.3396831102,820092, Progressive loss of epinephrine and GLUCAGON response to hypoglycemia with prolonged duration of diabetes contributes to the diminished perception of the adrenergic symptoms of HYPOGLYCEMIA and increases the risk of severe events.,HYPOGLYCEMIA,GLUCAGON,RO-may_treat
862932346,1/18/2016 19:20:57,1862030538,1/18/2016 19:20:39,False,gifthunterclub,0.6944,30901412,GBR,G5,Canterbury,78.148.187.102,ACTIVATED CHARCOAL treats UREMIA,111,48,,116,66,treats,0.9863939237999999,820015,"Hemoperfusion  Hemoperfusion through columns of ACTIVATED CHARCOAL to remove endogenous or exogenous toxins in UREMIA hepatic failure, or acute toxicity associated with overdose of certain drugs.",UREMIA,ACTIVATED CHARCOAL,RO-may_treat
862932346,1/18/2016 19:21:34,1862030837,1/18/2016 19:21:09,False,clixsense,0.7976,6349089,USA,NJ,Rockaway,108.35.211.250,ACTIVATED CHARCOAL treats UREMIA,111,48,,116,66,treats,0.9863939237999999,820015,"Hemoperfusion  Hemoperfusion through columns of ACTIVATED CHARCOAL to remove endogenous or exogenous toxins in UREMIA hepatic failure, or acute toxicity associated with overdose of certain drugs.",UREMIA,ACTIVATED CHARCOAL,RO-may_treat
862932346,1/18/2016 19:25:52,1862032701,1/18/2016 19:25:37,False,prodege,0.6875,25257275,CAN,BC,Coquitlam,70.68.58.9,ACTIVATED CHARCOAL treats UREMIA,111,48,,116,66,treats,0.9863939237999999,820015,"Hemoperfusion  Hemoperfusion through columns of ACTIVATED CHARCOAL to remove endogenous or exogenous toxins in UREMIA hepatic failure, or acute toxicity associated with overdose of certain drugs.",UREMIA,ACTIVATED CHARCOAL,RO-may_treat
862932346,1/18/2016 19:28:30,1862033873,1/18/2016 19:27:29,False,cotter,0.4653,1495820,USA,AL,Talladega,24.177.180.29,no_relation,111,48,,116,66,treats,0.9863939237999999,820015,"Hemoperfusion  Hemoperfusion through columns of ACTIVATED CHARCOAL to remove endogenous or exogenous toxins in UREMIA hepatic failure, or acute toxicity associated with overdose of certain drugs.",UREMIA,ACTIVATED CHARCOAL,RO-may_treat
862932346,1/18/2016 19:43:00,1862038772,1/18/2016 19:40:39,False,prodege,0.6667,19520624,USA,CA,Riverside,108.244.25.24,ACTIVATED CHARCOAL treats UREMIA,111,48,,116,66,treats,0.9863939237999999,820015,"Hemoperfusion  Hemoperfusion through columns of ACTIVATED CHARCOAL to remove endogenous or exogenous toxins in UREMIA hepatic failure, or acute toxicity associated with overdose of certain drugs.",UREMIA,ACTIVATED CHARCOAL,RO-may_treat
862932346,1/18/2016 19:43:59,1862039021,1/18/2016 19:42:37,False,clixsense,0.569,21875134,GBR,,,87.114.181.2,ACTIVATED CHARCOAL treats UREMIA,111,48,,116,66,treats,0.9863939237999999,820015,"Hemoperfusion  Hemoperfusion through columns of ACTIVATED CHARCOAL to remove endogenous or exogenous toxins in UREMIA hepatic failure, or acute toxicity associated with overdose of certain drugs.",UREMIA,ACTIVATED CHARCOAL,RO-may_treat
862932346,1/18/2016 19:44:33,1862039214,1/18/2016 19:41:42,False,clixsense,0.7667,33878524,CAN,BC,Hope,75.156.80.18,ACTIVATED CHARCOAL treats UREMIA,111,48,,116,66,treats,0.9863939237999999,820015,"Hemoperfusion  Hemoperfusion through columns of ACTIVATED CHARCOAL to remove endogenous or exogenous toxins in UREMIA hepatic failure, or acute toxicity associated with overdose of certain drugs.",UREMIA,ACTIVATED CHARCOAL,RO-may_treat
862932361,1/18/2016 16:47:49,1861947153,1/18/2016 16:47:30,False,instagc,0.8611,27914150,USA,KS,Emporia,67.61.154.33,PREDNISONE METHYLPREDNISOLONE treats INFLAMMATION,584,653,,595,682,treats,0.9931270662999999,820056,"Continuous epidural analgesia with 0.1% bupivacaine for 5 to 7 days  Active against peripheral mechanisms of neuropathic pain  Hypotension, bradycardia, heart block, cardiac arrhythmias, cardiac arrest, myocardial depression, seizures, nausea, paresthesias, burning at catheter site, pruritus, restlessness  Inpatient treatment, frequent assessment of vital signs and neurologic status necessary Vitamin C  Reduces lipid peroxidation, scavenges hydroxyl radicals, protects the capillary endothelium, and inhibits vascular permeability  500 mg orally for 50 days after injury  Reduced INFLAMMATION  Diarrhea  Widely used as a supplement Corticosteroids (PREDNISONE METHYLPREDNISOLONE).",INFLAMMATION,PREDNISONE METHYLPREDNISOLONE,RO-may_treat
862932361,1/18/2016 16:50:10,1861948376,1/18/2016 16:48:21,False,points4rewards,0.7649,28703583,USA,,,184.53.32.59,PREDNISONE METHYLPREDNISOLONE treats INFLAMMATION,584,653,,595,682,treats,0.9931270662999999,820056,"Continuous epidural analgesia with 0.1% bupivacaine for 5 to 7 days  Active against peripheral mechanisms of neuropathic pain  Hypotension, bradycardia, heart block, cardiac arrhythmias, cardiac arrest, myocardial depression, seizures, nausea, paresthesias, burning at catheter site, pruritus, restlessness  Inpatient treatment, frequent assessment of vital signs and neurologic status necessary Vitamin C  Reduces lipid peroxidation, scavenges hydroxyl radicals, protects the capillary endothelium, and inhibits vascular permeability  500 mg orally for 50 days after injury  Reduced INFLAMMATION  Diarrhea  Widely used as a supplement Corticosteroids (PREDNISONE METHYLPREDNISOLONE).",INFLAMMATION,PREDNISONE METHYLPREDNISOLONE,RO-may_treat
862932361,1/18/2016 16:51:05,1861948957,1/18/2016 16:50:41,False,instagc,0.8139,21088425,USA,MI,Battle Creek,107.140.176.37,PREDNISONE METHYLPREDNISOLONE treats INFLAMMATION,584,653,,595,682,treats,0.9931270662999999,820056,"Continuous epidural analgesia with 0.1% bupivacaine for 5 to 7 days  Active against peripheral mechanisms of neuropathic pain  Hypotension, bradycardia, heart block, cardiac arrhythmias, cardiac arrest, myocardial depression, seizures, nausea, paresthesias, burning at catheter site, pruritus, restlessness  Inpatient treatment, frequent assessment of vital signs and neurologic status necessary Vitamin C  Reduces lipid peroxidation, scavenges hydroxyl radicals, protects the capillary endothelium, and inhibits vascular permeability  500 mg orally for 50 days after injury  Reduced INFLAMMATION  Diarrhea  Widely used as a supplement Corticosteroids (PREDNISONE METHYLPREDNISOLONE).",INFLAMMATION,PREDNISONE METHYLPREDNISOLONE,RO-may_treat
862932361,1/18/2016 16:53:25,1861950071,1/18/2016 16:52:42,False,prodege,0.7979999999999999,13300986,CAN,AB,Saint Albert,174.3.24.150,PREDNISONE METHYLPREDNISOLONE treats INFLAMMATION,584,653,,595,682,treats,0.9931270662999999,820056,"Continuous epidural analgesia with 0.1% bupivacaine for 5 to 7 days  Active against peripheral mechanisms of neuropathic pain  Hypotension, bradycardia, heart block, cardiac arrhythmias, cardiac arrest, myocardial depression, seizures, nausea, paresthesias, burning at catheter site, pruritus, restlessness  Inpatient treatment, frequent assessment of vital signs and neurologic status necessary Vitamin C  Reduces lipid peroxidation, scavenges hydroxyl radicals, protects the capillary endothelium, and inhibits vascular permeability  500 mg orally for 50 days after injury  Reduced INFLAMMATION  Diarrhea  Widely used as a supplement Corticosteroids (PREDNISONE METHYLPREDNISOLONE).",INFLAMMATION,PREDNISONE METHYLPREDNISOLONE,RO-may_treat
862932361,1/18/2016 16:53:32,1861950136,1/18/2016 16:53:05,False,clixsense,0.6107,22751911,NLD,4,Groningen,195.241.153.97,PREDNISONE METHYLPREDNISOLONE treats INFLAMMATION,584,653,,595,682,treats,0.9931270662999999,820056,"Continuous epidural analgesia with 0.1% bupivacaine for 5 to 7 days  Active against peripheral mechanisms of neuropathic pain  Hypotension, bradycardia, heart block, cardiac arrhythmias, cardiac arrest, myocardial depression, seizures, nausea, paresthesias, burning at catheter site, pruritus, restlessness  Inpatient treatment, frequent assessment of vital signs and neurologic status necessary Vitamin C  Reduces lipid peroxidation, scavenges hydroxyl radicals, protects the capillary endothelium, and inhibits vascular permeability  500 mg orally for 50 days after injury  Reduced INFLAMMATION  Diarrhea  Widely used as a supplement Corticosteroids (PREDNISONE METHYLPREDNISOLONE).",INFLAMMATION,PREDNISONE METHYLPREDNISOLONE,RO-may_treat
862932361,1/18/2016 16:53:47,1861950247,1/18/2016 16:53:19,False,clixsense,0.7107,10390268,USA,NY,New Paltz,100.40.135.136,PREDNISONE METHYLPREDNISOLONE treats INFLAMMATION,584,653,,595,682,treats,0.9931270662999999,820056,"Continuous epidural analgesia with 0.1% bupivacaine for 5 to 7 days  Active against peripheral mechanisms of neuropathic pain  Hypotension, bradycardia, heart block, cardiac arrhythmias, cardiac arrest, myocardial depression, seizures, nausea, paresthesias, burning at catheter site, pruritus, restlessness  Inpatient treatment, frequent assessment of vital signs and neurologic status necessary Vitamin C  Reduces lipid peroxidation, scavenges hydroxyl radicals, protects the capillary endothelium, and inhibits vascular permeability  500 mg orally for 50 days after injury  Reduced INFLAMMATION  Diarrhea  Widely used as a supplement Corticosteroids (PREDNISONE METHYLPREDNISOLONE).",INFLAMMATION,PREDNISONE METHYLPREDNISOLONE,RO-may_treat
862932361,1/18/2016 17:12:45,1861959395,1/18/2016 17:12:37,False,fusioncash,0.5714,22139728,USA,NY,Watertown,66.67.91.242,PREDNISONE METHYLPREDNISOLONE treats INFLAMMATION,584,653,,595,682,treats,0.9931270662999999,820056,"Continuous epidural analgesia with 0.1% bupivacaine for 5 to 7 days  Active against peripheral mechanisms of neuropathic pain  Hypotension, bradycardia, heart block, cardiac arrhythmias, cardiac arrest, myocardial depression, seizures, nausea, paresthesias, burning at catheter site, pruritus, restlessness  Inpatient treatment, frequent assessment of vital signs and neurologic status necessary Vitamin C  Reduces lipid peroxidation, scavenges hydroxyl radicals, protects the capillary endothelium, and inhibits vascular permeability  500 mg orally for 50 days after injury  Reduced INFLAMMATION  Diarrhea  Widely used as a supplement Corticosteroids (PREDNISONE METHYLPREDNISOLONE).",INFLAMMATION,PREDNISONE METHYLPREDNISOLONE,RO-may_treat
862932378,1/18/2016 18:18:54,1862004535,1/18/2016 18:17:48,False,points4rewards,0.7262,20113482,USA,IN,Muncie,165.139.149.169,no_relation,194,115,,220,164,treats,0.474341649,820058,"2  Confirm congenital antithrombin III deficiency based on clear family history of venous thrombosis and decreased ENDOGENOUS PLASMA ANTITHROMBIN III CONCENTRATIONS;  1 ,   6   exclude acquired ANTITHROMBIN III DEFICIENCY",ANTITHROMBIN III DEFICIENCY,ENDOGENOUS PLASMA ANTITHROMBIN III CONCENTRATIONS,RO-may_treat
862932378,1/18/2016 18:22:28,1862006601,1/18/2016 18:21:57,False,zoombucks,0.6833,4711962,CAN,ON,Markham,76.69.102.4,ENDOGENOUS PLASMA ANTITHROMBIN III CONCENTRATIONS treats ANTITHROMBIN III DEFICIENCY,194,115,,220,164,treats,0.474341649,820058,"2  Confirm congenital antithrombin III deficiency based on clear family history of venous thrombosis and decreased ENDOGENOUS PLASMA ANTITHROMBIN III CONCENTRATIONS;  1 ,   6   exclude acquired ANTITHROMBIN III DEFICIENCY",ANTITHROMBIN III DEFICIENCY,ENDOGENOUS PLASMA ANTITHROMBIN III CONCENTRATIONS,RO-may_treat
862932378,1/18/2016 18:29:06,1862010061,1/18/2016 18:28:34,False,neodev,0.7131,14861092,GBR,J1,Northampton,90.199.155.70,no_relation,194,115,,220,164,treats,0.474341649,820058,"2  Confirm congenital antithrombin III deficiency based on clear family history of venous thrombosis and decreased ENDOGENOUS PLASMA ANTITHROMBIN III CONCENTRATIONS;  1 ,   6   exclude acquired ANTITHROMBIN III DEFICIENCY",ANTITHROMBIN III DEFICIENCY,ENDOGENOUS PLASMA ANTITHROMBIN III CONCENTRATIONS,RO-may_treat
862932378,1/18/2016 18:30:53,1862010959,1/18/2016 18:29:16,False,neodev,0.7095,20306047,GBR,E6,Cirencester,92.14.17.197,ENDOGENOUS PLASMA ANTITHROMBIN III CONCENTRATIONS treats ANTITHROMBIN III DEFICIENCY,194,115,,220,164,treats,0.474341649,820058,"2  Confirm congenital antithrombin III deficiency based on clear family history of venous thrombosis and decreased ENDOGENOUS PLASMA ANTITHROMBIN III CONCENTRATIONS;  1 ,   6   exclude acquired ANTITHROMBIN III DEFICIENCY",ANTITHROMBIN III DEFICIENCY,ENDOGENOUS PLASMA ANTITHROMBIN III CONCENTRATIONS,RO-may_treat
862932378,1/18/2016 18:31:22,1862011165,1/18/2016 18:30:56,False,inboxpounds,0.6944,25200832,GBR,P3,Stratford-upon-avon,86.164.155.48,no_relation,194,115,,220,164,treats,0.474341649,820058,"2  Confirm congenital antithrombin III deficiency based on clear family history of venous thrombosis and decreased ENDOGENOUS PLASMA ANTITHROMBIN III CONCENTRATIONS;  1 ,   6   exclude acquired ANTITHROMBIN III DEFICIENCY",ANTITHROMBIN III DEFICIENCY,ENDOGENOUS PLASMA ANTITHROMBIN III CONCENTRATIONS,RO-may_treat
862932378,1/18/2016 18:36:49,1862013500,1/18/2016 18:36:18,False,prodege,0.8532,1924522,USA,NY,New York,96.224.13.135,no_relation,194,115,,220,164,treats,0.474341649,820058,"2  Confirm congenital antithrombin III deficiency based on clear family history of venous thrombosis and decreased ENDOGENOUS PLASMA ANTITHROMBIN III CONCENTRATIONS;  1 ,   6   exclude acquired ANTITHROMBIN III DEFICIENCY",ANTITHROMBIN III DEFICIENCY,ENDOGENOUS PLASMA ANTITHROMBIN III CONCENTRATIONS,RO-may_treat
862932378,1/18/2016 18:37:39,1862013836,1/18/2016 18:36:10,False,elite,0.8294,29768955,GBR,,,213.205.195.9,no_relation,194,115,,220,164,treats,0.474341649,820058,"2  Confirm congenital antithrombin III deficiency based on clear family history of venous thrombosis and decreased ENDOGENOUS PLASMA ANTITHROMBIN III CONCENTRATIONS;  1 ,   6   exclude acquired ANTITHROMBIN III DEFICIENCY",ANTITHROMBIN III DEFICIENCY,ENDOGENOUS PLASMA ANTITHROMBIN III CONCENTRATIONS,RO-may_treat
862932385,1/18/2016 17:27:54,1861965222,1/18/2016 17:26:50,False,gifthulk,0.9028,18666417,USA,PA,Linesville,72.23.136.188,METOPROLOL treats ANGINA PECTORIS,110,81,,124,91,treats,0.7071067812,820001,"Keech AC, Harper RW, Harrison PM et al. Pharmacokinetic interaction between oral METOPROLOL and verapamil for ANGINA PECTORIS",ANGINA PECTORIS,METOPROLOL,RO-may_treat
862932385,1/18/2016 17:34:50,1861967701,1/18/2016 17:34:32,False,clixsense,0.8804,24104564,AUS,2,Sydney,60.241.132.132,METOPROLOL treats ANGINA PECTORIS,110,81,,124,91,treats,0.7071067812,820001,"Keech AC, Harper RW, Harrison PM et al. Pharmacokinetic interaction between oral METOPROLOL and verapamil for ANGINA PECTORIS",ANGINA PECTORIS,METOPROLOL,RO-may_treat
862932385,1/18/2016 17:38:01,1861969289,1/18/2016 17:37:36,False,prodege,0.6885,22031444,GBR,M4,Southampton,92.24.213.252,METOPROLOL treats ANGINA PECTORIS,110,81,,124,91,treats,0.7071067812,820001,"Keech AC, Harper RW, Harrison PM et al. Pharmacokinetic interaction between oral METOPROLOL and verapamil for ANGINA PECTORIS",ANGINA PECTORIS,METOPROLOL,RO-may_treat
862932385,1/18/2016 18:14:26,1862001146,1/18/2016 18:13:42,False,points4rewards,0.7262,20113482,USA,IN,Muncie,165.139.149.169,METOPROLOL treats ANGINA PECTORIS,110,81,,124,91,treats,0.7071067812,820001,"Keech AC, Harper RW, Harrison PM et al. Pharmacokinetic interaction between oral METOPROLOL and verapamil for ANGINA PECTORIS",ANGINA PECTORIS,METOPROLOL,RO-may_treat
862932385,1/18/2016 18:20:26,1862005495,1/18/2016 18:18:53,False,zoombucks,0.6833,4711962,CAN,ON,Markham,76.69.102.4,METOPROLOL treats ANGINA PECTORIS,110,81,,124,91,treats,0.7071067812,820001,"Keech AC, Harper RW, Harrison PM et al. Pharmacokinetic interaction between oral METOPROLOL and verapamil for ANGINA PECTORIS",ANGINA PECTORIS,METOPROLOL,RO-may_treat
862932385,1/18/2016 18:25:50,1862008192,1/18/2016 18:24:54,False,neodev,0.7095,20306047,GBR,E6,Cirencester,92.14.17.197,METOPROLOL treats ANGINA PECTORIS,110,81,,124,91,treats,0.7071067812,820001,"Keech AC, Harper RW, Harrison PM et al. Pharmacokinetic interaction between oral METOPROLOL and verapamil for ANGINA PECTORIS",ANGINA PECTORIS,METOPROLOL,RO-may_treat
862932385,1/18/2016 18:26:42,1862008721,1/18/2016 18:26:08,False,neodev,0.7131,14861092,GBR,J1,Northampton,90.199.155.70,METOPROLOL treats ANGINA PECTORIS,110,81,,124,91,treats,0.7071067812,820001,"Keech AC, Harper RW, Harrison PM et al. Pharmacokinetic interaction between oral METOPROLOL and verapamil for ANGINA PECTORIS",ANGINA PECTORIS,METOPROLOL,RO-may_treat
862932394,1/18/2016 16:25:09,1861938556,1/18/2016 16:24:51,False,prodege,0.5694,4316379,CAN,ON,Windsor,206.47.90.133,OMEPRAZOLE treats HEARTBURN,135,158,,143,168,treats,0.9363821837999999,820074,Lansoprazole provided more effective and faster relief for heartburn than did omeprazole in erosive esophagitis  Keywords: Esophagitis HEARTBURN Lansoprazole OMEPRAZOLE  ACP Journal Club.,HEARTBURN,OMEPRAZOLE,RO-may_treat
862932394,1/18/2016 16:25:49,1861938878,1/18/2016 16:24:58,False,points4rewards,0.6696,28755767,USA,TN,Jonesborough,68.57.118.32,OMEPRAZOLE treats HEARTBURN,135,158,,143,168,treats,0.9363821837999999,820074,Lansoprazole provided more effective and faster relief for heartburn than did omeprazole in erosive esophagitis  Keywords: Esophagitis HEARTBURN Lansoprazole OMEPRAZOLE  ACP Journal Club.,HEARTBURN,OMEPRAZOLE,RO-may_treat
862932394,1/18/2016 16:26:44,1861939358,1/18/2016 16:24:47,False,clixsense,0.7063,35612952,GBR,C3,Cambridge,31.51.142.170,OMEPRAZOLE treats HEARTBURN,135,158,,143,168,treats,0.9363821837999999,820074,Lansoprazole provided more effective and faster relief for heartburn than did omeprazole in erosive esophagitis  Keywords: Esophagitis HEARTBURN Lansoprazole OMEPRAZOLE  ACP Journal Club.,HEARTBURN,OMEPRAZOLE,RO-may_treat
862932394,1/18/2016 16:27:26,1861939643,1/18/2016 16:27:17,False,clixsense,0.6429,28457001,CAN,ON,North Bay,24.204.202.220,OMEPRAZOLE treats HEARTBURN,135,158,,143,168,treats,0.9363821837999999,820074,Lansoprazole provided more effective and faster relief for heartburn than did omeprazole in erosive esophagitis  Keywords: Esophagitis HEARTBURN Lansoprazole OMEPRAZOLE  ACP Journal Club.,HEARTBURN,OMEPRAZOLE,RO-may_treat
862932394,1/18/2016 16:27:31,1861939683,1/18/2016 16:26:20,False,instagc,0.6845,18386513,USA,TN,Kingston,98.70.100.182,no_relation,135,158,,143,168,treats,0.9363821837999999,820074,Lansoprazole provided more effective and faster relief for heartburn than did omeprazole in erosive esophagitis  Keywords: Esophagitis HEARTBURN Lansoprazole OMEPRAZOLE  ACP Journal Club.,HEARTBURN,OMEPRAZOLE,RO-may_treat
862932394,1/18/2016 16:29:57,1861940724,1/18/2016 16:29:29,False,prizerebel,0.6643,35607359,USA,GA,Savannah,69.41.96.199,no_relation,135,158,,143,168,treats,0.9363821837999999,820074,Lansoprazole provided more effective and faster relief for heartburn than did omeprazole in erosive esophagitis  Keywords: Esophagitis HEARTBURN Lansoprazole OMEPRAZOLE  ACP Journal Club.,HEARTBURN,OMEPRAZOLE,RO-may_treat
862932394,1/18/2016 16:33:17,1861942071,1/18/2016 16:29:58,False,clixsense,0.6667,6339764,CAN,NS,North Sydney,24.89.248.92,no_relation,135,158,,143,168,treats,0.9363821837999999,820074,Lansoprazole provided more effective and faster relief for heartburn than did omeprazole in erosive esophagitis  Keywords: Esophagitis HEARTBURN Lansoprazole OMEPRAZOLE  ACP Journal Club.,HEARTBURN,OMEPRAZOLE,RO-may_treat
862932396,1/18/2016 19:05:22,1862024340,1/18/2016 19:05:13,False,neodev,0.622,33155316,GBR,M3,Bridgwater,86.138.4.186,GROWTH HORMONE treats DWARFISM,284,224,,291,238,treats,0.5897678246,820036,"Pituitary, anterior  Front portion of small gland below hypothalamus  Influences growth, sexual development, skin pigmentation, thyroid function, adrenocortical function through effects on other endocrine glands (except for GROWTH HORMONE which acts directly on cells)  Hypofunction: DWARFISM in child; decrease in all other endocrine gland functions except parathyroids Hyperfunction: Acromegaly in adult; giantism in child Pituitary, posterior  Back portion of small gland below hypothalamus  Oxytocin increases uterine contraction  Hypofunction: Diabetes insipidus Antidiuretic hormone increases absorption of water by kidney tubule  Hyperfunction: Unknown Testes and ovaries  Testes.",DWARFISM,GROWTH HORMONE,RO-may_treat
862932396,1/18/2016 19:10:20,1862026237,1/18/2016 19:09:23,False,prodege,0.6766,34650780,GBR,M3,Dulverton,81.154.41.50,GROWTH HORMONE treats DWARFISM,284,224,,291,238,treats,0.5897678246,820036,"Pituitary, anterior  Front portion of small gland below hypothalamus  Influences growth, sexual development, skin pigmentation, thyroid function, adrenocortical function through effects on other endocrine glands (except for GROWTH HORMONE which acts directly on cells)  Hypofunction: DWARFISM in child; decrease in all other endocrine gland functions except parathyroids Hyperfunction: Acromegaly in adult; giantism in child Pituitary, posterior  Back portion of small gland below hypothalamus  Oxytocin increases uterine contraction  Hypofunction: Diabetes insipidus Antidiuretic hormone increases absorption of water by kidney tubule  Hyperfunction: Unknown Testes and ovaries  Testes.",DWARFISM,GROWTH HORMONE,RO-may_treat
862932396,1/18/2016 19:11:45,1862026722,1/18/2016 19:11:10,False,points4rewards,0.6806,20306700,USA,WA,Kirkland,73.225.187.97,GROWTH HORMONE treats DWARFISM,284,224,,291,238,treats,0.5897678246,820036,"Pituitary, anterior  Front portion of small gland below hypothalamus  Influences growth, sexual development, skin pigmentation, thyroid function, adrenocortical function through effects on other endocrine glands (except for GROWTH HORMONE which acts directly on cells)  Hypofunction: DWARFISM in child; decrease in all other endocrine gland functions except parathyroids Hyperfunction: Acromegaly in adult; giantism in child Pituitary, posterior  Back portion of small gland below hypothalamus  Oxytocin increases uterine contraction  Hypofunction: Diabetes insipidus Antidiuretic hormone increases absorption of water by kidney tubule  Hyperfunction: Unknown Testes and ovaries  Testes.",DWARFISM,GROWTH HORMONE,RO-may_treat
862932396,1/18/2016 19:13:38,1862027492,1/18/2016 19:11:37,False,zoombucks,0.6528,6744840,CAN,BC,Kelowna,174.4.58.160,no_relation,284,224,,291,238,treats,0.5897678246,820036,"Pituitary, anterior  Front portion of small gland below hypothalamus  Influences growth, sexual development, skin pigmentation, thyroid function, adrenocortical function through effects on other endocrine glands (except for GROWTH HORMONE which acts directly on cells)  Hypofunction: DWARFISM in child; decrease in all other endocrine gland functions except parathyroids Hyperfunction: Acromegaly in adult; giantism in child Pituitary, posterior  Back portion of small gland below hypothalamus  Oxytocin increases uterine contraction  Hypofunction: Diabetes insipidus Antidiuretic hormone increases absorption of water by kidney tubule  Hyperfunction: Unknown Testes and ovaries  Testes.",DWARFISM,GROWTH HORMONE,RO-may_treat
862932396,1/18/2016 19:13:59,1862027634,1/18/2016 19:10:07,False,instagc,0.7020000000000001,18672993,CAN,BC,Vancouver,76.77.82.83,GROWTH HORMONE treats DWARFISM,284,224,,291,238,treats,0.5897678246,820036,"Pituitary, anterior  Front portion of small gland below hypothalamus  Influences growth, sexual development, skin pigmentation, thyroid function, adrenocortical function through effects on other endocrine glands (except for GROWTH HORMONE which acts directly on cells)  Hypofunction: DWARFISM in child; decrease in all other endocrine gland functions except parathyroids Hyperfunction: Acromegaly in adult; giantism in child Pituitary, posterior  Back portion of small gland below hypothalamus  Oxytocin increases uterine contraction  Hypofunction: Diabetes insipidus Antidiuretic hormone increases absorption of water by kidney tubule  Hyperfunction: Unknown Testes and ovaries  Testes.",DWARFISM,GROWTH HORMONE,RO-may_treat
862932396,1/18/2016 19:19:31,1862029894,1/18/2016 19:18:04,False,clixsense,0.7976,6349089,USA,NJ,Rockaway,108.35.211.250,GROWTH HORMONE treats DWARFISM,284,224,,291,238,treats,0.5897678246,820036,"Pituitary, anterior  Front portion of small gland below hypothalamus  Influences growth, sexual development, skin pigmentation, thyroid function, adrenocortical function through effects on other endocrine glands (except for GROWTH HORMONE which acts directly on cells)  Hypofunction: DWARFISM in child; decrease in all other endocrine gland functions except parathyroids Hyperfunction: Acromegaly in adult; giantism in child Pituitary, posterior  Back portion of small gland below hypothalamus  Oxytocin increases uterine contraction  Hypofunction: Diabetes insipidus Antidiuretic hormone increases absorption of water by kidney tubule  Hyperfunction: Unknown Testes and ovaries  Testes.",DWARFISM,GROWTH HORMONE,RO-may_treat
862932396,1/18/2016 19:25:25,1862032474,1/18/2016 19:23:41,False,cotter,0.4653,1495820,USA,AL,Talladega,24.177.180.29,no_relation,284,224,,291,238,treats,0.5897678246,820036,"Pituitary, anterior  Front portion of small gland below hypothalamus  Influences growth, sexual development, skin pigmentation, thyroid function, adrenocortical function through effects on other endocrine glands (except for GROWTH HORMONE which acts directly on cells)  Hypofunction: DWARFISM in child; decrease in all other endocrine gland functions except parathyroids Hyperfunction: Acromegaly in adult; giantism in child Pituitary, posterior  Back portion of small gland below hypothalamus  Oxytocin increases uterine contraction  Hypofunction: Diabetes insipidus Antidiuretic hormone increases absorption of water by kidney tubule  Hyperfunction: Unknown Testes and ovaries  Testes.",DWARFISM,GROWTH HORMONE,RO-may_treat
862932398,1/18/2016 17:29:04,1861965761,1/18/2016 17:28:21,False,gifthulk,0.9028,18666417,USA,PA,Linesville,72.23.136.188,METHOTREXATE treats LEUKEMIA,79,135,,86,147,treats,0.6882472016,820124,"Resistance to methotrexate was developed by continuous exposure of P388 murine LEUKEMIA cells in vitro to increasing concentrations of METHOTREXATE up to 1 X 10( 7) M. Once established, the resistance to methotrexate was stable.",LEUKEMIA,METHOTREXATE,RO-may_treat
862932398,1/18/2016 17:35:34,1861967982,1/18/2016 17:35:28,False,clixsense,0.8804,24104564,AUS,2,Sydney,60.241.132.132,METHOTREXATE treats LEUKEMIA,79,135,,86,147,treats,0.6882472016,820124,"Resistance to methotrexate was developed by continuous exposure of P388 murine LEUKEMIA cells in vitro to increasing concentrations of METHOTREXATE up to 1 X 10( 7) M. Once established, the resistance to methotrexate was stable.",LEUKEMIA,METHOTREXATE,RO-may_treat
862932398,1/18/2016 17:39:11,1861969696,1/18/2016 17:38:16,False,prodege,0.6885,22031444,GBR,M4,Southampton,92.24.213.252,METHOTREXATE treats LEUKEMIA,79,135,,86,147,treats,0.6882472016,820124,"Resistance to methotrexate was developed by continuous exposure of P388 murine LEUKEMIA cells in vitro to increasing concentrations of METHOTREXATE up to 1 X 10( 7) M. Once established, the resistance to methotrexate was stable.",LEUKEMIA,METHOTREXATE,RO-may_treat
862932398,1/18/2016 18:17:12,1862003447,1/18/2016 18:15:31,False,points4rewards,0.7262,20113482,USA,IN,Muncie,165.139.149.169,no_relation,79,135,,86,147,treats,0.6882472016,820124,"Resistance to methotrexate was developed by continuous exposure of P388 murine LEUKEMIA cells in vitro to increasing concentrations of METHOTREXATE up to 1 X 10( 7) M. Once established, the resistance to methotrexate was stable.",LEUKEMIA,METHOTREXATE,RO-may_treat
862932398,1/18/2016 18:21:13,1862005965,1/18/2016 18:21:02,False,zoombucks,0.6833,4711962,CAN,ON,Markham,76.69.102.4,METHOTREXATE treats LEUKEMIA,79,135,,86,147,treats,0.6882472016,820124,"Resistance to methotrexate was developed by continuous exposure of P388 murine LEUKEMIA cells in vitro to increasing concentrations of METHOTREXATE up to 1 X 10( 7) M. Once established, the resistance to methotrexate was stable.",LEUKEMIA,METHOTREXATE,RO-may_treat
862932398,1/18/2016 18:27:54,1862009422,1/18/2016 18:27:11,False,neodev,0.7131,14861092,GBR,J1,Northampton,90.199.155.70,METHOTREXATE treats LEUKEMIA,79,135,,86,147,treats,0.6882472016,820124,"Resistance to methotrexate was developed by continuous exposure of P388 murine LEUKEMIA cells in vitro to increasing concentrations of METHOTREXATE up to 1 X 10( 7) M. Once established, the resistance to methotrexate was stable.",LEUKEMIA,METHOTREXATE,RO-may_treat
862932398,1/18/2016 18:28:13,1862009564,1/18/2016 18:26:48,False,neodev,0.7095,20306047,GBR,E6,Cirencester,92.14.17.197,METHOTREXATE treats LEUKEMIA,79,135,,86,147,treats,0.6882472016,820124,"Resistance to methotrexate was developed by continuous exposure of P388 murine LEUKEMIA cells in vitro to increasing concentrations of METHOTREXATE up to 1 X 10( 7) M. Once established, the resistance to methotrexate was stable.",LEUKEMIA,METHOTREXATE,RO-may_treat
862932399,1/18/2016 16:25:49,1861938857,1/18/2016 16:25:10,False,prodege,0.5694,4316379,CAN,ON,Windsor,206.47.90.133,HYDROCHLOROTHIAZIDE treats HYPERTENSION,180,108,,191,127,treats,0.8285171561,820084,Dosage and Administration  General  Hypertension    Fixed combination olmesartan/amlodipine and olmesartan/HYDROCHLOROTHIAZIDE tablets should not be used for initial treatment of HYPERTENSION,HYPERTENSION,HYDROCHLOROTHIAZIDE,RO-may_treat
862932399,1/18/2016 16:27:02,1861939433,1/18/2016 16:25:50,False,points4rewards,0.6696,28755767,USA,TN,Jonesborough,68.57.118.32,HYDROCHLOROTHIAZIDE treats HYPERTENSION,180,108,,191,127,treats,0.8285171561,820084,Dosage and Administration  General  Hypertension    Fixed combination olmesartan/amlodipine and olmesartan/HYDROCHLOROTHIAZIDE tablets should not be used for initial treatment of HYPERTENSION,HYPERTENSION,HYDROCHLOROTHIAZIDE,RO-may_treat
862932399,1/18/2016 16:28:27,1861940101,1/18/2016 16:27:33,False,instagc,0.6845,18386513,USA,TN,Kingston,98.70.100.182,HYDROCHLOROTHIAZIDE treats HYPERTENSION,180,108,,191,127,treats,0.8285171561,820084,Dosage and Administration  General  Hypertension    Fixed combination olmesartan/amlodipine and olmesartan/HYDROCHLOROTHIAZIDE tablets should not be used for initial treatment of HYPERTENSION,HYPERTENSION,HYDROCHLOROTHIAZIDE,RO-may_treat
862932399,1/18/2016 16:30:18,1861940874,1/18/2016 16:29:58,False,prizerebel,0.6643,35607359,USA,GA,Savannah,69.41.96.199,HYDROCHLOROTHIAZIDE treats HYPERTENSION,180,108,,191,127,treats,0.8285171561,820084,Dosage and Administration  General  Hypertension    Fixed combination olmesartan/amlodipine and olmesartan/HYDROCHLOROTHIAZIDE tablets should not be used for initial treatment of HYPERTENSION,HYPERTENSION,HYDROCHLOROTHIAZIDE,RO-may_treat
862932399,1/18/2016 16:33:26,1861942129,1/18/2016 16:26:45,False,clixsense,0.7063,35612952,GBR,C3,Cambridge,31.51.142.170,HYDROCHLOROTHIAZIDE treats HYPERTENSION,180,108,,191,127,treats,0.8285171561,820084,Dosage and Administration  General  Hypertension    Fixed combination olmesartan/amlodipine and olmesartan/HYDROCHLOROTHIAZIDE tablets should not be used for initial treatment of HYPERTENSION,HYPERTENSION,HYDROCHLOROTHIAZIDE,RO-may_treat
862932399,1/18/2016 16:34:54,1861942677,1/18/2016 16:33:13,False,clixsense,0.6905,11106820,USA,MA,Taunton,173.76.210.82,HYDROCHLOROTHIAZIDE treats HYPERTENSION,180,108,,191,127,treats,0.8285171561,820084,Dosage and Administration  General  Hypertension    Fixed combination olmesartan/amlodipine and olmesartan/HYDROCHLOROTHIAZIDE tablets should not be used for initial treatment of HYPERTENSION,HYPERTENSION,HYDROCHLOROTHIAZIDE,RO-may_treat
862932399,1/18/2016 16:35:42,1861942978,1/18/2016 16:33:18,False,clixsense,0.6667,6339764,CAN,NS,North Sydney,24.89.248.92,no_relation,180,108,,191,127,treats,0.8285171561,820084,Dosage and Administration  General  Hypertension    Fixed combination olmesartan/amlodipine and olmesartan/HYDROCHLOROTHIAZIDE tablets should not be used for initial treatment of HYPERTENSION,HYPERTENSION,HYDROCHLOROTHIAZIDE,RO-may_treat
